PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Urakami, T; Kuwabara, R; Habu, M; Okuno, M; Suzuki, J; Takahashi, S				Urakami, Tatsuhiko; Kuwabara, Remi; Habu, Masako; Okuno, Misako; Suzuki, Junichi; Takahashi, Shori			Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes	JOURNAL OF DIABETES INVESTIGATION			English	Article						Children; Glulisine; Type 1 diabetes	ADOLESCENTS; PHARMACOKINETICS; ASPART; LISPRO	We investigated the efficacy and safety of switching to insulin glulisine (GLU) from other rapid-acting insulin analogs (Ra) in children with type 1 diabetes treated with multiple daily injections of insulin or continuous subcutaneous insulin infusion. A total of 26 children with type1 diabetes were included. Ra in all of these patients was changed to GLU, and they were observed for a 6-month period after having previously finished treatment with other Ra. The mean glycated hemoglobin value decreased from 7.6 +/- 1.0 to 7.4 +/- 0.9% (P=0.0034), and mean plasma glucose values after breakfast and supper also improved from 183 +/- 50 to 153 +/- 32mg/dL (P=0.0035), and from 203 +/- 29 to 164 +/- 23mg/dL (P<0.0001), respectively. Furthermore, the mean frequency of hypoglycemia was reduced from 7 +/- 6 to 4 +/- 4/month (P=0.0004), while insulin doses and obesity degree were stable with statistically non-significant differences. In conclusion, switching to GLU might be a good treatment option for improving glycemic control in children with type1 diabetes.	[Urakami, Tatsuhiko; Kuwabara, Remi; Habu, Masako; Okuno, Misako; Suzuki, Junichi; Takahashi, Shori] Nihon Univ Sch Med, Dept Pediat, Tokyo, Japan	Urakami, T (reprint author), Nihon Univ Sch Med, Dept Pediat, Tokyo, Japan.	urakami.tatsuhiko@nihon-u.ac.jp					Asayama K, 2003, PEDIATR INT, V45, P642, DOI 10.1046/j.1442-200X.2003.01795.x; Clarke W, 2009, PEDIATR DIABETES, V10, P134, DOI 10.1111/j.1399-5448.2009.00583.x; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x; Bartolo Paolo Di, 2008, Diabetes Technol Ther, V10, P495, DOI 10.1089/dia.2008.0013; Becker RHA, 2008, CLIN PHARMACOKINET, V47, P7; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; Bolli GB, 2011, DIABETES OBES METAB, V13, P251, DOI 10.1111/j.1463-1326.2010.01343.x; Danne T, 2005, DIABETES CARE, V28, P2100, DOI 10.2337/diacare.28.9.2100; Dreyer M, 2005, HORM METAB RES, V37, P702, DOI 10.1055/s-870584; Helms KL, 2009, ANN PHARMACOTHER, V43, P658, DOI 10.1345/aph.1E662; Hoogma PP, 2006, HORM METAB RES, V38, P429; International Diabetes Federation (IDF), 2011, GUID MAN POSTMEAL GL; Kawamori R, 2009, DIABETES OBES METAB, V11, P891, DOI 10.1111/j.1463-1326.2009.01086.x; Luzio S, 2008, DIABETES RES CLIN PR, V79, P269, DOI 10.1016/j.diabres.2007.11.013; Philotheou A, 2011, DIABETES TECHNOL THE, V13, P327, DOI 10.1089/dia.2010.0072; Taki K, 2010, DIABETES TECHNOL THE, V12, P523, DOI 10.1089/dia.2009.0167; Weinzimer SA, 2008, DIABETES CARE, V31, P210, DOI 10.2337/dc07-1378	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					87	90		10.1111/jdi.12253		4	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800013		
J	Ariyoshi, K; Okuya, S; Kunitsugu, I; Matsunaga, K; Nagao, Y; Nomiyama, R; Takeda, K; Tanizawa, Y				Ariyoshi, Kyoko; Okuya, Shigeru; Kunitsugu, Ichiro; Matsunaga, Kimie; Nagao, Yuko; Nomiyama, Ryuta; Takeda, Komei; Tanizawa, Yukio			Ultrasound analysis of gray-scale median value of carotid plaques is a useful reference index for cerebro-cardiovascular events in patients with type 2 diabetes	JOURNAL OF DIABETES INVESTIGATION			English	Article						Atherosclerosis; Eicosapentaenoic acid; Plaque echogenicity	CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; MYOCARDIAL-INFARCTION; EICOSAPENTAENOIC ACID; ARTERY-DISEASE; MORTALITY; RISK; FISH; PREVENTION; THICKNESS	Aims/IntroductionMeasurements of plaque echogenicity, the gray-scale median (GSM), were shown to correlate inversely with risk factors for cerebro-cardiovascular disease (CVD). The eicosapentaenoic acid (EPA)/arachidonic acid (AA) ratio is a potential predictor of CVD risk. In the present study, we assessed the usefulness of carotid plaque GSM values and EPA/AA ratios in atherosclerotic diabetics. Materials and MethodsA total of 84 type2 diabetics with carotid artery plaques were enrolled. On admission, platelet aggregation and lipid profiles, including EPA and AA, were examined. Using ultrasound, mean intima media thickness and plaque score were measured in carotid arteries. Plaque echogenicity was evaluated using computer-assisted quantification of GSM. The patients were then further observed for approximately 3years. ResultsGray-scale median was found to be a good marker of CVD events. On multivariate logistic regression analysis, GSM <32 and plaque score 5 were significantly associated with past history and onset of CVD during the follow-up period, the odds ratios being 7.730 (P=0.014) and 4.601 (P=0.046), respectively. EPA/AA showed a significant correlation with GSM (P=0.012) and high-density lipoprotein cholesterol (P=0.039), and an inverse correlation with platelet aggregation (P=0.046) and triglyceride (P=0.020). Although most patients with CVD had both low GSM and low EPA/AA values, an association of EPA/AA with CVD events could not be statistically confirmed. ConclusionsThe present results suggest the GSM value to be useful as a reference index for CVD events in high-risk atherosclerotic diabetics. Associations of the EPA/AA ratio with known CVD risk factors warrant a larger and more extensive study to show the usefulness of this parameter.	[Ariyoshi, Kyoko; Matsunaga, Kimie; Nagao, Yuko; Nomiyama, Ryuta; Takeda, Komei; Tanizawa, Yukio] Yamaguchi Univ Grad Med, Div Endocrinol Metab Hematol Sci & Therapeut, Dept Biosignal Anal, Ube, Yamaguchi, Japan; [Okuya, Shigeru] Yamaguchi Univ Org Univ Educ, Hlth Adm Ctr, Yamaguchi, Japan; [Kunitsugu, Ichiro] Yamaguchi Univ Grad Med, Dept Publ Hlth, Ube, Yamaguchi, Japan	Okuya, S (reprint author), Yamaguchi Univ Org Univ Educ, Hlth Adm Ctr, Yamaguchi, Japan.	okuya@yamaguchi-u.ac.jp					Matsuzaki M, 2009, CIRC J, V73, P1283; Yanagisawa N, 2010, J ATHEROSCLER THROMB, V17, P285; Allayee H, 2009, J NUTRIGENET NUTRIGE, V2, P140, DOI 10.1159/000235562; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; Ostling G, 2007, STROKE, V38, P2074, DOI 10.1161/STROKEAHA.106.480830; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; OZAKI Y, 1994, ANAL BIOCHEM, V218, P284, DOI 10.1006/abio.1994.1180; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; ELBARGHOUTY N, 1995, EUR J VASC ENDOVASC, V9, P389, DOI 10.1016/S1078-5884(05)80005-X; DesBlois J, 2012, CLIN PHYSIOL FUNCT I, V32, P400; Huang YC, 2010, NUTR RES, V30, P21, DOI 10.1016/j.nutres.2009.11.003; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Sabetai MM, 2000, STROKE, V31, P2189; Tavani A, 2001, CIRCULATION, V104, P2269, DOI 10.1161/hc4401.099450; Wohlin M, 2009, ATHEROSCLEROSIS, V205, P486, DOI 10.1016/j.atherosclerosis.2009.01.032	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					91	97		10.1111/jdi.12242		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800014		
J	Tanaka, K; Hara, S; Hattori, M; Sakai, K; Onishi, Y; Yoshida, Y; Kawazu, S; Kushiyama, A				Tanaka, Kentaro; Hara, Shigeko; Hattori, Masakazu; Sakai, Ken; Onishi, Yukiko; Yoshida, Yoko; Kawazu, Shoji; Kushiyama, Akifumi			Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes	JOURNAL OF DIABETES INVESTIGATION			English	Article						Risk factors; Type2 diabetic nephropathy; Uric acid	KIDNEY-DISEASE; PROGRESSION; HYPERURICEMIA; ALLOPURINOL; MELLITUS; TRIAL; JAPAN; HYPERFILTRATION; HYPERTENSION; INDIVIDUALS	Aims/IntroductionDespite the use of intensive therapies, declining renal function is often observed during the overt nephropathy stage of type2 diabetes. We aimed at investigating the role of serum uric acid (SUA) levels at the onset of overt nephropathy in the risk of renal function decline in type2 diabetes patients. Materials and MethodsThe present cohort study included 290 type2 diabetes patients who were followed from the onset of overt nephropathy. The relationship between SUA and declining renal function was assessed using Cox regression models after adjusting for known risk factors. ResultsOver a median 4.8-year follow-up period, 85 patients (4.9/100person-years) showed serum creatinine (Cr) doubling with a total cumulative incidence of 71.9% at 20years of follow up. The highest SUA tertile resulted in significantly a higher incidence (7.7/100person-years) and cumulative incidence at 20years (85.7%) than the middle (3.9/100person-years, 54.2%) and lowest (3.0/100person-years, 55.5%) tertiles. The univariate Cox hazard model resulted in significant risks for Cr doubling related to female sex, short diabetes duration, smoking and elevated levels of low-density lipoprotein cholesterol (LDL-c), glycated hemoglobin and SUA tertiles. SUA tertiles remained statistically significant in the multivariate model (highest vs lowest hazard ratio 2.68, 95% confidence interval 1.48-5.00, P=0.0009). ConclusionsElevated SUA levels within the normal range (men >6.3mg/dL, women >5.1) at the onset of overt nephropathy resulted in an increased risk for declining renal function in type2 diabetes patients.	[Tanaka, Kentaro; Hara, Shigeko; Onishi, Yukiko; Yoshida, Yoko; Kawazu, Shoji; Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Tokyo, Japan; [Sakai, Ken] Toho Univ, Fac Med, Sch Med, Dept Nephrol, Tokyo, Japan; [Hattori, Masakazu] Kyoto Med Ctr, Natl Hosp Org, Clin Res Ctr Endocrinol & Metab Dis, Div Diabet, Kyoto, Japan	Kushiyama, A (reprint author), Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Tokyo, Japan.	a-kushiyama@asahi-life.or.jp					AKIZUKI S, 1982, ANN RHEUM DIS, V41, P272, DOI 10.1136/ard.41.3.272; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; MEYER NL, 1994, AM J OBSTET GYNECOL, V170, P137; Kushiyama A, 2012, ARTERIOSCL THROM VAS, V32, P291, DOI 10.1161/ATVBAHA.111.234559; Hovind P, 2001, KIDNEY INT, V59, P702, DOI 10.1046/j.1523-1755.2001.059002702.x; Chang TI, 2013, AM J KIDNEY DIS, V61, pS4, DOI 10.1053/j.ajkd.2012.12.016; Miao Y, 2011, HYPERTENSION, V58, P2, DOI 10.1161/HYPERTENSIONAHA.111.171488; Wu J, 2013, EXP THER MED, V6, P1482, DOI 10.3892/etm.2013.1315; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Hovind P, 2009, DIABETES, V58, P1668, DOI 10.2337/db09-0014; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Tavil Y, 2008, ATHEROSCLEROSIS, V197, P159, DOI 10.1016/j.atherosclerosis.2007.03.008; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Merjanian R, 2003, KIDNEY INT, V64, P263, DOI 10.1046/j.1523-1755.2003.00068.x; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; [Anonymous], 1998, LANCET, V352, P837; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9; Krishnan E, 2007, HYPERTENSION, V49, P298, DOI 10.1161/01.HYP.0000254480.64564.b6; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Hansen HP, 2002, KIDNEY INT, V62, P220, DOI 10.1046/j.1523-1755.2002.00421.x; Zoppini G, 2009, DIABETES CARE, V32, P1716, DOI 10.2337/dc09-0625; Sezai A, 2013, CIRC J, V77, P2043, DOI 10.1253/circj.CJ-13-0082; Tanaka K, 2011, CLIN EXP NEPHROL, V15, P391, DOI 10.1007/s10157-011-0420-6; Floege J, 2010, COMPREHENSIVE CLIN N, P359; Gambaro G, 2001, DIABETES NUTR METAB, V14, P337; Horio M, 1996, Nihon Jinzo Gakkai Shi, V38, P296; Kushiyama A, 2011, J DIABETES INVEST, V4, P540; Pistrosch F, 2012, HORM METAB RES, V44, P914, DOI 10.1055/s-0032-1314836; Seaquist ER, 2010, J CLIN ENDOCR METAB, V95, P3103, DOI 10.1210/jc.2010-0504; Wakai K, 2004, NEPHROL DIAL TRANSPL, V19, P2044, DOI 10.1093/ndt/gfh317	36	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					98	104		10.1111/jdi.12243		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800015		
J	Osawa, S; Yasuda, T; Kaneto, H; Shimo, N; Yamamoto, Y; Kawamori, D; Miyatsuka, T; Matsuoka, T; Shimomura, I				Osawa, Saeko; Yasuda, Tetsuyuki; Kaneto, Hideaki; Shimo, Naoki; Yamamoto, Yuichi; Kawamori, Dan; Miyatsuka, Takeshi; Matsuoka, Taka-aki; Shimomura, Iichiro			Case of aniridia with a heterozygous PAX6 mutation in which the glucagon response to arginine was evaluated	JOURNAL OF DIABETES INVESTIGATION			English	Letter									[Osawa, Saeko; Yasuda, Tetsuyuki; Kaneto, Hideaki; Shimo, Naoki; Yamamoto, Yuichi; Kawamori, Dan; Miyatsuka, Takeshi; Matsuoka, Taka-aki; Shimomura, Iichiro] Osaka Univ Grad Sch Med, Dept Metab Med, Osaka, Japan	Kaneto, H (reprint author), Osaka Univ Grad Sch Med, Dept Metab Med, Osaka, Japan.	kaneto@endmet.med.osaka-u.ac.jp					Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Bessho M, 2013, DIABETES RES CLIN PR, V102, pE38, DOI 10.1016/j.diabres.2013.09.003; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; Yasuda T, 2002, DIABETES, V51, P224	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					105	106		10.1111/jdi.12251		2	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800016		
J	Mizushima, A; Futagami, K				Mizushima, Atsue; Futagami, Koichi			Non-cooperative versus cooperative family	JOURNAL OF ECONOMICS			English	Article						Household public goods; Cooperative game; Non-cooperative game; Stackelberg game; Time allocation; Strategic complementarity	WAGE GAP; MARRIAGE; LABOR; TIME; DECISION; LEISURE; COUPLES; WORK	This paper focuses on strategic interaction within a family and examines individual decision making. We set up a two-stage game model. In the first stage of the game, a man and a woman who have not yet met simultaneously determine their education levels non-cooperatively. In the second stage, they marry and determine their leisure time. In the second stage, we compare two decision modes, non-cooperative and cooperative, in order to characterize the nature of cooperation within the families. In addition, we extend the basic model on the basis of a Stackelberg game. In this setting, we consider the case in which a man acts as a leader and a woman acts as a follower. We show that the leader invests in higher education and chooses more leisure time than the follower. This coincides with the empirical findings.	[Mizushima, Atsue] Otaru Univ, Fac Econ, Otaru, Hokkaido 0478501, Japan; [Futagami, Koichi] Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan	Mizushima, A (reprint author), Otaru Univ, Fac Econ, 3-5-21 Midori, Otaru, Hokkaido 0478501, Japan.	mizushima@res.otaru-uc.ac.jp; futagami@econ.osaka-u.ac.jp					Vernon V, 2010, REV ECON HOUSEHOLD, V8, P433, DOI 10.1007/s11150-009-9086-1; Chiappori PA, 2009, AM ECON REV, V99, P1689, DOI 10.1257/aer.99.5.1689; O'Neill J, 2003, AM ECON REV, V93, P309, DOI 10.1257/000282803321947254; Konrad KA, 2000, CAN J ECON, V33, P471, DOI 10.1111/0008-4085.00024; MANSER M, 1980, INT ECON REV, V21, P31, DOI 10.2307/2526238; MCELROY MB, 1981, INT ECON REV, V22, P333, DOI 10.2307/2526280; Del Bono E, 2011, LABOUR ECON, V18, P130, DOI 10.1016/j.labeco.2010.06.002; Lundberg S, 1996, J ECON PERSPECT, V10, P139; Konrad KA, 1995, SCAND J ECON, V97, P581, DOI 10.2307/3440544; Weichselbaumer D, 2005, J ECON SURV, V19, P479; Hallberg D, 2003, LABOUR ECON, V10, P185, DOI 10.1016/S0927-5371(03)00006-X; Browning M, 1998, ECONOMETRICA, V66, P1241, DOI 10.2307/2999616; Connelly R, 2009, REV ECON HOUSEHOLD, V7, P361, DOI 10.1007/s11150-009-9060-y; Lundberg S, 2007, J ECON PERSPECT, V21, P3, DOI 10.1257/jep.21.2.3; Apps P, 2009, PUBLIC ECONOMICS AND THE HOUSEHOLD, P1, DOI 10.1017/CBO9780511626548; Beblo M, 2008, J POPUL ECON, V21, P281, DOI 10.1007/s00148-006-0132-5; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; Becker G., 1981, TREATISE FAMILY; Bergstrom T, 1997, HDB POPULATION EC A, V1A; CHIAPPORI PA, 1988, ECONOMETRICA, V56, P63, DOI 10.2307/1911842; CHIAPPORI PA, 1992, J POLIT ECON, V100, P437, DOI 10.1086/261825; Corneo G., 2005, EUROPEAN J POLITICAL, V21, P99, DOI 10.1016/j.ejpoleco.2004.02.009; Costa DL, 2000, J ECON PERSPECT, V14, P101, DOI 10.1257/jep.14.4.101; Garcia I., 2007, J FAM EC ISSUES, V28, P546, DOI 10.1007/s10834-007-9082-7; Hamermesh DS, 1999, ECON J, V109, P37, DOI 10.1111/1468-0297.00390; ILO, 1967, HOURS WORK WORLD SUR; ILO, 2007, WORK TIM WORLD TREND; Jenkins SP, 2003, ISER WORKING PAPER S, V2003-19; Krings S, 2011, STAT JB 2011; LEUTHOLD JH, 1968, J HUM RESOUR, V3, P312, DOI 10.2307/145103; Ministry of the Economy Finance and Industry, 2011, EV SAL NETS ANN MOYE; OECD, 2013, HOURS WORK AV ANN HO; SAMUELSON PA, 1956, Q J ECON, V70, P1, DOI 10.2307/1884510; Statistics Sweden, 2011, SAL STRUCT WHOL EC; Sullivan O, 1996, SOC INDIC RES, V38, P81, DOI 10.1007/BF00293787; TheMinistry of Health Labour and Welfare of Japan, 2011, CHANG WAG AM; United States Department of Labor, 2011, MED WEEKL EARN FULL; Williams M, 2011, 2011 ANN SURV HOURS	38	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0931-8658	1617-7134		J ECON	J. Econ.	JAN	2015	114	1					43	62		10.1007/s00712-014-0391-7		20	Economics	Business & Economics	AY0KE	WOS:000347284700003		
J	Suzuki, RO; Fujisaka, T; Ito, KO; Meng, XN; Sui, HT				Suzuki, Ryosuke O.; Fujisaka, Takeyuki; Ito, Keita O.; Meng, Xiangning; Sui, Hong-Tao			Dimensional Analysis of Thermoelectric Modules Under Constant Heat Flux	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermoelectric power generation; heat radiation; module design; heat transfer	GENERATION; OPTIMIZATION; SIMULATION; DESIGN; ENERGY; LENSES; MODEL	Thermoelectric power generation is examined in the case of radiative heating. A constant heat flux is assumed in addition to consideration of the Seebeck effect, Peltier effect, and Joule heating with temperature-dependent material properties. Numerical evaluations are conducted using a combination of the finite-volume method and an original simultaneous solver for the heat transfer, thermoelectric, and electric transportation phenomena. Comparison with experimental results shows that the new solver could work well in the numerical calculations. The calculations predict that the Seebeck effect becomes larger for longer thermoelectric elements because of the larger temperature difference. The heat transfer to the cold surface is critical to determine the junction temperatures under a constant heat flux from the hot surface. The negative contribution from Peltier cooling and heating can be minimized when the current is smaller for longer elements. Therefore, a thicker TE module can generate more electric power even under a constant heat flux.	[Suzuki, Ryosuke O.; Fujisaka, Takeyuki; Ito, Keita O.; Meng, Xiangning; Sui, Hong-Tao] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Suzuki, Ryosuke O.] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Suzuki, RO (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, Kita 13 Jou,Nishi 8 Chome, Sapporo, Hokkaido 0608628, Japan.	rsuzuki@eng.hokudai.ac.jp			Japan Science and Technology Agency (JST); Japanese Society of Promotion of Science (JSPS) [24002077, 246565740]	The authors acknowledge financial support from the Japan Science and Technology Agency (JST)-Core Research of Evolutional Science and Technology (CREST) project led by Prof. K. Koumoto at Nagoya University, Japan, and Japanese Society of Promotion of Science (JSPS) grants-in-aid for scientific research, Nos. 24002077 and 246565740. They also thank Prof. H. Anno and Dr. R. Funahashi for useful discussions.	Chen M, 2011, INT J HEAT MASS TRAN, V54, P345, DOI 10.1016/j.ijheatmasstransfer.2010.08.024; Xie WT, 2011, RENEW SUST ENERG REV, V15, P2588, DOI 10.1016/j.rser.2011.03.031; Suzuki RO, 2003, J POWER SOURCES, V122, P201, DOI 10.1016/S0378-7753(03)00396-3; Chen M, 2010, J ELECTRON MATER, V39, P1593, DOI 10.1007/s11664-010-1270-9; Xiao JS, 2012, APPL ENERG, V93, P33, DOI 10.1016/j.apenergy.2011.06.006; Singh R, 2011, SOL ENERGY, V85, P371, DOI 10.1016/j.solener.2010.11.012; Ju X, 2012, SOL ENERGY, V86, P1941, DOI 10.1016/j.solener.2012.02.024; Chen M, 2011, MATER TRANS, V52, P1549, DOI 10.2320/matertrans.E-M2011813; Wang N, 2011, ENERG ENVIRON SCI, V4, P3676, DOI 10.1039/c1ee01646f; Cheng CH, 2010, INT J HEAT MASS TRAN, V53, P2001, DOI 10.1016/j.ijheatmasstransfer.2009.12.056; Fujisaka T, 2013, J ELECTRON MATER, V42, P1688, DOI 10.1007/s11664-012-2400-3; Fujisaka T., 2012, P 38 C IEEE IND EL S, P5868; Gao X., 2008, INT J HYDROGEN ENERG, V33, P7137; Ito KO, 2014, J ELECTRON MATER, V43, P2086, DOI 10.1007/s11664-013-2965-5; Kyono T, 2003, IEEE T ENERGY CONVER, V18, P330, DOI 10.1109/TEC.2003.811721; Murphree QC, 2001, SOL ENERGY, V70, P85, DOI 10.1016/S0038-092X(00)00138-9; Palacios X. R., 2009, APPL THERM ENG, V29, P3501; Rowe DM, 2012, THERMOELECT ENERG, pIX; Rowe DM, 2011, J ELECTRON MATER, V40, P784, DOI 10.1007/s11664-011-1571-7; Suzuki RO, 2013, J ELECTRON MATER, V42, P1960, DOI 10.1007/s11664-013-2483-5	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JAN	2015	44	1					348	355		10.1007/s11664-014-3314-z		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AX1JP	WOS:000346703800046		
J	Nakayama, RS; Takeuchi, T				Nakayama, Ryu-Suke; Takeuchi, Tsunehiro			Thermal Rectification in Bulk Material Through Unusual Behavior of Electron Thermal Conductivity of Al-Cu-Fe Icosahedral Quasicrystal	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Thermal rectification; thermal conductivity; electronic structure; electron transport properties	THERMOELECTRIC PROPERTIES; BETA-AG2TE; ALPHA-AG2TE; AG2TE	In this study, a new thermal rectifier working at high temperatures above 300 K was developed using Al61.5Cu26.5Fe12 icosahedral quasicrystal and Ag2Te. The thermal conductivity of Al61.5Cu26.5Fe12 increased drastically with temperature and, at 1000 K, reached a value nine times larger than that at 300 K. The thermal conductivity of Ag2Te showed a sudden decrease at around 400 K, and the thermal conductivity at 423 K became 60% smaller than that at 300 K. By making a composite consisting of Al61.5Cu26.5Fe12 icosahedral quasicrystal and Ag2Te, we succeeded in obtaining a large thermal rectification ratio (TRR) of vertical bar J(large)vertical bar/vertical bar J(small)vertical bar = 1.63 using two heat reservoirs maintained at T-H = 543 K and T-L = 300 K. The obtained TRR value is the largest among those ever reported for bulk thermal rectifiers.	[Nakayama, Ryu-Suke; Takeuchi, Tsunehiro] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan; [Takeuchi, Tsunehiro] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan; [Takeuchi, Tsunehiro] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020075, Japan; [Takeuchi, Tsunehiro] Toyota Technol Inst, Nagoya, Aichi 4688511, Japan	Takeuchi, T (reprint author), Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan.	t_takeuchi@toyota-ti.ac.jp					Capps J, 2010, PHIL MAG LETT, V90, P677, DOI 10.1080/09500839.2010.495355; Fujikane M, 2005, J ALLOY COMPD, V393, P299, DOI 10.1016/j.jallcom.2004.10.002; Takeuchi T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.144202; VANDERLEE A, 1993, ACTA CRYSTALLOGR C, V49, P1444, DOI 10.1107/S0108270193003294; Kobayashi W, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3253712; Peyrard M, 2006, EUROPHYS LETT, V76, P49, DOI 10.1209/epl/i2006-10223-5; Takeuchi T, 2009, J ELECTRON MATER, V38, P1354, DOI 10.1007/s11664-009-0662-1; Hu B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.060201; Roberts NA, 2011, INT J THERM SCI, V50, P648, DOI 10.1016/j.ijthermalsci.2010.12.004; Dolinsek J, 2012, CHEM SOC REV, V41, P6730, DOI 10.1039/c2cs35036j; Kobayashi W, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.027302; Fujikane M, 2005, J ALLOY COMPD, V387, P297, DOI 10.1016/j.jallcom.2004.06.054; Janot C, 1996, PHYS REV B, V53, P181, DOI 10.1103/PhysRevB.53.181; MIYATANI S, 1959, J PHYS SOC JPN, V14, P996, DOI 10.1143/JPSJ.14.996; Nagata T, 2003, J APPL PHYS, V94, P6560, DOI 10.1063/1.1611636; Ohto M, 1996, J VAC SCI TECHNOL B, V14, P3452, DOI 10.1116/1.588778; PIERCE FS, 1993, PHYS REV B, V47, P5670, DOI 10.1103/PhysRevB.47.5670; Sawaki D., 2011, APPL PHYS LETT, V8, P98; Takeuchi T, 2012, J APPL PHYS, V111, DOI 10.1063/1.4712420; Takeuchi T., 2014, STAM UNPUB; Takeuchi T, 2011, J ELECT MAT, V40, P5	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JAN	2015	44	1					356	361		10.1007/s11664-014-3204-4		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AX1JP	WOS:000346703800047		
J	Toshima, N; Ichikawa, S				Toshima, Naoki; Ichikawa, Shoko			Conducting Polymers and Their Hybrids as Organic Thermoelectric Materials	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Organic thermoelectric materials; conducting polymers; polyaniline; PEDOT-PSS; solvent treatment; washing with water; hybrid film; inorganic nanoparticles	BISMUTH TELLURIDE; SEEBECK COEFFICIENT; POLYANILINE FILMS; NANOPARTICLES; ENHANCEMENT; IMPROVEMENT; ACID	Conducting polymers have received much attention recently as organic thermoelectric materials, because of such advantages as plentiful resources, easy synthesis, easy processing, low cost, low thermal conductivity, and easy fabrication of flexible, light, and printable devices with large area. Many reports on organic thermoelectric materials have recently been published. We have studied conducting polymers as organic thermoelectric materials since 1999. During these investigations, we found that the thermal conductivity of conducting polymers did not increase even though electrical conductivity increased; this was a major advantage of conducting polymers as organic thermoelectric materials. We also observed that molecular alignment was one of the most important factors for improvement of the thermoelectric performance of conducting polymers. Stretching of conducting polymers or their precursors was one of the most common techniques used to achieve good molecular alignment. Recently, alignment of the clusters of conducting polymers by treatment with solvents has been proposed as a means of achieving high electrical conductivity. Hybridization of conducting polymers with inorganic nanoparticles has also been found to improve thermoelectric performance. Here we present a brief history and discuss recent progress of research on conducting polymers as organic thermoelectric materials, and describe the techniques used to improve thermoelectric performance by treatment of conducting polymers with solvents and hybridization of conducting polymers with Bi2Te3 and gold nanoparticles.	[Toshima, Naoki; Ichikawa, Shoko] Tokyo Univ Sci, Dept Appl Chem, Yamaguchi 7560884, Japan	Toshima, N (reprint author), Tokyo Univ Sci, Dept Appl Chem, Yamaguchi 7560884, Japan.	toshima@rs.tus.ac.jp			Regional Innovation Strategy Support Program [21310077]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This work was financially supported by Grants-in-Aid for Scientific Research (B) (no. 21310077) and the Regional Innovation Strategy Support Program (global type) (Yamaguchi Green Materials Cluster) both from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Aleshin AN, 2008, PHYS SOLID STATE+, V50, P1978, DOI 10.1134/S1063783408100314; Yan H, 2001, MACROMOL MATER ENG, V286, P139, DOI 10.1002/1439-2054(20010301)286:3<139::AID-MAME139>3.3.CO;2-6; Zhao XB, 2004, J ALLOY COMPD, V368, P349, DOI 10.1016/j.jallcom.2003.08.070; GARNIER F, 1994, SCIENCE, V265, P1684, DOI 10.1126/science.265.5179.1684; Wei QS, 2013, ADV MATER, V25, P2831, DOI 10.1002/adma.201205158; Yan H, 2002, J THERM ANAL CALORIM, V69, P881, DOI 10.1023/A:1020612123826; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Kim GH, 2013, NAT MATER, V12, P719, DOI [10.1038/nmat3635, 10.1038/NMAT3635]; ROSI FD, 1959, J PHYS CHEM SOLIDS, V10, P191, DOI 10.1016/0022-3697(59)90074-5; [Anonymous], 2013, WHIT PAP EN US 2013, P101; Mateeva N, 1998, J APPL PHYS, V83, P3111, DOI 10.1063/1.367119; Takashiri M, 2008, J ALLOY COMPD, V462, P351, DOI 10.1016/j.jallcom.2007.08.054; Dirmyer MR, 2009, SMALL, V5, P933, DOI 10.1002/smll.200801206; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Takano T, 2012, MACROMOLECULES, V45, P3859, DOI 10.1021/ma300120g; Pinter E, 2007, J PHYS CHEM C, V111, P11872, DOI 10.1021/jp0726440; Toshima N, 2012, J ELECTRON MATER, V41, P1735, DOI 10.1007/s11664-012-2041-6; Taggart DK, 2011, NANO LETT, V11, P125, DOI 10.1021/nl103003d; Bubnova O., 2011, NAT MATER, V10, P439; Hiroshige Y, 2007, SYNTHETIC MET, V157, P467, DOI 10.1016/j.synthmet.2007.05.003; Luo T., 2013, J MATER CHEM A, V1, P7576; MacMiarmid A. G., 2001, ANGEW CHEM INT EDIT, V40, P2581; Shinohara Y., 2008, HDB THERMOELECTRIC T, P307; Takashiri M, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990774; Toshima N, 2011, J ELECTRON MATER, V40, P898, DOI 10.1007/s11664-010-1403-1; Toshima N, 2013, J ELECTRON MATER, V42, P1882, DOI 10.1007/s11664-012-2458-y; Toshima N, 2002, MACROMOL SYMP, V186, P81, DOI 10.1002/1521-3900(200208)186:1<81::AID-MASY81>3.0.CO;2-S; Toshima N., 2008, HDB THERMOELECTRIC T, P320; Watanabe N, 2004, CHEM LETT, V33, P1368, DOI 10.1246/cl.2004.1368; Watanabe N, 2007, B CHEM SOC JPN, V80, P208, DOI 10.1246/bcsj.80.208; Yan H, 1999, CHEM LETT, P1217, DOI 10.1246/cl.1999.1217	31	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JAN	2015	44	1					384	390		10.1007/s11664-014-3312-1		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AX1JP	WOS:000346703800051		
J	Sasaki, K; Horikawa, D; Goto, K				Sasaki, Keiichi; Horikawa, Daisuke; Goto, Koichi			Consideration of Thermoelectric Power Generation by Using Hot Spring Thermal Energy or Industrial Waste Heat	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Waste heat recovery; unharnessed thermal energy; temperature difference; natural heat source; hot springs; thermoelectric power generator; totally self-contained power supply		Today, we face some significant environmental and energy problems such as global warming, urban heat island, and the precarious balance of world oil supply and demand. However, we have not yet found a satisfactory solution to these problems. Wasteheat recovery is considered to be one of the best solutions because it can improve energy efficiency by converting heat exhausted from plants and machinery to electric power. This technology would also prevent atmospheric temperature increases caused by waste heat, and decrease fossil fuel consumption by recovering heat energy, thus also reducing CO2 emissions. The system proposed in this research generates electric power by providing waste heat or unharnessed thermal energy to built-in thermoelectric modules that can convert heat into electric power. Waste heat can be recovered from many places, including machinery in industrial plants, piping in electric power plants, waste incineration plants, and so on. Some natural heat sources such as hot springs and solar heat can also be used for this thermoelectric generation system. The generated power is expected to be supplied to auxiliary machinery around the heat source, stored as an emergency power supply, and so on. The attributes of this system are (1) direct power generation using hot springs or waste heat; (2) 24-h stable power generation; (3) stand-alone power system with no noise and no vibration; and (4) easy maintenance attributed to its simple structure with no moving parts. In order to maximize energy use efficiency, the temperature difference between both sides of the thermoelectric (TE) modules built into the system need to be kept as large as possible. This means it is important to reduce thermal resistance between TE modules and heat source. Moreover, the system's efficiency greatly depends on the base temperature of the heat sources and the material of the system's TE modules. Therefore, in order to make this system practical and efficient, it is necessary to choose the heat source first and then design the most appropriate structure for the source by applying analytical methods. This report describes how to design a prototype of a thermoelectric power generator using the analytical approach and the results of performance evaluation tests carried out in the field.	[Sasaki, Keiichi; Horikawa, Daisuke] Toshiba Co Ltd, Power & Ind Syst R&D Ctr, Fuchu, Tokyo 1838511, Japan; [Goto, Koichi] Toshiba Co Ltd, Power & Ind Syst R&D Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Sasaki, K (reprint author), Toshiba Co Ltd, Power & Ind Syst R&D Ctr, 1 Toshiba Cho, Fuchu, Tokyo 1838511, Japan.	Keiichi2.sasaki@toshiba.co.jp					Geological Survey of Japan AIST, 2005, DISTR MAP CAT IF HOT; Itoh Y., 2004, PERSONAL DISTRIBUTED, V131; Shindoh T., 2008, TOSHIBA REV, V63, P7	3	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JAN	2015	44	1					391	398		10.1007/s11664-014-3189-z		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AX1JP	WOS:000346703800052		
J	Matsumoto, R; Okabe, Y; Akuzawa, N				Matsumoto, Rika; Okabe, Yusuke; Akuzawa, Noboru			Thermoelectric Properties and Performance of n-Type and p-Type Graphite Intercalation Compounds	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Graphite intercalation compounds; electrical conductivity; thermal conductivity; Seebeck coefficient; thermoelectric performance	THERMAL TRANSPORT-PROPERTIES; SBCL5 GRAPHITE; CONDUCTIVITY; THERMOPOWER; POWER; ENHANCEMENT; DEPENDENCE; DIRECTION; FIBERS	n-Type alkali metal-graphite intercalation compounds (GICs) and p-type metal chloride-GICs were prepared from commercially available graphite sheets, namely PGS (R) and GRAFOIL (R). Their thermoelectric properties, electrical conductivity, thermal conductivity, and Seebeck coefficient were measured, and their thermoelectric performance was estimated in terms of the figure of merit and power factor. The electrical conductivity (10(3) S cm(-1) to 10 4 S cm(-1)) and thermal conductivity (40 W m(-1) K-1 to 200 W m(-1) K-1) of these GICs are much higher than those of other, conventional thermoelectric materials, whereas their absolute Seebeck coefficients (+/- 30 mu V K-1) are lower. Therefore, although the figures of merit of the GICs are somewhat lower (similar to 10(5) K-1) than those of other thermoelectric materials, their power factors (similar to 10(3) W m(-1) K-2) are sufficiently high. The thermoelectric properties of these GICs mainly depend on the host graphite type and slightly on the intercalated species. However, the Seebeck coefficient is independent of both, and the thermoelectric performance of the GICs is strongly governed by their high electrical conductivity. The power factors of almost all the GICs prepared from PGS were greater than 10(-3) W m(-1) K-2, which is a critical threshold value for use of thermoelectric materials in practical applications. Furthermore, the dilute K-GIC with stage-7 structure had a large Seebeck coefficient (-58 mu V J(-1)), which improved the power factor to more than 10(-2) W m(-1) K-2. Considering the advantages of GICs, this study confirms their significant potential as thermoelectric materials.	[Matsumoto, Rika; Okabe, Yusuke] Tokyo Polytech Univ, Fac Engn, Atsugi, Kanagawa 2430297, Japan; [Akuzawa, Noboru] Tokyo Natl Coll Technol, Dept Chem Sci & Engn, Hachioji, Tokyo 1930997, Japan	Matsumoto, R (reprint author), Tokyo Polytech Univ, Fac Engn, 1583 Iiyama, Atsugi, Kanagawa 2430297, Japan.	mrika@gen.t-kougei.ac.jp			JFE 21st Century Foundation	This work was partially supported by JFE 21st Century Foundation.	Matsumoto R, 2009, MATER TRANS, V50, P1607, DOI 10.2320/matertrans.E-M2009813; Hone J, 1998, PHYS REV LETT, V80, P1042, DOI 10.1103/PhysRevLett.80.1042; Dresselhaus MS, 2002, ADV PHYS, V51, P1, DOI 10.1080/00018730110113644; Yu CH, 2005, NANO LETT, V5, P1842, DOI 10.1021/nl051044e; Blackman L. C. F., 1960, P ROY SOC LOND A MAT, V25, P339; BOXUS J, 1981, SOLID STATE COMMUN, V38, P1117, DOI 10.1016/0038-1098(81)90969-8; ELZINGA M, 1982, PHYS REV B, V26, P3312, DOI 10.1103/PhysRevB.26.3312; Gotoh Y, 2013, J PHYS CHEM SOLIDS, V74, P1482, DOI 10.1016/j.jpcs.2013.05.010; Guerrero VH, 2002, COMPOS INTERFACE, V9, P395, DOI 10.1163/156855402760194737; HEREMANS J, 1981, PHYS LETT A, V84, P387, DOI 10.1016/0375-9601(81)90217-6; Mittal J, 1999, SYNTHETIC MET, V99, P79, DOI 10.1016/S0379-6779(98)01476-3; ISSI JP, 1982, SOLID STATE COMMUN, V44, P449, DOI 10.1016/0038-1098(82)90121-1; ISSI JP, 1983, PHYS REV B, V27, P1333, DOI 10.1103/PhysRevB.27.1333; KINANYALAOUI M, 1988, SOLID STATE COMMUN, V68, P1065, DOI 10.1016/0038-1098(88)90823-X; Matsumoto R, 2006, MATER TRANS, V47, P1458, DOI 10.2320/matertrans.47.1458; Matsumoto R, 2012, SYNTHETIC MET, V162, P2149, DOI 10.1016/j.synthmet.2012.10.010; Ohira M., 1986, TANSO, V1986, P45; Ohira M., 1992, THESIS HOKKAIDO U JA; PIRAUX L, 1989, SYNTHETIC MET, V30, P245, DOI 10.1016/0379-6779(89)90793-5; PIRAUX L, 1988, PHYS REV B, V38, P4329, DOI 10.1103/PhysRevB.38.4329; PIRAUX L, 1990, PHYS REV B, V41, P4961, DOI 10.1103/PhysRevB.41.4961; PIRAUX L, 1985, SOLID STATE COMMUN, V56, P413, DOI 10.1016/0038-1098(85)90021-3; PIRAUX L, 1992, SOLID STATE COMMUN, V82, P371, DOI 10.1016/0038-1098(92)90371-F; PIRAUX L, 1985, SOLID STATE COMMUN, V55, P517, DOI 10.1016/0038-1098(85)90325-4; TAKAHASHI O, 1981, SOLID STATE COMMUN, V37, P863, DOI 10.1016/0038-1098(81)90498-1; UHER C, 1985, SYNTHETIC MET, V12, P91, DOI 10.1016/0379-6779(85)90093-1	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JAN	2015	44	1					399	406		10.1007/s11664-014-3409-6		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AX1JP	WOS:000346703800053		
J	Liu, JW; Song, MH; Takeguchi, M; Tsujii, N; Isoda, Y				Liu, Ji-Wei; Song, Minghui; Takeguchi, Masaki; Tsujii, Naohito; Isoda, Yukihiro			Transmission Electron Microscopy Study of Mg2Si0.5Sn0.5 Solid Solution for High-Performance Thermoelectrics	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Mg2Si0.5Sn0.5; solid solution; microstructure; TEM; thermoelectric properties	TELLURIDE; SODIUM; POWER	A Mg2Si0.5Sn0.5 solid solution was prepared by mixing Mg2Si and Mg2Sn powders and hot-pressing the mixture. The Mg2Si0.5Sn0.5 samples exhibited a much lower thermal conductivity (1.92 W m(-1) K-1 at 300 K) than the parent Mg2Si (8.75 W m(-1) K-1) and Mg2Sn compounds (6.28 W m(-1) K-1). X-ray diffraction measurements confirmed the successful synthesis of the Mg2Si0.5Sn0.5 solid solution. Electron microscopy observations revealed that the grains were mainly 10-20 mu m in size and had clean grain boundaries without obvious inclusions and precipitates. The major phase was cubic Mg2Si0.5Sn0.5. MgO nanoparticles 10- 20 nm in diameter were evenly dispersed in the Mg2Si0.5Sn0.5 matrix, which probably reduced its thermal conductivity; moreover, uneven structures containing pure Si and Sn particles were found in the Mg2Si0.5Sn0.5 grains. The origin and the formation mechanisms of the MgO and other impurity particles, and their effect on thermoelectric properties of Mg2Si0.5Sn0.5, are discussed. The low thermal conductivity of Mg2Si0.5Sn0.5 resulted in a relatively high dimensionless figure of merit ZT = 0.0132 at 300 K, which may be further increased by optimizing the synthesis procedure, alloy composition, and doping level. This work provides information on the structure and chemistry and their relationship with the thermoelectric properties of the Mg2Si0.5Sn0.5 solid solution; it may help in developing other Mg2Si1-xSnx compounds with superior thermoelectric properties.	[Liu, Ji-Wei; Song, Minghui; Takeguchi, Masaki] Natl Inst Mat Sci, Nanocharacterizat Grp, Transmiss Electron Microscopy Stn, Tsukuba, Ibaraki 3050047, Japan; [Tsujii, Naohito] Natl Inst Mat Sci, Neutron Scattering Grp, Quantum Beam Unit, Tsukuba, Ibaraki 3050047, Japan; [Isoda, Yukihiro] Natl Inst Mat Sci, Ecoenergy Grp, Battery Mat Unit, Tsukuba, Ibaraki 3050047, Japan	Song, MH (reprint author), Natl Inst Mat Sci, Nanocharacterizat Grp, Transmiss Electron Microscopy Stn, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	minghui.song@nims.go.jp					Sootsman JR, 2009, ANGEW CHEM INT EDIT, V48, P8616, DOI 10.1002/anie.200900598; Mallik RC, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/10/105701; Bell LE, 2008, SCIENCE, V321, P1457, DOI 10.1126/science.1158899; Tan XJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.205212; Lan YC, 2010, ADV FUNCT MATER, V20, P357, DOI 10.1002/adfm.200901512; Zhang Q, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2981516; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Liu W, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/8/085406; Isoda Y, 2010, J ELECTRON MATER, V39, P1531, DOI 10.1007/s11664-010-1280-7; He JQ, 2012, NANO LETT, V12, P343, DOI 10.1021/nl203626n; [Anonymous], 2009, J THERMOELECTR; Liu W, 2012, J MATER CHEM, V22, P13653, DOI 10.1039/c2jm31919e; Liu W, 2011, CHEM MATER, V23, P5256, DOI 10.1021/cm202445d; Tada S, 2014, J ELECTRON MATER, V43, P1580, DOI 10.1007/s11664-013-2797-3; Vineis CJ, 2010, ADV MATER, V22, P3970, DOI 10.1002/adma.201000839; Dasgupta T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235207; Zhang Q, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/18/185103; Isoda Y, 2014, J ELECTRON MATER, V43, P2053, DOI 10.1007/s11664-013-2947-7; Ihou-Mouko H, 2011, J ALLOY COMPD, V509, P6503, DOI 10.1016/j.jallcom.2011.03.081; DiSalvo FJ, 1999, SCIENCE, V285, P703, DOI 10.1126/science.285.5428.703; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Nolas GS, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235204; He JQ, 2013, J AM CHEM SOC, V135, P4624, DOI 10.1021/ja312562d; Chen LX, 2011, J MATER RES, V26, P3038, DOI 10.1557/jmr.2011.385; Choi SM, 2012, J ELECTRON MATER, V41, P1071, DOI 10.1007/s11664-012-1985-x; Du ZL, 2012, J ELECTRON MATER, V41, P1222, DOI 10.1007/s11664-011-1886-4; Isoda Y., 2007, P 26 INT C THERM JEJ, P251; Isoda Y., 2005, P 23 INT C THERM, P496; Saleemi M, 2013, J MATER SCI, V48, P1940, DOI 10.1007/s10853-012-6959-0; Wang S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3139785; Zaitsev VK, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045207; Zhao XB, 2009, J ELECTRON MATER, V38, P1017, DOI 10.1007/s11664-009-0698-2	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JAN	2015	44	1					407	413		10.1007/s11664-014-3419-4		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AX1JP	WOS:000346703800054		
J	Lang, FQ; Yamaguchi, H; Nakagawa, H; Sato, H				Lang, Fengqun; Yamaguchi, Hiroshi; Nakagawa, Hiroshi; Sato, Hiroshi			Cyclic Thermal Stress-Induced Degradation of Cu Metallization on Si3N4 Substrate at-40 degrees C to 300 degrees C	JOURNAL OF ELECTRONIC MATERIALS			English	Article						Power electronics; Cu metallization; deformation; thermal cycling test; thermomechanical stress; active metal brazed Si3N4 substrate	NI-P FILMS; OXIDATION; COPPER; ALLOY; AIR	The high-temperature reliability of active metal brazed copper (AMC) on Si3N4 ceramic substrates used for fabricating SiC high-temperature power modules was investigated under harsh environments. The AMC substrate underwent isothermal storage at 300 degrees C for up to 3000 h and a thermal cycling test at -40 degrees C to 300 degrees C for up to 3000 cycles. During isothermal storage at 300 degrees C, the AMC substrate exhibited high reliability, characterized by very little deformation of the copper (Cu) layer, low crack growth, and low oxidation rate of the Cu layer. Under thermal cycling conditions at -40 degrees C to 300 degrees C, no detachment of the Cu layer was observed even after the maximum 3000 cycles of the experiment. However, serious deformation of the Cu layer occurred and progressed as the number of thermal cycles increased, thus significantly roughening the surface of the Cu metallized layer. The cyclic thermal stress led to a significant increase in the crack growth and oxidation of the Cu layer. The maximum depth of the copper oxides reached up to 5/6 of the Cu thickness. The deformation of the Cu layer was the main cause of the decrease of the bond strength under thermal cycling conditions. The shear strength of the SiC chips bonded on the AMC substrate with a Au-12 wt.%Ge solder decreased from the original 83 MPa to 14 MPa after 3000 cycles. Therefore, the cyclic thermal stress destroyed the Cu oxides and enhanced the oxidation of the Cu layer.	[Lang, Fengqun; Yamaguchi, Hiroshi; Nakagawa, Hiroshi; Sato, Hiroshi] Natl Inst Adv Ind Sci & Technol, Adv Power Elect Res Ctr ADPERC, Tsukuba, Ibaraki 3058568, Japan	Lang, FQ (reprint author), AIST, R&D Partnership Future Power Elect Technol, Tsukuba, Ibaraki, Japan.	fqlang03325@yahoo.co.jp			New Energy and Industrial Technology Development Organization (NEDO) Project	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) Project, Development of Next-Generation Power Electronics. This work was mainly conducted at the Advanced Power Electronics Research Center ( ADPERC), National Institute of Advanced Industrial Science and Technology (AIST).	Takaku Y, 2009, J ELECTRON MATER, V38, P54, DOI 10.1007/s11664-008-0528-y; Zhu YF, 2002, MATER TRANS, V43, P2173, DOI 10.2320/matertrans.43.2173; Song JY, 2002, THIN SOLID FILMS, V415, P167, DOI 10.1016/S0040-6090(02)00556-4; Zhou Y, 2011, ADV MATER, V23, P4563, DOI 10.1002/adma.201102462; Chasserio N, 2009, J ELECTRON MATER, V38, P164, DOI 10.1007/s11664-008-0571-8; Colino R. P., 2005, POWER ELECT MODULES; GUPTA K, 1974, J ELECTROCHEM SOC, V121, P118, DOI 10.1149/1.2396803; Huet F, 1999, J ELECTRON MATER, V28, P1440, DOI 10.1007/s11664-999-0137-4; Jeon YD, 2002, IEEE T COMPON PACK T, V25, P169; Kirschman R, 1999, HIGH TEMPERATURE ELE; Lang F. Q., 2011, INT C EXH HIGH TEMP, P139; Lang F. Q., 2012, P 2012 INT C ADV MAN, P37; Lu C., 2009, THIN SOLID FILMS, V517, P4408; McCluskey P., 2012, 7 INT C INT POW EL S; Ogwu A.A., 2007, J ACHIEVEMENTS MAT M, V24, P172; Sheng K, 2012, ECS TRANSACTIONS, V50, P179, DOI 10.1149/05003.0179ecst; Sichert I., 2011, 44 INT S MICR IMAPS2, P777; SICONOLFI DJ, 1989, J ELECTROCHEM SOC, V136, P2475, DOI 10.1149/1.2097436; Young RAR, 2013, MATER SCI FORUM, V740-742, P1065, DOI 10.4028/www.scientific.net/MSF.740-742.1065; Zhu YF, 2006, METALL MATER TRANS A, V37A, P1231	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	JAN	2015	44	1					482	489		10.1007/s11664-014-3357-1		8	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	AX1JP	WOS:000346703800064		
J	Conley, K; Uye, S				Conley, Keats; Uye, Shin-ichi			Effects of hyposalinity on survival and settlement of moon jellyfish (Aurelia aurita) planulae	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						Jellyfish; Larvae; Monsoon; Population dynamics; Rainfall; Salinity	LARVAL SETTLEMENT; SETTLING BEHAVIOR; SCYPHOZOA; CNIDARIA; BLOOMS; SEMAEOSTOMEAE; CONSEQUENCES; POPULATIONS; DENSITY; POLYPS	Presettlement processes likely influence the geographical distribution and abundance of scyphozoan jellyfish medusae. In East Asian coastal waters, Aurelia aurita s.l. spawning coincides with the summer monsoon season, and extreme rainfall events subject planulae to hyposaline conditions, presumably jeopardizing their survival and settlement. In this study, laboratory experiments were conducted to determine how prolonged exposure to hyposalinity (25, 20, and 15, in addition to control salinity 32) affects swimming speed, survivorship and settlement of planula larvae, and subsequent development of metamorphosed polyps. Nearly all planulae (>= 95%) in 32, 25, and 20 were geonegative during the first 4 h of exposure to respective salinities, but the majority of planulae (70%) in 15 were geopositive. Although no mortality was induced, hyposaline conditions affected larval behavior and the sequence of post-metamorphosis events. Salinity of 15 significantly increased planktonic larval duration and settled polyps had morphological deformities. At a salinity of 20, settled polyps had delayed tentacle development compared to control and 25 treatments. These anomalous results demonstrate that the response of planulae to environmental stress is more complex than previously assumed and may depend on the ability of the settled polyps to develop viable feeding tentacles. Salinity is proposed to be a principal factor influencing planulae dispersion and distribution in temperate monsoon regions. (C) 2014 Elsevier B.V. All rights reserved.	[Conley, Keats; Uye, Shin-ichi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan	Conley, K (reprint author), 5289 Univ Oregon, Dept Biol, Eugene, OR 97402 USA.	keats@uoregon.edu			Japan Society for the Promotion of Science [OISE-1316427]; National Science Foundation [OISE-1316427]; East Asia and Pacific Summer Institutes for U.S. Graduate Students (EAPSI) fellowship	We would like to thank Mariko Takao and Ryuji Furukawa for their assistance in field sampling and the laboratory experiment. We would also like to thank Kelly Sutherland and the anonymous reviewers for providing constructive feedback on the manuscript. This material is based upon work supported by the Japan Society for the Promotion of Science under Grant No. OISE-1316427 and the National Science Foundation under Grant No. OISE-1316427 for an East Asia and Pacific Summer Institutes for U.S. Graduate Students (EAPSI) fellowship.	Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Dawson MN, 2001, HYDROBIOLOGIA, V451, P259, DOI 10.1023/A:1011869215330; Ki JS, 2008, ICES J MAR SCI, V65, P443, DOI 10.1093/icesjms/fsn018; Trenberth KE, 2000, J CLIMATE, V13, P3969, DOI 10.1175/1520-0442(2000)013<3969:TGMAST>2.0.CO;2; OMORI M, 1995, ICES J MAR SCI, V52, P597, DOI 10.1016/1054-3139(95)80074-3; Dawson MN, 2003, MAR BIOL, V143, P369, DOI 10.1007/s00227-003-1070-3; Yuan D, 2008, DEV GENES EVOL, V218, P525, DOI 10.1007/s00427-008-0254-8; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Uye S, 2011, HYDROBIOLOGIA, V666, P71, DOI 10.1007/s10750-010-0208-9; PECHENIK JA, 1990, OPHELIA, V32, P63; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; MILLS CE, 1984, BIOL BULL, V166, P206, DOI 10.2307/1541442; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; BREWER RH, 1984, BIOL BULL, V166, P11, DOI 10.2307/1541426; BREWER RH, 1978, ESTUARIES, V1, P120, DOI 10.2307/1351601; BREWER RH, 1976, BIOL BULL, V150, P183, DOI 10.2307/1540467; CARGO DG, 1979, INT J INVER REP DEV, V1, P279; Duarte CM, 2012, FRONT ECOL ENVIRON, V11, P91, DOI DOI 10.1890/110246; Goldstein J., 2012, THESIS U ROSTOCK ROS; GOTELLI NJ, 1990, OPHELIA, V32, P95; GRONDAHL F, 1988, MAR ECOL PROG SER, V45, P87, DOI 10.3354/meps045087; GRONDAHL F, 1989, MAR ECOL PROG SER, V56, P119, DOI 10.3354/meps056119; Han CH, 2012, OCEAN SCI J, V47, P155; Hiroshima Agriculture Forestry Research Fisheries Center Development, 2013, TEMP SAL 2012 HIR BA; Hoist S., 2010, HYDROBIOLOGIA, V645, P53; KUWABARA R, 1969, BULL JAP SOC SCI FISH, V35, P156; Lee J.H., 2006, OCEAN POLAR RES, V28, P385; Manda A., 2014, SCI REP, V4, P1; MATSUDA O, 1990, Journal of the Faculty of Applied Biological Science Hiroshima University, V29, P135; Matsueda N., 1969, Bulletin of the Biological Station of Asamushi, V13, P187; Ping L.N., 1989, J ACTA ECOL SIN, V4, P3; Prieto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013793; R Core Team, 2013, R LANG ENV STAT COMP; Russell F.S., 1970, MEDUSAE BRIT ISLE S; SCHNEIDER G, 1985, HELGOLANDER MEERESUN, V39, P43, DOI 10.1007/BF01997518; SCHNEIDER G, 1994, ICES J MAR SCI, V51, P359, DOI 10.1006/jmsc.1994.1038; Toyokawa M., 2000, BIOL ECOL, V47, P48; Uye Shin-ichi, 2004, Bulletin of the Japanese Society of Fisheries Oceanography, V68, P9; [Вагелли А.А. Vagelli Alejandro A.], 2007, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V4, P111; Webster CN, 2012, J EXP MAR BIOL ECOL, V436, P50, DOI 10.1016/j.jembe.2012.08.014; Zar J.H, 1996, BIOSTATISTICS ANAL	44	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981	1879-1697		J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	JAN	2015	462						14	19		10.1016/j.jembe.2014.10.018		6	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AX5CD	WOS:000346943800003		
J	Shi, Y; Xu, PL; Liu, JN; Shi, C				Shi, Yun; Xu, Peiliang; Liu, Jingnan; Shi, Chuang			Alternative formulae for parameter estimation in partial errors-in-variables models	JOURNAL OF GEODESY			English	Article						Errors-in-variables; Partial EIV model; Structured EIV model; Total least squares	TOTAL LEAST-SQUARES; TRANSFORMATIONS	The purpose of this note is to derive alternative formulae for parameter estimation in partial errors-in-variables models to those given in Xu et al. (J Geod 86:661-675, 2012). We show that these new formulae are more compact and more straightforward to interpret the corrections of the random elements of the design matrix. Nevertheless, each formula has its own computational advantage, depending on the relationship between the number of measurements y and that of the independent random elements of the design matrix. The original formula is computationally more efficient, if the number of measurements y is significantly larger than that of the independent random elements of the design matrix; otherwise, the new alternative formula is much more efficient.	[Shi, Yun] Xian Univ Sci & Technol, Sch Geomat, Xian 710054, Peoples R China; [Xu, Peiliang] Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan; [Liu, Jingnan; Shi, Chuang] Wuhan Univ, GNSS Res Ctr, Wuhan 430071, Peoples R China	Xu, PL (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan.	shiyun0908@hotmail.com; pxu@rcep.dpri.kyoto-u.ac.jp			Natural Science Foundation of China [41204006, 41020144004];  [C25400449]	This work is partially supported by the Natural Science Foundation of China (No. 41204006 and No. 41020144004) and a Grant-in-Aid for Scientific Research C25400449. The authors thank the reviewers for their constructive comments, which have been fully implemented to improve the paper.	Adcock R., 1877, ANALYST, V4, P183, DOI 10.2307/2635777; Markovsky I, 2007, SIGNAL PROCESS, V87, P2283, DOI 10.1016/j.sigpro.2007.04.004; Xu PL, 2012, J GEODESY, V86, P661, DOI 10.1007/s00190-012-0552-9; Davis TG, 1999, J SURV ENG-ASCE, V125, P159, DOI 10.1061/(ASCE)0733-9453(1999)125:4(159); GOLUB GH, 1980, SIAM J NUMER ANAL, V17, P883, DOI 10.1137/0717073; ABATZOGLOU TJ, 1991, IEEE T SIGNAL PROCES, V39, P1070, DOI 10.1109/78.80955; Pearson K, 1901, PHILOS MAG, V2, P559; Carroll RJ., 2006, MEASUREMENT ERROR NO; Deming W E, 1964, STAT ADJUSTMENT DATA; Deming WE, 1931, PHILOS MAG, V11, P146; Deming WE, 1934, PHILOS MAG, V17, P804; Fang X, 2011, THESIS LEIBNIZ U HAN; Felus YA, 2009, GPS SOLUT, V13, P65, DOI 10.1007/s10291-008-0100-5; Fuller W.A., 1987, MEASUREMENT ERROR MO; Magnus J. R., 1988, MATRIX DIFFERENTIAL; Mahboub V, 2012, J GEODESY, V86, P359, DOI 10.1007/s00190-011-0524-5; Schaffrin B, 2008, IAG SYMP, V132, P238; Schaffrin B, 2012, J GEOD SCI, DOI [10.2478/v10156-011-0028-5, DOI 10.2478/V10156-011-0028-5]; Schaffrin B, 2009, STUD GEOPHYS GEOD, V53, P1, DOI 10.1007/s11200-009-0001-2; Tong XH, 2011, J SURV ENG-ASCE, V137, P120, DOI 10.1061/(ASCE)SU.1943-5428.0000055; Vandewalle J., 1991, TOTAL LEAST SQUARES; Xu PL, 2014, J GEODESY, V88, P705, DOI 10.1007/s00190-014-0716-x	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-7714	1432-1394		J GEODESY	J. Geodesy	JAN	2015	89	1					13	16		10.1007/s00190-014-0756-2		4	Geochemistry & Geophysics; Remote Sensing	Geochemistry & Geophysics; Remote Sensing	AX9WF	WOS:000347249300002		
J	Kawanishi, Y; Moritomo, H; Omokawa, S; Murase, T; Sugamoto, K; Yoshikawa, H				Kawanishi, Yohei; Moritomo, Hisao; Omokawa, Shohei; Murase, Tsuyoshi; Sugamoto, Kazuomi; Yoshikawa, Hideki			In Vivo 3-Dimensional Analysis of Stage III Kienbock Disease: Pattern of Carpal Deformity and Radioscaphoid Joint Congruity	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Kienbock disease; scaphoid rotatory subluxation; scapholunate dissociation; 3-dimensional analysis	PROXIMAL ROW CARPECTOMY; VASCULARIZED BONE-GRAFT; TRISCAPHE ARTHRODESIS; FOLLOW-UP; SCAPHOLUNATE DISSOCIATION; ROTATORY SUBLUXATION; WRIST FLEXION; LUNATE; INSTABILITY; KINEMATICS	Purpose To examine 3-dimensional carpal alignment and radioscaphoid joint (RSJ) congruity among normal wrists and those with Lichtman stage III Kienbock disease or scapholunate dislocation (SLD). Methods We conducted 3-dimensional analysis based on computed tomographic data to compare 10 wrists of stage III Kienbock disease (5 IIIa and 5 IIIb) with 5 normal wrists and 3 wrists with SLD. A markerless bone registration technique was used to investigate the 3-dimensional position of the scaphoid relative to the radius. To evaluate RSJ congruency, the inferred contact area between the scaphoid proximal pole and the distal radius was calculated from 3-dimensional bone models. Results The scaphoid position was not significantly different from normal wrists in stage IIIa Kienbock disease. Stage IIIb Kienbock disease was meaningfully associated with a flexed scaphoid and proximal translation of the centroid, but not dorsal translation of the scaphoid proximal pole, where RSJ congruity was preserved. With SLD, the scaphoid flexed to the same extent as that in stage IIIb Kienbock disease, and the proximal pole translated dorsally together with the capitate, producing RSJ incongruity. Conclusions The patterns of carpal collapse differed between stage IIIb Kienbock disease and SLD in terms of RSJ congruity. Our study showed that stage IIIb Kienbock disease did not involve dorsal subluxation of the scaphoid proximal pole and that RSJ congruity was retained, unlike SLD. Clinical relevance Our results suggest that carpal collapse in Kienbock disease is not associated with RSJ incongruity, which may explain why there are asymptomatic patients with Kienbock disease and carpal collapse. (Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.)	Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Suita, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Orthoped Biomat Sci, Suita, Osaka, Japan; [Moritomo, Hisao] Osaka Yukioka Coll Hlth Sci, Dept Phys Therapy, Ibaraki, Osaka 5670801, Japan; Nara Med Univ, Dept Orthoped, Nara, Japan	Moritomo, H (reprint author), Osaka Yukioka Coll Hlth Sci, Dept Phys Therapy, 1-1-41 Sojiji, Ibaraki, Osaka 5670801, Japan.	moritomo@tcct.zaq.ne.jp					Altay T, 2008, INT ORTHOP, V32, P747, DOI 10.1007/s00264-007-0428-4; Lutsky K, 2012, J HAND SURG-AM, V37A, P1942, DOI 10.1016/j.jhsa.2012.06.029; Elhassan BT, 2009, J HAND SURG-AM, V34A, P146, DOI 10.1016/j.jhsa.2008.10.014; Lumsden BC, 2008, J HAND SURG-AM, V33A, P493, DOI 10.1016/j.jhsa.2007.12.010; Lichtman DM, 2010, J HAND SURG-EUR VOL, V35E, P549, DOI 10.1177/1753193410374690; Moritomo H, 2000, J HAND SURG-AM, V25A, P520, DOI 10.1053/jhsu.2000.7381; Werner FW, 2004, J HAND SURG-AM, V29A, P418, DOI 10.1016/j.jhsa.2004.01.018; Neu CP, 2001, J BIOMECH, V34, P1429, DOI 10.1016/S0021-9290(01)00117-8; Rainbow MJ, 2013, J HAND SURG-AM, V38A, P278, DOI 10.1016/j.jhsa.2012.10.035; Pliefke J, 2008, SKELETAL RADIOL, V37, P139, DOI 10.1007/s00256-007-0410-7; Croog AS, 2008, J HAND SURG-AM, V33A, P1122, DOI 10.1016/j.jhsa.2008.02.031; Crisco JJ, 2005, J BONE JOINT SURG AM, V87A, P2729, DOI 10.2106/JBJS.D.03058; Calfee RP, 2010, J HAND SURG-AM, V35A, P1947, DOI 10.1016/j.jhsa.2010.08.017; Kuo CE, 2008, J HAND SURG-AM, V33A, P998, DOI 10.1016/j.jhsa.2008.04.027; LICHTMAN DM, 1977, J BONE JOINT SURG AM, V59, P899; Arimitsu S, 2009, J BONE JOINT SURG AM, V91A, P2180, DOI 10.2106/JBJS.H.01445; BELSOLE RJ, 1988, J ORTHOPAED RES, V6, P116, DOI 10.1002/jor.1100060115; BELSOLE RJ, 1991, J HAND SURG-AM, V16A, P82; BLANCO RH, 1985, J HAND SURG-AM, V10A, P1008; Buijze GA, 2011, J HAND SURG-AM, V36A, P1936, DOI 10.1016/j.jhsa.2011.09.016; BURGESS RC, 1987, J HAND SURG-AM, V12A, P771; De Smet L, 2005, J HAND SURG-BRIT EUR, V30B, P585, DOI 10.1016/j.jhsb.2005.06.024; Goldfarb CA, 2003, J HAND SURG-AM, V28A, P74, DOI 10.1053/jhsu.2003.50035; Goto A, 2004, J SHOULDER ELB SURG, V13, P441, DOI 10.1016/j.jse.2004.01.022; KAWAI H, 1988, J BONE JOINT SURG BR, V70, P287; Lorensen W. E., 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422; Mathoulin C, 2009, MICROSURG, V29, P373, DOI 10.1002/micr.20657; MINAMI A, 1994, J HAND SURG-AM, V19A, P219, DOI 10.1016/0363-5023(94)90009-4; Moore DC, 2011, J BIOMECH, V44, P2516, DOI 10.1016/j.jbiomech.2011.06.027; Moran SL, 2005, J HAND SURG-AM, V30A, P50, DOI 10.1016/j.jhsa.2004.10.002; Moritomo Hisao, 2004, Tech Hand Up Extrem Surg, V8, P110, DOI 10.1097/01.bth.0000126571.20944.47; Oka K, 2009, INT J MED ROBOT COMP, V5, P452, DOI 10.1002/rcs.277; Oka K, 2005, J HAND SURG-AM, V30A, P1136, DOI 10.1016/j.jhsa.2005.08.004; Omori S, 2013, J HAND SURG-AM, V38A, P1346, DOI 10.1016/j.jhsa.2013.04.004; Pollock J, 2013, J HAND SURG-AM, V38A, P1477, DOI 10.1016/j.jhsa.2013.04.037; ROGERS WD, 1989, J HAND SURG-AM, V14, P297, DOI 10.1016/0363-5023(89)90025-7; Simmons SP, 2009, J HAND SURG-AM, V34A, P155, DOI 10.1016/j.jhsa.2008.10.015; Tambe AD, 2005, INT ORTHOP, V29, P355, DOI 10.1007/s00264-005-0013-7; Taniguchi Y, 2002, J BONE JOINT SURG BR, V84B, P684, DOI 10.1302/0301-620X.84B5.12746; Tatebe Masahiro, 2006, Hand Surg, V11, P9, DOI 10.1142/S0218810406003012; Van den Dungen S, 2006, Chir Main, V25, P141, DOI 10.1016/j.main.2006.07.030; VIEGAS SF, 1990, J HAND SURG-AM, V15A, P564; Waitayawinyu T, 2008, J HAND SURG-AM, V33A, P1267, DOI 10.1016/j.jhsa.2008.04.006; WATSON HK, 1985, J HAND SURG-AM, V10A, P179; Watson HK, 1996, J HAND SURG-AM, V21A, P9, DOI 10.1016/S0363-5023(96)80148-1; Werner FW, 2007, J HAND SURG-AM, V32A, P55, DOI 10.1016/j.jhsa.2006.10.018; Zafra Manuel, 2005, Acta Orthop Belg, V71, P163	47	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	JAN	2015	40	1					74	80		10.1016/j.jhsa.2014.10.035		7	Orthopedics; Surgery	Orthopedics; Surgery	AX8WI	WOS:000347186000014		
J	Wada, T; Oda, T				Wada, T.; Oda, T.			Mallet fingers with bone avulsion and DIP joint subluxation	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Review						Mallet fractures; DIP joint; subluxation; extension block pinning	DISTAL INTERPHALANGEAL JOINT; TENSION WIRE FIXATION; FRACTURES; HAND	One-third of all mallet fingers are associated with a fracture. Mallet fractures associated with large fracture fragments may result in volar subluxation of the distal phalanx. The management of mallet fractures varies based on injury pattern and surgeon preference. These treatment options include splinting regimens, closed reduction and percutaneous pinning and open reduction and internal fixation. Although numerous surgical techniques have been described, there is little clear consensus on operative treatment. Moreover, there is insufficient evidence to support operative over nonoperative treatment for mallet fractures. Level of evidence: Level V	[Wada, T.; Oda, T.] Saisei Kai Otaru Hosp, Dept Orthopaed Surg, Otaru, Hokkaido 0470008, Japan	Wada, T (reprint author), Saisei Kai Otaru Hosp, Dept Orthopaed Surg, 10-1 Chikko, Otaru, Hokkaido 0470008, Japan.	twada@sapmed.ac.jp					Pegoli L, 2003, J HAND SURG-BRIT EUR, V28B, P15, DOI 10.1054/jhsb.2001.0733; Badia A, 2004, J HAND SURG-AM, V29A, P1051, DOI 10.1016/j.jhsa.2004.06.015; Fritz D, 2005, J HAND SURG-BRIT EUR, V30B, P180, DOI 10.1016/j.jhsb.2004.10.012; Kronlage SC, 2004, J HAND SURG-BRIT EUR, V29B, P135, DOI 10.1016/j.jhsb.2003.10.012; Richards SD, 2004, J HAND SURG-BRIT EUR, V29B, P61, DOI 10.1016/S0266-7681(03)00220-1; Zhang X, 2010, J HAND SURG-AM, V35A, P1864, DOI 10.1016/j.jhsa.2010.07.021; STARK HH, 1962, J BONE JOINT SURG AM, V44, P1061; WEHBE MA, 1984, J BONE JOINT SURG AM, V66A, P658; Kalainov DM, 2005, J HAND SURG-AM, V30A, P580, DOI 10.1016/j.jhsa.2005.02.010; Pike J, 2010, J HAND SURG-AM, V35A, P580, DOI 10.1016/j.jhsa.2010.01.005; Teoh LC, 2007, J HAND SURG-BRIT EUR, V32E, P24, DOI 10.1016/j.jhsb.2006.09.007; Bauze A, 1999, J HAND SURG-BRIT EUR, V24B, P688, DOI 10.1054/jhsb.1999.0284; BISCHOFF R, 1994, J HAND SURG-AM, V19A, P1019, DOI 10.1016/0363-5023(94)90109-0; CRAWFORD GP, 1984, J HAND SURG-AM, V9A, P231; DAMRON TA, 1994, CLIN ORTHOP RELAT R, P133; Darder-Prats A, 1998, J HAND SURG-BRIT EUR, V23B, P802, DOI 10.1016/S0266-7681(98)80102-2; Doyle JR, 1999, GREENS OPERATIVE HAN, V2, P1969; Hamas R S, 1978, J Hand Surg Am, V3, P361; Handoll HGH, 2008, COCHRANE DB SYST REV; Handoll HH, 2004, COCHRANE DB SYST REV; Hofmeister EP, 2003, J HAND SURG-AM, V28A, P453, DOI 10.1053/jhsu.2003.50089; Husain SN, 2008, J HAND SURG-AM, V33A, P26, DOI 10.1016/j.jhsa.2007.09.006; Ishiguro T, 1997, Tech Hand Up Extrem Surg, V1, P95, DOI 10.1097/00130911-199706000-00005; JUPITER JB, 1987, CLIN ORTHOP RELAT R, P113; Kakinoki Ryosuke, 2013, Hand Surg, V18, P235, DOI 10.1142/S0218810413500299; Lee HJ, 2014, ARCH ORTHOP TRAUM SU, V134, P741, DOI 10.1007/s00402-014-1968-x; Miura T, 2013, J HAND SURG AM; Neuhaus Valentin, 2013, Am J Orthop (Belle Mead NJ), V42, P223; Rocchi L, 2006, J HAND SURG-BRIT EUR, V31B, P407, DOI 10.1016/j.jhsb.2006.04.014; Strauch RJ, 2011, GREENS OPERATIVE HAN, V1, P168; Tung KY, 2012, ANN PLAS SURG, V69, P622, DOI 10.1097/SAP.0b013e3182741f9f	31	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	JAN	2015	40	1					8	15		10.1177/1753193414554772		8	Orthopedics; Surgery	Orthopedics; Surgery	AX4LB	WOS:000346903000002		
J	Liverneaux, PA; Ichihara, S; Hendriks, S; Facca, S; Bodin, F				Liverneaux, P. A.; Ichihara, S.; Hendriks, S.; Facca, S.; Bodin, F.			Fractures and dislocation of the base of the thumb metacarpal	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Review						First metacarpal; fracture; dislocation; Bennett; Rolando	TIBIAL PLATEAU FRACTURES; KIRSCHNER WIRE FIXATION; BENNETTS-FRACTURE; CLOSED REDUCTION; 1ST METACARPAL; FOLLOW-UP; PERCUTANEOUS FIXATION; SURGICAL-TREATMENT; ROLANDOS FRACTURE; SCREW FIXATION	Acute traumatic lesions of the base of the first metacarpal are frequent and their consequences can affect the opposition of the thumb. They usually occur after trauma in compression along the axis of the thumb in flexion. Restoring the anatomy and biomechanics of the trapeziometacarpal joint is essential when treating these injuries, hence why surgical treatment is usually indicated. We distinguish trapeziometacarpal dislocations, small-fragment and large-fragment Bennett's fractures, articular three-fragment Rolando and comminutive fractures and extra-articular fractures of the base of the first metacarpal. All carry the risk of narrowing of the first web. Recent studies have described poor results with conservative treatment. Surgical techniques are varied: percutaneous surgery, open surgery and arthroscopic surgery. The techniques of osteosynthesis are various: locking plates, and direct or indirect screw fixation or pinning. The prognosis depends on the quality of the restoration of the mobility of the trapeziometacarpal joint. Level of evidence: 4	[Liverneaux, P. A.; Ichihara, S.; Hendriks, S.; Facca, S.] Strasbourg Univ, FMTS, Strasbourg Univ Hosp, Dept Hand Surg, Illkirch Graffenstaden, France; [Ichihara, S.] Juntendo Univ, Dept Orthopaed Surg, Tokyo, Japan; [Bodin, F.] Strasbourg Univ, FMTS, Strasbourg Univ Hosp, Dept Plast Surg, Strasbourg, France	Liverneaux, PA (reprint author), Strasbourg Univ Hosp, Dept Hand Surg, 10 Ave Baumann, F-67403 Illkirch Graffenstaden, France.	Philippe.liverneaux@chru-strasbourg.fr					Adi Mohamed, 2014, Tech Hand Up Extrem Surg, V18, P77, DOI 10.1097/BTH.0000000000000040; HOVE LM, 1993, SCAND J PLAST RECONS, V27, P317; Ozer K, 2008, J HAND SURG-AM, V33A, P1724, DOI 10.1016/j.jhsa.2008.07.011; Page SM, 1998, J HAND SURG-AM, V23A, P827, DOI 10.1016/S0363-5023(98)80157-3; VANNIEKERK JLM, 1989, INJURY, V20, P359, DOI 10.1016/0020-1383(89)90014-4; HOLZACH P, 1994, J ORTHOP TRAUMA, V8, P273, DOI 10.1097/00005131-199408000-00001; EATON RG, 1973, J BONE JOINT SURG AM, VA 55, P1655; WAGNER CJ, 1950, AM J SURG, V80, P230, DOI 10.1016/0002-9610(50)90537-X; Culp RW, 2010, J HAND SURG-AM, V35A, P137, DOI 10.1016/j.jhsa.2009.10.019; Burdin G, 2013, ORTHOP TRAUMATOL-SUR, V99, pS208, DOI 10.1016/j.otsr.2012.11.011; Bennani A, 2012, CHIR MAIN, V31, P157, DOI 10.1016/j.main.2012.04.011; Bennett E H, 1886, Br Med J, V2, P12; Brazier J, 1996, Ann Chir Main Memb Super, V15, P91, DOI 10.1016/S0753-9053(96)80014-7; Brüske J, 2001, Acta Orthop Belg, V67, P368; CANNON SR, 1986, J HAND SURG-BRIT EUR, V11B, P426, DOI 10.1016/0266-7681(86)90172-5; Capo JT, 2009, J HAND SURG-AM, V34A, P637, DOI 10.1016/j.jhsa.2008.12.023; Cullen JP, 1997, J BONE JOINT SURG AM, V79A, P413; Diaconu M, 2011, CHIR MAIN, V30, P26, DOI 10.1016/j.main.2011.01.016; EDMUNDS I, 1994, AUST NZ J SURG, V64, P771, DOI 10.1111/j.1445-2197.1994.tb04537.x; FOSTER RJ, 1987, CLIN ORTHOP RELAT R, P121; Foucher G, 1982, ANN CHIR MAIN, V2, P168; Gedda KO, 1952, ACTA ORTHOP SCAND, V22, P249; GHILARDI G, 1960, Minerva Ortop, V11, P498; Giesen T, 2012, J HAND SURG-EUR VOL, V37E, P905, DOI 10.1177/1753193412451233; Greeven APA, 2012, INJURY, V43, P246, DOI 10.1016/j.injury.2011.10.038; Huang Jerry I, 2010, Instr Course Lect, V59, P343; ISELIN M, 1956, Mem Acad Chir (Paris), V82, P771; Kapandji A, 1983, ANN CHIR MAIN, V2, P179; KAPANDJI A, 1980, ANN CHIR, V34, P719; Keramidas EG, 2005, PLAST RECONSTR SURG, V116, P1326, DOI 10.1097/01.prs.0000181786.39062.0b; KJAERPETERSEN K, 1990, J HAND SURG-BRIT EUR, V15B, P58; Leclere FMP, 2012, ARCH ORTHOP TRAUM SU, V132, P1045, DOI 10.1007/s00402-012-1499-2; Liverneaux P, 2006, C ENS SOFCOT PAR EXP, P144; LIVESLEY PJ, 1990, J HAND SURG-BRIT EUR, V15B, P291, DOI 10.1016/0266-7681(90)90006-P; Lutz M, 2003, J HAND SURG-BRIT EUR, V28B, P142, DOI 10.1016/S0266-7681(02)00307-8/jhsb.2003.0880; Meyer C, 2003, ZBL CHIR, V128, P529; Moutet F, 1993, Ann Chir Main Memb Super, V12, P196, DOI 10.1016/S0753-9053(05)80101-2; OOSTERBOS CJM, 1995, J ORTHOP TRAUMA, V9, P23, DOI 10.1097/00005131-199502000-00004; Pavic R1, 2013, COLLEGIUM ANTROPOL, V7, P169; PEQUIGNOT J P, 1988, Annales de Chirurgie de la Main, V7, P14, DOI 10.1016/S0753-9053(88)80065-6; PROUBASTA IR, 1992, J BONE JOINT SURG BR, V74, P416; Sawaizumi T, 2005, J ORTHOP SCI, V10, P27, DOI 10.1007/s00776-004-0856-6; SCHATZKER J, 1979, CLIN ORTHOP RELAT R, P94; Sidharthan Sujith, 2010, Hand (N Y), V5, P440, DOI 10.1007/s11552-010-9266-8; Soyer A D, 1999, J Am Acad Orthop Surg, V7, P403; Stanton JS, 2007, J HAND SURG-EUR VOL, V32E, P626, DOI 10.1016/j.jhse.2007.06.017; Stern PJ, 2005, GREENS OPERATIVE HAN, V1, P277; STROMBERG L, 1977, ACTA ORTHOP SCAND, V48, P586; Surzur P, 1994, Ann Chir Main Memb Super, V13, P122, DOI 10.1016/S0753-9053(05)80385-0; TOUPIN JM, 1995, REV CHIR ORTHOP, V81, P27; TOURNE Y, 1988, REV CHIR ORTHOP, V74, P153; Uludag S, J HAND SURG-BRIT EUR, DOI [10.1177/1753193413494035., DOI 10.1177/1753193413494035]; Vichard P, 1982, Ann Chir Main, V1, P301, DOI 10.1016/S0753-9053(82)80082-3; WIGGINS HE, 1954, J BONE JOINT SURG AM, V36-A, P810; Wintman B I, 2000, Am J Orthop (Belle Mead NJ), V29, P229; Zemirline A, 2014, J HAND SURG ASIAN, V19, P281	56	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	JAN	2015	40	1					42	50		10.1177/1753193414554357		9	Orthopedics; Surgery	Orthopedics; Surgery	AX4LB	WOS:000346903000006		
J	Inui, A; Kokubu, T; Mifune, Y				Inui, A.; Kokubu, T.; Mifune, Y.			Volar dislocation of index and middle finger carpometacarpal joints: a case report	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter									[Inui, A.; Kokubu, T.; Mifune, Y.] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan	Inui, A (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan.	atsuyukiinui81@gmail.com					DEBEER JD, 1989, J HAND SURG-BRIT EUR, V14B, P105; Frick L, 2011, CHIR MAIN, V30, P333, DOI 10.1016/j.main.2011.06.010; Jameel Javed, 2013, J Orthop Traumatol, V14, P67, DOI 10.1007/s10195-012-0181-3; Makino T, 2007, J HAND SURG-BRIT, V12, P97	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	JAN	2015	40	1					99	100		10.1177/1753193413501589		2	Orthopedics; Surgery	Orthopedics; Surgery	AX4LB	WOS:000346903000015		
J	Yamaguchi, A; Kim, MS				Yamaguchi, Ayano; Kim, Min-Sun			Effects of self-construal and its relationship with subjective wellbeing across cultures	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						culture; health psychology; path analysis; satisfaction; self-perception; students; well-being	UNITED-STATES; HEALTH; EMOTION; JAPAN; GOALS	The purpose of this study is to test cross-cultural predictions of the associations between goal pursuits and subjective well-being among 601 college students (200 in Japan and 401 in the United States). The results indicated that interdependence in all cultures was associated with socially oriented subjective well-being. In the United States, it was also correlated with social goal pursuit. However, independence in the United States correlated with individual-oriented subjective well-being, while in Hawaii, it also correlated with hedonic goal pursuit. Discussion of these results and their implications are provided.	[Yamaguchi, Ayano] Reitaku Univ, Kashiwa, Chiba 2778686, Japan; [Kim, Min-Sun] Univ Hawaii Manoa, Honolulu, HI 96822 USA	Yamaguchi, A (reprint author), Reitaku Univ, 2-1-1 Hikarigaoka, Kashiwa, Chiba 2778686, Japan.	ayamag13@reitaku-u.ac.jp					MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P890, DOI 10.1037/0022-3514.91.5.890; Heine SJ, 1999, PERS SOC PSYCHOL B, V25, P915, DOI 10.1177/01461672992511001; Keyes CLM, 2007, AM PSYCHOL, V62, P95, DOI 10.1037/0003-066X.62.2.95; Ryan RM, 2000, PSYCHOL INQ, V11, P319, DOI 10.1207/S15327965PLI1104_03; Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157; Mesquita B, 2002, COGNITION EMOTION, V16, P127, DOI 10.1080/0269993014000176; Oishi S, 2001, PERS SOC PSYCHOL B, V27, P1674, DOI 10.1177/01461672012712010; Lu L, 2006, ASIAN J SOC PSYCHOL, V9, P36, DOI 10.1111/j.1367-2223.2006.00183.x; Cross SE, 2000, J PERS SOC PSYCHOL, V78, P791, DOI 10.1037//0022-3514.78.4.791; Richman LS, 2005, HEALTH PSYCHOL, V24, P422, DOI 10.1037/0278-6133.24.4.422; Morling B, 2002, PERS SOC PSYCHOL B, V28, P311, DOI 10.1177/0146167202286003; Sheldon KM, 1998, PERS SOC PSYCHOL B, V24, P1319, DOI 10.1177/01461672982412006; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037//0033-295X.106.4.766; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; Bagozzi R. P., 1988, J ACADEMY MARKETING, V16, P74, DOI DOI 10.1007/BF02723327; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Byrne B. M., 2001, STRUCTURAL EQUATION; Hatcher L., 1994, STEP BY STEP APPROAC; Kim M. S., 2002, NONWESTERN PERSPECTI; Kim M. S., 1997, REVISED SELF CONSTRU; Kim M.-S., 2009, J INT INTERCULTURAL, V2, P318, DOI [10.1080/17513050903177326, DOI 10.1080/17513050903177326]; Kitayama S., 1995, JAPANESE PSYCHOL REV, V38, P247; Kitayama Shinobu, 2000, CULTURE SUBJECTIVE W, P113; Kline R., 1998, PRINCIPLES PRACTICE; MARKUS HR, 1994, PERS SOC PSYCHOL B, V20, P568, DOI 10.1177/0146167294205013	27	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	JAN	2015	20	1					13	26		10.1177/1359105313496448		14	Psychology, Clinical	Psychology	AX4NF	WOS:000346908400002		
J	Usuki, T; Sakai, H; Shionoya, T; Sato, N; Sakane, F				Usuki, Takako; Sakai, Hiromichi; Shionoya, Takao; Sato, Naruki; Sakane, Fumio			Expression and Localization of Type II Diacylglycerol Kinase Isozymes delta and eta in the Developing Mouse Brain	JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY			English	Article						diacylglycerol kinase; central nerves system; age-dependent expression; cerebral cortex; olfactory bulb; hippocampus; Purkinje cell; in situ hybridization; epileptic seizure; bipolar disorder	PHOSPHATIDIC-ACID; BIPOLAR-DISORDER; MOLECULAR-CLONING; GENE-EXPRESSION; NERVOUS-SYSTEM; GRANULE CELLS; RAT-BRAIN; ACTIVATION; ISOFORMS; IDENTIFICATION	The functions of type II diacylglycerol kinase (DGK) and - in the brain are still unclear. As a first step, we investigated the spatial and temporal expression of DGK and - in the brains of mice. DGK2, but not DGK1, was highly expressed in layers II-VI of the cerebral cortex; CA-CA3 regions and dentate gyrus of hippocampus; mitral cell, glomerular and granule cell layers of the olfactory bulb; and the granule cell layer in the cerebellum in 1- to 32-week-old mice. DGK2 was expressed just after birth, and its expression levels dramatically increased from weeks 1 to 4. A substantial amount of DGK (1/2) was detected in layers II-VI of the cerebral cortex, CA1 and CA2 regions and dentate gyrus of the hippocampus, mitral cell and glomerular layers of the olfactory bulb, and Purkinje cells in the cerebellum of 1- to 32-week-old mice. DGK2 expression reached maximum levels at P5 and decreased by 4 weeks, whereas DGK1 increased over the same time frame. These results indicate that the expression patterns of DGK isozymes differ from each other and also from other isozymes, and this suggests that DGK and - play distinct and specific roles in the brain.	[Usuki, Takako; Sakai, Hiromichi; Shionoya, Takao; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Sato, Naruki] Chiba Univ, Dept Nanobiol, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan	Sakane, F (reprint author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	sakane@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26291017, 25116704, 23116505, 22370047]; Japan Science and Technology Agency [AS251Z01788Q, AS231Z00139G, AS221Z00794F]; Naito Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 26291017, 25116704, 23116505, 22370047); the Japan Science and Technology Agency (grant number AS251Z01788Q, AS231Z00139G, AS221Z00794F); the Naito Foundation; the Hamaguchi Foundation for the Advancement of Biochemistry; the Daiichi-Sankyo Foundation of Life Science; the Terumo Life Science Foundation; the Futaba Electronic Memorial Foundation; the Daiwa Securities Health Foundation; the Ono Medical Research Foundation; the Japan Foundation for Applied Enzymology; and the Food Science Institute Foundation.	Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Bizon JL, 2001, EUR J NEUROSCI, V14, P1739, DOI 10.1046/j.0953-816x.2001.01781.x; Maloku E, 2010, P NATL ACAD SCI USA, V107, P4407, DOI 10.1073/pnas.0914483107; Ron D, 1999, FASEB J, V13, P1658; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Hagihara H, 2013, NEURAL PLAST, DOI 10.1155/2013/318596; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; GOTO K, 1992, MOL BRAIN RES, V16, P75, DOI 10.1016/0169-328X(92)90196-I; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Goto K, 2006, ADV ENZYME REGUL, V46, P192, DOI 10.1016/j.advenzreg.2006.01.005; Hurley JH, 1997, PROTEIN SCI, V6, P477; LIMATOLA C, 1994, BIOCHEM J, V304, P1001; Musto A, 2006, EPILEPSIA, V47, P267, DOI 10.1111/j.1528-1167.2006.00418.x; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Goto K, 1996, P NATL ACAD SCI USA, V93, P11196, DOI 10.1073/pnas.93.20.11196; GOTO K, 1994, P NATL ACAD SCI USA, V91, P13042, DOI 10.1073/pnas.91.26.13042; Hisatsune C, 2006, J NEUROSCI, V26, P10916, DOI 10.1523/JNEUROSCI.3269-06.2006; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Klauck TM, 1996, J BIOL CHEM, V271, P19781; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; Moya PR, 2010, INT J NEUROPSYCHOPH, V13, P1127, DOI 10.1017/S1461145710000593; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sendrowski K, 2013, PHARMACOL REP, V65, P555; Soontornniyomkij V, 2010, AGE, V32, P309, DOI 10.1007/s11357-010-9145-9; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604	48	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0022-1554	1551-5044		J HISTOCHEM CYTOCHEM	J. Histochem. Cytochem.	JAN	2015	63	1					57	68		10.1369/0022155414559130		12	Cell Biology	Cell Biology	AX4PC	WOS:000346913100006		
J	Albrecht, K; Sakane, N; Inomata, Y; Yamamoto, K				Albrecht, Ken; Sakane, Noriko; Inomata, Yusuke; Yamamoto, Kimihisa			Effect of the Core Structure on the Sequential Coordination of Phenylazomethine Dendrimer	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Phenylazomethine; Dendrimer; Dendritic ligand; Potential gradient; Sequential coordination	STEPWISE RADIAL COMPLEXATION; METAL-ORGANIC FRAMEWORKS; MOLECULAR RECOGNITION; SIZE; NANOPARTICLES; CHEMISTRY; CATALYSIS; DENDRONS; FERROCENYL; DYNAMICS	Phenylazomethine dendrimer (DPA) is a dendritic ligand that coordinates to various Lewis acids in a stepwise radial fashion. Second generation para-substituted and meta-substituted phenylazomethine dendrimers with p-phenylenediamine and m-phenylenediamine core were synthesized and the coordination sequence was investigated by UV-vis titration. Stepwise radial complexation from the outer layer was observed for the m-phenylenediamine core meta-substituted phenylazomethine dendrimer (m-mG2). Other three dendrimers showed stepwise radial complexation from the inner layer. The reason could be explained with the binding constant of the 1st generation dendrimer (model of the 1st layer). This is suggesting that for controlling the coordination sequence of DPA, not only the dendron structure is important, but also the structure of the core is an important factor.	[Albrecht, Ken; Sakane, Noriko; Inomata, Yusuke; Yamamoto, Kimihisa] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Yamamoto, K (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yamamoto@res.titech.ac.jp	Albrecht, Ken/B-4423-2012	Albrecht, Ken/0000-0003-2159-2204	CREST program of the Japan Science and Technology (JST) Agency; JSPS KAKENHI [26410128, 80220458, 21108009]	This work was supported in part by the CREST program of the Japan Science and Technology (JST) Agency, Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Architectonics: Orchestration of Single Molecules for Novel Functions", and by JSPS KAKENHI Grant Numbers 26410128, 80220458, and 21108009.	Albrecht K, 2013, CHEM COMMUN, V49, P6861, DOI 10.1039/c3cc43249a; Albrecht K, 2014, CHEM COMMUN, V50, P12177, DOI 10.1039/c4cc05007j; Albrecht K, 2013, CHEM COMMUN, V49, P865, DOI 10.1039/c2cc36451d; Kollner C, 1998, J AM CHEM SOC, V120, P10274, DOI 10.1021/ja981137g; Satoh N, 2008, NAT NANOTECHNOL, V3, P106, DOI 10.1038/nnano.2008.2; Yamamoto K, 2014, ACCOUNTS CHEM RES, V47, P1127, DOI 10.1021/ar400257s; Friedle S, 2010, CHEM SOC REV, V39, P2768, DOI 10.1039/c003079c; Albrecht K, 2009, J INORG ORGANOMET P, V19, P118, DOI 10.1007/s10904-008-9239-3; Yamamoto K, 2009, NAT CHEM, V1, P397, DOI [10.1038/nchem.288, 10.1038/NCHEM.288]; Yamamoto K, 2005, B CHEM SOC JPN, V78, P349, DOI 10.1246/bcsj.78.349; Scott RWJ, 2005, J PHYS CHEM B, V109, P692, DOI 10.1021/jp0469665; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Sugimoto H, 2008, CHEM SOC REV, V37, P2609, DOI 10.1039/b610235m; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Bosman AW, 1999, CHEM REV, V99, P1665, DOI 10.1021/cr970069y; Newkome GR, 2010, CHEM REV, V110, P6338, DOI 10.1021/cr900341m; Grayson SM, 2001, CHEM REV, V101, P3819, DOI 10.1021/cr990116h; Takeuchi M, 2001, ACCOUNTS CHEM RES, V34, P865, DOI 10.1021/ar0000470; Balzani V, 1998, ACCOUNTS CHEM RES, V31, P26, DOI 10.1021/ar950202d; Zhou GJ, 2007, ANGEW CHEM INT EDIT, V46, P1149, DOI 10.1002/anie.200604094; Imaoka T, 2013, J AM CHEM SOC, V135, P13089, DOI 10.1021/ja405922m; Friscic T, 2012, CHEM SOC REV, V41, P3493, DOI 10.1039/c2cs15332g; Winkler JR, 2014, CHEM REV, V114, P3369, DOI 10.1021/cr4004715; Su MY, 1998, MAGN RESON MED, V39, P259, DOI 10.1002/mrm.1910390213; Stock N, 2012, CHEM REV, V112, P933, DOI 10.1021/cr200304e; Hu QS, 1999, J ORG CHEM, V64, P7528, DOI 10.1021/jo990856q; Ahmad N, 2014, COORDIN CHEM REV, V280, P1, DOI 10.1016/j.ccr.2014.07.005; Yamamoto K, 2002, NATURE, V415, P509, DOI 10.1038/415509a; TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; Tomalia DA, 2009, J NANOPART RES, V11, P1251, DOI 10.1007/s11051-009-9632-z; Zeng FW, 1997, CHEM REV, V97, P1681, DOI 10.1021/cr9603892; Kovbasyuk L, 2004, CHEM REV, V104, P3161, DOI 10.1021/cr030673a; Xia DB, 2014, ANGEW CHEM INT EDIT, V53, P1048, DOI 10.1002/anie.201307311; Buschbeck R., 2005, ORGANOMET CHEM, V62, P696; Choi MS, 2003, ANGEW CHEM INT EDIT, V42, P4060, DOI 10.1002/anie.200351460; Chow HF, 1997, J ORG CHEM, V62, P5116, DOI 10.1021/jo970383s; Crooks RM, 2001, ACCOUNTS CHEM RES, V34, P181, DOI 10.1021/ar000110a; Fischer M., 1999, ANGEW CHEM INT EDIT, V34, P884, DOI DOI 10.1002/SICI)1521-3773(19990401)38:7<884::AID-ANIE884>3.0.CO; Frisch M J, 2010, GAUSSIAN 09 REVISION; Higuchi M, 2001, J AM CHEM SOC, V123, P4414, DOI 10.1021/ja004239r; Imaoka T, 2012, CHEM COMMUN, V48, P7235, DOI 10.1039/c2cc31954c; Oh M, 2011, DALTON T, V40, P5720, DOI 10.1039/c1dt10220f; Ong W, 2004, CHEM COMMUN, P1677, DOI 10.1039/b401186d; Ornelas C, 2009, J AM CHEM SOC, V131, P590, DOI 10.1021/ja8062343; Shinoda S, 2007, J INCL PHENOM MACRO, V59, P1, DOI 10.1007/s10847-007-9315-2; Shinoda S, 2007, CHEM-EUR J, V13, P81, DOI 10.1002/chem.200600076; Takanashi K, 2007, B CHEM SOC JPN, V80, P1563, DOI 10.1246/bcsj.80.1563; Takanashi K, 2004, ORG LETT, V6, P1709, DOI 10.1021/ol049656d; Wiener EC, 1996, J AM CHEM SOC, V118, P7774, DOI 10.1021/ja9536126	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	JAN	2015	25	1					133	139		10.1007/s10904-014-0116-y		7	Polymer Science	Polymer Science	AY0KT	WOS:000347286200015		
J	Miyachi, M; Yamamoto, Y; Yamanoi, Y; Nishihara, H				Miyachi, Mariko; Yamamoto, Yuki; Yamanoi, Yoshinori; Nishihara, Hiroshi			Preparation of Pd Nanoparticles with Tetrahedral, Spherical, Plate, and Feather Shapes by Capping with 1-Pentyl Isocyanide	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Palladium; Nanoparticles; Isocyanide ligands; Polyol method; Particle shapes	HYDROGEN STORAGE PROPERTIES; CATALYTIC-ACTIVITY; PALLADIUM; SIZE; MORPHOLOGY; PRECURSOR; NANOCRYSTALS; CHEMISTRY	In this study, we synthesized n-alkyl-isocyanide-protected palladium colloidal nanoparticles with different shapes. The 1-pentyl-isocyanide-protected Pd nanoparticles prepared by the reduction of the Pd complex with ethylene glycol had various geometric shapes. Transmission electron micrographs showed that tetrahedral particles were predominant, although some spherical, plate-, and feather-shaped particles were also observed. The enriched nanotetrahedra were isolated as a black powder by reprecipitation with methanol-chloroform and the particle size was controlled by the reaction conditions.	[Miyachi, Mariko; Yamamoto, Yuki; Yamanoi, Yoshinori; Nishihara, Hiroshi] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Yamanoi, Y (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yamanoi@chem.s.u-tokyo.ac.jp; nisihara@chem.s.u-tokyo.ac.jp	Nishihara, Hiroshi/B-4755-2012		Ministry of Education, Culture, Sports, Science, and Technology, Japan [2107, 21108002, 2509, 26110505, 26110506]; Kurata Memorial Hitachi Science and Technology Foundation	The work was financially supported by Grant-in-Aids for Scientific Research on Innovative Areas "Coordination Programming: Science of Super-molecular Structure and Creation of Chemical Elements" (area 2107, No. 21108002), and "Molecular Architectonics: Orchestration of Single Molecules for Novel Functions" (area 2509, Nos. 26110505 and 26110506) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported in part by the Kurata Grant awarded by the Kurata Memorial Hitachi Science and Technology Foundation.	SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002; Liu K, 2008, ANGEW CHEM INT EDIT, V47, P1255, DOI 10.1002/anie.200703199; Kowalczyk B, 2011, CURR OPIN COLLOID IN, V16, P135, DOI 10.1016/j.cocis.2011.01.004; Huang XQ, 2009, J AM CHEM SOC, V131, P13916, DOI 10.1021/ja9059409; Narayanan R, 2004, J AM CHEM SOC, V126, P7194, DOI 10.1021/ja0486061; Dong Q, 2012, ADV MATER, V24, P1034, DOI 10.1002/adma.201104171; Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Narayanan R, 2004, NANO LETT, V4, P1343, DOI 10.1021/nl0495256; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Xiong YJ, 2005, J AM CHEM SOC, V127, P17118, DOI 10.1021/ja056498s; Wiley B, 2007, ACCOUNTS CHEM RES, V40, P1067, DOI 10.1021/ar7000974; Teranishi T, 2000, J INORG ORGANOMET P, V10, P145, DOI 10.1023/A:1009476128466; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Horinouchi S, 2006, LANGMUIR, V22, P1880, DOI 10.1021/la052657+; Dong QC, 2014, ADV FUNCT MATER, V24, P857, DOI 10.1002/adfm.201301143; Crespo-Quesada M, 2011, LANGMUIR, V27, P7909, DOI 10.1021/la201007m; Park KH, 2007, ANGEW CHEM INT EDIT, V46, P1152, DOI 10.1002/anie.200603961; Long NV, 2012, J EXP NANOSCI, V7, P426, DOI 10.1080/17458080.2010.543988; FIEVET F, 1989, SOLID STATE IONICS, V32-3, P198, DOI 10.1016/0167-2738(89)90222-1; Xiong YJ, 2005, J AM CHEM SOC, V127, P7332, DOI 10.1021/ja0513741; Choo HP, 2001, J MATER CHEM, V11, P2906, DOI 10.1039/b106578p; Choo H, 2006, J MOL CATAL A-CHEM, V244, P217, DOI 10.1016/j.molcata.2005.09.009; Moulder J. F., 1992, HDB XRAY PHOTOELECTR; Norimatsu FY, 2006, CHEM LETT, V35, P276, DOI 10.1246/cl.2006.276; Pearson P. Villars, 1997, PEARSONS HDB CRYSTAL; Schmid G., 2004, NANOPARTICLES THEORY; Shiju NR, 2009, APPL CATAL A-GEN, V356, P1, DOI 10.1016/j.apcata.2008.11.034; Xiong YJ, 2007, J AM CHEM SOC, V129, P3665, DOI 10.1021/ja0688023; Yamamoto Y, 2011, J NANOPART RES, V13, P6333, DOI 10.1007/s11051-011-0628-0; Yamamoto Y, 2014, J INORG ORGANOMET P, V24, P208, DOI 10.1007/s10904-013-9925-7; Yamanoi Y, 2013, LANGMUIR, V29, P8768, DOI 10.1021/la401896d	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	JAN	2015	25	1					140	144		10.1007/s10904-014-0121-1		5	Polymer Science	Polymer Science	AY0KT	WOS:000347286200016		
J	Amaya, T; Isaji, T; Abe, M; Hirao, T				Amaya, Toru; Isaji, Tadayuki; Abe, Masashi; Hirao, Toshikazu			Synthesis of Polyaniline and Transition Metal Nanoparticles Hybrids	JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS			English	Article						Polyaniline; Conducting polymer; Metal nanoparticles; Template synthesis	SULFONIC ACID)/GOLD NANOPARTICLES; CONJUGATED COMPLEX-SYSTEMS; CATALYTIC APPLICATION; GOLD NANOPARTICLES; EMERALDINE BASE; REDOX; COMPOSITE; PALLADIUM; OXIDATION; POLYMER	Synthesis of polyaniline (PANI)/metal nanoparticles hybrids (M NPs, M = Pd, Au, and Pt) through the template approach and their characterization were investigated. The IR study suggests that the partial oxidation of PANI main chain in the complexation of the metal salts. Subsequent reduction of the metal salts to form the M NPs induced the partial reduction of PANI main chain. Hypochromic phenomenon for pi-pi* and charge transfer (CT) bands were observed in UV-Vis-NIR absorption spectra for PANI/M NPs. SEM-EDX analysis revealed the uniform dispersion of M NPs. The M NPs (average diameter 2-3 nm) were clearly observed in PANI/Pd, Au, and Pt NPs. They were proton-doped, and their conductivity was investigated.	[Amaya, Toru; Isaji, Tadayuki; Hirao, Toshikazu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Isaji, Tadayuki; Abe, Masashi] Nissan Chem Ind Co Ltd, Sodegaura, Chiba 2990266, Japan	Hirao, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.	hirao@chem.eng.osaka-u.ac.jp					Amaya T., 2011, SYNLETT, V435; Amaya T, 2012, HETEROCYCLES, V86, P927, DOI 10.3987/COM-12-S(N)71; Amaya T, 2008, MACROMOL SYMP, V270, P88, DOI 10.1002/masy.200851011; Ivanov S, 2010, SENSOR ACTUAT B-CHEM, V150, P271, DOI 10.1016/j.snb.2010.07.004; Liu K, 2008, ANGEW CHEM INT EDIT, V47, P1255, DOI 10.1002/anie.200703199; Zhai DY, 2013, ACS NANO, V7, P3540, DOI [10.1021/nn400482d, 10.1021/nn4004132d]; Li D, 2009, ACCOUNTS CHEM RES, V42, P135, DOI 10.1021/ar800080n; Hirao T, 1999, TETRAHEDRON LETT, V40, P3009, DOI 10.1016/S0040-4039(99)00405-0; Li WG, 2006, POLYMER, V47, P23, DOI 10.1016/j.polymer.2005.11.032; Oueiny C, 2014, PROG POLYM SCI, V39, P707, DOI 10.1016/j.progpolymsci.2013.08.009; Amaya T, 2012, TETRAHEDRON LETT, V53, P6144, DOI 10.1016/j.tetlet.2012.09.002; Tanami G, 2010, LANGMUIR, V26, P4239, DOI 10.1021/la903284g; Drelinkiewicz A, 2009, REACT FUNCT POLYM, V69, P630, DOI 10.1016/j.reactfunctpolym.2009.04.007; Wang JG, 2001, J COLLOID INTERF SCI, V239, P78, DOI 10.1006/jcis.2001.7576; Gangopadhyay R, 2000, CHEM MATER, V12, P608, DOI 10.1021/cm990537f; Tseng RJ, 2005, NANO LETT, V5, P1077, DOI 10.1021/nl050587l; Han J, 2013, POLYM CHEM-UK, V4, P313, DOI 10.1039/c2py20536j; Amaya T, 2007, TETRAHEDRON LETT, V48, P2729, DOI 10.1016/j.tetlet.2007.02.059; Kinyanjui JM, 2004, MACROMOLECULES, V37, P8745, DOI 10.1021/ma0488313; XIA YN, 1995, CHEM MATER, V7, P443, DOI 10.1021/cm00051a002; Kang ET, 1998, PROG POLYM SCI, V23, P277, DOI 10.1016/S0079-6700(97)00030-0; Amaya T, 2013, TETRAHEDRON LETT, V54, P2409, DOI 10.1016/j.tetlet.2013.02.098; Gallon BJ, 2007, ANGEW CHEM INT EDIT, V46, P7251, DOI 10.1002/anie.200701389; Huang YF, 2012, J PHYS CHEM C, V116, P11272, DOI 10.1021/jp303538z; Dimitriev OP, 1999, SYNTHETIC MET, V104, P27, DOI 10.1016/S0379-6779(99)00058-2; Saio D, 2010, ADV SYNTH CATAL, V352, P2177, DOI 10.1002/adsc.201000451; ASTURIAS GE, 1989, SYNTHETIC MET, V29, pE157; Drelinkiewicz A, 1999, J CATAL, V186, P123, DOI 10.1006/jcat.1999.2493; Higuchi M, 1996, MACROMOLECULES, V29, P8277, DOI 10.1021/ma960761f; HIRAO T, 1995, TETRAHEDRON LETT, V36, P5925, DOI 10.1016/0040-4039(95)01143-6; Hirao T, 1999, SYNTHETIC MET, V106, P67, DOI 10.1016/S0379-6779(99)00107-1; Hirao T, 2001, SYNTHETIC MET, V123, P373, DOI 10.1016/S0379-6779(01)00314-9; Houdayer A, 2005, APPL ORGANOMET CHEM, V19, P1239, DOI 10.1002/aoc.999; Isaji T, 2014, B CHEM SOC JPN, V87, P1130, DOI 10.1246/bcsj.20140106; Komathi S, 2010, MACROMOL CHEM PHYS, V211, P1330, DOI 10.1002/macp.200900640; Kosydar R, 2013, CHEM PAP, V67, P1087, DOI 10.2478/s11696-013-0383-z; Mallick K, 2007, PLATIN MET REV, V51, P3, DOI 10.1595/147106707X174203; Mallick K, 2006, GOLD BULL, V39, P166; Nyczyk A, 2008, EUR POLYM J, V44, P1594, DOI 10.1016/j.eurpolymj.2008.03.004; Nyczyk A, 2009, SYNTHETIC MET, V159, P561, DOI 10.1016/j.synthmet.2008.11.019; Premvardhan LL, 2001, J CHEM PHYS, V115, P4359, DOI 10.1063/1.1388559; Saio D, 2009, J INORG ORGANOMET P, V19, P79, DOI 10.1007/s10904-008-9241-9; Sanches E.A., 2011, J NANOMATER, V1; Sarma TK, 2002, CHEM COMMUN, P1048, DOI 10.1039/b201014c; Sarma TK, 2004, J PHYS CHEM A, V108, P7837, DOI 10.1021/jp049348x; Shen XL, 2004, TETRAHEDRON LETT, V45, P4733, DOI 10.1016/j.tetlet.2004.04.073; Wessling M., 2010, POLYMERS, V2, P786	47	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1574-1443	1574-1451		J INORG ORGANOMET P	J. Inorg. Organomet. Polym. Mater.	JAN	2015	25	1					145	152		10.1007/s10904-014-0123-z		8	Polymer Science	Polymer Science	AY0KT	WOS:000347286200017		
J	Chiricozzi, E; Ciampa, MG; Brasile, G; Compostella, F; Prinetti, A; Nakayama, H; Ekyalongo, RC; Iwabuchi, K; Sonnino, S; Mauri, L				Chiricozzi, Elena; Ciampa, Maria Grazia; Brasile, Giuseppina; Compostella, Federica; Prinetti, Alessandro; Nakayama, Hitoshi; Ekyalongo, Roudy C.; Iwabuchi, Kazuhisa; Sonnino, Sandro; Mauri, Laura			Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cells	JOURNAL OF LIPID RESEARCH			English	Article						lactosylceramide; photoactivable sphingolipids; C24 fatty acid chain; interdigitation	CEREBELLAR GRANULE CELLS; ENRICHED MEMBRANE DOMAINS; FATTY-ACID INTERDIGITATION; MELANOMA B16 CELLS; PLASMA-MEMBRANE; HUMAN-FIBROBLASTS; GANGLIOSIDE GM3; HL-60 CELLS; CULTURE; CERAMIDE	Lactosylceramide [LacCer; beta-Gal-(1-4)-beta-Glc-(1-1)-Cer] has been shown to contain very long fatty acids that specifically modulate neutrophil properties. The interactions between LacCer and proteins and their role in cell signaling processes were assessed by synthesizing two molecular species of azide-photoactivable tritium-labeled LacCer having acyl chains of different lengths. The lengths of the two acyl chains corresponded to those of a short/medium and very long fatty acid, comparable to the lengths of stearic and lignoceric acids, respectively. These derivatives, designated C18-[H-3] LacCer-(N-3) and C24-[H-3]LacCer-(N-3), were incorporated into the lipid rafts of plasma membranes of neutrophilic differentiated HL-60 (D-HL-60) cells. C24-[H-3] LacCer-(N-3), but not C18-[H-3] LacCer-(N-3), induced the phosphorylation of Lyn and promoted phagocytosis. Incorporation of C24-[H-3]LacCer-(N-3) into plasma membranes, followed by illumination, resulted in the formation of several tritium-labeled LacCer-protein complexes, including the LacCer-Lyn complex, into plasma membrane lipid rafts. Administration of C18-[H-3]LacCer-(N-3) to cells, however, did not result in the formation of the LacCer-Lyn complex. These results suggest that LacCer derivatives mimic the biological properties of natural LacCer species and can be utilized as tools to study LacCer-protein interactions, and confirm a specific direct interaction between LacCer species containing very long fatty acids, and Lyn protein, associated with the cytoplasmic layer via myristic/palmitic chains.	[Chiricozzi, Elena; Ciampa, Maria Grazia; Brasile, Giuseppina; Compostella, Federica; Prinetti, Alessandro; Sonnino, Sandro; Mauri, Laura] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Nakayama, Hitoshi; Ekyalongo, Roudy C.; Iwabuchi, Kazuhisa] Juntendo Univ, Grad Sch Med, Inst Environm Gender Specif Med, Chiba, Japan	Iwabuchi, K (reprint author), Juntendo Univ, Grad Sch Med, Inst Environm Gender Specif Med, Chiba, Japan.	iwabuchi@juntendo.ac.jp			Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [S1201013, S1311011]; Matsumae Foundation; Department of Medical Biotechnology and Translational Medicine, University of Milan	This study was supported in part by a grant-in-aid (S1201013, S1311011) from the Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by Matsumae Foundation (for K.I.). S.S. was supported by funds obtained through performance in tariff of the Department of Medical Biotechnology and Translational Medicine, University of Milan.	Allende D, 2004, TRENDS BIOCHEM SCI, V29, P325, DOI 10.1016/j.tibs.2004.04.002; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Chigorno V, 2000, EUR J BIOCHEM, V267, P4187, DOI 10.1046/j.1432-1327.2000.01454.x; Fujita A, 2009, BBA-MOL CELL BIOL L, V1791, P388, DOI 10.1016/j.bbalip.2009.01.008; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Kusumi A, 2010, FEBS LETT, V584, P1814, DOI 10.1016/j.febslet.2010.02.047; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Iwabuchi K, 2002, BLOOD, V100, P1454; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Mehlen P, 1998, NATURE, V395, P801; Nakayama H, 2008, J LEUKOCYTE BIOL, V83, P728, DOI 10.1189/jlb.0707478; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; Prinetti A, 2001, J BIOL CHEM, V276, P21136, DOI 10.1074/jbc.M010666200; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Sonnino S, 2009, GLYCOCONJUGATE J, V26, P615, DOI 10.1007/s10719-008-9215-8; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; WU H, 1991, DIFFERENTIATION, V48, P51, DOI 10.1111/j.1432-0436.1991.tb00242.x; Xu RH, 2005, CANCER RES, V65, P613; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; Kaga N, 2005, ANAL BIOCHEM, V337, P316, DOI 10.1016/j.ab.2004.11.003; Seino K, 1998, J IMMUNOL, V161, P4484; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Aureli M, 2012, GLYCOCONJUGATE J, V29, P585, DOI 10.1007/s10719-012-9385-2; Aureli M, 2010, J LIPID RES, V51, P798, DOI 10.1194/jlr.M001974; Aureli M, 2011, J NEUROCHEM, V116, P891, DOI 10.1111/j.1471-4159.2010.07019.x; BISSON R, 1981, BIOCHEM J, V193, P757; CHIGORNO V, 1990, FEBS LETT, V263, P329, DOI 10.1016/0014-5793(90)81406-E; Ekyalongo R. C., 2014, BIOCHIM BIO IN PRESS; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; Freitas JM, 2005, HELV CHIM ACTA, V88, P2470, DOI 10.1002/hlca.200590183; Gorczynski MJ, 2006, ORG LETT, V8, P2305, DOI 10.1021/ol060548w; GRANT CWM, 1987, BIOCHIM BIOPHYS ACTA, V902, P169, DOI 10.1016/0005-2736(87)90292-6; Haga Y, 2008, BBA-GEN SUBJECTS, V1780, P393, DOI 10.1016/j.bbagen.2007.10.018; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; Loberto N, 2003, J NEUROCHEM, V85, P224, DOI 10.1046/j.1471-4159.2003.01655.x; Mauri Laura, 2004, Glycoconj J, V20, P11; MEAGHER LC, 1988, CLIN EXP IMMUNOL, V74, P483; Ono M, 2001, BIOCHEMISTRY-US, V40, P6414, DOI 10.1021/bi0101998; Palestini P, 2000, J BIOL CHEM, V275, P9978, DOI 10.1074/jbc.275.14.9978; PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x; Prinetti A, 2000, GLYCOCONJUGATE J, V17, P223, DOI 10.1023/A:1026545424720; Prioni S, 2004, GLYCOCONJUGATE J, V21, P461, DOI 10.1007/s10719-004-5536-4; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; RIBONI L, 1992, EUR J BIOCHEM, V203, P107, DOI 10.1111/j.1432-1033.1992.tb19834.x; Ruettinger A, 2008, EUR BIOPHYS J BIOPHY, V37, P759, DOI 10.1007/s00249-008-0258-3; Sato T, 2006, J LEUKOCYTE BIOL, V80, P204, DOI 10.1189/jlb.0106069; SONNINO S, 1989, BIOCHEMISTRY-US, V28, P77, DOI 10.1021/bi00427a012; SONNINO S, 1992, NEUROCHEM INT, V20, P315, DOI 10.1016/0197-0186(92)90046-T; Suzaki K, 1965, J Neurochem, V12, P969; Yanagida M, 2007, PROTEOMICS, V7, P2398, DOI 10.1002/pmic.200700056; Yu R. K., 2007, GLYCOSPHINGOLIPID ST	53	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	JAN	2015	56	1					129	141		10.1194/jlr.M055319		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX5KB	WOS:000346963600013		
J	Tian, M; Yao, Y; Liu, ST; Yang, D; Zhang, LQ; Nishi, T; Ning, NY				Tian, Ming; Yao, Yang; Liu, Suting; Yang, Dan; Zhang, Liqun; Nishi, Toshio; Ning, Nanying			Separated-structured all-organic dielectric elastomer with large actuation strain under ultra-low voltage and high mechanical strength	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							ELECTROMECHANICAL RESPONSES; ARTIFICIAL MUSCLES; PERMITTIVITY; ENHANCEMENT; COMPOSITES; POLYMER; FILLER; FIELD	We report the design and preparation of a separated-structured all-organic dielectric elastomer (DE) with large actuation strain under ultra-low voltage and high mechanical strength. Based on the protonic-conductivity mechanism of gelatin, a novel organic conductive filler with high dielectric constant and low elastic modulus was prepared by mixing gelatin and glycerol (GG). The separated structured DE was prepared by spraying a solution of GG into the multiple layers of thermoplastic polyurethane elastomer (TPU) nonwoven fabric by electrospinning, followed by hot pressing under vacuum. The densely packed TPU nonwoven fabric not only ensures the good mechanical strength of GG/TPU DE, but also separates GG filler and stops the formation of the GG continuous phase, preventing the formation of a conducting path under an exerted electric field. The novel GG filler considerably increases the dielectric constant and decreases the elastic modulus of the GG/TPU DE. As a result, the as-prepared DE exhibits good mechanical strength and 5.2% actuation strain at a very low electric field (0.5 kV mm(-1)). To the best of our knowledge, the required electric field for the same actuation strain is the lowest compared to other DE reported in the literature. Because all components in this composite are organic and biocompatible, this study offers a new method for preparing a DE with large actuation strain at low electric fields for its application in biological and medical fields, in which a low electric field is required.	[Tian, Ming; Yao, Yang; Liu, Suting; Yang, Dan; Zhang, Liqun; Ning, Nanying] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Coll Mat Sci & Engn, Beijing 100029, Peoples R China; [Tian, Ming; Liu, Suting; Yang, Dan; Zhang, Liqun; Ning, Nanying] Beijing Univ Chem Technol, Key Lab Carbon Fiber & Funct Polymers, Minist Educ, Beijing 100029, Peoples R China; [Nishi, Toshio] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 113, Japan	Tian, M (reprint author), Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Coll Mat Sci & Engn, 15 Bei San Huan East Rd, Beijing 100029, Peoples R China.	tianm@mail.buct.edu.cn; ningny@mail.buct.edu.cn			National Natural Science Foundation of China [51173007, 51221002]	We would like to express our sincere gratitude to the National Natural Science Foundation of China (Grant no. 51173007 and 51221002) for financial support.	ALALLAK HM, 1988, J APPL PHYS, V64, P6477, DOI 10.1063/1.342064; Al-Kahlout A., 2009, IONICS, V16, P13; Opris DM, 2011, ADV FUNCT MATER, V21, P3531, DOI 10.1002/adfm.201101039; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; McCarthy DN, 2012, COMPOS SCI TECHNOL, V72, P731, DOI 10.1016/j.compscitech.2012.01.026; Risse S, 2012, ADV FUNCT MATER, V22, P3958, DOI 10.1002/adfm.201200320; Carpi F, 2008, ADV FUNCT MATER, V18, P235, DOI 10.1002/adfm.200700757; O'Halloran A, 2008, J APPL PHYS, V104, DOI 10.1063/1.2981642; Madden JD, 2007, SCIENCE, V318, P1094, DOI 10.1126/science.1146351; Carpi F, 2011, ADV FUNCT MATER, V21, P4152, DOI 10.1002/adfm.201101253; Wongtimnoi K, 2011, COMPOS SCI TECHNOL, V71, P885, DOI 10.1016/j.compscitech.2011.02.003; Tian M, 2014, J MATER CHEM C, V2, P8388, DOI 10.1039/c4tc01140f; Huang C, 2004, ADV FUNCT MATER, V14, P501, DOI 10.1002/adfm.200305021; Kim B, 2011, ADV FUNCT MATER, V21, P3242, DOI 10.1002/adfm.201100298; Huang C, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2105997; Stoyanov H, 2011, SOFT MATTER, V7, P194, DOI 10.1039/c0sm00715c; Kussmaul B, 2011, ADV FUNCT MATER, V21, P4589, DOI 10.1002/adfm.201100884; Yang D, 2012, MATER LETT, V76, P229, DOI 10.1016/j.matlet.2012.02.084; Chen LZ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2955513; Rosset S, 2009, ADV FUNCT MATER, V19, P470, DOI 10.1002/adfm.200801218; Molberg M, 2010, ADV FUNCT MATER, V20, P3280, DOI 10.1002/adfm.201000486; Huang C, 2005, ADV MATER, V17, P1153, DOI 10.1002/adma.200401161; Aschwanden M, 2006, OPT LETT, V31, P2610, DOI 10.1364/OL.31.002610; Brochu P, 2010, MACROMOL RAPID COMM, V31, P10, DOI 10.1002/marc.200900425; Huang JS, 2013, ADV FUNCT MATER, V23, P5056, DOI 10.1002/adfm.201300402; Carpi F, 2010, SCIENCE, V330, P1759, DOI 10.1126/science.1194773; Yang D, 2013, RSC ADV, V3, P21896, DOI 10.1039/c3ra42688b; Gallone G, 2007, MAT SCI ENG C-BIO S, V27, P110, DOI 10.1016/j.msec.2006.03.003; Hanai T, 1960, COLLOID POLYM SCI, V171, P23, DOI DOI 10.1007/BF01520320; NALWA HS, 1985, EUR POLYM J, V21, P943, DOI 10.1016/0014-3057(85)90180-6; Carpi F, 2008, DIELECTRIC ELASTOMERS AS ELECTROMECHANICAL TRANSDUCERS: FUNDAMENTALS, MATERIALS, DEVICES, MODELS AND APPLICATIONS OF AN EMERGING ELECTROACTIVE POLYMER TECHNOLOGY, P1	31	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	4					1483	1491		10.1039/c4ta04197f		9	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AX4MH	WOS:000346906100017		
J	Liu, HM; Yonezawa, A; Kumagai, K; Sano, M; Miyake, T				Liu, Huimin; Yonezawa, Akihiro; Kumagai, Keisuke; Sano, Makoto; Miyake, Takanori			Cs and Sr removal over highly effective adsorbents ETS-1 and ETS-2	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							ION-EXCHANGE; TITANOSILICATE ETS-10; SYNTHETIC ZEOLITES; LIQUID WASTE; ADSORPTION; SILICA; CESIUM; PURIFICATION; SELECTIVITY; ENVIRONMENT	Engelhard titanosilicate-1 (ETS-1) and Engelhard titanosilicate-2 (ETS-2) were prepared. It was the first time their properties were studied for applications in water treatment. The performance of ETS-1 and ETS-2 in Cs and Sr removal was investigated and compared with those of ETS-4, Na-Y and Na-ZSM-5. Characterization revealed successful synthesis of ETS-1 and ETS-2, having Layered structures with specific surface areas of about 120 m(2) g(-1) and 220 m(2) g(-1), respectively. The compositions of ETS-1 and ETS-2 were analyzed by XRF and TGA, and the theoretical exchange capacities for monovalent cations were calculated to be 6.70 mmol g(-1) and 8.12 mmol g(-1), respectively, assuming all the alkali metal cations could be exchanged. ETS-1 showed the highest Cs removal performance among the adsorbents studied, whereas ETS-2 was promising in Sr removal. In competitive removal experiments for Cs and Sr, the highest amount of Cs uptake was observed over ETS-1, though ETS-1 did not show specific selectivity to Cs removal.	[Liu, Huimin] Kansai Univ, Dept Chem Energy & Environm Engn, Suita, Osaka 5648680, Japan; Kansai Univ, High Technol Res Ctr, Suita, Osaka 5648680, Japan	Liu, HM (reprint author), Kansai Univ, Dept Chem Energy & Environm Engn, 3-3-35 Yamate, Suita, Osaka 5648680, Japan.	liuhuimin08@tsinghua.org.cn; tmiyake@kansai-u.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan)	This work was financially supported by MEXT*-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016. (* Ministry of Education, Culture, Sports, Science and Technology of Japan.)	Al-Attar L, 2003, J MATER CHEM, V13, P2969, DOI 10.1039/b308060a; Moon JK, 2004, KOREAN J CHEM ENG, V21, P1026, DOI 10.1007/BF02705588; Popa K, 2012, DESALINATION, V293, P78, DOI 10.1016/j.desal.2012.02.027; Chen CL, 2009, J HAZARD MATER, V164, P923, DOI 10.1016/j.jhazmat.2008.08.089; Cherry BR, 2004, J SOLID STATE CHEM, V177, P2079, DOI 10.1016/j.jssc.2004.02.020; Chegrouche S, 2009, DESALINATION, V235, P306, DOI 10.1016/j.desal.2008.01.018; Rezaei S, 2012, IND ENG CHEM RES, V51, P12430, DOI 10.1021/ie300244y; Pavel CC, 2014, CHEM ENG J, V245, P288, DOI 10.1016/j.cej.2014.02.036; Woolery GL, 1997, ZEOLITES, V19, P288, DOI 10.1016/S0144-2449(97)00086-9; Sudheesh N, 2014, APPL CATAL A-GEN, V473, P116, DOI 10.1016/j.apcata.2014.01.002; Park Y, 2013, CHEM ENG J, V220, P204, DOI 10.1016/j.cej.2013.01.027; Li YM, 2014, APPL CATAL A-GEN, V469, P45, DOI 10.1016/j.apcata.2013.09.028; Casnati A, 2001, J AM CHEM SOC, V123, P12182, DOI 10.1021/ja016597f; Barreira LD, 2009, CHEM ENG J, V155, P728, DOI 10.1016/j.cej.2009.09.014; Asadollahi M, 2010, SEP PURIF TECHNOL, V76, P120, DOI 10.1016/j.seppur.2010.09.029; Chitra S, 2013, J RADIOANAL NUCL CH, V295, P607, DOI 10.1007/s10967-012-1812-0; Cruciani G, 1998, MICROPOR MESOPOR MAT, V21, P143, DOI 10.1016/S1387-1811(97)00051-6; Dobelin N, 2007, MICROPOR MESOPOR MAT, V99, P279, DOI 10.1016/j.micromeso.2006.09.033; Dyer A, 2000, J MATER CHEM, V10, P1867, DOI 10.1039/b002435j; Kawai T, 1998, ADSORPTION, V4, P225, DOI 10.1023/A:1008825531341; Koudsi Y., 2001, J RADIOANAL NUCL CH, V247, P209, DOI 10.1023/A:1006720710807; Kuznicld S. M., 1991, US. Patent, Patent No. [US 5011591 A, 5011591]; Martland HS, 1925, J AMER MED ASSOC, V85, P1769; Naderi M, 1996, ZEOLITES, V17, P437, DOI 10.1016/S0144-2449(96)00096-6; Nair S, 2001, CHEM MATER, V13, P4247, DOI 10.1021/cm0103803; Noh YD, 2012, SEP PURIF TECHNOL, V95, P222, DOI 10.1016/j.seppur.2012.05.013; Noh YD, 2011, ENVIRON SCI TECHNOL, V45, P6954, DOI 10.1021/es200712r; Pavel CC, 2003, J RADIOANAL NUCL CH, V258, P243, DOI 10.1023/A:1026269217431; Pavel CC, 2011, J MATER CHEM, V21, P3831, DOI 10.1039/c0jm03135f; Pavel CC, 2008, J MATER CHEM, V18, P3342, DOI 10.1039/b805049j; Pavel CC, 2007, PHYS CHEM CHEM PHYS, V9, P3440, DOI 10.1039/b701773a; SINHA PK, 1995, WASTE MANAGE, V15, P149, DOI 10.1016/0956-053X(95)00014-Q; Song YJ, 2013, J INORG ORGANOMET P, V23, P1325, DOI 10.1007/s10904-013-9927-5; Thammawong C, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1689-z; Valtchev V, 1999, MICROPOR MESOPOR MAT, V32, P287, DOI 10.1016/S1387-1811(99)00117-1; Watanabe Y, 2004, SEPAR SCI TECHNOL, V39, P2091, DOI 10.1081/SS-120039306; Zhang AY, 2006, SEP PURIF TECHNOL, V50, P35, DOI 10.1016/j.seppur.2005.11.006	37	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	4					1562	1568		10.1039/c4ta06170e		7	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AX4MH	WOS:000346906100026		
J	Okunaka, S; Tokudome, H; Hitomi, Y; Abe, R				Okunaka, Sayuri; Tokudome, Hiromasa; Hitomi, Yutaka; Abe, Ryu			Facile preparation of stable aqueous titania sols for fabrication of highly active TiO2 photocatalyst films	JOURNAL OF MATERIALS CHEMISTRY A			English	Article							CHEMICAL-MODIFICATION; ANATASE TIO2; ACETIC-ACID; ISOPROPOXIDE; WATER; SEMICONDUCTOR; PEPTIZATION; HYDROLYSIS; TRANSITION; PRECURSORS	Highly stable aqueous titania sols were prepared via a facile process using titanium tetraisopropoxide in the co-existence of acetylacetone and acetic acid. Their co-existence efficiently suppressed the hydrolysis and condensation reaction of titanium tetraisopropoxide even in water, retaining the diameter of titania colloidal particles lower than 10 nm (average diameter d = ca. 4 nm). The titania sols possessed significantly high stability for more than 1 year and could be easily coated on various substrates such as quartz glass via a simple spin-coating method, forming highly homogeneous and transparent films. The calcinations of the coated films in the air at 600 degrees C produced densely packed anatase TiO2 particles; the diameter was retained below 50 nm even after the calcinations at 900 degrees C without phase transition to rutile, maintaining the fairly good transparency of the films. On the other hand, the TiO2 particles prepared on a quartz substrate from other precursors, such as titanium-peroxo-citrate complexes, were found to transform from anatase into the rutile phase at above 700 degrees C with a significant increase in the particle size up to ca. 200 nm. The TiO2 films prepared from the present aqueous titania sols exhibited higher activity for photo-induced surface superhydrophilicity under UV light irradiation than those prepared from other precursors.	[Okunaka, Sayuri; Tokudome, Hiromasa] TOTO LTD, Res Inst, Chigasaki, Kanagawa 2538577, Japan; [Hitomi, Yutaka] Doshisha Univ, Dept Mol Chem & Biochem, Fac Sci & Engn, Kyotanabe, Kyoto 6100321, Japan; [Okunaka, Sayuri; Abe, Ryu] Kyoto Univ, Dept Energy & Hydrocarbon Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Tokudome, H (reprint author), TOTO LTD, Res Inst, 2-8-1 Hanson, Chigasaki, Kanagawa 2538577, Japan.	hiromasa.tokudome@jp.toto.com; ryu-abe@scl.kyoto-u.ac.jp					Kakihana M, 2010, B CHEM SOC JPN, V83, P1285, DOI 10.1246/bcsj.20100103; LIVAGE J, 1988, PROG SOLID STATE CH, V18, P259, DOI 10.1016/0079-6786(88)90005-2; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; Shibata T, 2004, PHYS CHEM CHEM PHYS, V6, P1359, DOI 10.1039/b315777f; SANCHEZ C, 1988, J NON-CRYST SOLIDS, V100, P65, DOI 10.1016/0022-3093(88)90007-5; Schubert U, 2005, J MATER CHEM, V15, P3701, DOI [10.1039/b504269k, 10.1039/B504269K]; Barbe CJ, 1997, J AM CERAM SOC, V80, P3157; SERPONE N, 1995, J PHYS CHEM-US, V99, P16646, DOI 10.1021/j100045a026; Kakihana M, 2001, INORG CHEM, V40, P891, DOI 10.1021/ic001098l; Birnie DP, 1999, MATER CHEM PHYS, V59, P26, DOI 10.1016/S0254-0584(99)00021-8; Vinogradov AV, 2014, J AM CERAM SOC, V97, P290, DOI 10.1111/jace.12560; Chen HJ, 2007, MATER CHEM PHYS, V101, P12, DOI 10.1016/j.matchemphys.2006.02.007; CALZADA ML, 1995, J AM CERAM SOC, V78, P1802, DOI 10.1111/j.1151-2916.1995.tb08892.x; BISCHOFF BL, 1995, CHEM MATER, V7, P1772, DOI 10.1021/cm00058a004; Parra R, 2008, CHEM MATER, V20, P143, DOI 10.1021/cm702286e; DOEUFF S, 1987, J NON-CRYST SOLIDS, V89, P206, DOI 10.1016/S0022-3093(87)80333-2; Jung MW, 1999, B KOR CHEM SOC, V20, P1394; Attar AS, 2008, J MATER SCI, V43, P1723, DOI 10.1007/s10853-007-2244-z; Bersani D, 1998, J NON-CRYST SOLIDS, V232, P175, DOI 10.1016/S0022-3093(98)00489-X; Djaoued Y, 2002, J SOL-GEL SCI TECHN, V24, P255, DOI 10.1023/A:1015357313003; DOEUFF S, 1990, MATER RES BULL, V25, P1519, DOI 10.1016/0025-5408(90)90129-P; Lgaustic A., 1989, CHEM MATER, V1, P240; Lgaustic A., 1989, CHEM MATER, V1, P248; Livage J., 1992, J NONCRYST SOLIDS, V145, P11; Moran PD, 1998, INORG CHEM, V37, P2741, DOI 10.1021/ic9709436; Nakamoto K., 1962, INFRARED RAMAN SPECT; Ohya T, 2004, J SOL-GEL SCI TECHN, V30, P71, DOI 10.1023/B:JSST.0000034694.61859.78; Ohya Y, 1999, J AM CERAM SOC, V82, P2601; Pavia D.L., 1979, INTRO SPECTROSCOPY; Scolan E, 1998, CHEM MATER, V10, P3217, DOI 10.1021/cm980322q; Wentzel R. N., 1936, IND ENG CHEM, V28, P988; YAMAMOTO A, 1957, J AM CHEM SOC, V79, P4344, DOI 10.1021/ja01573a028	33	6	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7488	2050-7496		J MATER CHEM A	J. Mater. Chem. A		2015	3	4					1688	1695		10.1039/c4ta04680c		8	Chemistry, Physical; Energy & Fuels; Materials Science, Multidisciplinary	Chemistry; Energy & Fuels; Materials Science	AX4MH	WOS:000346906100042		
J	Kohri, M; Nannichi, Y; Taniguchi, T; Kishikawa, K				Kohri, Michinari; Nannichi, Yuri; Taniguchi, Tatsuo; Kishikawa, Keiki			Biomimetic non-iridescent structural color materials from polydopamine black particles that mimic melanin granules	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							AMORPHOUS ARRAYS; THIN-LAYER; SCATTERING; COATINGS; POLYMER; FILMS; NANOPARTICLES; PIGMENTS; SPHERES; SIZE	A novel approach for creating non-iridescent bright structural color materials from polydopamine (PDA) black particles is presented. Two biomimetic features, melanin granules and the amorphous structures found in nature, were incorporated into these materials, consisting of PDA black particles to develop a bright and non-iridescent structural color without using any additives.	[Kohri, Michinari; Nannichi, Yuri; Taniguchi, Tatsuo; Kishikawa, Keiki] Chiba Univ, Div Appl Chem & Biotechnol, Grad Sch Engn, Inage Ku, Chiba 2638522, Japan	Kohri, M (reprint author), Chiba Univ, Div Appl Chem & Biotechnol, Grad Sch Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	kohri@faculty.chiba-u.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26810065]; Noguchi Institute; JGC-S Scholarship Foundation; Murata Science Foundation; Nanohana Competition	M. K. acknowledges the support of a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 26810065), the Noguchi Institute, the JGC-S Scholarship Foundation, and the Murata Science Foundation. Y.N. acknowledges the support of the Nanohana Competition. We would like to thank Mr Kosuke Hamada and Dr Takashi Kojima (Chiba University) for their assistance with the experiments. We are grateful to the referees for valuable suggestions on revising the paper.	Ahn JS, 2007, ADV FUNCT MATER, V17, P3619, DOI 10.1002/adfm.200700251; Takeoka Y, 2012, J MATER CHEM, V22, P23299, DOI 10.1039/c2jm33643j; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Cong HL, 2013, OPT EXPRESS, V21, P17831, DOI 10.1364/OE.21.017831; Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J; Takeoka Y, 2013, ANGEW CHEM INT EDIT, V52, P7261, DOI 10.1002/anie.201301321; Dong BQ, 2010, OPT EXPRESS, V18, P14430, DOI 10.1364/OE.18.014430; Prum RO, 1998, NATURE, V396, P28, DOI 10.1038/23838; Farnad N, 2012, WATER AIR SOIL POLL, V223, P3535, DOI 10.1007/s11270-012-1131-7; Lee I, 2010, ADV MATER, V22, P4973, DOI 10.1002/adma.201001954; Kohri M, 2013, POLYM CHEM-UK, V4, P2696, DOI 10.1039/c3py00181d; Ai KL, 2013, ADV MATER, V25, P998, DOI 10.1002/adma.201203923; Ho CC, 2013, J MATER SCI-MATER M, V24, P2381, DOI 10.1007/s10856-013-4994-2; Prum RO, 2004, J EXP BIOL, V207, P3999, DOI 10.1242/jeb.01240; Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j; Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222; Prum RO, 2004, J EXP BIOL, V207, P2157, DOI 10.1242/jeb.00989; Noh H, 2010, ADV MATER, V22, P2871, DOI 10.1002/adma.200903699; Xia YN, 2001, ADV MATER, V13, P409, DOI 10.1002/1521-4095(200103)13:6<409::AID-ADMA409>3.0.CO;2-C; Ge DT, 2014, CHEM COMMUN, V50, P2469, DOI 10.1039/c3cc48962k; Kohri M, 2014, COLLOID SURFACE A, V449, P114, DOI 10.1016/j.colsurfa.2014.02.049; Dreyer DR, 2013, CHEM SCI, V4, P3796, DOI 10.1039/c3sc51501j; Forster JD, 2010, ADV MATER, V22, P2939, DOI 10.1002/adma.200903693; Sun JY, 2013, RSC ADV, V3, P14862, DOI 10.1039/c3ra41096j; Shawkey MD, 2006, J R SOC INTERFACE, V3, P527, DOI 10.1098/rsif.2006.0111; Kohri M, 2013, MACROMOL RAPID COMM, V34, P1220, DOI 10.1002/marc.201300395; Dong RH, 2013, CHEM-EUR J, V19, P13099, DOI 10.1002/chem.201301071; Ge DT, 2014, J MATER CHEM C, V2, P4395, DOI 10.1039/c4tc00063c; Harun-Ur-Rashid M, 2010, CHEMPHYSCHEM, V11, P579, DOI 10.1002/cphc.200900869; Yen YT, 2014, ACS APPL MATER INTER, V6, P4292, DOI 10.1021/am406048s; Yoshioka S, 2014, CHEMPHYSCHEM, V15, P2209, DOI 10.1002/cphc.201402095; Yoshioka S., 2007, J PHYS SOC JPN, V76; Yoshioka S., 2002, FORMA, V17, P169; Yue Q, 2013, J MATER CHEM B, V1, P6085, DOI 10.1039/c3tb21028f	34	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	4					720	724		10.1039/c4tc02383h		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX9NL	WOS:000347229200002		
J	Purc, A; Sobczyk, K; Sakagami, Y; Ando, A; Kamada, K; Gryko, DT				Purc, Anna; Sobczyk, Krzysztof; Sakagami, Yusuke; Ando, Akihiro; Kamada, Kenji; Gryko, Daniel T.			Strategy towards large two-photon absorption cross-sections for diketopyrrolopyrroles	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; PI-EXPANDED DIKETOPYRROLOPYRROLES; NEAR-INFRARED DYES; SOLAR-CELLS; ORGANIC PHOTOVOLTAICS; CONJUGATED POLYMERS; OPTICAL-PROPERTIES; DPP PIGMENTS; DERIVATIVES	Three quadrupolar donor-acceptor-donor compounds bearing diketopyrrolopyrroles as a central core and exceptionally electron-rich diarylaminofurans and dialkylaminobenzofuran as donors were designed. Straightforward synthesis afforded these dyes in good overall yield. These donor-acceptor-donor systems turned out to be strong red-emitters with fluorescence extending well into the NIR region. Two-photon brightness (850-1900 GM) was found to be larger than for any previously studied diketopyrrolopyrrole dyes.	[Purc, Anna; Sobczyk, Krzysztof; Gryko, Daniel T.] Polish Acad Sci, Inst Organ Chem, PL-01224 Warsaw, Poland; [Sobczyk, Krzysztof; Gryko, Daniel T.] Warsaw Univ Technol, Fac Chem, PL-00664 Warsaw, Poland; [Sakagami, Yusuke; Ando, Akihiro; Kamada, Kenji] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan; [Sakagami, Yusuke; Kamada, Kenji] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda, Hyogo 6691337, Japan; [Ando, Akihiro] Ritsumeikan Univ, Coll Life Sci, Dept Appl Chem, Kusatsu 5258577, Japan	Gryko, DT (reprint author), Polish Acad Sci, Inst Organ Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	k.kamada@aist.go.jp; dgryko@icho.edu.pl	Gryko, Daniel/A-7998-2008		European Commission (TOPBIO ITN); BASF-Schweiz; MEXT, Japan [25109544]; JSPS [25248007]	We thank the Foundation for Polish Science (TEAM-2009-4/3). This work was partially supported by the European Commission (TOPBIO ITN), BASF-Schweiz, and a Grant-in-Aid for Scientific Research on Innovative Areas 'Stimuli-Responsive Chemical Species' (no. 25109544, KK) from MEXT, Japan and no. 25248007 (KK) from JSPS. KK thanks Dr N. Murase for access to the TCSPC equipment.	Ha TJ, 2013, PHYS CHEM CHEM PHYS, V15, P9735, DOI 10.1039/c3cp51478a; Kamada K, 2003, J OPT SOC AM B, V20, P529, DOI 10.1364/JOSAB.20.000529; Li YN, 2012, PHYS CHEM CHEM PHYS, V14, P7162, DOI 10.1039/c2cp40937b; Shimizu S, 2013, CHEM COMMUN, V49, P1621, DOI 10.1039/c3cc38452g; Marks T, 2014, CHEM-EUR J, V20, P6494, DOI 10.1002/chem.201304235; Woo HY, 2005, J AM CHEM SOC, V127, P13794, DOI 10.1021/ja054911q; Lu C, 2013, CHEM-ASIAN J, V8, P2813, DOI 10.1002/asia.201300677; Qu SY, 2012, CHEM COMMUN, V48, P6972, DOI 10.1039/c2cc31998e; Coffin RC, 2009, NAT CHEM, V1, P657, DOI [10.1038/nchem.403, 10.1038/NCHEM.403]; Suraru SL, 2011, CHEM COMMUN, V47, P1767, DOI 10.1039/c0cc04395h; Fischer GM, 2010, CHEM COMMUN, V46, P5289, DOI 10.1039/c0cc00359j; Tantiwiwat M, 2008, J PHYS CHEM C, V112, P17402, DOI 10.1021/jp8068305; Hao ZM, 1997, CHEM SOC REV, V26, P203, DOI 10.1039/cs9972600203; Grzybowski M, 2012, ORG LETT, V14, P2670, DOI 10.1021/ol300674v; IQBAL A, 1988, B SOC CHIM BELG, V97, P615; Kamada K, 2003, CHEM PHYS LETT, V372, P386, DOI 10.1016/S0009-2614(03)00413-5; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Liu SY, 2013, J MATER CHEM A, V1, P2795, DOI 10.1039/c2ta01318e; Burgi L, 2008, ADV MATER, V20, P2217, DOI 10.1002/adma.200702775; Morton CJH, 2002, TETRAHEDRON, V58, P5547; Ripaud E, 2012, DYES PIGMENTS, V95, P126, DOI 10.1016/j.dyepig.2012.03.021; Kanibolotsky AL, 2011, ADV MATER, V23, P2093, DOI 10.1002/adma.201100308; Liu JH, 2013, ADV FUNCT MATER, V23, P47, DOI 10.1002/adfm.201201599; Fischer GM, 2009, CHEM-EUR J, V15, P4857, DOI 10.1002/chem.200801996; Grzybowski M, 2014, CHEM-EUR J, V20, P12493, DOI 10.1002/chem.201402569; Qu SY, 2012, CHEM COMMUN, V48, P3039, DOI 10.1039/c2cc17886a; He GS, 2008, CHEM REV, V108, P1245, DOI 10.1021/cr050054x; Wallquist O, 2002, MACROMOL SYMP, V187, P617, DOI 10.1002/1521-3900(200209)187:1<617::AID-MASY617>3.0.CO;2-5; Jeong YH, 2012, CHEM-ASIAN J, V7, P1562, DOI 10.1002/asia.201101038; Fischer GM, 2007, ANGEW CHEM INT EDIT, V46, P3750, DOI 10.1002/anie.200604763; Pawlicki M, 2009, ANGEW CHEM INT EDIT, V48, P3244, DOI 10.1002/anie.200805257; Burckstummer H, 2011, J ORG CHEM, V76, P2426, DOI 10.1021/jo2003117; Zambounis JS, 1997, NATURE, V388, P131, DOI 10.1038/40532; Yamagata T, 2014, TETRAHEDRON, V70, P1451, DOI 10.1016/j.tet.2013.12.090; Sonar P, 2012, J MATER CHEM, V22, P4425, DOI 10.1039/c2jm14989c; Yue W, 2014, ANGEW CHEM INT EDIT, V53, P6159, DOI 10.1002/anie.201403227; Wienk MM, 2008, ADV MATER, V20, P2556, DOI 10.1002/adma.200800456; Li YN, 2013, ENERG ENVIRON SCI, V6, P1684, DOI 10.1039/c3ee00015j; Yoon WS, 2013, ADV FUNCT MATER, V23, P3519, DOI 10.1002/adfm.201203065; Hendriks KH, 2013, ANGEW CHEM INT EDIT, V52, P8341, DOI 10.1002/anie.201302319; Colonna G, 2007, DYES PIGMENTS, V75, P125, DOI 10.1016/j.dyepig.2006.05.024; Duggeli M., 2010, Int. Pat. Appl., Patent No. [WO2010/049321, 2014054060]; FARNUM DG, 1974, TETRAHEDRON LETT, P2549; Ftouni H, 2013, DYES PIGMENTS, V97, P77, DOI 10.1016/j.dyepig.2012.11.028; GORVIN JH, 1988, J CHEM SOC PERK T 1, P1331, DOI 10.1039/p19880001331; Gudipati V, 2006, J ORG CHEM, V71, P3599, DOI 10.1021/jo060217x; Guo EQ, 2009, CHEM COMMUN, P5859, DOI 10.1039/b911808j; HIROTA T, 1986, J HETEROCYCLIC CHEM, V23, P1347; Kamada K, 2007, ANGEW CHEM INT EDIT, V46, P3544, DOI 10.1002/anie.200605061; Kaur M., 2014, CHEM SOC REV, DOI [10.1039/ c4cs00248b, DOI 10.1039/C4CS00248B;]; Kawamata J., 2012, CURR PHARM BIOTECHNO, V13, P256; Kim HM, 2009, CHEM COMMUN, P153, DOI 10.1039/b813280a; Kirkus M, 2013, J PHYS CHEM A, V117, P4828, DOI 10.1021/jp312315k; Kuwabara J, 2010, TETRAHEDRON, V66, P3736, DOI 10.1016/j.tet.2010.03.067; Kwon O, 2013, J MATER CHEM A, V1, P7118, DOI 10.1039/c3ta11058c; Nielsen C. B., 2013, ADV MATER, V13, P1859; Rochat A. C., 1983, EUR PAT APPL, Patent No. 94911; Stas S, 2013, DYES PIGMENTS, V97, P198, DOI 10.1016/j.dyepig.2012.12.005; Tieke B, 2010, BEILSTEIN J ORG CHEM, V6, P830, DOI 10.3762/bjoc.6.92; Yamagata T, 2010, TETRAHEDRON LETT, V51, P1596, DOI 10.1016/j.tetlet.2010.01.069	60	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	4					742	749		10.1039/c4tc02375g		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX9NL	WOS:000347229200006		
J	Teshima, M; Seki, T; Kawano, R; Takeuchi, S; Yoshioka, S; Takeoka, Y				Teshima, Midori; Seki, Takahiro; Kawano, Ryuji; Takeuchi, Shoji; Yoshioka, Shinya; Takeoka, Yukikazu			Preparation of structurally colored, monodisperse spherical assemblies composed of black and white colloidal particles using a micro-flow-focusing device	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							SHORT-RANGE ORDER; AMORPHOUS ARRAYS; PHOTONIC CRYSTALS; MICROFLUIDIC DEVICE; SILICA PARTICLES; LIGHT; SCATTERING; COLORATION; PIGMENTS; NANOSTRUCTURES	It is very annoying when colors fade over time from exposure to bright light. A structurally colored material is a strong candidate for the fabrication of non-fading colored materials composed of environmentally friendly and non-toxic chemicals. We demonstrate that by using a micro-flow-focusing device, monodisperse spherical assemblies displaying various structural colors in air can be prepared from a suspension containing environmentally friendly white and black colloidal particles: monodisperse submicron-sized SiO2 colloidal particles and black magnetite colloidal particles. The average size of the monodisperse spherical assemblies can be controlled by changing the amount of SiO2 colloidal particles used in the preparation of the suspension. The hue of the monodisperse spherical assemblies can be varied by simply altering the size of the SiO2 colloidal particles. These monodisperse spherical assemblies exhibit either iridescent or non-iridescent structural colors, depending on the aggregation state of the SiO2 colloidal particles, which can be controlled by the presence or absence of an electrolyte. Moreover, the saturation of the colors produced by the monodisperse spherical assemblies can be altered by modifying the amount of magnetite colloidal particles that is added. Our results should offer new possibilities for structurally colored materials for future application in pigments and test agents.	[Teshima, Midori; Seki, Takahiro; Takeoka, Yukikazu] Nagoya Univ, Dept Mol Design & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kawano, Ryuji; Takeuchi, Shoji] Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; [Kawano, Ryuji] Tokyo Univ Agr & Technol, Div Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Yoshioka, Shinya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Takeoka, Y (reprint author), Nagoya Univ, Dept Mol Design & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	syoshi@.s.osaka-u.ac.jp; ytakeoka@apchem.nagoya-u.ac.jp	Kawano, Ryuji/A-3177-2011		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23245047, 22340121, 22107012, 26400432]	This work was supported by Grants-in-Aid for Scientific Research (no. 23245047, No. 22340121, no. 22107012, and no. 26400432) on the Innovative Areas of "Fusion Materials" (area no. 2206) and "Engineering Neo-Biomimetics" (area no. 4402) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Takeoka Y, 2012, J MATER CHEM, V22, P23299, DOI 10.1039/c2jm33643j; Miguez H, 1998, ADV MATER, V10, P480, DOI 10.1002/(SICI)1521-4095(199804)10:6<480::AID-ADMA480>3.0.CO;2-Y; Noh H, 2010, OPT EXPRESS, V18, P11942, DOI 10.1364/OE.18.011942; Park JG, 2014, ANGEW CHEM INT EDIT, V53, P2899, DOI 10.1002/anie.201309306; Liew SF, 2011, OPT EXPRESS, V19, P8208, DOI 10.1364/OE.19.008208; Takeoka Y, 2013, ANGEW CHEM INT EDIT, V52, P7261, DOI 10.1002/anie.201301321; Kuang MX, 2014, ADV OPT MATER, V2, P34, DOI 10.1002/adom.201300369; Prum RO, 1998, NATURE, V396, P28, DOI 10.1038/23838; Yang JK, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.053838; Fudouzi H, 2003, ADV MATER, V15, P892, DOI 10.1002/adma.200304795; Garcia PD, 2007, ADV MATER, V19, P2597, DOI 10.1002/adma.200602426; Ge JP, 2011, ANGEW CHEM INT EDIT, V50, P1492, DOI 10.1002/anie.200907091; Rastogi V, 2008, ADV MATER, V20, P4263, DOI 10.1002/adma.200703008; Takeoka Y, 2009, ACS APPL MATER INTER, V1, P982, DOI 10.1021/am900074v; Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007; Cramer C, 2004, CHEM ENG SCI, V59, P3045, DOI 10.1016/j.ces.2004.04.006; Utada AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.094502; Velev OD, 2000, SCIENCE, V287, P2240, DOI 10.1126/science.287.5461.2240; Shi L, 2013, ADV MATER, V25, P5314, DOI 10.1002/adma.201301909; Marlow F, 2009, ANGEW CHEM INT EDIT, V48, P6212, DOI 10.1002/anie.200900210; Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Takeuchi S, 2005, ADV MATER, V17, P1067, DOI 10.1002/adma.200401738; Aguirre CI, 2010, ADV FUNCT MATER, V20, P2565, DOI 10.1002/adfm.201000143; Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y; Takeoka Y, 2013, J MATER CHEM C, V1, P6059, DOI 10.1039/c3tc30885e; Forster JD, 2010, ADV MATER, V22, P2939, DOI 10.1002/adma.200903693; Park SH, 1999, ADV MATER, V11, P462, DOI 10.1002/(SICI)1521-4095(199904)11:6<462::AID-ADMA462>3.0.CO;2-U; Liew SF, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.063818; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Kim SH, 2008, ADV MATER, V20, P4129, DOI 10.1002/adma.200801167; Moon JH, 2004, ADV MATER, V16, P605, DOI 10.1002/adma.200305446; Ge DT, 2014, J MATER CHEM C, V2, P4395, DOI 10.1039/c4tc00063c; Gotoh Y, 2012, NEW J CHEM, V36, P2171, DOI 10.1039/c2nj40368d; Harun-Ur-Rashid M, 2010, CHEMPHYSCHEM, V11, P579, DOI 10.1002/cphc.200900869; Hirashima R, 2014, J MATER CHEM C, V2, P344, DOI 10.1039/c3tc31438c; Kim SH, 2009, ADV MATER, V21, P3771, DOI 10.1002/adma.200901243; Lan WJ, 2011, LANGMUIR, V27, P13242, DOI 10.1021/la202055f; Miguez H, 2003, ADV MATER, V15, P597, DOI 10.1002/adma.200304043; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Takeoka Y., 2013, SCI REP, V3; Yi GR, 2002, ADV MATER, V14, P1137, DOI 10.1002/1521-4095(20020816)14:16<1137::AID-ADMA1137>3.0.CO;2-2; Yoshioka S, 2014, CHEMPHYSCHEM, V15, P2209, DOI 10.1002/cphc.201402095	43	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	4					769	777		10.1039/c4tc01929f		9	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX9NL	WOS:000347229200009		
J	Sato, T; Uejima, M; Tanaka, K; Kaji, H; Adachi, C				Sato, Tohru; Uejima, Motoyuki; Tanaka, Kazuyoshi; Kaji, Hironori; Adachi, Chihaya			A light-emitting mechanism for organic light-emitting diodes: molecular design for inverted singlet-triplet structure and symmetry-controlled thermally activated delayed fluorescence	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							VIBRONIC COUPLING DENSITY; ELECTROPHOSPHORESCENT DEVICES; OPERATIONAL STABILITY; ELECTROLUMINESCENCE; DERIVATIVES; ANTHRACENE; AZULENE; PYRENE; STATE	The concepts of symmetry-controlled thermally activated delayed fluorescence (SC-TADF) and inverted singlet-triplet (iST) structure are proposed. Molecules that can exhibit SC-TADF or have an iST structure can be employed as light-emitting molecules in organic light-emitting diodes. The molecular symmetry plays crucial roles in these concepts since they are based on the selection rules for the electric dipole transition, intersystem crossing, and nonradiative vibronic (electron-vibration) transitions. In addition to the symmetry conditions for the SC-TADF and iST molecules, the molecules should have small diagonal and off-diagonal vibronic coupling constants for suppressing vibrational relaxations and nonradiative vibronic transitions, respectively, and a large transition dipole moment for the fluorescence process. Analyses using the vibronic coupling and transition dipole moment densities are employed to reduce the vibronic coupling constants and to increase the transition dipole moment. The preferable point groups in the development of SC-TADF and iST molecules are discussed on the basis of the ratios of forbidden pairs of irreducible representations. It is found that the existence of the inversion symmetry is preferable for designing SC-TADF and iST molecules. On the basis of these guiding principles, we designed some anthracene and pyrene derivatives as candidate iST molecules. Their electronic structures, spin-orbit couplings, transition dipole moments, and vibronic couplings are discussed.	[Sato, Tohru; Uejima, Motoyuki; Tanaka, Kazuyoshi] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Sato, Tohru] Kyoto Univ, Unit Elements Strategy Initiat Catalysts & Batter, Nishikyo Ku, Kyoto 6158510, Japan; [Kaji, Hironori] Kyoto Univ, Chem Res Inst, Uji, Kyoto 6110011, Japan; [Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan	Sato, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	tsato@moleng.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24550210]	Numerical calculations were performed partly at the Super-computer Laboratory of Kyoto University and at the Research Center for Computational Science, Okazaki, Japan. This research was supported by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). This work was also supported by a Grant-in-Aid for Scientific Research (C) (24550210) from JSPS.	Altmann S., 1994, POINT GROUP THEORY T; MURATA S, 1972, CHEM PHYS LETT, V13, P101, DOI 10.1016/0009-2614(72)80054-X; BEER M, 1955, J CHEM PHYS, V23, P1390, DOI 10.1063/1.1742314; Sato T, 2013, J PHYS CONF SER, V428, DOI 10.1088/1742-6596/428/1/012010; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Itoh T, 2012, CHEM REV, V112, P4541, DOI 10.1021/cr200166m; Uejima M, 2014, CHEM PHYS, V430, P47, DOI 10.1016/j.chemphys.2013.12.015; Hayer A, 2006, J PHYS CHEM B, V110, P7653, DOI 10.1021/jp0573689; Adachi C, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.060101; Endo A, 2009, ADV MATER, V21, P4802, DOI 10.1002/adma.200900983; Baldo MA, 2000, NATURE, V403, P750; Laporte O, 1925, J OPT SOC AM REV SCI, V11, P459, DOI 10.1364/JOSA.11.000459; Fujimoto K, 2009, TETRAHEDRON, V65, P9357, DOI 10.1016/j.tet.2009.08.079; Nakagawa T, 2012, CHEM COMMUN, V48, P9580, DOI 10.1039/c2cc31468a; D'Andrade BW, 2004, ADV MATER, V16, P1585, DOI 10.1002/adma.200400684; Kwong RC, 2002, APPL PHYS LETT, V81, P162, DOI 10.1063/1.1489503; ADACHI C, 1989, APPL PHYS LETT, V55, P1489, DOI 10.1063/1.101586; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Meerheim R, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2268354; LOWER SK, 1966, CHEM REV, V66, P199, DOI 10.1021/cr60240a004; Hung LS, 2002, MAT SCI ENG R, V39, P143, DOI 10.1016/S0927-796X(02)00093-1; Endo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558906; Sato T, 2008, CHEM PHYS LETT, V458, P152, DOI 10.1016/j.cplett.2008.04.084; Wu CC, 2004, ADV MATER, V16, P61, DOI 10.1002/adma.200305619; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Bachilo SM, 2000, J PHYS CHEM A, V104, P11265, DOI 10.1021/jp002742k; Baleizao C, 2008, ANN NY ACAD SCI, V1130, P224, DOI 10.1196/annals.1430.044; Berlman I.B., 1965, HDB FLUORESCENCE SPE; Bersuker I. B., 1989, VIBRONIC INTERACTION; Birks J. B., 1970, PHOTOPHYSICS AROMATI; Cleave V, 1999, ADV MATER, V11, P285; Fischer G., 1984, VIBRONIC COUPLING IN; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hamermesh M, 1962, GROUP THEORY ITS APP; KASHA M, 1950, DISCUSS FARADAY SOC, P14, DOI 10.1039/df9500900014; KASHA M, 1960, Radiat Res, VSuppl 2, P243, DOI 10.2307/3583599; KOSEKI S, 1995, J PHYS CHEM-US, V99, P12764, DOI 10.1021/j100034a013; LANGHOFF SR, 1980, J CHEM PHYS, V73, P2379, DOI 10.1063/1.440388; Park YH, 2006, CURR APPL PHYS, V6, P691, DOI 10.1016/j.cap.2005.04.021; Salazar FA, 1997, CHEM PHYS LETT, V271, P361, DOI 10.1016/S0009-2614(97)00469-7; Sato T, 2008, J PHYS CHEM A, V112, P758, DOI 10.1021/jp076962a; Sato T, 2009, SPRINGER SER CHEM PH, V97, P99; Su TH, 2013, J MATER CHEM C, V1, P5084, DOI 10.1039/c3tc30823e; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Tao Y., 2014, ADV MATER, P1; Tseng RJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2167814; Tsuzuki T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3073709; Turro N.J., 1991, MODERN MOL PHOTOCHEM; Uejima M, 2014, CHEM PHYS LETT, V602, P80, DOI 10.1016/j.cplett.2014.04.017; Valeur B., 2002, MOL FLUORESCENCE, V158, P41; Wang BC, 2003, J MOL STRUC-THEOCHEM, V629, P11, DOI 10.1016/S0166-12800(02)00787-X; Yao L., 2014, ANGEW CHEM, V126, P2151	52	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C		2015	3	4					870	878		10.1039/c4tc02320j		9	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX9NL	WOS:000347229200020		
J	Davies, CM; Ahn, J; Tsunori, M; Dye, D; Nikbin, KM				Davies, C. M.; Ahn, J.; Tsunori, M.; Dye, D.; Nikbin, K. M.			The Influence of Pre-existing Deformation on GMA Welding Distortion in Thin Steel Plates	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						DH-36 steel; distortion; residual stress; welding simulation	RESIDUAL-STRESS; NUMERICAL-SIMULATION; MODEL; SUPERALLOY; JOINT	Weld distortion is particularly problematic for large thin structures that are used in the assembly of ships. The drive toward lighter ships and thinner plate is restricted by the significant increase in distortion as the plate thickness decreases. The influence of pre-existing deformation in the plates to be joined on the resultant distortion in gas metal arc welded structure has been studied. DH-36 steel plate surface profiles were measured before and after the butt welding of two plates 1000 x 500 x 4 mm in size. Three dimensional finite element models that incorporate the initial plate profile have been created to simulate the welding process and to examine the relationship between the final welded plate profiles and the initial deformation present in the plates. Both symmetric and asymmetric models were considered. A significant variation in the unwelded base plates' initial distortion was observed. Generally, it has been found that if an out-of-plane deformation exists in a plate prior to welding, the level of distortion further increases in the same direction following welding. The final distortions are strongly related to the initial plate profiles. The residual stress distributions in the plates are also to some extent affected by the level of distortion initially present.	[Davies, C. M.; Ahn, J.; Nikbin, K. M.] Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, London SW7 2AZ, England; [Tsunori, M.] Ishikawajima Harima Heavy Ind Co Ltd, Isogo Ku, Yokohama, Kanagawa 2358501, Japan; [Dye, D.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England	Ahn, J (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mech Engn, South Kensington Campus, London SW7 2AZ, England.	joseph.ahn08@imperial.ac.uk	Ahn, Joseph/M-2538-2014; Dye, David/B-5603-2012	Ahn, Joseph/0000-0002-3109-5941; Dye, David/0000-0002-8756-3513	EPSRC [EP/D060729/1, GR/T26344/01, EP/H004882/1]	The authors would like to acknowledge Dr. Martyn Lightfoot of Newcastle University for the provision of the experimental distortion data and Dr. Norrie McPherson of BAE Systems, Govan, Scotland, UK for provision of welding facilities and materials. Funding was supplied via EPSRC Grants EP/D060729/1, GR/T26344/01 and EP/H004882/1.	ABAQUS, 2006, AN US MAN V6 6; GOLDAK J, 1984, METALL TRANS B, V15, P299, DOI 10.1007/BF02667333; Shan X, 2009, INT J PRES VES PIP, V86, P110, DOI 10.1016/j.ijpvp.2008.11.005; Mollicone P, 2006, J MATER PROCESS TECH, V176, P77, DOI 10.1016/j.jmatprotec.2006.02.022; Tsirkas SA, 2003, J MATER PROCESS TECH, V134, P59, DOI 10.1016/S0924-0136(02)00921-4; Smith MC, 2009, INT J PRES VES PIP, V86, P79, DOI 10.1016/j.ijpvp.2008.11.017; Sadovsky Z, 2006, J CONSTR STEEL RES, V62, P369, DOI 10.1016/j.jcsr.2005.07.013; Abid M, 2005, INT J PRES VES PIP, V82, P860, DOI 10.1016/j.ijpvp.2005.06.008; Lindgren LE, 2001, J THERM STRESSES, V24, P141, DOI 10.1080/01495730150500442; LINDGREN LE, 1988, INT J NUMER METH ENG, V25, P635, DOI 10.1002/nme.1620250223; Lindgren LE, 2001, J THERM STRESSES, V24, P195, DOI 10.1080/014957301300006380; BIBBY MJ, 1985, CAN METALL QUART, V24, P101; Cui W., 1998, MARINE STRUCTURES, V11, P251, DOI 10.1016/S0951-8339(98)00012-4; Davies C. M., 2009, ASME PRESS VESS PIP, P327; Davies CM, 2007, PRES VES P, P851; Dye D, 2001, METALL MATER TRANS A, V32, P1713, DOI 10.1007/s11661-001-0149-z; Dye D., 2010, SCI TECHNOL WELD JOI, V15, P393; Gardner L, 2004, J STRUCT ENG-ASCE, V130, P1586, DOI 10.1061/(ASCE)0733-9445(2004)130:10(1586); Goldan M., 2003, J SHIP PROD, V192, P98; Huang T. D., 2003, TECHNOL REV J, V11, P1; Lexhas V., 2006, INSPECTION CERTIFICA; Lightfoot MP, 2006, J MATER PROCESS TECH, V172, P238, DOI 10.1016/j.jmatprotec.2005.10.023; Mateus F., 2001, ENG STRUCT, V23, P172; McPherson N. A., 2008, COMMUNICATION; McPherson N. A., 2006, WELD CUTT, V5, P277; Mollicone P, 2008, THIN WALL STRUCT, V46, P1021, DOI 10.1016/j.tws.2008.01.044; Murakawa H., 2008, T JWRI, V37, P75; Oddy S., 1992, J PRESS VESSEL TECHN, V114, P33; Preston RV, 2004, ACTA MATER, V52, P4973, DOI 10.1016/j.actamat.2004.06.048; Roed E., 2006, CERTIFIED MAT TESTS; Stone HJ, 2000, METALL MATER TRANS A, V31, P2261, DOI 10.1007/s11661-000-0143-x; Tsunori M., 2008, ASME PRESS VESS PIP, P299; Yang Y. P., 2004, ASME PRESS VESS PIP, P99	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	JAN	2015	24	1					261	273		10.1007/s11665-014-1313-0		13	Materials Science, Multidisciplinary	Materials Science	AX6KG	WOS:000347030600029		
J	Yonezu, A; Kusano, R; Hiyoshi, T; Chen, X				Yonezu, Akio; Kusano, Ryota; Hiyoshi, Tomohiro; Chen, Xi			A Method to Estimate Residual Stress in Austenitic Stainless Steel Using a Microindentation Test	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						austenitic stainless steel; indentation test; pre-strain; residual stress; reverse analysis	MEASURING ELASTOPLASTIC PROPERTIES; INSTRUMENTED SHARP INDENTATION; MECHANICAL-PROPERTIES; SPHERICAL INDENTATION; SENSING INDENTATION; ALUMINUM-ALLOY; INDENTERS; LOAD	This study proposed a method to evaluate the residual stress and plastic strain of an austenitic stainless steel using a microindentation test. The austenitic stainless steel SUS316L obeys the Ludwick's work hardening law and is subjected to in-plane equi-biaxial residual stress. A numerical experiment with the finite element method (FEM) was carried out to simulate an indentation test for SUS316L having various plastic strains (pre-strains) and residual stresses. It was found that the indentation force increased with increasing pre-strain as well as with compressive residual stress. Next, a parametric FEM study by changing both residual stress sigma(res) and pre-strain epsilon(pre) was conducted to deduce the relationship between the indentation curve and the parameters epsilon(pre) and sigma(res) (which were employed for the FEM study). This relationship can be expressed by a dimensionless function with simple formulae. Thus, the present method can estimate both epsilon(pre) and sigma(res), when a single indentation test is applied to SUS316L.	[Yonezu, Akio; Kusano, Ryota; Hiyoshi, Tomohiro] Chuo Univ, Dept Precis Mech, Bunkyo Ku, Tokyo 1128551, Japan; [Chen, Xi] Columbia Univ, Dept Earth & Environm Engn, New York, NY 10027 USA; [Chen, Xi] Xi An Jiao Tong Univ, Sch Aerosp, SV Lab, Int Ctr Appl Mech, Xian 710049, Peoples R China	Yonezu, A (reprint author), Chuo Univ, Dept Precis Mech, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	yonezu@mech.chuo-u.ac.jp; xichen@columbia.edu	Yonezu, Akio/A-1404-2009; Chen, Xi/B-1539-2008	Chen, Xi/0000-0002-2428-180X	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS) [26420025]; National Natural Science Foundation of China [11172231, 11372241]; AFOSR [FA9550-12-1-0159]; DARPA [W91CRB-11-C-0112]	The work of A.Y. was supported by JSPS KAKENHI (Grant No. 26420025) from the Japan Society for the Promotion of Science (JSPS). The work of X.C. was supported by the National Natural Science Foundation of China (11172231 and 11372241), AFOSR (FA9550-12-1-0159), and DARPA (W91CRB-11-C-0112).	Chen X, 2006, MAT SCI ENG A-STRUCT, V416, P139, DOI 10.1016/j.msea.2005.10.034; Tsui TY, 1996, J MATER RES, V11, P752, DOI 10.1557/JMR.1996.0091; Suresh S, 1998, ACTA MATER, V46, P5755, DOI 10.1016/S1359-6454(98)00226-2; Cruise RB, 2008, J CONSTR STEEL RES, V64, P352, DOI 10.1016/j.jcsr.2007.08.001; Cheng YT, 2004, MAT SCI ENG R, V44, P91, DOI 10.1016/j.mser.2004.05.001; Cheng YT, 1998, J APPL PHYS, V84, P1284, DOI 10.1063/1.368196; Bocciarelli M, 2007, COMP MATER SCI, V39, P381, DOI 10.1016/j.commatsci.2006.07.001; Yonezu A, 2010, MAT SCI ENG A-STRUCT, V527, P7646, DOI 10.1016/j.msea.2010.08.014; Swadener JG, 2001, J MATER RES, V16, P2091, DOI 10.1557/JMR.2001.0286; Ogasawara N, 2009, MECH MATER, V41, P1025, DOI 10.1016/j.mechmat.2009.04.010; Le MQ, 2009, INT J SOLIDS STRUCT, V46, P2988, DOI 10.1016/j.ijsolstr.2009.03.027; Dao M, 2001, ACTA MATER, V49, P3899, DOI 10.1016/S1359-6454(01)00295-6; Zhao MH, 2006, ACTA MATER, V54, P2823, DOI 10.1016/j.actamat.2006.02.026; Cao YP, 2004, ACTA MATER, V52, P1143, DOI 10.1016/j.actamat.2003.11.001; Estrin Y, 2013, ACTA MATER, V61, P782, DOI 10.1016/j.actamat.2012.10.038; Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001; Yonezu A, 2013, MATER DESIGN, V52, P812, DOI 10.1016/j.matdes.2013.06.015; Bowden F. P., 1950, FRICTION LUBRICANTS; Chen X, 2007, J MECH PHYS SOLIDS, V55, P1618, DOI 10.1016/j.jmps.2007.01.010; Giorgi M. D., 2011, INT J FATIGUE, V33, P507; Jang JI, 2009, J CERAM PROCESS RES, V10, P391; Lu J., 1996, HDB MEASUREMENT RESI; Marc, 2011, THEOR US MAN A; Matsuoka S., 2004, J JAPAN SOC MECH E A, V70, P1535; Nishikawa M, 2011, MATER DESIGN, V32, P3240, DOI 10.1016/j.matdes.2011.02.044; Ohno T., 2007, JPN SOC MECH ENG A, V3, P338; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Tabor D., 1951, HARDNESS METALS; Takemoto M., 2013, COMMUNICATION; Xu B., 2006, J MATER RES, V22, P186; Yonezu A, 2006, MEAS SCI TECHNOL, V17, P2447, DOI 10.1088/0957-0233/17/9/011	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	JAN	2015	24	1					362	372		10.1007/s11665-014-1280-5		11	Materials Science, Multidisciplinary	Materials Science	AX6KG	WOS:000347030600039		
J	Nishimoto, R; Zhu, QQ; Miyamoto, T; Sato, T; Tu, XF; Aneksampant, A; Fukushima, M				Nishimoto, Ryo; Zhu, Qianqian; Miyamoto, Takafumi; Sato, Tsutomu; Tu, Xuefei; Aneksampant, Apichaya; Fukushima, Masami			Monopersulfate oxidation of Acid Orange 7 with an iron(III)-tetrakis(N-methylpyridinium-4-yl)porphyrin intercalated into the layers of montmorillonite and pillared clay	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Iron(III)-tetrakis(N-methylpyridinium-4-yl)porphyrin; Montmorillonite; Pillared clay; Intercalation; Catalytic oxidation	BIOMIMETIC CATALYTIC-SYSTEM; ANION-EXCHANGE RESINS; HYDROGEN-PEROXIDE; HUMIC-ACID; FORMALDEHYDE POLYCONDENSATION; PORPHYRIN COMPLEXES; IRON(III) PORPHYRIN; IRON PORPHYRINS; PENTACHLOROPHENOL; DEGRADATION	A biomimetic catalyst, iron(III)-tetrakis(N-methylpyridinium-4-yl)porphyrin (FeTMPyP), was loaded into montmorillonite (Mt) and pillared clay (Pi). The catalytic activities of the prepared catalysts for the decolorization of Acid Orange 7 (AO7) in the absence and presence of,humic acid (HA), a major component of waste water, were compared. Turnover frequencies (TOFs) for the FeTMPyP-loaded Pi (6.7-9.4 h(-1)) were larger than those for the FeTMPyP-loaded Mt (2.9-3.3 h(-1)), while decolorization for the FeTMPyP-loaded Mt was inhibited in the presence of HA (TOFs of 1.3-2.1 h(-1)). These results can be attributed to the fact that the large expansion in basal spacing for the Mt permitted the catalyst to be eluted and HA to be inserted into the Mt layer. However, the levels of catalyst elution and the inhibition of AO7 decolorization by HA were significantly suppressed in the case of the FeTMPyP-loaded Pi catalyst, which was prepared using smaller OH/Al and Al/Mt ratios. These results indicate that the Pi is more suitable support far the FeTMPyP catalyst than the Mt. (C) 2014 Elsevier B.V. All rights reserved.	[Nishimoto, Ryo; Zhu, Qianqian; Miyamoto, Takafumi; Sato, Tsutomu; Tu, Xuefei; Aneksampant, Apichaya; Fukushima, Masami] Hokkaido Univ, Fac Engn, Div Sustainable Resources Engn, Sapporo, Hokkaido 0606828, Japan	Fukushima, M (reprint author), Hokkaido Univ, Fac Engn, Div Sustainable Resources Engn, Sapporo, Hokkaido 0606828, Japan.	m-fukush@eng.hokudai.ac.jp	Fukushima, Masami/D-6150-2012		Japan Society for the Promotion of Science [25241017]	This work was supported by Grants-in-Aid for Scientific Research A from the Japan Society for the Promotion of Science (25241017).	Mukherjee M, 2007, J MOL CATAL A-CHEM, V266, P207, DOI 10.1016/j.molcata.2006.11.012; Machado GS, 2008, J MOL CATAL A-CHEM, V283, P99, DOI 10.1016/j.molcata.2007.12.009; GE ZH, 1994, MICROPOROUS MATER, V3, P165, DOI 10.1016/0927-6513(94)00020-4; Yao YY, 2014, J HAZARD MATER, V264, P323, DOI 10.1016/j.jhazmat.2013.10.063; Shigetatsu S, 2010, J ENVIRON SCI HEAL A, V45, P1536, DOI 10.1080/10934529.2010.506110; Rosa ILV, 2000, J MOL CATAL A-CHEM, V160, P199, DOI 10.1016/S1381-1169(00)00214-4; Miyamoto T, 2014, J MOL CATAL B-ENZYM, V99, P150, DOI 10.1016/j.molcatb.2013.11.002; Machado AM, 2002, J COLLOID INTERF SCI, V254, P158, DOI 10.1006/jcis.2002.8488; Kawahigashi M, 2005, J COLLOID INTERF SCI, V284, P463, DOI 10.1016/j.jcis.2004.10.023; Machado GS, 2013, CATAL SCI TECHNOL, V3, P1094, DOI 10.1039/c2cy20736b; Zhu QQ, 2013, J ENVIRON SCI HEAL A, V48, P1593, DOI 10.1080/10934529.2013.815078; Zhu QQ, 2014, J MOL CATAL A-CHEM, V385, P31, DOI 10.1016/j.molcata.2014.01.013; Bolzon LB, 2013, MICROPOR MESOPOR MAT, V168, P37, DOI 10.1016/j.micromeso.2012.09.039; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P2406, DOI 10.1021/bi00279a016; Yan W, 2012, J COLLOID INTERF SCI, V372, P141, DOI 10.1016/j.jcis.2012.01.016; Fukushima M, 2009, J MOL STRUCT, V917, P142, DOI 10.1016/j.molstruc.2008.07.006; Holland BT, 1998, J PHYS CHEM B, V102, P4301, DOI 10.1021/jp9812738; Zucca P, 2007, J MOL CATAL A-CHEM, V278, P220, DOI 10.1016/j.molcata.2007.09.017; Rismayani S, 2004, J HAZARD MATER, V114, P175, DOI 10.1016/j.jhazmat.2004.08.006; Kameyama H, 2006, J MOL CATAL A-CHEM, V258, P172, DOI 10.1016/j.molcata.2006.05.022; Rismayani S, 2004, J MOL CATAL A-CHEM, V217, P13, DOI 10.1016/j.molcata.2004.03.030; Tauchert E, 2006, CHEMOSPHERE, V64, P1458, DOI 10.1016/j.chemosphere.2005.12.064; Zhu QQ, 2013, MOLECULES, V18, P5360, DOI 10.3390/molecules18055360; Zucca P, 2009, J MOL CATAL A-CHEM, V306, P89, DOI 10.1016/j.molcata.2009.02.029; Fukushima M, 2007, BIOMACROMOLECULES, V8, P386, DOI 10.1021/bm060829r; Barros VP, 2008, INT BIODETER BIODEGR, V61, P337, DOI 10.1016/j.ibiod.2007.10.008; Barros VP, 2013, J BRAZIL CHEM SOC, V24, P830, DOI 10.5935/0103-5053.20130110; Bergaya F, 2006, DEV CLAY SCI, V1, P1; Farzaneh F, 2014, J POROUS MAT, V21, P189, DOI 10.1007/s10934-013-9763-6; Fukuchi S, 2012, CLAY MINER, V47, P355, DOI 10.1180/claymin.2012.047.3.06; Fukushima M, 2003, ENVIRON SCI TECHNOL, V37, P386, DOI 10.1021/es020747k; Fukushima M, 2006, J MOL CATAL A-CHEM, V245, P178, DOI 10.1016/j.molcata.2005.09.051; Fukushima M, 2005, ENVIRON SCI TECHNOL, V39, P9337, DOI 10.1021/es051355r; Fukushima M, 2008, J MOL CATAL A-CHEM, V293, P103, DOI 10.1016/j.molcata.2008.07.014; Fukushima M, 2003, ENVIRON SCI TECHNOL, V37, P1031, DOI 10.1021/es020681t; Fulcushima M., 2008, J MOL CATAL A-CHEM, V286, P47; GANESH R, 1994, WATER RES, V28, P1367, DOI 10.1016/0043-1354(94)90303-4; Hassan SA, 2010, J MOL CATAL A-CHEM, V332, P93, DOI 10.1016/j.molcata.2010.09.004; Mifune M, 2005, CHEM PHARM BULL, V53, P1006, DOI 10.1248/cpb.53.1006; Miura A, 2009, APPL CLAY SCI, V46, P277, DOI 10.1016/j.clay.2009.08.017; Nakagaki S, 2006, J CATAL, V242, P110, DOI 10.1016/j.jcat.2006.06.003; Nakagaki S, 2002, J MOL CATAL A-CHEM, V185, P203, DOI 10.1016/S1381-1169(02)00025-0; PESQUERA C, 1991, APPL CATAL, V69, P97, DOI 10.1016/S0166-9834(00)83294-7; SAKURAI H, 1991, B CHEM SOC JPN, V64, P227, DOI 10.1246/bcsj.64.227; Salavati-Niasari M, 2001, J MOL CATAL A-CHEM, V175, P105, DOI 10.1016/S1381-1169(01)00101-7; Watanabe T., 1988, Clay Science, V7, P129; Zucca P, 2010, J MOL CATAL A-CHEM, V321, P27, DOI 10.1016/j.molcata.2010.01.015	47	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	JAN	2015	396						84	89		10.1016/j.molcata.2014.09.035		6	Chemistry, Physical	Chemistry	AY0CJ	WOS:000347265200012		
J	Veisi, H; Gholami, J; Ueda, H; Mohammadi, P; Noroozi, M				Veisi, Hojat; Gholami, Javad; Ueda, Hiroshi; Mohammadi, Pourya; Noroozi, Mohammad			Magnetically palladium catalyst stabilized by diaminoglyoxime-functionalized magnetic Fe3O4 nanoparticles as active and reusable catalyst for Suzuki coupling reactions	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Fe3O4/DAG/Pd; Magnetic nano composite; Catalysis; Recyclable; Suzuki reaction	ONE-POT SYNTHESIS; HETEROGENEOUS CATALYST; SOLVOTHERMAL SYNTHESIS; RECYCLABLE CATALYST; MESOPOROUS SBA-15; HECK REACTION; NANO FE3O4; ACID; NANOCOMPOSITE; EFFICIENT	A Pd supported on diaminoglyoxime (DAG)-functionalized Fe3O4 (Fe3O4/DAG/Pd) hybrid materials was fabricated for the first time. In this fabrication, DAG played an important role as a capping agent. The immobilized palladium catalyst was an efficient catalyst without added phosphine ligands for the Suzuki cross-coupling reaction of several aryl halides with phenylboronic acid in aqueous phase at room temperature. The yields of the products were in the range from 70% to 98%. The prepared heterogeneous nanocatalyst was characterized by XRD, XPS, EDS, FT-IR, ICP, FESEM, VSM and TEM. Interestingly, the novel catalyst could be recovered in a facile manner from the reaction mixture by applying an external magnet device and recycled eight times without any significant loss in activity. (C) 2014 Elsevier B.V. All rights reserved.	[Veisi, Hojat; Mohammadi, Pourya] Payame Noor Univ, Dept Chem, Tehran 193954697, Iran; [Gholami, Javad] Tarbiat Modares Univ, Fac Nano Mat, Tehran, Iran; [Ueda, Hiroshi] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Noroozi, Mohammad] Res Inst Petr Ind, Ctr Res & Dev Petr Technol Kermanshah, Kermanshah, Iran	Veisi, H (reprint author), Payame Noor Univ, Dept Chem, Tehran 193954697, Iran.	hojatveisi@yahoo.com	Ueda, Hiroshi/A-3515-2011	Ueda, Hiroshi/0000-0001-8849-4217			Reddy BVS, 2011, TETRAHEDRON LETT, V52, P1359, DOI 10.1016/j.tetlet.2011.01.074; WALDRON RD, 1955, PHYS REV, V99, P1727, DOI 10.1103/PhysRev.99.1727; Parella R, 2012, CATAL COMMUN, V29, P118, DOI 10.1016/j.catcom.2012.09.030; Ghorbani-Vaghei R, 2014, J MOL CATAL A-CHEM, V393, P240, DOI 10.1016/j.molcata.2014.06.025; Rafiee E, 2014, INORG CHIM ACTA, V409, P302, DOI 10.1016/j.ica.2013.09.042; Zhang HG, 2007, ADV FUNCT MATER, V17, P2766, DOI 10.1002/adfm.200601146; Ma ML, 2012, CATAL COMMUN, V17, P168, DOI 10.1016/j.catcom.2011.10.015; Wang ZF, 2006, COLLOID SURFACE A, V276, P116, DOI 10.1016/j.colsurfa.2005.10.028; Li GP, 2012, RSC ADV, V2, P5108, DOI 10.1039/c2ra20504a; Liu HF, 2011, CATAL TODAY, V175, P293, DOI 10.1016/j.cattod.2011.04.042; Matheron ME, 2004, PLANT DIS, V88, P665, DOI 10.1094/PDIS.2004.88.6.665; Ai LH, 2011, CATAL COMMUN, V14, P68, DOI 10.1016/j.catcom.2011.07.014; Li PH, 2012, ADV SYNTH CATAL, V354, P1307, DOI 10.1002/adsc.201100725; Kong AG, 2012, APPL CATAL A-GEN, V417, P183, DOI 10.1016/j.apcata.2011.12.040; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Zamani F, 2014, CATAL COMMUN, V43, P164, DOI 10.1016/j.catcom.2013.09.029; Teranishi T, 1998, CHEM MATER, V10, P594, DOI 10.1021/cm9705808; Dai CY, 2001, J AM CHEM SOC, V123, P2719, DOI 10.1021/ja003954y; Du QW, 2012, TETRAHEDRON, V68, P3577, DOI 10.1016/j.tet.2012.03.008; Liu J, 2012, RSC ADV, V2, P2262, DOI 10.1039/c2ra01241c; Veisi H, 2014, J POROUS MAT, V21, P141, DOI 10.1007/s10934-013-9758-3; Herrmann WA, 1999, J ORGANOMET CHEM, V576, P23, DOI 10.1016/S0022-328X(98)01050-X; Lee HM, 2000, ORG LETT, V2, P2053, DOI 10.1021/ol005956t; Lightowler S, 2005, CHEM MATER, V17, P5538, DOI 10.1021/cm0512068; Zhang DH, 2004, NANO LETT, V4, P2151, DOI 10.1021/nl048758u; Sharpe M, 2001, DRUGS, V61, P1501, DOI 10.2165/00003495-200161100-00009; Walker SD, 2004, ANGEW CHEM INT EDIT, V43, P1871, DOI 10.1002/anie.200353615; Ay AN, 2013, INORG CHEM COMMUN, V27, P64, DOI 10.1016/j.inoche.2012.10.020; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Ke Y., 2012, RSC ADV, V1, P5676; Kim H., 2007, ALLOYS COMPD, V434-435, P633; SCHMIDT U, 1992, SYNTHESIS-STUTTGART, P1248; Li SZ, 2012, J MOL CATAL A-CHEM, V359, P81, DOI 10.1016/j.molcata.2012.03.025; Matsunaga T, 1998, SUPRAMOL SCI, V5, P391, DOI 10.1016/S0968-5677(98)00037-6; Militello M. C., 1994, SURF SCI SPECTRA, V3, P387, DOI 10.1116/1.1247783; Niu HY, 2012, J HAZARD MATER, V227, P195, DOI 10.1016/j.jhazmat.2012.05.036; Poetsch E., 1988, KONTAKTE, V2, P15; Racuciu M, 2005, J OPTOELECTRON ADV M, V7, P2859; Rao Z. M., 1995, ACTA PHYS-CHIM SIN, V11, P395; Sreedhar B., 2011, SYNLETT, V8, P1081; STILLE JK, 1986, ANGEW CHEM INT EDIT, V25, P508, DOI 10.1002/anie.198605081; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Suzuki A. J., 1999, ORGANOMET CHEM, V576, P147; Tang S., 2012, FUEL PROCESS TECHNOL, V93, P84; Tremblay-Morin JP, 2006, TETRAHEDRON LETT, V47, P3043, DOI 10.1016/j.tetlet.2006.03.018; Veisi H., 2014, J MOL CATAL A-CHEM, V384, P61; Veisi H, 2014, J MOL CATAL A-CHEM, V395, P25, DOI 10.1016/j.molcata.2014.07.030; Wang ZF, 2005, CHEM ENG J, V113, P27, DOI 10.1016/j.cej.2005.08.003; Xia JH, 2008, MATER RES BULL, V43, P2213, DOI 10.1016/j.materresbull.2007.08.032; Xu ZH, 1997, APPL SURF SCI, V120, P269, DOI 10.1016/S0169-4332(97)00234-1; Yinghuai Z., 2007, ADV SYNTH CATAL, V349, P1917, DOI 10.1002/adsc.200700021; Zhan XW, 2003, CHEM MATER, V15, P1963, DOI 10.1021/cm020843k; Zhang FW, 2012, MATER RES BULL, V47, P504, DOI 10.1016/j.materresbull.2011.10.030	53	12	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	JAN	2015	396						216	223		10.1016/j.molcata.2014.10.012		8	Chemistry, Physical	Chemistry	AY0CJ	WOS:000347265200027		
J	Wu, YQ; Xie, HJ; Tian, SP; Tsubaki, N; Han, YZ; Tan, YS				Wu, Yingquan; Xie, Hongjuan; Tian, Shaopeng; Tsubaki, Noritatsu; Han, Yizhuo; Tan, Yisheng			Isobutanol synthesis from syngas over K-Cu/ZrO2-La2O3(x) catalysts: Effect of La-loading	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						CO hydrogenation; Isobutanol; K-Cu/ZrO2 catalyst; La2O3	HIGHER ALCOHOL SYNTHESIS; METHANOL SYNTHESIS; CO2 HYDROGENATION; CALCINATION TEMPERATURE; ZIRCONIA CATALYSTS; COPPER-CATALYSTS; SYNTHESIS GAS; MECHANISM; OXIDES; PERFORMANCE	A series of K-Cu/ZrO2 catalysts with different La loadings for isobutanol synthesis from CO hydrogenation were prepared by a co-precipitation method. The catalysts were characterized by XRD, reactive N2O adsorption, XPS, H-2-TPR, in situ IR and Raman techniques, and then tested for isobutanol synthesis from CO hydrogenation at the conditions of 360 degrees C, 10.0 MPa, GHSV = 3000 h(-1) and H-2/CO = 2.5. These characterization results showed that incorporation of La into the K/Cu-Zr catalyst resulted in increase of BET surface area and dispersion of catalyst particles. Especially, medium La addition facilitated the synergistic effect between Cu-Zr interactions, improved the reducibility of catalyst and increased the amounts of dispersed copper. An enrichment of Cl intermediates on catalyst surface related to high dispersed CuO is better for chain growth. In the isobutanol synthesis reaction, the conversion of CO and selectivity of isobutanol increased first and then decreased as the increase of La concentration. Among these La-promoted K/Cu-Zr catalysts, the 3% La/CuiZr catalyst exhibited the highest alcohol selectivity of 32.8 wt%, which can be radically attributed to the highest Cu surface area. (C) 2014 Elsevier B.V. All rights reserved.	[Wu, Yingquan; Xie, Hongjuan; Tian, Shaopeng; Han, Yizhuo; Tan, Yisheng] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, Taiyuan 030001, Shanxi, Peoples R China; [Wu, Yingquan; Tian, Shaopeng] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Tsubaki, Noritatsu] Toyama Univ, Dept Appl Chem, Toyama 9308555, Japan	Tan, YS (reprint author), Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, Taiyuan 030001, Shanxi, Peoples R China.	tan@sxicc.ac.cn			Prospective Project of Institute of Coal Chemistry; Chinese Academy of Sciences [2011SQZBJ13]; Special-funded Program on National Key Scientific Instruments and Equipment Development of China [2011YQ120039]	This work was supported by the Prospective Project of Institute of Coal Chemistry, The Chinese Academy of Sciences (No. 2011SQZBJ13) and the Special-funded Program on National Key Scientific Instruments and Equipment Development of China (No. 2011YQ120039).	Avgouropoulos G, 2005, APPL CATAL B-ENVIRON, V56, P87, DOI 10.1016/j.apcatb.2004.07.017; KEIM W, 1989, CATAL LETT, V3, P59, DOI 10.1007/BF00765055; Yu Q, 2012, APPL CATAL A-GEN, V423, P42, DOI 10.1016/j.apcata.2012.02.017; Fisher IA, 1997, CATAL LETT, V44, P11, DOI 10.1023/A:1018916806816; SMITH KJ, 1984, J CATAL, V85, P428, DOI 10.1016/0021-9517(84)90232-X; Velu S, 2002, PHYS CHEM CHEM PHYS, V4, P1990, DOI 10.1039/b109766k; Epling WS, 1997, J CATAL, V169, P438, DOI 10.1006/jcat.1997.1725; Lebarbier VM, 2011, J PHYS CHEM C, V115, P17440, DOI 10.1021/jp204003q; Arena F, 2008, APPL CATAL A-GEN, V350, P16, DOI 10.1016/j.apcata.2008.07.028; Weigel J, 1996, LANGMUIR, V12, P5319, DOI 10.1021/la9506990; Papavasiliou A, 2010, APPL CATAL A-GEN, V382, P73, DOI 10.1016/j.apcata.2010.04.025; Hoang DL, 2003, THERMOCHIM ACTA, V400, P153, DOI 10.1016/S0040-6031(02)00491-4; Pokrovski K, 2001, LANGMUIR, V17, P4297, DOI 10.1021/la001723z; Guo XM, 2010, J CATAL, V271, P178, DOI 10.1016/j.jcat.2010.01.009; Stagg-Williams SM, 2000, J CATAL, V194, P240, DOI 10.1006/jcat.2000.2939; Slating TA, 2011, WISC LAW REV, P1109; Adachi M, 1996, B CHEM SOC JPN, V69, P1509, DOI 10.1246/bcsj.69.1509; Liu YY, 2013, FUEL, V104, P62, DOI 10.1016/j.fuel.2010.08.014; Zhang YP, 2006, ENERG CONVERS MANAGE, V47, P3360, DOI 10.1016/j.enconman.2006.01.010; Ortelli EE, 1998, CATAL LETT, V54, P41, DOI 10.1023/A:1019032022881; Sato AG, 2013, J CATAL, V307, P1, DOI 10.1016/j.jcat.2013.06.022; Beretta A, 1996, IND ENG CHEM RES, V35, P1534, DOI 10.1021/ie9505219; Sun H, 2010, BIORESOURCE TECHNOL, V101, P953, DOI 10.1016/j.biortech.2009.08.089; NUNAN JG, 1988, J CATAL, V113, P410, DOI 10.1016/0021-9517(88)90268-0; Li SG, 2013, CATAL LETT, V143, P345, DOI 10.1007/s10562-013-0977-7; Jung KD, 2000, J CATAL, V193, P207, DOI 10.1006/jcat.2000.2881; Guo XM, 2011, J MOL CATAL A-CHEM, V345, P60, DOI 10.1016/j.molcata.2011.05.019; Beretta A, 1996, IND ENG CHEM RES, V35, P2154, DOI 10.1021/ie950618v; BIANCHI D, 1995, APPL CATAL A-GEN, V123, P89, DOI 10.1016/0926-860X(94)00242-8; Burcham MM, 1998, IND ENG CHEM RES, V37, P4657, DOI 10.1021/ie9705620; Cai Y.N., 1996, J FUEL CHEM TECHNOL, V24, P11; Chuah GK, 1996, APPL CATAL A-GEN, V145, P267, DOI 10.1016/0926-860X(96)00152-4; ELLIOTT DJ, 1988, J CATAL, V114, P90, DOI 10.1016/0021-9517(88)90011-5; Fisher IA, 1997, J CATAL, V172, P222, DOI 10.1006/jcat.1997.1870; Haddad GJ, 1996, J CATAL, V160, P43, DOI 10.1006/jcat.1996.0122; He DP, 2005, CHINESE J CATAL, V26, P961; Hilmen AM, 1998, APPL CATAL A-GEN, V169, P355, DOI 10.1016/S0926-860X(98)00025-8; Jiang T., 2000, CHINESE J CATAL, V21, P319; KIENNEMANN A, 1991, IND ENG CHEM RES, V30, P1130, DOI 10.1021/ie00054a009; KOEPPEL RA, 1992, APPL CATAL A-GEN, V84, P77, DOI 10.1016/0926-860X(92)80340-I; Li GR, 2004, CATAL TODAY, V93-5, P595, DOI 10.1016/j.cattod.2004.06.010; NIX RM, 1987, J CATAL, V106, P216, DOI 10.1016/0021-9517(87)90226-0; Park SH, 2011, KOREAN J CHEM ENG, V28, P402, DOI 10.1007/s11814-010-0356-7; Peltier F.L., 1997, J MOL CATAL A-CHEM, V122, P131, DOI 10.1016/S1381-1169(97)00034-4; [冉宏峰 Ran Hongfeng], 2010, [天然气化工. C1化学与化工, Natural Gas Chemical Industry], V35, P1; Ribeiro NFP, 2008, J POWER SOURCES, V179, P329, DOI 10.1016/j.jpowsour.2007.12.096; Sanchez-Escribano V, 2007, APPL CATAL A-GEN, V316, P68, DOI 10.1016/j.apcata.2006.09.020; SCHILD C, 1990, J MOL CATAL, V63, P223, DOI 10.1016/0304-5102(90)85146-9; Sun Q, 1998, APPL CATAL A-GEN, V171, P301, DOI 10.1016/S0926-860X(98)00096-9; Tan Y.S., 1996, J FUEL CHEM TECHNOL, V24, P368; Wang J.W., 1998, J FUEL CHEM TECHNOL, V26, P390; Wu G.S., 1999, J FUEL CHEM TECHNOL, V27, P472; 吴贵升, 2001, 燃料化学学报, V29, P490; Wu GS, 1999, ACTA PHYS-CHIM SIN, V15, P564, DOI 10.3866/PKU.WHXB19990616; Xu MT, 1999, J CATAL, V188, P125, DOI 10.1006/jcat.1999.2650; Zhao N, 2002, CHINESE J CATAL+, V23, P571	56	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	JAN	2015	396						254	260		10.1016/j.molcata.2014.10.003		7	Chemistry, Physical	Chemistry	AY0CJ	WOS:000347265200032		
J	Ohno, T; Higo, T; Saito, H; Yuajn, S; Jin, ZY; Yang, Y; Tsubota, T				Ohno, Teruhisa; Higo, Takayoshi; Saito, Hirofumi; Yuajn, Saisai; Jin, Zhengyuan; Yang, Yin; Tsubota, Toshiki			Dependence of photocatalytic activity on aspect ratio of a brookite TiO2 nanorod and drastic improvement in visible light responsibility of a brookite TiO2 nanorod by site-selective modification of Fe3+ on exposed faces	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Photocatalyst; Titanium(IV) oxide; Brookite TiO2 nanorod; Separation of redox sites; Visible light responsibility	ANATASE TITANIUM(IV) OXIDE; HYDROTHERMAL CONDITIONS; CRYSTAL FACES; RUTILE; PHASE; PARTICLES; DIOXIDE; GROWTH; TICL3; FILMS	Exposed crystal face-controlled brookite titanium(IV) oxide (TiO2) nanorods with various aspect ratios were prepared by a hydrothermal process with or without PVA or PVP as an aspect reagent. The nanorodshaped brookite TiO2 had larger {2 1 0} and smaller {2 1 2} exposed crystal faces, which were assigned by TEM with the SAED technique. Their aspect ratios were greatly influenced by the addition of PVA or PVP as an aspect ratio control reagent to the reaction solution used in the hydrothermal treatment. The photocatalytic activity for decomposition of acetaldehyde increased with increase in the aspect ratio because the surface area ratio of {2 1 0} to {2 I 2} exposed crystal faces, which are attributed to reduction and oxidation sites, respectively, became more optimal. The {2 1 2} exposed crystal faces of surface-controlled brookite TiO2 were site-selectively modified with trivalent iron(III) (Fe3+) ions by utilizing the adsorption property of iron(III)/iron(II) (Fe3+/Fe2+) ions. The brookite TiO2 nanorod with site-selective modification of Fe ions showed much higher photocatalytic activity than that of commercial brookite TiO2 loaded with Fe ions under visible-light irradiation because of the separation of redox sites. In other words, oxidation and reduction proceed over Fe3+ ion-modified {2 1 2} faces of the TiO2 surface and on {2 1 0} faces of the TiO2 surface without modification of Fe3+, respectively. (C) 2014 Elsevier B.V. All rights reserved.	[Ohno, Teruhisa; Higo, Takayoshi; Saito, Hirofumi; Yuajn, Saisai; Jin, Zhengyuan; Yang, Yin; Tsubota, Toshiki] Kyushu Inst Technol, Fac Engn, Dept Mat Sci, Kitakyushu, Fukuoka 8048550, Japan; [Ohno, Teruhisa] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ohno, Teruhisa] JST, ACT C, Kawaguchi, Saitama 3320012, Japan	Ohno, T (reprint author), Kyushu Inst Technol, Fac Engn, Dept Mat Sci, 1-1 Sensuicho, Kitakyushu, Fukuoka 8048550, Japan.	tohno@che.kyutech.ac.jp			JST PRESTO program; JST ACT-C program	This work was supported by the JST PRESTO program and the JST ACT-C program.	Amano F, 2009, CHEM COMMUN, P2311, DOI 10.1039/b822634b; Zhu JA, 2010, CRYSTENGCOMM, V12, P2219, DOI 10.1039/c000128g; Kandiel TA, 2010, CHEM MATER, V22, P2050, DOI 10.1021/cm903472p; Barnard AS, 2004, J PHYS CHEM B, V108, P18435, DOI 10.1021/jp0472459; Li YZ, 2004, LANGMUIR, V20, P10838, DOI 10.1021/la0489716; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Zhang DQ, 2010, CRYST GROWTH DES, V10, P1130, DOI 10.1021/cg900961k; Hosono E, 2004, J AM CHEM SOC, V126, P7790, DOI 10.1021/ja048820p; Murakami N, 2010, APPL CATAL B-ENVIRON, V97, P115, DOI 10.1016/j.apcatb.2010.03.030; Ohno T, 2002, NEW J CHEM, V26, P1167, DOI 10.1039/b202140d; Li JM, 2010, CHEM COMMUN, V46, P2301, DOI 10.1039/b923755k; Amano F, 2010, TOP CATAL, V53, P455, DOI 10.1007/s11244-010-9472-1; Ohno T, 1997, J PHYS CHEM B, V101, P6415, DOI 10.1021/jp971093i; Zhang HZ, 2000, J PHYS CHEM B, V104, P3481, DOI 10.1021/jp000499j; Bae E, 2009, J MOL CATAL A-CHEM, V300, P72, DOI 10.1016/j.molcata.2008.10.048; Oliver PM, 1997, J MATER CHEM, V7, P563, DOI 10.1039/a606353e; Bae E, 2009, APPL CATAL B-ENVIRON, V91, P634, DOI 10.1016/j.apcatb.2009.06.034; Barnard AS, 2005, NANO LETT, V5, P1261, DOI 10.1021/nl050355m; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Murakami N, 2011, J PHYS CHEM C, V115, P419, DOI 10.1021/jp109057s; Li JM, 2010, CRYST GROWTH DES, V10, P2111, DOI 10.1021/cg9012087; Murakami N, 2010, CRYSTENGCOMM, V12, P532, DOI 10.1039/b913586n; Murakami N, 2008, APPL CATAL A-GEN, V348, P148, DOI 10.1016/j.apcata.2008.06.040; Yang HG, 2009, J AM CHEM SOC, V131, P4078, DOI 10.1021/ja808790p; Kakiuchi K, 2006, J CRYST GROWTH, V293, P541, DOI 10.1016/j.jcrysgro.2006.06.004; Murakami N, 2009, J PHYS CHEM C, V113, P3062, DOI 10.1021/jp809104t; Amano F, 2009, CHEM MATER, V21, P2601, DOI 10.1021/cm9004344; Bae E, 2010, APPL CATAL A-GEN, V380, P48, DOI 10.1016/j.apcata.2010.03.029; Dai Y., 2009, NANO LETT, V9, P6; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Kobayashi M, 2009, J AM CERAM SOC, V92, pS21, DOI 10.1111/j.1551-2916.2008.02641.x; Kobayashi M, 2007, SOL ST PHEN, V124-126, P723; Mahaney O.O.P., 2009, CHEM LETT, V38, P238; Murakami N, 2009, CATAL COMMUN, V10, P963, DOI 10.1016/j.catcom.2008.12.038; Wang DH, 2006, J AM CHEM SOC, V128, P13670, DOI 10.1021/ja0655993; Yoshinaga K, 2005, CHEM LETT, V34, P1094, DOI 10.1246/cl.2005.1094	36	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	JAN	2015	396						261	267		10.1016/j.molcata.2014.09.036		7	Chemistry, Physical	Chemistry	AY0CJ	WOS:000347265200033		
J	Ishihara, A; Kawaraya, D; Sonthisawate, T; Kimura, K; Hashimoto, T; Nasu, H				Ishihara, Atsushi; Kawaraya, Daisuke; Sonthisawate, Thanita; Kimura, Kentaro; Hashimoto, Tadanori; Nasu, Hiroyuki			Catalytic cracking of soybean oil by hierarchical zeolite containing mesoporous silica-aluminas using a Curie point pyrolyzer	JOURNAL OF MOLECULAR CATALYSIS A-CHEMICAL			English	Article						Catalytic cracking; Soybean oil; Hierarchical zeolite-containing catalyst; Mesoporous silica-aluminas; Curie point pyrolyzer	ZSM-5 ZEOLITE; VEGETABLE-OILS; RENEWABLE DIESEL; N-DODECANE; PALM OIL; FUEL; FEEDSTOCKS; CRYSTALS; MIXTURE; IMPACT	Catalytic cracking of soybean oil using hierarchical zeolite-containing mesoporous silica-aluminas was successfully estimated using a Curie point pyrolyzer. Most of the prepared catalysts exhibited higher catalytic activity and selectivity for gasoline than did a simple zeolite. The catalysts prepared using a larger amount of malic acid developed mesoporous structures and showed higher olefin/paraffin ratios and research octane numbers (RONs) than the simple zeolite and a catalyst with a microporous structure. When beta zeolite-containing catalysts were used, the ratio of multi/single branched products in the gasoline fraction reached more than 0.40, which was considerably larger than that obtained using a simple zeolite. When the yields of gasoline, single-branched products and multi-branched products were plotted against the conversion of soybean oil, approximately linear relationships were observed for every plot. When the yields of gasoline and single-branched products were compared at the same conversion, the yields from the HY zeolite-containing catalysts were higher than those from the beta zeolite-containing catalysts. These results were consistent with those for the catalytic cracking of VG previously reported. However, the yields of multi-branched products from beta zeolite-containing catalysts were higher than those from HY zeolite-containing catalysts. This result was different for VGO cracking, where the yield of multi-branched products from HY zeolite was higher. Furthermore, the RON of gasoline and the yield of aromatic compounds were higher than those for the catalytic cracking of VGO. (C) 2014 Elsevier B.V. All rights reserved.	[Ishihara, Atsushi; Kawaraya, Daisuke; Sonthisawate, Thanita; Kimura, Kentaro; Hashimoto, Tadanori; Nasu, Hiroyuki] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie, Japan	Ishihara, A (reprint author), Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie, Japan.	ishihara@chem.mie-u.ac.jp	Ishihara, Atsushi/N-9481-2015; HASHIMOTO, Tadanori/J-3909-2013	Ishihara, Atsushi/0000-0002-6390-8898; HASHIMOTO, Tadanori/0000-0003-2887-7536	JSPS KAKENHI [25289286]	A part of this work was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (B) Grant Number 25289286.	ANDERSON PC, 1972, J I PETROL, V58, P83; van Donk S, 2003, CATAL REV, V45, P297, DOI 10.1081/CR-120023908; Ishihara A, 2010, APPL CATAL A-GEN, V388, P68, DOI 10.1016/j.apcata.2010.08.027; Choi M, 2006, NAT MATER, V5, P718, DOI 10.1038/nmat1705; Liu YY, 2011, ENERG FUEL, V25, P4675, DOI 10.1021/ef200889e; Simacek P, 2011, FUEL, V90, P2473, DOI 10.1016/j.fuel.2011.03.013; Perez-Ramirez J, 2009, ADV FUNCT MATER, V19, P3972, DOI 10.1002/adfm.200901394; Jacobsen CJH, 2000, J AM CHEM SOC, V122, P7116, DOI 10.1021/ja000744c; Graca I, 2011, FUEL, V90, P467, DOI 10.1016/j.fuel.2010.09.028; Veriansyah B, 2012, FUEL, V94, P578, DOI 10.1016/j.fuel.2011.10.057; Ishihara A, 2012, CATAL COMMUN, V28, P163, DOI 10.1016/j.catcom.2012.08.023; Al-Sabawi M, 2012, ENERG FUEL, V26, P5355, DOI 10.1021/ef3006417; Corma A, 2007, J CATAL, V247, P307, DOI 10.1016/j.jcat.2007.01.023; Xiao FS, 2006, ANGEW CHEM INT EDIT, V45, P3090, DOI 10.1002/anie.200600241; Tani H, 2011, CATAL TODAY, V164, P410, DOI 10.1016/j.cattod.2010.10.059; Inayat A, 2012, ANGEW CHEM INT EDIT, V51, P1962, DOI 10.1002/anie.201105738; Bielansky P, 2011, FUEL PROCESS TECHNOL, V92, P2305, DOI 10.1016/j.fuproc.2011.07.021; Ooi YS, 2004, ENERG FUEL, V18, P1555, DOI 10.1021/ef049948v; Ishihara A, 2011, CHEM LETT, V40, P558, DOI 10.1246/cl.2011.558; Qin ZX, 2011, J CATAL, V278, P266, DOI 10.1016/j.jcat.2010.12.013; Groen JC, 2007, J AM CHEM SOC, V129, P355, DOI 10.1021/ja065737o; Ishihara A, 2012, J CATAL, V295, P81, DOI 10.1016/j.jcat.2012.07.027; Doronin VP, 2013, FUEL, V106, P757, DOI 10.1016/j.fuel.2012.11.027; Kim SS, 2003, CHEM MATER, V15, P1664, DOI 10.1021/cm021762r; Jin JS, 2014, IND ENG CHEM RES, V53, P3406, DOI 10.1021/ie403486x; Bao SG, 2011, APPL CATAL A-GEN, V405, P61, DOI 10.1016/j.apcata.2011.07.028; Gates B.C., 1979, CHEM CATALYTIC PROCE, P1; Habib S, 2008, APPL CATAL A-GEN, V344, P61, DOI 10.1016/j.apcata.2008.04.001; He Y, 2012, FUEL, V96, P469, DOI 10.1016/j.fuel.2012.01.033; Iki H, 2012, J JPN PETROL INST, V55, P349; Ishihara A, 2014, J JPN PETROL INST, V57, P34; Li JH, 2011, MATER CHEM PHYS, V125, P286, DOI 10.1016/j.matchemphys.2010.09.036; Nam LTH, 2011, FUEL, V90, P1069, DOI 10.1016/j.fuel.2010.10.060; Odedairo T, 2011, J MOL CATAL A-CHEM, V345, P21, DOI 10.1016/j.molcata.2011.05.015; Ogura M, 2000, CHEM LETT, P882, DOI 10.1246/cl.2000.882; Rao TVM, 2012, MICROPOR MESOPOR MAT, V164, P148, DOI 10.1016/j.micromeso.2012.07.016; Triantafyllidis KS, 2000, IND ENG CHEM RES, V39, P307	37	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-1169	1873-314X		J MOL CATAL A-CHEM	J. Mol. Catal. A-Chem.	JAN	2015	396						310	318		10.1016/j.molcata.2014.10.010		9	Chemistry, Physical	Chemistry	AY0CJ	WOS:000347265200040		
J	Ono, S; Domschke, K; Deckert, J				Ono, Shinji; Domschke, Katharina; Deckert, Juergen			Genomic structural variation in affective, anxiety, and stress-related disorders	JOURNAL OF NEURAL TRANSMISSION			English	Review						Major depressive disorder (MDD); Bipolar disorder; Panic disorder; Structural variation (SV); Copy number variants (CNV)	COPY NUMBER VARIATION; MAJOR DEPRESSIVE DISORDER; CASE-CONTROL SAMPLE; BIPOLAR-DISORDER; PANIC DISORDER; CONTROL INDIVIDUALS; MENTAL-DISORDERS; GENE-EXPRESSION; INCREASE RISK; DETECT DUP25	Anxiety and stress-related disorders are common and debilitating mental diseases. Genetic factors as well as environmental factors and life events contribute to their pathogenesis and partly mediate treatment response. However, these disorders are clinically heterogeneous, genetically complex, and the exact genetic causes are still unclear. Recently, some evidence has emerged for structural variation including copy number variants and small deletions/duplications to be associated with mental disorders. Here, the current state of knowledge on the role of genomic structural variation in affective, anxiety and stress-related disorders is reviewed, followed by a critical discussion of present methods to detect structural changes, future directions, and clinical implications including a potential role in personalized medicine.	[Ono, Shinji; Domschke, Katharina; Deckert, Juergen] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Ctr Mental Hlth, D-97070 Wurzburg, Germany; [Ono, Shinji] Nagasaki Univ, Grad Sch Med, Dept Psychiat, Nagasaki 852, Japan	Ono, S (reprint author), Nagasaki Univ, Grad Sch Med, Dept Psychiat, Nagasaki 852, Japan.	shinji1231zzz@nagasaki-u.ac.jp			German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [SFB-TRR-58]; SENSHIN Medical Research Foundation	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), SFB-TRR-58, projects C02 (KD, JD), Z02 (JD) and SENSHIN Medical Research Foundation (SO). We are grateful to H. Mishima and Y. Yoshioka for their support.	Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Kawamura Y, 2011, J HUM GENET, V56, P852, DOI 10.1038/jhg.2011.117; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Van Den Bossche MJ, 2012, AM J MED GENET B, V159B, P812, DOI 10.1002/ajmg.b.32088; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Grozeva D, 2010, ARCH GEN PSYCHIAT, V67, P318, DOI 10.1001/archgenpsychiatry.2010.25; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Weiland Y, 2003, AM J HUM GENET, V72, P1349, DOI 10.1086/375168; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Priebe L, 2012, MOL PSYCHIATR, V17, P421, DOI 10.1038/mp.2011.8; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Nomura J, 2012, NEURAL PLAST, DOI 10.1155/2012/589524; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Knight HM, 2009, AM J HUM GENET, V85, P833, DOI 10.1016/j.ajhg.2009.11.003; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Rucker JJH, 2013, MOL PSYCHIATR, V18, P183, DOI 10.1038/mp.2011.144; Zhu GS, 2004, EUR J HUM GENET, V12, P505, DOI 10.1038/sj.ejhg.5201181; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; McQuillin A, 2011, EUR J HUM GENET, V19, P588, DOI 10.1038/ejhg.2010.221; Gershon ES, 2013, AM J PSYCHIAT, V170, P968, DOI 10.1176/appi.ajp.2013.12121558; Speicher MR, 2005, NAT REV GENET, V6, P782, DOI 10.1038/nrg1692; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Henrichsen CN, 2004, AM J MED GENET B, V128B, P80, DOI 10.1002/ajmg.b.30037; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Karlsson R, 2012, BIOL PSYCHIAT, V71, P922, DOI 10.1016/j.biopsych.2012.01.020; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; He YJ, 2011, TRENDS MOL MED, V17, P244, DOI 10.1016/j.molmed.2011.01.007; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Tansey KE, 2014, PHARMACOGENOMICS J, V14, P395, DOI 10.1038/tpj.2013.51; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Fung WLA, 2010, AM J PSYCHIAT, V167, P998, DOI 10.1176/appi.ajp.2010.09101463; Tabiner M, 2003, AM J HUM GENET, V72, P535, DOI 10.1086/367777; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Ronai Z, 2014, AM J MED GENET B, V165, P217, DOI 10.1002/ajmg.b.32223; Degenhardt F, 2012, AM J MED GENET B, V159B, P263, DOI 10.1002/ajmg.b.32034; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Arlt MF, 2011, P NATL ACAD SCI USA, V108, P17360, DOI 10.1073/pnas.1109272108; Armengol L, 2002, MOL PSYCHIATR, V7, P928, DOI 10.1038/sj.mp.4001134; BABU VR, 1991, CYTOGENET CELL GENET, V57, P16, DOI 10.1159/000133104; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bloom RJ, 2013, SCHIZOPHR RES, V146, P289, DOI 10.1016/j.schres.2013.02.021; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Degenhardt F, 2013, PSYCHIAT GENET, V23, P45, DOI 10.1097/YPG.0b013e328358645b; Glessner JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015463; Goldman D, 2014, INT J NEUROPSYCHOPH, V17, P1717, DOI 10.1017/S1461145714000789; Han KD, 2008, P NATL ACAD SCI USA, V105, P19366, DOI 10.1073/pnas.0807866105; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hayes JL, 2013, GENOMICS, V102, P174, DOI 10.1016/j.ygeno.2013.04.006; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Martis S, 2013, PHARMACOGENOMICS J, V13, P558, DOI 10.1038/tpj.2012.48; Mehta D, 2014, NEUROSCI RES, V79, P22, DOI 10.1016/j.neures.2013.10.009; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; O'Dushlaine C, 2014, BIOL PSYCHIAT, DOI [10.1016/j.biopsych.2013.10.028, DOI 10.1016/J.BI0PSYCH.2013.10.028]; Olsen L, 2011, PSYCHIAT GENET, V21, P319, DOI 10.1097/YPG.0b013e3283463deb; Perlis RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046315; Pickard BS, 2012, PSYCHIAT GENET, V22, P269, DOI 10.1097/YPG.0b013e32835185b3; Rasmussen HB, 2012, PHARMACOGENET GENOM, V22, P471, DOI 10.1097/FPC.0b013e328352c770; Rucker JJH, 2012, DEV PSYCHOPATHOL, V24, P1335, DOI 10.1017/S0954579412000740; Schumacher J, 2003, HUM GENET, V114, P115, DOI 10.1007/s00439-003-1022-5; Scoles HA, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-19; UMEHARA F, 1995, J NEUROL SCI, V133, P173, DOI 10.1016/0022-510X(95)00188-8; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Yang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004474; Zhao L, 2001, CANCER GENET CYTOGEN, V127, P143, DOI 10.1016/S0165-4608(00)00438-6; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1	94	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	JAN	2015	122	1			SI		69	78		10.1007/s00702-014-1309-9		10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AX8KZ	WOS:000347159600007		
J	Kanasaki, H; Oride, A; Kyo, S				Kanasaki, H.; Oride, A.; Kyo, S.			Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Modulating Hypothalamus-Pituitary Neuroendocrine Functions in Mouse Cell Models	JOURNAL OF NEUROENDOCRINOLOGY			English	Review						pituitary adenylate cyclase-activating polypeptide; luteinising hormone; follicle-stimulating hormone; gonadotrophin-releasing hormone	GONADOTROPIN-RELEASING-HORMONE; SIGNAL-REGULATED KINASE; VASOACTIVE INTESTINAL POLYPEPTIDE; FOLLISTATIN GENE-EXPRESSION; PERIFUSED L-BETA-T2 CELLS; MESSENGER-RNA LEVELS; SUBUNIT GENE; PROTEIN-KINASE; RAT PITUITARY; GNRH RECEPTOR	Pituitary adenylate cyclase-activating polypeptide (PACAP) was originally identified as a hypothalamic activator of cyclic adenosine monophosphate production in pituitary cells. PACAP and its receptor are expressed not only in the central nervous system, but also in peripheral organs, and function to stimulate pituitary hormone synthesis and secretion as both a hypothalamic-pituitary-releasing factor and an autocrine-paracrine factor within the pituitary. PACAP stimulates the expression of the gonadotrophin , luteinising hormone (LH) and follicle-stimulating hormone (FSH) subunits, as well as the gonadotrophin-releasing hormone (GnRH) receptor and its own PACAP type I receptor (PAC1R) in gonadotrophin-secreting pituitary cells. In turn, GnRH, which is known to be a crucial component of gonadotrophin secretion, stimulates the expression of PACAP and PAC1R in gonadotrophs. In addition, PAC1R and PACAP modulate the functions of GnRH-producing neurones in the hypothalamus. This review summarises the current understanding of the possible roles of PACAP and PAC1R in modulating hypothalamus and pituitary neuroendocrine cells in the mouse models.	[Kanasaki, H.; Oride, A.; Kyo, S.] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan	Kanasaki, H (reprint author), Shimane Univ, Sch Med, Dept Obstet & Gynecol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	kanasaki@med.shimane-u.ac.jp					Anderson ST, 1996, ENDOCRINOLOGY, V137, P3424, DOI 10.1210/en.137.8.3424; Bonfil D, 2004, ENDOCRINOLOGY, V145, P2228, DOI 10.1210/en.2003-1418; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Romanelli F, 1997, NEUROPEPTIDES, V31, P311, DOI 10.1016/S0143-4179(97)90064-0; Pincas H, 2014, MOL CELL ENDOCRINOL, V385, P56, DOI 10.1016/j.mce.2013.08.015; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; STOJILKOVIC SS, 1994, ENDOCR REV, V15, P462, DOI 10.1210/er.15.4.462; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; WILDT L, 1981, ENDOCRINOLOGY, V109, P376; KOVES K, 1991, NEUROENDOCRINOLOGY, V54, P159, DOI 10.1159/000125864; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; SHIODA S, 1994, ENDOCRINOLOGY, V135, P818, DOI 10.1210/en.135.3.818; HART GR, 1992, J ENDOCRINOL, V134, P33, DOI 10.1677/joe.0.1340033; YADA T, 1993, PEPTIDES, V14, P235, DOI 10.1016/0196-9781(93)90035-F; CANNY BJ, 1992, ENDOCRINOLOGY, V130, P211, DOI 10.1210/en.130.1.211; Scaldaferri ML, 2000, ENDOCRINOLOGY, V141, P1158, DOI 10.1210/en.141.3.1158; GHARIB SD, 1990, ENDOCR REV, V11, P177; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; Besecke LM, 1996, ENDOCRINOLOGY, V137, P3667, DOI 10.1210/en.137.9.3667; Burrin JM, 1998, ENDOCRINOLOGY, V139, P1731, DOI 10.1210/en.139.4.1731; Choi EJ, 2000, MOL BRAIN RES, V80, P35, DOI 10.1016/S0169-328X(00)00116-9; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; DOW RC, 1994, J ENDOCRINOL, V142, pR1, DOI 10.1677/joe.0.142R001; Fahrenkrug J, 1996, NEUROSCIENCE, V73, P1049, DOI 10.1016/0306-4522(96)00082-6; Fujii Y, 2002, MOL CELL ENDOCRINOL, V192, P55, DOI 10.1016/S0303-7207(02)00109-0; Garrel G, 2002, J BIOL CHEM, V277, P46391, DOI 10.1074/jbc.M203763200; Grafer CM, 2009, MOL ENDOCRINOL, V23, P1022, DOI 10.1210/me.2008-0477; Gras S, 1996, ENDOCRINOLOGY, V137, P4779, DOI 10.1210/en.137.11.4779; HANNIBAL J, 1995, REGUL PEPTIDES, V55, P133, DOI 10.1016/0167-0115(94)00099-J; Harada T, 2007, BIOL REPROD, V77, P707, DOI 10.1095/biolreprod.107.060327; Isaac ER, 2008, MOL CELL ENDOCRINOL, V280, P13, DOI 10.1016/j.mce.2007.09.003; Jamen F, 2000, ANN NY ACAD SCI, V921, P400; Jin L, 2001, ENDOCRINOLOGY, V142, P1703, DOI 10.1210/en.142.5.1703; Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46; Kanasaki H, 2009, BIOL REPROD, V81, P465, DOI 10.1095/biolreprod.108.074765; Kanasaki H, 2013, GEN COMP ENDOCR, V193, P95, DOI 10.1016/j.ygcen.2013.07.013; Kanasaki H, 2011, REGUL PEPTIDES, V167, P227, DOI 10.1016/j.regpep.2011.02.010; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Kantor O, 2000, ANN NY ACAD SCI, V921, P405; Kidane AH, 2008, ENDOCRINOLOGY, V149, P4177, DOI 10.1210/en.2008-0131; KOVES K, 1990, ENDOCRINOLOGY, V127, P264; Koves K, 1998, PEPTIDES, V19, P1069, DOI 10.1016/S0196-9781(98)00049-7; Koves K, 2003, J MOL NEUROSCI, V20, P141, DOI 10.1385/JMN:20:2:141; Koves K, 2014, J MOL NEUROSCI, V54, P494, DOI 10.1007/s12031-014-0294-7; Koves K, 1996, ACTA BIOL HUNG, V47, P239; Lariviere S, 2008, ENDOCRINOLOGY, V149, P6389, DOI 10.1210/en.2008-0504; Li SY, 1996, MOL BRAIN RES, V41, P157; Marshall JC, 1992, T AM CLIN CLIMATOLOG, V104, P31; McArdle CA, 1996, TRENDS ENDOCRIN MET, V7, P168, DOI 10.1016/1043-2760(96)00051-3; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; Moore JP, 2012, ENDOCRINOLOGY, V153, P1421, DOI 10.1210/en.2011-1115; Mutiara S, 2006, MOL CELL ENDOCRINOL, V259, P22, DOI 10.1016/j.mce.2006.07.005; Mutiara S, 2009, MOL CELL ENDOCRINOL, V307, P125, DOI 10.1016/j.mce.2009.02.030; Nguyen KA, 2010, ENDOCRINOLOGY, V151, P4882, DOI 10.1210/en.2009-1483; Olcese J, 1997, J NEUROENDOCRINOL, V9, P937, DOI 10.1046/j.1365-2826.1997.00663.x; OSUGA Y, 1992, ENDOCRINOL JAPON, V39, P153; Pincas H, 2001, J BIOL CHEM, V276, P23562, DOI 10.1074/jbc.M100563200; Purwana IN, 2010, PEPTIDES, V31, P1748, DOI 10.1016/j.peptides.2010.05.012; Purwana IN, 2011, BIOCHEM BIOPH RES CO, V410, P295, DOI 10.1016/j.bbrc.2011.05.135; Purwana IN, 2011, BIOL REPROD, V84, P996, DOI 10.1095/biolreprod.110.088526; Radleff-Schlimme A, 1998, ANN NY ACAD SCI, V865, P486, DOI 10.1111/j.1749-6632.1998.tb11222.x; RAWLINGS SR, 1994, J BIOL CHEM, V269, P5680; Reddy GR, 2013, MOL ENDOCRINOL, V27, P253, DOI 10.1210/me.2012-1168; Sawangjaroen K, 1997, J NEUROENDOCRINOL, V9, P279, DOI 10.1046/j.1365-2826.1997.00580.x; SCHOMERUS E, 1994, ENDOCRINOLOGY, V134, P315, DOI 10.1210/en.134.1.315; Shintani N, 2002, REGUL PEPTIDES, V109, P45, DOI 10.1016/S0167-0115(02)00169-6; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444; Sukhbaatar U, 2013, GEN COMP ENDOCR, V194, P94, DOI 10.1016/j.ygcen.2013.09.002; Sundaresan S, 1996, ENDOCRINOLOGY, V137, P304, DOI 10.1210/en.137.1.304; Szabo E, 2004, REGUL PEPTIDES, V123, P139, DOI 10.1016/j.regpep.2004.04.021; Szabo E, 2002, REGUL PEPTIDES, V109, P75, DOI 10.1016/S0167-0115(02)00186-6; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; TSUJII T, 1995, LIFE SCI, V56, P1103, DOI 10.1016/0024-3205(95)00047-A; TSUJII T, 1994, ENDOCRINOLOGY, V135, P826, DOI 10.1210/en.135.3.826; Tsutsumi R, 2010, J BIOL CHEM, V285, P20262, DOI 10.1074/jbc.M110.132662; Usuki S, 2001, GYNECOL ENDOCRINOL, V15, P184, DOI 10.1080/713602838; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; VIGH S, 1991, PEPTIDES, V12, P313, DOI 10.1016/0196-9781(91)90018-K; Weck J, 1998, MOL ENDOCRINOL, V12, P451, DOI 10.1210/me.12.3.451; WEST AP, 1995, J ENDOCRINOL, V144, P215, DOI 10.1677/joe.0.1440215	81	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	JAN	2015	27	1					1	7		10.1111/jne.12230		7	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	AX1XC	WOS:000346735900001		
J	Matsuda, F; Nakatsukasa, K; Suetomi, Y; Naniwa, Y; Ito, D; Inoue, N; Wakabayashi, Y; Okamura, H; Maeda, KI; Uenoyama, Y; Tsukamura, H; Ohkura, S				Matsuda, F.; Nakatsukasa, K.; Suetomi, Y.; Naniwa, Y.; Ito, D.; Inoue, N.; Wakabayashi, Y.; Okamura, H.; Maeda, K. -I.; Uenoyama, Y.; Tsukamura, H.; Ohkura, S.			The Luteinising Hormone Surge-Generating System is Functional in Male Goats as in Females: Involvement of Kisspeptin Neurones in the Medial Preoptic Area	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						kisspeptin; medial preoptic area; luteinising hormone surge; sexual differentiation; goat	ESTROGEN-POSITIVE FEEDBACK; SEXUAL DIFFERENTIATION; GONADOTROPIN-SECRETION; ESTRADIOL; EWE; LH; EXPRESSION; RELEASE; SHEEP; HYPOTHALAMUS	A luteinising hormone (LH) surge is fundamental to the induction of ovulation in mammalian females. The administration of a preovulatory level of oestrogen evokes an LH surge in ovariectomised females, whereas the response to oestrogen in castrated males differs among species; namely, the LH surge-generating system is sexually differentiated in some species (e.g. rodents and sheep) but not in others (e.g. primates). In the present study, we aimed to determine whether there is a functional LH surge-generating system in male goats, and whether hypothalamic kisspeptin neurones in male goats are involved in the regulation of surge-like LH secretion. By i.v. infusion of oestradiol (E-2; 6g/h) for 16h, a surge-like LH increase occurred in both castrated male and ovariectomised female goats, although the mean peak LH concentration was lower and the mean peak of the LH surge was later in males compared to females. Dual staining with KISS1 in situ hybridisation and c-Fos immunohistochemistry revealed that E-2 treatment significantly increased c-Fos expression in the medial preoptic area (mPOA) KISS1 cells in castrated males, as well as ovariectomised females. By contrast, dual-labelled cells were scarcely detected in the arcuate nucleus (ARC) after E-2 treatment in both sexes. These data suggest that kisspeptin neurones in the mPOA, but not those in the ARC, are involved in the induction of surge-like LH secretion in both male and female goats. In summary, our data show that the mechanism that initiates the LH surge in response to oestrogen, the mPOA kisspeptin neurones, is functional in male goats. Thus, sexual differentiation of the LH surge-generating system would not be applicable to goats.	[Matsuda, F.; Nakatsukasa, K.; Suetomi, Y.; Naniwa, Y.; Ito, D.; Ohkura, S.] Nagoya Univ, Lab Anim Prod Sci, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Inoue, N.; Uenoyama, Y.; Tsukamura, H.] Nagoya Univ, Lab Reprod Sci, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Wakabayashi, Y.; Okamura, H.] Natl Inst Agrobiol Sci, Neurobiol Lab, Tsukuba, Ibaraki, Japan; [Maeda, K. -I.] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol, Bunkyo Ku, Tokyo, Japan	Ohkura, S (reprint author), Nagoya Univ, Lab Anim Prod Sci, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	saohkura@agr.nagoya-u.ac.jp					MORI Y, 1984, J REPROD FERTIL, V72, P223; KARSCH FJ, 1973, SCIENCE, V179, P484, DOI 10.1126/science.179.4072.484; Unsworth WP, 2005, BIOL REPROD, V72, P619, DOI 10.1095/biolreprod.104.035691; Maeda K, 2010, BRAIN RES, V1364, P103, DOI 10.1016/j.brainres.2010.10.026; Smith JT, 2009, ENDOCRINOLOGY, V150, P5530, DOI 10.1210/en.2009-0712; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; BARRACLOUGH C, 1961, ENDOCRINOLOGY, V68, P62; Sharma TP, 2002, BIOL REPROD, V66, P924, DOI 10.1095/biolreprod66.4.924; Hoffman GE, 2011, ENDOCRINOLOGY, V152, P214, DOI 10.1210/en.2010-0066; Goodman RL, 2012, ENDOCRINOLOGY, V153, P5105, DOI 10.1210/en.2012-1550; Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; HERBISON AE, 1992, NEUROSCIENCE, V50, P283, DOI 10.1016/0306-4522(92)90423-Y; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Inoue N, 2011, P NATL ACAD SCI USA, V108, P17527, DOI 10.1073/pnas.1113035108; Homma T, 2009, BIOL REPROD, V81, P1216, DOI 10.1095/biolreprod.109.078311; KNOBIL E, 1988, HUM REPROD, V3, P469; Jackson LM, 2013, ENDOCRINOLOGY, V154, P1612, DOI 10.1210/en.2012-1613; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Merkley CM, 2012, ENDOCRINOLOGY, V153, P5406, DOI 10.1210/en.2012-1357; Estrada KM, 2006, J NEUROENDOCRINOL, V18, P806, DOI 10.1111/j.1365-2826.2006.01485.x; BLACHE D, 1991, BRAIN RES, V546, P241, DOI 10.1016/0006-8993(91)91488-M; BROWNGRA.K, 1974, J ENDOCRINOL, V62, P319, DOI 10.1677/joe.0.0620319; DIAL GD, 1985, THERIOGENOLOGY, V23, P351, DOI 10.1016/0093-691X(85)90037-8; FOSTER DL, 1975, ENDOCRINOLOGY, V97, P1205; Goubillon ML, 1999, NEUROENDOCRINOLOGY, V70, P228, DOI 10.1159/000054481; HODGES JK, 1978, J REPROD FERTIL, V52, P83; Kano Y, 1982, MAMMALIAN REPROD PHY, P367; KARSCH FJ, 1975, ENDOCRINOLOGY, V97, P373; Knobil E, 1980, Recent Prog Horm Res, V36, P53; KNOBIL E, 1972, Acta Endocrinologica Supplementum, V166, P137; NORMAN RL, 1976, ENDOCRINOLOGY, V99, P59; Ohkura S, 2004, ENDOCRINOLOGY, V145, P3239, DOI 10.1210/en.2003-1516; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Robinson JE, 2010, BIOL REPROD, V82, P163, DOI 10.1095/biolreprod.109.079004; Roselli CF, 2007, J STEROID BIOCHEM, V106, P143, DOI 10.1016/j.jsbmb.2007.05.014; SHARPE RM, 1987, J ENDOCRINOL, V113, P1, DOI 10.1677/joe.0.1130001; Smith JT, 2010, BIOL REPROD, V83, P568, DOI 10.1095/biolreprod.110.085407; STEARNS EL, 1973, J CLIN ENDOCR METAB, V37, P635; TANAKA T, 1992, NEUROENDOCRINOLOGY, V56, P641, DOI 10.1159/000126287; Uenoyama Y, 2009, J NEUROENDOCRINOL, V21, P299, DOI 10.1111/j.1365-2826.2009.01853.x	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	JAN	2015	27	1					57	65		10.1111/jne.12235		9	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	AX1XC	WOS:000346735900006		
J	Suzuki, T; Sugawara, K; Takagi, M; Higashi, T				Suzuki, Tomotaka; Sugawara, Kenichi; Takagi, Mineko; Higashi, Toshio			Excitability changes in primary motor cortex just prior to voluntary muscle relaxation	JOURNAL OF NEUROPHYSIOLOGY			English	Article						transcranial magnetic stimulation; muscle relaxation; motor cortex; motor evoked potential; electromyography	REACTION-TIME; MAGNETIC STIMULATION; CONTRACTION; MOVEMENT; INHIBITION; COACTIVATION; IMPAIRMENT; HUMANS; STROKE	We postulated that primary motor cortex (M1) activity does not just decrease immediately prior to voluntary muscle relaxation; rather, it is dynamic and acts as an active cortical process. Thus we investigated the detailed time course of M1 excitability changes during muscle relaxation. Ten healthy participants performed a simple reaction time task. After the go signal, they rapidly terminated isometric abduction of the right index finger from a constant muscle force output of 20% of their maximal voluntary contraction force and performed voluntary muscle relaxation. Transcranial magnetic stimulation pulses were randomly delivered before and after the go signal, and motor evoked potentials (MEPs) were recorded from the right first dorsal interosseous muscle. We selected the time course relative to an appropriate reference point, the onset of voluntary relaxation, to detect excitability changes in M1. MEP amplitude from 80 to 60 ms before the estimated electromyographic offset was significantly greater than that in other intervals. Dynamic excitability changes in M1 just prior to quick voluntary muscle relaxation indicate that cortical control of muscle relaxation is established through active processing and not by simple cessation of activity. The cortical mechanisms underlying muscle relaxation need to be reconsidered in light of such dynamics.	[Suzuki, Tomotaka; Sugawara, Kenichi; Takagi, Mineko] Kanagawa Univ Human Serv, Sch Rehabil, Fac Hlth & Social Serv, Yokosuka, Kanagawa 2388522, Japan; [Suzuki, Tomotaka; Higashi, Toshio] Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Dept Community Based Rehabil Sci, Nagasaki 852, Japan	Sugawara, K (reprint author), Kanagawa Univ Human Serv, Sch Rehabil, Fac Hlth & Social Serv, 1-10-1 Heisei Cho, Yokosuka, Kanagawa 2388522, Japan.	sugawara-k@kuhs.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25750212]	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant No. 25750212.	DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Motawar B, 2012, EXP BRAIN RES, V221, P299, DOI 10.1007/s00221-012-3173-x; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 1998, MOVEMENT DISORD, V13, P330, DOI 10.1002/mds.870130221; TERADA K, 1995, ELECTROEN CLIN NEURO, V95, P335, DOI 10.1016/0013-4694(95)00098-J; Buccolieri A, 2003, CLIN NEUROPHYSIOL, V114, P313, DOI 10.1016/S1388-2457(02)00379-6; Begum T, 2005, NEUROSCI RES, V53, P428, DOI 10.1016/j.neures.2005.09.002; Chae J, 2002, MUSCLE NERVE, V25, P568, DOI 10.1002/mus.10061; SCHIEPPATI M, 1984, EXP BRAIN RES, V56, P448; Buccolieri A, 2004, MOVEMENT DISORD, V19, P681, DOI 10.1002/mds.10711; Stinear CM, 2009, NEUROSCI BIOBEHAV R, V33, P662, DOI 10.1016/j.neubiorev.2008.08.013; Pope PA, 2007, CLIN NEUROPHYSIOL, V118, P1044, DOI 10.1016/j.clinph.2007.02.002; SCHIEPPATI M, 1986, HUM NEUROBIOL, V5, P59; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Toma K, 1999, J NEUROSCI, V19, P3527; Sugawara K, 2009, INT J NEUROSCI, V119, P442, DOI 10.1080/00207450802480077; Buccolieri A, 2004, J PHYSIOL-LONDON, V558, P685, DOI 10.1113/jphysiol.2004.064774; Burke D, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e31827624a7; Kamper DG, 2001, MUSCLE NERVE, V24, P673, DOI 10.1002/mus.1054; Labyt E, 2006, CLIN NEUROPHYSIOL, V117, P1922, DOI 10.1016/j.clinph.2006.05.017; Reynolds C, 1999, NEUROLOGY, V53, P730; Soto O, 2010, J NEUROPHYSIOL, V104, P1392, DOI 10.1152/jn.00620.2009; STARR A, 1988, ELECTROEN CLIN NEURO, V70, P26, DOI 10.1016/0013-4694(88)90191-5; Terada K, 1999, CLIN NEUROPHYSIOL, V110, P397, DOI 10.1016/S1388-2457(98)00017-0; WEISS AD, 1965, J GERONTOL, V20, P60; Yazawa S, 1998, NEUROSCI LETT, V244, P145, DOI 10.1016/S0304-3940(98)00149-9	26	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JAN 1	2015	113	1					110	115		10.1152/jn.00489.2014		6	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AX8SG	WOS:000347178100010		
J	Inoue, M; Uchimura, M; Karibe, A; O'Shea, J; Rossetti, Y; Kitazawa, S				Inoue, Masato; Uchimura, Motoaki; Karibe, Ayaka; O'Shea, Jacinta; Rossetti, Yves; Kitazawa, Shigeru			Three timescales in prism adaptation	JOURNAL OF NEUROPHYSIOLOGY			English	Article						prism adaptation; reaching; motor learning; two-state model; three-state model	LONG-TERM DEPRESSION; MOTOR MEMORY; CEREBELLUM; LESIONS; CORTEX; MONKEY; CONSOLIDATION; MOVEMENTS; MODELS; SHIFTS	It has been proposed that motor adaptation depends on at least two learning systems, one that learns fast but with poor retention and another that learns slowly but with better retention (Smith MA, Ghazizadeh A, Shadmehr R. PLoS Biol 4: e179, 2006). This two-state model has been shown to account for a range of behavior in the force field adaptation task. In the present study, we examined whether such a two-state model could also account for behavior arising from adaptation to a prismatic displacement of the visual field. We first confirmed that an "adaptation rebound," a critical prediction of the two-state model, occurred when visual feedback was deprived after an adaptation-extinction episode. We then examined the speed of decay of the prism aftereffect (without any visual feedback) after repetitions of 30, 150, and 500 trials of prism exposure. The speed of decay decreased with the number of exposure trials, a phenomenon that was best explained by assuming an "ultraslow" system, in addition to the fast and slow systems. Finally, we compared retention of aftereffects 24 h after 150 or 500 trials of exposure: retention was significantly greater after 500 than 150 trials. This difference in retention could not be explained by the two-state model but was well explained by the three-state model as arising from the difference in the amount of adaptation of the " ultraslow process." These results suggest that there are not only fast and slow systems but also an ultraslow learning system in prism adaptation that is activated by prolonged prism exposure of 150-500 trials.	[Inoue, Masato; Uchimura, Motoaki; Karibe, Ayaka; Kitazawa, Shigeru] Juntendo Univ, Dept Neurophysiol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Uchimura, Motoaki; Kitazawa, Shigeru] Osaka Univ, Dynam Brain Network Lab, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [O'Shea, Jacinta] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Nuffield Dept Clin Neurosci, Oxford, England; [O'Shea, Jacinta; Rossetti, Yves] Univ Lyon 1, ImpAct, Ctr Neurosci Lyon, INSERM UMR S 1028,CNRS UMR 5292, Bron, France; [Rossetti, Yves] Hosp Civils Lyon, St Genis Laval, France; [Rossetti, Yves] Hop Henry Gabrielle, Ctr Rech Neurosci Lyon, Serv Reeducat Neurol, St Genis Laval, France; [Kitazawa, Shigeru] Osaka Univ, Dept Brain Physiol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Kitazawa, Shigeru] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Suita, Osaka 5650871, Japan	Kitazawa, S (reprint author), Osaka Univ, Dynam Brain Network Lab, Grad Sch Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kitazawa@fbs.osaka-u.ac.jp			Human Frontiers Science Program Organization; Royal Society (United Kingdom);  [25119002]	This research was supported by a research grant from the Human Frontiers Science Program Organization and by a Grant-in-Aid for Scientific Research on Innovative Areas (no. 25119002). J. O'Shea is supported by the Royal Society (United Kingdom).	Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Joiner WM, 2008, J NEUROPHYSIOL, V100, P2948, DOI 10.1152/jn.90706.2008; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Tanaka H, 2012, NEURAL COMPUT, V24, P939, DOI 10.1162/NECO_a_00262; Hatada Y, 2006, EXP BRAIN RES, V169, P417, DOI 10.1007/s00221-005-0159-y; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.neuro.12.1.85; Yin PB, 2001, EXP BRAIN RES, V141, P250, DOI 10.1007/s002210100892; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Jacquin-Courtois S, 2013, NEUROSCI BIOBEHAV R, V37, P594, DOI 10.1016/j.neubiorev.2013.02.007; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Danckert J, 2008, EUR J NEUROSCI, V28, P1696, DOI 10.1111/j.1460-9568.2008.06460.x; Vaswani PA, 2013, J NEUROSCI, V33, P7700, DOI 10.1523/JNEUROSCI.0124-13.2013; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Ito M, 2001, PHYSIOL REV, V81, P1143; WEINER MJ, 1983, NEUROLOGY, V33, P766; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Anzai M, 2010, NEUROSCI RES, V68, P191, DOI 10.1016/j.neures.2010.07.2038; Berniker M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002210; Burnham K. P., 2002, MODEL SELECTION MULT; Dum RP, 2002, ANN NY ACAD SCI, V978, P289, DOI 10.1111/j.1749-6632.2002.tb07575.x; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; Kitazawa S, 1997, J NEUROSCI, V17, P1481; Nagao S, 2013, NEURAL NETWORKS, V47, P72, DOI 10.1016/j.neunet.2013.01.017; O'Shea J, 2014, NEUROPSYCHOLOGIA, V55, P15, DOI 10.1016/j.neuropsychologia.2013.09.021; Pisella L, 2005, NEUROLOGY, V65, P150, DOI 10.1212/01.wnl.0000167945.34177.5e	35	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JAN 1	2015	113	1					328	338		10.1152/jn.00803.2013		11	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AX8SG	WOS:000347178100027		
J	Nakatomi, H; Miyazaki, H; Tanaka, M; Kin, T; Yoshino, M; Oyama, H; Usui, M; Moriyama, H; Kojima, H; Kaga, K; Saito, N				Nakatomi, Hirofumi; Miyazaki, Hidemi; Tanaka, Minoru; Kin, Taichi; Yoshino, Masanori; Oyama, Hiroshi; Usui, Masaaki; Moriyama, Hiroshi; Kojima, Hiromi; Kaga, Kimitaka; Saito, Nobuhito			Improved preservation of function during acoustic neuroma surgery	JOURNAL OF NEUROSURGERY			English	Article						acoustic neuroma surgery; continuous direct brainstem auditory evoked potential monitoring; oncology	VESTIBULAR SCHWANNOMA SURGERY; CEREBELLOPONTINE ANGLE SURGERY; AUDITORY-EVOKED POTENTIALS; FACIAL-NERVE; HEARING PRESERVATION; VASOACTIVE TREATMENT; COCHLEAR NERVE; TUMOR; BAEP; MECHANISMS	OBJECT Restoration of cranial nerve functions during acoustic neuroma (AN) surgery is crucial for good outcome. The effects of minimizing the injury period and maximizing the recuperation period were investigated in 89 patients who consecutively underwent retrosigmoid unilateral AN surgery. METHODS Cochlear nerve and facial nerve functions were evaluated during AN surgery by use of continuous auditory evoked dorsal cochlear nucleus action potential monitoring and facial nerve root exit zone-elicited compound muscle action potential monitoring, respectively. Factors affecting preservation of function at the same (preoperative) grade were analyzed. RESULTS A total of 23 patients underwent standard treatment and investigation of the monitoring threshold for preservation of function; another 66 patients underwent extended recuperation treatment and assessment of its effect on recovery of nerve function. Both types of final action potential monitoring response and extended recuperation treatment were associated with preservation of function at the same grade. CONCLUSIONS Preservation of function was significantly better for patients who received extended recuperation treatment.	[Nakatomi, Hirofumi; Tanaka, Minoru; Kin, Taichi; Yoshino, Masanori; Saito, Nobuhito] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 1138655, Japan; [Miyazaki, Hidemi; Moriyama, Hiroshi; Kojima, Hiromi] Jikei Univ, Dept Otolaryngol, Tokyo, Japan; [Oyama, Hiroshi] Univ Tokyo, Dept Med Informat, Tokyo, Japan; [Usui, Masaaki] Toranomon Gen Hosp, Dept Neurosurg, Tokyo, Japan; [Kaga, Kimitaka] Tokyo Med Ctr, Dept Otolaryngol, Tokyo, Japan	Nakatomi, H (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hnakatomi-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology/Japan [24592154]; Japan Brain Foundation	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (no. 24592154) and by the Japan Brain Foundation Grant-in-Aid for Scientific Research 2012. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.	Abbas GM, 2001, ANN OTO RHINOL LARYN, V110, P867; Amano M, 2011, ACTA NEUROCHIR, V153, P1059, DOI 10.1007/s00701-010-0937-6; ANDERSON T. P., 1951, ARCH PHYS MED, V32, P71; Tomii M, 2003, J NEUROSURG, V99, P121, DOI 10.3171/jns.2003.99.1.0121; Wanibuchi M, 2009, J NEUROSURG, V111, P845, DOI 10.3171/2008.12.JNS08620; Romstock J, 2000, J NEUROSURG, V93, P586, DOI 10.3171/jns.2000.93.4.0586; Jacob A, 2007, LARYNGOSCOPE, V117, P2087, DOI 10.1097/MLG.0b013e3181453a07; Brackmann DE, 2000, AM J OTOL, V21, P417, DOI 10.1016/S0196-0709(00)80054-X; Strauss C, 2006, NEUROSURGERY, V59, P577, DOI 10.1227/01.NEU.0000230260.95477.0A; Legatt AD, 2002, J CLIN NEUROPHYSIOL, V19, P396, DOI 10.1097/00004691-200210000-00003; Moriyama T, 2002, J NEUROSURG, V97, P337, DOI 10.3171/jns.2002.97.2.0337; Strauss C, 2001, J NEUROSURG, V95, P771, DOI 10.3171/jns.2001.95.5.0771; Sasaki T, 2009, J NEUROSURG, V110, P648, DOI 10.3171/2008.4.17514; Samii M, 1997, NEUROSURGERY, V40, P684, DOI 10.1097/00006123-199704000-00006; Asai Y, 1996, ANN OTO RHINOL LARYN, V105, P472; Aslan A, 2005, J LARYNGOL OTOL, V119, P600; Esquia-Medina GN, 2009, OTOL NEUROTOL, V30, P392, DOI 10.1097/MAO.0b013e3181967874; JAMES J A, 1964, Acta Otolaryngol, V57, P306, DOI 10.3109/00016486409137089; Matthies C, 2002, NEUROCHIRURGIE, V48, P461; Matthies C, 1997, J NEUROSURG, V86, P1057, DOI 10.3171/jns.1997.86.6.1057; Matthies C, 1997, NEUROSURGERY, V40, P459, DOI 10.1097/00006123-199703000-00007; Mohr G, 2005, J NEUROSURG, V102, P1, DOI 10.3171/jns.2005.102.1.0001; Neu M, 1999, CLIN NEUROPHYSIOL, V110, P1935, DOI 10.1016/S1388-2457(99)00148-0; SCHEFTER RP, 1986, ANN OTO RHINOL LARYN, V95, P146; Schmerber S, 2004, ACTA OTO-LARYNGOL, V124, P53, DOI 10.1080/00016480310014840; Sekiya T, 2002, HEARING RES, V173, P91, DOI 10.1016/S0378-5955(02)00633-0; SEKIYA T, 1986, ACTA NEUROCHIR, V81, P142, DOI 10.1007/BF01401237; SEKIYA T, 1988, SURG NEUROL, V30, P117, DOI 10.1016/0090-3019(88)90096-1; YOUNG W, 1981, NEUROSURGERY, V8, P689; Zaouche S, 2005, ACTA OTO-LARYNGOL, V125, P363, DOI 10.1080/00016480410025216	30	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2015	122	1					24	33		10.3171/2014.8.JNS132525		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5DQ	WOS:000346947600003		
J	Yoneyama, T; Kawamata, T; Tanaka, M; Yamaguchi, K; Okada, Y				Yoneyama, Taku; Kawamata, Takakazu; Tanaka, Masahiko; Yamaguchi, Koji; Okada, Yoshikazu			Omnidirectional retractor-supporting ring as a new device for carotid endarterectomy	JOURNAL OF NEUROSURGERY			English	Article						carotid endarterectomy; device; omnidirectional; retractor; surgical technique	SHUNT SYSTEM	In carotid endarterectomy (CEA), the traditional retractors are often difficult to use because they tend to obstruct surgical manipulations, especially in the deep operative field on the rostra! side. The authors have invented a new omnidirectional retractor-supporting ring (OD ring) to solve the problems of traditional retractors. The OD ring has an ellipsoid-shaped frame (major axis: 275 mm, minor axis: 192 mm) with 22 equally spaced outward protrusions. Rubber bands from which blunt mini-hooks are hung are twisted around the protrusions. The OD ring was placed on the operative area, and the. skin edges were retracted by mini-hooks placed symmetrically. The hooks were moved gradually from the shallow to the deep operative field as surgical dissection continued to expose the carotid bifurcation and distal internal carotid artery (ICA). The OD ring was used in 158 consecutive CEAs in the authors' institute between July 2010 and October 2013. The OD ring provided a flatter surgical field and was less obstructive than traditional retractors, thereby facilitating surgical manipulation in the deep operative field such as at the distal ICA. Furthermore, because of its simpler shape, angiorrhaphy could be conducted more smoothly, with less tangled thread during closure of the arteriotomy. There were no technical complications related to the OD ring. As a new retractor system for CEA, the OD ring is less obstructive and provides a flatter surgical field than traditional retractors, thereby facilitating surgical manipulations in the deep operative field around the distal ICA.	[Yoneyama, Taku; Kawamata, Takakazu; Tanaka, Masahiko; Yamaguchi, Koji; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo 1628666, Japan	Kawamata, T (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tkawamata@nij.twmu.ac.jp			Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan	The authors received research funding from the Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan,	Kawamata T, 2005, NEUROSURGERY, V56, P913, DOI 10.1227/01.NEU.0000157924.59637.3A; Kawamata T, 2009, NEUROSURGERY, V64, P447, DOI 10.1227/01.NEU.0000339110.73385.8A; Loftus CM, 2007, CAROTID ENDARTERECTO; Okada Y, 2001, NEUROL SURG TOKYO, V29, P497; Shima T, 1998, NEUROSURGERY, V42, P1182, DOI 10.1097/00006123-199805000-00146; Sundt Jr TM, 1994, SUNDTS OCCLUSIVE CER, P198	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2015	122	1					148	151		10.3171/2014.9.JNS132856		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5DQ	WOS:000346947600022		
J	Sugimoto, T; Park, YS; Nakagawa, I; Nishimura, F; Motoyama, Y; Nakase, H				Sugimoto, Tadashi; Park, Young-Su; Nakagawa, Ichiro; Nishimura, Fumihiko; Motoyama, Yasushi; Nakase, Hiroyuki			Effectiveness of intraoperative indocyanine green videoangiography in direct surgical treatment of pediatric intracranial pial arteriovenous fistula	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pial arteriovenous fistula; indocyanine green videoangiography; direct surgery; varix; pediatric; embolization; vascular disorders	OSLER-WEBER DISEASE; VASCULAR MALFORMATIONS; CHILDREN; BRAIN; FLOW	Intracranial pial arteriovenous fistulas (AVFs) are rare cerebrovascular lesions. The authors report a rare case of pediatric pial AVF treated by direct disconnection with the aid of indocyanine green (ICG) videoangiography. A 3-year-old girl presented with developmental problems. Magnetic resonance imaging revealed brain atrophy and an anomalous left temporal vascular mass. Angiography showed a high-flow pial AVF in the early arterial phase fed by the M-1 portion of the left middle cerebral artery and draining into the superficial sylvian vein and the vein of Trolard with a large varix. Given that her fistula was located in a superficial region that was easily accessible by craniotomy, the authors successfully disconnected her pial AVF by direct surgery aided by ICG videoangiography, which clearly confirmed the shunting point. In this report, the authors discuss the existing literature and compare the relative merits of endovascular versus surgical options for the treatment of pial AVF.	[Sugimoto, Tadashi] Higashiosaka City Gen Hosp, Dept Neurosurg, Osaka, Japan; [Park, Young-Su; Nakagawa, Ichiro; Nishimura, Fumihiko; Motoyama, Yasushi; Nakase, Hiroyuki] Nara Med Univ, Dept Neurosurg, Nara, Japan	Sugimoto, T (reprint author), Higashiosaka City Gen Hosp, Dept Neurosurg, 3-4-5 Nishiiwata, Higashiosaka, Osaka 5788588, Japan.	sugimoto-t@higashiosaka-hosp.jp					LASJAUNIAS P, 1986, NEUROSURG REV, V9, P253, DOI 10.1007/BF01743632; Hoh BL, 2001, NEUROSURGERY, V49, P1351, DOI 10.1097/00006123-200112000-00011; HALBACH VV, 1989, AM J NEURORADIOL, V10, P747; Paramasivam S, 2013, J NEUROINTERV SURG, V5, P184, DOI 10.1136/neurintsurg-2011-010241; TOMLINSON FH, 1993, J NEUROSURG, V79, P16, DOI 10.3171/jns.1993.79.1.0016; Weon YC, 2005, ACTA NEUROCHIR, V147, P17, DOI 10.1007/s00701-004-0341-1; Madsen PJ, 2013, J NEUROSURG-PEDIATR, V12, P344, DOI 10.3171/2013.6.PEDS13110; Yang WH, 2011, BRIT J NEUROSURG, V25, P580, DOI 10.3109/02688697.2011.566382; Raabe A, 2003, NEUROSURGERY, V52, P132, DOI 10.1227/01.NEU.0000038965.50033.9A; GARCIAMONACO R, 1995, NEURORADIOLOGY, V37, P60; Miyoshi Y, 2011, CLIN NEUROL NEUROSUR, V113, P239, DOI 10.1016/j.clineuro.2010.10.014; SANTOSH C, 1991, NEURORADIOLOGY, V33, P65; AOKI N, 1991, NEUROSURGERY, V28, P619; KIKUCHI K, 1994, SURG NEUROL, V41, P374, DOI 10.1016/0090-3019(94)90030-2; Lasjaunias P, 1997, Interv Neuroradiol, V3, P275; MORIMOTO T, 1995, ACTA NEUROCHIR, V137, P98, DOI 10.1007/BF02188790; Nakiri GS, 2010, ARQ NEURO-PSIQUIAT, V68, P463, DOI 10.1590/S0004-282X2010000300026; Nelson K, 1992, NEUROIMAG CLIN N AM, V2, P309; OYESIKU NM, 1988, DEV MED CHILD NEUROL, V30, P245; Wang YC, 2004, J NEUROSURG, V100, P201	20	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2015	15	1					55	59		10.3171/2014.9.PEDS13683		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AX5DP	WOS:000346947500009		
J	Odagaki, T; Saruyama, Y; Ueno, T				Odagaki, T.; Saruyama, Y.; Ueno, T.			Temperature-modulation spectroscopy of non-equilibrium systems	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article; Proceedings Paper	7th International Discussion Meeting on Relaxations in Complex Systems (IDMRCS)	JUL 21-26, 2013	Univ Politecnica Catalunya, Barcelona, SPAIN	Energia Campus Int Excellence, Barcelona Knowledge Campus, Inst Laue Langevin, Julich Forschungszentrum, CNRS, Lab Leon Brillouin, Int Dielectr Soc, AirLiquide, Almirall, Bruker, Extrasolution, Matgas, Mettler Toledo, Novocontrol Technologies, TA Instruments, Polish Acad Sci, Inst High Pressure Phys	Univ Politecnica Catalunya	Temperature-modulation spectroscopy; Non-equilibrium systems; Non-linear response; Free energy landscape; Effective temperature		In order to devise experiments which give information on the structure of the free energy landscape (FEL), we present a theoretical framework to handle the temperature-modulation spectroscopy. We first test the superposition rule which serves as a basic principle of the linear response analysis of the temperature modulation. To this end, we exploit a simple two-state system and show that the response to a step modulation can be represented by the difference of two relaxations against two different temperature jumps. We also show that the response can be described by a properly defined effective temperature. (C) 2014 Elsevier B.V. All rights reserved.	[Odagaki, T.; Ueno, T.] Tokyo Denki Univ, Dept Phys, Hatoyamacho, Saitama 3500394, Japan; [Saruyama, Y.] Kyoto Inst Technol, Dept Macromol Sci & Engn, Kyoto 6068585, Japan	Odagaki, T (reprint author), Tokyo Denki Univ, Dept Phys, Hatoyamacho, Saitama 3500394, Japan.	odagaki@mail.dendai.ac.jp					Angelani L, 2000, PHYS REV E, V61, P1681, DOI 10.1103/PhysRevE.61.1681; Das S. P., 2011, STAT PHYS LIQUIDS FR; Harada A., 2012, J PHYS SOC JPN, V81, P1; Odagaki T, 2009, J NON-CRYST SOLIDS, V355, P681, DOI 10.1016/j.jnoncrysol.2008.10.018; Odagaki T., 2012, J PHYS SOC JPN, V81, P1; Tagawa F., 2008, J PHYS CONDENS MATT, V20, P1; Tagawa T., 2006, J PHYS SOC JPN, V75, P1; Takegawa K, 2005, THERMOCHIM ACTA, V432, P212, DOI 10.1016/j.tca.2005.04.008	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093	1873-4812		J NON-CRYST SOLIDS	J. Non-Cryst. Solids	JAN 1	2015	407				SI		57	60		10.1016/j.jnoncrysol.2014.07.047		4	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	AX6FJ	WOS:000347018300009		
J	Zeidler, A; Chirawatkul, P; Salmon, PS; Usuki, T; Kohara, S; Fischer, HE; Howells, WS				Zeidler, Anita; Chirawatkul, Prae; Salmon, Philip S.; Usuki, Takeshi; Kohara, Shinji; Fischer, Henry E.; Howells, W. Spencer			Structure of the network glass-former ZnCl2: From the boiling point to the glass	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article; Proceedings Paper	7th International Discussion Meeting on Relaxations in Complex Systems (IDMRCS)	JUL 21-26, 2013	Univ Politecnica Catalunya, Barcelona, SPAIN	Energia Campus Int Excellence, Barcelona Knowledge Campus, Inst Laue Langevin, Julich Forschungszentrum, CNRS, Lab Leon Brillouin, Int Dielectr Soc, AirLiquide, Almirall, Bruker, Extrasolution, Matgas, Mettler Toledo, Novocontrol Technologies, TA Instruments, Polish Acad Sci, Inst High Pressure Phys	Univ Politecnica Catalunya	Liquid and glass structure; Correlation lengths; Neutron diffraction; X-ray diffraction; Reverse Monte-Carlo modeling	INTERMEDIATE-RANGE ORDER; MOLTEN ZINC-CHLORIDE; COMPTON-SCATTERING FACTORS; SHARP DIFFRACTION PEAK; X-RAY-DIFFRACTION; NEUTRON-DIFFRACTION; TRANSITION THERMODYNAMICS; TETRAHEDRAL COORDINATION; ELECTRON-DIFFRACTION; MOLECULAR-DYNAMICS	The structure of the network glass-forming material ZnCl2 was measured using both neutron and high-energy x-ray diffraction for the glass at 298(1) K and for the liquid over the temperature range 601(1)-977(2) K. Intermediate range order, as manifested by the appearance of a first-sharp diffraction peak in the measured diffraction pattern for the glass at a scattering vector K-FSDP similar or equal to 1 angstrom(-1), is retained in the liquid state even at temperatures close to the boiling point. The correlation lengths associated with both the intermediate and extended range ordering are found to be inversely proportional to temperature. The reverse Monte Carlo (RMC) method was used to model the material, and the results at two different temperatures are compared to those obtained from RMC models based on the partial structure factors measured by using the method of isotope substitution in neutron diffraction. The models show temperature dependent structural variability in which there is an interplay between the fractions of corner-sharing versus edge-sharing ZnCl4 tetrahedra. Corner-sharing motifs are predominant in the glass, and edge-sharing motifs become more numerous in the liquid as the temperature is increased. The appearance of a first-sharp diffraction peak in the Bhatia-Thornton concentration-concentration partial structure factor is discussed in the context of classifying the different network types for glass-forming materials. (C) 2014 Elsevier B.V. All rights reserved.	[Zeidler, Anita; Chirawatkul, Prae; Salmon, Philip S.; Usuki, Takeshi] Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England; [Kohara, Shinji] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Fischer, Henry E.] Inst Laue Langevin, F-38042 Grenoble 9, France; [Howells, W. Spencer] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England	Salmon, PS (reprint author), Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England.	p.s.salmon@bath.ac.uk		Zeidler, Anita/0000-0001-6501-8525; Salmon, Philip/0000-0001-8671-1011			ALLEN DA, 1991, J CHEM PHYS, V94, P5071, DOI 10.1063/1.460544; Angell C. A., 1985, RELAXATION COMPLEX S, P3; FINGER LW, 1994, J APPL CRYSTALLOGR, V27, P892, DOI 10.1107/S0021889894004218; Zeidler A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104208; FABER TE, 1965, PHILOS MAG, V11, P153, DOI 10.1080/14786436508211931; Ozen AS, 2014, PHYS LETT A, V378, P431, DOI 10.1016/j.physleta.2013.11.040; BERTAGNOLLI H, 1976, MOL PHYS, V32, P759, DOI 10.1080/00268977600102201; Celino M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.125502; Massobrio C, 2010, LECT NOTES PHYS, V795, P343, DOI 10.1007/978-3-642-04650-6_10; YAKEL HL, 1978, INORG CHEM, V17, P3294, DOI 10.1021/ic50189a067; SCOTT GD, 1969, J PHYS D APPL PHYS, V2, P863, DOI 10.1088/0022-3727/2/6/311; Massobrio C, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.174202; Fischer HE, 2006, REP PROG PHYS, V69, P233, DOI 10.1088/0034-4885/69/1/R05; Neuefeind J, 1998, J NON-CRYST SOLIDS, V224, P205, DOI 10.1016/S0022-3093(97)00480-8; MACKENZIE JD, 1960, J CHEM PHYS, V33, P366, DOI 10.1063/1.1731151; JAL JF, 1990, PHILOS MAG B, V62, P351, DOI 10.1080/13642819008215241; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Salmon PS, 2006, J PHYS-CONDENS MAT, V18, P11443, DOI 10.1088/0953-8984/18/50/004; Wilson M, 2012, PHYS CHEM CHEM PHYS, V14, P12701, DOI 10.1039/c2cp41644a; KING SV, 1967, NATURE, V213, P1112, DOI 10.1038/2131112a0; CROMER DT, 1967, J CHEM PHYS, V47, P1892, DOI 10.1063/1.1712213; ANGELL CA, 1977, J PHYS CHEM-US, V81, P238, DOI 10.1021/j100518a011; VASHISHTA P, 1990, PHYS REV B, V41, P12197, DOI 10.1103/PhysRevB.41.12197; Le Roux S, 2010, J APPL CRYSTALLOGR, V43, P181, DOI [10.1107/S00218898090511929, 10.1107/S0021889809051929]; Salmon PS, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/41/415110; Bhatia AB, 1970, PHYS REV B-SOLID ST, V2, P3004, DOI 10.1103/PhysRevB.2.3004; Donald KJ, 2009, CHEM-EUR J, V15, P158, DOI 10.1002/chem.200801035; Hargittai M, 2005, STRUCT CHEM, V16, P33, DOI 10.1007/s11224-005-1078-z; Le Roux S, 2011, COMP MATER SCI, V50, P1217, DOI 10.1016/j.commatsci.2010.10.012; Wasse JC, 1998, J PHYS-CONDENS MAT, V10, P8139, DOI 10.1088/0953-8984/10/37/003; VANLAAR B, 1984, J APPL CRYSTALLOGR, V17, P47, DOI 10.1107/S0021889884011006; Salmon PS, 2004, J PHYS-CONDENS MAT, V16, P195, DOI 10.1088/0953-8984/16/3/002; ELLIOTT SR, 1991, NATURE, V354, P445, DOI 10.1038/354445a0; KAUPP M, 1994, INORG CHEM, V33, P4718, DOI 10.1021/ic00099a023; Fischer HE, 2002, APPL PHYS A-MATER, V74, pS160, DOI 10.1007/s003390101087; Wilson M, 1998, PHYS REV LETT, V80, P532, DOI 10.1103/PhysRevLett.80.532; BOHMER R, 1993, J CHEM PHYS, V99, P4201; VASHISHTA P, 1989, PHYS REV LETT, V62, P1651, DOI 10.1103/PhysRevLett.62.1651; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; PENFOLD IT, 1991, PHYS REV LETT, V67, P97, DOI 10.1103/PhysRevLett.67.97; Salmon PS, 2013, PHYS CHEM CHEM PHYS, V15, P15286, DOI 10.1039/c3cp51741a; ANGELL CA, 1970, J CHEM PHYS, V53, P2053, DOI 10.1063/1.1674287; HARGITTAI M, 1986, INORG CHEM, V25, P3163, DOI 10.1021/ic00238a014; Sharma Bevan K, 2008, Journal of Physics: Condensed Matter, V20, DOI 10.1088/0953-8984/20/24/244123; Dyre JC, 2006, REV MOD PHYS, V78, P953, DOI 10.1103/RevModPhys.78.953; Le Roux S, 2010, COMP MATER SCI, V49, P70, DOI 10.1016/j.commatsci.2010.04.023; Neuefeind J, 2001, PHYS CHEM CHEM PHYS, V3, P3987, DOI 10.1039/b100101i; Salmon PS, 1998, PHYS REV B, V58, P6115, DOI 10.1103/PhysRevB.58.6115; Massobrio C, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014206; Pavlatou EA, 1997, J PHYS CHEM B, V101, P8748, DOI 10.1021/jp970343s; Salmon PS, 2003, J PHYS-CONDENS MAT, V15, pS1509, DOI 10.1088/0953-8984/15/16/301; Madden PA, 1996, CHEM SOC REV, V25, P339, DOI 10.1039/cs9962500339; Cavagna A, 2009, PHYS REP, V476, P51, DOI 10.1016/j.physrep.2009.03.003; Salmon PS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.235502; Salmon PS, 2005, NATURE, V435, P75, DOI 10.1038/nature03475; Wilson M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2931936; BIGGIN S, 1981, J PHYS C SOLID STATE, V14, P3129, DOI 10.1088/0022-3719/14/22/008; Bockris J. O'M., 1962, REV CHIM ACAD REPUB, V2, P59; Boolchand P., 2000, INSULATING SEMICONDU; Bouzid A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739953; BREHLER B, 1959, NATURWISSENSCHAFTEN, V46, P554; Brehler B., 1961, Z KRISTALLOGR, V115, P373, DOI 10.1524/zkri.1961.115.5-6.373; CROMER DT, 1969, J CHEM PHYS, V50, P4857, DOI 10.1063/1.1670980; DESA JAE, 1982, J NON-CRYST SOLIDS, V51, P57; Elliott S. R., 1990, PHYS AMORPHOUS MAT; Feltz A., 1993, AMORPHOUS INORGANIC; Gereben O, 2007, J OPTOELECTRON ADV M, V9, P3021; Giacomazzi L, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155208; HOWELLS WS, 1984, NUCL INSTRUM METH A, V219, P543, DOI 10.1016/0167-5087(84)90228-X; IYETOMI H, 1991, PHYS REV B, V43, P1726, DOI 10.1103/PhysRevB.43.1726; Janz G. J., 1975, Journal of Physical and Chemical Reference Data, V4; Kartini E., 1998, PHYSICA B, V241-243, P909; Kob W, 1999, J PHYS-CONDENS MAT, V11, pR85, DOI 10.1088/0953-8984/11/10/003; Kohara S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/50/506101; Koura A, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798376; Lide D R, 2004, HDB CHEM PHYS; Maslen E.N., 1999, INT TABLES CRYSTALLO, VC, P548; McGreevy RL, 2001, J PHYS-CONDENS MAT, V13, pR877, DOI 10.1088/0953-8984/13/46/201; Mei Q, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.144204; Moss S.C., 1985, PHYSICS DISORDERED M, P77; Petri I, 2000, PHYS REV LETT, V84, P2413, DOI 10.1103/PhysRevLett.84.2413; PRICE DL, 1988, J PHYS C SOLID STATE, V21, pL1069, DOI 10.1088/0022-3719/21/32/001; Salmon PS, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/45/455208; SALMON PS, 1994, P R SOC-MATH PHYS SC, V445, P351, DOI 10.1098/rspa.1994.0065; Salmon PS, 2005, J PHYS-CONDENS MAT, V17, pS3537, DOI 10.1088/0953-8984/17/45/045; SALMON PS, 1992, P ROY SOC LOND A MAT, V437, P591, DOI 10.1098/rspa.1992.0081; SALMON PS, 1988, J PHYS F MET PHYS, V18, P2345, DOI 10.1088/0305-4608/18/11/007; Sears VF, 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]; Sharma BK, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.060201; TRIOLO R, 1981, J CHEM PHYS, V74, P703, DOI 10.1063/1.440829; Tucker MG, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/33/335215; VASHISHTA P, 1989, PHYS REV B, V39, P6034, DOI 10.1103/PhysRevB.39.6034; Weber JKR, 1998, NATURE, V393, P769, DOI 10.1038/31662; Wilson M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.157801; WILSON M, 1993, J PHYS-CONDENS MAT, V5, P6833, DOI 10.1088/0953-8984/5/37/004; Yannopoulos SN, 2003, J CHEM PHYS, V118, P3197, DOI 10.1063/1.1537246; Zeidler A, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/47/474217	97	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093	1873-4812		J NON-CRYST SOLIDS	J. Non-Cryst. Solids	JAN 1	2015	407				SI		235	245		10.1016/j.jnoncrysol.2014.08.027		11	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	AX6FJ	WOS:000347018300034		
J	Kawaguchi, D; Tateishi, Y; Tanaka, K				Kawaguchi, Daisuke; Tateishi, Yohei; Tanaka, Keiji			Time-resolved fluorescence analysis for dye-labeled polystyrene in thin films	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article; Proceedings Paper	7th International Discussion Meeting on Relaxations in Complex Systems (IDMRCS)	JUL 21-26, 2013	Univ Politecnica Catalunya, Barcelona, SPAIN	Energia Campus Int Excellence, Barcelona Knowledge Campus, Inst Laue Langevin, Julich Forschungszentrum, CNRS, Lab Leon Brillouin, Int Dielectr Soc, AirLiquide, Almirall, Bruker, Extrasolution, Matgas, Mettler Toledo, Novocontrol Technologies, TA Instruments, Polish Acad Sci, Inst High Pressure Phys	Univ Politecnica Catalunya	Polystyrene; Relaxation; Thin films; Fluorescence anisotropy	GLASS-TRANSITION TEMPERATURE; ULTRATHIN POLYMER-FILMS; POLY(METHYL METHACRYLATE); INTERFACIAL MOBILITY; MOLECULAR MOBILITY; SURFACE; DYNAMICS; RELAXATION; THICKNESS; BULK	Time-resolved fluorescence spectroscopy and anisotropy were applied to dye-labeled polystyrene in thin films. Both fluorescence lifetime and rotational relaxation time decreased with decreasing thickness once the film became thinner than approximately 100 nm. The results could be well reproduced by a tri-layer model composed of surface, interface and bulk regions. The model analysis clearly indicates that the chain dynamics in the surface and substrate interfacial regions is, respectively, faster and slower than that in the internal bulk phase. (c) 2014 Elsevier B.V. All rights reserved.	[Kawaguchi, Daisuke] Kyushu Univ, Educ Ctr Global Leaders Mol Syst Devices, Fukuoka 8190395, Japan; [Tateishi, Yohei; Tanaka, Keiji] Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan; [Tanaka, Keiji] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI 12CNER, Fukuoka 8190395, Japan	Kawaguchi, D (reprint author), Kyushu Univ, Educ Ctr Global Leaders Mol Syst Devices, 744 Motooka Nishi Ku, Fukuoka 8190395, Japan.	d-kawaguchi@cstf.kyushu-u.ac.jp; k-tanaka@cstf.kyushu-u.ac.jp					Berriot J, 2002, MACROMOLECULES, V35, P9756, DOI 10.1021/ma0212700; de Gennes PG, 2000, EUR PHYS J E, V2, P201, DOI 10.1007/PL00013665; Tanaka K, 2009, J PHYS CHEM B, V113, P4571, DOI 10.1021/jp810370f; Bliznyuk VN, 2002, MACROMOLECULES, V35, P6613, DOI 10.1021/ma011326a; Bansal A, 2005, NAT MATER, V4, P693, DOI 10.1038/nmat1447; WALLACE WE, 1995, PHYS REV E, V52, pR3329; Fryer DS, 2000, MACROMOLECULES, V33, P6439, DOI 10.1021/ma0003349; Stafford CM, 2006, MACROMOLECULES, V39, P5095, DOI 10.1021/ma060790i; Kajiyama T, 1997, MACROMOLECULES, V30, P280, DOI 10.1021/ma960582y; KEDDIE JL, 1994, FARADAY DISCUSS, V98, P219, DOI 10.1039/fd9949800219; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Priestley RD, 2005, SCIENCE, V309, P456, DOI 10.1126/science.1112217; O'Connell PA, 2005, SCIENCE, V307, P1760, DOI 10.1126/science.1105658; Grohens Y, 1998, LANGMUIR, V14, P2929, DOI 10.1021/la971397w; REITER G, 1992, PHYS REV LETT, V68, P75, DOI 10.1103/PhysRevLett.68.75; Zheng X, 1997, PHYS REV LETT, V79, P241, DOI 10.1103/PhysRevLett.79.241; Paeng K, 2011, J AM CHEM SOC, V133, P8444, DOI 10.1021/ja2022834; Prucker O, 1998, MACROMOL CHEM PHYSIC, V199, P1435, DOI 10.1002/(SICI)1521-3935(19980701)199:7<1435::AID-MACP1435>3.0.CO;2-#; DeMaggio GB, 1997, PHYS REV LETT, V78, P1524, DOI 10.1103/PhysRevLett.78.1524; Kawana S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021501; Kawaguchi D, 2003, MACROMOLECULES, V36, P1235, DOI 10.1021/ma025667f; Roth CB, 2007, MACROMOLECULES, V40, P2568, DOI 10.1021/ma062864w; Fryer DS, 2001, MACROMOLECULES, V34, P5627, DOI 10.1021/ma001932q; Kim H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068302; Tanaka K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335593; Sharp JS, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.235701; Baschnagel J, 2005, J PHYS-CONDENS MAT, V17, pR851, DOI 10.1088/0953-8984/17/32/R02; vanZanten JH, 1996, PHYS REV E, V53, pR2053; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Forrest JA, 2000, PHYS REV E, V61, pR53, DOI 10.1103/PhysRevE.61.R53; TONEY MF, 1995, NATURE, V374, P709, DOI 10.1038/374709a0; Alcoutlabi M, 2005, J PHYS-CONDENS MAT, V17, pR461, DOI 10.1088/0953-8984/17/15/R01; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Fukao K, 2000, PHYS REV E, V61, P1743, DOI 10.1103/PhysRevE.61.1743; Tsui OKC, 2001, MACROMOLECULES, V34, P5535, DOI 10.1021/ma000028v; Miyazaki T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061803; Tateishi Y, 2007, J PHYS CHEM B, V111, P7761, DOI 10.1021/jp0705065; BEAUCAGE G, 1993, J POLYM SCI POL PHYS, V31, P319, DOI 10.1002/polb.1993.090310310; Paeng K, 2012, SOFT MATTER, V8, P819, DOI 10.1039/c1sm06501g; Efremov MY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085703; Grohens Y, 2002, EUR PHYS J E, V8, P217, DOI 10.1140/epje/i2001-10088-4; Shundo A, 2012, MACROMOLECULES, V45, P329, DOI 10.1021/ma201901x; Tanaka K, 1996, MACROMOLECULES, V29, P3040, DOI 10.1021/ma951378y; Yang ZH, 2010, SCIENCE, V328, P1676, DOI 10.1126/science.1184394; Tanaka K, 2000, MACROMOLECULES, V33, P7588, DOI 10.1021/ma000406w; MAYES AM, 1994, MACROMOLECULES, V27, P3114, DOI 10.1021/ma00089a033; Long D, 2001, EUR PHYS J E, V4, P371, DOI 10.1007/s101890170120; Fakhraai Z, 2008, SCIENCE, V319, P600, DOI 10.1126/science.1151205; ANWAND D, 1991, MAKROMOL CHEM, V192, P1981; BOKOBZA L, 1981, POLYMER, V22, P1309, DOI 10.1016/0032-3861(81)90225-1; Fukao K, 1999, EUROPHYS LETT, V46, P649, DOI 10.1209/epl/i1999-00309-6; Jean YC, 1997, PHYS REV B, V56, pR8459; MITCHELL AR, 1976, TETRAHEDRON LETT, P3795; NISHIJIM.Y, 1970, BERICH BUNSEN GESELL, V74, P778; Sharp JS, 2004, EUR PHYS J E, V15, P473, DOI 10.1140/epje/i2004-10078-0; TAO T, 1969, BIOPOLYMERS, V8, P609, DOI 10.1002/bip.1969.360080505; White CC, 2001, POLYM ENG SCI, V41, P1497, DOI 10.1002/pen.10848	57	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093	1873-4812		J NON-CRYST SOLIDS	J. Non-Cryst. Solids	JAN 1	2015	407				SI		284	287		10.1016/j.jnoncrysol.2014.09.010		4	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	AX6FJ	WOS:000347018300040		
J	Huang, SS; Kitao, S; Kobayashi, Y; Yoshiie, T; Xu, Q; Sato, K; Seto, M				Huang, S. S.; Kitao, S.; Kobayashi, Y.; Yoshiie, T.; Xu, Q.; Sato, K.; Seto, M.			Study of neutron irradiation on F82H alloys by Mossbauer spectroscopy	JOURNAL OF NUCLEAR MATERIALS			English	Article							FE-CR ALLOYS; SHORT-RANGE-ORDER; POSITRON-ANNIHILATION; MISCIBILITY GAP; REACTOR; STEELS	The effects of neutron irradiation on F82H ferritic/martensitic stainless steel and its model alloys were studied by Mossbauer spectroscopy. The microstructural damage mechanisms of these alloys, during the void incubation period were interpreted using the short range order (SRO) parameters. Results show that within Fe-8Cr alloy, the atoms in the nearest neighbor (NN) of the Fe nuclei were inhomogeneous, prior to irradiation. A configuration trapping model of Cr supported the negative average SRO observed for the NN shells in our Fe-Cr alloys. We found that irradiation also accelerated the SRO in Fe-8Cr through a diffusion mechanism, where Cr atom repulsion was concentration dependent. Finally, comparative studies were conducted on F82H model alloys using the present Mossbauer measurements and our previously reported work on positron annihilation spectroscopy, which further established that irradiation of the alloys promoted the growth of a M23C6 complex. (C) 2014 Elsevier B.V. All rights reserved.	[Huang, S. S.; Kitao, S.; Kobayashi, Y.; Yoshiie, T.; Xu, Q.; Sato, K.; Seto, M.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka Fu 5900494, Japan	Huang, SS (reprint author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka Fu 5900494, Japan.	h.shaosong@ht8.ecs.kyoto-u.ac.jp					Shim JH, 2006, J NUCL MATER, V351, P56, DOI 10.1016/j.jnucmat.2006.02.021; Klaver TPC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094435; Garner FA, 2000, J NUCL MATER, V276, P123, DOI 10.1016/S0022-3115(99)00225-1; COWLEY JM, 1950, PHYS REV, V77, P669, DOI 10.1103/PhysRev.77.669; Bonny G, 2008, SCRIPTA MATER, V59, P1193, DOI 10.1016/j.scriptamat.2008.08.008; DUBIEL SM, 1987, Z METALLKD, V78, P544; Terentyev D, 2007, J NUCL MATER, V362, P167, DOI 10.1016/j.jnucmat.2007.01.069; MIREBEAU I, 1984, PHYS REV LETT, V53, P687, DOI 10.1103/PhysRevLett.53.687; Cook I, 2006, NAT MATER, V5, P77, DOI 10.1038/nmat1584; BRAUER G, 1990, HYPERFINE INTERACT, V56, P1563, DOI 10.1007/BF02405476; Dubiel SM, 2013, J NUCL MATER, V434, P235, DOI 10.1016/j.jnucmat.2012.10.048; Filippova NP, 2000, PHYS MET METALLOGR+, V90, P145; Huang S. S., 2013, J NUCL MAT IN PRESS; Huang SS, 2013, J NUCL MATER, V440, P617, DOI 10.1016/j.jnucmat.2013.05.015; Idczak R, 2012, J PHYS CHEM SOLIDS, V73, P1095, DOI 10.1016/j.jpcs.2012.05.010; Idczak R, 2012, SOLID STATE COMMUN, V152, P1924, DOI 10.1016/j.ssc.2012.07.027; Jiraskova Y, 2005, APPL SURF SCI, V239, P132, DOI 10.1016/j.apsusc.2004.05.289; Olsson P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104416; PRINCIPI G, 1983, GAZZ CHIM ITAL, V113, P281; Sagaradze V. V., 2001, PHYS MET METALLOGR, V92, P505; Yoshiie T, 2003, NUCL INSTRUM METH A, V498, P522, DOI 10.1016/S0168-9002(02)02143-5; Zeman A, 2007, J NUCL MATER, V362, P259, DOI 10.1016/j.jnucmat.2007.01.068	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	JAN	2015	456						266	271		10.1016/j.jnucmat.2014.09.062		6	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AY0GC	WOS:000347274500034		
J	Masahira, Y; Ohishia, Y; Kurosaki, K; Muta, H; Yamanaka, S; Komamine, S; Fukui, T; Ochi, E				Masahira, Yusuke; Ohishia, Yuji; Kurosaki, Ken; Muta, Hiroaki; Yamanaka, Shinsuke; Komamine, Satoshi; Fukui, Toshiki; Ochi, Eiji			Effect of Mo content on thermal and mechanical properties of Mo-Ru-Rh-Pd alloys	JOURNAL OF NUCLEAR MATERIALS			English	Article							FISSION-PRODUCT BEHAVIOR; THERMOPHYSICAL PROPERTIES; CHEMICAL-STATE; NUCLEAR-FUEL; OXIDE FUELS; HIGH BURNUP; THERMODYNAMICS; VAPORIZATION; PLATINOIDS; SYSTEMS	Metallic inclusions are precipitated in irradiated oxide fuels. The composition of the phases varies with the burnup and the conditions such as temperature gradients and oxygen potential of the fuel. In the present work Mox/0.7+x (Ru0.5Rh0.1Pd0.1)(0.7/0.7+x) (x = 0, 0.05, 0.1, 0.15, 0.2, and 0.25) alloys were prepared by arc melting, followed by annealing in a high vacuum. The thermal and mechanical properties of the alloys such as elastic moduli, Debye temperature, micro-Vickers hardness, electrical resistivity, and thermal conductivity have been evaluated to elucidate the effect of Mo content on these physical properties of the alloys. The alloys with lower Mo contents show higher thermal conductivity. The thermal conductivity of the alloy with x = 0 is almost twice of that of the alloy with x = 0.25. The thermal conductivities of the alloys are dominated by electronic contribution, which has been evaluated using the Wiedemann-Franz-Lorenz relation from the electrical resistivity data. It is confirmed that the variation of the Mo contents of the alloys considerably affects the mechanical and thermal properties of the alloys. (C) 2014 Elsevier B.V. All rights reserved.	[Masahira, Yusuke; Ohishia, Yuji; Kurosaki, Ken; Muta, Hiroaki; Yamanaka, Shinsuke] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Suita, Osaka 565, Japan; [Yamanaka, Shinsuke] Univ Fukui, Res Inst Nucl Engn, Tsuruga, Fukui, Japan; [Komamine, Satoshi; Fukui, Toshiki; Ochi, Eiji] Japan Nucl Fuel Ltd, Rokkasho, Aomori, Japan	Ohishia, Y (reprint author), Yamadaoka 2-1, Suita, Osaka, Japan.	ohishi@see.eng.osaka-u.ac.jp	Kurosaki, Ken/E-8081-2012		Japan Nuclear Fuel Limited; Ministry of Economy, Trade and Industry	This work was carried out as a part of the research supported by Japan Nuclear Fuel Limited with Grant-in-Aid by the Ministry of Economy, Trade and Industry.	KLEYKAMP H, 1985, J NUCL MATER, V131, P221, DOI 10.1016/0022-3115(85)90460-X; Yamanaka S, 2001, J NUCL MATER, V294, P99, DOI 10.1016/S0022-3115(01)00474-3; Kaye MH, 2007, J NUCL MATER, V366, P8, DOI 10.1016/j.jnucmat.2006.11.014; LUCUTA PG, 1995, J NUCL MATER, V223, P51, DOI 10.1016/0022-3115(94)00703-9; KLEYKAMP H, 1989, J NUCL MATER, V167, P49, DOI 10.1016/0022-3115(89)90424-8; Barin I., 1977, THERMOCHEMICAL PROPE, P643; Barin I., 1977, THERMOCHEMICAL PROPE, P646; Barina I., 1977, THERMOCHEMICAL PROPE, P484; BROWN HL, 1966, J LESS-COMMON MET, V11, P135, DOI 10.1016/0022-5088(66)90078-6; CORDFUNKE EHP, 1989, THERMOCHIM ACTA, V139, P99, DOI 10.1016/0040-6031(89)87013-3; EWART FT, 1976, J NUCL MATER, V61, P254, DOI 10.1016/0022-3115(76)90264-6; Johson I., 1973, J NUCL MATER, V48, P21; KLEYKAMP H, 1988, J LESS-COMMON MET, V144, P79, DOI 10.1016/0022-5088(88)90351-7; KLEYKAMP H, 1979, J NUCL MATER, V84, P109, DOI 10.1016/0022-3115(79)90154-5; KLEYKAMP H, 1985, J NUCL MATER, V130, P426, DOI 10.1016/0022-3115(85)90329-0; KLEYKAMP H, 1988, NUCL TECHNOL, V80, P412; KLEYKAMP H, 1977, J NUCL MATER, V66, P292, DOI 10.1016/0022-3115(77)90118-0; Kolarik Z, 2003, PLATIN MET REV, V47, P74; Kolarik Z, 2005, PLATIN MET REV, V49, P79, DOI 10.1595/147106705X35263; Matsuda T, 2001, J ALLOY COMPD, V322, P77, DOI 10.1016/S0925-8388(01)01263-4; MATSUI T, 1989, J NUCL SCI TECHNOL, V26, P1102; MATSUI T, 1989, THERMOCHIM ACTA, V139, P299, DOI 10.1016/0040-6031(89)87030-3; O'Boyle D. R., 1970, J NUCL MATER, V35, P257; OBOYLE DR, 1969, J NUCL MATER, V29, P27, DOI 10.1016/0022-3115(69)90124-X; Oversby V. M., 1994, NUCL MAT MAT SCI T B, V108; Sarin I., 1977, THERMOCHEMICAL PROPE, P630; Sato I, 1999, J NUCL MATER, V273, P239, DOI 10.1016/S0022-3115(99)00071-9; Sato I, 1999, J NUCL SCI TECHNOL, V36, P775, DOI 10.3327/jnst.36.775; Sato I, 1997, J NUCL MATER, V247, P46, DOI 10.1016/S0022-3115(97)00062-7; Tanaka K, 2011, J NUCL MATER, V414, P316, DOI 10.1016/j.jnucmat.2011.04.057; Tanaka K, 2012, J NUCL MATER, V422, P163, DOI 10.1016/j.jnucmat.2011.12.036; TOURASSE M, 1992, J NUCL MATER, V188, P49, DOI 10.1016/0022-3115(92)90453-R; Yamanaka S, 2005, J NUCL MATER, V344, P61, DOI 10.1016/j.jnucmat.2005.04.017; Yamanaka S, 2004, J SOLID STATE CHEM, V177, P3484, DOI 10.1016/j.jssc.2004.05.039; Yamanaka S, 2003, J ALLOY COMPD, V353, P269, DOI 10.1016/S0925-8388(02)01211-2	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	JAN	2015	456						369	372		10.1016/j.jnucmat.2014.10.009		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AY0GC	WOS:000347274500048		
J	Krsjak, V; Kuriplach, J; Shen, T; Sabelova, V; Sato, K; Dai, Y				Krsjak, Vladimir; Kuriplach, Jan; Shen, Tielong; Sabelova, Veronika; Sato, Koichi; Dai, Yong			Helium behavior in ferritic/martensitic steels irradiated in spallation target	JOURNAL OF NUCLEAR MATERIALS			English	Article							POSITRON-ANNIHILATION SPECTROSCOPY; LIFETIME MEASUREMENTS; CONTAINING HYDROGEN; MARTENSITIC STEEL; STIP-II; DEFECTS; PROGRAM; MICROSTRUCTURE; BUBBLES; ALLOYS	Two positron annihilation spectroscopy (PAS) techniques have been used for the investigation of helium behavior in STIP samples. Positron lifetime measurements and coincidence Doppler broadening spectroscopy have been employed together in a complex PAS characterization of RAFM steel irradiated in a mixed neutron-proton spectrum up to 20 dpa and 1800 appm He. Both techniques show an increase of the He-to-dpa ratio up to similar to 10 dpa. At higher irradiation loads, the ratio is decreasing, which was attributed to the formation and growth of helium bubbles. (C) 2014 Elsevier B.V. All rights reserved.	[Krsjak, Vladimir; Shen, Tielong; Dai, Yong] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Kuriplach, Jan] Charles Univ Prague, Fac Math & Phys, Dept Low Temp Phys, CR-18000 Prague 8, Czech Republic; [Sabelova, Veronika] Slovak Univ Technol Bratislava, Inst Nucl & Phys Engn, Bratislava 81219, Slovakia; [Sato, Koichi] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan	Krsjak, V (reprint author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	vladimir.krsjak@psi.ch			APVV Project (Slovakia) [2013-0197]; MSMT Project (Czech Republic) within the framework of the Czech-Slovak cooperation MOBILITY [7AMB14SK185]	VS and JK acknowledge support from the APVV Project No. 2013-0197 (Slovakia) and MSMT Project 7AMB14SK185 (Czech Republic) within the framework of the Czech-Slovak cooperation MOBILITY.	Alinger MJ, 2009, MAT SCI ENG A-STRUCT, V518, P150, DOI 10.1016/j.msea.2009.04.040; Amarendra G., 1992, PHYS REV B, V45, P18; Trinkaus H, 2003, J NUCL MATER, V323, P229, DOI 10.1016/j.jnucmat.2003.09.001; Kimura A, 2000, J NUCL MATER, V283, P827, DOI 10.1016/S0022-3115(00)00090-8; VEHANEN A, 1982, PHYS REV B, V25, P762, DOI 10.1103/PhysRevB.25.762; Brusa RS, 2002, NUCL INSTRUM METH B, V194, P519, DOI 10.1016/S0168-583X(02)00953-9; Morishita K, 2003, NUCL INSTRUM METH B, V202, P76, DOI 10.1016/S0168-583X(02)01832-3; Eldrup M, 1997, J NUCL MATER, V251, P132, DOI 10.1016/S0022-3115(97)00221-3; Kansy J, 1996, NUCL INSTRUM METH A, V374, P235, DOI 10.1016/0168-9002(96)00075-7; Babu SH, 2013, J PHYS CONF SER, V443, DOI 10.1088/1742-6596/443/1/012010; Cizek J, 2000, NUCL INSTRUM METH A, V450, P325; Dai Y, 2005, J NUCL MATER, V343, P33, DOI 10.1016/j.jnucmat.2005.01.027; Dai Y, 2012, J NUCL MATER, V431, P2, DOI 10.1016/j.jnucmat.2011.11.004; Dai Y, 2011, J NUCL MATER, V415, P306, DOI 10.1016/j.jnucmat.2011.04.029; Gilbert MR, 2013, J NUCL MATER, V442, pS755, DOI 10.1016/j.jnucmat.2013.03.085; Jia X, 2006, J NUCL MATER, V356, P105, DOI 10.1016/j.jnucmat.2006.05.006; KRAUSEREHBERG R, 1992, PHYS STATUS SOLIDI A, V134, pK45, DOI 10.1002/pssa.2211340228; Krause-Rehberg R, 2005, NUCL INSTRUM METH B, V240, P719, DOI 10.1016/j.nimb.2005.04.130; Krsjak V, 2012, J NUCL MATER, V421, P97, DOI 10.1016/j.jnucmat.2011.11.067; Luzginova NV, 2012, J NUCL MATER, V428, P192, DOI 10.1016/j.jnucmat.2011.08.030; Maji S, 2001, PHYS LETT A, V281, P76, DOI 10.1016/S0375-9601(01)00091-3; McManamy T, 2008, J NUCL MATER, V377, P1, DOI 10.1016/j.jnucmat.2008.02.024; Sabelova V, 2014, J NUCL MATER, V450, P54, DOI 10.1016/j.jnucmat.2013.10.039; Sato K, 2014, J NUCL MATER, V450, P59, DOI 10.1016/j.jnucmat.2013.09.009; Sato K, 2012, J NUCL MATER, V431, P52, DOI 10.1016/j.jnucmat.2011.11.015; Slugen V, 2002, APPL SURF SCI, V194, P150, DOI 10.1016/S0169-4332(02)00116-2; SUBRAHMANYAM VS, 1994, SOLID STATE COMMUN, V89, P523, DOI 10.1016/0038-1098(94)90749-8; Troev T, 2009, NUCL INSTRUM METH B, V267, P535, DOI 10.1016/j.nimb.2008.11.045; Troev T, 2006, J NUCL MATER, V359, P93, DOI 10.1016/j.jnucmat.2006.07.020; Troev T, 2009, PHYS STATUS SOLIDI C, V6, P2373, DOI 10.1002/pssc.200982129; Weber M., 2004, NT57F0401120MWMMAARW; Zhang H, 2008, J NUCL MATER, V377, P122, DOI 10.1016/j.jnucmat.2008.02.037	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	JAN	2015	456						382	388		10.1016/j.jnucmat.2014.10.014		7	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	AY0GC	WOS:000347274500050		
J	Kim, M; Achmad, A; Higuchi, T; Arisaka, Y; Yokoo, H; Yokoo, S; Tsushima, Y				Kim, Mai; Achmad, Arifudin; Higuchi, Tetsuya; Arisaka, Yukiko; Yokoo, Hideaki; Yokoo, Satoshi; Tsushima, Yoshito			Effects of Intratumoral Inflammatory Process on F-18-FDG Uptake: Pathologic and Comparative Study with F-18-Fluoro-alpha-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma	JOURNAL OF NUCLEAR MEDICINE			English	Article						inflammation; MTV; OSCC; F-18-FAMT; F-18-FDG	METABOLIC TUMOR VOLUME; TOTAL LESION GLYCOLYSIS; POSITRON-EMISSION-TOMOGRAPHY; ACID TRANSPORTER 1; FDG-PET; PATIENT-MANAGEMENT; SOLID TUMORS; NECK-CANCER; HEAD; SURVIVAL	The accurate depiction of both biologic and anatomic profiles of tumors has long been a challenge in PET imaging. An inflammation, which is innate in the carcinogenesis of oral squamous cell carcinoma (OSCC), frequently complicates the image analysis because of the limitations of F-18-FDG and maximum standardized uptake values (SUVmax). New PET parameters, metabolic tumor volume (MTV) and total lesion glycolysis (TLG), as well as (18)Ffluoro- alpha-methyltyrosine (F-18-FAMT), a malignancy-specific amino acid-based PET radiotracer, are considered more comprehensive in tumor image analysis. Here, we showed the substantial effects of the intratumoral inflammatory process on F-18-FDG uptake and further study the possibility of MTV and TLG to predict both tumor biology (proliferation activity) and anatomy (pathologic tumor volume). Methods: F-18-FDG and F-18-FAMT PET images from 25 OSCC patients were analyzed. SUVmax on the tumor site was obtained. PET volume computerized-assisted reporting was used to generate a volume of interest to obtain MTV and TLG for F-18-FDG and total lesion retention (TLR) for F-18-FAMT. The whole tumor dissected from surgery was measured and sectioned for pathologic analysis of tumor inflammation grade and Ki-67 labeling index. Results: The high SUVmax of F-18-FDG was related to the high inflammation grade. The SUVmax ratio of F-18-FDG to F-18-FAMT was higher in inflammatory tumors (P < 0.05) whereas the corresponding value in tumors with a low inflammation grade was kept low. All F-18-FAMT parameters were correlated with Ki-67 labeling index (P < 0.01). Pathologic tumor volume predicted from MTV of F-18-FAMT was more accurate (R = 0.90, bias = 3.4 +/- 6.42 cm(3), 95% confidence interval = 0.77-6.09 cm(3)) than that of F-18-FDG (R = 0.77, bias = 8.1 +/- 11.17 cm(3), 95% confidence interval = 3.45-12.67 cm(3)). Conclusion: F-18-FDG uptake was overestimated by additional uptake related to the intratumoral inflammatory process, whereas F-18-FAMT simply accumulated in tumors according to tumor activity as evaluated by Ki-67 labeling index in OSCC.	[Kim, Mai; Yokoo, Satoshi] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 3718511, Japan; [Kim, Mai; Achmad, Arifudin; Higuchi, Tetsuya; Arisaka, Yukiko; Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 3718511, Japan; [Achmad, Arifudin] Gunma Univ, Human Resource Cultivat Ctr, Kiryu, Gunma, Japan; [Achmad, Arifudin] Gadjah Mada Univ, Fac Med, Dept Radiol, Yogyakarta, Indonesia; [Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 3718511, Japan	Kim, M (reprint author), Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	kimmu@gunma-u.ac.jp					Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Hyun SH, 2014, EUR J NUCL MED MOL I, V41, P50, DOI 10.1007/s00259-013-2530-8; Zini A, 2010, J ORAL PATHOL MED, V39, P299, DOI 10.1111/j.1600-0714.2009.00845.x; Kunkel M, 2003, CANCER, V98, P2257, DOI 10.1002/cncr.11763; Nobusawa A, 2013, EUR J NUCL MED MOL I, V40, P1692, DOI 10.1007/s00259-013-2477-9; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Tomiyoshi K, 1997, NUCL MED COMMUN, V18, P169, DOI 10.1097/00006231-199702000-00013; Kim M, 2013, ANN NUCL MED, V27, P423, DOI 10.1007/s12149-013-0701-0; Cooper JS, 2009, HEAD NECK-J SCI SPEC, V31, P748, DOI 10.1002/hed.21022; Hooper SJ, 2009, HEAD NECK-J SCI SPEC, V31, P1228, DOI 10.1002/hed.21140; Pak K, 2014, J NUCL MED, V55, P884, DOI 10.2967/jnumed.113.133801; Thomas B, 2014, LARYNGOSCOPE, V124, P688, DOI 10.1002/lary.24357; Quon A, 2007, J NUCL MED, V48, p58S; Xie P, 2011, J CANCER RES CLIN, V137, P1085, DOI 10.1007/s00432-010-0972-y; Myoung H, 2006, INT J ORAL MAX SURG, V35, P1005, DOI 10.1016/j.ijom.2006.07.016; Murphy JD, 2011, RADIOTHER ONCOL, V101, P356, DOI 10.1016/j.radonc.2011.05.040; Klintrup K, 2005, EUR J CANCER, V41, P2645, DOI 10.1016/j.ejca.2005.07.017; Sridhar P, 2014, AM J ROENTGENOL, V202, P1114, DOI 10.2214/AJR.13.11456; Abd El-Hafez YG, 2013, ORAL ONCOL, V49, P261, DOI 10.1016/j.oraloncology.2012.09.005; Culverwell AD, 2011, CLIN RADIOL, V66, P366, DOI 10.1016/j.crad.2010.12.004; Kim CH, 2006, ANTICANCER RES, V26, P2943; Lonneux M, 2010, J CLIN ONCOL, V28, P1190, DOI 10.1200/JCO.2009.24.6298; Dibble EH, 2012, J NUCL MED, V53, P709, DOI 10.2967/jnumed.111.099531; Chan SC, 2013, ORAL ONCOL, V49, P71, DOI 10.1016/j.oraloncology.2012.07.016; Burger IA, 2012, NUCL MED BIOL, V39, P666, DOI 10.1016/j.nucmedbio.2011.11.002; Jacob R, 2001, ORL J OTO-RHINO-LARY, V63, P307, DOI 10.1159/000055764; Kim DK, 2004, ANTICANCER RES, V24, P1671; Kurokawa H, 2005, J ORAL PATHOL MED, V34, P602, DOI 10.1111/j.1600-0714.2005.00358.x; Lim R, 2012, J NUCL MED, V53, P1506, DOI 10.2967/jnumed.111.101402; Miyakubo M, 2007, ANN NUCL MED, V21, P129; Miyashita G, 2010, ANN NUCL MED, V24, P579, DOI 10.1007/s12149-010-0398-2; Motta Rafael Da Ros, 2009, Braz. j. otorhinolaryngol., V75, P544, DOI 10.1590/S1808-86942009000400013; Senft A, 2008, RADIOTHER ONCOL, V87, P221, DOI 10.1016/j.radonc.2008.03.008; van den Hoff J, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-77; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307	36	1	1	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	JAN	2015	56	1					16	21		10.2967/jnumed.114.144014		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX9PG	WOS:000347233700023		
J	Chen, CJ; Bando, K; Ashino, H; Taguchi, K; Shiraishi, H; Shima, K; Fujimoto, O; Kitamura, C; Matsushima, S; Uchida, K; Nakahara, Y; Kasahara, H; Minamizawa, T; Jiang, C; Zhang, MR; Ono, M; Tokunaga, M; Suhara, T; Higuchi, M; Yamada, K; Ji, B				Chen, Chun-Jen; Bando, Kazunori; Ashino, Hiroki; Taguchi, Kazumi; Shiraishi, Hideaki; Shima, Keiji; Fujimoto, Osuke; Kitamura, Chiemi; Matsushima, Satoshi; Uchida, Keisuke; Nakahara, Yuto; Kasahara, Hiroyuki; Minamizawa, Takao; Jiang, Cheng; Zhang, Ming-Rong; Ono, Maiko; Tokunaga, Masaki; Suhara, Tetsuya; Higuchi, Makoto; Yamada, Kazutaka; Ji, Bin			In Vivo SPECT Imaging of Amyloid-beta Deposition with Radioiodinated Imidazo[1,2-a] Pyridine Derivative DRM106 in a Mouse Model of Alzheimer's Disease	JOURNAL OF NUCLEAR MEDICINE			English	Article						Alzheimer's disease (AD); amyloid imaging; amyloid precursor protein (APP) transgenic mouse; DRM106; single photon emission computed tomography (SPECT)	POSITRON-EMISSION-TOMOGRAPHY; PITTSBURGH COMPOUND-B; BRAIN; PET; IMPY; PLAQUES; AGENT; MICE; PIB	Noninvasive determination of amyloid-beta peptide (A beta) deposition has important significance for early diagnosis and medical intervention for Alzheimer's disease (AD). In the present study, we investigated the availability of radiolabeled DRM106 (I-123/125-DRM106 [6-iodo-2[ 4-(1H-3-pyrazolyl) phenyl] imidazo[1,2-a] pyridine]), a compound with sufficient affinity for the synthesis of human A beta fibrils and satisfactory metabolic stability, as a SPECT ligand in living brains. Method: The sensitivity of I-125-DRM106 for detecting A beta deposition was compared with that of I-125-IMPY (2-(4'-dimethylaminophenyl)-6-iodo-imidazo[1,2-a] pyridine), a well-known amyloid SPECT ligand, by ex vivo autoradiographic analyses in 18-mo-old amyloid precursor protein transgenic mice. To verify the sensitivity and quantitation of radiolabeled DRM106 for in vivo imaging, we compared the detectability of A beta plaques with I-123-DRM106 and a well-known amyloid PET agent, C-11-labeled Pittsburgh compound B (C-11-PiB), in 29-mo-old transgenic mice and age-matched nontransgenic littermates. Additionally, we compared the binding characteristics of I-125-DRM106 with those of C-11-PiB and C-11-PBB3, which selectively bind to A beta plaques and preferentially to tau aggregates, respectively, in postmortem AD brain sections. Results: Ex vivo autoradiographic analysis showed that measurement with I-125-DRM106 has a higher sensitivity for detecting A beta accumulation than with I-125-IMPY in transgenic mice. SPECT imaging with I-123-DRM106 also successfully detected A beta deposition in living aged transgenic mice and showed strong correlation (R = 0.95, P < 0.01) in quantitative analysis for A beta plaque detection by PET imaging with C-11-PiB, implying that sensitivity and quantitation of SPECT imaging with I-123-DRM106 are almost as good as C-11-PiB PET for the detectability of A beta deposition. Further, the addition of nonradiolabeled DRM106 fully blocked the binding of I-125-DRM106 and C-11-PiB, but not C-11-PBB3, to AD brain sections, and I-125-DRM106 showed a lower binding ratio of the diffuse plaque-rich lateral temporal cortex to the dense-cored/neuritic plaque-rich hippocampal CA1 area, compared with C-11-PiB. Conclusion: All of these data demonstrated the high potential of I-123-DRM106 for amyloid imaging in preclinical and clinical application, and it might more preferentially detect dense-cored/neuritic amyloid deposition, which is expected to be closely associated with neuropathologic changes of AD.	[Chen, Chun-Jen; Bando, Kazunori; Ashino, Hiroki; Taguchi, Kazumi; Shiraishi, Hideaki; Shima, Keiji; Fujimoto, Osuke; Kitamura, Chiemi; Matsushima, Satoshi; Uchida, Keisuke; Nakahara, Yuto; Kasahara, Hiroyuki; Minamizawa, Takao] Fujifilm RI Pharma Co LTD, Res Dept, Chiba, Japan; [Chen, Chun-Jen; Zhang, Ming-Rong; Ono, Maiko; Tokunaga, Masaki; Suhara, Tetsuya; Higuchi, Makoto; Ji, Bin] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; [Chen, Chun-Jen; Yamada, Kazutaka] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Jiang, Cheng] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China	Ji, B (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	kihin@nirs.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23111009]	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This work was supported in part by grants-in-aid for Japan Advanced Molecular Imaging Program and Core Research for Evolutional Science and Technology and Scientific Research on Innovative Areas ("Brain Environment") 23111009 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. No other potential conflict of interest relevant to this article was reported.	BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Song PJ, 2008, NUCL MED BIOL, V35, P197, DOI 10.1016/j.nucmedbio.2007.10.005; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Kawarabayashi T, 2001, J NEUROSCI, V21, P372; Leinonen V, 2008, ARCH NEUROL-CHICAGO, V65, P1304, DOI 10.1001/archneur.65.10.noc80013; Cselenyi Z, 2012, J NUCL MED, V53, P415, DOI 10.2967/jnumed.111.094029; Newberg AB, 2006, J NUCL MED, V47, P748; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Kung MP, 2002, BRAIN RES, V956, P202, DOI 10.1016/S0006-8993(02)03436-4; Snellman A, 2012, EUR J NUCL MED MOL I, V39, P1784, DOI 10.1007/s00259-012-2178-9; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Ito H, 2014, EUR J NUCL MED MOL I, V41, P745, DOI 10.1007/s00259-013-2620-7; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Chen CJ, 2014, BIOORGAN MED CHEM, V22, P4189, DOI 10.1016/j.bmc.2014.05.043; Hampel H, 2011, PROG NEUROBIOL, V95, P579, DOI 10.1016/j.pneurobio.2010.11.005; Kung MP, 2004, EUR J NUCL MED MOL I, V31, P1136, DOI 10.1007/s00259-004-1487-z; Kung Mei-Ping, 2012, Chang Gung Med J, V35, P211; Maya Y, 2014, ALZH ASS INT C JUL 1; Ono M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074104; Zhang W, 2007, NUCL MED BIOL, V34, P89, DOI 10.1016/j.nucmedbio.2006.10.003	25	4	4	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	JAN	2015	56	1					120	126		10.2967/jnumed.114.146944		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX9PG	WOS:000347233700039		
J	Saeed, M; Kadioglu, O; Khalid, H; Sugimoto, Y; Efferth, T				Saeed, Mohamed; Kadioglu, Onat; Khalid, Hassan; Sugimoto, Yoshikazu; Efferth, Thomas			Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Chemotherapy; Flavonoids; Multidrug resistance; Natural products; Pharmacogenomics; Molecular docking and modelling	ACUTE MYELOID-LEUKEMIA; BREAST-CANCER CELLS; P-GLYCOPROTEIN; PROSTATE-CANCER; CYCLE ARREST; IN-VIVO; TETRAZOLIUM ASSAY; MONONUCLEAR-CELLS; INDUCED APOPTOSIS; CARCINOMA CELLS	Apigenin is a common dietary flavonoid with considerable cytotoxic activity in vitro and in vivo. Despite many mechanistic studies, less is known about resistance factors hampering apigenin's activity. We investigated the ATP-binding cassette (ABC) transporters BCRP/ABCG2, P-glycoprotein/ABCB1 and its close relative ABCB5. Multidrug-resistant cells overexpressing these ABC transporters were not cross-resistant toward apigenin. Moreover, apigenin inhibited not only P-glycoprotein but also BCRP by increasing cellular uptake of doxorubicin and synergistic inhibition of cell viability in combination with doxorubicin or docetaxel in multidrug-resistant cells. To perform in silico molecular docking studies, we first generated homology models for human P-glycoprotein and ABCB5 based on the crystal structure of murine P-glycoprotein. Their nucleotide binding domains (NDBs) revealed the highest degrees of sequence homologies (89%-100%), indicating that ATP binding and cleavage is of crucial importance for ABC transporters. Molecular docking of apigenin bound to the NDBs of P-glycoprotein and ABCB5 in molecular docking studies. Hence, apigenin may compete with ATP for NDB-binding leading to energy depletion to fuel the transport of ABC transporter substrates. Furthermore, we performed COMPARE and hierarchical cluster analyses of transcriptome-wide mRNA expression profiles of the National Cancer Institute tumor cell line panel. Microarray-based mRNA expressions of genes of diverse biological functions (signal transduction, transcriptional regulation, ubiquitination, autophagy, metabolic activity, xenobiotic detoxification and microtubule formation) significantly predicted responsiveness of tumor cells to apigenin. In conclusion, apigenin's activity is not hampered by classical mechanisms of multidrug resistance and the inhibition of ABC transporters by apigenin indicates that apigenin may overcome multidrug resistance in otherwise refractory tumors. (C) 2015 Elsevier Inc. All rights reserved.	[Saeed, Mohamed; Kadioglu, Onat; Efferth, Thomas] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Dept Pharmaceut Biol, D-55128 Mainz, Germany; [Khalid, Hassan] Univ Khartoum, Dept Pharmacognosy, Khartoum, Sudan; [Sugimoto, Yoshikazu] Keio Univ, Fac Pharm, Div Chemotherapy, Tokyo, Japan	Efferth, T (reprint author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Dept Pharmaceut Biol, Staudinger Weg 5, D-55128 Mainz, Germany.	efferth@uni-mainz.de			Sudanese government (National Research Center)	We are grateful to the Sudanese government (National Research Center) for providing a stipend to M.S.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Efferth T, 2008, CLIN CANCER RES, V14, P2405, DOI 10.1158/1078-0432.CCR-07-4525; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; AFZAL M, 1980, HETEROCYCLES, V14, P1973; Patel D, 2007, INT J ONCOL, V30, P233; Le XF, 2011, CANCER BIOL THER, V12, P260, DOI 10.4161/cbt.12.4.16430; Benderra Z, 2004, CLIN CANCER RES, V10, P7896, DOI 10.1158/1078-0432.CCR-04-0795; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867; Zeino M, 2014, INVEST NEW DRUG, V32, P618, DOI 10.1007/s10637-014-0098-1; Cooray HC, 2002, NEUROREPORT, V13, P2059, DOI 10.1097/00001756-200211150-00014; Zapata-Torres G, 2004, J NAT PROD, V67, P416, DOI 10.1021/np034011s; Kachadourian R, 2006, FREE RADICAL BIO MED, V41, P65, DOI 10.1016/j.freeradbiomed.2006.03.002; Kumar S, 2006, PHARM BIOL, V44, P84, DOI 10.1080/13880200600591758; Plaumann B, 1996, ONCOGENE, V13, P1605; ALLEY MC, 1988, CANCER RES, V48, P589; Angelini A, 2010, J BIOL REG HOMEOS AG, V24, P197; Kim SH, 2013, MOL CELL ENDOCRINOL, V369, P130, DOI 10.1016/j.mce.2013.01.012; Efferth T, 2011, CURR DRUG TARGETS, V12, P122, DOI 10.2174/138945011793591626; Chen WY, 2011, INVEST NEW DRUG, V29, P1347, DOI 10.1007/s10637-010-9497-0; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Tong X, 2012, MOL CARCINOGEN, V51, P268, DOI 10.1002/mc.20793; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Yang J, 2013, FOOD FUNCT, V4, P939, DOI 10.1039/c3fo60071h; Seligmann J, 2013, FUTURE MED CHEM, V5, P339, DOI [10.4155/fmc.12.217, 10.4155/FMC.12.217]; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Yin F, 1999, ANTICANCER RES, V19, P4297; Huang CS, 2013, ARCH TOXICOL, V87, P167, DOI 10.1007/s00204-012-0913-4; Lin J K, 1997, J Cell Biochem Suppl, V28-29, P39; Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kawanobe T, 2012, BIOCHEM BIOPH RES CO, V418, P736, DOI 10.1016/j.bbrc.2012.01.090; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Maliepaard M, 2001, CANCER RES, V61, P3458; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Grimm M, 2012, EUR J CANCER, V48, P3186, DOI 10.1016/j.ejca.2012.05.027; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Kuete V, 2012, PLANTA MED, V78, P193, DOI 10.1055/s-0031-1280319; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Zhu YZ, 2013, MOL CANCER THER, V12, P1829, DOI 10.1158/1535-7163.MCT-13-0208; Tew KD, 2011, DRUG METAB REV, V43, P179, DOI 10.3109/03602532.2011.552912; Shen M, 2012, ANTI-CANCER AGENT ME, V12, P891; Gallagher EJ, 2011, ANN NY ACAD SCI, V1243, P54, DOI 10.1111/j.1749-6632.2011.06285.x; Hadjeri M, 2003, J MED CHEM, V46, P2125, DOI 10.1021/jm021099i; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Wang WQ, 2000, MOL CARCINOGEN, V28, P102; Franzen CA, 2009, CANCER PREV RES, V2, P830, DOI 10.1158/1940-6207.CAPR-09-0066; Efferth T, 2006, MOL CANCER THER, V5, P1986, DOI 10.1158/1535-7163.MCT-06-0086; Middleton E, 2000, PHARMACOL REV, V52, P673; Zheng PW, 2005, LIFE SCI, V76, P1367, DOI 10.1016/j.lfs.2004.08.023; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; HAGIWARA M, 1988, BIOCHEM PHARMACOL, V37, P2987; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; EFFERTH T, 1993, TUMORDIAGN THER, V14, P238; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Lin CC, 2012, J AGR FOOD CHEM, V60, P11395, DOI 10.1021/jf303446x; KIMMIG A, 1990, CANCER RES, V50, P6793; Badhan R, 2006, EUR J MED CHEM, V41, P285, DOI 10.1016/j.ejmech.2005.11.012; Mafuvadze B, 2012, HORM CANCER-US, V3, P160, DOI 10.1007/s12672-012-0114-x; Long XH, 2008, MOL CANCER THER, V7, P2096, DOI 10.1158/1535-7163.MCT-07-2350; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Clarke R, 2005, SEMIN ONCOL, V32, pS9, DOI 10.1053/j.seminoncol.2005.09.009; Damiani D, 2006, HAEMATOL-HEMATOL J, V91, P825; De Luca A, 2013, CELL CYCLE, V13; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Dordevic S, 2000, WORKING LIVING ENV P, V1, P87; Doxani C, 2013, BIOMARKERS, V18, P425, DOI 10.3109/1354750X.2013.808263; Efferth T, 2012, BIOCH ANAL BIOCH, V1; EFFERTH T, 1991, ANTICANCER RES, V11, P1275; Efferth Thomas, 2001, Current Molecular Medicine (Hilversum), V1, P45, DOI 10.2174/1566524013364194; Efferth T, 2001, J LEUKOCYTE BIOL, V69, P340; EFFERTH T, 1995, J MOL MED-JMM, V73, P47; Efferth T, 2012, CURR MED CHEM, V19, P5735; Ganesan S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001946; Garcia-Santisteban I, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-91; Jang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.85; Kang R, 2010, LEUKEMIA, V24, P177, DOI 10.1038/leu.2009.224; Khalid H, 2012, NAT PROD BIOPROSPECT, V2, P92; Kim B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062766; Kuramoto K, 2000, CANCER RES, V60, P425; Lin KYK, 2011, METHOD CELL BIOL, V103, P21, DOI 10.1016/B978-0-12-385493-3.00002-4; Loo TW, 2014, J BIOL CHEM, V289, P8484, DOI 10.1074/jbc.M114.552075; Murphy GF, 2013, MOL ASPECTS MED, V39, P33; Ninfali P, 2013, FITOTERAPIA, V89, P188, DOI 10.1016/j.fitote.2013.06.004; Petitprez A, 2013, CURR PHARM DESIGN, V19, P958; Ruela-de-Sousa RR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.18; SCHREIBER A, 1990, PLANTA MED, V56, P179, DOI 10.1055/s-2006-960920; Shukla S, 2006, MOL CANCER THER, V5, P843, DOI 10.1158/1535-7163.MCT-05-0370; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Torigoe Takayuki, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P15, DOI 10.2174/1568011053352587; Touil YS, 2009, NUTR CANCER, V61, P310, DOI 10.1080/01635580802521346; Yang MH, 2011, LEUKEMIA LYMPHOMA, V52, P298, DOI 10.3109/10428194.2010.538776	94	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	JAN	2015	26	1					44	56		10.1016/j.jnutbio.2014.09.008		13	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AX4EU	WOS:000346887400006		
J	Yoshinaga, K; Sasaki, K; Watanabe, H; Nagao, K; Inoue, N; Shirouchi, B; Yanagita, T; Nagai, T; Mizobe, H; Kojima, K; Beppu, F; Gotoh, N				Yoshinaga, Kazuaki; Sasaki, Keiichi; Watanabe, Hiroyuki; Nagao, Koji; Inoue, Nao; Shirouchi, Bungo; Yanagita, Teruyoshi; Nagai, Toshiharu; Mizobe, Hoyo; Kojima, Koichi; Beppu, Fumiaki; Gotoh, Naohiro			Differential effects of triacylglycerol positional isomers containing n-3 series highly unsaturated fatty acids on lipid metabolism in C57BL/6J mice	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						C57BL/6J mouse; Eicosapentaenoic acid; Docosahexaenoic acid; Triacylglycerol; Positional isomer; Lipid metabolism	LOW-DENSITY-LIPOPROTEIN; FISH-OIL; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; EICOSANOID PRODUCTION; RAT HEPATOCYTES; MESSENGER-RNA; SEAL OIL; CELLS; DIETS	The present study investigated the effects of binding position of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to triacylglycerol (TAG) on lipid metabolism in C5781/6J mice. Mice were treated with pure TAG positional isomers, including 1,2 (2,3)-dipalmitoy1-3(1)-eicosapentaenoyl glycerol, 1,3-dipalmitoy1-2-eicosapentaenoyl glycerol, 1,2(2,3)-dipalmitoy1-3(1)-docosahexaenoyl glycerol, and 1,3-dipalmitoy1-2-docosahexaenoyl glycerol. Compared to DHA bound to the a-position of TAG, DHA bound to the beta-position more effectively inhibited fatty acid synthetic enzymes and cholesterol-metabolism enzymes and thus reduced TAG and cholesterol concentrations in the serum and liver. EPA bound to the alpha-position of TAG, but not EPA bound to the beta-position of TAG, significantly decreased hepatic cholesterol concentrations. Additionally, EPA bound to the alpha-position of TAG increased the ratio of PGI(2) to TXA(2) to a higher degree than EPA bound to the beta-position. These results suggested that the binding position of EPA and DHA to TAG affected TAG and cholesterol metabolism as well as eicosanoid production in C57BL/6J mice. (C) 2015 Elsevier Inc. All rights reserved.	[Yoshinaga, Kazuaki; Nagai, Toshiharu; Mizobe, Hoyo; Kojima, Koichi] Tsukishima Foods Ind Co Ltd, Edogawa Ku, Tokyo 1348520, Japan; [Yoshinaga, Kazuaki; Sasaki, Keiichi; Beppu, Fumiaki; Gotoh, Naohiro] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Tokyo 1088477, Japan; [Watanabe, Hiroyuki] Kochi Univ, Dept Hlth Sci, Kochi 7810111, Japan; [Nagao, Koji; Inoue, Nao; Shirouchi, Bungo] Saga Univ, Dept Appl Biochem & Food Sci, Saga 8408502, Japan; [Yanagita, Teruyoshi] Nishikyushu Univ, Dept Hlth & Nutr Sci, Kanzaki, Saga 8428585, Japan	Gotoh, N (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	ngotoh@kaiyodai.ac.jp	BEPPU, Fumiaki/O-1986-2014; GOTOH, Naohiro/O-1975-2014				REEVES PG, 1993, J NUTR, V123, P1939; GARG ML, 1988, BIOCHEM J, V249, P351; Kajikawa S, 2009, PROSTAG LEUKOTR ESS, V80, P229, DOI 10.1016/j.plefa.2009.02.004; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7; Mann NJ, 2010, LIPIDS, V45, P669, DOI 10.1007/s11745-010-3450-z; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; HARRIS WS, 1989, J LIPID RES, V30, P785; ACKMAN RG, 1988, ATHEROSCLEROSIS, V70, P171, DOI 10.1016/0021-9150(88)90112-8; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Gotoh N, 2009, J AGR FOOD CHEM, V57, P11047, DOI 10.1021/jf9026553; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ikeda I, 1998, BIOSCI BIOTECH BIOCH, V62, P675, DOI 10.1271/bbb.62.675; Ohama H, 2006, TOXICOLOGY, V221, P95, DOI 10.1016/j.tox.2006.01.015; KELLEY DS, 1986, BIOCHEM J, V235, P87; Yoshida H, 1999, J NUTR SCI VITAMINOL, V45, P411; CHRISTENSEN MS, 1995, NUTR RES, V15, P359, DOI 10.1016/0271-5317(95)00004-6; Dubey Pratibha, 2011, Nutr Metab Insights, V4, P7, DOI 10.4137/NMI.S6728; FOLCH J, 1957, J BIOL CHEM, V226, P497; Froyland L, 1996, LIPIDS, V31, P169, DOI 10.1007/BF02522617; Fujimoto K, 1998, FOOD SCI TECHNOL INT, V4, P140; Gotoh N, 2011, FOOD CHEM, V127, P467, DOI 10.1016/j.foodchem.2011.01.020; Ikeda I, 2001, J NUTR, V131, P1159; Ikeda I, 1998, LIPIDS, V33, P897, DOI 10.1007/s11745-998-0286-7; KELLEY DS, 1984, BIOCHEM J, V217, P543; Lazarow P B, 1981, Methods Enzymol, V72, P315; LINDSEY S, 1992, J LIPID RES, V33, P647; Markwell MAK, 1973, J BIOL CHEM, V248, P3433; Mayer BJ, 2009, LIPIDS, V44, P827; Murphy MG, 1999, LIPIDS, V34, P115, DOI 10.1007/s11745-999-0344-1; NESTEL PJ, 1984, J CLIN INVEST, V74, P82, DOI 10.1172/JCI111422; NISHINA PM, 1993, J LIPID RES, V34, P1413; OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4; ROACH PD, 1987, FEBS LETT, V222, P159, DOI 10.1016/0014-5793(87)80211-9; Saito J, 1997, ATHEROSCLEROSIS, V131, P219, DOI 10.1016/S0021-9150(97)00048-8; Toshima G, 2013, J BIOL MACROMOL, V13, P21; Tran K, 2006, BBA-MOL CELL BIOL L, V1761, P463, DOI 10.1016/j.bbalip.2006.03.018; Wanasundara UN, 1997, J FOOD LIPIDS, V4, P51, DOI 10.1111/j.1745-4522.1997.tb00080.x; Yoshida H, 1996, BIOSCI BIOTECH BIOCH, V60, P1293	40	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	JAN	2015	26	1					57	63		10.1016/j.jnutbio.2014.09.004		7	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AX4EU	WOS:000346887400007		
J	Yamamoto, R; Kizawa, Y; Nakazawa, Y; Ohde, S; Tetsumi, S; Miyashita, M				Yamamoto, Ryo; Kizawa, Yoshiyuki; Nakazawa, Yoko; Ohde, Sachiko; Tetsumi, Sato; Miyashita, Mitsunori			Outcome Evaluation of the Palliative Care Emphasis Program on Symptom Management and Assessment for Continuous Medical Education: Nationwide Physician Education Project for Primary Palliative Care in Japan	JOURNAL OF PALLIATIVE MEDICINE			English	Article								Objective: Palliative care is an essential part of medicine, but most physicians have had no formal opportunity to acquire basic skills in palliative care. In Japan, the Palliative care Emphasis program on symptom management and Assessment for Continuous Medical Education (PEACE) was launched to provide formal primary palliative care education for all physicians engaged in cancer care. This study sought to determine whether PEACE could improve physicians' knowledge of, practices in, and difficulties with palliative care. Methods: In 2011, we conducted questionnaire-based surveys before, just after, and 2 months after completion of the PEACE program in physicians participating in the program at each of 15 designated cancer hospitals in Japan. Knowledge was measured using the palliative care knowledge questionnaire for PEACE (PEACE-Q). Practices and difficulties were evaluated using the Palliative Care self-reported Practice Scale (PCPS) and the Palliative Care Difficulties Scale (PCDS), respectively. Results: Among 223 physicians participating in the program, 85 (38%) answered the follow-up survey. Significant improvements were noted on the PEACE-Q compared with baseline immediately after completion of the program, and this progress was maintained at 2 months (21.7 +/- 5.56 versus 29.5 +/- 2.10 versus 28.7 +/- 3.28, respectively; p<0.0001). Similarly, significant improvements were noted for total scores on both the PCPS and the PCDS at 2 months after completion of the program (62.1 +/- 13.9 versus 69.6 +/- 9.94 [pp<0.0001] for the PCDS). Conclusions: The PEACE education program improved physicians' knowledge of, practices in, and difficulties with palliative care.	[Yamamoto, Ryo] Saku Cent Hosp, Adv Care Ctr, Dept Palliat Med, Nagano, Japan; [Kizawa, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Palliat Med, Kobe, Hyogo 6500017, Japan; [Nakazawa, Yoko] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Med Support & Partnership Div, Tokyo 104, Japan; [Ohde, Sachiko] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Tetsumi, Sato] Hirosaki Univ, Dept Anesthesia & Palliat Care, Aomori, Japan; [Miyashita, Mitsunori] Tohoku Univ, Grad Sch Med, Dept Palliat Nursing, Sendai, Miyagi 980, Japan	Kizawa, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Palliat Med, 6-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kizawa-ysyk@umin.org			Health and Labor Sciences Research Grant for Clinical Cancer Research	This study was supported by a Health and Labor Sciences Research Grant for Clinical Cancer Research.	Yamamoto R, 2013, J PALLIAT MED, V16, P1423, DOI 10.1089/jpm.2013.0112; Morita T, 2013, LANCET ONCOL, V14, P638, DOI 10.1016/S1470-2045(13)70127-X; Maeda I, 2014, J PAIN SYMPTOM MANAG, V48, P367; McAleer S, 2009, PRACTICAL GUIDE MED, P318; Ministry of Health Labour and Welfare, ED DOCT CANC CAR; Morita T, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-2; Nakazawa Y, 2010, J PALLIAT MED, V13, P423; Robinson Katya, 2004, J Palliat Med, V7, P637, DOI 10.1089/jpm.2004.7.637; Shaw Elizabeth Ann, 2010, J Palliat Med, V13, P1091, DOI 10.1089/jpm.2010.0034; Tsuneto S, 2013, JPN J CLIN ONCOL, V43, P17, DOI 10.1093/jjco/hys188; World Health Organization, 2007, CANC CONTR KNOWL ACT	11	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	JAN 1	2015	18	1					45	49		10.1089/jpm.2014.0122		5	Health Care Sciences & Services	Health Care Sciences & Services	AX8IF	WOS:000347152600010		
J	Shimabukuro, Y; Nakayama, Y; Ogata, Y; Tamazawa, K; Shimauchi, H; Nishida, T; Ito, K; Chikazawa, T; Kataoka, S; Murakami, S				Shimabukuro, Yoshio; Nakayama, Yohei; Ogata, Yorimasa; Tamazawa, Kaoru; Shimauchi, Hidetoshi; Nishida, Tetsuya; Ito, Koichi; Chikazawa, Takashi; Kataoka, Shinsuke; Murakami, Shinya			Effects of an Ascorbic Acid-Derivative Dentifrice in Patients With Gingivitis: A Double-Masked, Randomized, Controlled Clinical Trial	JOURNAL OF PERIODONTOLOGY			English	Article						Antioxidants; controlled clinical trials, randomized; dentifrices, ascorbic acid; gingivitis; reactive oxygen species; saliva	STANNOUS FLUORIDE DENTIFRICE; TOTAL ANTIOXIDANT CAPACITY; PERIODONTAL-DISEASE; POLYMORPHONUCLEAR LEUKOCYTES; OXIDATIVE STRESS; CREVICULAR FLUID; VITAMIN-C; SALIVA; HEALTH; PLAQUE	Background: Reactive oxygen species might be associated with the onset and progression of gingival inflammation. The aim of this study is to investigate the effect of a dentifrice containing L-ascorbic acid 2-phosphate magnesium salt (APM), a long-acting ascorbic acid derivative with antioxidant properties, on gingival inflammation. Methods: The clinical effects of APM were investigated in a multicenter, randomized, parallel-group, controlled clinical trial comprising 300 individuals with gingivitis. Half of the participants were given an APM-containing dentifrice and half were given a control dentifrice. The primary outcome was the gingival index (GI) at 3 months. Secondary outcomes included gingival redness as an indicator of the degree of local gingival inflammation, gingival bleeding as a measure of the gingivitis severity index, and total antioxidant activity of the saliva. Results: Under the intent-to-treat analysis, GI did not significantly differ between the groups (P = 0.12). However, under the per-protocol analysis, GI was significantly lower in the APM group (P = 0.01) than in the control group. In the APM group, gingival redness was significantly lower, and the difference from the baseline gingivitis severity index was significantly greater (P = 0.04 and P = 0.02, respectively). The total antioxidant activity of the saliva was significantly higher in the APM group (P = 0.03). The incidence of adverse events did not significantly differ between the groups (P > 0.15). Conclusion: These findings indicate that the regular application of an APM-containing dentifrice could reduce gingival inflammation.	[Shimabukuro, Yoshio; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka 5650871, Japan; [Nakayama, Yohei; Ogata, Yorimasa] Nihon Univ, Sch Dent Matsudo, Dept Periodontol, Matsudo, Chiba, Japan; [Tamazawa, Kaoru; Shimauchi, Hidetoshi] Tohoku Univ, Grad Sch Dent, Dept Periodontol & Endodontol, Sendai, Miyagi 980, Japan; [Nishida, Tetsuya; Ito, Koichi] Nihon Univ, Sch Dent, Dept Periodontol, Tokyo 101, Japan; [Chikazawa, Takashi; Kataoka, Shinsuke] Lion Corp, Tokyo, Japan	Murakami, S (reprint author), Osaka Univ, Grad Sch Dent, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ipshinya@dent.osaka-u.ac.jp			Lion Corporation	This study was supported by Lion Corporation, which proposed the study protocol and was responsible for data collection and prespecified statistical analysis. The manuscript was prepared independently by the authors, and the views expressed in this article do not necessarily reflect those of Lion Corporation. The authors thank all examiners who participated in this trial (Osaka University Graduate School of Dentistry, Osaka: YS, M. Kitamura, S. Yamada, T. Nozaki, T. Hashikawa, M. Yanagita, T. Saho, M. Terakura, T. Egashira, Y. Ozawa, K. Morisaki; Nihon University School of Dentistry at Matsudo, Chiba: YO, YN, H. Masunaga, H. Takai, N. Kato; Tohoku University Graduate School of Dentistry, Sendai: KT, S. Shoji, E. Nemoto, H. Endo, K. Yamaki, Y. Itagaki, M. Ikawa, H. Ishihata, K. Shoji; Nihon University School of Dentistry, Tokyo: TN, N. Yoshinuma, M. Takane, A. Sakai, H. Iwasaki, M. Igarashi, Y. Iwano, H. Kamishige, H. Kawashima, D. Takenouchi). The authors also thank the collaborators at the Lion Corporation, Tokyo, Japan (M. Kigawa and A. Amano, researchers; M. Yamamoto, assistant research manager; H. Kadoya, research manager; T. Yamamoto, associate senior research manager; and K. Shibasaki, director) for supporting this study. The authors thank Professor Mark I. Ryder (University of California at San Francisco) for his helpful suggestions and comments. SM has received research grants from Lion Corporation, as a research consultant. TC and SK are employees and stockholders of Lion Corporation. YS, YN, YO, KT, HS, TN, and KI report no conflicts of interest related to this study.	OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Halvorsen BL, 2002, J NUTR, V132, P461; Sculley DV, 2002, P NUTR SOC, V61, P137, DOI 10.1079/PNS2001141; Chapple ILC, 1997, ANN CLIN BIOCHEM, V34, P412; Guentsch A, 2008, CLIN ORAL INVEST, V12, P345, DOI 10.1007/s00784-008-0202-z; Kaufman E, 2000, J CLIN PERIODONTOL, V27, P453, DOI 10.1034/j.1600-051x.2000.027007453.x; Brock GR, 2004, J CLIN PERIODONTOL, V31, P515, DOI 10.1111/j.1600-051X.2004.00509.x; THOMPSON HL, 1991, INFECT IMMUN, V59, P932; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Nishida M, 2000, J PERIODONTOL, V71, P1215, DOI 10.1902/jop.2000.71.8.1215; Sculley DV, 2003, CLIN SCI, V105, P167, DOI 10.1042/CS20030031; MOORE S, 1994, FREE RADICAL RES, V21, P417, DOI 10.3109/10715769409056594; Wright HJ, 2008, J IMMUNOL, V181, P5775; Chapple ILC, 2002, J CLIN PATHOL-MOL PA, V55, P367; Chapple ILC, 2007, J NUTR, V137, P657; Amarasena N, 2005, J CLIN PERIODONTOL, V32, P93, DOI 10.1111/j.1600-051X.2004.00643.x; Battino M, 2002, J CLIN PERIODONTOL, V29, P189, DOI 10.1034/j.1600-051X.2002.290301x.x; D'Aiuto F, 2010, J DENT RES, V89, P1241, DOI 10.1177/0022034510375830; Miller NJ, 1996, REDOX REP, V2, P161; Chandra RV, 2013, J PERIODONTAL IMPLAN, V43, P121, DOI 10.5051/jpis.2013.43.3.121; Diab-Ladki Randa, 2003, Clin Oral Investig, V7, P103, DOI 10.1007/s00784-003-0208-5; Fredriksson MI, 2003, J PERIODONTOL, V74, P219, DOI 10.1902/jop.2003.74.2.219; Halvorsen BL, 2006, AM J CLIN NUTR, V84, P95; HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103; Ikeda K, 1981, Nihon Shishubyo Gakkai Kaishi, V23, P437; Kigawa Mari, 2008, Vitamins (Kyoto), V82, P127; KIMURA S, 1993, J PERIODONTAL RES, V28, P197, DOI 10.1111/j.1600-0765.1993.tb01069.x; Kobayashi S, 1996, PHOTOCHEM PHOTOBIOL, V64, P224, DOI 10.1111/j.1751-1097.1996.tb02447.x; LEGGOTT PJ, 1991, J DENT RES, V70, P1531, DOI 10.1177/00220345910700121101; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Lynch MC, 1999, INFECT IMMUN, V67, P3367; Mallatt M, 2007, J CLIN PERIODONTOL, V34, P762, DOI 10.1111/j.1600-051X.2007.01109.x; McClanahan SF, 1997, J CLIN DENT, V8, P39; Muller HP, 2006, J CLIN PERIODONTOL, V33, P811, DOI 10.1111/j.1600-051X.2006.00993.x; NAKAMOTO T, 1984, J THEOR BIOL, V108, P163, DOI 10.1016/S0022-5193(84)80063-6; Palomo F, 1989, Am J Dent, V2 Spec No, P231; Tsutsumi K, 2012, J PERIODONTAL RES, V47, P263, DOI 10.1111/j.1600-0765.2011.01430.x; U.S. Department of Health and Human Services Food and Drug Administration, GUID IND GING DEV EV	38	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.		2015	86	1					27	35		10.1902/jop.2014.140138		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX4JD	WOS:000346898200005		
J	Shimizu, Y; Sato, S				Shimizu, Yutaka; Sato, Soh			In Vitro Study on Regeneration of Periodontal Tissue Microvasculature Using Human Dedifferentiated Fat Cells	JOURNAL OF PERIODONTOLOGY			English	Article						Adipocytes; coculture techniques; endothelial cells; periodontal diseases; pericytes; regeneration	MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; MATURE ADIPOCYTES; ADIPOSE-TISSUE; DFAT CELLS; DIFFERENTIATION; MODEL; TRANSPLANTATION; RATS; BETA	Background: Human dedifferentiated fat cells (HDFATs) may be a new cell type suitable for regenerative therapies. The aim of this study is to assess the potential of HDFATs for vascular regeneration of periodontal tissue. To do this, HDFATs and human gingival endothelial cells (HGECs) were cocultivated, and vascular regeneration was examined in vitro. Methods: HDFATs were isolated from subcutaneous adipose tissue, and HGECs were isolated from gingival cells using anti-cluster of differentiation 31 antibody-coated magnetic beads. HDFATs were cocultured with HGECs in microvascular endothelial cell growth medium-2 (EGM-2MV) for 7 days. Expression of endothelial cell (EC) markers, the formation of capillary-like tubes, and the expression of pericyte markers were determined. Results: HDFATs, cultured in EGM-2MV or cocultured with HGECs, expressed EC markers. HDFATs in both conditions initiated tube formation within 5 hours of seeding and formed extensive capillary-like structures within 12 hours. These structures disintegrated within 24 hours when cells were cultured in EGM-2MV alone, whereas cocultured HDFATs maintained tubes for >24 hours. Cocultured HDFATs significantly increased expression of pericyte markers, a cell type associated with microvasculature. Conclusion: HDFATs possess the ability to express EC markers, and coculture with HGECs promotes differentiation into pericytes involved in the maturation and stabilization of the microvasculature.	[Shimizu, Yutaka; Sato, Soh] Nippon Dent Univ, Sch Life Dent Niigata, Dept Periodontol, Niigata 9518580, Japan; [Sato, Soh] Nippon Dent Univ, Sch Life Dent Niigata, Adv Res Ctr, Div Cell Regenerat & Transplantat, Niigata 9518580, Japan	Shimizu, Y (reprint author), Nippon Dent Univ, Sch Life Dent Niigata, Dept Periodontol, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	ytk0312@ngt.ndu.ac.jp			Nippon Dental University School of Life Dentistry at Niigata	This study was supported by the Nippon Dental University School of Life Dentistry at Niigata. The authors report no conflicts of interest related to this study.	Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; DAMORE PA, 1987, ANNU REV PHYSIOL, V49, P453; Sugiyama S, 2012, J CLIN BIOCHEM NUTR, V51, P108, DOI 10.3164/jcbn.11-103; Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281; Iwasaki K, 2013, J PERIODONTOL, V84, P1425, DOI 10.1902/jop.2012.120547; Cines DB, 1998, BLOOD, V91, P3527; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Ohta Y, 2008, CELL TRANSPLANT, V17, P877, DOI 10.3727/096368908786576516; Konno M, 2010, BIOCHEM BIOPH RES CO, V400, P461, DOI 10.1016/j.bbrc.2010.08.029; Ning HX, 2009, J SEX MED, V6, P967, DOI 10.1111/j.1743-6109.2008.01172.x; Aoki S, 2003, CELL STRUCT FUNCT, V28, P55; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Obinata D, 2011, INT J UROL, V18, P827, DOI 10.1111/j.1442-2042.2011.02865.x; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Yang Y, 2010, BIOMATERIALS, V31, P8574, DOI 10.1016/j.biomaterials.2010.06.026; Sugawara A, 2014, HUM CELL, V27, P12, DOI 10.1007/s13577-013-0075-6; Gao Q, 2012, MOL BIOL REP, V39, P5791, DOI 10.1007/s11033-011-1371-4; Guo X, 2013, AM J PHYSIOL-CELL PH, V304, pC289, DOI 10.1152/ajpcell.00298.2012; Hirschi KK, 2003, CIRC RES, V93, P429, DOI 10.1161/01.RES.0000091259.84556.D5; Mealey BL, 1999, PERIODONTOL 2000, V21, P197, DOI 10.1111/j.1600-0757.1999.tb00176.x; Mizuno N, 2008, J PERIODONTOL, V79, P2361, DOI 10.1902/jop.2008.070577 ; Nobusue H, 2008, CELL TISSUE RES, V332, P435, DOI 10.1007/s00441-008-0593-9; Sakuma T, 2009, J UROLOGY, V182, P355, DOI 10.1016/j.juro.2009.02.103; Shen JF, 2011, INT J ORAL SCI, V3, P117, DOI 10.4248/IJOS11044; Tsubokawa M, 2014, J PERIODONTOL, V85, P1135, DOI 10.1902/jop.2013.130209; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055	30	0	0	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.		2015	86	1					129	136		10.1902/jop.2014.140045		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX4JD	WOS:000346898200016		
J	Lee, HY; Jeong, YI; Kim, EJ; Lee, KD; Choi, SH; Kim, YJ; Kim, DH; Choi, KC				Lee, Hyo-Young; Jeong, Young-Il; Kim, Eun Jin; Lee, Kyung Dong; Choi, Seon-Hee; Kim, Yun Jin; Kim, Da Hye; Choi, Ki-Choon			Preparation of Caffeic Acid Phenethyl Ester-Incorporated Nanoparticles and Their Biological Activity	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						caffeic acid phenethyl ester; nanoparticles; metastasis; invasion; cancer chemotherapy; natural products; polymeric drug carrier	NF-KAPPA-B; IN-VIVO; POLYMERIC MICELLES; ANTITUMOR-ACTIVITY; SONORAN PROPOLIS; SOLID TUMORS; ANTIBACTERIAL; CAPE; METASTASIS; SUPPRESSES	The aim of this study is to fabricate caffeic acid phenethyl ester (CAPE)-incorporated nanoparticles using methoxy poly(ethylene glycol)-b-poly(epsilon-caprolactone) (CE) copolymer and to study their antitumor activity against pulmonary metastasis model of CT26 colon carcinoma cells. CAPE-incorporated nanoparticles showed spherical shapes having small diameters less than 300 nm and CAPE was continuously released from CE nanoparticles over 4 days. CAPE-incorporated polymeric micelles properly inhibited proliferation and induced apoptosis of CT26 cells as well as CAPE itself. Furthermore, they showed similar anti-invasive and antimigrative effect against CT26 cells at in vitro compared with CAPE itself, indicating that CAPE-incorporated nanoparticles have at least equivalent anticarcinogenic activity against CT26 cells compared with CAPE itself. At pulmonary metastasis model of CT26 cells using nude mouse, CAPE-incorporated nanoparticles have superior antimetastatic efficacy against, that is, control treatment with pulmonary metastasis model showed significant increase of lung weight because of the metastasis of tumor cells, whereas CAPE or CAPE-incorporated nanoparticles properly inhibited metastasis of tumor cells. We suggest CAPE-incorporated nanoparticles as a promising candidate for antimetastatic chemotherapeutic agent. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:144-154, 2015	[Lee, Hyo-Young; Choi, Seon-Hee] Pusan Natl Univ, Sch Med, Dept Med Sci, Yangsan 626770, Gyeongnam, South Korea; [Jeong, Young-Il] Pusan Natl Univ Hosp, Pusan 602739, South Korea; [Kim, Eun Jin] MI Tech Co Ltd Pyeongtaek, R&D Ctr, Gyeonggi Do 451864, South Korea; [Lee, Kyung Dong] Dongsin Univ, Dept Oriental Med Mat, Naju 520714, South Korea; [Kim, Yun Jin] Pusan Natl Univ Hosp, Dept Family Med, Pusan 602739, South Korea; [Kim, Da Hye] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane, Japan; [Choi, Ki-Choon] Natl Inst Anim Sci, Rural Dev Adm, Grassland & Forages Div, Chungnam 331808, South Korea	Choi, KC (reprint author), Natl Inst Anim Sci, Rural Dev Adm, Grassland & Forages Div, Chungnam 331808, South Korea.	nanomed@naver.com; leekd@dsu.ac.kr; choiwh@rda.go.kr					Agata I, 1999, YAKUGAKU ZASSHI, V119, P237; Liao HF, 2003, J AGR FOOD CHEM, V51, P7907, DOI 10.1021/jf034729d; Jeong YI, 2012, COLLOID SURFACE B, V90, P28, DOI 10.1016/j.colsurfb.2011.09.043; Akyol S, 2012, CELL BIOCHEM FUNCT, V30, P438, DOI 10.1002/cbf.2817; Demestre M, 2009, PHYTOTHER RES, V23, P226, DOI 10.1002/ptr.2594; Hwang HJ, 2006, J NUTR BIOCHEM, V17, P356, DOI 10.1016/j.jnutbio.2005.08.009; Couvreur Patrick, 2012, Biologie Aujourd hui, V206, P237, DOI 10.1051/jbio/2012025; Chan GCF, 2013, CLIN REV ALLERG IMMU, V44, P262, DOI 10.1007/s12016-012-8322-2; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Sakhrani NM, 2013, DRUG DES DEV THER, V7, P585, DOI 10.2147/DDDT.S45614; Shim YH, 2011, J MICROBIOL BIOTECHN, V21, P28, DOI 10.4014/jmb.1007.07041; Park SG, 2008, TOXICOL APPL PHARM, V226, P22, DOI 10.1016/j.taap.2007.08.003; Son S, 2002, J AGR FOOD CHEM, V50, P468, DOI 10.1021/jf010830b; El-Refaei MF, 2010, CHEM-BIOL INTERACT, V186, P152, DOI 10.1016/j.cbi.2010.04.019; Dinarvand R, 2011, INT J NANOMED, V6, P877, DOI 10.2147/IJN.S18905; Matsumura Y, 2011, ADV DRUG DELIVER REV, V63, P184, DOI 10.1016/j.addr.2010.05.008; YOKOYAMA M, 1991, CANCER RES, V51, P3229; Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.2478/18693, 10.5603/FHC.2012.0004]; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Velazquez C, 2007, J APPL MICROBIOL, V103, P1747, DOI 10.1111/j.1365-2672.2007.03409.x; Hrkach JS, 1997, BIOMATERIALS, V18, P27, DOI 10.1016/S0142-9612(96)00077-4; Shvarzbeyn J, 2011, ANTIVIR RES, V90, P108, DOI 10.1016/j.antiviral.2011.03.177; Hamaguchi T, 2005, BRIT J CANCER, V92, P1240, DOI 10.1038/sj.bjc.6602479; HUANG MT, 1988, CANCER RES, V48, P5941; Nishiyama N, 2003, CANCER RES, V63, P8977; Coimbra M, 2012, J CONTROL RELEASE, V160, P232, DOI 10.1016/j.jconrel.2011.10.019; Huleihel M, 2009, J PHOTOCH PHOTOBIO B, V96, P17, DOI 10.1016/j.jphotobiol.2009.03.009; Jeong YI, 2013, INT J NANOMED, V8, P485, DOI 10.2147/IJN.S40580; Kawakami S, 2005, J PHARM SCI-US, V94, P2606, DOI 10.1002/jps.20487; Messerli SM, 2009, PHYTOTHER RES, V23, P423, DOI 10.1002/ptr.2658; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Navarro-Navarro M, 2013, FOODBORNE PATHOG DIS, V10, P150, DOI 10.1089/fpd.2012.1318; Scheller S, 2000, ARZNEIMITTEL-FORSCH, V50, P72; Srivastava AK, 2013, INT J NANOMED, V8, P1451, DOI 10.2147/IJN.S26364; Steichen S.D., 2012, EUR J PHARM SCI, V48, P416; Wang SH, 2009, PLANTA MED, V75, P1237, DOI 10.1055/s-0029-1185521	36	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	JAN	2015	104	1					144	154		10.1002/jps.24278		11	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX4OA	WOS:000346910400017		
J	Handa, K; Nakagome, I; Yamaotsu, N; Gouda, H; Hirono, S				Handa, Koichi; Nakagome, Izumi; Yamaotsu, Noriyuki; Gouda, Hiroaki; Hirono, Shuichi			Three-Dimensional Quantitative Structure-Activity Relationship Analysis for Human Pregnane X Receptor for the Prediction of CYP3A4 Induction in Human Hepatocytes: Structure-Based Comparative Molecular Field Analysis	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						computational ADME; structure activity relationship (SAR); protein structure; QSAR; molecular modeling	XENOBIOTIC RECEPTOR; PXR; INHIBITORS; ACTIVATION; REGULATOR; DISCOVERY; DOCKING; COMPLEX; DRUGS; COMFA	The pregnane X receptor [PXR (NR1I2)] induces the expression of xenobiotic metabolic genes and transporter genes. In this study, we aimed to establish a computational method for quantifying the enzyme-inducing potencies of different compounds via their ability to activate PXR, for the application in drug discovery and development. To achieve this purpose, we developed a three-dimensional quantitative structure-activity relationship (3D-QSAR) model using comparative molecular field analysis (CoMFA) for predicting enzyme-inducing potencies, based on computer-ligand docking to multiple PXR protein structures sampled from the trajectory of a molecular dynamics simulation. Molecular mechanics-generalized born/surface area scores representing the ligand-protein-binding free energies were calculated for each ligand. As a result, the predicted enzyme-inducing potencies for compounds generated by the CoMFA model were in good agreement with the experimental values. Finally, we concluded that this 3D-QSAR model has the potential to predict the enzyme-inducing potencies of novel compounds with high precision and therefore has valuable applications in the early stages of the drug discovery process. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:223-232, 2015	[Handa, Koichi; Nakagome, Izumi; Yamaotsu, Noriyuki; Gouda, Hiroaki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan; [Handa, Koichi] Toyama Chem Co Ltd, Res Labs, Toyama 9308508, Japan	Handa, K (reprint author), Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan.	koichi_handa@toyama-chemical.co.jp; hironos@pharm.kitasato-u.ac.jp					Watanabe K, 2013, BIOCHEM PHARMACOL, V86, P428, DOI 10.1016/j.bcp.2013.05.016; Xiao L, 2011, BIOCHEM PHARMACOL, V81, P669, DOI 10.1016/j.bcp.2010.12.003; Shukla SJ, 2011, DRUG METAB DISPOS, V39, P151, DOI 10.1124/dmd.110.035105; Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753; Handa K, 2013, DRUG METAB PHARMACOK, V28, P345, DOI 10.2133/dmpk.DMPK-12-RG-133; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Ung CY, 2007, MOL PHARMACOL, V71, P158, DOI 10.1124/mol.106.027623; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Aszalos A, 2007, DRUG DISCOV TODAY, V12, P838, DOI 10.1016/j.drudis.2007.07.021; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001.0038; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Raucy J, 2002, J PHARMACOL EXP THER, V303, P412, DOI 10.1124/jpet.102.038653; Kortagere S, 2009, PHARM RES-DORD, V26, P1001, DOI 10.1007/s11095-008-9809-7; CLARK M, 1993, QUANT STRUCT-ACT REL, V12, P137, DOI 10.1002/qsar.19930120205; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Stanley LA, 2006, DRUG METAB REV, V38, P515, DOI 10.1080/03602530600786232; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Chrencik JE, 2005, MOL ENDOCRINOL, V19, P1125, DOI 10.1210/me.2004-0346; Khandelwal A, 2008, CHEM RES TOXICOL, V21, P1457, DOI 10.1021/tx800102e; Liu YH, 2011, XENOBIOTICA, V41, P259, DOI 10.3109/00498254.2010.537395; Chen Jun, 2009, Drug Metab Lett, V3, P61; Cheng Y, 2011, PROTEIN SCI, V20, P1713, DOI 10.1002/pro.706; Cui Xiaoming, 2005, Journal of Pharmacological and Toxicological Methods, V52, P234, DOI 10.1016/j.vascn.2005.02.001; Ekins S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000594; Ho GD, 2009, BIOORG MED CHEM LETT, V19, P2519, DOI 10.1016/j.bmcl.2009.03.031; Kliewer SA, 2003, J NUTR, V133, p2444S; Kokh BD, 2011, COMP MOL SCI, V1, P298; Ngan CH, 2009, BIOCHEMISTRY-US, V48, P11572, DOI 10.1021/bi901578n; Sinz Michael W, 2007, Drug Metab Lett, V1, P147, DOI 10.2174/187231207780363561; U. S. Department of Health and Human Services Food and Drug Administration, 2012, CTR DRUG EV RES CDER; Yasuo K, 2009, J CHEM INF MODEL, V49, P853, DOI 10.1021/ci800313h; Zhang L, 2011, CURR MED CHEM, V18, P923	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	JAN	2015	104	1					223	232		10.1002/jps.24235		10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX4OA	WOS:000346910400024		
J	Kawakami, K				Kawakami, Kohsaku			Surface Effects on the Crystallization of Ritonavir Glass	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						amorphous; crystallization; physical stability; surface effect; glass transition; thermal analysis	INDOMETHACIN CRYSTALLIZATION; AMORPHOUS STATE; DOSAGE FORMS; POLY(VINYLPYRROLIDONE); DRUGS	In our previous study, initiation time of crystallization was shown to be basically expressed as a function of only the reduced temperature, which was a ratio of storage and glass transition temperatures. This conclusion was obtained using quenched glasses with minimized surface area stored under a dried atmosphere. In this study, the surface effects on the crystallization were investigated using freeze-dried ritonavir (RTV) glass. Although quenched RTV glass exhibited exceptionally long initiation time, the initiation was accelerated by using the freeze-dried glasses. Storage of the samples under humid conditions further accelerated the crystallization. These surface effects eliminated the energetic barrier for nucleation, and the RTV glass exhibited universal initiation time. In contrast, subsequent crystal growth was slower for the freeze-dried glasses relative to the quenched one, presumably because of less condensed and porous structures that would suppress molecular cooperativity. Storage under a humid atmosphere also appeared to inhibit the crystal growth, presumably because of disruption of the molecular network by water. These findings support the existence of the universal initiation time for crystallization and indicated the importance of surface effects in crystallization behavior. Also, the suppression of crystal growth because of the void structure and incorporation of water molecules were indicated. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:276-279, 2015	Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan	Kawakami, K (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.	kawakami.kohsaku@nims.go.jp			Ministry of Health, Labour and Welfare of Japan; World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan; Low-carbon Research Network, Japan	This work was in part supported by Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan; World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan; and Low-carbon Research Network, Japan.	Airaksinen S, 2003, J PHARM SCI-US, V92, P516, DOI 10.1002/jps.10328; Wu T, 2007, LANGMUIR, V23, P5148, DOI 10.1021/la070050i; Kawakami K, 2014, MOL PHARMACEUT, V11, P1835, DOI 10.1021/mp400679m; Kawakami K, 2012, ADV DRUG DELIVER REV, V64, P480, DOI 10.1016/j.addr.2011.10.009; Bhugra C, 2008, J PHARM SCI-US, V97, P1329, DOI 10.1002/jps.21138; Heljo VP, 2012, PHARM RES-DORDR, V29, P2684, DOI 10.1007/s11095-011-0658-4; Kawakami K, 2009, J PHARM SCI-US, V98, P2875, DOI 10.1002/jps.21816; Serajuddin ATM, 1999, J PHARM SCI, V88, P1058, DOI 10.1021/js980403l; Crowley KJ, 2003, PHARMACEUT RES, V20, P1417, DOI 10.1023/A:1025706110520; Kawakami K, 2002, J PHARM SCI, V91, P417, DOI 10.1002/jps.10017; Kawakami K, 2006, J PHARM SCI-US, V95, P1354, DOI 10.1002/jps.20458; Matsumoto T, 1999, PHARMACEUT RES, V16, P1722, DOI 10.1023/A:1018906132279; OTSUKA M, 1994, CHEM PHARM BULL, V42, P156; Wu T, 2006, PHARM RES, V23, P2350, DOI 10.1007/s11095-006-9023-4; Yu L, 2001, ADV DRUG DELIVER REV, V48, P27, DOI 10.1016/S0169-409X(01)00098-9	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	JAN	2015	104	1					276	279		10.1002/jps.24229		4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX4OA	WOS:000346910400029		
J	Takechi, M; Wada, T; Yagi, H; Masuko, T; Kawabata, A				Takechi, Masayuki; Wada, Tetsuyuki; Yagi, Hideki; Masuko, Takashi; Kawabata, Atsufumi			Ouabain exerts cytoprotection by diminishing the intracellular K+ concentration increase caused by distinct stimuli in human leukemic cells	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						cytoprotection; flow cytometry; human leukemic cells; intracellular K+ concentration; ouabain	APOPTOSIS; ACTIVATION; CHANNELS; DEATH	Objectives We tested if modulation of cytosolic K+ levels by ouabain, an inhibitor of Na+/K+-ATPase, exerts cytoprotection against distinct stressful stimuli in human leukemic cells. Methods The cytosolic K+, Na+ or Ca2+ levels and the cytotoxicity were evaluated by flow cytometry. Key findings Various cytotoxic chemicals and ultraviolet irradiation induced cell death and increased intracellular concentrations of K+, Na+ or Ca2+. Ouabain reduced the cytotoxicity and the elevation of cytosolic levels of K+ but not those of Na+ or Ca2+. Conclusions Our data thus suggest that elevated cytosolic K+ levels are associated with the cytotoxicity in response to distinct stressful stimuli and that ouabain exerts cytoprotection most probably by regulating intracellular K+ levels.	[Takechi, Masayuki; Wada, Tetsuyuki; Yagi, Hideki; Masuko, Takashi; Kawabata, Atsufumi] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan	Takechi, M (reprint author), Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan.	mt471019@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government.	Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Liu CH, 2005, BRAIN RES, V1031, P164, DOI 10.1016/j.brainres.2004.10.029; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Wang L, 1999, J MEMBRANE BIOL, V172, P113, DOI 10.1007/s002329900589; Golden WC, 2006, NEUROSCIENCE, V137, P133, DOI 10.1016/j.neuroscience.2005.10.004; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Storey NM, 2003, J BIOL CHEM, V278, P33319, DOI 10.1074/jbc.M300443200; Gomes P, 2008, BBA-MOL CELL RES, V1783, P1884, DOI 10.1016/j.bbamcr.2008.06.011; Haas Michael, 2002, Journal of Biological Chemistry, V277, P18694, DOI 10.1074/jbc.M111357200; Lee AL, 2003, J NEUROCHEM, V86, P1079, DOI 10.1046/j.1471-4159.2003.01880.x; Marklund L, 2004, BASIC CLIN PHARMACOL, V94, P245; Takechi M, 2003, PHYTOTHER RES, V17, P83, DOI 10.1002/ptr.1081	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	JAN	2015	67	1					126	132		10.1111/jphp.12317		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5ZU	WOS:000347004100013		
J	Kumar, P; Pascher, T; Tachiya, M; Pal, SK				Kumar, Pushpendra; Pascher, Torbjorn; Tachiya, M.; Pal, Suman Kalyan			Global analysis of quenching of the time-resolved emission of ZnO nanocrystals by adsorbed rhodamine B on the basis of Tachiya theory	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Energy transfer; Tachiya model; ZnO NCs; Trap states; Time-resolved fluorescence; TCSPC	RESONANCE ENERGY-TRANSFER; LUMINESCENT PROBES; DYE MOLECULES; QUANTUM DOTS; ZINC OXIDE; TRANSITIONS; DYNAMICS; KINETICS; DONORS; GREEN	Normally dye molecules are adsorbed onto the nanocrystal (NC) surface in dye-NC mixed solution, but it is very unlikely that all dye molecules present in the solution will be attached to NCs. The distribution of dye molecules on the NC surface is an important factor to take into account while investigating the quenching of NC emission via energy transfer to adsorbed dye molecules. Here, we analysed time-resolved fluorescence data of ZnO NCs in the presence of rhodamine B (RhB) using Tachiya theory, which assumes the Poisson distribution of dye molecules among the NCs. Energy transfer rate from NC to a dye molecule was found to be much faster than the intrinsic fluorescence decay rate of NCs and fluorescence quenching rate due to intrinsic trap states present in the NC. The association constant was also calculated to acquire information on the nature of association of dye molecules with NCs. (C) 2014 Elsevier B.V. All rights reserved.	[Kumar, Pushpendra; Pal, Suman Kalyan] Indian Inst Technol Mandl, Sch Basic Sci, Mandi 775001, Himachal Prades, India; [Pascher, Torbjorn] Lund Univ, Dept Chem Phys, Lund, Sweden; [Tachiya, M.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Pal, SK (reprint author), Indian Inst Technol Mandl, Sch Basic Sci, Mandi 775001, Himachal Prades, India.	suman@iitmandi.ac.in			Indian Institute of Technology (IIT) Mandi [IITM/SG/SUG/004]	S.K. Pal acknowledges the financial support of the Indian Institute of Technology (IIT) Mandi (Grant No. IITM/SG/SUG/004) for this work. P. Kumar thanks IIT Mandi for awarding fellowship. Thanks to Dr. S. Mitra and Mrs. S. Phukan, Department of Chemistry, North-Eastern Hill University Shillong, Shillong for their help in measuring fluorescence lifetime.	TACHIYA M, 1975, CHEM PHYS LETT, V33, P289, DOI 10.1016/0009-2614(75)80158-8; Sadhu S, 2010, J PHYS CHEM C, V114, P3891, DOI 10.1021/jp911801m; SMITH JM, 1970, PHYS LETT A, VA 31, P147, DOI 10.1016/0375-9601(70)90199-4; Makhal A, 2010, J PHYS CHEM C, V114, P10390, DOI 10.1021/jp102042j; TACHIYA M, 1982, J CHEM PHYS, V76, P340, DOI 10.1063/1.442728; Crooker SA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.186802; Beane GA, 2012, J PHYS CHEM C, V116, P3305, DOI 10.1021/jp209638g; Dworak L, 2014, J PHYS CHEM C, V118, P4396, DOI 10.1021/jp409807x; Becker K, 2006, NAT MATER, V5, P777, DOI 10.1038/nmat1738; Medintz IL, 2003, NAT MATER, V2, P630, DOI 10.1038/nmat961; Lima RC, 2008, J PHYS CHEM A, V112, P8970, DOI 10.1021/jp8022474; DINGLE R, 1969, PHYS REV LETT, V23, P579, DOI 10.1103/PhysRevLett.23.579; Makhal A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/26/265703; Zheng KB, 2014, J AM CHEM SOC, V136, P6259, DOI 10.1021/ja411127w; Stewart MH, 2012, ACS NANO, V6, P5330, DOI 10.1021/nn301177h; Chen W, 2012, NANO RES, V5, P320, DOI 10.1007/s12274-012-0212-7; Boerseth T.M., 2006, APPL PHYS LETT, V89; Boulesbaa A., 2009, J PHYS CHEM C, V114, P962; Djurisic AB, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2182096; Funston AM, 2008, ADV MATER, V20, P4274, DOI 10.1002/adma.200703186; Kumar P, 2014, J PHOTOCH PHOTOBIO A, V278, P46, DOI 10.1016/j.jphotochem.2013.12.021; Park JK, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3153117; Rakshit Sabyasachi, 2008, ACS Nano, V2, P1473, DOI 10.1021/nn800152a; Sadhu S, 2009, J PHYS CHEM C, V113, P19488, DOI 10.1021/jp906160z; Shi JX, 2013, NANO RES, V6, P441, DOI 10.1007/s12274-013-0321-y; van D.A., 2000, J LUMIN, V87-89, P454; Xiao J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2183; Yu HH, 2008, CHEM COMMUN, P4912, DOI 10.1039/b809071h	28	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	JAN 1	2015	296						35	39		10.1016/j.jphotochem.2014.09.011		5	Chemistry, Physical	Chemistry	AX4GK	WOS:000346891400005		
J	Uchida, S; Kagitani, F				Uchida, Sae; Kagitani, Fusako			Autonomic nervous regulation of ovarian function by noxious somatic afferent stimulation	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Review						Ovarian blood flow; Ovarian estradiol secretion; Ovarian sympathetic nerve; Noxious cutaneous stimulation; Reflex; Rat	BLOOD-FLOW; ANESTHETIZED RATS; MECHANICAL STIMULATION; ELECTRICAL-STIMULATION; TESTOSTERONE SECRETION; ADRENERGIC-INNERVATION; ESTRADIOL SECRETION; INSULIN-SECRETION; FEMALE RAT; FIBERS	It is well known that ovarian function is regulated by hypothalamic-pituitary-ovarian hormones. However, although several histological studies have described the autonomic innervation of the ovary, the involvement of these autonomic nerves in ovarian function is unclear. Recently, it has been shown that both the superior ovarian nerve (SON) and the ovarian nerve plexus (ONP) induce vasoconstrictor activity by activation of alpha 1-adrenoceptors, whereas the SON, but not the ONP, inhibits ovarian estradiol secretion by activation of alpha 2-adrenoceptors. Furthermore, reflex activation of these ovarian nerves by noxious cutaneous stimulation of the rat hindpaw results in ovarian vasoconstriction and inhibition of estradiol secretion. Thus, in addition to long-term regulation of ovarian function by hormones, ovarian autonomic innervation may be involved in rapid regulation of ovarian function by responding to either internal or external environmental changes.	[Uchida, Sae; Kagitani, Fusako] Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Itabashi Ku, Tokyo 1730015, Japan	Uchida, S (reprint author), Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	suchida@center.tmig.or.jp			 [24590308]	This work was supported by a Grant-in Aid for Scientific Research (No. 24590308) to SU.	BURDEN HW, 1983, ANAT REC, V207, P623, DOI 10.1002/ar.1092070410; Zackrisson U, 2000, HUM REPROD, V15, P264, DOI 10.1093/humrep/15.2.264; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51; BALJET B, 1979, ACTA ANAT, V104, P243; LAWRENCE IE, 1980, ANAT REC, V196, P51, DOI 10.1002/ar.1091960106; Christensen A, 2012, HORM METAB RES, V44, P587, DOI 10.1055/s-0032-1306301; Gerendai I, 1998, NEUROENDOCRINOLOGY, V68, P244, DOI 10.1159/000054372; BERKLEY KJ, 1988, J NEUROPHYSIOL, V59, P142; ROBBINS A, 1990, NEUROSCI LETT, V110, P82, DOI 10.1016/0304-3940(90)90791-7; BERKLEY KJ, 1990, J NEUROPHYSIOL, V63, P256; LARA HE, 1993, ENDOCRINOLOGY, V133, P2690, DOI 10.1210/en.133.6.2690; Gerendai I, 2000, J AUTONOM NERV SYST, V80, P40, DOI 10.1016/S0165-1838(00)00071-0; SATO A, 1973, PHYSIOL REV, V53, P916; Hanada T, 2011, AUTON NEUROSCI-BASIC, V164, P6, DOI 10.1016/j.autneu.2011.05.001; Kagitani F, 2008, J PHYSIOL SCI, V58, P133, DOI 10.2170/physiolsci.RP001508; BERKLEY KJ, 1993, J NEUROPHYSIOL, V69, P533; ARAKI T, 1984, NEUROSCIENCE, V12, P289, DOI 10.1016/0306-4522(84)90154-4; Berga S, 2012, GYNECOL ENDOCRINOL, V28, P9, DOI 10.3109/09513590.2012.651929; Burden HW, 1985, SERONO S PUBLICATION, V18, P261; BURDEN HW, 1972, AM J ANAT, V133, P455, DOI 10.1002/aja.1001330407; GANONG WF, 1982, FRONT NEUROENDOCRIN, V7, P231; Greene EC, 1963, ANATOMY RAT; Hotta H, 1999, J AUTONOM NERV SYST, V75, P23, DOI 10.1016/S0165-1838(98)00170-2; Kagitani F, 2011, J PHYSIOL SCI, V61, P247, DOI 10.1007/s12576-011-0135-1; Kagitani F, 2013, J PHYSIOL SCI, V63, pS215; Kanai C, 2006, AUTONOMIC NERV SYS, V43, P410; KIMURA A, 1995, NEUROSCI RES, V22, P297, DOI 10.1016/0168-0102(95)00907-B; MASSA HM, 1994, J REPROD FERTIL, V101, P605; METZ SA, 1978, DIABETES, V27, P554; MURAKAMI T, 1988, ARCH HISTOL CYTOL, V51, P299, DOI 10.1679/aohc.51.299; NAKAKI T, 1981, J PHARMACOL EXP THER, V216, P607; Ojeda S. R., 2012, TXB ENDOCRINE PHYSL, P3; Ojeda S.R., 2012, TXB ENDOCRINE PHYSL, P194; Owman C, 1988, HDB CHEM NEUROANATOM, V6, P445; PORTE D, 1973, J CLIN INVEST, V52, P210, DOI 10.1172/JCI107168; REITER RJ, 1982, FRONT NEUROENDOCRIN, V7, P287; REYNOLDS LP, 1984, J REPROD FERTIL, V71, P65; Sato A, 1997, REV PHYSIOL BIOCH P, V130, P1, DOI 10.1007/BFb0046598; Sato Y, 1996, J AUTONOM NERV SYST, V59, P151, DOI 10.1016/0165-1838(96)00019-7; SELSTAM G, 1985, J REPROD FERTIL, V75, P351; Sverrisdottir YB, 2008, AM J PHYSIOL-ENDOC M, V294, pE576, DOI 10.1152/ajpendo.00725.2007; Traurig H.H., 1993, NERVOUS CONTROL UROG, P103; Uchida S, 2007, J PHYSIOL SCI, V57, P227, DOI 10.2170/physioisci.RP003507; Uchida S, 2003, AUTON NEUROSCI-BASIC, V106, P91, DOI 10.1016/S1566-0702(03)00073-0; Uchida S, 2012, AUTON NEUROSCI-BASIC, V171, P14, DOI 10.1016/j.autneu.2012.08.014; Uchida S, 2014, AUTON NEUROSCI-BASIC, V180, P48, DOI 10.1016/j.autneu.2013.10.007; Uchida S, 2005, JPN J PHYSIOL, V55, P265, DOI 10.2170/jjphysiol.R2133; VARGA B, 1979, GYNECOL OBSTET INVES, V10, P81	48	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					1	9		10.1007/s12576-014-0324-9		9	Physiology	Physiology	AX4ND	WOS:000346908200001		
J	Takeuchi, A; Kim, BJ; Matsuoka, S				Takeuchi, Ayako; Kim, Bongju; Matsuoka, Satoshi			The destiny of Ca2+ released by mitochondria	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Review						Mitochondria; Ca2+ dynamics; NCLX; Letm1; Cellular function	SINOATRIAL NODE CELLS; WOLF-HIRSCHHORN-SYNDROME; RAT KIDNEY MITOCHONDRIA; CALCIUM UNIPORTER; ENDOPLASMIC-RETICULUM; HEART-MITOCHONDRIA; PERMEABILITY TRANSITION; VENTRICULAR MYOCYTES; NA+-CA2+ EXCHANGE; HL-1 CARDIOMYOCYTES	Mitochondrial Ca2+ is known to regulate diverse cellular functions, for example energy production and cell death, by modulating mitochondrial dehydrogenases, inducing production of reactive oxygen species, and opening mitochondrial permeability transition pores. In addition to the action of Ca2+ within mitochondria, Ca2+ released from mitochondria is also important in a variety of cellular functions. In the last 5 years, the molecules responsible for mitochondrial Ca2+ dynamics have been identified: a mitochondrial Ca2+ uniporter (MCU), a mitochondrial Na+-Ca2+ exchanger (NCLX), and a candidate for a mitochondrial H+-Ca2+ exchanger (Letm1). In this review, we focus on the mitochondrial Ca2+ release system, and discuss its physiological and pathophysiological significance. Accumulating evidence suggests that the mitochondrial Ca2+ release system is not only crucial in maintaining mitochondrial Ca2+ homeostasis but also participates in the Ca2+ crosstalk between mitochondria and the plasma membrane and between mitochondria and the endoplasmic/sarcoplasmic reticulum.	[Takeuchi, Ayako; Matsuoka, Satoshi] Univ Fukui, Dept Integrat & Syst Physiol, Fac Med Sci, Eiheiji, Fukui 9101193, Japan; [Kim, Bongju] Univ Tokushima, Div Expt Immunol, Inst Genome Res, Tokushima 7708503, Japan	Takeuchi, A (reprint author), Univ Fukui, Dept Integrat & Syst Physiol, Fac Med Sci, 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	atakeuti@u-fukui.ac.jp			JSPS Kakenhi grant [25136707, 23689011, 23390042]	This work was supported by JSPS Kakenhi grant numbers 25136707, 23689011, and 23390042 (A.T. and S.M.).	AFFOLTER H, 1980, BIOCHEM BIOPH RES CO, V95, P193, DOI 10.1016/0006-291X(80)90723-8; Wang XD, 2001, GENE DEV, V15, P2922; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Marchi S, 2014, J PHYSIOL-LONDON, V592, P829, DOI 10.1113/jphysiol.2013.268235; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Severi S, 2012, J PHYSIOL-LONDON, V590, P4483, DOI 10.1113/jphysiol.2012.229435; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Takeuchi A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02766; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kim B, 2008, J PHYSIOL-LONDON, V586, P1683, DOI 10.1113/jphysiol.2007.148726; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cai XJ, 2004, J BIOL CHEM, V279, P5867, DOI 10.1074/jbc.M310908200; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Celsi F, 2009, BBA-BIOENERGETICS, V1787, P335, DOI 10.1016/j.bbabio.2009.02.021; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Gilabert JA, 2012, ADV EXP MED BIOL, V740, P483, DOI 10.1007/978-94-007-2888-2_20; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; van Vliet AR, 2014, BBA-MOL CELL RES, V1843, P2253, DOI 10.1016/j.bbamcr.2014.03.009; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Yang ZJ, 2011, J CARDIOVASC PHARM, V57, P28, DOI 10.1097/FJC.0b013e3181fda7c4; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Adachi T, 2013, J PHYSIOL SCI, V63, P133, DOI 10.1007/s12576-012-0248-1; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dedkova EN, 2009, J PHYSIOL-LONDON, V587, P851, DOI 10.1113/jphysiol.2008.165423; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Bernardi P, 1999, PHYSIOL REV, V79, P1127; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Jiang DW, 2013, P NATL ACAD SCI USA, V110, pE2249, DOI 10.1073/pnas.1308558110; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Tsai MF, 2014, J GEN PHYSIOL, V143, P67, DOI 10.1085/jgp.201311096; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Maltsev VA, 2009, AM J PHYSIOL-HEART C, V296, pH594, DOI 10.1152/ajpheart.01118.2008; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kohlhaas M, 2010, CIRCULATION, V121, P1606, DOI 10.1161/CIRCULATIONAHA.109.914911; Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Kim B, 2012, J PHYSIOL-LONDON, V590, P459, DOI 10.1113/jphysiol.2011.222927; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Wei AC, 2011, BBA-MOL CELL RES, V1813, P1373, DOI 10.1016/j.bbamcr.2011.02.012; Patron M, 2013, J BIOL CHEM, V288, P10750, DOI 10.1074/jbc.R112.420752; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; ASHCROFT SJ, 1973, BIOCHEM J, V132, P223; BASSANI RA, 1994, J PHYSIOL-LONDON, V476, P295; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; CHACON E, 1991, TOXICOL APPL PHARM, V107, P117, DOI 10.1016/0041-008X(91)90336-D; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; FISKUM G, 1979, J BIOL CHEM, V254, P6236; GUNTER KK, 1991, J BIOL CHEM, V266, P21640; Gunter TE, 1990, AM J PHYSIOL, V258, pC755; Guo JQ, 1997, PFLUG ARCH EUR J PHY, V433, P390, DOI 10.1007/s004240050293; HARRIS DA, 1993, BIOCHEM SOC T, V21, P778; Haworth RA, 1980, FEBS LETT, V110, P210; Himeno Y, 2008, J PHYSIOL SCI, V58, P53, DOI 10.2170/physiolsci.RP015207; Himeno Y, 2011, AM J PHYSIOL-HEART C, V300, pH251, DOI 10.1152/ajpheart.00764.2010; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Jo H, 2006, J MOL CELL CARDIOL, V40, P394, DOI 10.1016/j.yjmcc.2005.12.012; JURKOWITZ MS, 1982, J BIOENERG BIOMEMBR, V14, P435, DOI 10.1007/BF00743069; Khatami Mehri, 2010, Cardiovasc Pathol, V19, pe21, DOI 10.1016/j.carpath.2008.12.009; Kim B, 2013, J PHYSIOL SCI, V63, pS136; Kim B, 2013, ADV EXP MED BIOL, V961, P193, DOI 10.1007/978-1-4614-4756-6_16; Lawrie AM, 1996, J BIOL CHEM, V271, P10753; Malli R, 2005, J BIOL CHEM, V280, P12114, DOI 10.1074/jbc.M409353200; Niescier RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00148; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Nowikovsky K, 2012, J GEN PHYSIOL, V139, P445, DOI 10.1085/jgp.201110757; Opuni K, 2000, J BIOL CHEM, V275, P21549, DOI 10.1074/jbc.M003158200; Parnis J, 2013, J NEUROSCI, V33, P7206, DOI 10.1523/JNEUROSCI.5721-12.2013; Proverbio MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068740; SCHOLZ TD, 1994, AM J PHYSIOL, V266, pH2396; Takeuchi A, 2014, J PHYSIOL SCI, V64, pS68; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166; Yaniv Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037582	111	6	6	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					11	24		10.1007/s12576-014-0326-7		14	Physiology	Physiology	AX4ND	WOS:000346908200002		
J	Kazama, I				Kazama, Itsuro			Physiological significance of delayed rectifier K+ channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Review						Lymphocytes; Delayed rectifier K+ channels (Kv1.3); Membrane capacitance (C-m); Immunomodulatory effects; Overexpression of Kv1.3 channels; Chronic kidney disease (CKD)	GATED POTASSIUM CHANNEL; CHRONIC-RENAL-FAILURE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALVEOLAR EPITHELIAL-CELLS; MULTIPLE-SCLEROSIS; MURINE THYMOCYTES; ION CHANNELS; CYTOKINE PRODUCTION; THERAPEUTIC TARGET; MACROLIDE ANTIBIOTICS	T lymphocytes predominantly express delayed rectifier K+ channels (Kv1.3) in their plasma membranes. More than 30 years ago, patch-clamp studies revealed that the channels play crucial roles in facilitating the calcium influx necessary to trigger lymphocyte activation and proliferation. In addition to selective channel inhibitors that have been developed, we recently showed physiological evidence that drugs such as nonsteroidal anti-inflammatory drugs, antibiotics, and anti-hypertensives effectively suppress the channel currents in lymphocytes, and thus exert immunosuppressive effects. Using experimental animal models, previous studies revealed the pathological relevance between the expression of ion channels and the progression of renal diseases. As an extension, we recently demonstrated that the overexpression of lymphocyte Kv1.3 channels contributed to the progression of chronic kidney disease (CKD) by promoting cellular proliferation and interstitial fibrosis. Together with our in-vitro results, the studies indicated the therapeutic potency of Kv1.3-channel inhibitors in the treatment or the prevention of CKD.	Tohoku Univ, Grad Sch Med, Dept Physiol 1, Aoba Ku, Sendai, Miyagi 980, Japan	Kazama, I (reprint author), Tohoku Univ, Grad Sch Med, Dept Physiol 1, Aoba Ku, Seiryo Cho, Sendai, Miyagi 980, Japan.	kazaitsu@med.tohoku.ac.jp					ALLISON MEM, 1974, J CLIN INVEST, V53, P1402, DOI 10.1172/JCI107689; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; GAO JX, 1993, INT J IMMUNOPHARMACO, V15, P793; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Villalonga N, 2010, BIOCHEM PHARMACOL, V80, P858, DOI 10.1016/j.bcp.2010.05.012; Kazama I, 2013, IMMUNOPHARM IMMUNOT, V35, P28, DOI 10.3109/08923973.2012.723011; YOUNG HS, 1992, BIOPHYS J, V61, P1244; Kazama I, 2012, IMMUNOPHARM IMMUNOT, V34, P874, DOI 10.3109/08923973.2012.666249; MAZZEI T, 1993, J ANTIMICROB CHEMOTH, V31, P1; DEUTSCH C, 1993, P NATL ACAD SCI USA, V90, P10036, DOI 10.1073/pnas.90.21.10036; Kazama I, 2012, J PHYSIOL SCI, V62, P267, DOI 10.1007/s12576-012-0195-x; Volberg WA, 2002, J PHARMACOL EXP THER, V302, P320, DOI 10.1124/jpet.302.1.320; MORRISON AB, 1962, LAB INVEST, V11, P321; LEWIS RS, 1989, CELL REGUL, V1, P99; DECOURSEY TE, 1995, J GEN PHYSIOL, V106, P745, DOI 10.1085/jgp.106.4.745; McCloskey C, 2010, J PHYSIOL-LONDON, V588, P1399, DOI 10.1113/jphysiol.2010.188136; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Kazama I, 2014, MED HYPOTHESES, V82, P196, DOI 10.1016/j.mehy.2013.11.037; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Mahaut-Smith MP, 2003, BIOPHYS J, V84, P2646, DOI 10.1016/S0006-3495(03)75070-X; Kazama I, 2014, CLIN APPL THROMB-HEM, V20, P318, DOI 10.1177/1076029612461845; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Fisher JL, 2004, AM J RESP CELL MOL, V31, P200, DOI 10.1165/rcmb.2003-0224OC; HERBETTE LG, 1986, BIOPHYS J, V49, P91; Hackstein H, 2001, J IMMUNOL, V166, P7053; Jang SH, 2009, BMB REP, V42, P535; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Kazama I, 2014, PHARMACOL REP, V66, P712, DOI 10.1016/j.pharep.2014.03.002; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Matsumori A, 2010, CIRC J, V74, P567, DOI 10.1253/circj.CJ-09-0467; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Iniguez MA, 1999, J IMMUNOL, V163, P111; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Mouhat S, 2006, MOL PHARMACOL, V69, P354, DOI 10.1124/mol.105.017210; Kazama I, 2013, PHARM BIOL, V51, P760, DOI 10.3109/13880209.2013.764539; Zuckerman JM, 2004, INFECT DIS CLIN N AM, V18, P621, DOI 10.1016/j.idc.2004.04.010; Judge SIV, 2006, J REHABIL RES DEV, V43, P111, DOI 10.1682/JRRD.2004.09.011; Hu L, 2007, J IMMUNOL, V179, P4563; Morris CE, 2001, J MEMBRANE BIOL, V179, P79; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Sugiyama K, 2007, CLIN EXP IMMUNOL, V147, P540, DOI 10.1111/j.1365-2249.2007.03299.x; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Khan AA, 1999, INT J ANTIMICROB AG, V11, P121, DOI 10.1016/S0924-8579(98)00091-0; BACON KB, 1989, BIOCHEM BIOPH RES CO, V165, P349, DOI 10.1016/0006-291X(89)91076-0; Kazama I, 2013, CELL PHYSIOL BIOCHEM, V31, P592, DOI 10.1159/000350079; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Robe RJ, 2000, BRIT J PHARMACOL, V131, P1275, DOI 10.1038/sj.bjp.0703723; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Liu WL, 2011, CURR OPIN INFECT DIS, V24, P254, DOI 10.1097/QCO.0b013e3283463e5b; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; CHESTER DW, 1987, BIOPHYS J, V52, P1021; Rauer H, 1999, BRIT J PHARMACOL, V127, P1065, DOI 10.1038/sj.bjp.0702599; Abdul M, 2002, CANCER LETT, V186, P99, DOI 10.1016/S0304-3835(02)00348-8; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; Jang SH, 2011, EUR J PHARMACOL, V651, P26, DOI 10.1016/j.ejphar.2010.10.066; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; AVIOLI LV, 1969, SCIENCE, V166, P1154, DOI 10.1126/science.166.3909.1154; BENCOSME SA, 1960, ARCH PATHOL, V69, P470; BIRX DL, 1984, J IMMUNOL, V133, P2904; BOHLE A, 1994, EXP NEPHROL, V2, P205; BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618; BRENNER BM, 1982, NEW ENGL J MED, V307, P652; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197; Chandy KG, 2001, TOXICON, V39, P1269, DOI 10.1016/S0041-0101(01)00120-9; CHATENOUD L, 1986, P NATL ACAD SCI USA, V83, P7457, DOI 10.1073/pnas.83.19.7457; Cho JY, 2007, ARCH PHARM RES, V30, P64, DOI 10.1007/BF02977780; Escobar LI, 2004, AM J PHYSIOL-CELL PH, V286, pC965, DOI 10.1152/ajpcell.00074.2003; FUKUDA S, 1980, NEPHRON, V25, P139, DOI 10.1159/000181770; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; Gluais P, 2003, FUND CLIN PHARMACOL, V17, P691, DOI 10.1046/j.1472-8206.2003.00186.x; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hamilton D, 2014, J PHYSIOL SCI, V64, P13, DOI 10.1007/s12576-013-0285-4; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI 10.1093/hmg/ddp001; HORVATH M, 1991, J INVEST ALLERG CLIN, V1, P404; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85; Huang S, 2010, J GERIATR CARDIOL, V7, P40; Hyodo T, 2010, AM J PHYSIOL-RENAL, V299, pF1258, DOI 10.1152/ajprenal.00374.2010; ISHIDA Y, 1993, J IMMUNOL, V151, P610; Jones SE, 2003, KIDNEY INT, V64, P906, DOI 10.1046/j.1523-1755.2003.00183.x; KARASAWA A, 1988, JPN J PHARMACOL, V47, P35, DOI 10.1254/jjp.47.35; Kaysen GA, 2003, J RENAL NUTR, V13, P158, DOI 10.1053/jren.2003.50021; Kazama I., 2012, CASE REP MED, V2012; Kazama I, 2012, INT J NEPHROL, V2012; Kazama Itsuro, 2011, Nephron Extra, V1, P147, DOI 10.1159/000333018; Kitakaze M, 1999, J AM COLL CARDIOL, V33, P242, DOI 10.1016/S0735-1097(98)00556-7; Kohzuki M, 1995, J HYPERTENS, V13, P1785; KONDO Y, 1972, LAB INVEST, V27, P620; KUMANO K, 1986, KIDNEY INT, V30, P433, DOI 10.1038/ki.1986.203; LAN HY, 1995, KIDNEY INT, V48, P753, DOI 10.1038/ki.1995.347; LEWIS RS, 1993, J GEN PHYSIOL, V101, P801, DOI 10.1085/jgp.101.6.801; Litjens NHR, 2006, CLIN IMMUNOL, V118, P83, DOI 10.1016/j.clim.2005.09.007; Michimata M, 2003, NEPHRON PHYSIOL, V93, P34; Miyazaki T, 1997, Kidney Int Suppl, V62, pS15; Morikawa K, 2002, INT J ANTIMICROB AG, V19, P53, DOI 10.1016/S0924-8579(01)00457-5; Nahas AM El, 2000, MECH MANAGEMENT PROG, P104; Orban C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00234; Palamaras Ioulios, 2005, Dermatol Online J, V11, P8; PLATT R, 1952, CLIN SCI, V11, P217; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Sanada S, 2009, NEPHROLOGY, V14, P735, DOI 10.1111/j.1440-1797.2009.01110.x; Schilling T, 2003, PFLUG ARCH EUR J PHY, V447, P312, DOI 10.1007/s00424-003-1155-3; Sugiyama K, 2011, INT J CLIN PHARM TH, V49, P145, DOI 10.5414/CPP49145; Suzuki K, 2005, NEPHRON PHYSIOL, V99, P16; SUZUKI K, 1994, ARZNEIMITTEL-FORSCH, V44-1, P129; Teisseyre A, 1996, NEPHRON, V72, P587; Toldi G, 2013, IMMUNOBIOLOGY, V218, P311, DOI 10.1016/j.imbio.2012.05.013; VATER W, 1972, ARZNEI-FORSCHUNG, V22, P1; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; YAMAMOTO M, 1990, BRIT J PHARMACOL, V100, P669; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008811	119	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					25	35		10.1007/s12576-014-0331-x		11	Physiology	Physiology	AX4ND	WOS:000346908200003		
J	Tomida, T				Tomida, Taichiro			Visualization of the spatial and temporal dynamics of MAPK signaling using fluorescence imaging techniques	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Review						MAPK; Fluorescence imaging; Systems analysis; Environmental response	ACTIVATED PROTEIN-KINASES; SINGLE LIVING CELLS; IN-VIVO; OSCILLATORY PHOSPHORYLATION; CASPASE ACTIVATION; REGULATED KINASE; FRET BIOSENSORS; GENE-EXPRESSION; ERK ACTIVATION; RAS ACTIVATION	Conserved mitogen-activated protein kinase (MAPK) signaling pathways are major mechanisms through which cells perceive and respond properly to their surrounding environment. Such homeostatic responses maintain the life of the organism. Since errors in MAPK signaling pathways can lead to cancers and to defects in immune responses, in the nervous system and metabolism, these pathways have been extensively studied as potential therapeutic targets. Although much has been studied about the roles of MAPKs in various cellular functions, less is known regarding regulation of MAPK in living organisms. This review will focus on the latest understanding of the dynamic regulation of MAPK signaling in intact cells that was revealed by using novel fluorescence imaging techniques and advanced systems-analytical methods. These techniques allowed quantitative analyses of signal transduction in situ with high spatio-temporal resolution and have revealed the nature of the molecular dynamics that determine cellular responses and fates.	Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Minato Ku, Tokyo 1088639, Japan	Tomida, T (reprint author), Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tomida@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	The author thanks Drs. Haruo Saito and Pauline O'Grady for critical reading of this review and valuable advice. The author's work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Carlson HJ, 2009, CURR OPIN BIOTECH, V20, P19, DOI 10.1016/j.copbio.2009.01.003; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; TRAVERSE S, 1992, BIOCHEM J, V288, P351; Takemoto K, 2007, P NATL ACAD SCI USA, V104, P13367, DOI 10.1073/pnas.0702733104; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Miyawaki A, 1997, NATURE, V388, P882; Kawai H, 2005, J PHARMACOL SCI, V97, P361, DOI 10.1254/jphs.FP0040592; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hughey JJ, 2010, WIRES SYST BIOL MED, V2, P194, DOI 10.1002/wsbm.52; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Tomida T, 2009, MOL CELL BIOL, V29, P6117, DOI 10.1128/MCB.00571-09; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Chickarmane V, 2007, J THEOR BIOL, V244, P68, DOI 10.1016/j.jtbi.2006.05.013; Tiwari DK, 2013, DEV GROWTH DIFFER, V55, P491, DOI 10.1111/dgd.12064; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Kamioka Y, 2012, CELL STRUCT FUNCT, V37, P65; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Kiyokawa E, 2011, ANNU REV PHARMACOL, V51, P337, DOI 10.1146/annurev-pharmtox-010510-100234; Kolossov VL, 2011, EXP BIOL MED, V236, P681, DOI 10.1258/ebm.2011.011009; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/nmeth.1317, 10.1038/NMETH.1317]; Robin E, 2007, J BIOL CHEM, V282, P19133, DOI 10.1074/jbc.M701917200; Sato M, 2002, NAT BIOTECHNOL, V20, P287, DOI 10.1038/nbt0302-287; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; BUDAY L, 1995, ONCOGENE, V11, P1327; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Vinkenborg JL, 2007, CHEMBIOCHEM, V8, P1119, DOI 10.1002/cbic.200700109; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Ueda Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00163; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Esposito A, 2008, BIOCHEMISTRY-US, V47, P13115, DOI 10.1021/bi8009482; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Fujii H, 2013, CELL REP, V3, P978, DOI 10.1016/j.celrep.2013.03.033; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; Grunberg R, 2013, NAT METHODS, V10, P1021, DOI [10.1038/nmeth.2625, 10.1038/NMETH.2625]; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Kholodenko BN, 2009, WIRES SYST BIOL MED, V1, P28, DOI 10.1002/wsbm.16; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lippincott-Schwartz J, 2008, METHOD CELL BIOL, V85, P45, DOI 10.1016/S0091-679X(08)85003-0; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; Nagai Y, 2000, NAT BIOTECHNOL, V18, P313; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; NAKIELNY S, 1992, EMBO J, V11, P2123; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Pearce LL, 2000, P NATL ACAD SCI USA, V97, P477, DOI 10.1073/pnas.97.1.477; Qui M S, 1992, Neuron, V9, P705; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; Sato M, 2007, ANAL CHEM, V79, P2570, DOI 10.1021/ac062171d; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Suzuki H, 2010, SUPRAMOL CHEM, V22, P434, DOI 10.1080/10610278.2010.484864; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Yano T, 2010, MOL CELL BIOL, V30, P3758, DOI 10.1128/MCB.00121-10	113	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					37	49		10.1007/s12576-014-0332-9		13	Physiology	Physiology	AX4ND	WOS:000346908200004		
J	Ohhashi, T; Kawai, Y				Ohhashi, Toshio; Kawai, Yoshiko			Proposed new lymphology combined with lymphatic physiology, innate immunology, and oncology	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Review						Active lymph transport; Nitric oxide; Condensing albumin in lymph; Inflammatory cytokine; Sentinel lymph node; Shear stress; Micrometastasis; Acidic microenvironment	BOVINE MESENTERIC LYMPHATICS; VASCULAR ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE; PROTEIN-CONCENTRATION; IN-VIVO; TUMOR LYMPHANGIOGENESIS; ELECTRICAL-ACTIVITY; ADHESION MOLECULES; SKELETAL-MUSCLE	As one of the lymphatic functions, it is well known that the transport and drainage of hydrophilic substances including plasma protein through the lymphatic system play pivotal roles in maintaining the homeostasis of the internal environment between the cells in tissues in collaboration with the exchange of the substances through the blood capillaries and venules. The physiological functions of the lymphatic system have been studied by many investigations of microcirculation, i.e., Yoffey and Courtice, Ruszunyak et al., Foldie and Casley-Smigh et al., Roddie, Schmid-Schonbein et al., and Ohhashi et al. On the other hand, it is also well known that the initial clinical signs of primary diseases such as inflammation, tumors, and circulatory disorders including infarction and thrombosis appear as functional abnormalities of the internal environment in tissues. These abnormalities of the functions are strongly related to immunological defense reactions around the internal environment and abnormal actions of the transport and drainage of the lymphatic system. Taking into consideration the current inspired findings in lymphatic physiology, innate immunology, and oncology, we have proposed a new lymphology combined with new knowledge of the three above-mentioned academic fields from a defense mechanism points of view. In this review, we would like to demonstrate comprehensively our latest studies related to the possibility of establishing a new lymphology, hoping the readers will evaluate this possibility.	[Ohhashi, Toshio] Shinshu Univ, Sch Med, Dept Innovat Med & Hlth Sci Res, Matsumoto, Nagano 3908621, Japan; [Kawai, Yoshiko] Shinshu Univ, Dept Physiol, Sch Med, Matsumoto, Nagano 3908621, Japan	Ohhashi, T (reprint author), Shinshu Univ, Sch Med, Dept Innovat Med & Hlth Sci Res, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	ohhashi@shinshu-u.ac.jp			Japanese Ministry of Education, Science, Sports, and Culture [19209044, 22249052, 24659098, 24590272]; METI (Japan) [2007-2012]	This study was financially supported, in part, by Grants-in-Aid for Scientific Research (19209044, 22249052, 24659098, 24590272) from the Japanese Ministry of Education, Science, Sports, and Culture and the Intelligent Surgical Instruments Project of the METI (Japan) (2007-2012).	SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; IGNARRO LJ, 1985, ANNU REV PHARMACOL, V25, P171, DOI 10.1146/annurev.pharmtox.25.1.171; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; DAVIES PF, 1995, PHYSIOL REV, V75, P519; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Wykoff CC, 2000, CANCER RES, V60, P7075; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; BENOIT JN, 1989, AM J PHYSIOL, V257, pH2059; HARGENS AR, 1977, AM J PHYSIOL, V233, pH57; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Nase GP, 2003, AM J PHYSIOL-HEART C, V285, pH507, DOI 10.1152/ajpheart.00759.2002; RODDIE IC, 1990, NEWS PHYSIOL SCI, V5, P85; Palumbo R, 2000, CIRCULATION, V102, P225; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Gashev AA, 2002, J PHYSIOL-LONDON, V540, P1023, DOI 10.1113/jphysiol.2002.016642; Yamamoto K, 2007, AM J PHYSIOL-HEART C, V293, pH1646, DOI 10.1152/ajpheart.01385.2006; EGLEN RM, 1985, BRIT J PHARMACOL, V84, P3; FREDRICKS KT, 1994, AM J PHYSIOL, V267, pH580; ADAIR TH, 1982, AM J PHYSIOL, V243, pH351; FOX SB, 1995, J PATHOL, V177, P369, DOI 10.1002/path.1711770407; Bulanova E, 2010, PURINERG SIGNAL, V6, P3, DOI 10.1007/s11302-009-9173-z; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; ADAIR TH, 1983, AM J PHYSIOL, V245, pH616; Shirasawa Y, 2000, AM J PHYSIOL-GASTR L, V278, pG551; Kitagawa Y, 2002, J SURG ONCOL, V79, P188, DOI 10.1002/jso.10065; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48; Ono N, 2000, JPN J PHYSIOL, V50, P25, DOI 10.2170/jjphysiol.50.25; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; ADAIR TH, 1985, AM J PHYSIOL, V249, pH777; MARTIN W, 1985, J PHARMACOL EXP THER, V232, P708; QUIN JW, 1977, J PHYSIOL-LONDON, V264, P307; Lopez-Castejon G, 2011, CELL MOL LIFE SCI, V68, P3095, DOI 10.1007/s00018-010-0609-y; Karpanen T, 2001, CANCER RES, V61, P1786; Ebbesen P, 2009, J ENZYM INHIB MED CH, V24, P1, DOI 10.1080/14756360902784425; Mizuno R, 1998, AM J PHYSIOL-REG I, V274, pR790; BARANKAY T, 1976, PFLUG ARCH EUR J PHY, V366, P53, DOI 10.1007/BF02486560; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; MESSINA EJ, 1992, CIRC RES, V71, P790; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; KNOX P, 1983, J PHYSIOL-LONDON, V345, P1; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; AZUMA T, 1977, P SOC EXP BIOL MED, V155, P270; Baez S, 1960, FLOW PROPERTIES BLOO, P398; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; BERGOFSKY EH, 1962, J CLIN INVEST, V41, P1971, DOI 10.1172/JCI104655; BRACE RA, 1977, MICROVASC RES, V14, P243, DOI 10.1016/0026-2862(77)90023-1; BUSSE R, 1983, PFLUG ARCH EUR J PHY, V397, P78, DOI 10.1007/BF00585175; Cahoon L, 2011, NAT MED, V17, P271, DOI 10.1038/nm0311-271; Dfrnyei G, 1996, AM J PHYSIOL, V271, pH267; FARRELL KJ, 1979, AM J PHYSIOL, V236, pH846; Foldi M, 1983, LYMPHANGIOLOGY; Fukaya Y, 1996, AM J PHYSIOL-HEART C, V270, pH99; Guyton AC, 1975, CIRCULATORY PHYSL 2, P125; HALL J. G., 1965, J PHYSIOL [LONDON], V180, P336; Hangai-Hoger N, 2004, AM J PHYSIOL-HEART C, V286, pH878, DOI 10.1152/ajpheart.00913.2003; HARGENS AR, 1976, MICROVASC RES, V11, P89, DOI 10.1016/0026-2862(76)90080-7; Ikomi F, 2000, JPN J PHYSL, V50, pS74; JACOBSSON S, 1964, ACTA PHYSIOL SCAND, V60, P278, DOI 10.1111/j.1748-1716.1964.tb02889.x; JOHNSON JP, 1991, CANCER METAST REV, V10, P11, DOI 10.1007/BF00046840; JOHNSTON MG, 1995, PORTL PR P, P181; Kawai Y, 2012, CANCER SCI, V103, P1245, DOI 10.1111/j.1349-7006.2012.02289.x; Kawai Y, 2014, LYMPHAT RES BIOL, V12, P124, DOI 10.1089/lrb.2014.0002; Kawai Y, 2008, AM J PHYSIOL-CELL PH, V295, pC1123, DOI 10.1152/ajpcell.00247.2008; Kawai Y, 2011, CANCER SCI, V102, P2073, DOI 10.1111/j.1349-7006.2011.02048.x; Kawai Y, 2009, CANCER SCI, V100, P419, DOI 10.1111/j.1349-7006.2008.01064.x; Kawai Y, 2013, AM J PHYSIOL-CELL PH, V305, pC1139, DOI 10.1152/ajpcell.00199.2013; Kinmonth JB, 1956, J PHYSIOL-LONDON, V133, P3; Koller A, 1995, FLOW DEPENDENT REGUL, P236; KUO L, 1993, CIRC RES, V72, P607; LEAK LV, 1968, J CELL BIOL, V36, P129, DOI 10.1083/jcb.36.1.129; LU DJ, 1990, J BIOL CHEM, V265, P13721; Manevich Y, 2001, AM J PHYSIOL-HEART C, V280, pH2126; Marchetti C, 1997, ANAT REC, V248, P490; Marshall JM, 2000, ACTA PHYSIOL SCAND, V168, P561, DOI 10.1046/j.1365-201x.2000.00709.x; Matsui K, 1999, NEPHROL DIAL TRANSPL, V14, P9, DOI 10.1093/ndt/14.suppl_1.9; MAWHINNE.HJ, 1973, J PHYSIOL-LONDON, V229, P339; MAYERSON HS, 1962, AM J PHYSIOL, V203, P98; Mayerson HS, 1963, HDB PHYSL 2, V2, P1035; Mislin H., 1961, Revue Suisse de Zoologie, V68, P228; MISLIN H., 1962, REV SUISSE ZOOL, V69, P334; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Nojiri H, 1999, MICROCIRCULATION, V6, P75, DOI 10.1080/713773929; Ohhashi T, 2005, PHARMACOL THERAPEUT, V105, P165, DOI 10.1016/j.pharmthera.2004.10.009; OHHASHI T, 1994, JPN J PHYSIOL, V44, P327, DOI 10.2170/jjphysiol.44.327; OHHASHI T, 1990, AM J PHYSIOL, V259, pH42; OHHASHI T, 1982, MICROVASC RES, V23, P93, DOI 10.1016/0026-2862(82)90034-6; OHHASHI T, 1980, AM J PHYSIOL, V239, pH88; OHHASHI T, 1982, MICROVASC RES, V24, P377, DOI 10.1016/0026-2862(82)90024-3; OHHASHI T, 1978, P SOC EXP BIOL MED, V159, P350; OHHASHI T, 1991, AM J PHYSIOL, V260, pH1172; Ohhashi T, 1990, PROGR LYMPHOLOGY, P135; OHHASHI T, 1977, P SOC EXP BIOL MED, V154, P582; OLSZEWSKI WL, 1980, AM J PHYSIOL, V239, pH775; PARK KH, 1992, CIRC RES, V71, P992; POHL U, 1989, AM J PHYSIOL, V256, pH1595; Ruszunyak I, 1967, LYMPHATICS LYMPH CIR; SAKAGUCHI M, 1979, PFLUG ARCH EUR J PHY, V378, P263, DOI 10.1007/BF00592745; SPEDEN RN, 1964, NATURE, V202, P193, DOI 10.1038/202193a0; Tsunemoto H, 2003, JPN J PHYSIOL, V53, P157, DOI 10.2170/jjphysiol.53.157; von der Weid PY, 2001, AM J PHYSIOL-HEART C, V280, pH2707; WALDECK F, 1965, PFLUG ARCH GES PHYS, V283, P285, DOI 10.1007/BF00380587; WASSERMAN K, 1951, AM J PHYSIOL, V165, P15; WATANABE M, 1988, CIRC RES, V62, P86; Wei ZH, 2001, AM J PHYSIOL-HEART C, V281, pH2226; WU NZ, 1992, CANCER RES, V52, P4265; Yashiro Y, 1997, AM J PHYSIOL-HEART C, V273, pH2217; Yoffey JM, 1970, LYMPHATICS LYMPH LYM; YOKOYAMA S, 1993, AM J PHYSIOL, V264, pH1460	114	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					51	66		10.1007/s12576-014-0343-6		16	Physiology	Physiology	AX4ND	WOS:000346908200005		
J	Uchida, S; Kagitani, F				Uchida, Sae; Kagitani, Fusako			Effect of acupuncture-like stimulation on cortical cerebral blood flow in aged rats	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Acupuncture; Cortical cerebral blood flow; Cortical acetylcholine release; Cholinergic vasodilation; Aging; Rat	AFFERENT NERVE-FIBERS; BASAL FOREBRAIN; NUCLEUS BASALIS; ALZHEIMERS-DISEASE; ACETYLCHOLINE-RELEASE; ANESTHETIZED RATS; CHOLINERGIC SYSTEM; CORTEX; INCREASES; MEYNERT	This study aimed to examine the effect of acupuncture-like stimulation on cortical cerebral blood flow (CBF) in aged rats and the contribution of the intracranial cholinergic vasodilatory system on its response. In urethane-anesthetized rats of 30-37 months of age, manual acupuncture-like stimulation of a forepaw produced an increase in the CBF, independent of systemic arterial pressure. The increase in the CBF induced by forepaw stimulation was abolished by intravenous administration of cholinergic receptor antagonists. Manual acupuncture-like stimulation of a forepaw increased extracellular acetylcholine release in the cerebral cortex. These results suggest that natural somatic afferent stimulation, such as acupuncture-like stimulation, activates the intracranial - most likely, basal forebrain - cholinergic vasodilatory system in the cerebral cortex, even in extremely aged rats.	[Uchida, Sae; Kagitani, Fusako] Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Itabashi Ku, Tokyo 1730015, Japan	Uchida, S (reprint author), Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	suchida@center.tmig.or.jp					Akaishi T, 1990, Neuroreport, V1, P37, DOI 10.1097/00001756-199009000-00011; Chen F, 2014, PROG NEUROBIOL, V115, P246, DOI 10.1016/j.pneurobio.2013.12.007; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Kagitani F, 2010, AUTON NEUROSCI-BASIC, V157, P2, DOI 10.1016/j.autneu.2010.03.004; Jones BE, 2004, PROG BRAIN RES, V145, P157, DOI 10.1016/S0079-6123(03)45011-5; Hotta H, 2007, J PHYSIOL SCI, V57, P383, DOI 10.2170/physiolsci.SC008107; Kagitani F, 2005, JPN J PHYSIOL, V55, P149, DOI 10.2170/jjphysiol.R2120; Zeng BY, 2013, INT REV NEUROBIOL, V111, P181, DOI 10.1016/B978-0-12-411545-3.00009-2; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; KUROSAWA M, 1989, NEUROSCI LETT, V98, P45, DOI 10.1016/0304-3940(89)90371-6; JOHNSTON MV, 1981, EXP BRAIN RES, V43, P159; Demeter E, 2013, NEUROPHARMACOLOGY, V64, P294, DOI 10.1016/j.neuropharm.2012.06.060; BARZO P, 1993, NEUROSURGERY, V32, P611; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Grothe M, 2013, NEUROBIOL AGING, V34, P1210, DOI 10.1016/j.neurobiolaging.2012.10.018; Gutierrez H, 1999, BRAIN RES, V834, P136, DOI 10.1016/S0006-8993(99)01519-X; HERRERAMARSCHITZ M, 1990, NEUROSCI LETT, V110, P172, DOI 10.1016/0304-3940(90)90807-L; Hotta H, 2014, J PHYSIOL SCI, V64, P253, DOI 10.1007/s12576-014-0313-z; HU HH, 1993, NEUROEPIDEMIOLOGY, V12, P106, DOI 10.1159/000110308; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056736; KUROSAWA M, 1992, NEUROCHEM INT, V21, P423, DOI 10.1016/0197-0186(92)90194-V; Liu C, 1996, J Tradit Chin Med, V16, P18; MCGEER PL, 1984, NEUROLOGY, V34, P741; Pepeu G., 2006, BRAIN CHOLINERGIC ME, P221; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sato A, 2002, AUTON NEUROSCI-BASIC, V96, P13, DOI 10.1016/S1566-0702(01)00367-8; SATO A, 1992, NEUROSCI RES, V14, P242, DOI 10.1016/0168-0102(92)90071-J; Suzuki A, 2004, JPN J PHYSIOL, V54, P137, DOI 10.2170/jjphysiol.54.137; Uchida S, 2000, JPN J PHYSIOL, V50, P495, DOI 10.2170/jjphysiol.50.495; Uchida S, 2000, NEUROSCI LETT, V294, P109, DOI 10.1016/S0304-3940(00)01556-1; Uchida S, 2013, J PHYSIOL SCI, V63, P95, DOI 10.1007/s12576-012-0239-2; Wong AMK, 1999, AM J PHYS MED REHAB, V78, P117, DOI 10.1097/00002060-199903000-00006; Zhang JH, 2014, NEUROEPIDEMIOLOGY, V42, P50, DOI 10.1159/000355435	33	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					67	75		10.1007/s12576-014-0340-9		9	Physiology	Physiology	AX4ND	WOS:000346908200006		
J	Matsumoto, H; Saito, K; Konoma, Y; Okabe, S; Ugawa, Y; Ishibashi, Y				Matsumoto, Hideyuki; Saito, Katsunori; Konoma, Yuko; Okabe, Shingo; Ugawa, Yoshikazu; Ishibashi, Yoshitaka			Motor cortical excitability in peritoneal dialysis: a single-pulse TMS study	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Chronic renal failure (CRF); Chronic kidney disease (CKD); Peritoneal dialysis (PD); Transcranial magnetic stimulation (TMS); Central motor conduction time (CMCT); Cortical silent period (CSP)	TRANSCRANIAL MAGNETIC STIMULATION; CHRONIC-RENAL-FAILURE; ELECTROENCEPHALOGRAPHIC CHANGES; NEGATIVE MYOCLONUS; ASTERIXIS; HEMODIALYSIS; UREMIA; COMPLICATIONS; EPILEPSY; DISEASE	The aim of this paper is to investigate cortical excitability in patients with end-stage renal disease receiving peritoneal dialysis (PD) without any symptoms suggestive of uremic encephalopathy. We performed transcranial magnetic stimulation for 52 PD patients and 28 normal subjects. We compared the active motor threshold (AMT), resting motor threshold (RMT), root latency, central motor conduction time (CMCT), and cortical silent period (CSP) in PD patients to those in normal subjects. AMT, RMT, CMCT, and CSP were not significantly different between PD patients and normal subjects. However, root latency was significantly prolonged in PD patients compared to normal subjects. The root latency correlated linearly with HbA1c or duration of PD in the patients. The results suggest that the corticospinal tract and the cortical and spinal excitabilities are preserved but the peripheral nerves are disturbed in PD patients. The severity of peripheral neuropathy corresponds to the severity of DM and the duration of PD. We uncovered no evidence suggestive of any subclinical abnormality of the motor cortical excitability in PD patients.	[Matsumoto, Hideyuki; Konoma, Yuko; Okabe, Shingo] Japanese Red Cross Med Ctr, Dept Neurol, Shibuya Ku, Tokyo 1508935, Japan; [Saito, Katsunori; Ishibashi, Yoshitaka] Japanese Red Cross Med Ctr, Dept Nephrol, Shibuya Ku, Tokyo 1508935, Japan; [Ugawa, Yoshikazu] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima 9601295, Japan	Matsumoto, H (reprint author), Japanese Red Cross Med Ctr, Dept Neurol, Shibuya Ku, 4-1-22 Hiroo, Tokyo 1508935, Japan.	hideyukimatsumoto.jp@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25293206]; Ministry of Health and Welfare of Japan; Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications; Uehara Memorial Foundation	Dr. Ugawa was supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 25293206); by grants for the Research Committee on degenerative ataxia from the Ministry of Health and Welfare of Japan; by the Research Committee on insomnia in Parkinson's disease from the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications; and by a grant from the Uehara Memorial Foundation.	Matsumoto L, 2010, BRAIN STIMUL, V3, P153, DOI 10.1016/j.brs.2009.09.001; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; FRASER CL, 1988, ANN INTERN MED, V109, P143; Matsumoto H, 2009, J NEUROL SCI, V284, P46, DOI 10.1016/j.jns.2009.04.003; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; UGAWA Y, 1989, J NEUROL NEUROSUR PS, V52, P1025, DOI 10.1136/jnnp.52.9.1025; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; Guerrini R, 2001, BRAIN, V124, P2459, DOI 10.1093/brain/124.12.2459; Burn DJ, 1998, J NEUROL NEUROSUR PS, V65, P810, DOI 10.1136/jnnp.65.6.810; UGAWA Y, 1989, J NEUROL NEUROSUR PS, V52, P89, DOI 10.1136/jnnp.52.1.89; Tilki HE, 2009, J ELECTROMYOGR KINES, V19, P500, DOI 10.1016/j.jelekin.2007.10.011; Battaglia F, 2005, CLIN NEUROPHYSIOL, V116, P1507, DOI 10.1016/j.clinph.2005.02.016; BOLTON CF, 1980, CAN J NEUROL SCI, V7, P89; GEISSLER A, 1995, RADIOLOGY, V194, P693; Hanajima R, 2007, CLIN NEUROPHYSIOL, V118, P2120, DOI 10.1016/j.clinph.2007.05.067; Inghilleri M, 1998, ELECTROMYOGR MOTOR C, V109, P70, DOI 10.1016/S0924-980X(97)00062-3; Inoue M, 2012, CLIN NEUROPHYSIOL, V123, P1858, DOI 10.1016/j.clinph.2012.01.021; JACOB JC, 1965, NEUROLOGY, V15, P419; Janda Katarzyna, 2007, Przegl Lek, V64, P423; Jovanovic DB, 2009, PERITON DIALYSIS INT, V29, P102; Kalita J, 2004, Electromyogr Clin Neurophysiol, V44, P7; Kanai H, 2001, AM J KIDNEY DIS, V38, pS129, DOI 10.1053/ajkd.2001.27421; KENNEDY AC, 1963, LANCET, V1, P408; LAVY S, 1969, ELECTROEN CLIN NEURO, V27, P217; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P293, DOI 10.1016/j.neucli.2006.12.008; LEWIS EG, 1978, ELECTROEN CLIN NEURO, V44, P223, DOI 10.1016/0013-4694(78)90268-7; LOCKWOOD AH, 1989, NEUROL CLIN, V7, P617; Lu CS, 1998, MOVEMENT DISORD, V13, P140, DOI 10.1002/mds.870130126; Matsumoto H, 2010, CLIN NEUROPHYSIOL, V121, P1930, DOI 10.1016/j.clinph.2010.04.014; Matsumoto H, 2009, CLIN NEUROPHYSIOL, V120, P770, DOI 10.1016/j.clinph.2009.01.004; Matsumoto H, 2012, MUSCLE NERVE, V46, P932, DOI 10.1002/mus.23430; Matsumoto H, 2012, CLIN NEUROPHYSIOL, V123, P1695, DOI 10.1016/j.clinph.2012.02.063; Matsumoto H, 2013, BRAIN STIMUL, V6, P538, DOI 10.1016/j.brs.2012.09.008; Matsumoto H, 2010, CLIN NEUROL NEUROSUR, V112, P131, DOI 10.1016/j.clineuro.2009.11.005; Matsunaga K, 2000, CLIN NEUROPHYSIOL, V111, P471, DOI 10.1016/S1388-2457(99)00277-1; Ugawa Y, 2003, CLIN NEUROPHYSIOL, V114, P1278, DOI 10.1016/S1388-2457(03)00126-3; UGAWA Y, 1990, J NEUROL NEUROSUR PS, V53, P260, DOI 10.1136/jnnp.53.3.260; YU YL, 1991, ACTA NEUROL SCAND, V83, P89	40	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					113	119		10.1007/s12576-014-0347-2		7	Physiology	Physiology	AX4ND	WOS:000346908200011		
J	Suwa, M; Nakano, H; Radak, Z; Kumagai, S				Suwa, Masataka; Nakano, Hiroshi; Radak, Zsolt; Kumagai, Shuzo			A comparison of chronic AICAR treatment-induced metabolic adaptations in red and white muscles of rats	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						AMP-activated protein kinase; Mitochondrial biogenesis; Nicotinamide phosphoribosyltransferase; SIRT1; Skeletal muscle	ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; HUMAN SKELETAL-MUSCLE; GAMMA-SUBUNIT ISOFORMS; AMPK ACTIVATION; INSULIN-RESISTANCE; GLUCOSE-UPTAKE; MITOCHONDRIAL BIOGENESIS; ENZYME-ACTIVITIES; ADIPOSE-TISSUE	The signaling molecule 5'-AMP-activated protein kinase plays a pivotal role in metabolic adaptations. Treatment with 5-aminoimidazole-4-carboxamide-1-beta-d-ribofranoside (AICAR) promotes the expression of metabolic regulators and components involved in glucose uptake, mitochondrial biogenesis, and fatty acid oxidation in skeletal muscle cells. Our aim was to determine whether AICAR-induced changes in metabolic regulators and components were more prominent in white or red muscle. Rats were treated with AICAR (1 mg/g body weight/day) for 14 days, resulting in increased expression levels of nicotinamide phosphoribosyltransferase (NAMPT), peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), glucose transporter 4 proteins, and enhanced mitochondrial biogenesis. These changes were more prominent in white rather than red gastrocnemius muscle or were only observed in the white gastrocnemius. Our results suggest that AICAR induces the expression of metabolic regulators and components, especially in type II (B) fibers.	[Suwa, Masataka] Tohoku Inst Technol, Fac Life Design, Taihaku Ku, Sendai, Miyagi 9828588, Japan; [Nakano, Hiroshi] Nakamura Gakuen Univ, Fac Educ, Jonan Ku, Fukuoka 8140198, Japan; [Radak, Zsolt] Semmelweis Univ, Inst Sport Sci, Fac Phys Educ & Sport Sci, H-1085 Budapest, Hungary; [Kumagai, Shuzo] Kyushu Univ, Fac Arts & Sci, Kasuga, Fukuoka 8168580, Japan; [Kumagai, Shuzo] Kyushu Univ, Grad Sch Human Environm Studies, Kasuga, Fukuoka 8168580, Japan	Suwa, M (reprint author), Tohoku Inst Technol, Fac Life Design, Taihaku Ku, 6 Futatsusawa, Sendai, Miyagi 9828588, Japan.	suwa-m@tohtech.ac.jp		Suwa, Masataka/0000-0002-1169-5448	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20700524]	This work was supported by a Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 20700524) to MS.	Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009; Nilsson EC, 2006, J BIOL CHEM, V281, P7244, DOI 10.1074/jbc.M510461200; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180; Lihn A, 2004, BIOCHEM BIOPH RES CO, V316, P853, DOI 10.1016/j.bbrc.2004.02.139; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Delp MD, 1996, J APPL PHYSIOL, V80, P261; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Rivero JLL, 1999, HISTOCHEM CELL BIOL, V111, P277, DOI 10.1007/s004180050358; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Winder WW, 2000, J APPL PHYSIOL, V88, P2219; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; CHI MMY, 1983, AM J PHYSIOL, V244, pC276; Ljubicic V, 2012, AM J PHYSIOL-CELL PH, V302, pC110, DOI 10.1152/ajpcell.00183.2011; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Longnus SL, 2003, AM J PHYSIOL-REG I, V284, pR936, DOI 10.1152/ajpregu.00319.2002; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Woods A, 1996, J BIOL CHEM, V271, P10282; Lihn AS, 2008, MOL CELL ENDOCRINOL, V292, P36, DOI 10.1016/j.mce.2008.06.004; Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Brandauer J, 2013, J PHYSIOL-LONDON, V591, P5207, DOI 10.1113/jphysiol.2013.259515; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; GALLER S, 1994, J PHYSIOL-LONDON, V478, P513; Guerra B, 2010, EUR J APPL PHYSIOL, V109, P731, DOI 10.1007/s00421-010-1413-y; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Kitaoka Y, 2014, J PHYSIOL SCI, V64, P59, DOI 10.1007/s12576-013-0290-7; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; Park S, 2014, BRAIN RES BULL, V108, P18, DOI 10.1016/j.brainresbull.2014.08.002; Pereira Sant'Ana JA, 1997, PFLUGERS ARCH, V435, P151; Putman CT, 2003, J PHYSIOL-LONDON, V551, P169, DOI 10.1113/jphysiol.2003.04069; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stoppani J, 2002, AM J PHYSIOL-ENDOC M, V283, pE1239, DOI 10.1152/ajpendo.00278.2002; Suwa M, 2013, BASIC BIOL CURRENT U; Suwa M, 2003, J APPL PHYSIOL, V94, P185, DOI 10.1152/japplphysiol.00295.2002; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Suwa M, 2011, METABOLISM, V60, P394, DOI 10.1016/j.metabol.2010.03.003; Suwa Masataka, 2013, Curr Aging Sci, V6, P178; TAKEKURA H, 1989, JPN J PHYSIOL, V39, P385, DOI 10.2170/jjphysiol.39.385; TAKEKURA H, 1990, J MUSCLE RES CELL M, V11, P105, DOI 10.1007/BF01766489; Winder WW, 2001, J APPL PHYSIOL, V91, P1017; Zhang ZF, 2009, FEBS LETT, V583, P470, DOI 10.1016/j.febslet.2008.12.053	67	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					121	130		10.1007/s12576-014-0349-0		10	Physiology	Physiology	AX4ND	WOS:000346908200012		
J	Yasuda, T; Loenneke, JP; Thiebaud, RS; Abe, T				Yasuda, Tomohiro; Loenneke, Jeremy P.; Thiebaud, Robert S.; Abe, Takashi			Effects of detraining after blood flow-restricted low-intensity concentric or eccentric training on muscle size and strength	JOURNAL OF PHYSIOLOGICAL SCIENCES			English	Article						Cessation; Vascular occlusion; Muscle hypertrophy; Strength gain	CROSS-SECTIONAL AREA; NEURAL ACTIVATION; OLDER-ADULTS; WOMEN; MEN	We investigated the effects of 6 weeks of detraining on muscle size and strength in young men who had previously participated in 6 weeks (3 days/week) of 30 % of concentric one-repetition maximal (1-RM) dumbbell curl training [one arm: concentric blood flow restricted (BFR) exercise (CON-BFR); the other arm: eccentric BFR exercise (ECC-BFR)]. MRI-measured muscle cross-sectional area (CSA) at 10 cm above the elbow joint increased from pre to post (p < 0.01), and the muscle CSA following detraining remained greater than pre (p < 0.01) but was similar to that observed at post. Maximal voluntary contraction (MVC) increased from pre to post (p < 0.05), and the MVC following detraining remained greater than pre (p < 0.05) but was similar to that observed at post. The ECC-BFR did not produce any changes across time. Increased muscle strength following 6 weeks of CON-BFR was well preserved at 6 weeks of detraining, which may be primarily related to muscle hypertrophy.	[Yasuda, Tomohiro] Univ Tokyo, Dept Ischem Circulatory Physiol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Loenneke, Jeremy P.; Abe, Takashi] Univ Mississippi, Kevser Ermin Appl Physiol Lab, Dept Hlth Exercise Sci & Recreat Management, University, MS 38677 USA; [Thiebaud, Robert S.] Texas Wesleyan Univ, Dept Kinesiol, Ft Worth, TX USA	Yasuda, T (reprint author), Univ Tokyo, Dept Ischem Circulatory Physiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasuda-tomohiro@umin.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology [23700713, 25750288]	The authors thank the students who participated in this study. We also thank Toshiaki Nakajima, MD, PhD, the University of Tokyo School of Medicine, for helpful discussion and technical support. This study was supported in part by grants-in-aid (#23700713 and #25750288 to TY) from the Japan Ministry of Education, Culture, Sports, Science and Technology.	Abe T, 2005, INT J KAATSU TRAININ, V1, P6, DOI 10.3806/ijktr.1.6; American College of Sports Medicine, 2009, MED SCI SPORTS EXERC, V41, P687, DOI DOI 10.1249/MSS.0B013E3181915670; Tokmakidis SP, 2009, CLIN PHYSIOL FUNCT I, V29, P316, DOI 10.1111/j.1475-097X.2009.00866.x; Fatouros IG, 2005, BRIT J SPORT MED, V39, P776, DOI 10.1136/bjsm.2005.019117; Yasuda T, 2009, J SPORT SCI, V27, P479, DOI 10.1080/02640410802626567; Farthing JP, 2003, EUR J APPL PHYSIOL, V89, P578, DOI 10.1007/s00421-003-0842-2; Loenneke JP, 2012, EUR J APPL PHYSIOL, V112, P1849, DOI 10.1007/s00421-011-2167-x; Lee M, 2007, SPORTS MED, V37, P1, DOI 10.2165/00007256-200737010-00001; HATHER BM, 1991, ACTA PHYSIOL SCAND, V143, P177, DOI 10.1111/j.1748-1716.1991.tb09219.x; Higbie EJ, 1996, J APPL PHYSIOL, V81, P2173; Hakkinen K, 2000, EUR J APPL PHYSIOL, V83, P51, DOI 10.1007/s004210000248; Lovell DI, 2010, EUR J APPL PHYSIOL, V109, P429, DOI 10.1007/s00421-010-1375-0; Abe T, 2000, EUR J APPL PHYSIOL O, V81, P174, DOI 10.1007/s004210050027; Bemben DA, 2000, MED SCI SPORT EXER, V32, P1949, DOI 10.1097/00005768-200011000-00020; Cohen J, 1988, STAT POWER ANAL BEHA, P19; HOUSTON ME, 1983, EUR J APPL PHYSIOL O, V51, P25, DOI 10.1007/BF00952534; NARICI MV, 1989, EUR J APPL PHYSIOL O, V59, P310, DOI 10.1007/BF02388334; Thiebaud Robert S, 2013, Interv Med Appl Sci, V5, P53, DOI 10.1556/IMAS.5.2013.2.1; Yasuda T, 2012, PLOS ONE, V12; Yasuda T, 2014, SCAND J MED SCI SPOR, V24, P799, DOI 10.1111/sms.12087; Yasuda T, 2014, AGING CLIN EXP RES, V26, P561, DOI 10.1007/s40520-014-0208-0	21	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1880-6546	1880-6562		J PHYSIOL SCI	J. Physiol. Sci.	JAN	2015	65	1					139	144		10.1007/s12576-014-0345-4		6	Physiology	Physiology	AX4ND	WOS:000346908200014		
J	Kamal, AHM; Rashid, H; Sakata, K; Komatsu, S				Kamal, Abu Hena Mostafa; Rashid, Hamid; Sakata, Katsumi; Komatsu, Setsuko			Gel-free quantitative proteomic approach to identify cotyledon proteins in soybean under flooding stress	JOURNAL OF PROTEOMICS			English	Article						Soybean; Flooding stress; Gel-free proteomics; Cotyledon	SEED STORAGE PROTEINS; INITIATION-FACTOR 5A; GENE-EXPRESSION; ASCORBATE PEROXIDASE; MASS-SPECTROMETRY; IDENTIFICATION; SUPERFAMILY; TOLERANCE; SEEDLINGS; PLANTS	Flooding stress causes growth inhibition and ultimately death in most crop species by limiting of energy production. To better understand plant responses to flooding stress, here, flooding-responsive proteins in the cotyledons of soybean were identified using a gel-free quantitative proteomic approach. One hundred forty six proteins were commonly observed in both control and flooding-stressed plants, and 19 were identified under only flooding stress conditions. The main functional categories were protein and development-related proteins. Protein protein interaction analysis revealed that zincin-like metalloprotease and cupin family proteins were found to highly interact with other proteins under flooding stress. Plant stearoyl acyl-carrier protein, ascorbate peroxidase 1, and secretion-associated RAS superfamily 2 were down-regulated, whereas ferretin 1 was up-regulated at the transcription level. Notably, the levels of all corresponding proteins were decreased, indicating that mRNA translation to proteins is impaired under flooding conditions. Decreased levels of ferritin may lead to a strong deregulation of the expression of several metal transporter genes and over-accumulation of iron, which led to increased levels of reactive oxygen species, resulting to detoxification of these reactive species. Taken together, these results suggest that ferritin might have an essential role in protecting plant cells against oxidative damage under flooding conditions. Biological significance This study reported the comparative proteomic analysis of cotyledon of soybean plants between non-flooding and flooding conditions using the gel-free quantitative techniques. Mass spectrometry analysis of the proteins from cotyledon resulted in the identification of a total of 165 proteins under flooding stress. These proteins were assigned to different functional categories, such as protein, development, stress, redox, and glycolysis. Therefore, this study provides not only the comparative proteomic analysis but also the molecular mechanism underlying the flooding responsive protein functions in the cotyledon. (C) 2014 Elsevier B.V. All rights reserved.	[Kamal, Abu Hena Mostafa; Komatsu, Setsuko] NARO, Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Rashid, Hamid] Mohammad All Jinnah Univ, Islamabad, Pakistan; [Sakata, Katsumi] Maebashi Inst Technol, Maebashi, Gumma 3710816, Japan	Komatsu, S (reprint author), Natl Agr & Food Res Org, Natl Inst Crop Sci, Kannondai 2-1-18, Tsukuba, Ibaraki 3058518, Japan.	skomatsu@affrc.go.jp			Japan Society for the Promotion of Science (JSPS) [25.03515]	The authors thank Dr. Yohei Nanjo and Dr. Keito Nishizawa at the National Institute of Crop Science for useful discussions. This study was supported by a KAKENHI grant (no. 25.03515) from the Japan Society for the Promotion of Science (JSPS).	Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Ishibashi Y, 2013, ANN BOT-LONDON, V111, P95, DOI 10.1093/aob/mcs240; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Gomez-Gomez L, 1998, PLANT PHYSIOL, V117, P397, DOI 10.1104/pp.117.2.397; Khuri S, 2001, MOL BIOL EVOL, V18, P593; Wang HG, 2007, J INTEGR PLANT BIOL, V49, P1455, DOI 10.1111/j.1672-9072.2007.00553.x; Komatsu S, 2011, PLANT MOL BIOL, V77, P309, DOI 10.1007/s11103-011-9812-y; Komatsu S, 2013, J PROTEOME RES, V12, P4769, DOI 10.1021/pr4001898; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Lenssen JPM, 2004, J VEG SCI, V15, P305, DOI 10.1658/1100-9233(2004)015[0305:DDFWCM]2.0.CO;2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Nanjo Y, 2011, PLANT MOL BIOL, V77, P129, DOI 10.1007/s11103-011-9799-4; America AHP, 2008, PROTEOMICS, V8, P731, DOI 10.1002/pmic.200700694; Han C, 2014, J PROTEOME RES, V13, P1766, DOI 10.1021/pr401295c; GIDROL X, 1994, EUR J BIOCHEM, V224, P21, DOI 10.1111/j.1432-1033.1994.tb19990.x; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Komatsu S, 2010, AMINO ACIDS, V39, P1435, DOI 10.1007/s00726-010-0608-1; Teixeira FK, 2006, PLANTA, V224, P300, DOI 10.1007/s00425-005-0214-8; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Macara IG, 1996, FASEB J, V10, P625; Baumlein H, 1995, J MOL EVOL, V41, P1070; Tanaka N, 2005, MOL CELL PROTEOMICS, V4, P796, DOI 10.1074/mcp.M400211-MCP200; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; Torres-Franklin ML, 2009, ENVIRON EXP BOT, V65, P162, DOI 10.1016/j.envexpbot.2008.12.010; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Yan SP, 2005, PROTEOMICS, V5, P235, DOI [10.1002/pmic.200400853, 10.1002/pmic.200500140]; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Rodrigues SP, 2012, J PROTEOMICS, V75, P3191, DOI 10.1016/j.jprot.2012.03.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Sairam RK, 2009, J PLANT PHYSIOL, V166, P602, DOI 10.1016/j.jplph.2008.09.005; Voesenek LACJ, 2004, ECOLOGY, V85, P16, DOI 10.1890/02-740; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; ARSHAD M, 1990, BIOL FERT SOILS, V10, P29; Boru G, 2003, EUPHYTICA, V132, P151, DOI 10.1023/A:1024622405505; Bouny JM, 1996, PLANT PHYSIOL, V111, P187; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555; Cha JY, 2012, PLANT PHYSIOL BIOCH, V58, P29, DOI 10.1016/j.plaphy.2012.06.006; Chelius D, 2003, ANAL CHEM, V75, P6658, DOI 10.1021/ac034607k; Gibberd MR, 2001, ANN BOT-LONDON, V88, P579, DOI 10.1006/anbo.2001.1506; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Jackson M.B., 2004, IMPACT FLOODING STRE; Jackson MB, 2003, ECOL STU AN, V168, P193; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Kato-Noguchi H, 2007, J PLANT PHYSIOL, V164, P168, DOI 10.1016/j.jplph.2005.09.017; Katz E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-68; Komatsu S, 2012, J PROTEOME RES, V11, P68, DOI 10.1021/pr2008863; Komatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065301; Komatsui S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00071; Lal SK, 1998, PLANT PHYSIOL, V118, P1285, DOI 10.1104/pp.118.4.1285; Lebska M, 2010, J BIOL CHEM, V285, P6217, DOI 10.1074/jbc.M109.018770; Macedo IQ, 1999, BIOTECHNOL TECH, V13, P677, DOI 10.1023/A:1008933016748; Morimura Y, 1999, PLANT SCI, V142, P123, DOI 10.1016/S0168-9452(99)00013-8; Nishizawa K, 2013, BIOSCI BIOTECH BIOCH, V77, P2205, DOI 10.1271/bbb.130384; Noordermeer MA, FATTY ACID HYDROPERO; Pavelic D, 2000, PLANT PHYSIOL, V124, P1285, DOI 10.1104/pp.124.3.1285; RAGLAND M, 1990, J BIOL CHEM, V265, P18339; Ramos OHP, 2001, GENET MOL BIOL, V24, P285, DOI 10.1590/S1415-47572001000100037; Rees T, 1987, PLANT LIFE AQUATIC A, P227; Ricard B, 1998, PLANT PHYSIOL, V116, P1323, DOI 10.1104/pp.116.4.1323; SPRINGER B, 1986, MOL GEN GENET, V205, P461, DOI 10.1007/BF00338083; Suri SS, 2008, PLANT CELL ENVIRON, V31, P218, DOI 10.1111/j.1365-3040.2007.01754.x; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Voit E. O., 2000, COMPUTATIONAL ANAL B; Whittle E, 2005, J BIOL CHEM, V280, P28169, DOI 10.1074/jbc.M504205200; WILSON KA, 1986, PLANT PHYSIOL, V82, P71, DOI 10.1104/pp.82.1.71; Xu YF, 2010, J PLANT PHYSIOL, V167, P512, DOI 10.1016/j.jplph.2009.10.010	72	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3919	1876-7737		J PROTEOMICS	J. Proteomics	JAN 1	2015	112						1	13		10.1016/j.jprot.2014.08.014		13	Biochemical Research Methods	Biochemistry & Molecular Biology	AX6GM	WOS:000347021100001		
J	Ben-Ezra, M; Shigemura, J; Palgi, Y; Hamama-Raz, Y; Lavenda, O; Suzuki, M; Goodwin, R				Ben-Ezra, Menachem; Shigemura, Jun; Palgi, Yuval; Hamama-Raz, Yaira; Lavenda, Osnat; Suzuki, Miki; Goodwin, Robin			From Hiroshima to Fukushima: PTSD symptoms and radiation stigma across regions in Japan	JOURNAL OF PSYCHIATRIC RESEARCH			English	Letter									[Ben-Ezra, Menachem; Hamama-Raz, Yaira; Lavenda, Osnat] Ariel Univ, Sch Social Work, Ariel, Israel; [Shigemura, Jun] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan; [Palgi, Yuval] Univ Haifa, Dept Gerontol, Fac Social Welf & Hlth Sci, IL-31999 Haifa, Israel; [Suzuki, Miki; Goodwin, Robin] Brunel Univ, Coll Hlth & Life Sci, Uxbridge UB8 3PH, Middx, England	Ben-Ezra, M (reprint author), Ariel Univ, Sch Social Work, Ariel, Israel.	menbe@ariel.ac.il		Shigemura, Jun/0000-0002-7907-5034			Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Raguram R, 1996, AM J PSYCHIAT, V153, P1043; Ben-Ezra M, 2012, WORLD PSYCHIATRY, V11, P133; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Tone M, 2014, NURS HEALTH SCI, V16, P52, DOI 10.1111/nhs.12117	5	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JAN	2015	60						185	186		10.1016/j.jpsychires.2014.10.006		2	Psychiatry	Psychiatry	AY0DR	WOS:000347268500024		
J	Ito, Y; Tochio, T; Fukushima, S; Taborda, A; Sampaio, JM; Marques, JP; Parente, F; Indelicato, P; Santos, JP				Ito, Y.; Tochio, T.; Fukushima, S.; Taborda, A.; Sampaio, J. M.; Marques, J. P.; Parente, F.; Indelicato, P.; Santos, J. P.			Experimental and theoretical determination of the K alpha(2)/K alpha(1) intensity ratio for zinc	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article							DIRAC-FOCK CALCULATIONS; ELECTRON SELF-ENERGY; RAY-EMISSION SPECTRA; STRONG COULOMB FIELD; TRANSITION-PROBABILITIES; K-SHELL; QED CORRECTIONS; HEAVY-ELEMENTS; DECAY-RATES; IONS	X-ray intensity ratios, such as the K alpha(2)/K alpha(1) ratio, are parameters with a large application in atomic physics and related scientific and technological areas. Despite the measurements carried out for several elements since 1969, available data are scarce for some elements. In this work, we present experimental and theoretical values for the intensity ratio K alpha(2)/K alpha(1) that were obtained within a collaboration between an experimental and a theoretical group. The value of K alpha(2)/K alpha(1) for zinc was measured using a double-crystal spectrometer. Calculations were performed within the Multiconfiguration Dirac Fock method, including relativistic and QED corrections. Results show a very good agreement between the experiment and theory (1.2%). (C) 2014 Elsevier Ltd. All rights reserved.	[Ito, Y.] Kyoto Univ, Inst Chem Res, Lab Atom & Mol Phys, Uji, Kyoto 6110011, Japan; [Tochio, T.] Kobe Univ, Dept Phys, Nada Ku, Kobe 657850, Japan; [Fukushima, S.] NIMS, ASCA, Tsukuba, Ibaraki 3050047, Japan; [Taborda, A.; Sampaio, J. M.; Marques, J. P.] Univ Lisbon, FCUL, Fac Ciencias, Dept Fis,Ctr Fis Atom, P-1749016 Lisbon, Portugal; [Parente, F.; Santos, J. P.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Fis, Ctr Fis Atom, P-2829516 Caparica, Portugal; [Indelicato, P.] Univ Paris 06, CNRS, Ecole Normale Super, Lab Kastler Brossel, F-75252 Paris 05, France	Santos, JP (reprint author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Fis, Ctr Fis Atom, P-2829516 Caparica, Portugal.	jps@fct.unl.pt	Sampaio, Jorge/M-4750-2013; Santos, Jose Paulo/F-4186-2010; Indelicato, Paul/D-7636-2011; Marques, Jose/A-4152-2014	Sampaio, Jorge/0000-0003-4359-493X; Santos, Jose Paulo/0000-0002-5890-0971; Indelicato, Paul/0000-0003-4668-8958; Marques, Jose/0000-0002-3797-3880	FCT - Fundacao para a Ciencia e a Tecnologia (Portugal) - European Community Fund FEDER through the COMPETE Competitiveness Factors Operational Programme [PEstOE/FIS/UI0303/2011, PTDC/FIS/117606/2010]; Allianz Program of the Helmholtz Association [EMMI HA-216]	This research was supported in part by FCT - Fundacao para a Ciencia e a Tecnologia (Portugal), through the Projects no. PEstOE/FIS/UI0303/2011 and PTDC/FIS/117606/2010, financed by the European Community Fund FEDER through the COMPETE Competitiveness Factors Operational Programme. Laboratoire Kastler Brossel (LKB) is "Unite Mixte de Recherche du CNRS, de l'ENS et de l'UPMC no 8552". We also thank the Allianz Program of the Helmholtz Association, Contract no EMMI HA-216 "Extremes of Density and Temperature: Cosmic Matter in the Laboratory".	Angeli I, 2004, ATOM DATA NUCL DATA, V87, P185, DOI 10.1016/j.adt.2004.04.002; BEARDEN JA, 1967, REV MOD PHYS, V39, P78, DOI 10.1103/RevModPhys.39.78; Audi G, 2003, NUCL PHYS A, V729, P337, DOI 10.1016/j.nuclphysa.2003.11.003; SCOFIELD JH, 1974, PHYS REV A, V9, P1041, DOI 10.1103/PhysRevA.9.1041; MOHR PJ, 1992, PHYS REV A, V46, P4421, DOI 10.1103/PhysRevA.46.4421; LOWDIN PO, 1955, PHYS REV, V97, P1474, DOI 10.1103/PhysRev.97.1474; MOHR PJ, 1993, PHYS REV LETT, V70, P158, DOI 10.1103/PhysRevLett.70.158; INDELICATO P, 1990, PHYS REV A, V42, P5139, DOI 10.1103/PhysRevA.42.5139; INDELICATO P, 1992, PHYS REV A, V46, P172, DOI 10.1103/PhysRevA.46.172; Santos JP, 1999, J PHYS B-AT MOL OPT, V32, P2089, DOI 10.1088/0953-4075/32/9/304; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329; Guimaraes D, 2012, J TRACE ELEM MED BIO, V26, P285, DOI 10.1016/j.jtemb.2012.02.006; Apaydin G, 2008, RADIAT PHYS CHEM, V77, P923, DOI 10.1016/j.radphyschem.2008.03.007; Baskaran R, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1891371; DEPINHO AG, 1971, PHYS REV A, V3, P905, DOI 10.1103/PhysRevA.3.905; DESCLAUX JP, 1975, COMPUT PHYS COMMUN, V9, P31, DOI 10.1016/0010-4655(75)90054-5; DEUTSCH M, 1995, PHYS REV A, V51, P283, DOI 10.1103/PhysRevA.51.283; Ebert PJ, 1969, PHYS REV, P188; Grant IP, 1988, ADV ATOM MOL PHYS, V23, P37, DOI 10.1016/S0065-2199(08)60105-0; HANSEN JS, 1970, NUCL PHYS A, VA142, P604, DOI 10.1016/0375-9474(70)90816-X; Hibbert A, 2003, J PHYS B-AT MOL OPT, V36, P4703, DOI 10.1088/0953-4075/36/23/008; INDELICATO P, 1987, J PHYS B-AT MOL OPT, V20, P651, DOI 10.1088/0022-3700/20/4/007; Indelicato P, 1998, HYPERFINE INTERACT, V114, P147, DOI 10.1023/A:1012622505367; INDELICATO P, 1995, PHYS REV A, V51, P1132, DOI 10.1103/PhysRevA.51.1132; INDELICATO P, 1992, PHYS REV A, V46, P2426, DOI 10.1103/PhysRevA.46.2426; Indelicato P, 1998, EUR PHYS J D, V3, P29, DOI 10.1007/s100530050146; Ito Y, 2006, RADIAT PHYS CHEM, V75, P1534, DOI 10.1016/j.radphyschem.2005.10.023; KASAGI J, 1986, PHYS REV A, V34, P2480, DOI 10.1103/PhysRevA.34.2480; Le Bigot EO, 2001, PHYS REV A, V64; Martins MC, 2006, EUR PHYS J D, V39, P167, DOI 10.1140/epjd/e2006-00101-8; MARTINS MC, 1989, J PHYS B-AT MOL OPT, V22, P3167, DOI 10.1088/0953-4075/22/20/009; Martins MC, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.032501; MCCRARY JH, 1971, PHYS REV A, V4, P1745, DOI 10.1103/PhysRevA.4.1745; MOHR PJ, 1992, PHYS REV A, V45, P2727, DOI 10.1103/PhysRevA.45.2727; MUKOYAMA T, 1987, PHYS REV A, V36, P693, DOI 10.1103/PhysRevA.36.693; NELSON GC, 1969, PHYS REV, V188, P108, DOI 10.1103/PhysRev.188.108; Pe-LeveSantos SC, 2014, J SOIL SEDIMENT, V14, P778, DOI [DOI 10.1007/S11368-013-0788-X, 10.1007/s11368-013-0788-x]; ROSNER HR, 1970, Z PHYS, V231, P347, DOI 10.1007/BF01397516; Salem S. I., 1974, Atomic Data and Nuclear Data Tables, V14, DOI 10.1016/S0092-640X(74)80017-3; SALEM SI, 1970, PHYS REV A, V2, P1121, DOI 10.1103/PhysRevA.2.1121; Santos JP, 2006, EUR PHYS J D, V37, P201, DOI 10.1140/epjd/e2006-00002-x; Scofield J. H., 1974, Atomic Data and Nuclear Data Tables, V14, DOI 10.1016/S0092-640X(74)80019-7; Shigemi A, 1999, X-RAY SPECTROM, V28, P478, DOI 10.1002/(SICI)1097-4539(199911/12)28:6<478::AID-XRS382>3.3.CO;2-X; Tochio T., 2002, Physical Review A (Atomic, Molecular, and Optical Physics), V65, DOI 10.1103/PhysRevA.65.042502	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	JAN	2015	151						295	299		10.1016/j.jqsrt.2014.10.013		5	Optics; Spectroscopy	Optics; Spectroscopy	AY0BM	WOS:000347263000031		
J	Matsufuji, S; Shoji, T; Yano, Y; Tsujimoto, Y; Kishimoto, H; Tabata, T; Emoto, M; Inaba, M				Matsufuji, Shota; Shoji, Tetsuo; Yano, Yoshiaki; Tsujimoto, Yoshihiro; Kishimoto, Hiroshi; Tabata, Tsutomu; Emoto, Masanori; Inaba, Masaaki			Effect of Chair Stand Exercise on Activity of Daily Living: A Randomized Controlled Trial in Hemodialysis Patients	JOURNAL OF RENAL NUTRITION			English	Article							MUSCLE STRENGTH; RESISTANCE EXERCISE; PHYSICAL-ACTIVITY; QUALITY; DISEASE; ATROPHY; HEALTH; AGE	Objective: Muscle atrophy and weakness impair activity of daily living (ADL). We examined whether chair stand exercise can improve ADL of hemodialysis patients. Design: A randomized controlled trial. Setting and Participants: A single center study. Subjects: Outpatients on hemodialysis older than 60 years (61-79 years). Intervention: Twelve weeks of intervention with chair stand exercise, 3 sessions/week versus the control exercise (stretch, 1 session/week). Main Outcome Measure: The primary outcome was the change in functional independence measure (FIM) score from baseline. The secondary outcomes were changes in thigh circumference, muscle strength of quadriceps, 6-minute walking distance, maximum duration of chair stand exercise, health-related quality of life, cognitive function serum albumin, and hemoglobin. Results: Among the 27 patients who were randomized, 17 completed the study. The change in FIM from baseline was greater in the intervention group (1 [1-3] vs. 0 [0-0], median (minimum to maximum), P < .001) due to the significant improvement in the FIM subscales related to mobility (bed/chair/wheel chair) and locomotion (stair). Among the secondary outcomes, significant difference was noticed in the changes in thigh circumference and the physical component summary score of health-related quality of life by Medical Outcome Study 36-Item Short-Form Health Survey (SF-36v2). Conclusions: Chair stand exercise improved ADL in the hemodialysis patients aged older than 60 years. (C) 2015 by the National Kidney Foundation, Inc. All rights reserved.	[Matsufuji, Shota; Yano, Yoshiaki] Inoue Hosp, Div Rehabil, Suita, Osaka, Japan; [Shoji, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka 558, Japan; [Tsujimoto, Yoshihiro; Kishimoto, Hiroshi; Tabata, Tsutomu] Inoue Hosp, Div Internal Med, Suita, Osaka, Japan; [Emoto, Masanori; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan	Shoji, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Geriatr & Vasc Med, Osaka 558, Japan.	t-shoji@med.osaka-cu.ac.jp					ANDERSON ALBERT D., 1964, ARCH PHYS MED AND REHABIT, V45, P140; Headley S, 2002, AM J KIDNEY DIS, V40, P355, DOI 10.1053/ajkd.2002.34520; Painter P, 2000, AM J KIDNEY DIS, V35, P482, DOI 10.1016/S0272-6386(00)70202-2; Kopple JD, 2007, J AM SOC NEPHROL, V18, P2975, DOI 10.1681/ASN.2006070794; Kouidi E, 1998, NEPHROL DIAL TRANSPL, V13, P685, DOI 10.1093/ndt/13.3.685; Painter P, 2000, AM J KIDNEY DIS, V36, P600, DOI 10.1053/ajkd.2000.16200; Johansen KL, 2006, J AM SOC NEPHROL, V17, P2307, DOI 10.1681/ASN.2006010034; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/S0021-9290(96)80001-7; Suzukamo Y, 2011, J CLIN EPIDEMIOL, V64, P301, DOI 10.1016/j.jclinepi.2010.04.017; Tentori F, 2010, NEPHROL DIAL TRANSPL, V25, P3050, DOI 10.1093/ndt/gfq138; Johansen KL, 2003, KIDNEY INT, V63, P291, DOI 10.1046/j.1523-1755.2003.00704.x; Fahal IH, 1997, NEPHROL DIAL TRANSPL, V12, P119, DOI 10.1093/ndt/12.1.119; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; FISHER NM, 1990, ARCH PHYS MED REHAB, V71, P729; Segura-Orti E, 2009, CLIN NEPHROL, V71, P527; Johansen KL, 2000, KIDNEY INT, V57, P2564, DOI 10.1046/j.1523-1755.2000.00116.x; Yamashita F, 2012, J MUSCULOSKEL NEURON, V12, P74; Cheema B, 2007, AM J KIDNEY DIS, V50, P574, DOI 10.1053/j.ajkd.2007.07.005; Dohi Y., 1976, MED TOKYO, V13, P1068; ERA P, 1992, EUR J APPL PHYSIOL O, V64, P84, DOI 10.1007/BF00376446; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209; Humphries B, 1999, J Sci Med Sport, V2, P364, DOI 10.1016/S1440-2440(99)80009-7; Nishimoto K, 1999, RIGAKURYOHO KAGAKU, V14, P181, DOI 10.1589/rika.14.181; Ohara S, 2013, J OSAKA SOC DIAL THE, V31, P163; Pallicino P, 1992, Stroke, V23, P919; SONN U, 1995, SCAND J REHABIL MED, V27, P119	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1051-2276	1532-8503		J RENAL NUTR	J. Renal Nutr.	JAN	2015	25	1					17	24		10.1053/j.jrn.2014.06.010		8	Nutrition & Dietetics; Urology & Nephrology	Nutrition & Dietetics; Urology & Nephrology	AX4ON	WOS:000346911700005		
J	Kondo, A; Maeda, K				Kondo, Atsushi; Maeda, Kazuyuki			Anisotropic thermal expansion of a 3D metal-organic framework with hydrophilic and hydrophobic pores	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Anisotropic thermal expansion; Negative thermal expansion; Metal-organic framework; Inclusion	X-RAY-DIFFRACTION; COORDINATION FRAMEWORK; GAS-ADSORPTION; ZEOLITES; NETWORK; TOPOLOGY; FLEXIBILITY; POLYMERS; ALPO4-17; CRYSTAL	A 3D flexible metal-organic framework (MOF) with 1D hydrophilic and hydrophobic pores shows anisotropic thermal expansion with relatively large thermal expansion coefficient (alpha(a)= -21 x 10(-6) K-1 and alpha(c)=79 x 10(-6) K-1) between 133 K and 383 K. Temperature change gives deformation of both pores, which expand in diameter and elongate in length on cooling and vice versa. The thermally induced structural change should be derived from a unique framework topology like "lattice fence". Silica accommodation changes not only the nature of the MOF but also thermal responsiveness of the MOF. Since the hydrophobic pores in the material are selectively blocked by the silica, the MOF with the silica is considered as a hydrophilic microporous material. Furthermore, inclusion of silica resulted in a drastic pore contraction in diameter and anisotropically changed the thermal responsiveness of the MOF. (C) 2014 Elsevier Inc. All rights reserved.	[Kondo, Atsushi; Maeda, Kazuyuki] Tokyo Univ Agr & Technol, Koganei, Tokyo 1838588, Japan	Kondo, A (reprint author), Tokyo Univ Agr & Technol, 2-24-16 Naka Cho, Koganei, Tokyo 1838588, Japan.	kondoa@cc.tuat.ac.jp	Kondo, Atsushi/C-3788-2013; Maeda, Kazuyuki/B-7113-2013	Maeda, Kazuyuki/0000-0003-4253-3094			Amri M, 2010, J PHYS CHEM C, V114, P6726, DOI 10.1021/jp100368c; Chapman KW, 2005, J AM CHEM SOC, V127, P15630, DOI 10.1021/ja055197f; Yang C, 2009, ANGEW CHEM INT EDIT, V48, P2500, DOI 10.1002/anie.200804739; Kondo A, 2011, J AM CHEM SOC, V133, P10512, DOI 10.1021/ja201170c; Tao JZ, 2003, J PHYS CHEM SOLIDS, V64, P1473, DOI 10.1016/S0022-3697(03)00102-1; Kajiro H, 2010, INT J MOL SCI, V11, P3803, DOI 10.3390/ijms11103803; Villaescusa LA, 2001, J AM CHEM SOC, V123, P5453, DOI 10.1021/ja015797o; Amri M, 2009, CHEM MATER, V21, P3380, DOI 10.1021/cm901140u; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; Wu Y, 2008, ANGEW CHEM INT EDIT, V47, P8929, DOI 10.1002/anie.200803925; Altomare A, 2009, J APPL CRYSTALLOGR, V42, P1197, DOI 10.1107/S0021889809042915; Carlucci L, 2003, COORDIN CHEM REV, V246, P247, DOI 10.1016/S0010-8545(03)00126-7; Duyker SG, 2013, ANGEW CHEM INT EDIT, V52, P5266, DOI 10.1002/anie.201300619; Dubbeldam D, 2007, ANGEW CHEM INT EDIT, V46, P4496, DOI 10.1002/anie.200700218; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Grobler I, 2013, J AM CHEM SOC, V135, P6411, DOI 10.1021/ja401671p; Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; Woodcock DA, 1999, CHEM MATER, V11, P2508, DOI 10.1021/cm991047q; DeVries LD, 2011, J AM CHEM SOC, V133, P14848, DOI 10.1021/ja2032822; Bull I, 2003, J AM CHEM SOC, V125, P4342, DOI 10.1021/ja0292400; Evans JSO, 1997, SCIENCE, V275, P61, DOI 10.1126/science.275.5296.61; Hibble SJ, 2007, ANGEW CHEM INT EDIT, V46, P7116, DOI 10.1002/anie.200701246; Lightfoot P, 2001, J MATER CHEM, V11, P212, DOI 10.1039/b002950p; Phillips AE, 2008, ANGEW CHEM INT EDIT, V47, P1396, DOI 10.1002/anie.200704421; DUBININ MM, 1960, CHEM REV, V60, P235, DOI 10.1021/cr60204a006; Attfield MP, 1998, CHEM MATER, V10, P2013, DOI 10.1021/cm9801587; Goodwin AL, 2009, J AM CHEM SOC, V131, P6334, DOI 10.1021/ja901355b; Nishibori E, 2001, NUCL INSTRUM METH A, V467, P1045, DOI 10.1016/S0168-9002(01)00639-8; Goodwin AL, 2008, SCIENCE, V319, P794, DOI 10.1126/science.1151442; Evans JSO, 1996, CHEM MATER, V8, P2809, DOI 10.1021/cm9602959; Attfield MP, 1998, CHEM COMMUN, P601, DOI 10.1039/a707141h; Carey T, 2012, CHEM COMMUN, V48, P5829, DOI 10.1039/c2cc30582h; Carlucci L, 2002, CHEM COMMUN, P1354, DOI 10.1039/b202588d; COUVES JW, 1993, J PHYS-CONDENS MAT, V5, pL329, DOI 10.1088/0953-8984/5/27/001; Evans JSO, 1999, J CHEM SOC DALTON, P3317, DOI 10.1039/a904297k; Goodwin AL, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.140301; Hagrman PJ, 1999, ANGEW CHEM INT EDIT, V38, P2638, DOI DOI 10.1002/(SICI)1521-3773(19990917)38; Hibble SJ, 2003, INORG CHEM, V42, P4724, DOI 10.1021/ic0342043; Kanoh H, 2009, J COLLOID INTERF SCI, V334, P1, DOI 10.1016/j.jcis.2009.03.020; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Miller W, 2009, J MATER SCI, V44, P5441, DOI 10.1007/s10853-009-3692-4; Morcok J.L., 2009, J AM CHEM SOC, V131, P4866; Noguchi D, 2008, J AM CHEM SOC, V130, P6367, DOI 10.1021/ja077469f; Pretsch T, 2006, CHEM COMMUN, P1857, DOI 10.1039/b601344a; Sluis P., 1990, ACTA CRYSTALLOGR A, V46, P194; Wei T.-S., 2013, CHEM SCI, V4, P1539	46	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	JAN	2015	221						126	131		10.1016/j.jssc.2014.09.022		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AY0BT	WOS:000347263700017		
J	Nishii, A; Shinozaki, K; Honma, T; Komatsu, T				Nishii, Akihito; Shinozaki, Kenji; Honma, Tsuyoshi; Komatsu, Takayuki			Morphology and orientation of beta-BaB2O4 crystals patterned by laser in the inside of samarium barium borate glass	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Laser-induced crystallization; beta-BaB2O4; Glass inside; Birefringence imaging; Crystal orientation	2ND-HARMONIC GENERATION; INDUCED CRYSTALLIZATION; CERAMICS; GROWTH; NANOCRYSTALS; IRRADIATION; SURFACE; LINES; PHOTOLUMINESCENCE; FABRICATION	Nonlinear optical beta-BaB2O4 crystal lines (beta-BBO) were patterned in the inside of 8Sm(2)O(3)-42BaO-50B(2)O(3) glass by irradiations of continuous-wave Yb:YVO4 lasers with a wavelength of 1080 nm (power: P=0.8-1.0 W, scanning speed: S=0.2-2.5 mu m/s), in which the laser focal position was moved gradually from the surface to the inside. The morphology, size, and orientation of beta-BBO crystals were examined from polarization optical microscope and birefringence imaging observations. It was demonstrated that c-axis oriented beta-BBO crystals with long lengths (e.g., 20 mm) were patterned in the inside of the glass. The morphology of beta-BBO in the cross-section of lines was a rectangular shape with rounded corners, and the volume of beta-BBO formed increased with increasing laser power and with decreasing laser scanning speed. The maximum depth in the inside from the surface for beta-BBO patterning increased with increasing laser power, e.g., D-max similar to 100 mu m at P=0.8 W, D-max similar to 170 mu m at P=0.9 W, and D-max similar to 200 mu m at P=1 W. The present study proposes that the laser-induced crystallization opens a new door for applied engineering in glassy solids. (C) 2014 Elsevier Inc. All rights reserved.	[Nishii, Akihito; Shinozaki, Kenji; Honma, Tsuyoshi; Komatsu, Takayuki] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Komatsu, T (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka Cho, Nagaoka, Niigata 9402188, Japan.	komatsu@mst.nagaokaut.ac.jp		Shinozaki, Kenji/0000-0001-5383-340X	Ministry of Education, Science, Sports, Culture and Technology, Japan [23246114]; Program for High Reliable Materials Design and Manufacturing in Nagaoka University of Technology	This work was supported from the Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology, Japan (No. 23246114) and by the Program for High Reliable Materials Design and Manufacturing in Nagaoka University of Technology.	Miura K, 2000, OPT LETT, V25, P408, DOI 10.1364/OL.25.000408; Honma T, 2008, J CERAM SOC JPN, V116, P1314, DOI 10.2109/jcersj2.116.1314; Yu B, 2004, J OPT SOC AM B, V21, P83, DOI 10.1364/JOSAB.21.000083; Tsukada Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086725; Maruyama N, 2009, J SOLID STATE CHEM, V182, P246, DOI 10.1016/j.jssc.2008.10.028; Honma T, 2003, APPL PHYS LETT, V83, P2796, DOI 10.1063/1.1615833; Tanaka H, 2003, J PHYS CHEM SOLIDS, V64, P1179, DOI 10.1016/S0022-3697(03)00047-7; Suzuki F, 2014, J PHYS CHEM SOLIDS, V75, P954, DOI 10.1016/j.jpcs.2014.04.007; CHEN CT, 1990, J CRYST GROWTH, V99, P790, DOI 10.1016/S0022-0248(08)80028-0; Yamazawa T, 2009, J AM CERAM SOC, V92, P2924, DOI 10.1111/j.1551-2916.2009.03348.x; Komatsu T, 2007, J AM CERAM SOC, V90, P699, DOI 10.1111/j.1551-2916.2006.01441.x; Honma T, 2004, J PHYS CHEM SOLIDS, V65, P1705, DOI 10.1016/j.jpcs.2004.04.010; Stone A, 2010, J NON-CRYST SOLIDS, V356, P3059, DOI 10.1016/j.jnoncrysol.2010.03.048; Ida H, 2012, J SOLID STATE CHEM, V196, P384, DOI 10.1016/j.jssc.2012.07.006; Sakamoto A, 2010, INT J APPL GLASS SCI, V1, P237, DOI 10.1111/j.2041-1294.2010.00027.x; Ogawa K, 2013, J SOLID STATE CHEM, V207, P6, DOI 10.1016/j.jssc.2013.08.021; Sakai R, 2000, APPL PHYS LETT, V77, P2118, DOI 10.1063/1.1313805; Gupta P, 2011, OPT MATER EXPRESS, V1, P652; Muller R, 2000, J NON-CRYST SOLIDS, V274, P208, DOI 10.1016/S0022-3093(00)00214-3; Teng Y, 2014, J NON-CRYST SOLIDS, V383, P91, DOI 10.1016/j.jnoncrysol.2013.04.015; Komatsu T, 2013, INT J APPL GLASS SCI, V4, P125, DOI 10.1111/ijag.12023; Suzuki F, 2012, J SOLID STATE CHEM, V185, P130, DOI 10.1016/j.jssc.2011.11.005; KAO YH, 1994, J NON-CRYST SOLIDS, V167, P247, DOI 10.1016/0022-3093(94)90247-X; Krol DM, 2008, J NON-CRYST SOLIDS, V354, P416, DOI 10.1016/j.jnoncrysol.2007.01.098; Komatsu T, 2011, J SOLID STATE CHEM, V184, P411, DOI 10.1016/j.jssc.2010.12.016; Jain H, 2004, FERROELECTRICS, V306, P111, DOI 10.1080/00150190490458446; Suzuki F, 2013, J AM CERAM SOC, V96, P1339, DOI 10.1111/jace.12275; EIMERL D, 1987, J APPL PHYS, V62, P1968, DOI 10.1063/1.339536; Avansi W., 2008, J NONCRYST SOLIDS, V352, P3398; Beal G.H., 2009, J AM CERAM SOC, V82, P5; Holand W., 2012, GLASS CERAMIC TECHNO; Honma T, 2008, IOP CONF SER-MAT SCI, V1, DOI 10.1088/1757-8981/1/1/012006; Ihara R, 2006, ADV MAT RES, V11-12, P197; Komatsu T., 2012, T GIGAKU, V1; Komatsu T., 2013, J ASIAN CERAM SOC, V1, P9; NIKOGOSYAN DN, 1991, APPL PHYS A-MATER, V52, P359, DOI 10.1007/BF00323647; Poberaj G, 2009, OPT MATER, V31, P1049, DOI 10.1016/j.optmat.2007.12.020; Shinozaki K, 2012, J APPL PHYS, V112	38	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	JAN	2015	221						145	151		10.1016/j.jssc.2014.09.031		7	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AY0BT	WOS:000347263700020		
J	Gursoy, M; Takeda, M; Albert, B				Guersoy, M.; Takeda, M.; Albert, B.			High-pressure densified solid solutions of alkaline earth hexaborides (Ca/Sr, Ca/Ba, Sr/Ba) and their high-temperature thermoelectric properties	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Boride; Thermoelectric; Solid solution; Alkaline earth metal	ION-BEAM EVAPORATION; BORON-CARBIDE; ELECTRONIC-STRUCTURE; BORIDES	Solid solutions of alkaline earth hexaborides were synthesized and densified by spark plasma sintering at 100 MPa. The high-temperature thermoelectric properties (Seebeck coefficients, electrical and thermal diffusivities, heat capacities) were measured between room temperature and 1073 K. CaB6, SrB6, BaB6 and the ternary hexaborides CaxSr1-xB6, CaxBa1-xB6, SrxBa1-xB6 (x = 0.25, 0.5, 0.75) are n-type conducting compounds over the whole compositional and thermal ranges. The values of the figure of merit ZT for CaB6 (ca. 0.3 at 1073 K) were found to be significantly increased compared to earlier investigations which is attributed to the densification process. (C) 2014 Elsevier Inc. All rights reserved.	[Guersoy, M.; Albert, B.] Tech Univ Darmstadt, Eduard Zintl Inst Inorgan & Phys Chem, D-64287 Darmstadt, Germany; [Takeda, M.] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan	Albert, B (reprint author), Tech Univ Darmstadt, Eduard Zintl Inst Inorgan & Phys Chem, Alarich Weiss Str 12, D-64287 Darmstadt, Germany.	albert@ac.chemie.tu-darmstadt.de			project IN-TEG within the framework of ThermoPower of the Bundesministerium of Bildung und Forschung [03X3555G]	Financial support of the project IN-TEG (03X3555G) within the framework of ThermoPower of the Bundesministerium of Bildung und Forschung is gratefully acknowledged.	Maruyama S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4869131; WOOD C, 1988, REP PROG PHYS, V51, P459, DOI 10.1088/0034-4885/51/4/001; Aselage TL, 1998, PHYS REV LETT, V81, P2316, DOI 10.1103/PhysRevLett.81.2316; Mori T, 2007, J APPL PHYS, V101, DOI 10.1063/1.2730571; Mori T, 2014, DALTON T, V43, P15048, DOI 10.1039/c4dt01303d; Takeda M, 2004, J SOLID STATE CHEM, V177, P471, DOI 10.1016/j.jssc.2003.02.005; Brown SR, 2006, CHEM MATER, V18, P1873, DOI 10.1021/cm060261t; JONKER GH, 1968, PHILIPS RES REP, V23, P131; BOUCHACOURT M, 1985, J MATER SCI, V20, P1237, DOI 10.1007/BF01026319; WOOD C, 1984, PHYS REV B, V29, P4582, DOI 10.1103/PhysRevB.29.4582; Mori T, 2006, J SOLID STATE CHEM, V179, P2908, DOI 10.1016/j.jssc.2006.03.030; Aselage TL, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054302; BLUM P, 1954, ACTA CRYSTALLOGR, V7, P81, DOI 10.1107/S0365110X54000151; Bruker AXS, 2009, PROGR TOP 4 2; Frotscher M., 2008, THESIS TU DARMSTADT; Gunjishima I, 2001, MATER TRANS, V42, P1445, DOI 10.2320/matertrans.42.1445; Maruyama S, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4758297; Massidda S, 1997, Z PHYS B CON MAT, V102, P83, DOI 10.1007/s002570050267; Ott HR, 1997, Z PHYS B CON MAT, V102, P337, DOI 10.1007/s002570050297; Sasaki S, 2005, SCI TECHNOL ADV MAT, V6, P181, DOI 10.1016/j.stam.2004.11.010; Schmitt K, 2001, SOLID STATE SCI, V3, P321, DOI 10.1016/S1293-2558(00)01091-8; Stober F., 2012, THESIS TU DARMSTADT; Suematsu H, 2002, THIN SOLID FILMS, V407, P132, DOI 10.1016/S0040-6090(02)00026-3; Takeda M., 2003, Proceedings ICT'03. 22nd International Conference on Thermoelectrics (IEEE Cat. No.03TH8726), DOI 10.1109/ICT.2003.1287498; Takeda M., 2002, Proceedings ICT'02. 21st International Conference on Thermoelectrics (Cat. No.02TH8657); Takeda M, 2006, J SOLID STATE CHEM, V179, P2823, DOI 10.1016/j.jssc.2006.01.025; TAKEDA M, 2003, MATER RES SOC S P, V793, P219; Young DP, 1999, NATURE, V397, P412	28	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	JAN	2015	221						191	195		10.1016/j.jssc.2014.10.001		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AY0BT	WOS:000347263700027		
J	Segawa, K; Taskin, AA; Ando, Y				Segawa, Kouji; Taskin, A. A.; Ando, Yoichi			Pb5Bi24Se41: A new member of the homologous series forming topological insulator heterostructures	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Topological insulator; Bismuth selenide; Crystal growth; Quasi-two-dimensional transport	CRYSTAL; CROSSOVER; BI2SE3	We have synthesized Pb5Bi24Se41, which is a new member of the (PbSe)(5)(Bi2Se3)(3m) homologous series with m=4. This series of compounds consist of alternating layers of the topological insulator Bi2Se3 and the ordinary insulator PbSe. Such a naturally-formed heterostructure has recently been elucidated to give rise to peculiar quasi-two-dimensional topological states throughout the bulk, and the discovery of Pb5Bi24Se41 expands the tunability of the topological states in this interesting homologous series. The trend in the resistivity anisotropy in this homologous series suggests an important role of hybridization of the topological states in the out-of-plane transport. (C) 2014 Elsevier Inc. All rights reserved.	[Segawa, Kouji; Taskin, A. A.; Ando, Yoichi] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Ando, Y (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	y_ando@sanken.osa-u.ac.jp	Ando, Yoichi/B-8163-2013	Ando, Yoichi/0000-0002-3553-3355	JSPS [KAKENHI 25220708, 24540320, 25400328]; MEXT (Innovative Area "Topological Quantum Phenomena") [KAKENHI 22103004]; AFOSR [AOARD 124038]	We acknowledge the Comprehensive Analysis Center, ISIR, Osaka University, for technical supports in the CCD X-ray diffraction analysis. We also thank T. Toba for technical assistances. This work was supported by JSPS (KAKENHI 25220708, 24540320, and 25400328), MEXT (Innovative Area "Topological Quantum Phenomena" KAKENHI 22103004), and AFOSR (AOARD 124038).	Allev I.I., 2008, INORG MATER, V44, P1179; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Souma S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.116801; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; STORDEUR M, 1992, PHYS STATUS SOLIDI B, V169, P505, DOI 10.1002/pssb.2221690222; Shelimova LE, 2008, INORG MATER+, V44, P927, DOI 10.1134/S0020168508090057; Ando Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.102001; Nakayama K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.236804; Cava RJ, 2013, J MATER CHEM C, V1, P3176, DOI 10.1039/c3tc30186a; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Zhang Y, 2010, NAT PHYS, V6, P584, DOI 10.1038/NPHYS1689; Zhang YG, 2005, J APPL CRYSTALLOGR, V38, P433, DOI 10.1107/S0021889805005686; NAKAMURA Y, 1993, PHYS REV B, V47, P8369, DOI 10.1103/PhysRevB.47.8369; Peng HL, 2012, NAT CHEM, V4, P281, DOI 10.1038/nchem.1277; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Eremeev SV, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1638; Fang L., 2013, ARXIV13070260; Kanatzidis MG, 2005, ACCOUNTS CHEM RES, V38, P359, DOI 10.1021/ar040176w; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057	19	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	JAN	2015	221						196	201		10.1016/j.jssc.2014.09.034		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AY0BT	WOS:000347263700028		
J	Ben Yahia, H; Shikano, M; Gaudin, E; Avdeev, M; Ling, CD				Ben Yahia, Hamdi; Shikano, Masahiro; Gaudin, Etienne; Avdeev, Maxim; Ling, Chris D.			Single crystal and magnetic structures of maricite-type AgMnVO4	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						Vanadate; Flux growth; Single crystal; Magnetic structure	BOND-VALENCE PARAMETERS; RBMNPO4; OXIDES	Single crystals of the ternary manganese vanadate AgMnVO4, were grown using AgVO3 flux. The structure was determined from single crystal X-ray diffraction data. The magnetic structure and properties of AgMnVO4 were characterized by magnetic susceptibility, specific heat, and low-temperature neutron powder diffraction measurements. AgMnVO4 crystallizes in the maricite-type structure with space group Prima, a=9.5393(12), b=6.8132(9), c= 5.3315(7) angstrom and Z=4. AgMnVO4 contains MnO4 chains made up of edge-sharing MnO6 octahedra, and these chains are interlinked by the VO4 and AgO4 tetrahedra. The specific heat measurements indicate a 3D-antiferromagnetic ordering at similar to 12.1 K and the neutron powder diffraction measurements at 5 K show that the Mn2+ magnetic moments are antiferromagnetically coupled within the chains which are antiferromagnetically coupled to each other. (C) 2014 Elsevier Inc. All rights reserved.	[Ben Yahia, Hamdi; Shikano, Masahiro] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan; [Gaudin, Etienne] Univ Bordeaux 1, CNRS, ICMCB, F-33608 Pessac, France; [Avdeev, Maxim] Australian Nucl Sci & Technol Org, Bragg Inst, Lucas Heights, NSW 2234, Australia; [Ling, Chris D.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Ben Yahia, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	benyahia.hamdi@voila.fr; shikano.masahiro@aist.go.jp	Ling, Chris D/B-2228-2009; 	Ling, Chris D/0000-0003-2205-3106; BEN YAHIA, Hamdi/0000-0001-6577-9498; , hamdi/0000-0002-3447-017X	Japan Society for the Promotion of Science (JSPS) [24e02506]	Part of this work was supported by Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows Grant number 24e02506.	CHARDON B, 1986, J MAGN MAGN MATER, V58, P128, DOI 10.1016/0304-8853(86)90132-0; Padhi AK, 1997, J SOLID STATE CHEM, V128, P267, DOI 10.1006/jssc.1996.7217; Avdeev M, 2013, INORG CHEM, V52, P8685, DOI 10.1021/ic400870x; GOODENOUGH JB, 1960, PHYS REV, V117, P1442, DOI 10.1103/PhysRev.117.1442; GELLER S, 1960, ACTA CRYSTALLOGR, V13, P325, DOI 10.1107/S0365110X60002521; Petricek V, 2014, Z KRISTALLOGR, V229, P345, DOI 10.1515/zkri-2014-1737; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Kittaka S, 1999, J SOLID STATE CHEM, V142, P360, DOI 10.1006/jssc.1998.8044; MOTIDA K, 1970, J PHYS SOC JPN, V28, P1188, DOI 10.1143/JPSJ.28.1188; MORING J, 1986, J SOLID STATE CHEM, V61, P379, DOI 10.1016/0022-4596(86)90046-0; Ben Yahia H., 2005, INORG CHEM, V44, P3087; Ben Yahia H, 2010, INORG CHEM, V49, P8578, DOI 10.1021/ic101180h; Ben Yahia H, 2007, CHEM MATER, V19, P5563, DOI 10.1021/cm070452b; Ben Yahia H, 2009, Z NATURFORSCH B, V64, P875; Ben Yahia H, 2007, J ALLOY COMPD, V442, P74, DOI 10.1016/j.jallcom.2006.06.110; Ben Yahia H, 2008, J SOLID STATE CHEM, V181, P3103, DOI 10.1016/j.jssc.2008.08.001; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; LUJAN M, 1995, Z NATURFORSCH B, V50, P1210; Nenert G, 2013, INORG CHEM, V52, P9627, DOI 10.1021/ic401408f; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; YAKUBOVICH OV, 1990, KRISTALLOGRAFIYA+, V35, P42	21	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	JAN	2015	221						306	310		10.1016/j.jssc.2014.09.017		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AY0BT	WOS:000347263700043		
J	Hayami, W				Hayami, Wataru			Structural stability and electronic properties of beta-tetragonal boron: A first-principles study	JOURNAL OF SOLID STATE CHEMISTRY			English	Article						beta-Tetragonal boron; Density functional theory; Atomic structure; Electronic structure	RHOMBOHEDRAL BORON; CRYSTALLINE BORON; DENSITY; ENERGY; FORM; PSEUDOPOTENTIALS; NANOBELTS	It is known that elemental boron has five polymorphs: alpha- and beta-rhombohedral, alpha- and beta-tetragonal, and the high-pressure gamma phase. beta-tetragonal (beta-t) boron was first discovered in 1960, but there have been only a few studies since then. We have thoroughly investigated, using first-principles calculations, the atomic and electronic structures of beta-t boron, the details of which were not known previously. The difficulty of calculation arises from the fact that beta-t boron has a large unit cell that contains between 184 and 196 atoms, with 12 partially-occupied interstitial sites. This makes the number of configurations of interstitial atoms too great to calculate them all. By introducing assumptions based on symmetry and preliminary calculations, the number of configurations to calculate can be greatly reduced. It was eventually found that beta-t boron has the lowest total energy, with 192 atoms (8 interstitial atoms) in an orthorhombic lattice. The total energy per atom was between those of alpha- and beta-rhombohedral boron. Another tetragonal structure with 192 atoms was found to have a very close energy. The valence bands were fully filled and the gaps were about 1.16 to 1.54 eV, making it comparable to that of beta-rhombohedral boron. (C) 2014 Elsevier Inc. All rights reserved.	Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Hayami, W (reprint author), Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	hayami.wataru@nims.go.jp					AMBERGER E, 1971, J LESS-COMMON MET, V23, P21, DOI 10.1016/0022-5088(71)90004-X; Andreoni W, 2000, PARALLEL COMPUT, V26, P819, DOI 10.1016/S0167-8191(00)00014-4; DECKER BF, 1959, ACTA CRYSTALLOGR, V12, P503, DOI 10.1107/S0365110X59001529; Kirihara K, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1935036; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; SLACK GA, 1988, J SOLID STATE CHEM, V76, P52, DOI 10.1016/0022-4596(88)90192-2; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Laubengayer AW, 1943, J AM CHEM SOC, V65, P1924, DOI 10.1021/ja01250a036; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Oganov AR, 2009, NATURE, V457, P863, DOI 10.1038/nature07736; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; KLEINMAN L, 1982, PHYS REV LETT, V48, P1425, DOI 10.1103/PhysRevLett.48.1425; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Ekimov EA, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/5/055009; Hayami W, 2007, J PHYS CHEM C, V111, P10394, DOI 10.1021/jp072594z; Hayami W, 2010, J SOLID STATE CHEM, V183, P1521, DOI 10.1016/j.jssc.2010.04.036; HUGHES RE, 1963, J AM CHEM SOC, V85, P361, DOI 10.1021/ja00886a036; Hyodo H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.024515; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; LEE S, 1990, PHYS REV B, V42, P1316, DOI 10.1103/PhysRevB.42.1316; Ma YZ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174116; Marx D., 2000, MODERN METHODS ALGOR, P301; PARK CS, 1985, THIN SOLID FILMS, V131, P205, DOI 10.1016/0040-6090(85)90141-5; Qin JQ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.014107; TALLEY CP, 1960, ACTA CRYSTALLOGR, V13, P271, DOI 10.1107/S0365110X60000613; VLASSE M, 1979, J LESS-COMMON MET, V67, P1, DOI 10.1016/0022-5088(79)90067-5; Wang ZK, 2003, CHEM PHYS LETT, V368, P663, DOI 10.1016/S0009-2614(02)01964-4; WERHEIT H, 1993, PHYS STATUS SOLIDI B, V176, P415, DOI 10.1002/pssb.2221760215; Widom M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064113; Zarechnaya EY, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/4/044209	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596	1095-726X		J SOLID STATE CHEM	J. Solid State Chem.	JAN	2015	221						378	383		10.1016/j.jssc.2014.10.012		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	AY0BT	WOS:000347263700053		
J	Ishikawa, D; Ellis, DS; Uchiyama, H; Baron, AQR				Ishikawa, Daisuke; Ellis, David S.; Uchiyama, Hiroshi; Baron, Alfred Q. R.			Inelastic X-ray scattering with 0.75 meV resolution at 25.7 keV using a temperature-gradient analyzer	JOURNAL OF SYNCHROTRON RADIATION			English	Article						inelastic X-ray scattering; high-resolution analyzer; X-ray optics	MEV ENERGY RESOLUTION; DETECTORS; DYNAMICS	The use of temperature-gradient analyzers for non-resonant high-resolution inelastic X-ray scattering is investigated. The gradient compensates for geometrical broadening of the energy resolution by adjusting the lattice spacing of the analyzer crystal. Applying a similar to 12 mK temperature gradient across a 9.5 cm analyzer, resolutions of 0.75 (2) meV FWHM at 25.7 keV for Si(13 13 13) and 1.25 (2) meV at 21.7 keV for Si(11 11 11) were measured, while retaining large (250 mm) clearance between the sample position and detector, and reasonable (9.3 mrad x 8.8 mrad) analyzer acceptance. The temperature control and stability are discussed.	[Ishikawa, Daisuke; Ellis, David S.; Uchiyama, Hiroshi; Baron, Alfred Q. R.] RIKEN SPring 8 Ctr, Mat Dynam Lab, Sayo, Hyogo 6795148, Japan; [Ishikawa, Daisuke; Uchiyama, Hiroshi; Baron, Alfred Q. R.] Japan Synchrotron Radiat Res Inst JASRI, Res & Utilizat Div, Sayo, Hyogo 6795198, Japan	Ishikawa, D (reprint author), RIKEN SPring 8 Ctr, Mat Dynam Lab, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	disikawa@spring8.or.jp					Said AH, 2011, J SYNCHROTRON RADIAT, V18, P492, DOI 10.1107/S0909049511001828; Huotari S, 2005, J SYNCHROTRON RADIAT, V12, P467, DOI 10.1107/S0909049505010630; Bechhoefer J, 2005, REV MOD PHYS, V77, P783, DOI 10.1103/RevModPhys.77.783; Masciovecchio C, 1996, NUCL INSTRUM METH B, V111, P181, DOI 10.1016/0168-583X(95)01288-5; Huotari S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2198805; Sinn H, 2001, NUCL INSTRUM METH A, V467, P1545, DOI 10.1016/S0168-9002(01)00755-0; Baron AQR, 2000, J PHYS CHEM SOLIDS, V61, P461, DOI 10.1016/S0022-3697(99)00337-6; Baron A. Q. R., 2010, SPRING 8 INFO NEWS, V15, P14; Baron AQR, 2008, J PHYS CHEM SOLIDS, V69, P3100, DOI 10.1016/j.jpcs.2008.06.119; Burkel E., 1991, SPRINGER TRACTS MODE, V125; Dorner D., 1983, NUCL INSTRUM METHODS, V208, P587; Fujii Y., 1982, 895 SSRL; Fukui H, 2008, J SYNCHROTRON RADIAT, V15, P618, DOI 10.1107/S0909049508023248; GLASSBRENNER CJ, 1964, PHYS REV, V134, P1058; Ishikawa D, 2010, J SYNCHROTRON RADIAT, V17, P12, DOI 10.1107/S0909049509043167; Masciovecchio C, 1996, NUCL INSTRUM METH B, V117, P339, DOI 10.1016/0168-583X(96)00334-5; Miwa D., 2002, THESIS HIMEJI I TECH; Sette F, 1998, SCIENCE, V280, P1550, DOI 10.1126/science.280.5369.1550; Verbeni R, 2005, J PHYS CHEM SOLIDS, V66, P2299, DOI 10.1016/j.jpcs.2005.09.079	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	JAN	2015	22		1				3	9		10.1107/S1600577514021006		7	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AX3PC	WOS:000346850200002		
J	Ichiyanagi, K; Sekiguchi, H; Sato, T; Nozawa, S; Tomita, A; Hoshino, M; Adachi, S; Sasaki, YC				Ichiyanagi, Kouhei; Sekiguchi, Hiroshi; Sato, Tokushi; Nozawa, Shunsuke; Tomita, Ayana; Hoshino, Manabu; Adachi, Shin-ichi; Sasaki, Yuji C.			Cooling dynamics of self-assembled monolayer coating for integrated gold nanocrystals on a glass substrate	JOURNAL OF SYNCHROTRON RADIATION			English	Article						time-resolved X-ray diffraction; thermal conductance; nanocrystal; thermal flow	X-RAY-DIFFRACTION; THERMAL TRANSPORT; AU PARTICLES; TIME; CONDUCTANCE; EXCITATION; NANOSCALE; SIZE	Picosecond time-resolved X-ray diffraction has been used to study the nanoscale thermal transportation dynamics of bare gold nanocrystals and thiol-based self-assembled monolayer (SAM)-coated integrated gold nanocrystals on a SiO2 glass substrate. A temporal lattice expansion of 0.30-0.33% was observed in the bare and SAM-coated nanocrystals on the glass substrate; the thermal energy inside the gold nanocrystals was transported to the contacted substrate through the gold-SiO2 interface. The interfacial thermal conductivity between the single-layered gold nanocrystal film and the SiO2 substrate is estimated to be 45 MW m(-2) K-1 from the decay of the Au 111 peak shift, which was linearly dependent on the transient temperature. For the SAM-coated gold nanocrystals, the thermal dissipation was faster than that of the bare gold nanocrystal film. The thermal flow from the nanocrystals to the SAM-coated molecules promotes heat dissipation from the laser-heated SAM-coated gold nanocrystals. The thermal transportation of the laser-heated SAM-coated gold nanocrystal film was analyzed using the bidirectional thermal dissipation model.	[Ichiyanagi, Kouhei; Sasaki, Yuji C.] High Energy Accelerator Res Org, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Sekiguchi, Hiroshi] SPring 8, Japan Synchrotron Radiat Res Inst JASRI, Kobe, Hyogo 6795198, Japan; [Sato, Tokushi; Nozawa, Shunsuke; Tomita, Ayana; Adachi, Shin-ichi] Deutsch Elektronen Synchrotron DESY, D-22607 Hamburg, Germany; [Hoshino, Manabu] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Ichiyanagi, K (reprint author), High Energy Accelerator Res Org, Photon Factory, Inst Mat Struct Sci, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.	kouhei.ichiyanagi@kek.jp	SEKIGUCHI, Hiroshi/C-7365-2011	SEKIGUCHI, Hiroshi/0000-0001-7590-3624	Futaba Electric Memorial Foundation	This work was performed with the approval of the Photon Factory Advisory Committee (proposals No. 2011G631 and 2013G624) and was supported by the Futaba Electric Memorial Foundation.	Cahill DG, 2003, J APPL PHYS, V93, P793, DOI 10.1063/1.1524305; Smith AN, 2000, MICROSCALE THERM ENG, V4, P51; Pernot G, 2010, NAT MATER, V9, P491, DOI [10.1038/nmat2752, 10.1038/NMAT2752]; Plech A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195423; Juve V, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195406; Nozawa S, 2007, J SYNCHROTRON RADIAT, V14, P313, DOI 10.1107/S0909049507025496; Sheu YM, 2011, SOLID STATE COMMUN, V151, P826, DOI 10.1016/j.ssc.2011.03.022; Wang ZH, 2007, SCIENCE, V317, P787, DOI 10.1126/science.1145220; Losego MD, 2012, NAT MATER, V11, P502, DOI [10.1038/nmat3303, 10.1038/NMAT3303]; Cahill DG, 2002, J HEAT TRANS-T ASME, V124, P223, DOI 10.1115/1.1454111; Hu M, 2002, J PHYS CHEM B, V106, P7029, DOI 10.1021/jp020581+; Siemens ME, 2010, NAT MATER, V9, P26, DOI [10.1038/nmat2568, 10.1038/NMAT2568]; Nozawa S, 2010, J AM CHEM SOC, V132, P61, DOI 10.1021/ja907460b; Banfi F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673559; Ge ZB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.186101; Harikrishna H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812749; Hartland GV, 2002, J CHEM PHYS, V116, P8048, DOI 10.1063/1.1469021; Highland M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075337; Hodak JH, 1999, J CHEM PHYS, V111, P8613, DOI 10.1063/1.480202; Hopkins PE, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068476; Ichiyanagi K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.024110; Inouye H., 1998, PHYS REV B, V57, P11134; Okumura Y, 2005, THIN SOLID FILMS, V471, P91, DOI 10.1016/j.tsf.2004.04.033; Plech A, 2003, EUROPHYS LETT, V61, P762, DOI 10.1209/epl/i2003-00299-3; Sheu YM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045317	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	JAN	2015	22		1				29	33		10.1107/S1600577514019730		5	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AX3PC	WOS:000346850200006		
J	Shinohara, Y; Yamamoto, N; Kishimoto, H; Amemiya, Y				Shinohara, Yuya; Yamamoto, Naoko; Kishimoto, Hiroyuki; Amemiya, Yoshiyuki			X-ray irradiation induces local rearrangement of silica particles in swollen rubber	JOURNAL OF SYNCHROTRON RADIATION			English	Article						X-ray photon correlation spectroscopy; filled rubber	PHOTON-CORRELATION SPECTROSCOPY; HETEROGENEOUS DYNAMICS; SUPERCOOLED LIQUIDS; SLOW DYNAMICS; SOFT MATTER; REINFORCEMENT; FILLER; ELASTOMERS; RHEOLOGY	X-ray photon correlation spectroscopy (XPCS) of swollen rubber containing spherical silica nanoparticles is reported. It is shown that irradiation by intense X-rays leads to the breakdown of cross-links, thereby inducing the local rearrangement of silica nanoparticles. This rearrangement process depends on the cross-link density and is characterized by a compressed exponential relaxation with aging behaviour, which resembles a common feature of complex fluids observed with XPCS.	[Shinohara, Yuya; Yamamoto, Naoko; Amemiya, Yoshiyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan; [Kishimoto, Hiroyuki] Sumitomo Rubber Ind Ltd, Chuo Ku, Kobe, Hyogo 6510072, Japan	Shinohara, Y (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	yuya@k.u-tokyo.ac.jp	Shinohara, Yuya/F-8608-2010		Japan Society for the Promotion of Sciences KAKENHI [24710092]; Photon and Quantum Basic Research Coordinated Development Program from Ministry of Education, Culture, Sports, Science and Technology, Japan	The XPCS and SAXS experiments were conducted under the approval of the SPring-8 Proposal Advisory Committee (proposal Nos. 2011B1131, 2012A1121, 2012B1103 and 2012B1809). Preliminary SAXS experiments were performed at the Photon Factory under the approval of the Photon Factory Program Advisory Committee (proposal No. 2010G526). This work is partially supported by the Japan Society for the Promotion of Sciences KAKENHI (proposal No. 24710092) and the Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors thank the experimental support from A. Watanabe and I. Ichiro (University of Tokyo) and K. Aoyama and N. Ohta (JASRI/SPring-8).	WITTEN TA, 1993, J PHYS II, V3, P367; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Nusser K, 2013, MACROMOLECULES, V46, P6263, DOI 10.1021/ma3025927; GOTZE W, 1992, REP PROG PHYS, V55, P241, DOI 10.1088/0034-4885/55/3/001; Leheny RL, 2012, CURR OPIN COLLOID IN, V17, P3, DOI 10.1016/j.cocis.2011.11.002; Bouchaud JP, 2001, EUR PHYS J E, V6, P231, DOI 10.1007/s101890170005; Perez-Aparicio R, 2013, MACROMOLECULES, V46, P8964, DOI 10.1021/ma401910c; Ruta B, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790131; Baeza GP, 2013, MACROMOLECULES, V46, P6621, DOI 10.1021/ma401016d; GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495; Chen SW, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217201; Ediger MD, 2000, ANNU REV PHYS CHEM, V51, P99, DOI 10.1146/annurev.physchem.51.1.99; Caronna C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.055702; Srivastava S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021408; Cipelletti L, 2003, FARADAY DISCUSS, V123, P237, DOI 10.1039/b204495a; Ehrburger-Dolle F, 2012, MACROMOLECULES, V45, P8691, DOI 10.1021/ma3013674; Cipelletti L, 2005, J PHYS-CONDENS MAT, V17, pR253, DOI 10.1088/0953-8984/17/6/R01; Madsen A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055001; Kluppel M, 2003, ADV POLYM SCI, V164, P1, DOI 10.1007/b11054; Sutton M, 2003, OPT EXPRESS, V11, P2268, DOI 10.1364/OE.11.002268; Oberdisse J, 2006, SOFT MATTER, V2, P29, DOI 10.1039/b511959f; Guo HY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075702; Shinohara Y, 2010, MACROMOLECULES, V43, P9480, DOI 10.1021/ma102095b; Bandyopadhyay R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228302; Bouchaud JP, 1996, PHYSICA A, V226, P243, DOI 10.1016/0378-4371(95)00423-8; Fluerasu A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.010401; Mewis J., 2012, COLLOIDAL SUSPENSION; Richert R, 2002, J PHYS-CONDENS MAT, V14, pR703, DOI 10.1088/0953-8984/14/23/201; Shinohara Y, 2010, J SYNCHROTRON RADIAT, V17, P737, DOI 10.1107/S090904951003726X; Shinohara Y, 2007, JPN J APPL PHYS 2, V46, pL300, DOI 10.1143/JJAP.46.L300; Shinohara Y, 2012, SOFT MATTER, V8, P3457, DOI 10.1039/c2sm07165g; Solomon MJ, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051402; Sonn-Segev A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.088301; Sutton M, 2008, CR PHYS, V9, P657, DOI 10.1016/j.crhy.2007.04.008	34	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	JAN	2015	22		1				119	123		10.1107/S1600577514022954		5	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AX3PC	WOS:000346850200018		
J	Takashima, K; Hoshino, M; Uesugi, K; Yagi, N; Matsuda, S; Nakahira, A; Osumi, N; Kohzuki, M; Onodera, H				Takashima, Kenta; Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto; Matsuda, Shojiro; Nakahira, Atsushi; Osumi, Noriko; Kohzuki, Masahiro; Onodera, Hiroshi			X-ray phase-contrast computed tomography visualizes the microstructure and degradation profile of implanted biodegradable scaffolds after spinal cord injury	JOURNAL OF SYNCHROTRON RADIATION			English	Article						X-ray phase-contrast CT; Talbot grating interferometer; biodegradation; tissue engineering; spinal cord injury	POLY(GLYCOLIC ACID) SUTURES; HYDROLYTIC DEGRADATION; SYNCHROTRON-RADIATION; NERVE-TISSUE; GLIAL SCAR; REGENERATION; MICROTOMOGRAPHY; INTERFEROMETRY; STRATEGIES; INVITRO	Tissue engineering strategies for spinal cord repair are a primary focus of translational medicine after spinal cord injury (SCI). Many tissue engineering strategies employ three-dimensional scaffolds, which are made of biodegradable materials and have microstructure incorporated with viable cells and bioactive molecules to promote new tissue generation and functional recovery after SCI. It is therefore important to develop an imaging system that visualizes both the microstructure of three-dimensional scaffolds and their degradation process after SCI. Here, X-ray phase-contrast computed tomography imaging based on the Talbot grating interferometer is described and it is shown how it can visualize the polyglycolic acid scaffold, including its microfibres, after implantation into the injured spinal cord. Furthermore, X-ray phase-contrast computed tomography images revealed that degradation occurred from the end to the centre of the braided scaffold in the 28 days after implantation into the injured spinal cord. The present report provides the first demonstration of an imaging technique that visualizes both the microstructure and degradation of biodegradable scaffolds in SCI research. X-ray phase-contrast imaging based on the Talbot grating interferometer is a versatile technique that can be used for a broad range of preclinical applications in tissue engineering strategies.	[Takashima, Kenta; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 980, Japan; [Takashima, Kenta; Onodera, Hiroshi] Univ Tokyo, Dept Elect & Elect Engn, Tokyo, Japan; [Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto] SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan; [Matsuda, Shojiro] Gunze Ltd, R&D Dept, Moriyama, Shiga, Japan; [Nakahira, Atsushi] Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Osaka, Japan; [Osumi, Noriko] Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Sendai, Miyagi 980, Japan	Takashima, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi 980, Japan.	takashima-k@med.tohoku.ac.jp			Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST); Japan Synchrotron Radiation Research Institute [2012A1568]	We thank Dr Tatsunori Seki for technical assistance. We are also grateful to all members of the Osumi Laboratory for fruitful discussions. This work was supported by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST) and 2012A Budding Researchers Support Proposals of the Japan Synchrotron Radiation Research Institute (No. 2012A1568).	Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035; Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Tanaka J, 2013, Z MED PHYS, V23, P222, DOI 10.1016/j.zemedi.2012.11.004; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Shinohara M, 2008, AM J PHYSIOL-HEART C, V294, pH1094, DOI 10.1152/ajpheart.01149.2007; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI [10.1143/JJAP.42.L866, 10.1143/JJAP.L866]; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002; Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006; Beckmann F, 1999, BIOPHYS J, V76, P98; Bracken MB, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.00001046.PUB2; CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527; CHU CC, 1981, J BIOMED MATER RES, V15, P795, DOI 10.1002/jbm.820150604; CHU CC, 1981, J BIOMED MATER RES, V15, P19, DOI 10.1002/jbm.820150106; Connor DM, 2009, NEUROIMAGE, V46, P908, DOI 10.1016/j.neuroimage.2009.03.019; Gunatillake P., 2003, EUR CELLS MATER, V5, P1; Hagenmuller H., 2007, BIOMATERIALS, V28, P2479; Hoshino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025140; Hoshino M, 2012, BIOL OPEN, V1, P269, DOI 10.1242/bio.2012430; Hu JZ, 2012, PHYS MED BIOL, V57, pN55, DOI 10.1088/0031-9155/57/5/N55; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027628; Pashuck E. T., 2012, SCI TRANSL MED, V4; Rooney GE, 2008, SPINE, V33, pE914, DOI 10.1097/BRS.0b013e318186b2b1; Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108; Wu J, 2009, KIDNEY INT, V75, P945, DOI 10.1038/ki.2009.42	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	JAN	2015	22		1				136	142		10.1107/S160057751402270X		7	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AX3PC	WOS:000346850200021		
J	Itou, M; Orikasa, Y; Gogyo, Y; Suzuki, K; Sakurai, H; Uchimoto, Y; Sakurai, Y				Itou, Masayoshi; Orikasa, Yuki; Gogyo, Yuma; Suzuki, Kosuke; Sakurai, Hiroshi; Uchimoto, Yoshiharu; Sakurai, Yoshiharu			Compton scattering imaging of a working battery using synchrotron high-energy X-rays	JOURNAL OF SYNCHROTRON RADIATION			English	Article						synchrotron X-ray imaging; lithium battery; in situ analysis; Compton scattering	SPINEL	Results of studies on Compton scattering imaging using synchrotron high-energy X-rays are reported. The technique is applied to a discharging coin cell, and the intensity of Compton scattered X-rays from the inside of the cell has been measured as a function of position and time. The position-time intensity map captures the migration of lithium ions in the positive electrode and reveals the structural change due to the volume expansion of the electrode. This experiment is a critical step in developing synchrotron-based Compton scattering imaging for electrochemical cells at a product level.	[Itou, Masayoshi; Sakurai, Yoshiharu] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Orikasa, Yuki; Gogyo, Yuma; Uchimoto, Yoshiharu] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Suzuki, Kosuke; Sakurai, Hiroshi] Gunma Univ, Fac Sci & Technol, Kiryu, Gunma 3768515, Japan	Itou, M (reprint author), Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan.	mito@spring8.or.jp			Development of Systems and Technology for Advanced Measurement and Analysis program under Japan Science and Technology Agency	This work was supported by the Development of Systems and Technology for Advanced Measurement and Analysis program under the Japan Science and Technology Agency. The experiment was performed at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2011B2004).	Greedan JE, 1998, CHEM MATER, V10, P3058, DOI 10.1021/cm9801789; Harding G, 2010, APPL RADIAT ISOTOPES, V68, P993, DOI 10.1016/j.apradiso.2010.01.035; Andrejczuk A, 2014, J SYNCHROTRON RADIAT, V21, P57, DOI 10.1107/S1600577513026593; Thackeray MM, 1999, J AM CERAM SOC, V82, P3347; GUZZARDI R, 1988, CRIT REV BIOMED ENG, V15, P237; HOLT RS, 1984, NUCL INSTRUM METH A, V221, P98, DOI 10.1016/0167-5087(84)90187-X; Marechal XM, 1998, J SYNCHROTRON RADIAT, V5, P431, DOI 10.1107/S0909049597017081; McMaster WH., 1969, UCRL50174; Sakurai Y, 1998, J SYNCHROTRON RADIAT, V5, P208, DOI 10.1107/S0909049598002052; Sharaf JM, 2001, APPL RADIAT ISOTOPES, V54, P801, DOI 10.1016/S0969-8043(00)00333-X; Suzuki K., 2015, UNPUB; Yamaoka H, 2000, J SYNCHROTRON RADIAT, V7, P69, DOI 10.1107/S090904959901691X	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0909-0495	1600-5775		J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	JAN	2015	22		1				161	164		10.1107/S1600577514024321		4	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	AX3PC	WOS:000346850200024		
J	Ebi, H; Oze, I; Nakagawa, T; Ito, H; Hosono, S; Matsuda, F; Takahashi, M; Takeuchi, S; Sakao, Y; Hida, T; Faber, AC; Tanaka, H; Yatabe, Y; Mitsudomi, T; Yano, S; Matsuo, K				Ebi, Hiromichi; Oze, Isao; Nakagawa, Takayuki; Ito, Hidemi; Hosono, Satoyo; Matsuda, Fumihiko; Takahashi, Meiko; Takeuchi, Shinji; Sakao, Yukinori; Hida, Toyoaki; Faber, Anthony C.; Tanaka, Hideo; Yatabe, Yasushi; Mitsudomi, Tetsuya; Yano, Seiji; Matsuo, Keitaro			Lack of Association between the BIM Deletion Polymorphism and the Risk of Lung Cancer with and without EGFR Mutations	JOURNAL OF THORACIC ONCOLOGY			English	Article						BIM polymorphism; Lung cancer; Susceptibility; EGFR mutation	TYROSINE KINASE INHIBITORS; GENETIC SUSCEPTIBILITY; LEUKEMIC-CELLS; PROTEIN BIM; RESISTANCE; APOPTOSIS; BCL-2; ADENOCARCINOMA; EXPRESSION; RESPONSES	Introduction: The BIM deletion polymorphism in intron 2 was found in a significant percent of the Asian population. Patients with epidermal growth factor receptor (EGFR) mutant lung cancers harboring this BIM polymorphism have shorter progression free survival and overall response rates to EGFR tyrosine kinase inhibitors. However, the association between the BIM deletion polymorphism and lung cancer risk is unknown. Methods: The BIM deletion polymorphism was screened by polymerase chain reaction in 765 lung cancer cases and 942 healthy individuals. Results: Carriers possessing one allele of the BIM polymorphism were observed in 13.0% of control cases and 12.8% of lung cancer cases, similar to incidence rates reported earlier in healthy individuals. Homozygote for the BIM polymorphism was observed in four of 942 healthy controls and three of 765 lung cancer cases. The frequency of the BIM deletion polymorphism in lung cancer patients was not related to age, sex, smoking history, or family history of lung cancer. The BIM deletion polymorphism was found in 30 of 212 patients with EGFR wild type lung cancers and 16 of 120 patients with EGFR mutant lung cancers. The frequency of the BIM polymorphism is similar between cancers with wild type EGFR and mutated EGFR (p = 0.78). Conclusion: The BIM deletion polymorphism was not associated with lung cancer susceptibility. Furthermore, the BIM polymorphism is not associated with EGFR mutant lung cancer.	[Ebi, Hiromichi; Nakagawa, Takayuki; Takeuchi, Shinji; Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan; [Oze, Isao; Ito, Hidemi; Hosono, Satoyo; Tanaka, Hideo; Matsuo, Keitaro] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Matsuda, Fumihiko; Takahashi, Meiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Sakao, Yukinori; Yatabe, Yasushi; Mitsudomi, Tetsuya] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Hida, Toyoaki] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan; [Faber, Anthony C.] Virginia Commonwealth Univ, Sch Dent, VCU Philips Inst Oral Hlth Res, Richmond, VA USA; [Faber, Anthony C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Sayama, Osaka, Japan; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan	Matsuo, K (reprint author), Kyushu Univ, Fac Med Sci, Dept Prevent Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	keit-arom@med.kyushu-u.ac.jp					Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Ito H, 2012, J THORAC ONCOL, V7, P790, DOI 10.1097/JTO.0b013e3182475028; Deng J, 2007, CANCER RES, V67, P11867, DOI 10.1158/0008-5472.CAN-07-1961; Marshall AL, 2013, CARCINOGENESIS, V34, P487, DOI 10.1093/carcin/bgt016; Zhao MC, 2014, CANCER-AM CANCER SOC, V120, P2299, DOI 10.1002/cncr.28725; Isobe K, 2014, J THORAC ONCOL, V9, P483, DOI 10.1097/JTO.0000000000000125; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Costa C, 2014, CLIN CANCER RES, V20, P2001, DOI 10.1158/1078-0432.CCR-13-2233; Faber AC, 2012, ADV PHARMACOL, V65, P519, DOI 10.1016/B978-0-12-397927-8.00016-6; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Lee JH, 2014, J THORAC ONCOL, V9, P1385, DOI 10.1097/JTO.0000000000000238; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Li Z, 2007, CELL DEATH DIFFER, V14, P318, DOI 10.1038/sj.cdd.4401983; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Lee JK, 2013, ANN ONCOL, V24, P2080, DOI 10.1093/annonc/mdt127; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Augis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078582; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hamajima N, 2001, ASIAN PAC J CANCER P, V2, P99; Katz SG, 2014, BLOOD, V123, P884, DOI 10.1182/blood-2013-04-499079; Nakane Y, MOL CARCINO IN PRESS; Tajima K, 2000, ASIAN PAC J CANCER P, V1, P35; Yang IA, 2013, J THORAC DIS, V5, pS454, DOI 10.3978/j.issn.2072-1439.2013.08.06	38	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	JAN	2015	10	1					59	66		10.1097/JTO.0000000000000371		8	Oncology; Respiratory System	Oncology; Respiratory System	AX5SC	WOS:000346986500009		
J	Kurose, K; Ohue, Y; Sato, E; Yamauchi, A; Eikawa, S; Isobe, M; Nishio, Y; Uenaka, A; Oka, M; Nakayama, E				Kurose, Koji; Ohue, Yoshihiro; Sato, Eiichi; Yamauchi, Akira; Eikawa, Shingo; Isobe, Midori; Nishio, Yumi; Uenaka, Akiko; Oka, Mikio; Nakayama, Eiichi			Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)	JOURNAL OF THORACIC ONCOLOGY			English	Article						Lung cancer; Tregs; CCR4; Anti-hCCR4 mAb; Treg depletion	REGULATORY T-CELLS; CHEMOKINE RECEPTOR CCR4; MONOCLONAL-ANTIBODY; LEUKEMIA-LYMPHOMA; MELANOMA PATIENTS; PERIPHERAL-BLOOD; IMMUNOTHERAPY; LYMPHOCYTES; VACCINATION; METASTASIS	Introduction: Tregs infiltrate tumors and inhibit immune responses against them. Methods: We investigated subpopulations of Foxp3(+) CD4 T cells previously defined by Miyara et al. (Immunity 30, 899-911, 2009) in peripheral blood mononuclear cells (PBMCs) and tumor infiltrating lymphocytes (TILs) in lung cancer. We also showed that Tregs in healthy donors that express CCR4 could be efficiently eliminated in vitro by cotreatment with antihuman (h) CCR4 mAb (KM2760) and NK cells. Results: In lung cancer, the number of activated/effector Tregs and non-Tregs, but not resting/naive Tregs, was increased in TILs compared with the number of those cells in PBMCs. The non-Treg population contained Th2 and Th17. CCR4 expression on activated/effector Tregs and non-Tregs in TILs was down-regulated compared with that on those cells in PBMCs. Chemokinetic migration of CD25(+) CD4 T cells containing the Treg population sorted from the PBMCs of healthy donors to CCL22/MDC was abrogated by pretreatment with anti-hCCR4 mAb (KM2760). The inhibitory activity of CD25(+) CD127(dim/-) CD4 Tregs on the proliferative response of CD4 and CD8 T cells stimulated with anti-CD3/CD28 coated beads was abrogated by adding an anti-hCCR4 mAb (KM2760) and CD56(+) NK cells to the culture. Conclusions: The findings suggested the CCR4 on activated/effector Tregs and non-Tregs was functionally involved in the chemokinetic migration and accumulation of those cells to the tumor site. In vitro findings of efficient elimination of Tregs may give the basis for implementation of a clinical trial to investigate Treg depletion by administration of an anti-hCCR4 mAb to solid cancer patients.	[Kurose, Koji; Ohue, Yoshihiro; Isobe, Midori; Nishio, Yumi; Oka, Mikio] Kawasaki Med Univ, Dept Resp Med, Kurashiki, Okayama, Japan; [Sato, Eiichi] Tokyo Med Univ, Dept Pathol, Tokyo 1608402, Japan; [Yamauchi, Akira] Kawasaki Med Univ, Dept Biochem, Kurashiki, Okayama, Japan; [Eikawa, Shingo] Okayama Univ, Dept Immunol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Uenaka, Akiko; Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Kurashiki, Okayama 7010193, Japan	Nakayama, E (reprint author), Kawasaki Univ Med Welf, Fac Hlth & Welf, 288 Matsushima, Kurashiki, Okayama 7010193, Japan.	nakayama@mw.kawasaki-m.ac.jp					Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742; Onizuka S, 1999, CANCER RES, V59, P3128; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Jandus C, 2008, CANCER IMMUNOL IMMUN, V57, P1795, DOI 10.1007/s00262-008-0507-4; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Mariani M, 2004, EUR J IMMUNOL, V34, P231, DOI 10.1002/eji.200324429; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Yamagiwa S, 2001, J IMMUNOL, V166, P7282; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Miyara M, 2011, IMMUNOL CELL BIOL, V89, P346, DOI 10.1038/icb.2010.137; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bonertz A, 2009, J CLIN INVEST, V119, P3311, DOI 10.1172/JCI39608; Attia P, 2005, J IMMUNOTHER, V28, P582, DOI 10.1097/01.cji.0000175468.19742.10; Yang YM, 2011, CANCER SCI, V102, P1264, DOI 10.1111/j.1349-7006.2011.01934.x; Tsujikawa T, 2013, INT J CANCER, V132, P2755, DOI 10.1002/ijc.27966; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Nishikawa H, 2005, BLOOD, V106, P1008, DOI 10.1182/blood-2005-02-0607; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Jacobs JFM, 2010, CLIN CANCER RES, V16, P5067, DOI 10.1158/1078-0432.CCR-10-1757; Nakamura ES, 2006, CLIN EXP METASTAS, V23, P9, DOI 10.1007/s10585-006-9006-1; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Ishida T, 2011, INT J HEMATOL, V94, P443, DOI 10.1007/s12185-011-0941-5; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; Yamauchi A, 2014, J IMMUNOL METHODS, V404, P59, DOI 10.1016/j.jim.2013.12.005	39	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	JAN	2015	10	1					74	83		10.1097/JTO.0000000000000364		10	Oncology; Respiratory System	Oncology; Respiratory System	AX5SC	WOS:000346986500011		
J	Togashi, Y; Hayashi, H; Terashima, M; de Velasco, MA; Sakai, K; Fujita, Y; Tomida, S; Nakagawa, K; Nishio, K				Togashi, Yosuke; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nakagawa, Kazuhiko; Nishio, Kazuto			Inhibition of beta-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non-small-cell Lung Cancer with a T790M Mutation	JOURNAL OF THORACIC ONCOLOGY			English	Article						Non-small-cell lung cancer; Epidermal growth factor receptor T790M mutation; Epidermal growth factor receptor tyrosine kinase inhibitor; beta-Catenin; Stem cell-like properties	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; PHASE-II TRIAL; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; DRUG-RESISTANCE; STEM-CELLS; OPEN-LABEL; WNT; GEFITINIB	Introduction: Patients with non-small-cell lung cancer (NSCLC) with somatic activating mutations of the epidermal growth factor receptor gene (EGFR mutations) generally respond to EGFR tyrosine kinase inhibitors (EGFR-TKIs). beta-Catenin is a key component of the Wnt/beta-Catenin signal and is an important oncogene that is involved in the pathogenesis and progression of malignant tumors, especially cancer stem cells. Methods and Results: We found that EGFR-mutated NSCLC cell lines exhibited a high expression level of beta-Catenin, compared with cell lines with the wild-type EGFR gene, and XAV939 (a beta-Catenin inhibitor) enhanced the sensitivities to EGFR-TKI in EGFR-mutated NSCLC cell lines. In EGFR-mutated NSCLC cell lines with the acquired resistance threonine-to-methionine mutation in codon 790 (T790M) mutation, XAV939 enhanced the sensitivity of the cells to an irreversible EGFR-TKI but not a reversible EGFR-TKI. The combination of XAV939 and EGFR-TKIs strongly inhibited the beta-Catenin signal and strongly decreased the phosphorylation of EGFR, compared with the use of EGFR-TKIs alone, suggesting an interaction between EGFR and the beta-Catenin signal. The stem cell-like properties of the EGFR-mutated cell line carrying the T790M mutation were inhibited by XAV939 and BIBW2992 (an irreversible EGFR-TKI). Furthermore, the stem cell-like properties were strongly inhibited by a combination of both the agents. A xenograft study demonstrated that beta-Catenin knockdown enhanced the antitumor effect of BIBW2992 in the EGFR-mutated NSCLC cell line carrying the T790M mutation. Conclusion: Our findings indicate that beta-Catenin might be a novel therapeutic target in EGFR-mutated NSCLC carrying the T790M mutation.	[Togashi, Yosuke; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka 5898511, Japan; [Hayashi, Hidetoshi; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Sayama, Osaka 5898511, Japan; [Hayashi, Hidetoshi] Kishiwada Municipal Hosp, Dept Med Oncol, Kishiwada, Japan	Nishio, K (reprint author), Kinki Univ, Fac Med, Dept Genome Biol, 377-2 Ohnohigashi, Sayama, Osaka 5898511, Japan.	knishio@med.kindai.ac.jp					Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Remon J, 2014, CANCER TREAT REV, V40, P93, DOI 10.1016/j.ctrv.2013.06.002; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; O'Connor ML, 2014, CANCER LETT, V344, P180, DOI 10.1016/j.canlet.2013.11.012; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Arao T, 2013, HEPATOLOGY, V57, P1407, DOI 10.1002/hep.25956; Casas-Selves M, 2012, CANCER RES, V72, P4154, DOI 10.1158/0008-5472.CAN-11-2848; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Pietanza MC, 2012, J THORAC ONCOL, V7, P219, DOI 10.1097/JTO.0b013e31822eebf9; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Yeh CT, 2012, AM J RESP CRIT CARE, V186, P1180, DOI 10.1164/rccm.201207-1180OC; Katakami N, 2013, J CLIN ONCOL, V31, P3335, DOI 10.1200/JCO.2012.45.0981; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Fang X, 2014, PULM PHARMACOL THER, V28, P41, DOI 10.1016/j.pupt.2013.05.005; Ghosh G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-95; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Tamura D, 2010, CANCER SCI, V101, P1403, DOI 10.1111/j.1349-7006.2010.01544.x; Yang JCH, 2014, J CLIN ONCOL, V32	47	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	JAN	2015	10	1					93	101		10.1097/JTO.0000000000000353		9	Oncology; Respiratory System	Oncology; Respiratory System	AX5SC	WOS:000346986500013		
J	Ueki, N; Matsuo, Y; Togashi, Y; Kubo, T; Shibuya, K; Iizuka, Y; Mizowaki, T; Togashi, K; Mishima, M; Hiraoka, M				Ueki, Nami; Matsuo, Yukinori; Togashi, Yosuke; Kubo, Takeshi; Shibuya, Keiko; Iizuka, Yusuke; Mizowaki, Takashi; Togashi, Kaori; Mishima, Michiaki; Hiraoka, Masahiro			Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival after Stereotactic Body Radiation Therapy for Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Article						Lung cancer; Stereotactic body radiation therapy; Interstitial lung disease; Radiation pneumonitis	IDIOPATHIC PULMONARY-FIBROSIS; PHASE-II TRIAL; ACUTE EXACERBATION; SHORT-TERM; RADIOTHERAPY; KL-6; RISK; SURGERY; TUMORS; EXPERIENCE	Introduction: To investigate the impact of pre-existing radiological interstitial lung disease (ILD) findings on the incidence of radiation pneumonitis (RP) and clinical outcomes after stereotactic body radiation therapy (SBRT) for stage I non-small-cell lung cancer. Methods: We included 157 consecutive patients who underwent SBRT alone for stage I non-small-cell lung cancer and whose pretreatment lung computed tomography images were available for retrospective review. The pretreatment computed tomography images were evaluated retrospectively for the presence of ILD. The incidence of RP, overall survival (OS) rate, and the incidence of disease progression and local progression were evaluated between patients with ILD (ILD[+]) and without ILD (ILD[-]). Results: Pre-existing ILD was identified in 20 patients. The median follow-up period was 39.5 months. The incidences of RP worse than grade 2 (>= Gr2 RP) and worse than grade 3 (>= Gr3 RP) were significantly higher in ILD(+) than ILD(-) (1 year >= Gr2 RP rate, 55.0% versus 13.3%; p < 0.001 and 1year >= Gr3 RP rate 10.0% versus 1.5%; p = 0.020). Multivariate analysis also indicated that ILD(+) was a risk factor for >= Gr2 and >= Gr3 RP, and the volume of the irradiated lung. The OS rate tended to be worse in ILD(+) than ILD(-) (3-year OS, 53.8% versus 70.8%; p = 0.28). No difference was observed in the disease progression or local progression rates. Conclusions: Pre-existing ILD was a significant risk factor for symptomatic and severe RP. Prescreening for ILD findings is important for determining the radiation pneumonitis risk when planning SBRT.	[Ueki, Nami; Matsuo, Yukinori; Iizuka, Yusuke; Mizowaki, Takashi; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Togashi, Yosuke] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan; [Togashi, Yosuke; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Kubo, Takeshi; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Shibuya, Keiko] Yamaguchi Univ, Grad Sch Med, Dept Therapeut Radiol, Ube, Yamaguchi 755, Japan	Matsuo, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan.	ymatsuo@kuhp.kyoto-u.ac.jp	Matsuo, Yukinori/O-6200-2014	Matsuo, Yukinori/0000-0002-4372-8259			American Association of Physicists in Medicine, 2004, 85 AM ASS PHYS MED, VMedical Physics Publishing; Kinoshita T, 2012, ONCOL LETT, V4, P477, DOI 10.3892/ol.2012.753; Matsuo Y, 2012, INT J RADIAT ONCOL, V83, pE545, DOI 10.1016/j.ijrobp.2012.01.018; Yamaguchi S, 2013, LUNG CANCER, V82, P260, DOI 10.1016/j.lungcan.2013.08.024; Baumann P, 2009, J CLIN ONCOL, V27, P3290, DOI 10.1200/JCO.2008.21.5681; Baker R, 2013, INT J RADIAT ONCOL, V85, P190, DOI 10.1016/j.ijrobp.2012.03.041; Makimoto T, 1999, JPN J CLIN ONCOL, V29, P192, DOI 10.1093/jjco/29.4.192; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; Guckenberger M, 2012, J THORAC ONCOL, V7, P542, DOI 10.1097/JTO.0b013e31824165d7; Voltolini L, 2013, EUR J CARDIO-THORAC, V43, pE17, DOI 10.1093/ejcts/ezs560; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977; Miyazaki K, 2009, ANTICANCER RES, V29, P2671; Matsuo Y, 2011, INT J RADIAT ONCOL, V79, P1104, DOI 10.1016/j.ijrobp.2009.12.022; Borst GR, 2009, RADIOTHER ONCOL, V91, P307, DOI 10.1016/j.radonc.2009.02.003; Harris JM, 2010, THORAX, V65, P70, DOI 10.1136/thx.2009.121962; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P258; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860; Barriger RB, 2012, INT J RADIAT ONCOL, V82, P457, DOI 10.1016/j.ijrobp.2010.08.056; Sato T, 2014, J THORAC CARDIOV SUR, V147, P1604, DOI 10.1016/j.jtcvs.2013.09.050; Watanabe A, 2008, J THORAC CARDIOV SUR, V136, P1357, DOI 10.1016/j.jtcvs.2008.07.016; Raz DJ, 2007, CHEST, V132, P193, DOI 10.1378/chest.06-3096; Uematsu M, 1998, CANCER-AM CANCER SOC, V82, P1062, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G; Nagata Y, 2010, INT J RADIAT ONCOL, V78, pS27; Saito Y, 2011, ANN THORAC SURG, V92, P1812, DOI 10.1016/j.athoracsur.2011.06.055; Fujimoto T, 2003, ANN THORAC SURG, V76, P1674, DOI 10.1016/S0003-4975(03)00966-4; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Sanuki N, 2012, J RADIAT RES, V53, P110, DOI 10.1269/jrr.110142; BLOMGREN H, 1995, ACTA ONCOL, V34, P861; Chida M, 2008, EUR J CARDIO-THORAC, V34, P878, DOI 10.1016/j.ejcts.2008.07.028; Chida M, 2012, ANN THORAC CARDIOVAS, V18, P314, DOI 10.5761/atcs.oa.11.01839; Chiyo M, 2003, J THORAC CARDIOV SUR, V126, P1141, DOI 10.1016/S0022-5223(03)00791-8; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hiraoka M, 2010, JPN J CLIN ONCOL, V40, P846, DOI 10.1093/jjco/hyq134; Iwata H, 2011, RADIOTHER ONCOL, V101, P267, DOI 10.1016/j.radonc.2011.05.031; Mampuya WA, 2013, MED DOSIM, V38, P95, DOI 10.1016/j.meddos.2012.07.007; Nagata Y, 2012, INT J RADIAT ONCOL, V84, pS46; Onishi H, 2009, INT J RADIAT ONCOL, V75, pS62; R Foundation for Statistical Computing, 2013, R LANG ENV STAT COMP; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Takayama K, 2005, INT J RADIAT ONCOL, V61, P1565, DOI 10.1016/j.ijrobp.2004.12.066; Travis WD, 2002, AM J RESP CRIT CARE, V165, P277; Yamashita H, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-21; Yamashita H, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-32	46	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	JAN	2015	10	1					116	125		10.1097/JTO.0000000000000359		10	Oncology; Respiratory System	Oncology; Respiratory System	AX5SC	WOS:000346986500016		
J	Mizuno, T; Okumura, M; Asamura, H; Yoshida, K; Niwa, H; Kondo, K; Horio, H; Matsumura, A; Yokoi, K				Mizuno, Tetsuya; Okumura, Meinoshin; Asamura, Hisao; Yoshida, Kazuo; Niwa, Hiroshi; Kondo, Kazuya; Horio, Hirotoshi; Matsumura, Akihide; Yokoi, Kohei		Japanese Assoc Res Thymus	Surgical Management of Recurrent Thymic Epithelial Tumors A Retrospective Analysis Based on the Japanese Nationwide Database	JOURNAL OF THORACIC ONCOLOGY			English	Article						Recurrent thymic epithelial tumors; Thymic cancer; Thymoma; Surgical resection; Disease-free interval	CLINICOPATHOLOGICAL FEATURES; THYMOMA; CARCINOMA; SURVIVAL; PATTERNS; OUTCOMES; RELAPSE	Background: There is no standard treatment for recurrent thymic epithelial tumors. Although the efficacy has not been validated based on the large series studies, surgical resection is sometimes employed for patients with recurrent thymic tumors. The aim of this study is to evaluate the surgical outcomes for recurrent thymic epithelial tumors based on the Japanese nationwide database. Methods: From the database of patients whose thymic epithelial tumors were treated surgically from 1991 through 2010, the cohort who developed recurrence after the initial resection was extracted. Clinicopathological factors were reviewed, and the prognostic factors of re-resected cases were examined. Results: Twenty-eight hundred thirty-five patients who underwent surgical resection of thymic epithelial tumors were registered to the database. Among these patients, 420 (14.8%) experienced recurrence. One hundred sixty-two patients were treated surgically and 243 were treated nonsurgically for recurrent disease. The 5- and 10-year postrecurrence survival rates were 82.7% and 68.2%, respectively, in the surgery group and 43.5% and 25.4%, respectively, in the nonsurgery group (p < 0.001). According to univariate analyses, female sex and the pathological Masaoka I-II stage, nonthymic carcinoma, absence of preoperative treatment and longer recurrent-free interval (RFI) were significantly favorable factors for survival in the surgery group. According to the multivariate analysis, nonthymic carcinoma histology and longer RFI were identified to be independent prognostic factors. Conclusions: The surgical outcomes of recurrent thymic epithelial tumors are favorable in selected patients. The role of re-resection may be limited in the setting of thymic carcinoma and/or a short RFI.	[Mizuno, Tetsuya; Yokoi, Kohei] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4668550, Japan; [Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; [Asamura, Hisao] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan; [Yoshida, Kazuo] Shinshu Univ, Sch Med, Dept Thorac Surg, Matsumoto, Nagano 390, Japan; [Niwa, Hiroshi] Seirei Mikatahara Gen Hosp, Div Thorac Surg, Resp Dis Ctr, Hamamatsu, Shizuoka, Japan; [Kondo, Kazuya] Univ Tokushima, Inst Hlth Biosci, Dept Thorac Endocrine Surg & Oncol, Tokushima 770, Japan; [Horio, Hirotoshi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gen Thorac Surg, Tokyo, Japan; [Matsumura, Akihide] Natl Hosp Org, Dept Surg, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan	Yokoi, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	k-yokoi@med.nagoya-u.ac.jp	Kondo, Kazuya/J-9163-2012				Okumura M, 2007, J SURG ONCOL, V95, P40, DOI 10.1002/jso.20671; Lucchi M, 2009, J THORAC CARDIOV SUR, V137, P1185, DOI 10.1016/j.jtcvs.2008.09.033; Huang J, 2009, J THORAC CARDIOV SUR, V138, P26, DOI 10.1016/j.jtcvs.2009.03.033; Strobel P, 2004, J CLIN ONCOL, V22, P1501, DOI 10.1200/JCO.2004.10.113; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; BLUMBERG D, 1995, ANN THORAC SURG, V60, P908, DOI 10.1016/0003-4975(95)00669-C; Bott MJ, 2011, ANN THORAC SURG, V92, P1984, DOI 10.1016/j.athoracsur.2011.07.078; Haniuda M, 2001, J SURG ONCOL, V78, P183, DOI 10.1002/jso.1146; Yano M, 2011, INTERACT CARDIOV TH, V13, P21, DOI 10.1510/icvts.2010.264036; Ruffini E, 1997, J THORAC CARDIOV SUR, V113, P55, DOI 10.1016/S0022-5223(97)70399-4; Bae MK, 2012, J THORAC ONCOL, V7, P1304, DOI 10.1097/JTO.0b013e3182598a91; Margaritora S, 2011, EUR J CARDIO-THORAC, V40, P894, DOI 10.1016/j.ejcts.2011.01.025; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; Hamaji M, 2012, ANN THORAC SURG, V94, P247, DOI 10.1016/j.athoracsur.2012.02.092; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; MASAOKA A, 1994, EUR J CARDIO-THORAC, V8, P251, DOI 10.1016/1010-7940(94)90155-4	16	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	JAN	2015	10	1					199	205		10.1097/JTO.0000000000000378		7	Oncology; Respiratory System	Oncology; Respiratory System	AX5SC	WOS:000346986500026		
J	Ogura, T; Lefor, AT; Nakano, M; Izawa, Y; Morita, H				Ogura, Takayuki; Lefor, Alan T.; Nakano, Minoru; Izawa, Yoshimitsu; Morita, Hideo			Nonoperative management of hemodynamically unstable abdominal trauma patients with angioembolization and resuscitative endovascular balloon occlusion of the aorta	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Abdominal trauma; resuscitative endovascular balloon occlusion of the aorta; angioembolization	EASTERN ASSOCIATION; HEMORRHAGIC-SHOCK; INJURY; GUIDELINE; SURGERY	BACKGROUND: Many hemodynamically stable patients with blunt abdominal solid organ injuries are successfully managed nonoperatively, while unstable patients often require urgent laparotomy. Recently, therapeutic angioembolization has been used in the treatment of intra-abdominal hemorrhage in hemodynamically unstable patients. We undertook this study to review a series of hemodynamically unstable patients with abdominal solid organ injuries managed nonoperatively with angioembolization and resuscitative endovascular balloon occlusion of the aorta. METHODS: The institutional review board approved this study. All patients were appropriately resuscitated with transfusions, and angiography was performed after computed tomography. Resuscitative endovascular balloon occlusion of the aorta was performed before computed tomography in all patients. RESULTS: Seven patients underwent resuscitative endovascular balloon occlusion of the aorta following severe blunt abdominal trauma. The 28-day survival rate was 86% (6 of 7). There were no complications related to the procedure. CONCLUSION: We describe the first clinical series of hemodynamically unstable patients with abdominal solid organ injury treated nonoperatively with angioembolization and resuscitative endovascular balloon occlusion of the aorta. Survival rate was 86%, supporting the need for further study of this modality as an adjunct to the nonoperative management of patients with severe traumatic injuries. Copyright (c) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Ogura, Takayuki; Nakano, Minoru] Japan Red Cross Maebashi Hosp, Adv Med Emergency Dept, Maebashi, Gumma, Japan; [Ogura, Takayuki; Nakano, Minoru] Japan Red Cross Maebashi Hosp, Crit Care Ctr, Maebashi, Gumma, Japan; [Morita, Hideo] Japan Red Cross Maebashi Hosp, Dept Radiol, Maebashi, Gumma, Japan; [Lefor, Alan T.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan; [Izawa, Yoshimitsu] Jichi Med Univ, Dept Emergency Med, Shimotsuke, Tochigi, Japan	Ogura, T (reprint author), Japan Red Cross Maebashi Hosp, Adv Med Emergency Dept, 371-0014 Asahi Cho,3-21-36, Maebashi, Gumma, Japan.	alongthelongestway2003@yahoo.co.jp		Lefor, Alan/0000-0001-6673-5630			ABUNEMA T, 1988, CIRC SHOCK, V24, P55; Velmahos GC, 2003, ARCH SURG-CHICAGO, V138, P844, DOI 10.1001/archsurg.138.8.844; Hotaling JM, 2011, J UROLOGY, V185, P1316, DOI 10.1016/j.juro.2010.12.003; MURRY CE, 1986, CIRCULATION, V74, P1124; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS288, DOI 10.1097/TA.0b013e318270160d; Avaro JP, 2011, J TRAUMA, V71, P720, DOI 10.1097/TA.0b013e318221a94a; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Yanar H, 2008, J TRAUMA, V64, P943, DOI 10.1097/TA.0b013e3180342023; Giannopoulos GA, 2009, SCAND J TRAUMA RESUS, V13, P17; Japan Trauma Data Bank, JAP TRAUM DAT BANK R; Mejaddam AY, 2013, J TRAUMA ACUTE CARE, V75, P398, DOI 10.1097/TA.0b013e31829a8b7a; Okazaki K, 1999, Masui, V48, P1323; Raza M, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-14; Santucci Richard A, 2005, J Trauma, V59, P493, DOI 10.1097/01.ta.0000179956.55078.c0	15	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2015	78	1					132	135		10.1097/TA.0000000000000473		4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AX3OB	WOS:000346847500027		
J	Kato, M; Tsuji-Kawahara, S; Kawasaki, Y; Kinoshita, S; Chikaishi, T; Takamura, S; Fujisawa, M; Kawada, A; Miyazawa, M				Kato, Maiko; Tsuji-Kawahara, Sachiyo; Kawasaki, Yuri; Kinoshita, Saori; Chikaishi, Tomomi; Takamura, Shiki; Fujisawa, Makoto; Kawada, Akira; Miyazawa, Masaaki			Class Switch Recombination and Somatic Hypermutation of Virus-Neutralizing Antibodies Are Not Essential for Control of Friend Retrovirus Infection	JOURNAL OF VIROLOGY			English	Article							MURINE LEUKEMIA-VIRUS; IMMUNE-RESPONSES; ENVELOPE PROTEIN; DISEASE; FORM	Toll-like receptor 7 and Myd88 are required for antiretroviral antibody and germinal center responses, but whether somatic hypermutation and class-switch recombination are required for antiretroviral immunity has not been examined. Mice deficient in activation-induced cytidine deaminase (AID) resisted Friend virus infection, produced virus-neutralizing antibodies, and controlled viremia. Passive transfer demonstrated that immune IgM from AID-deficient mice contributes to Friend virus control in the presence of virus-specific CD4(+) T cells.	[Kato, Maiko; Tsuji-Kawahara, Sachiyo; Kawasaki, Yuri; Kinoshita, Saori; Chikaishi, Tomomi; Takamura, Shiki; Fujisawa, Makoto; Miyazawa, Masaaki] Kinki Univ, Dept Immunol, Fac Med, Osaka, Japan; [Kato, Maiko; Kawada, Akira] Kinki Univ, Dept Dermatol, Fac Med, Osaka, Japan; [Chikaishi, Tomomi] Unmet Med Needs Pharma Inc, Yokohama, Kanagawa, Japan	Miyazawa, M (reprint author), Kinki Univ, Dept Immunol, Fac Med, Osaka, Japan.	masaaki@med.kindai.ac.jp			National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT; Ministry of Health, Labor and Welfare of Japan	Animal experiments and flow cytometry were supported by members of the Central Research Facilities, Kinki University Faculty of Medicine. AID-deficient B6 (BRC 00897) and BALB/c (BRC 00901) mice were kindly provided by Tasuku Honjo through the Riken BioResource Center with the support of the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). We thank I. B. Dowell for critical reading and correction of the manuscript.; This work was supported in part by Grants-in-Aid for Scientific Research (KAKENHI and the Anti-aging Center Project) from MEXT and those from the Ministry of Health, Labor and Welfare of Japan for research on HIV/AIDS.	Halemano K, 2014, P NATL ACAD SCI USA, V111, P7759, DOI 10.1073/pnas.1403361111; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; ROBERTSON MN, 1991, J VIROL METHODS, V34, P255, DOI 10.1016/0166-0934(91)90105-9; Tsuji-Kawahara S, 2010, J VIROL, V84, P6082, DOI 10.1128/JVI.02516-09; Browne EP, 2013, J VIROL, V87, P7357, DOI 10.1128/JVI.00788-13; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Miyazawa M, 2008, VACCINE, V26, P2981, DOI 10.1016/j.vaccine.2008.01.004; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; CHESEBRO B, 1990, ANNU REV IMMUNOL, V8, P477, DOI 10.1146/annurev.immunol.8.1.477; HASENKRUG KJ, 1995, P NATL ACAD SCI USA, V92, P10492, DOI 10.1073/pnas.92.23.10492; ISHIHARA C, 1991, J IMMUNOL, V146, P3958; Kawabata H, 2006, INT IMMUNOL, V18, P183, DOI 10.1093/intimm/dxh361; MIYAZAWA M, 1995, J IMMUNOL, V155, P748; Persons DA, 1999, NAT GENET, V23, P159; Tsuji-Kawahara S, 2014, J VIROL, V88, P1854, DOI 10.1128/JVI.03271-13; Tsuji-Kawahara S, 2013, J VIROL, V87, P13760, DOI 10.1128/JVI.02506-13	18	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JAN	2015	89	2					1468	1473		10.1128/JVI.02293-14		6	Virology	Virology	AX8SN	WOS:000347178900052		
J	Furusawa, M; Brewster, C				Furusawa, Masayuki; Brewster, Chris			The bi-cultural option for global talent management: The Japanese/Brazilian Nikkeijin example	JOURNAL OF WORLD BUSINESS			English	Article						International HRM (IHRM); Global talent management; Expatriation; Localization; Boundary-spanners; Bi-culturals; Nikkeijin; Dekassegui; Japanese MNCs; Brazil	FIRM PERFORMANCE; CHALLENGES; LOCALIZATION; ADJUSTMENT; COGNITION; STRATEGY; IMPACT; CHINA	This paper reports on an important subgroup of international boundary-spanners - immigrants and second or third generation migrants from the MNC's home country living in the subsidiary host country. We take as our example the Nikkeijin (Japanese immigrants and their descendants) in Brazil. Such bicultural people are a largely unexplored source of boundary-spanning internationally competent talent for multinational enterprises. Using two different surveys, we find that this group is recognized as a source of talent by Japanese MNCs, but that their HRM practices are not appropriate to attract and use them in their global talent management programmes. (C) 2014 Elsevier Inc. All rights reserved.	[Furusawa, Masayuki] Osaka Univ Commerce, Fac Business Adm, Higashiosaka, Osaka 5778505, Japan; [Brewster, Chris] Univ Reading, Henley Business Sch, Reading RG6 6UD, Berks, England	Furusawa, M (reprint author), Osaka Univ Commerce, Fac Business Adm, Mikuriyasakaemachi, Higashiosaka, Osaka 5778505, Japan.	furusawa@daishodai.ac.jp; c.j.brewster@henley.reading.ac.uk					Andresen M., 2012, SELF INITIATED EXPAT; Collings DG, 2007, J WORLD BUS, V42, P198, DOI 10.1016/j.jwb.2007.02.005; Collings DG, 2014, J WORLD BUS, V49, P253, DOI 10.1016/j.jwb.2013.11.009; Tymon WG, 2010, J WORLD BUS, V45, P109, DOI 10.1016/j.jwb.2009.09.016; Shen Y, 2009, HUM RESOUR MANAGE, V48, P793, DOI 10.1002/hrm.20314; Tarique I, 2010, J WORLD BUS, V45, P122, DOI 10.1016/j.jwb.2009.09.019; Jackson SE, 2014, ACAD MANAG ANN, V8, P1, DOI 10.1080/19416520.2014.872335; Hong YY, 2000, AM PSYCHOL, V55, P709, DOI 10.1037//0003-066X.55.7.709; Butler CL, 2012, IND ORGAN PSYCHOL-US, V5, P240, DOI 10.1111/j.1754-9434.2012.01439.x; Fitzsimmons SR, 2011, ORGAN DYN, V40, P199, DOI 10.1016/j.orgdyn.2011.04.007; Stahl GK, 2012, MIT SLOAN MANAGE REV, V53, P25; Cerdin JL, 2014, J WORLD BUS, V49, P245, DOI 10.1016/j.jwb.2013.11.008; Kepes S, 2009, PERS PSYCHOL, V62, P497; Haslberger A, 2013, TALENT MANAGEMENT OF SELF-INITIATED EXPATRIATES: A NEGLECTED SOURCE OF GLOBAL TALENT, P1; Osland JS, 2006, ELGAR ORIG REF, P197; Fryxell GE, 2004, J WORLD BUS, V39, P268, DOI 10.1016/j.jwb.2004.04.006; Shaw JD, 2005, ACAD MANAGE J, V48, P594; Levy O, 2007, J INT BUS STUD, V38, P231, DOI 10.1057/palgrave.jibs.8400265; Iles P, 2010, J WORLD BUS, V45, P179, DOI 10.1016/j.jwb.2009.09.014; Harzing AW, 2001, HUM RESOUR MANAGE-US, V40, P139; Selmer J, 2004, INT J HUM RESOUR MAN, V15, P1094, DOI 10.1080/09585190410001677322; Benet-Martinez V, 2005, J PERS, V73, P1015, DOI 10.1111/j.1467-6494.2005.00337.x; Puck JF, 2008, INT J HUM RESOUR MAN, V19, P2182, DOI 10.1080/09585190802479413; Friedman R, 2009, UNDERSTANDING CULTURE: THEORY, RESEARCH, AND APPLICATION, P343; Al Ariss A, 2014, J WORLD BUS, V49, P173, DOI 10.1016/j.jwb.2013.11.001; Huselid MA, 2000, PERS PSYCHOL, V53, P835, DOI 10.1111/j.1744-6570.2000.tb02419.x; Appiah K.A, 1998, COSMOPOLITICS THINKI, P91; Arora A., 2004, J INT MANAG, V10, P393, DOI [10.1016/j.intman.2004.05.001, DOI 10.1016/J.INTMAN.2004.05.001]; BARTLETT CA, 1988, HUM RESOURCE MANAGE, V27, P19, DOI 10.1002/hrm.3930270102; Bartlett C A, 1998, MANAGING BORDERS TRA; Bochner S., 1981, MEDIATING PERSON BRI; Brannen M. Y., 2010, INT J CROSS CULTURAL, V10, P5; Brewster C., 2011, INT HUMAN RESOURCE M; Dore R. P., 1973, BRIT FACTORY JAPANES; Doz Y., 2001, GLOBAL METANATIONAL; EDSTROM A, 1977, ADMIN SCI QUART, V22, P248, DOI 10.2307/2391959; Ehnert I., 2008, INT HRM CONT ISSUES, P107; Evans P., 2002, GLOBAL CHALLENGE INT; Fernandez J.P., 1993, DIVERSITY ADVANTAGE; Friedman T., 2007, WORLD IS FLAT GLOBAL; Fujino T., 1995, HIKAKUKEIEIRON; Furusawa M., 2008, GLOBAL JINTEKISHIGEN; Furusawa M., 2013, NIKKEIJIN KATSUYOU S; Hall Edward T., 1976, CULTURE; Hannerz Ulf, 1990, GLOBAL CULTURE NATL, P237; Harzing A.-W. K., 1999, INT HRM CONT ISSUES, P67; Hayashi K., 1994, IBUNKA INTERFACE KEI; Hayashi K., 1985, IBUNKA INTERFACE KAN; Hong H., 2010, INT J CROSS CULTURAL, V10, P93, DOI DOI 10.1177/1470595809359582; Japan Institute of Labour, 1988, LAB SIT BRAZ JAP AFF; Japan Overseas Enterprises Association, 2008, HDB EXP BRAZ; Japan-Brazil Chamber of Commerce, 2004, REP 3 SURV LOC MAN J; Joyce WF, 2012, ORGAN DYN, V41, P183, DOI 10.1016/j.orgdyn.2012.03.001; Kajita T., 2005, KAO MIENAI TEIJUUKA; Khatri N., 2001, HUMAN RESOURCE MANAG, V11, P54, DOI DOI 10.1111/J.1748-8583.2001.TB00032.X; Kim S, 2012, ASIA PAC J HUM RESOU, V50, P439, DOI 10.1111/j.1744-7941.2012.00038.x; Koike Y., 2008, GEKKAN GLOBAL KEIEI, V316, P4; LAFROMBOISE T, 1993, PSYCHOL BULL, V114, P395, DOI 10.1037//0033-2909.114.3.395; Lewis R. E., 2006, Human Resources Management Review, V16, DOI 10.1016/j.hrmr.2006.03.001; Lone S., 2001, JAPANESE COMMUNITY B; Mayrhofer W., 1996, INT EXECUTIVE, V38, P749, DOI 10.1002/tie.5060380605; MENDENHALL ME, 1987, HUM RESOURCE MANAGE, V26, P331, DOI 10.1002/hrm.3930260303; Miyao S., 2002, BORDERLESS NI NIKKEI; Nakasumi T., 1998, BRAZIL NIKKEI SHAKAI; Ninomiya M., 2006, NIKKEIJIN GLOBALIZAT, P373; Ninomiya M., 2008, GEKKAN GLOBAL KEIEI, V316, P10; Rhinesmith S. H., 1995, TRAINING DEV, V49, P35; Roth K., 2008, S CAROLINA CIBER WOR; Schein E.H., 1978, CAREER DYNAMICS MATC; Scullion H, 2006, ROUT GLOB HUM RESOUR, P1; Sparrow P., 2004, GLOBALIZING HUMAN RE; Suzuki T., 2008, BRAZIL KYODAIKEIZAI; Suzuki T., 2010, 2020 NEN BRAZIL KEIZ; Tanaka M., 1998, CHIKYUU URAGAWA KARA; Tarique I., 2009, INT J TRAINING DEV, V13, P148; Teo S. T. T., 2012, INT J HUM RESOUR MAN, V23, P3522; Tian XW, 2014, ORGAN DYN, V43, P44, DOI 10.1016/j.orgdyn.2013.10.006; Toh SM, 2005, ACAD MANAGE EXEC, V19, P132; Tomlinson John, 1999, GLOBALIZATION CULTUR; Tung R. L., 1988, ACADEMY MANAGEMENT E, V2, P241; Tung RL, 2006, INT J HUM RESOUR MAN, V17, P1853, DOI 10.1080/09585190600999992; Ueda M., 2010, BRAZIL NIKKEIJIN, P339; Vertovec S., 1998, MUSLIM EUROPEAN YOUT, P1; White M., 1985, JAPANESE MANAGEMENT; Yasumuro K., 1997, GENBAISM NO KAIGAIKE; Yoshino M. Y., 1976, JAPANS MULTINATIONAL	86	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1090-9516	1878-5573		J WORLD BUS	J. World Bus.	JAN	2015	50	1					133	143		10.1016/j.jwb.2014.02.005		11	Business	Business & Economics	AY1PD	WOS:000347363800013		
J	Yamao, S; Sekiguchi, T				Yamao, Sachiko; Sekiguchi, Tomoki			Employee commitment to corporate globalization: The role of English language proficiency and human resource practices	JOURNAL OF WORLD BUSINESS			English	Article						Language proficiency; Non-native English-speaking employees; HR practices; Commitment to change; Globalization of the firm	PERCEIVED ORGANIZATIONAL SUPPORT; METHOD VARIANCE; SELF-EFFICACY; NORMATIVE COMMITMENT; CONTINUANCE; WORK; EXPLORATION; PERSPECTIVE; TURNOVER; COMMUNICATION	We investigate factors affecting the commitment of non-native English-speaking employees to the globalization of their firms, focusing on the role of self-perceived English language proficiency and human resource (HR) practices. By surveying 693 non-native English speakers in Japan, we found that their self-perceived English language proficiency and HR practices that promote learning a foreign language have direct and interactive effects on the affective and normative commitment to their firms' globalization. It is important for firms based in non-Anglophone countries to promote English language proficiency of their employees through HR practices when they consider globalizing their operations to other countries. (C) 2014 Elsevier Inc. All rights reserved.	[Yamao, Sachiko] Univ Melbourne, Dept Management & Mkt, Parkville, Vic 3010, Australia; [Sekiguchi, Tomoki] Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan	Yamao, S (reprint author), Univ Melbourne, Dept Management & Mkt, Level 10,198 Berkeley St, Parkville, Vic 3010, Australia.	syamao@unimelb.edu.au; tomoki@econ.osaka-u.ac.jp					Aiken L. S., 1991, MULTIPLE REGRESSION; Harzing AW, 2013, J WORLD BUS, V48, P87, DOI 10.1016/j.jwb.2012.06.011; Richards DA, 2011, J APPL PSYCHOL, V96, P169, DOI 10.1037/a0020372; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037//0003-066X.37.2.122; Oreg S, 2003, J APPL PSYCHOL, V88, P680, DOI 10.1037/0021-9010.88.4.680; MCGEE GW, 1987, J APPL PSYCHOL, V72, P638, DOI 10.1037/0021-9010.72.4.638; Liu MH, 2008, MOD LANG J, V92, P71, DOI 10.1111/j.1540-4781.2008.00687.x; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; Allen DG, 2003, J MANAGE, V29, P99, DOI 10.1177/014920630302900107; Rugman AM, 2004, J INT BUS STUD, V35, P3, DOI 10.1057/palgrave.jibs.8400073; Fushino K, 2010, TESOL QUART, V44, P700, DOI 10.5054/tq.2010.235993; Harzing AW, 2011, J WORLD BUS, V46, P279, DOI 10.1016/j.jwb.2010.07.005; Rafferty AE, 2010, J MANAGE, V36, P1309, DOI 10.1177/0149206309341480; WILLIAMS LJ, 1994, ORGAN BEHAV HUM DEC, V57, P185, DOI 10.1006/obhd.1994.1011; PODSAKOFF PM, 1986, J MANAGE, V12, P531, DOI 10.1177/014920638601200408; Wright PM, 2005, PERS PSYCHOL, V58, P409, DOI 10.1111/j.1744-6570.2005.00487.x; Meyer JP, 2010, HUM RESOUR MANAGE R, V20, P283, DOI 10.1016/j.hrmr.2009.09.001; [Anonymous], 2011, AEON CHUGOKU NADO 6; Vaara E, 2005, J MANAGE STUD, V42, P595, DOI 10.1111/j.1467-6486.2005.00510.x; Triana MD, 2010, PERS PSYCHOL, V63, P817; Harrison DA, 1998, ACAD MANAGE J, V41, P96, DOI 10.2307/256901; EISENBERGER R, 1986, J APPL PSYCHOL, V71, P500, DOI 10.1037/0021-9010.75.1.51; Kraimer ML, 2012, ACAD MANAGE J, V55, P399, DOI 10.5465/amj.2009.0644; Dewaele JM, 2008, LANG LEARN, V58, P911, DOI 10.1111/j.1467-9922.2008.00482.x; Farmer SM, 2003, ACAD MANAGE J, V46, P618; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842; [Anonymous], 2011, SHIMIZU KENSETSU RYU; ALLEN NJ, 1990, J OCCUP PSYCHOL, V63, P1; Rhoades L, 2001, J APPL PSYCHOL, V86, P825, DOI 10.1037//0021-9010.86.5.825; MARKUS H, 1987, ANNU REV PSYCHOL, V38, P299, DOI 10.1146/annurev.psych.38.1.299; Neeley TB, 2013, ORGAN SCI, V24, P476, DOI 10.1287/orsc.1120.0739; Piekkari R, 2005, INT J HUM RESOUR MAN, V16, P330, DOI 10.1080/0958519042000339534; Baker SC, 2000, LANG LEARN, V50, P311, DOI 10.1111/0023-8333.00119; Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114; Van Knippenberg B, 2006, J ORGAN BEHAV, V27, P685, DOI 10.1002/job.391; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191; Montes SD, 2009, J APPL PSYCHOL, V94, P1243, DOI 10.1037/a0015725; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Neeley TB, 2012, ORGAN DYN, V41, P236, DOI 10.1016/j.orgdyn.2012.03.008; Herold DM, 2007, J APPL PSYCHOL, V92, P942, DOI 10.1037/0021-9010.92.4.942; Herscovitch L, 2002, J APPL PSYCHOL, V87, P474, DOI 10.1037/0021-9010.87.3.474; Piccolo RF, 2006, ACAD MANAGE J, V49, P327; Kuvaas B, 2009, HUM RESOUR MANAG J, V19, P217, DOI 10.1111/j.1748-8583.2009.00103.x; Kraimer ML, 2011, J APPL PSYCHOL, V96, P485, DOI 10.1037/a0021452; Barner-Rasmussen W, 2011, J WORLD BUS, V46, P288, DOI 10.1016/j.jwb.2010.07.006; Bartlett C., 1989, MANAGING BORDERS TRA; Cohen J., 2003, APPL MULTIPLE REGRES; Crystal D., 2003, ENGLISH GLOBAL LANGU; de Saint Leger D., 2009, SYSTEM, V37, P269, DOI [10.1016/j.system.2009.01.001, DOI 10.1016/J.SYSTEM.2009.01.001]; Donovan L. A., 2004, COMMUNICATION RES RE, V21, P420; EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003; English First, 2013, EF ENGL PROF IND; Feely A. J., 2003, CROSS CULTURAL MANAG, V10, P37, DOI DOI 10.1108/13527600310797586; Fredriksson R., 2006, Corporate Communications, V11, DOI 10.1108/13563280610713879; Fugate M, 2012, RES PERS H, V31, P177, DOI 10.1108/S0742-7301(2012)0000031007; Fumoto S., 2011, TENKI MUKAETA SHUKAT; Harpaz I., 2003, HDB INT MANAGEMENT R, P17; Igarashi D., 2010, RAKUTEN MAKE ENGLISH; Jacoby Sanford, 2005, EMBEDDED CORPORATION; Kline R. B., 2005, PRINCIPLES PRACTICE; MacIntyre P. D., 2007, MOD LANG J, V91, P564, DOI DOI 10.1111/J.1540-4781.2007.00623.X; Maclntyre P. D., 1991, LANG LEARN, V41, P513; Marschan-Piekkari R., 1999, INT J HUM RESOUR MAN, V10, P377; Marschan-Piekkari R., 1999, INT BUSINESS REV, V8, P421, DOI DOI 10.1016/S0969-5931(99)00015-3; Meyer J. P., 2001, HUMAN RESOURCE MANAG, V11, P299, DOI DOI 10.1016/S1053-4822(00)00053-X; Ministry of Education C. Sports Science and Technology of Japan (MEXT), 2012, KYOIK SHIH KOK HIK H; Paik Y, 2004, J WORLD BUS, V39, P61, DOI 10.1016/j.jwb.2003.08.003; RILEY A, 1995, SOC PSYCHOL QUART, V58, P61, DOI 10.2307/2787146; SAKS AM, 1995, J APPL PSYCHOL, V80, P211; Schwab K, 2012, GLOBAL COMPETITIVENE; Statistics Bureau of Japan, 2011, POP EST MONTHL REP D; Statistics Bureau of Japan, 2011, LAB FORC SURV DET TA; Taing MU, 2011, J BUS PSYCHOL, V26, P269, DOI 10.1007/s10869-010-9188-z; The Japan Institute for Labour Policy and Training, 2004, LAB LAWS JAP PROV TR; Whelan-Berry K. S., 2010, J CHANGE MANAG, V10, P175; Yoshihara H., 1989, GENCHIJIN SHACHO UCH; Yoshihara H., 2001, EIGO KEIEISURU JIDAI	79	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1090-9516	1878-5573		J WORLD BUS	J. World Bus.	JAN	2015	50	1					168	179		10.1016/j.jwb.2014.03.001		12	Business	Business & Economics	AY1PD	WOS:000347363800017		
J	Sakai, N; Wada, T				Sakai, Norihiko; Wada, Takashi			Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells	KIDNEY INTERNATIONAL			English	Editorial Material							DISEASE; INJURY		[Sakai, Norihiko] Kanazawa Univ Hosp, Div Blood Purificat, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Med, Dept Lab Med, Kanazawa, Ishikawa, Japan	Wada, T (reprint author), Dept Lab Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	twada@m-kanazawa.jp					Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Lee SH, 2004, AM J NEPHROL, V24, P410, DOI 10.1159/000080044; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Turner CM, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-21; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	JAN	2015	87	1					11	14		10.1038/ki.2014.322		4	Urology & Nephrology	Urology & Nephrology	AX5PB	WOS:000346977900004		
J	Eriguchi, M; Tsuruya, K; Haruyama, N; Yamada, S; Tanaka, S; Suehiro, T; Noguchi, H; Masutani, K; Torisu, K; Kitazono, T				Eriguchi, Masahiro; Tsuruya, Kazuhiko; Haruyama, Naoki; Yamada, Shunsuke; Tanaka, Shigeru; Suehiro, Takaichi; Noguchi, Hideko; Masutani, Kosuke; Torisu, Kumiko; Kitazono, Takanari			Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney disease	KIDNEY INTERNATIONAL			English	Article						angiotensin; chronic kidney disease; fibrosis; renin-angiotensin system; renal ablation	RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC-NERVE ACTIVITY; NITRIC-OXIDE SYNTHESIS; RESISTANT HYPERTENSION; CARDIORENAL SYNDROME; INTRARENAL ANGIOTENSINOGEN; RENORENAL REFLEXES; CARDIAC-FUNCTION; TRANSGENIC RATS; DE-NOVO	We elucidate the underlying mechanisms of bidirectional cardiorenal interaction, focusing on the sympathetic nerve driving disruption of the local renin-angiotensin system (RAS). A rat model of N-omega-nitro-L-arginine methyl ester (L-NAME; a nitric oxide synthase inhibitor) administration was used to induce damage in the heart and kidney, similar to cardiorenal syndrome. L-NAME induced sympathetic nerve-RAS overactivity and cardiorenal injury accompanied by local RAS elevations. These were suppressed by bilateral renal denervation, but not by hydralazine treatment, despite the blood pressure being kept the same between the two groups. Although L-NAME induced angiotensinogen (AGT) protein augmentation in both organs, AGT mRNA decreased in the kidney and increased in the heart in a contradictory manner. Immunostaining for AGT suggested that renal denervation suppressed AGT onsite generation from activated resident macrophages of the heart and circulating AGT excretion from glomeruli of the kidney. We also examined rats treated with L-NAME plus unilateral denervation to confirm direct sympathetic regulation of intrarenal RAS. The levels of urinary AGT and renal angiotensin II content and the degrees of renal injury from denervated kidneys were less than those from contralateral innervated kidneys within the same rats. Thus, renal denervation has blood pressure-independent beneficial effects associated with local RAS inhibition.	[Eriguchi, Masahiro; Tsuruya, Kazuhiko; Haruyama, Naoki; Yamada, Shunsuke; Tanaka, Shigeru; Suehiro, Takaichi; Noguchi, Hideko; Masutani, Kosuke; Torisu, Kumiko; Kitazono, Takanari] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Dept Integrated Therapy Chron Kidney Dis, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Tsuruya, K (reprint author), Kyushu Univ, Dept Integrated Therapy Chron Kidney Dis, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp					Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Bongartz LG, 2005, EUR HEART J, V26, P11, DOI 10.1093/eurheratj/ehi020; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Dostal DE, 1999, CIRC RES, V85, P643; Levick SP, 2010, HYPERTENSION, V55, P270, DOI 10.1161/HYPERTENSIONAHA.109.142042; Ellis B, 2012, AM J PHYSIOL-REG I, V302, pR494, DOI 10.1152/ajpregu.00487.2011; DZAU VJ, 1994, CIRCULATION, V89, P493; Kobori H, 2001, J AM SOC NEPHROL, V12, P431; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; Witkowski A, 2011, HYPERTENSION, V58, P559, DOI 10.1161/HYPERTENSIONAHA.111.173799; Nakano D, 2012, J AM SOC NEPHROL, V23, P1847, DOI 10.1681/ASN.2012010078; Kumar R, 2007, TRENDS ENDOCRIN MET, V18, P208, DOI 10.1016/j.term.2007.05.001; LINDPAINTNER K, 1991, CIRC RES, V68, P905; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; SAKUMA I, 1992, CIRC RES, V70, P607; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bongartz LG, 2012, AM J PHYSIOL-RENAL, V303, pF1253, DOI 10.1152/ajprenal.00392.2012; Brandt MC, 2012, J AM COLL CARDIOL, V60, P1956, DOI 10.1016/j.jacc.2012.08.959; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P1558, DOI 10.1681/ASN.2006060554; Singh VP, 2007, AM J PHYSIOL-HEART C, V293, pH939, DOI 10.1152/ajpheart.00391.2007; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Kopkan L, 2009, PHYSIOL RES, V58, pS55; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Hering D, 2012, J AM SOC NEPHROL, V23, P1250, DOI 10.1681/ASN.2011111062; Ikeda H, 2009, KIDNEY INT, V75, P147, DOI 10.1038/ki.2008.507; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Brandt MC, 2012, J AM COLL CARDIOL, V59, P901, DOI 10.1016/j.jacc.2011.11.034; Mahfoud F, 2012, HYPERTENSION, V60, P419, DOI 10.1161/HYPERTENSIONAHA.112.193870; Yoo TH, 2007, KIDNEY INT, V71, P1019, DOI 10.1038/sj.ki.5002195; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Nagasu H, 2010, NEPHROL DIAL TRANSPL, V25, P2889, DOI 10.1093/ndt/gfq139; Mahfoud F, 2011, CIRCULATION, V123, P1940, DOI 10.1161/CIRCULATIONAHA.110.991869; Palazzuoli A, 2011, HEART FAIL REV, V16, P503, DOI 10.1007/s10741-011-9267-x; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Kim J, 2013, J AM SOC NEPHROL, V24, P229, DOI 10.1681/ASN.2012070678; Sakai K, 2007, J CLIN INVEST, V117, P1088, DOI 10.1172/JCI31242; Campese VM, 2002, HYPERTENSION, V39, P519, DOI 10.1161/hy0202.102815; COLINDRES RE, 1980, AM J PHYSIOL, V239, pF265; Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9; Dostal DE, 2000, BASIC RES CARDIOL, V95, P485, DOI 10.1007/s003950070025; GOMEZ RA, 1993, HYPERTENSION, V21, P470; Gonzalez-Villalobos RA, 2013, J CLIN INVEST, V123, P2011, DOI 10.1172/JCI65460; Jordan J, 2013, KIDNEY INT, V84, P250, DOI 10.1038/ki.2013.56; Kashiwagi M, 2000, J AM SOC NEPHROL, V11, P616; Katwa LC, 1997, J MOL CELL CARDIOL, V29, P1375, DOI 10.1006/jmcc.1997.0376; KITAZONO T, 1995, CIRCULATION, V91, P1129; Kobori H, 2007, AM J PHYSIOL-RENAL, V293, pF938, DOI 10.1152/ajprenal.00146.2007; KOPP UC, 1985, AM J PHYSIOL, V249, pF507; LEVENS NR, 1981, CIRC RES, V48, P157; Lu XF, 2013, NEPHROL DIAL TRANSPL, V28, P2977, DOI 10.1093/ndt/gft333; Matsusaka T, 2013, KIDNEY INT, V85, P1068; Miyazawa T, 2013, KIDNEY INT, V84, P1176, DOI 10.1038/ki.2013.214; Pohl M, 2010, J BIOL CHEM, V285, P41935, DOI 10.1074/jbc.M110.150284; Rabkin R, 2008, J AM SOC NEPHROL, V19, P1774, DOI 10.1681/ASN.2007121386; Schinke M, 1999, P NATL ACAD SCI USA, V96, P3975, DOI 10.1073/pnas.96.7.3975; Shabeeh H, 2013, AM J PHYSIOL-HEART C, V304, pH1225, DOI 10.1152/ajpheart.00783.2012; Takemoto M, 1997, J CLIN INVEST, V99, P278, DOI 10.1172/JCI119156; Tian XL, 2004, HUM MOL GENET, V13, P1441, DOI 10.1093/hmg/ddh147; Veelken R, 2008, J AM SOC NEPHROL, V19, P1371, DOI 10.1681/ASN.2007050552	60	4	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	JAN	2015	87	1					116	127		10.1038/ki.2014.220		12	Urology & Nephrology	Urology & Nephrology	AX5PB	WOS:000346977900015		
J	Kajimoto, H; Kai, H; Aoki, H; Uchiwa, H; Aoki, Y; Yasuoka, S; Anegawa, T; Mishina, Y; Suzuki, A; Fukumoto, Y; Imaizumi, T				Kajimoto, Hidemi; Kai, Hisashi; Aoki, Hiroki; Uchiwa, Hiroki; Aoki, Yuji; Yasuoka, Suguru; Anegawa, Takahiro; Mishina, Yuji; Suzuki, Akira; Fukumoto, Yoshihiro; Imaizumi, Tsutomu			BMP type I receptor inhibition attenuates endothelial dysfunction in mice with chronic kidney disease	KIDNEY INTERNATIONAL			English	Article						bone morphogenetic protein receptor activation; chronic kidney disease; endothelial dysfunction; nitric oxide synthase; phosphatase-and-tensin homolog; signal transduction	BONE MORPHOGENETIC PROTEINS; SMOOTH-MUSCLE-CELLS; STAGE RENAL-DISEASE; CARDIOVASCULAR MORTALITY; VASCULAR CALCIFICATION; OSTEOGENIC PROTEIN-1; ALL-CAUSE; DIFFERENTIATION; POPULATION; MECHANISMS	The molecular mechanisms of endothelial dysfunction and vascular calcification have been considered independently and potential links are currently unknown in chronic kidney disease (CKD). Bone morphogenetic protein (BMP) receptor signaling mediates calcification of atherosclerotic plaques. Here we tested whether BMP receptor signaling contributes to endothelial dysfunction, as well as to osteogenic differentiation of vascular smooth muscle cells (VSMCs), in a model of short-term CKD. In C57BL/6 mice, subtotal nephrectomy activated BMP receptor and increased phosphatase-and-tensin homolog (PTEN) protein in the endothelial cells and medial VSMCs without vascular remodeling in the aorta. In the endothelial cells, PTEN induction led to inhibition of the Akt-endothelial nitric oxide synthase (eNOS) pathway and endothelial dysfunction. In VSMCs, the PTEN increase induced early osteogenic differentiation. CKD-induced inhibition of eNOS phosphorylation and the resultant endothelial dysfunction were inhibited in mice with endothelial cell-specific PTEN ablation. Knockout of the BMP type I receptor abolished endothelial dysfunction, the inhibition of eNOS phosphorylation, and VSMC osteogenic differentiation in mice with CKD. A small molecule inhibitor of BMP type I receptor, LDN-193189, prevented endothelial dysfunction and osteogenic differentiation in CKD mice. Thus, BMP receptor activation is a mechanism for endothelial dysfunction in addition to vascular osteogenic differentiation in a short-term CKD model. PTEN may be key in linking BMP receptor activation and endothelial dysfunction in CKD.	[Kajimoto, Hidemi; Kai, Hisashi; Uchiwa, Hiroki; Aoki, Yuji; Yasuoka, Suguru; Anegawa, Takahiro; Fukumoto, Yoshihiro; Imaizumi, Tsutomu] Kurume Univ, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 8300011, Japan; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 812, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welfare, Fukuoka Sanno Hosp, Fukuoka, Japan	Kai, H (reprint author), Kurume Univ, Dept Internal Med, Div Cardiovasc Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	naikai@med.kurume-u.ac.jp			grant for the Science Frontier Research Promotion Centers (Cardiovascular Research Institute); Ministry of Education, Science, Sports, and Culture, Japan; Kidney Foundation	This study was supported, in part, by a grant for the Science Frontier Research Promotion Centers (Cardiovascular Research Institute), Grants-in-Aid for Scientific Research (HK and TI) from the Ministry of Education, Science, Sports, and Culture, Japan, and research grants from the Kidney Foundation (HK). We thank Katsue Shiramizu, Miyuki Nishigata, Kimiko Kimura, Miho Nakao, and Makiko Kiyohiro for technical assistance.	TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Chen NX, 2006, KIDNEY INT, V70, P1046, DOI 10.1038/sj.ki.5001663; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Morris STW, 2001, KIDNEY INT, V60, P1077, DOI 10.1046/j.1523-1755.2001.0600031077.x; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Kim CW, 2013, ARTERIOSCL THROM VAS, V33, P1350, DOI 10.1161/ATVBAHA.112.300287; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Fujii M, 1999, MOL BIOL CELL, V10, P3801; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Ebisawa T, 1999, J CELL SCI, V112, P3519; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Huang PH, 2005, CHEST, V128, P810, DOI 10.1378/chest.128.2.810; Kajimoto H, 2012, KIDNEY INT, V81, P762, DOI 10.1038/ki.2011.476; Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069	27	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	JAN	2015	87	1					128	136		10.1038/ki.2014.223		9	Urology & Nephrology	Urology & Nephrology	AX5PB	WOS:000346977900016		
J	Bailie, GR; Larkina, M; Goodkin, DA; Li, Y; Pisoni, RL; Bieber, B; Mason, N; Tong, L; Locatelli, F; Marshall, MR; Inaba, M; Robinson, BM				Bailie, George R. '; Larkina, Maria; Goodkin, David A.; Li, Yun; Pisoni, Ronald L.; Bieber, Brian; Mason, Nancy; Tong, Lin; Locatelli, Francesco; Marshall, Mark R.; Inaba, Masaaki; Robinson, Bruce M.			Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality	KIDNEY INTERNATIONAL			English	Article						dialysis; erythropoietin; hemodialysis; hemodialysis adequacy; hospitalization; mortality	RECOMBINANT-HUMAN-ERYTHROPOIETIN; HEMODIALYSIS-PATIENTS; PARENTERAL IRON; INSTRUMENTAL VARIABLES; ANEMIA MANAGEMENT; HEMOGLOBIN LEVELS; WEAK INSTRUMENTS; SERUM FERRITIN; DOPPS; OVERLOAD	Intravenous (IV) iron is required for optimal management of anemia in the majority of hemodialysis (HD) patients. While IV iron prescription has increased over time, the best dosing strategy is unknown and any effect of IV iron on survival is unclear. Here we used adjusted Cox regression to analyze associations between IV iron dose and clinical outcomes in 32,435 HD patients in 12 countries from 2002 to 2011 in the Dialysis Outcomes and Practice Patterns Study. The primary exposure was total prescribed IV iron dose over the first 4 months in the study, expressed as an average dose/month. Compared with 100-199mg/month (the most common dose range), case-mix-adjusted mortality was similar for the 0, 1-99, and 200-299mg/month categories but significantly higher for the 300-399mg/month (HR of 1.13, 95% CI of 1.00-1.27) and 400mg/month or more (HR of 1.18, 95% CI of 1.07-1.30) groups. Convergent validity was proved by an instrumental variable analysis, using HD facility as the instrument, and by an analysis expressing IV iron dose/kg body weight. Associations with cause-specific mortality (cardiovascular, infectious, and other) were generally similar to those for all-cause mortality. The hospitalization risk was elevated among patients receiving 300mg/month or more compared with 100-199mg/month (HR of 1.12, 95% CI of 1.07-1.18). In light of these associations, a well-powered clinical trial to evaluate the safety of different IV iron-dosing strategies in HD patients is urgently needed.	[Bailie, George R. '] Albany Coll Pharm & Hlth Sci, Dept Pharm Practice, Albany, NY 12208 USA; [Larkina, Maria; Goodkin, David A.; Li, Yun; Pisoni, Ronald L.; Bieber, Brian; Tong, Lin; Robinson, Bruce M.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Li, Yun; Robinson, Bruce M.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Mason, Nancy] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA; [Locatelli, Francesco] Alessandro Manzoni Hosp, Dept Nephrol & Dialysis & Renal Transplant, Lecce, Italy; [Marshall, Mark R.] Univ Auckland, Middlemore Hosp, Fac Med & Hlth Sci, Dept Renal Med, Auckland 1, New Zealand; [Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endrocrinol & Mol Med, Osaka 558, Japan	Bailie, GR (reprint author), Albany Coll Pharm & Hlth Sci, 106 New Scotland Ave, Albany, NY 12208 USA.	george.bailie@acphs.edu			Amgen; Kyowa Hakko Kirin; AbbVie; Sanofi Renal; Baxter Healthcare; Vifor Fresenius Medical Care Renal Pharma; Germany by Hexal; Germany by DGfN; Germany by Shire; Germany by WiNe Institute	The DOPPS program is supported by Amgen, Kyowa Hakko Kirin, AbbVie, Sanofi Renal, Baxter Healthcare, and Vifor Fresenius Medical Care Renal Pharma. Additional support for specific projects and countries is also provided in Canada by Amgen, BHC Medical, Janssen, Takeda, Kidney Foundation of Canada (for logistics support); in Germany by Hexal, DGfN, Shire, WiNe Institute; and for PDOPPS in Japan by the Japanese Society for Peritoneal Dialysis (JSPD). All support is provided without restrictions on publications. Study design, data interpretation, and manuscript development were performed solely by the authors. Some of these data were presented at the XLVII ERA/EDTA Congress, Munich, Germany, June 2010, and the American Society of Nephrology annual meeting, Denver, CO, USA, November 2010.	Stefansson BV, 2011, NEPHRON CLIN PRACT, V118, pC249, DOI 10.1159/000321645; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Lopes AA, 2012, AM J KIDNEY DIS, V60, P90, DOI 10.1053/j.ajkd.2011.12.025; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Danielson BG, 2004, J AM SOC NEPHROL, V15, pS93, DOI 10.1097/01.ASN.0000143814.49713.C5; Tentori F, 2012, NEPHROL DIAL TRANSPL, V27, P4180, DOI 10.1093/ndt/gfs021; Rostoker G, 2012, AM J MED, V125, P991, DOI 10.1016/j.amjmed.2012.01.015; Canavese C, 2004, KIDNEY INT, V65, P1091, DOI 10.1111/j.1523-1755.2004.00480.x; Pisoni RL, 2009, AM J KIDNEY DIS, V53, P475, DOI 10.1053/j.ajkd.2008.10.043; Sirken G, 2006, CLIN NEPHROL, V66, P348; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Nakanishi T, 2012, CLIN EXP NEPHROL, V16, P819, DOI 10.1007/s10157-012-0694-3; Van Buren P, 2012, INT UROL NEPHROL, V44, P499, DOI 10.1007/s11255-011-0028-5; Coyne DW, 2007, J AM SOC NEPHROL, V18, P975, DOI 10.1681/ASN.2006091034; Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC; Young EW, 2000, KIDNEY INT, V57, pS74; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Hasegawa T, 2011, KIDNEY INT, V79, P340, DOI 10.1038/ki.2010.382; FISHBANE S, 1995, AM J KIDNEY DIS, V26, P41, DOI 10.1016/0272-6386(95)90151-5; Wysowski DK, 2010, AM J HEMATOL, V85, P650, DOI 10.1002/ajh.21794; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Brookhart MA, 2010, JAMA-J AM MED ASSOC, V303, P857, DOI 10.1001/jama.2010.206; Provenzano R, 2009, CLIN J AM SOC NEPHRO, V4, P386, DOI 10.2215/CJN.02840608; Neven E, 2011, NEPHROL DIAL TRANSPL, V26, P1137, DOI 10.1093/ndt/gfq858; Munoz M, 2011, J CLIN PATHOL, V64, P287, DOI 10.1136/jcp.2010.086991; Besarab A, 1999, AM J KIDNEY DIS, V34, P21, DOI 10.1016/S0272-6386(99)70103-4; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Charytan C, 2001, AM J KIDNEY DIS, V37, P300, DOI 10.1053/ajkd.2001.21293; GEISSER P, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1439; Kamanna VS, 2012, AM J NEPHROL, V35, P114, DOI 10.1159/000334939; Khalafallah AA, 2012, BMJ OPEN, V2; Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Working Group, 2012, KIDNEY INT S, V2, P279; Kuo KL, 2008, J AM SOC NEPHROL, V19, P1817, DOI 10.1681/ASN.2007101084; National Clinical Guideline Centre (UK), 2011, AN MAN CHRON KIDN DI; National Kidney Foundation, NKF KDOQI CLIN PRACT; Pisoni Ronald L, 2004, Am J Kidney Dis, V44, P7, DOI 10.1016/S0272-6386(04)01099-6; Raghunathan TE, 1998, IVEWARE IMPUTATION V; Toblli JE, 2010, NEPHROL DIAL TRANSPL, V25, P3631, DOI 10.1093/ndt/gfq260; United States Food and Drug Administration, PUBL HLTH ADV ER AG; United States Renal Data System USRDS 2010, 2010, ANN DAT REP ATL CHRO; Vaziri ND, 2012, AM J MED, V125, P951, DOI 10.1016/j.amjmed.2012.02.009; Wooldridge JM, 2002, INTRO ECONOMETRICS	49	15	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	JAN	2015	87	1					162	168		10.1038/ki.2014.275		7	Urology & Nephrology	Urology & Nephrology	AX5PB	WOS:000346977900019		
J	Yoshikawa, N; Nakanishi, K; Sako, M; Oba, MS; Mori, R; Ota, E; Ishikura, K; Hataya, H; Honda, M; Ito, S; Shima, Y; Kaito, H; Nozu, K; Nakamura, H; Igarashi, T; Ohashi, Y; Iijima, K				Yoshikawa, Norishige; Nakanishi, Koichi; Sako, Mayumi; Oba, Mari S.; Mori, Rintaro; Ota, Erika; Ishikura, Kenji; Hataya, Hiroshi; Honda, Masataka; Ito, Shuichi; Shima, Yuko; Kaito, Hiroshi; Nozu, Kandai; Nakamura, Hidefumi; Igarashi, Takashi; Ohashi, Yasuo; Iijima, Kazumoto		Japanese Study Grp Kidney Dis Chil	A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment	KIDNEY INTERNATIONAL			English	Article						initial treatment; nephrotic syndrome; pediatric nephrology; randomized controlled trial; steroid	CHILDREN; THERAPY; LONG; MANAGEMENT; EPISODE; DISEASE	In this multicenter, open-label, randomized controlled trial, we determined whether 2-month prednisolone therapy for steroid-sensitive nephrotic syndrome was inferior or not to 6-month therapy despite significantly less steroid exposure. The primary end point was time from start of initial treatment to start of frequently relapsing nephrotic syndrome. The pre-specified non-inferiority margin was a hazard ratio of 1.3 with one-sided significance of 5%. We randomly assigned 255 children with an initial episode of steroid-sensitive nephrotic syndrome to either 2 - or 6-month treatment of which 246 were eligible for final analysis. The total prednisolone exposure counted both initial and relapse prednisolone treatment administered over 24 months. Median follow-up in months was 36.7 in the 2-month and 38.2 in the 6-month treatment group. Time to frequent relaps was similar in both groups; however, the median was reached only in the 6-month group (799 days). The hazard ratio was 0.86 (90% confidence interval, 0.64-1.16) and met the non-inferior margin. Time to first relapse was also similar in both groups: median day 242 (2-month) and 243 (6-month). Frequency and severity of adverse events were similar in both groups. Most adverse events were transient and occurred during initial or relapse therapy. Thus, 2 months of initial prednisolone therapy for steroid-sensitive nephrotic syndrome, despite less prednisolone exposure, is not inferior to 6 months of initial therapy in terms of time to onset of frequently relapsing nephrotic syndrome.	[Yoshikawa, Norishige; Nakanishi, Koichi; Shima, Yuko] Wakayama Med Univ, Dept Pediat, Wakayama 6418510, Japan; [Sako, Mayumi; Nakamura, Hidefumi] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Div Clin Trials, Tokyo, Japan; [Oba, Mari S.] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Mori, Rintaro; Ota, Erika] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Ishikura, Kenji; Hataya, Hiroshi; Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo, Japan; [Ito, Shuichi] Natl Ctr Child Hlth & Dev, Dept Nephrol & Rheumatol, Tokyo, Japan; [Kaito, Hiroshi; Nozu, Kandai] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 657, Japan; [Igarashi, Takashi] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Ohashi, Yasuo] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Yoshikawa, N (reprint author), Wakayama Med Univ, Dept Pediat, 811-1 Kimiidera, Wakayama 6418510, Japan.	nori@wakayama-med.ac.jp			Ministry of Health, Labour and Welfare, Japan [H19-shouni-002]	We thank all our patients, their families, and the site investigators. We thank Emma Barber for editing the article. We thank Drs Jonathan Craig, Patrick Niaudet, and Tohru Kobayashi for their helpful advice. The trial was supported by a grant from the Ministry of Health, Labour and Welfare, Japan (H19-shouni-002). The results of this trial were presented in abstract form at the annual meeting of the American Society of Nephrology, November 7-10, 2013, Atlanta, USA. This trial is registered at the University Hospital Medical Information Network clinical trial registry (UMIN-CTR) (http://www.umin.ac.jp/ctr/), registration number UMIN000000747. See the Supplementary Information online for complete Methods (Clinical Study Protocol).	Tarshish P, 1997, J AM SOC NEPHROL, V8, P769; Hiraoka M, 2003, AM J KIDNEY DIS, V41, P1155, DOI 10.1016/S0272-6386(03)00346-9; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Bagga A, 1999, PEDIATR NEPHROL, V13, P824; EHRICH JHH, 1993, EUR J PEDIATR, V152, P357, DOI 10.1007/BF01956754; Hodson EM, 2013, J AM SOC NEPHROL, V24, P7, DOI 10.1681/ASN.2012111093; Hodson EM, 2005, PEDIATR NEPHROL, V20, P1523, DOI 10.1007/s00467-005-1968-8; Hodson EM, 2008, CURR OPIN PEDIATR, V20, P145, DOI 10.1097/MOP.0b013e3282f4307a; Hodson EM, 2008, COCHRANE DB SYST REV, V23; Hodson EM, 2010, COCHRANE DB SYST REV, V4; Iijima K, 2014, CLIN J AM SOC NEPHRO, V9, P271, DOI 10.2215/CJN.13071212; KSIAZEK J, 1995, ACTA PAEDIATR, V84, P889; MacHardy N, 2009, PEDIATR NEPHROL, V24, P2193, DOI 10.1007/s00467-009-1282-y; Mishra OP, 2012, J NEPHROL, V25, P394, DOI 10.5301/jn.5000016; Nakanishi K, 2013, CLIN J AM SOC NEPHRO, V8, P756, DOI 10.2215/CJN.09010912; SCHLESIN.ER, 1968, AM J DIS CHILD, V116, P623; Teeninga N, 2013, J AM SOC NEPHROL, V24, P149, DOI 10.1681/ASN.2012070646; UEDA N, 1988, J PEDIATR-US, V112, P122, DOI 10.1016/S0022-3476(88)80136-7; van Husen M, 2011, PEDIATR NEPHROL, V26, P881, DOI 10.1007/s00467-010-1717-5; Yoshikawa N, 1998, JPN J NEPHROL, V40, P587	20	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	JAN	2015	87	1					225	232		10.1038/ki.2014.260		8	Urology & Nephrology	Urology & Nephrology	AX5PB	WOS:000346977900027		
J	Inoue, T; Umezawa, A; Takenaka, T; Suzuki, H; Okada, H				Inoue, Tsutomu; Umezawa, Akihiro; Takenaka, Tsuneo; Suzuki, Hiromichi; Okada, Hirokazu			The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease models	KIDNEY INTERNATIONAL			English	Article						interstitial fibrosis; obstructive nephropathy; renal tubular epithelial cells	TRANSFORMING GROWTH-FACTOR-BETA-1; FIBROBLASTS DERIVE; FIBROCYTES; INDUCTION; CELLS; MICE	The impact of the epithelial-mesenchymal transition (EMT) to the formation of renal fibrosis has been debated in several lineage-tracing studies, with conflicting findings. Such disparities may have arisen from varying experimental conditions such as different disease models, the mouse strain, and type of genetic alteration used. In order to determine the contribution of these factors to EMT, we generated four kidney disease models in several mouse strains genetically modified to express enhanced green fluorescence protein (EGFP) in cortical tubular epithelial cells under the control of the gamma-glutamyl transpeptidase promoter. Using this approach, the EMT was visible and quantifiable based on a count of EGFP-positive interstitial cells in the fibrotic kidney sections of the four renal disease models found to be either EMT-prone or -resistant. The EMT-prone models consisted of unilateral ureteral obstruction and ischemic nephropathy in SJL mice. The EMT-resistant models consisted of ureteral obstruction in C57B/6 and F1 (C57B/6 x SJL) mice, adriamycin nephrosis in 129 mice, and nephrotoxic serum nephritis in SJL mice. Analyses of these renal disease models suggest the emergence of EMT-derived fibroblasts arises in a disease-specific and strain-dependent manner. Thus, when considering molecular mechanisms and involvement of the EMT in renal fibrosis, it is important to take into account the experimental conditions, particularly the mouse strain and type of disease model.	[Inoue, Tsutomu; Takenaka, Tsuneo; Suzuki, Hiromichi; Okada, Hirokazu] Saitama Med Univ, Fac Med, Dept Nephrol, Saitama 3500495, Japan; [Inoue, Tsutomu; Suzuki, Hiromichi; Okada, Hirokazu] Saitama Med Univ, Res Ctr Genom Med, Project Res Div, Saitama 3500495, Japan; [Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan	Okada, H (reprint author), Saitama Med Univ, Fac Med, Dept Nephrol, 38 Morohongo, Saitama 3500495, Japan.	hirookda@saitama-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Asubio Pharma	This work was supported in part by research grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology and Asubio Pharma.	Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Kim J, 2009, AM J PHYSIOL-RENAL, V297, pF461, DOI 10.1152/ajprenal.90735.2008; BUCALA R, 1994, MOL MED, V1, P71; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Artunc F, 2008, AM J PHYSIOL-RENAL, V295, pF1624, DOI 10.1152/ajprenal.00032.2008; Inoue T, 2009, CLIN EXP NEPHROL, V13, P385, DOI 10.1007/s10157-009-0168-4; Inoue Tsutomu, 2003, FASEB Journal, V17, P268; Kato N, 2008, KIDNEY INT, V73, P1017, DOI 10.1038/KI.2008.7; Okada H, 2008, J AM SOC NEPHROL, V19, P933, DOI 10.1681/ASN.2007060648; Okada H, 2006, AM J PATHOL, V169, P1577, DOI 10.2353/ajpath.2006.060178	20	9	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	JAN	2015	87	1					233	238		10.1038/ki.2014.235		6	Urology & Nephrology	Urology & Nephrology	AX5PB	WOS:000346977900028		
J	Takasu, M; Tsuji, E; Imaeda, N; Matsubara, T; Maeda, M; Ito, Y; Shibata, S; Ando, A; Nishii, N; Yamazoe, K; Kitagawa, H				Takasu, Masaki; Tsuji, Eriko; Imaeda, Noriaki; Matsubara, Tatsuya; Maeda, Masami; Ito, Yusuke; Shibata, Sanae; Ando, Asako; Nishii, Naohito; Yamazoe, Kazuaki; Kitagawa, Hitoshi			Body and major organ sizes of young mature microminipigs determined by computed tomography	LABORATORY ANIMALS			English	Article						microminipig; CT image; size	TOXICOLOGY; MODEL; MINIPIG	To understand the anatomical characteristics of microminipigs, one of the smallest miniature pigs, as a large animal model, we measured the body and organ sizes of four-, five-, six-, and seven-month-old microminipigs (n=4, females) using computed tomography. In addition, the results were compared with those of young mature beagles (10 months old, two males and three females), which have been widely used as a large animal model. The microminipigs at 4-6 months of age were much smaller than the beagles. However, when the microminipigs reached seven months of age, their overall size was similar to that of the beagles. The thoracic cavity volume of the seven-month-old microminipigs was less than half that of the beagles, and the cavity was largely filled by the heart. The liver size of the seven-month-old microminipigs was approximately half of that of the beagles. Moreover, the spleen of the seven-month-old microminipigs was different in morphology, but not different in size from that of the beagles. In addition, although their volumes were the same, the kidneys of the seven-month-old microminipigs, unlike those of the beagles, were flattened in shape. Collectively, the major abdominal organs of the seven-month-old microminipigs were either the same size or smaller than those of the beagles, but the abdominal cavity volume of the seven-month-old microminipigs was larger than that of the beagles. Thus, the abdominal cavity of microminipigs is assumed to be filled with the gastrointestinal tract. The anatomical characteristics of the young mature microminipigs revealed in our study suggest that microminipigs could have great potential as a large animal model for biomedical research.	[Takasu, Masaki; Tsuji, Eriko; Imaeda, Noriaki; Matsubara, Tatsuya; Maeda, Masami; Ito, Yusuke; Shibata, Sanae; Nishii, Naohito; Yamazoe, Kazuaki; Kitagawa, Hitoshi] Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Gifu 501113, Japan; [Ando, Asako] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Kanagawa 2591100, Japan	Takasu, M (reprint author), Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, 1-1 Yanagido, Gifu 501113, Japan.	takasu@gifu-u.ac.jp					Allan JS, 2001, XENOTRANSPLANTATION, V8, P90, DOI 10.1034/j.1399-3089.2001.00176.x; Kawaguchi H, 2011, J PHARMACOL SCI, V115, P115, DOI 10.1254/jphs.10R17FM; Aleman CL, 2000, LAB ANIM, V34, P379, DOI 10.1258/002367700780387741; Bollen P, 1997, PHARMACOL TOXICOL, V80, P3; Svendsen O, 2006, EXP TOXICOL PATHOL, V57, P335, DOI 10.1016/j.etp.2006.03.003; Sato J, 2012, J TOXICOL PATHOL, V25, P103, DOI 10.1293/tox.25.103; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/j.annals.1334.015; Kaneko N, 2011, J PHARMACOL SCI, V115, P112, DOI 10.1254/jphs.10R16FM; Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Simianer H, 2010, J PHARMACOL TOX MET, V62, P221, DOI 10.1016/j.vascn.2010.05.004; Dorso L, 2008, TOXICOL PATHOL, V36, P917, DOI 10.1177/0192623308324958; Dyce KM, 2009, TXB VET ANATOMY; Fitzwater KL, 2011, AM J VET RES, V72, P1178, DOI 10.2460/ajvr.72.9.1178; Kawaguchi H, 2012, J VET MED SCI, V74, P933, DOI 10.1292/jvms.11-0571; Konig HE, 2009, VET ANATOMY DOMESTIC; Lunney JK, 2007, INT J BIOL SCI, V3, P179; Miyoshi N, 2010, IN VIVO, V24, P671	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0023-6772	1758-1117		LAB ANIM-UK	Lab. Anim.	JAN	2015	49	1					65	70		10.1177/0023677214557169		6	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	AX4SN	WOS:000346921700008		
J	Markar, SR; Wiggins, T; Ni, M; Steyerberg, EW; Van Lanschot, JJB; Sasako, M; Hanna, GB				Markar, Sheraz R.; Wiggins, Tom; Ni, Melody; Steyerberg, Ewout W.; Van Lanschot, J. Jan B.; Sasako, Mitsuru; Hanna, George B.			Assessment of the quality of surgery within randomised controlled trials for the treatment of gastro-oesophageal cancer: a systematic review	LANCET ONCOLOGY			English	Review							PHASE-III TRIAL; NEGATIVE GASTRIC-CANCER; SQUAMOUS-CELL CARCINOMA; ADJUVANT CHEMOTHERAPY; ESOPHAGEAL CANCER; CLINICAL-TRIAL; PERIOPERATIVE CHEMOTHERAPY; THORACIC ESOPHAGUS; D2 GASTRECTOMY; OPEN-LABEL	Multicentre, randomised, controlled trials (RCTs) provide level 1 evidence for surgery in the treatment of gastro-oesophageal cancer. This systematic review investigated whether standardisation of surgical techniques in RCTs reduces the variation in lymph-node harvest, in-hospital mortality, and locoregional cancer recurrence. The range in the coefficients of variation for lymph-node harvest (0-07-0-61), proportion of patients with locoregional cancer recurrence (1-1-46-2%), and in-hospital mortality (0-10%) was wide. Credentialing of surgeons through assessment of operative reports and monitoring of their performance through data collection were important factors that reduced the variation in lymph-node harvest. Factors that reduced adjusted in-hospital mortality included credentialing surgeons through procedural volume and operative reports, and standardisation of surgical techniques. Future RCTs should include an assessment of surgical performance as an important aspect of study design to reduce variation in clinical outcomes.	[Markar, Sheraz R.; Wiggins, Tom; Hanna, George B.] Univ London Imperial Coll Sci Technol & Med, Div Surg, Dept Surg & Canc, St Marys Hosp, London W2 1NY, England; [Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr, Ctr Med Decis Sci, Dept Publ Hlth, Rotterdam, Netherlands; [Van Lanschot, J. Jan B.] Erasmus MC Univ Med Ctr, Dept Surg, Rotterdam, Netherlands; [Sasako, Mitsuru] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan	Hanna, GB (reprint author), Univ London Imperial Coll Sci Technol & Med, Div Surg, Dept Surg & Canc, St Marys Hosp, London W2 1NY, England.	g.hanna@imperial.ac.uk					Ando N, 1997, J THORAC CARDIOV SUR, V114, P205, DOI 10.1016/S0022-5223(97)70146-6; Miyashiro I, 2011, GASTRIC CANCER, V14, P212, DOI 10.1007/s10120-011-0027-3; Bouche O, 2005, ANN ONCOL, V16, P1488, DOI 10.1093/annonc/mdi270; Nakajima T, 1999, LANCET, V354, P273, DOI 10.1016/S0140-6736(99)01048-X; Schuhmacher C, 2010, J CLIN ONCOL, V28, P5210, DOI 10.1200/JCO.2009.26.6114; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Di Costanzo F, 2008, J NATL CANCER I, V100, P388, DOI 10.1093/jnci/djn054; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Burmeister BH, 2005, LANCET ONCOL, V6, P659, DOI 10.1016/S1470-2045(05)70288-6; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Nitti D, 2006, ANN ONCOL, V17, P262, DOI 10.1093/annonc/mdj077; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Yonemura Y, 2008, INT J CLIN ONCOL, V13, P132, DOI 10.1007/s10147-007-0727-1; Nakajima T, 2007, BRIT J SURG, V94, P1468, DOI 10.1002/bjs.5996; Kulig J, 2007, AM J SURG, V193, P10, DOI 10.1016/j.amjsurg.2006.04.018; Imamura H, 2011, WORLD J SURG, V35, P625, DOI 10.1007/s00268-010-0914-5; Boonstra JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-181; Chiu PWY, 2005, J GASTROINTEST SURG, V9, P794, DOI 10.1016/j.gassur.2005.05.005; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Nashimoto A, 2003, J CLIN ONCOL, V21, P2282, DOI 10.1200/JCO.2003.06.103; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Teoh AYB, 2013, ANN ONCOL, V24, P165, DOI 10.1093/annonc/mds206; Bajetta E, 2002, ANN ONCOL, V13, P299, DOI 10.1093/annonc/mdf040; Degiuli M, 2014, BRIT J SURG, V101, P23, DOI 10.1002/bjs.9345; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.4760; Miskovic D, 2013, ANN SURG, V257, P476, DOI 10.1097/SLA.0b013e318275b72a; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; BUNT AMG, 1994, J CLIN ONCOL, V12, P417; Cuschieri Sir Alfred, 2014, Ann Surg, V259, pe90, DOI 10.1097/SLA.0000000000000418; Foster JD, 2014, ANN SURG, V260, P220, DOI 10.1097/SLA.0000000000000660; Hanna GB, 2013, HISTOPATHOLOGY, V63, P316, DOI 10.1111/his.12167; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Macdonald JS, 2004, 2004 AM SOC CLIN ONC; Sasako M, 2009, SURGERY, V145, P598, DOI 10.1016/j.surg.2009.03.008; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Suzuki Haruhisa, 2006, Gastric Cancer, V9, P315, DOI 10.1007/s10120-006-0399-y	45	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	JAN	2015	16	1					E23	E31				9	Oncology	Oncology	AX4OZ	WOS:000346912800025		
J	Das, B; Singh, A; Panda, SN; Yasuda, H				Das, Biswadip; Singh, Ajay; Panda, Sudhindra N.; Yasuda, Hiroshi			Optimal land and water resources allocation policies for sustainable irrigated agriculture	LAND USE POLICY			English	Article						Management policies; Optimal allocation; Conjunctive use; Interseasonal allocation; Linear programming; Sensitivity analysis	DECISION-SUPPORT-SYSTEM; CONJUNCTIVE USE; SURFACE-WATER; GROUNDWATER-MANAGEMENT; MULTICROP IRRIGATION; OPTIMIZATION MODEL; INTEGRATED SALT; CANAL COMMAND; OPERATION; OPTIONS	Conjunctive use of surface water and groundwater is being practiced in many regions of the world to bring more areas under irrigation, increase agricultural production and productivity, and also maintain overall system balance. Successful agricultural water management policies put the physical, hydro-geological, and socio-economic constraints on these integrated water supplies. To sustain these constraints, a linear programming (LP) model has been developed for optimal land and water resources allocation in various sectors of the Hirakud Canal Command, a multi-purpose irrigation project on the river Mahanadi in eastern India. To enhance the decision-taking ability of the Hirakud command area development authority, a menu-driven and user-friendly software has been developed by Visual-Basic that incorporates model-base, data-base, knowledge-base subsystems along with the user-interface. The model-base subsystem includes LP, groundwater balance, and evapotranspiration models. The data-base subsystem includes the meteorological, crop, and water resources data. The knowledge-base subsystem was developed from the knowledge derived from the results of the aforementioned models. Sensitivity analysis of the LP model parameters was performed by varying the parameters that affect the optimal cropping pattern and groundwater allocation. The result indicates that conjunctive use of 87% surface water and 13% groundwater is the sustainable water allocation policy of the command area. The model results also indicate that a 20% deviation in existing cropping pattern is the best alternative as it considered socio-economic need and also meets the entire food demand of the study area. (C) 2014 Elsevier Ltd. All rights reserved.	[Das, Biswadip; Singh, Ajay; Panda, Sudhindra N.] Indian Inst Technol, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India; [Yasuda, Hiroshi] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan	Singh, A (reprint author), Indian Inst Technol, Agr & Food Engn Dept, Kharagpur 721302, W Bengal, India.	erajay07@yahoo.co.in					Allen R.G., 1998, 56 FAO, P300; Singh A, 2013, WATER RESOUR MANAG, V27, P3421, DOI 10.1007/s11269-013-0355-7; Singh A, 2012, EXP AGR, V48, P99, DOI 10.1017/S0014479711000780; Singh A, 2012, J HYDROL, V466, P167, DOI 10.1016/j.jhydrol.2012.08.004; Singh A, 2012, AGR WATER MANAGE, V115, P267, DOI 10.1016/j.agwat.2012.09.014; Singh A, 2012, J IRRIG DRAIN E, V138, P955, DOI 10.1061/(ASCE)IR.1943-4774.0000511; Singh DK, 2001, AGR WATER MANAGE, V50, P1, DOI 10.1016/S0378-3774(01)00104-4; Sethi LN, 2006, AGR WATER MANAGE, V83, P209, DOI 10.1016/j.agwat.2005.11.009; Khare D, 2007, RESOUR CONSERV RECY, V51, P487, DOI 10.1016/j.resconrec.2006.09.011; Moradi-Jalal M, 2007, AGR WATER MANAGE, V90, P149, DOI 10.1016/j.agwat.2007.02.013; Singh A, 2012, J IRRIG DRAIN E, V138, P830, DOI 10.1061/(ASCE)IR.1943-4774.0000474; Gorantiwar SD, 2003, J IRRIG DRAIN E-ASCE, V129, P155, DOI 10.1061/(ASCE)0733-9437(2003)129:3(155); Khare D, 2006, J HYDROL, V328, P764, DOI 10.1016/j.jhydrol.2006.01.018; Gaur S, 2011, J HYDROL, V402, P217, DOI 10.1016/j.jhydrol.2011.03.016; Lu HW, 2011, APPL MATH MODEL, V35, P4330, DOI 10.1016/j.apm.2011.03.008; Davies EGR, 2011, ADV WATER RESOUR, V34, P684, DOI 10.1016/j.advwatres.2011.02.010; Singh AK, 2014, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-81-322-1548-6_1; Ito K, 2001, J WATER RES PL-ASCE, V127, P272, DOI 10.1061/(ASCE)0733-9496(2001)127:4(272); REICHARD EG, 1995, WATER RESOUR RES, V31, P2845, DOI 10.1029/95WR02328; Rangarajan R, 2000, J HYDROL, V234, P38, DOI 10.1016/S0022-1694(00)00239-0; Singh A, 2012, J IRRIG DRAIN E, V138, P964, DOI 10.1061/(ASCE)IR.1943-4774.0000510; de Fraiture C, 2010, AGR WATER MANAGE, V97, P502, DOI 10.1016/j.agwat.2009.08.008; Singh A, 2014, AGR WATER MANAGE, V141, P23, DOI 10.1016/j.agwat.2014.04.003; Sethi LN, 2002, WATER RESOUR MANAG, V16, P145, DOI 10.1023/A:1016137726131; Vedula S, 2005, AGR WATER MANAGE, V73, P193, DOI 10.1016/j.agwat.2004.10.014; ARNOLD U, 1989, J WATER RES PL-ASCE, V115, P775; Arumugam N, 1997, J WATER RES PL-ASCE, V123, P266, DOI 10.1061/(ASCE)0733-9496(1997)123:5(266); Bharati L, 2008, AGR WATER MANAGE, V95, P925, DOI 10.1016/j.agwat.2008.03.009; Bouman BAM, 2007, AGR WATER MANAGE, V88, P23, DOI 10.1016/j.agwat.2006.10.005; Carvallo H. O., 1998, J WATER RESOUR PLAN, V105, P260; CASTLE EN, 1960, J FARM ECON, V42, P150, DOI 10.2307/1235328; Central Ground Water Board, 1998, STUD CONJ US SURF GR; Chiu YC, 2010, J WATER RES PL-ASCE, V136, P299, DOI 10.1061/(ASCE)WR.1943-5452.0000034; Dash NB, 2010, NEURAL COMPUT APPL, V19, P1251, DOI 10.1007/s00521-010-0360-1; Dastane N. G., 1978, 25 FAO, P62; Eschenback EA, 2001, J WATER RES PL-ASCE, V127, P108, DOI 10.1061/(ASCE)0733-9496(2001)127:2(108); Fallah-Mehdipour E, 2013, J IRRIG DRAIN ENG, V139, P490, DOI 10.1061/(ASCE)IR.1943-4774.0000572; Ford DT, 2001, J WATER RES PL-ASCE, V127, P254, DOI 10.1061/(ASCE)0733-9496(2001)127:4(254); Fredericks JW, 1998, J WATER RES PL-ASCE, V124, P69, DOI 10.1061/(ASCE)0733-9496(1998)124:2(69); Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; ILLANGASEKARE TH, 1984, J HYDROL, V74, P233, DOI 10.1016/0022-1694(84)90017-9; Karamouz M., 2004, J IRRIGATION DRAINAG, V130, P93; Kitanidis P. K., 1998, WATER RESOUR RES, V34, P1307; MAKNOON R, 1978, J AM WATER WORKS ASS, V70, P419; Marques GF, 2010, J WATER RES PL-ASCE, V136, P386, DOI 10.1061/(ASCE)WR.1943-5452.0000045; O'Mara G. T., 1988, EFFICIENCY IRRIGATIO; ONTA PR, 1991, J WATER RES PL-ASCE, V117, P662, DOI 10.1061/(ASCE)0733-9496(1991)117:6(662); PAUDYAL GN, 1990, J IRRIG DRAIN E-ASCE, V116, P273, DOI 10.1061/(ASCE)0733-9437(1990)116:2(273); PERALTA RC, 1995, J WATER RES PL-ASCE, V121, P471, DOI 10.1061/(ASCE)0733-9496(1995)121:6(471); Prajamwong S, 1997, J IRRIG DRAIN E-ASCE, V123, P106, DOI 10.1061/(ASCE)0733-9437(1997)123:2(106); RAMAN H, 1992, J IRRIG DRAIN E-ASCE, V118, P229, DOI 10.1061/(ASCE)0733-9437(1992)118:2(229); Simonovic SP, 1996, WATER INT, V21, P233; Simonovic SP, 1996, WATER INT, V21, P223; Singh A, 2013, J HYDROL, V481, P220, DOI 10.1016/j.jhydrol.2012.12.042; Singh A., 2014, SCI TOTAL ENV; Singh A, 2010, AGR WATER MANAGE, V97, P1443, DOI 10.1016/j.agwat.2010.04.010; Singh A, 2015, LAND USE POLICY, V42, P244, DOI 10.1016/j.landusepol.2014.08.006; Watkins DW, 1998, ADV WATER RESOUR, V21, P283, DOI 10.1016/S0309-1708(96)00061-9	58	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-8377	1873-5754		LAND USE POLICY	Land Use Pol.	JAN	2015	42						527	537		10.1016/j.landusepol.2014.09.012		11	Environmental Studies	Environmental Sciences & Ecology	AX6FN	WOS:000347018700049		
J	Zhang, L; Kono, Y; Kobayashi, S; Hu, HB; Zhou, R; Qin, YC				Zhang, Le; Kono, Yasuyuki; Kobayashi, Shigeo; Hu, Huabin; Zhou, Rui; Qin, Yaochen			The expansion of smallholder rubber farming in Xishuangbanna, China: A case study of two Dai villages	LAND USE POLICY			English	Article						Land use; Livelihood transition; Forest policy; Community forest	LAND-USE; FOREST MANAGEMENT; SOUTHWEST CHINA; SW CHINA; CONSERVATION; PLANTATIONS; LIVELIHOODS; YUNNAN; RISK	During the last half century, rubber plantations have spread widely and rapidly in Xishuangbanna, China. This study characterizes the process of expansion in smallholder rubber farming and the subsequent changes in upland use through an in-depth case study of two Dai villages in Xishuangbanna. The results show that the area of smallholder rubber farming has increased in the study villages, as observed in other parts of Xishuangbanna. The evolution of forest policy governing the community forest in Xishuangbanna is divided into three periods: the initial, transition and strict control periods. In the initial period, customary law governed the community forest, and planting rubber was a risky choice in the eyes of villagers, while the government-provided subsidy and techniques spurred the conversion from subsistence cropping to rubber gardens. In the transition period, forest governance by the government began to intervene in the land use customs. Villagers recognized the profitability of rubber farming, and they had chance to convert community forests into rubber gardens because the forest policy was ambiguous. The expansion of rubber farming had a substantial impact on forest cover in the transition period, while the village communities conserved a part of community forest because they have a stake in conserving forest resource. In the strict control period, the government initiated a strict control, especially targeting logging. Consequently, even though there remains a strong demand for the expansion of rubber farms, the new lands chosen for rubber farms were areas in which other crops were already established. In conclusion, strict government governance with a clear objective and support from local communities has been sufficient to control the encroachment of smallholder rubber farming into natural forests in Xishuangbanna. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Le; Qin, Yaochen] Henan Univ, Coll Environm & Planning, Kaifeng 475004, Peoples R China; [Kono, Yasuyuki] Kyoto Univ, Ctr Southeast Asian Studies, Kyoto 6068501, Japan; [Kobayashi, Shigeo] Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto 6068501, Japan; [Hu, Huabin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla 666303, Peoples R China; [Zhou, Rui] Fudan Univ, Res Ctr Urban Planning & Dev, Shanghai 200433, Peoples R China	Zhang, L (reprint author), Henan Univ, Coll Environm & Planning, Jinming Rd, Kaifeng City, Henan Province, Peoples R China.	zhangle9527@gmail.com	Hu, Huabin/B-2613-2008	Hu, Huabin/0000-0003-1352-2206			ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Senf C, 2013, REMOTE SENS-BASEL, V5, P2795, DOI 10.3390/rs5062795; BRANDON KE, 1992, WORLD DEV, V20, P557, DOI 10.1016/0305-750X(92)90044-V; CHAPMAN EC, 1991, GEOGR J, V157, P36, DOI 10.2307/635142; Su SL, 2011, APPL GEOGR, V31, P439, DOI 10.1016/j.apgeog.2010.10.008; Henrich J, 2002, CURR ANTHROPOL, V43, P172, DOI 10.1086/338291; Grainger A, 2006, FOREST POLICY ECON, V8, P67, DOI 10.1016/j.forpol.2004.05.005; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Yi ZF, 2014, LAND USE POLICY, V38, P646, DOI 10.1016/j.landusepol.2013.12.013; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Yi ZF, 2014, ECOL INDIC, V36, P788, DOI 10.1016/j.ecolind.2013.03.016; Xiao JY, 2006, LANDSCAPE URBAN PLAN, V75, P69, DOI 10.1016/j.landurbanplan.2004.12.005; GIBSON CC, 1995, WORLD DEV, V23, P941, DOI 10.1016/0305-750X(95)00025-8; Fox J, 2013, J PEASANT STUD, V40, P155, DOI 10.1080/03066150.2012.750605; Ziegler AD, 2009, SCIENCE, V324, P1024, DOI 10.1126/science.1173833; Pagdee A, 2006, SOC NATUR RESOUR, V19, P33, DOI 10.1080/08941920500323260; Falco S. D., 2005, ECOLOGICAL EC, V55, P459; Fox J. M., 2014, ASIAPAC ISSUES, V114, P1; Fu YN, 2009, INT J SUST DEV WORLD, V16, P22, DOI 10.1080/13504500902753246; Kono Y., 2009, SE ASIAN STUD, V47, P244; Lambert DK, 1998, J AGR ECON, V49, P378, DOI 10.1111/j.1477-9552.1998.tb01279.x; Liu DongMei, 2002, Journal of Northeast Forestry University, V30, P83; Mann C. C., 2009, SCIENCE, V325, P565; Mengla administration, 2008, CERT CONTR MAN RUR L; Poore M. E. D, 2003, CHANGING LANDSCAPES; SBMC (Statistical Bureau of Mengla County), 2010, MENGL STAT YB; SBMC (Statistical Bureau of Mengla County), 1980, MENGL STAT YB; SBMC (Statistical Bureau of Mengla County), 2000, MENGL STAT YB; SHAHABUDDIN Q, 1986, OXFORD ECON PAP, V38, P122; Sturgeon JC, 2010, GEOFORUM, V41, P318, DOI 10.1016/j.geoforum.2009.10.010; Zhang L, 2014, AGR SYST, V124, P32, DOI 10.1016/j.agsy.2013.10.006	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-8377	1873-5754		LAND USE POLICY	Land Use Pol.	JAN	2015	42						628	634		10.1016/j.landusepol.2014.09.015		7	Environmental Studies	Environmental Sciences & Ecology	AX6FN	WOS:000347018700060		
J	Batty, AO				Batty, Aaron Olaf			A comparison of video- and audio-mediated listening tests with many-facet Rasch modeling and differential distractor functioning	LANGUAGE TESTING			English	Article						differential distractor functioning; language assessment; listening assessment; many-facet Rasch measurement; nonverbal communication; video listening test	COMPREHENSION; PERFORMANCE; QUESTIONS; STUDENTS; BEHAVIOR; GESTURES	The rise in the affordability of quality video production equipment has resulted in increased interest in video-mediated tests of foreign language listening comprehension. Although research on such tests has continued fairly steadily since the early 1980s, studies have relied on analyses of raw scores, despite the growing prevalence of item response theory in the field of language testing as a whole. The present study addresses this gap by comparing data from identical, counter-balanced multiple-choice listening test forms employing three text types (monologue, conversation, and lecture) administered to 164 university students of English in Japan. Data were analyzed via many-facet Rasch modeling to compare the difficulties of the audio and video formats; to investigate interactions between format and text-type, and format and proficiency level; and to identify specific items biased toward one or the other format. Finally, items displaying such differences were subjected to differential distractor functioning analyses. No interactions between format and text-type, or format and proficiency level, were observed. Four items were discovered displaying format-based differences in difficulty, two of which were found to correspond to possible acting anomalies in the videos. The author argues for further work focusing on item-level interactions with test format.	[Batty, Aaron Olaf] Keio Univ, Fujisawa, Kanagawa 2520882, Japan; [Batty, Aaron Olaf] Univ Lancaster, Lancaster LA1 4YW, England	Batty, AO (reprint author), Keio Univ, 5322 Endo, Fujisawa, Kanagawa 2520882, Japan.	abatty@sfc.keio.ac.jp					Wagner E, 2008, LANG ASSESS Q, V5, P218, DOI 10.1080/15434300802213015; Mayer RE, 1997, EDUC PSYCHOL, V32, P1, DOI 10.1207/s15326985ep3201_1; Cubilo J, 2013, LANG ASSESS Q, V10, P371, DOI 10.1080/15434303.2013.824972; Wagner E, 2013, LANG ASSESS Q, V10, P178, DOI 10.1080/15434303.2013.769552; RISEBOROUGH MG, 1981, J NONVERBAL BEHAV, V5, P172, DOI 10.1007/BF00986134; Wagner E, 2010, LANG TEST, V27, P493, DOI 10.1177/0265532209355668; Wagner E, 2007, LANG LEARN TECHNOL, V11, P67; Penfield RD, 2008, J EDUC MEAS, V45, P247, DOI 10.1111/j.1745-3984.2008.00063.x; KELLERMAN S, 1992, APPL LINGUIST, V13, P239, DOI 10.1093/applin/13.3.239; Wagner E, 2010, SYSTEM, V38, P280, DOI 10.1016/j.system.2010.01.003; Sueyoshi A, 2005, LANG LEARN, V55, P661, DOI 10.1111/j.0023-8333.2005.00320.x; BALTOVA I, 1994, CAN MOD LANG REV, V50, P507; Bachman L. F., 1990, FUNDAMENTAL CONSIDER; Bonk W., 2003, LANG TEST, V20, P89, DOI 10.1191/0265532203lt245oa; Brett P., 1997, SYSTEM, V25, p[39, 53], DOI DOI 10.1016/S0346-251X(96)00059-0; Brindley G., 1998, ANNU REV APPL LINGUI, V18, P171, DOI DOI 10.1017/S0267190500003536; Buck G., 2001, ASSESSING LISTENING; Burgoon J.K., 1994, HDB INTERPERSONAL CO, P229; Coniam D., 2001, SYSTEM, V29, P1, DOI 10.1016/S0346-251X(00)00057-9; Engelhard G, 2009, EDUC PSYCHOL MEAS, V69, P585, DOI 10.1177/0013164408323240; Ginther A, 2002, LANG TEST, V19, P133, DOI [10.1191/0265532202lt225oa, DOI 10.1191/0265532202LT225OA]; Gruba P, 1993, JALT J, V15, P85; Gruba P, 1997, SYSTEM, V25, P335, DOI 10.1016/S0346-251X(97)00026-2; Hernandez S. S., 2004, THESIS NEW YORK U NE; Linacre J. M., 2012, FACETS VERSION 3 70; Linacre J. M., 1989, MANY FACET RASCH MEA; Lynch T, 1998, ANNU REV APPL LINGUI, V18, P3, DOI 10.1017/S0267190500003457; MacWilliam I, 1986, ELT J, V40, P131, DOI 10.1093/elt/40.2.131; Ockey G.J., 2007, LANG TEST, V24, P517, DOI 10.1177/0265532207080771; Penfield R. D., 2010, DDFS VERSION 1 0; Progosh D., 1996, TESL CANADA J, V14, P34; Rost M., 1987, THESIS U LANCASTER L; Rost M., 2002, TEACHING RES LISTENI; Rost M., 1990, LISTENING LANGUAGE L; Ruhe V., 1996, TESL CANADA J, V14, P45; Shin D., 1998, INT J LISTENING, V12, P57; Suvorov R., 2013, THESIS IOWA STATE U; Suvorov R., 2009, DEV EVALUATING LANGU, P53; Wagner E., 2002, WORKING PAPERS TESOL, V2; Wagner E., 2006, THESIS COLUMBIA U NE; Weidenmann B., 1989, KNOWL ACQUIS, P157, DOI DOI 10.1016/S0166-4115(08)62153-6; Wright B. D., 1994, RASCH MEASUREMENT T, V8, P370	42	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0265-5322	1477-0946		LANG TEST	Lang. Test.	JAN	2015	32	1					3	20		10.1177/0265532214531254		18	Linguistics; Language & Linguistics	Linguistics	AX4QX	WOS:000346917600001		
J	Koizumi, R				Koizumi, Rie			Vocabulary Knowledge: Human Ratings and Automated Measures	LANGUAGE TESTING			English	Book Review									[Koizumi, Rie] Juntendo Univ, Urayasu, Chiba, Japan	Koizumi, R (reprint author), Juntendo Univ, Urayasu, Chiba, Japan.						Chapelle C. A., 2013, COMPANION LANGUAGE A, VIII, P1079; Cumming A., 2012, ENCY APPL LINGUISTIC, P6006; Daller H., 2007, MODELLING ASSESSING; JARVIS S, 2013, VOCABULARY KNOWLEDGE	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0265-5322	1477-0946		LANG TEST	Lang. Test.	JAN	2015	32	1					124	126		10.1177/0265532214541233		3	Linguistics; Language & Linguistics	Linguistics	AX4QX	WOS:000346917600008		
J	Kageyama, S; Hata, K; Tanaka, H; Hirao, H; Kubota, T; Okamura, Y; Iwaisako, K; Takada, Y; Uemoto, S				Kageyama, Shoichi; Hata, Koichiro; Tanaka, Hirokazu; Hirao, Hirofumi; Kubota, Toyonari; Okamura, Yusuke; Iwaisako, Keiko; Takada, Yasutsugu; Uemoto, Shinji			Intestinal Ischemic Preconditioning Ameliorates Hepatic Ischemia/Reperfusion Injury in Rats: Role of Heme Oxygenase 1 in the Second Window of Protection	LIVER TRANSPLANTATION			English	Article							REPERFUSION INJURY; INFLAMMATORY RESPONSE; LIVER-TRANSPLANTATION; COLD PRESERVATION; EXPRESSION; RESECTION; HEPATOCYTES; MYOCARDIUM; MECHANISMS; OCCLUSION	Preconditioning by brief ischemia protects not only the concerned organ but also other distant organs against subsequent lethal damage; this is called remote ischemic preconditioning (RIPC). This study was designed to investigate the impact of intestinal RIPC on hepatic ischemia/reperfusion injury (IRI) with a special interest in heme oxygenase 1 (HO-1) induction in the second window of protection (SWOP). Male Wistar rats were randomly assigned to 1 of 2 groups: an RIPC group or a sham group. Before hepatic IRI, either intestinal RIPC, consisting of 2 cycles of 4-minute superior mesenteric artery clamping separated by 11 minutes of declamping (RIPC group), or a sham procedure (sham group) was performed. After 48 hours of recovery, the rats were exposed to 30 minutes of total hepatic IRI. Transaminase releases and proinflammatory cytokines were determined at several time points after reperfusion. Histopathological analysis and animal survival were also investigated. Intestinal RIPC significantly lowered transaminase release (alanine aminotransferase at 2 hours: 873.3 +/- 176.4 IU/L for the RIPC group versus 3378.7 +/- 871.1 IU/L for the sham group, P<.001) as well as proinflammatory cytokine production (tumor necrosis factor at 2 hours: 930 +/- 42 versus 387 +/- 17 pg/L, P<.001). The morphological integrity of the liver and the ileum was maintained significantly better with intestinal RIPC; this reached statistical significance not only in Suzuki's liver injury score (3.5 +/- 0.2 versus 0.7 +/- 0.5, P=.007) but also in Park's score for intestinal damage (4.0 +/- 0.4 versus 2.0 +/- 0.2, P=.007). Animal survival was also markedly improved (83.1% versus 15.4%, P<.001). As a mechanism underlying this protection, HO-1 was substantially induced in liver tissue, especially in hepatocytes, with remarkable up-regulation of bradykinin in the portal blood, whereas HO-1 protein induction in enterocytes was not significant. In conclusion, intestinal RIPC remarkably attenuates hepatic IRI in the SWOP, presumably by HO-1 induction in hepatocytes. Liver Transpl 21:112-122, 2015. (c) 2014 AASLD.	[Kageyama, Shoichi; Hata, Koichiro; Tanaka, Hirokazu; Hirao, Hirofumi; Kubota, Toyonari; Okamura, Yusuke; Iwaisako, Keiko; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6088507, Japan; [Kageyama, Shoichi; Takada, Yasutsugu] Ehime Univ, Grad Sch Med, Dept Hepatobiliary Pancreat & Breast Surg, Matsuyama, Ehime 790, Japan	Hata, K (reprint author), Kyoto Univ, Grad Sch Med, Div Hepatopancreatobiliary Surg & Transplantat, Dept Surg,Sakyo Ku, 54 Kawaharacho, Kyoto 6088507, Japan.	khata@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [21689035, 23390313]	This work was supported by Grants-in-Aid for Young Scientists A (21689035 to Koichiro Hata) and for Scientific Research B (23390313 to Shinji Uemoto and Koichiro Hata) from the Japan Society for the Promotion of Science.	Lai IR, 2006, TRANSPLANTATION, V81, P1311, DOI 10.1097/01.tp.0000203555314546.63; Carini R, 2000, HEPATOLOGY, V31, P166, DOI 10.1002/hep.510310125; Aufricht C, 2002, PEDIATR RES, V51, P722, DOI 10.1023/01.PDR.0000015128.65800.28; Theodoraki K, 2011, SURG TODAY, V41, P620, DOI 10.1007/s00595-010-4444-4; MURRY CE, 1986, CIRCULATION, V74, P1124; Lim SY, 2010, BASIC RES CARDIOL, V105, P651, DOI 10.1007/s00395-010-0099-y; Holland J, 2005, AM J SURG, V190, P393, DOI 10.1016/j.amjsurg.2005.03.038; PRZYKLENK K, 1993, CIRCULATION, V87, P893; Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324; Patel A, 2004, TRANSPLANTATION, V78, P1479, DOI 10.1097/01.TP.0000144182.27897.1E; Ellett JD, 2010, J IMMUNOL, V184, P5849, DOI 10.4049/jimmunol.0902024; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015; PARK PO, 1990, SURGERY, V107, P574; Kato H, 2001, AM J TRANSPLANT, V1, P121, DOI 10.1034/j.1600-6143.2001.10205.x; Teoh N, 2002, HEPATOLOGY, V36, P94, DOI 10.1053/jhep.2002.34134; Kanoria S, 2007, TRANSPLANTATION, V84, P445, DOI 10.1097/01.tp.0000228235.55419.e8; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Peralta C, 1998, HEPATOLOGY, V28, P768, DOI 10.1002/hep.510280325; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Yan S, 2010, HEPATOB PANCREAT DIS, V9, P346; Makino N, 2001, HEPATOLOGY, V33, P32, DOI 10.1053/jhep.2001.21161; Tamion F, 2002, AM J PHYSIOL-GASTR L, V283, pG408, DOI 10.1152/ajpgi.00348.2001; Dixon E, 2005, AM J SURG, V190, P75, DOI 10.1016/j.amjsurg.2004.10.007; Filos KS, 2004, INJURY, V35, P35, DOI 10.1016/S0020-1383(03)00288-2; Hasegawa T, 2007, AM J PHYSIOL-GASTR L, V292, pG1385, DOI 10.1152/ajpgi.00246.2006; Hata K, 2003, J SURG RES, V115, P310, DOI 10.1016/S0022-4804(03)00650-4; Kanoria S, 2006, BRIT J SURG, V93, P762, DOI 10.1002/bjs.5331; Kobayashi T, 2005, TRANSPLANTATION, V79, P977, DOI 10.1097/01.TP.0000155245.85967.AD; Lai IR, 2004, TRANSPLANTATION, V77, P1004, DOI 10.1097/01.TP.0000121507.84801.36; Lemasters J J, 1995, Liver Transpl Surg, V1, P124, DOI 10.1002/lt.500010211; Mallick IH, 2010, AM J SURG, V199, P223, DOI 10.1016/j.amjsurg.2009.01.011; McNally SJ, 2006, TRANSPLANTATION, V81, P623, DOI 10.1097/01.tp.0000184635.62570.13; Zeng Z, 2010, WORLD J GASTROENTERO, V16, P1285, DOI 10.3748/wjg.v16.i10.1285	35	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	JAN	2015	21	1					112	122		10.1002/lt.24006		11	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	AX1TC	WOS:000346727900015		
J	Kuroda, S; Tashiro, H; Kimura, Y; Hirata, K; Tsutada, M; Mikuriya, Y; Kobayashi, T; Amano, H; Tanaka, Y; Ohdan, H				Kuroda, Shintaro; Tashiro, Hirotaka; Kimura, Yasuhiro; Hirata, Kaori; Tsutada, Misaki; Mikuriya, Yoshihiro; Kobayashi, Tsuyoshi; Amano, Hironobu; Tanaka, Yuka; Ohdan, Hideki			Rho-Kinase Inhibitor Targeting the Liver Prevents Ischemia/Reperfusion Injury in the Steatotic Liver Without Major Systemic Adversity in Rats	LIVER TRANSPLANTATION			English	Article							SECONDARY BILIARY-CIRRHOSIS; NITRIC-OXIDE SYNTHASE; REPERFUSION INJURY; SIGNALING CONTRIBUTES; PORTAL-HYPERTENSION; RHOA/RHO-KINASE; FATTY LIVER; ISCHEMIA; TRANSPLANTATION; COMPLICATIONS	Rho-kinase (ROCK) inhibitors improve liver blood flow after ischemia/reperfusion (IR) injury, especially in the setting of steatosis, by decreasing the resistance of intrahepatic microcirculation through hepatic stellate cell (HSC) relaxation. However, the systemic administration of ROCK inhibitors causes severe hypotension; therefore, liver-specific ROCK inhibition is required. Here, we tested vitamin A (VA)-coupled liposomes carrying the ROCK inhibitor Y-27632 for targeted HSCs in steatotic rats. Rat livers with steatosis induced by a choline-deficient diet were subjected to IR injury. The delivery site and effect of the ROCK inhibitor were investigated. After liposomal Y-27632 injection, the survival rate after IR, the liver blood flow, the portal perfused pressure, and the hemodynamics were investigated. Immunohistochemical studies showed VA-coupled liposome accumulation in livers. Liposomal Y-27632 was 100-fold more effective in inhibiting HSC activation than free Y-27632. Liposomal Y-27632 improved the survival rate after IR injury, the liver blood flow, and the portal perfusion pressure without severe hypotension. In contrast, untargeted Y-27632 elicited severe systemic hypotension. We conclude that VA-coupled liposomes carrying the ROCK inhibitor yield enhanced drug accumulation in the liver and thus mitigate IR injury in the steatotic liver and reduce major systemic adversity. Liver Transpl 21:123-131, 2015. (c) 2014 AASLD.	[Kuroda, Shintaro; Tashiro, Hirotaka; Mikuriya, Yoshihiro; Kobayashi, Tsuyoshi; Amano, Hironobu; Tanaka, Yuka; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Hiroshima 7348551, Japan; [Kimura, Yasuhiro; Hirata, Kaori; Tsutada, Misaki] Hiroshima Univ Hosp, Dept Pharmaceut Serv, Hiroshima, Japan	Tashiro, H (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	htashiro@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [21591748]	This work was supported in part by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research 21591748 to Hirotaka Tashiro). This work was carried out in part at the Analysis Center of Life Science in Hiroshima University.	El-Badry AM, 2007, HEPATOLOGY, V45, P855, DOI 10.1002/hep.21625; Hennenberg M, 2008, GUT, V57, P1300, DOI 10.1136/gut.2007.144584; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Anegawa G, 2008, HEPATOLOGY, V47, P966, DOI 10.1002/hep.22089; Kuroda S, 2012, J HEPATOL, V56, P146, DOI 10.1016/j.jhep.2011.04.029; Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; van der Heijden M, 2008, APOPTOSIS, V13, P404, DOI 10.1007/s10495-007-0173-6; Gomez D, 2007, BRIT J SURG, V94, P1395, DOI 10.1002/bjs.5820; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; McCormack L, 2007, ANN SURG, V245, P923, DOI 10.1097/01.sla.0000251747.80025.b7; Caraceni P, 1997, HEPATOLOGY, V25, P943, DOI 10.1002/hep.510250426; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hennenberg M, 2006, GASTROENTEROLOGY, V130, P838, DOI 10.1053/j.gastro.2005.11.029; HUI AM, 1994, HEPATOLOGY, V20, P1287, DOI 10.1002/hep.1840200528; Kikuchi A, 1999, HUM GENE THER, V10, P947, DOI 10.1089/10430349950018346; Mizunuma K, 2003, TRANSPLANTATION, V75, P579, DOI 10.1097/01.TP.0000052593.16876.AF; Ogawa T, 2007, AM J TRANSPLANT, V7, P347, DOI 10.1111/j.1600-6143.2006.01647.x; Schepke M, 2001, HEPATOLOGY, V34, P884, DOI 10.1053/jhep.2001.28794; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; Takeda K, 2003, SURGERY, V133, P197, DOI 10.1067/msy.2003.59; Trevisani F, 1996, J HEPATOL, V24, P114, DOI 10.1016/S0168-8278(96)80195-4; ZHANG JX, 1995, AM J PHYSIOL-GASTR L, V269, pG269; Zhou Q, 2006, GUT, V55, P1296, DOI 10.1136/gut.2005.081059	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	JAN	2015	21	1					123	131		10.1002/lt.24020		9	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	AX1TC	WOS:000346727900016		
J	Ichikawa, S; Motosugi, U; Morisaka, H; Sano, K; Ichikawa, T; Tatsumi, A; Enomoto, N; Matsuda, M; Fujii, H; Onishi, H				Ichikawa, Shintaro; Motosugi, Utaroh; Morisaka, Hiroyuki; Sano, Katsuhiro; Ichikawa, Tomoaki; Tatsumi, Akihisa; Enomoto, Nobuyuki; Matsuda, Masanori; Fujii, Hideki; Onishi, Hiroshi			Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis	MAGNETIC RESONANCE IMAGING			English	Article						Magnetic resonance elastography; Transient elastography; Hepatic fibrosis; Liver stiffness	STAGING LIVER FIBROSIS; MR ELASTOGRAPHY; NONINVASIVE ASSESSMENT; STIFFNESS MEASUREMENTS; CIRRHOSIS; DISEASE; REPEATABILITY; FEASIBILITY; COMBINATION; BIOPSY	Objectives: To compare the diagnostic accuracies of magnetic resonance elastography (MRE) and transient elastography (TE) for hepatic fibrosis. Materials and Methods: This retrospective study was approved by the institutional review board and included 113 patients (mean age, 63.1 +/- 12.2 years; 84 men and 29 women) with chronic liver disease who underwent liver biopsy or resection, histopathologic assessment (METAVIR scoring system), and TE within 6 months of MRE. Diagnostic accuracies of MRE and TE were compared using receiver operating characteristic curve analysis. Appropriate cutoff values of the two methods determined by maximum positive and minimum negative likelihood ratios were used to calculate the positive and negative predictive values for discriminating significant fibrosis (>= F2) from F0-F1 or cirrhosis (F4) from F0-F3. Results: Mean (95% confidence interval) area under the receiver operating characteristic curve values of MRE for cirrhosis (F4) (0.97 [0.93-0.99] vs. 0.93 [0.87-0.96]; P = 0.0308), clinically significant fibrosis (>= F2) (0.98 [0.94-0.99] vs. 0.87 [0.79-0.92]; P = 0.0003), and any fibrosis (>= F1) (0.97 [0.92-0.99] vs. 0.87 [0.76-0.93]; P = 0.0126) were significantly higher than those of TE. By using the cutoff values derived from the maximum positive likelihood ratio, the positive and negative predictive values for >= F2 were 98.8% and 83.9%, respectively, by MRE and 98.2% and 44.8%, respectively, by TE; and for F4, 97.0% and 86.3%, respectively, by MRE and 95.8% and 77.5%, respectively, by TE. Conclusion: MRE has better diagnostic accuracy than TE for staging hepatic fibrosis. (C) 2014 Elsevier Inc. All rights reserved.	[Ichikawa, Shintaro; Motosugi, Utaroh; Morisaka, Hiroyuki; Sano, Katsuhiro; Ichikawa, Tomoaki; Onishi, Hiroshi] Univ Yamanashi, Dept Radiol, Chuo, Yamanashi 4093898, Japan; [Tatsumi, Akihisa; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Chuo, Yamanashi 4093898, Japan; [Matsuda, Masanori; Fujii, Hideki] Univ Yamanashi, Dept Surg 1, Chuo, Yamanashi 4093898, Japan; [Motosugi, Utaroh] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA	Motosugi, U (reprint author), Univ Yamanashi, Dept Radiol, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	si99006@yahoo.co.jp; umotosugi@uwhealth.org; morisakahiroyuki@hotmail.co.jp; snkthr@yahoo.co.jp; ichikawa@yamanashi.ac.jp; tatsumi@yamanashi.ac.jp; enomoto@yamanashi.ac.jp; masam@yamanashi.ac.jp; hfujii@yamanashi.ac.jp; honishi1829@gmail.com					Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Motosugi U, 2011, MAGN RESON IMAGING, V29, P1047, DOI 10.1016/j.mri.2011.05.007; Bohte AE, 2014, EUR RADIOL, V24, P638, DOI 10.1007/s00330-013-3046-0; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; Regev A, 2002, AM J GASTROENTEROL, V97, P2614; Talwalkar JA, 2009, AM J ROENTGENOL, V193, P122, DOI 10.2214/AJR.07.3504; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Shire NJ, 2011, J MAGN RESON IMAGING, V34, P947, DOI 10.1002/jmri.22716; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942; Wang QB, 2012, HEPATOLOGY, V56, P239, DOI 10.1002/hep.25610; Kim YK, 2012, INVEST RADIOL, V47, P159, DOI 10.1097/RLI.0b013e31823a1495; Kim YK, 2012, RADIOLOGY, V265, P104, DOI 10.1148/radiol.12112649; Hines CDG, 2010, J MAGN RESON IMAGING, V31, P725, DOI 10.1002/jmri.22066; Motosugi U, 2013, MAGN RESON MED SCI, V12, P161, DOI 10.2463/mrms.2012-0085; Mannelli L, 2012, CLIN RADIOL, V67, P258, DOI 10.1016/j.crad.2011.08.022; Foucher J, 2006, EUR J GASTROEN HEPAT, V18, P411, DOI 10.1097/00042737-200604000-00015; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Mitsufuji T, 2013, JPN J RADIOL, V31, P336, DOI 10.1007/s11604-013-0195-7; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Taouli B, 2009, AM J ROENTGENOL, V193, P14, DOI 10.2214/AJR.09.2601; Yoon JH, 2013, KOREAN J RADIOL, V14, P202, DOI 10.3348/kjr.2013.14.2.202; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Fraquelli M, 2007, HEPATOLOGY, V46, P282, DOI 10.1002/hep.21653; Friedrich-Rust M, 2007, Z GASTROENTEROL, V45, P387, DOI 10.1055/s-2007-963008; Guo Y, 2014, ABDOM IMAGING; Ichikawa S, 2012, MAGN RESON MED SCI, V11, P291; Motosugi U, 2011, JPN J RADIOL, V29, P639, DOI 10.1007/s11604-011-0607-5; Motosugi U, 2010, JPN J RADIOL, V28, P623, DOI 10.1007/s11604-010-0478-1; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580	37	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JAN	2015	33	1					26	30		10.1016/j.mri.2014.10.003		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX8EO	WOS:000347143300002		
J	Numano, T; Mizuhara, K; Hata, J; Washio, T; Homma, K				Numano, Tomokazu; Mizuhara, Kazuyuki; Hata, Junichi; Washio, Toshikatsu; Homma, Kazuhiro			A simple method for MR elastography: a gradient-echo type multi-echo sequence	MAGNETIC RESONANCE IMAGING			English	Article						MR elastography; Multi-echo sequence; Motion encoding gradient; Pneumatic vibration; Synchronization; Psoas major muscle	MAGNETIC-RESONANCE ELASTOGRAPHY; ACOUSTIC STRAIN WAVES; BRAIN; LIVER; VISUALIZATION; MUSCLE	To demonstrate the feasibility of a novel MR elastography (MRE) technique based on a conventional gradient-echo type multi-echo MR sequence which does not need additional bipolar magnetic field gradients (motion encoding gradient: MEG), yet is sensitive to vibration. In a gradient-echo type multi-echo MR sequence, several images are produced from each echo of the train with different echo times (TEs). If these echoes are synchronized with the vibration, each readout's gradient lobes achieve a MEG-like effect, and the later generated echo causes a greater MEG-like effect. The sequence was tested for the tissue-mimicking agarose gel phantoms and the psoas major muscles of healthy volunteers. It was confirmed that the readout gradient lobes caused an MEG-like effect and the later TE images had higher sensitivity to vibrations. The magnitude image of later generated echo suffered the 12 decay and the susceptibility artifacts, but the wave image and elastogram of later generated echo were unaffected by these effects. In in vivo experiments, this method was able to measure the mean shear modulus of the psoas major muscle. From the results of phantom experiments and volunteer studies, it was shown that this method has clinical application potential. (C) 2014 Elsevier Inc. All rights reserved.	[Numano, Tomokazu; Hata, Junichi] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Arakawa Ku, Tokyo 158, Japan; [Mizuhara, Kazuyuki] Tokyo Denki Univ, Dept Mech Engn, Tokyo, Japan; [Hata, Junichi] Tokyo Univ Hosp, Tokyo, Japan; [Numano, Tomokazu; Washio, Toshikatsu; Homma, Kazuhiro] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan	Numano, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Arakawa Ku, 7-2-10 Higashiogu, Tokyo 158, Japan.	t-numano@tmu.ac.jp			Adaptable and Seamless Technology transfer Program [A-STEP AS242Z01253P];  [25461838]	This work was supported in part by a Grant-in-Aid for Scientific Research (25461838) and an Adaptable and Seamless Technology transfer Program (A-STEP AS242Z01253P).	Plewes DB, 2000, PHYS MED BIOL, V45, P1591, DOI 10.1088/0031-9155/45/6/314; Arani A, 2011, MAGN RESON MED, V66, P1649, DOI 10.1002/mrm.22967; Sahebjavaher RS, 2013, MAGN RESON MED, V69, P411, DOI 10.1002/mrm.24268; Plewes DB, 1995, JMRI-J MAGN RESON IM, V5, P733, DOI 10.1002/jmri.1880050620; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.0.CO;2-1; Muthupillai R, 1996, MAGNET RESON MED, V36, P266, DOI 10.1002/mrm.1910360214; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Latta P, 2011, MAGN RESON IMAGING, V29, P147, DOI 10.1016/j.mri.2010.07.014; Asbach P, 2008, MAGN RESON MED, V60, P373, DOI 10.1002/mrm.21636; Di leva A, 2010, NEUROSURG REV, V33, P137; Liu GR, 2009, ACTA RADIOL, V50, P423, DOI 10.1080/02841850902751681; Maderwald S, 2006, J MAGN RESON IMAGING, V23, P774, DOI 10.1002/jmri.20570; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Weaver JB, 2003, P 11 ANN M ISMRM TRO	22	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JAN	2015	33	1					31	37		10.1016/j.mri.2014.10.002		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX8EO	WOS:000347143300003		
J	Noda, Y; Kanematsu, M; Goshima, S; Kondo, H; Watanabe, H; Kawada, H; Kawai, N; Tanahashi, Y; Bae, KT				Noda, Yoshifumi; Kanematsu, Masayuki; Goshima, Satoshi; Kondo, Hiroshi; Watanabe, Haruo; Kawada, Hiroshi; Kawai, Nobuyuki; Tanahashi, Yukichi; Bae, Kyongtae T.			Prediction of early response to uterine artery embolization in fibroids: Value of MR signal intensity ratio	MAGNETIC RESONANCE IMAGING			English	Article						Magnetic resonance imaging; Uterine fibroid; Uterine artery embolization; Signal intensity ratio	IMAGING CHARACTERISTICS; FAILURE; HYSTERECTOMY; PATIENT; UTERUS; TRIAL	Objective: To quantitatively assess magnetic resonance (MR) imaging findings that help predict early post-therapeutic response in fibroids following uterine artery embolization (UAE). Methods: Fifteen patients with a total of 52 fibroids underwent UAE. The signal intensity ratio (SIR) on T1-, T2-, diffusion weighted and gadolinium-enhanced images was calculated by dividing the mean signal intensity of fibroids by that of the abdominal rectus muscle. Fibroids were divided into the two groups: affected (post-UAE volume reduction rate > median of all fibroids) and unaffected (<median rate). The SIRs were compared between the two groups. ROC analysis was used to evaluate the predictive performance for differentiating the affected from unaffected lesions. Results: The SIRs of the affected group were significantly lower on T1-weighted images (0.85 +/- 0.1 vs 0.95 +/- 0.2) (P = 0.0001), but higher on T2-weighted (130 +/- 0.6 vs 1.12 +/- 0.9) (P = 0.026) and gadolinium-enhanced images (1.51 +/- 02 vs 120 +/- 0.4) (P = 0.0002) than those of the unaffected group. There was no significant difference in ADC values between the two groups (P = 0.510). The sensitivity, specificity, and area under the ROC curve (AUC) in the prediction of the affected lesions were 92%, 50%, and 0.712 with SIR on T1-weighted images, and 85%, 62%, and 0.731 with SIR on gadolinium-enhanced images, respectively. Conclusions: The SIRs on T1-weighted images and gadolinium-enhanced images were useful for the prediction of the changes in size of fibroids responding to UAE. (C) 2014 Elsevier Inc. All rights reserved.	[Noda, Yoshifumi; Kanematsu, Masayuki; Goshima, Satoshi; Kondo, Hiroshi; Watanabe, Haruo; Kawada, Hiroshi; Kawai, Nobuyuki; Tanahashi, Yukichi] Gifu Univ Hosp, Dept Radiol, Gifu 5011194, Japan; [Kanematsu, Masayuki] Gifu Univ Hosp, Dept Radiol Serv, Gifu 5011194, Japan; [Bae, Kyongtae T.] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA USA	Kanematsu, M (reprint author), Gifu Univ Hosp, Dept Radiol, 1-1 Yanagido, Gifu 5011194, Japan.	masa_gif@yahoo.co.jp					Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Edwards RD, 2007, NEW ENGL J MED, V356, P360; Spies JB, 2002, RADIOLOGY, V222, P45; Cura M, 2006, ACTA RADIOL, V47, P1105, DOI 10.1080/02841850600965047; Manyonda IT, 2012, CARDIOVASC INTER RAD, V35, P530, DOI 10.1007/s00270-011-0228-5; Omary RA, 2002, J VASC INTERV RADIOL, V13, P1149, DOI 10.1016/S1051-0443(07)61957-5; Burn PR, 2000, RADIOLOGY, V214, P729; ORSINI LF, 1984, RADIOLOGY, V153, P113; Hehenkamp WJK, 2008, RADIOLOGY, V246, P823, DOI 10.1148/radiol.2463070260; Jha RC, 2000, RADIOLOGY, V217, P228; KAWAKAMI S, 1994, J COMPUT ASSIST TOMO, V18, P925, DOI 10.1097/00004728-199411000-00014; Bradley LD, 2009, AM J OBSTET GYNECOL, V201, P127, DOI 10.1016/j.ajog.2009.01.031; Burn PR, 1998, RADIOLOGY, V209P, P225; HANLEY JA, 1983, RADIOLOGY, V148, P839; Hecht EM, 2011, J MAGN RESON IMAGING, V33, P641, DOI 10.1002/jmri.22459; Matson M, 2000, CARDIOVASC INTER RAD, V23, P393, DOI 10.1007/s002700010090; Spies JB, 2003, J VASC INTERV RADIOL, V14, P11, DOI 10.1097/01.RVI.0000052286.26939.f9; Toor SS, 2008, J VASC INTERV RADIOL, V19, P662, DOI 10.1016/j.jvir.2007.12.454	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JAN	2015	33	1					51	55		10.1016/j.mri.2014.09.006		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX8EO	WOS:000347143300006		
J	Goto, T; Kabasawa, H				Goto, Takao; Kabasawa, Hiroyuki			Robust automated bolus tracker positioning for MRI liver scans	MAGNETIC RESONANCE IMAGING			English	Article						Magnetic resonance; Workflow; Bolus tracker; AdaBoost; Mean shift	TUBULAR STRUCTURES; MEDICAL IMAGES; ANGIOGRAPHY; SEGMENTATION; MODELS	Purpose: To improve the workflow of MRI abdominal scans by reducing the examination time and operator skill dependence related to bolus tracker positioning. Methods: Ten or more axial images of two-dimensional scout scan were analyzed to identify the aorta and detect its center position using the mean shift to allow automated bolus tracker placement. Adaptive boosting (AdaBoost) classifier was used to identify the aorta rotating a sub-window around the cerebrospinal fluid (CSF), the location of which was detected in each axial image in advance. The search region of the aorta in the next inferior axial image was restricted to half to reduce computation time. Tests were conducted using the proposed method with a 1.5 T scanner in 31 volunteers. Results: The success rate of aorta detection was 98.4%, and the accuracy of center location was around 0 - 5 mm shift from the true center. The computation time was 30 s on MATLAB, which was half that required for non-restrictive search. Conclusion: The proposed algorithm was able to accurately detect the aorta in all volunteers with practical computation time so that the automated bolus tracker placement improved the workflow of MRI abdominal scans. (C) 2014 Elsevier Inc. All rights reserved.	[Goto, Takao; Kabasawa, Hiroyuki] GE Healthcare, Applicat & Workflow, Hino, Tokyo, Japan	Goto, T (reprint author), GE Healthcare, Global Applicat & Workflow, 4-7-127 Asahigaoka, Hino, Tokyo, Japan.	Takao.Goto@ge.com					Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Materne R, 2000, JMRI-J MAGN RESON IM, V11, P244, DOI 10.1002/(SICI)1522-2586(200003)11:3<244::AID-JMRI2>3.0.CO;2-Q; Behrens T, 2003, IEEE T SYST MAN CY B, V33, P554, DOI 10.1109/TSMCB.2003.814305; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Frydrychowicz A, 2012, J MAGN RESON IMAGING, V35, P492, DOI 10.1002/jmri.22833; Wheaton AJ, 2012, J MAGN RESON IMAGING, V36, P286, DOI 10.1002/jmri.23641; Avidan S, 2007, IEEE T PATTERN ANAL, V29, P261, DOI 10.1109/TPAMI.2007.35; Bernstein MA, 2004, HDB MRI PULSE SEQUEN, P648, DOI 10.1016/B978-012092861-3/50022-4; de Bruijne M, 2003, LECT NOTES COMPUT SC, V2732, P136; Fan ZY, 2009, MAGN RESON MED, V62, P1523, DOI 10.1002/mrm.22142; Goto T, 2013, MED IMAG TECH, V31, P105; Goto T, 2012, P 20 ANN M ISMRM MEL, P3402; Goto T, 2013, P 21 ANN M ISMRM SAL, P3725; Ho VB, 1998, INVEST RADIOL, V33, P515, DOI 10.1097/00004424-199809000-00006; Hodge JV, 2004, ARTIF INTELL REV, V22, P85; Levi K, 2004, IEEE COMP SOC C COMP, P1063; Rueckert D, 1997, IEEE T MED IMAGING, V16, P581, DOI 10.1109/42.640747; Schapire RE, 2001, P MSRI WORKSH NONL E; Vignaux O, 2002, J MAGN RESON IMAGING, V15, P654, DOI 10.1002/jmri.10115; Viola P, 2001, IEEE COMP SOC C COMP; Wells W M 3rd, 1996, Med Image Anal, V1, P35, DOI 10.1016/S1361-8415(96)80004-1; Zhao F, 2009, MED IMAGE ANAL, V13, P483, DOI 10.1016/j.media.2009.02.005	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JAN	2015	33	1					63	71		10.1016/j.mri.2014.08.038		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX8EO	WOS:000347143300008		
J	Shimizu, H; Isoda, H; Ohno, T; Yamashita, R; Kawahara, S; Furuta, A; Fujimoto, K; Kido, A; Kusahara, H; Togashi, K				Shimizu, Hironori; Isoda, Hiroyoshi; Ohno, Tsuyoshi; Yamashita, Rikiya; Kawahara, Seiya; Furuta, Akihiro; Fujimoto, Koji; Kido, Aki; Kusahara, Hiroshi; Togashi, Kaori			Non-contrast-enhanced MR portography and hepatic venography with time-spatial labeling inversion pulses: Comparison of imaging with the short tau inversion recovery method and the chemical shift selective method	MAGNETIC RESONANCE IMAGING			English	Article						Non-contrast-enhanced MR portography; Non-contrast-enhanced MR hepatic venography; Time-spatial labeling inversion pulses; CHESS method; STIR method	FAST SPIN-ECHO; VASCULAR ANATOMY; ROW CT; ANGIOGRAPHY; SEQUENCE	Purpose: To compare and evaluate images of non-contrast enhanced magnetic resonance (MR) portography and hepatic venography acquired with two different fat suppression methods, the chemical shift selective (CHESS) method and short tau inversion recovery (STIR) method. Materials and methods: Twenty-two healthy volunteers were examined using respiratory-triggered three-dimensional true steady-state free-precession with two time-spatial labeling inversion pulses. The CHESS or STIR methods were used for fat suppression. The relative signal-to-noise ratio and contrast-to-noise ratio (CNR) were quantified, and the quality of visualization was scored. Results: Image acquisition was successfully conducted in all volunteers. The STIR method significantly improved the CNRs of MR portography and hepatic venography. The image quality scores of main portal vein and right portal vein were higher with the STIR method, but there were no significant differences. The image quality scores of right hepatic vein, middle hepatic vein, and left hepatic vein (LHV) were all higher, and the visualization of LHV was significantly better (p < 0.05). Conclusion: The STIR method contributes to further suppression of the background signal and improves visualization of the portal and hepatic veins. The results support using non-contrast-enhanced MR portography and hepatic venography in clinical practice. (C) 2014 Elsevier Inc. All rights reserved.	[Shimizu, Hironori; Isoda, Hiroyoshi; Ohno, Tsuyoshi; Yamashita, Rikiya; Kawahara, Seiya; Furuta, Akihiro; Fujimoto, Koji; Kido, Aki; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Kusahara, Hiroshi] Toshiba Med Syst Corp, Dept MRI Syst Dev, Tokyo, Japan	Shimizu, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	hshimizu@kuhp.kyoto-u.ac.jp; sayuki@kuhp.kyoto-u.ac.jp; goohno@kuhp.kyoto-u.ac.jp; rickdom@kuhp.kyoto-u.ac.jp; butaemon@kuhp.kyoto-u.ac.jp; akihirof@kuhp.kyoto-u.ac.jp; kfb@kuhp.kyoto-u.ac.jp; akikido@kuhp.kyoto-u.ac.jp; hiroshi.kusahara@glb.toshiba.co.jp; ktogashi@kuhp.kyoto-u.ac.jp					Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; Delfaut EM, 1999, RADIOGRAPHICS, V19, P373; GAIANI S, 1991, GASTROENTEROLOGY, V100, P160; Shimada K, 2009, J MAGN RESON IMAGING, V29, P1140, DOI 10.1002/jmri.21753; Isoda H, 2007, J MAGN RESON IMAGING, V25, P1000, DOI 10.1002/jmri.20892; Guiney MJ, 2003, RADIOLOGY, V229, P401, DOI 10.1148/radiol.2292021437; Shimada K, 2009, J MAGN RESON IMAGING, V29, P474, DOI 10.1002/jmri.21636; Heilmaier C, 2007, RADIOLOGY, V245, P872, DOI 10.1148/radiol.2453062103; Shimada K, 2009, AM J ROENTGENOL, V193, P106, DOI 10.2214/AJR.08.1626; Lee MW, 2007, EUR RADIOL, V17, P1074, DOI 10.1007/s00330-006-0447-3; Bernstein MA, 2004, HDB MRI PULSE SEQUEN, P960, DOI 10.1016/B978-012092861-3/50026-1; Buhaescu I, 2008, INT J CLIN PRACT, V62, P1113, DOI 10.1111/j.1742-1241.2007.01582.x; Shimada K, 2011, EUR J RADIOL, V77, P137, DOI 10.1016/j.ejrad.2009.05.051	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JAN	2015	33	1					81	85		10.1016/j.mri.2014.08.013		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX8EO	WOS:000347143300010		
J	Yamasaki, T; Fujiwara, H; Oda, R; Mikami, Y; Ikeda, T; Nagae, M; Shirai, T; Morisaki, S; Ikoma, K; Masugi-Tokita, M; Yamada, K; Kawata, M; Kubo, T				Yamasaki, Tetsuro; Fujiwara, Hiroyoshi; Oda, Ryo; Mikami, Yasuo; Ikeda, Takumi; Nagae, Masateru; Shirai, Toshiharu; Morisaki, Shinsuke; Ikoma, Kazuya; Masugi-Tokita, Miwako; Yamada, Kei; Kawata, Mitsuhiro; Kubo, Toshikazu			In vivo evaluation of rabbit sciatic nerve regeneration with diffusion tensor imaging (DTI): correlations with histology and behavior	MAGNETIC RESONANCE IMAGING			English	Article						Peripheral nerve; Regeneration; Diffusion tenor imaging; Rabbit; Fractional anisotropy; Toe-spreading reflex	MAGNETIC-RESONANCE NEUROGRAPHY; SPINAL-CORD; MULTIPLE-SCLEROSIS; PERONEAL NERVE; RETINAL ISCHEMIA; OPTIC-NERVE; INJURY; DEGENERATION; PATHOLOGY; MRI	Diffusion tensor imaging (DTI) is widely used in the study of the central nervous system. DTI represents a potential diagnostic tool for the peripheral nerve. However, more detailed information is needed for application of DTI in the clinical setting. In this study, peripheral degeneration and regeneration were evaluated using DTI-based analyses in a rabbit model. The changes in DTI parameters were compared to histological and functional changes after nerve injury. We used a high magnetic field (7.04 T) MRI system. Japanese white male rabbits were used as the model of sciatic nerve crush injury. MR images were obtained before injury and at 2, 4, 6 and 8 weeks post-injury. The DTI parameters of fractional anisotropy (FA), axial diffusivity (lambda(parallel to)), and radial diffusivity (Xi were calculated. Our results showed decreased FA and increased X during the degenerative phase after sciatic nerve injury. In contrast, increased FA and decreased X., were observed during the regenerative phase. FA changes were correlated with axon number and with motor function recovery, assessed with the toe-spreading index. This study clearly demonstrates the validity of applying DTI parameters to the in vivo evaluation of peripheral nerve regeneration. Furthermore, results suggest that DTI can be a potent tool for predicting the extent of functional recovery after peripheral nerve injury. (C) 2014 Elsevier Inc. All rights reserved.	[Yamasaki, Tetsuro; Fujiwara, Hiroyoshi; Oda, Ryo; Mikami, Yasuo; Ikeda, Takumi; Nagae, Masateru; Shirai, Toshiharu; Morisaki, Shinsuke; Ikoma, Kazuya; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan; [Masugi-Tokita, Miwako; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Anat & Neurobiol, Kamigyo Ku, Kyoto 6028566, Japan; [Yamada, Kei] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kamigyo Ku, Kyoto 6028566, Japan	Oda, R (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan.	roda@koto.kpu-m.ac.jp					Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Stanisz GJ, 2001, MAGNET RESON MED, V45, P415, DOI 10.1002/1522-2594(200103)45:3<415::AID-MRM1054>3.0.CO;2-M; Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI [10.1016/j.expneurol.2009.10.012, 10.1016/j.expneuro1.2009.10.012]; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; FILLER AG, 1993, LANCET, V341, P659, DOI 10.1016/0140-6736(93)90422-D; Morisaki S, 2011, J MAGN RESON IMAGING, V33, P535, DOI 10.1002/jmri.22442; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Bendszus M, 2004, EXP NEUROL, V188, P171, DOI 10.1016/j.expneurol.2004.03.025; Li XC, 2013, EUR J RADIOL, V82, pE707, DOI 10.1016/j.ejrad.2013.07.018; Jirjis MB, 2013, J NEUROTRAUM, V30, P1577, DOI 10.1089/neu.2013.2897; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; Kouyoumdjian JA, 2006, MUSCLE NERVE, V34, P785, DOI 10.1002/mus.20624; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1006/jmrb.1996.0086; Beer GM, 2008, J RECONSTR MICROSURG, V24, P11, DOI 10.1055/s-2008-1042960; Brennan FH, 2013, NEUROIMAGE, V82, P574, DOI 10.1016/j.neuroimage.2013.06.019; Derr JJ, 2009, AM J PHYS MED REHAB, V88, P547, DOI [10.1097/PHM.0b013e3181a9f519, 10.1097/PHM.0b013e181a9f519]; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Drobyshevsky A, 2007, J CEREBR BLOOD F MET, V27, P270, DOI 10.1038/sj.jcbfm.9600333; Filler AG, 1996, J NEUROSURG, V85, P299, DOI 10.3171/jns.1996.85.2.0299; Gutmann E, 1942, J EXP BIOL, V19, P14; Gutmann E, 1942, J NEUROL PSYCHIATRY, V5, P81, DOI 10.1136/jnnp.5.3-4.81; Keen NN, 2012, SKELETAL RADIOL, V41, P401, DOI 10.1007/s00256-011-1251-y; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Ludeman NA, 2008, NEUROLOGY, V71, P1676, DOI 10.1212/01.wnl.0000304084.59964.e2; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Marciniak C, 2005, MUSCLE NERVE, V31, P520, DOI 10.1002/mus.20308; Nilsson M, 2013, MAGMA, P1; Raducan A, 2013, ROM J MORPHOL EMBRYO, V54, P735; Schmitz HC, 2001, LAB ANIM-UK, V35, P334, DOI 10.1258/0023677011911921; Schmitz HC, 2001, LAB ANIM-UK, V35, P340, DOI 10.1258/0023677011911930; Zollinger LV, 2011, J MAGN RESON IMAGING, V33, P557, DOI 10.1002/jmri.22502	37	7	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JAN	2015	33	1					95	101		10.1016/j.mri.2014.09.005		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX8EO	WOS:000347143300012		
J	Lee, Y; Han, Y; Park, H; Watanabe, H; Garwood, M; Park, JY				Lee, Yoojin; Han, Yeji; Park, HyunWook; Watanabe, Hidehiro; Garwood, Michael; Park, Jang-Yeon			New Phase-Based B-1 Mapping Method Using Two-Dimensional Spin-Echo Imaging with Hyperbolic Secant Pulses	MAGNETIC RESONANCE IN MEDICINE			English	Article						B-1 mapping; flip-angle mapping; RF field mapping; spin-echo imaging; hyperbolic secant pulse; frequency-modulation pulse	IN-VIVO; RADIOFREQUENCY FIELD; MAGNETIC-RESONANCE; 7 T; NONUNIFORMITIES; INVERSION; SEQUENCE; NMR; MRI	PurposeTo propose a new phase-based B-1-mapping method that exploits phase information created by hyperbolic secant (HS) pulses in conventional 2D spin-echo imaging. MethodsIn this B-1-mapping method, HS pulses are used to accomplish /2 excitation and refocusing in standard multislice spin-echo imaging. When setting the ratio of pulse lengths of the /2 and HS pulses to 2:1, the spin-echo phase is independent of offset frequency and varies as a function of B-1 strength. To eliminate undesired phase accumulations induced by unknown factors other than the B-1 strength, two spin-echo images are acquired using HS pulses applied with opposite frequency-sweep directions, and the resulting phase images are subtracted from each other. To demonstrate the performance of the proposed method, phantom and in vivo experiments were performed using a surface coil and a volume coil. ResultsThe B-1 maps obtained by using the proposed method were in accordance with the B-1 maps obtained using previous methods in both phantom and in vivo experiments. ConclusionThe proposed method is easy to implement without any sequence modification, is insensitive to B-0 inhomogeneity and chemical shift, and is robust in a reasonably wide range of B-1 field strength. Magn Reson Med 73:170-181, 2015. (c) 2014 Wiley Periodicals, Inc.	[Lee, Yoojin; Han, Yeji; Park, HyunWook] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea; [Watanabe, Hidehiro] Natl Inst Environm Studies, Ctr Environm Measurement & Anal, Tsukuba, Ibaraki, Japan; [Garwood, Michael] Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Garwood, Michael] Univ Minnesota, Sch Med, Dept Radiol, Minneapolis, MN 55455 USA; [Park, Jang-Yeon] Res Inst Biomed Engn, Coll Biomed & Hlth Sci, Sch Biomed Engn, Chungju, South Korea	Park, JY (reprint author), Konkuk Univ, Sch Biomed Engn, Danwol Dong 322, Chungju Si 380701, Chungcheongbuk, South Korea.	jyparu@kku.ac.kr	Park, Hyun Wook/C-2038-2011		Konkuk University	Grant sponsor: The Faculty Research Fund of Konkuk University in 2010.	CONOLLY S, 1991, MAGNET RESON MED, V18, P28, DOI 10.1002/mrm.1910180105; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Stollberger R, 1996, MAGNET RESON MED, V35, P246, DOI 10.1002/mrm.1910350217; Wang JH, 2005, MAGNET RESON MED, V53, P408, DOI 10.1002/mrm.20354; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Moore J, 2012, J MAGN RESON, V214, P212, DOI 10.1016/j.jmr.2011.11.010; Cunningham CH, 2006, MAGN RESON MED, V55, P1326, DOI 10.1002/mrm.20896; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Arnold JB, 2001, NEUROIMAGE, V13, P931, DOI 10.1006/nimg.2001.0756; Balchandani P, 2012, MAGN RESON MED, V67, P1077, DOI 10.1002/mrm.23089; Center for Devices and Radiologic Health, 2003, GUID SUBM PREM NOT M; Chang YLV, 2012, MAGN RESON MED, V67, P718, DOI 10.1002/mrm.23051; INSKO EK, 1993, J MAGN RESON SER A, V103, P82, DOI 10.1006/jmra.1993.1133; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Lin C, 2001, P 9 ANN M ISMRM GLAS; Morrell GR, 2008, MAGN RESON MED, V60, P889, DOI 10.1002/mrm.21729; OH CH, 1990, MAGN RESON IMAGING, V8, P21, DOI 10.1016/0730-725X(90)90207-I; Park JY, 2008, P 16 ANN M ISMRM TOR; Park JY, 2009, MAGN RESON MED, V61, P175, DOI 10.1002/mrm.21822; Park JY, 2006, MAGN RESON MED, V55, P848, DOI 10.1002/mrm.20821; SILVER MS, 1984, NATURE, V310, P681, DOI 10.1038/310681a0; SILVER MS, 1985, PHYS REV A, V31, P2753, DOI 10.1103/PhysRevA.31.2753; Wang JH, 2005, MAGNET RESON MED, V53, P666, DOI 10.1002/mrm.20377; Watanabe H, 2011, J MAGN RESON, V212, P426, DOI 10.1016/j.jmr.2011.08.001	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0740-3194	1522-2594		MAGN RESON MED	Magn. Reson. Med.	JAN	2015	73	1					170	181		10.1002/mrm.25110		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX4NJ	WOS:000346908800016		
J	Yang, E; Yin, LS				Yang, Enlin; Yin, Linsheng			Derivatives of Siegel modular forms and modular connections	MANUSCRIPTA MATHEMATICA			English	Article							DIFFERENTIAL-OPERATORS	We introduce a method in differential geometry to study the derivative operators of Siegel modular forms. By determining the coefficients of the invariant Levi-Civita connection on a Siegel upper half plane, and further by calculating the expressions of the differential forms under this connection, we get a non-holomorphic derivative operator of the Siegel modular forms. In order to get a holomorphic derivative operator, we introduce a weaker notion, called modular connection, on the Siegel upper half plane. Then we show that on a Siegel upper half plane there exists at most one holomorphic -modular connection in some sense, and get a possible holomorphic derivative operator of Siegel modular forms.	[Yang, Enlin; Yin, Linsheng] Tsinghua Univ, Dept Math Sci, Beijing 100084, Peoples R China	Yang, E (reprint author), Univ Tokyo, Dept Math Sci, Tokyo 1538914, Japan.	yangenlin0727@126.com; lsyin@math.tsinghua.edu.cn			NSFC [11271212]	This paper was partially supported by NSFC No. 11271212.	Andrianov A, 2009, UNIVERSITEXT, P1; Bocherer S, 2013, INT MATH RES NOTICES, P2534, DOI 10.1093/imrn/rns116; Bocherer S., 1998, COMM MATH U SANCTI P, V47, P135; Bump D., 1997, CAMBRIDGE STUDIES AD, V55; Chern S. S., 1999, LECT DIFFERENTIAL GE; Eholzer W, 1998, INT J MATH, V9, P443, DOI 10.1142/S0129167X98000191; Goldfeld D, 2006, CAMBRIDGE STUDIES AD, V99; HARRIS M, 1981, MATH ANN, V258, P135, DOI 10.1007/BF01450530; Ibukiyama T., 1999, COMM MATH U ST PAULI, V48, P103; Jost J., 1988, RIEMANNIAN GEOMETRY; Koblitz N., 1984, INTRO ELLIPTIC CURVE; Maass H., 1971, LNM, V216; Maass H., 1955, LECT SIEGELS MODULAR; Paradan P.-E., SYMMETRIC SPACES NON; SHIMURA G, 1981, DUKE MATH J, V48, P813, DOI 10.1215/S0012-7094-81-04845-6; van der Geer G., 2008, LECT SUMMER SCH NORD, P181; WEISSAUER R, 1983, J REINE ANGEW MATH, V343, P184; WEISSAUER R, 1987, LECT NOTES MATH, V1240, P304; Yang J., ARXIV13011156; Zagier D., 2008, LECT SUMMER SCH NORD, P1	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-2611	1432-1785		MANUSCRIPTA MATH	Manuscr. Math.	JAN	2015	146	1-2					65	84		10.1007/s00229-014-0687-5		20	Mathematics	Mathematics	AX8MZ	WOS:000347164800003		
J	Ushikoshi, E				Ushikoshi, Erika			New approach to the Hadamard variational formula for the Green function of the Stokes equations	MANUSCRIPTA MATHEMATICA			English	Article							DOMAINS	We consider the Hadamard variational formula for the Green function of the Stokes equations which describes the motion of the incompressible fluid moving infinitesimally on the bounded domain Omega with the smooth boundary a,Omega. Under the perturbation with preserving its volume and keeping its topological type, we establish a more refined proof of its formula of the Green function not only for the first variation but also the second variation for both velocity and pressure. Our method gives a new systematic proof of the Hadamard variational formula, which enables us to deal with the higher derivatives with respect to the perturbation of domains.	Tamagawa Univ, Fac Engn, Tokyo 1948611, Japan	Ushikoshi, E (reprint author), Tamagawa Univ, Fac Engn, Tokyo 1948611, Japan.	ushikoshi@eng.tamagawa.ac.jp			JSPS KAKENHI [25887045]	The author would like to appreciate to Professor Hideo Kozono for giving her variable comments and encouragement. This work was supported by JSPS KAKENHI Grant Number 25887045.	Odqvist FKG, 1930, MATH Z, V32, P329, DOI 10.1007/BF01194638; PEETRE J, 1980, J DIFFER EQUATIONS, V36, P335, DOI 10.1016/0022-0396(80)90053-4; AOMOTO K, 1979, J FUNCT ANAL, V34, P493, DOI 10.1016/0022-1236(79)90090-9; Bogovskii M.E., 1980, SOLUTIONS SOME PROBL, V1; BORCHERS W., 1990, HOKKAIDO MATH J, V19, P67; FUJIWARA D, 1978, P JPN ACAD A-MATH, V54, P215; Garabedian P. R., 1964, PARTIAL DIFFERENTIAL; Garabedian P.R., 1953, J ANAL MATH, V2, P281; Hadamard J., 1908, MEMOIRE PROBLEME ANA, V33, P515; Inoue A., 1977, Journal of the Faculty of Science, University of Tokyo, Section 1A (Mathematics), V24; Kozono H, 2013, ARCH RATION MECH AN, V208, P1005, DOI 10.1007/s00205-013-0611-2; Ladyzhenskaya O. A., 1963, MATH THEORY VISCOUS; Ozawa S., 1979, THESIS U TOKYO; OZAWA S, 1978, P JPN ACAD A-MATH, V54, P322; OZAWA S, 1981, DUKE MATH J, V48, P767, DOI 10.1215/S0012-7094-81-04842-0; Solonnikov V.A., 1966, P STEKLOV I MATH, V92, P269; Ushikoshi E, 2013, INDIANA U MATH J, V62, P1315	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-2611	1432-1785		MANUSCRIPTA MATH	Manuscr. Math.	JAN	2015	146	1-2					85	106		10.1007/s00229-014-0695-5		22	Mathematics	Mathematics	AX8MZ	WOS:000347164800004		
J	Mase, M; Ueda, K				Mase, Makiko; Ueda, Kazushi			A note on bimodal singularities and mirror symmetry	MANUSCRIPTA MATHEMATICA			English	Article							CONSTRUCTION; MANIFOLDS	We discuss the relation between transposition mirror symmetry of Berglund and Hubsch for bimodal singularities and polar duality of Batyrev for associated toric K3 hypersurfaces. We also show that homological mirror symmetry for singularities implies the geometric construction of Coxeter-Dynkin diagrams of bimodal singularities by Ebeling and Ploog.	[Mase, Makiko] Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan; [Mase, Makiko] Osaka City Univ, Adv Math Inst, Sumiyoshi Ku, Osaka 5588585, Japan; [Ueda, Kazushi] Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Mase, M (reprint author), Tokyo Metropolitan Univ, Dept Math & Informat Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	mtmase@arion.ocn.ne.jp; kazushi@math.sci.osaka-u.ac.jp			JSPS [24740043]	We thank the anonymous referee for reading the paper carefully and suggesting several improvements. K. U. is supported by JSPS Grant-in-Aid for Young Scientists No. 24740043. A part of this work is done while K. U. is visiting Korea Institute for Advanced Study, whose hospitality and wonderful working environment is gratefully acknowledged.	WITTEN E, 1993, NUCL PHYS B, V403, P159, DOI 10.1016/0550-3213(93)90033-L; BERGLUND P, 1993, NUCL PHYS B, V393, P377, DOI 10.1016/0550-3213(93)90250-S; Futaki M, 2011, SEL MATH-NEW SER, V17, P435, DOI 10.1007/s00029-010-0055-6; ARNOLD VI, 1976, INVENT MATH, V35, P87, DOI 10.1007/BF01390134; EISENBUD D, 1980, T AM MATH SOC, V260, P35, DOI 10.2307/1999875; GREENE BR, 1989, NUCL PHYS B, V324, P371, DOI 10.1016/0550-3213(89)90471-9; Seidel P, 2010, COMMUN MATH PHYS, V297, P515, DOI 10.1007/s00220-009-0944-8; VAFA C, 1989, PHYS LETT B, V218, P51, DOI 10.1016/0370-2693(89)90473-5; Orlov D, 2009, PROG MATH, V270, P503, DOI 10.1007/978-0-8176-4747-6_16; Batyrev V. V., 1994, J ALGEBRAIC GEOM, V3, P493; Buchweitz R.-O., 1987, MAXIMAL COHEN MACAUL; Ebeling W, 2013, MANUSCRIPTA MATH, V140, P195, DOI 10.1007/s00229-012-0536-3; Futaki M, 2013, MATH Z, V273, P633, DOI 10.1007/s00209-012-1024-x; IArnold V., 1975, USPEKCHI MAT NAUK, V30, P3, DOI 10.1070/RM1975v030n05ABEH001521; Kobayashi M., 2008, TOKYO J MATH, V31, P225, DOI 10.3836/tjm/1219844834; Kontsevich M., 1995, P INT C MATH ZUR 199, P120; Krawitz M., ARXIV09060796; Martinec E.J., 1990, PHYSICS MATH STRINGS, P389; Orlov D., 2004, T MAT I STEKLOVA, V246, P240; Seidel P, 2008, ZUR LECT ADV MATH, P1; Takahashi A., 2009, WORKSH HOM MIRR SYMM; Ueda K., P AM MATH S IN PRESS	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-2611	1432-1785		MANUSCRIPTA MATH	Manuscr. Math.	JAN	2015	146	1-2					153	177		10.1007/s00229-014-0693-7		25	Mathematics	Mathematics	AX8MZ	WOS:000347164800007		
J	Di Proietto, V; Shiho, A				Di Proietto, Valentina; Shiho, Atsushi			On p-adic differential equations on semistable varieties II	MANUSCRIPTA MATHEMATICA			English	Article								This paper is a complement to the paper "On p-adic differential equations on semistable varieties" by Di Proietto. Given an open variety over a DVR with semistable reduction, the author constructed in that paper a fully faithful algebraization functor from the category of certain log overconvergent isocrystals on the special fiber to the category of modules with regular integrable connection on the generic fiber. In this paper, we prove that, with convenable hypothesis, this functor is a tensor functor whose essential image is closed under extensions and subquotients. As a consequence, we can find suitable Tannakian subcategories of log overconvergent isocrystals and of modules with regular integrable connection on which the algebraization functor is an equivalence of Tannakian categories.	[Di Proietto, Valentina] Univ Strasbourg, Inst Rech Math Avancee, F-67084 Strasbourg, France; [Shiho, Atsushi] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Di Proietto, V (reprint author), Univ Strasbourg, Inst Rech Math Avancee, 7 Rue Rene Descartes, F-67084 Strasbourg, France.	diproietto@math.unistra.fr			Japanese Society for the Promotion of Science (JSPS); Labex IRMIA; JSPS [21740003, 22340001, 25400008, 23340001]	The main part of this work was done when the first author was at the Graduate School of Mathematical Sciences of the University of Tokyo supported by a postdoctoral fellowship and kaken-hi (grant-in-aid) of the Japanese Society for the Promotion of Science (JSPS). She is now supported by a postdoctoral fellowship of Labex IRMIA. When the main part of this work was done, the second author was supported by JSPS Grant-in-Aid for Young Scientists (B) 21740003 and Grant-in-Aid for Scientific Research (B) 22340001. Currently he is supported by JSPS Grant-in-Aid for Scientific Research (C) 25400008 and Grant-in-Aid for Scientific Research (B) 23340001.	Andre Y., 2001, PROGR MATH, V189; Baldassarri F., 2005, MILAN J MATH, V73, P237, DOI 10.1007/s00032-005-0046-9; BALDASSARRI F, 1993, DUKE MATH J, V72, P241, DOI 10.1215/S0012-7094-93-07210-9; Berthelot P., 1996, IRMAR 96 03; Deligne P., 1982, LECT NOTES MATH, V900, P101; Deligne P., 1990, PROGR MATH, V87, P111; Deligne P., 1970, LECT NOTES MATH, V163; Di Proietto V, 2013, MATH Z, V274, P1047, DOI 10.1007/s00209-012-1106-9; Kedlaya KS, 2007, COMPOS MATH, V143, P1164, DOI 10.1112/S0010437X07002886; Shiho A., ARXIV07071743; Shiho A., ARXIV10104364; Shiho A, 2010, MANUSCRIPTA MATH, V132, P517, DOI 10.1007/s00229-010-0360-6; Shiho A., 2000, J MATH SCI-U TOKYO, V7, P509; Shiho A, 2011, MATH Z, V269, P59, DOI 10.1007/s00209-010-0716-3; Shiho A, 2010, MATH ANN, V348, P467, DOI 10.1007/s00208-010-0489-3	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-2611	1432-1785		MANUSCRIPTA MATH	Manuscr. Math.	JAN	2015	146	1-2					179	199		10.1007/s00229-014-0691-9		21	Mathematics	Mathematics	AX8MZ	WOS:000347164800008		
J	Herppich, WB; Matsushima, U; Graf, WG; Zabler, S; Dawson, M; Choinka, G; Manke, I				Herppich, Werner B.; Matsushima, Uzuki; Graf, Wolfgang; Zabler, Simon; Dawson, Martin; Choinka, Gerard; Manke, Ingo			Synchrotron X-ray CT of rose peduncles - evaluation of tissue damage by radiation	MATERIALS TESTING			English	Article						Computer tomography; synchrotron X-ray tomography	COLD NEUTRON; COMPUTED MICROTOMOGRAPHY; CHLOROPHYLL FLUORESCENCE; ELECTRON TOMOGRAPHY; MATERIALS SCIENCE; WATER-FLOW; VISUALIZATION; RADIOGRAPHY; BEAM	"Bent-neck" syndrome, an important postharvest problem of cut roses, is probably caused by water supply limitations and/or the structural weakness of vascular bundles of the peduncle tissue. For this reason, advanced knowledge about the microstructures of rose peduncles and their cultivar specific variations may lead to a better understanding of the underlying mechanisms. Synchrotron X-ray computed tomography (SXCT), especially phase-based CT, is a highly suitable technique to nondestructively investigate plants' micro anatomy. SXCT with monochromatic X-ray beams of 30, 40 and 50 keV photon energy was used to evaluate the three-dimensional inner structures of the peduncles of 3 rose cultivars that differ greatly in their bent-neck susceptibility. Results indicated that this technique achieves sufficiently high spatial resolution to investigate complex tissues. However, further investigations with chlorophyll fluorescence analysis (CFA) and optical microscope imagery reveal different kinds of heavy damage of the irradiated regions induced by synchrotron X-rays; in a cultivar-specific manner, partial destruction of cell walls occurred a few hours after X-ray irradiation. Furthermore, a delayed inhibition of photosynthesis accompanied by the degradation of chlorophyll was obvious from CFA within hours and days after the end of CT measurements. Although SXCT is certainly well suited for three-dimensional anatomical analysis of rose peduncles, the applied technique is not nondestructive.	[Herppich, Werner B.] Univ Bayreuth, Munster, Germany; [Herppich, Werner B.] Univ Munster, D-48149 Munster, Germany; [Herppich, Werner B.] Potsdam Bornim eV, Leibniz Inst Agrartechn, Abt Techn Gartenbau, D-14469 Potsdam, Germany; [Matsushima, Uzuki] Univ Ryukyus, Nishihara, Okinawa 90301, Japan; [Matsushima, Uzuki] Iwate Univ, Fac Agr Environm Sci Recycling Bioprod Engn, Morioka, Iwate 020, Japan; [Matsushima, Uzuki] Iwate Univ, Fac Agr, Morioka, Iwate 020, Japan; [Graf, Wolfgang] Assoc Technol & Struct Agr KTBL, Darmstadt, Germany; [Zabler, Simon] MPIKG Golm, Potsdam, Germany; [Zabler, Simon] TU Berlin, Berlin, Germany; [Zabler, Simon] Fraunhofer IIS, Project Grp NanoCT Syst NCTS, Erlangen, Germany; [Zabler, Simon] Univ Wurzburg, Chair Xray Microscopy, Wurzburg, Germany; [Dawson, Martin] Helmholtz Zentrum Berlin Mat & Energy, Berlin, Germany; [Manke, Ingo] Helmholtz Ctr Berlin Mat & Energy HZB, Imaging Grp, Berlin, Germany; [Manke, Ingo] Fraunhofer Inst Reliabil & Microintegrat, Berlin, Germany; [Manke, Ingo] HZB, Berlin, Germany	Herppich, WB (reprint author), Potsdam Bornim eV, Leibniz Inst Agrartechn, Max Eyth Allee 100, D-14469 Potsdam, Germany.	wherppich@atb-potsdam.de			Hans-Bockler-Stiftung; JSPS	W. Graf was supported by a grant of the Hans-Bockler-Stiftung. U. Matsushima is grateful for travel grants from the JSPS (Joint research project, joint seminars, researcher exchanges program). The authors thank H. Gruneberg, Humboldt Universitat zu Berlin, Germany for his help with the rose plants.	Steppe K, 2004, J STRUCT BIOL, V148, P11, DOI 10.1016/j.jsb.2004.05.001; Mendoza F, 2007, PLANTA, V226, P559, DOI 10.1007/s00425-007-0504-4; Grothausmann R, 2011, J AM CHEM SOC, V133, P18161, DOI 10.1021/ja2032508; Matsushima U, 2012, POSTHARVEST BIOL TEC, V72, P27, DOI 10.1016/j.postharvbio.2012.04.013; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Dunn DN, 1999, APPL PHYS LETT, V75, P3414, DOI 10.1063/1.125311; Cloetens P, 2006, P NATL ACAD SCI USA, V103, P14626, DOI 10.1073/pnas.0603490103; Rack A, 2008, NUCL INSTRUM METH A, V586, P327, DOI [10.1016/j.nima.2007.11.020, 10.1016/.j.nima.2007.11.020]; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Matsushima U, 2009, NUCL INSTRUM METH A, V605, P185, DOI 10.1016/j.nima.2009.01.150; Dhondt S, 2010, TRENDS PLANT SCI, V15, P419, DOI 10.1016/j.tplants.2010.05.002; Kardjilov N, 2011, MATER TODAY, V14, P248, DOI 10.1016/S1369-7021(11)70139-0; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Lee SJ, 2008, ANN BOT-LONDON, V101, P595, DOI 10.1093/aob/mcm312; Banhart J., 2010, INT J MATER RES, V9, P1069, DOI [10.3139/146.110382, DOI 10.3139/146.110382]; Cherezov V, 2002, J SYNCHROTRON RADIAT, V9, P333, DOI 10.1107/S0909049502014528; Graf W., 2006, P 5 PLANT BIOM C STO, P365, DOI 10.1016/j.jpowsour.2010.11.025; Graf W., 2010, THESIS; Graf W., 2009, 5 INT S ROS RES CULT, P57; Herppich W. B., 2001, 6 INT S FRUIT NUT VE, P609, DOI [10.1016/j.jsg.2008.03.002, DOI 10.1016/J.JSG.2008.03.002]; Leccia E, 2010, J STRUCT BIOL, V170, P69, DOI 10.1016/j.jsb.2009.11.006; Matsushima U, 2010, ACTA HORTIC, V858, P387; Matsushima U, 2013, INT AGROPHYS, V27, P23, DOI 10.2478/v10247-012-0064-0; Matsushima U, 2009, NUCL INSTRUM METH A, V605, P146, DOI 10.1016/j.nima.2009.01.187; Nedbal L, 2000, BORNIM AGRARTECH BER, V25, P127; Strobl M, 2009, NUCL INSTRUM METH A, V604, P640, DOI 10.1016/j.nima.2009.03.020; von Willert D.J., 1995, EXPT PFLANZENOKOLOGI, P4; Williams SH, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/02/P02014; ZAMSKI E, 1991, ISRAEL J BOT, V40, P1	29	0	0	CARL HANSER VERLAG	MUNICH	KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY	0025-5300			MATER TEST	Mater. Test.		2015	57	1					59	63		10.3139/120.110675		5	Materials Science, Characterization & Testing	Materials Science	AX9TX	WOS:000347245900010		
J	Kimoto, A; Yamada, Y				Kimoto, Akira; Yamada, Yuji			A new layered sensor for simultaneous measurement of EMG, MMG and oxygen consumption at the same position	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Layered sensor; Electromyography; Mechanomyography; Near-infrared spectroscopy	NEAR-INFRARED SPECTROSCOPY; ISOMETRIC CONTRACTION; MUSCULAR SOUND; ACCELEROMETER; MECHANOMYOGRAPHY; ELECTROMYOGRAM; MICROPHONE; VOLUNTARY; SIGNALS; MUSCLE	A new layered sensor for simultaneous measurement of electromyography (EMG), mechanomyography (MMG) and oxygen consumption based on near-infrared spectroscopy (NIRS) at the same position of the muscle is presented. The proposed sensor is a layered structure of a thin stainless-steel electrode, a PVDF film with transparent electrodes and optical sensors. EMG, MMG and oxygen consumption based on NIRS are measured by the stainless-steel electrodes, PVDF film and optical sensors, respectively. Using the three types of data, muscular activity can be analyzed in more detail. Additionally, the proposed sensor system reduces the constraint of the sensors arranged on the skin in measurements at multiple points because three types of information, previously obtained with three types of general sensors, are detected by a pair of proposed sensors. In an experiment, simultaneous measurement of EMG, MMG and oxygen consumption via NIRS at the forearm was demonstrated using the proposed sensor under fluorescent light. The performance of the layered sensor was evaluated.	[Kimoto, Akira; Yamada, Yuji] Saga Univ, Saga 8408502, Japan	Kimoto, A (reprint author), Saga Univ, Honjo Machi 1, Saga 8408502, Japan.	kimotoa@cc.saga-u.ac.jp					Akataki K, 2004, ELECTROMYOGR CLIN NE, V44, P489; Gregori B, 2003, MED BIOL ENG COMPUT, V41, P665, DOI 10.1007/BF02349974; GORDON G, 1948, J PHYSIOL-LONDON, V107, P456; Madeleine P, 2006, MED BIOL ENG COMPUT, V44, P290, DOI 10.1007/s11517-006-0036-2; Madeleine P, 2006, J NEUROSCI METH, V158, P89, DOI 10.1016/j.jneumeth.2006.05.018; DEBLASI RA, 1993, EUR J APPL PHYSIOL, V67, P20; ORIZIO C, 1989, EUR J APPL PHYSIOL O, V58, P528, DOI 10.1007/BF02330708; Watakabe M, 2001, MED BIOL ENG COMPUT, V39, P195, DOI 10.1007/BF02344804; Watakabe M, 2003, MED BIOL ENG COMPUT, V41, P198, DOI 10.1007/BF02344888; ORIZIO C, 1989, J APPL PHYSIOL, V66, P1593; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Barry DT, 1987, BIOPHYS J, V51, P5769; Binzoni T, 2010, PHYSIOL MEAS, V31, P1257, DOI 10.1088/0967-3334/31/9/014; Cescon C, 2004, MED BIOL ENG COMPUT, V42, P121, DOI 10.1007/BF02351021; Feipel V, 2002, MED BIOL ENG COMPUT, V40, P497, DOI 10.1007/BF02345446; Gersak V, 2009, XIX IMEKO WORLD CONGRESS: FUNDAMENTAL AND APPLIED METROLOGY, PROCEEDINGS, P1634; Hendrix CR, 2010, J NEUROSCI METH, V194, P64, DOI 10.1016/j.jneumeth.2010.07.006; Ioi H, 2006, ORTHODONTIC WAVES, V65, P15, DOI 10.1016/j.odw.2005.12.002; Kimoto A, 2012, P MEMEA2012; Ostlund N, 2004, MED BIOL ENG COMPUT, V42, P825, DOI 10.1007/BF02345217; Piancino MG, 2012, J ELECTROMYOGR KINES, V22, P273, DOI 10.1016/j.jelekin.2011.12.003; Staudenmann D, 2006, IEEE T BIO-MED ENG, V53, P712, DOI 10.1109/TBME.2006.870246; Xu G, 2011, J PHYS C SER, V227, P1	23	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	JAN	2015	53	1					15	22		10.1007/s11517-014-1208-0		8	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	AX8LU	WOS:000347161800002		
J	Murata, A; Ooya, T; Takeuchi, T				Murata, Akiko; Ooya, Tooru; Takeuchi, Toshifumi			Two-layer reflectometric interference spectroscopy-based immunosensing for C-reactive protein	MICROCHIMICA ACTA			English	Article						Immunosensing; Antibody; Liquid phase deposition; Reflectometric interference spectroscopy; C-reactive protein	SURFACE-PLASMON RESONANCE; LIQUID-PHASE DEPOSITION; LABEL-FREE DETECTION; OXIDE THIN-FILMS; SENSING SYSTEM; ANTIBODY; INTERFEROMETRY; BIOSENSOR	We report on dual interference layers for use in reflectometric interference spectroscopy (RIfS)-based immunosensing. The layers consist of (a) an antibody-embedded organic/inorganic hybrid titanium dioxide (TiO2) layer (similar to 60 nm thick) as a sensitive layer, and (b) a TiO2 layer (similar to 110 nm thick) as an interference base layer placed on a silicone substrate by liquid phase deposition. A monoclonal antibody against C-reactive protein (anti-CRP) was co-embedded with poly(L-lysine) as an organic binder during deposition of the TiO2 layer. The optical properties of layer with the antibody were optimized to achieve high sensitivity. Atomic force microscopy images of the sensor surface showed it to consist of a mesoporous structure with nano-scale unevenness. The binding of CRP to the sensor chips was monitored by RIfS, and CRP was repeatedly detected by this biosensor with a detection limit of similar to 60 ng mL(-1). We presume that this two-layer method has a wide scope in that various kinds of biochips can be constructed for use in label-free optical biosensing.	[Murata, Akiko; Ooya, Tooru; Takeuchi, Toshifumi] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeuchi, T (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	takeuchi@gold.kobe-u.ac.jp	Ooya, Tooru/C-5573-2012; Takeuchi, Toshifumi/E-6379-2014	Takeuchi, Toshifumi/0000-0002-5641-2333	New Energy and Industrial Technology Development Organization (NEDO); KONICA MINOLTA, Inc. (Tokyo, Japan)	This work was supported in part by the innovation promotion program of New Energy and Industrial Technology Development Organization (NEDO) and KONICA MINOLTA, Inc. (Tokyo, Japan).	Chen H, 2009, BIOSENS BIOELECTRON, V24, P3399, DOI 10.1016/j.bios.2009.03.020; Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p; Tatemichi M, 2007, J AM CHEM SOC, V129, P10906, DOI 10.1021/ja071890m; BRECHT A, 1992, SENSOR ACTUAT B-CHEM, V6, P96, DOI 10.1016/0925-4005(92)80038-Y; NAGAYAMA H, 1988, J ELECTROCHEM SOC, V135, P2013, DOI 10.1149/1.2096198; BRECHT A, 1995, ANAL CHIM ACTA, V311, P289, DOI 10.1016/0003-2670(95)00120-O; GAUGLITZ G, 1993, SENSOR ACTUAT B-CHEM, V11, P21, DOI 10.1016/0925-4005(93)85234-2; Vestergaard M, 2008, TALANTA, V74, P1038, DOI 10.1016/j.talanta.2007.06.009; Lehr J, 2014, ANAL CHEM, V86, P2559, DOI 10.1021/ac403727h; Kurihara Y, 2012, LANGMUIR, V28, P13609, DOI 10.1021/la302221y; Deki S, 1997, J MATER CHEM, V7, P1769, DOI 10.1039/a700628d; Vaisocherova H, 2007, BIOSENS BIOELECTRON, V22, P1020, DOI 10.1016/j.bios.2006.04.021; BRECHT A, 1994, FRESEN J ANAL CHEM, V349, P360, DOI 10.1007/BF00326600; Casa E, 2006, ELECTROCHEMISTRY, V74, P153; Choi HW, 2011, ANAL METHODS-UK, V3, P1366, DOI 10.1039/c0ay00762e; Choi HW, 2012, ANAL CHIM ACTA, V728, P64, DOI 10.1016/j.aca.2012.03.030; Deki S, 1996, CHEM LETT, P433, DOI 10.1246/cl.1996.433; Fujimura T, 2005, JPN J APPL PHYS 1, V44, P2849, DOI 10.1143/JJAP.44.2849; Gauglitz G, 2008, ADV BIOCHEM ENG BIOT, V109, P395, DOI 10.1007/10_2007_076; GAUGLITZ G, 1991, BER BUNSEN PHYS CHEM, V95, P1558; KIRCHMER CJ, 1988, ACS SYM SER, V361, P78; Kurihara Y, 2013, BIOSENS BIOELECTRON, V40, P247, DOI 10.1016/j.bios.2012.07.032; Murata A, 2013, BIOSENS BIOELECTRON, V43, P45, DOI 10.1016/j.bios.2012.11.021; Shastry S, 2013, INT J FARMING ALLIED, V2, P59; SPITZNAGEL TM, 1993, BIO-TECHNOL, V11, P825, DOI 10.1038/nbt0793-825	25	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-3672	1436-5073		MICROCHIM ACTA	Microchim. Acta	JAN	2015	182	1-2					307	313		10.1007/s00604-014-1334-2		7	Chemistry, Analytical	Chemistry	AX8LD	WOS:000347160100033		
J	Hyakutake, T; Nagai, S				Hyakutake, Toru; Nagai, Shinya			Numerical simulation of red blood cell distributions in three-dimensional microvascular bifurcations	MICROVASCULAR RESEARCH			English	Article						Numerical simulation; Microvascular bifurcation; Red blood cell; Lattice Boltzmann method; Immersed boundary method	FREE LAYER; AGGREGATION; FLOWS; HEMODYNAMICS; DEFORMATION; MOTION	We constructed three-dimensional microvascular bifurcation models using a parent vessel of diameter 10 mu m and investigated the flow behavior of the red blood cells (RBCs) through bifurcations. We considered symmetric and asymmetric model types. Two cases of equal daughter vessel diameter were employed for the asymmetric models, where the first was 10 mu m, which is the same as the parent vessel and the second was 7.94 mu m, which satisfies Murray's law. Simulated blood flow was computed using the lattice Boltzmann method in conjunction with the immersed boundary method for incorporating fluid membrane interactions between the flow field and deformable RBCs. First, we investigated the flow behavior of a single RBC through microvascular bifurcations. In the case of the symmetric bifurcation, the turning point of the fractional plasma flow wherein the RBC flow changed from one daughter vessel to the other was 0.50. This turning point was however different for asymmetric bifurcations. Additionally, we varied the initial offset of RBCs from the centerline of the parent vessel. The simulation results indicated that the RBCs preferentially flow through the branch of a larger flow ratio. Next, we investigated the distribution characteristics of multiple RBCs. Simulations indicated that the results of the symmetric model were similar to those predicted by a previously published empirical model. On the other hand, results of asymmetric models deviated from those of the symmetric and empirical models. These results suggest that the distribution of RBCs varies according to the bifurcation angle and daughter vessel diameter in a microvascular bifurcation of the size considered. (C) 2014 Elsevier Inc All rights reserved.	[Hyakutake, Toru] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan; [Nagai, Shinya] Yokohama Natl Univ, Grad Sch Engn, Yokohama, Kanagawa 2408501, Japan	Hyakutake, T (reprint author), Yokohama Natl Univ, Fac Engn, 79-5 Hodogaya, Yokohama, Kanagawa 2408501, Japan.	hyaku@ynu.ac.jp			JSPS KAKENHI [23700527]; MEXT SPIRE Supercomputational Life Science	This research was supported by JSPS KAKENHI Grant Number (No. 23700527) and MEXT SPIRE Supercomputational Life Science.	Zhang JF, 2008, J BIOMECH, V41, P47, DOI 10.1016/j.jbiomech.2007.07.020; Sugiyama K, 2010, COMPUT MECH, V46, P147, DOI 10.1007/s00466-010-0484-2; Crowl LM, 2010, INT J NUMER METH BIO, V26, P471, DOI 10.1002/cnm.1274; Liu YL, 2006, J COMPUT PHYS, V220, P139, DOI 10.1016/j.jcp.2006.05.010; Zhang JF, 2009, MICROVASC RES, V77, P265, DOI 10.1016/j.mvr.2009.01.010; GOLDSMITH HL, 1986, MICROVASC RES, V31, P121, DOI 10.1016/0026-2862(86)90029-4; Alizadehrad D, 2012, J BIOMECH, V45, P2684, DOI 10.1016/j.jbiomech.2012.08.026; Barber JO, 2008, ANN BIOMED ENG, V36, P1690, DOI 10.1007/s10439-008-9546-4; EVANS E, 1972, MICROVASC RES, V4, P335, DOI 10.1016/0026-2862(72)90069-6; BHATNAGAR PL, 1954, PHYS REV, V94, P511, DOI 10.1103/PhysRev.94.511; Zhao H, 2010, J COMPUT PHYS, V229, P3726, DOI 10.1016/j.jcp.2010.01.024; Imai Y, 2010, J BIOMECH, V43, P1386, DOI 10.1016/j.jbiomech.2010.01.011; Tsubota K, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011910; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; PRIES AR, 1990, CIRC RES, V67, P826; Bagchi P, 2005, J BIOMECH ENG-T ASME, V127, P1070, DOI 10.1115/1.2112907; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; Boryczko K, 2003, J MOL MODEL, V9, P16, DOI 10.1007/s00894-002-0105-x; Chesnutt JKW, 2009, MICROVASC RES, V78, P301, DOI 10.1016/j.mvr.2009.09.003; Chien S., 1985, AM J PHYSIOL-HEART C, V248, P568; Dupin MM, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066707; Fung Y. C., 1997, BIOMECHANICS CIRCULA; Guo Z., 2002, PHYS REV E, V65; Hyakutake T, 2006, MATH COMPUT SIMULAT, V72, P134, DOI 10.1016/j.matcom.2006.05.010; Hyakutake T, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838024; Hyakutake T, 2010, IFMBE PROC, V31, P1059; Inamuro T, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/2/024001; INAMURO T, 1995, PHYS FLUIDS, V7, P2928, DOI 10.1063/1.868766; Liu YL, 2004, INT J NUMER METH FL, V46, P1237, DOI 10.1002/fld.798; McNamara G, 1998, PHYS REV LETT, V61, P2332; Qian T.H., 1992, EPL-EUROPHYS LETT, V17, P479; Succi S., 2001, LATTICE BOLTZMANN EQ; Waugh R.E., 2006, BIOMEDICAL ENG FUNDA; Xiong WJ, 2012, BIOMECH MODEL MECHAN, V11, P575, DOI 10.1007/s10237-011-0334-y; Xu Y., 2012, THEOR APPL MECH LETT, V2; Yin XW, 2013, MICROVASC RES, V89, P47, DOI 10.1016/j.mvr.2013.05.002; Zhang JF, 2007, PHYS BIOL, V4, P285, DOI 10.1088/1478-3975/4/4/005	37	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0026-2862	1095-9319		MICROVASC RES	Microvasc. Res.	JAN	2015	97						115	123		10.1016/j.mvr.2014.10.001		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX4IA	WOS:000346895400017		
J	Yokota, S; Kikuchi, M; Nozawa, T; Kanetaka, T; Sato, T; Yamazaki, K; Sakurai, N; Hara, R; Mori, M				Yokota, Shumpei; Kikuchi, Masako; Nozawa, Tomo; Kanetaka, Taichi; Sato, Tomomi; Yamazaki, Kazuko; Sakurai, Nodoka; Hara, Ryoki; Mori, Masaaki			Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome"	MODERN RHEUMATOLOGY			English	Review						cryopyrin-associated periodic syndrome; inflammation; innate immunity; Kawasaki disease; systemic-onset juvenile idiopathic arthritis	MACROPHAGE ACTIVATION SYNDROME; NECROSIS-FACTOR-ALPHA; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; INTRAVENOUS IMMUNOGLOBULIN; INFLIXIMAB TREATMENT; GENE-EXPRESSION; GAMMA-GLOBULIN; DOUBLE-BLIND; PERMEABILITY TRANSITION; ENDOTHELIAL-CELLS	Inflammation has often been considered to be a nonspecific response and to play a bridging role in the activation of adaptive immunity. However, it is now accepted that inflammation is the product of an independent innate immune system closely linked to the adaptive immune system. The key mediators of inflammation are inflammatory cytokines, as determined by multiple lines of evidence both in vitro and in vivo. Due to the crucial role of inflammatory cytokines in the pathogenesis of autoimmune disorders, anti-cytokine treatment has been developed as a therapy for rheumatoid arthritis, juvenile idiopathic arthritis (JIA), and inflammatory bowel diseases. We recently completed several clinical trials of anti-cytokine treatment for children with systemic inflammatory diseases: anti-IL-6 receptor monoclonal antibody (tocilizumab) for children with two subtypes of JIA (poly-JIA and systemic JIA), anti-TNF-alpha monoclonal antibody (infliximab) for children with Kawasaki disease, and anti-IL-1-beta monoclonal antibody (canakinumab) for children with cryopyrin-associated periodic syndrome. This review summarizes the basis of inflammation in terms of innate immunity and adaptive immunity in these systemic inflammatory diseases, clinical efficacy, and tolerability of these biologic agents, and attempts to determine the roles of individual inflammatory cytokines in disease pathogenesis.	[Yokota, Shumpei; Kikuchi, Masako; Nozawa, Tomo; Kanetaka, Taichi; Sato, Tomomi; Yamazaki, Kazuko; Sakurai, Nodoka; Hara, Ryoki; Mori, Masaaki] Yokohama City Univ, Dept Pediat, Sch Med, Yokohama, Kanagawa 2360004, Japan	Yokota, S (reprint author), Yokohama City Univ, Dept Pediat, Sch Med, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.	syokota@med.yokohama-cu.ac.jp					de Benedetti F, 2005, ARTHRITIS RHEUM, V52, P687, DOI 10.1002/art.20946; Mori M, 2000, J PEDIATR-US, V137, P177, DOI 10.1067/mpd.2000.107890; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Bugl S, 2012, ANN NY ACAD SCI, V1266, P171, DOI 10.1111/j.1749-6632.2012.06607.x; Savic S, 2012, CURR OPIN RHEUMATOL, V24, P103, DOI 10.1097/BOR.0b013e32834dd2d5; Bradham CA, 1998, MOL CELL BIOL, V18, P6353; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Janka G, 2009, KLIN PADIATR, V221, P278, DOI 10.1055/s-0029-1237386; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; STEPHAN JL, 1993, CLIN EXP RHEUMATOL, V11, P451; Matsubara T, 2005, CLIN EXP IMMUNOL, V141, P381, DOI 10.1111/j.1365-2249.2005.02821.x; Burns JC, 2005, J PEDIATR-US, V146, P662, DOI 10.1016/j.jpeds.2004.12.022; Raj DSC, 2009, SEMIN ARTHRITIS RHEU, V38, P382, DOI 10.1016/j.semarthrit.2008.01.006; Grom AA, 2004, ARTHRITIS RHEUM, V50, P689, DOI 10.1002/art.20198; Yu JR, 2011, CURR ALLERGY ASTHM R, V11, P12, DOI 10.1007/s11882-010-0160-9; Newburger JW, 2007, NEW ENGL J MED, V356, P663, DOI 10.1056/NEJMoa061235; Jin B, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/836485; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Grom AA, 2010, CURR OPIN RHEUMATOL, V22, P561, DOI 10.1097/01.bor.0000381996.69261.71; Soriano ME, 2004, J BIOL CHEM, V279, P36803, DOI 10.1074/jbc.M405297200; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Padeh S, 2005, PEDIATR CLIN N AM, V52, P577, DOI 10.1016/j.pcl.2005.01.005; Burns JC, 2008, J PEDIATR, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; de Jager W, 2009, ARTHRITIS RHEUM, V60, P2782, DOI 10.1002/art.24750; Levi M, 2010, HAMOSTASEOLOGIE, V30, P10; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Levi M, 2010, SEMIN THROMB HEMOST, V36, P367, DOI 10.1055/s-0030-1254046; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Nishikawa T, 2008, J IMMUNOL, V180, P3492; Imagawa T, 2013, CLIN EXP RHEUMATOL, V31, P302; Vastert SJ, 2009, BEST PRACT RES CL RH, V23, P655, DOI 10.1016/j.berh.2009.08.003; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254; Yokota S, 2005, ARTHRITIS RHEUM, V52, P818, DOI 10.1002/art.20944; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Castillo L, 2009, PEDIATR CRIT CARE ME, V10, P387, DOI 10.1097/PCC.0b013e3181a1ae08; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; van der Poll T, 2012, CURR VASC PHARMACOL, V10, P632; Galeotti C, 2010, AUTOIMMUN REV, V9, P441, DOI 10.1016/j.autrev.2009.12.004; Arlet JB, 2010, PEDIATRICS, V126, pE1608, DOI 10.1542/peds.2010-1123; Chun JK, 2011, CLIN EXP RHEUMATOL, V29, P743; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; Demirkol D, 2012, CRIT CARE, V16, DOI 10.1186/cc11256; Devi S, 2011, J RHEUMATOL, V38, P764; Dhimolea E, 2010, MABS-AUSTIN, V2, P3; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Goldbach-Mansky R, 2012, CLIN EXP IMMUNOL, V167, P391, DOI 10.1111/j.1365-2249.2011.04533.x; Gupta M, 2001, J CLIN IMMUNOL, V21, P193, DOI 10.1023/A:1011039216251; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Hokosaki T, 2012, PEDIATR INT, V54, P99, DOI 10.1111/j.1442-200X.2011.03487.x; Imamura T, 2005, EUR J PEDIATR, V164, P526, DOI 10.1007/s00431-005-1699-7; Kone-Paut I, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3535; Kota RS, 2005, J BIOL CHEM, V280, P31076, DOI 10.1074/jbc.M412189200; Levi M, 2010, HAMOSTASEOLOGIE, V30, P14; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Lomater C, 2000, J RHEUMATOL, V27, P491; McMichael M, 2012, TOP COMPANION ANIM M, V27, P40, DOI 10.1053/j.tcam.2012.07.005; Mehta B, 2012, INT J INFLAM, V2012, DOI DOI 10.1155/2012/298405; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Mori M, 2012, J RHEUMATOL, V39, P864, DOI 10.3899/jrheum.110877; Mori Masaaki, 2004, Mod Rheumatol, V14, P43, DOI 10.1007/s10165-003-0264-3; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Oicard C, 2011, CLIN MICROBIOL REV, V24, P490; Orenstein JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038998; Piccinini AM, 2010, MEDIAT INFLAMM, DOI [10.1155/2010/672396, DOI 10.1155/2010/672396]; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Reindel R, 2012, NAT REV RHEUMATOL, V8, P373, DOI 10.1038/nrrheum.2012.65; Shibamiya A, 2009, BLOOD, V113, P714, DOI 10.1182/blood-2008-02-137901; Sireci G, 2000, MOL MED, V6, P581; Si-Tahar M, 2009, CLIN EXP IMMUNOL, V156, P194, DOI 10.1111/j.1365-2249.2009.03893.x; Takahashi A, 2009, MOD RHEUMATOL, V19, P302, DOI 10.1007/s10165-009-0152-6; Takahashi Kei, 2010, Ann Vasc Dis, V3, P173, DOI 10.3400/avd.sasvp01003; tenCate JW, 1997, THROMB HAEMOSTASIS, V78, P415; van der Hilst JCH, 2005, CLIN EXP MED, V5, P87, DOI 10.1007/s10238-005-0071-6; Vraetz T, 1999, NEPHROL DIAL TRANSPL, V14, P2137, DOI 10.1093/ndt/14.9.2137; Yokota Shumpei, 2012, Ther Adv Musculoskelet Dis, V4, P387, DOI 10.1177/1759720X12455960; YOKOTA S, 1993, CLIN IMMUNOL IMMUNOP, V67, P163, DOI 10.1006/clin.1993.1060; Zaki Faizah Mohd, 2012, J Radiol Case Rep, V6, P1, DOI 10.3941/jrcr.v6i3.745	86	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					1	10		10.3109/14397595.2014.902747		10	Rheumatology	Rheumatology	AX1XF	WOS:000346736400001		
J	Takeuchi, T; Yamamoto, K; Yamanaka, H; Ishiguro, N; Tanaka, Y; Eguchi, K; Watanabe, A; Origasa, H; Shoji, T; Miyasaka, N; Koike, T				Takeuchi, Tsutomu; Yamamoto, Kazuhiko; Yamanaka, Hisashi; Ishiguro, Naoki; Tanaka, Yoshiya; Eguchi, Katsumi; Watanabe, Akira; Origasa, Hideki; Shoji, Toshiharu; Miyasaka, Nobuyuki; Koike, Takao			Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies	MODERN RHEUMATOLOGY			English	Article						Certolizumab pegol; Long-term outcomes; Radiographic progression; Remission; Rheumatoid arthritis	COLLEGE-OF-RHEUMATOLOGY; RECOMMENDATIONS	Objectives. A post-hoc analysis was performed to determine the relationship between the timing and magnitude of DAS28(ESR) response and long term outcomes in Japanese patients after 1 year of CZP treatment. Methods. Our analysis included 82 J-RAPID trial patients treated with CZP 200 mg and methotrexate, and 116 HIKARI trial patients treated with CZP 200 mg alone or with disease-modifying agents other than methotrexate. Remission rates and changes in mTSS at year 1 were compared to the DAS28(ESR) response at week 12 of CZP treatment. Results. After 1 year of treatment, remission was achieved in 41.3% of the J-RAPID and 34.9% of the HIKARI patients with a week 12 DAS28(ESR) response of >= 1.2. In comparison, patients with a DAS28(ESR) response of < 1.2 at week 12 only had a < 7% probability of achieving remission and displayed higher change in mTSS after 1-year treatment. Conclusions. The likelihood of remission and extent of radiographic progression after 1 year was associated with the week 12 DAS28(ESR) response. The DAS28(ESR) response at 12 weeks could be beneficial for identifying patients that are unlikely to respond to prolonged CZP treatment.	[Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjyuku Ku, Tokyo 1608582, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo, Japan; [Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo, Japan; [Ishiguro, Naoki] Nagoya Univ, Grad Sch, Dept Orthoped Surg, Nagoya, Aichi 4648601, Japan; [Ishiguro, Naoki] Fac Med, Nagoya, Aichi, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka, Japan; [Eguchi, Katsumi] Sasebo City Gen Hosp, Nagasaki, Japan; [Watanabe, Akira] Tohoku Univ, Inst Dev Aging & Canc, Res Div Dev Antiinfect Agents, Sendai, Miyagi 980, Japan; [Origasa, Hideki] Toyama Univ, Sch Med, Div Biostat & Clin Epidemiol, Toyama 930, Japan; [Shoji, Toshiharu] UCB Japan Co Ltd, Dept Clin Res & Dev, Shinjuku Ku, Tokyo, Japan; [Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Dept Med & Rheumatol, Grad Sch Med & Dent, Bunkyo Ku, Tokyo, Japan; [Koike, Takao] NTT Sapporo Med Ctr, Sapporo, Hokkaido, Japan	Takeuchi, T (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjyuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tsutake@z5.keio.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	UCB	We thank the investigators who were part of J-RAPID and HIKARI studies. This study was funded by UCB. Ikuko Kambayashi provided editorial services for this manuscript. All costs associated with development of this manuscript were funded by UCB.	Keystone EC, 2011, J RHEUMATOL, V38, P990, DOI 10.3899/jrheum.100935; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Yamamoto K, 2014, MOD RHEUMATOL, V24, P552, DOI 10.3109/14397595.2013.843764; Aletaha D, 2007, ARTHRITIS RHEUM, V56, P3226, DOI 10.1002/art.22943; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Yamamoto K, 2014, MOD RHEUMATOL, V24, P715, DOI 10.3109/14397595.2013.864224; Takeuchi T, 2013, ARTHRITIS RHEUM-US, V65, pS989; Tanaka Y, 2014, MOD RHEUMATOL, V24, P725, DOI 10.3109/14397595.2013.865822; Tanaka Y, 2014, MOD RHEUMATOL, DOI [10.3109/14397595.2014.881709, DOI 10.3109/14397595.2014.881709.]; van del Heijde D, 2012, RHEUMATOLOGY, V39, P1326, DOI [10.3899/jrheum.111171, DOI 10.3899/JRHEUM.111171]; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Weinblatt M, 2012, ANN RHEUM DIS, V71, P520; Welsing Paco M J, 2004, J Rheumatol Suppl, V69, P14	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					11	20		10.3109/14397595.2014.904475		10	Rheumatology	Rheumatology	AX1XF	WOS:000346736400002		
J	Takeuchi, T; Tanaka, Y; Close, D; Godwood, A; Wu, CY; Saurigny, D				Takeuchi, Tsutomu; Tanaka, Yoshiya; Close, David; Godwood, Alex; Wu, Chi-Yuan; Saurigny, Didier			Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study	MODERN RHEUMATOLOGY			English	Article						Granulocyte-macrophage colony-stimulating factor; Mavrilimumab; Phase II; Rheumatoid arthritis	GM-CSF RECEPTOR; COLONY-STIMULATING FACTOR; MONOCLONAL-ANTIBODY; FELTYS-SYNDROME; FLARE-UP; DISEASE; PROTEIN; EXPRESSION; CRITERIA	Objective. A phase IIa study investigated efficacy and safety/tolerability of ascending doses of mavrilimumab (anti-granulocyte-macrophage colony-stimulating factor receptor [GM-CSFR]alpha monoclonal antibody) in adult subjects with moderate to severe rheumatoid arthritis from Japan and Europe. Findings from the Japanese population are presented. Methods. Fifty-one subjects received mavrilimumab (10-100 mg) or placebo subcutaneously every other week for 12 weeks, followed by a 12-week follow-up period. The primary endpoint was the proportion of subjects achieving a Disease Activity Score using 28 joints (DAS28)-C-reactive protein (CRP) response (decrease > 1.2 from baseline). Secondary endpoints included DAS28-CRP remission, Health Assessment Questionnaire Disability Index (HAQ-DI) and American College of Rheumatology (ACR) response. Results. By Week 12, more mavrilimumab-versus placebo-treated subjects achieved a DAS28-CRP response (50.0% vs. 23.5%, p = 0.081); a significant response was seen in the 30 mg and 100 mg dose groups (both 75.0% vs. 23.5%, p = 0.028). The 100 mg group also demonstrated statistically significant HAQ-DI and ACR20 responses at Week 12. Results were generally consistent between Japanese and European populations. Overall, adverse events (AEs) were mild to moderate in intensity with one serious AE of pneumonia, considered possibly treatment-related. Conclusions. A rapid and clinically meaningful response was seen in subjects treated with GM-CSFR alpha blockade with mavrilimumab, supporting further investigation of mavrilimumab for the treatment of RA in Japanese subjects.	[Takeuchi, Tsutomu] Keio Univ, Sch Med, Tokyo, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Fukuoka, Japan; [Close, David; Godwood, Alex; Saurigny, Didier] MedImmune, Cambridge, England; [Wu, Chi-Yuan] MedImmune, Hayward, CA USA	Saurigny, D (reprint author), MedImmune, Sir Aaron Klug Bldg,Granta Pk, Cambridge, England.	saurignyd@medimmune.com	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	MedImmune	This study was sponsored by MedImmune and in part by AstraZeneca K.K. Medical writing services were provided by Sarah Reynolds (BSc) from QXV Communications, Macclesfield, UK, funded by MedImmune.	HAZENBERG BPC, 1989, BLOOD, V74, P2769; Takeuchi T, 2010, NAT REV RHEUMATOL, V6, P644, DOI 10.1038/nrrheum.2010.154; DEVRIES EGE, 1991, LANCET, V338, P517, DOI 10.1016/0140-6736(91)90594-F; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Yamanaka H, 2014, MOD RHEUMATOL, V24, P33, DOI 10.3109/14397595.2013.854059; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; Burmester GR, 2011, ANN RHEUM DIS, V70, P1542, DOI 10.1136/ard.2010.146225; Trapnell BC, 2009, CURR OPIN IMMUNOL, V21, P514, DOI 10.1016/j.coi.2009.09.004; FIELD M, 1993, LANCET, V342, P1244, DOI 10.1016/0140-6736(93)92229-M; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; FIEHN C, 1992, Z RHEUMATOL, V51, P121; PEREIRA J, 1994, ACTA HAEMATOL-BASEL, V92, P154; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Ohnishi H, 2002, AM J RESP CRIT CARE, V165, P378; Burmester GR, 2013, ANN RHEUM DIS, V72, P1445, DOI 10.1136/annrheumdis-2012-202450; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BELL AL, 1995, RHEUMATOL INT, V14, P177, DOI 10.1007/BF00262295; BERENBAUM F, 1994, EUR CYTOKINE NETW, V5, P43; Davis JM, 2010, J IMMUNOL, V184, P7297, DOI 10.4049/jimmunol.0904180; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Khan Muhammad Asim, 1995, Current Opinion in Rheumatology, V7, P263, DOI 10.1097/00002281-199507000-00001; Koike Ryuji, 2007, Mod Rheumatol, V17, P451, DOI 10.1007/s10165-007-0626-3; Koike R, 2009, MOD RHEUMATOL, V19, P351, DOI 10.1007/s10165-009-0197-6; Minter RR, 2013, BRIT J PHARMACOL, V168, P200, DOI 10.1111/j.1476-5381.2012.02173.x; Saeki Y, 2012, EXPERT REV CLIN IMMU, V8, P455, DOI [10.1586/eci.12.35, 10.1586/ECI.12.35]; Upchurch KS, 2012, RHEUMATOLOGY, V51, P28, DOI 10.1093/rheumatology/kes278; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; Wang B, 2012, ANN M POP APPR GROUP, P21; Wang B, 2012, J CLIN PHARMACOL, V52, P1150, DOI 10.1177/0091270011412964	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					21	30		10.3109/14397595.2014.896448		10	Rheumatology	Rheumatology	AX1XF	WOS:000346736400003		
J	Izumi, K; Kaneko, Y; Yasuoka, H; Seta, N; Kameda, H; Kuwana, M; Takeuchi, T				Izumi, Keisuke; Kaneko, Yuko; Yasuoka, Hidekata; Seta, Noriyuki; Kameda, Hideto; Kuwana, Masataka; Takeuchi, Tsutomu			Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: A single-center retrospective cohort study (KEIO-TCZ study) at week 52	MODERN RHEUMATOLOGY			English	Article						Joint destruction; Methotrexate; Remission; Rheumatoid arthritis; Tocilizumab	NECROSIS-FACTOR-ALPHA; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; TRIAL; THERAPY; COMBINATION; ADALIMUMAB; INTERLEUKIN-6; MULTICENTER; PROGRESSION	Objectives. To explore the effectiveness and safety of tocilizumab (TCZ) with or without methotrexate (MTX) in active rheumatoid arthritis (RA) patients showing inadequate responses to DMARDs and/or TNF inhibitors in clinical practice. Methods. We observed consecutive 115 RA patients initiating TCZ treatment in Keio University Hospital, dividing them into two groups with (TCZ + MTX group) or without MTX (TCZ group), and evaluated clinical, functional and structural outcomes besides safety at week 52. Results. Overall mean age, RA duration, and DAS28-ESR were 55.4, 8.4 years, and 5.0, respectively. Proportions of the prior use of TNF inhibitors and concomitant MTX were 45.5% and 57.4%, respectively. Mean dose of concomitant MTX was 8.4 mg/week. Baseline characteristics were comparable between the groups. TCZ improved disease activity measured by DAS28-ESR to 2.1 at week 52 overall, without significant difference between the groups. Clinical (DAS28-ESR < 2.6), functional (HAQ-DI <= 0.5), and structural (Delta TSS <= 0.5) remission rates in the TCZ group and the TCZ + MTX group were 79.1%/63.8% (P = 0.10), 62.8%/54.4% (P = 0.40), and 70.0%/53.8% (P = 0.61), respectively. Retention rates were 81.0% in the TCZ + MTX group and 88.5% in the TCZ group (P = 0.47). The rate of serious adverse events was comparable between the groups. Conclusions. TCZ was clinically, functionally, and radiographically effective and safe either with or without low-dose MTX.	[Izumi, Keisuke; Kaneko, Yuko; Yasuoka, Hidekata; Seta, Noriyuki; Kameda, Hideto; Kuwana, Masataka; Takeuchi, Tsutomu] Keio Univ, Sch Med, Div Rheumatol, Dept Internal Med, Tokyo 1608582, Japan; [Yasuoka, Hidekata] Toho Univ, Sch Med, Div Rheumatol, Dept Internal Med, Tokyo, Japan	Izumi, K (reprint author), Keio Univ, Sch Med, Div Rheumatol, Dept Internal Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	izz@a7.keio.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	Chugai Pharmaceutical Co., Ltd.	The publication fees were partly supported by Chugai Pharmaceutical Co., Ltd.	PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Nishina N, 2013, CLIN RHEUMATOL, V32, P1661, DOI 10.1007/s10067-013-2309-0; Strand V, 2002, ANN RHEUM DIS, V61, P64; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Yamanaka H, 2011, MOD RHEUMATOL, V21, P122, DOI 10.1007/s10165-010-0366-7; Shimamoto K, 2013, J RHEUMATOL, V40, P1074, DOI 10.3899/jrheum.121389; Dougados M, 2013, ANN RHEUM DIS, V72, P43, DOI 10.1136/annrheumdis-2011-201282; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Takeuchi T, 2011, RHEUMATOLOGY, V50, P1908, DOI 10.1093/rheumatology/ker221; Maini RN, 2006, ARTHRITIS RHEUM, V54, P2817, DOI 10.1002/art.22033; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Burmester GR, 2007, ANN RHEUM DIS, V66, P732, DOI 10.1136/ard.2006.066761; Bruynesteyn K, 2002, J RHEUMATOL, V29, P2306; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Dougados M, 2014, ANN RHEUM DIS, V73, P803, DOI 10.1136/annrheumdis-2013-204761; Emery P, 2009, ARTHRITIS RHEUM, V60, P2272, DOI 10.1002/art.24638; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Chugai Pharmaceutical Company Limited, 2012, FIN REP POSTM SURV A; Kameda H, 2010, MOD RHEUMATOL, V20, P531, DOI 10.1007/s10165-010-0324-4; Koike R, 2009, MOD RHEUMATOL, V19, P351, DOI 10.1007/s10165-009-0197-6; Nakashima Y, 2013, MOD RHEUMATOL; Takeuchi T, 2012, MOD RHEUMATOL, V22, P327, DOI 10.1007/s10165-011-0516-6	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					31	37		10.3109/14397595.2014.897793		7	Rheumatology	Rheumatology	AX1XF	WOS:000346736400004		
J	Matsuno, H				Matsuno, Hiroaki			Remarkable efficacy of tocilizumab for treating rheumatoid arthritis in patients with high platelet counts	MODERN RHEUMATOLOGY			English	Article						Bone destruction; Disease activity score; Hemoglobin; Platelet count; Rheumatoid arthritis; Tocilizumab	JOINT DAMAGE; CRITERIA; CLASSIFICATION; INFLAMMATION; PROGRESSION; LEAGUE; MICE	Objectives. To optimize the efficacy of treatment with tocilizumab for rheumatoid arthritis (RA), we comparatively analyzed the outcome of tocilizumab treatment in patients with normal background changes associated closely with IL-6. Patients and Methods. The study involved 87 patients with RA satisfying the diagnostic criteria of the American College of Rheumatology (ACR) and receiving continuous tocilizumab treatment for 24 weeks or longer. The outcome of tocilizumab treatment in these patients was comparatively analyzed in relation to the baseline platelet count (the high platelet count group and the normal group), pretreatment hemoglobin levels (the low group and the normal platelet count group), and speed of bone destruction (the rapid progression group and slow progression group). Results. Treatment with tocilizumab significantly improved the 28-joint disease activity score using the erythrocyte sedimentation rate (DAS28-ESR) and Clinical Disease Activity Index (CDAI), regardless of baseline platelet count, hemoglobin level, or annual speed of bone destruction (Delta TSS). The margins of improvement in DAS28-ESR and CDAI did not differ depending on baseline hemoglobin level or Delta TSS, but the improvement was significantly greater in the high platelet count group than in the normal platelet count group. Conclusions. These results suggest that in patients with high platelet count, IL-6 is a more important factor involved in RA pathogenesis and that tocilizumab is suitable as a first-line biologic for the treatment of RA patients with high platelet count.	[Matsuno, Hiroaki] Matsuno Clin Rheumat Dis, Toyama 9300138, Japan; [Matsuno, Hiroaki] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan	Matsuno, H (reprint author), Matsuno Clin Rheumat Dis, 7187-2 Kureha Cho, Toyama 9300138, Japan.	info@toyama-ra.com					Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI 10.1136/ard.2010.138461; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; VANDERHEIJDE DM, 1989, LANCET, V1, P1036; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.061081204; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Campbell Ken, 2004, Nurs Times, V100, P40; Chiu Y, 2012, CLIN RHEUMATOL, V31, P1005, DOI 10.1007/s10067-011-1936-6; ISHIBASHI T, 1989, BLOOD, V74, P1241; Katsume A, 2002, CYTOKINE, V20, P304, DOI 10.1006/cyto.2002.2012; Matsuno H, 2013, INNOVATIVE RHEUMATOL, P95; Matsuno H, 2013, INNOVATIVE RHEUMATOL, P165	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					38	42		10.3109/14397595.2014.915073		5	Rheumatology	Rheumatology	AX1XF	WOS:000346736400005		
J	Kaneko, Y; Koike, T; Oda, H; Yamamoto, K; Miyasaka, N; Harigai, M; Yamanaka, H; Ishiguro, N; Tanaka, Y; Takeuchi, T				Kaneko, Yuko; Koike, Takao; Oda, Hiromi; Yamamoto, Kazuhiko; Miyasaka, Nobuyuki; Harigai, Masayoshi; Yamanaka, Hisashi; Ishiguro, Naoki; Tanaka, Yoshiya; Takeuchi, Tsutomu			Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan	MODERN RHEUMATOLOGY			English	Article						Implementation; Obstacle; Rheumatoid arthritis; Treat-to-target	DISEASE-ACTIVITY; RECOMMENDATIONS; REMISSION; VALIDITY	Objective. To clarify the obstacles preventing the implementation of the treat-to-target (T2T) strategy for rheumatoid arthritis (RA) in clinical practice. Methods. A total of 301 rheumatologists in Japan completed a questionnaire. In the first section, participants were indirectly questioned on the implementation of basic components of T2T, and in the second section, participants were directly questioned on their level of agreement and application. Results. Although nearly all participants set treatment targets for the majority of RA patients with moderate to high disease activity, the proportion who set clinical remission as their target was 59%, with only 45% of these using composite measures. The proportion of participants who monitored X-rays and Health Assessment Questionnaires for all their patients was 44% and 14%, respectively. The proportion of participants who did not discuss treatment strategies was 44%, with approximately half of these reasoning that this was due to a proportion of patients having a lack of understanding of the treatment strategy or inability to make decisions. When participants were directly questioned, there was a high level of agreement with the T2T recommendations. Conclusion. Although there was a high level of agreement with the T2T recommendations, major obstacles preventing its full implementation still remain.	[Kaneko, Yuko; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjuku Ku, Tokyo, Japan; [Koike, Takao] NTT East Corp, Sapporo Med Ctr, Sapporo, Hokkaido, Japan; [Oda, Hiromi] Saitama Med Univ, Dept Orthopaed Surg, Iruma, Saitama, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo, Japan; [Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med & Rheumatol, Bunkyo Ku, Tokyo, Japan; [Harigai, Masayoshi] Tokyo Med & Dent Univ, Dept Pharmacovigilance, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo, Japan; [Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi 4648601, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan	Takeuchi, T (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol,Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	tsutake@z5.keio.jp	Takeuchi, Tsutomu/L-2327-2013	Takeuchi, Tsutomu/0000-0003-1111-8218	AbbVie; Eisai	This survey was conducted under a financial support from AbbVie (formerly Abbott Japan) and Eisai.	Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177; VANDERHEIJDE DMFM, 1992, BRIT J RHEUMATOL, V31, P519; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Pincus T, 2002, ARTHRITIS RHEUM, V46, P851, DOI 10.1002/art.10202; van Tuyl LHD, 2010, ARTHRIT CARE RES, V62, P108, DOI 10.1002/acr.20021; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Hanoui B, 2011, ANN RHEUM DIS, V70, P1999; Hanoui B, 2012, J RHEUMATOL, V39, P949; Rollnick S., 2008, MOTIVATIONAL INTERVI; Vermeer M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4099	13	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					43	49		10.3109/14397595.2014.926607		7	Rheumatology	Rheumatology	AX1XF	WOS:000346736400006		
J	Katayama, K; Okubo, T; Sato, T; Ito, H; Fukai, R; Baba, H				Katayama, Kou; Okubo, Takanobu; Sato, Toshikazu; Ito, Hiroshi; Fukai, Richio; Baba, Hisashi			Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice	MODERN RHEUMATOLOGY			English	Article						DAS28 remission; Non-biological DMARD; Radiographic joint destruction; Retrospective study; Rheumatoid arthritis	COMBINATION THERAPY; AMERICAN-COLLEGE; DOUBLE-BLIND; RHEUMATOLOGY/EUROPEAN LEAGUE; TREATMENT STRATEGY; PROGNOSTIC-FACTORS; PLUS METHOTREXATE; CONTROLLED-TRIAL; RECOMMENDATIONS; LEFLUNOMIDE	Objective. We retrospectively investigated the inhibitory effect on radiographic joint damage (RJD) for non-biological disease-modifying antirheumatic drug (non-bioDMARD) monotherapy or methotrexate (MTX) combination therapy for rheumatoid arthritis (RA) in the disease activity score with 28 joint counts with erythrocyte sedimentation rate (DAS28) remission. Methods. Eighty-four patients (55 cases of monotherapy, 29 cases of MTX-combination therapy) in DAS28 remission (DAS28 <= 2.6) were investigated from 538 RA patients newly registered between February 2007 and August 2010. The patients were analyzed for radiological assessments using the modified total Sharp score/year (mTSS/y). Results. The remission rates and Delta mTSS/y for each agent using monotherapy were 7.1% and 0.17 for sulfasalazine; 11.9% and 0.49 for bucillamine (BUC); and 23.9% and 2.06 for MTX. Those using combination therapy were 6.8% and 1.39 for MTX + BUC; 23.5% and -1.64 for MTX + leflunomide; and 8.0% and 0.31 for MTX + tacrolimus. The cumulative distribution in the single and combination therapy groups showed improvement of percentages in structural remission from baseline to 1-year treatment, 34.1% to 60.9% (P < 0.05) and from 0% to 56.7% (P < 0.0001), respectively. Baseline mTSS (r = 0.67, P < 0.0001), disease duration (r = 0.40, P < 0.01), swollen joint counts (r = 0.33, P < 0.05), and anti-cyclic citrullinated peptide antibody (r = 0.31, P < 0.05) were useful predictors of RJD for non-bioDMARD monotherapy, but not for combination therapy. Conclusion. Satisfactory inhibition of RJD was observed in the DAS28 remission cases of monotherapy or MTX combination therapy with a non-bioDMARD.	[Katayama, Kou; Okubo, Takanobu; Sato, Toshikazu] Katayama Orthopaed Rheumatol Clin, Asahikawa, Hokkaido 0788243, Japan; [Ito, Hiroshi] Asahikawa Med Univ, Dept Orthopaed Surg, Asahikawa, Hokkaido, Japan; [Fukai, Richio] Seien Pharm, Asahikawa, Hokkaido, Japan; [Baba, Hisashi] Co Rheu Con, Osaka, Japan	Katayama, K (reprint author), Katayama Orthopaed Rheumatol Clin, 13-4-5-17 Toyooka, Asahikawa, Hokkaido 0788243, Japan.	kou@kata-rheum.or.jp					Abe C, 1994, INT J IMMUNOTHER, V11, P129; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; van Aken J, 2004, ANN RHEUM DIS, V63, P274, DOI 10.1136/ard.2003.010298; Makinen H, 2007, J RHEUMATOL, V34, P316; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; Stenger AAME, 1998, BRIT J RHEUMATOL, V37, P1157; Aletaha D, 2011, ARTHRITIS RHEUM-US, V63, P3702, DOI 10.1002/art.30634; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; van der Heijde D, 2006, ARTHRITIS RHEUM, V54, P1063, DOI 10.1002/art.21655; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; Shahouri SH, 2011, ARTHRITIS RHEUM-US, V63, P3204, DOI 10.1002/art.30524; Katchamart W, 2009, ANN RHEUM DIS, V68, P1105, DOI 10.1136/ard.2008.099861; Kremer JM, 2002, ANN INTERN MED, V137, P726; FUCHS HA, 1989, J RHEUMATOL, V16, P585; Schoels M, 2010, ANN RHEUM DIS, V69, P638, DOI 10.1136/ard.2009.123976; Combe B, 2001, ARTHRITIS RHEUM, V44, P1736, DOI 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I; Courvoisier N, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2498; Dirven L, 2010, ACR ARHP ANN SCI M A; Dougados M, 2003, J RHEUMATOL, V30, P2572; Maini Ravinder N, 2002, Arthritis Res, V4 Suppl 2, pS22, DOI 10.1186/ar549; Gremese E, 2012, ANN RHEUM DIS, V72, P858; Ichikawa Yoichi, 2005, Mod Rheumatol, V15, P323, DOI 10.1007/s10165-005-0420-z; Kashiwazaki S, 1996, JPN J INFLAMM, V16, P437; Katayama K, 2009, MOD RHEUMATOL, V19, P513, DOI 10.1007/s10165-009-0201-1; kinen H M, 2006, CLIN EXP RHEUMAT S43, V24, pS22; Okada M, 2013, EULAR ANN SCI M MADR; Quinn MA, 2001, RHEUMATOLOGY, V40, P1211, DOI 10.1093/rheumatology/40.11.1211; Rantalaiho V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3060; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; St Clair E William, 2004, Arthritis Rheum, V50, P3432, DOI 10.1002/art.20568; TUGWELL P, 1995, NEW ENGL J MED, V333, P137, DOI 10.1056/NEJM199507203330301	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					50	55		10.3109/14397595.2014.924385		6	Rheumatology	Rheumatology	AX1XF	WOS:000346736400007		
J	Yamada, K; Suzuki, A; Takahashi, S; Yasuda, H; Koike, T; Nakamura, H				Yamada, Kentaro; Suzuki, Akinobu; Takahashi, Shinji; Yasuda, Hiroyuki; Koike, Tatsuya; Nakamura, Hiroaki			Severe low back pain in patients with rheumatoid arthritis is associated with Disease Activity Score but not with radiological findings on plain X-rays	MODERN RHEUMATOLOGY			English	Article						Rheumatoid arthritis; Low back pain; Disease Activity Score; Prevalence; Multiple logistic regression analysis	LUMBAR DISC DEGENERATION; QUALITY-OF-LIFE; RADIOGRAPHIC FEATURES; SPINE; CLASSIFICATION; POPULATION; PREVALENCE; EFFICACY; IMPACT; JAPAN	Objective. To investigate the prevalence and associated factors of severe low back pain (LBP) among patients with rheumatoid arthritis (RA). Methods. This cross-sectional study included 201 patients with RA without prior spinal surgery. Severe LBP was defined as that with a visual analog scale (VAS) score of >= 50 mm within the previous 4 weeks. Lumbar lesions, sagittal alignment, and disc degeneration were evaluated by plain standing X-rays and magnetic resonance imaging. Associated factors of severe LBP were evaluated using multiple logistic regression analysis. Results. Forty-eight patients (23.8%) had LBP with a VAS score of >= 50 mm. Multivariate analysis indicated that the associated factors for severe LBP were female, smoking, and moderate and high disease activity on the Disease Activity Score in 28 joints-erythrocyte sedimentation rate (DAS28-ESR). There was no relationship between severe LBP and any radiological findings. Among DAS28-ESR subscores, patients with severe LBP had significantly higher tender joint counts and VAS scores for general health. Conclusions. The prevalence of severe LBP was relatively high in patients with RA. The factor most closely associated with severe LBP was Disease Activity Score, but not radiological findings. Severe LBP was related to the tender joint count or subjective complaints of RA.	[Yamada, Kentaro; Suzuki, Akinobu; Takahashi, Shinji; Yasuda, Hiroyuki; Nakamura, Hiroaki] Osaka City Univ, Dept Orthopaed Surg, Sch Med, Osaka 5458585, Japan; [Koike, Tatsuya] Osaka City Univ, Sch Med, Dept Rheumatosurg, Osaka 5458585, Japan	Suzuki, A (reprint author), Osaka City Univ, Dept Orthopaed Surg, Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	a-suzuki@msic.med.osaka-cu.ac.jp			Takeda Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Chugai Pharmaceutical; Eisai; Abbott Japan; Teijin Pharma; Banyu Pharmaceutical; Ono Pharmaceutical	T.K. has received research grants and/or speaking fees from Takeda Pharmaceutical, Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical, Eisai, Abbott Japan, Teijin Pharma, Banyu Pharmaceutical, and Ono Pharmaceutical. For the remaining authors, no funding or conflict of interest is declared.	Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Matsudaira K, 2012, SPINE, V37, P1324, DOI 10.1097/BRS.0b013e3182498382; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; de Schepper EIT, 2010, SPINE, V35, P531, DOI 10.1097/BRS.0b013e3181aa5b33; GENANT HK, 1993, J BONE MINER RES, V8, P1137; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Pye SR, 2004, J RHEUMATOL, V31, P753; Sakai T, 2008, SPINE J, V8, P605, DOI 10.1016/j.spince.2007.03.008; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659; Ton E, 2012, J RHEUMATOL, V39, P22, DOI 10.3899/jrheum.110072; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Baykara RA, 2013, J BACK MUSCULOSKELET, V26, P367, DOI 10.3233/BMR-130393; Chaléat-Valayer Emmanuelle, 2011, Eur Spine J, V20 Suppl 5, P634, DOI 10.1007/s00586-011-1931-2; Emery P, 2011, ANN RHEUM DIS, V70, P2126, DOI 10.1136/ard.2011.154500; Fairbank JC, 1980, PHYSIOTHERAPY, V66, P271; HELLIWELL PS, 1993, BRIT J RHEUMATOL, V32, P216; HEYWOOD AWB, 1986, J BONE JOINT SURG BR, V68, P362; Inaoka M, 2000, ARCH ORTHOP TRAUM SU, V120, P380, DOI 10.1007/PL00013766; Kawaguchi Y, 2003, J SPINAL DISORD TECH, V16, P38; Kothe R, 2007, PAIN, V127, P103, DOI 10.1016/j.pain.2006.08.011; LAWRENCE JS, 1964, ANN RHEUM DIS, V23, P205, DOI 10.1136/ard.23.3.205; Mochizuki T, 2013, MOD RHEUMATOL, V23, P994, DOI 10.1007/s10165-012-0790-y; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; PINCUS T, 1983, ARTHRITIS RHEUM, V26, P1346, DOI 10.1002/art.1780261107; SHICHIKAWA K, 1978, INT ORTHOP, V2, P53; Shiri R, 2010, AM J MED, V123, DOI DOI 10.1016/J.AMJMED.2009.05.028; SIMSWILLIAMS H, 1977, ANN RHEUM DIS, V36, P524, DOI 10.1136/ard.36.6.524; Yamada K, 2013, MOD RHEUMAT IN PRESS	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					56	61		10.3109/14397595.2014.924187		6	Rheumatology	Rheumatology	AX1XF	WOS:000346736400008		
J	Miyamae, T; Tanaka, E; Kishi, T; Matsuyama, T; Igarashi, T; Fujikawa, S; Taniguchi, A; Momohara, S; Yamanaka, H				Miyamae, Takako; Tanaka, Eiichi; Kishi, Takayuki; Matsuyama, Tsuyoshi; Igarashi, Tohru; Fujikawa, Satoshi; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi			Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan	MODERN RHEUMATOLOGY			English	Article						Biologic agents; Juvenile chronic arthritis; Juvenile idiopathic arthritis; Juvenile rheumatoid arthritis; Outcome assessment	JUVENILE IDIOPATHIC ARTHRITIS; COHORT; LIFE	Objective. To evaluate the long-term outcome of patients with juvenile idiopathic arthritis (JIA) using data from a large cohort database, Institute of Rheumatology, Rheumatoid Arthritis, managed by the Tokyo Women's Medical University. Methods. Of 182 patients identified from the database from 2000 to 2013, 114 were verified as having JIA. The transition of medical care and the contributions of biological DMARDs were evaluated. Results. The mean age of the patients (93 females, 81.6%) at the latest examination was 36.6 +/- 13.3 years. The mean age at disease onset and mean disease duration were 11.6 +/- 3.4 and 25.0 +/- 13.3 years, respectively. Of the 114 patients, 106 (93.0%) had poly- or oligoarthritis. Only one-fourth transferred from general pediatricians or pediatric rheumatologists. More patients with recent disease onset were treated with biological DMARDs (16.7% in the 1970s, vs. 80.0% in the 2000s). Disease activity assessed with DAS28 was significantly lower when disease onset was more recent (3.9 +/- 1.3 for onset in the 1960s vs. 2.2 +/- 1.1 for onset in the 2000s, p = 0.04). The percentage of patients requiring orthopedic surgery has decreased (53.8% before the 1970s vs. 10.0% in the 2000s). Conclusion. Patients with more recent disease onset showed an improved outcome. Establishing and sharing a transition program among pediatric and non-pediatric rheumatologists is desirable.	[Miyamae, Takako; Tanaka, Eiichi; Kishi, Takayuki; Matsuyama, Tsuyoshi; Igarashi, Tohru; Taniguchi, Atsuo; Momohara, Shigeki; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo 1620054, Japan; [Miyamae, Takako; Kishi, Takayuki] Tokyo Womens Med Univ, Dept Pediat, Shinjuku Ku, Tokyo 1620054, Japan; [Igarashi, Tohru] Nippon Med Sch, Dept Pediat, Tokyo 113, Japan; [Fujikawa, Satoshi] Fujikawa Pediat Clin, Fukuoka, Japan	Miyamae, T (reprint author), Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, 10-22 Kawada Cho, Tokyo 1620054, Japan.	miyamaet@gmail.com					Packham JC, 2002, RHEUMATOLOGY, V41, P1428, DOI 10.1093/rheumatology/41.12.1428; Takeuchi T, 2010, NAT REV RHEUMATOL, V6, P644, DOI 10.1038/nrrheum.2010.154; Nakajima A, 2010, SCAND J RHEUMATOL, V39, P360, DOI 10.3109/03009741003604542; Matsuda Y, 2003, ARTHRIT RHEUM-ARTHR, V49, P784, DOI 10.1002/art.11465; Petty RE, 2004, J RHEUMATOL, V31, P390; Zak M, 2000, RHEUMATOLOGY, V39, P198, DOI 10.1093/rheumatology/39.2.198; Bertilsson L, 2013, J RHEUMATOL, V40, P715, DOI 10.3899/jrheum.120602; Foster HE, 2003, ARTHRITIS RHEUM, V48, P767, DOI 10.1002/art.10863; Fujikawa S, 1997, ACTA PAEDIATR JAPON, V39, P242; Ishizaki Yuko, 2012, Biopsychosoc Med, V6, P8, DOI 10.1186/1751-0759-6-8; Koivuniemi R, 1999, CLIN RHEUMATOL, V18, P220, DOI 10.1007/s100670050088; McErlane F, 2013, RHEUMATOLOGY, V52, P1905, DOI 10.1093/rheumatology/ket248; Seto Y, 2011, MOD RHEUMATOL, V21, P579, DOI 10.1007/s10165-011-0445-4; Yamanaka Hisashi, 2007, Mod Rheumatol, V17, P283, DOI 10.1007/s10165-007-0587-6; Yamanaka Hisashi, 2006, Mod Rheumatol, V16, P75, DOI 10.1007/s10165-006-0464-8; Yokota S, 2000, PUBLIC WELFARE LABOR	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					62	66		10.3109/14397595.2014.929558		5	Rheumatology	Rheumatology	AX1XF	WOS:000346736400009		
J	Shibuya, H; Yoshitomi, H; Murata, K; Kobayashi, S; Furu, M; Ishikawa, M; Fujii, T; Ito, H; Matsuda, S				Shibuya, Hideyuki; Yoshitomi, Hiroyuki; Murata, Koichi; Kobayashi, Shio; Furu, Moritoshi; Ishikawa, Masahiro; Fujii, Takayuki; Ito, Hiromu; Matsuda, Shuichi			TNF alpha, PDGF, and TGF beta synergistically induce synovial lining hyperplasia via inducible PI3K delta	MODERN RHEUMATOLOGY			English	Article						Fibroblast-like synoviocytes; PI3K/Akt pathway; PI3K delta; PDGF; TGF beta	GROWTH-FACTOR-BETA; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; PHOSPHATIDYLINOSITOL 3-KINASE; EMBRYONIC LETHALITY; IMMUNE-RESPONSES; B-CELL; FIBROBLASTS; SUBUNIT; MICE	Objectives. To determine the mechanism underlying hypertrophic synovium in rheumatoid arthritis (RA). Methods. We examined micromass cultures of fibroblast-like synoviocytes (FLSs) stimulated with tumor necrosis factor alpha (TNF alpha), platelet-derived growth factor (PDGF), and/or transforming growth factor beta (TGF beta). The hypertrophic architecture of the micromasses, expression of phosphoinositide 3 kinase (PI3K) isoforms, and persistent activation of PI3K-Akt pathways were investigated. FLSs transfected with siRNA were also examined in the micromass cultures. Results. The combination of TNF alpha, PDGF, and TGF beta (TPT condition) induced obvious hypertrophic architecture of the intimal lining layer in FLSs in micromass cultures, and was accompanied by upregulated expression of matrix metalloproteinase-3 (MMP3), Cadherin-11, and PI3K delta. In monolayer FLSs, the TPT condition enhanced the expression of PI3K delta and persistent activation of the PI3K-Akt pathway. Knockdown of PI3K delta significantly inhibited the formation of the hypertrophic synovial lining in the TPT condition. Conclusions. These results collectively indicate that inducible PI3K delta plays a crucial role in persistent activation of PI3K-Akt in FLSs, and in the formation of a hypertrophic synovial lining. PI3K delta may be an alternative treatment target for the regulation of proliferative synovium in RA.	[Shibuya, Hideyuki; Yoshitomi, Hiroyuki; Murata, Koichi; Furu, Moritoshi; Ishikawa, Masahiro; Fujii, Takayuki; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068501, Japan; [Yoshitomi, Hiroyuki; Kobayashi, Shio] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto 6068501, Japan; [Furu, Moritoshi; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto 6068501, Japan	Yoshitomi, H (reprint author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	yositomi@kuhp.kyoto-u.ac.jp			Health and Labor Sciences Research Grants for Research on Allergic Disease and Immunology from the Ministry of Health, Labor and Welfare [10103190]; Special Coordination Funds for Promoting Science and Technology from Ministry of Education, Culture, Sports Science and Technology; Astellas Pharma Inc.	Supported by Health and Labor Sciences Research Grants for Research on Allergic Disease and Immunology from the Ministry of Health, Labor and Welfare (Grant No. 10103190) and by the Special Coordination Funds for Promoting Science and Technology from Ministry of Education, Culture, Sports Science and Technology and Astellas Pharma Inc.	Aletaha D, 2011, ANN RHEUM DIS, V70, P1975, DOI 10.1136/ard.2011.153734; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Zhang HJ, 2011, MOL CELL BIOCHEM, V355, P309, DOI 10.1007/s11010-011-0869-3; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Okkenhaug K, 2002, SCIENCE, V297, P1031; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Bartok B, 2012, AM J PATHOL, V180, P1906, DOI 10.1016/j.ajpath.2012.01.030; Yamanishi Y, 2002, J IMMUNOL, V168, P1405; Murata K, 2014, ARTHRITIS RHEUMATOL, V66, P549, DOI 10.1002/art.38269; Tanida S, 2011, CYTOKINE, V55, P237, DOI 10.1016/j.cyto.2011.04.020; Kim G, 2002, ARTHRITIS RHEUM, V46, P1504, DOI 10.1002/art.10314; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Kiener HP, 2010, ARTHRITIS RHEUM-US, V62, P742, DOI 10.1002/art.27285; Kiener HP, 2006, MOL BIOL CELL, V17, P2366, DOI 10.1091/mbc.E05-08-0745; Kobayashi S, 2013, ARTHRITIS RHEUM-US, V65, P3063, DOI 10.1002/art.38173; Kubo S, 2014, ANN RHEUM DIS, V73, P2192, DOI 10.1136/annrheumdis-2013-203756; LAFYATIS R, 1989, J IMMUNOL, V143, P1142; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; LOTZ M, 1990, J IMMUNOL, V144, P4189; Minghetti PP, 2000, J RHEUMATOL, V27, P653; MONIER S, 1994, CLIN EXP RHEUMATOL, V12, P595; Nishitani K, 2010, J CELL BIOCHEM, V109, P425, DOI 10.1002/jcb.22421; REMMERS EF, 1991, SEMIN ARTHRITIS RHEU, V21, P191, DOI 10.1016/0049-0172(91)90009-O; Rosengren S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2981; Su YJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-459; THORNTON SC, 1991, CLIN EXP IMMUNOL, V86, P79; WAHL SM, 1990, J IMMUNOL, V145, P2514; Wright HL, 2012, RHEUMATOLOGY, V51, P451, DOI 10.1093/rheumatology/ker338	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					72	78		10.3109/14397595.2014.900847		7	Rheumatology	Rheumatology	AX1XF	WOS:000346736400011		
J	Tono, T; Aihara, S; Hoshiyama, T; Arinuma, Y; Nagai, T; Hirohata, S				Tono, Toshihiro; Aihara, Satoko; Hoshiyama, Takayuki; Arinuma, Yoshiyuki; Nagai, Tatsuo; Hirohata, Shunsei			Effects of anti-IL-6 receptor antibody on human monocytes	MODERN RHEUMATOLOGY			English	Article						Apoptosis; IL-6; Monocytes; Rheumatoid arthritis; Tocilizumab	RHEUMATOID-ARTHRITIS PATIENTS; MONOCLONAL-ANTIBODY; DOSE-ESCALATION; SYNOVIAL TISSUE; BLOOD MONOCYTES; PLASMA IL-6; TNF-ALPHA; INTERLEUKIN-6; INHIBITION; CYTOKINES	Objective. To explore the effects of anti-IL-6 receptor antibody, tocilizumab on function of human monocytes. Methods. Monocytes from healthy donors were cultured in the presence of staphylococcal enterotoxin B (SEB) with pharmacologically attainable concentrations of tocilizumab or control IgG. The expression of IL-6 mRNA was determined using quantitative RT-PCR. The expression of CD80 and CD86 and the induction of apoptosis of monocytes were measured using flow cytometry. Results. Tocilizumab promoted apoptosis of SEB-stimulated monocytes. The induction of apoptosis of monocytes by tocilizumab were reversed by addition of IgG, but not IgG F(ab')(2) fragments. Tocilizumab significantly suppressed the expression of CD80, but not that of CD86, on SEB-stimulated monocytes. Finally, tocilizumab significantly suppressed the expression of mRNA for IL-6 of monocytes stimulated with SEB. Conclusions. These results demonstrate that one of the mechanism of action of tocilizumab involves the induction of apoptosis of monocytes, which requires interaction with Fc receptor on monocytes. Moreover, the data also indicate that tocilizumab inhibit IL-6 production of monocytes at mRNA levels.	[Tono, Toshihiro; Aihara, Satoko; Hoshiyama, Takayuki; Arinuma, Yoshiyuki; Nagai, Tatsuo; Hirohata, Shunsei] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 2520374, Japan	Tono, T (reprint author), Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	ttoshi@med.kitasato-u.ac.jp			Parents'Association Grant from Kitasato University School of Medicine; Mitsubishi Tanabe Pharma Co., Tokyo; Takeda Pharmaceutical Co., Tokyo; Chugai Pharmaceutical Co., Tokyo, Japan	This work was supported by Parents'Association Grant from Kitasato University School of Medicine and grants from Mitsubishi Tanabe Pharma Co., Tokyo, Takeda Pharmaceutical Co., Tokyo, and Chugai Pharmaceutical Co., Tokyo, Japan. These grants have no influences on the study design, the collection, analysis, and interpretation of data, the writing of the report, and in the decision to submit the paper for publication.	McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Nishina N, 2013, CLIN RHEUMATOL, V32, P1661, DOI 10.1007/s10067-013-2309-0; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Takeuchi T, 2012, ANN RHEUM DIS, V71, P1583, DOI 10.1136/annrheumdis-2011-201069; Mandron M, 2008, J INVEST DERMATOL, V128, P882, DOI 10.1038/sj.jid.5701112; Wong PKK, 2003, ARTHRITIS RHEUM, V48, P1177, DOI 10.1002/art.10943; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Iwahashi M, 2004, ARTHRITIS RHEUM, V50, P1457, DOI 10.1002/art.20219; Mitoma H, 2008, ARTHRITIS RHEUM, V58, P1248, DOI 10.1002/art.23447; Fleischmann RM, 2003, ARTHRITIS RHEUM, V48, P927, DOI 10.1002/art.10870; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Burmester GR, 1997, ARTHRITIS RHEUM, V40, P5, DOI 10.1002/art.1780400104; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P3856, DOI 10.1002/art.20678; CURNOW SJ, 1993, CANCER IMMUNOL IMMUN, V36, P149, DOI 10.1007/BF01741085; Hirohata S, 1996, ARTHRITIS RHEUM, V39, P836, DOI 10.1002/art.1780390517; Lipsky PE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1918; Nishimoto N, 2010, J CLIN EXP MED, V234, P110; Nishina N, 2013, CLIN RHEUMATOL; SIDELL N, 1991, J IMMUNOL, V146, P3809; Takeuchi T, 2011, ANN RHEUM DIS, V70, P1208, DOI 10.1136/ard.2011.153023; Tejima S, 2013, KITASATO MED J, V43, P126	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					79	84		10.3109/14397595.2014.914016		6	Rheumatology	Rheumatology	AX1XF	WOS:000346736400012		
J	Horai, Y; Koga, T; Fujikawa, K; Takatani, A; Nishino, A; Nakashima, Y; Suzuki, T; Kawashiri, S; Iwamoto, N; Ichinose, K; Tamai, M; Nakamura, H; Ida, H; Kakugawa, T; Sakamoto, N; Ishimatsu, Y; Mukae, H; Hamaguchi, Y; Fujimoto, M; Kuwana, M; Origuchi, T; Kohno, S; Kawakami, A				Horai, Yoshiro; Koga, Tomohiro; Fujikawa, Keita; Takatani, Ayuko; Nishino, Ayako; Nakashima, Yoshikazu; Suzuki, Takahisa; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Tamai, Mami; Nakamura, Hideki; Ida, Hiroaki; Kakugawa, Tomoyuki; Sakamoto, Noriho; Ishimatsu, Yuji; Mukae, Hiroshi; Hamaguchi, Yasuhito; Fujimoto, Manabu; Kuwana, Masataka; Origuchi, Tomoki; Kohno, Shigeru; Kawakami, Atsushi			Serum interferon-alpha is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis	MODERN RHEUMATOLOGY			English	Article						IFN-alpha; anti-MDA5 antibody; CADM; RPILD; Ferritin	CLINICALLY AMYOPATHIC DERMATOMYOSITIS; INTERSTITIAL LUNG-DISEASE; JAPANESE PATIENTS; POTENTIAL CONTRIBUTION; AUTOANTIBODIES; MYOSITIS; POLYMYOSITIS; FERRITIN; IL-18; DM	Objective. We have tried to clarify the clinical importance of the measurement of serum type-I interferon (IFN) in patients with anti-melanoma differentiation-associated gene 5 Ab (MDA5 Ab)-positive dermatomyositis (DM). Methods. We studied 30 patients with DM: 10 were anti-MDA5 Ab-positive and 20 were anti-MDA5 Ab-negative. At each patient's initial visit, serum IFN-alpha, IFN-beta, interleukin 18 (IL-18), ferritin, and the titer of anti-MDA5 Ab were measured using enzyme-linked immunosorbent assays (ELISAs). The associations between the IFNs and with the other variables were examined. Results. Rapidly progressive interstitial lung disease (RPILD) was confirmed in 10 patients, most of whom were complicated in the anti-MDA5 Ab-positive DM patients. The presence of clinically amyopathic dermatomyositis (CADM) as well as the serum concentrations of IFN-alpha and ferritin was significantly higher in the anti-MDA5 Ab-positive DM patients. Serum concentration of IL-18 did not differ between anti-MDA5 Ab-positive and anti-MDA5 Ab-negative groups; however, a positive correlation was found between IFN-alpha and IL-18 in the anti-MDA5 Ab-positive DM patients (r = 0.8139, p = 0.0146). Conclusion. Serum IFN-alpha can be used as a useful biomarker in patients with anti-MDA5 Ab-positive DM, which may reflect the presence of RPILD.	[Horai, Yoshiro; Koga, Tomohiro; Takatani, Ayuko; Nishino, Ayako; Nakashima, Yoshikazu; Suzuki, Takahisa; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Tamai, Mami; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki 8528501, Japan; [Fujikawa, Keita] Isahaya Hlth Insurance Gen Hosp, Dept Rheumatol, Nagasaki, Japan; [Ida, Hiroaki] Kurume Univ, Sch Med, Dept Med, Div Respirol Neurol & Rheumatol, Fukuoka, Japan; [Kakugawa, Tomoyuki; Sakamoto, Noriho; Ishimatsu, Yuji; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528501, Japan; [Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Fukuoka, Japan; [Hamaguchi, Yasuhito; Fujimoto, Manabu] Kanazawa Univ, Dept Dermatol, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Div Rheumatol, Dept Internal Med, Tokyo, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Rehabil Sci, Unit Translat Med, Nagasaki 8528501, Japan	Horai, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	yoshirohorai0518@yahoo.co.jp					Kameda H, 2005, J RHEUMATOL, V32, P1719; Gono T, 2012, RHEUMATOLOGY, V51, P1336, DOI 10.1093/rheumatology/kes012; Stam TC, 2002, EUR J CLIN INVEST, V32, P79, DOI 10.1046/j.1365-2362.2002.0320s1079.x; Koga T, 2012, RHEUMATOLOGY, V51, P1278, DOI 10.1093/rheumatology/ker518; Gono T, 2010, RHEUMATOLOGY, V49, P1878, DOI 10.1093/rheumatology/keq196; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Sato S, 2005, ARTHRITIS RHEUM, V52, P1571, DOI 10.1002/art.21023; Tucci M, 2007, ANN NY ACAD SCI, V1107, P184, DOI 10.1196/annals.1381.020; Sato S, 2010, CURR OPIN RHEUMATOL, V22, P639, DOI 10.1097/BOR.0b013e32833f1987; Cao H, 2012, ARTHRIT CARE RES, V64, P1602, DOI 10.1002/acr.21728; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Fujikawa K, 2009, SCAND J RHEUMATOL, V38, P263, DOI 10.1080/03009740802687455; Gong X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-224; Gono T, 2012, RHEUMATOLOGY, V51, P1563, DOI 10.1093/rheumatology/kes102; Greenberg S A, 2012, CURR RHEUMATOL REP, V12, P198; Koenig M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2276; Krol P, 2010, ANN RHEUM DIS, V70, P879; Sun WC, 2012, BRIT J DERMATOL, V167, P1236, DOI 10.1111/j.1365-2133.2012.11145.x	21	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					85	89		10.3109/14397595.2014.900843		5	Rheumatology	Rheumatology	AX1XF	WOS:000346736400013		
J	Kataoka, H; Yasuda, S; Fukaya, S; Oku, K; Horita, T; Atsumi, T; Koike, T				Kataoka, Hiroshi; Yasuda, Shinsuke; Fukaya, Shinji; Oku, Kenji; Horita, Tetsuya; Atsumi, Tatsuya; Koike, Takao			Decreased expression of Runx1 and lowered proportion of Foxp3(+)CD25(+)CD4(+) regulatory T cells in systemic sclerosis	MODERN RHEUMATOLOGY			English	Article						Foxp3; Runx1; Regulatory T cell; Systemic sclerosis	LUPUS-ERYTHEMATOSUS; INCREASED FREQUENCY; BINDING-SITE; BLOOD; FOXP3; TRANSPLANTATION; RECONSTITUTION; PROLIFERATION; MECHANISMS; PSORIASIS	Objectives. To investigate the role of Foxp3(+)CD25(+)CD4(+) regulatory T cells (Treg) and their transcription factor, Runt-related transcription factor 1 (Runx1), in the pathogenesis and development of systemic sclerosis (SSc). Methods. We collected 23 blood samples from patients with SSc including 19 females and 4 males, 11 early-stage cases within 3 years from onset and 12 late-stage cases and 22 samples from age-matched healthy subjects (HS). Total CD4(+) T cells were assessed for the expression of Treg-related markers, CD25 and CD127, on their surface and intracellular Foxp3 using flow cytometry. Relative expression of Runx1 mRNA in magnetically purified Treg was analyzed using real-time PCR. Results. Proportion of Foxp3(+) cells in total CD4(+) T cells was decreased in patients with either early-or late-stage SSc compared with that in HS, and Runx1 mRNA expression in purified Treg was lower in patients with SSc than in HS. Runx1 mRNA expression level was related to the frequency of Treg in SSc. Conclusions. This is the first report on Runx1 expression in Treg of a human autoimmune disease. Low expression of Runx1 along with reduced proportion of Treg in CD4(+) T cells may be associated with development of SSc even in early disease.	[Kataoka, Hiroshi; Yasuda, Shinsuke; Fukaya, Shinji; Oku, Kenji; Horita, Tetsuya; Atsumi, Tatsuya; Koike, Takao] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido 0608638, Japan	Kataoka, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Med 2, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	douglas@med.hokudai.ac.jp			KAKENHI from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21790931]	This work was supported by KAKENHI (grant-in-aid for Young Scientists (B): 21790931) granted from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We thank M. Aoto, H. Miidera, Y. Nakagawa, H. Nakagawa and T. Terada for their technical assistance.	Valencia X, 2007, J IMMUNOL, V178, P2579; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Bonelli M, 2009, J IMMUNOL, V182, P1689; Hasegawa M, 1997, J RHEUMATOL, V24, P328; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Zhan H, 2008, PEDIATRICS, V121, pE998, DOI 10.1542/peds.2007-1863; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Kumar M, 2006, J NEUROIMMUNOL, V180, P178, DOI 10.1016/j.jneuroim.2006.08.003; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Kurasawa K, 2000, ARTHRITIS RHEUM, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Antiga E, 2010, BRIT J DERMATOL, V162, P1056, DOI 10.1111/j.1365-2133.2010.09633.x; KAHAN A, 1991, ANN RHEUM DIS, V50, P354, DOI 10.1136/ard.50.6.354; Giovannetti A, 2010, CLIN IMMUNOL, V137, P122, DOI 10.1016/j.clim.2010.06.004; Slobodin G, 2010, CELL IMMUNOL, V261, P77, DOI 10.1016/j.cellimm.2009.12.009; Tsuji-Yamada J, 2001, J RHEUMATOL, V28, P1252; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sugiyama H, 2005, J IMMUNOL, V174, P164; Denton CP, 2006, NAT CLIN PRACT RHEUM, V2, P134, DOI 10.1038/ncprheum0115; Sakkas LI, 2006, NAT CLIN PRACT RHEUM, V2, P679, DOI 10.1038/ncprheum0346; Antiga E, 2010, CELL IMMUNOL, V264, P186, DOI 10.1016/j.cellimm.2010.06.007; Bohgaki T, 2009, J RHEUMATOL, V36, P1240, DOI 10.3899/jrheum.081025; Chen X, 2006, EUR J IMMUNOL, V36, P2139, DOI 10.1002/eji.2006.35873; Kawaguchi Y, 1999, J CLIN INVEST, V103, P1253, DOI 10.1172/JCI4304; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005981; UMEHARA H, 1988, ARTHRITIS RHEUM, V31, P401, DOI 10.1002/art.1780310312	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					90	95		10.3109/14397595.2014.899736		6	Rheumatology	Rheumatology	AX1XF	WOS:000346736400014		
J	Niikura, AJ; Yamachika, S; Yamamoto, K; Okamoto, MR; Ikeda, YF; Nakamura, S; Oda, E; Imamura, TK; Saito, I; Nakagawa, Y				Niikura, Asumi J.; Yamachika, Shigeo; Yamamoto, Ken; Okamoto, Mariko R.; Ikeda, Yuko F.; Nakamura, Sachika; Oda, Etsuko; Imamura, Takahiro K.; Saito, Ichiro; Nakagawa, Yoichi			Efficient diagnosis of Sjogren's syndrome to reduce the burden on patients	MODERN RHEUMATOLOGY			English	Article						Anti-SS-A antibody; Diagnostic criteria; Lip biopsy; Parotid sialography; Sjogren's syndrome	CLASSIFICATION CRITERIA; RISK-FACTORS; SIALOGRAPHY; PREVALENCE	Objective. The purpose of this study was to investigate the procedures for efficiently diagnosing Sjogren's syndrome to reduce patient burden. Methods. This study analyzed data from 254 Japanese patients diagnosed with Sjogren's syndrome out of 4967 who visited our clinic complaining of xerostomia. Results. Of the 254 Sjogren's syndrome patients, 140 fulfilled the criteria proposed by the Committee on Sjogren's Syndrome of the Ministry of Health and Welfare of Japan, 228 fulfilled the criteria proposed by the American-European Consensus Group, and 69 fulfilled the criteria proposed by the American College of Rheumatology. Numbers of definitive cases varied with each set of criteria. Logistic regression analysis was used to analyze useful examination items for definitive diagnosis of Sjogren's syndrome, demonstrating that anti-Ro/SSA (odds ratio (OR), 7.165), lip biopsy (OR, 4.273), sialography (OR, 2.402), and ANA (OR, 0.678) correlated significantly with definitive diagnosis of Sjogren's syndrome. Conclusions. These results suggest that the following diagnostic procedure for Sjogren's syndrome would reduce burden on patients. When clinicians choose examination items for diagnosing Sjogren's syndrome, they should first select which criteria to use. Then, to minimize the number of examination items, examinations should be performed in order of anti-SSA antibody, lip biopsy, and parotid gland sialography.	[Niikura, Asumi J.; Yamachika, Shigeo; Yamamoto, Ken; Okamoto, Mariko R.; Ikeda, Yuko F.; Nakamura, Sachika; Oda, Etsuko; Imamura, Takahiro K.; Saito, Ichiro; Nakagawa, Yoichi] Tsurumi Univ, Dent Hosp, Dept Clin Pathophysiol, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan	Nakagawa, Y (reprint author), Tsurumi Univ, Dent Hosp, Dept Clin Pathophysiol, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	nakagawa-y@tsurumi-u.ac.jp					Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Kruszka P, 2009, AM FAM PHYSICIAN, V79, P465; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Tsuboi H, 2013, MOD RHEUMATOL, V23, P219, DOI 10.1007/s10165-012-0812-9; Kalk WWI, 2001, ANN RHEUM DIS, V60, P1110, DOI 10.1136/ard.60.12.1110; Fujibayashi Takashi, 2004, Mod Rheumatol, V14, P425, DOI 10.3109/s10165-004-0338-x; Houghton K, 2005, J RHEUMATOL, V32, P2225; Kalk WWI, 2002, ORAL SURG ORAL MED O, V94, P131, DOI 10.1067/moe.2002.126017; Manthorpe R, 2002, ANN RHEUM DIS, V61, P482, DOI 10.1136/ard.61.6.482; Nederfors T, 2000, Adv Dent Res, V14, P48; Ohbayashi N, 1998, RADIOLOGY, V209, P683; Shimizu M, 2008, ORAL SURG ORAL MED O, V106, P587, DOI 10.1016/j.tripleo.2007.11.007; Yamachika S, 2012, OPEN J STOMATOL, V2, P103	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					100	104		10.3109/14397595.2014.927969		5	Rheumatology	Rheumatology	AX1XF	WOS:000346736400016		
J	Ebe, H; Tsuboi, H; Hagiya, C; Takahashi, H; Yokosawa, M; Hagiwara, S; Hirota, T; Kurashima, Y; Takai, C; Miki, H; Asashima, H; Umeda, N; Kondo, Y; Ogishima, H; Suzuki, T; Chino, Y; Matsumoto, I; Sumida, T				Ebe, Hiroshi; Tsuboi, Hiroto; Hagiya, Chihiro; Takahashi, Hiroyuki; Yokosawa, Masahiro; Hagiwara, Shinya; Hirota, Tomoya; Kurashima, Yuko; Takai, Chinatsu; Miki, Haruka; Asashima, Hiromitsu; Umeda, Naoto; Kondo, Yuya; Ogishima, Hiroshi; Suzuki, Takeshi; Chino, Yusuke; Matsumoto, Isao; Sumida, Takayuki			Clinical features of patients with IgG4-related disease complicated with perivascular lesions	MODERN RHEUMATOLOGY			English	Article						IgG4-related disease; Perivascular lesions; Steroid therapy	REGULATORY IMMUNE-REACTIONS; AUTOIMMUNE PANCREATITIS; LYMPHOPLASMACYTIC AORTITIS; SYSTEMIC-DISEASE; IGG4 PRODUCTION; CT FINDINGS; TH2	Objective. To define the clinical features of IgG4-related disease (IgG4-RD) complicated with perivascular lesions. Methods. The clinical features of seven patients with IgG4-RD and perivascular lesions diagnosed at the University of Tsukuba Hospital between October 2008 and October 2013, were analyzed, including clinical background, results of imaging studies, satisfaction of the 2011 comprehensive diagnostic criteria (CDC) for IgG4-RD, laboratory data, distribution of perivascular lesions, involvement of other organs, and response to steroid therapy. Results. We studied six men and one woman with a mean age of 66.9 +/- 6.7 years (+/- SD). Six of seven patients were diagnosed as definite IgG4-RD, while the seventh was considered possible IgG4-RD, based on the CDC for IgG4-RD. Serum IgG4 levels at diagnosis were higher than 135 mg/dl in all seven patients (mean, 933 +/- 527). Serum C-reactive protein (CRP) levels were elevated in two only (mean, 1.42 +/- 3.56 mg/dl). The perivascular lesions were located in the pulmonary artery (n = 1), thoracic aorta (n = 2), abdominal aorta (n = 6), coronary (n = 1), celiac (n = 1), superior mesenteric (n = 1), renal (n = 2), inferior mesenteric (n = 5), and iliac (n = 3) arteries. In addition to perivascular lesions, six patients showed involvement of other organs. All seven patients were treated with prednisolone (0.6 mg/kg/day), which rapidly improved the perivascular and other organ lesions in six patients (the other one patient have not yet been evaluated due to the short follow-up). Conclusion. Perivascular lesions show wide distribution in patients with IgG4-RD. Serum CRP levels are not necessarily elevated in these patients. Steroid therapy is effective in IgG4-RD and results in resolution of lesions.	[Ebe, Hiroshi; Tsuboi, Hiroto; Hagiya, Chihiro; Takahashi, Hiroyuki; Yokosawa, Masahiro; Hagiwara, Shinya; Hirota, Tomoya; Kurashima, Yuko; Takai, Chinatsu; Miki, Haruka; Asashima, Hiromitsu; Umeda, Naoto; Kondo, Yuya; Ogishima, Hiroshi; Suzuki, Takeshi; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; [Chino, Yusuke] Univ Tsukuba Hosp, Dept Rheumatol, Mito Med Ctr, Mito, Ibaraki, Japan	Sumida, T (reprint author), Univ Tsukuba, Fac Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tsumida@md.tsukuba.ac.jp			Health and Labour Sciences Research Grants for research on intractable diseases (Research on IgG4-related disease) from the Ministry of Health, Labour and Welfare of Japan	This work was supported in part by Health and Labour Sciences Research Grants for research on intractable diseases (Research on IgG4-related disease) from the Ministry of Health, Labour and Welfare of Japan.	Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Miyake K, 2008, MOD RHEUMATOL, V18, P86, DOI 10.1007/s10165-007-0010-3; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Fujinaga Y, 2010, EUR J RADIOL, V76, P228, DOI 10.1016/j.ejrad.2009.06.010; Inoue D, 2011, RADIOLOGY, V261, P625, DOI 10.1148/radiol.11102250; Stone JH, 2010, ARTHRIT CARE RES, V62, P316, DOI 10.1002/acr.20095; Inoue D, 2009, RADIOLOGY, V251, P260, DOI 10.1148/radiol.2511080965; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Chari ST, 2009, CLIN GASTROENTEROL H, V7, P1097, DOI 10.1016/j.cgh.2009.04.020; Reefer AJ, 2004, J IMMUNOL, V172, P2763; Sahani DV, 2004, RADIOLOGY, V233, P345, DOI 10.1148/radiol.2332031436; Jeannin P, 1998, J IMMUNOL, V160, P3555; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Takahashi N, 2007, RADIOLOGY, V242, P791, DOI 10.1148/radiol.2423060003; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Hagiya C, 2013, MOD RHEUMATOL; Iakashima H, 2010, CLIN NEPHROL, V73, P385; Kasashima S, 2010, J VASC SURG, V52, P1587, DOI 10.1016/j.jvs.2010.06.072; Stone JH, 2009, ARTHRITIS RHEUM, V60, P3139, DOI 10.1002/art.24798; Takahira M, 2012, INT J RHEUMATOL, V2012, DOI DOI 10.1155/2012/635473; Tsuboi H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3924; Umehara H, 2011, MOD RHEUMATOL, V2012, P21, DOI DOI 10.1007/S10165-011-0571-Z	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					105	109		10.3109/14397595.2014.903596		5	Rheumatology	Rheumatology	AX1XF	WOS:000346736400017		
J	Shima, Y; Hosen, N; Hirano, T; Arimitsu, J; Nishida, S; Hagihara, K; Narazaki, M; Ogata, A; Tanaka, T; Kishimoto, T; Kumanogoh, A				Shima, Yoshihito; Hosen, Naoki; Hirano, Toru; Arimitsu, Junsuke; Nishida, Sumiyuki; Hagihara, Keisuke; Narazaki, Masashi; Ogata, Atsushi; Tanaka, Toshio; Kishimoto, Tadamitsu; Kumanogoh, Atsushi			Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab	MODERN RHEUMATOLOGY			English	Article						Systemic sclerosis; Tocilizumab; Range of joint motion	MYCOPHENOLATE-MOFETIL; DIFFUSE SCLERODERMA; CYCLOSPORINE-A; LUNG-DISEASE; SERUM-LEVELS; RECENT-ONSET; INTERLEUKIN-6; SKIN; TRIAL; CYCLOPHOSPHAMIDE	Systemic sclerosis (SSc) presents stiffness of extremities due to sclerosis of the tissue especially at fingers, hands, and forearms. Here we report the case of a patient with diffuse cutaneous SSc who was administered anti-interleukin-6 receptor antibody tocilizumab (TCZ). Skin condition of SSc is evaluated by pinching the skin according to the Rodnan skin score, but sometimes tissue atrophy results in overestimation of the condition. To understand how the extremities softened after initiation of TCZ, we observed mobility of extremities. Range of motion (ROM) of joints was measured every four months after initiation of TCZ. The patient presented not only reduction of Rodnan score but also amelioration of mobility of extremities. The Rodnan skin score reduced from 35 to 7 within sixteen months, and ROM of most joints except ankle was expanded.	[Shima, Yoshihito; Hosen, Naoki; Hirano, Toru; Arimitsu, Junsuke; Nishida, Sumiyuki; Hagihara, Keisuke; Narazaki, Masashi; Ogata, Atsushi; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Tanaka, Toshio] Osaka Univ, Grad Sch Med, Dept Clin Applicat Biol, Suita, Osaka 5650871, Japan; [Kishimoto, Tadamitsu] Osaka Univ, Immunoregulat Lab, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Shima, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	ryanjin@imed3.med.osaka-u.ac.jp			Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan	Our heartfelt appreciation goes to Dr. Kuwahara, Dr. Watanabe, and Dr. Kawai, whose outstanding medical work was of inestimable value for our study. We are indebted to Dr. Iwatani, Dr. Sakata, Dr. Okano, and Dr. Takahashi, whose extensive knowledge in nephrology, cardiology, and gastroenterology made an enormous contribution to our work. This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan.	Shima Y, 2010, RHEUMATOLOGY, V49, P2408, DOI 10.1093/rheumatology/keq275; Pope JE, 2001, ARTHRITIS RHEUM, V44, P1351, DOI 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Nihtyanova SI, 2007, RHEUMATOLOGY, V46, P442, DOI 10.1093/rheumatology/kel244; McGonagle D, 2008, RHEUMATOLOGY, V47, P552, DOI 10.1093/rheumatology/kem357; Steen VD, 1998, ARTHRITIS RHEUM, V41, P1613, DOI 10.1002/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O; Clements PJ, 1999, ARTHRITIS RHEUM, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7; Kowal-Bielecka O, 2009, ANN RHEUM DIS, V68, P620, DOI 10.1136/ard.2008.096677; Denton CP, 2009, ANN RHEUM DIS, V68, P1433, DOI 10.1136/ard.2008.096123; DENTON CP, 1994, BRIT J RHEUMATOL, V33, P90; FEGHALI CA, 1992, J RHEUMATOL, V19, P1207; Filaci G, 1999, RHEUMATOLOGY, V38, P992, DOI 10.1093/rheumatology/38.10.992; GURRAM M, 1994, ANN ALLERGY, V73, P493; Hasegawa M, 1998, J RHEUMATOL, V25, P308; Kawaguchi Y, 1999, J CLIN INVEST, V103, P1253, DOI 10.1172/JCI4304; Khan K, 2012, ANN RHEUM DIS; Kuhn A, 2010, RHEUMATOLOGY, V49, P1336, DOI 10.1093/rheumatology/keq077; Mendoza FA, 2012, J RHEUMATOL, V39, P1241, DOI 10.3899/jrheum.111229; PLOTZ PH, 1979, ANN INTERN MED, V91, P221; Stratton RJ, 2001, RHEUMATOLOGY, V40, P84, DOI 10.1093/rheumatology/40.1.84; Takehara K, 2004, CLIN EXP RHEUMATOL, V22, pS87	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					134	137		10.3109/14397595.2013.874749		4	Rheumatology	Rheumatology	AX1XF	WOS:000346736400022		
J	Iijima, T; Suwabe, T; Sumida, K; Hayami, N; Hiramatsu, R; Hasegawa, E; Yamanouchi, M; Hoshino, J; Sawa, N; Takaichi, K; Oohashi, K; Fujii, T; Ubara, Y				Iijima, Takashi; Suwabe, Tatsuya; Sumida, Keiichi; Hayami, Noriko; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Hoshino, Junichi; Sawa, Naoki; Takaichi, Kenmei; Oohashi, Kenichi; Fujii, Takeshi; Ubara, Yoshifumi			Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis	MODERN RHEUMATOLOGY			English	Article						Systemic rheumatoid vasculitis; Necrotizing crescentic glomerulonephritis; Humanized anti-interleukin-6 receptor antibody; Tocilizumab	ARTHRITIS; ANTIBODY	We report a Japanese woman with systemic rheumatoid vasculitis (SRV) complicated by necrotizing crescentic glomerulonephritis (NCGN). Rheumatoid arthritis first occurred at the age of 19 years, followed by interstitial pneumonia, hepatitis, rheumatoid nodules, mononeuritis multiplex, and hypocomplementemia in chronological order. At the age of 51 years, rapidly progressive renal failure occurred with nephrotic proteinuria, and NCGN with subepithelial deposits was revealed by renal biopsy. Severe destructive changes of multiple joints and scleritis were detected, but anti-neutrophil cytoplasmic antibody was negative on enzyme-linked immunosorbent assays and indirect immunofluorescence. SRV was diagnosed due to involvement of multiple extra-articular organs. An anti-interleukin (IL)-6 receptor antibody (tocilizumab) was started at dosage of 280 mg (8 mg/kg) monthly. After 18 months, her serum creatinine decreased from 1.7 to 1.3 mg/dL, and urinary protein excretion declined from 5.2 to 1.2 g daily. Tocilizumab may be a therapeutic option for SRV associated with NCGN.	[Iijima, Takashi; Suwabe, Tatsuya; Sumida, Keiichi; Hayami, Noriko; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Hoshino, Junichi; Sawa, Naoki] Toranomon Hosp Kajigaya, Nephrol Ctr, Takatsu Ku, Kawasaki, Kanagawa 2138587, Japan; [Oohashi, Kenichi; Fujii, Takeshi] Toranomon Hosp Kajigaya, Dept Pathol, Kawasaki, Kanagawa 2138587, Japan; [Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Hosp Kajigaya, Okinaka Mem Inst Med Res, Kawasaki, Kanagawa 2138587, Japan	Ubara, Y (reprint author), Toranomon Hosp Kajigaya, Nephrol Ctr, Takatsu Ku, 1-3-1 Kajigaya, Kawasaki, Kanagawa 2138587, Japan.	ubara@toranomon.gr.jp					Sumida K, 2011, RHEUMATOLOGY, V50, P1928, DOI 10.1093/rheumatology/ker222; Genta MS, 2006, SEMIN ARTHRITIS RHEU, V36, P88, DOI 10.1016/j.semarthrit.2006.04.006; BOERS M, 1987, ANN RHEUM DIS, V46, P658, DOI 10.1136/ard.46.9.658; Ashok D, 2008, CLIN RHEUMATOL, V27, P261, DOI 10.1007/s10067-007-0712-0; Cojocaru Manole, 2010, Maedica (Buchar), V5, P286; Fournier A, 2009, NEPHROL THER, V5, P652, DOI 10.1016/j.nephro.2009.03.005; Goto Akiko, 2005, Mod Rheumatol, V15, P118, DOI 10.1007/s10156-004-0370-y; Harper L, 1997, QJM-MON J ASSOC PHYS, V90, P125, DOI 10.1093/qjmed/90.2.125; Hoshino J, 2006, NEPHRON CLIN PRACT, V104, pC15, DOI 10.1159/0000932254; Huugen D, 2006, CLIN J AM SOC NEPHRO, V1, P1100, DOI 10.2215/CJN.02181205; KUZNETSKY KA, 1986, CLIN NEPHROL, V26, P257; Messiaen T, 1998, Am J Kidney Dis, V32, pE6, DOI 10.1016/S0272-6386(98)70153-2; Sumida K, 2011, CLIN EXP RHEUMATOL, V29, P133; Yorioka N, 1999, AM J NEPHROL, V19, P527, DOI 10.1159/000013494	14	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					138	142		10.3109/14397595.2013.874748		5	Rheumatology	Rheumatology	AX1XF	WOS:000346736400023		
J	Izumi, Y; Miyashita, T; Kitajima, T; Yoshimura, S; Takeoka, A; Eguchi, K; Motomura, M; Kawakami, A; Migita, K				Izumi, Yasumori; Miyashita, Taiichiro; Kitajima, Tsubasa; Yoshimura, Shunsuke; Takeoka, Atsushi; Eguchi, Katsumi; Motomura, Masakatsu; Kawakami, Atsushi; Migita, Kiyoshi			Two cases of refractory polymyositis accompanied with steroid myopathy	MODERN RHEUMATOLOGY			English	Article						Branched-chain amino acids; Glucocorticoid; Polymyositis; Steroid myopathy	INTERSTITIAL LUNG-DISEASE; IDIOPATHIC INFLAMMATORY MYOSITIS; MUSCLE ATROPHY; AMINO-ACIDS; DERMATOMYOSITIS	Polymyositis (PM) is an inflammatory muscle disease characterized by chronic inflammation in skeletal muscle. Although most patients with PM respond to corticosteroids, some cases show an unsatisfactory response and other therapeutic options must be considered. Furthermore, glucocorticosteroid (GC) toxicity leads to a significant disability known as steroid myopathy, particularly in elderly patients. Here we report two patients with refractory PM. Combined treatment with high-dose GCs, tacrolimus, and intravenous immunoglobulin resulted in beneficial effects against myositis. However, muscle weakness and the disability progressed due to steroid myopathy, and subsequent oral intake became impossible because of swallowing disturbance in these two patients. Nutritional intervention, including branched-chain amino acids (BCAAs) and rehabilitation, was undertaken in addition to treatment against myositis. These treatments finally improved the muscle weakness and activities of daily living, and the two patients were discharged after recovery. The high-dose GC treatment caused elevation of serum levels of amino acids, including BCAAs, but these amino acids subsequently declined during BCAA replacement therapy. These findings suggest that the catabolic effects of the glucocorticoid treatment impair the balance of amino acids, including BCAAs, within the muscle, leading to steroid myopathy.	[Izumi, Yasumori; Miyashita, Taiichiro; Kitajima, Tsubasa; Yoshimura, Shunsuke; Takeoka, Atsushi; Migita, Kiyoshi] NHO Natl Nagasaki Med Ctr, Dept Gen Internal Med & Rheumatol, Omura, Japan; [Eguchi, Katsumi] Sasebo City Gen Hosp, Dept Rheumatol, Sasebo, Japan; [Motomura, Masakatsu; Kawakami, Atsushi; Migita, Kiyoshi] Nagasaki Univ Hosp, Dept Neurol & Rheumatol, Nagasaki, Japan	Migita, K (reprint author), Nagasaki Univ Hosp, Dept Neurol & Rheumatol, Nagasaki, Japan.	migita@nmc.hosp.go.jp					Yamamoto D, 2010, MUSCLE NERVE, V41, P819, DOI 10.1002/mus.21621; Sultan SM, 2002, RHEUMATOLOGY, V41, P22, DOI 10.1093/rheumatology/41.1.22; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Kanda F, 1999, MUSCLE NERVE, V22, P213, DOI 10.1002/(SICI)1097-4598(199902)22:2<213::AID-MUS9>3.0.CO;2-M; Oddis CV, 1999, LANCET, V353, P1762, DOI 10.1016/S0140-6736(99)01927-3; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; Pereira RMR, 2011, JOINT BONE SPINE, V78, P41, DOI 10.1016/j.jbspin.2010.02.025; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Takada K, 2005, AUTOIMMUNITY, V38, P383, DOI 10.1080/08916930500124023; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Minetto MA, 2011, J ENDOCRINOL INVEST, V34, P370; JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Ponyi A, 2005, RHEUMATOLOGY, V44, P83, DOI 10.1093/rheumatology/keh404; BEAUFRERE B, 1989, AM J PHYSIOL, V257, pE712; Choy EHS, 2002, RHEUMATOLOGY, V41, P7, DOI 10.1093/rheumatology/41.1.7; Hirakata M, 2000, CURR OPIN RHEUMATOL, V12, P501, DOI 10.1097/00002281-200011000-00005; Ioannou Yiannis, 1999, Current Opinion in Rheumatology, V11, P468, DOI 10.1097/00002281-199911000-00005; LaPier T K, 1997, J Cardiopulm Rehabil, V17, P76, DOI 10.1097/00008483-199703000-00002; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715; SIMMONS PS, 1984, J CLIN INVEST, V73, P412, DOI 10.1172/JCI111227	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					143	149		10.3109/14397595.2013.874750		7	Rheumatology	Rheumatology	AX1XF	WOS:000346736400024		
J	Kameda, T; Dobashi, H; Susaki, K; Danjo, J; Nakashima, S; Shimada, H; Izumikawa, M; Takeuchi, Y; Mitsunaka, H; Bandoh, S; Imataki, O; Nose, M; Matsunaga, T				Kameda, Tomohiro; Dobashi, Hiroaki; Susaki, Kentaro; Danjo, Junichi; Nakashima, Shusaku; Shimada, Hiromi; Izumikawa, Miharu; Takeuchi, Yohei; Mitsunaka, Hiroki; Bandoh, Shuji; Imataki, Osamu; Nose, Masato; Matsunaga, Takuya			A case of catastrophic antiphospholipid syndrome, which presented an acute interstitial pneumonia-like image on chest CT scan	MODERN RHEUMATOLOGY			English	Article						Catastrophic antiphospholipid syndrome; Acute interstitial pneumonia; Mixed connective tissue disease	DISEASE	We report the case of catastrophic antiphospholipid syndrome (CAPS) complicated with mixed connective tissue disease (MCTD). A female patient was diagnosed with acute interstitial pneumonia (AIP) with MCTD by chest CT scan. Corticosteroid therapy was refractory for lung involvement, and she died due to acute respiratory failure. The autopsy revealed that AIP was compatible with lung involvement of CAPS. We therefore suggest that chest CT might reveal AIP-like findings in CAPS patients whose condition is complicated with pulmonary manifestations.	[Kameda, Tomohiro; Dobashi, Hiroaki; Susaki, Kentaro; Danjo, Junichi; Nakashima, Shusaku; Shimada, Hiromi; Izumikawa, Miharu; Takeuchi, Yohei; Bandoh, Shuji; Imataki, Osamu; Matsunaga, Takuya] Kagawa Univ, Fac Med, Dept Internal Med, Div Endocrinol & Metab, Miki, Kagawa 7610793, Japan; [Mitsunaka, Hiroki] Kagawa Prefectural Cent Hosp, Dept Internal Med, Kagawa, Japan; [Nose, Masato] Ehime Univ, Grad Sch Med, Dept Pathogen, Matsuyama, Ehime, Japan	Dobashi, H (reprint author), Kagawa Univ, Fac Med, Dept Internal Med, Div Endocrinol & Metab, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hdobashi@kms.ac.jp					Cervera R, 2009, J AUTOIMMUN, V32, P240, DOI 10.1016/j.jaut.2009.02.008; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Laskin CA, 1997, NEW ENGL J MED, V337, P148, DOI 10.1056/NEJM199707173370302; HUGHES GRV, 1983, BRIT MED J, V287, P1088; Asherson RA, 2002, JCR-J CLIN RHEUMATOL, V8, P157, DOI 10.1097/01.RHU.0000017454.53879.07; Boura P, 2005, CLIN RHEUMATOL, V24, P420, DOI 10.1007/s10067-004-1062-9; CERVERA R, 1993, MEDICINE, V72, P113; HARRIS EN, 1990, BRIT J HAEMATOL, V74, P1, DOI 10.1111/j.1365-2141.1990.tb02530.x; Hirakawa E, 2011, MOD RHEUMATOL; HUGHES GRV, 1986, J RHEUMATOL, V13, P486; RAMOSNIEMBRO F, 1979, ARTHRITIS RHEUM, V22, P43, DOI 10.1002/art.1780220107; Vora Setu K, 2006, J Intensive Care Med, V21, P144, DOI 10.1177/0885066606287041; Wani AM, 2010, BMJ CASE REP; Wiedermann FJ, 2000, J INTERN MED, V247, P723, DOI 10.1046/j.1365-2796.2000.00687.x	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					150	153		10.3109/14397595.2013.874751		4	Rheumatology	Rheumatology	AX1XF	WOS:000346736400025		
J	Maeshima, K; Torigoe, M; Iwakura, M; Yamanaka, K; Ishii, K				Maeshima, Keisuke; Torigoe, Masataka; Iwakura, Mikako; Yamanaka, Kunitoshi; Ishii, Koji			Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis	MODERN RHEUMATOLOGY			English	Article						Leukocytapheresis (LCAP); Rheumatoid arthritis; Hemodialysis; Drug-free remission	INFLIXIMAB TREATMENT; ETANERCEPT; DIALYSIS; EFFICACY; LCAP	We report the case of a 44-year-old female undergoing maintenance hemodialysis in whom early-phase rheumatoid arthritis (RA) was successfully treated by leukocytapheresis (LCAP). The effects of prednisone, tacrolimus, and etanercept were limited, but LCAP was highly effective and its efficacy continued even after cessation of LCAP. Moreover, remission was maintained for 2 years after discontinuation of medication. LCAP may be an important treatment option for RA patients with end-stage renal failure who are on hemodialysis.	[Maeshima, Keisuke; Torigoe, Masataka; Iwakura, Mikako; Ishii, Koji] Oita Univ, Fac Med, Dept Internal Med 1, Oita 87011, Japan; [Yamanaka, Kunitoshi] Nakatsu Daiichi Hosp, Dept Internal Med, Oita, Japan	Ishii, K (reprint author), Oita Univ, Fac Med, Dept Internal Med 1, Oita 87011, Japan.	kois@oita-u.ac.jp					Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; Sakai Y, 2009, THER APHER DIAL, V13, P179, DOI 10.1111/j.1744-9987.2009.00657.x; Iwamoto M, 2011, RHEUMATOL INT, V31, P559, DOI 10.1007/s00296-010-1430-5; van der Woude D, 2009, ARTHRITIS RHEUM, V60, P2262, DOI 10.1002/art.24661; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Basile C, 2002, NEPHROL DIAL TRANSPL, V17, P530, DOI 10.1093/ndt/17.3.530; Hammoudeh M, 2006, RHEUMATOLOGY, V45, P357, DOI 10.1093/rheumatology/kei264; Hayashi W, 2006, KYUSHU J RHEUMATOL, V26, P36; Hidaka T, 1999, Ther Apher, V3, P178, DOI 10.1046/j.1526-0968.1999.00136.x; Hidaka Toshihiko, 2011, Nihon Rinsho Meneki Gakkai Kaishi, V34, P447; Hidaka T, 2001, J CLIN APHERESIS, V16, P74, DOI 10.1002/jca.1016; Hidaka T, 1999, ARTHRITIS RHEUM, V42, P431, DOI 10.1002/1529-0131(199904)42:3<431::AID-ANR6>3.0.CO;2-2; Izumi Yasumori, 2006, Mod Rheumatol, V16, P20, DOI 10.1007/s10165-005-0448-0; Nagase K, 2004, THER APHER DIAL, V8, P45, DOI 10.1111/j.1526-0968.2004.00086.x; Nakamura T, 2010, RHEUMATOL INT, V30, P1527, DOI 10.1007/s00296-010-1452-z; Ohsawa I, 2007, CLIN NEPHROL, V68, P121; Onuma S, 2006, THER APHER DIAL, V10, P404, DOI 10.1111/j.1744-9987.2006.00403.x; Sato T, 1994, Nihon Rinsho, V52, P3032; Singh R, 2002, J RHEUMATOL, V29, P636; Sugioka Y, 2008, MOD RHEUMATOL, V18, P293, DOI 10.1007/s10165-008-0041-4; Ueki Y, 2007, CLIN EXP RHEUMATOL, V25, P810; Umekita K, 2009, MOD RHEUMATOL, V19, P265, DOI 10.1007/s10165-009-0164-2; Yamaji K, 2002, THER APHER, V6, P402, DOI 10.1046/j.1526-0968.2002.00459.x; Yamashita M, 2008, MOD RHEUMATOL, V18, P296, DOI 10.1007/s10165-008-0044-1; Yoshihara R, 2010, J JPN SOC DIAL THER, V43, P341	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					154	157		10.3109/14397595.2013.874752		4	Rheumatology	Rheumatology	AX1XF	WOS:000346736400026		
J	Iizuka, M; Tsuboi, H; Asashima, H; Hirota, T; Kondo, Y; Matsui, M; Matsumoto, I; Sumida, T				Iizuka, Mana; Tsuboi, Hiroto; Asashima, Hiromitsu; Hirota, Tomoya; Kondo, Yuya; Matsui, Minoru; Matsumoto, Isao; Sumida, Takayuki			M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjogren's syndrome like sialadenitis	MODERN RHEUMATOLOGY			English	Article						Sjogren's syndrome; M3 muscarinic acetylcholine receptor; IL-17; B cells; mouse Model			[Iizuka, Mana; Tsuboi, Hiroto; Asashima, Hiromitsu; Hirota, Tomoya; Kondo, Yuya; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; [Matsui, Minoru] Tokyo Nishi Tokushukai Hosp, Dept Clin Res & Gen Med, Tokyo, Japan	Sumida, T (reprint author), Univ Tsukuba, Fac Med, Dept Internal Med, 1-1-1 Tenodai, Tsukuba, Ibaraki 3058575, Japan.	tsumida@md.tsukuba.ac.jp			Health and Labour Science Research Grants, Research on intractable diseases, The Clinical Study Group for autoimmune diseases	This work was supported by the Health and Labour Science Research Grants 2012, Research on intractable diseases, The Clinical Study Group for autoimmune diseases.	Naito Y, 2005, ANN RHEUM DIS, V64, P510, DOI 10.1136/ard.2004.025478; Dawson LJ, 2006, ARTHRITIS RHEUM, V54, P1165, DOI 10.1002/art.21764; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Reksten TR, 2009, RHEUMATOLOGY, V48, P1102, DOI 10.1093/rheumatology/kep149; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Fox Robert I, 2002, Scand J Rheumatol Suppl, V116, P3; Iizuka M, 2013, MOD RHEUMATOL, V23, P614, DOI 10.1007/s10165-012-0785-8; Iizuka M, 2010, J AUTOIMMUN, V35, P383, DOI 10.1016/j.jaut.2010.08.004; Sumida T, 1996, LANCET, V348, P1667, DOI 10.1016/S0140-6736(05)65741-8	10	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					158	160		10.3109/14397595.2014.884683		3	Rheumatology	Rheumatology	AX1XF	WOS:000346736400027		
J	Taniguchi, Y; Karashima, T; Yoshinaga, Y; Shuin, T; Fujimoto, S; Terada, Y				Taniguchi, Yoshinori; Karashima, Takashi; Yoshinaga, Yasuhiko; Shuin, Taro; Fujimoto, Shimpei; Terada, Yoshio			Clinical characteristics of Japanese patients with reactive arthritis following intravesical BCG therapy for bladder cancer	MODERN RHEUMATOLOGY			English	Article						Bacillus Calmette-Guerin; Reactive arthritis; Bladder cancer; Enthesitis	IMMUNOTHERAPY; COMPLICATIONS		[Taniguchi, Yoshinori; Fujimoto, Shimpei; Terada, Yoshio] Kochi Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi 7838505, Japan; [Karashima, Takashi; Shuin, Taro] Kochi Univ, Sch Med, Dept Urol, Nankoku, Kochi 7838505, Japan; [Yoshinaga, Yasuhiko] Kurashiki Med Ctr, Ctr Rheumat Dis, Kurashiki, Okayama, Japan	Taniguchi, Y (reprint author), Kochi Univ, Sch Med, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi 7838505, Japan.	taniguchiy@kochi-u.ac.jp					Bernini L, 2013, AUTOIMMUN REV, V12, P1150, DOI 10.1016/j.autrev.2013.06.017; Clavel G, 2006, JOINT BONE SPINE, V73, P24, DOI 10.1016/j.jbspin.2004.12.003; LAMM DL, 1992, J UROLOGY, V147, P596; LAMM DL, 1986, J UROLOGY, V135, P272; Tinazzi E, 2006, RHEUMATOL INT, V26, P481, DOI 10.1007/s00296-005-0059-2; Murata Hideyuki, 2004, Mod Rheumatol, V14, P82, DOI 10.1007/s10165-003-0272-3; YAMAGUCHI A, 1995, ARTHRITIS RHEUM, V38, P1672, DOI 10.1002/art.1780381120	7	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					161	163		10.3109/14397595.2014.926853		3	Rheumatology	Rheumatology	AX1XF	WOS:000346736400028		
J	Mokuda, S; Miyazaki, T; Saeki, Y; Masumoto, J; Kanno, M; Takasugi, K				Mokuda, Sho; Miyazaki, Tatsuhiko; Saeki, Yukari; Masumoto, Junya; Kanno, Masamoto; Takasugi, Kiyoshi			Epstein-Barr virus-related MTX-LPD in rheumatoid arthritis patients exhibits a viral pattern of the CD64 and CD35 expression on neutrophils: Three case reports	MODERN RHEUMATOLOGY			English	Letter							LYMPHOPROLIFERATIVE DISORDERS; METHOTREXATE		[Mokuda, Sho; Takasugi, Kiyoshi] Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Internal Med, Matsuyama, Ehime 7900858, Japan; [Mokuda, Sho; Kanno, Masamoto] Hiroshima Univ, Grad Sch Biomed Sci, Dept Immunol, Hiroshima, Japan; [Mokuda, Sho; Miyazaki, Tatsuhiko; Masumoto, Junya] Ehime Univ, Grad Sch Med, Dept Analyt Pathol, Toon City, Japan; [Saeki, Yukari] Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Clin Lab, Matsuyama, Ehime 7900858, Japan	Mokuda, S (reprint author), Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Internal Med, 21-21 Otsu Dohgo Himezuka, Matsuyama, Ehime 7900858, Japan.	sho-mokuda@hiroshima-u.ac.jp					Hoshida Y, 2007, J RHEUMATOL, V34, P322; Salloum E, 1996, J CLIN ONCOL, V14, P1943; Mokuda S, 2012, MOD RHEUMATOL, V22, P750, DOI 10.1007/s10165-011-0587-4; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Dawson TM, 2001, J RHEUMATOL, V28, P47; Harris NL, 2001, PATHOLOGY GENETICS T, P270	6	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-7595	1439-7609		MOD RHEUMATOL	Mod. Rheumatol.	JAN	2015	25	1					166	168		10.3109/14397595.2013.875641		3	Rheumatology	Rheumatology	AX1XF	WOS:000346736400030		
J	Hirai, J; Kuriyama, M; Ichikawa, T; Hidaka, K; Tsuda, A				Hirai, J.; Kuriyama, M.; Ichikawa, T.; Hidaka, K.; Tsuda, A.			A metagenetic approach for revealing community structure of marine planktonic copepods	MOLECULAR ECOLOGY RESOURCES			English	Article						28S rDNA: D2; 454 genome sequencer; biodiversity; Copepoda; metagenetics	SPECIES IDENTIFICATION; RARE BIOSPHERE; RAPID IDENTIFICATION; DNA BARCODES; DEEP-SEA; DIVERSITY; BIODIVERSITY; PATTERNS; QUALITY; NORTH	Marine planktonic copepods are an ecologically important group with high species richness and abundance. Here, we propose a new metagenetic approach for revealing the community structure of marine planktonic copepods using 454 pyrosequencing of nuclear large subunit ribosomal DNA. We determined an appropriate similarity threshold for clustering pyrosequencing data into molecular operational taxonomic units (MOTUs) using an artificial community containing 33 morphologically identified species. The 99% similarity threshold had high species-level resolution for MOTU clustering but overestimated species richness. The artificial community was appropriately clustered into MOTUs at 97% similarity, with little inflation in MOTU numbers and with relatively high species-level resolution. The number of sequence reads of each MOTU was correlated with dry weight of that taxon, suggesting that sequence reads could be used as a proxy for biomass. Next, we applied the method to field-collected samples, and the results corresponded reasonably well with morphological analysis of these communities. Numbers of MOTUs were well correlated with species richness at 97% similarity, and large numbers of sequence reads were generally observed in MOTUs derived from species with large biomass. Further, MOTUs were successfully classified into taxonomic groups at the family level at 97% similarity; similar patterns of species richness and biomass were revealed within families with metagenetic and morphological analyses. At the 99% similarity threshold, MOTUs with high proportions of sequence reads were identified as biomass-dominant species in each field-collected sample. The metagenetic approach reported here can be an effective tool for rapid and comprehensive assessment of copepod community structure.	[Hirai, J.; Kuriyama, M.; Ichikawa, T.; Hidaka, K.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Tsuda, A.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Hirai, J (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	jhirai@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan; Japan Society for the Promotion of Science [247024, 24121004]	We wish to thank the captains, crews and researchers aboard the FRV 'Soyo-Maru' for assistance with the field collections. The work was carried out using a 454 GS Junior second-generation sequencer (Roche) owned by the Center for Earth Surface System Dynamics at the Atmosphere and Ocean Research Institute (AORI), The University of Tokyo. We would like to thank E. Goetze (University of Hawaii) and K. Hamasaki (AORI) for constructive comments on an earlier draft of this paper. The cruise of the FRV 'Soyo-Maru' was supported by the Ministry of Agriculture, Forestry and Fisheries, Japan, through a research project entitled 'Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries'. This work was supported by grants from the Japan Society for the Promotion of Science (Grant Numbers 247024 to J.H.; 24121004 to A.T.).	Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Bottger-Schnack R, 2011, HYDROBIOLOGIA, V666, P111, DOI 10.1007/s10750-010-0094-1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Turner JT, 2004, ZOOL STUD, V43, P255; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hirai J, 2013, J PLANKTON RES, V35, P644, DOI 10.1093/plankt/fbt016; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Sugisaki Hiroya, 2010, P330; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Blanco-Bercial L, 2011, MOL PHYLOGENET EVOL, V59, P103, DOI 10.1016/j.ympev.2011.01.008; Boxshall G. A., 2004, INTRO COPEPOD DIVERS; Bron JE, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-22; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Kiesling TL, 2002, MAR BIOTECHNOL, V4, P30, DOI 10.1007/s10126-001-0077-3; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; Mauchline J., 1998, BIOL CALANOID COPEPO; Nakata K, 2003, FISH OCEANOGR, V12, P234, DOI 10.1046/j.1365-2419.2003.00249.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rombouts I, 2010, LIMNOL OCEANOGR, V55, P2219, DOI 10.4319/lo.2010.55.5.2219; Shih CT, 1998, J MARINE SYST, V15, P533, DOI 10.1016/S0924-7963(97)00053-5; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Terazaki M, 1997, J ADV MARINE SCI TEC, V3, P127; UYE S-I, 1988, Journal of the Oceanographical Society of Japan, V44, P280, DOI 10.1007/BF02302570	61	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-098X	1755-0998		MOL ECOL RESOUR	Mol. Ecol. Resour.	JAN	2015	15	1					68	80		10.1111/1755-0998.12294		13	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AX1HT	WOS:000346699100007		
J	Saitoh, T; Sugita, N; Someya, S; Iwami, Y; Kobayashi, S; Kamigaichi, H; Higuchi, A; Asai, S; Yamamoto, Y; Nishiumi, I				Saitoh, Takema; Sugita, Norimasa; Someya, Sayaka; Iwami, Yasuko; Kobayashi, Sayaka; Kamigaichi, Hiromi; Higuchi, Aki; Asai, Shigeki; Yamamoto, Yoshihiro; Nishiumi, Isao			DNA barcoding reveals 24 distinct lineages as cryptic bird species candidates in and around the Japanese Archipelago	MOLECULAR ECOLOGY RESOURCES			English	Article						cryptic species; DNA barcoding; Japanese birds; Palearctic region; taxonomy	GENETIC CONSEQUENCES; ERITHACUS-KOMADORI; KOREAN BIRDS; ICE AGES; PHYLOGEOGRAPHY; SPECIATION; COMPLEX; EAST; IDENTIFICATION; POPULATIONS	DNA barcoding using a partial region (648bp) of the cytochrome c oxidase I (COI) gene is a powerful tool for species identification and has revealed many cryptic species in various animal taxa. In birds, cryptic species are likely to occur in insular regions like the Japanese Archipelago due to the prevention of gene flow by sea barriers. Using COI sequences of 234 of the 251 Japanese-breeding bird species, we established a DNA barcoding library for species identification and estimated the number of cryptic species candidates. A total of 226 species (96.6%) had unique COI sequences with large genetic divergence among the closest species based on neighbour-joining clusters, genetic distance criterion and diagnostic substitutions. Eleven cryptic species candidates were detected, with distinct intraspecific deep genetic divergences, nine lineages of which were geographically separated by islands and straits within the Japanese Archipelago. To identify Japan-specific cryptic species from trans-Paleartic birds, we investigated the genetic structure of 142 shared species over an extended region covering Japan and Eurasia; 19 of these species formed two or more clades with high bootstrap values. Excluding six duplicated species from the total of 11 species within the Japanese Archipelago and 19 trans-Paleartic species, we identified 24 species that were cryptic species candidates within and surrounding the Japanese Archipelago. Repeated sea level changes during the glacial and interglacial periods may be responsible for the deep genetic divergences of Japanese birds in this insular region, which has led to inconsistencies in traditional taxonomies based on morphology.	[Saitoh, Takema; Iwami, Yasuko; Kobayashi, Sayaka; Asai, Shigeki; Yamamoto, Yoshihiro] Yamashina Inst Ornithol, Div Nat Hist, Abiko, Chiba 2701145, Japan; [Sugita, Norimasa; Someya, Sayaka; Iwami, Yasuko; Kamigaichi, Hiromi; Higuchi, Aki; Nishiumi, Isao] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki 3050005, Japan	Saitoh, T (reprint author), Yamashina Inst Ornithol, Div Nat Hist, 115 Konoyama, Abiko, Chiba 2701145, Japan.	saitoh@yamashina.or.jp; nishiumi@kahaku.go.jp			National Museum of Nature and Science; JSPS KAKENHI [21370039, 24657066]; 'Development and disclosure of the Yamashina Institute for Ornithology database system' from the Ministry of Education, Culture, Sports, Science & Technology in Japan	We thank the following institutions and people for providing specimens: the Higashi Taisetsu Museum of Natural History; the Botanical Garden, Field Science Centre for Northern Biosphere, Hokkaido University; the Hokkaido Seabird Centre, the Kushiro-Shitsugen Wildlife Centre, the Iriomote Wildlife Centre, the Amami Wildlife Centre, the Yambaru Wildlife Conservation Centre and Raptor Conservation Centre, the Ministry of the Environment, Japan; Miyakojima City Museum; the Hokkaido Research Centre, the Forestry and Forest Products Research Institute; Okhotsk Chapter and Sapporo Chapter, the Wild Bird Society of Japan; Shunkunitai Wild Bird Sanctuary; the Lake Utonai Wildlife Centre; the Lake Shikaribetsu Nature Centre; the Akkeshi Waterfowl Observation Centre; the Institute for Raptor Biomedicine Japan; the Ushiku Nature Sanctuary; the Ibaraki Nature Museum; the Gyotoku Wild Bird Observation Centre; the Hachijo visitor's centre; the Miyake Nature Centre; the Yonagunijima Ayamihabiru Museum; the Graduate School of Science, Osaka City University; the Graduate School of Fisheries Sciences, Hokkaido University; Hiroshima City Asa Zoological Park; the Ehime Prefectural Science Museum; Sanbonmatsu High School; Crane Park Izimi; Amami Ornithologists' Club; the Ikeya Animal Hospital; and the Takizawa Animal Hospital. We also thank Dr. Takeshi Yamasaki and Dr. Sayaka Mori for helping us to obtain specimen records. This study was funded by the research project of the National Museum of Nature and Science, 'DNA barcoding of birds from Japan and East Asia', JSPS KAKENHI Grant Numbers 21370039 and 24657066, and a Grant-in-Aid for Scientific Research (Specially Designated Research Promotion), 'Development and disclosure of the Yamashina Institute for Ornithology database system (2009-)' from the Ministry of Education, Culture, Sports, Science & Technology in Japan.	Akimova A, 2007, RUSSIAN J ORNITHOLOG, V356, P567; Alstrom P, 2011, IBIS, V153, P395, DOI 10.1111/j.1474-919X.2011.01116.x; BALL RM, 1992, AUK, V109, P626; Conroy CJ, 2000, MOL ECOL, V9, P165, DOI 10.1046/j.1365-294x.2000.00846.x; Johnson KP, 1999, AUK, V116, P792; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2006.01678.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Friesen VL, 1996, MOL BIOL EVOL, V13, P359; McKay BD, 2014, SYST BIOL, V63, P505, DOI 10.1093/sysbio/syu016; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Zink RM, 2006, MOL PHYLOGENET EVOL, V40, P679, DOI 10.1016/j.ympev.2005.11.002; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hewitt GM, 2004, PHILOS T ROY SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hogner S, 2012, ECOL EVOL, V2, P2974, DOI 10.1002/ece3.398; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Hernandez-Davila A, 2012, MOL ECOL RESOUR, V12, P590, DOI 10.1111/j.1755-0998.2012.03125.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Yoo HS, 2006, MOL CELLS, V22, P323; Blakiston TW, 1883, T ASIATIC SOC JAPAN, V11, P126; BRAZIL M., 2009, FIELD GUIDE BIRDS E; Clements JF., 2007, CLEMENTS CHECKLIST B; Conservation International, 2012, BIOD HOTSP; Dickinson EC, 2003, HOWARD MOORE COMPLET; Drovetski SV, 2004, P ROY SOC B-BIOL SCI, V271, P545, DOI 10.1098/rspb.2003.2638; Hamao S, 2013, B NATL MUSEUM NATURE, V39, P51; Hebert P.D.N., 2003, P ROY SOC LOND B BIO, V270, P596, DOI DOI 10.1098/RSBL.2003.0025; Kerr KCR, 2007, MOL ECOL NOTES, V7, P533; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kizaki K, 1980, NATURAL HIST RYUKYUS, P8; Koopman NE, 2005, J AVIAN BIOL, V36, P179; Kulikova IV, 2004, AUK, V121, P930, DOI 10.1642/0004-8038(2004)121[0930:AHASGF]2.0.CO;2; Lijtmaer DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020744; Mila B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040541; Nishiumi I, 2006, MEM NATN SCI MUS TOK, V44, P11; Ornithological Society of Japan, 2012, CHECK LIST JAP BIRDS, V7th revised; Park HY, 2011, GENES GENOM, V33, P91, DOI 10.1007/s13258-010-0089-3; Saitoh T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-35; Seki SI, 2007, MOL ECOL, V16, P101, DOI 10.1111/j.1365-294X.2006.03117.x; Seki SI, 2006, MOL PHYLOGENET EVOL, V39, P899, DOI 10.1016/j.ympev.2006.01.028; SEUTIN G, 1995, EVOLUTION, V49, P962, DOI 10.2307/2410418; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Sorenson M. D., 2005, CUCKOOS, P68; Takagi M, 2013, WILSON J ORNITHOL, V125, P358; Tavares ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028543; Webb WC, 2011, MOL ECOL, V20, P2390, DOI 10.1111/j.1365-294X.2011.05095.x; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.2307/2410802	53	6	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-098X	1755-0998		MOL ECOL RESOUR	Mol. Ecol. Resour.	JAN	2015	15	1					177	186		10.1111/1755-0998.12282		10	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AX1HT	WOS:000346699100017		
J	Funamoto, R; Saito, K; Oyaizu, H; Aono, T; Saito, M				Funamoto, Rintaro; Saito, Katsuharu; Oyaizu, Hiroshi; Aono, Toshihiro; Saito, Masanori			pH measurement of tubular vacuoles of an arbuscular mycorrhizal fungus, Gigaspora margarita	MYCORRHIZA			English	Article						6-Carboxyfluorescein diacetate; Arbuscular mycorrhizal symbiosis; Laser scanning confocal microscopy; Tubular vacuole; Vacuolar pH	SACCHAROMYCES-CEREVISIAE; PISOLITHUS-TINCTORIUS; INTRACELLULAR PH; GROWING HYPHAE; P-31 NMR; POLYPHOSPHATE; TRANSPORT; SYSTEM; TRANSLOCATION; METABOLISM	Arbuscular mycorrhizal fungi play an important role in phosphate supply to the host plants. The fungal hyphae contain tubular vacuoles where phosphate compounds such as polyphosphate are accumulated. Despite their importance for the phosphate storage, little is known about the physiological properties of the tubular vacuoles in arbuscular mycorrhizal fungi. As an indicator of the physiological state in vacuoles, we measured pH of tubular vacuoles in living hyphae of arbuscular mycorrhizal fungus Gigaspora margarita using ratio image analysis with pH-dependent fluorescent probe, 6-carboxyfluorescein. Fluorescent images of the fine tubular vacuoles were obtained using a laser scanning confocal microscope, which enabled calculation of vacuolar pH with high spatial resolution. The tubular vacuoles showed mean pH of 5.6 and a pH range of 5.1-6.3. These results suggest that the tubular vacuoles of arbuscular mycorrhizal fungi have a mildly acidic pH just like vacuoles of other fungal species including yeast and ectomycorrhizal fungi.	[Funamoto, Rintaro; Oyaizu, Hiroshi; Aono, Toshihiro] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Saito, Katsuharu] Shinshu Univ, Fac Agr, Nagano 3994598, Japan; [Saito, Masanori] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Saito, M (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Amamiya, Sendai, Miyagi 9818555, Japan.	msaito@bios.tohoku.ac.jp	Saito, Katsuharu/I-9304-2014		Programme for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) of the Bio-oriented Technology Research Advancement Institution of Japan; Ministry of Education, Culture, Sports, Science and Technology	We thank Ryo Ohtomo, Tomoko Kojima, and Shotaro Ando (National Agriculture and Food Research Organization) for experimental support. We also thank Yukari Kuga (Hiroshima University) for critical reading of the manuscript. This work was supported in part by the Programme for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry to KS. This work was also supported in part by the Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) of the Bio-oriented Technology Research Advancement Institution of Japan, and for Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research (B) to MS.	Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; SMITH SE, 1988, ANNU REV PLANT PHYS, V39, P221, DOI 10.1146/annurev.arplant.39.1.221; Harrison MJ, 1999, ANNU REV PLANT PHYS, V50, P361, DOI 10.1146/annurev.arplant.50.1.361; Darrah PR, 2006, EUKARYOT CELL, V5, P1111, DOI 10.1128/EC.00026-06; COX G, 1980, NEW PHYTOL, V84, P649, DOI 10.1111/j.1469-8137.1980.tb04778.x; Ogawa N, 2000, MOL BIOL CELL, V11, P4309; Kuga Y, 2008, NEW PHYTOL, V178, P189, DOI 10.1111/j.1469-8137.2007.02345.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Ashford AE, 1998, ADV BOT RES, V28, P119; Ashford AE, 2007, MYCOTA BIOL FUNGAL C, P49; ASHFORD AE, 1994, NEW PHYTOL, V126, P239, DOI 10.1111/j.1469-8137.1994.tb03942.x; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Cole L, 1998, FUNGAL GENET BIOL, V24, P86, DOI 10.1006/fgbi.1998.1051; Harrison TS, 2002, MED MYCOL, V40, P329, DOI 10.1080/714031107; Haugland RP, 1996, HDB FLUORESCENT PROB; Hesse SJA, 2002, EUR J BIOCHEM, V269, P3485, DOI 10.1046/j.1432-1033.2002.03042.x; Jolicoeur M, 1998, PLANT PHYSIOL, V116, P1279, DOI 10.1104/pp.116.4.1279; MACDONALD JC, 1987, J MAGN RESON, V72, P48, DOI 10.1016/0022-2364(87)90174-0; MAKAROW M, 1987, J CELL BIOL, V104, P67, DOI 10.1083/jcb.104.1.67; Rasmussen N, 2000, PLANT SOIL, V226, P245, DOI 10.1023/A:1026411801081; REES B, 1994, MYCOL RES, V98, P985; ROST FWD, 1995, MYCOL RES, V99, P549, DOI 10.1016/S0953-7562(09)80711-9; Saito K, 2004, PLANT SOIL, V261, P231, DOI 10.1023/B:PLSO.0000035574.54040.c5; SHEPHERD VA, 1993, J CELL SCI, V104, P495; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Tani C, 2009, APPL ENVIRON MICROB, V75, P7044, DOI 10.1128/AEM.01519-09; Uetake Y, 2002, NEW PHYTOL, V154, P761, DOI 10.1046/j.1469-8137.2002.00425.x; Viereck N, 2004, NEW PHYTOL, V162, P783, DOI 10.1111/j.1469-8137.2004.01048.x; Yao Q, 2010, PLANT SOIL, V330, P303, DOI 10.1007/s11104-009-0201-0; Zhang JW, 1998, J BIOL CHEM, V273, P18470, DOI 10.1074/jbc.273.29.18470	32	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6360	1432-1890		MYCORRHIZA	Mycorrhiza	JAN	2015	25	1					55	60		10.1007/s00572-014-0588-1		6	Mycology	Mycology	AX8KQ	WOS:000347158800005		
J	Pissuwan, D; Niidome, T				Pissuwan, Dakrong; Niidome, Takuro			Polyelectrolyte-coated gold nanorods and their biomedical applications	NANOSCALE			English	Article							CONTRAST AGENTS; PHOTOTHERMAL THERAPY; SURFACE-CHEMISTRY; CELLULAR UPTAKE; BREAST-CANCER; CELLS; DELIVERY; DRUG; CYTOTOXICITY; EXPRESSION	Gold nanorods (GNRs) have been extensively used in biomedical applications, because of their favourable optical properties. Their longitudinal surface plasmon resonance can be tuned, providing a strong near-infrared (NIR) extinction coefficient peak within the tissue transparency window. However, the modification of the surface of GNRs is essential before they can be used for biomedical applications. The number of GNRs taken up by cells and their biodistribution depend on their surface modification. Here, we review the recent advances in modifying GNR surfaces with polyelectrolytes for biomedical applications. Major polyelectrolytes used to coat GNR surfaces over the past few years and the biocompatibility of polyelectrolyte-coated GNRs are discussed.	[Pissuwan, Dakrong] Mahidol Univ, Fac Sci, Multidisciplinary Unit, Mat Sci & Engn Program, Bangkok 10700, Thailand; [Niidome, Takuro] Kumamoto Univ, Grad Sch Sci & Technol, Dept Appl Chem & Biochem, Kumamoto 860, Japan	Pissuwan, D (reprint author), Mahidol Univ, Fac Sci, Multidisciplinary Unit, Mat Sci & Engn Program, Bangkok 10700, Thailand.	dakrong.pis@mahidol.ac.th; niidome@kumamoto-u.ac.jp			Talent Management Project and Materials Science and Engineering Program, Multidisciplinary Unit, Faculty of Science, Mahidol University, Thailand	This work was supported by the Talent Management Project and Materials Science and Engineering Program, Multidisciplinary Unit, Faculty of Science, Mahidol University, Thailand.	Andersson Helen A, 2014, Vaccines (Basel), V2, P216, DOI 10.3390/vaccines2020216; Chakravarthy KV, 2010, P NATL ACAD SCI USA, V107, P10172, DOI 10.1073/pnas.0914561107; Wang JH, 2013, BIOMATERIALS, V34, P4274, DOI 10.1016/j.biomaterials.2013.02.012; Zhu YY, 2012, J MATER CHEM, V22, P2387, DOI 10.1039/c2jm15238j; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Alkilany AM, 2012, SMALL, V8, P1270, DOI 10.1002/smll.201101948; Hauck TS, 2008, SMALL, V4, P153, DOI 10.1002/smll.200700217; Castellana ET, 2011, J AM CHEM SOC, V133, P4182, DOI 10.1021/ja109936h; Link S, 2000, INT REV PHYS CHEM, V19, P409, DOI 10.1080/01442350050034180; Kawano T, 2009, BIOCONJUGATE CHEM, V20, P209, DOI 10.1021/bc800480k; Shi ZZ, 2014, BIOMATERIALS, V35, P7058, DOI 10.1016/j.biomaterials.2014.04.105; Alkilany AM, 2010, ACS APPL MATER INTER, V2, P3417, DOI 10.1021/am100879j; von Maltzahn G, 2009, ADV MATER, V21, P3175, DOI 10.1002/adma.200803464; Tong L, 2009, PHOTOCHEM PHOTOBIOL, V85, P21, DOI 10.1111/j.1751-1097.2008.00507.x; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Lee O, 2013, SKIN RES TECHNOL, V19, pE390, DOI 10.1111/j.1600-0846.2012.00656.x; Wang LM, 2013, NANOSCALE, V5, P8384, DOI 10.1039/c3nr01626a; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006; Sisco PN, 2008, NANO LETT, V8, P3409, DOI 10.1021/nl802142h; Gole A, 2005, CHEM MATER, V17, P1325, DOI 10.1021/cm048297d; Xu LG, 2012, NANO LETT, V12, P2003, DOI 10.1021/nl300027p; Xiao LF, 2014, ANAL CHIM ACTA, V843, P73, DOI 10.1016/j.aca.2014.06.036; Huang HC, 2009, ACS NANO, V3, P2941, DOI 10.1021/nn900947a; Zhang ZJ, 2012, ADV MATER, V24, P1418, DOI 10.1002/adma.201104714; Rayavarapu RG, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145101; Pissuwan D, 2008, BIOTECHNOL GENET ENG, V25, P93; Scranton AB, 1995, ADV POLYM SCI, V122, P1; Ding H, 2007, J PHYS CHEM C, V111, P12552, DOI 10.1021/jp0733419; Wang J, 2012, DALTON T, V41, P11134, DOI 10.1039/c2dt31227a; Wang BK, 2014, BIOMATERIALS, V35, P1954, DOI 10.1016/j.biomaterials.2013.11.066; Kirui DK, 2011, MACROMOL BIOSCI, V11, P779, DOI 10.1002/mabi.201100050; Chen HY, 2014, BIOMATER SCI-UK, V2, P996, DOI 10.1039/c3bm60323g; Wilson CG, 2009, BIOMATERIALS, V30, P5639, DOI 10.1016/j.biomaterials.2009.07.011; Borg KT, 1997, CARDIOVASC PATHOL, V6, P261, DOI 10.1016/S1054-8807(96)00138-X; Chen LL, 2010, J ZHEJIANG UNIV-SC B, V11, P417, DOI 10.1631/jzus.B0910731; Chen S. H., 2010, NANO BIOMED ENG, V2, P15; Kuo TR, 2010, J AM CHEM SOC, V132, P14163, DOI 10.1021/ja105360z; Luo JY, 2001, J CELL BIOCHEM, V80, P522, DOI 10.1002/1097-4644(20010315)80:4<522::AID-JCB1006>3.3.CO;2-8; Pissuwan D, 2013, PART PART SYST CHAR, V30, P427, DOI 10.1002/ppsc.201200115; Ramos J., 2013, CELLULAR SUBCELLULAR, p[991, 81]; Stone J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/29/295102; Tang FX, 1999, J CONTROL RELEASE, V62, P345, DOI 10.1016/S0168-3659(99)00158-3; Vu L, 2012, THERANOSTICS, V2, P1160, DOI 10.7150/thno.4492; Wilson G. C., 2009, J MATER CHEM, V19, P6332; Yu WY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215102; Zhu J, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/28/285106	47	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	1					59	65		10.1039/c4nr04350b		7	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX4RN	WOS:000346919200003		
J	Zhou, H; Li, P; Guo, JJ; Yan, RY; Fan, TX; Zhang, D; Ye, JH				Zhou, Han; Li, Peng; Guo, Jianjun; Yan, Runyu; Fan, Tongxiang; Zhang, Di; Ye, Jinhua			Artificial photosynthesis on tree trunk derived alkaline tantalates with hierarchical anatomy: towards CO2 photo-fixation into CO and CH4	NANOSCALE			English	Article							RENEWABLE HYDROCARBON FUEL; SENSITIZED SOLAR-CELL; HIGH-YIELD SYNTHESIS; VISIBLE-LIGHT; CARBON-DIOXIDE; PHOTOCATALYTIC REDUCTION; PHOTOELECTROCHEMICAL REDUCTION; CONVERSION; PHOTOREDUCTION; HYDROGEN	Artificial photosynthesis, the photochemical fixation and recycling of CO2 back to hydrocarbon fuels using sunlight and water, is both a significant challenge and an opportunity that, if realized, could have a revolutionary impact on our energy system. Herein, we demonstrate one of the first examples using biomass derived hierarchical porous photocatalysts for CO2 photo-fixation into sustainable hydrocarbon fuels. A generic method is proposed to build a series of alkaline tantalates MTaO3 (M = Li, Na, K) with hierarchical anatomy from macro-to nanoscales using activated carbonized tree trunks as templates. Artificial photosynthesis is carried out on MTaO3 series using only artificial sunlight, water, and carbon dioxide as inputs to produce carbon monoxide and methane as the main outputs. The CO2 photo-fixation performance can be enhanced by introducing a macropore network, which mainly enhances light transfer and accelerates gas diffusion. The research provides prototype models that integrate individual nanoscale components into higher level macroscopic artificial photosynthetic systems for better solar-to-fuel conversion efficiencies. This work would have potential significance for the ultimate construction of "artificial trees" and provide envisions creating "forests" of these CO2-capturing artificial trees to remove carbon dioxide from the atmosphere and convert it into sustainable fuels.	[Zhou, Han; Li, Peng; Guo, Jianjun; Ye, Jinhua] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Zhou, Han; Li, Peng; Guo, Jianjun; Ye, Jinhua] Natl Inst Mat Sci, Environm Remediat Mat Unit, Tsukuba, Ibaraki 3050044, Japan; [Zhou, Han; Yan, Runyu; Fan, Tongxiang; Zhang, Di] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China; [Li, Peng; Guo, Jianjun; Ye, Jinhua] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan; [Ye, Jinhua] Tianjin Univ, Sch Mat Sci & Engn, TU NIMS Joint Res Ctr, Tianjin 300072, Peoples R China	Ye, JH (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Jinhua.YE@nims.go.jp	Li, Peng/D-3072-2013	Li, Peng/0000-0002-5715-548X	World Premier International Research Center Initiative on Materials Nanoarchitectonics, MEXT, Japan; National Basic Research Program of China (973 Program) [2014CB239301]; National Natural Science Foundation of China [51102163]	We are grateful for financial support by the World Premier International Research Center Initiative on Materials Nanoarchitectonics, MEXT, Japan, and National Basic Research Program of China (973 Program, 2014CB239301) and the National Natural Science Foundation of China (51102163).	Zhang N, 2011, CHEM COMMUN, V47, P2041, DOI 10.1039/c0cc04687f; Osterloh FE, 2008, CHEM MATER, V20, P35, DOI 10.1021/cm7024203; Yan SC, 2012, CHEM COMMUN, V48, P1048, DOI 10.1039/c1cc16185g; Liu J, 2014, PHYS CHEM CHEM PHYS, V16, P14699, DOI 10.1039/c4cp01348d; Feng SC, 2014, NANOSCALE, V6, P1896, DOI 10.1039/c3nr05219b; Liu Q, 2012, J MATER CHEM, V22, P2033, DOI 10.1039/c1jm14122h; Pan J, 2011, CHEM COMMUN, V47, P8361, DOI 10.1039/c1cc13034j; In SI, 2012, ANGEW CHEM INT EDIT, V51, P3915, DOI 10.1002/anie.201108936; Hoffmann MR, 2011, DALTON T, V40, P5151, DOI 10.1039/c0dt01777a; Mitchell S, 2012, NAT CHEM, V4, P825, DOI [10.1038/nchem.1403, 10.1038/NCHEM.1403]; Li Y, 2012, ADV FUNCT MATER, V22, P4634, DOI 10.1002/adfm.201200591; Jiao W, 2012, ACS CATAL, V2, P1854, DOI 10.1021/cs300229e; Xi GC, 2012, ANGEW CHEM INT EDIT, V51, P2395, DOI 10.1002/anie.201107681; Cindrella L, 2009, J POWER SOURCES, V194, P146, DOI 10.1016/j.jpowsour.2009.04.005; Zhou Y, 2011, ACS APPL MATER INTER, V3, P3594, DOI 10.1021/am2008147; Silva CG, 2011, J AM CHEM SOC, V133, P595, DOI 10.1021/ja1086358; Roy SC, 2010, ACS NANO, V4, P1259, DOI 10.1021/nn9015423; Li XK, 2012, J PHYS CHEM C, V116, P16047, DOI 10.1021/jp303365z; Varghese OK, 2009, NANO LETT, V9, P731, DOI 10.1021/nl803258p; Peterson AA, 2010, ENERG ENVIRON SCI, V3, P1311, DOI 10.1039/c0ee00071j; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; Li ZD, 2012, CRYST GROWTH DES, V12, P1476, DOI 10.1021/cg201568q; Yan SC, 2010, ANGEW CHEM INT EDIT, V49, P6400, DOI 10.1002/anie.201003270; Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752; Kumar B, 2012, ANNU REV PHYS CHEM, V63, P541, DOI 10.1146/annurev-physchem-032511-143759; Fu YH, 2012, ANGEW CHEM INT EDIT, V51, P3364, DOI 10.1002/anie.201108357; HALMANN M, 1978, NATURE, V275, P115, DOI 10.1038/275115a0; Dimitrijevic NM, 2011, J AM CHEM SOC, V133, P3964, DOI 10.1021/ja108791u; Koo HJ, 2008, INORG CHIM ACTA, V361, P677, DOI 10.1016/j.ica.2007.05.017; Tu WG, 2012, ADV FUNCT MATER, V22, P1215, DOI 10.1002/adfm.201102566; Yan SC, 2013, ADV FUNCT MATER, V23, P758, DOI 10.1002/adfm.201202042; Liu Q, 2010, J AM CHEM SOC, V132, P14385, DOI 10.1021/ja1068596; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Zhou H, 2010, ADV MATER, V22, P951, DOI 10.1002/adma.200902039; Cheng HF, 2012, CHEM COMMUN, V48, P9729, DOI 10.1039/c2cc35289c; Navalon S, 2013, CHEMSUSCHEM, V6, P562, DOI 10.1002/cssc.201200670; Bensaid S, 2012, CHEMSUSCHEM, V5, P500, DOI 10.1002/cssc.201100661; BUTLER MA, 1978, J ELECTROCHEM SOC, V125, P228, DOI 10.1149/1.2131419; Antonietti M, 2013, ANGEW CHEM INT EDIT, V52, P1086, DOI 10.1002/anie.201207937; GOREN Z, 1990, J PHYS CHEM-US, V94, P3784, DOI 10.1021/j100372a080; Greil P, 2001, J EUR CERAM SOC, V21, P105, DOI 10.1016/S0955-2219(00)00179-5; Halasi G, 2012, J PHYS CHEM C, V116, P15396, DOI 10.1021/jp3030478; Hendricks TJ, 1996, J HEAT TRANS-T ASME, V118, P911, DOI 10.1115/1.2822588; Inoue I., 1979, NATURE, V277, P637; Li P., 2012, J PHYS CHEM C, V116, P65; Lira E, 2011, J AM CHEM SOC, V133, P6529, DOI 10.1021/ja200884w; Liu J, 2013, ENERG ENVIRON SCI, V6, P1486, DOI 10.1039/c3ee40696b; Michl J, 2011, NAT CHEM, V3, P268, DOI 10.1038/nchem.1021; Mie G., 2008, ANN PHYS, V330, P377, DOI DOI 10.1002/ANDP.19083300302; SALVADOR P, 1983, SURF SCI, V124, P398, DOI 10.1016/0039-6028(83)90799-9; Sieber H, 2000, ADV ENG MATER, V2, P105, DOI 10.1002/(SICI)1527-2648(200003)2:3<105::AID-ADEM105>3.0.CO;2-P; Zhou H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01667	52	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	1					113	120		10.1039/c4nr03019b		8	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX4RN	WOS:000346919200011		
J	Aoki, H; Nojiri, M; Mukai, R; Ito, S				Aoki, Hiroyuki; Nojiri, Mayumi; Mukai, Rieko; Ito, Shinzaburo			Near-infrared absorbing polymer nano-particle as a sensitive contrast agent for photo-acoustic imaging	NANOSCALE			English	Article							IN-VIVO; DRUG-DELIVERY; GOLD NANORODS; LIVING MICE; NANOPARTICLES; TOMOGRAPHY; NANOCAGES; SYSTEM	Polymer nano-particles (PNPs) with a near-infrared (NIR) light absorption were prepared by the nanoemulsion method to develop contrast agents for photo-acoustic (PA) imaging. The PNP containing silicon naphthalocyanine showed a high absorption coefficient up to 10(10) M-1 cm(-1). This is comparable to plasmonic gold nano-particles, which have been studied as PA contrast agents. For the PNP larger than 100 nm, the enhancement of the PA signal was observed compared to the gold nano-particle with a similar absorption coefficient and size. In the case of the PNP, the heat by the light absorption is confined in the particle due to the low thermal diffusivity of polymer materials. We showed that the strong thermal confinement effect of PNP results in the enhancement of the efficiency of the PA signal generation and that the PA intensity can be enhanced by the increase of the Gruneisen parameter of the matrix polymer of PNP. The PA signal from the PNP of poly(methyl methacrylate) was 9-fold larger than that of gold nano-particles with the same absorption coefficient. We demonstrated that in the in vivo PA imaging the detection limit of PNP was of the order of 10(-13) M. The NIR absorbing PNP will be a promising candidate of a sensitive contrast agent for PA imaging.	[Aoki, Hiroyuki; Nojiri, Mayumi; Ito, Shinzaburo] Kyoto Univ, Dept Polymer Chem, Nishikyo Ku, Kyoto 6108510, Japan; [Aoki, Hiroyuki; Mukai, Rieko] Kyoto Univ, Adv Biomed Engn Res Unit, Nishikyo Ku, Kyoto 6108510, Japan	Aoki, H (reprint author), Kyoto Univ, Dept Polymer Chem, Nishikyo Ku, Kyoto 6108510, Japan.	aoki@photo.polym.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by the Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Doane TL, 2012, CHEM SOC REV, V41, P2885, DOI 10.1039/c2cs15260f; Jokerst JV, 2012, ACS NANO, V6, P5920, DOI 10.1021/nn302042y; De Jong WH, 2008, INT J NANOMED, V3, P133; Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004; Luke GP, 2012, ANN BIOMED ENG, V40, P422, DOI 10.1007/s10439-011-0449-4; Cho EC, 2009, J PHYS CHEM C, V113, P9023, DOI 10.1021/jp903343p; Bhattacharyya S, 2008, BIOCONJUGATE CHEM, V19, P1186, DOI 10.1021/bc700482u; BRASLAVSKY SE, 1992, CHEM REV, V92, P1381, DOI 10.1021/cr00014a007; Diebold GJ, 2002, J ACOUST SOC AM, V112, P1780, DOI 10.1121/1.1508788; Pan DPJ, 2012, ACS NANO, V6, P1260, DOI 10.1021/nn203895n; Agarwal A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777127; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Eghtedari M, 2007, NANO LETT, V7, P1914, DOI 10.1021/nl070557d; Song KH, 2009, NANO LETT, V9, P183, DOI 10.1021/nl802746w; Kim S, 2009, EUR J PHARM BIOPHARM, V71, P420, DOI 10.1016/j.ejpb.2008.09.021; Yang XM, 2007, NANO LETT, V7, P3798, DOI 10.1021/nl072349r; Chen YS, 2011, NANO LETT, V11, P348, DOI 10.1021/nl1042006; Chang SS, 1999, LANGMUIR, V15, P701, DOI 10.1021/la980929l; Calasso IG, 2001, PHYS REV LETT, V86, P3550, DOI 10.1103/PhysRevLett.86.3550; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Razansky D, 2007, OPT LETT, V32, P2891, DOI 10.1364/OL.32.002891; Ku G, 2005, OPT LETT, V30, P507, DOI 10.1364/OL.30.000507; de la Zerda A, 2012, ACS NANO, V6, P4694, DOI 10.1021/nn204352r; Anton N, 2008, J CONTROL RELEASE, V128, P185, DOI 10.1016/j.jconrel.2008.02.007; Cai X, 2011, ACS NANO, V5, P9658, DOI 10.1021/nn203124x; Boase NRB, 2012, POLYM CHEM-UK, V3, P1384, DOI 10.1039/c2py20132a; Brandrup J., 1999, POLYM HDB; MORITA E, 1968, JPN J APPL PHYS, V7, P451, DOI 10.1143/JJAP.7.451; NORTH AM, 1977, POLYMER, V18, P324, DOI 10.1016/0032-3861(77)90076-3; Wang L. V., 2007, BIOMEDICAL OPTICS PR	31	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	1					337	343		10.1039/c4nr04724a		7	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX4RN	WOS:000346919200037		
J	Ho, D; Zou, JL; Zdyrko, B; Iyer, KS; Luzinov, I				Ho, Dominic; Zou, Jianli; Zdyrko, Bogdan; Iyer, K. Swaminathan; Luzinov, Igor			Capillary force lithography: the versatility of this facile approach in developing nanoscale applications	NANOSCALE			English	Review							BY-LAYER DEPOSITION; TOP-DOWN APPROACH; SOFT LITHOGRAPHY; POLYMER-FILMS; STEM-CELLS; NANOPARTICLE ARRAYS; CONJUGATED POLYMER; HYALURONIC-ACID; SOLAR-CELLS; LARGE-AREA	Since its inception as a simple, low cost alternative to more complicated lithographic techniques such as electron-beam and dip-pen lithography, capillary force lithography (CFL) has developed into a versatile tool to form sub-100 nm patterns. Utilizing the concept of a polymer melt, structures and devices generated by the technique have been used in applications varying from surfaces regulating cell growth to gas sensing. In this review, we discuss various CFL methodologies which have evolved, their application in both biological and non-biological research, and finally a brief outlook in areas of research where CFL is destined to make an enormous impact in the near future.	[Ho, Dominic; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia; [Ho, Dominic] Univ Western Australia, Sch Anat Physiol & Human Anat, Perth, WA 6009 USA; [Zou, Jianli] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Zdyrko, Bogdan; Luzinov, Igor] Clemson Univ, Dept Mat Sci & Engn, Clemson, SC 29634 USA	Iyer, KS (reprint author), Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia.	swaminatha.iyer@uwa.edu.au; luzinov@clemson.edu		Zou, Jianli/0000-0003-3105-7213	Australian Research Council; National Science Foundation [DMR-1107786, CMMI-0825773]	The authors would like to thank the Australian Research Council and the National Science Foundation (grant numbers DMR-1107786 and CMMI-0825773) for their funding support.	Ahn EH, 2014, BIOMATERIALS, V35, P2401, DOI 10.1016/j.biomaterials.2013.11.037; Peng ZM, 2009, NANO TODAY, V4, P143, DOI 10.1016/j.nantod.2008.10.010; Shir D, 2010, NANO LETT, V10, P3041, DOI 10.1021/nl101510q; Zdyrko B, 2008, SOFT MATTER, V4, P2213, DOI 10.1039/b810038a; Jeong JW, 2013, ACS NANO, V7, P6747, DOI 10.1021/nn401611z; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Zou JL, 2012, CHEM COMMUN, V48, P1033, DOI 10.1039/c1cc15522a; KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0; Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X; Lipomi DJ, 2008, NANO LETT, V8, P2100, DOI 10.1021/nl8009318; Boltau M, 1998, NATURE, V391, P877; Liu Y, 2006, J AM CHEM SOC, V128, P8106, DOI 10.1021/ja061646f; Kwak R, 2009, SMALL, V5, P790, DOI 10.1002/smll.200900219; Jeong JW, 2012, ADV MATER, V24, P3526, DOI 10.1002/adma.201200356; Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771; Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Jiang CY, 2005, ADV MATER, V17, P1669, DOI 10.1002/adma.200500016; Lal S, 2008, CHEM SOC REV, V37, P898, DOI 10.1039/b705969h; Im SG, 2008, J AM CHEM SOC, V130, P14424, DOI 10.1021/ja806030z; Jo PS, 2012, ADV MATER, V24, P3269, DOI 10.1002/adma.201200524; Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f; Zhang H, 2003, NANO LETT, V3, P43, DOI 10.1021/nl0258473; Suh KY, 2001, ADV MATER, V13, P1386, DOI 10.1002/1521-4095(200109)13:18<1386::AID-ADMA1386>3.0.CO;2-X; Jeong HE, 2006, NANO LETT, V6, P1508, DOI 10.1021/nl061045m; Zheng PW, 2011, LANGMUIR, V27, P7976, DOI 10.1021/la201141k; Kwon KW, 2011, LANGMUIR, V27, P3238, DOI 10.1021/la2000156; Yang HS, 2014, BIOMATERIALS, V35, P1478, DOI 10.1016/j.biomaterials.2013.10.067; Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174; Soci C, 2007, ADV FUNCT MATER, V17, P632, DOI 10.1002/admf.200600199; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cheng YS, 2014, SOL ENERG MAT SOL C, V120, P566, DOI 10.1016/j.solmat.2013.09.040; Moga KA, 2013, ADV MATER, V25, P5060, DOI 10.1002/adma.201300526; Jeong HE, 2009, NANOSCALE, V1, P331, DOI 10.1039/b9nr00106a; Shi G, 2012, J COLLOID INTERF SCI, V368, P655, DOI 10.1016/j.jcis.2011.11.042; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Song KH, 2012, BIOMATERIALS, V33, P2007, DOI 10.1016/j.biomaterials.2011.12.002; An CJ, 2014, SMALL, V10, P1278, DOI 10.1002/smll.201302653; Zdyrko B, 2008, CHEM COMMUN, P1284, DOI 10.1039/b717222b; Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033; Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015; Hu XL, 2008, ADV MATER, V20, P4845, DOI 10.1002/adma.200801433; Jeon HJ, 2010, NANO LETT, V10, P3604, DOI 10.1021/nl1025776; Suh KY, 2004, LANGMUIR, V20, P6080, DOI 10.1021/la049217n; Khademhosseini A, 2003, ADV MATER, V15, P1995, DOI 10.1002/adma.200305433; Bruinink CM, 2006, ADV FUNCT MATER, V16, P1555, DOI 10.1002/adfm.200500629; Chang S, 2011, J PHYS CHEM C, V115, P4387, DOI 10.1021/jp109348b; Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038; Kwon KW, 2012, J IMMUNOL, V189, P2266, DOI 10.4049/jimmunol.1102273; Malynych S, 2001, NANO LETT, V1, P647, DOI 10.1021/n1015604v; Lee SK, 2010, LANGMUIR, V26, P14359, DOI 10.1021/la100414c; Walheim S, 1999, SCIENCE, V283, P520, DOI 10.1126/science.283.5401.520; Kim JS, 2014, ADV FUNCT MATER, V24, P841, DOI 10.1002/adfm.201302494; Wicklein A, 2009, ACS NANO, V3, P1107, DOI 10.1021/nn9001165; Khang DY, 2004, ADV MATER, V16, P176, DOI 10.1002/adma.200305673; Suh KY, 2005, ADV MATER, V17, P560, DOI 10.1002/adma.200401089; Bhuvana T, 2008, ACS NANO, V2, P457, DOI 10.1021/nn700372h; Suh KY, 2002, ADV FUNCT MATER, V12, P405, DOI 10.1002/1616-3028(20020618)12:6/7<405::AID-ADFM405>3.0.CO;2-1; Jeong HE, 2008, SMALL, V4, P1913, DOI 10.1002/smll.200800151; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Park M, 2010, CHEM MATER, V22, P4166, DOI 10.1021/cm100614e; Baek YK, 2010, ADV FUNCT MATER, V20, P4273, DOI 10.1002/adfm.201001051; Bruinink CM, 2004, ADV MATER, V16, P1086, DOI 10.1002/adma.200306523; Cai YJ, 2012, ACS NANO, V6, P1548, DOI 10.1021/nn2045278; Choi Y, 2009, NANO LETT, V9, P3726, DOI 10.1021/nl901911p; Duan XX, 2010, ADV FUNCT MATER, V20, P663, DOI 10.1002/adfm.200901700; Gunawidjaja R, 2006, ADV MATER, V18, P2895, DOI 10.1002/adma.200600540; Jeong HE, 2009, J COLLOID INTERF SCI, V339, P202, DOI 10.1016/j.jcis.2009.07.020; Jeong HE, 2009, P NATL ACAD SCI USA, V106, P5639, DOI 10.1073/pnas.0900323106; Jung JM, 2007, ADV MATER, V19, P4392, DOI 10.1002/adma.200701310; Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821; Kim DH, 2006, LANGMUIR, V22, P5419, DOI 10.1021/la060283u; Kim J, 2010, DISPLAYS, V31, P82, DOI 10.1016/j.displa.2010.02.002; Kim S, 2006, J APPL PHYS, V99, DOI 10.1063/1.2173938; Kim WS, 2007, LANGMUIR, V23, P4732, DOI 10.1021/la070074p; Ko HH, 2005, CHEM MATER, V17, P5489, DOI 10.1021/cm050864p; Korczagin I, 2008, EUR POLYM J, V44, P2523, DOI 10.1016/j.eurpolymj.2008.05.034; Korczagin I, 2003, CHEM MATER, V15, P3663, DOI 10.1021/cm031024i; Kwon KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073960; Lee SY, 2009, LANGMUIR, V25, P12535, DOI 10.1021/la901726b; Li X, 2004, SURF SCI, V571, P12, DOI 10.1016/j.susc.2004.07.052; Liao X., 2013, NAT COMMUN, V4; Na SI, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2802561; Service RF, 1997, SCIENCE, V278, P383, DOI 10.1126/science.278.5337.383; Shih CF, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3117226; Suh KY, 2002, ADV MATER, V14, P346, DOI 10.1002/1521-4095(20020304)14:5<346::AID-ADMA346>3.0.CO;2-Y; Suh KY, 2006, NANO LETT, V6, P1196, DOI 10.1021/nl060571a; Suh KY, 2002, MACROMOLECULES, V35, P4414, DOI 10.1021/ma0118901; Suh KY, 2004, ADV MATER, V16, P1401, DOI 10.1002/adma.200400101; Takahashi S, 2009, J BIOSCI BIOENG, V108, P544, DOI 10.1016/j.jbiosc.2009.06.013; Yoo PJ, 2002, MACROMOLECULES, V35, P3205, DOI 10.1021/ma0116021; Yoo PJ, 2008, NANO LETT, V8, P1081, DOI 10.1021/nl073079f; Yoon H, 2010, J COLLOID INTERF SCI, V346, P476, DOI 10.1016/j.jcis.2010.03.023; Yu XH, 2005, POLYMER, V46, P11099, DOI 10.1016/j.polymer.2005.09.015; Zemla J, 2012, COLLOID SURFACE B, V90, P144, DOI 10.1016/j.colsurfb.2011.10.011; Zhang DY, 2010, OPT EXPRESS, V18, P15009, DOI 10.1364/OE.18.015009; Zhang HL, 2004, NANO LETT, V4, P1513, DOI 10.1021/nl049285u; Zhang Y, 2010, SMALL, V6, P768, DOI 10.1002/smll.200901843; Zhao DW, 2011, SOL ENERG MAT SOL C, V95, P921, DOI 10.1016/j.solmat.2010.11.023; Zourob M, 2006, ADV MATER, V18, P655, DOI 10.1002/adma.200501840	100	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	2					401	414		10.1039/c4nr03565h		14	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX9TS	WOS:000347245500002		
J	Pal, J; Ganguly, M; Mondal, C; Negishi, Y; Pal, T				Pal, Jaya; Ganguly, Mainak; Mondal, Chanchal; Negishi, Yuichi; Pal, Tarasankar			Precursor salt assisted syntheses of high-index faceted concave hexagon and nanorod-like polyoxometalates	NANOSCALE			English	Article							VISIBLE-LIGHT PHOTOCATALYSIS; HYDROTHERMAL SYNTHESIS; EFFICIENT DEGRADATION; WATER OXIDATION; NANOCRYSTALS; NANOCUBES; LINDGRENITE; IRRADIATION; REDUCTION; COMPOSITE	This paper describes an effective method for a precursor salt assisted fabrication and reshaping of two different polyoxometalates [(NH4)(2)Cu(MoO4)(2) (ACM) and Cu-3(MoO4)(2)(OH)(2) (CMOH)] into five distinctive shapes through straightforward and indirect routes. Explicit regulation of the structural arrangements of ACM and CMOH has been studied in detail with altered precursor salt concentration employing our laboratory developed modified hydrothermal (MHT) method. Morphologically different ACM 3D architectures are evolved with higher molybdate concentration, whereas 1D growth of CMOH is observed with increased copper concentration. Interesting morphological transformation of the products has been accomplished employing one precursor salt at a time without using any other foreign reagent. It has been proven that large ACMs become labile in the presence of incoming Cu(II) and NH4+ ions of the precursor salts. A new strategy for the conversion of faceted ACMs (hexagonal plate, circular plate and hollow flower) to exclusive CMOH nanorods through a Cu(II) assisted reaction has been adopted. According to thermodynamic consideration, the synthesis of rare concave nanostructures with high index facet is still challenging due to their higher reactivity. In this study, concave hexagonal ACM with high index facet {hkl} has been successfully prepared for the first time from hexagonal ACM through simple etching with ammonium heptamolybdate (AHM), which is another precursor salt. Hexagonal ACM corrugates to a concave hexagon because of the higher reactivity of the {001} crystal plane than that of the {010} plane. It has been shown that high index facet exposed concave hexagonal ACM serves as a better catalyst for the photodegradation of dye than the other microstructures enclosed by low index facets.	[Pal, Jaya; Ganguly, Mainak; Mondal, Chanchal; Pal, Tarasankar] Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India; [Negishi, Yuichi] Tokyo Univ Sci, Dept Appl Chem, Tokyo 1628601, Japan	Pal, T (reprint author), Indian Inst Technol, Dept Chem, Kharagpur 721302, W Bengal, India.	tpal@chem.iitkgp.ernet.in			UGC; DST; BRNS; CSIR, New Delhi	The authors are thankful to the UGC, DST, BRNS and CSIR, New Delhi, for financial assistance and IIT Kharagpur for research facilities.	Aguey-Zinsou KF, 2003, J AM CHEM SOC, V125, P530, DOI 10.1021/ja028293e; Hill CL, 1998, CHEM REV, V98, P1, DOI 10.1021/cr960395y; Zhang H, 2011, J AM CHEM SOC, V133, P6078, DOI 10.1021/ja201156s; Song FY, 2013, ENERG ENVIRON SCI, V6, P1170, DOI 10.1039/c3ee24433d; Lisnard L, 2007, CHEM-EUR J, V13, P3525, DOI 10.1002/chem.200601252; Yang Y, 2005, J MOL CATAL A-CHEM, V225, P203, DOI 10.1016/j.molcata.2004.08.031; Ogliaro F, 2002, J AM CHEM SOC, V124, P2806, DOI 10.1021/ja0171963; Liu P, 2011, ACS NANO, V5, P4748, DOI 10.1021/nn2007282; Yang Y, 2004, APPL CATAL A-GEN, V273, P201, DOI 10.1016/j.apcata.2004.06.032; Li D, 2011, J AM CHEM SOC, V133, P14010, DOI 10.1021/ja204034g; Niu WX, 2014, CHEM MATER, V26, P2180, DOI 10.1021/cm500210u; Moghimi N, 2013, J AM CHEM SOC, V135, P10958, DOI 10.1021/ja405504q; Artero V, 2003, J AM CHEM SOC, V125, P11156, DOI 10.1021/ja036257p; Song J, 2011, J AM CHEM SOC, V133, P16839, DOI 10.1021/ja203695h; Mohamed MB, 1998, J PHYS CHEM B, V102, P9370, DOI 10.1021/jp9831482; Kim M, 2012, ACS APPL MATER INTER, V4, P5038, DOI 10.1021/am3015058; Pal J, 2014, CRYSTENGCOMM, V16, P883, DOI 10.1039/c3ce41766b; Lv HJ, 2014, J AM CHEM SOC, V136, P9268, DOI 10.1021/ja5045488; Xie SF, 2012, ANGEW CHEM INT EDIT, V51, P10266, DOI 10.1002/anie.201206044; Zhang J, 2006, INORG CHEM, V45, P3732, DOI 10.1021/ic0519943; Tripathy D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2404469; Pal J, 2014, ACS APPL MATER INTER, V6, P9173, DOI 10.1021/am502866t; Xie SF, 2013, NANO LETT, V13, P6262, DOI 10.1021/nl403770g; Zhuang X, 2009, CHEM MATER, V21, P706, DOI 10.1021/cm8028577; Xu JS, 2007, J SOLID STATE CHEM, V180, P119, DOI 10.1016/j.jssc.2006.09.030; Kim SS, 2002, SOLID STATE IONICS, V146, P249, DOI 10.1016/S0167-2738(01)01013-X; Georgi A, 2007, APPL CATAL B-ENVIRON, V72, P26, DOI 10.1016/j.apcatb.2006.10.009; Jana NR, 2002, LANGMUIR, V18, P922, DOI 10.1021/la0114530; Pal J, 2013, J PHYS CHEM C, V117, P24640, DOI 10.1021/jp409271r; Xu H, 2013, CHEM MATER, V25, P405, DOI 10.1021/cm303502b; Rycenga M, 2012, NANO LETT, V12, P6218, DOI 10.1021/nl3032235; Zeng J, 2010, J AM CHEM SOC, V132, P8552, DOI 10.1021/ja103655f; Shores MP, 2005, J AM CHEM SOC, V127, P17986, DOI 10.1021/ja056666g; Ma WH, 2003, ANGEW CHEM INT EDIT, V42, P1029, DOI 10.1002/anie.200390264; Zhang H, 2013, ACCOUNTS CHEM RES, V46, P1783, DOI 10.1021/ar300209w; Sinha AK, 2009, CRYSTENGCOMM, V11, P1210, DOI 10.1039/b906041n; Zhang ZC, 2012, LANGMUIR, V28, P14845, DOI 10.1021/la302973r; Salavati H, 2012, ULTRASON SONOCHEM, V19, P546, DOI 10.1016/j.ultsonch.2011.09.001; Xu JS, 2006, J PHYS CHEM B, V110, P17400, DOI 10.1021/jp0632788; Jin RC, 2001, SCIENCE, V294, P1901, DOI 10.1126/science.1066541; CALVERT LD, 1957, CANADIAN MINERALOGIS, V0006; COSTAMAGNA J, 1993, J SOLID STATE CHEM, V105, P567, DOI 10.1006/jssc.1993.1249; Gabler C, 2011, GREEN CHEM, V13, P2869, DOI 10.1039/c1gc15148g; Garin J. L., 1989, POWDER DIFFR, V4, P233; Hamelmann F, 2005, J OPTOELECTRON ADV M, V7, P393; Ivanov A., 2009, CHEM ENG J, V154, P189; Kar A, 2009, ENVIRON SCI TECHNOL, V43, P3260, DOI 10.1021/es8031049; Lebukhova NV, 2013, SURF COAT TECH, V231, P144, DOI 10.1016/j.surfcoat.2012.05.065; Li DF, 2011, ADV MATER RES-SWITZ, V298, P96, DOI 10.4028/www.scientific.net/AMR.298.96; Liu HW, 2010, IONICS, V16, P57, DOI 10.1007/s11581-009-0345-1; MOINI A, 1986, INORG CHEM, V25, P3782, DOI 10.1021/ic00241a016; OZIN GA, 1992, ACCOUNTS CHEM RES, V25, P553, DOI 10.1021/ar00024a002; Pavani K, 2005, EUR J INORG CHEM, P3080, DOI 10.1002/ejic.200500092; Pazdzior K, 2009, CHEMOSPHERE, V75, P250, DOI 10.1016/j.chemosphere.2008.12.016; Song C. S., 2002, APPL CATAL B-ENVIRON, V41, P207; Tangestaninejad S, 2008, ULTRASON SONOCHEM, V15, P815, DOI 10.1016/j.ultsonch.2007.10.008; Vilminot S, 2006, INORG CHEM, V45, P10938, DOI 10.1021/ic061182m; Wang QM, 2005, MATER CHEM PHYS, V94, P241, DOI 10.1016/j.matchemphys.2005.04.054; Yang Y, 2003, APPL CATAL A-GEN, V252, P305, DOI 10.1016/S0926-860X(03)00446-0; Yu S, 2007, CRYST GROWTH DES, V7, P2397, DOI 10.1021/cg060611o; Zhang L, 2011, CHEM COMMUN, V47, P10353, DOI 10.1039/c1cc13344f	61	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	2					708	719		10.1039/c4nr06309k		12	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX9TS	WOS:000347245500040		
J	Nishimura, S				Nishimura, Satoshi			Personification and Narrative: The Blurred Boundaries of the Inanimate in Hardy and Woolf	NARRATIVE			English	Article							FOCALIZATION		Chubu Univ, Kasugai, Aichi 487, Japan	Nishimura, S (reprint author), Chubu Univ, Kasugai, Aichi 487, Japan.	nishimura@isc.chubu.ac.jp					Alber Jan, 2013, POETICS UNNATURAL NA, P45; Alber J, 2010, NARRATIVE, V18, P113; HERMAN D, 1994, NARRATIVE, V2, P230; Bernaerts L, 2014, NARRATIVE, V22, P68; Burns A, 2002, PAP LANG LIT, V38, P339; Nelles W, 2001, NARRATIVE, V9, P188; Bailey J. O., 1970, POETRY T HARDY HDB C; De Man Paul, 1984, RHETORIC ROMANTICISM; Flint C, 1998, PMLA, V113, P212, DOI 10.2307/463361; Genette G., 1988, NARRATIVE DISCOURSE; Hardy Florence Emily, 1962, LIFE T HARDY 1840 19; Hardy Thomas, 1990, RETURN NATIVE; Hardy Thomas, 1982, COMPLETE POEMS T HAR, P111; Jahn M, 2007, CAMBR COMPANION LIT, P94, DOI 10.1017/CCOL0521856965.007; Iversen Stefan, 2013, POETICS UNNATURAL NA, P94; Johnson Barbara, 2008, PERSONS THINGS; Kooser Ted, 1980, SURE SIGNS NEW SELEC, P64; Lewin Jane E., 1980, NARRATIVE DISCOURSE; Miller J. Hillis, 1970, T HARDY DISTANCE DES; Miller J. Hillis, 1986, POETRY EPISTEMOLOGY, P398; Miller J. Hillis, 1995, TOPOGRAPHIES; Nishimura S, 2003, STUD ENGL LIT-1500, V43, P897, DOI 10.1353/sel.2003.0044; Nishimura Satoshi, 2012, B T HARDY SOC JAPAN, V38, P1; Ruskin J., 1903, WORKS; Tate Allen, 1959, COLLECTED ESSAYS, P185; Woolf Virginia, 1989, LIGHTHOUSE; Woolf Virginia, 1986, THE COMMON READER, P245	27	0	0	OHIO STATE UNIV PRESS	COLUMBUS	1050 CARMACK RD, COLUMBUS, OH 43210 USA	1063-3685	1538-974X		NARRATIVE	Narrative	JAN	2015	23	1					27	39				13	Literature	Literature	AX8DW	WOS:000347141500002		
J	Liu, MJ; Ishida, Y; Ebina, Y; Sasaki, T; Hikima, T; Takata, M; Aida, T				Liu, Mingjie; Ishida, Yasuhiro; Ebina, Yasuo; Sasaki, Takayoshi; Hikima, Takaaki; Takata, Masaki; Aida, Takuzo			An anisotropic hydrogel with electrostatic repulsion between cofacially aligned nanosheets	NATURE			English	Article							MAGNETIC-FIELDS; LONG-RANGE; CLAY; DIFFUSION; ALIGNMENT; POLYMER; ION	Machine technology frequently puts magnetic or electrostatic repulsive forces to practical use, as in maglev trains, vehicle suspensions or non-contact bearings(1,2). In contrast, materials design overwhelmingly focuses on attractive interactions, such as in the many advanced polymer-based composites, where inorganic fillers interact with a polymer matrix to improve mechanical properties. However, articular cartilage strikingly illustrates how electrostatic repulsion can be harnessed to achieve unparalleled functional efficiency: it permits virtually friction-less mechanical motion within joints, even under high compression(3,4). Here we describe a composite hydrogel with anisotropic mechanical properties dominated by electrostatic repulsion between negatively charged unilamellar titanate nanosheets(5) embedded within it. Crucial to the behaviour of this hydrogel is the serendipitous discovery of cofacial nanosheet alignment in aqueous colloidal dispersions subjected to a strong magnetic field, which maximizes electrostatic repulsion(6) and thereby induces a quasi-crystalline structural ordering(7,8) over macroscopic length scales and with uniformly large face-to-face nanosheet separation. We fix this transiently induced structural order by transforming the dispersion into a hydrogel(9,10) using light-triggered in situ vinyl polymerization(11). The resultant hydrogel, containing charged inorganic structures that align cofacially in a magnetic flux(12-19), deforms easily under shear forces applied parallel to the embedded nanosheets yet resists compressive forces applied orthogonally. We anticipate that the concept of embedding anisotropic repulsive electrostatics within a composite material, inspired by articular cartilage, will open up new possibilities for developing soft materials with unusual functions.	[Liu, Mingjie; Ishida, Yasuhiro; Aida, Takuzo] RIKEN Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Ebina, Yasuo; Sasaki, Takayoshi] Int Ctr Mat Nanoarchitecton, Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Hikima, Takaaki; Takata, Masaki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795198, Japan; [Aida, Takuzo] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Ishida, Y (reprint author), RIKEN Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	y-ishida@riken.jp; aida@macro.t.u-tokyo.ac.jp	Ishida, Yasuhiro/I-8204-2012; Liu, Mingjie/G-1109-2010; Aida, Takuzo/I-9117-2012	Liu, Mingjie/0000-0003-0824-9858; 	 [25000005]	This work was financially supported by a Grant-in-Aid for Specially Promoted Research (25000005) on "Physically Perturbed Assembly for Tailoring High-Performance Soft Materials with Controlled Macroscopic Structural Anisotropy''. We also acknowledge the ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). The synchrotron X-ray diffraction experiments were performed at BL45XUin SPring-8 with the approval of the RIKEN SPring-8 Center (proposal 20140073).	ANANDARAJAH A, 1991, INT J NUMER ANAL MET, V15, P683, DOI 10.1002/nag.1610151002; TORBET J, 1981, NATURE, V289, P91, DOI 10.1038/289091a0; Tamesue S, 2013, J AM CHEM SOC, V135, P15650, DOI 10.1021/ja408547g; Wu ZL, 2011, MACROMOLECULES, V44, P3535, DOI 10.1021/ma2001228; Wu JJ, 2012, SOFT MATTER, V8, P3620, DOI 10.1039/c2sm07411g; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Feng S, 2009, MACROMOLECULES, V42, P281, DOI 10.1021/ma8015932; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; Dean D, 2006, J BIOMECH, V39, P2555, DOI 10.1016/j.jbiomech.2005.09.007; RHIM WK, 1993, REV SCI INSTRUM, V64, P2961, DOI 10.1063/1.1144475; Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Ida S, 2008, J AM CHEM SOC, V130, P7052, DOI 10.1021/ja7114772; Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340; Osada M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.153301; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; Haque MA, 2010, ADV MATER, V22, P5110, DOI 10.1002/adma.201002509; MARET G, 1985, TOP APPL PHYS, V57, P143; Palmer LC, 2014, J AM CHEM SOC, V136, P14377, DOI [10.1021/ja5082519, 10.1021/ja50825191]; Budtova T, 1997, MACROMOLECULES, V30, P6556, DOI 10.1021/ma970304e; Eguchi M, 2008, J PHYS CHEM C, V112, P11280, DOI 10.1021/jp802702m; Hull JR, 2000, SUPERCOND SCI TECH, V13, pR1, DOI 10.1088/0953-2048/13/2/201; Kleinschmidt F, 2005, MACROMOLECULES, V38, P9772, DOI 10.1021/ma051479o; Liu MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3029; Lowen H, 2001, J PHYS-CONDENS MAT, V13, pR415, DOI 10.1088/0953-8984/13/24/201; Prosser S., 1996, J AM CHEM SOC, V118, P269; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; Tan CB, 2002, J AM CHEM SOC, V124, P11827, DOI 10.1021/ja027079n; UYEDA C, 1993, PHYS CHEM MINER, V20, P77; Verwey E. J. W., 1948, THEORY STABILITY LYO	30	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					68	72		10.1038/nature14060		5	Multidisciplinary Sciences	Science & Technology - Other Topics	AX8SI	WOS:000347178400036		
J	Suga, M; Akita, F; Hirata, K; Ueno, G; Murakami, H; Nakajima, Y; Shimizu, T; Yamashita, K; Yamamoto, M; Ago, H; Shen, JR				Suga, Michihiro; Akita, Fusamichi; Hirata, Kunio; Ueno, Go; Murakami, Hironori; Nakajima, Yoshiki; Shimizu, Tetsuya; Yamashita, Keitaro; Yamamoto, Masaki; Ago, Hideo; Shen, Jian-Ren			Native structure of photosystem II at 1.95 angstrom resolution viewed by femtosecond X-ray pulses	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; O BOND FORMATION; CRYSTAL-STRUCTURE; MANGANESE COMPLEX; ROOM-TEMPERATURE; MN4CA CLUSTER; WATER; SPECTROSCOPY; DIFFRACTION; MODELS	Photosynthesis converts light energy into biologically useful chemical energy vital to life on Earth. The initial reaction of photosynthesis takes place in photosystem II (PSII), a 700-kilodalton homodimeric membrane protein complex that catalyses photo-oxidation of water into dioxygen through an S-state cycle of the oxygen evolving complex (OEC). The structure of PSII has been solved by X-ray diffraction (XRD) at 1.9 angstrom resolution, which revealed that the OEC is a Mn4CaO5-cluster coordinated by a well defined protein environment(1). However, extended X-ray absorption fine structure (EXAFS) studies showed that the manganese cations in the OEC are easily reduced by X-ray irradiation(2), and slight differences were found in the Mn-Mn distances determined by XRD1, EXAFS(3-7) and theoretical studies(8-14). Here we report a 'radiation-damage-free' structure of PSII from Thermosynechococcus vulcanus in the S-1 state at a resolution of 1.95 angstroms using femtosecond X-ray pulses of the SPring-8 angstrom compact free-electron laser (SACLA) and hundreds of large, highly isomorphous PSII crystals. Compared with the structure from XRD, the OEC in the X-ray free electron laser structure has Mn-Mn distances that are shorter by 0.1-0.2 angstroms. The valences of each manganese atom were tentatively assigned as Mn1D(III), Mn2C(IV), Mn3B(IV) and Mn4A(III), based on the average Mn-ligand distances and analysis of the Jahn-Teller axis on Mn(III). One of the oxo-bridged oxygens, O5, has significantly longer distances to Mn than do the other oxo-oxygen atoms, suggesting that O5 is a hydroxide ion instead of a normal oxygen dianion and therefore may serve as one of the substrate oxygen atoms. These findings provide a structural basis for the mechanism of oxygen evolution, and we expect that this structure will provide a blueprint for the design of artificial catalysts for water oxidation.	[Suga, Michihiro; Akita, Fusamichi; Nakajima, Yoshiki; Shimizu, Tetsuya; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Photosynth Res Ctr, Okayama 7008530, Japan; [Hirata, Kunio; Ueno, Go; Murakami, Hironori; Yamashita, Keitaro; Yamamoto, Masaki; Ago, Hideo] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Hirata, Kunio] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan	Ago, H (reprint author), RIKEN, SPring Ctr 8, 1-1-1 Kouto Sayo, Mikazuki, Hyogo 6795148, Japan.	yamamoto@riken.jp; ago@spring8.or.jp; shen@cc.okayama-u.ac.jp	Yamamoto, Masaki/B-7844-2015; Akita, Fusamichi/C-2034-2015; Suga, Michi/C-2870-2015; Shen, Jian-Ren/B-2558-2011	Yamamoto, Masaki/0000-0002-1311-1768; Akita, Fusamichi/0000-0003-0537-6157; 	The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT; JST/CREST; Japan Synchrotron Radiation Research Institute (JASRI) [2012A8011, 2012B8040, 2013A8047, 2013B8052, 2014A8036]	We thank T. Ishikawa, M. Yabashi, K. Tono and Y. Inubushi for help in using the SACLA beamline, T. Tsukihara and S. Yoshikawa for suggestions and comments on the experiments, F. Seno for assistance with sample preparation, and K. Kawakami and Y. Umena for suggestions in the initial stage of the project. F. H. M. Koua participated in the initial stage of this work. This work was supported by an X-ray Free Electron Laser Priority Strategy Program (The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT) (H. A. and J.-R. S.), a JST/CREST grant (K. H.), a grant-in-aid for Specially Promoted Research no. 24000018 (J.-R. S.) and KAKENHI grant no. 26840023 (M. S.) from JSPS, MEXT, Japan. The XFEL experiments were performed at beamline 3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal nos 2012A8011, 2012B8040, 2013A8047, 2013B8052 and 2014A8036), and we thank staff at SACLA for their help.	Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/nmeth.2962, 10.1038/NMETH.2962]; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Blomberg MRA, 2014, CHEM REV, V114, P3601, DOI 10.1021/cr400388t; Glockner C, 2013, J BIOL CHEM, V288, P22607, DOI 10.1074/jbc.M113.476622; Holton JM, 2010, ACTA CRYSTALLOGR D, V66, P393, DOI 10.1107/S0907444910007262; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Dau H, 2008, PHILOS T R SOC B, V363, P1237, DOI 10.1098/rstb.2007.2220; Galstyan A, 2012, J AM CHEM SOC, V134, P7442, DOI 10.1021/ja300254n; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Murray JW, 2004, J APPL CRYSTALLOGR, V37, P513, DOI 10.1107/S0021889804010660; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Shoji M., MOL PHYS; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013	35	87	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					99	U265		10.1038/nature13991		17	Multidisciplinary Sciences	Science & Technology - Other Topics	AX8SI	WOS:000347178400043		
J	Reincke, M; Sbiera, S; Hayakawa, A; Theodoropoulou, M; Osswald, A; Beuschlein, F; Meitinger, T; Mizuno-Yamasaki, E; Kawaguchi, K; Saeki, Y; Tanaka, K; Wieland, T; Graf, E; Saeger, W; Ronchi, CL; Allolio, B; Buchfelder, M; Strom, TM; Fassnacht, M; Komada, M				Reincke, Martin; Sbiera, Silviu; Hayakawa, Akira; Theodoropoulou, Marily; Osswald, Andrea; Beuschlein, Felix; Meitinger, Thomas; Mizuno-Yamasaki, Emi; Kawaguchi, Kohei; Saeki, Yasushi; Tanaka, Keiji; Wieland, Thomas; Graf, Elisabeth; Saeger, Wolfgang; Ronchi, Cristina L.; Allolio, Bruno; Buchfelder, Michael; Strom, Tim M.; Fassnacht, Martin; Komada, Masayuki			Mutations in the deubiquitinase gene USP8 cause Cushing's disease	NATURE GENETICS			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR DOWN-REGULATION; ENDOCYTIC TRAFFICKING; PITUITARY-ADENOMAS; UBPY; UBIQUITYLATION; DEGRADATION; ENDOSOMES; PROTEIN; DOMAIN	Cushing's disease is caused by corticotroph adenomas of the pituitary. To explore the molecular mechanisms of endocrine autonomy in these tumors, we performed exome sequencing of 10 corticotroph adenomas. We found somatic mutations in the USP8 deubiquitinase gene in 4 of 10 adenomas. The mutations clustered in the 14-3-3 protein binding motif and enhanced the proteolytic cleavage and catalytic activity of USP8. Cleavage of USP8 led to increased deubiqutination of the EGF receptor, impairing its downregulation and sustaining EGF signaling. USP8 mutants enhanced promoter activity of the gene encoding proopiomelanocortin. In summary, our data show that dominant mutations in USP8 cause Cushing's disease via activation of EGF receptor signaling.	[Reincke, Martin; Osswald, Andrea; Beuschlein, Felix] Univ Munich, Med Klin & Poliklin 4, Munich, Germany; [Sbiera, Silviu] Univ Wurzburg, D-97070 Wurzburg, Germany; [Hayakawa, Akira; Mizuno-Yamasaki, Emi; Kawaguchi, Kohei; Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Theodoropoulou, Marily] Max Planck Inst Psychiat, Dept Endocrinol, D-80804 Munich, Germany; [Meitinger, Thomas; Wieland, Thomas; Graf, Elisabeth; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Meitinger, Thomas] DZHK, German Ctr Cardiovasc Res, Munich, Germany; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Tokyo 113, Japan; [Saeger, Wolfgang] Univ Hamburg, Inst Neuropathol, Hamburg, Germany; [Ronchi, Cristina L.; Fassnacht, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Allolio, Bruno] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Buchfelder, Michael] Klinikum Univ Erlangen, Neurochirurg Klin, Erlangen, Germany	Fassnacht, M (reprint author), Univ Munich, Med Klin & Poliklin 4, Munich, Germany.	martin.reincke@med.uni-muenchen.de; fassnacht_m@ukw.de	Meitinger, Thomas/O-1318-2015		Else Kroner-Fresenius-Stiftung [2012_A103]; Bundesministerium fur Bildung und Forschung [BMBF 01EO1004-D2]; Wilhelm Sander-Stiftung [2012.095.1]; Ministry of Education, Culture, Science and Technology of Japan [24112003, 24112008]; Novartis AG; Pfizer; Ipsen for the Hypophysenregister der Arbeitsgemeinschaft Hypophyse of the German Society of Endocrinology; NovoNordisk; German Federal Ministry of Education and Research [01EX1021B]; Verbund Personalisierte Medizin, Teilprojekt NeoExNET [PM1]	We thank Minoru Fukuda and Mitsunori Fukuda for the LAMP2 antibody and EGFP-Rab11A<SUP>S25A</SUP> expression vector, respectively. The study was supported in by the Else Kroner-Fresenius-Stiftung (grant 2012_A103 to M.R.), Bundesministerium fur Bildung und Forschung (grant BMBF 01EO1004-D2 to M.F. and B.A.), the Wilhelm Sander-Stiftung (grant 2012.095.1 to B.A.), and Grants-in-aid from the Ministry of Education, Culture, Science and Technology of Japan (grant 24112003 to M.K. and 24112008 to Y.S.). W.S. is supported by funds from Novartis AG, Pfizer and NovoNordisk and Ipsen for the Hypophysenregister der Arbeitsgemeinschaft Hypophyse of the German Society of Endocrinology. M.T. is supported by a grant from the German Federal Ministry of Education and Research (01EX1021B, Spitzencluster M4, Verbund Personalisierte Medizin, Teilprojekt NeoExNET (PM1)). We thank B. Mauracher, P. Rank, J. Stalla and J.L. Monteserin-Garcia for excellent technical assistance.	Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Dworakowska D, 2012, EUR J CLIN INVEST, V42, P665, DOI 10.1111/j.1365-2362.2011.02621.x; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; STALLA GK, 1988, ENDOCRINOLOGY, V122, P618; Theodoropoulou M, 2004, J ENDOCRINOL, V183, P385, DOI 10.1677/joe.1.05616; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Ishida M, 2012, J CELL SCI, V125, P5177, DOI 10.1242/jcs.109314; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Cushing H., 1932, B J HOPKINS HOSP, V50, P127; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; LIU B, 1992, MOL CELL BIOL, V12, P3978; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Nomura N, 1994, DNA Res, V1, P223, DOI 10.1093/dnares/1.5.223; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; Phillips A, 1997, MOL CELL BIOL, V17, P5946	39	14	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					31	+		10.1038/ng.3166		10	Genetics & Heredity	Genetics & Heredity	AX5TM	WOS:000346990400008		
J	Debette, S; Kamatani, Y; Metso, TM; Kloss, M; Chauhan, G; Engelter, ST; Pezzini, A; Thijs, V; Markus, HS; Dichgans, M; Wolf, C; Dittrich, R; Touze, E; Southerland, AM; Samson, Y; Abboud, S; Bejot, Y; Caso, V; Bersano, A; Gschwendtner, A; Sessa, M; Cole, J; Lamy, C; Medeiros, E; Beretta, S; Bonati, LH; Grau, AJ; Michel, P; Majersik, JJ; Sharma, P; Kalashnikova, L; Nazarova, M; Dobrynina, L; Bartels, E; Guillon, B; van den Herik, EG; Fernandez-Cadenas, I; Jood, K; Nalls, MA; De Leeuw, FE; Jern, C; Cheng, YC; Werner, I; Metso, AJ; Lichy, C; Lyrer, PA; Brandt, T; Boncoraglio, GB; Wichmann, HE; Gieger, C; Johnson, AD; Bottcher, T; Castellano, M; Arveiler, D; Ikram, MA; Breteler, MMB; Padovani, A; Meschia, JF; Kuhlenbaumer, G; Rolfs, A; Worrall, BB; Ringelstein, EB; Zelenika, D; Tatlisumak, T; Lathrop, M; Leys, D; Amouyel, P; Dallongeville, J				Debette, Stephanie; Kamatani, Yoichiro; Metso, Tiina M.; Kloss, Manja; Chauhan, Ganesh; Engelter, Stefan T.; Pezzini, Alessandro; Thijs, Vincent; Markus, Hugh S.; Dichgans, Martin; Wolf, Christiane; Dittrich, Ralf; Touze, Emmanuel; Southerland, Andrew M.; Samson, Yves; Abboud, Sherine; Bejot, Yannick; Caso, Valeria; Bersano, Anna; Gschwendtner, Andreas; Sessa, Maria; Cole, John; Lamy, Chantal; Medeiros, Elisabeth; Beretta, Simone; Bonati, Leo H.; Grau, Armin J.; Michel, Patrik; Majersik, Jennifer J.; Sharma, Pankaj; Kalashnikova, Ludmila; Nazarova, Maria; Dobrynina, Larisa; Bartels, Eva; Guillon, Benoit; van den Herik, Evita G.; Fernandez-Cadenas, Israel; Jood, Katarina; Nalls, Michael A.; De Leeuw, Frank-Erik; Jern, Christina; Cheng, Yu-Ching; Werner, Inge; Metso, Antti J.; Lichy, Christoph; Lyrer, Philippe A.; Brandt, Tobias; Boncoraglio, Giorgio B.; Wichmann, Heinz-Erich; Gieger, Christian; Johnson, Andrew D.; Bottcher, Thomas; Castellano, Maurizio; Arveiler, Dominique; Ikram, M. Arfan; Breteler, Monique M. B.; Padovani, Alessandro; Meschia, James F.; Kuhlenbaumer, Gregor; Rolfs, Arndt; Worrall, Bradford B.; Ringelstein, Erich-Bernd; Zelenika, Diana; Tatlisumak, Turgut; Lathrop, Mark; Leys, Didier; Amouyel, Philippe; Dallongeville, Jean		Int Stroke Genetics Consortium; CADISP Grp	Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ABDOMINAL AORTIC-ANEURYSM; HUMAN ENDOTHELIAL-CELLS; VASCULAR RISK-FACTORS; ISCHEMIC-STROKE; INTRACRANIAL ANEURYSM; MYOCARDIAL-INFARCTION; YOUNG-ADULTS; IDENTIFIES 3; LOCI	Cervical artery dissection (CeAD), a mural hematoma in a carotid or vertebral artery, is a major cause of ischemic stroke in young adults although relatively uncommon in the general population (incidence of 2.6/100,000 per year)(1). Minor cervical traumas, infection, migraine and hypertension are putative risk factors(1-3), and inverse associations with obesity and hypercholesterolemia are described(3,4). No confirmed genetic susceptibility factors have been identified using candidate gene approaches(5). We performed genome-wide association studies (GWAS) in 1,393 CeAD cases and 14,416 controls. The rs9349379[G] allele (PHACTR(1)) was associated with lower CeAD risk (odds ratio (OR) = 0.75, 95% confidence interval (CI) = 0.69-0.82; P = 4.46 x 10(-10)), with confirmation in independent follow-up samples (659 CeAD cases and 2,648 controls; P = 3.91 x 10(-3); combined P = 1.00 x 10(-11)). The rs9349379[G] allele was previously shown to be associated with lower risk of migraine and increased risk of myocardial infarction(6-9). Deciphering the mechanisms underlying this pleiotropy might provide important information on the biological underpinnings of these disabling conditions.	[Debette, Stephanie; Amouyel, Philippe; Dallongeville, Jean] INSERM, U744, F-59045 Lille, France; [Debette, Stephanie; Amouyel, Philippe; Dallongeville, Jean] Inst Pasteur, F-59019 Lille, France; [Debette, Stephanie; Amouyel, Philippe] Lille Univ Hosp, Lille, France; [Debette, Stephanie; Leys, Didier] Dept Neurol, Equipe Accueil 1046, Lille, France; [Debette, Stephanie; Chauhan, Ganesh; Leys, Didier] Univ Bordeaux, INSERM, U897, Bordeaux, France; [Kamatani, Yoichiro; Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Kamatani, Yoichiro; Lathrop, Mark] CEPH, Fdn Jean Dausset, Paris, France; [Kamatani, Yoichiro] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Metso, Tiina M.; Metso, Antti J.; Tatlisumak, Turgut] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Kloss, Manja; Werner, Inge; Lichy, Christoph] Univ Heidelberg Hosp, Dept Neurol, Heidelberg, Germany; [Engelter, Stefan T.; Lyrer, Philippe A.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Pezzini, Alessandro; Padovani, Alessandro] Brescia Univ Hosp, Neurol Clin, Dept Clin & Expt Sci, Brescia, Italy; [Thijs, Vincent] Leuven Univ Hosp, Dept Neurol, Leuven, Belgium; [Thijs, Vincent] VIB, Vesalius Res Ctr, Leuven, Belgium; [Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Dichgans, Martin; Gschwendtner, Andreas] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Dichgans, Martin; Gschwendtner, Andreas] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Wolf, Christiane] Max Planck Inst Psychiat, Dept Stat Genet, D-80804 Munich, Germany; [Dittrich, Ralf; Ringelstein, Erich-Bernd] Univ Hosp Munster, Dept Neurol, Munster, Germany; [Touze, Emmanuel] Univ Hosp Sainte Anne, Dept Neurol, Paris, France; [Touze, Emmanuel] Univ Hosp Caen, Dept Neurol, Caen, France; [Southerland, Andrew M.; Worrall, Bradford B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Samson, Yves] Assistance Publ Hop Paris Salpetriere Urgences Ce, Paris, France; [Abboud, Sherine] Univ Libre Bruxelles, Lab Expt Neurol, Brussels, Belgium; [Bejot, Yannick] Dijon Univ Hosp, Dept Neurol, Dijon, France; [Caso, Valeria] Univ Perugia, Santa Maria Misericordia Hosp, Stroke Unit, SantAndrea Fratte, I-06100 Perugia, Italy; [Caso, Valeria] Univ Perugia, Santa Maria Misericordia Hosp, Div Cardiovasc Med, SantAndrea Fratte, I-06100 Perugia, Italy; [Bersano, Anna; Boncoraglio, Giorgio B.] Ist Neurol Carlo Besta, Fdn Ist Ricovero Cura Carattere Sci, Dept Cerebrovasc Dis, Milan, Italy; [Sessa, Maria] San Raffaele Univ Hosp, Dept Neurol, Milan, Italy; [Cole, John; Cheng, Yu-Ching] Univ Maryland, Sch Med, Dept Neurol, Maryland Stroke Ctr, Baltimore, MD 21201 USA; [Lamy, Chantal] Amiens Univ Hosp, Dept Neurol, Amiens, France; [Medeiros, Elisabeth] Besancon Univ Hosp, Dept Neurol, Besancon, France; [Beretta, Simone] Univ Milano Bicocca, San Gerardo Hosp, Dept Neurol, Monza, Italy; [Grau, Armin J.] Klinikum Ludwigshafen, Dept Neurol, Ludwigshafen, Germany; [Michel, Patrik] Univ Lausanne Hosp, Dept Neurol, Lausanne, Switzerland; [Majersik, Jennifer J.] Univ Utah, Dept Neurol, Divis Vasc Neurol, Salt Lake City, UT USA; [Sharma, Pankaj] Royal Holloway Univ London ICR2UL, Inst Cardiovasc Res, London, England; [Sharma, Pankaj] Ashford & St Peters Hosp, London, England; [Kalashnikova, Ludmila; Dobrynina, Larisa] Russian Acad Med Sci, Res Ctr Neurol, Moscow, Russia; [Nazarova, Maria] Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia; [Bartels, Eva] Ctr Neurol Vasc Diagnost, Munich, Germany; [Guillon, Benoit] Nantes Univ Hosp, Dept Neurol, Nantes, France; Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Fernandez-Cadenas, Israel] Fdn Docencia Recerca MutuaTerrassa, Terrassa, Spain; [Fernandez-Cadenas, Israel] Hosp Valle De Hebron, Inst Recerca, Lab Neurovasc, Barcelona, Spain; [Jood, Katarina] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Nalls, Michael A.] NIA, Neurogenet Lab, Mol Genet Sect, NIH, Bethesda, MD 20892 USA; [De Leeuw, Frank-Erik; Jern, Christina] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain,Cognit & Behav,Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Brandt, Tobias] Schmieder Klin, Dept Rehabil, Heidelberg, Germany; [Wichmann, Heinz-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Gieger, Christian] Helmholtz Ctr Munich, Inst Genet Epidemiol, Neuherberg, Germany; [Johnson, Andrew D.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Bottcher, Thomas] Rostock Univ Hosp, Dept Neurol, Rostock, Germany; [Castellano, Maurizio] Brescia Univ Hosp, Med Clin, Dept Clin & Expt Sci, Brescia, Italy; [Arveiler, Dominique] Strasbourg Univ, EA 3430, Dept Epidemiol & Publ Hlth, Strasbourg, France; [Ikram, M. Arfan; Breteler, Monique M. B.] Univ Med Ctr, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Univ Med Ctr, Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Netherlands Consortium Healthy Aging, Leiden, Netherlands; [Breteler, Monique M. B.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Meschia, James F.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA; [Kuhlenbaumer, Gregor] Univ Kiel, Inst Expt Med, Kiel, Germany; [Worrall, Bradford B.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada	Debette, S (reprint author), INSERM, U744, F-59045 Lille, France.	stephdebette@wanadoo.fr	Boncoraglio, Giorgio/B-8647-2011; Thijs, Vincent/C-3647-2009; Nazarova, Maria/D-8810-2012; Leeuw, H.F./L-4479-2015; Bonati, Leo/G-4058-2012	Thijs, Vincent/0000-0002-6614-8417; Nazarova, Maria/0000-0001-5347-5948; Ikram, Mohammad Arfan/0000-0003-0372-8585; Bonati, Leo/0000-0003-1163-8133	INSERM; Lille 2 University; Institut Pasteur de Lille; Lille University Hospital; European Regional Development Fund; Region Nord-Pas-de-Calais [09120030]; Centre National de Genotypage; Emil Aaltonen Foundation; Paavo Ilmari Ahvenainen Foundation; Helsinki University Central Hospital Research Fund; Helsinki University Medical Foundation; Paivikki and Sakari Sohlberg Foundation; Aarne Koskelo Foundation; Maire Taponen Foundation; Aarne and Aili Turunen Foundation; Lilly Foundation; Alfred Kordelin Foundation; Finnish Medical Foundation; Orion Farmos Research Foundation; Maud Kuistila Foundation; Finnish Brain Foundation; Biomedicum Helsinki Foundation; Projet Hospitalier de Recherche Clinique Regional, Fondation de France; Genopole de Lille; Adrinord; Basel Stroke Funds; Kathe-ZinggSchwichtenberg- Fonds of the Swiss Academy of Medical Sciences; Swiss Heart Foundation; Swiss National Science Foundation [33CM30-124119]; Chair of Excellence from the French National Research Agency (ANR); Leducq Foundation; Vascular Dementia Research Foundation; Spanish Ministry of Health [CP12/03298]; Department of Health (UK); American Heart Association/American Stroke Association National Clinical Research Program (AHA) [3CRP14140001]; Fonds Wetenschappelijk Onderzoek Flanders	The authors thank the staff and participants of all CADISP centers for their important contributions. The CADISP study has been supported by INSERM, Lille 2 University, Institut Pasteur de Lille and Lille University Hospital and received funding from the European Regional Development Fund (FEDER funds) and Region Nord-Pas-de-Calais in the framework of Contrat de Projets Etat-Region 2007-2013 Region Nord-Pas-de-Calais (grant 09120030), Centre National de Genotypage, the Emil Aaltonen Foundation, the Paavo Ilmari Ahvenainen Foundation, the Helsinki University Central Hospital Research Fund, the Helsinki University Medical Foundation, the Paivikki and Sakari Sohlberg Foundation, the Aarne Koskelo Foundation, the Maire Taponen Foundation, the Aarne and Aili Turunen Foundation, the Lilly Foundation, the Alfred Kordelin Foundation, the Finnish Medical Foundation, the Orion Farmos Research Foundation, the Maud Kuistila Foundation, the Finnish Brain Foundation, the Biomedicum Helsinki Foundation, Projet Hospitalier de Recherche Clinique Regional, Fondation de France, Genopole de Lille, Adrinord, the Basel Stroke Funds, the Kathe-ZinggSchwichtenberg- Fonds of the Swiss Academy of Medical Sciences and the Swiss Heart Foundation. L.H.B., S.T.E. and P.A.L. were supported, in part, by a grant from the Swiss National Science Foundation (33CM30-124119). S.D. is supported by a Chair of Excellence from the French National Research Agency (ANR). S.D. and M.D. are supported by a grant from the Leducq Foundation. M.D. is supported by the Vascular Dementia Research Foundation. I.F.-C. is supported by the Miguel Servet programme (CP12/03298) from the Spanish Ministry of Health (Instituto de Salud Carlos III). G.K. is a member of the Deutsche Forschungsgemeinschaft Cluster of Excellence 'Inflammation at Interfaces'. P.S. is supported by a Department of Health (UK) senior fellowship. A.M.S. is supported by the American Heart Association/American Stroke Association National Clinical Research Program (AHA 3CRP14140001). V.T. is supported by Fonds Wetenschappelijk Onderzoek Flanders. More detailed acknowledgments can be found in the Supplementary Note.	Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Fils-Aime N, 2013, J BIOL CHEM, V288, P11807, DOI 10.1074/jbc.M112.430934; LeMaire SA, 2011, NAT GENET, V43, P996, DOI 10.1038/ng.934; Debette S, 2009, INT J STROKE, V4, P224, DOI 10.1111/j.1747-4949.2009.00281.x; Shantikumar S, 2010, EUR J VASC ENDOVASC, V39, P200, DOI 10.1016/j.ejvs.2009.10.014; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Metso TM, 2012, NEUROLOGY, V78, P1221, DOI 10.1212/WNL.0b013e318251595f; Calvet D, 2004, STROKE, V35, P2078, DOI 10.1161/01.STR.0000136721.95301.8d; Lee VH, 2006, NEUROLOGY, V67, P1809, DOI 10.1212/01.wnl.0000244486.30455.71; Pezzini A, 2007, STROKE, V38, P3145, DOI 10.1161/STROKEAHA.107.491506; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Debette S, 2011, NEUROLOGY, V77, P1174, DOI 10.1212/WNL.0b013e31822f03fc; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Low SK, 2012, HUM MOL GENET, V21, P2102, DOI 10.1093/hmg/dds020; Debette S, 2011, CIRCULATION, V123, P1537, DOI 10.1161/CIRCULATIONAHA.110.000125; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Longoni M, 2006, NEUROLOGY, V66, P1273, DOI 10.1212/01.wnl.0000208411.01172.0b; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Norman PE, 2007, CONNECT TISSUE RES, V48, P125, DOI 10.1080/03008200701331524; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Debette S, 2009, STROKE, V40, pE459, DOI 10.1161/STROKEAHA.108.534669; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rubinstein SM, 2005, STROKE, V36, P1575, DOI 10.1161/01.STR.0000169919.73219.30; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Arnold M, 2009, J NEUROL NEUROSUR PS, V80, P232, DOI 10.1136/jnnp.2008.151324; Callaghan FM, 2011, AM J PHYSIOL-HEART C, V300, pH1451, DOI 10.1152/ajpheart.00871.2010; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Coronary Artery Disease Genetics Consortium, 2011, NAT GENET, V43, P339; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Hager J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038663; Jarray R, 2011, BIOCHIMIE, V93, P1668, DOI 10.1016/j.biochi.2011.07.010; Kurth T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7357; Mehta Nehal N, 2011, Circ Cardiovasc Genet, V4, P465, DOI 10.1161/CIRCGENETICS.111.960989; Pezzini A, 2002, STROKE, V33, P664, DOI 10.1161/hs0302.103625	51	5	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					78	+		10.1038/ng.3154		8	Genetics & Heredity	Genetics & Heredity	AX5TM	WOS:000346990400015		
J	Nishi, M				Nishi, Masayuki			DEEP WATER CYCLE Mantle hydration	NATURE GEOSCIENCE			English	News Item							EARTHS MANTLE; PHASE D; TRANSPORT; STABILITY; SILICATE; GPA		Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan	Nishi, M (reprint author), Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan.	nishi@sci.ehime-u.ac.jp					INOUE T, 1995, GEOPHYS RES LETT, V22, P117, DOI 10.1029/94GL02965; Tsuchiya J, 2013, GEOPHYS RES LETT, V40, P4570, DOI 10.1002/grl.50875; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Komabayashi T, 2006, PHYS EARTH PLANET IN, V156, P89, DOI 10.1016/j.pepi.2006.02.002; Helffrich GR, 2001, NATURE, V412, P501, DOI 10.1038/35087500; SMYTH JR, 1987, AM MINERAL, V72, P1051; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; Pamato MG, 2015, NAT GEOSCI, V8, P75, DOI [10.1038/ngeo2306, 10.1038/NGEO2306]; Ballaran TB, 2010, AM MINERAL, V95, P1113, DOI 10.2138/am.2010.3462; Ghosh S, 2014, GEOCHIM COSMOCHIM AC, V145, P72, DOI 10.1016/j.gca.2014.06.025; Nishi M, 2014, NAT GEOSCI, V7, P224, DOI [10.1038/ngeo2074, 10.1038/NGEO2074]; Ohira I, 2014, EARTH PLANET SC LETT, V401, P12, DOI 10.1016/j.epsl.2014.05.059	12	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	JAN	2015	8	1					9	10				2	Geosciences, Multidisciplinary	Geology	AX3FF	WOS:000346825000006		
J	Dudok, B; Barna, L; Ledri, M; Szabo, SI; Szabadits, E; Pinter, B; Woodhams, SG; Henstridge, CM; Balla, GY; Nyilas, R; Varga, C; Lee, SH; Matolcsi, M; Cervenak, J; Kacskovics, I; Watanabe, M; Sagheddu, C; Melis, M; Pistis, M; Soltesz, I; Katona, I				Dudok, Barna; Barna, Laszlo; Ledri, Marco; Szabo, Szilard I.; Szabadits, Eszter; Pinter, Balazs; Woodhams, Stephen G.; Henstridge, Christopher M.; Balla, Gyula Y.; Nyilas, Rita; Varga, Csaba; Lee, Sang-Hun; Matolcsi, Mate; Cervenak, Judit; Kacskovics, Imre; Watanabe, Masahiko; Sagheddu, Claudia; Melis, Miriam; Pistis, Marco; Soltesz, Ivan; Katona, Istvan			Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling	NATURE NEUROSCIENCE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; PRESYNAPTIC ACTIVE ZONE; FRAGILE-X-SYNDROME; GABA RELEASE; ENDOCANNABINOID SYSTEM; INHIBITORY SYNAPSES; AMPA RECEPTORS; AXON TERMINALS; CA2+ CHANNELS; MARIJUANA USE	A major challenge in neuroscience is to determine the nanoscale position and quantity of signaling molecules in a cell type- and subcellular compartment-specific manner. We developed a new approach to this problem by combining cell-specific physiological and anatomical characterization with super-resolution imaging and studied the molecular and structural parameters shaping the physiological properties of synaptic endocannabinoid signaling in the mouse hippocampus. We found that axon terminals of perisomatically projecting GABAergic interneurons possessed increased CB1 receptor number, active-zone complexity and receptor/effector ratio compared with dendritically projecting interneurons, consistent with higher efficiency of cannabinoid signaling at somatic versus dendritic synapses. Furthermore, chronic Delta(9)-tetrahydrocannabinol administration, which reduces cannabinoid efficacy on GABA release, evoked marked CB1 downregulation in a dose-dependent manner. Full receptor recovery required several weeks after the cessation of Delta(9)-tetrahydrocannabinol treatment. These findings indicate that cell type-specific nanoscale analysis of endogenous protein distribution is possible in brain circuits and identify previously unknown molecular properties controlling endocannabinoid signaling and cannabis-induced cognitive dysfunction.	[Dudok, Barna; Barna, Laszlo; Ledri, Marco; Szabo, Szilard I.; Szabadits, Eszter; Pinter, Balazs; Woodhams, Stephen G.; Henstridge, Christopher M.; Balla, Gyula Y.; Katona, Istvan] Hungarian Acad Sci, Inst Expt Med, Momentum Lab Mol Neurobiol, Budapest, Hungary; [Dudok, Barna; Balla, Gyula Y.] Semmelweis Univ, Sch PhD Studies, H-1085 Budapest, Hungary; [Varga, Csaba; Lee, Sang-Hun; Soltesz, Ivan] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Matolcsi, Mate] Hungarian Acad Sci, Alfred Renyi Inst Math, Budapest, Hungary; [Cervenak, Judit; Kacskovics, Imre] ImmunoGenes Kft, Budakeszi, Hungary; [Kacskovics, Imre] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Sagheddu, Claudia; Melis, Miriam; Pistis, Marco] Cittadella Univ Monserrato, Univ Cagliari, Dept Biomed Sci, Monserrato, Italy; [Pistis, Marco] CNR, Inst Neurosci, Cagliari, Italy	Katona, I (reprint author), Hungarian Acad Sci, Inst Expt Med, Momentum Lab Mol Neurobiol, Budapest, Hungary.	katona@koki.hu	Dudok, Barna/G-1515-2011; WATANABE, Masahiko/A-4055-2012; 	Dudok, Barna/0000-0001-5078-0090; Henstridge, Christopher/0000-0002-0393-180X	European Research Council [243153]; Momentum Program of the Hungarian Academy of Sciences [LP2013-54/2013]; Hungarian Academy of Sciences Equipment Grant [IF-22/2012]; Wellcome Trust International Senior Research Fellowship [090946/Z/09/Z]; US National Institutes of Health [NS74432]; Italian Ministry of University [200928EEX4]; Fondazione Banco di Sardegna	We are grateful to E. Tischler and G. Goda for their excellent technical assistance, I. Mihaly for bouton distribution analysis, and C. Cserep and C. Fekete for their help with immunostaining and antibody labeling protocols. The authors are indebted to A. Zimmer (University of Bonn) for providing the CB<INF>1</INF> knockout mouse line and to A. Timar for his help with software analysis. We also thank N. Hajos, N. Holderith, N. Lenkey and Z. Nusser for their comments on the manuscript. The help of the Nikon Microscopy Center at the Institute of Experimental Medicine, Nikon Europe B.V., Nikon Austria GmbH and Auro-Science Consulting is greatly acknowledged for kindly providing microscopy support. This study was primarily supported by the European Research Council Grant 243153 and by the Momentum Program (LP2013-54/2013) of the Hungarian Academy of Sciences to I. Katona. The project was also funded by the Hungarian Academy of Sciences Equipment Grant (IF-22/2012) for super-resolution microscopy. I. Katona is a recipient of the Wellcome Trust International Senior Research Fellowship (090946/Z/09/Z). Additional support was provided by the US National Institutes of Health (NS74432) to I.S., and by the Italian Ministry of University (Grant PRIN 2009: 200928EEX4) and "Fondazione Banco di Sardegna" to M.P.	O'Rourke NA, 2012, NAT REV NEUROSCI, V13, P365, DOI 10.1038/nrn3170; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Varvel SA, 2005, J PHARMACOL EXP THER, V314, P329, DOI 10.1124/jpet.104.080739; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Bass CE, 2000, DRUG ALCOHOL DEPEN, V60, P113, DOI 10.1016/S0376-8716(99)00150-7; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.1460-9568.2004.03384.x; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Huestis MA, 2001, ARCH GEN PSYCHIAT, V58, P322, DOI 10.1001/archpsyc.58.4.322; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Pertwee RG, 2012, PHILOS T R SOC B, V367, P3353, DOI 10.1098/rstb.2011.0381; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Lee SH, 2010, J NEUROSCI, V30, P7993, DOI 10.1523/JNEUROSCI.6238-09.2010; Stott CG, 2013, EUR J CLIN PHARMACOL, V69, P1135, DOI 10.1007/s00228-012-1441-0; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Zhang LH, 2010, J NEUROSCI, V30, P5724, DOI 10.1523/JNEUROSCI.0795-10.2010; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Hangya B, 2014, CURR OPIN NEUROBIOL, V26, P117, DOI 10.1016/j.conb.2014.01.007; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Hoffman AF, 2007, LEARN MEMORY, V14, P63, DOI 10.1101/lm.439007; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; McKinney DL, 2008, J PHARMACOL EXP THER, V324, P664, DOI 10.1124/jpet.107.130328; Lovinger David M., 2008, V184, P435; Holderith N, 2012, NAT NEUROSCI, V15, P988, DOI 10.1038/nn.3137; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Bolla KI, 2002, NEUROLOGY, V59, P1337; Choquet D, 2013, NEURON, V80, P691, DOI 10.1016/j.neuron.2013.10.013; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; Puighermanal E, 2013, NEUROPSYCHOPHARMACOL, V38, P1334, DOI 10.1038/npp.2013.31; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Katona I, 1999, J NEUROSCI, V19, P4544; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Baranyi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076839; DeLong GT, 2010, DRUG ALCOHOL DEPEN, V112, P126, DOI 10.1016/j.drugalcdep.2010.05.019; Ester M., 1996, P 2 INT C KNOWL DISC, P226; HEISHMAN SJ, 1990, PHARMACOL BIOCHEM BE, V37, P561, DOI 10.1016/0091-3057(90)90028-G; Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x	64	9	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2015	18	1					75	+		10.1038/nn.3892		16	Neurosciences	Neurosciences & Neurology	AX5WH	WOS:000346995000014		
J	Jia, N; Nakazawa, Y; Guo, CW; Shimada, M; Sethi, M; Takahashi, Y; Ueda, H; Nagayama, Y; Ogi, T				Jia, Nan; Nakazawa, Yuka; Guo, Chaowan; Shimada, Mayuko; Sethi, Mieran; Takahashi, Yoshito; Ueda, Hiroshi; Nagayama, Yuji; Ogi, Tomoo			A rapid, comprehensive system for assaying DNA repair activity and cytotoxic effects of DNA-damaging reagents	NATURE PROTOCOLS			English	Article							NUCLEOTIDE-EXCISION-REPAIR; UV-SENSITIVE SYNDROME; XERODERMA-PIGMENTOSUM VARIANT; COCKAYNE-SYNDROME; HUMAN-FIBROBLASTS; CLICK CHEMISTRY; RNA-SYNTHESIS; HUMAN-CELLS; 2 DECADES; IN-VIVO	DNA repair systems protect cells from genomic instability and carcinogenesis. Therefore, assays for measuring DNA repair activity are valuable, not only for clinical diagnoses of DNA repair deficiency disorders but also for basic research and anticancer drug development. Two commonly used assays are UDS (unscheduled DNA synthesis, requiring a precise measurement of an extremely small amount of repair DNA synthesis) and RRS (recovery of RNA synthesis after DNA damage). Both UDS and RRS are major endpoints for assessing the activity of nucleotide excision repair (NER), the most versatile DNA repair process. Conventional UDS and RRS assays are laborious and time-consuming, as they measure the incorporation of radiolabeled nucleosides associated with NER. Here we describe a comprehensive protocol for monitoring nonradioactive UDS and RRS by studying the incorporation of alkyne-conjugated nucleoside analogs followed by a fluorescent azide-coupling click-chemistry reaction. The system is also suitable for quick measurement of cell sensitivity to DNA-damaging reagents and for lentivirus-based complementation assays, which can be used to systematically determine the pathogenic genes associated with DNA repair deficiency disorders. A typical UDS or RRS assay using primary fibroblasts, including a virus complementation test, takes 1 week to complete.	[Jia, Nan; Ueda, Hiroshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacol & Therapeut Innovat, Nagasaki 852, Japan; [Jia, Nan; Nakazawa, Yuka; Guo, Chaowan; Shimada, Mayuko; Ogi, Tomoo] Nagasaki Univ, Nagasaki Univ Res Ctr Genom Instabil & Carcinogen, Nagasaki 852, Japan; [Jia, Nan; Nakazawa, Yuka; Guo, Chaowan; Shimada, Mayuko; Nagayama, Yuji; Ogi, Tomoo] Nagasaki Univ, Atom Bomb Dis Inst, Dept Mol Med, Nagasaki 852, Japan; [Sethi, Mieran] Guys & St Thomas Hosp, St Johns Inst Dermatol, London SE1 9RT, England; [Takahashi, Yoshito] Kanebo Cosmetics Inc, Innovat Beauty Sci Lab, Odawara, Kanagawa, Japan; [Ogi, Tomoo] Natl Inst Genet, Microbial Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka 411, Japan	Ogi, T (reprint author), Nagasaki Univ, Nagasaki Univ Res Ctr Genom Instabil & Carcinogen, Nagasaki 852, Japan.	togi@nagasaki-u.ac.jp		Ogi, Tomoo/0000-0002-5492-9072	Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS) [24790321]; Sagawa Foundation for Promotion of Cancer Research; Japan Science Society; Mochida Memorial Founds for Medical and Pharmaceutical Research; Inamori Foundation; JSPS [24681008, 24659533]; Ministry of Health Labour and Welfare [26310301]; Kanae Foundation for the Promotion of Medical Science; Sumitomo Foundation	We are grateful to H. Niki for his support with the project. This work was supported by Special Coordination Funds for Promoting Science and Technology from Japan Science and Technology Agency, KAKENHI Grants-in-Aid for Young Scientists B (24790321) from the Japan Society for the Promotion of Science (JSPS), a cancer research grant from The Sagawa Foundation for Promotion of Cancer Research, the Sasakawa Scientific Research Grant from the Japan Science Society, a medical research grant from Mochida Memorial Founds for Medical and Pharmaceutical Research and a science research grant from Inamori Foundation to Y. Nakazawa; KAKENHI Grants-in-Aids for Young Scientists A (24681008) and for Exploratory Research (24659533) from JSPS, a grant for Health Labour Sciences Research (26310301) from The Ministry of Health Labour and Welfare, a research grant from The Kanae Foundation for the Promotion of Medical Science, a basic science research grant from The Sumitomo Foundation, a basic research grant from The Nakatomi Foundation, a research grant from Suzuken Memorial Foundation, a science research grant from Ube Industries Foundation for Promotion of Science, a science research grant from The Uehara Memorial Foundation to T.O.; KAKENHI Grants-in-Aid for Young Scientists B (25870534) from JSPS to C.G.; and the project is partly supported by Platform for Drug Discovery, Informatics and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Arlett CF, 2006, BRIT J RADIOL, V79, P510, DOI 10.1259/bjr/83726649; Kleijer WJ, 2008, DNA REPAIR, V7, P744, DOI 10.1016/j.dnarep.2008.01.014; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Masutani C, 1999, NATURE, V399, P700; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Ren Y, 2003, GENES GENET SYST, V78, P93; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Woodbine L, 2013, J CLIN INVEST, V123, P2969, DOI 10.1172/JCI67349; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; LEHMANN AR, 1980, MUTAT RES, V69, P177, DOI 10.1016/0027-5107(80)90187-6; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; ARLETT CF, 1988, INT J RADIAT BIOL, V54, P911, DOI 10.1080/09553008814552321; Friedberg E. C., 2005, DNA REPAIR MUTAGENES; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Hashimoto S, 2009, J DERMATOL, V36, P138, DOI 10.1111/j.1346-8138.2009.00608.x; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Kraemer KH, 2004, NAT GENET, V36, P677, DOI 10.1038/ng0704-676; LEHMANN AR, 1993, J MED GENET, V30, P679, DOI 10.1136/jmg.30.8.679; MAYNE LV, 1982, CANCER RES, V42, P1473; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; PROTICSABLJIC M, 1986, CARCINOGENESIS, V7, P1765, DOI 10.1093/carcin/7.10.1765; Scharer OD, 2008, DNA REPAIR, V7, P339, DOI 10.1016/j.dnarep.2007.10.007; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; Stefanini M, 1996, HUM GENET, V97, P418; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625	38	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	JAN	2015	10	1					12	24		10.1038/nprot.2014.194		13	Biochemical Research Methods	Biochemistry & Molecular Biology	AX8KX	WOS:000347159400002		
J	Eisfeld, AJ; Neumann, G; Kawaoka, Y				Eisfeld, Amie J.; Neumann, Gabriele; Kawaoka, Yoshihiro			At the centre: influenza A virus ribonucleoproteins	NATURE REVIEWS MICROBIOLOGY			English	Review							GENOMIC RNA SEGMENTS; PROTEIN-KINASE-C; STIMULATORY HOST FACTOR; NUCLEAR EXPORT PROTEIN; VIRAL MATRIX PROTEIN; M1 PROTEIN; PACKAGING SIGNALS; MESSENGER-RNA; POLYMERASE COMPLEX; NS2 PROTEIN	Influenza A viral ribonucleoprotein (vRNP) complexes comprise the eight genomic negative-sense RNAs, each of which is bound to multiple copies of the vRNP and a trimeric viral polymerase complex. The influenza virus life cycle centres on the vRNPs, which in turn rely on host cellular processes to carry out functions that are necessary for the successful completion of the virus life cycle. In this Review, we discuss our current knowledge about vRNP trafficking within host cells and the function of these complexes in the context of the virus life cycle, highlighting how structure contributes to function and the crucial interactions with host cell pathways, as well as on the information gaps that remain. An improved understanding of how vRNPs use host cell pathways is essential to identify mechanisms of virus pathogenicity, host adaptation and, ultimately, new targets for antiviral intervention.	[Eisfeld, Amie J.; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53711 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo 1088639, Japan	Kawaoka, Y (reprint author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, 575 Sci Dr, Madison, WI 53711 USA.	kawaokay@svm.vetmed.wisc.edu			Ministry of Health, Labour, and Welfare, Japan; ERATO (Japan Science and Technology Agency); National Institute of Allergy and Infectious Diseases Public Health Service research grants	The authors are grateful to S. Watson for scientific editing of the manuscript. This work was supported by grants-in-aid from the Ministry of Health, Labour, and Welfare, Japan, by ERATO (Japan Science and Technology Agency) and by National Institute of Allergy and Infectious Diseases Public Health Service research grants.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Cao S, 2012, J VIROL, V86, P4883, DOI 10.1128/JVI.06586-11; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Bradel-Tretheway BG, 2011, J VIROL, V85, P8569, DOI 10.1128/JVI.00496-11; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Poon LLM, 1999, J VIROL, V73, P3473; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Chou YY, 2012, P NATL ACAD SCI USA, V109, P9101, DOI 10.1073/pnas.1206069109; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; MARTIN K, 1991, J VIROL, V65, P232; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Brunotte L, 2014, J BIOL CHEM, V289, P20067, DOI 10.1074/jbc.M114.569178; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; BAUDIN F, 1994, EMBO J, V13, P3158; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Bui M, 1996, J VIROL, V70, P8391; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Gabriel G, 2014, CURR TOP MICROBIOL, V385, P35, DOI 10.1007/82_2014_386; MARK GE, 1979, J VIROL, V29, P744; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2004.00263.x; Alamares-Sapuay JG, 2013, J VIROL, V87, P6020, DOI 10.1128/JVI.01258-12; COMPANS RW, 1972, J VIROL, V10, P795; Perez-Gonzalez A, 2006, J MOL BIOL, V362, P887, DOI 10.1016/j.jmb.2006.07.085; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Yanguez E, 2011, VIRUS RES, V156, P1, DOI 10.1016/j.virusres.2010.12.016; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Whittaker G, 1996, J VIROL, V70, P2743; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Hutchinson EC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002993; Rodriguez A, 2011, J VIROL, V85, P12062, DOI 10.1128/JVI.00684-11; SUBBARAO EK, 1993, J VIROL, V67, P1761; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985; ONEILL RE, 1995, J BIOL CHEM, V270, P22701; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Llompart CM, 2014, J VIROL, V88, P3455, DOI 10.1128/JVI.02263-13; Neumann G, 1997, J VIROL, V71, P9690; Gavazzi C, 2013, P NATL ACAD SCI USA, V110, P16604, DOI 10.1073/pnas.1314419110; Avilov SV, 2012, VACCINE, V30, P7411, DOI 10.1016/j.vaccine.2012.09.077; Chase GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002187; Chou YY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003358; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; Eisfeld AJ, 2011, J VIROL, V85, P9588, DOI 10.1128/JVI.05064-11; Essere B, 2013, P NATL ACAD SCI USA, V110, pE3840, DOI 10.1073/pnas.1308649110; FODOR E, 1993, J GEN VIROL, V74, P1327, DOI 10.1099/0022-1317-74-7-1327; Fournier E, 2012, VACCINE, V30, P7359, DOI 10.1016/j.vaccine.2012.09.079; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gavazzi C, 2013, NUCLEIC ACIDS RES, V41, P1241, DOI 10.1093/nar/gks1181; Huang SP, 2013, J VIROL, V87, P767, DOI 10.1128/JVI.06519-11; Hudjetz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002488; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Imai M, 2003, ARCH VIROL, V148, P1873, DOI 10.1007/s00705-003-0166-x; Iwatsuki-Horimoto K, 2006, J VIROL, V80, P5233, DOI 10.1128/JVI.00049-06; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kawaguchi A, 2012, J VIROL, V86, P11086, DOI 10.1128/JVI.00453-12; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; KEMLER I, 1994, VIROLOGY, V202, P1028, DOI 10.1006/viro.1994.1432; KISTNER O, 1989, J GEN VIROL, V70, P2421, DOI 10.1099/0022-1317-70-9-2421; KUROKAWA M, 1990, J GEN VIROL, V71, P2149, DOI 10.1099/0022-1317-71-9-2149; Landeras-Bueno S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002397; Liang YH, 2008, J VIROL, V82, P229, DOI 10.1128/JVI.01541-07; Ma K, 2001, VIROLOGY, V282, P215, DOI 10.1006/viro.2001.0833; Manzoor R., 2014, J BIOL CHEM; Marjuki H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-134; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Matsuoka Y, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-97; McCown MF, 2005, J VIROL, V79, P3595, DOI 10.1128/JVI.79.6.3595-3605.2005; Momose F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021123; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Muramoto Y, 2006, J VIROL, V80, P2318, DOI 10.1128/JVI.80.5.2318-2325.2006; NATH ST, 1990, MOL CELL BIOL, V10, P4139; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Noda T., 2006, NATURE, V439, P490; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; PETRI T, 1981, J GEN VIROL, V57, P185, DOI 10.1099/0022-1317-57-1-185; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; ROBERTSON JS, 1981, J VIROL, V38, P157; Sakaguchi A, 2003, VIROLOGY, V306, P244, DOI 10.1016/S0042-6822(02)00013-2; Schneider J, 2009, VACCINE, V27, P6312, DOI 10.1016/j.vaccine.2009.01.015; SCHOLTIS.C, 1971, J GEN VIROL, V10, P11, DOI 10.1099/0022-1317-10-1-11; Shaw M. L., 2013, FIELDS VIROLOGY; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017; Simonsen L., 1999, VACCINE, V17, P3; Takizawa N, 2010, VIROLOGY, V401, P248, DOI 10.1016/j.virol.2010.02.030; Wang P., 1997, J VIROL, V71, P1850; Watanabe K, 2001, VIRUS RES, V77, P31, DOI 10.1016/S0168-1702(01)00263-5; Wright P. F., 2013, FIELDS VIROLOGY; Wu WWH, 2007, J MOL BIOL, V374, P910, DOI 10.1016/j.imb.2007.10.022; YAMANAKA K, 1990, J BIOL CHEM, V265, P11151; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110; Yu MR, 2012, J VIROL, V86, P4970, DOI 10.1128/JVI.06159-11; Zhirnov OP, 1997, VIROLOGY, V235, P302, DOI 10.1006/viro.1997.8700; Zhou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4259	135	15	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1740-1526	1740-1534		NAT REV MICROBIOL	Nat. Rev. Microbiol.	JAN	2015	13	1					28	41		10.1038/nrmicro3367		14	Microbiology	Microbiology	AX8BP	WOS:000347135900009		
J	Asano, Y; Sato, S				Asano, Yoshihide; Sato, Shinichi			New criteria improve recognition of early systemic sclerosis	NATURE REVIEWS RHEUMATOLOGY			English	Editorial Material							2013 CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLINICAL-TRIALS; SCLERODERMA	In systemic sclerosis (SSc), new classification criteria highly sensitive to early and limited forms of the disease could facilitate not only the recognition of early SSc, but also the discovery of biomarkers of poor prognosis, with potential benefits for conducting clinical trials.	[Asano, Yoshihide; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan	Sato, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	satos-der@h.u-tokyo.ac.jp					Alhajeri H., ARTHRITIS CARE RES; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI 10.1136/annrheumdis-2013-204424; Lonzetti LS, 2001, ARTHRITIS RHEUM, V44, P735; Amjadi S, 2009, ARTHRITIS RHEUM, V60, P2490, DOI 10.1002/art.24681; WHITE B, 1995, ARTHRITIS RHEUM, V38, P351, DOI 10.1002/art.1780380309; Minier T., ANN RHEUM DIS; Nadashkevich O, 2004, MED SCI MONITOR, V10, pCR615; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098	10	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4790	1759-4804		NAT REV RHEUMATOL	Nat. Rev. Rheumatol.	JAN	2015	11	1					3	4		10.1038/nrrheum.2014.191		2	Rheumatology	Rheumatology	AX4UJ	WOS:000346926500001		
J	Su, J; Tanaka, Y; Muratsubaki, T; Kano, M; Kanazawa, M; Fukudo, S				Su, J.; Tanaka, Y.; Muratsubaki, T.; Kano, M.; Kanazawa, M.; Fukudo, S.			Injection of corticotropin-releasing hormone into the amygdala aggravates visceral nociception and induces noradrenaline release in rats	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						brain-gut interaction; central amygdaloid nucleus; CRD; dopamine; noradrenaline; serotonin	IRRITABLE-BOWEL-SYNDROME; RECEPTOR-MEDIATED MECHANISMS; STRESS-RELATED ALTERATIONS; VENTRAL TEGMENTAL AREA; GUT MOTOR FUNCTION; COLORECTAL DISTENSION; LOCUS-COERULEUS; CENTRAL NUCLEUS; C-FOS; COLONIC HYPERSENSITIVITY	BackgroundCorticotropin-releasing hormone (CRH) and its receptor 1 (CRH-R1) play an important role in the colonic response to stress. The central nucleus of the amygdala (CeA) is a major extrahypothalamic site that contains a large number of neurons expressing both CRH and CRH-R1. Here, we verified the hypothesis that CRH in the CeA sensitizes visceral nociception via CRH-R1 with release of noradrenaline, dopamine, and serotonin (5-HT) in the CeA. MethodsIn male Wistar rats, visceral sensitivity was quantified by recording the visceromotor response to colorectal distension (CRD) with administration of vehicle, CRH, or the CRH-R1 antagonist CP-154526+ CRH or CRH-R1 antagonist CP-154526 alone into the CeA. Simultaneously, extracellular levels of noradrenaline, dopamine, and 5-HT were measured in the CeA using microdialysis. All data were obtained under restraint conditions. Key ResultsAdministration of CRH into the CeA significantly increased the number of abdominal muscle contractions in response to CRD. CP-154526 significantly blocked the number of abdominal muscle contractions in response to CRD with the administration of CRH into the CeA. Noradrenaline in the CeA was increased by CRD, further increased by CRH, and inhibited by CRH-R1 antagonist. Dopamine in the CeA was also exaggerated by CRH but was not inhibited by CRH-R1 antagonist. 5-HT in the CeA was unchanged. Conclusions & InferencesThese results suggest that CRH in the CeA sensitizes visceral nociception via CRH-R1 with release of noradrenaline.	[Su, J.; Tanaka, Y.; Muratsubaki, T.; Kano, M.; Kanazawa, M.; Fukudo, S.] Tohoku Univ, Dept Behav Med, Grad Sch Med, Sendai, Miyagi 9808575, Japan	Fukudo, S (reprint author), Tohoku Univ, Dept Behav Med, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	sfukudo@med.tohoku.ac.jp			Ministry of Ministry of Education, Culture, Sports, Science and Technology Ministry of Health, Labour and Welfare, Japan	This research was supported by a Grant-in-Aid for Scientific Research from Ministry of Ministry of Education, Culture, Sports, Science and Technology Ministry of Health, Labour and Welfare, Japan.	Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Finlay JM, 1997, NEUROCHEM RES, V22, P1387, DOI 10.1023/A:1022075324164; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; KALIVAS PW, 1987, J PHARMACOL EXP THER, V242, P757; Kim DY, 2000, AM J GASTROENTEROL, V95, P2698, DOI 10.1016/S0002-9270(00)01970-5; Fukudo S, 1998, GUT, V42, P845; CABIB S, 1988, BRAIN RES, V441, P153, DOI 10.1016/0006-8993(88)91393-5; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Ide S, 2013, J NEUROSCI, V33, P5881, DOI 10.1523/JNEUROSCI.4278-12.2013; Mayer EA, 2008, GUT, V57, DOI 10.1136/gut.2006.101675; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Saito-Nakaya K, 2008, NEUROGASTROENT MOTIL, V20, P1147, DOI 10.1111/j.1365-2982.2008.01151.x; KOEGLERMULY SM, 1993, J NEUROENDOCRINOL, V5, P95, DOI 10.1111/j.1365-2826.1993.tb00367.x; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; MERTZ H, 1995, GASTROENTEROLOGY, V109, P40, DOI 10.1016/0016-5085(95)90267-8; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; FUKUDO S, 1993, J CLIN GASTROENTEROL, V17, P133, DOI 10.1097/00004836-199309000-00009; LIANG KC, 1992, J NEUROSCI, V12, P2303; Hubbard CS, 2011, J NEUROSCI, V31, P12491, DOI 10.1523/JNEUROSCI.1860-11.2011; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Tache Y, 2001, AM J PHYSIOL-GASTR L, V280, pG173; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Myers DA, 2005, BEHAV BRAIN RES, V161, P39, DOI 10.1016/j.bbr.2005.03.001; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; LAVICKY J, 1993, J NEUROCHEM, V60, P602, DOI 10.1111/j.1471-4159.1993.tb03191.x; Mulak A, 2004, MED SCI MONITOR, V10, pRA55; SCHWABER JS, 1982, J NEUROSCI, V2, P1424; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; GRAY TS, 1993, ANN NY ACAD SCI, V697, P53, DOI 10.1111/j.1749-6632.1993.tb49922.x; Price ML, 2001, J NEUROSCI, V21, P2833; Lechner SM, 1997, BRAIN RES, V756, P114, DOI 10.1016/S0006-8993(97)00116-9; Retson TA, 2013, J CHEM NEUROANAT, V52, P9, DOI 10.1016/j.jchemneu.2013.04.003; Bouin M, 2002, GASTROENTEROLOGY, V122, P1771, DOI 10.1053/gast.2002.33601; BERNARD JF, 1994, J NEUROPHYSIOL, V71, P1646; BUTLER PD, 1990, J NEUROSCI, V10, P176; Ciccocioppo R, 2014, J NEUROSCI, V34, P363, DOI 10.1523/JNEUROSCI.2400-13.2014; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Forster GL, 2006, NEUROSCIENCE, V141, P1047, DOI 10.1016/j.neuroscience.2006.04.006; Fukudo S, 2013, NAT REV GASTRO HEPAT, V10, P569, DOI 10.1038/nrgastro.2013.166; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; Greenwood-van Meerveld B, 2005, NEUROGASTROENT MOTIL, V17, P415, DOI 10.1111/j.1365-2982.2005.00648.x; GUE M, 1994, BRAIN RES, V658, P232; Gurkovskaya OV, 2005, SYNAPSE, V57, P202, DOI 10.1002/syn.20172; HERMAN JP, 1982, LIFE SCI, V30, P2207, DOI 10.1016/0024-3205(82)90295-8; Homberg JR, 2009, J NEUROSCI, V29, P13743, DOI 10.1523/JNEUROSCI.4362-09.2009; Johnson AC, 2012, NEUROGASTROENT MOTIL, V24, P479, DOI 10.1111/j.1365-2982.2012.01899.x; Kim SH, 2010, J KOREAN MED SCI, V25, P1646, DOI 10.3346/jkms.2010.25.11.1646; Kosoyan HP, 2005, BRAIN RES, V1056, P85, DOI 10.1016/j.brainres.2005.07.010; KUMAR D, 1985, LANCET, V2, P973; Lazovic J, 2005, NEUROGASTROENT MOTIL, V17, P548, DOI 10.1111/j.1365-2982.2005.00655.x; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lyubashina O A, 2004, Neurosci Behav Physiol, V34, P379, DOI 10.1023/B:NEAB.0000018750.65372.18; Mayer EA, 2001, J CLIN PSYCHIAT S8, V62, P37; Mayey EA, 2001, J CLIN PSYCHIAT, V62, P28; MONNIKES H, 1994, BRAIN RES, V644, P101, DOI 10.1016/0006-8993(94)90352-2; Muramatsu T, 2006, PHARMACOL BIOCHEM BE, V85, P435, DOI 10.1016/j.pbb.2006.09.013; Paxinos G, 1998, RAT BRAIN STEREOTAXI; PETROV T, 1994, CELL TISSUE RES, V277, P289; RAY A, 1988, NEUROSCI LETT, V84, P302, DOI 10.1016/0304-3940(88)90525-3; ROSTAD H, 1973, ACTA PHYSIOL SCAND, V89, P169, DOI 10.1111/j.1748-1716.1973.tb05508.x; Saito K, 2002, BRAIN RES, V947, P146, DOI 10.1016/S0006-8993(02)03007-X; Saito K, 2005, GASTROENTEROLOGY, V129, P1533, DOI 10.1053/j.gastro.2005.07.053; Taché Yvette, 2005, Gend Med, V2, P146, DOI 10.1016/S1550-8579(05)80043-9; Traub RJ, 1996, NEUROSCI LETT, V215, P165, DOI 10.1016/0304-3940(96)12978-5	67	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	JAN	2015	27	1					30	39		10.1111/nmo.12462		10	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	AX8NX	WOS:000347167100004		
J	Shiotani, A; Kusunoki, H; Ishii, M; Imamura, H; Manabe, N; Kamada, T; Hata, J; Merchant, JL; Haruma, K				Shiotani, A.; Kusunoki, H.; Ishii, M.; Imamura, H.; Manabe, N.; Kamada, T.; Hata, J.; Merchant, J. L.; Haruma, K.			Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						resistance; serotonin type 3 receptor antagonists; TPH1 rs211105	SEROTONIN TRANSPORTER GENE; TRYPTOPHAN-HYDROXYLASE ISOFORM; RECEPTOR ANTAGONIST RAMOSETRON; FUNCTIONAL POLYMORPHISM; LACTOSE-MALABSORPTION; ULCERATIVE-COLITIS; HAPLOTYPE ANALYSIS; MAJOR DEPRESSION; DISEASE; DISORDERS	BackgroundSerotonin type 3 receptor (5-HT3R) antagonists are potentially useful therapeutic agents for diarrhea-predominant irritable bowel syndrome (IBS-D). To identify biomarkers predicting effectiveness of the 5-HT3R antagonist (ramosetron) in IBS-D. MethodsIrritable bowel syndrome-D Japanese subjects received 2.5 or 5g of ramosetron once daily for 4weeks. Colonic mucosal S100A and tryptophan hydroxylase (TPH) mRNA expression levels were measured before treatment. Genomic DNA was extracted from blood and polymorphisms of TPH1 and TPH2 were analyzed. Key ResultsForty-two patients (27 men and 15 women, mean age 42years) with IBS-D were included for analysis. Improvement of IBS symptoms was seen in 26 (61.9%). Baseline S100A10 (p=0.02) and TPH1 (p=0.02) expression were significantly higher in the ramosetron responders than in the non-responders. The frequencies of the TPH1 rs4537731G allele in linkage disequilibrium with the TPH1 rs7130929 T allele (11.5% vs 50%, p=0.003; OR: 12; 95% CI: 2.1-69) along with TPH1 rs211105 C allele (3.8% vs 43.8%, p=0.0003; OR: 19; 95% CI: 2.1-181) were significantly lower in the responders than in the non-responders. The mean scores of diarrhea at baseline were significantly higher (5.2 vs 3.7, p=0.005) in patients with TPH1 rs211105 T/T than those with the G allele. Conclusions & InferencesTPH1 gene polymorphisms and S100A10 expression, which correlate with 5-HT signaling were associated with ramosetron effectiveness in IBS-D, and may possibly lead to prospective identification of the resistance to treatment.	[Shiotani, A.; Ishii, M.; Kamada, T.; Haruma, K.] Kawasaki Med Univ, Dept Internal Med, Kurashiki, Okayama 7010192, Japan; [Kusunoki, H.] Kawasaki Med Univ, Dept Comprehens Med, Kurashiki, Okayama 7010192, Japan; [Imamura, H.; Manabe, N.; Hata, J.] Kawasaki Med Univ, Dept Clin Pathol & Lab Med, Kurashiki, Okayama 7010192, Japan; [Merchant, J. L.] Univ Michigan, Dept Internal Med & Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Shiotani, A (reprint author), Kawasaki Med Univ, Dept Internal Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	shiotani@med.kawasaki-m.ac.jp			NIH [R01-DK55732]	Juanita L Merchant received funding from NIH grant R01-DK55732.	Andreou D, 2010, PSYCHIAT RES, V180, P63, DOI 10.1016/j.psychres.2009.11.018; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Cremon C, 2011, AM J GASTROENTEROL, V106, P1290, DOI 10.1038/ajg.2011.86; Warner-Schmidt JL, 2009, J NEUROSCI, V29, P1937, DOI 10.1523/JNEUROSCI.5343-08.2009; Camilleri M, 2007, GASTROENTEROLOGY, V132, P17, DOI 10.1053/j.gastro.2006.11.020; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Heils A, 1996, J NEUROCHEM, V66, P2621; Ghoshal UC, 2013, J GASTROEN HEPATOL, V28, P1462, DOI 10.1111/jgh.12273; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Pata C, 2002, AM J GASTROENTEROL, V97, P1780; Gizatullin R, 2006, BIOL PSYCHIAT, V59, P295, DOI 10.1016/j.biopsych.2005.07.034; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Matsueda K, 2008, SCAND J GASTROENTERO, V43, P1202, DOI 10.1080/00365520802240255; Essien BE, 2013, GASTROENTEROLOGY, V144, P1466, DOI 10.1053/j.gastro.2013.01.057; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Camilleri M, 2002, GASTROENTEROLOGY, V123, P425, DOI 10.1053/gast.2002.34780; Shiotani A, 2013, DIGEST DIS SCI, V58, P2314, DOI 10.1007/s10620-013-2677-y; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Foell D, 2004, ARTHRITIS RHEUM, V50, P3762, DOI 10.1002/art.20631; GABRYS JB, 1985, PSYCHOL REP, V57, P1091; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451; Farup PG, 2004, SCAND J GASTROENTERO, V39, P645, DOI 10.1080/00365520410005405; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Grasberger H, 2013, AM J GASTROENTEROL, V108, P1766, DOI 10.1038/ajg.2013.304; Wade PR, 1996, J NEUROSCI, V16, P2352; Brown PM, 2011, GASTROENTEROLOGY, V141, P507, DOI 10.1053/j.gastro.2011.05.005; Camilleri M, 2011, NEUROGASTROENT MOTIL, V23, P193, DOI 10.1111/j.1365-2982.2010.01643.x; Coulie B, 1997, AM J PHYSIOL-GASTR L, V272, pG902; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gracie DJ, 2012, NEUROGASTROENT MOTIL, V24, P983; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Humphrey PPA, 1999, ALIMENT PHARM THERAP, V13, P31; Jarcho JM, 2008, ALIMENT PHARM THER, V28, P344, DOI 10.1111/j.1365-2036.2008.03721.x; Jun S, 2011, NEUROGASTROENT MOTIL, V23, pe116; Jun S, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01623.x; Kennedy AP, 2012, AM J MED GENET B, V159B, P829, DOI 10.1002/ajmg.b.32090; Kerckhoffs APM, 2012, AM J PHYSIOL-GASTR L, V302, pG1053, DOI 10.1152/ajpgi.00153.2011; Leach ST, 2007, SCAND J GASTROENTERO, V42, P1321, DOI 10.1080/00365520701416709; Liu X, 2006, J MED GENET, V43, DOI 10.1136/jmg.2004.029397; Mangel AW, 1999, ALIMENT PHARM THERAP, V13, P77, DOI 10.1046/j.1365-2036.1999.00010.x; Manolakis AC, 2011, DIGEST DIS SCI, V56, P1601, DOI 10.1007/s10620-010-1494-9; Matsueda K, 2008, DIGESTION, V77, P225, DOI 10.1159/000150632; Mertz H, 2005, J CLIN GASTROENTEROL, V39, pS247, DOI 10.1097/01.mcg.0000156113.14974.f5; Oka T, 2007, BIOPSYCHOSOC MED, V1, P21; Sun HS, 2005, ALCOHOL CLIN EXP RES, V29, P1, DOI 10.1097/01.ALC.0000150635.51934.6D; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Tack J, 2011, GASTROENTEROLOGY, V141, P420, DOI 10.1053/j.gastro.2011.06.024; Tenner K, 2007, J NEUROCHEM, V102, P1887, DOI 10.1111/j.1471-4159.2007.04664.x; Wilson ST, 2012, PSYCHIAT GENET, V22, P15, DOI 10.1097/YPG.0b013e32834c0c4c; Yoshida K, 2002, PROG NEURO-PSYCHOPH, V26, P383, DOI 10.1016/S0278-5846(01)00287-1	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	JAN	2015	27	1					82	91		10.1111/nmo.12473		10	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	AX8NX	WOS:000347167100009		
J	Ihara, E; Yu, Q; Chappellaz, M; MacDonald, JA				Ihara, E.; Yu, Q.; Chappellaz, M.; MacDonald, J. A.			ERK and p38MAPK pathways regulate myosin light chain phosphatase and contribute to Ca2+ sensitization of intestinal smooth muscle contraction	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						calcium sensitization; ERK; ileum; intestine; mitogen-activated protein kinase; myosin phosphatase; p38MAPK; smooth muscle	ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; MURINE EXPERIMENTAL COLITIS; II-INDUCED CONTRACTION; PHOSPHORYLATION SITES; CELL-MIGRATION; TARGET SUBUNIT; MAP KINASE; MECHANISM; CALCIUM	BackgroundMitogen-activated protein kinases (MAPKs), including extracellular signal-regulated protein kinase (ERK) and p38MAPK, are known regulators of smooth muscle contractility. The contraction of smooth muscle is mainly regulated by the phosphorylation of regulatory light chains of myosin II (LC20), which is driven by the balance between myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP). We hypothesized that one possible mechanism for MAPK-dependent modulation of intestinal smooth muscle contractility is via the regulation of MLCP activity. MethodsContractile responses to carbachol (CCh) and effects of MAPK inhibitors on CCh-induced contractions were assessed with isolated rat ileal longitudinal smooth muscle strips. Biochemical assessments of MLCP activity and myosin phosphatse targeting subunit (MYPT1) and CPI-17 phosphorylations were completed. Key ResultsTreatment of ileal smooth muscle with PD98059 (10M; MEK inhibitor) or SB203580 (10M; p38MAPK inhibitor) significantly inhibited CCh-induced contractile force. Decreased MLCP activity was observed during sustained contractions induced by CCh; the MLCP activity was recovered by treatment with PD98059 and SB203580. However, MYPT1 (Thr697 and Thr855) and CPI-17 (Thr38) phosphorylations were not affected. Application of ML-7 (MLCK inhibitor) during CCh-induced sustained contraction elicited an MLCP-dependent relaxation, the rate of which was accelerated by application of PD98059 and SB203580 with proportional changes in LC20 phosphorylation levels but not MYPT1 phosphorylation (Thr697 or Thr855). Conclusions & InferencesERK and p38MAPK contribute to CCh-induced sustained contraction in a LC20 phosphorylation dependent manner. Moreover, both kinases inhibit MLCP activity possibly by a novel mechanism.	[Ihara, E.; Yu, Q.; Chappellaz, M.; MacDonald, J. A.] Univ Calgary, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4Z6, Canada; [Ihara, E.] Kyushu Univ, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 812, Japan	MacDonald, JA (reprint author), Univ Calgary, Dept Biochem & Mol Biol, HRIC GAA20,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	jmacdo@ucalgary.ca			Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada	This work was supported by grants from the Canadian Institutes of Health Research and the Crohn's and Colitis Foundation of Canada.	Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Carlson DA, 2013, ACS CHEM BIOL, V8, P2715, DOI 10.1021/cb400407c; Koga Y, 2005, J BIOL CHEM, V280, P4983, DOI 10.1074/jbc.M410909200; Ohama Takashi, 2007, Journal of Smooth Muscle Research, V43, P43, DOI 10.1540/jsmr.43.43; Vetterkind S, 2010, MOL BIOL CELL, V21, P1214, DOI 10.1091/mbc.E09-08-0711; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Barona I, 2011, J PHARM PHARMACOL, V63, P657, DOI 10.1111/j.2042-7158.2011.01253.x; Kordowska J, 2006, J BIOMED SCI, V13, P159, DOI 10.1007/s11373-005-9060-8; Xiao DL, 2005, AM J PHYSIOL-HEART C, V288, pH2828, DOI 10.1152/ajpheart.01189.2004; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Gerthoffer WT, 2005, AM J PHYSIOL-GASTR L, V288, pG849, DOI 10.1152/ajpgi.00530.2004; Vetterkind S, 2009, J CELL MOL MED, V13, P887, DOI 10.1111/j.1582-4934.2008.00374.x; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Koga Y, 2008, MOL BIOL CELL, V19, P1062, DOI 10.1091/mbc.E07-07-0668; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cheng KR, 2003, CANCER RES, V63, P6744; Dziema H, 2002, J NEUROPHYSIOL, V88, P1374, DOI 10.1152/jn.00896.2001; Eto M, 2012, IUBMB LIFE, V64, P732, DOI 10.1002/iub.1067; GONG MC, 1992, J BIOL CHEM, V267, P21492; Gonzalo S, 2010, EUR J PHARMACOL, V648, P171, DOI 10.1016/j.ejphar.2010.08.041; Harnett KM, 2005, AM J PHYSIOL-GASTR L, V288, pG407, DOI 10.1152/ajpgi.00398.2004; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2012, NEUROGASTROENT MOTIL, V24, pE15, DOI 10.1111/j.1365-2982.2011.01821.x; Jeong Seung Il, 2011, J Pharm Pharmacol, V63, P245, DOI 10.1111/j.2042-7158.2010.01212.x; Khasnis M, 2014, BIOCHEMISTRY-US, V53, P2701, DOI 10.1021/bi5001728; Lee HM, 2007, J PHARMACOL SCI, V103, P427, DOI 10.1254/jphs.FP0070039; Lontay B, 2005, CELL SIGNAL, V17, P1265, DOI 10.1016/j.cellsig.2005.01.008; Martin SW, 2006, CELL CALCIUM, V39, P275, DOI 10.1016/j.ceca.2005.11.002; Meloche S, 2000, AM J PHYSIOL-HEART C, V279, pH741; Muranyi A, 2002, BIOCHEM J, V366, P211; Ohanian J, 2001, ARTERIOSCL THROM VAS, V21, P1921, DOI 10.1161/hq1201.100264; Paul J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021542; Puri RN, 2002, AM J PHYSIOL-GASTR L, V283, pG390, DOI 10.1152/ajpgi.00025.2002; Slack BE, 2000, BIOCHEM J, V348, P381, DOI 10.1042/0264-6021:3480381; Somara S, 2006, AM J PHYSIOL-GASTR L, V291, pG630, DOI 10.1152/ajpgi.00350.2005; Surks HK, 2005, J BIOL CHEM, V280, P42543, DOI 10.1074/jbc.M506863200; Takeuchi T, 2004, BRIT J PHARMACOL, V142, P657, DOI 10.1038/sj.bjp.0705820; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Tran JA, 2006, J PHARMACOL EXP THER, V318, P649, DOI 10.1124/jpet.106.103093; VONDEROHE MR, 1993, NEW ENGL J MED, V329, P1073	55	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	JAN	2015	27	1					135	146		10.1111/nmo.12491		12	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	AX8NX	WOS:000347167100015		
J	Naitou, K; Shiina, T; Sugita, R; Nakamori, H; Shimizu, Y				Naitou, K.; Shiina, T.; Sugita, R.; Nakamori, H.; Shimizu, Y.			Characterization of ghrelin-sensitive neurons in the lumbosacral defecation center in rats	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						AMPK; colorectal motility; in vivo; leptin; NPY; TTX	GROWTH-HORMONE SECRETAGOGUE; ARCUATE NUCLEUS; LEPTIN ACTION; SPINAL-CORD; FOOD-INTAKE; RECEPTOR; IDENTIFICATION; ACTIVATION; PEPTIDE; SECRETION	BackgroundGhrelin is involved in the regulation of somatic growth, feeding behavior and energy homeostasis. Ghrelin stimulates neuropeptide Y (NPY) neurons and activates intracellular AMP-activated protein kinase (AMPK) in the hypothalamus. These NPY neurons also express the leptin receptor and leptin inhibits ghrelin-induced activation of NPY neurons. In the spinal cord, we have demonstrated colokinetic action of ghrelin. However, the precise characteristics of the ghrelin-sensitive neurons remain to be clarified. The aim of this study was firstly to confirm that the action of ghrelin is mediated via a neurogenic pathway in the spinal cord, and secondly to characterize the ghrelin-sensitive neurons by comparing with hypothalamic ghrelin-sensitive neurons. MethodsRats were anesthetised with alpha-chloralose and ketamine, and colorectal intraluminal puressure and expelled volume were recorded in vivo. Drugs were applied intrathecally. Key ResultsGhrelin caused enhancement of propulsive contractions. Tetrodotoxin completely blocked the colokinetic effect of ghrelin. An AMPK activator, aminoimidazole carboxamide ribonucleotide, failed to mimic the ghrelin effect. Leptin had no effect on the spontanious contractions and did not exert a suppressive effect on the ghrelin-enhanced colorectal motility. An NPY Y1 receptor antagonist did not affect the action of ghrelin. NPY had no effect on the colorectal motility. Conclusions & InferencesThis study showed that intrathecal injection of ghrelin stimulates colorectal motility by acting on ghrelin-sensitive neurons in the lumbosacral defecation center. The characteristics of ghrelin-sensitive neurons in the spinal cord are quite different from those of ghrelin-sensitive neurons in the hypothalamus.	[Naitou, K.; Shiina, T.; Sugita, R.; Nakamori, H.; Shimizu, Y.] Gifu Univ, Dept Vet Basic Sci, Physiol Lab, United Grad Sch Vet Sci, Gifu 5011193, Japan	Shimizu, Y (reprint author), Gifu Univ, Dept Vet Basic Sci, Physiol Lab, United Grad Sch Vet Sci, 1-1 Yanagido, Gifu 5011193, Japan.	yshimizu@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22380157, 26292164]	This research was supported in part by Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22380157 and 26292164).	Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Mountjoy PD, 2007, DIABETOLOGIA, V50, P168, DOI 10.1007/s00125-006-0473-3; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Furness JB, 2012, CELL TISSUE RES, V348, P397, DOI 10.1007/s00441-012-1405-9; Kohno D, 2007, ENDOCRINOLOGY, V148, P2251, DOI 10.1210/en.2006-1240; Hirayama H, 2010, NEUROGASTROENT MOTIL, V22, P1124, DOI 10.1111/j.1365-2982.2010.01553.x; Ferens DM, 2010, NEUROSCIENCE, V166, P671, DOI 10.1016/j.neuroscience.2010.01.001; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Bogeski G, 2005, NEUROGASTROENT MOTIL, V17, P262, DOI 10.1111/j.1365-2982.2004.00605.x; Shimizu Y, 2006, J PHYSIOL-LONDON, V576, P329, DOI 10.1113/jphysiol.2006.116160; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Coyral-Castel S, 2008, J NEUROENDOCRINOL, V20, P335, DOI 10.1111/j.1365-2826.2007.01643.x; Niimi M, 1999, J NEUROENDOCRINOL, V11, P605; Perello M, 2012, J COMP NEUROL, V520, P281, DOI 10.1002/cne.22690; Pustovit RV, 2014, NEUROGASTROENT MOTIL, V26, P264, DOI 10.1111/nmo.12259	23	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	JAN	2015	27	1					147	155		10.1111/nmo.12492		9	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	AX8NX	WOS:000347167100016		
J	Suzuki, K; Izumi, M				Suzuki, Kazuo; Izumi, Manabu			The incidence of hemorrhagic stroke in Japan is twice compared with western countries: the Akita stroke registry	NEUROLOGICAL SCIENCES			English	Article						Brain image; Registry and stroke incidence	CASE-FATALITY; RISK-FACTORS; SERUM-CHOLESTEROL; BLOOD-PRESSURE; HEART-DISEASE; COMMUNITY; ASSOCIATIONS; POPULATION; INFARCTION; ANEURYSMS	The purpose of this study is to find out new knowledge about stroke among huge Japanese stroke registry involving complete brain images. The first stroke events from 1995 to 2004 in the Akita stroke registry (28,781 cases) were included in this study. According to brain images, we classified them into three types; cerebral infarction (CI 18,018 cases, 62.6 %), cerebral hemorrhage (CH 7,423 cases, 25.8 %), and subarachnoid hemorrhage (SAH 3,340, 11.6 %). CI and CH were classified according to the lesional areas, respectively. SAH was divided into three types according to arterial sites of ruptured aneurysm. The proportion of hemorrhagic stroke in Japan (37.4 %) was two times higher than in Western countries. Among CI group; lacunar infarction, cortical infarction, and infratentorial infarction occupied 5,437 (30.2 %), 6,121 (34.0 %), and 2,703 (15.0 %) cases, respectively. Among CH group; putamen, thalamus, and subcortex occupied 1,379 (18.6 %), 2,251 (30.3 %), and 1,204 (16.2 %) cases, respectively. According to ruptured cerebral aneurysm site, they were obviously different between men and women, proportion of internal carotid artery was the most (40.8 %) in women and that of anterior communicating artery was the most (46.8 %) in men on the contrary. The incidence of hemorrhagic stroke in Japan is twice as much as in the western countries.	[Suzuki, Kazuo] Res Inst Brain & Blood Vessels, Dept Epidemiol, Akita 0100874, Japan; [Izumi, Manabu] Saiseikai Utsunomiya Hosp, Dept Gen Med, Utsunomiya, Tochigi 3210974, Japan	Izumi, M (reprint author), Saiseikai Utsunomiya Hosp, Dept Gen Med, 911-1 Takebayashi Cho, Utsunomiya, Tochigi 3210974, Japan.	manabu_izumi@saimiya.com					KONISHI M, 1993, STROKE, V24, P954; Takao H, 2012, STROKE, V43, P1436, DOI 10.1161/STROKEAHA.111.640995; Ueshima H, 2007, J ATHEROSCLER THROMB, V14, P278; SUZUKI K, 1987, STROKE, V18, P402; Inagawa T, 2010, CEREBROVASC DIS, V30, P72, DOI 10.1159/000314623; Vemmos KN, 1999, STROKE, V30, P363; Suzuki K, 2011, CEREBROVASC DIS, V31, P100, DOI 10.1159/000321506; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; YANO K, 1989, STROKE, V20, P1460; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; TANAKA H, 1982, STROKE, V13, P62; Brown RD, 1996, STROKE, V27, P372; CHOUDHURY SR, 1995, J HYPERTENS, V13, P587, DOI 10.1097/00004872-199506000-00003; Daniel T, 2014, STROKE, V45, P315; Ghods Ali J, 2012, Front Neurol, V3, P78, DOI 10.3389/fneur.2012.00078; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kolominsky-Rabas PL, 1998, STROKE, V29, P2501; Lindenstrom Boysen G, 1994, BMJ-BRIT MED J, V309, P11; LONGSTRETH WT, 1985, STROKE, V16, P377; MASUDA J, 1983, STROKE, V14, P934; Suzuki K, 2013, J STROKE CEREBROVASC, V22, P1064, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.009; SUZUKI K, 1994, NEUROEPIDEMIOLOGY, V13, P236, DOI 10.1159/000110385; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Thirft AG, 2000, STROKE, V31, P2087; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583; UESHIMA H, 1980, PREV MED, V9, P722, DOI 10.1016/0091-7435(80)90017-1	30	1	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JAN	2015	36	1					155	160		10.1007/s10072-014-1917-z		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY0LE	WOS:000347287200022		
J	Kanbayashi, T; Kamiya, H; Hokkoku, K; Hatanaka, Y; Sonoo, M				Kanbayashi, Takamichi; Kamiya, Hisao; Hokkoku, Keiichi; Hatanaka, Yuki; Sonoo, Masahiro			Restless legs syndrome heralding an acute exacerbation of multiple sclerosis	NEUROLOGICAL SCIENCES			English	Letter							DIAGNOSTIC-CRITERIA		[Kanbayashi, Takamichi; Kamiya, Hisao; Hokkoku, Keiichi; Hatanaka, Yuki; Sonoo, Masahiro] Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Tokyo 1738605, Japan	Sonoo, M (reprint author), Teikyo Univ, Sch Med, Dept Neurol, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	ta_kanba@yahoo.co.jp; hkamiya@med.teikyo-u.ac.jp; k1-hokkoku@hotmail.co.jp; y-hata@med.teikyo-u.ac.jp; sonoom@med.teikyo-u.ac.jp					Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Manconi M, 2008, MULT SCLER, V14, P86, DOI 10.1177/1352458507080734; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Bernheimer JH, 2011, MULT SCLER INT, DOI [10.1155/2011/872948, DOI 10.1155/2011/872948]; Deliu M, 2009, MOVEMENT DISORD, V24, P697	5	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JAN	2015	36	1					173	174		10.1007/s10072-014-1872-8		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY0LE	WOS:000347287200027		
J	Shibasaki, C; Takebayashi, M; Fujita, Y; Yamawaki, S				Shibasaki, Chiyo; Takebayashi, Minoru; Fujita, Yasutaka; Yamawaki, Shigeto			Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						electroconvulsive therapy; relapse; risk factors; schizophrenia	ECT	Purpose: Electroconvulsive therapy (ECT) is an effective treatment for depression and schizophrenia. However, there is a high rate of relapse after an initial response to ECT, even with antidepressant or antipsychotic maintenance therapy. This study was carried out to examine the factors that influence the risk of relapse in schizophrenic patients after a response to ECT. Patients and methods: We retrospectively reviewed the records of 43 patients with schizophrenia who received and responded to an acute ECT course. We analyzed the associated clinical variables and relapse after response to the acute ECT. Relapse was defined as a Clinical Global Impressions Improvement score. 6 or a psychiatric rehospitalization. Results: All patients were treated with neuroleptic medication after the acute ECT course. The relapse-free rate of all 43 patients at 1 year was 57.3%, and the median relapse-free period was 21.5 months. Multivariate analysis showed that the number of ECT sessions was associated with a significant increase in the risk of relapse (hazard ratio: 1.159; P=0.033). Patients who were treated with adjunctive mood stabilizers as maintenance pharmacotherapy after the response to the acute ECT course were at a lower risk of relapse than were those treated without mood stabilizers (hazard ratio: 0.257; P=0.047). Conclusion: Our study on the recurrence of schizophrenia after a response to an acute ECT course suggests that the number of ECT sessions might be related to the risk of relapse and that adjunctive mood stabilizers might be effective in preventing relapse.	[Shibasaki, Chiyo; Takebayashi, Minoru; Fujita, Yasutaka] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, Kure, Hiroshima 7370023, Japan; [Shibasaki, Chiyo; Takebayashi, Minoru; Fujita, Yasutaka] Chugoku Canc Ctr, Kure, Hiroshima 7370023, Japan; [Takebayashi, Minoru] NHO Kure Med Ctr, Dept Psychiat, Kure, Hiroshima, Japan; [Yamawaki, Shigeto] Hiroshima Univ, Div Frontier Med Sci, Programs Biomed Res, Grad Sch Biomed Sci,Dept Psychiat & Neurosci,Mina, Hiroshima, Japan	Takebayashi, M (reprint author), Natl Hosp Org, Kure Med Ctr, Dept Psychiat, 3-1 Aoyama, Kure, Hiroshima 7370023, Japan.	mtakebayashi@kure-nh.go.jp; yamawaki@hiroshima-u.ac.jp					American Psychiatric Association, 2001, PRACT EL THER REC TR; Ravanic DB, 2009, PSYCHIAT DANUB, V21, P179; Tandon R, 2008, SCHIZOPHR RES, V100, P20, DOI 10.1016/j.schres.2007.11.033; Petrides G, 1996, CONVULSIVE THER, V12, P138; Zervas IM, 2012, WORLD J BIOL PSYCHIA, V13, P96, DOI 10.3109/15622975.2011.564653; Sackeim HA, 2001, JAMA-J AM MED ASSOC, V285, P1299, DOI 10.1001/jama.285.10.1299; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; Flamarique I, 2012, J CLIN PSYCHOPHARM, V32, P756, DOI 10.1097/JCP.0b013e318270e2c7; Citrome L, 2004, PSYCHIAT SERV, V55, P290, DOI 10.1176/appi.ps.55.3.290; TERAO T, 1995, ACTA PSYCHIAT SCAND, V92, P220, DOI 10.1111/j.1600-0447.1995.tb09572.x; Chanpattana W, 2010, J ECT, V26, P289, DOI 10.1097/YCT.0b013e3181cb5e0f; Davidson L, 1997, CAN J PSYCHIAT, V42, P34; Hustig H, 2009, EUR PSYCHIAT, V24, P521, DOI 10.1016/j.eurpsy.2009.04.005; Kristensen D, 2011, EUR ARCH PSY CLIN N, V261, P425, DOI 10.1007/s00406-010-0173-3; Kristensen D, 2011, DRUG DISCOV TODAY, V8, P53; Leiknes KA, 2012, BRAIN BEHAV, V2, P283, DOI 10.1002/brb3.37; Padhy SK, 2011, PRIM CARE COMPANION, V13; Suzuki K, 2004, J ECT, V20, P99, DOI 10.1097/00124509-200406000-00005; Takebayashi M, 2010, J ECT, V26, P14, DOI 10.1097/YCT.0b013e3181c18a79	19	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						67	73		10.2147/NDT.S74303		7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AY0NM	WOS:000347293000002		
J	Kodera, T; Arishima, H; Kitai, R; Kikuta, K; Iino, S; Noriki, S; Naiki, H				Kodera, Toshiaki; Arishima, Hidetaka; Kitai, Ryuhei; Kikuta, Ken-ichiro; Iino, Satoshi; Noriki, Sakon; Naiki, Hironobu			Utility of postmortem imaging system for anatomical education in skull base surgery	NEUROSURGICAL REVIEW			English	Article						Cadaver dissection; Medical education; Postmortem imaging; Skull base surgery; Surgical anatomy		Although cadaver dissections are important for skull base surgeons to acquire anatomical knowledge and techniques, their opportunities are limited in Japan. The Autopsy Imaging Center of the University of Fukui Hospital has both a CT scanner and an MR unit solely for deceased patients. The authors applied the postmortem imaging to cadaver dissections and evaluated its usefulness in surgical education. Ten sides of five formalin-fixed cadaver heads were dissected by ten neurosurgeons. Five neurosurgeons were young, three were moderately experienced, and two were experts in skull base surgery. They performed orbitozygomatic, anterior transpetrosal, posterior transpetrosal, and transcondylar approaches. CT bone images were taken before and after dissections, and MR images were taken before dissection to merge with the CT bone images. The usefulness of the images for each neurosurgeon and for each skull base approach was evaluated. The postmortem imaging system was useful for all neurosurgeons, especially in anterior transpetrosal, posterior transpetrosal, and transcondylar approaches. They could find the insufficiency or excessiveness of their drilling of specific bony structures with the images. Even the experts in skull base surgery could identify regions in which they could add drilling safely to widen the surgical field more. The postmortem imaging system was useful for skull base cadaver dissections. This system is expected to be utilized for education and research on surgical anatomy.	[Kodera, Toshiaki; Arishima, Hidetaka; Kitai, Ryuhei; Kikuta, Ken-ichiro] Univ Fukui, Fac Med Sci, Dept Neurosurg, Fukui 9101193, Japan; [Iino, Satoshi; Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Anat, Fukui 9101193, Japan; [Noriki, Sakon] Univ Fukui, Fac Med Sci, Autopsy Imaging Div, Educ & Res Ctr Med Imaging, Fukui 9101193, Japan	Kodera, T (reprint author), Univ Fukui, Fac Med Sci, Dept Neurosurg, Fukui 9101193, Japan.	kode@u-fukui.ac.jp	Naiki, Hironobu/G-5599-2014				BERTALANFFY H, 1991, NEUROSURGERY, V29, P815; Japanese Ministry of Health Labour and Welfare, 2011, RES MED I JAP MIN HL; KAWASE T, 1991, NEUROSURGERY, V28, P869; Matsushima T, 1997, OPERATIVE SKULL BASE, P45; Ohata K, 1996, SURG ANATOMY SKULL B, P109; Organization for Economic Co-operation and Development, 2013, OECD HLTH DAT ORG EC; Wanibuchi M, 2009, PHOTO ATLAS SKULL BA, P385; Wanibuchi M, 2009, PHOTO ATLAS SKULL BA, P207	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	JAN	2015	38	1					165	170		10.1007/s10143-014-0574-2		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX8MD	WOS:000347162600031		
J	Oyama, K; Ditzel, LFS; Muto, J; de Souza, DG; Gun, R; Otto, BA; Carrau, RL; Prevedello, DM				Oyama, Kenichi; Ditzel Filho, Leo F. S.; Muto, Jun; de Souza, Daniel G.; Gun, Ramazan; Otto, Bradley A.; Carrau, Ricardo L.; Prevedello, Daniel M.			Endoscopic endonasal cranial base surgery simulation using an artificial cranial base model created by selective laser sintering	NEUROSURGICAL REVIEW			English	Article						Anatomical model; Cranial base; Endonasal approach; Endoscope	TRANSSPHENOIDAL SURGERY; TEMPORAL BONE; TRAINER; SKILLS	Mastery of the expanded endoscopic endonasal approach (EEA) requires anatomical knowledge and surgical skills; the learning curve for this technique is steep. To a great degree, these skills can be gained by cadaveric dissections; however, ethical, religious, and legal considerations may interfere with this paradigm in different regions of the world. We assessed an artificial cranial base model for the surgical simulation of EEA and compared its usefulness with that of cadaveric specimens. The model is made of both polyamide nylon and glass beads using a selective laser sintering (SLS) technique to reflect CT-DICOM data of the patient's head. It features several artificial cranial base structures such as the dura mater, venous sinuses, cavernous sinuses, internal carotid arteries, and cranial nerves. Under endoscopic view, the model was dissected through the nostrils using a high-speed drill and other endonasal surgical instruments. Anatomical structures around and inside the sphenoid sinus were accurately reconstructed in the model, and several important surgical landmarks, including the medial and lateral optico-carotid recesses and vidian canals, were observed. The bone was removed with a high-speed drill until it was eggshell thin and the dura mater was preserved, a technique very similar to that applied in patients during endonasal cranial base approaches. The model allowed simulation of almost all sagittal and coronal plane EEA modules. SLS modeling is a useful tool for acquiring the anatomical knowledge and surgical expertise for performing EEA while avoiding the ethical, religious, and infection-related problems inherent with use of cadaveric specimens.	[Oyama, Kenichi; Ditzel Filho, Leo F. S.; Muto, Jun; de Souza, Daniel G.; Prevedello, Daniel M.] Ohio State Univ, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Gun, Ramazan; Otto, Bradley A.; Carrau, Ricardo L.] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Oyama, Kenichi] Nippon Med Sch, Dept Neurol Surg, Bunkyo Ku, Tokyo 1130022, Japan	Oyama, K (reprint author), Nippon Med Sch, Dept Neurol Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1130022, Japan.	ko-neuro@nms.ac.jp	Otto, Bradley/E-3800-2011		Japanese Foundation for Research and Promotion of Endoscopy	This study was performed with a grant support from The Japanese Foundation for Research and Promotion of Endoscopy; it was performed at the ALT-VISION lab at The Ohio State University. The ALT-VISION lab receives unrestricted educational supports from the following companies: Carl Zeiss Microscopy, Intuitive Surgical Corp., KLS Martin Corp., Karl Storz Endoscopy, Leica Microscopy, Medtronic Corp., Stryker Corp., and Vycor Medical. The authors have no personal financial or institutional interest in any of the drugs, materials, and devices described in this article.	Snyderman C, 2007, LARYNGOSCOPE, V117, P699, DOI 10.1097/mlg.0b013e318031c817; Okuda T, 2010, ACTA NEUROCHIR, V152, P1801, DOI 10.1007/s00701-010-0728-0; Kassam AB, 2008, J NEUROSURG, V108, P177, DOI 10.3171/JNS/2008/108/01/0177; Suzuki M, 2004, ACTA OTO-LARYNGOL, V124, P400, DOI 10.1080/00016480410016478; Malekzadeh S, 2011, OTOLARYNG HEAD NECK, V145, P530, DOI 10.1177/0194599811413373; Jho HD, 1997, J NEUROSURG, V87, P44, DOI 10.3171/jns.1997.87.1.0044; Prevedello DM, 2007, J NEUROSURG, V107, P206, DOI 10.3171/JNS-07/07/0206; Carrau RL, 1996, LARYNGOSCOPE, V106, P914, DOI 10.1097/00005537-199607000-00025; Cappabianca P, 2004, NEUROSURGERY, V55, P933, DOI 10.1227/01.NEU.0000137330.02549.0D; Hirayama R, 2013, J NEUROSURG, V118, P1120, DOI 10.3171/2012.12.JNS12908; Kassam Amin, 2005, Neurosurg Focus, V19, pE4; Kassam Amin, 2005, Neurosurg Focus, V19, pE3; Labib AM, 2013, NEUROSURGERY, V72, P66; Morera Victor A, 2010, Neurosurgery, V66, P211, DOI 10.1227/01.NEU.0000369926.01891.5D; Mori Kentaro, 2010, Neurosurgery, V66, P339; Mori K, 2009, NEUROSURG REV, V32, P233, DOI 10.1007/s10143-008-0177-x; Mori K, 2008, NEUROL MED-CHIR, V48, P582; Ogino-Nishimura E, 2012, LARYNGOSCOPE, V122, P2154, DOI 10.1002/lary.23399; Oyama K, 2007, ACTA NEUROCHIR, V149, P299, DOI 10.1007/s00701-006-1105-x; Rhoton Albert L. Jr., 2002, Neurosurgery (Baltimore), V51, P335; Wanibuchi M, 2010, ACTA NEUROCHIR, V152, P1055, DOI 10.1007/s00701-010-0624-7	21	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	JAN	2015	38	1					171	178		10.1007/s10143-014-0580-4		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX8MD	WOS:000347162600033		
J	Katoh, A; Chikazawa, Y; Uzawa, M; Kaneko, F; Ide, A				Katoh, Atsushi; Chikazawa, Yoshitaka; Uzawa, Masayuki; Kaneko, Fumiaki; Ide, Akihiro			EVALUATION OF EXTERNAL EVENT EFFECTS ON JSFR FUEL HANDLING SYSTEM	NUCLEAR TECHNOLOGY			English	Article						sodium-cooled fast reactor; external event; fuel handling system	FEASIBILITY; DESIGN	In response to the accident at the Fukushima Daiichi (1F) nuclear power plant, designers of the 2010 version of the Japan sodium-cooled fast reactor (JSFR) have been studying the robustness of JSFR's fuel handling system (FHS) against an earthquake and a tsunami. In the earthquake evaluation, the margin of seismic resistance and sloshing in the ex-vessel fuel storage tank (EVST) against an earthquake of the IF-envelop condition were estimated. In the tsunami evaluation, for the case of loss of emergency power supply, a scenario is studied where fuel subassemblies are led to a stable cooling state, and potentialities for the cooling system are examined. As a result, it is shown that the original design of the JSFR FHS already had the potential to prevent the release of radioactive material. Additionally, some design improvements of the EVST cooling system are introduced.	[Katoh, Atsushi; Chikazawa, Yoshitaka] Japan Atom Energy Agcy, Oarai, Ibaraki, Japan; [Uzawa, Masayuki; Kaneko, Fumiaki; Ide, Akihiro] Mitsubishi FBR Syst, Shibuya Ku, Tokyo 1500001, Japan	Katoh, A (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki, Japan.	kato.atsushi@jaea.go.jp					[Anonymous], 1978, LDSO02 NUCL SAF COMM; Yamano H, 2010, NUCL TECHNOL, V170, P159; [Anonymous], 2003, HDB VIBR BUCKL EV SH; Ukai S, 2002, J NUCL SCI TECHNOL, V39, P778, DOI 10.3327/jnst.39.778; KITAMURA S., 1987, PNCTN941087125 JAP A; Mizuno T, 2004, NUCL TECHNOL, V146, P155; NAKAI R., 2008, P 8 JAP KOR S NUCL T; Okamura S, 2011, J NUCL SCI TECHNOL, V48, P688, DOI 10.3327/jnst.48.688; USUI S., 2008, P 2008 INT C ADV NUC	9	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	JAN	2015	189	1					30	44				15	Nuclear Science & Technology	Nuclear Science & Technology	AX5CJ	WOS:000346944400003		
J	Lu, YH; Edmonds, JW; Yamashita, Y; Zhou, B; Jaegge, A; Baxley, M				Lu, YueHan; Edmonds, Jennifer W.; Yamashita, Youhei; Zhou, Bin; Jaegge, Andrea; Baxley, Matthew			Spatial variation in the origin and reactivity of dissolved organic matter in Oregon-Washington coastal waters	OCEAN DYNAMICS			English	Article						Dissolved organic matter (DOM); Oregon-Washington coastal waters; Columbia River plume; Stable carbon isotope (delta C-13); Absorption properties; Fluorescence properties; Excitation emission matrices-parallel factor analysis (EEM-PARAFAC)	COLUMBIA RIVER PLUME; EXCITATION-EMISSION MATRIX; PARALLEL FACTOR-ANALYSIS; TEMPERATE HEADWATER STREAMS; FLUORESCENCE SPECTROSCOPY; LAND-USE; MARINE ENVIRONMENTS; CALIFORNIA CURRENT; OPTICAL-PROPERTIES; MOLECULAR-WEIGHT	Combining stable carbon isotopic signatures (delta C-13-DOC) and optical properties of dissolved organic matter (DOM), we examined spatial variability in the sources and reactivity of DOM from Oregon-Washington coastal waters, with a particular focus on evaluating whether these measurements may reliably trace terrigenous DOM in coastal oceans. We sampled four stations on the continental shelf and four stations on the continental slope near the mouth of the Columbia River, with sampling depths ranging from 0 to 1,678 m. Nitrate and phosphate concentrations were largely controlled by organic matter (OM) regeneration although the river plume may have led to excess nitrates in relation to phosphates near the river mouth and/or the surface. Four fluorescence components (C1 to C4) were identified by using excitation emission matrices-parallel factor analysis. C1 and C2 were assigned as humic-like components which represented degraded DOM rather than OM of allochthonous or autochthonous origin. C3 and C4 were both labile, protein-like components representing autochthonous contributions, while C4 was more sensitive to diagenesis. In the shallow water layer (salinity a parts per thousand currency sign32.5 and depth a parts per thousand currency sign50 m), the variation in absorption properties (SUVA(254) and E >(280)), fluorescence index, freshness index (beta/alpha), percent fluorescence of C3, and delta C-13-DOC revealed that the Columbia River plume exported DOM that was characterized by greater aromaticity, higher molecular weight, and being more decomposed than marine, autochthonous DOM. However, these signatures of terrigenous DOM disappeared rapidly with increasing depth and offshore distance. In the intermediate and deep water layers (salinity > 32.5), the DOM indices were most driven by diagenesis, with changes in percent fluorescence components indicating increasing accumulation of humic DOM relative to protein-like DOM with depth. Principal component analysis that collectively assessed the DOM indices suggests that diagenesis was the primary factor driving the spatial variability of DOM properties in the study region, underlining challenges in tracing allochthonous DOM in coastal waters.	[Lu, YueHan; Jaegge, Andrea] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35487 USA; [Edmonds, Jennifer W.] Nevada State Coll, Henderson, NV 89002 USA; [Yamashita, Youhei] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Zhou, Bin] Nanjing Univ, Key Lab Surficial Geochem, Sch Earth Sci & Engn, Nanjing 210023, Jiangsu, Peoples R China; [Baxley, Matthew] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA	Lu, YH (reprint author), Univ Alabama, Dept Geol Sci, 201 7th Ave,Room 2003, Tuscaloosa, AL 35487 USA.	yuehan.lu@ua.edu	Yamashita, Youhei/A-3858-2012	Yamashita, Youhei/0000-0002-9415-8743	Research Grant Committee Grant from the University of Alabama; Undergraduate Research Grant from the University of Alabama; National Science Foundation (NSF) [EAR-1255724]; NSF [OCE-1125396]	We acknowledge funding support from the Research Grant Committee Grant from the University of Alabama (to Y. H. L.) and the Undergraduate Research Grant from the University of Alabama (to Y. H. L. and A. J.), in collaboration with National Science Foundation (NSF) support EAR-1255724 to Y. H. L. We thank participating scientists and supporting crew of UNOLS Chief Scientist Training cruise W1106A on the R/V Wecoma. Special thanks go to Drs. Clare Reimers and Patricia Wheeler for acting as the cruise mentors, Daryl Swensen for providing technical support at sea, and Dr. Alyson Santoro for processing the CTD data. The cruise and training program were supported by the NSF through grant OCE-1125396. We thank the two anonymous reviewers for their thoughtful and helpful comments which helped us to improve this contribution.	Aguilar-Islas AM, 2006, MAR CHEM, V101, P233, DOI 10.1016/j.marchem.2006.03.005; Hill JK, 2002, PROG OCEANOGR, V53, P369, DOI 10.1016/S0079-6611(02)00037-X; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Opsahl SP, 2001, GEOPHYS RES LETT, V28, P2417, DOI 10.1029/2000GL012686; Lu YH, 2013, J GEOPHYS RES-BIOGEO, V118, P566, DOI 10.1002/jgrg.20048; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P1415; Coble PG, 2007, CHEM REV, V107, P402, DOI 10.1021/cr050350+; Cory RM, 2010, LIMNOL OCEANOGR-METH, V8, P67; Kowalczuk P, 2003, AQUAT SCI, V65, P384, DOI 10.1007/s00027-003-0678-1; Stedmon CA, 2003, MAR CHEM, V82, P239, DOI 10.1016/S0304-4203(03)00072-0; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Sullivan BE, 2001, GEOCHIM COSMOCHIM AC, V65, P1125, DOI 10.1016/S0016-7037(00)00565-2; Lohan MC, 2006, MAR CHEM, V98, P260, DOI 10.1016/j.marchem.2005.10.003; Determann S, 1998, MAR CHEM, V62, P137, DOI 10.1016/S0304-4203(98)00026-7; Guo WD, 2007, MAR CHEM, V107, P357, DOI 10.1016/j.marchem.2007.03.006; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391; CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015; Yamashita Y, 2011, OCEAN DYNAM, V61, P569, DOI 10.1007/s10236-010-0365-4; Spencer RGM, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003231; DRISCOLL CT, 1988, J ENVIRON QUAL, V17, P101; Romera-Castillo C, 2010, LIMNOL OCEANOGR, V55, P446, DOI 10.4319/lo.2010.55.1.0446; Para J, 2010, BIOGEOSCIENCES, V7, P4083, DOI 10.5194/bg-7-4083-2010; Thomas AC, 2006, REMOTE SENS ENVIRON, V100, P167, DOI 10.1016/j.rse.2005.10.018; Benner R, 2015, ANNU REV MAR SCI, V7, P185, DOI 10.1146/annurev-marine-010213-135126; Lu YH, 2014, BIOGEOCHEMISTRY, V119, P275, DOI 10.1007/s10533-014-9965-2; HUYER A, 1977, LIMNOL OCEANOGR, V22, P442; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572; Fellman JB, 2010, LIMNOL OCEANOGR, V55, P2452, DOI 10.4319/lo.2010.55.6.2452; Sulzberger B, 2009, AQUAT SCI, V71, P104, DOI 10.1007/s00027-008-8082-5; Opsahl S, 1999, LIMNOL OCEANOGR, V44, P2017; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Jorgensen L, 2014, GEOPHYS RES LETT, V41, P2481, DOI 10.1002/2014GL059428; Retamal L, 2007, ESTUAR COAST SHELF S, V72, P261, DOI 10.1016/j.ecss.2006.10.022; Yamashita Y, 2008, LIMNOL OCEANOGR, V53, P1900, DOI 10.4319/lo.2008.53.5.1900; Guo LD, 1995, LIMNOL OCEANOGR, V40, P1392; Yamashita Y, 2008, ENVIRON SCI TECHNOL, V42, P7374, DOI 10.1021/es801357h; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Walker SA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000990; Yamashita Y, 2003, MAR CHEM, V82, P145, DOI 10.1016/S0304-4203(03)00049-5; Hickey BM, 1998, J GEOPHYS RES-OCEANS, V103, P10339, DOI 10.1029/97JC03290; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P686; Rochelle-Newall EJ, 2002, MAR CHEM, V77, P23, DOI 10.1016/S0304-4203(01)00073-1; Ogawa H, 2003, J OCEANOGR, V59, P129, DOI 10.1023/A:1025528919771; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38; Murphy KR, 2008, MAR CHEM, V108, P40, DOI 10.1016/j.marchem.2007.10.003; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Fellman JB, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000790; MOPPER K, 1993, MAR CHEM, V41, P229, DOI 10.1016/0304-4203(93)90124-7; Barnes CA, 1972, COLUMBIA RIVER ESTUA, P71; Benner R., 2003, AQUATIC ECOSYSTEMS I, P121, DOI 10.1016/B978-012256371-3/50006-8; Benner R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002398; BLOUGH NV, 1993, J GEOPHYS RES-OCEANS, V98, P2271, DOI 10.1029/92JC02763; Fichot CG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01053; FIEDLER PC, 1990, INT J REMOTE SENS, V11, P999; Hickey B. M., 1979, Progress in Oceanography, V8, DOI 10.1016/0079-6611(79)90002-8; Huyer A, 1975, LIMNOL OCEANOGR, V29, P90; Kirchman DL, 2003, AQUATIC ECOSYSTEMS I, P218; Lu YH, 2010, J PALEOLIMNOL, V43, P261, DOI 10.1007/s10933-009-9330-y; Montgomery S, 2000, SCI TOTAL ENVIRON, V261, P33, DOI 10.1016/S0048-9697(00)00593-3; Neal V.T., 1972, COLUMBIA RIVER ESTUA, P19; Osburn CL, 2011, MAR CHEM, V126, P281, DOI 10.1016/j.marchem.2011.06.007; PRAHL FG, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P451; Staal M, 2007, BIOGEOSCIENCES, V4, P613; Tanaka K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05292; Tyrrell T, 1997, NATURE, V387, P793, DOI 10.1038/42915; Walker SA, 2013, J GEOPHYS RES-BIOGEO, V118, P1689, DOI 10.1002/2013JG002320; Williamson CE, 1994, ADV LIMNOLOGY, V43, P9; Worrall F, 1997, CHEMOSPHERE, V34, P87, DOI 10.1016/S0045-6535(96)00369-4	70	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1616-7341	1616-7228		OCEAN DYNAM	Ocean Dyn.	JAN	2015	65	1					17	32		10.1007/s10236-014-0793-7		16	Oceanography	Oceanography	AX8MG	WOS:000347162900002		
J	Onuki, Y; Hibiya, T				Onuki, Yohei; Hibiya, Toshiyuki			Excitation mechanism of near-inertial waves in baroclinic tidal flow caused by parametric subharmonic instability	OCEAN DYNAMICS			English	Article						Parametric subharmonic instability; Resonant triad interaction; Nonlinear energy cascade; Semidiurnal tidal flow; Near-inertial wave; Beat frequency	NONLINEAR ENERGY-TRANSFER; INTERNAL TIDE; DIFFUSIVITY; SPECTRUM; OCEAN	Parametric subharmonic instability (PSI) transfers energy from low-mode semidiurnal baroclinic tidal flow to high-mode near-inertial waves at latitudes similar to 30A degrees, inducing strong ocean mixing and hence affecting the global ocean circulation. Nevertheless, intuitive descriptions of the physical mechanism for energy transfer by PSI are very sparse. In this study, we reformulate this phenomenon to present a visual image of its mechanism based on a combination of simple classical theories such as beats and parametric excitation without adhering to a strict mathematical formula. It is shown that two small-scale near-inertial waves with slightly different wavenumbers propagating in opposite directions superpose to create beats. When the resulting beats have the peak-to-peak length and the phase velocity equal to the wavelength and the phase velocity of large-scale semidiurnal baroclinic tidal flow, respectively, continuous acceleration of near-inertial motions takes place under the effects of convergence and horizontal shear of the background semidiurnal baroclinic tidal flow. The resonant condition for PSI can thus be easily understood by introducing the well-known concept of beats which also provides a natural explanation for the large difference in spatial scales between the semidiurnal baroclinic tidal flow and the resulting near-inertial waves.	[Onuki, Yohei; Hibiya, Toshiyuki] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	Onuki, Y (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	onuki@eps.s.u-tokyo.ac.jp					MCCOMAS CH, 1977, J GEOPHYS RES-OC ATM, V82, P1397, DOI 10.1029/JC082i009p01397; MacKinnon J. A., 2005, Geophysical Research Letters, V32, DOI 10.1029/2005GL023376; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MacKinnon JA, 2013, J PHYS OCEANOGR, V43, P17, DOI 10.1175/JPO-D-11-0108.1; Tsujino H, 2000, J PHYS OCEANOGR, V30, P2853, DOI 10.1175/1520-0485(2001)031<2853:DPCCBV>2.0.CO;2; Hibiya T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL017998; BRYAN F, 1987, J PHYS OCEANOGR, V17, P970, DOI 10.1175/1520-0485(1987)017<0970:PSOPEO>2.0.CO;2; Garrett C., 1972, Geophysical Fluid Dynamics, V3, DOI 10.1080/03091927208236082; HASSELMA.K, 1966, REV GEOPHYS, V4, P1, DOI 10.1029/RG004i001p00001; Hazewinkel J, 2011, J PHYS OCEANOGR, V41, P1673, DOI 10.1175/2011JPO4605.1; Hibiya T, 1996, J GEOPHYS RES-OCEANS, V101, P14123, DOI 10.1029/96JC01001; Hibiya T, 1998, J GEOPHYS RES-OCEANS, V103, P18715, DOI 10.1029/98JC01362; Hibiya T, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001210; Landau L. D., 1960, MECHANICS; Munk W.H., 1966, DEEP-SEA RES, V13, P707, DOI DOI 10.1016/0011-7471(66)90602-4; Young WR, 2008, J FLUID MECH, V607, P25, DOI 10.1017/S0022112008001742	16	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1616-7341	1616-7228		OCEAN DYNAM	Ocean Dyn.	JAN	2015	65	1					107	113		10.1007/s10236-014-0789-3		7	Oceanography	Oceanography	AX8MG	WOS:000347162900008		
J	Koyama, N				Koyama, Naoyuki			A method of step height measurement within the unambiguous range of two laser wavelengths interferometer	OPTIK			English	Article						Michelson interferometer; Two wavelengths interferometry; Step height measurement		When two laser beams of different wavelength are simultaneously applied to a Michelson interferometer, a moire of parallel patterns appears due to the difference in optical path length between the reference beam and the measuring beam. The pattern appears with a wavelength of lambda(a)lambda(b)/vertical bar lambda(a)-lambda(b)vertical bar, and the distance between the zeroes of the envelope is also lambda(a)lambda(b)/vertical bar lambda(a)-lambda(b)vertical bar. Using the moire of parallel patterns, unambiguous range of step height is half of lambda(a)lambda(b)/vertical bar lambda(a)-lambda(b)vertical bar. However, intensity varies with an average wavelength of lambda(a)lambda(b)/(lambda(a) + lambda(b)), and intensity variation differs between the zeroes of each envelope. The unambiguous range is several times wider than lambda(a)lambda(b)/vertical bar lambda(a)-lambda(b)vertical bar. Intensity variation over the unambiguous range is measured, and coincides with calculated intensity variation, step height can be measured. (C) 2014 Elsevier GmbH. All rights reserved.	Koyama Res Grp Distance Measurement, Maebashi, Gunma 3710812, Japan	Koyama, N (reprint author), Koyama Res Grp Distance Measurement, 4-206,3-32-2 Hirose Cho, Maebashi, Gunma 3710812, Japan.	koyama70@hotmail.co.jp					WYANT JC, 1971, APPL OPTICS, V10, P2113, DOI 10.1364/AO.10.002113; DEGROOT PJ, 1994, APPL OPTICS, V33, P5948, DOI 10.1364/AO.33.005948; Feynman R P, 1963, FEYNMAN LECT PHYS, V1; POLHEMUS C, 1973, APPL OPTICS, V12, P2071, DOI 10.1364/AO.12.002071	4	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0030-4026			OPTIK	Optik		2015	126	3					313	316		10.1016/j.ijleo.2014.08.178		4	Optics	Optics	AY0GW	WOS:000347276400003		
J	Miyauchi, A; Sukegawa, N				Miyauchi, Atsushi; Sukegawa, Noriyoshi			Redundant constraints in the standard formulation for the clique partitioning problem	OPTIMIZATION LETTERS			English	Article						Graph partitioning; Mathematical programming; Integer linear programming; Transitivity constraints	GROUP-TECHNOLOGY; ALGORITHM	The clique partitioning problem is among the most fundamental graph partitioning problems. Given a complete weighted undirected graph, we find a vertex-disjoint union of cliques so as to maximize the sum of the weights within the cliques. The problem is known to be NP-hard, and exact algorithms and heuristics have been developed so far. In 1989, Grotschel and Wakabayashi (Math Program 45:59-96, 1989) proposed an integer linear programming formulation for the problem. Although this formulation has been employed by many algorithms, it is prohibitive even for relatively small graphs because it contains numerous constraints called transitivity constraints. In this study, we theoretically derive a certain class of redundant constraints in the formulation. Furthermore, we show that the constraints in the derived class are also redundant in the linear programming relaxation of the formulation. By using our results, the number of constraints treated in exact algorithms and heuristics may be reduced. We confirmed that more than half of the transitivity constraints are redundant for some instances, and that computation times to find an optimal solution are shortened for most instances.	[Miyauchi, Atsushi; Sukegawa, Noriyoshi] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528552, Japan	Miyauchi, A (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	miyauchi.a.aa@m.titech.ac.jp					Oosten M, 2001, NETWORKS, V38, P209, DOI 10.1002/net.10004; GROTSCHEL M, 1989, MATH PROGRAM, V45, P59, DOI 10.1007/BF01589097; Agarwal G, 2008, EUR PHYS J B, V66, P409, DOI 10.1140/epjb/e2008-00425-1; Aloise D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046112; Blake C., 1998, UCI MACHINE LEARNING; Brusco MJ, 2009, PSYCHOMETRIKA, V74, P685, DOI 10.1007/s11336-009-9126-z; Chan HM, 1982, J MANUF SYST, V1, P65, DOI 10.1016/S0278-6125(82)80068-X; Dinh T.N., INTERNET MATH; King K.R, 1980, OMEGA, V8, P193; Kochenberger G, 2005, J COMB OPTIM, V10, P77, DOI 10.1007/s10878-005-1861-1; Kumar R.K., 1986, EUR J OPER RES, V24, P387; Malakooti B, 2002, IIE TRANS, V34, P837, DOI 10.1023/A:1015557007084; Miltenburg J., 1991, J OPERATIONS MANAGEM, V10, P44, DOI 10.1016/0272-6963(91)90035-V; Miyauchi A, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40006-7; Rogers DF, 2005, EUR J OPER RES, V160, P423, DOI 10.1016/j.ejor.2003.07.005; Wakabayashi Y., 1986, THESIS U AUGSBURG; Wang HB, 2006, INT J FLEX MANUF SYS, V18, P77, DOI 10.1007/s10696-006-9011-3	17	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1862-4472	1862-4480		OPTIM LETT	Optim. Lett.	JAN	2015	9	1					199	207		10.1007/s11590-014-0754-6		9	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	AX9UP	WOS:000347247800014		
J	Ohki, T; Sakai, T; Tsuneoka, H				Ohki, Tetsutaro; Sakai, Tsutomu; Tsuneoka, Hiroshi			Focal Choroidal Excavation Associated with Focal Retinochoroiditis	OPTOMETRY AND VISION SCIENCE			English	Article						focal choroidal excavation; spectral-domain optical coherence tomography; focal retinochoroiditis; steroid	CENTRAL SEROUS CHORIORETINOPATHY; OPTICAL COHERENCE TOMOGRAPHY; NEOVASCULARIZATION; CHOROIDOPATHY; EYES	Purpose. To describe detailed spectral-domain optical coherence tomography (OCT) findings for two patients with focal choroidal excavation (FCE) associated with focal retinochoroiditis. Case Report. Three eyes from two patients with FCE associated with focal retinochoroiditis were evaluated by funduscopy, fluorescence angiography, indocyanine green angiography, and spectral-domain OCT during follow-up. Both patients with focal retinochoroiditis developed new FCE after oral steroid treatment and two eyes showed regression of the FCE during the follow-up. Both eyes from one patient transformed from the conforming to the nonconforming type and neither of the eyes were stable during the follow-up. Ultimately, all eyes exhibited the conforming-type FCE. Conclusions. Focal choroidal excavation can be seen as a tomographic phenotype after the treatment of focal retinochoroiditis. Spectral-domain OCT was useful for detecting the development of FCE after the treatment and for observing FCE regression.	[Ohki, Tetsutaro; Sakai, Tsutomu; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo 1058461, Japan	Sakai, T (reprint author), Jikei Univ, Sch Med, Dept Ophthalmol, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	tstmski@jikei.ac.jp					Ellabban AA, 2013, AM J OPHTHALMOL, V156, P673, DOI 10.1016/j.ajo.2013.05.010; Margolis R, 2011, ARCH OPHTHALMOL-CHIC, V129, P1320, DOI 10.1001/archophthalmol.2011.148; Spaide RF, 2008, AM J OPHTHALMOL, V146, P111, DOI 10.1016/j.ajo.2008.02.027; Xu HF, 2014, OPHTHALMOLOGY, V121, P246, DOI 10.1016/j.ophtha.2013.08.014; Jampol LM, 2006, RETINA-J RET VIT DIS, V26, P1072, DOI 10.1097/01.iae.0000248819.86737.a5; Obata R, 2013, RETINA-J RET VIT DIS, V33, P1201, DOI 10.1097/IAE.0b013e31827b6452; Say EAT, 2013, OPHTHAL SURG LAS IM, V44, P409, DOI 10.3928/23258160-20130715-12; Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P1315, DOI 10.1097/IAE.0b013e318286cc77; Lee CS, 2014, OPHTHALMOLOGY, V121, P1029, DOI 10.1016/j.ophtha.2013.11.043; Khanamiri HN, 2013, SURV OPHTHALMOL, V58, P203, DOI 10.1016/j.survophthal.2012.08.008; Lee JH, 2014, AM J OPHTHALMOL, V157, P710, DOI 10.1016/j.ajo.2013.12.011; Punjabi OS, 2008, OPHTHAL SURG LAS IM, V39, pS95; Suzuki M, 2014, RETINA-J RET VIT DIS, V34, P1216, DOI 10.1097/IAE.0000000000000045	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2015	92	1					E12	E20				9	Ophthalmology	Ophthalmology	AX1UW	WOS:000346732300003		
J	Okata, H; Nakamura, M; Henmi, A; Yamaguchi, S; Mikami, Y; Shimauchi, H; Sasano, Y				Okata, H.; Nakamura, M.; Henmi, A.; Yamaguchi, S.; Mikami, Y.; Shimauchi, H.; Sasano, Y.			Calcification during bone healing in a standardised rat calvarial defect assessed by micro-CT and SEM-EDX	ORAL DISEASES			English	Article						calcification; bone healing; micro-CT; EDX; mineral; rats	EXTRACELLULAR-MATRIX MOLECULES; AGE-RELATED-CHANGES; I COLLAGEN; EMBRYONIC OSTEOGENESIS; GENE-EXPRESSION; CORTICAL BONE; HIND-LIMB; MINERALIZATION; REPAIR; PROTEOGLYCANS	ObjectiveThe study was designed to investigate the process of calcification during bone healing in a standardised rat calvarial bone defect model, measured by bone mineral density and the concentrations and distributions of calcium, phosphorus and carbon in the bone matrix. Materials and methodsA standard defect was made on the parietal bone of 12-week-old rats under anaesthesia. The rats were fixed in weeks 1, 2, 4 and 8, and the calvaria were resected and examined with microcomputed tomography, then frozen and sectioned for histology and analysed with energy-dispersive X-ray spectroscopy (EDX). Parietal bone of 12-week-old control rats was processed similarly. ResultsThe mineral density of healing bone increased with time. The healing bone became thicker and denser with time in histology. The distributions of Ca and P expanded over the bone matrix, whereas that of C became localised and complemented that of C and P. The Ca/P concentration ratio increased, whereas the C/Ca and C/P ratios decreased in the healing bone matrix. ConclusionHealing bone is immaturely calcified initially and proceeds calcification gradually, that is, as the bone volume increases, mineral increases in density and matures in quality, while organic components decrease.	[Okata, H.; Shimauchi, H.] Tohoku Univ, Grad Sch Dent, Div Periodontol & Endodontol, Sendai, Miyagi 9808575, Japan; [Okata, H.; Nakamura, M.; Henmi, A.; Mikami, Y.; Sasano, Y.] Tohoku Univ, Grad Sch Dent, Div Craniofacial Dev & Regenerat, Sendai, Miyagi 9808575, Japan; [Yamaguchi, S.] Tohoku Univ, Grad Sch Dent, Div Aging & Geriatr Dent, Sendai, Miyagi 9808575, Japan	Sasano, Y (reprint author), Tohoku Univ, Grad Sch Dent, Div Craniofacial Dev & Regenerat, Sendai, Miyagi 9808575, Japan.	sasano@anat.dent.tohoku.ac.jp			Japan Society for the Promotion of Science [23592694, 24791959, 24792170]	This work was supported in part by grants-in-aid (23592694, 24791959, 24792170) from the Japan Society for the Promotion of Science.	Akesson A, 1994, CALCIFIED TISSUE INT, V55, P236; Andou K, 2011, ORAL DIS, V17, P379, DOI 10.1111/j.1601-0825.2010.01761.x; Donnelly E, 2010, J BIOMED MATER RES A, V92A, P1048, DOI 10.1002/jbm.a.32442; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Tarnowski CP, 2002, J BONE MINER RES, V17, P1118, DOI 10.1359/jbmr.2002.17.6.1118; LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309; Nakamura M, 2005, J HISTOCHEM CYTOCHEM, V53, P1553, DOI 10.1369/jhc.5A6669.2005; Sasano Y, 2002, J HISTOCHEM CYTOCHEM, V50, P325; Sasano Y, 2000, ANAT EMBRYOL, V202, P31, DOI 10.1007/PL00008242; Honma T, 2008, ORAL DIS, V14, P457, DOI 10.1111/j.1601-0825.2007.01401.x; Carpentier VT, 2012, BONE, V50, P688, DOI 10.1016/j.bone.2011.11.021; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; LEGROS R, 1987, CALCIFIED TISSUE INT, V41, P137, DOI 10.1007/BF02563793; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031; Akkus O, 2004, BONE, V34, P443, DOI 10.1016/j.bone.2003.11.003; Gorski JP, 2004, J BIOL CHEM, V279, P25455, DOI 10.1074/jbc.M312408200; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Sakuraba I, 2006, J MOL HISTOL, V37, P87, DOI 10.1007/s10735-006-9037-6; Midura RJ, 2007, BONE, V41, P1005, DOI 10.1016/j.bone.2007.08.036; Allori AC, 2008, TISSUE ENG PT B-REV, V14, P275, DOI 10.1089/ten.teb.2008.0083; Busa B, 2005, CALCIFIED TISSUE INT, V77, P386, DOI 10.1007/s00223-005-0148-y; DEAN DD, 1992, CALCIFIED TISSUE INT, V50, P342, DOI 10.1007/BF00301632; Henmi A, 2011, J ELECTRON MICROSC, V60, P393, DOI 10.1093/jmicro/dfr075; Hoshi K, 2001, J BONE MINER RES, V16, P289, DOI 10.1359/jbmr.2001.16.2.289; Hoshi K, 1999, J BONE MINER RES, V14, P273, DOI 10.1359/jbmr.1999.14.2.273; Itagaki T, 2008, ANAT REC, V291, P1038, DOI 10.1002/ar.20717; Kawamoto T, 2000, HISTOL CYTOL, V66, P123; Kimura Y, 2011, J ELECTRON MICROSC, V60, P345, DOI 10.1093/jmicro/dfr068; Maruya Y, 2003, J ELECTRON MICROSC, V52, P593, DOI 10.1093/jmicro/52.6.593; Masuda T, 2010, TISSUE ENG PART C-ME, V16, P471, DOI 10.1089/ten.TEC.2009.0212; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402; Moucha CS, 2005, BONE REGENERATION AND REPAIR: BIOLOGY AND CLINICAL APPLICATIONS, P169, DOI 10.1385/1-59259-863-3:169; Nikdin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031525; Ryaby JT, 2005, BONE REGENERATION AND REPAIR: BIOLOGY AND CLINICAL APPLICATIONS, P291, DOI 10.1385/1-59259-863-3:291; SASAKI T, 1987, J DENT RES, V66, P778, DOI 10.1177/00220345870660031501; Sasano Y, 2000, HISTOCHEM J, V32, P591, DOI 10.1023/A:1026720003564; Sasano Y, 2012, J ORAL BIOSCI, V54, P25; Sugars RV, 2013, BONE, V53, P459, DOI 10.1016/j.bone.2013.01.022; Sutherland D, 2005, BONE REGENERATION AND REPAIR: BIOLOGY AND CLINICAL APPLICATIONS, P133, DOI 10.1385/1-59259-863-3:133; Zhu JX, 2001, HISTOCHEM J, V33, P25, DOI 10.1023/A:1017587712914	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JAN	2015	21	1					74	82		10.1111/odi.12212		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX0QM	WOS:000346656800022		
J	Ozeki, N; Yamaguchi, H; Hiyama, T; Kawai, R; Nakata, K; Mogi, M; Nakamura, H				Ozeki, N.; Yamaguchi, H.; Hiyama, T.; Kawai, R.; Nakata, K.; Mogi, M.; Nakamura, H.			IL-1 beta-induced matrix metalloproteinase-3 regulates cell proliferation in rat dental pulp cells	ORAL DISEASES			English	Article						matrix metalloproteinases; IL-1; cytokines; inflammation; dental pulp cells	NECROSIS-FACTOR-ALPHA; COLLAGEN DEGRADATION; PERIAPICAL LESIONS; OSTEOBLASTIC CELLS; EXPRESSION; ACTIVATION; INTERLEUKIN-1-BETA; PROCOLLAGENASE; INFLAMMATION; STROMELYSIN	ObjectiveWe previously reported that matrix metalloproteinase-3(MMP-3) accelerates wound healing following dental pulp injury. In this study, we tested the hypothesis that induction of MMP-3 activity by interleukin-1 would promote proliferation and apoptosis of dental pulp cells. Materials and MethodsDental pulp cells were isolated from rat incisors and subjected to interleukin-1. Matrix metalloproteinase-3 mRNA and protein expression were assessed using reverse transcription-polymerase chain reaction and Western blotting, respectively. Matrix metalloproteinase-3 activity was measured using fluorescence. Dental pulp cell proliferation and apoptosis were determined using enzyme-linked immunosorbent assays (ELISA) for BrdU and DNA fragmentation, respectively. siRNA was used to reduce MMP-3 transcripts in these cells. ResultsTreatment with interleukin-1 increased MMP-3 mRNA and protein levels as well as its activity in dental pulp cells. Cell proliferation was also markedly increased, with no changes in apoptosis observed. Treatment with siRNA against MMP-3 potently suppressed this interleukin-1-induced increase in MMP-3 expression and activity, and also suppressed cell proliferation but unexpectedly increased apoptosis in these cells (P<0.05). This siRNA-mediated increase in apoptosis could be reversed with exogenous MMP-3 stimulation (P<0.05). ConclusionsInterleukin-1 induces MMP-3-regulated cell proliferation and suppresses apoptosis in dental pulp cells.	[Ozeki, N.; Yamaguchi, H.; Hiyama, T.; Kawai, R.; Nakata, K.; Nakamura, H.] Aichi Gakuin Univ, Dept Endodont, Sch Dent, Nagoya, Aichi 4648651, Japan; [Mogi, M.] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Nagoya, Aichi 4648651, Japan	Ozeki, N (reprint author), Aichi Gakuin Univ, Dept Endodont, Sch Dent, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.	ozeki@g.agu.ac.jp			JSPS [12908500]	This work was supported by JSPS KAKENHI Grant Number 12908500.	Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Ozeki N, 2002, ARCH ORAL BIOL, V47, P511, DOI 10.1016/S0003-9969(02)00035-3; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Wisithphrom K, 2006, J ENDODONT, V32, P186, DOI 10.1016/j.joen.2005.10.055; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wahlgren J, 2002, INT ENDOD J, V35, P897, DOI 10.1046/j.1365-2591.2002.00587.x; Paula-Silva FWG, 2010, J ENDODONT, V36, P231, DOI 10.1016/j.joen.2009.10.030; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Ozeki N, 2014, ORAL DIS, V20, P505, DOI 10.1111/odi.12165; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; WOESSNER JF, 1991, FASEB J, V5, P2145; Herrera I, 2013, J BIOL CHEM, V288, P25964, DOI 10.1074/jbc.M113.459784; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; TANIISHII N, 1995, ORAL MICROBIOL IMMUN, V10, P213, DOI 10.1111/j.1399-302X.1995.tb00145.x; Shin SJ, 2002, J ENDODONT, V28, P313, DOI 10.1097/00004770-200204000-00013; Koyama Y, 2008, BIOCHEM BIOPH RES CO, V371, P659, DOI 10.1016/j.bbrc.2008.04.064; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; Pezelj-Ribaric S, 2002, ARCH MED RES, V33, P482, DOI 10.1016/S0188-4409(02)00396-X; Tabares LC, 2006, BIOCHEMISTRY-US, V45, P1919, DOI 10.1021/bi051947m; Azuma Y, 2007, EUR J PHARMACOL, V568, P260, DOI 10.1016/j.ejphar.2007.05.001; BRINCKERHOFF CE, 1990, J BIOL CHEM, V265, P22262; Dummer P M, 1980, Int Endod J, V13, P27, DOI 10.1111/j.1365-2591.1980.tb00834.x; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; MITCHELL D F, 1960, Oral Surg Oral Med Oral Pathol, V13, P1360, DOI 10.1016/0030-4220(60)90301-7; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Morand M A, 1981, J Endod, V7, P156, DOI 10.1016/S0099-2399(81)80229-4; Ní Ainle Fionnuala, 2011, J Biol Chem, V286, P1323, DOI 10.1074/jbc.M110.159475; Palosaari H, 2000, J DENT RES, V79, P77; Rajah Roopa, 1995, Progress in Growth Factor Research, V6, P273, DOI 10.1016/0955-2235(95)00012-7; Teles J C, 1967, Rev Bras Odontol, V25, P305; Yokose S, 2000, CALCIFIED TISSUE INT, V66, P139, DOI 10.1007/s002230010028; Yonehiro J, 2013, INT ENDOD J, V46, P119, DOI 10.1111/j.1365-2591.2012.02095.x	32	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JAN	2015	21	1					97	105		10.1111/odi.12219		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX0QM	WOS:000346656800025		
J	Ohta, K; Ishida, Y; Fukui, A; Nishi, H; Naruse, T; Takechi, M; Kamata, N				Ohta, K.; Ishida, Y.; Fukui, A.; Nishi, H.; Naruse, T.; Takechi, M.; Kamata, N.			Itraconazole inhibits TNF-alpha-induced CXCL10 expression in oral fibroblasts	ORAL DISEASES			English	Article						itraconazole; TNF-; CXCL10; oral fibroblasts	HUMAN PERIODONTAL-DISEASE; T-CELLS; CHEMOKINE RECEPTORS; ATOPIC-DERMATITIS; CANDIDA-ALBICANS; LICHEN-PLANUS; PHARMACOKINETICS; ANTIMYCOTICS; FLUCONAZOLE; INFECTIONS	ObjectiveItraconazole (ICZ) has a broad spectrum of antifungal activity including a wide range of Candida spp. TNF-, an inflammatory cytokine associated with Th1-mediated oral inflammatory disease, enhances inflammatory mediators, such as CXCR3-agonistic chemokines including CXCL10. We examined the anti-inflammatory potential of ICZ against TNF--induced chemokines in oral fibroblasts. Materials and methodsWe investigated the effects of ICZ on mRNA expressions of various TNF--induced chemokines in immortalized oral keratinocytes (RT7) and oral fibroblasts (GT1) using quantitative PCR analysis. Subsequently, the effects of ICZ and fluconazole (FLZ) on TNF--induced CXCL10 proteins in GT1 and primary fibroblasts were examined using enzyme-linked immunosorbent assays (ELISA). The effect of ICZ on signal transduction protein phosphorylation involved in CXCL10 production from TNF--stimulated GT1 was examined by western blotting. ResultsICZ inhibited TNF--induced CXCL10 mRNA in GT1, but not RT7. Although ICZ did not affect TNF--induced IL-8 mRNA, the mRNAs of TNF--induced CXCR3-agonistic chemokines such as CXCL9 and CXCL11 were inhibited by ICZ in GT1. TNF--induced CXCL10 protein production in GT1 and primary fibroblasts was inhibited by ICZ, but not FLZ. Finally, ICZ inhibited TNF--induced phosphorylation of c-JUN, which is related to CXCL10 production by TNF--stimulated GT1. ConclusionICZ may be useful as therapy for Th1-mediated oral inflammatory disease.	[Ohta, K.; Ishida, Y.; Fukui, A.; Nishi, H.; Naruse, T.; Takechi, M.; Kamata, N.] Hiroshima Univ, Dept Oral & Maxillofacial Surg, Div Cervico Gnathostmatol, Programs Appl Biomed,Grad Sch Biomed Sci,Minami K, Hiroshima 7348553, Japan	Ohta, K (reprint author), Hiroshima Univ, Dept Oral & Maxillofacial Surg, Div Cervico Gnathostmatol, Programs Appl Biomed,Grad Sch Biomed Sci,Minami K, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	otkouji@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [17791460]	This work was supported by a Grant-in-Aid for scientific research from the Japan Society for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (No. 17791460).	Taubman MA, 2001, CRIT REV ORAL BIOL M, V12, P125; SEYMOUR GJ, 1991, J CLIN PERIODONTOL, V18, P421, DOI 10.1111/j.1600-051X.1991.tb02310.x; Scolletta S, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/876319; Martin MV, 1999, J ANTIMICROB CHEMOTH, V44, P429, DOI 10.1093/jac/44.4.429; Kolmer HL, 1996, J ALLERGY CLIN IMMUN, V98, P702, DOI 10.1016/S0091-6749(96)70106-9; Wark PAB, 2003, J ALLERGY CLIN IMMUN, V111, P952, DOI 10.1067/mai.2003.1388; Kamata N, 2004, J ORAL PATHOL MED, V33, P417, DOI 10.1111/j.1600-0714.2004.00228.x; SCULLY C, 1994, CRIT REV ORAL BIOL M, V5, P125; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Page RC, 1997, PERIODONTOL 2000, V14, P216, DOI 10.1111/j.1600-0757.1997.tb00199.x; Iijima W, 2003, AM J PATHOL, V163, P261, DOI 10.1016/S0002-9440(10)63649-8; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Gemmell E, 2001, CLIN EXP IMMUNOL, V125, P134, DOI 10.1046/j.1365-2249.2001.01511.x; Garlet GP, 2003, J PERIODONTAL RES, V38, P210, DOI 10.1034/j.1600-0765.2003.02012.x; Ausaneya U, 2006, J INVEST DERMATOL, V126, P1028, DOI 10.1038/sj.jid.5700102; DJEU JY, 1986, J IMMUNOL, V137, P2980; Fleming I, 2001, NEPHROL DIAL TRANSPL, V16, P1309, DOI 10.1093/ndt/16.7.1309; Guma Monica, 2012, Open Rheumatol J, V6, P220, DOI 10.2174/1874312901206010220; Haria M, 1996, DRUGS, V51, P585; Hay RJ, 1997, CLIN EXP DERMATOL, V22, P3; Ichimura M, 2006, J ORAL PATHOL MED, V35, P167, DOI 10.1111/j.1600-0714.2006.00402.x; Ikezawa Z, 2004, EUR J DERMATOL, V14, P400; Ishibashi H, 2007, J ANTIMICROB CHEMOTH, V59, P317, DOI 10.1093/jac/dkl472; Kanda N, 2001, J INVEST DERMATOL, V117, P1635, DOI 10.1046/j.0022-202x.2001.01566.x; Kunisch E, 2007, ANN RHEUM DIS, V66, P1043, DOI 10.1136/ard.20006.062521; Mihara M, 1998, ARCH DERMATOL, V134, P639, DOI 10.1001/archderm.134.5.639; Ohta K, 2008, J DENT RES, V87, P1161; Oliveira Marcos André M de, 2007, Microbiol Immunol, V51, P713; Olkkola KT, 1996, ANESTH ANALG, V82, P511, DOI 10.1097/00000539-199603000-00015; Potter M, 2005, J ANTIMICROB CHEMOTH, V56, P49, DOI 10.1093/jac/dki224; Prentice AG, 2005, J ANTIMICROB CHEMOTH, V56, P17; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Sakai A, 2006, J PERIODONTOL, V77, P856, DOI 10.1902/iop.2006.050340; Sasaki M, 2003, AM J PHYSIOL-CELL PH, V284, P422; Sasaki M, 2004, AM J PHYSIOL-CELL PH, V286, P931; Singh UP, 2008, J INTERF CYTOK RES, V28, P31, DOI 10.1089/jir.2007.0059; Steel HC, 2008, CHEM BIOL DRUG DES, V72, P225, DOI 10.1111/j.1747-0285.2008.00694.x; ZUCKERMAN JM, 1994, INFECT CONT HOSP EP, V15, P397	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JAN	2015	21	1					106	112		10.1111/odi.12226		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX0QM	WOS:000346656800026		
J	Takeuchi, N; Hayashi, Y; Murakami, M; Alvarez, FJ; Horibe, H; Iohara, K; Nakata, K; Nakamura, H; Nakashima, M				Takeuchi, N.; Hayashi, Y.; Murakami, M.; Alvarez, F. J.; Horibe, H.; Iohara, K.; Nakata, K.; Nakamura, H.; Nakashima, M.			Similar in vitro effects and pulp regeneration in ectopic tooth transplantation by basic fibroblast growth factor and granulocyte-colony stimulating factor	ORAL DISEASES			English	Article						basic fibroblast growth factor; granulocyte-colony stimulating factor; pulp regeneration; homing; migration factor	MESENCHYMAL STEM-CELLS; SIDE POPULATION CELLS; DENTAL-PULP; BONE-MARROW; STEM/PROGENITOR CELLS; CEREBRAL-ISCHEMIA; TISSUE; MIGRATION; ANGIOGENESIS; ENDODONTICS	ObjectivesGranulocyte-colony stimulating factor (G-CSF) has been shown to have combinatorial trophic effects with dental pulp stem cells for pulp regeneration. The aim of this investigation is to examine the effects of basic fibroblast growth factor (bFGF) in vitro and in vivo compared with those of G-CSF and to assess the potential utility of bFGF as an alternative to G-CSF for pulp regeneration. Materials and methodsFive different types of cells were examined in the in vitro effects of bFGF on cell migration, proliferation, anti-apoptosis, neurite outgrowth, angiogenesis, and odontogenesis compared with those of G-CSF. The in vivo regenerative potential of pulp tissue including vasculogenesis and odontoblastic differentiation was also compared using an ectopic tooth transplantation model. ResultsBasic fibroblast growth factor was similar to G-CSF in high migration, proliferation and anti-apoptotic effects and angiogenic and neurite outgrowth stimulatory activities in vitro. There was no significant difference between bFGF and G-CSF in the regenerative potential in vivo. ConclusionsThe potential utility of bFGF for pulp regeneration is demonstrated as a homing/migration factor similar to the influence of G-CSF.	[Takeuchi, N.; Hayashi, Y.; Murakami, M.; Alvarez, F. J.; Horibe, H.; Iohara, K.; Nakashima, M.] Natl Ctr Geriatr & Gerontol, Res Inst, Ctr Adv Med Dent Oral Dis, Dept Dent Regenerat Med, Morioka, Obu 4748511, Japan; [Takeuchi, N.; Nakata, K.; Nakamura, H.] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 464, Japan; [Hayashi, Y.] Aichi Gakuin Univ, Sch Dent, Dept Pediat Dent, Nagoya, Aichi 464, Japan; [Horibe, H.] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 464, Japan	Nakashima, M (reprint author), Natl Ctr Geriatr & Gerontol, Res Inst, Ctr Adv Med Dent Oral Dis, Dept Dent Regenerat Med, 35 Gengo, Morioka, Obu 4748511, Japan.	misako@ncgg.go.jp			Budget for promoting science and technology in Japan; Council for Science and Technology Policy (CSTP); Research Grant for Longevity Sciences from Ministry of Health, Labour and Welfare [23-10]	This work was supported by the Budget for promoting science and technology in Japan, with directly following the policy of the Council for Science and Technology Policy (CSTP) chaired by Prime Minister (M.N.) and the Research Grant for Longevity Sciences (23-10) from the Ministry of Health, Labour and Welfare (M.N.).	Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013; Shimabukuro Y, 2009, J ENDODONT, V35, P1529, DOI 10.1016/j.joen.2009.08.010; Kassis I, 2011, CURR STEM CELL RES T, V6, P63, DOI 10.2174/157488811794480762; Mullane EM, 2008, J DENT RES, V87, P1144; Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.TEA.2010.0615, 10.1089/ten.tea.2010.0615]; Langer HF, 2009, J MOL CELL CARDIOL, V47, P315, DOI 10.1016/j.yjmcc.2009.03.011; Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.TEB.2011.0488, 10.1089/ten.teb.2011.0488]; Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5; Iohara K, 2013, STEM CELL TRANSL MED, V2, P521, DOI 10.5966/sctm.2012-0132; Ishizaka R, 2013, BIOMATERIALS, V34, P1888, DOI 10.1016/j.biomaterials.2012.10.045; Wang MK, 2010, DIFFERENTIATION, V79, P21, DOI 10.1016/j.diff.2009.08.002; Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426; Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864; Murakami S, 2011, PERIODONTOL 2000, V56, P188, DOI 10.1111/j.1600-0757.2010.00365.x; Pan HC, 2008, J CLIN NEUROSCI, V15, P656, DOI 10.1016/j.jocn.2007.03.020; Akasaka Y, 2010, J PATHOL, V221, P285, DOI 10.1002/path.2710; Ishizaka R, 2012, BIOMATERIALS, V33, P2109, DOI 10.1016/j.biomaterials.2011.11.056; Akita S, 2008, WOUND REPAIR REGEN, V16, P635, DOI 10.1111/j.1524-475X.2008.00414.x; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Qin C, 2007, J DENT RES, V86, P1134; Morito A, 2009, ARCH HISTOL CYTOL, V72, P51; Ponte AL, 2012, STEM CELLS DEV, V21, P3162, DOI 10.1089/scd.2012.0048; Wu KH, 2007, J CELL BIOCHEM, V100, P608, DOI 10.1002/jcb.21078; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95; Hargreaves KM, 2008, J ENDODONT, V34, pS51, DOI 10.1016/j.joen.2008.02.032; Murakami M, 2013, BIOMATERIALS, V34, P9036, DOI 10.1016/j.biomaterials.2013.08.011; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Jin X, 2010, EXP MOL MED, V42, P574, DOI 10.3858/emm.2010.42.8.058; Kawaguchi Hiroshi, 2009, Clin Calcium, V19, P653, DOI CliCa0905653659; Kitamura C, 2012, INT J DENT, V2012; Kodama Y, 2004, BIOCHEM BIOPH RES CO, V320, P108, DOI 10.1016/j.bbrc.2004.05.019; Liu J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-80; Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6; Morotomi T, 2012, CELLS TISSUES ORGANS, V196, P398, DOI 10.1159/000336029; Nakashima M., 2013, ENDODONTIC TOPICS, V28, P38; Nakashima M, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P461; Nitta N, 2012, EXP THER MED, V4, P201, DOI 10.3892/etm.2012.574; Okumura M, 1996, ARZNEIMITTEL-FORSCH, V46, P547; Pan HC, 2009, BIOCHEM BIOPH RES CO, V382, P177, DOI 10.1016/j.bbrc.2009.03.003; Parr AM, 2007, NEUROSURGERY, V60, P926, DOI 10.1227/01.NEU.0000255441.59612.98; PRESTA M, 1986, MOL CELL BIOL, V6, P4060; Re'em T, 2011, ADV BIOCH ENG BIOTEC; SAKSELA O, 1987, J CELL BIOL, V105, P957, DOI 10.1083/jcb.105.2.957; Silva TA, 2004, ORAL DIS, V10, P63, DOI 10.1111/j.1601-0825.2004.00992.x; Sugiyama M, 2011, TISSUE ENG PT A, V17, P1303, DOI [10.1089/ten.TEA.2010.0306, 10.1089/ten.tea.2010.0306]; Takehara Naofumi, 2013, Ann Vasc Dis, V6, P137, DOI 10.3400/avd.ra.13.00019; Yamamoto T, 2012, DENTISTRY, V2; Yu QA, 2011, MOL MED REP, V4, P31, DOI 10.3892/mmr.2010.387; Zhang XM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-61	52	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JAN	2015	21	1					113	122		10.1111/odi.12227		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX0QM	WOS:000346656800027		
J	Ahmad, F; Murata, T; Shimizu, K; Degerman, E; Maurice, D; Manganiello, V				Ahmad, F.; Murata, T.; Shimizu, K.; Degerman, E.; Maurice, D.; Manganiello, V.			Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets	ORAL DISEASES			English	Review						phosphodiesterase (PDE); protein kinase A (PKA); A-kinase anchoring protein (AKAP); cAMP; signalosome; cancer; oral and systemic diseases	OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; CAMP-SPECIFIC PHOSPHODIESTERASES; BONE MORPHOGENETIC PROTEIN-2; DUCHENNE MUSCULAR-DYSTROPHY; ROD CGMP PHOSPHODIESTERASE; STATIONARY NIGHT BLINDNESS; TYPE-2 DIABETES-MELLITUS; MULTIPLE MOLECULAR-FORMS	By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their intracellular concentrations and their biological effects. As these intracellular second messengers control many cellular homeostatic processes, dysregulation of their signals and signaling pathways initiate or modulate pathophysiological pathways related to various disease states, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication, chronic obstructive pulmonary disease, and psoriasis. Alterations in expression of PDEs and PDE-gene mutations (especially mutations in PDE6, PDE8B, PDE11A, and PDE4) have been implicated in various diseases and cancer pathologies. PDEs also play important role in formation and function of multimolecular signaling/regulatory complexes, called signalosomes. At specific intracellular locations, individual PDEs, together with pathway-specific signaling molecules, regulators, and effectors, are incorporated into specific signalosomes, where they facilitate and regulate compartmentalization of cyclic nucleotide signaling pathways and specific cellular functions. Currently, only a limited number of PDE inhibitors (PDE3, PDE4, PDE5 inhibitors) are used in clinical practice. Future paths to novel drug discovery include the crystal structure-based design approach, which has resulted in generation of more effective family-selective inhibitors, as well as burgeoning development of strategies to alter compartmentalized cyclic nucleotide signaling pathways by selectively targeting individual PDEs and their signalosome partners.	[Ahmad, F.; Manganiello, V.] NHLBI, Cardiovasc & Pulm Branch, Bethesda, MD 20892 USA; [Murata, T.; Shimizu, K.] Mie Univ, Grad Sch Med, Dept Clin Sci, Dept Oral & Maxillofacial Surg, Tsu, Mie, Japan; [Degerman, E.] Lund Univ, Dept Expt Med Sci, Div Diabet Metab & Endocrinol, Lund, Sweden; [Maurice, D.] Queens Univ, Kingston, ON, Canada	Ahmad, F (reprint author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10,Rm 5N311, Bethesda, MD 20892 USA.	ahmadf@nhlbi.nih.gov			NHLBI Intramural Research Program; Swedish Diabetes Association; Albert Pahlssons Foundation; Canadian Institutes of Health Research (CIHR); JSPS [16390585, 18390537, 20378368, 23659943, 80242965]	FA and VM were supported by NHLBI Intramural Research Program, ED by Swedish Diabetes Association and Albert Pahlssons Foundation, DM by Canadian Institutes of Health Research (CIHR) operating grants, and TM and KS by JSPS KAKENHI Grant Numbers 16390585, 18390537, 20378368, 23659943, 80242965.	Aghaloo TL, 2006, J PERIODONTOL, V77, P21, DOI 10.1902/jop.2006.77.1.21; Ahmad F, 2012, HORM METAB RES, V44, P776, DOI 10.1055/s-0032-1312646; Ahmad F, 2007, BIOCHEM J, V404, P257, DOI 10.1042/BJ20060960; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Zhang LZ, 2011, INT J CANCER, V129, P1162, DOI 10.1002/ijc.25785; Canalis E, 2010, J CLIN ENDOCR METAB, V95, P1496, DOI 10.1210/jc.2009-2677; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Francis SH, 2011, CURR OPIN PHARMACOL, V11, P683, DOI 10.1016/j.coph.2011.08.004; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Bauman AL, 2007, IUBMB LIFE, V59, P163, DOI 10.1080/15216540701358593; Bjorgo E, 2010, MOL CELL BIOL, V30, P1660, DOI 10.1128/MCB.00696-09; Zaccolo M, 2000, NAT CELL BIOL, V2, P25; Wilson LS, 2008, P NATL ACAD SCI USA, V105, P13650, DOI 10.1073/pnas.0804738105; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Guirguis E, 2013, ENDOCRINOLOGY, V154, P3152, DOI 10.1210/en.2012-2185; Savai R, 2010, EXPERT OPIN INV DRUG, V19, P117, DOI 10.1517/13543780903485642; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Kelly MP, 2009, PROG BRAIN RES, V179, P67, DOI 10.1016/S0079-6123(09)17908-6; Begum N, 2011, J BIOL CHEM, V286, P26238, DOI 10.1074/jbc.M110.214155; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Malamas MS, 2011, J MED CHEM, V54, P7621, DOI 10.1021/jm2009138; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Uckert S, 2011, BRIT J CLIN PHARMACO, V72, P197, DOI 10.1111/j.1365-2125.2010.03828.x; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Card GL, 2005, NAT BIOTECHNOL, V23, P201, DOI 10.1038/nbt1059; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Hutson PH, 2011, NEUROPHARMACOLOGY, V61, P665, DOI 10.1016/j.neuropharm.2011.05.009; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Miyazawa T, 2002, ENDOCRINOLOGY, V143, P3604, DOI 10.1210/en.2002-220307; Lugnier C, 2011, CURR OPIN PHARMACOL, V11, P698, DOI 10.1016/j.coph.2011.09.012; LUGNIER C, 1986, BIOCHEM PHARMACOL, V35, P1743, DOI 10.1016/0006-2952(86)90333-3; Safavi M, 2013, EXPERT OPIN DRUG DIS, V8, P733, DOI 10.1517/17460441.2013.787986; Creighton J, 2008, J CELL SCI, V121, P110, DOI 10.1242/jcs.011692; Adamo CM, 2010, P NATL ACAD SCI USA, V107, P19079, DOI 10.1073/pnas.1013077107; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Claffey MM, 2012, J MED CHEM, V55, P9055, DOI 10.1021/jm3009635; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Percival JM, 2011, HANDB EXP PHARMACOL, V204, P323, DOI 10.1007/978-3-642-17969-3_14; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Sin YY, 2011, J MOL CELL CARDIOL, V50, P872, DOI 10.1016/j.yjmcc.2011.02.006; Reed TM, 2002, J NEUROSCI, V22, P5188; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Giembycz MA, 2014, CURR OPIN PHARMACOL, V16, P89, DOI 10.1016/j.coph.2014.04.001; Stevens JW, 2012, BRIT J SURG, V99, P1630, DOI 10.1002/bjs.8895; Oudiz RJ, 2012, J AM COLL CARDIOL, V60, P768, DOI 10.1016/j.jacc.2012.05.004; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Azzouni F, 2011, J SEX MED, V8, P2894, DOI 10.1111/j.1743-6109.2011.02382.x; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Tinsley HN, 2011, CANCER PREV RES, V4, P1275, DOI 10.1158/1940-6207.CAPR-11-0095; Soda T, 2013, MOL PSYCHIATR, V18, P898, DOI 10.1038/mp.2013.38; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Kinoshita T, 2000, BONE, V27, P811, DOI 10.1016/S8756-3282(00)00395-1; Zhang LZ, 2008, P NATL ACAD SCI USA, V105, P19532, DOI 10.1073/pnas.0806152105; Ho GD, 2012, BIOORG MED CHEM LETT, V22, P2585, DOI 10.1016/j.bmcl.2012.01.113; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; Zhang R, 2009, ENDOCRINOLOGY, V150, P3076, DOI 10.1210/en.2009-0108; Beca S, 2013, CIRC RES, V112, P289, DOI 10.1161/CIRCRESAHA.111.300003; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Davis RJ, 2008, INVEST OPHTH VIS SCI, V49, P5067, DOI 10.1167/iovs.07-1422; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; FitzGerald O, 2014, NAT REV RHEUMATOL, V10, P385, DOI 10.1038/nrrheum.2014.77; Schudt C, 2011, HANDB EXP PHARMACOL, V204, P1, DOI 10.1007/978-3-642-17969-3_1; Movsesian MA, 2011, HANDB EXP PHARMACOL, V204, P237, DOI 10.1007/978-3-642-17969-3_10; Teitelbaum SL, 2011, ARTHRITIS RHEUM-US, V63, P325, DOI 10.1002/art.30135; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Asirvatham AL, 2004, J IMMUNOL, V173, P4806; Fan GC, 2006, CIRC RES, V99, P1233, DOI 10.1161/01.RES.0000251074.19348.af; Tenor H, 2011, HANDB EXP PHARMACOL, V204, P85, DOI 10.1007/978-3-642-17969-3_3; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Saag KG, 2003, ENDOCRIN METAB CLIN, V32, P135, DOI 10.1016/S0889-8529(02)00064-6; Shailubhai K, 2000, CANCER RES, V60, P5151; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; WACHTEL H, 1983, NEUROPHARMACOLOGY, V22, P267, DOI 10.1016/0028-3908(83)90239-3; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; Kita Toshiyuki, 2009, Allergology International, V58, P267, DOI 10.2332/allergolint.08-OA-0053; Beca S, 2011, CIRC RES, V109, P1024, DOI 10.1161/CIRCRESAHA.111.250464; Nakao Y, 2009, BONE, V44, P872, DOI 10.1016/j.bone.2009.01.370; Calzetta L, 2013, J PHARMACOL EXP THER, V346, P414, DOI 10.1124/jpet.113.204644; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Meng F, 2012, J MED CHEM, V55, P8549, DOI 10.1021/jm301189c; Lee LCY, 2013, FUTURE MED CHEM, V5, P451, DOI [10.4155/fmc.12.216, 10.4155/FMC.12.216]; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Millar JK, 2007, J PHYSIOL-LONDON, V584, P401, DOI 10.1113/jphysiol.2007.140210; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473; Tiwari S, 2005, BIOCHEM PHARMACOL, V69, P473, DOI 10.1016/j.bcp.2004.10.009; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Nawrocki AR, 2014, DIABETES, V63, P300, DOI 10.2337/db13-0247; Lin DC, 2013, P NATL ACAD SCI USA, V110, P6109, DOI 10.1073/pnas.1218206110; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Rabe KF, 2011, BRIT J PHARMACOL, V163, P53, DOI 10.1111/j.1476-5381.2011.01218.x; Yuan JQ, 2013, EUR UROL, V63, P902, DOI 10.1016/j.eururo.2013.01.012; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; LUKERT BP, 1990, ANN INTERN MED, V112, P352; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; Liu SP, 2008, P NATL ACAD SCI USA, V105, P13309, DOI 10.1073/pnas.0708850105; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Movsesian M, 2011, CURR OPIN PHARMACOL, V11, P707, DOI 10.1016/j.coph.2011.09.001; Movsesian M, 2009, HEART FAIL REV, V14, P255, DOI 10.1007/s10741-008-9130-x; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Pullamsetti SS, 2013, ONCOGENE, V32, P1121, DOI 10.1038/onc.2012.136; Wiersma A, 1998, J CLIN INVEST, V102, P532, DOI 10.1172/JCI2566; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; MacKenzie KF, 2011, BIOCHEM J, V435, P755, DOI 10.1042/BJ20101184; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Kritzer MD, 2012, J MOL CELL CARDIOL, V52, P351, DOI 10.1016/j.yjmcc.2011.05.002; Bollen E, 2012, IUBMB LIFE, V64, P965, DOI 10.1002/iub.1104; Ahmad F, 2009, BIOCHEM J, V424, P399, DOI 10.1042/BJ20090842; Carson CC, 2014, INT J CLIN PRACT, V68, P94, DOI 10.1111/ijcp.12305; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Kukreja RC, 2011, EXP CLIN CARDIOL, V16, pE30; Ghigo A, 2012, CIRCULATION, V126, P2073, DOI 10.1161/CIRCULATIONAHA.112.114074; Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Oger S, 2005, J IMMUNOL, V174, P8082; Murray F, 2007, AM J PHYSIOL-LUNG C, V292, pL294, DOI 10.1152/ajplung.00190.2006; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Kehler J, 2011, CURR PHARM DESIGN, V17, P137; Banner KH, 2009, BRIT J PHARMACOL, V157, P892, DOI 10.1111/j.1476-5381.2009.00170.x; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Karami-Tehrani F, 2012, ARCH MED RES, V43, P470, DOI 10.1016/j.arcmed.2012.08.006; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; Favot L, 2003, THROMB HAEMOSTASIS, V90, P334, DOI 10.1160/TH03-02-0084; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; Perez P, 2010, INT J BIOCHEM CELL B, V42, P773, DOI 10.1016/j.biocel.2010.02.012; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Chan S, 2011, CURR OPIN PHARMACOL, V11, P720, DOI 10.1016/j.coph.2011.09.002; Vasta V, 2006, P NATL ACAD SCI USA, V103, P19925, DOI 10.1073/pnas.0609483103; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Keravis T, 2010, CURR PHARM DESIGN, V16, P1114; Biel Martin, 2009, V191, P111; Wakabayashi S, 2002, J BONE MINER RES, V17, P249, DOI 10.1359/jbmr.2002.17.2.249; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; Zhang W, 2002, MOL PHARMACOL, V62, P514, DOI 10.1124/mol.62.3.514; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Wang HT, 2014, CURR MED RES OPIN, V30, P1565, DOI 10.1185/03007995.2014.909391; Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Degerman E, 1997, J BIOL CHEM, V272, P6823; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Katakami N, 2010, CIRCULATION, V121, P2584, DOI 10.1161/CIRCULATIONAHA.109.892414; Ariga M, 2004, J IMMUNOL, V173, P7531; Bessay EP, 2007, FRONT BIOSCI-LANDMRK, V12, P1899, DOI 10.2741/2196; Bielekova B, 2009, MULT SCLER, V15, P1206, DOI 10.1177/1352458509345903; Bischoff E, 2004, INT J IMPOT RES, V16, pS11, DOI 10.1038/sj.ijir.3901208; Bjorgo E, 2011, HANDB EXP PHARMACOL, V204, P345, DOI 10.1007/978-3-642-17969-3_15; Blokland A, 2012, EXPERT OPIN THER PAT, V22, P349, DOI 10.1517/13543776.2012.674514; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Broderick KE, 2007, MOL ENDOCRINOL, V21, P1148, DOI 10.1210/me.2005-0389; Brown KM, 2013, P NATL ACAD SCI USA, V110, pE1533, DOI 10.1073/pnas.1303004110; Cai YJ, 2011, ARTERIOSCL THROM VAS, V31, P616, DOI 10.1161/ATVBAHA.110.212621; Chaudhary LR, 1998, MOL CELL BIOCHEM, V178, P59, DOI 10.1023/A:1006807221545; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chellaiah MA, 2003, J BIOL CHEM, V278, P29086, DOI 10.1074/jbc.M211074200; Chen RW, 2007, NEUROSCI LETT, V418, P165, DOI 10.1016/j.neulet.2007.03.033; Chi Yung-Wei, 2008, Vasc Health Risk Manag, V4, P1197; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Collins DM, 2008, CELL SIGNAL, V20, P2356, DOI 10.1016/j.cellsig.2008.09.017; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; Degerman E, 2004, DIABETES MELLITUS FU, P373; desRooij J, 1998, NATURE, V396, P474; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dong HL, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-680; Dov A, 2008, ENDOCRINOLOGY, V149, P741, DOI 10.1210/en.2007-0968; Duong L T, 2001, Rev Endocr Metab Disord, V2, P95, DOI 10.1023/A:1010063225902; Elbatarny HS, 2005, AM J PHYSIOL-ENDOC M, V289, pE695, DOI 10.1152/ajpendo.00125.2005; ELKS ML, 1985, ENDOCRINOLOGY, V116, P2119; Epstein P. M., 2012, BONE METABOLIC FUNCT, DOI [10.1007/978-1-4471-2745-1_16, DOI 10.1007/978-1-4471-2745-1_16]; Fatemi SH, 2008, SCHIZOPHR RES, V101, P36, DOI 10.1016/j.schres.2008.01.029; Faucz FR, 2011, J CLIN ENDOCR METAB, V96, pE135, DOI 10.1210/jc.2010-1655; Fox D, 2014, CELL SIGNAL, V26, P657, DOI 10.1016/j.cellsig.2013.12.003; Franciosi LG, 2013, LANCET RESP MED, V1, P714, DOI 10.1016/S2213-2600(13)70187-5; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; Gacci M, 2014, DRUG AGING, V31, P425, DOI 10.1007/s40266-014-0177-1; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Giembycz MA, 2011, HANDB EXP PHARMACOL, V204, P415, DOI 10.1007/978-3-642-17969-3_18; Giembycz MA, 2014, CLIN CHEST MED, V35, P203, DOI 10.1016/j.ccm.2013.09.007; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Gurney ME, 2011, HANDB EXP PHARMACOL, V204, P167, DOI 10.1007/978-3-642-17969-3_7; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311; Harndahl L, 2002, J BIOL CHEM, V277, P37446, DOI 10.1074/jbc.M205401200; HASHIMOTO Y, 1989, J BIOL CHEM, V264, P10884; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hiramoto K, 2014, CELL SIGNAL, V26, P1807, DOI 10.1016/j.cellsig.2014.03.031; Horiuchi H, 2002, BONE, V30, P589, DOI 10.1016/S8756-3282(02)00681-6; Horiuchi H, 2004, J BONE MINER METAB, V22, P329, DOI 10.1007/s00774-003-0490-y; Horvath A, 2009, CANCER RES, V69, P5301, DOI 10.1158/0008-5472.CAN-09-0884; Jacques P, 2013, EXPERT OPIN EMERG DR, V18, P231, DOI 10.1517/14728214.2013.807339; Jin S.L.C., 2006, CYCLIC NUCLEOTIDE PH, P323; Kambayashi J, 2007, CYCLIC NUCLEOTIDE PH, P627; KERAVIS TM, 1980, BIOCHIM BIOPHYS ACTA, V613, P116, DOI 10.1016/0005-2744(80)90198-9; Kerfant BG, 2007, CIRC RES, V101, P400, DOI 10.1161/CIRCRESAHA.107.156422; Labuda M, 2011, MEDIAT INFLAMM, DOI 10.1155/2011/301695; Lee WH, 2013, THROMB RES, V132, P190, DOI 10.1016/j.thromres.2013.01.036; Lefievre L, 2002, BIOL REPROD, V67, P423, DOI 10.1095/biolreprod67.2.423; Leroy J, 2011, J CLIN INVEST, V121, P2651, DOI 10.1172/JCI44747; Levy I, 2011, CURR OPIN PHARMACOL, V11, P689, DOI 10.1016/j.coph.2011.10.003; Libe R, 2011, J CLIN ENDOCR METAB, V96, pE208, DOI 10.1210/jc.2010-1704; Libe R, 2008, CLIN CANCER RES, V14, P4016, DOI 10.1158/1078-0432.CCR-08-0106; Lipina TV, 2012, NEUROPHARMACOLOGY, V62, P1252, DOI 10.1016/j.neuropharm.2011.02.020; Liu YG, 2011, HANDB EXP PHARMACOL, V204, P211, DOI 10.1007/978-3-642-17969-3_9; MANGANIE.V, 1973, J BIOL CHEM, V248, P7164; Manganiello VC, 2007, PHOSPHODIESTERASE IN, P101; Mangas A, 2010, CURR OPIN NEUROL, V23, P287, DOI 10.1097/WCO.0b013e32833960f6; Marko Doris, 1998, Cell Biochemistry and Biophysics, V28, P75, DOI 10.1007/BF02737806; Matte SL, 2012, J BIOL CHEM, V287, P20111, DOI 10.1074/jbc.M112.354647; Maurice DH, 2014, BIOCHEM SOC T, V42, P250, DOI 10.1042/BST20130268; Medina AE, 2010, P NATL ACAD SCI USA, V107, P9921, DOI 10.1073/pnas.1005138107; Morin F, 2001, J NEUROCHEM, V78, P88, DOI 10.1046/j.1471-4159.2001.00407.x; Morita H, 2013, ONCOL REP, V29, P1275, DOI 10.3892/or.2013.2260; Muradov KG, 2003, BIOCHEMISTRY-US, V42, P3305, DOI 10.1021/bi027095x; Murata T, 2001, ANTI-CANCER DRUG, V12, P79, DOI 10.1097/00001813-200101000-00011; Murata T, 2002, ANTICANCER RES, V22, P3171; News and analysis, 2011, NAT REV DRUG DISCOV, V10, P329; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Noh ALSM, 2009, BIOL PHARM BULL, V32, P1844; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Park H, 2007, ARCH PHARM RES, V30, P486, DOI 10.1007/BF02980224; Peter D, 2007, J IMMUNOL, V178, P4820; Puxeddu E, 2009, P NATL ACAD SCI USA, V106, P6158, DOI 10.1073/pnas.0901558106; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; RivetBastide M, 1997, J CLIN INVEST, V99, P2710, DOI 10.1172/JCI119460; RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Rothenbuhler A, 2012, CLIN ENDOCRINOL, V77, P195, DOI 10.1111/j.1365-2265.2012.04366.x; Sanabra C, 2013, J CHEM NEUROANAT, V47, P96, DOI 10.1016/j.jchemneu.2012.12.005; Sano H, 2008, J NEUROCHEM, V105, P546, DOI 10.1111/j.1471-4159.2007.05152.x; Satoh Keitaro, 2009, J Oral Sci, V51, P173; Schaper W, 2005, CARDIOVASC DRUG THER, V19, P357, DOI 10.1007/s10557-005-4659-6; Schmidt CJ, 2010, CURR TOP MED CHEM, V10, P222; Schultz JE, 2011, HANDB EXP PHARMACOL, V204, P151, DOI 10.1007/978-3-642-17969-3_6; Shakur Y, 2002, CARDIOVASC DRUG THER, V16, P417, DOI 10.1023/A:1022186402442; Shen WX, 2010, CELL CYCLE, V9, P4720, DOI 10.4161/cc.9.23.14090; Shimizu K, 2006, ARCH ORAL BIOL, V51, P83, DOI 10.1016/j.archoralbio.2005.06.012; Shimizu K, 2004, CANCER RES, V64, P2568, DOI 10.1158/0008-5472.CAN-03-3551; Shimizu K, 2009, ANTICANCER RES, V29, P1119; Singh D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-26; TAIRA M, 1993, J BIOL CHEM, V268, P18573; Tamhane U, 2009, EUROINTERVENTION, V5, P384, DOI 10.4244/V5I3A60; Thompson W J, 1979, Adv Cyclic Nucleotide Res, V10, P69; THOMPSON WJ, 1971, ANN NY ACAD SCI, V185, P36; Tokuhara Y, 2010, J BONE MINER METAB, V28, P17, DOI 10.1007/s00774-009-0103-5; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351; Tsai LCL, 2011, MOL PHARMACOL, V79, P639, DOI 10.1124/mol.110.069104; Tsai LCL, 2011, CURR OPIN PHARMACOL, V11, P670, DOI 10.1016/j.coph.2011.09.003; Uzawa K, 2013, CANCER MED-US, V2, P40, DOI 10.1002/cam4.56; Vellas B, 2011, CURR ALZHEIMER RES, V8, P203; Walz HA, 2007, CELL SIGNAL, V19, P1505, DOI 10.1016/j.cellsig.2007.01.030; Wang P, 2001, GENE, V280, P183, DOI 10.1016/S0378-1119(01)00783-1; WEISHAAR RE, 1985, J MED CHEM, V28, P537, DOI 10.1021/jm50001a001; Wilson LS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217026; Wimalawansa SJ, 2008, EXPERT OPIN PHARMACO, V9, P3025, DOI 10.1517/14656560802197162 ; Wittmann Miriam, 2013, Dermatol Ther (Heidelb), V3, P1, DOI 10.1007/s13555-013-0023-0; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200; Wu P, 2004, P NATL ACAD SCI USA, V101, P17634, DOI 10.1073/pnas.0407649101; Yamagami H, 2003, BIOCHEM PHARMACOL, V66, P801, DOI 10.1016/S0006-2952(03)00409-X; YAMAMOTO T, 1983, J BIOL CHEM, V258, P4173; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yano M, 2000, AM J PHYSIOL-HEART C, V279, pH1898; Yao W., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P119; Yoshida H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046432; Zhang GH, 1999, ARCH ORAL BIOL, V44, P735, DOI 10.1016/S0003-9969(99)00065-5; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zmuda-Trzebiatowska E, 2006, CELL SIGNAL, V18, P382, DOI 10.1016/j.cellsig.2005.05.007	306	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JAN	2015	21	1					E25	E50		10.1111/odi.12275		26	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX0QM	WOS:000346656800003		
J	Sato, M; Toriumi, T; Watanabe, N; Watanabe, E; Akita, D; Mashimo, T; Akiyama, Y; Isokawa, K; Shirakawa, T; Honda, MJ				Sato, M.; Toriumi, T.; Watanabe, N.; Watanabe, E.; Akita, D.; Mashimo, T.; Akiyama, Y.; Isokawa, K.; Shirakawa, T.; Honda, M. J.			Characterization of mesenchymal progenitor cells in crown and root pulp from human mesiodentes	ORAL DISEASES			English	Article						CD105; human dental pulp; dental pulp progenitor cells; mesiodens; supernumerary teeth	HUMAN DENTAL-PULP; STEM-CELLS; SUPERNUMERARY TEETH; STROMAL CELLS; IN-VITRO; POPULATION; FEATURES; CRITERIA; ANTIGEN; TISSUE	ObjectiveMesiodentes are usually found in the central position of the upper or lower jaw as supernumerary teeth. Here, we obtained 10 mesiodentes and three permanent teeth (PT) and separated the dental pulp (DP) from these into crown and root portions. We then characterized and compared the isolated crown portion-derived cells (crown cells) with root portion-derived cells (root cells) using a range of in vitro assays. Materials and methodsCrown cells and root cells were examined for cell surface marker expression, colony-forming unit-fibroblast (CFU-F), cell proliferation, cell cycle characteristics and markers, and osteogenic and adipogenic differentiation. ResultsThe proportion of CD105-positive cells (CD105(+) cells) in the crown cells vs the root cells varied among the mesiodentes, but not among the PT. When there were more CD105(+) cells in the root cells than in the crown cells, the root cells showed higher CFU-F, proliferation capacity, and osteogenic differentiation capacity. In contrast, when the crown cells contained more CD105(+) cells than the root cells, the crown cells showed the higher CFU-F, proliferation capacity, and osteogenic differentiation capacity. In addition, the sorted CD105(+) cells showed higher CFU-F and proliferation capacity than the sorted CD105(-) cells. ConclusionThese results indicated that proportion of CD105(+) cells is an effective means of characterizing DP-derived cells in mesiodentes.	[Sato, M.; Akita, D.; Mashimo, T.; Akiyama, Y.] Nihon Univ, Grad Sch Dent, Tokyo 1018310, Japan; [Toriumi, T.; Isokawa, K.; Honda, M. J.] Nihon Univ, Sch Dent, Dept Anat, Tokyo 1018310, Japan; [Watanabe, N.; Watanabe, E.] Univ Tokyo, Inst Med Sci, Lab Diagnost Med, Tokyo, Japan; [Isokawa, K.; Shirakawa, T.; Honda, M. J.] Nihon Univ, Sch Dent, Dent Res Ctr, Tokyo 1018310, Japan; [Shirakawa, T.] Nihon Univ, Sch Dent, Dept Pediat, Tokyo 1018310, Japan	Honda, MJ (reprint author), Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	honda.masaki@nihon-u.ac.jp			Nihon University Graduate School of Dentistry [10010105]; Nihon University Research Grant;  [21390528];  [24390447]	This work was supported in part by Grant-in-Aid for Scientific Research (B) (21390528 and 24390447 to Honda M), Nihon University Graduate School of Dentistry research fund (10010105, Sato M), and Nihon University Research Grant for 2011 and 2012 (Honda M).	Alaejos C, 2000, MED ORAL, V5, P81; Fonsatti E, 2001, J CELL PHYSIOL, V188, P1, DOI 10.1002/jcp.1095; Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009; Huang AHC, 2008, J ORAL PATHOL MED, V37, P571, DOI 10.1111/j.1600-0714.2008.00654.x; Atari M, 2011, HISTOL HISTOPATHOL, V26, P1057; Fleming PS, 2010, BRIT DENT J, V208, P25, DOI 10.1038/sj.bdj.2009.1177; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Mikami Y, 2011, STEM CELLS DEV, V20, P901, DOI 10.1089/scd.2010.0299; Huang GTJ, 2006, CELL TISSUE RES, V324, P225, DOI 10.1007/s00441-005-0117-9; Hilkens P, 2013, CELL TISSUE RES, V353, P65, DOI 10.1007/s00441-013-1630-x; Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x; Zhang WB, 2006, TISSUE ENG, V12, P2813, DOI 10.1089/ten.2006.12.2813; d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; D'Souza RN, 2007, CELLS TISSUES ORGANS, V186, P60, DOI 10.1159/000102681; Fardi A, 2011, MED ORAL PATOL ORAL, V16, pE56, DOI 10.4317/medoral.16.e56; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Cobourne MT, 2010, SEMIN CELL DEV BIOL, V21, P314, DOI 10.1016/j.semcdb.2010.01.007; Hyun HK, 2009, J ORAL MAXIL SURG, V67, P2639, DOI 10.1016/j.joms.2009.07.041; Govindasamy V, 2010, J ENDODONT, V36, P1504, DOI 10.1016/j.joen.2010.05.006; Bäckman B, 2001, Int J Paediatr Dent, V11, P11, DOI 10.1046/j.1365-263x.2001.00205.x; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; BROOK AH, 1975, COMMUNITY DENT ORAL, V3, P288, DOI 10.1111/j.1600-0528.1975.tb00326.x; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Fernandez Montenegro P, 2006, MED ORAL PATOL ORAL, V11, pe339; Ferres-Padro E, 2009, MED ORAL PATOL ORAL, V14, pE146; Ferro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048945; Gallas MM, 2000, BRIT DENT J, V188, P63; Garvey M T, 1999, J Can Dent Assoc, V65, P612; GOUGOS A, 1988, J IMMUNOL, V141, P1925; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Honda MJ, 2007, INT ENDOD J, V40, P949, DOI 10.1111/j.1365-2591.2007.01301.x; Karamzadeh R, 2012, J VIS EXP, V69, pe4372; Koyam N, 2009, J ORAL MAXIL SURG, V67, P501, DOI 10.1016/j.joms.2008.09.011; Leco Berrocal MI, 2007, MED ORAL PATOL ORAL, V12, pE134; LEE S, 2011, J REGEN MED, V6, P689; Liu Jeng-Fen, 1995, ASDC (American Society of Dentistry for Children) Journal of Dentistry for Children, V62, P262; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; NAZIF MM, 1983, J AM DENT ASSOC, V106, P201; Patchett C L, 2001, Int J Paediatr Dent, V11, P259, DOI 10.1046/j.1365-263X.2001.00282.x; Rajab L D, 2002, Int J Paediatr Dent, V12, P244, DOI 10.1046/j.1365-263X.2002.00366.x; Solares R, 2004, PEDIATR DENT, V26, P450; Stellzig A, 1997, J Orofac Orthop, V58, P144, DOI 10.1007/BF02676545; TAY F, 1984, J DENT CHILD, V51, P289; Yassin OM, 2009, J CLIN PEDIATR DENT, V33, P247	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	JAN	2015	21	1					E86	E97		10.1111/odi.12234		12	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX0QM	WOS:000346656800008		
J	Arakaki, A; Shimizu, K; Oda, M; Sakamoto, T; Nishimura, T; Kato, T				Arakaki, Atsushi; Shimizu, Katsuhiko; Oda, Mayumi; Sakamoto, Takeshi; Nishimura, Tatsuya; Kato, Takashi			Biomineralization-inspired synthesis of functional organic/inorganic hybrid materials: organic molecular control of self-organization of hybrids	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Review							AMORPHOUS CALCIUM-CARBONATE; MAGNETOSPIRILLUM-MAGNETICUM AMB-1; THIN-FILM FORMATION; SP STRAIN AMB-1; MAGNETOTACTIC BACTERIA; SILICATEIN-ALPHA; BIOLOGICAL-MATERIALS; LOW-TEMPERATURE; MARINE SPONGE; MAGNETOSOME MEMBRANE	Organisms produce various organic/inorganic hybrid materials, which are called biominerals. They form through the self-organization of organic molecules and inorganic elements under ambient conditions. Biominerals often have highly organized and hierarchical structures from nanometer to macroscopic length scales, resulting in their remarkable physical and chemical properties that cannot be obtained by simple accumulation of their organic and inorganic constituents. These observations motivate us to create novel functional materials exhibiting properties superior to conventional materials-both synthetic and natural. Herein, we introduce recent progress in understanding biomineralization processes at the molecular level and the development of organic/inorganic hybrid materials by these processes. We specifically outline fundamental molecular studies on silica, iron oxide, and calcium carbonate biomineralization and describe material synthesis based on these mechanisms. These approaches allow us to design a variety of advanced hybrid materials with desired morphologies, sizes, compositions, and structures through environmentally friendly synthetic routes using functions of organic molecules.	[Arakaki, Atsushi; Oda, Mayumi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Shimizu, Katsuhiko] Tottori Univ, Org Reg Ind Acad Cooperat, Minami Ku, Tottori 6808550, Japan; [Sakamoto, Takeshi; Nishimura, Tatsuya; Kato, Takashi] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Arakaki, A (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	arakakia@cc.tuat.ac.jp; kato@chiral.t.u-tokyo.ac.jp	Arakaki, Atsushi/B-9984-2013; Nishimura, Tatsuya/A-3013-2013	Arakaki, Atsushi/0000-0001-6692-9398; Nishimura, Tatsuya/0000-0002-8416-4007	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [2206]	This work was partially supported by a Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas of "Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control" (no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Adamson DH, 2007, MACROMOLECULES, V40, P5710, DOI 10.1021/ma0627929; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Mohri K, 2008, DEV DYNAM, V237, P3024, DOI 10.1002/dvdy.21708; Arakaki A, 2008, J R SOC INTERFACE, V5, P977, DOI 10.1098/rsif.2008.0170; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; Kajiyama S, 2014, SMALL, V10, P1634, DOI 10.1002/smll.201302745; Ihli J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4169; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Hosoda N, 2003, MACROMOLECULES, V36, P6449, DOI 10.1021/ma025869b; Yamamoto Y, 2008, CRYST GROWTH DES, V8, P4062, DOI 10.1021/cg800447w; Inoue H, 2007, PEPTIDES, V28, P566, DOI 10.1016/j.peptides.2006.12.005; Sugawara A, 2003, ANGEW CHEM INT EDIT, V42, P5299, DOI 10.1002/anie.200351541; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI [10.1038/nchem.899, 10.1038/NCHEM.899]; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Natalio F, 2010, ACTA BIOMATER, V6, P3720, DOI 10.1016/j.actbio.2010.03.010; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Osaka T, 2006, ANAL BIOANAL CHEM, V384, P593, DOI 10.1007/s00216-005-0255-7; Brutchey RL, 2008, CHEM REV, V108, P4915, DOI 10.1021/cr078256b; Zhou Y, 1999, ANGEW CHEM INT EDIT, V38, P780; Cartwright JHE, 2012, ANGEW CHEM INT EDIT, V51, P11960, DOI 10.1002/anie.201203125; Zhu FJ, 2013, CHEM-ASIAN J, V8, P3002, DOI 10.1002/asia.201300745; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Katagiri K, 2011, SMALL, V7, P1683, DOI 10.1002/smll.201002180; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Brutchey RL, 2006, J AM CHEM SOC, V128, P10288, DOI 10.1021/ja063107g; Zhu FJ, 2014, CRYSTENGCOMM, V16, P1496, DOI 10.1039/c3ce41649f; Aizenberg J, 1999, NATURE, V398, P495; Meldrum FC, 2003, INT MATER REV, V48, P187, DOI 10.1179/095066003225005836; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Wang LJ, 2012, BIOMACROMOLECULES, V13, P98, DOI 10.1021/bm201278u; Jiang Y, 2013, ADV FUNCT MATER, V23, P1547, DOI 10.1002/adfm.201202294; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Kisailus D, 2006, P NATL ACAD SCI USA, V103, P5652, DOI 10.1073/pnas.0508488103; Kozhemyako VB, 2010, MAR BIOTECHNOL, V12, P403, DOI 10.1007/s10126-009-9225-y; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Natalio F, 2013, SCIENCE, V339, P1298, DOI 10.1126/science.1216260; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Rai A, 2012, J MATER CHEM, V22, P4790, DOI 10.1039/c2jm15810h; Kisailus D, 2005, ADV MATER, V17, P1234, DOI 10.1002/adma.200401109; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Lange B, 2007, MACROMOL RAPID COMM, V28, P1987, DOI 10.1002/marc.200700284; Tugulu S, 2006, ANGEW CHEM INT EDIT, V45, P7458, DOI 10.1002/anie.200602382; Polini A, 2011, ADV MATER, V23, P4674, DOI 10.1002/adma.201102691; Han YL, 2014, POLYM J, V46, P499, DOI 10.1038/pj.2014.36; Han YL, 2014, CRYSTENGCOMM, V16, P3540, DOI 10.1039/c3ce42646g; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; Kisailus D, 2005, ADV MATER, V17, P314, DOI 10.1002/adma.200400815; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Fuchs I, 2014, J PHYS CHEM B, V118, P2104, DOI 10.1021/jp4114317; Wu XH, 2013, ADV HEALTHC MATER, V2, P326, DOI 10.1002/adhm.201200205; Kim YY, 2014, NANOSCALE, V6, P852, DOI 10.1039/c3nr05081e; Prozorov T, 2007, ACS NANO, V1, P228, DOI 10.1021/nn700194h; Andre R, 2011, CHEM MATER, V23, P5358, DOI 10.1021/cm201977c; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108; Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101; Tanaka M, 2006, PROTEOMICS, V6, P5234, DOI 10.1002/pmic.200500887; Shukoor MI, 2008, CHEM MATER, V20, P3567, DOI 10.1021/cm7029954; Imai H, 2006, B CHEM SOC JPN, V79, P1834, DOI 10.1246/bcsj.79.1834; Arakaki A, 2003, J BIOL CHEM, V278, P8745, DOI 10.1074/jbc.M211729200; Veremeichik GN, 2011, MAR BIOTECHNOL, V13, P810, DOI 10.1007/s10126-010-9343-6; Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k; Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328; Yamamoto Y, 2010, POLYM J, V42, P583, DOI 10.1038/pj.2010.32; Nishimura T, 2008, ANGEW CHEM INT EDIT, V47, P2800, DOI 10.1002/anie.200705062; Tahir MN, 2009, ADV FUNCT MATER, V19, P285, DOI 10.1002/adfm.200800841; Siponen MI, 2013, NATURE, V502, P681, DOI 10.1038/nature12573; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; Muller WEG, 2008, CELL TISSUE RES, V333, P339, DOI 10.1007/s00441-008-0624-6; Hosoda N, 2001, CHEM MATER, V13, P688, DOI 10.1021/cm000817r; Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P; Nudelman F, 2012, ANGEW CHEM INT EDIT, V51, P6582, DOI 10.1002/anie.201106715; Zlotnikov I, 2014, ADV MATER, V26, P1682, DOI 10.1002/adma.201304696; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; Vereda F, 2013, J COLLOID INTERF SCI, V392, P50, DOI 10.1016/j.jcis.2012.09.064; Galloway JM, 2011, J MATER CHEM, V21, P15244, DOI [10.1039/c1jm12003d/, 10.1039/c1jm12003d]; Muller WEG, 2007, CELL TISSUE RES, V329, P363, DOI 10.1007/s00441-007-0402-x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Chen SF, 2013, CHEM COMMUN, V49, P9564, DOI 10.1039/c3cc45427d; Amemiya Y, 2007, BIOMATERIALS, V28, P5381, DOI 10.1016/j.biomaterials.2007.07.051; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Kumagai H, 2012, FARADAY DISCUSS, V159, P483, DOI 10.1039/c2fd20057k; Noel EH, 2013, CRYSTENGCOMM, V15, P697, DOI 10.1039/c2ce26529j; Sumerel JL, 2003, CHEM MATER, V15, P4804, DOI 10.1021/cm030254u; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Galloway JM, 2012, SMALL, V8, P204, DOI 10.1002/smll.201101627; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Wang SS, 2013, ANGEW CHEM INT EDIT, V52, P6317, DOI 10.1002/anie.201301184; Sakamoto T, 2011, ANGEW CHEM INT EDIT, V50, P5856, DOI 10.1002/anie.201008191; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Tomono H, 2013, J PHYS CHEM B, V117, P14849, DOI 10.1021/jp407721x; Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632; Sakamoto T, 2009, CRYST GROWTH DES, V9, P622, DOI 10.1021/cg8009628; Arakaki A, 2010, J COLLOID INTERF SCI, V343, P65, DOI 10.1016/j.jcis.2009.11.043; Arakaki A, 2014, MOL MICROBIOL, V93, P554, DOI 10.1111/mmi.12683; Arakaki A., 2009, MRS ONLINE P LIB, V1187, pKK03; Blakemore R. P., 1975, NATURE, V190, P377; BOULIGAN.Y, 1972, TISSUE CELL, V4, P189, DOI 10.1016/S0040-8166(72)80042-9; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; Coelfen H., 2005, ANGEW CHEM INT EDIT, V44, P5576; Hecker A, 2003, FEBS LETT, V535, P49, DOI 10.1016/S0014-5793(02)03856-5; Kaluzhnaya OV, 2005, NATURWISSENSCHAFTEN, V92, P134, DOI 10.1007/s00114-004-0600-2; Kanazawa A, 2012, CHEM COMMUN, V48, P10904, DOI 10.1039/c2cc36218j; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Kato T, 2000, CHEM LETT, P186; Kim YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5341; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Kroeger Nils, 1999, Science (Washington D C), V286, P1129; Kumar S, 2010, CRYSTENGCOMM, V12, P2021, DOI 10.1039/b923049a; Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899; Lee I, 2010, J CRYST GROWTH, V312, P2107, DOI 10.1016/j.jcrysgro.2010.03.043; LOWENSTAM HA, 1962, GEOL SOC AM BULL, V73, P435, DOI 10.1130/0016-7606(1962)73[435:MIDCIR]2.0.CO;2; Lydon J. E., 2004, LIQUID CRYSTALS TODA, V13, P1, DOI 10.1080/14645180512331340171; Matsunaga S, 2007, CHEMBIOCHEM, V8, P1729, DOI 10.1002/cbic.200700305; Mueller W. E. G., 2007, EUR J CELL BIOL, V86, P473; Mueller W. E. G., 2009, APPL MICROBIOL BIOT, V83, P397; Okamura Y, 2001, J BIOL CHEM, V276, P48183, DOI 10.1074/jbc.M106408200; Saito T, 2014, MATER HORIZONS, V1, P321, DOI 10.1039/c3mh00134b; Sakamoto T, 2009, POLYM J, V41, P522, DOI 10.1295/polymj.PJ2009024; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Simpson T. L., 1981, SILICON SILICEOUS ST; Sugawara A, 2000, CHEM COMMUN, P487, DOI 10.1039/a909566g; Sugawara A, 2004, COMPOS INTERFACE, V11, P287, DOI 10.1163/1568554041738175; Sugawara-Narutaki A, 2013, POLYM J, V45, P269, DOI 10.1038/pj.2012.171; Suzuki T, 2006, J BACTERIOL, V188, P2275, DOI 10.1128/JB.188.6.2275-2279.2006; Tahir MN, 2005, CHEM COMMUN, P5533, DOI 10.1039/b510113a; Tahir MN, 2004, CHEM COMMUN, P2848, DOI 10.1039/b410283e; Tanaka M, 2011, J BIOL CHEM, V286, P6386, DOI 10.1074/jbc.M110.183434; Tanaka M, 2010, MOL MICROBIOL, V76, P480, DOI 10.1111/j.1365-2958.2010.07117.x; Uebe R, 2011, MOL MICROBIOL, V82, P818, DOI 10.1111/j.1365-2958.2011.07863.x; Wang XD, 2011, EVID-BASED COMPL ALT, P1, DOI 10.1155/2011/745262; Weaver JC, 2003, MICROSC RES TECHNIQ, V62, P356, DOI 10.1002/jemt.10401; Wolf SE, 2010, DALTON T, V39, P9245, DOI 10.1039/b921640e	139	9	9	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.		2015	13	4					974	989		10.1039/c4ob01796j		16	Chemistry, Organic	Chemistry	AX9NO	WOS:000347229500002		
J	Ogawa, A; Doi, Y				Ogawa, Atsushi; Doi, Yasunori			Investigation of end processing and degradation of premature tRNAs and their application to stabilization of in vitro transcripts in wheat germ extract	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Article							SITE-SPECIFIC INCORPORATION; SUPPRESSOR TRANSFER-RNAS; PROTEIN-SYNTHESIS SYSTEM; NONNATURAL AMINO-ACIDS; CELL-FREE TRANSLATION; EUKARYOTIC TRANSLATION; ESCHERICHIA-COLI; NUCLEAR; SYNTHETASE; EXPRESSION	We investigated the end processing and degradation of premature tRNAs in wheat germ extract (WGE), which led to the discovery of end protectors useful for stabilizing an in vitro transcript against various ribonucleases and thereby enhancing its apparent activity in WGE.	[Ogawa, Atsushi; Doi, Yasunori] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 7908577, Japan	Ogawa, A (reprint author), Ehime Univ, Proteosci Ctr, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	ogawa.atsushi.mf@ehime-u.ac.jp			JSPS KAKENHI Grant [25708027]	This work was supported by JSPS KAKENHI Grant Number 25708027.	Abe R, 2010, J BIOSCI BIOENG, V110, P32, DOI 10.1016/j.jbiosc.2010.01.003; Akahoshi A, 2011, BIOCHEM BIOPH RES CO, V414, P625, DOI 10.1016/j.bbrc.2011.09.137; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Abe N, 2007, J AM CHEM SOC, V129, P15108, DOI 10.1021/ja0754453; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Ogawa A, 2011, RNA, V17, P478, DOI 10.1261/rna.2433111; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Lee Y, 1997, RNA, V3, P175; Ponchon L, 2007, NAT METHODS, V4, P571, DOI 10.1038/NMETH1058; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019; Murakami H, 2003, CHEM BIOL, V10, P1077, DOI 10.1016/j.chembiol.2003.10.010; Hodgman CE, 2012, METAB ENG, V14, P261, DOI 10.1016/j.ymben.2011.09.002; Gudipati RK, 2012, MOL CELL, V48, P409, DOI [10.1016/j.molcel.2012.08.018, 10.1016/j.molce1.2012.08.018]; Arends S, 1997, EUR J BIOCHEM, V244, P635, DOI 10.1111/j.1432-1033.1997.t01-1-00635.x; Carnes J, 2000, RNA, V6, P1468, DOI 10.1017/S1355838200001242; Gubbens J, 2010, RNA, V16, P1660, DOI 10.1261/rna.2024810; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Mayer M, 2000, BIOCHEMISTRY-US, V39, P2096, DOI 10.1021/bi992253e; Muranaka N, 2009, ANAL LETT, V42, P108, DOI 10.1080/00032710802568556; Ogawa A, 2013, CHEMBIOCHEM, V14, P1539, DOI 10.1002/cbic.201300362; Ogawa A, 2009, CHEMBIOCHEM, V10, P2465, DOI 10.1002/cbic.200900497; Ogawa A, 2011, CHEMBIOCHEM, V12, P881, DOI 10.1002/cbic.201000744; Ogawa A, 2008, CHEMBIOCHEM, V9, P2204, DOI 10.1002/cbic.200800294; Ogawa A, 2014, BIOORG MED CHEM LETT, V24, P3724, DOI 10.1016/j.bmcl.2014.07.004; Ogawa A, 2011, ORG BIOMOL CHEM, V9, P8495, DOI 10.1039/c1ob06351k; Ohno S, 2007, J BIOCHEM, V141, P335, DOI 10.1093/jb/mvm036; Schiffer S, 2003, BIOL CHEM, V384, P333, DOI 10.1515/BC.2003.039; Shen XC, 1999, J BIOTECHNOL, V75, P221, DOI 10.1016/S0168-1656(99)00164-9	33	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.		2015	13	4					1008	1012		10.1039/c4ob02221a		5	Chemistry, Organic	Chemistry	AX9NO	WOS:000347229500006		
J	Yagi, Y; Kimura, H; Arimitsu, K; Ono, M; Maeda, K; Kusuhara, H; Kajimoto, T; Sugiyama, Y; Saji, H				Yagi, Yusuke; Kimura, Hiroyuki; Arimitsu, Kenji; Ono, Masahiro; Maeda, Kazuya; Kusuhara, Hiroyuki; Kajimoto, Tetsuya; Sugiyama, Yuichi; Saji, Hideo			The synthesis of [F-18]pitavastatin as a tracer for hOATP using the Suzuki coupling	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HEPATOBILIARY TRANSPORT; MEDICINAL CHEMISTRY; HEPATIC-UPTAKE; PET; ACID; SUCCINIMIDYL; PITAVASTATIN; RADIOLIGAND; QUINOLINE	Fluorine-18 labeled radiotracers, such as [F-18]fluorodeoxyglucose, can be used as practical diagnostic agents in positron emission tomography (PET). Furthermore, the properties of pharmaceuticals can be enhanced significantly by the introduction of fluorine groups into their original structures, and significant progress has been made during the last three decades towards the development of practical procedures for the introduction of fluorine. The replacement of the fluorine atoms present in pharmaceuticals with radioactive F-18 atoms is a rational approach for designing novel PET tracers. As a fluorine-containing pharmaceutical agent, pitavastatin has attracted considerable interest from researchers working in the life sciences because it can act as an antihyperlipidemic agent as well as a substrate for hepatic organic anion transporting polypeptides (hOATP). With this in mind, it was envisaged that [F-18]pitavastatin would be used as an excellent imaging agent for hOATP, which prompted us to investigate the synthesis of this agent. Herein, we report a practical method for the synthesis of [F-18]pitavastatin by the Suzuki coupling reaction of p-iodofluorobenzene and a quinoline boronate derivative, with the desired product being formed in a radiochemical yield of 12 +/- 3% (decay corrected from [F-18]fluoride ions, n = 3).	[Yagi, Yusuke; Kimura, Hiroyuki; Arimitsu, Kenji; Ono, Masahiro; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto 6068501, Japan; [Kimura, Hiroyuki] Kyoto Univ, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068501, Japan; [Arimitsu, Kenji] Mukogawa Womens Univ, Sch Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan; [Maeda, Kazuya; Kusuhara, Hiroyuki; Sugiyama, Yuichi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Bunkyo Ku, Tokyo 1130033, Japan; [Kajimoto, Tetsuya] Ritsumeikan Univ, Res Ctr Drug Discovery & Pharmaceut Dev Sci, Res Org Sci & Technol, Kusatsu, Shiga 5258577, Japan; [Sugiyama, Yuichi] RIKEN, RIKEN Res Cluster Innovat, Sugiyama Lab, RIKEN Innovat Ctr,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Kimura, H (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	hkimura@pharm.kyoto-u.ac.jp; hsaji@pharm.kyoto-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO). Crude phosphonate 3 material was provided by Nissan Chemical Industries, Ltd, and Kowa Company, Ltd. We would also like to thank KNC Laboratories Co., Ltd and Dr Hidekazu Imahori. No other potential conflicts of interest relevant to this article have been reported.	MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Ackermann U, 2011, J LABELLED COMPD RAD, V54, P671, DOI 10.1002/jlcr.1892; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Fei XS, 2004, NUCL MED BIOL, V31, P1033, DOI 10.1016/j.nucmedbio.2004.02.006; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; MIYACHI N, 1993, TETRAHEDRON LETT, V34, P8267, DOI 10.1016/S0040-4039(00)61407-7; Suzuki A, 2002, J ORGANOMET CHEM, V653, P83, DOI 10.1016/S0022-328X(02)01269-X; Acemoglu M, 2007, HELV CHIM ACTA, V90, P1069, DOI 10.1002/hlca.200790106; Moon BS, 2011, ORG BIOMOL CHEM, V9, P8346, DOI 10.1039/c1ob06277h; Perlmutter JS, 1997, J NEUROSCI, V17, P843; Barthel H, 2011, LANCET NEUROL, V10, P424, DOI 10.1016/S1474-4422(11)70077-1; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Manske RH, 1942, CHEM REV, V30, P113, DOI 10.1021/cr60095a006; Mu L, 2012, EUR J ORG CHEM, P889, DOI 10.1002/ejoc.201101730; Tredwell M, 2012, ANGEW CHEM INT EDIT, V51, P11426, DOI 10.1002/anie.201204687; He JK, 2014, MOL PHARMACEUT, V11, P2745, DOI 10.1021/mp500027c; Suzuki M, 2001, BIOORGAN MED CHEM, V9, P2727, DOI 10.1016/S0968-0896(01)00198-5; Wangler B, 2004, NUCL MED BIOL, V31, P639, DOI 10.1016/j.nucmedbio.2004.01.007; Koole M, 2009, J NUCL MED, V50, P818, DOI 10.2967/jnumed.108.060756; PIKE VW, 1993, NUCL MED BIOL, V20, P503, DOI 10.1016/0969-8051(93)90082-6; Suzuki M, 1999, BIOORG MED CHEM LETT, V9, P2977, DOI 10.1016/S0960-894X(99)00519-3; Camus V, 2012, EUR J NUCL MED MOL I, V39, P621, DOI 10.1007/s00259-011-2021-8; Hirano M, 2004, J PHARMACOL EXP THER, V311, P139, DOI 10.1124/jpet.104.068056; Degnan AP, 2008, J MED CHEM, V51, P4858, DOI 10.1021/jm800546t; Banister S., 2010, CURR RADIOPHARM, V3, P68; Franklin EC, 1944, CHEM REV, V35, P77; Fujino H., 1999, XENOBIO METABOL DISP, V14, P415; Ijuin R, 2012, BIOORGAN MED CHEM, V20, P3703, DOI 10.1016/j.bmc.2012.04.051; KARANEWSKY DS, 1991, J ORG CHEM, V56, P3744, DOI 10.1021/jo00011a064; Kimura H, 2014, J LABELLED COMPD RAD, V57, P680, DOI 10.1002/jlcr.3232; REIVICH M, 1979, CIRC RES, V44, P127; Scott PJH, 2010, J LABELLED COMPD RAD, V53, P586, DOI 10.1002/jlcr.1785; Takashima T, 2010, J PHARMACOL EXP THER, V335, P314, DOI 10.1124/jpet.110.170092; Takashima T, 2011, MOL PHARMACEUT, V8, P1789, DOI 10.1021/mp200160t	34	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.		2015	13	4					1113	1121		10.1039/c4ob01953a		9	Chemistry, Organic	Chemistry	AX9NO	WOS:000347229500019		
J	Yamaguchi, M; Matsuda, A; Ichikawa, S				Yamaguchi, Mayumi; Matsuda, Akira; Ichikawa, Satoshi			Synthesis of isoxazolidine-containing uridine derivatives as caprazamycin analogues	ORGANIC & BIOMOLECULAR CHEMISTRY			English	Article							INTRAMOLECULAR NITRONE CYCLOADDITIONS; NITRILE OXIDE CYCLOADDITIONS; 1ST MEMBRANE STEP; ANTIBACTERIAL AGENTS; NUCLEOSIDE ANTIBIOTICS; STREPTOMYCES SP; BAD BUGS; MRAY; BIOSYNTHESIS; DISCOVERY	Simplification of caprazamycins, which are promising antibacterial nucleoside natural products, was conducted by scaffold-hopping of the structurally complex diazepanone moiety to the isoxazolidine scaffold. The designed isoxazolidine-containing uridine derivatives were synthesized by an intramolecular 1,3-dipolar cycloaddition of alkenyl nitrone as a key step. The lactone-fused isoxazolidine intermediate was easily converted to the target compounds by sequential introduction of key substituents upon ring-opening the lactone moiety by nucleophilic substitution and electrophilic capping of the resulting primary alcohol. Several analogues exhibited good activity against H. influenzae ATCC 10211 (MIC 0.25-0.5 mu g mL(-1)) and moderate activity against vancomycin-resistant E. faecalis SR7914 (MIC 4-8 mu g mL(-1)).	[Yamaguchi, Mayumi; Matsuda, Akira; Ichikawa, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Ichikawa, Satoshi] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Ichikawa, S (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	ichikawa@pharm.hokudai.ac.jp			JSPS [22659020, 24102502, 25293026]	This research was supported by JSPS Grant-in-Aid for Challenging Exploratory Research (SI, grant number 22659020), Scientific Research on Innovative Areas "Chemical Biology of Natural Products" (SI, grant number 24102502), and Scientific Research (B) (SI, grant number 25293026). We thank Mr Kouichi Uotani (Discovery Research Laboratories, Shionogi & Co., Ltd) for evaluating the antibacterial activities of the synthesized analogs. We also thank Ms S. Oka and Ms A. Tokumitsu (Center for Instrumental Analysis, Hokkaido University) for measurement of the mass spectra.	ANNUNZIATA R, 1988, TETRAHEDRON LETT, V29, P2881, DOI 10.1016/0040-4039(88)85237-7; ANNUNZIATA R, 1990, J ORG CHEM, V55, P1901, DOI 10.1021/jo00293a040; Annuziata R., 1987, TETRAHEDRON, V17, P4051; Hirano S, 2008, BIOORGAN MED CHEM, V16, P428, DOI 10.1016/j.bmc.2007.09.022; Gothelf KV, 1998, CHEM REV, V98, P863, DOI 10.1021/cr970324e; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Hirano S, 2008, BIOORGAN MED CHEM, V16, P5123, DOI 10.1016/j.bmc.2008.03.020; Ii K, 2010, J MED CHEM, V53, P3793, DOI 10.1021/jm100243n; HOUK KN, 1986, J AM CHEM SOC, V108, P2754, DOI 10.1021/ja00270a044; Overbye KM, 2005, DRUG DISCOV TODAY, V10, P45, DOI 10.1016/S1359-6446(04)03285-4; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Igarashi M, 2005, J ANTIBIOT, V58, P327; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Ichikawa S, 2007, EXPERT OPIN THER PAT, V17, P487, DOI 10.1571/13543776.17.5.487; Hirano S, 2008, J ORG CHEM, V73, P569, DOI 10.1021/jo702264e; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; Rice LB, 2006, BIOCHEM PHARMACOL, V71, P991, DOI 10.1016/j.bcp.2005.09.018; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; HOUK KN, 1984, J AM CHEM SOC, V106, P3880, DOI 10.1021/ja00325a040; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Ciapetti P., 2008, PRACTICE MED CHEM, V16, P290; Dini C, 2005, CURR TOP MED CHEM, V5, P1221, DOI 10.2174/156802605774463042; Igarahi M, 2003, J ANTIBIOT, V56, P580; Miyake M., 2004, [No title captured], Patent No. [WO 2004067544, 2004067544]; Monaghan RL, 2006, BIOCHEM PHARMACOL, V71, P901, DOI 10.1016/j.bcp.2005.11.023; Takeuchi T., 2001, [No title captured], Patent No. [JP 2003012687, 2003012687]; Tanino T., 2014, EUR J ORG CHEM, P1836; Tufariello J. J., 1984, 1 3 DIPOLAR CYCLOADD, V2, P83	32	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-0520	1477-0539		ORG BIOMOL CHEM	Org. Biomol. Chem.		2015	13	4					1187	1197		10.1039/c4ob02142h		11	Chemistry, Organic	Chemistry	AX9NO	WOS:000347229500027		
J	Nakamaru, Y; Takagi, D; Homma, A; Hatakeyama, S; Fukuda, S				Nakamaru, Yuji; Takagi, Dai; Homma, Akihiro; Hatakeyama, Shigetsugu; Fukuda, Satoshi			Oxidative Stress Regulates IL-4 Gene Expression in Mast Cells through the Reduction of Histone Deacetylase	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						histone deacetylase; interleukin (IL)-4; mast cell; oxidative stress	HYDROGEN-PEROXIDE; HISTAMINE-RELEASE; ASTHMA; TRANSCRIPTION; INHIBITION; CHILDREN; RHINITIS; DISEASES; AIRWAYS	Objective Many proinflammatory cytokines are regulated by the acetylation and deacetylation of the core histone. Since dysregulation of T helper 2 cytokine production is a key in the pathogenesis of allergic diseases, we examined the role of histone deacetylase (HDAC) on interleukin (IL)-4 gene expression in mast cells. We also examined whether oxidative stress has any impact on HDAC activity. Study Design In vitro study. Setting Academic research laboratory. Methods An IgE-sensitized mast cell line (RBL-2H3 cells) was treated with varying concentrations of the HDAC inhibitors trichostatin A (TSA) and H2O2 and stimulated with antigens. The amount of IL-4 gene expression was quantified by real-time polymerase chain reaction. Quantitative measurement of IL-4 in the cell supernatant was performed using enzyme-linked immunosorbent assay. Moreover, HDAC activity was measured with the use of a nonisotopic assay that utilized an HDAC Fluorescent Activity Assay Kit. Results IL-4 mRNA expression was induced by antigens in IgE-sensitized RBL-2H3 cells. Pretreatment with TSA and H2O2 enhanced IL-4 mRNA expression up to 5-fold in a dose-dependent manner. Furthermore, HDAC activity in RBL-2H3 cells was reduced after treatment with H2O2. Conclusion Our results suggest that oxidative stress may up-regulate IL-4 gene expression in mast cells via a decrease in HDAC activity.	[Nakamaru, Yuji; Takagi, Dai; Homma, Akihiro; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido 0608638, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Sapporo, Hokkaido 0608638, Japan	Nakamaru, Y (reprint author), Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, West 7,North 15, Sapporo, Hokkaido 0608638, Japan.	nmaru@med.hokudai.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979	Japanese Ministry of Education, Culture, Sports, Science and Technology	The Japanese Ministry of Education, Culture, Sports, Science and Technology.	Aberg N, 1996, ALLERGY, V51, P232, DOI 10.1111/j.1398-9995.1996.tb04598.x; Barnes PJ, 2005, EUR RESPIR J, V25, P552, DOI 10.1183/09031936.05.00117504; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Barnes PJ, 1998, PHARMACOL REV, V50, P515; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Black PN, 1997, EUR RESPIR J, V10, P6, DOI 10.1183/09031936.97.10010006; Bowler RP, 2002, AM J RESP CRIT CARE, V166, pS38, DOI 10.1164/rccm.2206014; Kobayashi Y, 2013, BRIT J PHARMACOL, V169, P1024, DOI 10.1111/bph.12187; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Hogan SP, 1997, PHARMACOL THERAPEUT, V74, P259, DOI 10.1016/S0163-7258(97)00001-6; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Jorres R, 1996, AM J RESP CRIT CARE, V153, P56; MARTINEZ FD, 1992, PEDIATRICS, V89, P21; OGASAWARA H, 1986, J ALLERGY CLIN IMMUN, V78, P321, DOI 10.1016/S0091-6749(86)80083-5; OHMORI H, 1980, BIOCHEM PHARMACOL, V29, P741, DOI 10.1016/0006-2952(80)90550-X; Ozkaya E, 2013, AM J RHINOL ALLERGY, V27, P13, DOI 10.2500/ajra.2013.27.3837; PEDEN DB, 1994, AM J PHYSIOL, V267, pL85; Valapour M, 2002, J ALLERGY CLIN IMMUN, V109, P238, DOI 10.1067/mai.2002.121145; WILLIAMS ME, 1993, EUR J IMMUNOL, V23, P1910, DOI 10.1002/eji.1830230827; Wu Z, 2004, CURR PHARM DESIGN, V10, P899, DOI 10.2174/1381612043452875	25	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	JAN	2015	152	1					48	52		10.1177/0194599814559189		5	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	AX6ZK	WOS:000347066300005		
J	Noro, M; Zhu, X; Takagi, T; Sahara, N; Narabayashi, Y; Hashimoto, H; Ito, N; Enomoto, Y; Nakamura, K; Kujime, S; Sakai, T; Sakata, T; Sugi, K				Noro, Mahito; Zhu, Xin; Takagi, Takahito; Sahara, Naohiko; Narabayashi, Yuriko; Hashimoto, Hikari; Ito, Naoshi; Enomoto, Yoshinari; Nakamura, Keijirou; Kujime, Shingo; Sakai, Tuyoshi; Sakata, Takao; Sugi, Kaoru			Left Axillary Pacemaker Generator Implantation with a Direct Puncture of the Left Axillary Vein	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						cosmetic outcome; direct axillary vein puncture; functional; left axillary generator implantation; mental burden	COSMETIC APPROACH; DEVICE; DEFIBRILLATORS; SAFETY; WOMEN	BackgroundPacemaker generators are routinely implanted in the anterior chest. However, where to place the generator may need to be considered from the mental, functional, and cosmetic standpoints. MethodsIn this study, we performed the left axillary pacemaker generator implantation with a direct puncture of the left axillary vein in 40 consecutive patients, and evaluated the late safety and efficacy of this implantation. Complications, changes in the lead sensing, pacing threshold, and impedance were used as safety indexes for a mean follow-up of 3.4 years. In addition, the efficacy was also evaluated by comparing their questionnaire survey results to 119 patients in a control group of anterior chest implantation. ResultsLead dislodgements were observed in two patients of the experiment group. There were no migrations of generators from the implantation site or abnormal variations in the pacing threshold, lead sensing, or impedance. In the left anterior chest and left axillary groups, 85% and 10% of the patients were worried about an external impact, 80% and 25% were worried about electromagnetic interference, and 68% and 0% answered that the pacemaker implantation site was noticeable, respectively. Apparently, more patients had a sense of security and cosmetic satisfaction with the left axillary implantation. ConclusionThe left axillary generator implantations may reduce the mental burden and cause no safety concerns, and may be performed if functional or cosmetic outcomes are required.	[Noro, Mahito; Takagi, Takahito; Sahara, Naohiko; Narabayashi, Yuriko; Hashimoto, Hikari; Ito, Naoshi; Enomoto, Yoshinari; Nakamura, Keijirou; Kujime, Shingo; Sakata, Takao; Sugi, Kaoru] Toho Univ, Div Cardiovasc Med, Ohashi Med Ctr, Meguro Ku, Tokyo 538515, Japan; [Zhu, Xin] Univ Aizu, Biomed Informat Technol Lab, Aizu Wakamatsu, Fukushima, Japan; [Sakai, Tuyoshi] Saiseikai Yokohamashi Tobu Hosp, Div Cardiovasc Med, Yokohama, Kanagawa, Japan	Noro, M (reprint author), Toho Univ, Div Cardiovasc Med, Ohashi Med Ctr, Meguro Ku, 2-17-6 Ohashi, Tokyo 538515, Japan.	noro@oha.toho-u.ac.jp					Al-Bataineh M, 2010, J INTERV CARD ELECTR, V27, P137, DOI 10.1007/s10840-009-9444-1; Sowell LV, 2006, J WOMENS HEALTH, V15, P830, DOI 10.1089/jwh.2006.15.830; Ramza BM, 1997, AM J CARDIOL, V80, P892, DOI 10.1016/S0002-9149(97)00542-0; Babuty D, 2012, ANN THORAC SURG, V93, P331, DOI 10.1016/j.athoracsur.2011.08.045; Belott PH, 2008, CARDIAC PACING CLIN, P107, DOI 10.1007/978-0-387-72763-9_4; Collins KK, 2009, PEDIATR CARDIOL, V30, P1157, DOI 10.1007/s00246-009-9492-4; Dodge-Khatami AD, 2005, EUR J CARDIO-THORAC, V28, P541, DOI 10.1016/j.ejcts.2005.06.040; Giudici MC, 2001, PACE, V24, P1679, DOI 10.1046/j.1460-9592.2001.01679.x; Giudici MC, 2010, PACE, V33, P1373, DOI 10.1111/j.1540-8159.2010.02871.x; Lee JCR, 2004, PACE, V27, P304, DOI 10.1111/j.1540-8159.2004.00432.x; Netter FH, 2004, ATLAS HUMAN ANATOMY, P411; Putz R, 2006, SOBOTTA ATLAS ANATOM, P228; Rausch CM, 2010, AM J CARDIOL, V106, P1646, DOI 10.1016/j.amjcard.2010.07.025; ROELKE M, 1994, PACE, V17, P1793, DOI 10.1111/j.1540-8159.1994.tb03747.x; Rosenthal E, 2000, PACE, V23, P1397, DOI 10.1111/j.1540-8159.2000.tb00969.x; Shefer A, 1996, PACE, V19, P1646, DOI 10.1111/j.1540-8159.1996.tb03194.x	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	JAN	2015	38	1					35	41		10.1111/pace.12500		7	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	AX9PY	WOS:000347235500005		
J	Kuroda, M				Kuroda, Masamichi			Q-BASES OF THE NERON-SEVERI GROUPS OF CERTAIN ELLIPTIC SURFACES	PACIFIC JOURNAL OF MATHEMATICS			English	Article						elliptic surfaces; Neron-Severi groups	NUMBERS	P. Stiller computed the rank of the Neron-Severi group (known as the Picard number) for several families of elliptic surfaces. However, he did not give the generators of these groups. In this paper we give Q-bases of these groups explicitly. If these surfaces are rational, we also show that they are Z-bases.	Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan	Kuroda, M (reprint author), Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan.	m-kuroda@math.sci.hokudai.ac.jp					KODAIRA K, 1963, ANN MATH, V78, P1, DOI 10.2307/1970500; KODAIRA K, 1963, ANN MATH, V77, P563, DOI 10.2307/1970131; COX DA, 1979, INVENT MATH, V53, P1, DOI 10.1007/BF01403189; Hartshorne R., 1977, GRAD TEXTS MATH, V52; SHIODA T, 1972, J MATH SOC JPN, V24, P20; Shioda T., 1990, COMMENT MATH U ST PA, V39, P211; Silverman J. H., 1994, GRADUATE TEXTS MATH, V151; Silverman JH, 2000, J ALGEBRAIC GEOM, V9, P301; STILLER PF, 1987, PAC J MATH, V128, P157	9	0	0	PACIFIC JOURNAL MATHEMATICS	BERKELEY	PO BOX 4163, BERKELEY, CA 94704-0163 USA	0030-8730			PAC J MATH	Pac. J. Math.	JAN	2015	273	1					101	121		10.2140/pjm.2015.273.101		21	Mathematics	Mathematics	AX4MF	WOS:000346905900005		
J	Hasegawa, T; Saito, S				Hasegawa, Takehiro; Saito, Seiken			ON A PRIME ZETA FUNCTION OF A GRAPH	PACIFIC JOURNAL OF MATHEMATICS			English	Article						Ihara zeta functions; primes in graphs; Mertens' theorem	NUMBER THEOREM; CLOSED ORBITS; ANALOG	In the first half of this paper, we introduce a prime zeta function associated with the Ihara zeta function, and study several properties of this function. In the last half, using results of the first half, we present graph-theoretic analogues to Mertens' theorems.	[Hasegawa, Takehiro] Shiga Univ, Otsu, Shiga 5200862, Japan; [Saito, Seiken] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan	Hasegawa, T (reprint author), Shiga Univ, Otsu, Shiga 5200862, Japan.	thasegawa3141592@yahoo.co.jp; seiken.saitou@gmail.com					Stark HM, 1996, ADV MATH, V121, P124, DOI 10.1006/aima.1996.0050; PARRY W, 1983, ANN MATH, V118, P573, DOI 10.2307/2006982; IHARA Y, 1966, J MATH SOC JPN, V18, P219; Apostol T. M., 1974, MATH ANAL; Bass H., 1992, INT J MATH, V3, P717, DOI 10.1142/S0129167X92000357; Froberg C.-E., 1968, NORD TIDSKR INFORM, V8, P187; Glaisher J. W. L., 1891, Q J MATH, V25, P347; Hardy G. H., 2008, INTRO THEORY NUMBERS; Hashimoto K., 1989, ADV STUD PURE MATH, V15, P211; Horton MD, 2006, CONTEMP MATH, V415, P173; Jameson G. J. O., 2003, LONDON MATH SOC STUD, V53; Korevaar J, 2002, B AM MATH SOC, V39, P475, DOI 10.1090/S0273-0979-02-00951-5; Landau E., 1920, REND CIRC MAT PALERM, V44, P82; Lebedev N. N., 1972, SPECIAL FUNCTIONS TH; Mertens F., 1874, J REINE ANGEW MATH, V78, P46; Northshield S, 1998, J COMB THEORY B, V74, P408, DOI 10.1006/jctb.1998.1861; PARRY W, 1983, ISRAEL J MATH, V45, P41, DOI 10.1007/BF02760669; Sharp R., 1991, BOL SOC BRAS MAT, V21, P205, DOI 10.1007/BF01237365; Storm C., 2010, ELECTRON J COMB, V17; Sunada T., 2000, J MATH SCI-U TOKYO, V7, P7; Terras A. A., 2011, CAMBRIDGE STUDIES AD, V128; Titchmarsh B. C., 1986, THEORY RIEMANN ZETA; Titchmarsh E. C., 1958, THEORY FUNCTIONS	23	2	2	PACIFIC JOURNAL MATHEMATICS	BERKELEY	PO BOX 4163, BERKELEY, CA 94704-0163 USA	0030-8730			PAC J MATH	Pac. J. Math.	JAN	2015	273	1					123	146		10.2140/pjm.2015.273.123		24	Mathematics	Mathematics	AX4MF	WOS:000346905900006		
J	Kume, K; Masamune, A; Ariga, H; Shimosegawa, T				Kume, Kiyoshi; Masamune, Atsushi; Ariga, Hiroyuki; Shimosegawa, Tooru			Alcohol Consumption and the Risk for Developing Pancreatitis A Case-Control Study in Japan	PANCREAS			English	Article						acute pancreatitis; chronic pancreatitis; ethanol; nationwide survey; smoking; ALDH - aldehyde dehydrogenase; AP - acute pancreatitis; CI - confidence interval; CP - chronic pancreatitis; OR - odds ratio; SD - standard deviation	NATIONWIDE EPIDEMIOLOGIC SURVEY; CIGARETTE-SMOKING; DRINKING; METAANALYSIS; POPULATION; DISEASES; HABITS; COHORT; MEN	Objective This study aimed to estimate the association of alcohol consumption and pancreatitis in Japan. Methods We performed a nationwide case-control study, which included 982 patients (574 patients with acute pancreatitis and 408 patients with chronic pancreatitis) and 1015 controls who were individually matched for sex, age, hospital, and time of their first hospital visit. Conditional logistic regression was used to assess the association of alcohol consumption and smoking with pancreatitis. Results The patients had a mean (SD) age of 57.6 (17.0) years; 71.8% were male. Compared with nondrinkers, alcohol consumption of less than 20 g/d was not associated with the risk for total pancreatitis (odds ratio [OR], 1.0; 95% confidence interval [CI], 0.7-1.4). In patients with acute pancreatitis, the ORs (95% CI) for alcohol consumption of 20 approximate to < 40 g/d, 40 approximate to < 60 g/d, 60 approximate to < 80 g/d, 80 approximate to < 100 g/d, and 100 g/d or greater were 1.7 (0.9-3.0), 3.1 (1.6-5.9), 4.2 (2.1-8.2), 5.3 (2.4-12.0), and 6.4 (3.4-12.4), respectively. In patients with chronic pancreatitis, the ORs (95% CI) for alcohol consumption of 20 approximate to < 40 g/d, 40 approximate to < 60 g/d, 60 approximate to < 80 g/d, 80 approximate to < 100 g/d, and 100 g/d or greater were 2.6 (1.2-5.5), 3.2 (1.5-7.1), 9.2 (4.1-20.3), 13.0 (5.3-31.6), and 19.6 (8.2-46.8), respectively. Conclusions Our study precisely measured the quantitative effect of alcohol on the risk for developing pancreatitis.	[Kume, Kiyoshi; Masamune, Atsushi; Ariga, Hiroyuki; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 9808574, Japan	Masamune, A (reprint author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	amasamune@med.tohoku.ac.jp					Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Blomgren KB, 2002, EUR J CLIN PHARMACOL, V58, P275, DOI 10.1007/s00228-002-0471-4; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; Kristiansen L, 2008, AM J EPIDEMIOL, V168, P932, DOI 10.1093/aje/kwn222; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Nair S, 2001, AM J GASTROENTEROL, V96, P1200, DOI 10.1111/j.1572-0241.2001.03702.x; Maisonneuve P, 2005, GUT, V54, P510, DOI 10.1136/gut.2004.039263; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; DURBEC JP, 1978, DIGESTION, V18, P337; HABER PS, 1993, PANCREAS, V8, P568, DOI 10.1097/00006676-199309000-00007; Hamada S, 2014, PANCREAS, V43, P1244, DOI 10.1097/MPA.0000000000000200; Higuchi S, 2007, ADDICTION, V102, P1849, DOI 10.1111/j.1360-0443.2007.01902.x; Hirota M, 2012, PANCREATOLOGY, V12, P79, DOI 10.1016/j.pan.2012.02.005; Irving Hyacinth M, 2009, JOP, V10, P387; Lankisch MR, 2001, MAYO CLIN PROC, V76, P242; LEVY P, 1995, PANCREAS, V10, P231; Lin YS, 2001, AM J GASTROENTEROL, V96, P2622, DOI 10.1016/S0002-9270(01)02683-1; Masamune A, 2013, PANCREAS, V42, P578, DOI 10.1097/MPA.0b013e31827a02bc; Maskarinec G, 2009, ETHNIC DIS, V19, P49; Nakamura Yuji, 2003, Pancreas, V26, pe27, DOI 10.1097/00006676-200303000-00022; Ogawa M, 2002, PANCREAS, V25, P325, DOI 10.1097/00006676-200211000-00001; Otsuki M, 2003, J GASTROENTEROL, V38, P315, DOI 10.1007/s005350300058; Otsuki M, 2007, INTERNAL MED, V46, P109, DOI 10.2169/internaimedicine.46.1787; Sand J, 2007, PANCREATOLOGY, V7, P147, DOI 10.1159/000104251; SCHMIDT DN, 1991, INT J PANCREATOL, V8, P45; World Health Organization, 2009, GLOB HLTH RISKS MORT; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851	29	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	JAN	2015	44	1					53	58		10.1097/MPA.0000000000000256		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX9QL	WOS:000347236900007		
J	Kitahashi, T; Takahashi, M; Imai, T				Kitahashi, Tsukasa; Takahashi, Mami; Imai, Toshio			Biphasic Alterations in Expression and Subcellular Localization of MUC1 in Pancreatic Ductal Carcinogenesis in Syrian Hamsters	PANCREAS			English	Article						pancreatic ductal adenocarcinoma; MUC1; cytoplasmic domain; epithelial-mesenchymal transition	GOLDEN-HAMSTER; INTRAEPITHELIAL NEOPLASIA; CANCER; LESIONS; ADENOCARCINOMA; CELLS; P16(INK4A); ONCOGENE; GENETICS; PROFILE	Objectives The aim of the present study was to characterize molecular targets for the prevention/diagnosis of pancreatic cancer using a chemically induced hamster pancreatic carcinogenesis model, in which background injuries to the parenchyma, for example, chronic pancreatitis or acinar atrophy, are limited. Methods Gene expression profiles in atypical hyperplasias were first investigated using a microarray technique. Immunohistochemical analyses of early lesions and invasive ductal carcinoma (IDC) were then conducted for MUC1, of which mRNA levels were prominent among the up-regulated genes, in contrast with the coexpression of epithelial-mesenchymal transition (EMT)-related proteins. Results Immunohistochemistry for MUC1 cytoplasmic domain (MUC1-CD), which was not detected in normal-like pancreatic ducts, was positive in the apical surfaces of the epithelia of hyperplasias with and without atypia and IDC areas with distinct tubular patterns. In contrast, cytoplasmic/nuclear positivity for MUC1-CD was observed in the invasive front of IDCs. The coexpression of EMT-related proteins, such as slug and vimentin, with cytoplasmic/nuclear MUC1-CD was also detected. Conclusions Alterations in the expression and subcellular localization of MUC1 represent a biphasic phenomenon, and the latter may be associated with EMT in pancreatic carcinogenesis in hamsters, which indicates that changes in MUC1 are important targets for pancreatic cancer prevention and chemotherapy.	[Kitahashi, Tsukasa; Takahashi, Mami; Imai, Toshio] Natl Canc Ctr, Res Inst, Cent Anim Div, Tokyo 1040045, Japan	Imai, T (reprint author), Natl Canc Ctr, Res Inst, Cent Anim Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	toimai@ncc.go.jp					Kufe DW, 2009, CANCER BIOL THER, V8, P1197, DOI 10.4161/cbt.8.13.8844; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Cutts RJ, 2011, NUCLEIC ACIDS RES, V39, pD1023, DOI 10.1093/nar/gkq937; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Nagata K, 2007, J HEPATO-BILIARY-PAN, V14, P243, DOI 10.1007/s00534-006-1169-2; Krejs GJ, 2010, DIGEST DIS, V28, P355, DOI 10.1159/000319414; Logsdon CD, 2003, CANCER RES, V63, P2649; Pan S, 2009, ELECTROPHORESIS, V30, P1132, DOI 10.1002/elps.200800752; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Kitahashi T, 2011, ONCOL LETT, V2, P229, DOI 10.3892/ol.2011.252; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Terada T, 1996, J PATHOL, V180, P160, DOI 10.1002/(SICI)1096-9896(199610)180:2<160::AID-PATH625>3.0.CO;2-A; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Hori M, 2011, PANCREAS, V40, P1234, DOI 10.1097/MPA.0b013e318220e742; BAECKSTROM D, 1993, CANCER RES, V53, P755; BIRT D F, 1985, Nutrition and Cancer, V7, P167; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Frampton AE, 2012, EXPERT REV ANTICANC, V12, P1275, DOI [10.1586/era.12.108, 10.1586/ERA.12.108]; FUJII H, 1990, MOL CARCINOGEN, V3, P296, DOI 10.1002/mc.2940030510; Kigure Sonomi, 2006, Rinsho Byori, V54, P447; Kim HN, 2007, PANCREAS, V34, P325, DOI 10.1097/MPA.0b013e3180317b01; KONISHI Y, 1990, INT J PANCREATOL, V7, P83; Konishi Y, 1998, PANCREAS, V16, P300, DOI 10.1097/00006676-199804000-00015; Lau SKM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036753; Li JN, 2004, CARCINOGENESIS, V25, P263, DOI 10.1093/carcin/bgh007; Li JN, 2003, BIOCHEM BIOPH RES CO, V304, P241, DOI 10.1016/S0006-291X(03)00577-1; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Muscarella P, 2001, GENE, V278, P235, DOI 10.1016/S0378-1119(01)00728-4; TAKAHASHI M, 1978, J NATL CANCER I, V60, P355; Yuan ZL, 2009, J SURG RES, V157, pE39, DOI 10.1016/j.jss.2008.09.005	40	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	JAN	2015	44	1					76	86		10.1097/MPA.0000000000000178		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX9QL	WOS:000347236900010		
J	Furukawa, K; Kawamoto, K; Eguchi, H; Tanemura, M; Tanida, T; Tomimaru, Y; Akita, H; Hama, N; Wada, H; Kobayashi, S; Nonaka, Y; Takamatsu, S; Shinzaki, S; Kumada, T; Satomura, S; Ito, T; Serada, S; Naka, T; Mori, M; Doki, Y; Miyoshi, E; Nagano, H				Furukawa, Kenta; Kawamoto, Koichi; Eguchi, Hidetoshi; Tanemura, Masahiro; Tanida, Tsukasa; Tomimaru, Yoshito; Akita, Hirofumi; Hama, Naoki; Wada, Hiroshi; Kobayashi, Shogo; Nonaka, Yuji; Takamatsu, Shinji; Shinzaki, Shinichiro; Kumada, Takashi; Satomura, Shinji; Ito, Toshifumi; Serada, Satoshi; Naka, Tetsuji; Mori, Masaki; Doki, Yuichiro; Miyoshi, Eiji; Nagano, Hiroaki			Clinicopathological Significance of Leucine-Rich alpha 2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer	PANCREAS			English	Article						leucine-rich 2-glycoprotein-1; pancreatic cancer; biomarker	MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; DIFFERENCE GEL-ELECTROPHORESIS; PLASMA PROTEOMICS; ADENOCARCINOMA; APPENDICITIS; RESECTION; ACID; LRG1	Objectives Leucine-rich 2-glycoprotein-1 (LRG-1) is an inflammatory protein. Serum LRG-1 levels can reportedly be used as a cancer biomarker for several types of carcinoma. In the present study, we investigated the clinical usefulness of serum LRG-1 levels as a biomarker of pancreatic cancer. Methods A total of 124 patients with pancreatic cancer, 35 patients with chronic pancreatitis (CP), and 144 healthy volunteers were enrolled in the study. Serum LRG-1 levels were assayed by enzyme-linked immunosorbent assay. Immunohistochemistry was used to examine LRG-1 expression in pancreatic cancer tissues. Results Serum LRG-1 levels were significantly increased in patients with pancreatic cancer compared with CP patients and healthy volunteers. The LRG-1 levels increased with progressive clinical stages of pancreatic cancer. Receiver operator curve analysis showed that a combination of carbohydrate antigen 19-9 and LRG-1 resulted in a higher area under the curve for the diagnosis of pancreatic cancer. Positive staining was observed in all cases of pancreatic cancer, but positive signal was scarcely detected in tissues from CP patients or normal surrounding tissue. Conclusions These results suggest that serum LRG-1 is a promising biomarker for pancreatic cancer.	[Furukawa, Kenta; Kawamoto, Koichi; Eguchi, Hidetoshi; Tanida, Tsukasa; Tomimaru, Yoshito; Akita, Hirofumi; Hama, Naoki; Wada, Hiroshi; Kobayashi, Shogo; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Tanemura, Masahiro] Natl Hosp Org, Kure Med Ctr, Dept Surg, Hiroshima, Japan; [Tanemura, Masahiro] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Hiroshima, Japan; [Tanemura, Masahiro] Chugoku Canc Ctr, Hiroshima, Japan; [Nonaka, Yuji; Takamatsu, Shinji; Shinzaki, Shinichiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan; [Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Gifu, Japan; [Satomura, Shinji] Wako Pure Chem Ind Ltd, Osaka, Japan; [Ito, Toshifumi] Japan Community Hlth Care Org, Osaka Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka, Japan	Nagano, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	hnagano@gesurg.med.osaka-u.ac.jp					Ai J, 2008, J LEUKOCYTE BIOL, V83, P1277, DOI 10.1189/jlb.1107751; Andersen JD, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-21; Ladd JJ, 2012, CANCER PREV RES, V5, P655, DOI 10.1158/1940-6207.CAPR-11-0412; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Codina R, 2010, APOPTOSIS, V15, P139, DOI 10.1007/s10495-009-0412-0; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI 10.3322/caac.20105; Sandanayake NS, 2011, BRIT J CANCER, V105, P1370, DOI 10.1038/bjc.2011.376; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Humphris JL, 2012, ANN ONCOL, V23, P1713, DOI 10.1093/annonc/mdr561; Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484; Okano T, 2006, PROTEOMICS, V6, P3938, DOI 10.1002/pmic.200500883; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Kakisaka T, 2007, J CHROMATOGR B, V852, P257, DOI 10.1016/j.jchromb.2007.01.029; Kawakami T, 2005, PROTEOMICS, V5, P4287, DOI 10.1002/pmic.200401287; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Japanese Pancreas Society, 2009, GEN RUL STUD PANCR C; Kentsis A, 2012, ANN EMERG MED, V60, P78, DOI 10.1016/j.annemergmed.2011.12.015; Kharbanda AB, 2012, ACAD EMERG MED, V19, P56, DOI 10.1111/j.1553-2712.2011.01251.x; Kim ST, 2014, CANCER RES TREAT, V46, P48, DOI 10.4143/crt.2014.46.1.48; Ministry of Health Labour and Welfare, 2010, DYN STAT POP 2010; Sarvari J, 2011, ONCOL LETT, V2, P871, DOI 10.3892/ol.2011.321; Serada S, 2012, INFLAMM BOWEL DIS, V18, P2169, DOI 10.1002/ibd.22936; Shirai R, 2010, J BIOL CHEM, V285, P21607, DOI 10.1074/jbc.M110.122788	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	JAN	2015	44	1					93	98		10.1097/MPA.0000000000000205		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX9QL	WOS:000347236900012		
J	Kuwae, Y; Kakehashi, A; Wakasa, K; Wei, M; Yamano, S; Ishii, N; Ohsawa, M; Wanibuchi, H				Kuwae, Yuko; Kakehashi, Anna; Wakasa, Kenichi; Wei, Min; Yamano, Shotaro; Ishii, Naomi; Ohsawa, Masahiko; Wanibuchi, Hideki			Paraneoplastic Ma Antigen-Like 1 as a Potential Prognostic Biomarker in Human Pancreatic Ductal Adenocarcinoma	PANCREAS			English	Article						pancreatic ductal adenocarcinoma; proteomics; biomarker	MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; S-TRANSFERASE-PI; MOLECULAR MARKERS; CANCER; EXPRESSION; TUMOR; SPECTROMETRY; IDENTIFICATION; DISCOVERY	Objective The present study aimed to identify novel useful clinical biomarker at early stages and to elucidate the molecular background of carcinogenesis in human pancreatic ductal adenocarcinomas (PDACs). Methods Proteomes of dissected PDACs and adjacent nontumor pancreatic tissues from formalin-fixed and paraffin-embedded sections from 10 patients were analyzed using QSTAR Elite liquid chromatography-tandem mass spectrometry, ProteinPilot Software, and Ingenuity Pathway Analysis. Expression of potential biomarker candidates was validated immunohistochemically in 50 PDAC patients, followed by survival analyses and statistical comparison of protein expression with clinicopathologic variables. Results Eight hundred five proteins displaying significant quantitative changes were identified in human PDACs by liquid chromatography-tandem mass spectrometry. Based on altered expression of downstream molecules, Ingenuity Pathway Analysis predicted up-regulation and/or activation of nuclear factor -catenin, SOX11, enolase 1, NFE2L2, SP1, SMAD1, SMAD2, SMAD3, SMAD4, HIF-1, and others. From proteome analysis, paraneoplastic Ma antigen-like 1 was selected as a potential biomarker of human PDAC. Furthermore, paraneoplastic neuronal Ma antigen-like 1 immunohistochemical evaluation in 50 PDAC patients revealed that its positive expression was significantly associated with the better overall survival (log-rank test; P = 0.009) and histological differentiation of PDACs (well, moderate, and poor; P = 0.027) as compared with patients with negative expression. Conclusion Paraneoplastic Ma antigen-like 1 is suggested as a novel potential clinically useful prognostic biomarker for patients with PDAC.	[Kuwae, Yuko; Wakasa, Kenichi; Ohsawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka 5458585, Japan; [Kakehashi, Anna; Wei, Min; Yamano, Shotaro; Ishii, Naomi; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Osaka 5458585, Japan	Wanibuchi, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	wani@med.osaka-cu.ac.jp					Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Turtoi A, 2011, J PROTEOME RES, V10, P4302, DOI 10.1021/pr200527z; Fu YJ, 2011, INT J CANCER, V129, P1541, DOI 10.1002/ijc.26102; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Singh P, 2011, PANCREAS, V40, P644, DOI 10.1097/MPA.0b013e31821ff741; Tews B, 2006, INT J CANCER, V119, P792, DOI 10.1002/ijc.21901; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; DeSouza LV, 2007, MOL CELL PROTEOMICS, V6, P1170, DOI 10.1074/mcp.M600378-MCP200; Van den Broeck A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-68; Wang X, 2008, BRIT J HAEMATOL, V143, P248, DOI 10.1111/j.1365-2141.2008.07329.x; Chen R, 2005, MOL CELL PROTEOMICS, V4, P523, DOI 10.1074/mcp.R500004-MCP200; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kojima K, 2012, PROTEOMICS, V12, P3393, DOI 10.1002/pmic.201100663; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168; Kowara R, 2006, BRAIN RES, V1119, P40, DOI 10.1016/j.brainres.2006.08.047; Cappello P, 2013, GASTROENTEROLOGY, V144, P1098, DOI 10.1053/j.gastro.2013.01.020; Penzo-Mendez AI, 2010, INT J BIOCHEM CELL B, V42, P425, DOI 10.1016/j.biocel.2009.07.018; Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Weigle B, 2005, ONCOL REP, V13, P139; Chung K, 2011, CANCER BIOMARK, V10, P101, DOI 10.3233/CBM-2012-0234; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Buchler P, 2003, PANCREAS, V26, P56, DOI 10.1097/00006676-200301000-00010; Chen HL, 2010, J NEUROSCI RES, V88, P3508, DOI 10.1002/jnr.22506; Chung Kyukwang, 2012, Osaka City Med J, V58, P13; Dube V, 2007, J PROTEOME RES, V6, P2648, DOI 10.1021/pr070087o; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; Kakehashi A, 2011, TOXICOL SCI, V119, P61, DOI 10.1093/toxsci/kfq307; Komatsu H, 2013, CANCER BIOMARK, V13, P171, DOI 10.3233/CBM-130336; Leyhe T, 2006, J NEURO-ONCOL, V78, P49, DOI 10.1007/s11060-005-9052-6; NIITSU Y, 1989, CANCER, V63, P317, DOI 10.1002/1097-0142(19890115)63:2<317::AID-CNCR2820630219>3.0.CO;2-P; Riener MO, 2009, HISTOL HISTOPATHOL, V24, P1121; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Trachte AL, 2002, AM J SURG, V184, P642, DOI 10.1016/S0002-9610(02)01105-4; Ueda S, 2004, PANCREAS, V29, pE1, DOI 10.1097/00006676-200407000-00061; Yang ZX, 2013, HEPATO-GASTROENTEROL, V60, P349, DOI 10.5754/hge12642	39	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	JAN	2015	44	1					106	115		10.1097/MPA.0000000000000220		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX9QL	WOS:000347236900014		
J	Itoh, T; Nitta, T; Nishinakamura, H; Kojima, D; Mera, T; Ono, J; Kodama, S; Yasunami, Y				Itoh, Takeshi; Nitta, Tomoyuki; Nishinakamura, Hitomi; Kojima, Daibo; Mera, Toshiyuki; Ono, Junko; Kodama, Shohta; Yasunami, Yohichi			HMGB1-Mediated Early Loss of Transplanted Islets Is Prevented by Anti-IL-6R Antibody in Mice	PANCREAS			English	Article						islet transplantation; HMGB1; anti-IL-6R antibody; graft loss	PANCREATIC-ISLETS; INTERLEUKIN-6 FAMILY; RHEUMATOID-ARTHRITIS; CASTLEMANS-DISEASE; RECEPTOR; CELLS; CYTOKINES; MOUSE; LIVER; GP130	Objectives The limited success in achieving insulin independence of patients with type 1 diabetes mellitus after islet transplantation from a single donor, mainly due to early loss of transplanted islets, hampers clinical application of islet transplantation. Previously, we have shown in mice that the early loss of transplanted islets in the liver, the site of islet transplantation, is caused by innate immune rejection triggered by high-mobility group box 1 (HMGB1) protein released from transplanted islets. We herein determined whether the HMGB1-mediated early loss of transplanted mouse islets is prevented by anti-interleukin-6 receptor (IL-6R) antibody. Methods The effect of anti-IL-6R antibody on amelioration of hyperglycemia in streptozocin-induced diabetic mice receiving 200 islets into the liver from a single donor was evaluated in association with HMGB1-stimulated interferon- production of hepatic mononuclear cells. Results Hyperglycemia of diabetic mice receiving 200 syngeneic islets was ameliorated with down-regulation of interferon- production of hepatic natural killer T cells and neutrophils when anti-IL-6R was administered at the time of transplantation. This beneficial effect was also seen in allografts when alloimmune rejection was prevented by anti-CD4 antibody. Conclusions These findings demonstrate that anti-IL-6R antibody prevented the early loss of intrahepatic islet grafts with inhibiting HMGB1-induced immune activation after islet transplantation.	[Itoh, Takeshi; Nitta, Tomoyuki; Nishinakamura, Hitomi; Kojima, Daibo; Mera, Toshiyuki; Kodama, Shohta; Yasunami, Yohichi] Fukuoka Univ, Dept Regenerat Med & Transplantat, Fac Med, Fukuoka 8140180, Japan; [Ono, Junko] Murakami Karindo Hosp, Fukuoka, Japan	Yasunami, Y (reprint author), Fukuoka Univ, Dept Regenerat Med & Transplantat, Fac Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	yasunami@fukuoka-u.ac.jp					Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Navarro-Millan I, 2012, CLIN THER, V34, P788, DOI 10.1016/j.clinthera.2012.02.014; KISHIMOTO T, 1995, BLOOD, V86, P1243; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheurn0338; MADHOK R, 1993, ANN RHEUM DIS, V52, P232, DOI 10.1136/ard.52.3.232; YOSHIZAKI K, 1989, BLOOD, V74, P1360; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nitta T, 2009, TRANSPLANTATION, V88, P49, DOI 10.1097/TP.0b013e3181aa6c9b; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Satoh M, 2007, TRANSPLANTATION, V83, P1085, DOI 10.1097/01.tp.0000260161.81775.58; Citro A, 2012, J CLIN INVEST, V122, P3647, DOI 10.1172/JCI63089; Nishimoto N, 2000, BLOOD, V95, P56; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Bellin MD, 2012, AM J TRANSPLANT, V12, P1576, DOI 10.1111/j.1600-6143.2011.03977.x; Cabric S, 2007, DIABETES, V56, P2008, DOI 10.2337/db07-0358; Itoh T, 2014, CELL TRANSPLANT, V23, P153, DOI 10.3727/096368912X658980; KEMP CB, 1973, NATURE, V244, P447, DOI 10.1038/244447a0; Kojima D, 2012, TRANSPLANTATION, V93, P983, DOI 10.1097/TP.0b013e31824d3508; Kojima D, 2012, TRANSPLANTATION, V94, P348; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; Ohtsuka K, 1997, TRANSPLANTATION, V64, P633, DOI 10.1097/00007890-199708270-00015; OKEDA T, 1979, ENDOCRINOL JAPON, V26, P495; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Yasunami Y, 2005, J EXP MED, V202, P913, DOI 10.1084/jem.20050448	26	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	JAN	2015	44	1					166	171		10.1097/MPA.0000000000000188		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX9QL	WOS:000347236900022		
J	Cox, CD; Nakayama, Y; Nomura, T; Martinac, B				Cox, C. D.; Nakayama, Y.; Nomura, T.; Martinac, B.			The evolutionary 'tinkering' of MscS-like channels: generation of structural and functional diversity	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						MscS-like channels; Mechanosensitive; Bacteria; MscS; Evolution	BACTERIAL MECHANOSENSITIVE CHANNELS; ESCHERICHIA-COLI MSCS; ELECTRON DOUBLE-RESONANCE; SMALL-CONDUCTANCE MSCS; CORYNEBACTERIUM-GLUTAMICUM; ION CHANNELS; E. COLI; ELECTROPHYSIOLOGICAL CHARACTERIZATION; ARABIDOPSIS-THALIANA; OSMOTIC ADAPTATION	The mechanosensitive channel of small conductance (MscS)-like channel superfamily is present in cell-walled organisms throughout all domains of life (Bacteria, Archaea and Eukarya). In bacteria, members of this channel family play an integral role in the protection of cells against acute downward shifts in environmental osmolarity. In this review, we discuss how evolutionary 'tinkering' has taken MscS-like channels from their currently accepted physiological function in bacterial osmoregulation to potential roles in processes as diverse as amino acid efflux, Ca2+ regulation and cell division. We also illustrate how this structurally and functionally diverse family of channels represents an essential industrial component in the production of monosodium glutamate, an attractive antibiotic target and a rich source of membrane proteins for the studies of molecular evolution.	[Cox, C. D.; Nakayama, Y.; Martinac, B.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Nomura, T.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kamigyo Ku, Kyoto 6028566, Japan; [Martinac, B.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia	Martinac, B (reprint author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia.	b.martinac@victorchang.edu.au	Nakayama, Yoshitaka/J-4973-2014	Nakayama, Yoshitaka/0000-0001-6797-5556	National Health and Medical Research Council of Australia [APP1047980]	The authors would like to thank Dr C. Kung, Dr E.S. Haswell, Dr G. Maksaev, Dr P. Koprowski and Dr A. Kubalski for their insightful input and critical reading of the manuscript. This study was supported by APP1047980 grant from the National Health and Medical Research Council of Australia.	Anishkin A, 2008, J GEN PHYSIOL, V132, P67, DOI 10.1085/jgp.200810000; Kamaraju K, 2011, J GEN PHYSIOL, V138, P49, DOI 10.1085/jgp.201110606; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; Campbell AK, 2007, CELL CALCIUM, V41, P97, DOI 10.1016/j.ceca.2006.05.007; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Malcolm HR, 2012, CHEMBIOCHEM, V13, P2037, DOI 10.1002/cbic.201200410; Lai JY, 2013, PROTEIN SCI, V22, P502, DOI 10.1002/pro.2222; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Naseem R, 2009, J MOL BIOL, V391, P42, DOI 10.1016/j.jmb.2009.05.064; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Petrov E, 2013, BIOPHYS J, V104, P1426, DOI 10.1016/j.bpj.2013.01.055; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Maksaev G, 2013, CHANNELS, V7, P215, DOI 10.4161/chan.24505; Ward R, 2014, BIOPHYS J, V106, P834, DOI [10.1016/j.bpj.2014.01.008, 10.1016/j.bpj.20t4.01.008]; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18180, DOI 10.1073/pnas.1207977109; Nakayama Y, 2007, P NATL ACAD SCI USA, V104, P5883, DOI 10.1073/pnas.0609996104; Boer M, 2011, BIOCHEMISTRY-US, V50, P4087, DOI 10.1021/bi1019435; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Yamashita C, 2013, BIOSCI BIOTECH BIOCH, V77, P1008, DOI 10.1271/bbb.120988; Nguyen T, 2005, EUR BIOPHYS J BIOPHY, V34, P389, DOI 10.1007/s00249-005-0468-x; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Belyy V, 2010, J GEN PHYSIOL, V135, P641, DOI 10.1085/jgp.200910371; Rao YJ, 2011, CELL MOL LIFE SCI, V68, P3983, DOI 10.1007/s00018-011-0768-5; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Nakayama Y, 2013, BIOPHYS J, V105, P1366, DOI 10.1016/j.bpj.2013.06.054; Wilson ME, 2013, BIOCHEMISTRY-US, V52, P5708, DOI 10.1021/bi400804z; Reuter M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0850; Rasmussen A, 2007, BIOCHEMISTRY-US, V46, P10899, DOI 10.1021/bi701056k; Malcolm HR, 2011, BIOPHYS J, V101, P345, DOI 10.1016/j.bpj.2011.05.058; Booth IR, 2014, CURR OPIN MICROBIOL, V18, P16, DOI 10.1016/j.mib.2014.01.005; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Campbell AK, 2007, ARCH BIOCHEM BIOPHYS, V468, P107, DOI 10.1016/j.abb.2007.09.006; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Naseem R, 2008, BBA-BIOMEMBRANES, V1778, P1415, DOI 10.1016/j.bbamem.2008.02.006; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Naismith JH, 2012, ANNU REV BIOPHYS, V41, P157, DOI 10.1146/annurev-biophys-101211-113227; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Becker M, 2013, BBA-BIOMEMBRANES, V1828, P1230, DOI 10.1016/j.bbamem.2013.01.001; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sukharev S, 2002, BIOPHYS J, V83, P290; Borngen K, 2010, BBA-BIOMEMBRANES, V1798, P2141, DOI 10.1016/j.bbamem.2010.06.022; Maksaev G, 2012, P NATL ACAD SCI USA, V109, P19015, DOI 10.1073/pnas.1213931109; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Caldwell DB, 2010, BBA-BIOMEMBRANES, V1798, P1750, DOI 10.1016/j.bbamem.2010.06.001; Cox C. D., 2013, NAT COMMUN, V4; Cox CD, 2013, CHANNELS AUSTIN, V8; Edwards MD, 2012, CHANNELS, V6, P272, DOI 10.4161/chan.20998; Hurst AC, 2008, INT J BIOCHEM CELL B, V40, P581, DOI 10.1016/j.biocel.2007.03.013; Jensen GS, 2012, PLOS ONE, V7; Kakuda T, 2012, VET MICROBIOL, V160, P53, DOI 10.1016/j.vetmic.2012.04.044; Kamaraju K, 2007, BIOPHYS J, p114A; Kloda A, 2001, BIOPHYS J, V80, P229; Koprowski P, 2011, J BIOL CHEM, V286, P877, DOI 10.1074/jbc.M110.176131; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Li C, 2007, MOL MICROBIOL, V64, P560, DOI 10.1111/j.1365-2958.2007.05672.x; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; Malcolm HR, 2012, EUR BIOPHYS J BIOPHY, V41, P1003, DOI 10.1007/s00249-012-0855-z; Martinac B, 2000, BIOPHYS J, V78, p22A; Maurer JA, 2001, BBA-BIOMEMBRANES, V1514, P165, DOI 10.1016/S0005-2736(01)00390-X; McLaggan D, 2002, MOL MICROBIOL, V43, P521, DOI 10.1046/j.1365-2958.2002.02764.x; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Nakamaru J, 2007, APPL ENVIRON MICROB, P4491; Nakayama Y, 2013, NAT COMMUN, P3; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Pliotas C, 2012, P NATL ACAD SCI USA, V109, pE2675, DOI 10.1073/pnas.1202286109; Rowe I, 2013, J GEN PHYSIOL, V142, P75, DOI 10.1085/jgp.201310985; Schumann U, 2004, FEBS LETT, V572, P233, DOI 10.1016/j.febslet.2004.07.045; Shaikh S, 2014, CHANNELS, V8; Veley Kira M, 2012, Plant Signal Behav, V7, P668, DOI 10.4161/psb.19991; Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111; Wilson M, 2012, PLANT SIGNALING BEHA, V7, P157; Wilson ME, 2014, PLANT PHYSL	88	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JAN	2015	467	1					3	13		10.1007/s00424-014-1522-2		11	Physiology	Physiology	AX8KA	WOS:000347157200002		
J	Kawashima, Y; Kurima, K; Pan, BF; Griffith, AJ; Holt, JR				Kawashima, Yoshiyuki; Kurima, Kiyoto; Pan, Bifeng; Griffith, Andrew J.; Holt, Jeffrey R.			Transmembrane channel-like (TMC) genes are required for auditory and vestibular mechanosensation	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Channel; Deafness; Hair cell; Hearing; Mechanoelectrical; Mechanosensory; Mechanotransduction; TMC1; TMC2; Transduction	CELL MECHANOTRANSDUCER CHANNELS; HEARING-LOSS DFNA36; SENSORY HAIR-CELLS; MOUSE INNER-EAR; DEVELOPMENTAL ACQUISITION; EARLY-ONSET; TRANSDUCTION; DEAFNESS; PROTEINS; DOMINANT	Mutations of the transmembrane channel-like 1 (TMC1) gene can cause dominant and recessive forms of deafness in humans and mice. TMC1 is one of eight mammalian TMC genes of unknown function. The multi-pass transmembrane topologic structure of the proteins they encode suggests roles as a receptor, transporter, channel, or pump. Tmc1 and the closely related Tmc2 gene are expressed in neurosensory hair cells of the auditory and vestibular end organs of the mouse inner ear. Recent studies have demonstrated that Tmc1 and Tmc2 are specifically required for mechanoelectrical transduction in hair cells. The exact role of these proteins in mechanoelectrical transduction is unknown. TMC1 and TMC2 are viable candidates for the mechanoelectrical transduction channel of hair cells, whose component molecules have eluded identification for over 30 years. We expect that studies of TMC proteins will yield insights into molecular components and mechanisms of mechanosensation in auditory and vestibular hair cells, as well as in other tissues and organs.	[Kawashima, Yoshiyuki] Tokyo Med & Dent Univ, Dept Otolaryngol, Bunkyo Ku, Tokyo 1138519, Japan; [Kurima, Kiyoto; Griffith, Andrew J.] NIDCD, Mol Biol & Genet Sect, NIH, Bethesda, MD 20892 USA; [Pan, Bifeng; Holt, Jeffrey R.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Otolaryngol, Boston, MA 02115 USA; [Pan, Bifeng; Holt, Jeffrey R.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Griffith, AJ (reprint author), NIDCD, Mol Biol & Genet Sect, NIH, 35A Convent Dr,Room GF 103, Bethesda, MD 20892 USA.	griffita@nidcd.nih.gov; jeffrey.holt@childrens.harvard.edu			NIH [Z01-DC000060-13]; NIH/NIDCD [RO1DC013521]; JSPS KAKENHI [26462551]	Kiyoto Kurima and Andrew Griffith are supported by NIH intramural research fund Z01-DC000060-13. Bifeng Pan and Jeffrey R. Holt are supported by NIH/NIDCD grant no. RO1DC013521. Yoshiyuki Kawashima is supported by JSPS KAKENHI grant no. 26462551.	Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Chatzigeorgiou M, 2013, NATURE, V494, P95, DOI 10.1038/nature11845; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Labay V, 2010, BIOCHEMISTRY-US, V49, P8592, DOI 10.1021/bi1004377; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Beurg M, 2014, J GEN PHYSIOL, V144, P53, DOI 10.1085/jgp.201411173; Kim KX, 2013, J GEN PHYSIOL, V141, P141, DOI 10.1085/jgp.201210913; Wang QJ, 2013, AM J HUM GENET, V92, P301, DOI 10.1016/j.ajhg.2012.12.015; Holt JR, 2014, HEARING RES, V311, P17, DOI 10.1016/j.heares.2014.01.001; Makishima T, 2004, OTOL NEUROTOL, V25, P714, DOI 10.1097/00129492-200409000-00011; Marcotti W, 2014, J NEUROSCI, V34, P5505, DOI 10.1523/JNEUROSCI.4086-13.2014; Kim KX, 2013, J GEN PHYSIOL, V142, P493, DOI 10.1085/jgp.201311068; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; de Heer AMR, 2011, AUDIOL NEURO-OTOL, V16, P93, DOI 10.1159/000313282; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Yang T, 2010, CLIN GENET, V77, P395, DOI 10.1111/j.1399-0004.2009.01338.x; Kitajiri S, 2007, CLIN GENET, V71, P148, DOI 10.1111/j.1399-0004.2007.00739.x; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Griffith AJ, 2002, AUTOSOMAL X LINKED A; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Mutai H, 2005, NEUROSCIENCE, V132, P1115, DOI 10.1016/j.neuroscience.2005.01.046; Noguchi Y, 2006, GENETICS, V173, P2111, DOI 10.1534/genetics.106.057372; STEEL KP, 1980, NATURE, V288, P159, DOI 10.1038/288159a0; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097064	36	8	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JAN	2015	467	1					85	94		10.1007/s00424-014-1582-3		10	Physiology	Physiology	AX8KA	WOS:000347157200008		
J	Nakatani, M; Maksimovic, S; Baba, Y; Lumpkin, EA				Nakatani, Masashi; Maksimovic, Srdjan; Baba, Yoshichika; Lumpkin, Ellen A.			Mechanotransduction in epidermal Merkel cells	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Touch; Piezo2; Mechanosensitive channels; Mechanosensory cells; Tactile	SELECTIVE PHOTOTOXIC DESTRUCTION; SENSORY NEURONS; ESSENTIAL COMPONENTS; NEURAL MECHANISMS; TOUCH RECEPTORS; NERVE-ENDINGS; ION CHANNELS; HAIRY SKIN; RAT; MECHANORECEPTORS	The cellular and molecular basis of vertebrate touch reception remains least understood among the traditional five senses. Somatosensory afferents that innervate the skin encode distinct tactile qualities, such as flutter, slip, and pressure. Gentle touch is thought to be transduced by somatosensory afferents whose tactile end organs selectively filter mechanical stimuli. These tactile end organs comprise afferent terminals in association with non-neuronal cell types such as Merkel cells, keratinocytes, and Schwann cells. An open question is whether these non-neuronal cells serve primarily as passive mechanical filters or whether they actively participate in mechanosensory transduction. This question has been most extensively studied in Merkel cells, which are epidermal cells that complex with sensory afferents in regions of high tactile acuity such as fingertips, whisker follicles, and touch domes. Merkel cell-neurite complexes mediate slowly adapting type I (SAI) responses, which encode sustained pressure and represent object features with high fidelity. How Merkel cells contribute to unique SAI firing patterns has been debated for decades; however, three recent studies in rodent models provide some direct answers. First, whole-cell recordings demonstrate that Merkel cells are touch-sensitive cells with fast, mechanically activated currents that require Piezo2. Second, optogenetics and intact recordings show that Merkel cells mediate sustained SAI firing. Finally, loss-of-function studies in transgenic mouse models reveal that SAI afferents are also touch sensitive. Together, these studies identify molecular mechanisms of mechanotransduction in Merkel cells, reveal unexpected functions for these cells in touch, and support a revised, two-receptor site model of mechanosensory transduction.	[Nakatani, Masashi; Maksimovic, Srdjan; Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Nakatani, Masashi] Keio Univ, Grad Sch Syst Design & Management, Yokohama, Kanagawa 223, Japan; [Lumpkin, Ellen A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Lumpkin, Ellen A.] Columbia Univ, Program Neurobiol & Behav, New York, NY 10032 USA	Lumpkin, EA (reprint author), Columbia Univ, Dept Dermatol, 1150 St Nicholas Ave,Room 302B, New York, NY 10032 USA.	eal2166@columbia.edu			National Institutes of Health [R01AR051219, R01NS073119]; Japan Society for the Promotion of Science Research Fellowships for Young Scientists [24-7585];  [F32NS080544]	We thank Ms. Blair Jenkins for assistance with figures and members of the Lumpkin lab for discussions. The authors are supported by National Institutes of Health grants R01AR051219 (to EAL) and R01NS073119 (to EAL and Gregory J. Gerling), and fellowships to MN (Japan Society for the Promotion of Science Research Fellowships for Young Scientists 24-7585) and SM (F32NS080544).	Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Soya M, 2014, CELL CALCIUM, V55, P208, DOI 10.1016/j.ceca.2014.02.015; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/physiol.2006.117648; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Morrison KM, 2009, DEV BIOL, V336, P76, DOI 10.1016/j.ydbio.2009.09.032; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Pawson L, 2009, J NEUROSCI, V29, P2695, DOI 10.1523/JNEUROSCI.5974-08.2009; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; Rugiero F, 2010, J PHYSIOL-LONDON, V588, P301, DOI 10.1113/jphysiol.2009.182360; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Bechstedt S, 2008, CURR BIOL, V18, pR869, DOI 10.1016/j.cub.2008.07.069; Boulais N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007759; Boulais N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006528; Cha M, 2011, J NEUROPHYSIOL, V106, P460, DOI 10.1152/jn.00274.2011; Chan E, 1996, EXP BRAIN RES, V108, P357; Diamond J, 1988, Prog Brain Res, V74, P51; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; Haeberle H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001750; Haeberle H, 2008, CHEMOSENS PERCEPT, V1, P110, DOI 10.1007/s12078-008-9012-6; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Han Xue, 2011, Front Syst Neurosci, V5, P18, DOI 10.3389/fnsys.2011.00018; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; Iggo A, 1984, P INT S SENS REC MEC, P117; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Ma QF, 2014, CELL, V157, P531, DOI 10.1016/j.cell.2014.04.010; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Merkel F., 1875, ARCH MIKROSK ANAT, V11, P636, DOI 10.1007/BF02933819; MILLS LR, 1995, J NEUROCYTOL, V24, P117, DOI 10.1007/BF01181555; Nilius B, 2014, J PHYSIOL-LONDON, V592, P295, DOI 10.1113/jphysiol.2013.255968; Nunzi MG, 2004, J NEUROCYTOL, V33, P359, DOI 10.1023/B:NEUR.0000044196.45602.92; Nurse C, 1988, MECHANORECEPTORS DEV, P189, DOI 10.1007/978-1-4899-0812-4_35; Pacitti E G, 1988, Prog Brain Res, V74, P37; PHILLIPS JR, 1985, J ACOUST SOC AM, V77, P220, DOI 10.1121/1.392262; Piskorowski R, 2008, PFLUG ARCH EUR J PHY, V457, P197, DOI 10.1007/s00424-008-0496-3; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Press D, 2010, SOMATOSENS MOT RES, V27, P174, DOI 10.3109/08990220.2010.516670; Reinisch CM, 2005, ANN NEUROL, V58, P88, DOI 10.1002/ana.20527; Senok SS, 1996, EXP BRAIN RES, V110, P325; Tachibana T, 2005, ARCH HISTOL CYTOL, V68, P19, DOI 10.1679/aohc.68.19; Tachibana Tamiko, 2002, Anatomical Science International, V77, P26, DOI 10.1046/j.0022-7722.2002.00008.x; Tazaki M, 1998, NEUROSCI LETT, V243, P69, DOI 10.1016/S0304-3940(98)00066-4; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143; YAMASHITA Y, 1991, SOMATOSENS MOT RES, V8, P87	64	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JAN	2015	467	1					101	108		10.1007/s00424-014-1569-0		8	Physiology	Physiology	AX8KA	WOS:000347157200010		
J	Hirata, H; Tatsumi, H; Hayakawa, K; Sokabe, M				Hirata, Hiroaki; Tatsumi, Hitoshi; Hayakawa, Kimihide; Sokabe, Masahiro			Non-channel mechanosensors working at focal adhesion-stress fiber complex	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Focal adhesions; Talin; Integrin; Actin stress fibers; ADF/cofilin; Substrate-rigidity sensing	CULTURED ENDOTHELIAL-CELLS; VINCULIN BINDING-SITES; ACTIVATED ION CHANNELS; ACTIN RETROGRADE FLOW; TALIN ROD; F-ACTIN; CATCH BONDS; MECHANICAL FORCE; SUBSTRATE FLEXIBILITY; INTEGRIN ACTIVATION	Mechanosensitive ion channels (MSCs) have long been the only established molecular class of cell mechanosensors; however, in the last decade, a variety of non-channel type mechanosensor molecules have been identified. Many of them are focal adhesion-associated proteins that include integrin, talin, and actin. Mechanosensors must be non-soluble molecules firmly interacting with relatively rigid cellular structures such as membranes (in terms of lateral stiffness), cytoskeletons, and adhesion structures. The partner of MSCs is the membrane in which MSC proteins efficiently transduce changes in the membrane tension into conformational changes that lead to channel opening. By contrast, the integrin, talin, and actin filament form a linear complex of which both ends are typically anchored to the extracellular matrices via integrins. Upon cell deformation by forces, this structure turns out to be a portion that efficiently transduces the generated stress into conformational changes of composite molecules, leading to the activation of integrin (catch bond with extracellular matrices) and talin (unfolding to induce vinculin bindings). Importantly, this structure also serves as an "active" mechanosensor to detect substrate rigidity by pulling the substrate with contraction of actin stress fibers (SFs), which may induce talin unfolding and an activation of MSCs in the vicinity of integrins. A recent study demonstrates that the actin filament acts as a mechanosensor with unique characteristics; the filament behaves as a negative tension sensor in which increased torsional fluctuations by tension decrease accelerate ADF/cofilin binding, leading to filament disruption. Here, we review the latest progress in the study of those non-channel mechanosensors and discuss their activation mechanisms and physiological roles.	[Hirata, Hiroaki; Sokabe, Masahiro] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Tatsumi, Hitoshi] Nagoya Univ, Dept Physiol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Hayakawa, Kimihide; Sokabe, Masahiro] Nagoya Univ, Mechanobiol Lab, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Sokabe, M (reprint author), Nagoya Univ, Mechanobiol Lab, Grad Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	msokabe@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Space Forum; MBI	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to K.H., H.T., and M.S.), a grant from the Japan Space Forum (to H.T. and M.S.), and a Seed Grant from MBI (to MS).	Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; SAKAI R, 1994, EMBO J, V13, P3748; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Lo CM, 2000, BIOPHYS J, V79, P144; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; LANSMAN JB, 1987, NATURE, V325, P811, DOI 10.1038/325811a0; Kong F, 2013, MOL CELL, V49, P1060, DOI 10.1016/j.molcel.2013.01.015; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.90.057; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WECHEZAK AR, 1985, LAB INVEST, V53, P639; Gautel M, 2011, PFLUG ARCH EUR J PHY, V462, P119, DOI 10.1007/s00424-011-0946-1; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Perbal G, 2009, MICROGRAVITY SCI TEC, V21, P3, DOI 10.1007/s12217-008-9064-x; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Schwingel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054850; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Kraning-Rush CM, 2012, CELL ADHES MIGR, V6, P274, DOI 10.4161/cam.21076; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Uemura A, 2011, BIOPHYS J, V101, P1069, DOI 10.1016/j.bpj.2011.08.001; Dembo M, 1999, BIOPHYS J, V76, P2307; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Lee IJ, 2012, CYTOSKELETON, V69, P751, DOI 10.1002/cm.21052; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Tatsumi H, 2014, PLANT BIOLOGY, V16, P18, DOI 10.1111/plb.12095; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636; Xu WM, 1998, J CELL SCI, V111, P1535; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Butler B, 2006, CURR BIOL, V16, P242, DOI 10.1016/j.cub.2005.12.033; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; Dyle AD, 2005, J CELL SCI, V118, P369, DOI [10.1242/jcs.01590, DOI 10.1242/JCS.01590]; Echarri A, 2012, J CELL SCI, V125, P3097, DOI 10.1242/jcs.090134; Galkin VE, 2012, CURR BIOL, V22, pR96, DOI 10.1016/j.cub.2011.12.010; Gee EPS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002373; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Hirata H, 2007, BBA-GEN SUBJECTS, V1770, P1115, DOI 10.1016/j.bbagen.2007.03.010; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Kawakami K, 2001, J CELL SCI, V114, P3125; Kiyoshima D, 2011, J CELL SCI, V124, P3859, DOI 10.1242/jcs.088559; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Matsushita S, 2011, J BIOMECH, V44, P1776, DOI 10.1016/j.jbiomech.2011.04.012; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; Menon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017277; Mizuno H, 2011, SCIENCE, V331, P80, DOI 10.1126/science.1197692; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; Ohashi K, 2011, J BIOL CHEM, V286, P36340, DOI 10.1074/jbc.M111.259135; Ono S, 1996, CELL STRUCT FUNCT, V21, P491; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; POPP R, 1992, J PHYSIOL-LONDON, V454, P435; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331; Hirata H, 2014, AM J PHYSIOL-CELL PH, V306, pC607, DOI 10.1152/ajpcell.00122.2013; Tsaturyan AK, 2011, BIOPHYS J, V101, P404, DOI 10.1016/j.bpj.2011.06.008; Uribe R, 2009, MOL BIOL REP, V36, P121, DOI 10.1007/s11033-007-9159-2; Uyeda TQP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026200; Wang YL, 2007, SCI STKE, DOI 10.1126/stke.3772007pe10; Wong DY, 2011, J MOL BIOL, V413, P97, DOI 10.1016/j.jmb.2011.08.039; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Yao XQ, 2001, BBA-BIOMEMBRANES, V1511, P381, DOI 10.1016/S0005-2736(01)00300-5; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	138	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JAN	2015	467	1					141	155		10.1007/s00424-014-1558-3		15	Physiology	Physiology	AX8KA	WOS:000347157200014		
J	Rani, M; Sakurai, H; Ahmad, J				Rani, Malika; Sakurai, Hiroya; Ahmad, Javed			Magnetic properties of Ba2CrO4 with honeycomb layers	PHYSICA B-CONDENSED MATTER			English	Article						Specific heat; Honeycomb layer; Magnetic susceptibility; g-Value	ELECTRON-PARAMAGNETIC-RESONANCE; CHROMIUM-DOPED FORSTERITE; BA3CRO5; LATTICE; SR2CRO4; MODEL	Anew synthesis method of Ba2CrO4 is developed and its magnetic properties are investigated by magnetic susceptibility, magnetization curve, and specific heat measurements. The compound shows a conventional antiferromagnetic transition at T-N = 3.5 K although magnetic properties due to honeycomb lattice is seen in Sr2CrO4. The g-value of Cr4+ ions in Ba2CrO4 is estimated to be g=1.94, which agrees well with the g-values of Cr4+ ions in other compounds. (C) 2014 Elsevier B.V. All rights reserved.	[Rani, Malika; Sakurai, Hiroya] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Rani, Malika; Ahmad, Javed] Buhauddin Zakariya Univ Multan, Dept Phys, Multan 60800, Pakistan	Rani, M (reprint author), Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	wirdeali14@yahoo.com			NIMS (JAPAN); Higher Education Commission (HEC) of Pakistan	One of the authors (MR.) was supported by NIMS (JAPAN) internship program and by Higher Education Commission (HEC) of Pakistan.	Affleck I., 1987, PHYS REV LETT, V59, P899; Zheng WC, 2005, SPECTROCHIM ACTA A, V61, P1905, DOI 10.1016/j.saa.2004.07.021; AFFLECK I, 1988, COMMUN MATH PHYS, V115, P477, DOI 10.1007/BF01218021; HALDANE FDM, 1983, PHYS REV LETT, V50, P1153, DOI 10.1103/PhysRevLett.50.1153; Smirnova O, 2009, J AM CHEM SOC, V131, P8313, DOI 10.1021/ja901922p; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; Bethe H. A., 1931, Z PHYS, V25, P205; Boyarchenkov AS, 2005, J PHYS-CONDENS MAT, V17, P1769, DOI 10.1088/0953-8984/17/12/001; BUDIL DE, 1994, J CHEM PHYS, V101, P3538, DOI 10.1063/1.467540; CHAMBERLAND BL, 1985, J SOLID STATE CHEM, V59, P111, DOI 10.1016/0022-4596(85)90357-3; Ganesh R, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144414; GUNTER JR, 1994, J THERM ANAL, V41, P449, DOI 10.1007/BF02549326; HOFFMAN KR, 1991, PHYS REV B, V44, P12589, DOI 10.1103/PhysRevB.44.12589; Hosokoshi Y, 1999, PHYS REV B, V60, P12924, DOI 10.1103/PhysRevB.60.12924; LIU G, 1993, J SOLID STATE CHEM, V105, P78, DOI 10.1006/jssc.1993.1195; Mattausch V. H. J., 1974, Z ANORG ALLG CHEM, V407, P9; Matuda M., 2010, PHYS REV LETT, V105; Rani M, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/22/226001; Scholder V. R., 1956, Z ANORG ALLG CHEM, V285, P4; Tsujii H., 2007, J MAGN MAGN MATER, V310, P415; WHITMORE MH, 1993, J CHEM PHYS, V98, P3656, DOI 10.1063/1.464043; Zheludev A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104427	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526	1873-2135		PHYSICA B	Physica B	JAN 1	2015	456						182	184		10.1016/j.physb.2014.08.050		3	Physics, Condensed Matter	Physics	AX3LP	WOS:000346841200033		
J	Wang, RP; Kanzaki, M				Wang, Riping; Kanzaki, Masami			Phase diagram and thermodynamic properties of AIPO(4) based on first-principles calculations and the quasiharmonic approximation	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						AlPO4; Phase diagram; Thermodynamic properties; Density functional theory; Density functional perturbation theory; Quasiharmonic approximation	FUNCTIONAL PERTURBATION-THEORY; HIGH-PRESSURE BEHAVIOR; QUARTZ-LIKE MATERIALS; X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; BERLINITE ALPO4; MEMORY-GLASS; ALPHA-ALPO4; TEMPERATURE; MOGANITE	We calculated the phase diagram of up to 15 GPa and 2,000 K and investigated the thermodynamic properties of the high-pressure phases. The investigated phases include the berlinite, moganite-like, , and phases . The computational methods used include density functional theory, density functional perturbation theory, and the quasiharmonic approximation. The investigated thermodynamic properties include the thermal equation of state, isothermal bulk modulus, thermal expansivity, and heat capacity. With increasing pressure, the ambient phase berlinite transforms to the moganite-like phase, and then to the and phases, and further to the phase. The stability fields of the and phases are similar in pressure but different in temperature, as the phase is stable at low temperatures, whereas the phase is stable at high temperatures. All of the phase relationships agree well with those obtained by quench experiments, and they support the stabilities of the moganite-like, , and phases, which were not observed in room-temperature compression experiments.	[Wang, Riping; Kanzaki, Masami] Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan	Wang, RP (reprint author), Beijing Computat Sci Res Ctr, Beijing 10084, Peoples R China.	wang.riping.81@gmail.com	KANZAKI, Masami/B-1883-2011	KANZAKI, Masami/0000-0002-1659-4144	Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by a Grants-in-Aid for Scientific Research funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan to M.K. and Xianyu Xue. We thank Xianyu Xue for discussions and providing the PCs used for the calculations. R.W. also thanks Benjamin Moulton for discussions.	Agrawal G. P., 2001, NONLINEAR FIBER OPTI; Baroni S, 2010, REV MINERAL GEOCHEM, V71, P39, DOI 10.2138/rmg.2010.71.3; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Heaney PJ, 2001, AM MINERAL, V86, P1358; VOSKO SH, 1980, CAN J PHYS, V58, P1200; LOUIE SG, 1982, PHYS REV B, V26, P1738, DOI 10.1103/PhysRevB.26.1738; Jaffe JE, 2000, PHYS REV B, V62, P1660, DOI 10.1103/PhysRevB.62.1660; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; FISCHER TH, 1992, J PHYS CHEM-US, V96, P9768, DOI 10.1021/j100203a036; BIRCH F, 1952, J GEOPHYS RES, V57, P227, DOI 10.1029/JZ057i002p00227; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; BECK WR, 1949, J AM CERAM SOC, V32, P147, DOI 10.1111/j.1151-2916.1949.tb18940.x; BETHKE J, 1992, J PHYS-CONDENS MAT, V4, P5537, DOI 10.1088/0953-8984/4/25/007; Bradley C. J., 1972, MATH THEORY SYMMETRY; Christie DM, 1998, PHYS CHEM MINER, V25, P222, DOI 10.1007/s002690050106; COHEN LH, 1973, AM MINERAL, V58, P796; da Cunha MP, 1999, IEEE T ULTRASON FERR, V46, P1583, DOI 10.1109/58.808884; Delin A, 1998, J ALLOY COMPD, V275, P472, DOI 10.1016/S0925-8388(98)00374-0; Giannozzi P., 2009, J PHYS CONDENS MATT, V21; GILLET P, 1995, PHYS REV B, V51, P11262, DOI 10.1103/PhysRevB.51.11262; Haines J, 2004, Z KRISTALLOGR, V219, P314, DOI 10.1524/zkri.219.6.314.34639; HEMLEY RJ, 1994, REV MINERAL, V29, P41; Kanzaki M, 2012, INORG CHEM, V51, P6164, DOI 10.1021/ic300167k; Kanzaki M, 2011, ACTA CRYSTALLOGR B, V67, P30, DOI 10.1107/S0108768110051050; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Krempl PW, 2005, J PHYS IV, V126, P95, DOI 10.1051/jp4:2005126020; KRUGER MB, 1990, SCIENCE, V249, P647, DOI 10.1126/science.249.4969.647; Maradudin A. A., 1971, SOLID STATE PHYS S3, V2nd; MIEHE G, 1992, EUR J MINERAL, V4, P693; Muraoka Y, 1997, PHYS CHEM MINER, V24, P243, DOI 10.1007/s002690050036; Onac BP, 2003, AM MINERAL, V88, P1395; Otero-de-la-Roza A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.024109; Pellicer-Porres J, 2007, NAT MATER, V6, P698, DOI 10.1038/nmat1966; Philippot E, 1996, J SOLID STATE CHEM, V123, P1, DOI 10.1006/jssc.1996.0145; Poswal HK, 2013, AM MINERAL, V98, P285, DOI 10.2138/am.2013.3897; Seifert K, 1968, FORTSCHR MINERAL, V45, P214; Sharma SM, 2000, PHYS REV B, V62, P8824, DOI 10.1103/PhysRevB.62.8824; SOWA H, 1990, Z KRISTALLOGR, V192, P119; Stebbins JF, 2009, EUR J MINERAL, V21, P667, DOI 10.1127/0935-1221/2009/0021-1953; Tichy J, 2010, FUNDAMENTALS OF PIEZOELECTRIC SENSORICS: MECHANICAL, DIELECTRIC, AND THERMODYNAMICAL PROPERTIES OF PIEZOELECTRIC MATERIALS, P1; Tsuchiya J, 2005, J GEOPHYS RES, V110; Wallace D C, 1972, THERMODYNAMICS CRYST; Wang RP, 2013, SOLID STATE COMMUN, V155, P88, DOI 10.1016/j.ssc.2012.09.008; Wentzcovitch RM, 2010, REV MINERAL GEOCHEM, V71, P59, DOI 10.2138/rmg.2010.71.4	46	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-1791	1432-2021		PHYS CHEM MINER	Phys. Chem. Miner.	JAN	2015	42	1					15	27		10.1007/s00269-014-0695-8		13	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	AX8NF	WOS:000347165400002		
J	Pippinger, T; Miletich, R; Merlini, M; Lotti, P; Schouwink, P; Yagi, T; Crichton, WA; Hanfland, M				Pippinger, T.; Miletich, R.; Merlini, M.; Lotti, P.; Schouwink, P.; Yagi, T.; Crichton, W. A.; Hanfland, M.			Puzzling calcite-III dimorphism: crystallography, high-pressure behavior, and pathway of single-crystal transitions	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						Calcite; Calcite-III; Calcite-IIIb; Polymorphism; Phase diagram; High-pressure	X-RAY-DIFFRACTION; HIGH-TEMPERATURE; PHASE-TRANSITION; RAMAN-SPECTRA; ANVIL CELL; CACO3; CARBONATES; ARAGONITE; MAGNESITE; MGCO3	High-pressure phase transformations between the polymorphic forms I, II, III, and IIIb of CaCO3 were investigated by analytical in situ high-pressure high-temperature experiments on oriented single-crystal samples. All experiments at non-ambient conditions were carried out by means of Raman scattering, X-ray, and synchrotron diffraction techniques using diamond-anvil cells in the pressure range up to 6.5 GPa. The composite-gasket resistive heating technique was applied for all high-pressure investigations at temperatures up to 550 K. High-pressure Raman spectra reveal distinguishable characteristic spectral differences located in the wave number range of external modes with the occurrence of band splitting and shoulders due to subtle symmetry changes. Constraints from in situ observations suggest a stability field of CaCO3-IIIb at relatively low temperatures adjacent to the calcite-II field. Isothermal compression of calcite provides the sequence from I to II, IIIb, and finally, III, with all transformations showing volume discontinuities. Re-transformation at decreasing pressure from III oversteps the stability field of IIIb and demonstrates the pathway of pressure changes to determine the transition sequence. Clausius-Clapeyron slopes of the phase boundary lines were determined as: Delta P/Delta T = -2.79 +/- A 0.28 x 10(-3) GPa K-1 (I-II); +1.87 +/- A 0.31 x 10(-3) GPa K-1 (II/III); +4.01 +/- A 0.5 x 10(-3) GPa K-1 (II/IIIb); -33.9 +/- A 0.4 x 10(-3) GPa K-1 (IIIb/III). The triple point between phases II, IIIb, and III was determined by intersection and is located at 2.01(7) GPa/338(5) K. The pathway of transition from I over II to IIIb can be interpreted by displacement with small shear involved (by 2.9A degrees on I/II and by 8.2A degrees on II/IIIb). The former triad of calcite-I corresponds to the [20-1] direction in the P2(1)/c unit cell of phase II and to [101] in the pseudomonoclinic C setting of phase IIIb. Crystal structure investigations of triclinic CaCO3-III at non-ambient pressure-temperature conditions confirm the reported structure, and the small changes associated with the variation in P and T explain the broad stability of this structure with respect to variations in P and T. PVT equation of state parameters was determined from experimental data points in the range of 2.20-6.50 GPa at 298-405 K providing = 87.5(5.1) GPa, (delta K (T)/delta T) (P) = -0.21(0.23) GPa K-1, alpha (0) = 0.8(21.4) x 10(-5) K-1, and alpha (1) = 1.0(3.7) x 10(-7) K-1 using a second-order Birch-Murnaghan equation of state formalism.	[Pippinger, T.; Miletich, R.] Univ Vienna, Inst Mineral & Kristallog, A-1090 Vienna, Austria; [Merlini, M.; Lotti, P.] Univ Milan, Dipartimento Sci Terra, I-20133 Milan, Italy; [Schouwink, P.] Univ Geneva, Lab Cristallog, Geneva, Switzerland; [Yagi, T.] Ehime Univ, GRC, Matsuyama, Ehime, Japan; [Crichton, W. A.; Hanfland, M.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Pippinger, T (reprint author), Univ Vienna, Inst Mineral & Kristallog, Althanstr 14, A-1090 Vienna, Austria.	thomas.pippinger@univie.ac.at; ronald.miletich-pawliczek@univie.ac.at		Lotti, Paolo/0000-0003-2272-8281	Deep Carbon Observatory	Dedicated synchrotron beam time at ESRF was provided within the scope of experiment HS-4323. We gratefully acknowledge Diego Gatta for his help processing data and Herta Effenberger for discussions on the crystallography. We thank Andreas Wagner for the careful preparation of oriented sections and Julian Haines for making available Sm<SUP>2+</SUP>:SrB<INF>4</INF>O<INF>7</INF> material used in HPHT Raman measurements. We are grateful to the mineral spectroscopy group at Vienna for access to their instruments for the in situ Raman measurements. Marco Merlini acknowledges support from the Deep Carbon Observatory. Finally, the authors highly appreciate the comments and suggestions of the two reviewers, which significantly improved the manuscript.	Adams DM, 1980, J CHEM SOC DA, V8, P1482; Datchi F, 2007, HIGH PRESSURE RES, V27, P447, DOI 10.1080/08957950701659593; Angel RJ, 2014, Z KRISTALLOGR, V229, P405, DOI 10.1515/zkri-2013-1711; CIFRULAK SD, 1970, AM MINERAL, V55, P815; Angel RJ, 2000, REV MINERAL GEOCHEM, V41, P35; WILLIAMS Q, 1992, AM MINERAL, V77, P1158; MERRILL L, 1975, ACTA CRYSTALLOGR B, V31, P343, DOI 10.1107/S0567740875002774; Lin CC, 2013, PHYS CHEM MINER, V40, P157, DOI 10.1007/s00269-012-0555-3; DOVE MT, 1989, PHYS CHEM MINER, V16, P503; Merlini M, 2013, HIGH PRESSURE RES, V33, P511, DOI 10.1080/08957959.2013.831088; JOHANNES W, 1971, CONTRIB MINERAL PETR, V31, P28, DOI 10.1007/BF00373389; Zhang JZ, 1999, AM MINERAL, V84, P861; Suito K, 2001, AM MINERAL, V86, P997; FIQUET G, 1994, AM MINERAL, V79, P15; Oganov AR, 2008, EARTH PLANET SC LETT, V273, P38, DOI 10.1016/j.epsl.2008.06.005; GILLET P, 1993, PHYS CHEM MINER, V20, P1; Kabalah-Amitai L, 2013, SCIENCE, V340, P454, DOI 10.1126/science.1232139; Merlini M, 2012, EARTH PLANET SC LETT, V333, P265, DOI 10.1016/j.epsl.2012.04.036; Oganov AR, 2006, EARTH PLANET SC LETT, V241, P95, DOI 10.1016/j.epsl.2005.10.014; Ono S, 2007, AM MINERAL, V92, P1246, DOI 10.2138/am.2007.2649; Redfern SAT, 1999, CONTRIB MINERAL PETR, V134, P102, DOI 10.1007/s004100050471; Catalli K, 2005, AM MINERAL, V90, P1679, DOI 10.2138/am.2005.1954; Bridgman PW, 1939, AM J SCI, V237, P7; Fei YW, 2007, P NATL ACAD SCI USA, V104, P9182, DOI 10.1073/pnas.0609013104; REDFERN SAT, 1989, CONTRIB MINERAL PETR, V101, P479, DOI 10.1007/BF00372220; Ono S, 2005, AM MINERAL, V90, P667, DOI 10.2138/am.2005.1610; Boehler R, 2004, HIGH PRESSURE RES, V24, P391, DOI 10.1080/08957950412331323924; Fiquet G, 2002, AM MINERAL, V87, P1261; Arapan S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184115; BIELLMANN C, 1993, EUR J MINERAL, V5, P503; Bridgman PW, 1925, AM J SCI, V10, P483; COHEN LH, 1973, J GEOL, V81, P724; DAVIS BL, 1964, SCIENCE, V145, P489, DOI 10.1126/science.145.3631.489; FONG MY, 1971, J CHEM PHYS, V54, P579, DOI 10.1063/1.1674881; GILLET P, 1988, B MINERAL, V111, P1; Hagiya K, 2005, J MINER PETROL SCI, V100, P31, DOI 10.2465/jmps.100.31; Hess NJ, 1988, EOS T AM GEOPHYS UN, V69, P500; Hess N.J., 1991, RECENT TRENDS HIGH P, P236; LIU LG, 1990, AM MINERAL, V75, P801; Merlini M, 2014, MINERAL MAG, V78, P225, DOI 10.1180/minmag.2014.078.2.01; Miletich R, 2009, HIGH PRESSURE RES, V29, P290, DOI 10.1080/08957950902747403; Mirwald PW, 1979, NEUES JB MINERALOGIE, V7, P309; Oxford Diffraction, 2006, CRYSALISPRO; Pippinger T, 2014, PHYS CHEM MINER, V41, P737, DOI 10.1007/s00269-014-0687-8; Pippinger T, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3629136; SCHOCH RN, 1968, AM MINERAL, V53, P1910; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smyth JR, 1997, GEOPHYS RES LETT, V24, P1595, DOI 10.1029/97GL01603; TYBURCZY JA, 1986, J GEOPHYS RES-SOLID, V91, P4730, DOI 10.1029/JB091iB05p04730; Van Valkenburg A, 1965, C INT SUR LES HAUTS; WANG CY, 1968, J GEOPHYS RES, V73, P3937, DOI 10.1029/JB073i012p03937; Wang SX, 2011, SPECTROSC SPECT ANAL, V31, P2117, DOI 10.3964/j.issn.1000-0593(2011)08-2117-03; Weir CE, 1959, J RES NBS PHYS CHE A, V63A-1, P52	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-1791	1432-2021		PHYS CHEM MINER	Phys. Chem. Miner.	JAN	2015	42	1					29	43		10.1007/s00269-014-0696-7		15	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	AX8NF	WOS:000347165400003		
J	Komine-Aizawa, S; Hirohata, N; Aizawa, S; Abiko, Y; Hayakawa, S				Komine-Aizawa, S.; Hirohata, N.; Aizawa, S.; Abiko, Y.; Hayakawa, S.			Porphyromonas gingivalis lipopolysaccharide inhibits trophoblast invasion in the presence of nicotine	PLACENTA			English	Article						Periodontitis; Nicotine; Trophoblast invasion	TOLL-LIKE RECEPTORS; FETAL-GROWTH RESTRICTION; BEWO CELL-CULTURE; LOW-BIRTH-WEIGHT; PERIODONTAL-DISEASE; PREGNANCY OUTCOMES; CIGARETTE-SMOKING; PRETERM DELIVERY; MESSENGER-RNA; RAT PLACENTA	Introduction: Periodontitis is a chronic infectious disease associated with Gram-negative subgingival microflora. In pregnant women, periodontitis is thought to be associated with adverse pregnancy outcomes, although the pathophysiology is unknown. Additionally, smoking is an established risk factor for adverse pregnancy outcomes. In the present study, we examined the direct effects of Porphyromonas gingivalis lipopolysaccharides (PGLPS) and nicotine on a trophoblast cell line. Methods: HTR-8/SVneo cells were plated on Matrigel chambers with or without PGLPS and nicotine. The invasive activity of the cells was directly evaluated using microscopy. Results: PGLPS alone did not reduce the invasive activity of the HTR-8/SVneo cells. The co-administration of nicotine with PGLPS significantly reduced the invasive activity of the cells. Discussion: Our results suggest that although the direct pathogenic effects of P. gingivalis alone on trophoblast invasion may be limited, concurrent smoking reduces trophoblast invasion into the myometrium and inhibits maternal vascular reconstruction. (c) 2014 Elsevier Ltd. All rights reserved.	[Komine-Aizawa, S.; Hirohata, N.; Hayakawa, S.] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol,Itabashi Ku, Tokyo 1738610, Japan; [Hirohata, N.; Aizawa, S.] Nihon Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Oral Surg,Itabashi Ku, Tokyo 1738610, Japan; [Abiko, Y.] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba, Japan	Komine-Aizawa, S (reprint author), Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol,Itabashi Ku, 30-1 Ohyaguchikamicho, Tokyo 1738610, Japan.	aizawa.shihoko@nihon-u.ac.jp; mena12006@g.nihon-u.ac.jp; aizawa.sohichi@nihon-u.ac.jp; abiko.yoshimitsu@nihon-u.ac.jp; hayakawa.satoshi@nihon-u.ac.jp			"Academic Frontier" Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [07F003];  [24390382]	The present study was supported by the "Academic Frontier" Project for Private Universities and a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), 2007-2012 (07F003) and Grant-in-Aid for Scientific Research (B) 2012-2014 (24390382).	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; Spahr A, 2006, ARCH INTERN MED, V166, P554, DOI 10.1001/archinte.166.5.554; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; Ferguson JE, 2007, CLIN OBSTET GYNECOL, V50, P454, DOI 10.1097/GRF.0b013e31804c9f05; Jansson H, 2006, J CLIN PERIODONTOL, V33, P408, DOI 10.1111/j.1600-051X.2006.00929.x; Chambrone L, 2011, J CLIN PERIODONTOL, V38, P795, DOI 10.1111/j.1600-051X.2011.01755.x; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Abati S, 2013, J MATERN-FETAL NEO M, V26, P369, DOI 10.3109/14767058.2012.733776; Katz J, 2009, J DENT RES, V88, P575, DOI 10.1177/0022034509338032; Lin DM, 2003, INFECT IMMUN, V71, P5156, DOI 10.1128/IAI.71.9.5156-5162.2003; Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Lucchi NW, 2007, J REPROD IMMUNOL, V73, P20, DOI 10.1016/j.jri.2006.05.005; Anton L, 2012, HUM REPROD, V27, P61, DOI 10.1093/humrep/der362; Lin DM, 2003, INFECT IMMUN, V71, P5163, DOI 10.1128/IAI.71.9.5163-5168.2003; Arce RM, 2009, PLACENTA, V30, P156, DOI 10.1016/j.placenta.2008.11.017; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; Yoneda S, 2007, J OBSTET GYNAECOL RE, V33, P38, DOI 10.1111/j.1447-0756.2007.00474.x; Nomura K, 2004, J NUTR BIOCHEM, V15, P342, DOI 10.1016/j.jnutbio.2003.12.007; Genbacev O, 2000, REPROD TOXICOL, V14, P495, DOI 10.1016/S0890-6238(00)00107-6; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Repo JK, 2014, TOXICOL LETT, V224, P264, DOI 10.1016/j.toxlet.2013.10.032; Barksby HE, 2009, CLIN EXP IMMUNOL, V156, P479, DOI 10.1111/j.1365-2249.2009.03920.x; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; LaMarca HL, 2006, PLACENTA, V27, P137, DOI 10.1016/j.placenta.2005.03.003; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Balat O, 2003, Clin Exp Obstet Gynecol, V30, P57; Clothier B, 2007, BEST PRACT RES CL OB, V21, P451, DOI 10.1016/j.bpobgyn.2007.01.005; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; da Silva GM, 2012, J PERIODONTOL, V83, P1388, DOI 10.1902/jop.2012.110256; Hyland A, 2014, TOB CONTROL; Inaba H, 2009, CELL MICROBIOL, V11, P1517, DOI 10.1111/j.1462-5822.2009.01344.x; Inaba H, 2012, INFECT IMMUN, V80, P2847, DOI 10.1128/IAI.00258-12; Klaffenbach D, 2005, AM J REPROD IMMUNOL, V53, P77, DOI 10.1111/j.1600-0897.2004.00247.x; Kumar A, 2013, J OBSTET GYNAECOL RE, V39, P40, DOI 10.1111/j.1447-0756.2012.01957.x; Kweider N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047055; Lash GE, 2007, PLACENTA, V28, P390, DOI 10.1016/j.placenta.2006.06.001; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Piscoya MDBV, 2012, PEDIATR INT, V54, P68, DOI 10.1111/j.1442-200X.2011.03502.x; Polyzos NP, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7017; Sgolastra F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071387; Taghzouti N, 2012, J PERIODONTOL, V83, P871, DOI 10.1902/jop.2011.110342; Tanaka K, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-38; Tanuma A, 2003, PLACENTA, V24, P638, DOI 10.1016/S0143-4004(03)00033-X	46	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	JAN	2015	36	1					27	33		10.1016/j.placenta.2014.10.015		7	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	AX7JX	WOS:000347093400004		
J	Ratke, C; Pawar, PMA; Balasubramanian, VK; Naumann, M; Duncranz, ML; Derba-Maceluch, M; Gorzsas, A; Endo, S; Ezcurra, I; Mellerowicz, EJ				Ratke, Christine; Pawar, Prashant Mohan-Anupama; Balasubramanian, Vimal K.; Naumann, Marcel; Duncranz, Mathilda Lonnas; Derba-Maceluch, Marta; Gorzsas, Andras; Endo, Satoshi; Ezcurra, Ines; Mellerowicz, Ewa J.			Populus GT43 family members group into distinct sets required for primary and secondary wall xylan biosynthesis and include useful promoters for wood modification	PLANT BIOTECHNOLOGY JOURNAL			English	Article						secondary wall; xylan biosynthesis; poplar; genetic engineering; transgenic trees; wood development	CARBOHYDRATE-ACTIVE ENZYMES; PLANT-CELL WALLS; GLUCURONOXYLAN BIOSYNTHESIS; ARABIDOPSIS-THALIANA; INCREASED RESISTANCE; LIGNIN BIOSYNTHESIS; TRANSGENIC POPLAR; HYBRID POPLAR; EXPRESSION; GENES	The plant GT43 protein family includes xylosyltransferases that are known to be required for xylan backbone biosynthesis, but have incompletely understood specificities. RT-qPCR and histochemical (GUS) analyses of expression patterns of GT43 members in hybrid aspen, reported here, revealed that three clades of the family have markedly differing specificity towards secondary wall-forming cells (wood and extraxylary fibres). Intriguingly, GT43A and B genes (corresponding to the Arabidopsis IRX9 clade) showed higher specificity for secondary-walled cells than GT43C and D genes (IRX14 clade), although both IRX9 and IRX14 are required for xylosyltransferase activity. The remaining genes, GT43E, F and G (IRX9-L clade), showed broad expression patterns. Transient transactivation analyses of GT43A and B reporters demonstrated that they are activated by PtxtMYB021 and PNAC085 (master secondary wall switches), mediated in PtxtMYB021 activation by an AC element. The high observed secondary cell wall specificity of GT43B expression prompted tests of the efficiency of its promoter (pGT43B), relative to the CaMV 35S (35S) promoter, for overexpressing a xylan acetyl esterase (CE5) or downregulating REDUCED WALL ACETYLATION (RWA) family genes and thus engineering wood acetylation. CE5 expression was weaker when driven by pGT43B, but it reduced wood acetyl content substantially more efficiently than the 35S promoter. RNAi silencing of the RWA family, which was ineffective using 35S, was achieved when using GT43B promoter. These results show the utility of the GT43B promoter for genetically engineering properties of wood and fibres.	[Ratke, Christine; Pawar, Prashant Mohan-Anupama; Balasubramanian, Vimal K.; Naumann, Marcel; Derba-Maceluch, Marta; Mellerowicz, Ewa J.] Swedish Univ Agr Sci SLU, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Duncranz, Mathilda Lonnas; Ezcurra, Ines] Royal Inst Technol KTH, Sch Biotechnol, Stockholm, Sweden; [Gorzsas, Andras] Umea Univ, Dept Chem, Umea, Sweden; [Endo, Satoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	Mellerowicz, EJ (reprint author), Swedish Univ Agr Sci SLU, Dept Forest Genet & Plant Physiol, Umea, Sweden.	ewa.mellerowicz@slu.se	Gorzsas, Andras/B-1297-2015	Gorzsas, Andras/0000-0002-2298-8844	Formas (HemiPop); Formas (FuncFiber); Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (VINNOVA); Foundation for Strategic Research; European project RENEWALL; Bio4Energy; SamNordisk Skogsforskning [107]	Formas (including HemiPop and FuncFiber), the Swedish Research Council (VR), the Swedish Governmental Agency for Innovation Systems (VINNOVA) and the Foundation for Strategic Research, European project RENEWALL, Bio4Energy, SamNordisk Skogsforskning (project no. 107).	Anders N., 2011, ANN PLANT REV, P251; MargollesClark E, 1996, EUR J BIOCHEM, V237, P553, DOI 10.1111/j.1432-1033.1996.0553p.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Nilsson Ove, 1992, Transgenic Research, V1, P209, DOI 10.1007/BF02524751; Hawkins S, 1997, PLANT PHYSIOL, V113, P321; Baghdady A, 2006, PLANT PHYSIOL BIOCH, V44, P674, DOI 10.1016/j.plaphy.2006.10.027; Lee C, 2012, PLANT CELL PHYSIOL, V53, P135, DOI 10.1093/pcp/pcr158; Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Manabe Y, 2011, PLANT PHYSIOL, V155, P1068, DOI 10.1104/pp.110.168989; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Takahashi J, 2009, PLANT CELL PHYSIOL, V50, P1099, DOI 10.1093/pcp/pcp062; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Chen CY, 2000, PLANT PHYSIOL, V123, P853, DOI 10.1104/pp.123.3.853; Zeng W, 2010, PLANT PHYSIOL, V154, P78, DOI 10.1104/pp.110.159749; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.127.4.1513; Pesquet E, 2013, PLANT CELL, V25, P1314, DOI 10.1105/tpc.113.110593; Girijashankar V., 2011, Physiology and Molecular Biology of Plants, V17, P9, DOI 10.1007/s12298-010-0048-0; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Kitin P, 2010, PLANT PHYSIOL, V154, P887, DOI 10.1104/pp.110.156224; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Winzell A, 2010, BIOCHEM BIOPH RES CO, V394, P848, DOI 10.1016/j.bbrc.2010.03.101; Harding SA, 2002, PLANT PHYSIOL, V128, P428, DOI 10.1104/pp.128.2.428; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Love J, 2009, P NATL ACAD SCI USA, V106, P5984, DOI 10.1073/pnas.0811660106; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Senthil-Kumar M, 2011, METHODS MOL BIOL, V744, P13, DOI 10.1007/978-1-61779-123-9_2; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Ko JH, 2012, PLANT BIOTECHNOL J, V10, P587, DOI 10.1111/j.1467-7652.2012.00690.x; Li QZ, 2012, P NATL ACAD SCI USA, V109, P14699, DOI 10.1073/pnas.1212977109; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Lauvergeat V, 2002, PLANT MOL BIOL, V50, P497, DOI 10.1023/A:1019817913604; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chiniquy D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00083; DARVILL JE, 1980, PLANT PHYSIOL, V66, P1135, DOI 10.1104/pp.66.6.1135; Demura T., 2009, [No title captured], Patent No. [PCT/ JP2004/ 014308, 004014308]; Demura T., 2009, [No title captured], Patent No. [US2009/ 0004739 A1, 20090004739]; Eriksson L., 2006, MULTI MEGAVARIATE DA; FEUILLET C, 1995, PLANT MOL BIOL, V27, P651, DOI 10.1007/BF00020220; Gorzsas A, 2011, PLANT J, V66, P903, DOI 10.1111/j.1365-313X.2011.04542.x; Guerriero G, 2009, NEW PHYTOL, V184, P552, DOI 10.1111/j.1469-8137.2009.02977.x; Hussey SG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00325; Kong YZ, 2009, MOL PLANT, V2, P1040, DOI 10.1093/mp/ssp068; Lee C, 2009, PLANT CELL PHYSIOL, V50, P1982, DOI 10.1093/pcp/pcp131; Lee Chanhui, 2012, Plant Signal Behav, V7, P332, DOI 10.4161/psb.19269; Lee C, 2014, PLANT SIGNAL BEHAV, V9; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Lee CH, 2011, PLANT CELL PHYSIOL, V52, P1289, DOI 10.1093/pcp/pcr075; Manabe Y, 2013, PLANT PHYSIOL, V163, P1107, DOI 10.1104/pp.113.225193; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Mellerowicz EJ, 2012, J EXP BOT, V63, P551, DOI 10.1093/jxb/err339; Osakabe Y, 2009, PLANT PHYSIOL BIOCH, V47, P1031, DOI 10.1016/j.plaphy.2009.09.003; Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118; Pogorelko G, 2013, PLANT PHYSIOL, V162, P9, DOI 10.1104/pp.113.214460; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Winzell A, 2010, PLANT BIOTECHNOL, V27, P283, DOI 10.5511/plantbiotechnology.27.283; Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016; Zhong RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069219; Zhou GK, 2006, PLANT CELL PHYSIOL, V47, P1229, DOI 10.1093/pcp/pcj093	75	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	JAN	2015	13	1					26	37		10.1111/pbi.12232		12	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	AX4PW	WOS:000346915000004		
J	Alam, MM; Tanaka, T; Nakamura, H; Ichikawa, H; Kobayashi, K; Yaeno, T; Yamaoka, N; Shimomoto, K; Takayama, K; Nishina, H; Nishiguchi, M				Alam, Md Mahfuz; Tanaka, Toru; Nakamura, Hidemitsu; Ichikawa, Hiroaki; Kobayashi, Kappei; Yaeno, Takashi; Yamaoka, Naoto; Shimomoto, Kota; Takayama, Kotaro; Nishina, Hiroshige; Nishiguchi, Masamichi			Overexpression of a rice heme activator protein gene (OsHAP2E) confers resistance to pathogens, salinity and drought, and increases photosynthesis and tiller number	PLANT BIOTECHNOLOGY JOURNAL			English	Article						heme activator protein 2 (HAP2); rice; biotic stress; abiotic stress; photosynthesis; CCAAT	BINDING TRANSCRIPTION FACTOR; INTRON-MEDIATED ENHANCEMENT; FACTOR-Y SUBUNITS; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; SALICYLIC-ACID; SALT TOLERANCE; ABSCISIC-ACID; PLANT DEFENSE; FAMILY GENES	Heme activator protein (HAP), also known as nuclear factor Y or CCAAT binding factor (HAP/NF-Y/CBF), has important functions in regulating plant growth, development and stress responses. The expression of rice HAP gene (OsHAP2E) was induced by probenazole (PBZ), a chemical inducer of disease resistance. To characterize the gene, the chimeric gene (OsHAP2E::GUS) engineered to carry the structural gene encoding -glucuronidase (GUS) driven by the promoter from OsHAP2E was introduced into rice. The transgenic lines of OsHAP2Ein::GUS with the intron showed high GUS activity in the wounds and surrounding tissues. When treated by salicylic acid (SA), isonicotinic acid (INA), abscisic acid (ABA) and hydrogen peroxide (H2O2), the lines showed GUS activity exclusively in vascular tissues and mesophyll cells. This activity was enhanced after inoculation with Magnaporthe oryzae or Xanthomonas oryzae pv. oryzae. The OsHAP2E expression level was also induced after inoculation of rice with M. oryzae and X. oryzae pv. oryzae and after treatment with SA, INA, ABA and H2O2, respectively. We further produced transgenic rice overexpressing OsHAP2E. These lines conferred resistance to M. oryzae or X. oryzae pv. oryzae and to salinity and drought. Furthermore, they showed a higher photosynthetic rate and an increased number of tillers. Microarray analysis showed up-regulation of defence-related genes. These results suggest that this gene could contribute to conferring biotic and abiotic resistances and increasing photosynthesis and tiller numbers.	[Alam, Md Mahfuz; Kobayashi, Kappei; Yaeno, Takashi; Yamaoka, Naoto; Shimomoto, Kota; Takayama, Kotaro; Nishina, Hiroshige; Nishiguchi, Masamichi] Ehime Univ, Fac Agr, United Grad Sch Agr Sci, Matsuyama, Ehime 790, Japan; [Tanaka, Toru; Kobayashi, Kappei; Yaeno, Takashi; Yamaoka, Naoto; Shimomoto, Kota; Takayama, Kotaro; Nishina, Hiroshige; Nishiguchi, Masamichi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Nakamura, Hidemitsu; Ichikawa, Hiroaki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	Nishiguchi, M (reprint author), Ehime Univ, Fac Agr, United Grad Sch Agr Sci, Matsuyama, Ehime 790, Japan.	mnishigu@agr.ehime-u.ac.jp			Program for Promotion of Basic and Applied Researches in Bio-oriented Industry; Ministry of Education, Culture, Sports, Science and Technology of Japan [22119010]; Ministry of Agriculture, Forestry and Fisheries of Japan [EF-1001, EF-1004]	We are grateful to Drs. I. Mitsuhara, M. Mori and H. Ochiai for the seeds of transgenic rice carrying GUS driven by 35S promoter of cauliflower mosaic virus, Sensyou and Asominori, respectively. We thank Ms. M. Kajikawa and Ms. S. Ando and Dr. N. Endo-Higashi for their technical assistance on plasmid construction and production of transgenic rice plants. We thank Dr. Y. Nagamura and Ms. R. Motoyama (National Institute of Agrobiological Sciences, Japan) for the microarray experiment. We also thank Drs. T. Tachibana and T. Habu for the use of the Retoratome and the suggestions on microarray data, respectively. We are grateful to D. Murphy for checking the English in the manuscript. This work was supported by the Program for Promotion of Basic and Applied Researches in Bio-oriented Industry, the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research for Scientific Research (C), No. 22119010) to MN and by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Rice Genome Project to MN; Green Technology Project EF-1001 and EF-1004 to HI). The authors declare that they have no conflicts of interest.	Ahn Il-Pyung, 2005, Phytopathology, V95, P1248, DOI 10.1094/PHYTO-95-1248; Alam M.M., 2014, J GEN PLANT IN PRESS; Alam M.M., 2014, RICE IN PRESS; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Gao SQ, 2009, PLANT CELL REP, V28, P301, DOI 10.1007/s00299-008-0623-9; Stephenson TJ, 2011, FUNCT INTEGR GENOMIC, V11, P327, DOI 10.1007/s10142-011-0212-9; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18.0511; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Miyoshi K, 2003, PLANT J, V36, P532, DOI 10.1046/j.1365-313X.2003.01897.x; Zhang HW, 2004, PLANTA, V220, P262, DOI 10.1007/s00425-004-1347-x; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI [10.1104/pp.010320, 10.1104/pp.128.2.682]; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Rose AB, 2002, RNA, V8, P1444, DOI 10.1017/S1355838202020551; Husaini AM, 2008, PLANT SCI, V174, P446, DOI 10.1016/j.plantsci.2008.01.007; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Hu L, 2005, TREE PHYSIOL, V25, P1273; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Ito Y, 2011, PLANT SCI, V181, P105, DOI 10.1016/j.plantsci.2011.04.009; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; CHEN ZX, 1995, P NATL ACAD SCI USA, V92, P4134, DOI 10.1073/pnas.92.10.4134; Pasapula V, 2011, PLANT BIOTECHNOL J, V9, P88, DOI 10.1111/j.1467-7652.2010.00535.x; Wen N, 2003, MOL GENET GENOMICS, V269, P331, DOI 10.1007/s00438-003-0839-x; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Yang HF, 2011, MOL BIOL REP, V38, P929, DOI 10.1007/s11033-010-0186-z; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Xu MY, 2011, PLANT CELL REP, V30, P1949, DOI 10.1007/s00299-011-1103-1; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Hakata M, 2010, BREEDING SCI, V60, P575, DOI 10.1270/jsbbs.60.575; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Ballif J., 2011, PLANT PHYSL BIOCH, V30, P1; Combier J.P., 2008, GENES DEV, V22, P1549; Doyle J., 1987, PHYTOCHEM B, V19; Hwang JE, 2010, PLANT CELL REP, V29, P905, DOI 10.1007/s00299-010-0876-y; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI 10.1007/BF02667740; Koyama T, 2005, J BIOSCI BIOENG, V99, P38, DOI 10.1263/jbb.99.038; Kusajima M, 2010, J GEN PLANT PATHOL, V76, P161, DOI 10.1007/s10327-010-0218-5; Laloum T., 2013, TRENDS PLANT SCI, V18, P156; Levesque-Lemay M, 2003, PLANT CELL REP, V21, P804, DOI 10.1007/s00299-003-0588-7; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Li Y.J., 2013, PLOS ONE, V8; Nishiguchi M, 2004, RICE BLAST: INTERACTION WITH RICE AND CONTROL, P145; Rose AB, 2004, PLANT J, V40, P744, DOI 10.1111/j.1365-313X.2004.02247.x; Shimono Masaki, 2003, Journal of General Plant Pathology, V69, P76, DOI 10.1007/s10327-002-0010-2; SPSS Inc, 2007, SPSS WIND VERS 16 0; WATANABE T, 1977, J PESTIC SCI, V2, P291; Xu XB, 2010, BIOTECHNOL LETT, V32, P1533, DOI 10.1007/s10529-010-0312-y; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444	66	6	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1467-7644	1467-7652		PLANT BIOTECHNOL J	Plant Biotechnol. J.	JAN	2015	13	1					85	96		10.1111/pbi.12239		12	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	AX4PW	WOS:000346915000009		
J	Zargar, SM; Fujiwara, M; Inaba, S; Kobayashi, M; Kurata, R; Ogata, Y; Fukao, Y				Zargar, Sajad Majeed; Fujiwara, Masayuki; Inaba, Shoko; Kobayashi, Mami; Kurata, Rie; Ogata, Yoshiyuki; Fukao, Yoichiro			Correlation analysis of proteins responsive to Zn, Mn, or Fe deficiency in Arabidopsis roots based on iTRAQ analysis	PLANT CELL REPORTS			English	Article						Cosine correlation coefficients; iTRAQ; GLP5; PDR9/ABCG37; Quantitative proteomics	FERRIC-CHELATE REDUCTASE; TOMATO FRUIT-DEVELOPMENT; IRON-DEFICIENCY; MEMBRANE PROTEOMICS; METABOLITE ANALYSIS; ABCG37 TRANSPORTER; ZINC TRANSPORTER; PROTON EXTRUSION; PLANT DEFENSINS; EXCESS ZINC	For discovering the functional correlation between the identified and quantified proteins by iTRAQ analysis, here we propose a correlation analysis method with cosine correlation coefficients as a powerful tool. iTRAQ analysis is a quantitative proteomics approach that enables identification and quantification of a large number of proteins. In order to obtain proteins responsive to Zn, Mn, or Fe mineral deficiency, we conducted iTRAQ analysis using a microsomal fraction of protein extractions from Arabidopsis root tissues. We identified and quantified 730 common proteins in three biological replicates with less than 1 % false discovery rate. To determine the role of these proteins in tolerating mineral deficiencies and their relation to each other, we calculated cosine correlation coefficients and represented the outcomes on a correlation map for visual understanding of functional relations among the identified proteins. Functionally similar proteins were gathered into the same clusters. Interestingly, a cluster of proteins (FRO2, IRT1, AHA2, PDR9/ABCG37, and GLP5) highly responsive to Fe deficiency was identified, which included both known and unknown novel proteins involved in tolerating Fe deficiency. We propose that the correlation analysis with the cosine correlation coefficients is a powerful method for finding important proteins of interest to several biological processes through comprehensive data sets.	[Zargar, Sajad Majeed; Fujiwara, Masayuki; Inaba, Shoko; Kobayashi, Mami; Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Ikoma 6300192, Japan; [Zargar, Sajad Majeed] SK Univ Agr Sci & Technol, Sch Biotechnol, Jammu 180009, Jammu & Kashmir, India; [Fujiwara, Masayuki; Kurata, Rie; Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Ogata, Yoshiyuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan	Fukao, Y (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Takayama 8916-5, Ikoma 6300192, Japan.	fukao@bs.nasit.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23119512]; Nara Institute of Science and Technology by Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Advanced Plant Science Network	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23119512 to Y.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; a Grant-in-Aid for Scientific Research from Nara Institute of Science and Technology supported by The Ministry of Education, Culture, Sports, Science and Technology, Japan. This research was supported by Japan Advanced Plant Science Network.	Zamboni A, 2010, PLANT PHYSIOL, V154, P1439, DOI 10.1104/pp.110.160275; Wu T, 2012, J EXP BOT, V63, P859, DOI 10.1093/jxb/err314; Eckhardt U, 2001, PLANT MOL BIOL, V45, P437, DOI 10.1023/A:1010620012803; Han CL, 2008, MOL CELL PROTEOMICS, V7, P1983, DOI 10.1074/mcp.M800068-MCP200; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Oomen RJFJ, 2011, NEW PHYTOL, V192, P140, DOI 10.1111/j.1469-8137.2011.03792.x; Ogata Y, 2009, J WOOD SCI, V55, P395, DOI 10.1007/s10086-009-1058-9; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Ramesh SA, 2004, PLANT MOL BIOL, V54, P373, DOI 10.1023/B:PLAN.0000036370.70912.34; Huang TK, 2013, PLANT CELL, V25, P4044, DOI 10.1105/tpc.113.115998; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; Fourcroy P, 2014, NEW PHYTOL, V201, P155, DOI 10.1111/nph.12471; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Yin K, 2009, ACTA BIOCH BIOPH SIN, V41, P478, DOI 10.1093/abbs/gmp036; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Osorio S, 2012, PLANT PHYSIOL, V159, P1713, DOI 10.1104/pp.112.199711; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Enfissi EMA, 2010, PLANT CELL, V22, P1190, DOI 10.1105/tpc.110.073866; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Osorio S, 2011, PLANT PHYSIOL, V157, P405, DOI 10.1104/pp.111.175463; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; Bacaicoa E, 2011, PLANT PHYSIOL BIOCH, V49, P545, DOI 10.1016/j.plaphy.2011.02.018; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; Kramer U, 2005, TRENDS PLANT SCI, V10, P313, DOI 10.1016/j.tplants.2005.05.008; Landsberg EC, 1981, PLANT PHYSIOL, V67, P563; Lu M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-620; Luciano P, 1998, J MOL BIOL, V280, P193, DOI 10.1006/jmbi.1998.1858; MARSCHNER H., 1995, MINERAL NUTR HIGHER; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Millaleo R, 2010, J SOIL SCI PLANT NUT, V10, P476, DOI 10.4067/S0718-95162010000200008; Ogata Y, 2009, PLANT BIOTECHNOL, V26, P503, DOI 10.5511/plantbiotechnology.26.503; Schutz W, 2011, PLANT CELL, V23, P1701, DOI 10.1105/tpc.110.082016; Sudre D, 2013, J EXP BOT, V64, P2665, DOI 10.1093/jxb/ert112; Zargar SM, 2013, PLANT SIGNAL BEHAV, V8; Zeng JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053409	56	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	JAN	2015	34	1					157	166		10.1007/s00299-014-1696-2		10	Plant Sciences	Plant Sciences	AX9WS	WOS:000347250600014		
J	Hara, T; Katoh, H; Ogawa, D; Kagaya, Y; Sato, Y; Kitano, H; Nagato, Y; Ishikawa, R; Ono, A; Kinoshita, T; Takeda, S; Hattori, T				Hara, Tomomi; Katoh, Hirokazu; Ogawa, Daisuke; Kagaya, Yasuaki; Sato, Yutaka; Kitano, Hidemi; Nagato, Yasuo; Ishikawa, Ryo; Ono, Akemi; Kinoshita, Tetsu; Takeda, Shin; Hattori, Tsukaho			Rice SNF2 family helicase ENL1 is essential for syncytial endosperm development	PLANT JOURNAL			English	Article						Oryza sativa; syncytium; seed; PICH; chromosome	CELL-CYCLE CONTROL; ORYZA-SATIVA L; SEED DEVELOPMENT; GENOME SEQUENCE; T-DNA; ARABIDOPSIS; GENE; PICH; DIVISION; EMBRYO	The endosperm of cereal grains represents the most important source of human nutrition. In addition, the endosperm provides many investigatory opportunities for biologists because of the unique processes that occur during its ontogeny, including syncytial development at early stages. Rice endospermless 1 (enl1) develops seeds lacking an endosperm but carrying a functional embryo. The enl1 endosperm produces strikingly enlarged amoeboid nuclei. These abnormal nuclei result from a malfunction in mitotic chromosomal segregation during syncytial endosperm development. The molecular identification of the causal gene revealed that ENL1 encodes an SNF2 helicase family protein that is orthologous to human Plk1-Interacting Checkpoint Helicase (PICH), which has been implicated in the resolution of persistent DNA catenation during anaphase. ENL1-Venus (enhanced yellow fluorescent protein (YFP)) localizes to the cytoplasm during interphase but moves to the chromosome arms during mitosis. ENL1-Venus is also detected on a thread-like structure that connects separating sister chromosomes. These observations indicate the functional conservation between PICH and ENL1 and confirm the proposed role of PICH. Although ENL1 dysfunction also affects karyokinesis in the root meristem, enl1 plants can grow in a field and set seeds, indicating that its indispensability is tissue-dependent. Notably, despite the wide conservation of ENL1/PICH among eukaryotes, the loss of function of the ENL1 ortholog in Arabidopsis (CHR24) has only marginal effects on endosperm nuclei and results in normal plant development. Our results suggest that ENL1 is endowed with an indispensable role to secure the extremely rapid nuclear cycle during syncytial endosperm development in rice.	[Hara, Tomomi; Katoh, Hirokazu; Ogawa, Daisuke; Kitano, Hidemi; Takeda, Shin; Hattori, Tsukaho] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Kagaya, Yasuaki] Mie Univ, Life Sci Res Ctr, Tsu, Mie 5148507, Japan; [Sato, Yutaka] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nagato, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Ishikawa, Ryo] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Ono, Akemi; Kinoshita, Tetsu] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan	Hattori, T (reprint author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	hattori@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [18075007, 23021019]	The authors thank Rena Endo and Toshiko Komada for their excellent technical assistance. This work was partially supported by Grants-in-Aid for Scientific Research on Priority Areas (18075007 and 23021019 to T.H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Jurgens G, 2005, ANNU REV PLANT BIOL, V56, P281, DOI 10.1146/annurev.arplant.55.031603.141636; Hehenberger E, 2012, DEVELOPMENT, V139, P2031, DOI 10.1242/dev.077057; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Kang IH, 2008, PLANT CELL, V20, P635, DOI 10.1105/tpc.107.055137; Mizutani M, 2010, J EXP BOT, V61, P791, DOI 10.1093/jxb/erp343; Knizewski L, 2008, TRENDS PLANT SCI, V13, P557, DOI 10.1016/j.tplants.2008.08.004; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1004/pp.015248; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Guo J, 2007, PLANT MOL BIOL, V64, P349, DOI 10.1007/s11103-007-9154-y; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Huh JH, 2007, CURR OPIN GENET DEV, V17, P480, DOI 10.1016/j.gde.2007.08.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tzafrir I, 2002, PLANT PHYSIOL, V128, P38, DOI 10.1104/pp.128.1.38; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ishikawa R, 2011, PLANT J, V65, P798, DOI 10.1111/j.1365-313X.2010.04466.x; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; Liu CM, 2002, PLANT J, V29, P405, DOI 10.1046/j.1365-313x.2002.01224.x; LOPES MA, 1993, PLANT CELL, V5, P1383; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; An SY, 2003, PLANT PHYSIOL, V133, P2040, DOI 10.1104/pp.103.030478; Mayer U, 1999, EUR J CELL BIOL, V78, P100; Berger F., 2007, ENDOSPERM DEV MOL BI, V8, P91, DOI 10.1007/7089_2007_111; Guo J, 2010, PLANTA, V231, P293, DOI 10.1007/s00425-009-1051-y; Hong SK, 1996, DEVELOPMENT, V122, P2051; KAGEYAMA Y, 1991, JPN J BREED, V41, P341; Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950; Leng M, 2008, CELL CYCLE, V7, P1480, DOI 10.4161/cc.7.10.5951; Lu XM, 2010, CELL CYCLE, V9, P2908; Nagamura Y, 2011, PLANT CELL PHYSIOL, V52, P230, DOI 10.1093/pcp/pcq197; Olsen O. -A., 2007, MOL BIOL; Pignocchi C, 2009, PLANT CELL, V21, P90, DOI 10.1105/tpc.108.061812; Sakurai H, 2011, FEBS LETT, V585, P1923, DOI 10.1016/j.febslet.2011.04.074; Suzuki Katsumi, 2000, Plant Production Science, V3, P446	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	JAN	2015	81	1					1	12		10.1111/tpj.12705		12	Plant Sciences	Plant Sciences	AX4RF	WOS:000346918400001		
J	Matsuda, F; Nakabayashi, R; Yang, ZG; Okazaki, Y; Yonemaru, J; Ebana, K; Yano, M; Saito, K				Matsuda, Fumio; Nakabayashi, Ryo; Yang, Zhigang; Okazaki, Yozo; Yonemaru, Jun-ichi; Ebana, Kaworu; Yano, Masahiro; Saito, Kazuki			Metabolome-genome-wide association study dissects genetic architecture for generating natural variation in rice secondary metabolism	PLANT JOURNAL			English	Article						Oryza sativa; secondary metabolites; metabolome analysis; genome-wide association study; natural variation	QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA; BIOCHEMICAL INSIGHTS; PLANT METABOLOMICS; COMPLEX TRAITS; ARABIDOPSIS; FLAVONOIDS; MS/MS; IDENTIFICATION; EXPRESSION	Plants produce structurally diverse secondary (specialized) metabolites to increase their fitness for survival under adverse environments. Several bioactive compounds for new drugs have been identified through screening of plant extracts. In this study, genome-wide association studies (GWAS) were conducted to investigate the genetic architecture behind the natural variation of rice secondary metabolites. GWAS using the metabolome data of 175 rice accessions successfully identified 323 associations among 143 single nucleotide polymorphisms (SNPs) and 89 metabolites. The data analysis highlighted that levels of many metabolites are tightly associated with a small number of strong quantitative trait loci (QTLs). The tight association may be a mechanism generating strains with distinct metabolic composition through the crossing of two different strains. The results indicate that one plant species produces more diverse phytochemicals than previously expected, and plants still contain many useful compounds for human applications.	[Matsuda, Fumio; Nakabayashi, Ryo; Yang, Zhigang; Okazaki, Yozo; Saito, Kazuki] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Matsuda, Fumio] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Yonemaru, Jun-ichi; Ebana, Kaworu; Yano, Masahiro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba, Japan	Saito, K (reprint author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan.	ksaito@faculty.chiba-u.jp	Saito, Kazuki/D-2670-2009		Ministry of Agriculture, Forestry, and Fisheries of Japan [NVR-0005]; JST	We thank K. Akiyama, T. Sakurai, M. Suzuki, Dr. K Yonekura-Sakakibara (RIKEN Center for Sustainable Resource, Japan), and Dr. M. Yamasaki (Kobe University) for technical support and helpful comments. This work was partly supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation, NVR-0005) and JST, Strategic International Collaborative Research Program, SICORP for JP-US Metabolomics.	Afendi FM, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr165; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Kliebenstein DJ, 2001, GENETICS, V159, P359; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Carreno-Quintero N, 2013, TRENDS GENET, V29, P41, DOI 10.1016/j.tig.2012.09.006; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; BESSON E, 1985, PHYTOCHEMISTRY, V24, P1061, DOI 10.1016/S0031-9422(00)83183-0; Saito K, 2013, CURR OPIN PLANT BIOL, V16, P373, DOI 10.1016/j.pbi.2013.04.001; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Bottcher C, 2008, PLANT PHYSIOL, V147, P2107, DOI 10.1104/pp.108.117754; Brazier-Hicks M, 2009, J BIOL CHEM, V284, P17926, DOI 10.1074/jbc.M109.009258; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Simmonds MSJ, 2003, PHYTOCHEMISTRY, V64, P21, DOI 10.1016/S0031-9422(03)00293-0; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Kliebenstein DJ, 2009, PLANT CELL, V21, P1637, DOI 10.1105/tpc.109.067611; Wang H, 2012, ANTI-CANCER AGENT ME, V12, P1281; Sawada Y, 2012, PHYTOCHEMISTRY, V82, P38, DOI 10.1016/j.phytochem.2012.07.007; Mohanlal S, 2011, PLANT FOOD HUM NUTR, V66, P91, DOI 10.1007/s11130-011-0217-5; Lommen A, 2012, METABOLOMICS, V8, P719, DOI 10.1007/s11306-011-0369-1; Simmonds MSJ, 2001, PHYTOCHEMISTRY, V56, P245, DOI 10.1016/S0031-9422(00)00453-2; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Cavaliere C, 2005, RAPID COMMUN MASS SP, V19, P3143, DOI 10.1002/rcm.2185; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Schauer N, 2008, PLANT CELL, V20, P509, DOI 10.1105/tpc.107.056523; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Chang CL, 2010, PHYTOCHEMISTRY, V71, P271, DOI 10.1016/j.phytochem.2009.09.025; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Sakurai T, 2013, PLANT CELL PHYSIOL, V54, pE5, DOI 10.1093/pcp/pcs184; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Lisec J, 2009, PLANT J, V59, P777, DOI 10.1111/j.1365-313X.2009.03910.x; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Bouaziz M, 2002, PHYTOCHEMISTRY, V60, P515, DOI 10.1016/S0031-9422(02)00145-0; Chan EKF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001125; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Dong XK, 2014, J INTEGR PLANT BIOL, V56, P876, DOI 10.1111/jipb.12204; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Hill CB, 2013, PLANT PHYSIOL, V162, P1266, DOI 10.1104/pp.113.217851; Huang X., 2013, NAT GENET, V44, P32; Itoh T, 2007, GENOME RES, V17, P175, DOI DOI 10.1101/GR.5509507.PUBMED:17210932; Kim DH, 2009, PLANT PHYSIOL BIOCH, V47, P991, DOI 10.1016/j.plaphy.2009.08.004; Ko JH, 2008, J PLANT PHYSIOL, V165, P435, DOI 10.1016/j.jplph.2007.01.006; Matsuda F, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00040; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Yang ZG, 2014, METABOLOMICS, V10, P543, DOI 10.1007/s11306-013-0619-5; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	62	7	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	JAN	2015	81	1					13	23		10.1111/tpj.12681		11	Plant Sciences	Plant Sciences	AX4RF	WOS:000346918400002		
J	Nishizawa-Yokoi, A; Endo, M; Ohtsuki, N; Saika, H; Toki, S				Nishizawa-Yokoi, Ayako; Endo, Masaki; Ohtsuki, Namie; Saika, Hiroaki; Toki, Seiichi			Precision genome editing in plants via gene targeting and piggyBac-mediated marker excision	PLANT JOURNAL			English	Article						gene targeting; marker excision; piggyBac transposon; acetolactate synthase; cleistogamy 1; Oryza sativa; technical advance	HOMOLOGOUS RECOMBINATION; NEGATIVE SELECTION; ARABIDOPSIS FLOWER; RICE GENOME; STEM-CELLS; MUTATION; TRANSPOSON; NUCLEASES; MICRORNA; APETALA2	Precise genome engineering via homologous recombination (HR)-mediated gene targeting (GT) has become an essential tool in molecular breeding as well as in basic plant science. As HR-mediated GT is an extremely rare event, positive-negative selection has been used extensively in flowering plants to isolate cells in which GT has occurred. In order to utilize GT as a methodology for precision mutagenesis, the positive selectable marker gene should be completely eliminated from the GT locus. Here, we introduce targeted point mutations conferring resistance to herbicide into the rice acetolactate synthase (ALS) gene via GT with subsequent marker excision by piggyBac transposition. Almost all regenerated plants expressing piggyBac transposase contained exclusively targeted point mutations without concomitant re-integration of the transposon, resulting in these progeny showing a herbicide bispyribac sodium (BS)-tolerant phenotype. This approach was also applied successfully to the editing of a microRNA targeting site in the rice cleistogamy 1 gene. Therefore, our approach provides a general strategy for the targeted modification of endogenous genes in plants.	[Nishizawa-Yokoi, Ayako; Endo, Masaki; Ohtsuki, Namie; Saika, Hiroaki; Toki, Seiichi] Natl Inst Agrobiol Sci, Plant Genome Engn Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 2440813, Japan	Toki, S (reprint author), Natl Inst Agrobiol Sci, Plant Genome Engn Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	stoki@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [PGE1001, 23658012, 23310142]	We acknowledge Dr. B. Hohn for critical reading of the manuscript. We are grateful to Dr. R. Terada (Meijo University) and Dr. S. Iida (Shizuoka Pref. University) for providing the DT-A gene, Dr K. Uchino and Dr H. Sezutsu (National Institute of Agrobiological Sciences) for providing hyPBase, Dr. H. Rothnie for English editing, and Dr. K. Osakabe for insightful discussions and comments. We thank Ms. K. Amagai, Ms. A. Nagashii and Ms. F. Suzuki for general experimental technical support. This research was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation PGE1001) and KAKENHI (23658012 and 23310142).	Terada R, 2007, PLANT PHYSIOL, V144, P846, DOI 10.1104/pp.107.095992; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Yamauchi T, 2009, PLANT J, V60, P386, DOI 10.1111/j.1365-313X.2009.03947.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Puchta H, 2013, INT J DEV BIOL, V57, P629, DOI 10.1387/ijdb.130194hp; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Sun N, 2014, BIOTECHNOL BIOENG, V111, P1048, DOI 10.1002/bit.25018; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Terada R, 2002, NAT BIOTECHNOL, V20, P1030, DOI 10.1038/nbt737; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.2307/3869820; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Dang T. T., 2001, PLANT CELL PHYSL, V54, P2058; Endo M, 2007, PLANT J, V52, P157, DOI 10.1111/j.1365-313X.2007.03230.x; Johzuka-Hisatomi Y, 2008, NUCLEIC ACIDS RES, V36, P4727, DOI 10.1093/nar/gkn451; Lanar D. E., 1994, PCR METH APPL, V4, pS96; Lieberman-Lazarovich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085383; Morioka Y, 2014, GENESIS, V52, P68, DOI 10.1002/dvg.22727; Moritoh S, 2012, PLANT J, V71, P85, DOI 10.1111/j.1365-313X.2012.04974.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nishizawa-Yokoi A, 2014, PLANT J, V77, P454, DOI 10.1111/tpj.12367; Ono A, 2012, PLANT J, V71, P564, DOI 10.1111/j.1365-313X.2012.05009.x; Osakabe K, 2014, PLANT CELL PHYSIOL, V55, P658, DOI 10.1093/pcp/pct183; Saika H, 2010, PLANT CELL REP, V29, P1351, DOI 10.1007/s00299-010-0921-x; Saika H, 2011, PLANT PHYSIOL, V156, P1269, DOI 10.1104/pp.111.175778; Terada R, 2010, PLANT BIOTECHNOL, V27, P29, DOI 10.5511/plantbiotechnology.27.29	34	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	JAN	2015	81	1					160	168		10.1111/tpj.12693		9	Plant Sciences	Plant Sciences	AX4RF	WOS:000346918400013		
J	Yuan, Y; Ogawa, R				Yuan, Yi; Ogawa, Rei			Tissue-Engineered Breast Reconstruction: Bridging the Gap toward Large-Volume Tissue Engineering in Humans	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Letter									[Yuan, Yi; Ogawa, Rei] Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Tokyo 1138603, Japan; [Yuan, Yi] Southern Med Univ, Nanfang Hosp, Dept Plast Surg, Guangzhou, Guangdong, Peoples R China	Ogawa, R (reprint author), Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	r.ogawa@nms.ac.jp					Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Findlay MW, 2011, PLAST RECONSTR SURG, V128, P1206, DOI 10.1097/PRS.0b013e318230c5b2; Yang X, 2012, CELL PROLIFERAT, V45, P158, DOI 10.1111/j.1365-2184.2011.00802.x; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Huang CY, 2013, TRENDS MOL MED, V19, P555, DOI 10.1016/j.molmed.2013.05.005	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	JAN	2015	135	1					236E	237E		10.1097/PRS.0000000000000785		3	Surgery	Surgery	AX4OG	WOS:000346911000039		
J	Okano, H; Hong, X; Kanaya, E; Angkawidjaja, C; Kanaya, S				Okano, Hiroyuki; Hong, Xun; Kanaya, Eiko; Angkawidjaja, Clement; Kanaya, Shigenori			Structural and biochemical characterization of a metagenome-derived esterase with a long N-terminal extension	PROTEIN SCIENCE			English	Article						metagenome; esterase; N-terminal extension; crystal structure; stability	ALPHA/BETA-HYDROLASE FOLD; ACTIVE-SITE MOTIF; CRYSTAL-STRUCTURE; SULFOLOBUS-TOKODAII; LC11-RNASE H1; STABILITY; PROTEINS; ENZYMES; CLASSIFICATION; BIOCATALYSTS	The genes encoding six novel esterolytic/lipolytic enzymes, termed LC-Est1 approximate to 6, were isolated from a fosmid library of a leaf-branch compost metagenome by functional screening using tributyrin agar plates. These enzymes greatly vary in size and amino acid sequence. The highest identity between the amino acid sequence of each enzyme and that available from the database varies from 44 to 73%. Of these metagenome-derived enzymes, LC-Est1 is characterized by the presence of a long N-terminal extension (LNTE, residues 26-283) between a putative signal peptide (residues 1-25) and a C-terminal esterase domain (residues 284-510). A putative esterase from Candidatus Solibacter usitatus (CSu-Est) is the only protein, which shows the significant amino acid sequence identity (46%) to the entire region of LC-Est1. To examine whether LC-Est1 exhibits activity and its LNTE is important for activity and stability of the esterase domain, LC-Est1 (residues 26-510), LC-Est1C (residues 284-510), and LC-Est1C* (residues 304-510) were overproduced in E. coli, purified, and characterized. LC-Est1C* was only used for structural analysis. The crystal structure of LC-Est1C* highly resembles that of the catalytic domain of Thermotoga maritima esterase, suggesting that LNTE is not required for folding of the esterase domain. The enzymatic activity of LC-Est1C was lower than that of LC-Est1 by 60%, although its substrate specificity was similar to that of LC-Est1. LC-Est1C was less stable than LC-Est1 by 3.3 degrees C. These results suggest that LNTE of LC-Est1 rather exists as an independent domain but is required for maximal activity and stability of the esterase domain.	[Okano, Hiroyuki; Hong, Xun; Kanaya, Eiko; Angkawidjaja, Clement; Kanaya, Shigenori] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Angkawidjaja, Clement] Osaka Univ, Int Coll, Toyonaka, Osaka 5600043, Japan	Kanaya, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kanaya@mls.eng.osaka-u.ac.jp	Okano, Hideyuki/J-5973-2013; 	Angkawidjaja, Clement/0000-0002-5019-2536	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24380055]	Grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant number: 24380055.	Levisson M, 2009, J MOL BIOL, V385, P949, DOI 10.1016/j.jmb.2008.10.075; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Iqbal HA, 2012, CURR OPIN CHEM BIOL, V16, P109, DOI 10.1016/j.cbpa.2012.02.015; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Steele HL, 2009, J MOL MICROB BIOTECH, V16, P25, DOI 10.1159/000142892; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Boutz DR, 2007, J MOL BIOL, V368, P1332, DOI 10.1016/j.jmb.2007.02.078; HENDRICKSON WA, 1990, EMBO J, V9, P1665; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Lopez-Lopez O, 2014, CURR PROTEIN PEPT SC, V15, P445; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Tuffin Marla, 2009, Biotechnology Journal, V4, P1671, DOI 10.1002/biot.200900235; SHIRLEY BA, 1992, BIOCHEMISTRY-US, V31, P725, DOI 10.1021/bi00118a013; Challacombe JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024882; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; Kanaya E, 2010, J APPL MICROBIOL, V109, P974, DOI 10.1111/j.1365-2672.2010.04724.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen TN, 2012, PROTEIN SCI, V21, P553, DOI 10.1002/pro.2043; Nguyen TN, 2013, J STRUCT BIOL, V182, P144, DOI 10.1016/j.jsb.2013.02.018; Nguyen TN, 2013, FEBS LETT, V587, P1418, DOI 10.1016/j.febslet.2013.03.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sulaiman S, 2014, BIOCHEMISTRY-US, V53, P1858, DOI 10.1021/bi401561p; Sulaiman S, 2011, APPL ENVIRON MICROB, V78, P1556; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; WATANABE K, 1991, J BIOL CHEM, V266, P24287; You DJ, 2007, BIOCHEMISTRY-US, V46, P11494, DOI 10.1021/bi700830f	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	JAN	2015	24	1					93	104		10.1002/pro.2591		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX4PM	WOS:000346914100010		
J	Kikuchi, N; Irifune, M; Shimizu, Y; Yoshida, K; Morita, K; Kanematsu, T; Morioka, N; Nakata, Y; Sakai, N				Kikuchi, Nobuhito; Irifune, Masahiro; Shimizu, Yoshitaka; Yoshida, Keita; Morita, Katsuya; Kanematsu, Takashi; Morioka, Norimitsu; Nakata, Yoshihiro; Sakai, Norio			Selective blockade of N-methyl-D-aspartate channels in combination with dopamine receptor antagonism induces loss of the righting reflex in mice, but not immobility	PSYCHOPHARMACOLOGY			English	Article						General anesthesia; Analgesia; Loss of the righting reflex; Immobility; MK-801; Arousal; SCH-23390; Haloperidol; Pain suppression system; Dexmedetomidine	RAT NUCLEUS-ACCUMBENS; DIZOCILPINE MK-801; NMDA RECEPTORS; INDUCED HYPERLOCOMOTION; GENERAL-ANESTHESIA; LOCOMOTOR-ACTIVITY; NITROUS-OXIDE; SUBSTANCE-P; SPINAL-CORD; RELEASE	The selective N-methyl-d-aspartate (NMDA) channel blocker MK-801 is known to induce no loss of the righting reflex (LORR) and to stimulate catecholaminergic (CAergic) neurons in rodents, playing a crucial role in arousal. We examined whether MK-801 in combination with CA receptor ligands, which inhibit CAergic neuronal activities, could induce anesthesia including LORR. All drugs were administered systemically to mice. To assess anesthesia, three different behaviors were used: loss of nociceptive response (analgesia in the free-moving state without LORR), LORR, and loss of movement in response to noxious stimulation (immobility under LORR). A very large dose of MK-801 (50 mg/kg) induced neither analgesia nor LORR. In contrast, MK-801 in combination with a small dose of the dopamine (DA) receptor antagonist haloperidol (0.2 mg/kg) dose-dependently produced LORR with a 50 % effective dose (ED50) of 1.6 (0.9-3.0; 95 % confidence limit) mg/kg, but not immobility. The alpha(2)-adrenoceptor agonist dexmedetomidine induced not only analgesia, but also immobility in animals treated with MK-801 (5 mg/kg) plus haloperidol (0.2 mg/kg), which then lost their righting reflex. The ED50 value of 0.26 (0.10-0.66) mg/kg (various doses of dexmedetomidine plus a fixed dose of MK-801 and haloperidol) for immobility was approximately three-fold larger than that of 0.09 (0.03-0.23) mg/kg (dexmedetomidine plus vehicle saline) for analgesia. This may occur, as LORR induced by MK-801 plus haloperidol inhibits the pain suppression system. The other ligands had little or no effect. The DAergic stimulant actions of MK-801 may mask its LORR effects by NMDA channel blockade.	[Kikuchi, Nobuhito; Irifune, Masahiro; Shimizu, Yoshitaka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Dent Anesthesiol, Program Dent Sci,Minami Ku, Hiroshima 7348553, Japan; [Yoshida, Keita] Hiroshima Univ Hosp, Dept Oral & Maxillofacial Surg & Oral Med, Sect Dent Anesthesiol, Hiroshima, Japan; [Morita, Katsuya; Kanematsu, Takashi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Program Dent Sci, Hiroshima 7348553, Japan; [Morioka, Norimitsu; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Program Pharmaceut Sci, Hiroshima 7348553, Japan; [Sakai, Norio] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Pharmacol Neurosci, Med Sci Program, Hiroshima 7348553, Japan	Irifune, M (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Dent Anesthesiol, Program Dent Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	mirifun@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [18592037]	This study was supported in part by Grant-in-Aid No. 18592037 for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank Medical English Service Corp. (Kyoto, Japan) for English language editing.	CLARKE PBS, 1995, BRIT J PHARMACOL, V114, P315; IMPERATO A, 1990, EUR J PHARMACOL, V187, P555, DOI 10.1016/0014-2999(90)90387-L; GATTAZ WF, 1994, J NEURAL TRANSM-GEN, V96, P227, DOI 10.1007/BF01294789; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; AIMONE LD, 1989, PEPTIDES, V10, P1127, DOI 10.1016/0196-9781(89)90003-X; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Guo TZ, 1996, ANESTHESIOLOGY, V84, P873, DOI 10.1097/00000542-199604000-00015; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; Del Arco A, 2008, PSYCHOPHARMACOLOGY, V201, P325, DOI 10.1007/s00213-008-1288-3; IRIFUNE M, 1991, PHARMACOL BIOCHEM BE, V40, P399, DOI 10.1016/0091-3057(91)90571-I; Mathe JM, 1996, EUR J PHARMACOL, V309, P1, DOI 10.1016/0014-2999(96)00315-9; Kovacic P, 2010, OXID MED CELL LONGEV, V3, P13, DOI 10.4161/oxim.3.1.10028; Hu FY, 2012, ANESTHESIOLOGY, V117, P1006, DOI 10.1097/ALN.0b013e3182700ab9; Yan QS, 1997, BRAIN RES, V765, P149, DOI 10.1016/S0006-8993(97)00568-4; BIANCHI C, 1954, BRIT J PHARM CHEMOTH, V9, P280; DOZE VA, 1989, ANESTHESIOLOGY, V71, P75, DOI 10.1097/00000542-198907000-00014; Sakamoto S, 2006, ANESTH ANALG, V103, P1459, DOI 10.1213/01.ane.0000247792.03959.f1; LAPIN IP, 1995, BEHAV BRAIN RES, V70, P145, DOI 10.1016/0166-4328(95)80004-2; IRIFUNE M, 1995, PHARMACOL BIOCHEM BE, V51, P291, DOI 10.1016/0091-3057(94)00379-W; Mathe JM, 1999, NEUROPHARMACOLOGY, V38, P121, DOI 10.1016/S0028-3908(98)00163-4; FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.neuro.14.1.219; CARTER AJ, 1995, LIFE SCI, V57, P917, DOI 10.1016/0024-3205(95)02027-G; Chen XD, 2009, J NEUROSCI, V29, P560, DOI 10.1523/JNEUROSCI.3481-08.2009; Cooper JR, 2003, BIOCH BASIS NEUROPHA, P225; DANIELL LC, 1990, PHARMACOL BIOCHEM BE, V36, P111, DOI 10.1016/0091-3057(90)90134-4; Dutton RC, 2003, ANESTHESIOLOGY, V98, P1372, DOI 10.1097/00000542-200306000-00011; FISHMAN RHB, 1983, PROG NEUROBIOL, V20, P55, DOI 10.1016/0301-0082(83)90010-2; Foster AC, 1991, EXCITATORY AMINO ACI, P164; Guyton AC, 2006, TXB MED PHYSL, P598; HYNES MD, 1983, EUR J PHARMACOL, V90, P109, DOI 10.1016/0014-2999(83)90220-0; Iravani MM, 1999, SYNAPSE, V32, P212, DOI 10.1002/(SICI)1098-2396(19990601)32:3<212::AID-SYN7>3.0.CO;2-M; Irifune M, 2007, CAN J ANAESTH, V54, P998; IWATA S, 1989, PHARMACOL BIOCHEM BE, V33, P705; JACKSON DM, 1994, PHARMACOL BIOCHEM BE, V48, P465, DOI 10.1016/0091-3057(94)90554-1; Katayama S, 2007, ANESTH ANALG, V104, P1422, DOI 10.1213/01.ane.0000261519.04083.3e; Koblin DD, 2000, ANESTHESIA, P48; Masuzawa M, 2003, ANESTH ANALG, V96, P148, DOI 10.1213/01.ANE.0000041458.58089.E8; O'Brien CP., 2011, GOODMAN GILMANS PHAR, P649; Patel P. M., 2011, GOODMAN GILMANS PHAR, P527; RAMOA AS, 1990, J PHARMACOL EXP THER, V254, P71; Sinner B., 2008, V182, P313; SPYRAKI C, 1982, J NEURAL TRANSM, V54, P153, DOI 10.1007/BF01254925; TAKANO M, 1993, PEPTIDES, V14, P371, DOI 10.1016/0196-9781(93)90055-L; Westfall TC, 2011, GOODMAN GILMANS PHAR, P277; Woods JH, 1991, EXCITATORY AMINO ACI, P237	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JAN	2015	232	1					39	46		10.1007/s00213-014-3634-y		8	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AX8NI	WOS:000347165700004		
J	Miyaoka, T; Furuya, M; Horiguchi, J; Wake, R; Hashioka, S; Tohyama, M; Mori, N; Minabe, Y; Iyo, M; Ueno, S; Ezoe, S; Murotani, K; Hoshino, S; Seno, H				Miyaoka, Tsuyoshi; Furuya, Motohide; Horiguchi, Jun; Wake, Rei; Hashioka, Sadayuki; Tohyama, Masaya; Mori, Norio; Minabe, Yoshio; Iyo, Masaomi; Ueno, Shyuichi; Ezoe, Sachiko; Murotani, Kenta; Hoshino, Syuzo; Seno, Haruo			Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis)	PSYCHOPHARMACOLOGY			English	Article						Schizophrenia	YI-GAN-SAN; TRADITIONAL JAPANESE MEDICINE; PERVASIVE DEVELOPMENTAL DISORDER; INDUCED NEURONAL DEATH; OPEN-LABEL; PSYCHOLOGICAL SYMPTOMS; UNCARIA-SINENSIS; LEWY BODIES; VISUAL HALLUCINATIONS; ALZHEIMERS-DISEASE	Treating schizophrenia patients who fail to respond to antipsychotics is a major challenge, and the percentage of treatment-resistant patients is estimated to be 20-25 %. Recent studies indicate that yokukansan (YKS; D2 and 5HT1A partial agonist and 5HT2A and glutamate antagonist) to be safe and useful in treating behavioral and psychological symptoms associated with dementia and other neuropsychiatric conditions. We aimed at evaluating both the efficacy and safety of YKS in patients with treatment-resistant schizophrenia. This randomized, multicenter, double-blind, placebo-controlled study was conducted between May 2010 and August 2012. One hundred twenty antipsychotic-treated inpatients from 34 psychiatric hospitals in Japan were included. Patients were randomized to adjuvant treatment with YKS 7.5 g/day or placebo. During a 4-week follow-up, psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS) with five factors [excitement/hostility (P4, P7, G8, and G14), depression/anxiety (G1, G2, G3, G4, and G6), cognition (P2, N5, N7, G5, G10, G11, G12, G13, and G15], positive (P1, P3, P5, P6, and G9), and negative (N1, N2, N3, N4, N6, G7, and G16]]. Other assessments included, Clinical Global Impression-Severity (CGI-S), Global Assessment of Functioning (GAF), and Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). The primary efficacy outcome was the change in PANSS five-factor scores. The secondary outcomes were changes in the scores of CGI-S. The analysis was made on a modified intention to treat basis with the help of a last observation carried forward method. YKS showed a tendency of superiority to placebo in reducing total all PANSS five-factor scores in treatment-resistant schizophrenia, but the difference was not statistically significant in total, depression/anxiety, cognition, positive, and negative factors. However, compared to the placebo group, the YKS group showed statistically significant improvements in the PANSS excitement/hostility factor scores (p < 0.05). No substantial side effects were recorded. The results of the present study indicate YKS to be a potential adjunctive treatment strategy for treatment-resistant schizophrenia, particularly to improve excitement/hostility symptoms.	[Miyaoka, Tsuyoshi; Furuya, Motohide; Horiguchi, Jun; Wake, Rei; Hashioka, Sadayuki] Shimane Univ, Sch Med, Dept Psychiat, Izumo, Shimane, Japan; [Tohyama, Masaya] Kinki Univ, Res Inst Tradit Asian Med, Higashiosaka, Osaka 577, Japan; [Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Minabe, Yoshio] Kanazawa Univ, Sch Med, Dept Psychiat, Kanazawa, Ishikawa 920, Japan; [Iyo, Masaomi] Chiba Univ, Sch Med, Dept Psychiat, Chiba 280, Japan; [Ueno, Shyuichi] Ehime Univ, Sch Med, Dept Psychiat, Matsuyama, Ehime, Japan; [Ezoe, Sachiko] Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka, Japan; [Murotani, Kenta] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Hoshino, Syuzo] Takeda Gen Hosp, Dept Psychiat, Fukushima, Japan; [Seno, Haruo] Matsue Aoba Hosp, Dept Psychiat, Matsue, Shimane, Japan	Miyaoka, T (reprint author), Shimane Univ, Sch Med, Dept Psychiat, Izumo, Shimane, Japan.	miyanyan@med.shimane-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan [04 T-580]	This project (04 T-580) was supported by Grants-in-Aid for the Ministry of Health, Labor, and Welfare of Japan.	Aizawa R, 2002, PSYCHIAT CLIN NEUROS, V56, P303, DOI 10.1046/j.1440-1819.2002.01006.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Conley RR, 1997, SCHIZOPHRENIA BULL, V23, P663; Shimada Y, 1999, J PHARM PHARMACOL, V51, P715, DOI 10.1211/0022357991772853; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Kang TH, 2002, EUR J PHARMACOL, V455, P27, DOI 10.1016/S0014-2999(02)02581-5; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P1612; Howes OD, 2012, BRIT J PSYCHIAT, V201, P481, DOI 10.1192/bjp.bp.111.105833; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; Hayashi Y, 2010, PROG NEURO-PSYCHOPH, V34, P541, DOI 10.1016/j.pnpbp.2010.02.016; SMITH RS, 1995, MED HYPOTHESES, V45, P135, DOI 10.1016/0306-9877(95)90062-4; Anderson G, 2013, PROG NEURO-PSYCHOPH, V42, P1, DOI 10.1016/j.pnpbp.2012.10.008; Kanno H, 2009, J PHARM PHARMACOL, V61, P1249, DOI 10.1211/jpp/61.09.0016; Monji A, 2009, PROG NEURO-PSYCHOPH, V33, P308, DOI 10.1016/j.pnpbp.2008.12.008; Kawanabe T, 2010, PROG NEURO-PSYCHOPH, V34, P284, DOI 10.1016/j.pnpbp.2009.11.019; Kapur S, 1999, AM J PSYCHIAT, V156, P286; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; Citrome L, 2011, SCHIZOPHR RES, V131, P75, DOI 10.1016/j.schres.2011.05.018; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248; Shimada Y, 2001, AM J CHINESE MED, V29, P173, DOI 10.1142/S0192415X01000198; Demijaha A, 2012, AM J PSYCHIAT, V169, P1203; Egashira N, 2008, PROG NEURO-PSYCHOPH, V32, P1516, DOI 10.1016/j.pnpbp.2008.05.010; First MS, 1995, STRUCTURED CLIN INTE; Furuya M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-145; Guy W, 1976, ECDEU ASSESSMENT MAN, P218; Ikarashi Y, 2009, BIOL PHARM BULL, V32; Inada T, 2009, 20 COLL INT NEUR MEL, P23; Iwasaki K, 2011, J AM GERIATR SOC, V59, P936, DOI 10.1111/j.1532-5415.2011.03373.x; Iwasaki K, 2012, PSYCHOGERIATRICS, V12, P235, DOI 10.1111/j.1479-8301.2012.00413.x; Kajitani K, 2012, J AM GERIATR SOC, V60, P379, DOI 10.1111/j.1532-5415.2011.03801.x; KANATANI H, 1985, J PHARM PHARMACOL, V37, P401; KANE JM, 1988, PSYCHOPHARMACOL BULL, V24, P62; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Kimura T, 2010, PSYCHIAT CLIN NEUROS, V64, P207, DOI 10.1111/j.1440-1819.2010.02072.x; LINDENMAYER JP, 1995, SCHIZOPHR RES, V14, P229, DOI 10.1016/0920-9964(94)00041-6; Miyaoka T, 2009, PROG NEURO-PSYCHOPH, V33, P382, DOI 10.1016/j.pnpbp.2008.12.005; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P761, DOI 10.1016/j.pnpbp.2007.12.003; Miyaoka T, 2009, CLIN NEUROPHARMACOL, V32, P6, DOI 10.1097/WNF.0b013e31817e08c3; Miyaoka T, 2013, PHYTOMEDICINE, V20, P654, DOI 10.1016/j.phymed.2013.01.007; Miyaoka T, 2011, CLIN NEUROPHARMACOL, V34, P24, DOI 10.1097/WNF.0b013e318206785a; Miyaoka T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-215; Miyaoka T, 2009, CURR PSYCHIAT REV, V5, P271; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P150, DOI 10.1016/j.pnpbp.2007.07.026; Nakata K, 2012, PHYTOMEDICINE, V19, P524; Nishi A, 2010, 40 ANN M JAP SOC NEU; Okahara K, 2010, PROG NEURO-PSYCHOPH, V34, P532, DOI 10.1016/j.pnpbp.2010.02.013; Stern RG, 1997, BIOL PSYCHIAT, V42, P138, DOI 10.1016/S0006-3223(96)00295-8; Sumiyoshi H, 2011, AM J GERIAT PSYCHIAT, V19, P906, DOI 10.1097/JGP.0b013e318227f88e; Tahara E, 2003, KAMPO NO RINSHO, V1, P105; Taylor DM, 2003, J CLIN PSYCHIAT, V64, P30; Terawaki K, 2010, J ETHNOPHARMACOL, V127, P306, DOI 10.1016/j.jep.2009.11.003; The Ministry of Health Labour and Welfare, 2006, JAP PHARM; Wake R, 2013, J CHILD ADOL PSYCHOP, V23, P329, DOI 10.1089/cap.2012.0108	53	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JAN	2015	232	1					155	164		10.1007/s00213-014-3645-8		10	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AX8NI	WOS:000347165700012		
J	Xu, L; Sommer, W; Masaki, H				Xu, Lu; Sommer, Werner; Masaki, Hiroaki			The structure of motor programming: Evidence from reaction times and lateralized readiness potentials	PSYCHOPHYSIOLOGY			English	Article						Movement preparation; Mental chronometry; Lateralized readiness potential; Finger tapping; Kinematic parameter	HIERARCHICAL EDITOR MODEL; RAPID FINGER SEQUENCES; LRP ONSET; MOVEMENT SEQUENCES; PROCESSING STAGES; CHOICE REACTIONS; SCORING METHOD; DIRECTION; INFERENCES; DURATION	There is a widely accepted notion that movement elements are assembled prior to movement execution in a central motor programming stage. However, it is not clear how this stage is structuredwhether it is a unitary stage allowing different motor parameters to cross talk or whether there are several independent processes dealing with each motor parameter. We addressed this question by orthogonally manipulating two movement-related factors: response sequence complexity and movement duration. Both factors yielded main effects on reaction time but no interaction. Additive effects of both factors on the onsets of response- but not stimulus-synchronized lateralized readiness potentials suggest separable motoric loci of sequence complexity and duration. These findings are at variance with the notion of a unitary movement programming stage.	[Xu, Lu] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Xu, Lu] Japan Soc Promot Sci, Tokyo, Japan; [Sommer, Werner] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Masaki, Hiroaki] Waseda Univ, Fac Sport Sci, Saitama, Japan	Masaki, H (reprint author), Waseda Univ, Fac Sport Sci, Saitama, Japan.	masaki@waseda.jp	Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445	Japan Society for the Promotion of Science (JSPS); JSPS [24530925]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Portions of this work were presented at the 52nd Annual Meeting of the Society for Psychophysiological Research, New Orleans, LA, September, 2012. This study was supported by Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists to LX, a grant-in-aid for Scientific Research (C) 24530925 from the JSPS to HM, and the Global COE Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). We thank three anonymous reviewers for their valuable comments and suggestions on a previous version of this manuscript.	GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; Klapp ST, 2003, J MOTOR BEHAV, V35, P135; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469.8986.2004.00150.x; ROSENBAUM DA, 1984, J EXP PSYCHOL GEN, V113, P372, DOI 10.1037//0096-3445.113.3.372; Lee KM, 1999, NEUROIMAGE, V9, P117, DOI 10.1006/nimg.1998.0393; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; Muller-Gethmann H, 2003, PSYCHOPHYSIOLOGY, V40, P597, DOI 10.1111/1469-8986.00061; Schwarzenau P, 1998, BEHAV RES METH INS C, V30, P110, DOI 10.3758/BF03209421; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Smulders FTY, 1996, PSYCHOPHYSIOLOGY, V33, P194, DOI 10.1111/j.1469-8986.1996.tb02123.x; SMULDERS FTY, 1995, ACTA PSYCHOL, V90, P97, DOI 10.1016/0001-6918(95)00032-P; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1017/S0048577201000610; Leuthold H, 1996, J EXP PSYCHOL GEN, V125, P307, DOI 10.1037/0096-3445.125.3.307; HENRY FM, 1960, RES QUART, V31, P448; Arbib M.A., 1985, EXP BRAIN RES S, V10, P111; Coles M. G. H., 1995, OX PSYCH S, P1; HACKLEY SA, 1995, PSYCHOPHYSIOLOGY, V32, P230, DOI 10.1111/j.1469-8986.1995.tb02952.x; Immink MA, 2001, J EXP PSYCHOL HUMAN, V27, P423, DOI 10.1037//0096-1523.27.2.423; Keele S. W., 1981, HDB PHYSL 1, P1391, DOI 10.1002/cphy.cp010231; Kennerley SW, 2004, J NEUROPHYSIOL, V91, P978, DOI 10.1152/jn.00651.2003; KLAPP ST, 1995, J EXP PSYCHOL HUMAN, V21, P1015, DOI 10.1037//0096-1523.21.5.1015; KLAPP ST, 1974, J MOTOR BEHAV, V6, P263, DOI 10.1080/00222895.1974.10735002; Leuthold H, 2011, BIOL PSYCHOL, V86, P57, DOI 10.1016/j.biopsycho.2010.10.007; Leuthold H, 2011, PSYCHOPHYSIOLOGY, V48, P633, DOI 10.1111/j.1469-8986.2010.01126.x; Low KA, 2002, BRAIN, V125, P1980, DOI 10.1093/brain/awf206; Magnuson CE, 2008, J MOTOR BEHAV, V40, P532, DOI 10.3200/JMBR.40.6.532-544; MILLER J, 1992, J EXP PSYCHOL HUMAN, V18, P1121, DOI 10.1037/0096-1523.18.4.1121; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; Muller-Gethmann H, 2000, PSYCHOPHYSIOLOGY, V37, P507, DOI 10.1111/1469-8986.3740507; OSMAN A, 1995, ACTA PSYCHOL, V90, P111, DOI 10.1016/0001-6918(95)00029-T; Rosenbaum D. A., 1983, ADV PSYCHOL, V12, P231, DOI [10.1016/S0166-4115(08)61994-9, DOI 10.1016/S0166-4115(08)61994-9]; Rosenbaum D. A., 1985, MOTOR BEHAV PROGRAMM, P1, DOI 10.1007/978-3-642-69749-4_1; ROSENBAUM DA, 1987, J EXP PSYCHOL HUMAN, V13, P193, DOI 10.1037//0096-1523.13.2.193; Sanders A., 1998, ELEMENTS HUMAN PERFO; Sanders A. F., 1990, ACTA PSYCHOL, V74, P1, DOI 10.1016/0001-6918(90)90004-Y; Sanders A. F., 1980, ATTENTION PERFORM, P59; Schroter H, 2009, PSYCHOPHYSIOLOGY, V46, P388, DOI 10.1111/j.1469-8986.2008.00772.x; Sparks D. L., 1983, SPATIALLY ORIENTED B, P63, DOI [10.1007/978-1-4612-5488-1_4, DOI 10.1007/978-1-4612-5488-1_4]; SPIJKERS WAC, 1985, ACTA PSYCHOL, V58, P191, DOI 10.1016/0001-6918(85)90007-1; SPIJKERS WAC, 1984, PSYCHOL RES-PSYCH FO, V46, P59, DOI 10.1007/BF00308593; SPIJKERS WAC, 1987, ACTA PSYCHOL, V65, P285, DOI 10.1016/0001-6918(87)90054-0; STANOVICH KE, 1977, J EXP PSYCHOL HUMAN, V3, P411, DOI 10.1037//0096-1523.3.3.411; Sternberg S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00744; Verwey W. B., 1994, THESIS FREE U AMSTER; ZELAZNIK HN, 1985, J MOTOR BEHAV, V17, P190; ZELAZNIK HN, 1990, ADV PSYCHOL, V65, P279, DOI 10.1016/S0166-4115(08)61227-3	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	JAN	2015	52	1					149	155		10.1111/psyp.12296		7	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	AX4NL	WOS:000346909000016		
J	Yalcintas, E; Gaona, X; Scheinost, AC; Kobayashi, T; Altmaier, M; Geckeis, H				Yalcintas, Ezgi; Gaona, Xavier; Scheinost, Andreas C.; Kobayashi, Taishi; Altmaier, Marcus; Geckeis, Horst			Redox chemistry of Tc(VII)/Tc(IV) in dilute to concentrated NaCl and MgCl2 solutions	RADIOCHIMICA ACTA			English	Article						Technetium; redox reactions; salt brines; thermodynamics; Fe(II) minerals; XANES	RAY-ABSORPTION SPECTROSCOPY; AQUEOUS SODIUM DITHIONITE; CACL2 SOLUTIONS; PERTECHNETATE IMMOBILIZATION; ACTIVITY-COEFFICIENTS; REDUCING CONDITIONS; SOLVENT-EXTRACTION; PITZER PARAMETERS; FERROUS IRON; SOLUBILITY	The redox behaviour of Tc(VII)/Tc(IV) was investigated within the pH(c) range 2-14.6 in (0.5 M and 5.0 M) NaCl and (0.25 M, 2.0 M and 4.5 M) MgCl2 solutions in the presence of different reducing agents(Na2S2O4, Sn(II), Fe(II)/Fe(III), Fe powder) and macroscopic amounts of Fe minerals (magnetite, mackinawite, siderite: S/L = 20-30 g L-1). In the first group of samples, the decrease of the initial Tc concentration (1 x 10(-5) M, as Tc(VII)) indicated the reduction to Tc(IV) according to the chemical reaction TcO4- + 4H(+) + 3e(-) double left right arrow TcO2 center dot 1.6H(2)O(s) + 0.4H(2)O. Redox speciation of Tc in the aqueous phase was further confirmed by solvent extraction. A good agreement is obtained between the experimentally determined Tc redox distribution and thermodynamic calculations based on NEA-TDB (Nuclear Energy Agency, Thermochemical Database) and ionic strength corrections by SIT or Pitzer approaches. These observations indicate that experimental pH(c) and E-h values in buffered systems can be considered as reliable parameters to predict the redox behaviour of Tc in dilute to highly concentrated NaCl and MgCl2 solutions. E-h of the system and aqueous concentration of Tc(IV) in equilibrium with TcO2 center dot 1.6H(2)O(s) are strongly affected by elevated ionic strength, especially in the case of 4.5 M MgCl2 solutions. In such concentrated brines and under alkaline conditions (pH(c) = pH(max) similar to 9), kinetics play a relevant role and thermodynamic equilibriumfor the system Tc(IV)(aq) double left right arrow Tc(IV)(s) was not attained from over-saturation conditions within the timeframe of this study (395 days). Tc(VII) is reduced to Tc(IV) bymagnetite, mackinawite and siderite suspensions at pH(c) = 8-9 in concentrated NaCl and MgCl2 solutions. Sorption is very high in all cases (R-d >= 10(3) L kg(-1)), although R-d values are significantly lower in 4.5 M MgCl2 solutions. XANES (X-ray absorption near edge spectroscopy) evaluation of these samples confirms that Tc(VII) is reduced to Tc(IV) by Fe(II) minerals also in concentrated NaCl and MgCl2 brines.	[Yalcintas, Ezgi; Gaona, Xavier; Altmaier, Marcus; Geckeis, Horst] Karlsruhe Inst Technol, Inst Nucl Waste Disposal, D-76021 Karlsruhe, Germany; [Scheinost, Andreas C.] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Scheinost, Andreas C.] ESRF, Rossendorf Beamline ROBL, Grenoble, France; [Kobayashi, Taishi] Kyoto Univ, Dept Nucl Engn, Kyoto 606, Japan	Yalcintas, E (reprint author), Karlsruhe Inst Technol, Inst Nucl Waste Disposal, D-76021 Karlsruhe, Germany.	ezgi.yalcintas@kit.edu	Scheinost, Andreas/D-2275-2010; The Rossendorf Beamline at ESRF, ROBL/A-2586-2011				Altmaier M, 2009, RADIOCHIM ACTA, V97, P187, DOI 10.1524/ract.2009.1593; Cui DQ, 1996, ENVIRON SCI TECHNOL, V30, P2259, DOI 10.1021/es9506263; Warwick P, 2007, RADIOCHIM ACTA, V95, P709, DOI 10.1524/ract.2007.95.12.709; Llorens IA, 2008, RADIOCHIM ACTA, V96, P569, DOI 10.1524/ract.2008.1538; Cui DQ, 1996, ENVIRON SCI TECHNOL, V30, P2263, DOI 10.1021/es950627v; Kirsch R, 2011, ENVIRON SCI TECHNOL, V45, P7267, DOI 10.1021/es200645a; Poineau F, 2006, RADIOCHIM ACTA, V94, P283, DOI 10.1524/ract.2006.94.5.283; Maes A, 2004, ENVIRON SCI TECHNOL, V38, P2044, DOI 10.1021/es034720s; HARVIE CE, 1984, GEOCHIM COSMOCHIM AC, V48, P723, DOI 10.1016/0016-7037(84)90098-X; Livens FR, 2004, J ENVIRON RADIOACTIV, V74, P211, DOI 10.1016/j.jenvrad.2004.01.012; Gaona X, 2011, ENVIRON SCI TECHNOL, V45, P8765, DOI 10.1021/es2012897; Hess NJ, 2004, J SOLUTION CHEM, V33, P199, DOI 10.1023/B:JOSL.0000030285.11512.1f; Altmaier M, 2003, GEOCHIM COSMOCHIM AC, V67, P3595, DOI 10.1016/S0016-7037(03)00165-0; Geraedts K, 2002, RADIOCHIM ACTA, V90, P879, DOI 10.1524/ract.2002.90.12_2002.879; Liu Y, 2008, RADIOCHIM ACTA, V96, P823, DOI 10.1524/ract.2008.1528; Zachara JM, 2007, GEOCHIM COSMOCHIM AC, V71, P2137, DOI 10.1016/j.gca.2006.10.025; Um W, 2011, ENVIRON SCI TECHNOL, V45, P4904, DOI 10.1021/es104343p; Wharton MJ, 2000, APPL GEOCHEM, V15, P347, DOI 10.1016/S0883-2927(99)00045-1; Kobayashi T, 2013, RADIOCHIM ACTA, V101, P323, DOI 10.1524/ract.2013.2040; Peretyazhko TS, 2012, GEOCHIM COSMOCHIM AC, V92, P48, DOI 10.1016/j.gca.2012.05.041; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bischofer B. P., 2009, 1 ANN WORKSH P 7 EC; Blanchard D. L., 1997, PNNL11386UC2030; Chotkowski M, 2012, ELECTROCHIM ACTA, V76, P165, DOI 10.1016/j.electacta.2012.04.123; CIAVATTA L, 1990, ANN CHIM-ROME, V80, P255; ERIKSEN TE, 1992, RADIOCHIM ACTA, V58-9, P67; Fellhauer D, 2010, RADIOCHIM ACTA, V98, P541, DOI 10.1524/ract.2010.1751; FELMY AR, 1989, RADIOCHIM ACTA, V48, P29; GRASSI J, 1979, ANAL CHIM ACTA, V107, P47, DOI 10.1016/S0003-2670(01)93194-0; GRASSI J, 1978, J ELECTROANAL CHEM, V88, P97, DOI 10.1016/0368-1874(78)87109-3; Grenthe I., 2000, GUIDELINES EXTRAPOLA; Guillaumont R., 2003, UPDATE CHEM THERMODY, V5; Hummel W., 2009, TM440901 PSI; Konnecke T, 1997, J SOLUTION CHEM, V26, P561, DOI 10.1007/BF02767628; Kopunec R, 1998, J RADIOANAL NUCL CH, V230, P51, DOI 10.1007/BF02387446; Kupfer M. J., 1999, HNFSDWM740; LEM WJ, 1970, CAN J CHEMISTRY, V48, P776, DOI 10.1139/v70-126; Lemire R. J., 2013, CHEM THERMODYNAMIC A; Liu Y, 2007, RADIOCHIM ACTA, V95, P717, DOI 10.1524/ract.2007.95.12.717; MEYER RE, 1991, RADIOCHIM ACTA, V55, P19; Morrison G.H., 1957, SOLVENT EXTRACTION A; Neck V, 2009, PURE APPL CHEM, V81, P1555, DOI 10.1351/PAC-CON-08-09-05; Neck V, 1998, J SOLUTION CHEM, V27, P107, DOI 10.1023/A:1022625605743; Neck V, 2006, RADIOCHIM ACTA, V94, P501, DOI 10.1524/ract.2006.94.9.501; OMORI T, 1994, J RADIOAN NUCL CH AR, V178, P237, DOI 10.1007/BF02039717; OWUNWANNE A, 1977, J NUCL MED, V18, P1099; Pitzer K. S., 1991, ACTIVITY COEFFICIENT; Rard J. A., 1999, CHEM THERMODYNAMICS, V3; RUSSELL CD, 1978, J NUCL MED, V19, P694; Saeki M, 2012, INORG CHEM, V51, P5814, DOI 10.1021/ic3003405; Scharge T., 2010, 2 ANN WORKSH P 7 EC; Schnurr A., 2013, MIGR C BRIGHT UK; STERN HS, 1966, J NUCL MED, V7, P665; WAYMAN M, 1970, CAN J CHEMISTRY, V48, P782, DOI 10.1139/v70-127	54	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0033-8230			RADIOCHIM ACTA	Radiochim. Acta	JAN	2015	103	1					57	72		10.1515/ract-2014-2272		16	Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AX7QN	WOS:000347110200007		
J	Furuya, M; Ohata, K; Izumi, K; Matsubayashi, J; Tominaga, W; Mitani, A				Furuya, Makiko; Ohata, Koji; Izumi, Keisuke; Matsubayashi, Jun; Tominaga, Wataru; Mitani, Akira			Effect of the angle of shoulder flexion on the reach trajectory of children with spastic cerebral palsy	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Cerebral palsy; Shoulder flexion angle; Reach; Trajectory	HEMIPARETIC SUBJECTS; UPPER EXTREMITY; UPPER-LIMB; STROKE; REORGANIZATION; MOVEMENT; PATTERNS; AREA	Many children with cerebral palsy (CP) use a wheelchair during activities of daily living and often extend their hand upward and downward to reach objects in a seated position in a wheelchair. However, the effect of shoulder position on reaching movements of children with CP is not established. The purpose of this study was to determine the effect of the angle of shoulder flexion on the reach trajectory of children with spastic CP. Seven children with mild CP [Manual Ability Classification System (MACS) levels I-Ill, five children with severe CP (MACS levels III-V) and six typically developing (TD) children participated. We prepared the device to have a top board with variable tilting angle in order to reduce the effect of gravity imposing on reaching movements. By using this device, the subjects could extend their arm by sliding it on the board to push a target button. The reaching movements were performed with the more affected hand at three angles (60 degrees, 90 degrees and 120 degrees) of shoulder flexion and captured using a camera motion analysis system. Subjects in the TD and mild CP groups reached the target at 60 degrees, 90 degrees and 120 degrees of shoulder flexion. Subjects of the severe CP group reached the target at 60 degrees and 90 degrees of shoulder flexion, but two of the subjects could not reach the target at 120 degrees of shoulder flexion. The TD and mild CP groups showed smooth and almost straight trajectories at all three angles of shoulder flexion: however, the reach trajectory in the subjects with severe CP changed with the angle of shoulder flexion. A large angle of shoulder flexion induced great outward deviation in the trajectory. These findings suggest that the difficulty of the reaching task is changed depending on the shoulder joint angle in children with severe CP and that therapeutic interventions for children with severe CP should be provided in a manner appropriate for the shoulder joint angle. (C) 2014 Elsevier Ltd. All rights reserved.	[Furuya, Makiko; Matsubayashi, Jun; Tominaga, Wataru; Mitani, Akira] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Lab Neurorehabil, Kyoto 6068507, Japan; [Ohata, Koji; Izumi, Keisuke] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Kyoto 6068507, Japan	Mitani, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Lab Neurorehabil,Sakyo Ku, 53 Kawaharacho, Kyoto 6068507, Japan.	mitani.akira.6z@kyoto-u.ac.jp					DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Coluccini M, 2007, GAIT POSTURE, V25, P493, DOI 10.1016/j.gaitpost.2006.12.015; Yao J, 2009, NEUROIMAGE, V45, P490, DOI 10.1016/j.neuroimage.2008.12.002; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6; Miller LC, 2012, CLIN NEUROPHYSIOL, V123, P1216, DOI 10.1016/j.clinph.2012.01.009; Dewald JPA, 2001, MUSCLE NERVE, V24, P273, DOI 10.1002/1097-4598(200102)24:2<273::AID-MUS130>3.0.CO;2-Z; Arner M, 2008, J HAND SURG-AM, V33A, P1337, DOI 10.1016/j.jhsa.2008.02.032; Ellis MD, 2008, NEUROREHAB NEURAL RE, V22, P321, DOI 10.1177/1545968307313509; Ellis MD, 2007, EXP BRAIN RES, V176, P594, DOI 10.1007/s00221-006-0637-x; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; CAO Y, 1994, P NATL ACAD SCI USA, V91, P9612, DOI 10.1073/pnas.91.20.9612; Dewald JPA, 1999, MUSCLE NERVE, V22, P1209, DOI 10.1002/(SICI)1097-4598(199909)22:9<1209::AID-MUS7>3.0.CO;2-B; Jaspers E, 2011, RES DEV DISABIL, V32, P2283, DOI 10.1016/j.ridd.2011.07.038; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Van Der Heide JC, 2005, PEDIATR RES, V57, P883, DOI 10.1203/01.PDR.0000157771.20683.14	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	JAN	2015	36						413	418		10.1016/j.ridd.2014.10.037		6	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	AX1DX	WOS:000346689400042		
J	Liang, Y; Wang, GG; Liu, SY; Sun, YZ; Huang, YG; Hoshino, K				Liang, Yi; Wang, Guogang; Liu, Shengyou; Sun, Yuzhen; Huang, Yonggang; Hoshino, Kenichi			A Study on the Mineralization of the Woxi Au-Sb-W Deposit, Western Hunan, China	RESOURCE GEOLOGY			English	Article						fluid inclusion; gold fineness; LA-ICP-MS; native gold; scheelite; stibnite	NW HUNAN; PR CHINA; GOLD; METAL; ELEMENT; FLUID	The Woxi Au-Sb-W deposit in the western Hunan Province, China, is of hydrothermal vein type characterized by a rare mineral assemblage of stibnite, scheelite and native gold, of which gold fineness ranges from 998.6 to 1000. The mineralization sequence observed in the deposit is, from early to late, coarse-grained pyrite - scheelite - stibnite - Pb-Sb-S minerals - sphalerite (+ cubanite) - fine-grained pyrite. Native gold may have precipitated with scheelte. Microthermometric and LA-ICP-MS analyses of fluid inclusions in scheelite, quartz associated with scheelite and stibnite and barren quartz clarified that there may be at least three types of hydrothermal fluids during the vein formation in the Woxi deposit. Scheelite and native gold precipitated from the fluid of high temperature and salinity with high concentrations of metal elements, followed by stibnite precipitation. The later fluid of the highest temperature and salinity with low concentrations of the elements yielded the sphalerite mineralization. The latest fluid of low temperature and salinity with low concentrations of the elements is observed mainly in barren quartz. The remarkably high Au/Ag concentration ratios determined in the fluid inclusions in scheelite might be the reason for the extremely high gold fineness of native gold.	[Liang, Yi; Hoshino, Kenichi] Hiroshima Univ, Grad Sch Sci, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; [Wang, Guogang; Liu, Shengyou; Sun, Yuzhen; Huang, Yonggang] Chenzhou Min Grp, Geol Sect Woxi Mine, Chenzhou, Hunan, Peoples R China	Liang, Y (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan.	D122873@hiroshima-u.ac.jp			Society of Resource Geology; Japan Mining Promotive Foundation	The authors would like to thank Prof. Xiangping Gu of the Central South University in Hunan Province, China for his constructive suggestions. We deeply acknowledge Prof. Yoshio Takahashi, since he kindly allowed us to use his LA-ICP-MS instrument. We are grateful to Mr. Yasuhiro Shibata, Mr. Yuta Yoshie and Dr. Aya Katsube for their technical supports in EPMA and LA-ICP-MS analyses. Our field work in 2010 was financially supported by the Society of Resource Geology and the Japan Mining Promotive Foundation, which are gratefully acknowledged.	Pal'yanova G, 2008, CHEM GEOL, V255, P399, DOI 10.1016/j.chemgeo.2008.07.010; Ulrich T, 1999, NATURE, V399, P676; Landtwing MR, 2010, ECON GEOL, V105, P91; Heinrich CA, 2003, GEOCHIM COSMOCHIM AC, V67, P3473, DOI 10.1016/S0016-7037(03)00084-X; BROWN KL, 1986, ECON GEOL, V81, P979; Gan X.C., 1996, GEOCHIMICA, V25, P112; Gu XX, 2007, ORE GEOL REV, V31, P319, DOI 10.1016/j.oregeorev.2005.01.003; Henley R. W., 1984, REV EC GEOLOGY, V1, P115; Koga A., 1961, J CHEM SOC JAPAN, V82, P1476; Luo X. L., 1996, GEOLOGY WOXI TYPE ST; Minoru K., 1988, APPL GEOCHEM, V3, P237; Morrison G.W., 1991, ORE GEOL REV, V6, P333, DOI 10.1016/0169-1368(91)90009-V; Peng B, 2004, MINER DEPOSITA, V39, P313, DOI 10.1007/s00126-004-0409-0; Rae AJ, 2011, ECON GEOL, V106, P1425; SHIKAZONO N, 1987, MINER DEPOSITA, V22, P309; Tang X. X., 1994, CHINA REGIONAL GEOL, V1, P65; Ulrich T, 2002, ECON GEOL, V97, P1889, DOI 10.2113/97.8.1889; Yang SX, 1999, J GEOCHEM EXPLOR, V66, P441, DOI 10.1016/S0375-6742(99)00044-8; Yang SX, 1999, CHEM GEOL, V155, P151, DOI 10.1016/S0009-2541(98)00146-6	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	JAN	2015	65	1					27	38		10.1111/rge.12053		12	Geology; Mineralogy	Geology; Mineralogy	AX4QL	WOS:000346916500003		
J	Ishihara, S; Qin, KZ				Ishihara, Shunso; Qin, Kezhang			Oxygen Isotopic Compositions of the Cape Ashizuri Granitoids in Southwest Japan	RESOURCE GEOLOGY			English	Article						Cape Ashizuri; high-MgO gabbro; Miocene syenite; whole-rock O-18	SETOUCHI VOLCANIC BELT; PLUTONIC ROCKS; MAGMATISM; ORIGIN; ZIRCON; ARC	Oxygen isotopic composition was determined on representative samples of the Cape Ashizuri plutonic rocks, in order to estimate the genetic background of the biotite granite and alkaline granitoids. The biotite granite (70.1-76.1% SiO2) ranged from 8.61 to 9.30 parts per thousand O-18 and averaged as 8.9 parts per thousand O-18 (n = 3), which is much smaller than the same Miocene granitoids of the Okueyama (avg. 10.1 parts per thousand) and Takakumayama (11.6 parts per thousand) granitic bodies, which are associated with tin mineralization. Among the alkaline granitoids, quartz syenites also have values as low as 7.14-8.70 parts per thousand, with an average of 8.0 parts per thousand (n = 3), and monzonite and gabbro vary from 6.14 to 7.86 parts per thousand, with an average of 7.0 parts per thousand (n = 3). These alkaline granitoids may be lower crustal in origin. The gabbroids containing 12.5% MgO at the maximum with low Sr initial ratio, are considered to be derived from the upper mantle through the fore-arc tectonic break-up on the subducting slab.	[Ishihara, Shunso] AIST, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Qin, Kezhang] Chinese Acad Sci, Inst Geol & Geophys, Beijing, Peoples R China	Ishihara, S (reprint author), AIST, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan.	s-ishihara@aist.go.jp	Qin, Kezhang/B-6616-2012				CLAYTON RN, 1963, GEOCHIM COSMOCHIM AC, V27, P43, DOI 10.1016/0016-7037(63)90071-1; Ishihara S., 1978, J GEOL SOC LONDON, V135, P389, DOI 10.1144/gsjgs.135.4.0389; Ishihara S., 2005, B GEOL SURV JPN, V56, P315; Ishihara S, 1999, LITHOS, V46, P523, DOI 10.1016/S0024-4937(98)00081-4; Ishihara S., 1977, J GEOL SOC JPN, V83, P657; Ishihara S., 2002, B GEOLOGICAL SURVEY, V53, P421; Ishihara S., 1979, J GEOL SOC JPN, V85, P509; ISHIHARA S, 2013, BULL GEOL SURV JPN, V64, P1; Ishihara S., 1985, J GEOL SOC JAPAN, V91, P679; Ishihara S., 2006, B GEOL SURV JPN, V57, P89; Kimura J., 2013, GSA B, V117, P969; Matsuhisa Y., 1983, SOV JAP S IS GEOL IR, P42; Murakami N., 1989, KOCHI PREFECTURE SW, V36, P115; SHIBATA K, 1979, CONTRIB MINERAL PETR, V70, P381, DOI 10.1007/BF00371045; Shinjoe H, 2010, GEOCHEM J, V44, P275; Tatsumi Y, 2001, GEOPHYS J INT, V144, P625, DOI 10.1046/j.1365-246x.2001.01358.x; TATSUMI Y, 1982, EARTH PLANET SC LETT, V60, P305, DOI 10.1016/0012-821X(82)90009-7; Yajima T, 1972, J JAPANESE ASS MINER, V67, P247	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	JAN	2015	65	1					47	51		10.1111/rge.12054		5	Geology; Mineralogy	Geology; Mineralogy	AX4QL	WOS:000346916500005		
J	Takahashi, R				Takahashi, Ryohei			Geophysics for the Mineral Exploration Geoscientist	RESOURCE GEOLOGY			English	Book Review									[Takahashi, Ryohei] Akita Univ, Fac Int Resource Sci, Akita 010, Japan	Takahashi, R (reprint author), Akita Univ, Fac Int Resource Sci, Akita 010, Japan.						DENTITH M, GEOPHYS MINERAL EXPL	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-1698	1751-3928		RESOUR GEOL	Resour. Geol	JAN	2015	65	1					52	52		10.1111/rge.12057		1	Geology; Mineralogy	Geology; Mineralogy	AX4QL	WOS:000346916500006		
J	Iijima, R; Nagashima, Y; Sato, K; Tokue, M; Araki, T; Yamazaki, K; Shiba, M; Hara, H; Sugi, K; Nakamura, M				Iijima, Raisuke; Nagashima, Yoshinori; Sato, Kaori; Tokue, Masahide; Araki, Tadashi; Yamazaki, Kenji; Shiba, Masanori; Hara, Hidehiko; Sugi, Kaoru; Nakamura, Masato			SYNTAX Score Predicts Major Bleeding Following Drug-eluting Stent Implantation in an All-comers Population	REVISTA ESPANOLA DE CARDIOLOGIA			English	Article						Drug-eluting stent; SYNTAX score; Major bleeding; CRUSADE score; Dual antiplatelet therapy	DUAL-ANTIPLATELET THERAPY; ACUTE CORONARY SYNDROMES; CLOPIDOGREL THERAPY; TRIAL; INTERVENTIONS; MULTICENTER; THROMBOSIS; RATIONALE; DURATION; DESIGN	Introduction and objectives: Previous studies have reported that coronary intervention for complex lesions is independently correlated with major bleeding. The SYNTAX score is an angiographic tool used to grade the complexity of coronary artery diseases. The aim of this study was to assess the ability of the SYNTAX score to predict major bleeding following drug-eluting stent implantation. Methods: We analyzed 722 patients who underwent drug-eluting stent implantation in an all-comers population between January 2007 and April 2010. The incidence of major bleeding and stent thrombosis was investigated during a 2-year period. Major bleeding was evaluated using the CRUSADE score and Bleeding Academic Research Consortium criteria. Patients were stratified into the following groups according to the SYNTAX trial: low (<= 22; n = 484), intermediate (23-32; n = 128), and high (>= 33; n = 110). Results: Major bleeding was observed in 47 patients (6.5%) during the 2-year period, and there were 12 incidents of stent thrombosis (1.7%). Major bleeding rates for patients in the low, intermediate, and high SYNTAX score tertiles were 2.9%, 7.8%, and 20.9%, respectively (P < .0001). The SYNTAX score had an adjusted hazard ratio of 1.81 (95% confidence interval, 1.27-2.57) for 2-year major bleeding. The predictive value of the adjusted area under the receiver operating characteristic curve for major bleeding significantly improved after inclusion of the CRUSADE score (C statistic, 0.890 vs 0.812). Conclusions: Although the SYNTAX score can predict major bleeding risk, the predictive value of the CRUSADE score was higher. These scores may be useful in clinical decision-making on revascularization strategies and on the optimal duration of dual antiplatelet therapy following drug-eluting stent implantation. (C) 2014 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Iijima, Raisuke; Nagashima, Yoshinori; Sato, Kaori; Tokue, Masahide; Araki, Tadashi; Yamazaki, Kenji; Shiba, Masanori; Hara, Hidehiko; Sugi, Kaoru; Nakamura, Masato] Toho Univ, Med Ctr, Ohashi Hosp, Div Cardiovasc Med,Meguro Ku, Tokyo 1538515, Japan	Iijima, R (reprint author), Toho Univ, Med Ctr, Ohashi Hosp, Div Cardiovasc Med,Meguro Ku, 2-17-6 Ohashi, Tokyo 1538515, Japan.	raisuke@live.jp					Byrne RA, 2009, AM HEART J, V157, P620, DOI 10.1016/j.ahj.2008.12.019; Abu-Assi E, 2010, CIRCULATION, V121, P2419, DOI 10.1161/CIRCULATIONAHA.109.925594; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Ikeda N, 2012, EUR HEART J, V33, P113, DOI 10.1093/eurheartj/ehr399; Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jace.2007.01.003; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONHA.106.612812; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lopes RD, 2012, EUR HEART J, V33, P2044, DOI 10.1093/eurheartj/ehs012; Cassese S, 2013, REV ESP CARDIOL, V66, P435, DOI 10.1016/j.rec.2012.11.016; Erdem G, 2012, REV ESP CARDIOL, V65, P4, DOI [10.1016/j.recesp.2011.08.005, 10.1016/j.rec.2011.08.006]; Feres F, 2012, AM HEART J, V164, P810, DOI 10.1016/j.ahj.2012.09.009; Ielasi A, 2013, REV ESP CARDIOL, V66, P24, DOI 10.1016/j.recesp.2012.06.026; Iijima R, 2009, EUR HEART J, V30, P290, DOI 10.1093/eurheartj/ehn586; Latib A, 2008, AM J CARDIOL, V102, P1477, DOI 10.1016/j.amjcard.2008.07.038; Ruano-Ravina A, 2013, REV ESP CARDIOL, V66, P871, DOI 10.1016/j.rec.2013.05.029; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626	21	0	0	EDICIONES DOYMA S A	BARCELONA	TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN	0300-8932	1579-2242		REV ESP CARDIOL	Rev. Esp. Cardiol.	JAN	2015	68	1					54	62		10.1016/j.rec.2014.02.028		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX6LI	WOS:000347033400009		
J	Minakuchi, S; Uhira, K; Terada, Y; Takeda, N; Saito, N; Shimizu, T				Minakuchi, S.; Uhira, K.; Terada, Y.; Takeda, N.; Saito, N.; Shimizu, T.			Quality Control of Composite Bonded Joints Using Fiber-Optic-Based Process Monitoring	SAMPE JOURNAL			English	Article							BRAGG GRATING SENSORS; STRAIN	Stringent process control of bonding is one of the keys to realization of bonded joints in composite aircraft primary structures (i.e., realization of boltless structures). This study develops the first fiber-optic-based quality control technique. Bonding pressure and residual strain in the adhesive are monitored using a birefringence effect of embedded fiber Bragg grating (FBG) sensors, which enables manufacturing workers to identify areas with lack of bonding pressure before curing and to assure the quality of the bonded joint after curing. This paper begins by describing the basic concept and measurement method. The feasibility of the proposed system is then validated through bonding tests and finite element analysis. Finally, the sensitivity and stability of the technique is enhanced by employing cured adhesive chips. The proposed technique is a key technology to improve the reliability of bonded joints and to reduce the manufacturing cost.	[Minakuchi, S.; Uhira, K.; Terada, Y.; Takeda, N.] Univ Tokyo, Chiba, Japan; [Saito, N.; Shimizu, T.] Mitsubishi Heavy Ind Co Ltd, Nagoya, Aichi, Japan	Minakuchi, S (reprint author), Univ Tokyo, Chiba, Japan.	minakuchi@smart.k.u-tokyo.ac.jp			JSPS KAKENHI [26220912, 23246146]	N.T. and S.M. were partially supported by JSPS KAKENHI, Grant Numbers 26220912 and 23246146 during this work.	Albert C, 2002, COMPOS SCI TECHNOL, V62, P1895, DOI 10.1016/S0266-3538(02)00105-7; Canal LP, 2014, COMPOS STRUCT, V112, P241, DOI 10.1016/j.compstruct.2014.02.014; Gafsi R, 2000, OPT FIBER TECHNOL, V6, P299, DOI 10.1006/ofte.2000.0333; Takeda N, 2005, COMPOS SCI TECHNOL, V65, P2575, DOI 10.1016/j.compscitech.2005.07.014; Minakuchi S, 2013, COMPOS PART A-APPL S, V48, P153, DOI 10.1016/j.compositesa.2013.01.009; Kruse T., 2013, P 19 INT C COMP MAT, P5635; Minakuchi S, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/5/055025; Othonos A, 1999, FIBER BRAGG GRATINGS; Piehl M. J., 2013, SAMPE 2013 P, P58; Saito N., 2014, International Application, Patent No. [PCT/JP2014/054826, 2014054826]; Sulejmani S, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/7/075006; Takagaki K, 2014, ADV COMPOS MATER, V23, P195, DOI 10.1080/09243046.2013.844901; Webb S, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/2/025016	13	0	0	SAMPE PUBLISHERS	COVINA	1161 PARKVIEW DRIVE, COVINA, CA 91722 USA	0091-1062			SAMPE J	Sampe J.	JAN-FEB	2015	51	1					44	51				8	Engineering, Multidisciplinary; Materials Science, Multidisciplinary	Engineering; Materials Science	AX8CN	WOS:000347138200010		
J	Li, L; Xu, YG; Wang, QP; Nakamura, R; Jiang, Y; Ao, JP				Li, Liuan; Xu, Yonggang; Wang, Qingpeng; Nakamura, Ryosuke; Jiang, Ying; Ao, Jin-Ping			Metal-oxide-semiconductor AlGaN/GaN heterostructure field-effect transistors using TiN/AlO stack gate layer deposited by reactive sputtering	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article						AlGaN/GaN MOSHFET; TiN; AlO	DEVICES; GAN	In this paper, the influence of deposition conditions and post annealing upon the device performance of sputtering-deposited TiN/AlO/AlGaN/GaN metal-oxide-semiconductor heterostructure field-effect transistors is reported. The metal-oxide-semiconductor structure on GaN with AlO deposited in a medium O-2/Ar ratio possessed the smallest interfacial state density and reverse leakage current. Metal-oxide-semiconductor heterostructure field-effect transistors with a small hysteresis and a low leakage current were obtained by depositing AlO with a medium O2/Ar ratio and post-annealing at 600 degrees C for 1 min. After annealing, the maximum transconductance shows some decrease, resulting in a decrease of saturation drain current.	[Li, Liuan; Wang, Qingpeng; Nakamura, Ryosuke; Jiang, Ying; Ao, Jin-Ping] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Xu, Yonggang] Shanghai Inst Tech Phys, Natl Lab Infrared Phys, Shanghai 200083, Peoples R China	Li, L (reprint author), Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan.	jpao@ee.tokushima-u.ac.jp					Kumar V, 2008, ELECTRON LETT, V44, P1323, DOI 10.1049/el:20082040; Kang HS, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/15/155101; Zhang H, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159547; Ao JP, 2013, VACUUM, V87, P150, DOI 10.1016/j.vacuum.2012.02.038; Liu C, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198507; Denninghoff DJ, 2012, IEEE ELECTR DEVICE L, V33, P785, DOI 10.1109/LED.2012.2191134; Mishra UK, 2008, P IEEE, V96, P287, DOI 10.1109/JPROC.2007.911060; Thomann AL, 2013, THIN SOLID FILMS, V539, P88, DOI 10.1016/j.tsf.2013.05.075; Keller S, 2001, IEEE T ELECTRON DEV, V48, P552, DOI 10.1109/16.906450; Ao JP, 2014, SCI ADV MATER, V6, P1645, DOI 10.1166/sam.2014.1936; Kordos P, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2058206; Li LA, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NH01; Li L, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4862084; Marron T, 2012, PHYS STATUS SOLIDI C, V9, P907, DOI 10.1002/pssc.201100414; Nakano T, 2014, JPN J APPL PHYS, V53; Pang L, 2013, CS MANTECH C, P387; Ye PD, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861122	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	JAN	2015	30	1							015019	10.1088/0268-1242/30/1/015019		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	AX6LH	WOS:000347033300020		
J	Van Hai, L; Takahashi, M; Zhang, W; Sakai, S				Van Hai, Le; Takahashi, Mitsue; Zhang, Wei; Sakai, Shigeki			Novel process for widening memory window of sub-200nm ferroelectric-gate field-effect transistor by ferroelectric coating the gate-stack sidewall	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Editorial Material						FeFET; ferroelectric; nonvolatile memory	FENAND FLASH MEMORY; LONG RETENTION; CIRCUITS; LOGIC	Ferroelectric-gate field-effect transistors (FeFETs) with metallurgical-gate lengths of 140 nm, 160 nm and 190 nm were successfully fabricated using a novel fabrication process. The gate stacks of the FeFETs were Pt/Sr0.8Ca0.2Bi2Ta2O9(SCBT)/HfO2/Si. Key to the process was covering the as-etched gate-stack sidewalls with SCBT precursor films and annealing altogether. The FeFETs which underwent the novel process showed larger memory windows than those without the process by about 0.5 V at scanned gate-voltages of 1 +/- 5 V. Endurances of the FeFETs made by the novel process were measured up to 10(9) cycles with good separations of the on-and off-states. The endurance pulses were 1 +/- 5 V with 2 mu s period. Good data-retentions of them were also demonstrated which were measured for at least 6.5 days.	[Van Hai, Le; Takahashi, Mitsue; Zhang, Wei; Sakai, Shigeki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Van Hai, L (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	mitsue-takahashi@aist.go.jp					Wang SY, 2009, SEMICOND SCI TECH, V24, DOI 10.1088/0268-1242/24/10/105029; Yan K, 2012, APPL PHYS A-MATER, V108, P835, DOI 10.1007/s00339-012-6978-3; Hai LV, 2010, SEMICOND SCI TECH, V25, DOI 10.1088/0268-1242/25/11/115013; Ishiwara H, 2009, CURR APPL PHYS, V9, pS2, DOI 10.1016/j.cap.2008.02.013; Takahashi M, 2008, ELECTRON LETT, V44, P467, DOI 10.1049/el:20083230; Zhang XZ, 2012, INTEGR FERROELECTR, V132, P114, DOI 10.1080/10584587.2012.660836; Zhang XZ, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.04DD01; Sakai S, 2004, IEEE ELECTR DEVICE L, V25, P369, DOI 10.1109/LED.2004.828992; Sakai S, 2010, MATERIALS, V3, P4950, DOI 10.3390/ma3114950; Hai L. V., 2011, P 3 IEEE INT MEM WOR, P175; Miyaji K, 2011, SOLID STATE ELECTRON, V58, P34, DOI 10.1016/j.sse.2010.11.028; Muller J., 2012, VLSI TECHN VLSIT 201, P25; Sakai S, 2007, J VAC SCI TECHNOL A, V25, P903, DOI 10.1116/1.2748808; Sakai S., 2008, P 23 IEEE NONV SEM M, P103; Sakai S, 2004, JPN J APPL PHYS 1, V43, P7876, DOI 10.1143/JJAP.43.7876; Sakai Shigeki, 2012, Proceedings of the 2012 12th Annual Non-Volatile Memory Technology Symposium (NVMTS), DOI 10.1109/NVMTS.2013.6632862; Scott J F, 2000, FERROELECTRIC MEMORI, P175; Takahashi M, 2009, IEICE ELECTRON EXPR, V6, P831, DOI 10.1587/elex.6.831; Takahashi M, 2005, JPN J APPL PHYS 2, V44, pL800, DOI 10.1143/JJAP.44.L800; Tarui Y, 1997, APPL SURF SCI, V113, P656, DOI 10.1016/S0169-4332(96)00963-4; Zhang W, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/8/085003; Zhang X., 2011, P 3 IEEE INT MEM WOR, P155	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	JAN	2015	30	1							015024	10.1088/0268-1242/30/1/015024		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	AX6LH	WOS:000347033300025		
J	Ohno, H				Ohno, Hiroshi			Impact of commensal microbiota on the host pathophysiology: focusing on immunity and inflammation	SEMINARS IN IMMUNOPATHOLOGY			English	Editorial Material							GUT MICROBIOME; SYSTEM		[Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Ohno, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Ohno, H (reprint author), RIKEN Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan.	hiroshi.ohno@riken.jp	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661			Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Allegretti JR, 2014, WORLD J GASTROENTERO, V20, P3468, DOI 10.3748/wjg.v20.i13.3468; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Bianconi E, 2012, ANN HUM BIOL, V40, P463; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					1	3		10.1007/s00281-014-0472-2		3	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500001		
J	Aw, W; Fukuda, S				Aw, Wanping; Fukuda, Shinji			Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach	SEMINARS IN IMMUNOPATHOLOGY			English	Review						Gut ecosystem; Metabolomics; Choline; Bile acid; Phenol; Short-chain fatty acid	CHRONIC KIDNEY-DISEASE; PROTEIN-COUPLED RECEPTOR; CONJUGATED LINOLEIC-ACID; INFLAMMATORY-BOWEL-DISEASE; LACTOBACILLUS-RHAMNOSUS GG; REGULATORY T-CELLS; INTESTINAL MICROBIOTA; BUTYRIVIBRIO-FIBRISOLVENS; AKKERMANSIA-MUCINIPHILA; CARDIOVASCULAR-DISEASE	Recent advances in DNA sequencing and mass spectrometry technologies have allowed us to collect more data on microbiome and metabolome to assess the influence of the gut microbiota on human health at a whole-systems level. Major advances in metagenomics and metabolomics technologies have shown that the gut microbiota contributes to host overall health status to a large extent. As such, the gut microbiota is often likened to a measurable and functional organ consisting of prokaryotic cells, which creates the unique gut ecosystem together with the host eukaryotic cells. In this review, we discuss in detail the relationship between gut microbiota and its metabolites like choline, bile acids, phenols, and short-chain fatty acids in the host health and etiopathogenesis of various pathological states such as multiple sclerosis, autism, obesity, diabetes, and chronic kidney disease. By integrating metagenomic and metabolomic information on a systems biology-wide approach, we would be better able to understand this interplay between gut microbiome and host metabolism. Integration of the microbiome, metatranscriptome, and metabolome information will pave the way toward an improved holistic understanding of the complex mammalian superorganism. Through the modeling of metabolic interactions between lifestyle, diet, and microbiota, integrated omics-based understanding of the gut ecosystem is the new avenue, providing exciting novel therapeutic approaches for optimal host health.	[Aw, Wanping; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Fukuda, Shinji] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Fukuda, S (reprint author), Keio Univ, Inst Adv Biosci, 246-2 Mizukami, Tsuruoka, Yamagata 9970052, Japan.	sfukuda@sfc.keio.ac.jp					Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; GIBSON GR, 1995, J NUTR, V125, P1401; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Luoto R, 2010, INT J OBESITY, V34, P1531, DOI 10.1038/ijo.2010.50; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; WOSTMANN BS, 1973, J NUTR, V103, P982; Collado MC, 2008, AM J CLIN NUTR, V88, P894; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Kinross JM, 2011, J PROTEOME RES, V10, P277, DOI 10.1021/pr1003278; Ji YS, 2012, BENEF MICROBES, V3, P13, DOI 10.3920/BM2011.0046; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Coury DL, 2012, PEDIATRICS, V130, pS160, DOI 10.1542/peds.2012-0900N; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Fukuda S, 2014, SEMIN IMMUNOPATHOL, V36, P103, DOI 10.1007/s00281-013-0399-z; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Schepers E, 2010, BLOOD PURIFICAT, V29, P130, DOI 10.1159/000245639; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Kotanko P, 2006, NEPHROL DIAL TRANSPL, V21, P2057, DOI 10.1093/ndt/gfl281; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Arora T, 2012, BRIT J NUTR, V108, P1382, DOI 10.1017/S0007114511006957; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Borody TJ, 2004, J CLIN GASTROENTEROL, V38, P475, DOI 10.1097/01.mcg.0000128988.13808.dc; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Ranganathan N, 2006, ASAIO J, V52, P70, DOI 10.1097/01.mat.0000191345.45735.00; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; BONE E, 1976, AM J CLIN NUTR, V29, P1448; Borody TJ, 2000, AM J GASTROENTEROL, V95, P3028; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Finegold SM, 2008, MED HYPOTHESES, V70, P508, DOI 10.1016/j.mehy.2007.07.019; Fukuda S, 2005, J GEN APPL MICROBIOL, V51, P105, DOI 10.2323/jgam.51.105; Fukuda S, 2006, J APPL MICROBIOL, V100, P787, DOI 10.1111/j.1365-2672.2006.02864.x; Guarner F, 2009, DIGEST DIS, V27, P412, DOI 10.1159/000228582; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Holmes E, 2012, SCI TRANSL MED, V4; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; PRENTISS PG, 1961, ARCH BIOCHEM BIOPHYS, V94, P424, DOI 10.1016/0003-9861(61)90069-8; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Vendt N, 2006, J HUM NUTR DIET, V19, P51, DOI 10.1111/j.1365-277X.2006.00660.x; Wang FQ, 2012, DIGEST DIS SCI, V57, P2856, DOI 10.1007/s10620-012-2242-0; West DB, 1998, AM J PHYSIOL-REG I, V275, pR667; Williams B. L., 2012, MBIO, V3; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	123	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					5	16		10.1007/s00281-014-0456-2		12	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500002		
J	Furusawa, Y; Obata, Y; Hase, K				Furusawa, Yukihiro; Obata, Yuuki; Hase, Koji			Commensal microbiota regulates T cell fate decision in the gut	SEMINARS IN IMMUNOPATHOLOGY			English	Review						Microbiota; TH17 cells; Regulatory Tcells; Histone modifications; DNA methylation	FOXP3 EXPRESSION; DNA METHYLATION; DEACETYLASE INHIBITION; EPIGENETIC REGULATION; METABOLITE BUTYRATE; GENE-EXPRESSION; IMMUNE-SYSTEM; CUTTING EDGE; INDUCTION; BACTERIA	Commensal microbiota shapes the intestinal immune system by regulating T helper (T-H) cell lineage differentiation. For example, Bacteroides fragilis colonization not only optimizes the systemic T(H)1/T(H)2 balance, but also can induce regulatory T (Treg) cell differentiation in the gut. In addition, segmented filamentous bacteria (SFB) facilitate the development of T(H)17 cells in the small intestine. The 17 strains within clusters IV, XIVa, and XVIII of Clostridiales found in human feces can also induce the differentiation and expansion of Treg cells in the colon. Thus, the regulation of T-H cell differentiation by commensal bacteria is evident; however, the molecular mechanisms underlying these processes remain uncertain. Recent studies have demonstrated that bacterial components, as well as their metabolites, play a central role in regulating T-H cell development. Furthermore, these metabolites can elicit changes in histone posttranslational modification to modify the expression of critical regulators of T cell fate. In this review, we discuss the mechanisms and biological significance of microbiota-dependent T-H differentiation.	[Furusawa, Yukihiro; Hase, Koji] Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Tokyo 1058512, Japan; [Furusawa, Yukihiro; Obata, Yuuki; Hase, Koji] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Obata, Yuuki] Chiba Univ, Grad Sch Med, Chiba 2608670, Japan	Hase, K (reprint author), Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Tokyo 1058512, Japan.	hase@ims.u-tokyo.ac.jp			Japan Society for the Promotion of Science [24117723, 24890293]; Japan Science and Technology Agency; Ministry of Health Labour and Welfare	This work was supported in part with grants from the Japan Society for the Promotion of Science (24117723 to K.H. and 24890293 to Y.F.), the Japan Science and Technology Agency (K.H.), and the Ministry of Health Labour and Welfare (K.H.).	Afzali B, 2013, FRONT IMMUNOL, V4, P1; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Tanoue T, 2012, SEMIN IMMUNOL, V24, P50, DOI 10.1016/j.smim.2011.11.009; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Lal G, 2009, J IMMUNOL, V182, P259; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Yang WC, 2005, ONCOGENE, V24, P2104, DOI 10.1038/sj.onc.1208444; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cb.08.110192.003023; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Duan JY, 2011, CURR OPIN RHEUMATOL, V23, P372, DOI 10.1097/BOR.0b013e3283476d3e; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Burchill MA, 2007, J IMMUNOL, V178, P280; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Annison G, 2003, J NUTR, V133, P3523; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Riella LV, 2012, AM J TRANSPLANT, V12, P2575, DOI 10.1111/j.1600-6143.2012.04224.x; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Atarashi K, 2011, CURR OPIN IMMUNOL, V23, P761, DOI 10.1016/j.coi.2011.11.002; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Davie James R, 2003, J Nutr, V133, p2485S; Imanishi T, 2007, J IMMUNOL, V178, P6715; Kim JW, 2008, INT J AUTOMOT TECHN, V9, P37, DOI 10.1007/s12239-008-0005-x; Licciardi PV, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-24; Narushima Seiko, 2014, Gut Microbes, V5, P333, DOI 10.4161/gmic.28572; Tomboli CP, 2003, GUT, V53, P1; Turner SJ, 2013, FRONT GENET, V4, P1; Weiss JM, 2012, J EXP MED, V209, P1732; Zediak VP, 2011, CURR OPIN GENET DEV, V21, P154, DOI 10.1016/j.gde.2011.01.016; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403	72	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					17	25		10.1007/s00281-014-0455-3		9	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500003		
J	Moro, K; Koyasu, S				Moro, Kazuyo; Koyasu, Shigeo			Innate lymphoid cells, possible interaction with microbiota	SEMINARS IN IMMUNOPATHOLOGY			English	Review						ILC; Epithelia; Infection; Homeostasis; Allergy; Inflammation; Plasticity	NATURAL-KILLER-CELLS; ROR-GAMMA-T; TRANSCRIPTION FACTOR GATA3; MOLONEY LEUKEMIA-CELLS; TYPE-2 IMMUNITY; RECEPTOR-ALPHA; HELPER-CELLS; AIRWAY INFLAMMATION; ATOPIC-DERMATITIS; CYTOTOXIC-CELLS	Recent studies have identified novel lymphocyte subsets named innate lymphoid cells (ILCs) lacking antigen-specific receptors. ILCs are present in a wide variety of epithelial compartments and occupy an intermediate position between acquired immune cells and myeloid cells. ILCs are now classified into three groups: group 1 ILC, group 2 ILC, and group 3 ILC based on their cytokine production patterns that correspond to the helper T cell subsets Th1, Th2, and Th17, respectively. ILCs play important roles in protection against various invading microbes including multicellular parasites, and in the maintenance of homeostasis and repair of epithelial layers. Excessive activation of ILCs, however, leads to various inflammatory disease conditions. ILCs have thus attracted interests of many researchers in the fields of infectious immunity, inflammatory diseases, and allergic diseases. Because epithelial cells sense alterations in environmental cues, it is important to understand the functional interaction between epithelial cells, ILCs, and environmental factors such as commensal microbiota. We discuss in this review developmental pathways of ILCs, their functions, and contribution of commensal microbiota to the differentiation and function of ILCs.	[Moro, Kazuyo; Koyasu, Shigeo] RIKEN Ctr Integrat Med Sci IMS, Lab Immune Cell Syst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Moro, Kazuyo] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Chiyoda Ku, Tokyo 1020076, Japan; [Moro, Kazuyo] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Div Immunobiol,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Moro, K (reprint author), Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Div Immunobiol,Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	kazuyo.moro@riken.jp	Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038	PRESTO from the Japan Science and Technology Agency; Nakajima Foundation; Japan Society for the Promotion of Science (JSPS) [S) (22229004]; Ministry of Education, Culture, Sports, Science and Technology, Japan [23118526];  [22689013]	We thank Kafi N. Ealey for critical reading of this manuscript and members of the Laboratory for Immune Cell Systems for discussion. This work was supported by PRESTO to K.M. from the Japan Science and Technology Agency, a Grant-in Aid for Young Scientist (A) (22689013) to K.M., a research grant from The Nakajima Foundation to K.M. and a Grant-in-Aid for Scientific Research (S) (22229004) to S.K. from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research on Innovative Areas (23118526) to K.M. from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; KELLY KA, 1992, EUR J IMMUNOL, V22, P329, DOI 10.1002/eji.1830220207; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Yang Q, 2011, J IMMUNOL, V187, P5505, DOI 10.4049/jimmunol.1102039; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Kong YY, 1999, NATURE, V397, P315; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Mosconi I, 2013, MUCOSAL IMMUNOL, V6, P1157, DOI 10.1038/mi.2013.12; CHEN HM, 1995, ONCOGENE, V11, P1549; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kiss Elina A, 2012, Gut Microbes, V3, P577, DOI 10.4161/gmic.21865; Klein Wolterink RG, 2013, P NATL ACAD SCI USA, V110, P10240, DOI [10.1073/pnas.1217158110, DOI 10.1073/PNAS.1217158110]; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Li Ying, 2011, Cell, V147, P629, DOI 10.1016/j.cell.2011.09.025; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369	77	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					27	37		10.1007/s00281-014-0470-4		11	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500004		
J	Matsuoka, K; Kanai, T				Matsuoka, Katsuyoshi; Kanai, Takanori			The gut microbiota and inflammatory bowel disease	SEMINARS IN IMMUNOPATHOLOGY			English	Review						Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Dysbiosis	ACTIVE ULCERATIVE-COLITIS; NONPATHOGENIC ESCHERICHIA-COLI; BIFIDOBACTERIA-FERMENTED MILK; PLACEBO-CONTROLLED TRIAL; CONTROLLED PILOT TRIAL; CROHNS-DISEASE; FECAL MICROBIOTA; MAINTAINING REMISSION; DOUBLE-BLIND; LACTOBACILLUS GG	Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disorder of the gut. Although the precise cause of IBD remains unknown, the most accepted hypothesis of IBD pathogenesis to date is that an aberrant immune response against the gut microbiota is triggered by environmental factors in a genetically susceptible host. The advancement of next-generation sequencing technology has enabled identification of various alterations of the gut microbiota composition in IBD. While some results related to dysbiosis in IBD are different between studies owing to variations of sample type, method of investigation, patient profiles, and medication, the most consistent observation in IBD is reduced bacterial diversity, a decrease of Firmicutes, and an increase of Proteobacteria. It has not yet been established how dysbiosis contributes to intestinal inflammation. Many of the known IBD susceptibility genes are associated with recognition and processing of bacteria, which is consistent with a role of the gut microbiota in the pathogenesis of IBD. A number of trials have shown that therapies correcting dysbiosis, including fecal microbiota transplantation and probiotics, are promising in IBD.	[Matsuoka, Katsuyoshi; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, Tokyo 1608582, Japan	Kanai, T (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	takagast@z2.keio.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Health and Labour Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; Keio University Medical Fund	This study was supported by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology; the Health and Labour Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; and the Keio University Medical Fund.	Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Zocco MA, 2006, ALIMENT PHARM THERAP, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Ananthakrishnan AN, 2011, AM J GASTROENTEROL, V106, P2009, DOI 10.1038/ajg.2011.237; Martinez C, 2008, AM J GASTROENTEROL, V103, P643, DOI 10.1111/j.1572-0241.2007.01592.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Schultsz C, 1999, GASTROENTEROLOGY, V117, P1089, DOI 10.1016/S0016-5085(99)70393-8; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Schultz M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-5; Kato K, 2004, ALIMENT PHARM THERAP, V20, P1133, DOI 10.1111/j.1365-2036.2004.02268.x; Ishikawa H, 2003, J AM COLL NUTR, V22, P56; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Andrews CN, 2011, ALIMENT PHARM THER, V34, P374, DOI 10.1111/j.1365-2036.2011.04732.x; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Kunde S, 2013, J PEDIATR GASTR NUTR, V56, P597, DOI 10.1097/MPG.0b013e318292fa0d; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Ohkusa T, 2005, SCAND J GASTROENTERO, V40, P1334, DOI 10.1080/00365520510023648; Varela E, 2013, ALIMENT PHARM THER, V38, P151, DOI 10.1111/apt.12365; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Ott SJ, 2008, J CLIN MICROBIOL, V46, P3510, DOI 10.1128/JCM.01512-08; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Dey N, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-131; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Pitcher MCL, 2000, GUT, V46, P64, DOI 10.1136/gut.46.1.64; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Bousvaros A, 2005, INFLAMM BOWEL DIS, V11, P833, DOI 10.1097/01.MIB.0000175905.00212.2c; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Caselli M, 2013, AM J GASTROENTEROL, V108, P860, DOI 10.1038/ajg.2013.61; Miele E, 2009, AM J GASTROENTEROL, V104, P437, DOI 10.1038/ajg.2008.118; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Khan KJ, 2011, AM J GASTROENTEROL, V106, P661, DOI 10.1038/ajg.2011.72; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Furrie E, 2005, GUT, V54, P242, DOI 10.1136/gut.2004.044834; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; BENNET JD, 1989, LANCET, V1, P164; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Hayashi A, 2013, CELL HOST MICROBE, V13, P711, DOI 10.1016/j.chom.2013.05.013; Kamada N, 2008, INFECT IMMUN, V76, P214, DOI 10.1128/IAI.01193-07; Metal Feller, 2007, LANCET INFECT DIS, V7, P607, DOI [10.1016/s1473-3099(07)70211-6, DOI 10.1016/S1473-3099(07)70211-6]; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; OHKUSA T, 1993, J GASTROEN HEPATOL, V8, P116, DOI 10.1111/j.1440-1746.1993.tb01184.x; Soo I, 2008, CAN J GASTROENTEROL, V22, P237; Tong MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080702; VanDussen KL, 2014, GASTROENTEROLOGY, V146, P200, DOI 10.1053/j.gastro.2013.09.048; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049	76	5	7	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					47	55		10.1007/s00281-014-0454-4		9	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500006		
J	Inoue, Y; Shimojo, N				Inoue, Yuzaburo; Shimojo, Naoki			Microbiome/microbiota and allergies	SEMINARS IN IMMUNOPATHOLOGY			English	Review						Microbiome; Microbiota; Dysbiosis; Allergy; Probiotics; Prebiotics	PLACEBO-CONTROLLED TRIAL; RANDOMIZED-CONTROLLED-TRIAL; IMMUNOGLOBULIN-E PRODUCTION; REGULATORY T-CELLS; KOALA BIRTH COHORT; COWS MILK ALLERGY; 1ST 6 MONTHS; ATOPIC-DERMATITIS; FOOD ALLERGY; INTESTINAL MICROBIOTA	Allergies are characterized by a hypersensitive immune reaction to originally harmless antigens. In recent decades, the incidence of allergic diseases has markedly increased, especially in developed countries. The increase in the frequency of allergic diseases is thought to be primarily due to environmental changes related to a westernized lifestyle, which affects the commensal microbes in the human body. The human gut is the largest organ colonized by bacteria and contains more than 1000 bacterial species, called the "gut microbiota." The recent development of sequencing technology has enabled researchers to genetically investigate and clarify the diversity of all species of commensal microbes. The collective genomes of commensal microbes are together called the "microbiome." Although the detailed mechanisms remain unclear, it has been proposed that the microbiota/microbiome, especially that in the gut, impacts the systemic immunity and metabolism, thus affecting the development of various immunological diseases, including allergies. In this review, we summarize the recent findings regarding the importance of the microbiome/microbiota in the development of allergic diseases and also the results of interventional studies using probiotics or prebiotics to prevent allergies.	[Inoue, Yuzaburo; Shimojo, Naoki] Chiba Univ, Grad Sch Med, Dept Pediat, Chuou Ku, Chiba 2608670, Japan	Shimojo, N (reprint author), Chiba Univ, Grad Sch Med, Dept Pediat, Chuou Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	shimojo@faculty.chiba-u.jp					Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Chen YE, 2013, J AM ACAD DERMATOL, V69, P143, DOI 10.1016/j.jaad.2013.01.016; Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Niele N, 2013, EUR J PEDIATR, V172, P317, DOI 10.1007/s00431-012-1886-2; Betsi GL, 2008, AM J CLIN DERMATOL, V9, P93, DOI 10.2165/00128071-200809020-00002; Matsuzaki T, 1998, J DAIRY SCI, V81, P48; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Doege K, 2012, BRIT J NUTR, V107, P1, DOI 10.1017/S0007114511003400; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Dongarra ML, 2013, CURR ALLERGY ASTHM R, V13, P19, DOI 10.1007/s11882-012-0313-0; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Isolauri E, 2012, GASTROENTEROL CLIN N, V41, P747, DOI 10.1016/j.gtc.2012.08.007; Hol J, 2008, J ALLERGY CLIN IMMUN, V121, P1448, DOI 10.1016/j.jaci.2008.03.018; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Rose MA, 2010, CLIN EXP ALLERGY, V40, P1398, DOI 10.1111/j.1365-2222.2010.03560.x; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Sashihara T, 2006, J DAIRY SCI, V89, P2846; Bashir MEH, 2004, J IMMUNOL, V172, P6978; STRACHAN DP, 1989, BRIT MED J, V299, P1259; Perzanowski MS, 2006, J ALLERGY CLIN IMMUN, V117, P1082, DOI 10.1016/j.jaci.2005.12.1348; van der Aa LB, 2010, CLIN EXP ALLERGY, V40, P795, DOI 10.1111/j.1365-2222.2010.03465.x; Rask C, 2005, SCAND J IMMUNOL, V61, P529, DOI 10.1111/j.1365-3083.2005.01598.x; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Arslanoglu S, 2008, J NUTR, V138, P1091; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; Rautava S, 2012, NEONATOLOGY, V102, P178, DOI 10.1159/000339182; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0; Tamari M, 2013, ALLERGOL INT, V62, P21, DOI 10.2332/allergolint.13-RAI-0539; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Gruber C, 2010, J ALLERGY CLIN IMMUN, V126, P791, DOI 10.1016/j.jaci.2010.07.022; Rodriguez B, 2012, FEMS MICROBIOL ECOL, V79, P192, DOI 10.1111/j.1574-6941.2011.01207.x; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Linehan MF, 2014, J ALLERGY CLIN IMMUN, V133, P688, DOI 10.1016/j.jaci.2013.08.007; Ziegler E, 2007, J PEDIATR GASTR NUTR, V44, P359, DOI 10.1097/MPG.0b013e31802fca8c; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bager P, 2003, J ALLERGY CLIN IMMUN, V111, P51, DOI 10.1067/mai.2003.34; Boyce JA, 2010, J ALLERGY CLIN IMMUN, V126, P1105, DOI 10.1016/j.jaci.2010.10.008; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Forno Erick, 2008, Clin Mol Allergy, V6, P11, DOI 10.1186/1476-7961-6-11; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Kim Ha-Jung, 2013, Korean J Pediatr, V56, P369, DOI 10.3345/kjp.2013.56.9.369; Kummeling I, 2007, PEDIATRICS, V119, pE225, DOI 10.1542/peds.2006-0896; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Osborn DA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006474.pub3; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Ring J, 2006, HDB ATOPIC ECZEMA; Roberfroid M, 2007, J NUTR, V137, p830S; Rodriguez B, 2011, FEMS MICROBIOL ECOL, V76, P133, DOI 10.1111/j.1574-6941.2010.01035.x; Segawa S, 2008, INT J FOOD MICROBIOL, V121, P1, DOI 10.1016/j.ijfoodmicro.2007.10.004; Szajewska H, 2013, IMMUNOTHERAPY-UK, V5, P869, DOI [10.2217/imt.13.85, 10.2217/IMT.13.85]; Thomas DW, 2010, PEDIATRICS, V126, P1217, DOI 10.1542/peds.2010-2548; van der Aa LB, 2012, CLIN EXP ALLERGY, V42, P531, DOI 10.1111/j.1365-2222.2011.03890.x; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011	83	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					57	64		10.1007/s00281-014-0453-5		8	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500007		
J	Ohtani, N				Ohtani, Naoko			Microbiome and cancer	SEMINARS IN IMMUNOPATHOLOGY			English	Review						Cellular senescence; Inflammatory cytokine; Obesity; Colorectal cancer; Liver cancer; Deoxycholic acid; Microbial metabolite	CHAIN FATTY-ACIDS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; HEPATOCELLULAR-CARCINOMA; METABOLITE BUTYRATE; CELLULAR SENESCENCE; COLORECTAL-CANCER; COLON-CANCER; KAPPA-B; OBESITY	The human intestine is believed to contain approximately 100 trillion intestinal (gut) microbiota, comprising about 500-1000 different species. These intestinal microbiota exist in a symbiotic relationship with their host, by metabolizing compounds that the host is unable to utilize and controlling the immune balance of the host's body. However, the composition of the intestinal microbiota is known to vary, depending on diet, nutrition status, and other factors. The recently developed meta-omics microbial data and the technical progress for the metabolome analysis provide a substantial understanding of the role of intestinal microbes and their metabolism. Interestingly, accumulating evidence suggests that the intestinal microbiota contributes to the onset of colorectal cancer, not only via the pro-carcinogenic activities of specific pathogens but also via the influence of the bacterial metabolites. Moreover, since the gut microbial metabolites circulate in the host's body, it has been increasingly recognized that the intestinal microbiota are involved in the pathogenesis of diseases not only in the intestine but also in the organs located distant from the intestine. We recently found that metabolites from obesity-induced intestinal microbiota promoted liver cancer, and elucidated the underlying molecular mechanism. In this review, I first summarize the general understanding on the carcinogenic process by bacterial metabolites, and then discuss on the association between intestinal microbiota and colorectal cancer. In the last part, I will introduce our recent findings on liver cancer promotion by a metabolite of the obesity-induced intestinal microbiota.	[Ohtani, Naoko] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biosci, Noda, Chiba 278, Japan; [Ohtani, Naoko] Japanese Fdn Canc Res, Inst Canc, Div Canc Biol, Tokyo 170, Japan; [Ohtani, Naoko] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	Ohtani, N (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biosci, 2641 Yamazaki, Noda, Chiba 278, Japan.	naoko.ohtani@rs.tus.ac.jp					Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Homann N, 2001, ADDICT BIOL, V6, P309, DOI 10.1080/13556210020077028; KITAZAWA S, 1990, CARCINOGENESIS, V11, P1323, DOI 10.1093/carcin/11.8.1323; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Minamida K, 2006, BIOSCI BIOTECH BIOCH, V70, P332, DOI 10.1271/bbb.70.332; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/nature4441022a; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Ohtani N, 2013, CANCER SCI, V104, P525, DOI 10.1111/cas.12118; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Hamer HM, 2008, ALIMENT PHARM THERAP, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Beuers U, 2006, NAT CLIN PRACT GASTR, V3, P318, DOI 10.1038/ncpgasthep0521; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goncalves P, 2013, CURR DRUG METAB, V14, P994; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Yokote H, 2008, AM J PATHOL, V173, P1714, DOI 10.2353/ajpath.2008.080622; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016; Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; Ridlon JM, 2012, J LIPID RES, V53, P66, DOI 10.1194/jlr.M020313; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Bode C, 2005, ALCOHOL CLIN EXP RES, V29, p166S, DOI 10.1097/01.alc.0000189280.19073.28; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Natarajan N, 2014, AM J PHYSIOL-CELL PH, V307, pC979, DOI 10.1152/ajpcell.00228.2014; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Pai R, 2004, MOL BIOL CELL, V15, P2156, DOI 10.1091/mbc.E03-12-0894; RAFTER JJ, 1987, AM J CLIN NUTR, V45, P559; REDDY BS, 1973, J NATL CANCER I, V50, P1437; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Takuma Y, 2010, WORLD J GASTROENTERO, V16, P1436, DOI 10.3748/wjg.v16.i12.1436	71	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					65	72		10.1007/s00281-014-0457-1		8	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500008		
J	Nakamizo, S; Egawa, G; Honda, T; Nakajima, S; Belkaid, Y; Kabashima, K				Nakamizo, Satoshi; Egawa, Gyohei; Honda, Tetsuya; Nakajima, Saeko; Belkaid, Yasmine; Kabashima, Kenji			Commensal bacteria and cutaneous immunity	SEMINARS IN IMMUNOPATHOLOGY			English	Review						Commensal bacteria; Cutaneous immunity; IL-17; Dysbiosis; Atopic dermatitis; Probiotics	PLACEBO-CONTROLLED TRIAL; ANTIBIOTIC-ASSOCIATED DIARRHEA; HUMAN SKIN MICROBIOME; REGULATORY T-CELLS; ATOPIC-DERMATITIS; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; DENDRITIC CELLS; DOUBLE-BLIND; DISEASE	The skin is the human body's largest organ and is home to a diverse and complex variety of innate and adaptive immune functions that protect against pathogenic invasion. Recent studies have demonstrated that cutaneous commensal bacteria modulated the host immune system. For example, Staphylococcus epidermidis, a skin commensal bacterium, has been demonstrated to induce cutaneous interferon (IFN)-gamma- and interleukin (IL)-17A-producing T cells. In addition, cutaneous microbiota changes occur in the chronic inflammatory skin disorders, such as atopic dermatitis, and may influence the activity of skin diseases. In this article, we will review the recent findings related to the interactions of the commensal bacteria with skin homeostasis and discuss the role of the dysbiosis of these bacteria in the pathogenesis of skin diseases.	[Nakamizo, Satoshi; Egawa, Gyohei; Honda, Tetsuya; Nakajima, Saeko; Kabashima, Kenji] Kyoto Univ, Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Belkaid, Yasmine] NIAID, Immun Barrier Sites Initiat, NIH, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA	Kabashima, K (reprint author), Kyoto Univ, Sch Med, Dept Dermatol, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp					Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Schommer NN, 2013, TRENDS MICROBIOL, V21, P660, DOI 10.1016/j.tim.2013.10.001; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Morizane S, 2012, J DERMATOL, V39, P225, DOI 10.1111/j.1346-8138.2011.01483.x; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cho SH, 2001, J ALLERGY CLIN IMMUN, V108, P269, DOI 10.1067/mai.2001.117455; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Pohjavuori E, 2004, J ALLERGY CLIN IMMUN, V114, P131, DOI 10.1016/j.jaci.2004.03.036; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Matsumoto M, 2014, ANN ALLERG ASTHMA IM, V113, P209, DOI 10.1016/j.anai.2014.05.002; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Bunikowski R, 2000, J ALLERGY CLIN IMMUN, V105, P814, DOI 10.1067/mai.2000.105528; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Yang HJ, 2014, ALLERGY ASTHMA IMMUN, V6, P208, DOI 10.4168/aair.2014.6.3.208; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Harder J, 2010, J INVEST DERMATOL, V130, P1355, DOI 10.1038/jid.2009.432; Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Biswas PS, 2007, J IMMUNOL, V179, P4520; Chronnell CMT, 2001, J INVEST DERMATOL, V117, P1120, DOI 10.1046/j.0022-202x.2001.01569.x; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Krutmann J, 2009, J DERMATOL SCI, V54, P1, DOI 10.1016/j.jdermsci.2009.01.002; LEUNG DYM, 1993, J CLIN INVEST, V92, P1374, DOI 10.1172/JCI116711; Mallbris L, 2010, EXP DERMATOL, V19, P442, DOI 10.1111/j.1600-0625.2009.00918.x; Oyoshi MK, 2011, J CLIN INVEST, V121, P2210, DOI 10.1172/JCI43586	51	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2297	1863-2300		SEMIN IMMUNOPATHOL	Semin. Immunopathol.	JAN	2015	37	1					73	80		10.1007/s00281-014-0452-6		8	Immunology; Pathology	Immunology; Pathology	AX8NQ	WOS:000347166500009		
J	Fujii, S; Akiyama, K; Nakayama, S; Hamasaki, S; Yusa, S; Nakamura, Y				Fujii, Syuji; Akiyama, Ko; Nakayama, Saori; Hamasaki, Sho; Yusa, Shin-ichi; Nakamura, Yoshinobu			pH- and temperature-responsive aqueous foams stabilized by hairy latex particles	SOFT MATTER			English	Article							SILICA NANOPARTICLES; AIR/WATER INTERFACE; DIBLOCK COPOLYMERS; PICKERING FOAMS; WATER INTERFACE; SURFACE-TENSION; AIR BUBBLES; EMULSIONS; CHARGE; MICROSTRUCTURE	Polystyrene (PS) particles carrying pH- and temperature-responsive poly[2-(dimethylamino) ethyl methacrylate] (PDMA) hairs (PDMA-PS particles) were synthesized by dispersion polymerization. The diameter, diameter distribution, morphology, chemical composition and surface chemistry of the particles were characterized using scanning electron microscopy (SEM), elemental microanalysis, dynamic light scattering and zeta potential measurements. The hydrophilicity-hydrophobicity balance of the PDMA could be tuned by varying both pH and temperature and therefore these sterically stabilized particles acted as doubly stimuli-responsive stabilizers for aqueous foams by adsorption and desorption to/ from the air-water interface. At and above pH 6.0, in which range the PDMA hairs were either nonprotonated or partially protonated, particle-stabilized foams were formed at both 23 and 55 degrees C. The foam prepared at 55 degrees C was the more stable of the two, lasting for at least 24 h, whereas the 23 degrees C foam destabilized within 24 h. SEM studies indicated that the particles adsorbed at the air-water interface as monolayers at 23 degrees C and as multilayers at 55 degrees C. At and below pH 5, in which range the hairs were cationic, hydrophilic and water-soluble, no foam was formed irrespective of temperature. Rapid defoaming could be induced by lowering the solution pH at both temperatures, due to rapid in situ protonation of the PDMA hairs, prompting the PDMA-PS particles to desorb from the air-water interface. The foaming and defoaming cycles could be repeated at least five times.	[Fujii, Syuji; Akiyama, Ko; Nakayama, Saori; Hamasaki, Sho; Nakamura, Yoshinobu] Osaka Inst Technol, Fac Engn, Dept Appl Chem, Asahi Ku, Osaka 5358585, Japan; [Yusa, Shin-ichi] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Nakamura, Yoshinobu] Osaka Inst Technol, Asahi Ku, Nanomat Microdevices Res Ctr, Osaka 5358585, Japan	Fujii, S (reprint author), Osaka Inst Technol, Fac Engn, Dept Appl Chem, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.	syuji.fujii@oit.ac.jp			JSPS Bilateral; Ministry of Education, Culture, Sports, Science, and Technology of Japan	The authors would like to thank the following individuals: Prof. Dr Hans-Jurgen Butt (Max Planck Institute) for providing valuable comments on this manuscript, Prof. Hiroyuki Mayama for discussions concerning the non-adsorption behavior of the PDMA-PS particles at the air-water interface, and Mr Keita Nakai and Mr Ryusuke Enomoto (Hyogo U.) for their assistance in measuring hydrodynamic particle diameters and zeta potentials. This work was partially supported by JSPS Bilateral Joint Research Projects and by a Grant-in-Aid for Scientific Research on Innovative Areas "Engineering Neo-Biomimetics," "New Polymeric Materials Based on Element-Blocks" and "Molecular Soft Interface Science" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Finally, the authors are grateful to Wako Chemicals for the kind donation of 2,2'-azobis[2-methyl-N-(2-hydroxyethyl) propionamide].	Ahrens H, 2001, MACROMOLECULES, V34, P4504, DOI 10.1021/ma001520h; Yim H, 2002, MACROMOLECULES, V35, P9737, DOI 10.1021/ma0200468; Subramaniam AB, 2006, LANGMUIR, V22, P5986, DOI 10.1021/la060388x; Du ZP, 2003, LANGMUIR, V19, P3106, DOI 10.1021/la034042n; Studart AR, 2006, J AM CERAM SOC, V89, P1771, DOI 10.1111/j.1551-2916.2006.01044.x; Gonzenbach UT, 2007, LANGMUIR, V23, P1025, DOI 10.1021/la0624844; Dupin D, 2008, J MATER CHEM, V18, P545, DOI 10.1039/b714261g; Longo GS, 2011, MACROMOLECULES, V44, P147, DOI 10.1021/ma102312y; Sun YQ, 2002, METALL MATER TRANS A, V33, P3285, DOI 10.1007/s11661-002-0315-y; Subramaniam AB, 2005, NATURE, V438, P930, DOI 10.1038/438930a; Binks BP, 2007, LANGMUIR, V23, P8691, DOI 10.1021/la700444a; Fujii S, 2010, POLYMER, V51, P6240, DOI 10.1016/j.polymer.2010.10.041; Fujii S, 2012, MACROMOLECULES, V45, P2863, DOI 10.1021/ma300048m; Blanco E, 2013, LANGMUIR, V29, P10019, DOI 10.1021/la4014224; Takahashi M, 2005, J PHYS CHEM B, V109, P21858, DOI 10.1021/jp0445270; Binks BP, 2005, ANGEW CHEM INT EDIT, V44, P3722, DOI 10.1002/anie.200462470; IQBAL SH, 1973, T BRIT MYCOL SOC, V60, P37; Fujii S, 2011, LANGMUIR, V27, P12902, DOI 10.1021/la203062b; Butun V, 2001, POLYMER, V42, P5993, DOI 10.1016/S0032-3861(01)00066-0; Subramaniam AB, 2005, NAT MATER, V4, P553, DOI 10.1038/nmat1412; Alargova RG, 2004, LANGMUIR, V20, P10371, DOI 10.1021/la048647a; Cotanda P, 2013, J POLYM SCI POL CHEM, V51, P3333, DOI 10.1002/pola.26730; Fujii S, 2008, KONA POWDER PART J, V26, P153; Ramsden W, 1903, P R SOC LONDON, V72, P156, DOI 10.1098/rspl.1903.0034; Binks BP, 2005, ANGEW CHEM INT EDIT, V44, P4795, DOI 10.1002/anie.200501073; Kostakis T, 2006, LANGMUIR, V22, P1273, DOI 10.1021/la052193f; MATSUMOTO T, 1974, KOBUNSHI RONBUNSHU, V31, P669; Lam S, 2011, J AM CHEM SOC, V133, P13856, DOI 10.1021/ja205065w; Gonzenbach UT, 2006, ANGEW CHEM INT EDIT, V45, P3526, DOI 10.1002/anie.200503676; Wang HZ, 2012, J PHYS CHEM LETT, V3, P2986, DOI 10.1021/jz300909z; Dickinson E, 2004, LANGMUIR, V20, P8517, DOI 10.1021/la048913k; LEVINE S, 1989, COLLOID SURFACE, V38, P325, DOI 10.1016/0166-6622(89)80271-9; Fujii S, 2006, LANGMUIR, V22, P7512, DOI 10.1021/la060812u; Fujii S, 2006, J AM CHEM SOC, V128, P7882, DOI 10.1021/ja060640n; Binks B.P., 2006, COLLOIDAL PARTICLES; Brandrup J., 1999, POLYM HDB; Ciunel K, 2005, LANGMUIR, V21, P4790, DOI 10.1021/la050328b; Dognon A., 1941, REV SCI, V79, P613; Fuerstenau M. C., 2007, FROTH FLOTATION CENT; Fujii S, 2009, J POLYM SCI POL CHEM, V47, P3431, DOI 10.1002/pola.23424; Garrett P. R., 1993, DEFOAMING THEORY IND, V45; Haase MF, 2011, LANGMUIR, V27, P74, DOI 10.1021/la1027724; Hunter TN, 2008, ADV COLLOID INTERFAC, V137, P57, DOI 10.1016/j.cis.2007.07.007; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Jackson J. D., 1998, CLASSICAL ELECTRODYN; Jorba D. A., 2012, PCT Int. Appl, Patent No. [WO 2012174360 A1, 2012174360]; Kettlewell SL, 2007, LANGMUIR, V23, P11381, DOI 10.1021/la702099t; Matsuoka H, 2004, LANGMUIR, V20, P7412, DOI 10.1021/la0492153; Sadoc J. F., 1999, NATO ASI SERIES E, V354; VARGAFTIK NB, 1983, J PHYS CHEM REF DATA, V12, P817; Wong JCH, 2011, LANGMUIR, V27, P3254, DOI 10.1021/la200224k	51	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1744-683X	1744-6848		SOFT MATTER	Soft Matter		2015	11	3					572	579		10.1039/c4sm02236j		8	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Multidisciplinary; Polymer Science	Chemistry; Materials Science; Physics; Polymer Science	AX4OM	WOS:000346911600015		
J	Okada, E; Watanabe, K; Pang, L; Ogura, Y; Takahashi, Y; Hosogane, N; Toyama, Y; Matsumoto, M				Okada, Eijiro; Watanabe, Kota; Pang, Long; Ogura, Yoji; Takahashi, Yohei; Hosogane, Naobumi; Toyama, Yoshiaki; Matsumoto, Morio			Posterior Correction and Fusion Surgery Using Pedicle-Screw Constructs for Lenke Type 5C Adolescent Idiopathic Scoliosis A Preliminary Report	SPINE			English	Article						adolescent idiopathic scoliosis; thoracolumbar/lumbar curve; short fusion; pedicle-screw fixation; posterior spinal fusion; Lenke classification; 5C; upper instrumented vertebra (UIV); comparison study; fusion area	SCOLIOSIS-RESEARCH-SOCIETY-22 PATIENT QUESTIONNAIRE; THORACIC FUSION; FOLLOW-UP; LUMBAR; CURVES; INSTRUMENTATION; THORACOLUMBAR; FIXATION; RELIABILITY; VALIDITY	Study Design. A retrospective case series. Objective. To assess whether a short fusion strategy is applicable when treating adolescent idiopathic scoliosis with Lenke type 5C curve by posterior correction and fusion surgery using pedicle-screw constructs. Summary of Background Data. Previous studies have discussed the selection of the lower instrumented vertebra to best preserve motion segments and obtain coronal balance. However, reports evaluating the selection of the upper instrumented vertebra when treating Lenke type 5C curves are not available. Methods. We evaluated 29 patients who were treated surgically for adolescent idiopathic scoliosis with Lenke type 5C curve (mean age, 16.8 +/- 4.7 yr; range, 10-29 yr). The mean follow-up period was 28.0 +/- 6.3 months (range, 24-48 mo). We compared radiographical parameters and clinical outcomes between patients with an upper instrumented vertebra at the end vertebra (EV) (n = 10) and those treated by short fusion (S group), with a upper instrumented vertebra 1-level caudal to the EV (n = 19 patients). Results. In the EV group, a preoperative mean Cobb angle of 50 degrees +/- 15 degrees was corrected to 8 degrees +/- 7 degrees, which was maintained at the final follow-up (7 degrees +/- 1 degrees). In the S group, a mean preoperative Cobb angle of 47 degrees +/- 4 degrees was corrected to 8 degrees +/- 5 degrees, but this increased significantly to 12 degrees +/- 7 degrees at final follow-up (P = 0.033). The mean correction rate at final follow-up was significantly lower in the S group (72%) than in the EV group (86%) (P = 0.027). Coronal and sagittal balance, thoracic kyphosis, lumbar lordosis, L4 tilt, and clinical outcomes evaluated by Scoliosis Research Society patient questionnaire-22 were equivalent between the 2 groups. Conclusion. Scoliosis Research Society patient questionnaire-22 scores and radiographical parameters other than the correction rate were equivalent between the 2 groups. A short fusion strategy, in which the upper instrumented vertebra is 1-level caudal to the upper EV, is applicable to posterior correction and fusion surgery with pedicle-screw constructs for Lenke type 5C curves.	[Okada, Eijiro; Pang, Long; Ogura, Yoji; Takahashi, Yohei; Toyama, Yoshiaki; Matsumoto, Morio] Keio Univ, Dept Orthopaed Surg, Tokyo 1608582, Japan; [Okada, Eijiro] Saiseikai Cent Hosp, Dept Orthopaed Surg, Tokyo, Japan; [Watanabe, Kota] Keio Univ, Sch Med, Dept Adv Therapy Spine & Spinal Cord Disorders, Tokyo, Japan; [Pang, Long] Ningxia Med Univ, Gen Hosp, Dept Orthoped, Ward 3, Ningxia, Peoples R China; [Hosogane, Naobumi] Natl Def Med Coll, Dept Orthopaed Surg, Tokorozawa, Saitama 359, Japan	Matsumoto, M (reprint author), Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	morio@a5.keio.jp					Kamerlink JR, 2010, J BONE JOINT SURG AM, V92A, P1097, DOI 10.2106/JBJS.I.00879; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169; SUK SI, 1994, INT ORTHOP, V18, P341; Moe JH, 2007, CLIN ORTHOP RELAT R, P21, DOI 10.1097/BLO.0b013e3180686c07; Kim YJ, 2004, SPINE, V29, P2040, DOI 10.1097/01.brs.0000138268.12324.1a; Barr SJ, 1997, SPINE, V22, P1369, DOI 10.1097/00007632-199706150-00016; Asher M, 2003, SPINE, V28, P63, DOI 10.1097/00007632-200301010-00015; Asher M, 2003, SPINE, V28, P74, DOI 10.1097/00007632-200301010-00017; Bennett JT, 2013, J NEUROSURG-SPINE, V19, P658, DOI 10.3171/2013.8.SPINE12816; Bernstein RM, 1998, J PEDIATR ORTHOP B, V7, P124; DWYER AF, 1974, J BONE JOINT SURG BR, VB 56, P218; Geck MJ, 2009, SPINE, V34, P1942, DOI 10.1097/BRS.0b013e3181a3c777; Hwang SW, 2012, J NEUROSURG-SPINE, V17, P308, DOI 10.3171/2012.7.SPINE12273; Kuklo TR, 2005, SPINE, V30, P444, DOI 10.1097/01.brs.0000153702.99342.9c; Lark RK, 2013, SPINE, V38, P195, DOI 10.1097/BRS.0b013e3182634c85; Matsumoto M, 2013, J SPINAL DISORD TECH, V26, P93, DOI 10.1097/BSD.0b013e31823ac2e8; Matsumoto M, 2013, J ORTHOP SCI, V19, P6; Min K, 2013, EUR SPINE J, V22, P345, DOI 10.1007/s00586-012-2533-3; Shufflebarger HL, 2004, SPINE, V29, P76; Shufflebarger HL, 2004, SPINE, V29, P269, DOI 10.1097/01.BRS.0000109881.63411.48; Suk SI, 2005, SPINE, V30, P1602, DOI 10.1097/01.brs.0000169452.50705.61; Wang Y, 2013, SPINE, V38, pE894, DOI 10.1097/BRS.0b013e31829537be; Yilmaz G, 2012, J PEDIATR ORTHOPED, V32, P490, DOI 10.1097/BPO.0b013e318250c629	23	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JAN	2015	40	1					25	30		10.1097/BRS.0000000000000652		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AX1TT	WOS:000346729600017		
J	Sugiura, S; Aoki, Y; Toyooka, T; Shiga, T; Otsuki, K; Aikawa, E; Oyama, T; Kitoh, K; Chikako, S; Takata, Y; Ishizaki, T; Omori, Y; Kiguchi, Y; Takata, A; Kote, A; Nakanishi, Y; Matsushita, Y; Suzuki, T; Mori, C; Takahashi, K; Nishikawa, S				Sugiura, Shiro; Aoki, Yasuchika; Toyooka, Takeshi; Shiga, Tetsuo; Otsuki, Kazumi; Aikawa, Emi; Oyama, Takato; Kitoh, Kazuhisa; Chikako, Sakaida; Takata, Yuka; Ishizaki, Tohru; Omori, Yasutaka; Kiguchi, Yasumi; Takata, Akito; Kote, Ayako; Nakanishi, Yasuko; Matsushita, Yukio; Suzuki, Takane; Mori, Chisato; Takahashi, Kazuhisa; Nishikawa, Satoru			Characteristics of Low Back Pain in Adolescent Patients With Early-Stage Spondylolysis Evaluated Using a Detailed Visual Analogue Scale	SPINE			English	Article						early-stage spondylolysis; early diagnosis; visual analogue scale (VAS); detailed VAS; magnetic resonance imaging (MRI); acute low back pain; nonspecific low back pain; adolescent; sports; Oswestry Disability Index (ODI); postural posture	LUMBAR SPONDYLOLYSIS; PARS INTERARTICULARIS; CONSERVATIVE TREATMENT; ACTIVE SPONDYLOLYSIS; NATURAL-HISTORY; EARLY-DIAGNOSIS; SPONDYLOLISTHESIS; CHILDREN; MRI; INJURIES	Study Design. Retrospective comparative cohort study. Objective. To elucidate the characteristics of low back pain (LBP) in adolescent patients with early-stage spondylolysis (ESS). Summary of Background Data. ESS is a common cause of acute LBP in adolescents. When treating patients with ESS, early diagnosis is important; however, early diagnosis is difficult without magnetic resonance imaging. Methods. Adolescent patients (n = 77) with acute LBP showing no pathological findings on plain radiography were included (<1 m after onset). Patients were divided into ESS and nonspecifi c LBP (NS-LBP) groups by conducting magnetic resonance imaging; patients showing no pathological findings that explain the cause of LBP were classified as NS-LBP. LBP was evaluated using a traditional visual analogue scale (VAS; 0-10 cm), Oswestry Disability Index, and a detailed VAS scoring system in which pain is independently evaluated in 3 different postural situations (in motion, standing, and sitting); the values were compared between the 2 groups. Results. Of 77 patients, 41 (mean age: 14.6 yr; 33 adolescent boys/8 adolescent girls) had ESS and 36 (mean age: 14.3 yr; 20 adolescent boys/16 adolescent girls) were considered to have NS-LBP. Respective traditional VAS and Oswestry Disability Index scores were 4.9, 16.1 in the ESS group, and 6.2, 26.3 in the NS-LBP group. Both scores were significantly higher in the NS-LBP group. The results of the detailed VAS revealed that the ESS group showed significantly greater pain intensity while in motion than while standing or sitting (4.2, 2.0, and 2.0, respectively), whereas the NS-LBP group showed similar pain intensities in all 3 postural situations (5.3, 4.0, and 4.9, respectively). Conclusion. This study revealed that LBP characteristics may provide important information for distinguishing ESS from other low back disorders. Because early diagnosis is essential for the treatment of ESS, MRI examination is recommended for patients showing severe pain in motion, but less pain when standing or sitting.	[Sugiura, Shiro; Toyooka, Takeshi; Shiga, Tetsuo; Otsuki, Kazumi; Aikawa, Emi; Oyama, Takato; Kitoh, Kazuhisa; Chikako, Sakaida; Takata, Yuka; Ishizaki, Tohru; Omori, Yasutaka; Kiguchi, Yasumi; Takata, Akito; Kote, Ayako; Nakanishi, Yasuko; Matsushita, Yukio; Nishikawa, Satoru] Nishikawa Orthoped Clin, Sakura, Chiba 2850817, Japan; [Sugiura, Shiro; Suzuki, Takane; Mori, Chisato] Chiba Univ, Grad Sch Med, Dept Bioenvironm Med, Chiba, Japan; [Aoki, Yasuchika] Eastern Chiba Med Ctr, Dept Orthopaed Surg, Chiba, Japan; [Takahashi, Kazuhisa] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chiba, Japan	Sugiura, S (reprint author), Nishikawa Orthoped Clin, 1-14-2 Ohsakidai, Sakura, Chiba 2850817, Japan.	sugiuras@naoso.com					Sys J, 2001, EUR SPINE J, V10, P498, DOI 10.1007/s005860100326; AMATO M, 1984, RADIOLOGY, V153, P627; Fujii K, 2004, J BONE JOINT SURG BR, V86B, P225, DOI 10.1302/0301-620X.86B2.14339; Astfalck RG, 2010, MANUAL THER, V15, P240, DOI 10.1016/j.math.2009.12.007; Cavalier R, 2006, J AM ACAD ORTHOP SUR, V14, P417; ROSSI F, 1990, J SPORT MED PHYS FIT, V30, P450; ROSSI F, 1978, J SPORT MED PHYS FIT, V18, P317; Leone A, 2011, SKELETAL RADIOL, V40, P683, DOI 10.1007/s00256-010-0942-0; Bhatia NN, 2008, J PEDIATR ORTHOPED, V28, P230, DOI 10.1097/BPO.0b013e3181651bc8; MICHELI LJ, 1995, ARCH PEDIAT ADOL MED, V149, P15; Sakai T, 2009, SPINE, V34, P2346, DOI 10.1097/BRS.0b013e3181b4abbe; Ishibashi Y, 2002, CLIN J SPORT MED, V12, P79, DOI 10.1097/00042752-200203000-00003; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Aoki Y, 2012, PAIN RES TREAT, V2012, P680, DOI 10.1155/2012/680496; Balague F, 1999, EUR SPINE J, V8, P429, DOI 10.1007/s005860050201; Campbell RSD, 2005, SKELETAL RADIOL, V34, P63, DOI 10.1007/s00256-004-0878-3; Cillo JV, 1985, CLIN SPORTS MED, V4, P95; COMMANDRE FA, 1988, J SPORT MED PHYS FIT, V28, P104; CYRON BM, 1978, J BONE JOINT SURG BR, V60, P234; Elliott S, 1988, CLIN RADIOL, V39, P296; FREDRICKSON BE, 1984, J BONE JOINT SURG AM, V66A, P699; GRANHED H, 1988, AM J SPORT MED, V16, P530, DOI 10.1177/036354658801600517; Hensinger R N, 1983, Instr Course Lect, V32, P132; Hollenberg GM, 2002, SPINE, V27, P79; Itoh K, 1996, NUCL MED COMMUN, V17, P389, DOI 10.1097/00006231-199605000-00007; JACKSON DW, 1976, CLIN ORTHOP RELAT R, P68; JACKSON DW, 1981, AM J SPORT MED, V9, P304, DOI 10.1177/036354658100900504; Kim HJ, 2011, CURR OPIN PEDIATR, V23, P68, DOI 10.1097/MOP.0b013e32834255c2; Kobayashi A, 2012, AM J SPORTS MED, V41, P169; LETTS M, 1986, J PEDIATR ORTHOPED, V6, P40; Masci L, 2006, BRIT J SPORT MED, V40, P940, DOI 10.1136/bjsm.2006.030023; MICHELI LJ, 1985, CLIN SPORT MED, V4, P85; Morita R, 1995, J BONE JOINT SURG BR, V77, P620; Rossi F, 1994, Radiol Med, V87, P397; Sairyo K, 2010, AM J SPORTS, V38, P352; Sairyo K, 2006, SPINE, V31, P206, DOI 10.1097/01.brs.0000195161.60549.67; Witse LL, 1975, J BONE JOINT SURG AM, V57, P17; YAMANE T, 1993, J BONE JOINT SURG BR, V75, P764	38	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JAN	2015	40	1					E29	E34		10.1097/BRS.0000000000000657		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AX1TT	WOS:000346729600005		
J	Kubokawa, T; Marchand, E; Strawderman, WE				Kubokawa, Tatsuya; Marchand, Eric; Strawderman, William E.			On improved shrinkage estimators for concave loss	STATISTICS & PROBABILITY LETTERS			English	Article						Location parameters; Minimaxity; Stein estimation; Concave loss	SPHERICALLY SYMMETRIC DISTRIBUTIONS; MULTIVARIATE NORMAL-DISTRIBUTION; MINIMAX ESTIMATION; LOCATION PARAMETERS; QUADRATIC LOSS	We consider minimax shrinkage estimation of location for spherically symmetric distributions under a concave function of the usual squared error loss. Scale mixtures of normal distributions and losses with completely monotone derivatives are featured. (C) 2014 Elsevier B.V. All rights reserved.	[Kubokawa, Tatsuya] Univ Tokyo, Dept Econ, Tokyo 1130033, Japan; [Marchand, Eric] Univ Sherbrooke, Dept Math, Sherbrooke, PQ J1K 2R1, Canada; [Strawderman, William E.] Rutgers State Univ, DeptStat & Biostat, Piscataway, NJ 08855 USA	Strawderman, WE (reprint author), Rutgers State Univ, DeptStat & Biostat, 501 Hill Ctr,Busch Campus, Piscataway, NJ 08855 USA.	tatsuya@e.u-tokyo.acjp; eric.marchand@usherbrooke.ca; straw@stat.rutgers.edu			Japan Society for the Promotion of Science [19200020, 21540114]; Natural Sciences and Engineering Research of Canada [105806-2012]; Simons Foundation [209035]	The authors wish to thank an anonymous reviewer for a careful and helpful review of the paper. Tatsuya Kubokawa's research is supported by Grants-in-Aid for Scientific Research Nos. 19200020 and 21540114 from the Japan Society for the Promotion of Science, Eric Marchand's research is supported in part by a grant from the Natural Sciences and Engineering Research of Canada (105806-2012), and William Strawderman's research is partially supported by a grant from the Simons Foundation (#209035).	BRANDWEIN AC, 1993, ANN I STAT MATH, V45, P551, DOI 10.1007/BF00773355; BRANDWEIN AC, 1991, ANN STAT, V19, P1639, DOI 10.1214/aos/1176348267; Bagnoli M, 2005, ECON THEOR, V26, P445, DOI 10.1007/s00199-004-0514-4; BERGER J, 1975, ANN STAT, V3, P1318, DOI 10.1214/aos/1176343287; BARANCHI.AJ, 1970, ANN MATH STAT, V41, P642, DOI 10.1214/aoms/1177697104; BRANDWEIN AC, 1980, ANN STAT, V8, P279, DOI 10.1214/aos/1176344953; BRANDWEIN AC, 1979, J MULTIVARIATE ANAL, V9, P579, DOI 10.1016/0047-259X(79)90059-9; BRANDWEIN ARC, 1978, ANN STAT, V6, P377, DOI 10.1214/aos/1176344131; James W., 1961, P 4 BERK S MATH STAT, V1, P361; Kubokawa T., 2014, ARXIV14085297; STEIN CM, 1981, ANN STAT, V9, P1135, DOI 10.1214/aos/1176345632; Strawderman W. E., 1974, J MULTIVARIATE ANAL, V4, P255, DOI 10.1016/0047-259X(74)90032-3; STRAWDER.WE, 1971, ANN MATH STAT, V42, P385, DOI 10.1214/aoms/1177693528	13	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7152	1879-2103		STAT PROBABIL LETT	Stat. Probab. Lett.	JAN	2015	96						241	246		10.1016/j.spl.2014.09.024		6	Statistics & Probability	Mathematics	AX4HQ	WOS:000346894500031		
J	Nakata, T				Nakata, Toshio			Limit distributions of generalized St. Petersburg games	STATISTICS & PROBABILITY LETTERS			English	Article						St. Petersburg game; Residue analysis; Semi-stable distribution		The St. Petersburg game is known as a probability model with infinite expectation, and has some extensions. Gut and Martin-Lof (2013) studied convergence in distribution along a suitable specific subsequence under their generalization. In this article, we extend their results using residue analysis investigated by Vardi (1995). We give the explicit limit distributions via characteristic functions with gamma functions which become semi-stable or strictly semi-stable. (C) 2014 Elsevier B.V. All rights reserved.	Fukuoka Univ Educ, Dept Math, Munakata, Fukuoka 8114192, Japan	Nakata, T (reprint author), Fukuoka Univ Educ, Dept Math, Munakata, Fukuoka 8114192, Japan.	nakata@fulcuoka-edu.ac.jp			Fukuoka University of Education	The author would like to thank the anonymous referees for helpful comments. This work was partially supported by Research Fund at the Discretion of the President, Fukuoka University of Education 2014.	Andrews G., 2009, SPECIAL FUNCTIONS; FLAJOLET P, 1995, THEOR COMPUT SCI, V144, P3, DOI 10.1016/0304-3975(95)00002-E; Csorgo S., 1991, PROGR PROBABILITY, V23, P285; Csorgo S., 2002, ACTA SCI MATH SZEGED, V68, P815; Csorgo S., 2010, ACTA SCI MATH SZEGED, V76, P233; Davydov Y, 2009, J THEOR PROBAB, V22, P82, DOI 10.1007/s10959-008-0178-2; Feller W, 1968, INTRO PROBABILITY TH, VI; Gut A., 2013, RES REPORT, P3; Gut A., 2013, PROBABILITY GRADUATE; Gyorfi L, 2011, PERIOD MATH HUNG, V62, P13, DOI 10.1007/s10998-011-5013-3; MARTINLOF A, 1985, J APPL PROBAB, V22, P634, DOI 10.2307/3213866; Matsumoto K, 2013, J APPL PROBAB, V50, P54; Nakata T., 2015, ACTA MATH H IN PRESS; Pap G, 2011, J THEOR PROBAB, V24, P240, DOI 10.1007/s10959-009-0247-1; Sato K.-I., 1999, LEVY PROCESSES INFIN; VARDI I, 1995, P AM MATH SOC, V123, P2875, DOI 10.2307/2160590	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-7152	1879-2103		STAT PROBABIL LETT	Stat. Probab. Lett.	JAN	2015	96						307	314		10.1016/j.spl.2014.10.010		8	Statistics & Probability	Mathematics	AX4HQ	WOS:000346894500041		
J	Azhagurajan, M; Wen, R; Kim, YG; Itoh, T; Sashikata, K; Itaya, K				Azhagurajan, M.; Wen, R.; Kim, Y. G.; Itoh, T.; Sashikata, K.; Itaya, K.			Preparation and characterization of ultraflat Pt facets by atom-height-resolved differential optical microscopy	SURFACE SCIENCE			English	Article						Laser confocal microscopy with the differential interference microscopy (LCM-DIM); Ultraflat surfaces; Pt single crystal	SCANNING-TUNNELING-MICROSCOPY; SINGLE-CRYSTAL SURFACES; SULFURIC-ACID-SOLUTION; IN-SITU STM; OXYGEN REDUCTION; ELECTROCHEMICAL INTERFACES; PLATINUM SURFACES; ADSORBED-IODINE; DISSOLUTION; ADSORPTION	We recently demonstrated that improvements to our technique, laser confocal microscopy with differential interference microscopy (LCM-DIM), has rendered it fully capable of resolving monatomic steps with heights of ca. 0.25 nm on Au(111) and Pd(111) surfaces, even as low as 0.14 nm on Si(100), in aqueous solution. In this paper, we describe in detail a method to prepare and characterize, via atomic-layer-resolved LCM-DIM, ultraflat Pt(111) and Pt(100) facets over a wide surface area. The preparation of ultraflat surfaces is important in the characterization at the atomic scale of electrochemical processes under reaction conditions. To showcase the elegance of LCM-DIM, the anodic dissolution of Pt in aqueous HCl is briefly recounted. (C) 2014 Elsevier B.V. All rights reserved.	[Azhagurajan, M.; Itoh, T.; Itaya, K.] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Azhagurajan, M.; Itaya, K.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Wen, R.; Kim, Y. G.] Tohoku Univ, World Premier Int Res Ctr, Adv Inst Mat Res WPI AIMR, Sendai, Miyagi 9808577, Japan; [Wen, R.] Univ Kiel, Inst Expt & Appl Phys, D-24098 Kiel, Germany; [Sashikata, K.] Ishinomaki Senshu Univ, Ishinomaki 9868580, Japan	Itaya, K (reprint author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, 6-3Aoba, Sendai, Miyagi 9808578, Japan.	itaya@atom.che.tohoku.ac.jp	Wen, Rui/M-8677-2013	Wen, Rui/0000-0003-2644-7452	Ministry of Education, Culture, Sports, Science and Technology of Japan [25286011]; New Energy and Industrial Technology Development Organization (NEDO)	The authors acknowledge Mr. Y. Saito (Olympus Optical Co. Ltd.) and Prof. G. Sazaki (Hokkaido University) for assistance in the development and optimization of the LCM-DIM system. The authors are grateful to Profs. O. Ito (Tohoku University) and M. P. Soriaga (Texas A&M University) for their help in the writing of this manuscript. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant No. 25286011 and in part by the New Energy and Industrial Technology Development Organization (NEDO).	Andersen JET, 1996, J APPL ELECTROCHEM, V26, P161, DOI 10.1007/BF00364066; Yu XW, 2007, J POWER SOURCES, V172, P145, DOI 10.1016/j.jpowsour.2007.07.048; Tansel T, 2010, CHEMPHYSCHEM, V11, P1438, DOI 10.1002/cphc.200900939; Van Driessche AES, 2008, CRYST GROWTH DES, V8, P4316, DOI 10.1021/cg800782r; Shao YY, 2007, J POWER SOURCES, V171, P558, DOI 10.1016/j.jpowsour.2007.07.004; Stamenkovic V, 2001, J ELECTROANAL CHEM, V500, P44, DOI 10.1016/S0022-0728(00)00352-1; MARKOVIC NM, 1995, J PHYS CHEM-US, V99, P3411, DOI 10.1021/j100011a001; Gewirth AA, 1997, CHEM REV, V97, P1129, DOI 10.1021/cr960067y; Yoshimoto S, 2013, ANNU REV ANAL CHEM, V6, P213, DOI 10.1146/annurev-anchem-062012-092559; Itaya K, 1998, PROG SURF SCI, V58, P121, DOI 10.1016/S0079-6816(98)00022-7; Kuzume A, 2007, J ELECTROANAL CHEM, V599, P333, DOI 10.1016/j.jelechem.2006.05.006; Wen R, 2010, J AM CHEM SOC, V132, P13657, DOI 10.1021/ja106231x; WILL FG, 1965, J ELECTROCHEM SOC, V112, P451, DOI 10.1149/1.2423567; Ferreira PJ, 2005, J ELECTROCHEM SOC, V152, pA2256, DOI 10.1149/1.2050347; Hoshi N, 2009, J PHYS CHEM C, V113, P16843, DOI 10.1021/jp9076239; Macia MD, 2004, J ELECTROANAL CHEM, V564, P141, DOI 10.1016/j.jelechem.2003.09.035; Azhagurajan M, 2013, J ELECTROCHEM SOC, V160, pD361, DOI 10.1149/2.057309jes; Clavilier J., 1999, EXPT APPL, P231; HONBO H, 1990, ANAL CHEM, V62, P2424, DOI 10.1021/ac00221a003; Hubberd A., 1999, EXPT APPL, P211; Inoue M, 2011, J POWER SOURCES, V196, P4579, DOI 10.1016/j.jpowsour.2011.01.065; Kobayashi SI, 2011, ELECTROCHEM SOLID ST, V14, pH351, DOI 10.1149/1.3597657; Kolb DM, 2001, ANGEW CHEM INT EDIT, V40, P1162, DOI 10.1002/1521-3773(20010401)40:7<1162::AID-ANIE1162>3.3.CO;2-6; Kolb DM, 2000, ELECTROCHIM ACTA, V45, P2387, DOI 10.1016/S0013-4686(00)00328-5; Komanicky V, 2006, J ELECTROCHEM SOC, V153, pB446, DOI 10.1149/1.2229284; SASHIKATA K, 1991, J VAC SCI TECHNOL B, V9, P457, DOI 10.1116/1.585589; Sashikata K, 1996, J PHYS CHEM-US, V100, P20027, DOI 10.1021/jp9620532; Takizawa S, 2010, J POWER SOURCES, V195, P5966, DOI 10.1016/j.jpowsour.2009.12.055; Teshima T, 1997, J PHYS CHEM B, V101, P2046, DOI 10.1021/jp9639657; Thomas S, 1997, ACS SYM SER, V656, P126; Wang D, 2007, J PHYS CHEM C, V111, P16109, DOI 10.1021/jp0737202; Wen R, 2010, J ELECTROANAL CHEM, V649, P257, DOI 10.1016/j.jelechem.2010.06.009	32	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	JAN	2015	631				SI		57	62		10.1016/j.susc.2014.07.031		6	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AY0CR	WOS:000347266000009		
J	Kondo, T; Zegenhagen, J; Takakusagi, S; Uosaki, K				Kondo, Toshihiro; Zegenhagen, Joerg; Takakusagi, Satoru; Uosaki, Kohei			In situ real-time study on potential induced structure change at Au(111) and Au(100) single crystal electrode/sulfuric acid solution interfaces by surface x-ray scattering	SURFACE SCIENCE			English	Article						Au single crystal electrode; Reconstruction lifting; Surface reconstruction; Surface oxide formation; In situ surface X-ray scattering	SCANNING-TUNNELING-MICROSCOPY; ELECTROCHEMICAL-CELL; SULFURIC MEDIUM; GOLD OXIDATION; NOBLE-METALS; OXIDE-FILM; LAYER; ELECTRODES; GROWTH; STM	Surface X-ray scattering (SXS) measurements were carried out to monitor the potential induced structure changes such as surface reconstruction lifting, adsorption of oxygen species, formation of surface oxide bilayer, reduction of surface oxide, and surface reconstruction at Au(111)/H2SO4 and Au(100)/H2SO4 interfaces in situ in real time using intense high energy X-ray. The phase transition of the reconstruction/lifting, adsorption of oxygen species, and surface oxide formation/reduction at the Au(100) electrode proceed much slower, slightly slower, and faster, respectively, than at the Au(111) electrode, (C) 2014 Elsevier B.V. All rights reserved.	[Kondo, Toshihiro] Ochanomizu Univ, Grad Sch Humanities & Sci, Div Chem, Tokyo 1128610, Japan; [Zegenhagen, Joerg] European Synchrotron Radiat Facil, F-38043 Grenoble 9, France; [Takakusagi, Satoru; Uosaki, Kohei] Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; [Uosaki, Kohei] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan; [Uosaki, Kohei] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitechton MANA, Tsukuba, Ibaraki 3050044, Japan	Uosaki, K (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitechton MANA, Tsukuba, Ibaraki 3050044, Japan.	UOSAKI.kohei@nims.go.jp	Uosaki, Kohei/A-8217-2008; Takakusagi, Satoru/A-6953-2012	Takakusagi, Satoru/0000-0002-4095-172X	World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics; Development of Environmental Technology using Nanotechnology from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; European Synchrotron Radiation Facility (ESRF) [SI-1041];  [20550009]	This work was partially supported by the Grant-in-Aid for Scientific Research (C) (no. 20550009), the World Premier International Research Center (WPI) Initiative on Materials Nanoarchitectonics, and the Development of Environmental Technology using Nanotechnology from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The synchrotron radiation experiments were performed at European Synchrotron Radiation Facility (ESRF) as project of SI-1041.	Abruna H. D., 1991, ELECTROCHEMICAL INTE; Angerstein-Kozlowska A., 1987, J ELECTROANAL CHEM, V228, P429; Angerstein-Kozlowska A., 1986, ELECTROCHIM ACTA, V31, P1051; Cuesta A, 2000, PHYS CHEM CHEM PHYS, V2, P5684, DOI 10.1039/b006464p; Nagy Z, 2002, ELECTROCHIM ACTA, V47, P3037, DOI 10.1016/S0013-4686(02)00223-2; CONWAY BE, 1995, PROG SURF SCI, V49, P331, DOI 10.1016/0079-6816(95)00040-6; Schneeweiss MA, 1997, SOLID STATE IONICS, V94, P171, DOI 10.1016/S0167-2738(96)00587-5; Kondo T, 2007, J PHYS CHEM C, V111, P13197, DOI 10.1021/jp072601j; OCKO BM, 1990, PHYS REV LETT, V65, P1466, DOI 10.1103/PhysRevLett.65.1466; MAGNUSSEN OM, 1992, FARADAY DISCUSS, V94, P329, DOI 10.1039/fd9929400329; Zhumaev U, 2013, ELECTROCHIM ACTA, V112, P853, DOI 10.1016/j.electacta.2013.02.105; Sato K, 2006, ELECTROCHEM COMMUN, V8, P725, DOI 10.1016/j.elecom.2006.03.001; BOURKANE S, 1993, ELECTROCHIM ACTA, V38, P1023, DOI 10.1016/0013-4686(93)87022-6; BOURKANE S, 1993, ELECTROCHIM ACTA, V38, P1827, DOI 10.1016/0013-4686(93)80304-I; DICKERTM.D, 1974, J ELECTROANAL CHEM, V55, P429, DOI 10.1016/S0022-0728(74)80437-7; HORKANS J, 1974, SURF SCI, V46, P1, DOI 10.1016/0039-6028(74)90238-6; KOLB DM, 1988, BER BUNSEN PHYS CHEM, V92, P1175; KOLB DM, 1971, SURF SCI, V28, P321, DOI 10.1016/0039-6028(71)90102-6; Kondo T, 2002, J ELECTROANAL CHEM, V532, P201, DOI 10.1016/S0022-0728(02)00705-2; Kondo T, 2009, ELECTROCHEM COMMUN, V11, P804, DOI 10.1016/j.elecom.2009.01.036; Kondo T, 2002, ELECTROCHIM ACTA, V47, P3075, DOI 10.1016/S0013-4686(02)00226-8; Melendres C.A., 1994, NATO ASI SERIES C, V432; Naohara H, 1999, J ELECTROANAL CHEM, V473, P2, DOI 10.1016/S0022-0728(99)00083-2; Scherb G, 1998, REV SCI INSTRUM, V69, P512, DOI 10.1063/1.1148723; Shibata M, 2012, J PHYS CHEM C, V116, P26464, DOI 10.1021/jp3101283; Takahasi M, 2000, SURF SCI, V461, P213, DOI 10.1016/S0039-6028(00)00583-5; Toney M.F., 1993, ELECTROCHEM SOC INTE, V2, P22; Tremiliosi-Filho G, 2005, J ELECTROANAL CHEM, V578, P1, DOI 10.1016/j.jelechem.2004.12.007; Uosaki K, 2011, J PHYS CHEM C, V115, P12471, DOI 10.1021/jp2010502; Uosaki K, 2002, THIN FILMS: PREPARATION, CHARACTERIZATION, APPLICATIONS, P17; Vericat C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075506; VITUS CM, 1994, J ELECTROCHEM SOC, V141, P1291, DOI 10.1149/1.2054912; WANG J, 1992, SCIENCE, V255, P1416, DOI 10.1126/science.255.5050.1416; Yagi I, 2005, J AM CHEM SOC, V127, P12743, DOI 10.1021/ja053724p; Ye S, 1999, LANGMUIR, V15, P807, DOI 10.1021/la980812x	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	JAN	2015	631				SI		96	104		10.1016/j.susc.2014.06.013		9	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AY0CR	WOS:000347266000015		
J	Onogi, A; Ideta, O; Inoshita, Y; Ebana, K; Yoshioka, T; Yamasaki, M; Iwata, H				Onogi, Akio; Ideta, Osamu; Inoshita, Yuto; Ebana, Kaworu; Yoshioka, Takuma; Yamasaki, Masanori; Iwata, Hiroyoshi			Exploring the areas of applicability of whole-genome prediction methods for Asian rice (Oryza sativa L.)	THEORETICAL AND APPLIED GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; QUANTITATIVE TRAITS; GENETIC VALUES; ENABLED PREDICTION; REGRESSION METHODS; BREEDING VALUES; ASSISTED PREDICTION; VARIABLE SELECTION; MOLECULAR MARKERS; BAYESIAN LASSO	Our simulation results clarify the areas of applicability of nine prediction methods and suggest the factors that affect their accuracy at predicting empirical traits. Whole-genome prediction is used to predict genetic value from genome-wide markers. The choice of method is important for successful prediction. We compared nine methods using empirical data for eight phenological and morphological traits of Asian rice cultivars (Oryza sativa L.) and data simulated from real marker genotype data. The methods were genomic BLUP (GBLUP), reproducing kernel Hilbert spaces regression (RKHS), Lasso, elastic net, random forest (RForest), Bayesian lasso (Blasso), extended Bayesian lasso (EBlasso), weighted Bayesian shrinkage regression (wBSR), and the average of all methods (Ave). The objectives were to evaluate the predictive ability of these methods in a cultivar population, to characterize them by exploring the area of applicability of each method using simulation, and to investigate the causes of their different accuracies for empirical traits. GBLUP was the most accurate for one trait, RKHS and Ave for two, and RForest for three traits. In the simulation, Blasso, EBlasso, and Ave showed stable performance across the simulated scenarios, whereas the other methods, except wBSR, had specific areas of applicability; wBSR performed poorly in most scenarios. For each method, the accuracy ranking for the empirical traits was largely consistent with that in one of the simulated scenarios, suggesting that the simulation conditions reflected the factors that affected the method accuracy for the empirical results. This study will be useful for genomic prediction not only in Asian rice, but also in populations from other crops with relatively small training sets and strong linkage disequilibrium structures.	[Onogi, Akio; Inoshita, Yuto; Iwata, Hiroyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Ideta, Osamu] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan; [Ebana, Kaworu] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki 3058602, Japan; [Yoshioka, Takuma; Yamasaki, Masanori] Kobe Univ, Grad Sch Agr Sci, Food Resources Educ & Res Ctr, Kasai, Hyogo 6752103, Japan	Iwata, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aiwata@mail.ecc.u-tokyo.ac.jp			FIRST Program of JSPS;  [26.10661]	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (26.10661), and also by the FIRST Program of JSPS. We would like to thank the technical staff at the National Agriculture and Food Research Organization Western Region Agricultural Research Center.	Mutshinda CM, 2010, GENETICS, V186, P1067, DOI 10.1534/genetics.110.119586; Zhao YS, 2012, THEOR APPL GENET, V124, P769, DOI 10.1007/s00122-011-1745-y; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Crossa J, 2013, G3-GENES GENOM GENET, V3, P1903, DOI 10.1534/g3.113.008227; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Perez-Rodriguez P, 2012, G3-GENES GENOM GENET, V2, P1595, DOI 10.1534/g3.112.003665; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Yao C, 2013, J DAIRY SCI, V96, P6716, DOI 10.3168/jds.2012-6237; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Wimmer V, 2013, GENETICS, V195, P573, DOI 10.1534/genetics.113.150078; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Li ZT, 2012, GENETICS, V190, P231, DOI 10.1534/genetics.111.134866; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Ober U, 2011, GENETICS, V188, P695, DOI 10.1534/genetics.111.128694; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; de los Campos G, 2010, GENET RES, V92, P295, DOI 10.1017/S0016672310000285; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Gonzalez-Camacho JM, 2012, THEOR APPL GENET, V125, P759, DOI 10.1007/s00122-012-1868-9; Yamasaki M, 2013, BREEDING SCI, V63, P49, DOI 10.1270/jsbbs.63.49; Nagasaki H, 2010, BREEDING SCI, V60, P648, DOI 10.1270/jsbbs.60.648; Donoho D, 2006, IEEE IJCNN, P1916; Hickey JM, 2012, G3-GENES GENOM GENET, V2, P425, DOI 10.1534/g3.111.001297; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Meuwissen THE, 2001, GENETICS, V157, P1819; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Friedman J, 2010, J STAT SOFTW, V33, P1; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Breiman L., 1984, CLASSIFICATION REGRE; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1; Endelman JB, 2014, CROP SCI, V54, P48, DOI 10.2135/cropsci2013.03.0154; Falconer D.S., 1981, INTRO QUANTITATIVE G; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gonzalez-Recio O, 2008, GENETICS, V178, P2305, DOI 10.1534/genetics.107.084293; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hastie T., 2009, ELEMENTS STAT LEARNI; Hayashi T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-34; Hayashi Takeshi, 2010, BMC Genet, V11, P3, DOI 10.1186/1471-2156-11-3; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Jiang R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S65; Kohavi R, 1995, P INT JOINT C ART IN, V14, P1137; Krogh A., 1995, ADV NEURAL INFORMATI, V7, P231; Long N, 2011, J ANIM BREED GENET, V128, P247, DOI 10.1111/j.1439-0388.2011.00917.x; Long NY, 2010, GENET RES, V92, P209, DOI 10.1017/S0016672310000157; Lund Mogens Sandø, 2009, BMC Proc, V3 Suppl 1, pS1; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Nadaf Javad, 2012, BMC Proc, V6 Suppl 2, pS6, DOI 10.1186/1753-6561-6-S2-S6; Ogutu Joseph O, 2011, BMC Proc, V5 Suppl 3, pS11, DOI 10.1186/1753-6561-5-S3-S11; Ogutu Joseph O, 2012, BMC Proc, V6 Suppl 2, pS10, DOI 10.1186/1753-6561-6-S2-S10; R Development Core Team, 2011, R LANG ENV STAT COMP; Riedelsheimer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-452; Solberg TR, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-29; Sun XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049157; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	74	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	JAN	2015	128	1					41	53		10.1007/s00122-014-2411-y		13	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	AX9XE	WOS:000347251700004		
J	Shimizu, M; Pu, ZJ; Kawanabe, T; Kitashiba, H; Matsumoto, S; Ebe, Y; Sano, M; Funaki, T; Fukai, E; Fujimoto, R; Okazaki, K				Shimizu, Motoki; Pu, Zi-jing; Kawanabe, Takahiro; Kitashiba, Hiroyasu; Matsumoto, Satoru; Ebe, Yusuke; Sano, Monari; Funaki, Taketo; Fukai, Eigo; Fujimoto, Ryo; Okazaki, Keiichi			Map-based cloning of a candidate gene conferring Fusarium yellows resistance in Brassica oleracea	THEORETICAL AND APPLIED GENETICS			English	Article							ARABIDOPSIS-THALIANA; CLUBROOT RESISTANCE; VEGETATIVE COMPATIBILITY; COMPARATIVE GENOMICS; WILT RESISTANCE; CHINESE-CABBAGE; OXYSPORUM; RAPA; MARKERS; CONGLUTINANS	We identified the candidate gene conferring yellow wilt resistance (YR) in B. oleracea . This work will facilitate YR breeding programs for B. oleracea and its closely related species. Yellow wilt disease is one of the most serious diseases of cabbage worldwide. Type A resistance to the disease is controlled by a single dominant gene that is used in cabbage breeding. Our previous QTL study identified the FocBo1 locus controlling type A resistance. In this study, the FocBo1 locus was fine-mapped by using 139 recombinant F-2 plants derived from resistant cabbage (AnjuP01) and susceptible broccoli (GCP04) DH lines. As a result, we successfully delimited the location of FocBo1 within 1.00 cM between markers, BoInd 2 and BoInd 11. Analysis of BAC and cosmid sequences corresponding to the FocBo1 locus identified an orthologous gene of Bra012688 that was recently identified as an candidate gene that confers yellows resistance in Chinese cabbage. The candidate gene-specific DNA markers and phenotypes in F-1 cabbage cultivars and their selfed F-2 populations showed a perfect correlation. Our identification of the candidate gene for FocBo1 will assist introduction of fusarium resistance into B. oleracea cultivars and contribute further understanding of interaction between Brassica plants and fusarium.	[Shimizu, Motoki; Pu, Zi-jing; Ebe, Yusuke; Sano, Monari; Funaki, Taketo; Fukai, Eigo; Okazaki, Keiichi] Niigata Univ, Fac Agr, Grad Sch Sci & Technol, Lab Plant Breeding,Nishi Ku, Niigata 9502181, Japan; [Kawanabe, Takahiro; Fujimoto, Ryo] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kitashiba, Hiroyasu] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Matsumoto, Satoru] Natl Inst Vegetable & Tea Sci, Tsu, Mie 5142392, Japan	Okazaki, K (reprint author), Niigata Univ, Fac Agr, Grad Sch Sci & Technol, Lab Plant Breeding,Nishi Ku, 2-8050 Ikarashi, Niigata 9502181, Japan.	okazaki@agr.niigata-u.ac.jp			JSPS for Young Scientists; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Adaptable and Seamless Technology Transfer Program through target-driven R&D from Japan Science and Technology Agency (JST)	The authors sincerely thank Dr. Y. Kadota at the National Agriculture and Food Research Organization/NARO Tohoku Agricultural Research Center, Japan, for kindly providing Cong: 1-1 strain of F. oxysporum f. sp. conglutinans. This work was supported in part by Research Fellowships of JSPS for Young Scientists for M. Shimizu, the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry, and the Adaptable and Seamless Technology Transfer Program through target-driven R&D from Japan Science and Technology Agency (JST) to K. Okazaki.	Anderson EM, 1933, J AGR RES, V47, P639; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Lv HH, 2013, MOL BREEDING, V32, P961, DOI 10.1007/s11032-013-9925-x; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Walker JC, 1930, J AGRIC RES, V41, P0001; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Suwabe K, 2006, GENETICS, V173, P309, DOI 10.1534/genetics.104.038968; Pu ZJ, 2012, MOL BREEDING, V30, P809, DOI 10.1007/s11032-011-9665-8; Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Simons G, 1998, PLANT CELL, V10, P1055; Cole SJ, 2013, NEW PHYTOL, V200, P172, DOI 10.1111/nph.12368; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; Shimizu M, 2014, PLANT MOL BIOL, V85, P247, DOI 10.1007/s11103-014-0182-0; Enya J, 2008, PHYTOPATHOLOGY, V98, P475, DOI 10.1094/PHYTO-98-4-0475; Diener AC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-171; Shen YP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003525; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Beckman CH, 1987, AM PHYTOPATHOLOGICAL; Blank LM, 1937, J AGR RES, V55, P407; BOSLAND PW, 1987, CAN J BOT, V65, P2067; BOSLAND PW, 1988, PLANT DIS, V72, P777, DOI 10.1094/PD-72-0777; Brown D. W., 2013, FUSARIUM GENOMICS MO; Dixon G.R., 2007, VEGETABLE BRASSICAS; Farnham MW, 2001, PLANT DIS, V85, P890, DOI 10.1094/PDIS.2001.85.8.890; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Huang CC, 1997, EUPHYTICA, V93, P145, DOI 10.1023/A:1002943805229; Iijima T, 1971, B TOKYO TO AGR EXPT, V5, P7; Kato T, 2012, BREEDING SCI, V62, P282, DOI 10.1270/jsbbs.62.282; Morrison RH, 1994, PLANT DIS, V78, P614; Nomura Y, 1976, J CENT AGR EXPT STN, V24, P141; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Peterson DG, 2000, J AGR GENOMICS, V5; PUHALLA JE, 1985, CAN J BOT, V63, P179; RAMIREZVILLUPADUA J, 1985, PLANT DIS, V69, P612; Saito M, 2006, THEOR APPL GENET, V114, P81, DOI 10.1007/s00122-006-0412-1; Ueno H, 2012, PLANT MOL BIOL, V80, P621, DOI 10.1007/s11103-012-9971-5; Walker JC, 1927, J AGRIC RES, V35, P0785; Walker JC, 1928, J AGRIC RES, V37, P0233; Walker JC, 1930, J AGRIC RES, V40, P0721; Walker JC, 1953, PLANT DIS VEGETABLE	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	JAN	2015	128	1					119	130		10.1007/s00122-014-2416-6		12	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	AX9XE	WOS:000347251700009		
J	Kono, N; Arai, H				Kono, Nozomu; Arai, Hiroyuki			Intracellular Transport of Fat-Soluble Vitamins A and E	TRAFFIC			English	Review						CRABP; CRALBP; CRBP; lipid transfer protein; vitamin; -TTP	TOCOPHEROL-TRANSFER PROTEIN; RETINOL-BINDING-PROTEIN; RETINITIS PUNCTATA ALBESCENS; RAT SMALL-INTESTINE; RRR-ALPHA-TOCOPHEROL; RETINALDEHYDE-BINDING; E-DEFICIENCY; VISUAL CYCLE; PIGMENT EPITHELIUM; GAMMA-TOCOPHEROL	Vitamins are compounds that are essential for the normal growth, reproduction and functioning of the human body. Of the 13 known vitamins, vitamins A, D, E and K are lipophilic compounds and are therefore called fat-soluble vitamins. Because of their lipophilicity, fat-soluble vitamins are solubilized and transported by intracellular carrier proteins to exert their actions and to be metabolized properly. Vitamin A and its derivatives, collectively called retinoids, are solubilized by intracellular retinoid-binding proteins such as cellular retinol-binding protein (CRBP), cellular retinoic acid-binding protein (CRABP) and cellular retinal-binding protein (CRALBP). These proteins act as chaperones that regulate the metabolism, signaling and transport of retinoids. CRALBP-mediated intracellular retinoid transport is essential for vision in human. -Tocopherol, the main form of vitamin E found in the body, is transported by -tocopherol transfer protein (-TTP) in hepatic cells. Defects of -TTP cause vitamin E deficiency and neurological disorders in humans. Recently, it has been shown that the interaction of -TTP with phosphoinositides plays a critical role in the intracellular transport of -tocopherol and is associated with familial vitamin E deficiency. In this review, we summarize the mechanisms and biological significance of the intracellular transport of vitamins A and E.	[Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Arai, Hiroyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Arai, H (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST); Japanese Ministry of Education, Culture, Sports, Science, and Technology [23227004]; Naito Foundation	The work from the authors' laboratory discussed in this review was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST) (to H. A.); grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (23227004 to H. A.); and the Naito Foundation Subsidy for Promotion of Specific Research Projects (to N. K.).	Yeum KJ, 2002, ANNU REV NUTR, V22, P483, DOI 10.1146/annurev.nutr.22.010402.102834; Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Parker RO, 2010, EXP EYE RES, V91, P788, DOI 10.1016/j.exer.2010.08.013; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Larnaout A, 1997, ACTA NEUROPATHOL, V93, P633; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Morimura H, 1999, INVEST OPHTH VIS SCI, V40, P1000; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Horiguchi M, 2003, GENES CELLS, V8, P789, DOI 10.1046/j.1365-2443.2003.00676.x; Senoo H, 2007, VITAM HORM, V75, P131, DOI 10.1016/S0083-6729(06)75006-3; BOYLAN JF, 1992, J BIOL CHEM, V267, P21486; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; TRABER MG, 1992, J LIPID RES, V33, P1171; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; RONNE H, 1983, J CELL BIOL, V96, P907, DOI 10.1083/jcb.96.3.907; Kumar S, 2011, CELL, V147, P1422, DOI 10.1016/j.cell.2011.11.034; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; Copp RP, 1999, BRAIN RES, V822, P80, DOI 10.1016/S0006-8993(99)01090-2; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Di Donato I, 2010, NEUROL SCI, V31, P511, DOI 10.1007/s10072-010-0261-1; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Traber MG, 2013, J LIPID RES, V54, P2295, DOI 10.1194/jlr.R032946; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; NEURINGER M, 1988, ANNU REV NUTR, V8, P517; Bardowell SA, 2012, J BIOL CHEM, V287, P26077, DOI 10.1074/jbc.M112.373597; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Swanson JE, 1999, J LIPID RES, V40, P665; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Leonard SW, 2002, AM J CLIN NUTR, V75, P555; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Ulatowski L, 2014, NEUROSCIENCE, V260, P120, DOI 10.1016/j.neuroscience.2013.12.001; LI E, 1991, J BIOL CHEM, V266, P3622; MEYDANI M, 1989, J NUTR, V119, P1252; Folli C, 2001, P NATL ACAD SCI USA, V98, P3710, DOI 10.1073/pnas.061455898; FAWCETT D, 1995, DEVELOPMENT, V121, P671; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Nakamura M, 2005, AM J OPHTHALMOL, V139, P1133, DOI 10.1016/j.ajo.2004.12.011; TRABER MG, 1990, J LIPID RES, V31, P675; Bonilha VL, 2004, EXP EYE RES, V79, P419, DOI 10.1016/j.exer.2004.04.001; Mustacich DJ, 2007, VITAM HORM, V76, P1, DOI 10.1016/S0083-6729(07)76001-6; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Mardones P, 2004, J NUTR BIOCHEM, V15, P252, DOI 10.1016/j.nutbio.2004.02.006; Cooper AD, 1997, J LIPID RES, V38, P2173; Shichiri M, 2010, J NUTR BIOCHEM, V21, P451, DOI 10.1016/j.jnutbio.2009.02.002; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; Piantedosi R, 2005, J BIOL CHEM, V280, P24286, DOI 10.1074/jbc.M503906200; Delva L, 1999, MOL CELL BIOL, V19, P7158; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; LAMPRON C, 1995, DEVELOPMENT, V121, P539; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; BLOMHOFF R, 1988, P NATL ACAD SCI USA, V85, P3455, DOI 10.1073/pnas.85.10.3455; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; BIERI JG, 1974, AM J CLIN NUTR, V27, P980; BLOMHOFF R, 1982, P NATL ACAD SCI-BIOL, V79, P7326, DOI 10.1073/pnas.79.23.7326; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Burstedt MSI, 1999, INVEST OPHTH VIS SCI, V40, P995; CATIGNANI GL, 1975, BIOCHEM BIOPH RES CO, V67, P66, DOI 10.1016/0006-291X(75)90283-1; CROW JA, 1985, P NATL ACAD SCI USA, V82, P4707, DOI 10.1073/pnas.82.14.4707; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253; Yesim F, 2004, AM J OPHTHALMOL, V138, P171; desBruijn DR, 1994, DIFFERENTIATION, V58, P141; desSaint-Jean M, 2011, J CELL BIOL, V195, P965; Eichers ER, 2002, AM J HUM GENET, V70, P955, DOI 10.1086/339688; ERIKSSON U, 1984, J BIOL CHEM, V259, P3464; FIORELLA PD, 1991, J BIOL CHEM, V266, P16572; FIORELLA PD, 1994, J BIOL CHEM, V269, P10538; Fishman GA, 2004, ARCH OPHTHALMOL-CHIC, V122, P70, DOI 10.1001/archopht.122.1.70; FUTTERMAN S, 1977, J BIOL CHEM, V252, P3267; Golovleva I, 2003, J BIOL CHEM, V278, P12397, DOI 10.1074/jbc.M207300200; Goodman DS, 1984, RETINOIDS, V2, P41; GORRY P, 1994, P NATL ACAD SCI USA, V91, P9032, DOI 10.1073/pnas.91.19.9032; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Hoshino M, 1999, ANN NEUROL, V45, P809, DOI 10.1002/1531-8249(199906)45:6<809::AID-ANA19>3.0.CO;2-9; Humbert G, 2006, INVEST OPHTH VIS SCI, V47, P4719, DOI 10.1167/iovs.05-1488; IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), 1982, EUR J BIOCHEM, V123, P473; KAKKAD BP, 1988, J BIOL CHEM, V263, P12916; KATO M, 1984, J CELL BIOL, V98, P1696, DOI 10.1083/jcb.98.5.1696; Katsanis N, 2001, CLIN GENET, V59, P424, DOI 10.1034/j.1399-0004.2001.590607.x; LEVIN MS, 1988, J BIOL CHEM, V263, P17715; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; MACDONALD PN, 1987, J BIOL CHEM, V262, P10550; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; Morley S, 2008, J BIOL CHEM, V283, P17797, DOI 10.1074/jbc.M800121200; Nawrot M, 2004, INVEST OPHTH VIS SCI, V45, P393, DOI 10.1167/iovs.03-0989; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Saari JC, 2009, MOL VIS, V15, P844; SAARI JC, 1994, BIOCHEMISTRY-US, V33, P3106, DOI 10.1021/bi00176a045; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1982, J BIOL CHEM, V257, P13329; Saari JC, 2005, EXP EYE RES, V81, P245, DOI 10.1016/j.exer.2005.06.015; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; SATO Y, 1993, J BIOL CHEM, V268, P17705; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; SCHAEFER WH, 1989, J BIOL CHEM, V264, P4212; Shichiri M, 2012, J BIOL CHEM, V287, P2926, DOI 10.1074/jbc.M111.321281; Shimohara T, 1998, ANN NEUROL, V43, P273, DOI 10.1002/ana.410430222; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; STUBBS GW, 1979, J BIOL CHEM, V254, P8529; TRABER MG, 1989, AM J CLIN NUTR, V49, P517; Usuki F, 2000, J NEUROL NEUROSUR PS, V69, P254, DOI 10.1136/jnnp.69.2.254; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wardlaw SA, 1997, BIOL REPROD, V56, P125, DOI 10.1095/biolreprod56.1.125; Yokota T, 1997, ANN NEUROL, V41, P826, DOI 10.1002/ana.410410621; ZETTERSTROM RH, 1994, NEUROSCIENCE, V62, P899, DOI 10.1016/0306-4522(94)90482-0; E XP, 2002, J BIOL CHEM, V277, P36617, DOI 10.1074/jbc.M205519200; Zhang WX, 2011, J MOL BIOL, V405, P972, DOI 10.1016/j.jmb.2010.11.028; Zhang WX, 2009, LIPIDS, V44, P631, DOI 10.1007/s11745-009-3310-x	150	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-9219	1600-0854		TRAFFIC	Traffic	JAN	2015	16	1					19	34		10.1111/tra.12231		16	Cell Biology	Cell Biology	AX1WF	WOS:000346733300002		
J	Akaishi, R; Yamada, T; Kawaguchi, S; Kojima, T; Koyama, T; Umazume, T; Morikawa, M; Cho, K; Minakami, H				Akaishi, R.; Yamada, T.; Kawaguchi, S.; Kojima, T.; Koyama, T.; Umazume, T.; Morikawa, M.; Cho, K.; Minakami, H.			Uptake of non-invasive prenatal testing by Japanese women	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Letter									[Akaishi, R.; Yamada, T.; Kawaguchi, S.; Kojima, T.; Koyama, T.; Umazume, T.; Morikawa, M.; Cho, K.; Minakami, H.] Hokkaido Univ, Dept Obstet, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan	Yamada, T (reprint author), Hokkaido Univ, Dept Obstet, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan.	taka0197@med.hokudai.ac.jp					Dugoff L, 2005, OBSTET GYNECOL, V106, P260, DOI 10.1097/01.AOG.0000172419.37410.eb; Nicolaides KH, 2004, AM J OBSTET GYNECOL, V191, P45, DOI 10.1016/j.ajog.2004.03.090; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Nicolaides KH, 2011, PRENATAL DIAG, V31, P7, DOI 10.1002/pd.2637; Sasaki A, 2011, PRENATAL DIAG, V31, P1007, DOI 10.1002/pd.2816	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	JAN	2015	45	1					113	114		10.1002/uog.14676		2	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	AX9PC	WOS:000347233300019		
J	Aweya, JJ; Sze, CW; Bayega, A; Mohd-Ismail, NK; Deng, L; Hotta, H; Tan, YJ				Aweya, Jude Juventus; Sze, Ching Wooen; Bayega, Anthony; Mohd-Ismail, Nur Khairiah; Deng, Lin; Hotta, Hak; Tan, Yee-Joo			NS5B induces up-regulation of the BH3-only protein, BIK, essential for the hepatitis C virus RNA replication and viral release	VIROLOGY			English	Article						Hepatitis C virus (HCV); BIK; NS5B	PROGRAMMED CELL-DEATH; BREAST-CANCER CELLS; INFLUENZA-A VIRUS; INDUCED APOPTOSIS; BCL-2; INFECTION; SYSTEM; EXPRESSION; BAX; IDENTIFICATION	Hepatitis C virus (HCV) induces cytopathic effects in the form of hepatocytes apoptosis thought to be resulted from the interaction between viral proteins and host factors. Using pathway specific PCR array, we identified 9 apoptosis-related genes that are dysregulated during HCV infection, of which the BH3- only pro-apoptotic Bcl-2 family protein, BIK, was consistently up-regulated at the mRNA and protein levels. Depletion of BIK protected host cells from HCV-induced caspase-3/7 activation but not the inhibitory effect of HCV on cell viability. Furthermore, viral RNA replication and release were significantly suppressed in BIK-depleted cells and over-expression of the RNA-dependent RNA polymerase, NS5B, was able to induce BIK expression. Immunofluorescence and co-immunoprecipitation assays showed co-localization and interaction of BIK and NS5B, suggesting that BIK may be interacting with the HCV replication complex through NS5B. These results imply that BIK is essential for HCV replication and that NS5B is able to induce BIK expression. (C) 2014 Elsevier Inc. All rights reserved.	[Aweya, Jude Juventus; Sze, Ching Wooen; Bayega, Anthony; Tan, Yee-Joo] Natl Univ Singapore, NUHS, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Bayega, Anthony; Mohd-Ismail, Nur Khairiah; Tan, Yee-Joo] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Deng, Lin; Hotta, Hak] Kobe Univ, Grad Sch Med, Div Microbiol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Tan, YJ (reprint author), Natl Univ Singapore, NUHS, Yong Loo Lin Sch Med, Dept Microbiol, MD4,Level 3,5 Sci Dr 2, Singapore 117597, Singapore.	yee_joo_tan@nuhs.edu.sg	ASTAR, IMCB/E-2320-2012		Ministry of Education (MOE) of Singapore [AcRF] [MOE2012-T2-1-152]	We are grateful to T. Wakita for the JFH-1 construct, C. M. Rice for the pFL-J6/JFH1 and Huh7.5 cells. This work was supported by grants from the Ministry of Education (MOE) of Singapore [AcRF Tier 2, Grant no. MOE2012-T2-1-152)].	Sklan EH, 2007, J VIROL, V81, P11096, DOI 10.1128/JVI.01249-07; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017; ALTER HJ, 1975, LANCET, V2, P838; Park JH, 2013, VIROLOGY, V439, P13, DOI 10.1016/j.virol.2013.01.014; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Urban C, 2008, CELL DEATH DIFFER, V15, P1396, DOI 10.1038/cdd.2008.61; Lan L, 2008, J IMMUNOL, V181, P4926; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Bostan N, 2010, CRIT REV MICROBIOL, V36, P91, DOI 10.3109/10408410903357455; Happo L, 2012, J CELL SCI, V125, P1081, DOI 10.1242/jcs.090514; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Bouillet P, 2002, J CELL SCI, V115, P1567; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Park J, 2012, HEPATOLOGY, V56, P831, DOI 10.1002/hep.25726; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; LIN C, 1994, J VIROL, V68, P5063; Mebratu YA, 2008, J CELL BIOL, V183, P429, DOI 10.1083/jcb.200801186; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Manna D, 2010, VIROLOGY, V398, P21, DOI 10.1016/j.virol.2009.11.034; Aweya JJ, 2013, VIRUS RES, V172, P24, DOI 10.1016/j.virusres.2012.12.005; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Li CY, 2008, MOL CANCER THER, V7, P1647, DOI 10.1158/1535-7163.MCT-07-2444; Aweya JJ, 2011, FRONT BIOSCI-LANDMRK, V16, P608, DOI 10.2741/3709; Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Drexler JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003438; EASL, 2011, J HEPATOL, P245; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Hardwick J. M., 2013, COLD SPRING HARBOR P, V5; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; Houghton M, 2009, LIVER INT, V29, P82, DOI 10.1111/j.1478-3231.2008.01925.x; Lim EJ, 2012, WORLD J GASTROENTERO, V18, P2172, DOI 10.3748/wjg.v18.i18.2172; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj/onc/1205340; Mohd-Ismail NK, 2009, J VIROL, V83, P9993, DOI 10.1128/JVI.00509-09; Ng OW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102415; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Simonin Y, 2009, HEPATOLOGY, V50, P1370, DOI 10.1002/hep.23169; Subramanian T, 2007, J VIROL, V81, P10486, DOI 10.1128/JVI.00808-07; Tan ZH, 2010, J MED VIROL, V82, P467, DOI 10.1002/jmv.21709; Viedma-Rodriguez R., 2013, INT J ONCOL; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; World Health Organization, 2013, HEP C	63	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	JAN 1	2015	474						41	51		10.1016/j.virol.2014.10.027		11	Virology	Virology	AX4GA	WOS:000346890400006		
J	Zharnikov, TV; Syresin, DE				Zharnikov, T. V.; Syresin, D. E.			Formulation of the Riccati equation for the impedance operator in cylindrical coordinates for inhomogeneous anisotropic waveguides with the example of rectilinear anisotropy	WAVE MOTION			English	Article						Anisotropic waveguides; Impedance; Riccati equation; Cylindrical waveguides; Inhomogeneous media	WEAK ELASTIC-ANISOTROPY; ARBITRARY CROSS-SECTION; TUBE-WAVE; MEDIA; PROPAGATION; DISPERSION; CYLINDERS; MATRIX; MODES	The analysis of cylindrical waveguides with arbitrary anisotropy and inhomogeneities is more difficult than for isotropic or cylindrically anisotropic. The reason for this difficulty is because the independent consideration of different Fourier components of the wavefield is no longer possible. Taking into account the coupling between different Fourier components of the wavefield implies that the impedance tensor should be treated as the operator. Treating the impedance this way is the key difference between the isotropic and the cylindrical anisotropy case in which the independent consideration of the partial impedance matrices for each circumferential number n is possible. The natural approach to computing the impedance operator is to use the Riccati equation, which is presented by the authors in cylindrical coordinates. The matrix representations of the impedance operator and the Riccati equation over the basis of the time-harmonic cylindrical waves result in the infinite set of ordinary differential equations. The nondiagonal partial impedance matrices, which describe the coupling of different Fourier components, become nonzero. For the problems, which possess a symmetry, the formulation can be simplified by projecting the Fourier basis on that of the irreducible representations of the symmetry group. The numerical solution of the Riccati equation and its application to finding the dispersion curves of the eigenmodes of the waveguide have peculiarities due to the fact that the matrix representation is infinite. The feasibility of the proposed approach is demonstrated by computing the dispersion curves for the first monopole and dipole normal modes of a cylindrical waveguide in a homogeneous media possessing tilted transverse isotropy type of anisotropy. (C) 2014 Elsevier B.V. All rights reserved.	[Zharnikov, T. V.] Schlumberger Moscow Res, Moscow 119285, Russia; [Syresin, D. E.] Schlumberger Kabushiki Kaisha, Sagamihara, Kanagawa 2520206, Japan	Zharnikov, TV (reprint author), Schlumberger Moscow Res, Pudovkina 13, Moscow 119285, Russia.	tzharnikov@slb.com					THOMSEN L, 1986, GEOPHYSICS, V51, P1954, DOI 10.1190/1.1442051; Damljanovic V, 2004, J ACOUST SOC AM, V115, P1572, DOI 10.1121/1.1687424; Treyssede F, 2013, J ACOUST SOC AM, V133, P3827, DOI 10.1121/1.4802651; Bartoli I, 2006, J SOUND VIB, V295, P685, DOI 10.1016/j.jsv.2006.01.021; Kuznetsov EB, 2008, COMP MATH MATH PHYS+, V48, P2162, DOI 10.1134/S0965542508120063; Adamou ATI, 2004, J ACOUST SOC AM, V116, P1524, DOI 10.1121/1.1777871; LOWE MJS, 1995, IEEE T ULTRASON FERR, V42, P525, DOI 10.1109/58.393096; SINHA BK, 1994, GEOPHYSICS, V59, P1037, DOI 10.1190/1.1443660; Norris AN, 2010, Q J MECH APPL MATH, V63, P401, DOI 10.1093/qjmam/hbq010; Auld B. A., 1990, ACOUSTIC FIELDS WAVE; BIRYUKOV SV, 1985, SOV PHYS ACOUST+, V31, P350; BIRYUKOV SV, 1980, SOV PHYS ACOUST+, V26, P272; Charara M., 2011, SEG EXP ABSTR, V30, P432; ELLEFSEN KJ, 1991, J GEOPHYS RES-SOLID, V96, P537, DOI 10.1029/90JB02013; GOHBERG I, 1993, CLASSES LINEAR OPERA, V2; Golubeva E.V., 1990, SOV APPL MECH, V26, P23; Johnson WL, 2003, J ACOUST SOC AM, V113, P1826, DOI 10.1121/1.1558372; Karpfinger F, 2012, GEOPHYSICS, V77, pD199, DOI [10.1190/geo2011-0398.1, 10.1190/GEO2011-0398.1]; Landau L.D., 1964, THEORETICAL PHYS, VIII; LANG SW, 1987, GEOPHYSICS, V52, P530, DOI 10.1190/1.1442322; Lidskii V.B., 1963, USSR COMP MATH MATH, V2, P171, DOI 10.1016/0041-5553(63)90282-9; Machevariani M.M., 1971, SOV PHYS ACOUST, V17, P97; MIRSKY I, 1965, J ACOUST SOC AM, V37, P1016, DOI 10.1121/1.1909508; Morse P.M., 2005, METHODS THEORETICAL; Norris AN, 1996, J GEOPHYS RES-SOL EA, V101, P15945, DOI 10.1029/96JB01303; Norris AN, 2013, J SOUND VIB, V332, P2520, DOI 10.1016/j.jsv.2012.12.016; NORRIS AN, 1993, GEOPHYSICS, V58, P1091, DOI 10.1190/1.1443493; Shuvalov AL, 2003, Q J MECH APPL MATH, V56, P327, DOI 10.1093/qjmam/56.3.327; Shuvalov AL, 2003, P ROY SOC A-MATH PHY, V459, P1611, DOI 10.1098/rspa.2002.1075; Syresin DE, 2012, J ACOUST SOC AM, V131, P4263, DOI 10.1121/1.4707485; TYUTEKIN VV, 1983, SOV PHYS ACOUST+, V29, P314; Van Loan C. F., 1996, MATRIX COMPUTATIONS; Zharnikov TV, 2013, J ACOUST SOC AM, V134, P1739, DOI 10.1121/1.4817839	33	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2125	1878-433X		WAVE MOTION	Wave Motion	JAN	2015	52						1	14		10.1016/j.wavemoti.2014.08.004		14	Acoustics; Mechanics; Physics, Multidisciplinary	Acoustics; Mechanics; Physics	AX6GS	WOS:000347021700001		
J	Kimoto, K; Ichikawa, Y				Kimoto, Kazushi; Ichikawa, Yasuaki			A finite difference method for elastic wave scattering by a planar crack with contacting faces	WAVE MOTION			English	Article						Finite difference time domain; Crack; Higher harmonics; Contact problem	BOUNDARY-ELEMENT METHOD; SOLID-SOLID CONTACT; HARMONIC-GENERATION; ACOUSTIC NONLINEARITY; ULTRASONIC WAVE; DOMAIN; INTERFACES; PROPAGATION; MEDIA; FIELD	This paper presents a finite difference time-domain technique for 2D problems of elastic wave scattering by cracks with interacting faces. The proposed technique introduces cracks into the finite difference model using a set of split computational nodes. The split-node pair is bound together when the crack is closed while the nodes move freely when open, thereby a unilateral contact condition is considered. The development of the open/close status is determined by solving the equation of motion so as to yield a non-negative crack opening displacement. To check validity of the proposed scheme, 1D and 2D scattering problems for which exact solutions are known are solved numerically. The 1D problem demonstrates accuracy and stability of the scheme in the presence of the crack-face interaction. The 2D problem, in which the crack-face interaction is not considered, shows that the proposed scheme can properly reproduce the stress singularity at the tip of the crack. Finally, scattered fields from cracks with interacting faces are investigated assuming a stick and a frictionless contact conditions. In particular, the directivity and higher-harmonics are investigated in conjunction with the pre-stress since those are the basic information required for a successful ultrasonic testing of closed cracks. (C) 2014 Elsevier B.V. All rights reserved.	[Kimoto, Kazushi; Ichikawa, Yasuaki] Okayama Univ, Grad Sch Environm & Life Sci, Dept Urban Environm Dev, Okayama 7000081, Japan	Kimoto, K (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Dept Urban Environm Dev, 3-1-1 Tsushimanaka, Okayama 7000081, Japan.	kimoto@cc.okayama-u.ac.jp					Achenbach J. D., 1982, RAY METHODS WAVES EL; Achenbach J.D., 1973, WAVE PROPAGATION ELA; Chaillat S, 2008, COMPUT METHOD APPL M, V197, P4233, DOI 10.1016/j.cma.2008.04.024; RICHARDSON JM, 1979, INT J ENG SCI, V17, P73, DOI 10.1016/0020-7225(79)90008-9; Cantrell JH, 2001, INT J FATIGUE, V23, pS487; VIRIEUX J, 1986, GEOPHYSICS, V51, P889, DOI 10.1190/1.1442147; Delrue S, 2012, ULTRASONICS, V52, P315, DOI 10.1016/j.ultras.2011.09.001; FELLINGER P, 1995, WAVE MOTION, V21, P47, DOI 10.1016/0165-2125(94)00040-C; Blanloeuil P, 2014, WAVE MOTION, V51, P425, DOI 10.1016/j.wavemoti.2013.10.002; HIROSE S, 1993, J ACOUST SOC AM, V93, P142, DOI 10.1121/1.405651; BUCK O, 1978, APPL PHYS LETT, V33, P371, DOI 10.1063/1.90399; Biwa S, 2004, J APPL MECH-T ASME, V71, P508, DOI 10.1115/1.1767169; Drinkwater BW, 1996, P ROY SOC A-MATH PHY, V452, P2613, DOI 10.1098/rspa.1996.0139; Dominguez N, 2005, WAVE MOTION, V42, P31, DOI 10.1016/j.wavemoti.2004.09.005; Fukui T., 1992, BOUNDARY ELEMENT MET, P82; HIROSE S, 1994, WAVE MOTION, V19, P37, DOI 10.1016/0165-2125(94)90011-6; Kawashima K, 2006, ULTRASONICS, V44, pE1329, DOI 10.1016/j.ultras.2006.05.011; Margetan F. J., 1992, Journal of Nondestructive Evaluation, V11, DOI 10.1007/BF00566403; Masserey B, 2005, J ACOUST SOC AM, V118, P3585, DOI 10.1121/1.2109407; MENDELSOHN DA, 1989, WAVE MOTION, V11, P1, DOI 10.1016/0165-2125(89)90009-7; Messner M, 2010, ENG ANAL BOUND ELEM, V34, P944, DOI 10.1016/j.enganabound.2010.06.007; Nagy P. B., 1992, Journal of Nondestructive Evaluation, V11, DOI 10.1007/BF00566404; Nam T, 2012, ULTRASONICS, V52, P778, DOI 10.1016/j.ultras.2012.02.008; Nishimura N., 2002, APPL MECH REV, V55, P299, DOI DOI 10.1115/1.1482087; Rizos B.C., 1998, COMPUT MECH, V12, P108; SCANDRETT CL, 1987, WAVE MOTION, V9, P171, DOI 10.1016/0165-2125(87)90051-5; Schanz M, 2010, CMES-COMP MODEL ENG, V58, P109; Siebrits E., 1995, T MODEL SIMUL, V10; Takahashi T., 2002, ENG ANAL BOUNDARY EL, V28, P165; Yazdi AK, 2011, ENG ANAL BOUND ELEM, V35, P1142, DOI 10.1016/j.enganabound.2011.05.003; Yu GY, 1998, COMMUN NUMER METH EN, V14, P1171, DOI 10.1002/(SICI)1099-0887(199812)14:12<1171::AID-CNM217>3.0.CO;2-G; Yun D, 2013, ULTRASONICS, V53, P1349, DOI 10.1016/j.ultras.2013.04.002; Zhang Ch., 2003, CMES-COMP MODEL ENG, V4, P109	33	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2125	1878-433X		WAVE MOTION	Wave Motion	JAN	2015	52						120	137		10.1016/j.wavemoti.2014.09.007		18	Acoustics; Mechanics; Physics, Multidisciplinary	Acoustics; Mechanics; Physics	AX6GS	WOS:000347021700010		
J	Umeharaa, T; Hori, Y				Umehara, Takashi; Hori, Yuichiro			New Frontiers of Epigenetics Researches in Pharmaceutical Sciences Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Umehara, Takashi] RIKEN Ctr Life Sci Technol CLST, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hori, Yuichiro] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Hori, Yuichiro] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Umehara, Takashi; Hori, Yuichiro] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Umeharaa, T (reprint author), RIKEN Ctr Life Sci Technol CLST, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	takashi.umehara@riken.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					1	2				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100001		
J	Ariyoshi, M; Otani, J; Shirakawa, M				Ariyoshi, Mariko; Otani, Junji; Shirakawa, Masahiro			Structure Basis of Versatile Base Recognition of MBD4	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						epigenetics; DNA methylation; crystal structure	CPG BINDING DOMAIN; METHYLATED DNA; DEMETHYLATION; SEQUENCE; PROMOTER; UHRF1	DNA methylation is one of the major epigenetic marks in the mammalian genome to define chromatin higher-order structure, and plays essential roles in various developmental processes. In the mammalian genome, DNA methylation mainly occurs at the 5th position of cytosine bases in a palindromic 5'-CG-3'dinucleotide sequence. Methyl CpG binding domain (MBD) proteins recognize symmetrically methylated CpG sites ((5m)CG/(5m)CG) through a conserved MBD, and recruit transcriptional repressors or chromatin modifiers. One of the MBD proteins, MBD4, uniquely contains a C-terminal glycosylation domain together with an N-terminal MBD, and functions as a mismatch DNA repair enzyme specific for T/G or U/G mismatch bases generated by spontaneous deamination of 5-methylcytosine. The base excision activity of MBD4 is also implicated in active DNA demethylation initiated by the conversion of 5-methylcytosine to thymine by deaminases. Unlike other MBD proteins, MBD4 recognizes not only (5m)CG/(5m)CG but also T/G mismatched sites generated by spontaneous deamination of 5-methylcytosine ((5m)CG/TG). In addition, our biochemical data demonstrate that MBD also binds to intermediates in DNA demethylation pathways, such as 5-hydroxymethyl-cytosine (C-hm), 5-carboxyl-cytosine and 5-hydroxy-uracil. The crystal structures of MBDMBD4 in complex with (5m)CG/TG, (5m)CG/(5m)CG or (5m)CG/(hm)CG provide new structural insights into the versatility of base recognition by MBD4. A DNA interface of MBD4 has flexible structural features, in which an extensive hydration water network supports the versatile base specificity of MBD4. The versatile base recognition by MBDMBD4 implies multi-functional roles of MBD4 in the regulation of dynamic DNA methylation patterns.	[Ariyoshi, Mariko] Kyoto Univ, Inst Integrated Cells Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Otani, Junji; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6068501, Japan	Ariyoshi, M (reprint author), Kyoto Univ, Inst Integrated Cells Mat Sci, Sakyo Ku, Kyoto 6068501, Japan.	ariyoshi.mariko.2x@kyoto-u.ac.jp					Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					3	9				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100002		
J	Tsuneoka, M; Tanaka, Y; Okamoto, K				Tsuneoka, Makoto; Tanaka, Yuji; Okamoto, Kengo			A CxxC Domain That Binds to Unmethylated CpG Is Required for KDM2A to Control rDNA Transcription	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						ribosomal RNA transcription; lysine-specific demethylase 2A; CxxC-zinc finger	RNA-POLYMERASE-I; MOLECULAR-MECHANISMS; HISTONE DEMETHYLASES; CONTAINING PROTEINS; CHROMATIN-STRUCTURE; ISLANDS; METHYLATION; INHERITANCE; STARVATION; INHIBITOR	Dysfunction of ribosome biogenesis is commonly found in cancers. Because the transcription of ribosomal RNA genes (rDNA) is a rate-limiting step in ribosome biogenesis and is elevated in many cancer cells, ribosomal RNA transcription can be a target for cancer therapy. In eukaryotes, ribosomal RNA is transcribed specifically in nucleoli by RNA polymerase I but not by RNA polymerase II. Therefore, ribosomal RNA transcription by RNA polymerase I would have a distinct nature compared to transcription by RNA polymerase II. Genomic DNA with proteins including histones constitutes chromatin. The structure of chromatin has plasticity and is regulated by chemical modifications of chromatin's components. We had reported that histone demethylase KDM2A reduced ribosomal RNA transcription in response to starvation. In this symposium, we reported our recent results showing the mechanism by which KDM2A was recruited to rDNA chromatin. We found that KDM2A bound to a rDNA promoter with unmethylated CpG dinucleotides via KDM2A CxxC-zinc finger motif. This binding was required for KDM2A to demethylate histone in the rDNA promoter and reduce rDNA transcription resulting from starvation. Further, this binding was detected before starvation, independent of the demethylase activity. We also found that the histone demethylation by KDM2A in response to starvation was detected only in the rDNA promoter, but not in a gene promoter transcribed by Pol II, the P2RX4 promoter. These results suggest that it is important to consider genome regions and cell conditions when developing epigenetic drugs.	[Tsuneoka, Makoto; Tanaka, Yuji; Okamoto, Kengo] Takasaki Univ Hlth & Welf, Fac Pharm, Dept Mol Pharmacol, Takasaki, Gunma 3700033, Japan	Tsuneoka, M (reprint author), Takasaki Univ Hlth & Welf, Fac Pharm, Dept Mol Pharmacol, 60 Nakaorui Machi, Takasaki, Gunma 3700033, Japan.	tsuneoka@takasaki-u.ac.jp					Alberts B., 2009, ESSENTIAL CELL BIOL; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Draptchinskaia N, 1999, NAT GENET, V21, P169; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Tanaka Y, 2014, CELL STRUCT FUNCT, V39, P79; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Blackledge NP, 2011, EPIGENETICS-US, V6, P147, DOI 10.4161/epi.6.2.13640; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Rose NR, 2012, J MED CHEM, V55, P6639, DOI 10.1021/jm300677j; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Suzuki T, 2013, J MED CHEM, V56, P7222, DOI 10.1021/jm400624b; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Kenmochi Naoya, 2013, Seikagaku, V85, P909; Olson MOJ, 2011, PROTEIN REV, V15, P1, DOI 10.1007/978-1-4614-0514-6; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Tanaka Yuji, 2013, Seikagaku, V85, P852; Tsuneoka M., 2012, CELL TECHNOLOGY, V31, P901; Urabe A., 2011, KYOUNO CHIRYOYAKU 20, P204; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					11	21				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100003		
J	Hori, Y; Baba, R; Kikuchi, K				Hori, Yuichiro; Baba, Reisuke; Kikuchi, Kazuya			Development of Fluorogenic Probes for the Detection of Histone Deacetylase Activity	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						fluorogenic probe; histone deacetylase; epigenetics		Fluorescence imaging using synthetic probes is becoming increasingly popular as a chemistry-based technique for the analysis of biomolecules. Real-time visual information on various biological molecules can be obtained by designing probes with high flexibility. The focus of our research is to design fluorogenic probes which are non-fluorescent in their initial intact form, but exhibit enhanced fluorescence intensity upon reactions with target biomolecules. The fluorescence switch of these probes allows the detection of the function and the localization of biomolecules with a high signal-tonoise ratio. Thus far, we have succeeded in designing and synthesizing fluorogenic probes that visualize molecules involved in epigenetics. Histone deacetylases (HDACs) play an important role in the epigenetic regulation of gene expression. A significant amount of epigenetic information can be obtained by the detection of enzyme activity. However, the existing methods require complicated multistep procedures. To overcome this limitation, we developed fluorogenic probes for the detection of HDAC activity in a one-step procedure. In this review, the details of the strategy for probe design and the detection method have been described.	[Hori, Yuichiro; Baba, Reisuke; Kikuchi, Kazuya] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Hori, Yuichiro; Kikuchi, Kazuya] Osaka Univ, Immunol Frontier Res Ctr IFReC, Suita, Osaka 5650871, Japan; [Hori, Yuichiro] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Hori, Y (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kkikuchi@mls.eng.osaka-u.ac.jp					Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Zeng L, 2009, GERIATR GERONTOL INT, V9, P7, DOI 10.1111/j.1447-0594.2008.00504.x; Baba R, 2012, J AM CHEM SOC, V134, P14310, DOI 10.1021/ja306045j; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Hong Y., 2009, CHEM COMMUN, V29, P4332; Koushik D., 2012, CHEM COMMUN, V48, P11534	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					23	29				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100004		
J	Takahashi, R; Unno, K				Takahashi, Ryoya; Unno, Keiko			Recent Advances in the Functionality of Foods: Aging and Stress	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article									[Takahashi, Ryoya] Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Funabashi, Chiba 2748510, Japan; [Unno, Keiko] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, Shizuoka 4228526, Japan	Takahashi, R (reprint author), Toho Univ, Fac Pharmaceut Sci, Dept Biochem, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	takahasi@phar.toho-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					31	32				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100005		
J	Takahashi, R; Odera, K				Takahashi, Ryoya; Odera, Keiko			An Overview of Current Research of the Effect of Foods on Aging and Stress	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						aging; phytochemical; resveratrol; curcumin; polyphenol	EXTENDS LIFE-SPAN; CALORIC RESTRICTION; TRANS-RESVERATROL; OXIDATIVE STRESS; DIETARY RESTRICTION; RED WINES; LONGEVITY; CURCUMIN; CANCER; MICE	The aging process is largely influenced by dietary factors. For example, caloric restriction can slow age-related functional deterioration and the onset or progression of age-related diseases, as well as prolong mean and maximum life span in laboratory animals. However, the dietary factors that affect the aging process comprise not only calories, but also various nutrients, such as proteins, carbohydrates, fats, and vitamins. Phytochemicals, which are found in plants, are non-nutritive, yet many phytochemicals are known to act as antioxidants and prevent diseases associated with free radical production. Furthermore, certain phytochemicals can help prevent or reduce the risk of cancer, inflammation, and cardiovascular disease by alteration of several signal transduction pathways in cells. Therefore, much focus is being placed on the effects of dietary phytochemicals on aging and stress response. This paper reviews recent advances in the study of two major dietary phytochemicals, resveratrol and curcumin, on aging and stress response.	[Takahashi, Ryoya; Odera, Keiko] Toho Univ, Dept Biochem, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan	Takahashi, R (reprint author), Toho Univ, Dept Biochem, Fac Pharmaceut Sci, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	takahasi@phar.toho-u.ac.jp					Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133; Lam YY, 2013, EXP GERONTOL, V48, P1018, DOI 10.1016/j.exger.2013.04.005; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Manosso LM, 2013, FOOD FUNCT, V4, P1776, DOI 10.1039/c3fo60246j; Wong RHX, 2011, NUTR METAB CARDIOVAS, V21, P851, DOI 10.1016/j.numecd.2010.03.003; Bommareddy A, 2013, ANTICANCER RES, V33, P4163; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Tollefsbol TO, 2014, CANCER TREAT RES, V159, P257, DOI 10.1007/978-3-642-38007-5_15; Agarwal B, 2011, ANN NY ACAD SCI, V1215, P138, DOI 10.1111/j.1749-6632.2010.05850.x; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Nour V, 2012, J CHROMATOGR SCI, V50, P920, DOI 10.1093/chromsci/bms091; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Spindler SR, 2013, REJUV RES, V16, P143, DOI 10.1089/rej.2012.1386; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015; Soh JW, 2013, EXP GERONTOL, V48, P229, DOI 10.1016/j.exger.2012.09.007; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Martelo-Vidal MJ, 2014, FOOD CHEM, V158, P28, DOI 10.1016/j.foodchem.2014.02.080; Walsh ME, 2014, FREE RADICAL BIO MED, V66, P88, DOI 10.1016/j.freeradbiomed.2013.05.037; Shen LR, 2013, BIOFACTORS, V39, P133, DOI 10.1002/biof.1086; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Mark L, 2005, J CHROMATOGR SCI, V43, P445; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kitani K, 2007, BIOGERONTOLOGY, V8, P567, DOI 10.1007/s10522-007-9100-z; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Sanchez-Roman I, 2013, EXP GERONTOL, V48, P1030, DOI 10.1016/j.exger.2013.02.021; McCay CM, 1935, J NUTR, V10, P63; Popat R, 2013, BRIT J HAEMATOL, V160, P714, DOI 10.1111/bjh.12154; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Caesar I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031424; Choi KM, 2013, BIOCHEM BIOPH RES CO, V441, P236, DOI 10.1016/j.bbrc.2013.10.049; Derry Molly M, 2013, Front Oncol, V3, P119, DOI 10.3389/fonc.2013.00119; Edwards JA, 2011, ANN NY ACAD SCI, V1215, P131, DOI 10.1111/j.1749-6632.2010.05855.x; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Kadota Y., KANKYO EISEIYAKUGAKU; Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h; Nagpal Monika, 2013, J Nat Sci Biol Med, V4, P3, DOI 10.4103/0976-9668.107253; Ribari S., 2012, OXID MED CELL LONGEV, V2012; Suckow Brianne K, 2006, Int J Biomed Sci, V2, P402	44	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					33	40				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100006		
J	Unno, K				Unno, Keiko			Prevention of Senescence and Stress by Food Composition	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						cognitive function; green tea catechin; beta-cryptoxanthin; oxidative damage; stress; theanine	BRAIN; MICE; TEA	The high prevalence of dementia in aged individuals suggests that aging is the most important risk factor and that senescence further enhances dementia. We have searched for dietary factors that prevent brain senescence using a mouse model of age-related neurodegeneration (SAMP10). This mouse line is suitable for studying brain senescence because brain atrophy and cognitive dysfunction are observed with aging, similar to humans. The production of reactive oxygen species and oxidative damage are high in the brains of aged SAMP10. We found that green tea catechin and beta-cryptoxanthin in Japanese mandarin oranges prevented brain atrophy and cognitive dysfunction. In addition, psychosocially chronically stressed mice exhibited a shortened life span and accelerated cognitive dysfunction. These deficiencies were prevented by the ingestion of theanine, an amino acid in tea, under stressed conditions. While a number of factors affect brain senescence, our results suggest that non-nutritive food components such as catechin, beta-cryptoxanthin and theanine may be useful for preventing brain senescence.	Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, Shizuoka 4228526, Japan	Unno, K (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	unno@u-shizuoka-ken.ac.jp					Takagaki A, 2010, J AGR FOOD CHEM, V58, P1313, DOI 10.1021/jf903375s; Unno K, 2004, EXP GERONTOL, V39, P1027, DOI 10.1016/j.exger.2004.03.033; Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x; Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y; Shimada A, 2011, AGING DIS, V2, P414; Unno K, 2013, EXP PHYSIOL, V98, P290, DOI 10.1113/expphysiol.2012.065532; Unno K, 2011, BIOL PHARM BULL, V34, P311, DOI 10.1248/bpb.34.311	7	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					41	46				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100007		
J	Murakami, A				Murakami, Akira			Mechanisms Underlying Physiological Functions of Food Factors via Non-specific Interactions with Biological Proteins	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						cancer prevention; zerumbone; heat shock protein; proteasome; autophagy; stress	TROPICAL GINGER SESQUITERPENE; ZINGIBER-ZERUMBET SMITH; SUBTROPICAL GINGER; INDUCED COLITIS; SULFATE; MICE; CHEMOPREVENTION; NEPHROTOXICITY; ACTIVATION; EXPRESSION	We previously reported that zerumbone, a sesquiterpene found in Zingiber zerumbet SMITH, showed notable cancer preventive effects in various organs of experimental rodents. This agent up-regulated nuclear factor-E2-related factor (Nrf2) -dependent expressions of anti-oxidative and xenobiotics-metabolizing enzymes, leading to an increased self-defense capacity. On the other hand, zerumbone markedly suppressed the expression of cyclooxygenase-2, an inducible pro-inflammatory enzyme, by disrupting mRNA stabilizing processes. Binding experiments using a biotin derivative of zerumbone demonstrated that Keap1, an Nrf2 repressive protein, is one of its major binding proteins that promotes their dissociation for inducing Nrf2 transactivation. We then generated a specific antibody against zerumbone-modified proteins and found that zerumbone modified numerous cellular proteins in a non-specific manner, with global distribution of the modified proteins seen not only in cytoplasm but also the nucleus. Based on those observations, zerumbone was speculated to cause proteo-stress, a notion supported by previous findings that it increased the C-terminus of Hsc70 interacting protein-dependent protein ubiquitination and also promoted aggresome formation. Interestingly, zerumbone counteracted proteo-stress and heat stress via up-regulation of the protein quality control systems (PQCs), e.g., heat shock proteins (HSPs), ubiquitin-proteasome, and autophagy. Meanwhile, several phytochemicals, including ursolic acid and curcumin, were identified as marked HSP70 inducers, whereas most nutrients tested were scarcely active. Recent studies have revealed that PQCs play important roles in the prevention of many lifestyle related diseases, such as cancer, thus non-specific binding of phytochemicals to cellular proteins may be a novel and unique mechanism underlying their physiological activities.	Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan	Murakami, A (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	cancer@kais.kyoto-u.ac.jp					Murakami A, 2004, INT J CANCER, V110, P481, DOI 10.1002/ijc.20175; Chen BY, 2011, MOL VIS, V17, P854; OZAKI Y, 1991, CHEM PHARM BULL, V39, P2353; Murakami A, 2002, CARCINOGENESIS, V23, P795, DOI 10.1093/carcin/23.5.795; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Inoue H, 2011, CELL STRESS CHAPERON, V16, P653, DOI 10.1007/s12192-011-0280-8; Hu R, 2010, ANTIOXID REDOX SIGN, V13, P1679, DOI 10.1089/ars.2010.3276; Kim M, 2009, INT J CANCER, V124, P264, DOI 10.1002/ijc.23923; Shin JW, 2011, CANCER PREV RES, V4, P860, DOI 10.1158/1940-6207.CAPR-10-0354; Tanaka T, 2001, LIFE SCI, V69, P1935, DOI 10.1016/S0024-3205(01)01277-2; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Inoue H, 2013, BIOSCI BIOTECH BIOCH, V77, P1223, DOI 10.1271/bbb.121003; Cheng Y, 2002, CHINESE MED J-PEKING, V115, P1777; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; HATAYAMA T, 1993, J BIOCHEM-TOKYO, V114, P592; LEE M, 1995, TOHOKU J EXP MED, V176, P191, DOI 10.1620/tjem.176.191; Murakami A, 2003, BIOCHEM PHARMACOL, V66, P1253, DOI 10.1016/S0006-2952(03)00446-5; Murakami A, 1999, BIOSCI BIOTECH BIOCH, V63, P1811, DOI 10.1271/bbb.63.1811; Nakamura Y, 2004, FEBS LETT, V572, P245, DOI 10.1016/j.febslet.2004.07.042; Ohnishi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1905, DOI 10.1271/bbb.90265; Ohnishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058641; Ohnishi K, 2013, BIOCHEM BIOPH RES CO, V430, P616, DOI 10.1016/j.bbrc.2012.11.104; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Tzeng TF, 2014, FOOD CHEM TOXICOL, V69, P132, DOI 10.1016/j.fct.2014.03.036; Tzeng TF, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-64; Wenhong D, 2012, MEDIAT INFLAMM, V2012	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					47	55				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100008		
J	Tsuduki, T				Tsuduki, Tsuyoshi			Influence of Japanese Food on Senility and Health Maintenance	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						fish oil; lifespan; Japanese food; metabolic syndrome; senescence	SENESCENCE-ACCELERATED MOUSE; POLYUNSATURATED FATTY-ACIDS; CAENORHABDITIS-ELEGANS; LIPID-PEROXIDATION; LOS-ANGELES; LIFE-SPAN; STRESS; OMEGA-3-FATTY-ACIDS; LONGEVITY; DISEASES	One of the factors that is believed to contribute to Japanese longevity is their dietary life, which is unique and distinct from Westerners. However, there has been no study that examined whether Japanese food in itself is effective for health maintenance. Therefore, we investigated in rats whether Japanese food is beneficial to health maintenance compared with American food. As a result, we revealed that modern Japanese food is useful for health maintenance compared with modern American food. We subsequently investigated the health benefits of Japanese food from different eras. The menus of Japanese foods from 4 different years, 2005, 1990, 1975 and 1960 were prepared, cooked, and powderized. Each of the Japanese foods was provided to mice. We found that the Japanese food from 1975 exhibited health benefits with respect to the stages of growth, adolescence, maturity and old age. Furthermore, we focused on fish oil, which is one of the beneficial ingredients of Japanese food, and investigated the effect of its long-term intake on lifespan in mice. Surprisingly, long-term intake of large amounts of fish oil shortened the lifespan of these mice. By contrast, intake of small amounts of fish oil with antioxidants extended the lifespan. Moreover, while intake of large amounts of fish oil also shortened the lifespan of Caenorhabditis elegans (C. elegans), intake of small amounts of fish oil extended the lifespan. Thus, it was suggested that even when foods have been reported to have health benefits, ingestion of large amounts of individual foods is undesirable for health maintenance.	Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Tsuduki, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amemiyamachi, Sendai, Miyagi 9818555, Japan.	tsudukit@m.tohoku.ac.jp					MEYDANI M, 1991, J NUTR, V121, P484; Yamori Y, 2001, ASIA PAC J CLIN NUTR, V10, P144, DOI 10.1046/j.1440-6047.2001.00227.x; Zhou KI, 2011, AGING-US, V3, P733; Honma T, 2013, J JPN SOC FOOD SCI, V60, P541; TAKEDA T, 1991, J AM GERIATR SOC, V39, P911; Umezawa M, 2000, J NUTR, V130, P221; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026; Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; MIYASHITA K, 1986, J AM OIL CHEM SOC, V63, P1380, DOI 10.1007/BF02679607; Pike MC, 2002, CANCER EPIDEM BIOMAR, V11, P795; Rebrin I, 2005, FREE RADICAL BIO MED, V39, P549, DOI 10.1016/j.freeradbiomed.2005.04.008; GARRIDO A, 1989, LIPIDS, V24, P833, DOI 10.1007/BF02544593; Lim K, 2009, MOL CANCER THER, V8, P3046, DOI 10.1158/1535-7163.MCT-09-0551; SHIMIZU H, 1991, BRIT J CANCER, V63, P963, DOI 10.1038/bjc.1991.210; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109; Hung MC, 2001, BRIT J NUTR, V86, P163, DOI 10.1079/BJN2001391; Kaasgaard S. G., 1992, LIPIDS, V27, P740; Kitano Y., 2014, Journal of Japanese Society of Nutrition and Food Science, V67, P73, DOI 10.4327/jsnfs.67.73; Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6; Michael R., 1977, MECH AGEING DEV, V6, P413; Ministry of Agriculture Forestry and Fisheries, 2011, FOOD SUPPL DEM TABL; Ministry of Health and Welfare, 1999, NAT NUTR SURV REP 19; Ministry of Health Labour and Welfare, 2011, PAT SURV; Ministry of Health Labour and Welfare Japan, 2012, ABR LIF TABL JAP 201; Mizushima S, 1997, J Cardiovasc Risk, V4, P191, DOI 10.1097/00043798-199706000-00006; Mori TA, 2001, CURR OPIN LIPIDOL, V12, P11, DOI 10.1097/00041433-200102000-00003; SHIMADA A, 1981, SOC SCI MED-MED GEOG, V15, P187, DOI 10.1016/0160-8002(81)90029-0; Sugawara S, 2013, J CLIN BIOCHEM NUTR, V52, P139, DOI 10.3164/jcbn.12-88; Tsuduki T., 2008, Journal of Japanese Society of Nutrition and Food Science, V61, P255; Tsuduki T., 2011, UTILIZATION MARINE B, P39; Ueshima H, 2003, J HUM HYPERTENS, V17, P631, DOI 10.1038/sj.jhh.1001606; U.S. Depaertment of Agriculture (USDA), RES USDAS 1996 CONT; WHO, 2001, WORLD HLTH REP 2001; World Health Organization, 2002, WORLD HLTH REP 2002; World Health Organization (WHO), 2003, WOLD HLTH REP 2003 S	38	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					57	65				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100009		
J	Sugiura, M				Sugiura, Minoru			beta-Cryptoxanthin and the Risk for Lifestyle-related Disease: Findings from Recent Nutritional Epidemiologic Studies	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						carotenoid; beta-cryptoxanthin; lifestyle-related disease; nutritional epidemiologic survey	SERUM CAROTENOID CONCENTRATIONS; BONE-MINERAL DENSITY; LUNG-CANCER RISK; METABOLIC SYNDROME; FEMALE SUBJECTS; VITAMIN-A; ANTIOXIDANT; JAPANESE; SMOKING; COHORT	Antioxidant micronutrients, such as vitamins and carotenoids, exist in abundance in fruits and vegetables and have been known to contribute to the body's defense against reactive oxygen species. Numerous recent epidemiologic studies have demonstrated that a high dietary consumption of fruit and vegetables rich in carotenoids or with high serum carotenoid concentrations results in lower risks of certain cancers, diabetes, and cardiovascular disease. These epidemiologic studies have suggested that antioxidant carotenoids may have a protective effect against several lifestyle-related diseases. beta-Cryptoxanthin is a carotenoid pigment found in Japanese mandarin (Citrus unshiu MARC.) fruit, which is mainly produced in Japan. Our nutritional epidemiologic survey, the Mikkabi Study, utilized data derived from health examinations of inhabitants performed in the town of Mikkabi in Shizuoka, Japan. In this survey, we measured serum beta-cryptoxanthin as a specific biomarker to estimate the consumption of Japanese mandarin fruit. From the cross-sectional analyses from the Mikkabi Study, we found inverse associations of serum beta-cryptoxanthin with the risks for atherosclerosis, insulin resistance, liver dysfunction, metabolic syndrome, low bone mineral density, and oxidative stress. In this review, recent epidemiologic studies about the associations between serum beta-cryptoxanthin with the risk for several lifestyle-related diseases were reviewed.	Natl Agr & Food Res Org NARO, NARO Inst Fruit Tree Sci NIFTS, Okitsu Citrus Res Stn, Shimizu Ku, Shizuoka 4240292, Japan	Sugiura, M (reprint author), Natl Agr & Food Res Org NARO, NARO Inst Fruit Tree Sci NIFTS, Okitsu Citrus Res Stn, Shimizu Ku, 485-6 Okitsunaka Cho, Shizuoka 4240292, Japan.	msugiura@affrc.go.jp					Sugiura M, 2004, J NUTR SCI VITAMINOL, V50, P196; Mannisto S, 2004, CANCER EPIDEM BIOMAR, V13, P40, DOI 10.1158/1055-9965.EPI-038-3; Yuan JM, 2003, CANCER EPIDEM BIOMAR, V12, P890; Sugiura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052643; Yuan JM, 2001, CANCER EPIDEM BIOMAR, V10, P767; Voorrips LE, 2000, CANCER EPIDEM BIOMAR, V9, P357; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Sugiura M, 2005, J EPIDEMIOL, V15, P180, DOI 10.2188/jea.15.180; Sugiura M, 2006, J EPIDEMIOL, V16, P71, DOI 10.2188/jea.16.71; Pattison DJ, 2005, AM J CLIN NUTR, V82, P451; Sugiura M, 2009, BRIT J NUTR, V102, P1211, DOI 10.1017/S0007114509382124; Sugiura M, 2008, OSTEOPOROSIS INT, V19, P211, DOI 10.1007/s00198-007-0457-2; Sugiura M, 2008, BRIT J NUTR, V100, P1297, DOI 10.1017/S0007114508978302; Cerhan JR, 2003, AM J EPIDEMIOL, V157, P345, DOI 10.1093/aje/kwf205; Michikawa T, 2009, ASIA PAC J CLIN NUTR, V18, P1; Suzuki K, 2011, CLIN NUTR, V30, P369, DOI 10.1016/j.clnu.2010.12.006; Sugiura M, 2011, OSTEOPOROSIS INT, V22, P143, DOI 10.1007/s00198-010-1239-9; Montonen J, 2004, DIABETES CARE, V27, P362, DOI 10.2337/diacare.27.2.362; De Waart FG, 2001, INT J EPIDEMIOL, V30, P136, DOI 10.1093/ije/30.1.136; Nakamura M, 2006, ATHEROSCLEROSIS, V184, P363, DOI 10.1016/j.atherosclerosis.2005.04.006; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; SCHMITZ HH, 1991, J NUTR, V121, P1613; Sugiura M, 2006, DIABETES RES CLIN PR, V71, P82, DOI 10.1016/j.diabres.2005.05.004	23	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					67	76				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100010		
J	Yasuhara, T; Ohi, H				Yasuhara, Tomohisa; Ohi, Hiroaki			Faculty-led Pharmaceutical Educational Reform-Reform from the View of Third-party Evaluation of Pharmaceutical Education	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article									[Yasuhara, Tomohisa] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan; [Ohi, Hiroaki] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan	Yasuhara, T (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	ohikomei@phar.toho-u.ac.jp					Yamada T., 2013, RITSUMEIKAN HIGHER E, V13, P91	1	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					77	78				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100011		
J	Hirata, K				Hirata, Kazumasa			Perspectives of Pharmaceutical Education-While Explaining the Related Evaluation Standards and Their Viewpoints of "Evaluation of Pharmaceutical Education Programs"	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						third-party evaluation; pharmaceutical education evaluation; evaluation standard; pharmaceuticaleducation model and core curriculum		In 2013, a program to be implemented by the Japan Accreditation Board for Pharmaceutical Education, Third-party Pharmaceutical Education Evaluation, was initiated. The purposes of this program are: 1) to ensure the quality of education programs; 2) to promote their improvement; and 3) to provide support to actively obtain public understanding and cooperation. In the next 7 years, all pharmaceutical departments and universities will undergo this third-party evaluation. The evaluation standards specify the necessity of establishing indices to evaluate goal achievement levels and to ensure appropriate evaluation based on standards in a number of very important domains of pharmaceutical education. They also emphasize that it is necessary to similarly evaluate overall learning achievement levels in undergraduate degree accreditation. On the other hand, the revision of pharmaceutical education models and core curricula was also proposed and considered in 2013, and preparations for the adoption of revised curricula are currently proceeding. The revised models and core curricula are mainly characterized by setting learning goals within a learning-achievement-based education approach, taking into consideration the 10 qualities to be achieved before graduating. In line with this, in order to nurture pharmacists who appropriately meet social needs by enhancing the quality of their education and training, it is crucial for universities to establish methods to appropriately evaluate learning goal achievement levels as a basis for the realization of these qualities. In this article, appropriate pharmaceutical education curricula, particularly evaluation methods, will be discussed from the above-mentioned perspectives, while explaining the related third-party evaluation standards and their viewpoints.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Hirata, K (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	hirata@phs.osaka-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					79	88				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100012		
J	Sugihara, T				Sugihara, Takumichi			Current and Ideal Stages of Pharmaceutical Education	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						active learning; group learning; faculty development		Education in university is commonly based on active learning by the students themselves. Lectures, exercises, and training are major learning strategies in a university. Self-study is one of the methods of active learning and is considered to be a major part of the classes when calculating the credits. When the six-year pharmaceutical education program was started, degree of attitude education was increased dramatically. New learning strategies considered to be suitable for attitude education, such as small group discussion (SOD), World Cafe, team-based learning (TBL), and problem-based learning (PBL) -Tutorials, were introduced in the classes, and the students were very much attracted by these methods. Not only the tactics but also the skills and abilities of teachers are greatly influenced by using such strategies to realize efficient education. Therefore, the most important point becomes faculty development. The degree of learning and the satisfaction of the students are not always mutually related. The evaluation of learning strategies has become difficult because of ambiguous criteria. Whereas an integrated educational program of drug therapies stimulates the motivation for learning of the students, a well-designed program may ruin the delight in learning of students.	Niigata Univ Pharm & Appl Life Sci NUPALS, Akiha Ku, Niigata 9568603, Japan	Sugihara, T (reprint author), Niigata Univ Pharm & Appl Life Sci NUPALS, Akiha Ku, Higashi Jima 265-1, Niigata 9568603, Japan.	taku@nupals.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					89	92				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100013		
J	Wada, K; Yoshimura, T				Wada, Keiji; Yoshimura, Teruki			Education Reform with the Support of the Faculty-Introduction of a Supplementary Education Program Including Teacher Support and Individual Guidance	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						education reform; support program; support section		To deal with declining levels of academic ability and motivation among students (a situation attributable to fewer high school graduates, a greater number of universities, and the diversification of entrance examination methods), one must comprehend the conditions of faculties collectively, and take appropriate measures. Using the results of examinations carried out in each grade as indices, we examined levels of academic ability and established various support programs based on the results. Basic chemistry, biology, and physics courses were designed to help first-year students acquire essential academic skills. For second, third, and fourth-year students, two types of support programs were implemented: supplementary instruction to help students improve their understanding of basic topics in pharmaceutical sciences, and an e-learning system to promote self-study, requiring minimal assistance from teachers. Although educational benefits were observed in many students, the number of learners whose understanding failed to improve as a result of the support programs continued to increase. Consequently, The Support Section for Pharmaceutical Education opened in October 2011 to address these concerns. The support section functions mainly to provide individual assistance to students who lack strong academic abilities, and provides teachers with information useful for educational reform. Here, we describe the educational support provided by our faculty and its effectiveness.	[Wada, Keiji; Yoshimura, Teruki] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, Tobetsu, Hokkaido 0610293, Japan	Wada, K (reprint author), Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, 1757 Kanazawa, Tobetsu, Hokkaido 0610293, Japan.	yosimura@hoku-iryo-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					93	97				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100014		
J	Yasuhara, T; Sone, T; Kohno, T; Ogita, K				Yasuhara, Tomohisa; Sone, Tomomichi; Kohno, Takeyuki; Ogita, Kiyokazu			Concept Extraction of Graduate Research by Modified Grounded Theory Approach and Creating of Rubric Oriented to Performance Evaluation	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						performance evaluation; rubric; authentic assessment; modified grounded theory approach	PEER EVALUATION	A revised core curriculum model for pharmaceutical education, developed on the basis of the principles of outcome-based education, will be introduced in 2015. Inevitably, appropriate assessments of students' academic achievements will be required. Although evaluations of the cognitive domain can be carried out by paper tests, evaluation methods for the attitude domain and problem-solving abilities need to be established. From the viewpoint of quality assurance for graduates, pharmaceutical education reforms have become vital to evaluation as well as learning strategies. To evaluate student academic achievements on problem-solving abilities, authentic assessment is required. Authentic assessment is the evaluation that mimics the context tried in work and life. Specifically, direct evaluation of performances, demonstration or the learners' own work with integrated variety knowledge and skills, is required. To clarify the process of graduate research, we obtained qualitative data through focus group interviews with six teachers and analyzed the data using the modified grounded theory approach. Based on the results, we clarify the performance students should show in graduate research and create a rubric for evaluation of performance in graduate research.	[Yasuhara, Tomohisa; Sone, Tomomichi; Kohno, Takeyuki; Ogita, Kiyokazu] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 5730101, Japan	Yasuhara, T (reprint author), Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	yasuhara@pharm.setsunan.ac.jp					Association of American Colleges and Universities, VAL VAL ASS LEARN UN; Hart D, 2012, AUTHENTIC ASSESSMENT, P53; Japan Accreditation Board for Pharmaceutical Education, YAK KYOUIK HYOUK HDB; Kinoshita Y, 2003, GROUNDED THEORY APPR; Kinoshita Y, 1999, GROUNDED THEORY APPR; Kurio W, 2014, YAKUGAKU ZASSHI, V134, P1199; Matsushita K., 2012, KYOTO U RES HIGHER E, V18, P75; Matsumoto K, 2007, LECT NOTES COMPUT SC, V4541, P1; Ministry of Education Culture Sports Science and Technology, AR MIR KIZ DAIG SHIT; Sennen Y., 2000, J POPUL PROBL, V56, P56; Suetake Y., 2012, J JSEE, V60, P56; Tanaka K, 2008, KYOUIKU HYOUKA, P71; Tanaka K, 2010, ATARASHII HYOUKA ARI, P1; The Pharmaceutical Society of Japan, KAIT YAK KYOUIK MOD; Tsuji T., 2013, MED EDUC, V44, P121; Yasuhara T, 2014, YAKUGAKU ZASSHI, V134, P185; Yasuhara T, 2012, YAKUGAKU ZASSHI, V132, P1179; Yoshida Y., 2012, JPN J HLTH CARE SCI, V38, P288	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					99	105				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100015		
J	Kawamura, K; Ohsawa, M				Kawamura, Kazumi; Ohsawa, Masahiro			Importance of the Pharmacist Education Program to Build the Effective Interprofessional Collaboration Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Kawamura, Kazumi] Ship Healthcare Pharm East Japan Co Ltd, Izumi Ku, Sendai, Miyagi 9813133, Japan; [Ohsawa, Masahiro] Nagoya City Univ, Dept Neuropharmacol, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Kawamura, K (reprint author), Ship Healthcare Pharm East Japan Co Ltd, Izumi Ku, 1-7-1 Izumi Chuo, Sendai, Miyagi 9813133, Japan.	ohsawa@phar.nagoya-cu.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					107	108				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100016		
J	Son, D; Kawamura, K; Nakashima, M; Utsumi, M				Son, Daisuke; Kawamura, Kazumi; Nakashima, Mitsuko; Utsumi, Miho			The Pharmacist-Physician Collaboration for IPW: From Physician's Perspective	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						interprofessional work; pharmacist-physician collaboration; competency; Canadian Interprofessional Health Collaborative (CIHC)	BLOOD-PRESSURE CONTROL; RANDOMIZED-CONTROLLED-TRIAL; DIABETES INITIATIVE PROGRAM; COMMUNITY PHARMACISTS; CARE; HYPERTENSION; COMANAGEMENT; INTERVENTION; MANAGEMENT; PATIENT	Interprofessional work (IPW) is increasingly important in various settings including primary care, in which the role of pharmacists is particularly important. Many studies have shown that in cases of hypertension, diabetes, dyslipidemia, and metabolic syndrome, physician-pharmacist collaboration can improve medication adherence and help to identify drug-related problems. Some surveys and qualitative studies revealed barriers and key factors for effective physician-pharmacist collaboration, including trustworthiness and role clarification. In Japan, some cases of good collaborative work between pharmacists and physicians in hospitals and primary care settings have been reported. Still, community pharmacists in particular have difficulties collaborating with primary care doctors because they have insufficient medical information about patients, they feel hesitant about contacting physicians, and they usually communicate by phone or fax rather than face to face. Essential competencies for good interprofessional collaboration have been proposed by the Canadian Interprofessional Health Collaborative (CIHC) : interprofessional communication; patient/client/family/community-centered care; role clarification; team functioning; collaborative leadership; and interprofessional conflict resolution. Our interprofessional education (IPE) team regularly offers educational programs to help health professionals learn interprofessional collaboration skills. We expect many pharmacists to learn those skills and actively to facilitate interprofessional collaboration.	[Son, Daisuke] Univ Tokyo, Grad Sch Med, Int Res Ctr Med Educ, Bunkyo Ku, Tokyo 1130033, Japan; [Kawamura, Kazumi] Ship Healthcare Pharm East Japan Co, Izumi Ku, Sendai, Miyagi 9813133, Japan; [Nakashima, Mitsuko] Southern TOHOKU Res Inst Neurosci, Chiyoda Ku, Tokyo 1020073, Japan; [Utsumi, Miho] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan	Son, D (reprint author), Univ Tokyo, Grad Sch Med, Int Res Ctr Med Educ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sondtky@gmail.com					Akai N, 2009, YAKUGAKU ZASSHI, V129, P1393; Albsoul-Younes AM, 2011, SAUDI MED J, V32, P288; Carter BL, 2008, J CLIN HYPERTENS, V10, P260, DOI 10.1111/j.1751-7176.2008.07434.x; Carter BL, 2009, ARCH INTERN MED, V169, P1996, DOI 10.1001/archinternmed.2009.358; Snyder ME, 2010, RES SOC ADMIN PHARM, V6, P307, DOI 10.1016/j.sapharm.2009.11.008; Hunt JS, 2008, J GEN INTERN MED, V23, P1966, DOI 10.1007/s11606-008-0791-x; Von Muenster SJ, 2008, PHARM WORLD SCI, V30, P128, DOI 10.1007/s11096-007-9155-6; Weber CA, 2010, ARCH INTERN MED, V170, P1634, DOI 10.1001/archinternmed.2010.349; DeMik DE, 2013, RES SOC ADMIN PHARM, V9, P719, DOI 10.1016/j.sapharm.2013.01.003; Carter BL, 2010, PHARMACOTHERAPY, V30, P228, DOI 10.1592/phco.30.3.228; Chen ZQ, 2013, J CLIN HYPERTENS, V15, P337, DOI 10.1111/jch.12077; McKinnon A, 2009, CAN FAM PHYSICIAN, V55, pE86; Tarn DM, 2009, J AM GERIATR SOC, V57, P462, DOI 10.1111/j.1532-5415.2008.02133.x; Liu Y, 2011, CONTRIB PLASM PHYS, V51, P51, DOI 10.1002/ctpp.201000011; Carter BL, 2010, CIRC-CARDIOVASC QUAL, V3, P418, DOI 10.1161/CIRCOUTCOMES.109.908038; Farland MZ, 2013, ANN PHARMACOTHER, V47, P781, DOI 10.1345/aph.1S079; Franklin BE, 2013, ANN PHARMACOTHER, V47, P1627, DOI 10.1177/1060028013506883; Hammad EA, 2011, J MANAGE CARE PHARM, V17, P295; Howard-Thompson A, 2013, ANN PHARMACOTHER, V47, P1471, DOI 10.1177/1060028013504738; Iioka T., 2012, NIHON NAIKA GAKKAI Z, V101, P1720; Kalisch Lisa M, 2010, Future Cardiol, V6, P255, DOI 10.2217/fca.09.67; Katsuno J., 2009, JPN J CANC CHEMOT S1, V36, P101; Kelly Deborah V, 2013, Can Pharm J (Ott), V146, P218, DOI 10.1177/1715163513492642; Kobayashi R., 2011, J JPN SOC HOSP PHARM, V47, P1301; Lalonde L, 2011, RES SOC ADMIN PHARM, V7, P233, DOI 10.1016/j.sapharm.2010.05.003; Liu YF, 2010, RES SOC ADMIN PHARM, V6, P324, DOI 10.1016/j.sapharm.2009.11.002; Orchard C., 2010, NATL INTERPROFESSION; Rieck Allison, 2013, Qual Prim Care, V21, P105; Ried LD, 2010, J AM PHARM ASSOC, V50, P111, DOI 10.1331/JAPhA.2010.10506; Stead K, 2009, MED J AUSTRALIA, V190, pS128; Strickland Jennifer M, 2007, J Opioid Manag, V3, P295; Tanaka M., 2010, NINGEN DOCK, V25, P100; Tarn Derjung M, 2012, Int J Pharm Pract, V20, P285, DOI 10.1111/j.2042-7174.2012.00202.x; Tobari Hiroko, 2011, Nihon Eiseigaku Zasshi, V66, P608; Tobari H, 2010, AM J HYPERTENS, V23, P1144, DOI 10.1038/ajh.2010.127; Ueno Y., 2012, J JPN SOC HOSP PHARM, V48, P1195; Villeneuve J, 2009, J CONTIN EDUC HEALTH, V29, P201, DOI 10.1002/chp.20038; World Health Organization, 1988, REP WHO STUD GROUP M	38	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					109	115				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100017		
J	Nakashima, M; Son, D; Kawamura, K; Utsumi, M				Nakashima, Mitsuko; Son, Daisuke; Kawamura, Kazumi; Utsumi, Miho			The Pharmacist-Nurse Collaboration for IPW: From Nurse's Perspective	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						interprofessional work; turnover; job satisfaction; lack of understanding		The concept of interprofessional work (IPW) is becoming increasingly important recently and the role of nurses in IPW seems critical. In Japan, the problem of burnout and turnover of nurses has been recognized, and the solution seems embedded in the scheme of IPW, because it appears to improve their job satisfaction and recognition as health professionals. However, many obstacles lie ahead, such as "tribal conflict" between health professionals including between pharmacists and nurses. Although failure to understand the roles of other professionals or competencies may seem to hamper with the promotion of collaboration, we must realize that even a lack of understanding among nurses exists. The authors believe that the solution is to understand and respect not only other professionals but also colleagues of the same profession.	[Nakashima, Mitsuko] Southern TOHOKU Res Inst Neurosci, Chiyoda Ku, Tokyo 1020073, Japan; [Son, Daisuke] Univ Tokyo, Int Res Ctr Med Educ, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kawamura, Kazumi] Ship Healthcare Pharm East Japan Co Ltd, Izumi Ku, Sendai, Miyagi 9813133, Japan; [Utsumi, Miho] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan	Nakashima, M (reprint author), Southern TOHOKU Res Inst Neurosci, Chiyoda Ku, 4-3-26 Kudan Kita, Tokyo 1020073, Japan.	m-shima@wa2.so-net.ne.jp					Adams J. S., INEQUITY SOCIAL EXCH; VanEerde W, 1996, J APPL PSYCHOL, V81, P575, DOI 10.1037/0021-9010.81.5.575; Araki A., 2014, KANGO BUCHO TSUSHIN, V11, P9; Hara S., 2010, J KYUSHU U HLTH WELF, V11, P135; Hinshaw S. A., 1987, J NURS ADMIN, V17, P4; Japan Medical Association, ISH KENK SHEIN WO ME; Japanese Nursing Association, STAT DAT NURS SERV J; Nagai Y., 2006, NIIGATA J HLTH WELFA, V6, P126; Nakashima M., 2013, KANGO BUCHO TSUSHIN, V11, P2; Nakashima M., 2013, JAPANESE J NURSING S, V38, P1052; Nakashima M., 2008, J JAPAN SOC HEALTHCA, V45, P200; Nakashima M., 2013, NURSING BUSINESS, V7, P794; Paku H., 2011, J INTERPROF CARE, V3, P60; Saitama Prefectural University, 2009, IPW WO MAN, P12; Sano Itsuki, 2014, Seishin Shinkeigaku Zasshi, V116, P269; Stead K, 2009, MED J AUSTRALIA, V190, pS128; Syomura M., 2012, TOKAI U SCH HLTH SCI, V17, P73; Takenobu M., 2014, DIGEST SCI LABOUR, V69, P68; Tsuruta J., 2012, J JAPANESE ASS DENTA, V28, P94	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					117	121				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100018		
J	Kawamura, K; Son, D; Nakashima, M; Utsumi, M				Kawamura, Kazumi; Son, Daisuke; Nakashima, Mitsuko; Utsumi, Miho			Elucidating Obstructive Factors for IPW from the Pharmacist Position in Clinical Practice	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						interprofessional work; pharmacist collaboration; interprofessional education		In Japan, many health professionals do not seem to have adequate understandings of the competencies and specialties of other professionals. The competencies of pharmacists are especially overlooked because their expected roles have been changing rapidly in recent years and may vary depending on context in various settings. Due to this lack of understanding physicians themselves often perform therapeutic drug monitoring (TDM), and pharmacists sometimes suggest unnecessary prescription proposals to physicians without considering their treatment plans. Although "community and hospital pharmacist collaboration" has been emphasized for many years, many pharmacists in both settings still do not understand one another's situation. How can we make pharmacists' competencies appropriately understood and respected by other health professionals? What should we do to promote interprofessional work (IPW) with more incorporation of pharmacists so as to pursue patient/client/family-centered care? The key to success in IPW seems to lie in the answers to these questions.	[Kawamura, Kazumi] Ship Healthcare Pharm East Japan Co Ltd, Izumi Ku, Sendai, Miyagi 9813133, Japan; [Son, Daisuke] Univ Tokyo, Grad Sch Med, Int Res Ctr Med Educ, Bunkyo Ku, Tokyo 1130033, Japan; [Nakashima, Mitsuko] Southern TOHOKU Res Inst Neurosci, Chiyoda Ku, Tokyo 1020073, Japan; [Utsumi, Miho] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan	Kawamura, K (reprint author), Ship Healthcare Pharm East Japan Co Ltd, Izumi Ku, 1-7-1 Izumi Chuo, Sendai, Miyagi 9813133, Japan.	k.kawamura@shpe.co.jp					[Anonymous], 1987, IYAK HANB HDB, P3; Iioka T., 2012, NIHON NAIKA GAKKAI Z, V101, P1720; Japan Pharmaceutical Association, 2013, ASTHM PREV MAN GUID, P25; Keller JM, 2010, MOTIVATIONAL DESIGN FOR LEARNING AND PERFORMANCE: THE ARCS MODEL APPROACH, P1, DOI 10.1007/978-1-4419-1250-3; Ministry of Internal Affairs and Communications, 2001, IYAK KANS GYOUS KANS; Nagao T., 1997, J JAPANESE SOC MED H, V43, P92; Nakamura H., 2013, J HLTH CARE SOC, V22, P329; Ohishi M., 2014, BYOIN ANZEN KYOIKU, V1, P22; Orchard C., 2010, NATL INTERPRAFESSION; Post S. G., 2006, ENCY BIOETHICS, P2101; Shimizu T., 1949, NIHON YAKUGAKUSHI, P406	11	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					123	129				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100019		
J	Utsumi, M; Son, D; Kawamura, K; Nakashima, M				Utsumi, Miho; Son, Daisuke; Kawamura, Kazumi; Nakashima, Mitsuko			Trial of Interprofessional Education for Effective IPW	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						interprofessional education (IPE); interprofessional work (IPW); competency; instructional design (ID)		To work collaboratively in healthcare practice, health professionals should learn not only the competencies of their own specialties but also those of other professions so as to promote effective interprofessional work (IPW), thus optimizing patient/client outcomes. For this reason interprofessional education (IPE) is urgently needed. Since the establishment of Centre for the Advancement of Interprofessional Education (CAIPE) in 1987, many IPE programs have been developed and implemented worldwide. Currently, our Japan Society for Instructional Systems in Healthcare (JSISH) IPE program project team is conducting a study to develop an effective and versatile IPE program according to the framework of instructional design (ID). The main categories of learning goals of our program are intellectual skills and attitudes among Gagne's five categories. Therefore we designed our program to start from the drama (skit or video) of a bad example of IPW for learners to see and discuss the barriers of interprofessional collaboration. The drama of IPW seems to enhance attention and relevance for learners; both of which are components of the ARCS model. We expect every health professional including pharmacists to learn about IPW competencies through participating in our IPE program, enabling us further to pursue the ideal patient/client/family-centered care together.	[Utsumi, Miho] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan; [Son, Daisuke] Univ Tokyo, Grad Sch Med, Int Res Ctr Med Educ, Bunkyo Ku, Tokyo 1130033, Japan; [Kawamura, Kazumi] Ship Healthcare Pharm East Japan Co Ltd, Izumi Ku, Sendai, Miyagi 9813133, Japan; [Nakashima, Mitsuko] Southern TOHOKU Res Inst Neurosci, Chiyoda Ku, Tokyo 1020073, Japan	Utsumi, M (reprint author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	miho@pharm.kobegakuin.ac.jp					Ertmer P. A., 1993, PERFORMANCE IMPROVEM, V6, P50, DOI DOI 10.1111/J.1937-8327.1993.TB00605.X; Fukushima O., 2012, NIHON IKA DAIGAKU IG, V8, P255; Hopkins D, 2010, FRAMEWORK ACTION INT; Inagaki T., 2013, JYUGYOUSEKKEI MANUAL; Keller JM, 2010, MOTIVATIONAL DESIGN FOR LEARNING AND PERFORMANCE: THE ARCS MODEL APPROACH, P1, DOI 10.1007/978-1-4419-1250-3; Orchard C., 2010, NATL INTERPROFESSION; Stead K, 2009, MED J AUSTRALIA, V190, pS128	7	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					131	135				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100020		
J	Yamada, S				Yamada, Shizuo			Integration of Pharmacokinetics and Pharmacodynamics Based on the in Vivo Analysis of Drug-receptor Binding	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						drug-receptor binding; pharmacokinetics; pharmacodynamics; positron emission tomography; overactive bladder; anicholinergics	TREAT OVERACTIVE BLADDER; CENTRAL-NERVOUS-SYSTEM; POSITRON-EMISSION-TOMOGRAPHY; URINARY-BLADDER; ANTIMUSCARINIC AGENTS; IMIDAFENACIN KRP-197/ONO-8025; ANTICHOLINERGIC DRUGS; MUSCARINIC RECEPTORS; PLASMA-CONCENTRATION; SALIVARY-GLAND	As I was deeply interested in the effects of drugs on the human body, I chose pharmacology as the subject of special study when I became a 4th year student at Shizuoka College of Pharmacy. I studied abroad as a postdoctoral fellow for two years, from 1978, under the tutelage of Professor Henry I. Yamamura (pharmacology) in the College of Medicine at the University of Arizona, USA. He taught me a variety of valuable skills such as the radioreceptor binding assay, which represented the most advanced technology developed in the US at that time. After returning home, I engaged in clarifying receptor abnormalities in pathological conditions, as well as in drug action mechanisms, by making the best use of this radioreceptor binding assay. In 1989, following the founding of the University of Shizuoka, I was invited by Professor Ryohei Kimura to join the Department of Pharmacokinetics. This switch in discipline provided a good opportunity for me to broaden my perspectives in pharmaceutical sciences. I worked on evaluating drug-receptor binding in vivo as a combined index for pharmacokinetics and pharmacological effect manifestation, with the aim of bridging pharmacology and pharmacokinetics. In fact, by focusing on data from in vivo receptor binding, it became possible to clearly rationalize the important consideration of drug dose-concentration-action relationships, and to study quantitative and kinetic analyses of relationships among pharmacokinetics, receptor binding and pharmacological effects. Based on this concept, I was able to demonstrate the utility of dynamic analyses of drug-receptor binding in drug discovery, drug fostering, and the proper use of pharmacokinetics with regard to many drugs.	Univ Shizuoka, Grad Sch Pharmaceut Sci, CPFR, Suruga Ku, Shizuoka 4228526, Japan	Yamada, S (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, CPFR, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	yamada@u-shizuoka-ken.ac.jp					Henriksen G, 2008, BRAIN, V131, P1171, DOI 10.1093/brain/awm255; Borg J, 2008, BEHAV BRAIN RES, V195, P103, DOI 10.1016/j.bbr.2008.06.011; Oki T, 2006, J PHARMACOL EXP THER, V316, P1137, DOI 10.1124/jpet.105.094508; Ikeda K, 2002, N-S ARCH PHARMACOL, V366, P97, DOI 10.1007/s00210-002-0554-x; HUGHES KM, 1992, XENOBIOTICA, V22, P859; Talbot PS, 2002, EUR NEUROPSYCHOPHARM, V12, P503, DOI 10.1016/S0924-977X(02)00099-8; Ohtake A, 2004, EUR J PHARMACOL, V492, P243, DOI 10.1016/j.ejphar.2004.03.044; Horti AG, 2008, CURR PHARM DESIGN, V14, P3363, DOI 10.2174/138161208786549380; Davila GW, 2001, J UROLOGY, V166, P140, DOI 10.1016/S0022-5347(05)66095-8; Yamada S, 2011, J PHARMACOL EXP THER, V336, P365, DOI 10.1124/jpet.110.172288; Ancelin ML, 2006, BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Andersson KE, 2004, LANCET NEUROL, V3, P46, DOI 10.1016/S1474-4422(03)00622-7; Merchenthaler I, 2004, J COMP NEUROL, V473, P270, DOI 10.1002/cne.20128; Ito Y, 2009, BRIT J PHARMACOL, V156, P1147, DOI 10.1111/j.1476-5381.2009.00113.x; Yoshida A, 2010, J PHARMACOL SCI, V112, P142, DOI 10.1254/jphs.09R14FM; Kay G, 2006, EUR UROL, V50, P317, DOI 10.1016/j.eururo.2006.03.057; Doorduin J, 2008, CURR PHARM DESIGN, V14, P3297, DOI 10.2174/138161208786549443; Bohnen NI, 2007, MOL IMAGING BIOL, V9, P243, DOI 10.1007/s11307-007-0083-6; Kobayashi F, 2007, ARZNEIMITTEL-FORSCH, V57, P147; Heiss WD, 2006, J NUCL MED, V47, P302; Levashova Z, 2009, BIOCONJUGATE CHEM, V20, P742, DOI 10.1021/bc800443w; Scheife R, 2005, CLIN THER, V27, P144, DOI 10.1016/j.clinthera.2005.02.014; BEAUCHAMP HT, 1995, J PHARMACOL EXP THER, V272, P612; HARUNO A, 1989, FOLIA PHARMACOL JPN, V94, P145, DOI 10.1254/fpj.94.145; Homma Y, 2008, INT J UROL, V15, P986, DOI 10.1111/j.1442-2042.2008.02152.x; Homma Y, 2009, INT J UROL, V16, P499, DOI 10.1111/j.1442-2042.2009.02286.x; Kay GG, 2005, CLIN THER, V27, P127, DOI 10.1016/j.clinthera.2005.01.006; Knol RJJ, 2009, SYNAPSE, V63, P557, DOI 10.1002/syn.20629; Kobayashi F, 2007, ARZNEIMITTEL-FORSCH, V57, P92; Maruyama S, 2008, N-S ARCH PHARMACOL, V377, P463, DOI 10.1007/s00210-007-0207-1; Maruyama S, 2006, J UROLOGY, V175, P365, DOI 10.1016/S0022-5347(05)00017-0; Maruyama S, 2008, J PHARMACOL EXP THER, V325, P774, DOI 10.1124/jpet.108.136390; Masuda Y, 2007, BIOMED CHROMATOGR, V21, P940, DOI 10.1002/bmc.837; Miller TR, 2009, BRIT J PHARMACOL, V157, P139, DOI 10.1111/j.1476-5381.2009.00239.x; Nilvebrant L, 1997, EUR J PHARMACOL, V327, P195, DOI 10.1016/S0014-2999(97)89661-6; Nozawa Y, 1998, PHARMACEUT RES, V15, P911, DOI 10.1023/A:1011932800729; Ogawa M, 2009, BIOL PHARM BULL, V32, P337; Ohkura T, 1998, LIFE SCI, V63, P2147, DOI 10.1016/S0024-3205(98)00495-0; Oki T, 2005, BRIT J PHARMACOL, V145, P219, DOI 10.1038/sj.bjp.0706184; Oki T, 2006, EUR J PHARMACOL, V529, P157, DOI 10.1016/j.ejphar.2005.11.004; Ongali Brice, 2006, J Neurotrauma, V23, P696, DOI 10.1089/neu.2006.23.696; Pahlman I, 2001, ARZNEIMITTEL-FORSCH, V51, P125; RIOTTE J, 1987, ARZNEIMITTEL-FORSCH, V37, P300; Skeijanec A., 2006, CLIN PHARMACOKINET, V45, P325; Uchida S, 1997, LIFE SCI, V61, P2083, DOI 10.1016/S0024-3205(97)00881-3; Uchida S, 2007, LIFE SCI, V80, P2454, DOI 10.1016/j.lfs.2007.04.002; Urayama A., 2008, MOL PHARMACOKINETICS, P270; Urayama A, 2001, LIFE SCI, V70, P647, DOI 10.1016/S0024-3205(01)01445-X; Venneri A, 2007, MAGN RESON IMAGING, V25, P953, DOI 10.1016/j.mri.2007.02.004; Wada Y, 1995, ARCH INT PHARMACOD T, V330, P76; Yamada S, 2002, LIFE SCI, V70, P1999, DOI 10.1016/S0024-3205(01)01541-7; YAMADA S, 1985, MOL PHARMACOL, V28, P120; Yamada S, 2009, EUR UROL, V55, P482, DOI 10.1016/j.eururo.2008.03.015; Yamada S, 2006, LIFE SCI, V80, P127, DOI 10.1016/j.lfs.2006.08.028; Yamada S, 1999, J PHARMACOL EXP THER, V289, P1575; YAMADA S, 1980, J PHARMACOL EXP THER, V215, P176; Yamada S, 2001, J PHARMACOL EXP THER, V296, P160; Yamada Shizuo, 2009, Folia Pharmacologica Japonica, V134, P276; Yamada S., 1995, FARUMASHIA, V31, P1381; Yamamoto S, 2011, NEUROIMAGE, V58, P1, DOI 10.1016/j.neuroimage.2011.06.031; YAMAMURA HI, 1974, BRAIN RES, V80, P170, DOI 10.1016/0006-8993(74)90738-0; Yamamura HI, 1985, NEUROTRANSMITTER REC; Yoshida A., 2013, UROLOGY, V81; Yoshida A, 2010, LIFE SCI, V87, P175, DOI 10.1016/j.lfs.2010.06.008	64	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					137	150				14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100021		
J	Sakamoto, Y; Ogawa, T; Ogawa, M; Matsuo, Y; Hashikawa, N; Hashikawa, N				Sakamoto, Yusuke; Ogawa, Takumi; Ogawa, Mami; Matsuo, Yumi; Hashikawa, Naoya; Hashikawa, Narumi			Effects of 15-day Chronic Stress on Behavior and Neurological Changes in the Hippocampus of ICR Mice	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						depression; chronic stress; forced swim test; neurotrophic factor; antidepressant-drug	GENE-EXPRESSION; DEPRESSION; MEMORY; MODEL; MECHANISMS; ANXIETY; BRAIN; ACTH; RATS	Numerous rodent models of depression have been reported, most requiring a long experimental period and significant effort. We explored a new potential mouse model for depression by investigating whether exposure to a 15-day chronic stress paradigm could induce depression-like behavior in ICR mice. Animals in the stress-exposed groups were subjected to 3 h of restraint while immersed in a 28 degrees C water bath daily for 15 consecutive days. Immobility time in the forced swim test was increased in the chronic stress-exposed mice compared with the controls. Serum corticosterone levels were also much higher in the stressed mice than in the control mice. Hippocampal cell survival (BrdU-positive cells) and neurotrophic factor (NGF, TrkA) mRNA levels were significantly decreased in the chronic stress-exposed mice compared with controls. Administration of the anti-depressant drugs clomipramine (20 mg/kg/d) or imipramine (30 mg/kg/d) did not change the immobility time in the forced swim test, but treatment with lithium (100 mg/kg/d) did result in slight improvement. These results suggest that this 15-day chronic stress paradigm can induce depression-like behavior and neurological changes, in a short time and with minimal effort, facilitating the assessment of treatments for depression.	[Sakamoto, Yusuke; Ogawa, Takumi; Ogawa, Mami; Matsuo, Yumi; Hashikawa, Naoya; Hashikawa, Narumi] Okayama Univ Sci, Dept Life Sci, Kita Ku, Okayama 7000005, Japan	Sakamoto, Y (reprint author), Okayama Univ Sci, Dept Life Sci, Kita Ku, 1-1 Ridai Cho, Okayama 7000005, Japan.	hobara@dls.ous.ac.jp					Seo JS, 2012, J NEUROSCI, V32, P9690, DOI 10.1523/JNEUROSCI.0794-12.2012; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Shirayama Y, 2002, J NEUROSCI, V22, P3251; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Kitamura Y, 2002, PHARMACOL BIOCHEM BE, V71, P63, DOI 10.1016/S0091-3057(01)00625-6; Elsayed M, 2012, BIOL PSYCHIAT, V72, P258, DOI 10.1016/j.biopsych.2012.03.003; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Torner L, 2009, J NEUROSCI, V29, P1826, DOI 10.1523/JNEUROSCI.3178-08.2009; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Cline BH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-110; Furukawa T., 1982, SEISHIN IGAKU, V24, P211; Hayashi H, 2012, YAKUGAKU ZASSHI, V132, P173; Ihne JL, 2012, NEUROPHARMACOLOGY, V62, P464, DOI 10.1016/j.neuropharm.2011.08.045; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Kutiyanawalla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026153; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; McGeary JE, 2011, NEUROPEPTIDES, V45, P317, DOI 10.1016/j.npep.2011.06.002; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; OVERMIER JB, 1968, J EXP PSYCHOL, V78, P340, DOI 10.1037/h0026365; Shi CG, 2010, NEUROCHEM RES, V35, P1302, DOI 10.1007/s11064-010-0183-6	22	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	JAN	2015	135	1					151	158				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FB	WOS:000346951100022		
J	Rahman, MS; Nakagawa, T; Mizuno, S				Rahman, Md. Sazzadur; Nakagawa, Takeshi; Mizuno, Seigi			Growth of Si on Ag(111) and determination of large commensurate unit cell of high-temperature phase	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ENERGY-ELECTRON DIFFRACTION; GRAPHENE	We studied the structural transition for silicon adsorption on Ag(111) by using low-energy electron diffraction (LEED) and Auger electron spectroscopy at various substrate temperatures during deposition. We obtained a single phase of the (4 x 4) structure at 520 K, which was reported as a silicene. At 620 K, the (4 x 4) structure changed to a high-temperature phase which was determined (root 133 x root 133) R 4.3 degrees as by LEED, while in preceding works, it was assigned to a quasi (2 root 3 x 2 root 3) R 30 degrees or (3.5 x 3.5) R 26 degrees structure. Although the high-temperature phase had not been observed as a single phase, we obtained LEED patterns with a single phase for it, which enabled us to explain all the diffraction spots on the basis of the kinematic theory including double diffraction. The (root 133 x root 133) R 4.3 degrees was obtained by the multiplication of a (1.35 x 1.35) R 9.9 degrees subunit cell. We concluded that the (2 root 3 x 2 root 3) R 30 degrees and (3.5 x 3.5) R 26 degrees phases could instead be represented as a phase, and we proposed a possible atomic model.	[Rahman, Md. Sazzadur; Nakagawa, Takeshi; Mizuno, Seigi] Kyushu Univ, Dept Mol & Mat Sci, Kasuga, Fukuoka 8168580, Japan	Rahman, MS (reprint author), Kyushu Univ, Dept Mol & Mat Sci, Kasuga, Fukuoka 8168580, Japan.	sazzad_043@yahoo.com; mizuno.seigi@kyudai.jp					Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Guzman-Verri GG, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075131; Kawahara K, 2014, SURF SCI, V623, P25, DOI 10.1016/j.susc.2013.12.013; Liu CC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.076802; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Jamgotchian H, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/17/172001; Lemme MC, 2007, IEEE ELECTR DEVICE L, V28, P282, DOI 10.1109/LED.2007.891668; Ong MT, 2012, ACS NANO, V6, P1387, DOI 10.1021/nn204198g; Vogt P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155501; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; Chen L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.056804; OVER H, 1993, PHYS REV B, V48, P15353, DOI 10.1103/PhysRevB.48.15353; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Arafune R, 2013, SURF SCI, V608, P297, DOI 10.1016/j.susc.2012.10.022; Cahangirov S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.236804; TAKEDA K, 1994, PHYS REV B, V50, P14916, DOI 10.1103/PhysRevB.50.14916; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Lalmi B, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524215; SOUCHIERE JL, 1986, SURF SCI, V168, P52, DOI 10.1016/0039-6028(86)90835-6	20	6	7	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							UNSP 015502	10.7567/JJAP.54.015502		4	Physics, Applied	Physics	AX5HT	WOS:000346957900025		
J	Yamamoto, Y; Ozawa, Y; Kubouchi, K; Nakamura, S; Nakajima, Y; Inoue, T				Yamamoto, Yayoi; Ozawa, Yukihiko; Kubouchi, Kouichi; Nakamura, Seigo; Nakajima, Yasuo; Inoue, Tomio			Comparative Analysis of Imaging Sensitivity of Positron Emission Mammography and Whole-Body PET in Relation to Tumor Size	CLINICAL NUCLEAR MEDICINE			English	Article						PET; positron emission mammography; whole-body PET; breast cancer; Japanese women	BACKGROUND PARENCHYMAL ENHANCEMENT; PRIMARY BREAST-CANCER; FDG-PET; MRI; PERFORMANCE	Objective: Positron emission mammography (PEM) consists of a dedicated PET scanner for breast imaging with a higher spatial resolution than whole-body PET (WBPET) scanners. This study compared the imaging sensitivity of PEM with WBPET in relation to tumor size. Methods: Fifty-four Japanese women younger than 50 years with histologically confirmed breast lesions were retrospectively enrolled. Positron emission mammography and WBPET were conducted on the same day. Positron emission mammography and WBPET images were blindly evaluated and compared with histopathology. Tumors were classified into 3 groups based on size as follows: group 1, 1 cm or smaller; group 2, 1 to 2 cm; and group 3, larger than 2 cm. The sensitivities of PEM and WBPET were compared in overall subjects and in each size group. Results: In visual analysis, the overall imaging sensitivity was 78.6% (33/42) for PEM and 47.6% (20/42) for WBPET. The overall sensitivity of PEM was significantly higher than that ofWBPET (P < 0.001). The differences in sensitivities between PEM and WBPET were larger in smaller tumors: group 1 (66.7% vs 13.3%), group 2 (63.4% vs 36.4%), and group 3 (100.0% vs 87.5%). The sensitivity of PEM was significantly higher than that of WBPET in group 1 (P = 0.008); however, no significant differences were seen in group 2 (P = 0.500) or group 3 (P = 0.250). Overall, the imaging specificity of PEM and WEBPET was 90.6% (60/66) and 93.9% (62/66), respectively. Conclusions: The imaging sensitivity of PEM was higher than that of WBPET in Japanese women younger than 50 years. Positron emission mammography showed significant sensitivity in tumors smaller than 1 cm, which has been a weak point for WBPET.	[Yamamoto, Yayoi; Ozawa, Yukihiko] Yuai Clin, Yokohama, Kanagawa 2230059, Japan; [Kubouchi, Kouichi] Yokohama Breast & GI Hosp, Yokohama, Kanagawa, Japan; [Nakamura, Seigo] Showa Univ Sch Med, Dept Breast Surg Oncol, Tokyo, Japan; [Nakajima, Yasuo] St Marianna Univ Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Inoue, Tomio] Yokohama City Univ Sch Med, Dept Radiol, Yokohama, Kanagawa, Japan	Yamamoto, Y (reprint author), Yuai Clin, Kohoku Ku, 1-6-2 Kitashinyokohama, Yokohama, Kanagawa 2230059, Japan.	yamamoto.yayoi@yuai.org					American College of Radiology, 2003, ACR BI RADS BREAST I; Eo JS, 2012, BREAST, V21, P66, DOI 10.1016/j.breast.2011.08.002; Kalinyak JE, 2014, EUR J NUCL MED MOL I, V41, P260, DOI 10.1007/s00259-013-2553-1; Berg WA, 2006, BREAST J, V12, P309, DOI 10.1111/j.1075-122X.2006.00269.x; Koo HR, 2013, EUR J RADIOL, V82, P1738, DOI 10.1016/j.ejrad.2013.05.016; Schillaci O, 2012, SEMIN NUCL MED, V42, P267, DOI 10.1053/j.semnuclmed.2012.02.003; Rosen EL, 2007, RADIOGRAPHICS, V27, pS215, DOI 10.1148/rg.27si075517; Samson DJ, 2002, ACAD RADIOL, V9, P773, DOI 10.1016/S1076-6332(03)80347-1; Berg WA, 2006, RADIOLOGY, V258, P59; DeMartini WB, 2012, AM J ROENTGENOL, V198, pW373, DOI 10.2214/AJR.10.6272; Hasegawa S, 2003, J JPN ASS BREAST CAN, V12, P101; Kumar R, 2006, BREAST CANCER RES TR, V98, P267, DOI 10.1007/s10549-006-9159-2; Lim HS, 2007, RADIOGRAPHICS, V27, pS197, DOI 10.1148/rg.27si075507; MacDonald L, 2009, J NUCL MED, V50, P1666, DOI 10.2967/jnumed.109.064345; Narayanan D, 2011, AM J ROENTGENOL, V196, P971, DOI 10.2214/AJR.10.5081; Rosen EL, 2005, RADIOLOGY, V234, P527, DOI 10.1148/radiol.2342040654; Saika K., 2009, JMAJ - Japan Medical Association Journal, V52, P39; Schilling K, 2008, APPL RADIOL, V37, P26; Schilling K, 2011, EUR J NUCL MED MOL I, V38, P33; Tafra L, 2005, AM J SURG, V190, P628, DOI 10.1016/j.amjsurg.2005.06.029; Calonge N, 2009, ANN INTERN MED, V151, P716	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JAN	2015	40	1					21	25				5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX0HK	WOS:000346633400026		
J	Nakajima, R; Abe, K; Nakajima, A; Nishikawa, T; Sakai, S				Nakajima, Reiko; Abe, Koichiro; Nakajima, Ayako; Nishikawa, Toshio; Sakai, Shuji			Etanercept-Induced Sarcoidosis in Rheumatoid Arthritis FDG PET Findings	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						etanercept; tumor necrosis factor inhibitor; sarcoidosis; FDG PET/CT; rheumatoid arthritis	THERAPY		[Nakajima, Reiko; Abe, Koichiro; Sakai, Shuji] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nucl Med, Tokyo, Japan; [Nakajima, Ayako] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan; [Nishikawa, Toshio] Tokyo Womens Med Univ, Dept Surg Pathol, Tokyo, Japan	Abe, K (reprint author), Tokyo Womens Univ, Dept Diagnost Imaging & Nucl Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	abe.koichiro@twmu.ac.jp					Massara A, 2010, SEMIN ARTHRITIS RHEU, V39, P313, DOI 10.1016/j.semarthrit.2008.11.003; Nishiyama Y, 2006, J NUCL MED, V47, P1571; Vigne C, 2013, JOINT BONE SPINE, V80, P104, DOI 10.1016/j.jbspin.2012.05.001; Braun JJ, 2008, EUR J NUCL MED MOL I, V35, P1537, DOI 10.1007/s00259-008-0770-9; Ishiguro T, 2008, INTERNAL MED, V47, P1021, DOI 10.2169/internalmedicine.47.0602; Peno-Green L, 2002, CHEST, V122, P1858, DOI 10.1378/chest.122.5.1858; Skoie IM, 2012, RHEUMATOL INT, V32, P1049, DOI 10.1007/s00296-009-1349-x; Sweiss NJ, 2007, J RHEUMATOL, V34, P2129	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JAN	2015	40	1					58	61				4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX0HK	WOS:000346633400035		
J	Nakatani, K; Nakamoto, Y; Togashi, K				Nakatani, Koya; Nakamoto, Yuji; Togashi, Kaori			Unilateral Physiological FDG Uptake in Teres Minor Muscle Seems Well Associated With IV Tracer Injection Procedures	CLINICAL NUCLEAR MEDICINE			English	Editorial Material						FDG; PET-CT; rotator cuff; physiological			[Nakatani, Koya; Nakamoto, Yuji; Togashi, Kaori] Kyoto Univ Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto Univ Hosp, Kyoto 6068507, Japan	Nakatani, K (reprint author), Kyoto Univ Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	koyakn@kuhp.kyoto-u.ac.jp					Ackland DC, 2011, J ORTHOP RES, V29, P658, DOI 10.1002/jor.21269; Ahmad Sarji S, 2006, BIOMED IMAGING INTER, V2, pe59, DOI DOI 10.2349/BIIJ.2.4.E59; Melis B, 2011, SKELETAL RADIOL, V40, P1335, DOI 10.1007/s00256-011-1178-3; Cook GJR, 1996, SEMIN NUCL MED, V26, P308, DOI 10.1016/S0001-2998(96)80006-7; Emmering J, 2012, NUCL MED COMMUN, V33, P117, DOI 10.1097/MNM.0b013e32834e3ad0; Harisankar C N B, 2012, World J Nucl Med, V11, P22, DOI 10.4103/1450-1147.98741; Jackson Ryan S, 2006, J Nucl Med Technol, V34, P29; Sopov V, 2009, AM J ROENTGENOL, V192, P1029, DOI 10.2214/AJR.08.1686	8	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JAN	2015	40	1					62	64				3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX0HK	WOS:000346633400036		
J	Amemiya, S; Hibino, T; Nakano, H; Yamaguchi, M; Kuraishi, R; Kiyomoto, M				Amemiya, Shonan; Hibino, Taku; Nakano, Hiroaki; Yamaguchi, Masaaki; Kuraishi, Ritsu; Kiyomoto, Masato			Development ciliary bands in larvae. of the living isocrinid sea lily Metacrinus rotundus	ACTA ZOOLOGICA			English	Article						sea lily; crinoid; isocrinid; echinoderm; Articulata; ciliary band; Metacrilats mtundits; dipleurula; doliolaria; scanning electron microscopy	DOLIOLARIA LARVA; FLOROMETRA; ECHINODERM; METAMORPHOSIS; CRINOIDEA	Embryos and larvae of an isocrinid sea lily, Metacrinus rotundus, arc described by scanning electron microscopy. Around hatching (35 h after fertilization), the outer surface of the gastrula becomes ubiquitously covered with short cilia. At 40 h, the hatched swimming embryo develops a cilia free zone of ectoderm on the ventral side. By 3 days, the very early dipleurula larva develops a cilia free zone ventrally, densely ciliated regions laterally, and a sparsely ciliated region dorsally. At this stage, the posterior and anterior ciliary bands first appear: the former runs along a low ridge separating the densely from the sparsely ciliated epidermal regions, while the latter is visible, at first discontinuously, along the boundary between the densely ciliated lateral regions and the cilia-free ventral zone. In the late dipleurula larva (5 days after fertilization), the anterior and posterior loops of ciliary bands are 1,yell defined. The transition from the dipleurula to the semidoliolaria larva occurs at 6 days as the posterior loop becomes rearranged to form incompletely circumferential ciliary bands. The larva becomes competent to settle at this stage. The arrangement of the ciliary bands on the semidoliolaria is maintained during the second week of development, 1,vhile the larva retains its competence to settle. The larval ciliary patterns described here are compared with those of stalkless crinoids and eleutherozoan echinoderms. The closest morphological similarities are between M. rotundus and the basal eleutherozoan class Asteroidea.	[Amemiya, Shonan] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Amemiya, Shonan; Kiyomoto, Masato] Ochanomizu Univ, Marine & Coastal Res Ctr, Chiba 2940301, Japan; [Amemiya, Shonan; Kuraishi, Ritsu] Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 2238521, Japan; [Hibino, Taku] Saitama Univ, Fac Educ, Sakura Ku, Saitama 3388570, Japan; [Nakano, Hiroaki] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Yamaguchi, Masaaki] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan	Amemiya, S (reprint author), Ochanomizu Univ, Marine & Coastal Res Ctr, Chiba 2940301, Japan.	shonan@k.u-tokyo.ac.jp	拓, 日比野/D-8115-2013				Nakano H, 2003, NATURE, V421, P158, DOI 10.1038/nature01236; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; Rouse GW, 2013, MOL PHYLOGENET EVOL, V66, P161, DOI 10.1016/j.ympev.2012.09.018; MLADENOV PV, 1983, MAR BIOL, V73, P309, DOI 10.1007/BF00392257; Balser Elizabeth J., 2002, P463; Bishop CD, 2007, DEV GENES EVOL, V217, P585, DOI 10.1007/s00427-007-0169-9; Breimer A., 1978, TREATISE INVERTEBR T, V1, P9; Dan K, 1968, INVERTEBRATE EMBRYOL, p[280, 329]; Holland N. D, 1991, REPROD MARINE INVERT, V4, P247; HOLLAND ND, 1975, T AM MICROSC SOC, V94, P58, DOI 10.2307/3225532; LACALLI TC, 1993, ACTA ZOOL-STOCKHOLM, V74, P127; Lacalli TC, 2000, INVERTEBR BIOL, V119, P421; LACALLI TC, 1987, DEVELOPMENT, V99, P273; LACALLI TC, 1986, J EMBRYOL EXP MORPH, V96, P303; LACALLI TC, 1990, PHILOS T ROY SOC B, V330, P371, DOI 10.1098/rstb.1990.0206; McEdward Larry R., 2002, P499; MLADENOV PV, 1985, BIOL BULL, V168, P285, DOI 10.2307/1541241; Mortensen T, 1921, STUDIES DEV LARVAL F; Mortensen T., 1938, Kongelige Danske Videnskabernes Selskabs Skrifter (9), V7, P1; Mortensen T. H., 1937, SKRIFTER NATURVIDE 9, V7, P1; Nakano H, 2009, DEV GENES EVOL, V219, P565, DOI 10.1007/s00427-010-0317-5; Nielsen C., 2012, INTERRELATIONSHIPS L; Sewell Mary A., 2002, P513; Smiley S., 1991, P663	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-7272	1463-6395		ACTA ZOOL-STOCKHOLM	Acta Zool.	JAN	2015	96	1					37	44		10.1111/azo.12049		8	Anatomy & Morphology; Zoology	Anatomy & Morphology; Zoology	AX2LO	WOS:000346775600004		
J	Futagami, S; Itoh, T; Sakamoto, C				Futagami, S.; Itoh, T.; Sakamoto, C.			Systematic review with meta-analysis: post-infectious functional dyspepsia	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Review							IRRITABLE-BOWEL-SYNDROME; COLLOIDAL BISMUTH SUBCITRATE; PLACEBO-CONTROLLED TRIAL; GASTROINTESTINAL DISORDERS; HELICOBACTER-PYLORI; NONULCER DYSPEPSIA; SMOOTH-MUSCLE; SALMONELLA GASTROENTERITIS; CLINICAL CHARACTERISTICS; CROHNS-DISEASE	BackgroundThe prevalence of functional dyspepsia (FD) following infectious gastroenteritis has not been systematically reviewed. AimTo conduct a systematic review and calculate the summary odds ratio (OR) for the development of FD following infectious gastroenteritis, as compared to a control population. MethodsPublished studies in PubMed, EmBASE, and Cochrane Database and abstracts from standard sources were screened for eligible studies. Data from studies meeting inclusion criteria were pooled for meta-analysis. ResultsNineteen studies were eligible for inclusion. The mean prevalence of FD following acute gastroenteritis (AGE) was 9.55% (FD, n=909; AGE, n=9517) in adult populations. The summary OR for the development of post-infectious FD was 2.54 (95% CI=1.76-3.65) at more than 6months after AGE, as compared to the prevalence in controls within the same population. This is compared with the summary OR (3.51; 95% CI=2.05-6.00) for the development of post-infectious irritable bowel syndrome (IBS) in the same population at more than 6months after AGE. There was significant statistical heterogeneity with an I-2 of 72.8% for the summary OR of post-infectious FD. Several pathogens, including Salmonella spp., Escherichia coli O157, Campylobacter jejuni, Giardia lamblia and Norovirus have been shown to be associated with post-infectious FD symptoms. ConclusionsInfectious gastroenteritis is associated with an increased risk for subsequent dyspepsia as well as for irritable bowel syndrome. Post-infectious FD and post-infectious irritable bowel syndrome may represent different aspects of the same pathophysiology. Further studies will be needed to determine this.	[Futagami, S.; Sakamoto, C.] Nippon Med Sch, Div Gastroenterol, Dept Med, Tokyo 1138602, Japan; [Itoh, T.] Nippon Med Sch, Ctr Informat Sci, Tokyo 1138602, Japan	Futagami, S (reprint author), Nippon Med Sch, Dept Med, Div Gastroenterol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	seiji.futagami@gmail.com			Ministry of Education, Culture, and Science; Ministry of Health, Japan	This study was supported in part by grants from the Ministry of Education, Culture, and Science and from the Ministry of Health, Japan. We thank Dr Gudis Katya for rewriting the paper.	ANNESE V, 1995, J CLIN GASTROENTEROL, V21, P279, DOI 10.1097/00004836-199512000-00005; Spiller R, 2010, GASTROENTEROLOGY, V138, P1660, DOI 10.1053/j.gastro.2010.03.024; Parry SD, 2003, AM J GASTROENTEROL, V98, P1970, DOI 10.1016/S0002-9270(03)00627-0; Saps M, 2009, J PEDIATR GASTR NUTR, V49, P580, DOI 10.1097/MPG.0b013e31819bcbd2; Dunlop SP, 2003, AM J GASTROENTEROL, V98, P1578, DOI 10.1016/S0002-9270(03)000375-7; Hogan SP, 2001, NAT IMMUNOL, V2, P353, DOI 10.1038/86365; Stanghellini V, 1996, GASTROENTEROLOGY, V110, P1036, DOI 10.1053/gast.1996.v110.pm8612991; Talley NJ, 2006, REV GASTROENTEROL DI, V6, P72; Tuteja AK, 2008, DIGEST DIS SCI, V53, P271, DOI 10.1007/s10620-007-9853-x; Gwee KA, 1996, LANCET, V347, P150, DOI 10.1016/S0140-6736(96)90341-4; Spiller RC, 2007, J GASTROENTEROL, V42, P41, DOI 10.1007/s00535-006-1925-8; Pike BL, 2013, AM J GASTROENTEROL, V108, P1558, DOI 10.1038/ajg.2013.147; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Li XB, 2010, SCAND J GASTROENTERO, V45, P573, DOI 10.3109/00365521003632576; Talley NJ, 2007, CLIN GASTROENTEROL H, V5, P1175, DOI 10.1016/j.cgh.2007.05.015; Annese V, 1997, SCAND J GASTROENTERO, V32, P1107, DOI 10.3109/00365529709002989; Murch S, 2006, CURR OPIN GASTROEN, V22, P664, DOI 10.1097/01.mog.0000245546.18279.7e; Tack J, 2002, GASTROENTEROLOGY, V122, P1738, DOI 10.1053/gast.2002.33663; Hanevik K, 2007, J INFECTION, V55, P524, DOI 10.1016/j.jinf.2007.09.004; Cremon C, 2014, GASTROENTEROLOGY, V147, P69, DOI 10.1053/j.gastro.2014.03.013; Mawe GM, 2004, NEUROGASTROENT MOTIL, V16, P133, DOI 10.1111/j.1743-3150.2004.00489.x; WEISBRODT NW, 1994, AM J PHYSIOL, V266, pG856; Egger M, 1997, BRIT MED J, V315, P629; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1016/j.gast.2005.04.012; Spiller RC, 2004, BEST PRACT RES CL GA, V18, P641, DOI 10.1016/j.bpg.2004.04.002; Porter CK, 2012, CLIN INFECT DIS, V55, P915, DOI 10.1093/cid/cis576; Porter CK, 2011, AM J GASTROENTEROL, V106, P130, DOI 10.1038/ajg.2010.371; Kindt S, 2009, NEUROGASTROENT MOTIL, V21, P832, DOI 10.1111/j.1365-2982.2009.01299.x; Karamanolis G, 2006, GASTROENTEROLOGY, V130, P296, DOI 10.1053/j.gastro.2005.10.019; WALLAERT B, 1995, J EXP MED, V182, P1897, DOI 10.1084/jem.182.6.1897; Porter CK, 2011, DIGEST DIS SCI, V56, P3262, DOI 10.1007/s10620-011-1762-3; ZHEUTLIN LM, 1984, J IMMUNOL, V133, P2180; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Walker MM, 2009, ALIMENT PHARM THER, V29, P765, DOI 10.1111/j.1365-2036.2009.03937.x; Ford AC, 2010, GASTROENTEROLOGY, V138, P1727, DOI 10.1053/j.gastro.2010.01.043; MARZIO L, 1990, AM J PHYSIOL, V259, pG306; Bityutskiy LP, 1997, AM J GASTROENTEROL, V92, P1501; Talley NJ, 1999, GUT, V45, P37; Dizdar V, 2010, ALIMENT PHARM THER, V31, P883, DOI 10.1111/j.1365-2036.2010.04251.x; Futagami S, 2010, AM J GASTROENTEROL, V105, P1835, DOI 10.1038/ajg.2010.151; Dizdar V, 2007, NEUROGASTROENT MOTIL, V19, P977, DOI 10.1111/j.1365-2982.2007.00988.x; Trivedi KH, 2011, DIGEST DIS SCI, V56, P3602, DOI 10.1007/s10620-011-1766-z; Tack J, 2001, GASTROENTEROLOGY, V121, P526, DOI 10.1053/gast.2001.27180; Collins S, 2012, AM J GASTROENTEROL S, V1, P2; Cremonini F, 2004, ALIMENT PHARM THERAP, V20, P40, DOI 10.1111/j.1365-2036.2004.02184.x; DeBrosse CW, 2006, PEDIATR DEVEL PATHOL, V9, P210, DOI 10.2350/11-05-0130.1; Friesen CA, 2002, J PEDIATR GASTR NUTR, V35, P329, DOI 10.1097/01.MPG.0000025354.04164.5E; GOH KL, 1991, SCAND J GASTROENTERO, V26, P1123, DOI 10.3109/00365529108998603; Hsu PI, 2001, ALIMENT PHARM THERAP, V15, P195, DOI 10.1046/j.1365-2036.2001.00903.x; JACOBSON K, 1995, GASTROENTEROLOGY, V109, P718, DOI 10.1016/0016-5085(95)90378-X; LOFFELD RJLF, 1989, GUT, V30, P1206, DOI 10.1136/gut.30.9.1206; Malfertheiner P, 2003, ALIMENT PHARM THERAP, V18, P615, DOI 10.1046/j.1365-2036.2003.01695.x; MANOUSOS ON, 1965, GASTROENTEROLOGIA, V104, P249; Moreels TG, 2001, NEUROGASTROENT MOTIL, V13, P339, DOI 10.1046/j.1365-2982.2001.00273.x; Parry SD, 2005, EUR J GASTROEN HEPAT, V17, P1071, DOI 10.1097/00042737-200510000-00010; PATCHETT S, 1991, BRIT MED J, V303, P1238; Pires GV, 2004, ALLERGY ASTHMA PROC, V25, P253; Porter CK, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-46; ROKKAS T, 1988, GUT, V29, P1386, DOI 10.1136/gut.29.10.1386; Saps M, 2008, J PEDIATR, V152, P812, DOI 10.1016/j.jpeds.2007.11.042; SCOTT RB, 1989, CAN J PHYSIOL PHARM, V67, P553; Stanghellini V, 2001, ALIMENT PHARM THERAP, V15, P28, DOI 10.1046/j.1365-2036.2001.00104.x; Talley Nicholas J, 2005, Gastroenterology, V129, P1756, DOI 10.1053/j.gastro.2005.09.020; TOUKAN AU, 1985, DIGEST DIS SCI, V30, P313, DOI 10.1007/BF01403839; Turkkan E, 2009, J GASTROENTEROL, V44, P66, DOI 10.1007/s00535-008-2271-9; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Wang ZF, 2014, J CLIN NEUROSCI, V21, P2155, DOI 10.1016/j.jocn.2014.04.016	68	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	JAN	2015	41	2					177	188		10.1111/apt.13006		12	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	AX0OO	WOS:000346651800003		
J	Yamamoto, T; Tanaka, T; Sacco, R				Yamamoto, T.; Tanaka, T.; Sacco, R.			Letter: leucocytapheresis as a nonpharmacologic treatment for patients with ulcerative colitis during pregnancy	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Letter							APHERESIS; GRANULOCYTE; EFFICACY; DISEASE; SAFETY		[Yamamoto, T.] Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, Yokaichi, Japan; [Tanaka, T.] Akitsu Prefectural Hosp, Dept Gastroenterol, Hiroshima, Japan; [Sacco, R.] Pisa Univ Hosp, Dept Gastroenterol, Pisa, Italy	Yamamoto, T (reprint author), Yokkaichi Hazu Med Ctr, Ctr Inflammatory Bowel Dis, Yokaichi, Japan.	nao-taka@sannet.ne.jp					Dignass AU, 2010, ALIMENT PHARM THER, V31, P1286, DOI 10.1111/j.1365-2036.2010.04295.x; Sands BE, 2008, GASTROENTEROLOGY, V135, P400, DOI 10.1053/j.gastro.2008.04.023; Ljung T, 2007, SCAND J GASTROENTERO, V42, P221, DOI 10.1080/00365520600979369; Sands BE, 2013, GUT, V62, P1288, DOI 10.1136/gutjnl-2011-300995; Schulze H, 2014, ALIMENT PHARM THER, V40, P991, DOI 10.1111/apt.12949; Yamamoto T, 2015, ALIMENT PHARM THER, V41, P235; Yoshino T, 2014, DIGEST LIVER DIS, V46, P219, DOI 10.1016/j.dld.2013.10.011	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	JAN	2015	41	2					235	235		10.1111/apt.13031		1	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	AX0OO	WOS:000346651800016		
J	Kokai, S; Fukuyama, E; Sato, Y; Hsu, JC; Takahashi, Y; Harada, K; Ono, T				Kokai, Satoshi; Fukuyama, Eiji; Sato, Yutaka; Hsu, Jui-Chin; Takahashi, Yuzo; Harada, Kiyoshi; Ono, Takashi			Comprehensive treatment approach for bilateral cleft lip and palate in an adult with premaxillary osteotomy, tooth autotransplantation, and 2-jaw surgery	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							ENDOSSEOUS IMPLANTS; ALVEOLAR CLEFTS; BONE-GRAFT; MANAGEMENT; TRANSPLANTATION; SUBSEQUENT; INCISORS; WIDTH	We report the successful treatment of a woman aged 25 years 3 months with bilateral cleft lip and palate. She had a protruded premaxilla, collapsed posterior segments, wide alveolar defects with oronasal fistulae, a congenital missing tooth, and severe facial asymmetry with a transverse occlusal cant. The comprehensive treatment approach included (1) premaxillary osteotomy combined with alveolar bone grafting to reposition the premaxilla and minimize the wide alveolar defects, (2) autotransplantation of a tooth with complete root formation to the grafted bone region to restore the missing tooth without a prosthesis such as a dental implant or bridge, and (3) 2-jaw surgery to improve facial asymmetry. The premaxillary osteotomy was managed orthodontically, in combination with bone grafting. The results suggest that surgical orthodontic treatment with tooth autotransplantation might be useful to improve the occlusion and facial esthetics without prosthetics.	[Kokai, Satoshi; Fukuyama, Eiji; Hsu, Jui-Chin; Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Tokyo 1138549, Japan; [Sato, Yutaka; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial & Neck Reconstruct, Tokyo 1138549, Japan; [Takahashi, Yuzo] Ctr Dent Oral & Maxillofacial Surg, Tokyo, Japan	Kokai, S (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	skokai.orts@tmd.ac.jp					ANDREASEN JO, 1990, EUR J ORTHODONT, V12, P25; Mine K, 2005, ANGLE ORTHOD, V75, P637; BERGLAND O, 1986, CLEFT PALATE J, V23, P175; Araki T, 1992, QUINTESSENCE INT, V11, P725; BARDACH J, 1992, PLAST RECONSTR SURG, V89, P419, DOI 10.1097/00006534-199203000-00004; Czochrowska EM, 2002, AM J ORTHOD DENTOFAC, V122, P587, DOI 10.1067/mod.2002.127915; De Muynck S, 2004, CLEFT PALATE-CRAN J, V41, P447; FREIHOFER HPM, 1991, J CRANIO MAXILL SURG, V19, P2, DOI 10.1016/S1010-5182(05)80264-1; Fujita K, 2008, ORTHOD WAVES, V67, P128, DOI 10.1016/j.odw.2008.02.003; Fukuda M, 2000, J ORAL REHABIL, V27, P546, DOI 10.1046/j.1365-2842.2000.00539.x; Hamamoto N, 1998, J ORAL MAXIL SURG, V56, P1451, DOI 10.1016/S0278-2391(98)90416-5; HAYWARD JR, 1983, J ORAL MAXIL SURG, V41, P518, DOI 10.1016/0278-2391(83)90243-4; HEIDBUCHEL KLWM, 1993, J CRANIO MAXILL SURG, V21, P60, DOI 10.1016/S1010-5182(05)80149-0; HILLERUP S, 1987, CLEFT PALATE J, V24, P137; Hirakawa T, 2006, JOP, V10, P57; Iida A, 2001, J JPN CLEFT PALATE A, V26, P44; LONG RE, 1995, CLEFT PALATE-CRAN J, V32, P420, DOI 10.1597/1545-1569(1995)032<0420:CWASAB>2.3.CO;2; MCNEILL RW, 1973, ANGLE ORTHOD, V43, P24; Takahashi T, 1997, J ORAL MAXIL SURG, V55, P576, DOI 10.1016/S0278-2391(97)90488-2; van der Meij AJW, 2003, ORAL SURG ORAL MED O, V96, P19, DOI 10.1016/S1079-2104(03)00266-X	20	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	JAN	2015	147	1					114	126		10.1016/j.ajodo.2013.12.031		13	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX0IO	WOS:000346636300023		
J	Iwasa, A; Arakaki, R; Honma, N; Ushio, A; Yamada, A; Kondo, T; Kurosawa, E; Kujiraoka, S; Tsunematsu, T; Kudo, Y; Tanaka, E; Yoshimura, N; Harada, N; Hayashi, Y; Ishimaru, N				Iwasa, Akihiko; Arakaki, Rieko; Honma, Naoko; Ushio, Aya; Yamada, Akiko; Kondo, Tomoyuki; Kurosawa, Emi; Kujiraoka, Satoko; Tsunematsu, Takaaki; Kudo, Yasusei; Tanaka, Eiji; Yoshimura, Noriko; Harada, Nobuhiro; Hayashi, Yoshio; Ishimaru, Naozumi			Aromatase Controls Sjogren Syndrome-Like Lesions through Monocyte Chemotactic Protein-1 in Target Organ and Adipose Tissue-Associated Macrophages	AMERICAN JOURNAL OF PATHOLOGY			English	Article							AUTOIMMUNE-DISEASE; SEX-HORMONES; EXOCRINE GLANDS; SALIVARY-GLANDS; CYP19 GENE; MICE; DEFICIENT; ESTROGEN; APOPTOSIS; OBESITY	Several autoimmune diseases are known to develop in postmenopausal women. However, the mechanism by which estrogen deficiency influences autoimmunity is unknown. Aromatase is an enzyme that converts androgens to estrogens. Herein, we used female aromatase gene knockout (ArK0) mice as a model of estrogen deficiency to investigate the molecular mechanism that underlies the onset and development of autoimmunity. Histological analyses showed that inflammatory Lesions in the lacrimal and salivary glands of ArK0 mice increased with age. Adoptive transfer of spleen cells or bone marrow cells from ArK0 mice into recombination activating gene 2 knockout mice failed to induce the autoimmune lesions. Expression of mRNA encoding proinflammatory cytokines and monocyte chemotactic protein-1 increased in white adipose tissue of ArK0 mice and was significantly higher than that in wildtype mice. Moreover, an increased number of inflammatory M1 macrophages was observed in white adipose tissue of ArK0 mice. A significantly increased monocyte chemotactic protein-1 mRNA expression of the salivary gland tissue in ArK0 was found together with adiposity. Furthermore, the autoimmune lesions in a murine model of Sjogren syndrome were exacerbated by administration of an aromatase inhibitor. These results suggest that aromatase may play a key role in the pathogenesis of Sjogren syndrome-like lesions by controlling the target organ and adipose tissue-associated macrophage.	[Iwasa, Akihiko; Arakaki, Rieko; Ushio, Aya; Yamada, Akiko; Kondo, Tomoyuki; Kurosawa, Emi; Kujiraoka, Satoko; Tsunematsu, Takaaki; Kudo, Yasusei; Hayashi, Yoshio; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708504, Japan; [Iwasa, Akihiko; Tanaka, Eiji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthodont & Dentofacial Orthoped, Tokushima 7708504, Japan; [Honma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Yoshimura, Noriko; Harada, Nobuhiro] Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 47011, Japan	Ishimaru, N (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, 3-18-15 Kuramotocho, Tokushima 7708504, Japan.	ishimaru.n@tolcushima-u.ac.jp	Tanaka, Eiji/E-7105-2015		Program for Next Generation World-Leading Researchers in Japan [LS090]; Ministry of Education, Science, Sport, and Culture of Japan [25670798, 24659839, 23390429]; Uehara Memorial Foundation	Supported, in part, by the Funding Program for Next Generation World-Leading Researchers in Japan grant LS090, Ministry of Education, Science, Sport, and Culture of Japan Grants-in-Aid for Scientific Research 25670798, 24659839, and 23390429, and the Uehara Memorial Foundation.	Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Ishimaru N, 1999, AM J PATHOL, V155, P173, DOI 10.1016/S0002-9440(10)65111-5; Ishimaru N, 2006, MOL CELL BIOL, V26, P2924, DOI 10.1128/MCB.26.8.2924-2935.2006; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; Konttinen YT, 2012, J AUTOIMMUN, V39, P49, DOI 10.1016/j.jaut.2012.01.004; Bakker J, 2010, HORM BEHAV, V57, P390, DOI 10.1016/j.yhbeh.2009.11.005; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Procaccini C, 2011, EXPERT REV CLIN IMMU, V7, P287, DOI [10.1586/eci.11.18, 10.1586/ECI.11.18]; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Ishimaru N, 2008, J EXP MED, V205, P2915, DOI 10.1084/jem.20080174; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Voulgarelis M, 2010, NAT REV RHEUMATOL, V6, P529, DOI 10.1038/nrrheum.2010.118; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; HANEJI N, 1994, J IMMUNOL, V153, P2769; Stocco C, 2012, STEROIDS, V77, P27, DOI 10.1016/j.steroids.2011.10.013; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Misso ML, 2003, ENDOCRINOLOGY, V144, P1474, DOI 10.1210/en.2002-221123; Kohashi M, 2008, ARTHRITIS RHEUM, V58, P389, DOI 10.1002/art.23163; McPherson SJ, 2001, ENDOCRINOLOGY, V142, P2458, DOI 10.1210/en.142.6.2458; Cutolo M, 2004, LUPUS, V13, P635, DOI 10.1191/0961203304lu1094oa; Azzarolo AM, 1999, INVEST OPHTH VIS SCI, V40, P592; Shim GJ, 2004, P NATL ACAD SCI USA, V101, P12628, DOI 10.1073/pnas.040599101; Gleicher N, 2007, AUTOIMMUN REV, V6, P572, DOI 10.1016/j.autrev.2007.04.002; Waldmann H, 2010, NAT REV NEPHROL, V6, P569, DOI 10.1038/nrneph.2010.108; Mostafa S, 2012, EXP EYE RES, V96, P88, DOI 10.1016/j.exer.2011.12.016; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Han JM, 2013, J IMMUNOL, V191, P527, DOI 10.4049/jimmunol.1301035; Nadkarni S, 2013, CURR OPIN PHARMACOL, V13, P576, DOI 10.1016/j.coph.2013.05.007; Cutolo M, 2012, AUTOIMMUN REV, V11, pA460, DOI 10.1016/j.autrev.2011.11.014; Derdemezis CS, 2011, CLIN EXP RHEUMATOL, V29, P712; Hill RA, 2009, SEMIN REPROD MED, V27, P218, DOI 10.1055/s-0029-1216275; Hill RA, 2009, MOL CELL NEUROSCI, V41, P1, DOI 10.1016/j.mcn.2008.12.009; Iwamoto N, 2010, RHEUMATOLOGY, V49, P1472, DOI 10.1093/rheumatology/keq079; Izumi M, 1997, AM J NEURORADIOL, V18, P951; McCarthy M, 2000, LANCET, V356, P1088, DOI 10.1016/S0140-6736(05)74535-9; Nussinovitch U, 2012, AUTOIMMUN REV, V11, pA377, DOI 10.1016/j.autrev.2011.11.001; Ota Tsuguhito, 2013, Diabetes Metab J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Stofkova A, 2009, Endocr Regul, V43, P157; Toussirot E, 2012, CURR MED CHEM, V19, P5474	42	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JAN	2015	185	1					151	161		10.1016/j.ajpath.2014.09.006		11	Pathology	Pathology	AX4ES	WOS:000346887200014		
J	Kambara, K; Ohashi, W; Tomita, K; Takashina, M; Fujisaka, S; Hayashit, R; Mori, H; Tobe, K; Hattori, Y				Kambara, Kenta; Ohashi, Wakana; Tomita, Kengo; Takashina, Michinori; Fujisaka, Shiho; Hayashit, Ryuji; Mori, Hisashi; Tobe, Kazuyuki; Hattori, Yuichi			In Vivo Depletion of CD206(+) M2 Macrophages Exaggerates Lung Injury in Endotoxemic Mice	AMERICAN JOURNAL OF PATHOLOGY			English	Article							DIPHTHERIA-TOXIN RECEPTOR; NF-KAPPA-B; MURINE PNEUMOCOCCAL PNEUMONIA; ISCHEMIA-REPERFUSION INJURY; ALVEOLAR MACROPHAGES; POLARIZATION; ACTIVATION; CELLS; EXPRESSION; DISEASE	Although phenotypically polarized macrophages are now generally classified into two major subtypes termed proinflammatory M1 and anti-inflammatory M2 macrophages, a contributory role of Lung M2 macrophages in the pathophysiotogical features of acute lung injury is not fully understood. Herein, we show in an endotoxemic murine model that M2 macrophages serve as key anti-inflammatory cells that play a regulatory role in the severity of lung injury. To study whether M2 macrophages can modify inflammation, we depleted M2 macrophages from Lungs of CD206-diphtheria toxin (DT) receptor transgenic (Tg) mice during challenge with lipopolysaccharide. The i.p. administration of DT depleted CD206-positive cells in bronchoalveolar lavage fluid. The use of M2 macrophage markers Ym1 and arginase-1 identified pulmonary CD206-positive cells as M2 macrophages. A striking increase in neutrophits in bronchoalveolar Lavage fluid cell contents was found in DT-treated CD206-DT receptor Tg mice. In CD206-DT receptor Tg mice given DT, endotoxin challenge exaggerated Lung inflammation, including up-regulation of proinflammatory cytokines and increased histological Lung damage, but the endotoxemia-induced increase in NF-kappa B activity was significantly reduced, suggesting that M2 phenotype-dependent counteraction of inflammatory insult cannot be attributed to the inhibition of the NF-kappa B pathway. Our results indicate a critical role of CD206-positive pulmonary macrophages in triggering inflammatory cascade during endotoxemic Lung inflammation.	[Kambara, Kenta; Ohashi, Wakana; Tomita, Kengo; Takashina, Michinori; Hattori, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 9300194, Japan; [Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neurosci, Toyama 9300194, Japan; [Kambara, Kenta; Fujisaka, Shiho; Hayashit, Ryuji; Tobe, Kazuyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Internal Med 1, Toyama 9300194, Japan	Hattori, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 9300194, Japan.	yhattori@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18209033, 21591126]	Supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan Grants-in-Aid for Scientific Research 18209033 and 21591126 (K.T.).	Hess C, 2010, EUR RESPIR J, V35, P343, DOI 10.1183/09031936.00196408; Lomas-Neira J, 2006, AM J PHYSIOL-LUNG C, V290, pL51, DOI 10.1152/ajplung.00028.2005; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Knapp S, 2004, J IMMUNOL, V172, P3132; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Koay MA, 2002, AM J RESP CELL MOL, V26, P572; Quinton LJ, 2007, J IMMUNOL, V178, P1896; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9; Martinez FO, 2006, J IMMUNOL, V177, P7303; Jakubzick C, 2006, J IMMUNOL, V176, P3578; PAPPENHEIMER AM, 1982, J INFECT DIS, V145, P94; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; MAGNUSSON S, 1993, BIOCHEM J, V291, P749; MITAMURA T, 1995, J BIOL CHEM, V270, P1015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Kooguchi K, 1998, INFECT IMMUN, V66, P3164; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Amano H, 2004, J IMMUNOL, V172, P398; Fujisaka S, 2011, ENDOCRINOLOGY, V152, P1789, DOI 10.1210/en.2010-1312; Takano K, 2011, J PHARMACOL EXP THER, V336, P381, DOI 10.1124/jpet.110.171462; Zhao MQ, 2006, AM J PHYSIOL-LUNG C, V291, pL1018, DOI 10.1152/ajplung.00086.2006; Matsuda N, 2006, AM J RESP CELL MOL, V35, P198, DOI 10.1165/rcmb.2005-0272OC; Scotton CJ, 2005, J IMMUNOL, V174, P834; Oishi H, 2012, AM J PHYSIOL-LUNG C, V303, pL130, DOI 10.1152/ajplung.00363.2011; Baurle PA, 1994, ANNU REV IMMUNOL, V12, P141; Furukawa N, 2006, J BIOCHEM, V140, P831, DOI 10.1093/jb/mvj216; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128; Haltiwanger H, 1986, J BIOL CHEM, V261, P15696; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Lew BD, 1994, J CLIN INVEST, V94, P1855; Montovani A, 2004, TRENDS IMMUNOL, V25, P677; Naidu BV, 2003, J THORAC CARDIOV SUR, V126, P200, DOI 10.1016/S0022-5223(03)00390-8; Norrman F, 1997, J LEUKOCYTE BIOL, V61, P63; Surace Michael J, 2013, Am J Clin Exp Immunol, V2, P117; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	51	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JAN	2015	185	1					162	171		10.1016/j.ajpath.2014.09.005		10	Pathology	Pathology	AX4ES	WOS:000346887200015		
J	Aihara, N; Kamiie, J; Yamada, M; Shirotat, K				Aihara, Naoyuki; Kamiie, Junichi; Yamada, Moe; Shirotat, Kinji			The Development of Mixed Cryoglobulinemia in Capillaria hepatica-Infected Mice Is Associated with the Capillaria Antigen-Induced Selective Proliferation of Splenic B-1a Cells in Response to Interleukin-5 Stimulation	AMERICAN JOURNAL OF PATHOLOGY			English	Article							TH1 CYTOKINE PRODUCTION; B-CELLS; NATURAL IMMUNITY; MARGINAL ZONE; ACTIVATION; ANTIBODIES; EXPANSION; GENE; EOSINOPHILIA; AUTOIMMUNITY	Chronic infection by pathogens such as hepatitis C virus induces monoclonal or oligoclonal proliferation of B cells, which produce IgM rheumatoid factor, leading to the development of mixed cryogLobuLinemia (MC). Antigen-driven tymphoproliferation is essential to the onset of MC; however, the underlying mechanism is Largely unknown. Herein, we show that type II MC is induced by Capillaria hepatica infection through a mechanism in which splenic B-la cells reacting to C. hepatica-specific antigen selectively proliferate, producing IgM rheumatoid factor under co-stimulation of the specific worm antigen and IL-5. In vitro assays using B-la cells from infected mice showed that stimulation by C. hepatica soluble fraction promoted the proliferation of B-la cells and the secretion of IgM, which reacted with the 75-kDa antigen in the soluble fraction. The severity of MC was correlated with the increase in serum IL-5 Levels in the infected mice. Furthermore, i.p. injection of the soluble worm fraction caused MC without an inflammatory response in IL-5 transgenic mice, indicating that IL-5 is critical for the development of MC. These results indicate that the selective proliferation of IgM rheumatoid factor secreting B-la cells is induced by co-stimulation by the specific pathogen antigen and IL-5 in the development of MC in C. hepatica infected mice.	[Aihara, Naoyuki; Kamiie, Junichi; Yamada, Moe; Shirotat, Kinji] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa 2525201, Japan; [Shirotat, Kinji] Azabu Univ, Res Inst Biosci, Sagamihara, Kanagawa 2525201, Japan	Kamiie, J (reprint author), Azabu Univ, Sch Vet Med, Lab Vet Pathol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	kamiie@azabu-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [23580415]; Azabu University	Supported in part by the Japan Society for the Promotion of Science KAKENHI grant 23580415 (K.S.) and a grant-in-aid for the development of intellectual property, a research project grant awarded by Azabu University (J.K. and K.S.).	Aihara N, 2011, HISTOL HISTOPATHOL, V26, P1519; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5382, DOI 10.1073/pnas.1121631109; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; MASMOUDI H, 1990, INT IMMUNOL, V2, P515, DOI 10.1093/intimm/2.6.515; Hoogeboom R, 2013, J EXP MED, V210, P59, DOI 10.1084/jem.20121801; MANTOVANI L, 1993, J IMMUNOL, V151, P473; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; De Re V, 2000, BLOOD, V96, P3578; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Erickson LD, 2001, J IMMUNOL, V166, P1531; STALL AM, 1988, P NATL ACAD SCI USA, V85, P7312, DOI 10.1073/pnas.85.19.7312; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Yamanishi S, 2006, INFECT IMMUN, V74, P248, DOI 10.1128/IAI.74.1.248-256.2006; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Morse HC, 2001, LEUKEMIA RES, V25, P169, DOI 10.1016/S0145-2126(00)00107-7; Curry MP, 2003, J HEPATOL, V38, P642, DOI 10.1016/S0168-8278(03)00075-8; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; Fallahi P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/468107; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Itakura A, 2005, J IMMUNOL, V175, P7170; Atta AM, 2010, MICROB PATHOGENESIS, V48, P53, DOI 10.1016/j.micpath.2009.12.002; Casey SC, 2011, MOL ENDOCRINOL, V25, P933, DOI 10.1210/me.2010-0486; Curry MP, 2000, J HEPATOL, V32, P121, DOI 10.1016/S0168-8278(00)80198-1; Damoiseaux J, 2014, CLIN REV ALLERG IMMU, V47, P299, DOI 10.1007/s12016-013-8390-y; Falasca K, 2007, CLIN INVEST MED, V30, pE167; Ferri C, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-25; JEANES A, 1986, MOL IMMUNOL, V23, P999, DOI 10.1016/0161-5890(86)90131-8; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Kusakabe K, 2007, J REPROD DEVELOP, V53, P87, DOI 10.1262/jrd.18074; LeMaoult J, 1999, J IMMUNOL, V162, P6384; Loffreda S, 2003, J HEPATOL, V38, P230, DOI 10.1016/S0168-8278(02)00353-7; LOSPALLUTO J, 1962, AM J MED, V32, P142, DOI 10.1016/0002-9343(62)90191-2; Mizuochi T, 2009, BIOCHEM BIOPH RES CO, V389, P512, DOI 10.1016/j.bbrc.2009.09.012; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Monteverde A, 1997, SPRINGER SEMIN IMMUN, V19, P99, DOI 10.1007/BF00945028; Mueller A, 2005, AM J PATHOL, V167, P797, DOI 10.1016/S0002-9440(10)62052-4; Saadoun D, 2004, J HEPATOL, V41, P1031, DOI 10.1016/j.jhep.2004.08.011; Sautto G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/705013; Taira K, 2013, VET PARASITOL, V196, P397, DOI 10.1016/j.vetpar.2013.03.012; Taira K, 2003, PARASITOLOGY, V127, P593, DOI 10.1017/S0031182003004074; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; WINFIELD JB, 1983, HUM PATHOL, V14, P350, DOI 10.1016/S0046-8177(83)80121-X	48	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JAN	2015	185	1					172	184		10.1016/j.ajpath.2014.09.017		13	Pathology	Pathology	AX4ES	WOS:000346887200016		
J	Tsukahara, T; Watanabe, K; Watanabe, T; Yamagami, H; Sogawa, M; Tanigawa, T; Shiba, M; Tominaga, K; Fujiwara, Y; Maeda, K; Hirakawa, K; Arakawa, T				Tsukahara, Takuya; Watanabe, Kenji; Watanabe, Toshio; Yamagami, Hirokazu; Sogawa, Mitsue; Tanigawa, Tetsuya; Shiba, Masatsugu; Tominaga, Kazunari; Fujiwara, Yasuhiro; Maeda, Kiyoshi; Hirakawa, Kosei; Arakawa, Tetsuo			Tumor Necrosis Factor alpha Decreases Glucagon-Like Peptide-2 Expression by Up-Regulating G-Protein-Coupled Receptor 120 in Crohn Disease	AMERICAN JOURNAL OF PATHOLOGY			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL GROWTH-FACTOR; FATTY-ACID RECEPTOR; INSULIN-SECRETION; PROHORMONE CONVERTASES; ULCERATIVE-COLITIS; LINOLEIC-ACID; MURINE MODEL; TNF-ALPHA; CELLS	Glucagon-like peptide (GLP)-2, secreted by L cells in the small intestine, has anti-inflammatory effects in the gastrointestinal tract. A GLP-2 analogue has been an effective treatment for Crohn disease (CD). G-protein coupled receptor (GPR) 40 and GPR120 are probably involved in GLP-2 production, the mechanisms of which remain unclear. In our experiments, normal ilea mucosa expressed GPR40, but rarely expressed GPR120. However, both GPRs were overexpressed in the L cells of the inflamed ileal mucosa of CD patients. MucosaL inflammation induced the overexpression of GPR40, GPR120, and several inflammatory cytokines, with correlations between ilea concentrations of tumor necrosis factor (TNF)-alpha and GPR expression levels; however, inflammation did not induce the expression of proglucagon, a precursor of GLP-2 in CD patients. In rat L cells and GLUTag cells, TNF-alpha treatment increased GPR120 mRNA expression without affecting GPR40 mRNA expression. Dual agonists of GPR40 and GPR120, GW9508 and linoleic acid, respectively, increased GLP-2 production from L cells, but these agonists decreased it in the presence of TNF-alpha. The GPR40 antagonist, GW1100, inhibited the GW9508-induced increase in GLP-2 production, and silencing GPR120 resulted in further elevation of GLP-2 production. Thus, GPR120-dependent signaling inhibited the stimulatory effects of GPR40 on GLP-2 expression, and TNF-alpha treatment decreased GLP-2 expression by up-regulating GPR120 expression in L cells.	[Tsukahara, Takuya; Watanabe, Kenji; Watanabe, Toshio; Yamagami, Hirokazu; Sogawa, Mitsue; Tanigawa, Tetsuya; Shiba, Masatsugu; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka 558, Japan; [Maeda, Kiyoshi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan	Watanabe, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Abeno Ku, 14-3 Asahi Machi, Osaka 558, Japan.	watanabet@med.osaka-cu.ac.jp			Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan	Supported by the Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.	Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; L'Heureux MC, 2003, J PHARMACOL EXP THER, V306, P347, DOI 10.1124/jpet.103.051771; Alavi K, 2000, J PEDIATR SURG, V35, P847, DOI 10.1053/jpsu.2000.6861; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Jeppesen PB, 2012, GASTROENTEROLOGY, V143, P1473, DOI 10.1053/j.gastro.2012.09.007; Drozdowski L, 2009, WORLD J GASTROENTERO, V15, P385, DOI 10.3748/wjg.15.385; Dhanvantari S, 1996, MOL ENDOCRINOL, V10, P342, DOI 10.1210/me.10.4.342; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; van Bloemendaal L, 2014, J ENDOCRINOL, V221, pT1, DOI 10.1530/JOE-13-0414; Hira T, 2009, AM J PHYSIOL-GASTR L, V297, pG663, DOI 10.1152/ajpgi.90635.2008; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Jeppesen PB, 2011, GUT, V60, P902, DOI 10.1136/gut.2010.218271; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Habib AM, 2013, DIABETOLOGIA, V56, P1413, DOI 10.1007/s00125-013-2887-z; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; CARLOS TM, 1994, BLOOD, V84, P2068; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Plummer MP, 2014, DIABETES CARE, V37, P1509, DOI 10.2337/dc13-1813; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Guan XF, 2012, AM J PHYSIOL-ENDOC M, V303, pE853, DOI 10.1152/ajpendo.00245.2012; Meloni AR, 2013, DIABETES OBES METAB, V15, P15, DOI 10.1111/j.1463-1326.2012.01663.x; Drucker DJ, 2001, J CLIN ENDOCR METAB, V86, P1759, DOI 10.1210/jc.86.4.1759; Bohorquez DV, 2011, J MOL HISTOL, V42, P3, DOI 10.1007/s10735-010-9302-6; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Meier JJ, 2006, GASTROENTEROLOGY, V130, P44, DOI 10.1053/j.gastro.2005.10.004; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.0139; Ipharraguerre IR, 2013, J NUTR, V143, P1899, DOI 10.3945/jn.113.177865; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Saren P, 1996, J IMMUNOL, V157, P4159; Arthur GL, 2004, J PEDIATR SURG, V39, P448, DOI 10.1016/j.jpedsurg.2003.11.024; BERGONZELLI GE, 1992, ENDOCRINOLOGY, V131, P1467, DOI 10.1210/en.131.3.1467; Boushey RP, 1999, AM J PHYSIOL-ENDOC M, V277, pE937; Buchman AL, 2010, INFLAMM BOWEL DIS, V16, P962, DOI 10.1002/ibd.21117; Drucker DJ, 1999, AM J PHYSIOL-GASTR L, V276, pG79; Fredborg M, 2012, J ANIM SCI, V90, P10, DOI [10.2527/jas.53792, 10.2527/jas53792]; GAMBLE JR, 1985, P NATL ACAD SCI USA, V82, P8667, DOI 10.1073/pnas.82.24.8667; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Izumi H, 2009, J NUTR, V139, P1322, DOI 10.3945/jn.109.106401; Kim HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050128; Liu QR, 2004, BIOCHEM J, V377, P171, DOI 10.1042/BJ20030128; Plevy SE, 1997, J IMMUNOL, V159, P6276; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488; Schmidt PT, 2005, EUR J GASTROEN HEPAT, V17, P207, DOI 10.1097/00042737-200502000-00012; Suh HN, 2008, AM J PHYSIOL-CELL PH, V295, pC1518, DOI 10.1152/ajpcell.00368.2008; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078	50	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JAN	2015	185	1					185	196		10.1016/j.ajpath.2014.09.010		12	Pathology	Pathology	AX4ES	WOS:000346887200017		
J	Takata, K; Hong, ME; Sitthinamsuwan, P; Loong, F; Tan, SY; Liau, JY; Hsieh, PP; Ng, SB; Yang, SF; Pongpruttipan, T; Sukpanichnant, S; Kwong, YL; Ko, YH; Cho, YT; Chng, WJ; Matsushita, T; Yoshino, T; Chuang, SS				Takata, Katsuyoshi; Hong, Min-eui; Sitthinamsuwan, Panitta; Loong, Florence; Tan, Soo-Yong; Liau, Jau-Yu; Hsieh, Pin-Pen; Ng, Siok-Bian; Yang, Sheau-Fang; Pongpruttipan, Tawatchai; Sukpanichnant, Sanya; Kwong, Yok-Lam; Ko, Young Hyeh; Cho, Yung-Tsu; Chng, Wee Joo; Matsushita, Takashi; Yoshino, Tadashi; Chuang, Shih-Sung			Primary Cutaneous NK/T-cell Lymphoma, Nasal Type and CD56-positive Peripheral T-cell Lymphoma A Cellular Lineage and Clinicopathologic Study of 60 Patients From Asia	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						CD56; cutaneous lymphoma; cutaneous T-cell lymphoma; Epstein-Barr virus; extranodal natural killer/T-cell lymphoma; peripheral T-cell lymphoma	NATURAL-KILLER-CELL; GAMMA-DELTA; EXPRESSION; SMILE; SKIN	Primary cutaneous, extranodal natural killer/T-cell lymphoma, nasal type (PC-ENKTL), is a rare Epstein-Barr virus (EBV)-associated neoplasm with poorly defined clinicopathologic features. We performed a multinational retrospective study of PC-ENKTL and CD56-positive EBV-negative peripheral T-cell lymphoma (PC-CD56+PTCL) in Asia in an attempt to elucidate their clinicopathologic features. Using immunohistochemistry for T-cell receptors (TCRs), in situ hybridization for EBV, and TCR gene rearrangement, we classified 60 tumors into 51 with PC-ENKTL (20 of NK-cell, 17 T-cell, and 14 indeterminate lineages) and 9 with PC-CD56+PTCL. Tumors of T-cell origin accounted for 46% of PC-ENKTLs with half of these cases being TCR-silent. As compared with T-lineage tumors, PC-ENKTLs of NK-cell lineage had more frequent involvement of regional lymph nodes and more frequently CD8-negative and CD56-positive. Cases of PC-ENKTL showed more frequent tumor necrosis, younger age, and a higher frequency of CD16 and CD30 expression than cases of PC-CD56+PTCL. CD56-positive T-lineage PC-ENKTL tumors (n=8) had more localized disease in the TNM (tumor-node-metastasis) staging and were more often of gamma delta T-cell origin compared with cases of PC-CD56+PTCL (n=9). PC-ENKTLs and PC-CD56+PTCLs were equally aggressive, with a 5-year overall survival rate of 25%. Tumor necrosis and CD16 expression may serve as useful surrogates for differentiating PC-ENKTL from PC-CD56+PTCL. A single lesion, an elevated lactate dehydrogenase level, and the presence of B symptoms were independent poor prognostic factors for PC-ENKTL in multivariate analysis. Further studies with more cases are warranted to delineate the clinicopathologic features and significance of EBV in these rare lymphomas.	[Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Med Sch, Dept Pathol, Okayama, Japan; [Matsushita, Takashi] Kanazawa Univ, Fac Med, Dept Dermatol, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan; [Hong, Min-eui] Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Ko, Young Hyeh] Sungkyunkwan Univ, Dept Pathol, Seoul, South Korea; [Ko, Young Hyeh] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea; [Sitthinamsuwan, Panitta; Pongpruttipan, Tawatchai; Sukpanichnant, Sanya] Mahidol Univ, Dept Pathol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Loong, Florence] Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Kwong, Yok-Lam] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tan, Soo-Yong] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Ng, Siok-Bian] Natl Univ Hlth System, Dept Pathol, Singapore, Singapore; [Chng, Wee Joo] Natl Univ Hlth System, Dept Haematol Oncol, Singapore, Singapore; [Ng, Siok-Bian; Chng, Wee Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Liau, Jau-Yu] Natl Taiwan Univ, Coll Med, Dept Pathol, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chuang, Shih-Sung] Chi Mei Med Ctr, Dept Pathol, Tainan 71004, Taiwan; [Chuang, Shih-Sung] Taipei Med Univ, Taipei, Taiwan; [Chuang, Shih-Sung] Natl Taiwan Univ, Taipei 10764, Taiwan; [Cho, Yung-Tsu] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Hsieh, Pin-Pen] Kaohsiung Vet Gen Hosp, Dept Pathol, Kaohsiung, Taiwan; [Hsieh, Pin-Pen] Kaohsiung Vet Gen Hosp, Lab Med, Kaohsiung, Taiwan; [Yang, Sheau-Fang] Kaohsiung Med Univ, Dept Pathol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Yang, Sheau-Fang] Kaohsiung Med Univ, Dept Pathol, Coll Med, Kaohsiung, Taiwan	Chuang, SS (reprint author), Chi Mei Med Ctr, Dept Pathol, 901 Chung Hwa Rd, Tainan 71004, Taiwan.	cmh5301@mail.chimei.org.tw	Matsushita, Takashi /C-4750-2015	Matsushita, Takashi /0000-0002-1617-086X	National Science Council, Taipei, Taiwan [NSC101-2314-B-384-006, NSC102-2320-B-384-001]	Conflicts of Interest and Source of Funding: Supported by grants NSC101-2314-B-384-006 and NSC102-2320-B-384-001 from National Science Council, Taipei, Taiwan. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.	Takata K, 2013, MODERN PATHOL, V26, P22, DOI 10.1038/modpathol.2012.127; Kanemitsu N, 2012, CLIN CANCER RES, V18, P2164, DOI 10.1158/1078-0432.CCR-11-2395; Kwong YL, 2012, BLOOD, V120, P2973, DOI 10.1182/blood-2012-05-431460; Berti E, 2010, BLOOD, V116, P165, DOI 10.1182/blood-2009-11-252957; Pongpruttipan T, 2012, AM J SURG PATHOL, V36, P481, DOI 10.1097/PAS.0b013e31824433d8; Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Suzuki R, 2010, ANN ONCOL, V21, P1032, DOI 10.1093/annonc/mdp418; Hayashi E, 2013, HUM PATHOL, V44, P1927, DOI 10.1016/j.humpath.2013.03.002; Tse E, 2012, AM J HEMATOL, V87, P663, DOI 10.1002/ajh.23213; Chuang SS, 2009, AM J SURG PATHOL, V33, P1230, DOI 10.1097/PAS.0b013e3181a95c63; Ahn HK, 2012, ANN ONCOL, V23, P2703, DOI 10.1093/annonc/mds096; Kim TM, 2008, ANN ONCOL, V19, P1477, DOI 10.1093/annonc/mdn147; Garcia-Herrera A, 2011, AM J SURG PATHOL, V35, P1214, DOI 10.1097/PAS.0b013e31822067d1; Jaffe ES, 2013, MODERN PATHOL, V26, pS71, DOI 10.1038/modpathol.2012.181; Choi YL, 2009, BRIT J DERMATOL, V160, P333, DOI 10.1111/j.1365-2133.2008.08922.x; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Chuang SS, 2014, J AM ACAD DERMATOL, V70, P724, DOI 10.1016/j.jaad.2013.11.047; Iqbal J, 2012, BLOOD, V120, P679; Kim SJ, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-86; Kuo SY, 2011, J CLIN PATHOL, V64, P536, DOI 10.1136/jcp.2010.086637; Liao JB, 2010, ARCH PATHOL LAB MED, V134, P996, DOI 10.1043/2009-0132-OA.1; Miyata-Takata T, 2014, LEUK LYMPHOMA; Mraz-Gernhard S, 2001, J CLIN ONCOL, V19, P2179; Rodriguez-Pinilla SM, 2010, AM J SURG PATHOL, V34, P1773, DOI 10.1097/PAS.0b013e3181fbb4fd; Swerdlow SH, 2008, WHO CLASSIFICATIONS; Tan SY, 2012, AM J HEMATOL, V87, pE129, DOI 10.1002/ajh.23324; Yoshino T, 2002, BRIT J HAEMATOL, V118, P482, DOI 10.1046/j.1365-2141.2002.03607.x; Yu WW, 2013, J CUTAN PATHOL, V40, P310, DOI 10.1111/cup.12066	28	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	JAN	2015	39	1					1	12				12	Pathology; Surgery	Pathology; Surgery	AX2JE	WOS:000346768600001		
J	Takeishi, K; Shirabe, K; Yoshida, Y; Tsutsui, Y; Kurihara, T; Kimura, K; Itoh, S; Harimoto, N; Yamashita, YI; Ikegami, T; Yoshizumi, T; Nishie, A; Maehara, Y				Takeishi, K.; Shirabe, K.; Yoshida, Y.; Tsutsui, Y.; Kurihara, T.; Kimura, K.; Itoh, S.; Harimoto, N.; Yamashita, Y. -I.; Ikegami, T.; Yoshizumi, T.; Nishie, A.; Maehara, Y.			Correlation Between Portal Vein Anatomy and Bile Duct Variation in 407 Living Liver Donors	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						Anatomy; clinical research; practice; donor hepatectomy; donors and donation: living; liver transplantation; hepatology; liver transplantation: living donor	3-DIMENSIONAL COMPUTED-TOMOGRAPHY; BILIARY ANATOMY; CT CHOLANGIOGRAPHY; HEPATIC-ARTERY; RIGHT-LOBE; TRANSPLANTATION; UTILITY; GRAFT	Our aim was to determine whether variant bile duct (BD) anatomy is associated with portal vein (PV) and/or hepatic artery (HA) anatomy. We examined the associations between BD anatomy and PV and/or HA anatomy in 407 living donor transplantation donors. We also examined whether the right posterior BD (RPBD) course was associated with the PV and/or HA anatomy. Variant PV, HA and BD anatomies were found in 11%, 25% and 25%, respectively, of 407 donors enrolled in this study. The presence of a variant BD was more frequently associated with a variant PV than with a normal PV (61% vs. 20%, p<0.0001). By contrast, the presence of a variant HA was not associated with a variant BD. A supraportal RPBD was found in 357 donors (88%) and an infraportal RPBD was found in 50 donors (12%). An infraportal RPBD was significantly more common in donors with a variant PV than in donors with a normal PV (30% vs. 10%, p=0.0004). Variant PV, but not variant HA, anatomies were frequently associated with variant BD anatomy. Additionally, an infraportal RPBD was more common in donors with a variant PV than in donors with a normal PV. This study investigating the anatomy of 407 living liver donors indicates that variant portal vein, but not variant hepatic artery, anatomies are frequently associated with variant bile duct anatomy.	[Takeishi, K.; Shirabe, K.; Yoshida, Y.; Tsutsui, Y.; Kurihara, T.; Kimura, K.; Itoh, S.; Harimoto, N.; Yamashita, Y. -I.; Ikegami, T.; Yoshizumi, T.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Nishie, A.] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Fukuoka 812, Japan	Takeishi, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	ktake@surg2.med.kyushu-u.ac.jp					Koops A, 2004, SURG RADIOL ANAT, V26, P239, DOI 10.1007/s00276-004-0229-z; MacDonald DB, 2005, AM J ROENTGENOL, V185, P247; Kitami M, 2006, RADIOLOGY, V238, P156, DOI 10.1148/radiol.2381041783; Kasahara M, 2005, TRANSPLANTATION, V79, P626, DOI 10.1097/01.TP.0000146241.67033.21; Soejima Y, 2012, AM J TRANSPLANT, V12, P1877, DOI 10.1111/j.1600-6143.2012.04022.x; Varotti G, 2004, J AM COLL SURGEONS, V198, P577, DOI 10.1016/j.jamcollsurg.2003.11.014; Bogetti JD, 2001, LIVER TRANSPLANT, V7, P687, DOI 10.1053/jlts.2001.26351; Cheng YF, 1997, WORLD J SURG, V21, P297; Ikegami T, 2008, DIGEST SURG, V25, P117, DOI 10.1159/000121907; Jeon YM, 2013, ANN SURG, V257, P702, DOI 10.1097/SLA.0b013e318268a5d5; Kishi Y, 2010, SURGERY, V147, P30, DOI 10.1016/j.surg.2009.06.017; Lee KK, 2008, TRANSPL P, V40, P2517, DOI 10.1016/j.transproceed.2008.07.079; Lee VS, 2004, LIVER TRANSPLANT, V10, P1049, DOI 10.1002/lt.20181; Lindsey I, 1997, ANN SURG, V226, P174, DOI 10.1097/00000658-199708000-00009; McSweeney SE, 2012, EUR J RADIOL, V81, P6, DOI 10.1016/j.ejrad.2010.10.013; NILSSON U, 1987, ACTA RADIOL, V28, P571; Schroeder T, 2002, TRANSPLANTATION, V73, P1972, DOI 10.1097/00007890-200206270-00026; Shimizu H, 2009, ANN SURG, V249, P435, DOI 10.1097/SLA.0b013e31819a6c10; Suzuki H, 2007, J COMPUT ASSIST TOMO, V31, P840, DOI 10.1097/rct.0b013e3180471bc1; Takatsuki M, 2006, SURGERY, V140, P824, DOI 10.1016/j.surg.2006.02.021; Tan C E, 2001, J Hepatobiliary Pancreat Surg, V8, P295, DOI 10.1007/s005340170001; Uchida K, 2010, LIVER TRANSPLANT, V16, P1062, DOI 10.1002/lt.22109; Yoshizumi T, 2014, LIVER TRANSPLANT, V20, P1089, DOI 10.1002/lt.23924	23	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	JAN	2015	15	1					155	160		10.1111/ajt.12965		6	Surgery; Transplantation	Surgery; Transplantation	AX2JM	WOS:000346769500020		
J	O'Neill, L				O'Neill, Liam			If More Competition Is the Answer, Why Hasn't It Worked?	ANESTHESIA AND ANALGESIA			English	Editorial Material									[O'Neill, Liam] Univ N Texas, Dept Hlth Management & Policy, Miki, Kagawa 76107, Japan	O'Neill, L (reprint author), Univ N Texas, Hlth Sci Ctr, Dept Hlth Management & Policy, 3500 Camp Bowie Blvd, Miki, Kagawa 76107, Japan.	liam_oneill27@yahoo.com					Sinaiko AD, 2012, HEALTH AFFAIR, V31, P602, DOI 10.1377/hlthaff.2011.1197; O'Neill L, 2007, ANESTH ANALG, V104, P355, DOI 10.1213/01.ane.0000253092.04322.23; Devers KJ, 2003, HEALTH SERV RES, V38, P447, DOI 10.1111/1475-6773.00124; Glick DB, 2015, ANESTH ANALG, V120, P220, DOI 10.1213/ANE.0000000000000456; Kerr S., 1995, ACAD MANAGEMENT EXEC, V9, P7; Newhouse JP, 2013, VARIATION HLTH CARE	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999	1526-7598		ANESTH ANALG	Anesth. Analg.	JAN	2015	120	1					3	4		10.1213/ANE.0000000000000476		2	Anesthesiology	Anesthesiology	AW9TW	WOS:000346601300002		
J	Ogawa, S; Tanaka, KA; Nakajima, Y; Nakayama, Y; Takeshita, J; Arai, M; Mizobe, T				Ogawa, Satoru; Tanaka, Kenichi A.; Nakajima, Yasufumi; Nakayama, Yoshinobu; Takeshita, Jun; Arai, Masatoshi; Mizobe, Toshiki			Fibrinogen Measurements in Plasma and Whole Blood: A Performance Evaluation Study of the Dry-Hematology System	ANESTHESIA AND ANALGESIA			English	Article							FACTOR-XIII; ROTATION THROMBOELASTOMETRY; COAGULATION MANAGEMENT; MASSIVE HEMORRHAGE; PROTHROMBIN TIME; CARDIAC-SURGERY; CLOT FORMATION; HEMODILUTION; TESTS; COAGULOPATHY	BACKGROUND: An accurate and rapid determination of fibrinogen level is important during hemorrhage to establish a timely hemostatic intervention. The accuracy of fibrinogen measurements may be affected by the specific methodology for its determination, fluid therapies, and anticoagulant agents. The dry-hematology method (DRIHEMATO (R)) is a novel approach to determine fibrinogen levels in plasma and whole blood based on thrombin-activated coagulation time. We hypothesized that plasma or whole blood fibrinogen level using the dry-hematology method would be similar to those measured with conventional plasma fibrinogen assays. METHODS: Acquired hypofibrinogenemia was modeled by serial dilutions of blood samples obtained from 12 healthy volunteers. Citrated whole blood samples were diluted with either normal saline, 5% human albumin, or 6% hydroxyethyl starch to achieve 25%, 50%, and 75% volume replacement. The dry-hematology method, the Clauss method, the prothrombin time (PT)-derived method, determination of antigen levels, and thromboelastometric fibrin formation were compared in plasma or whole blood samples. The effect of heparin on each assay was examined (0 to 6 IU/mL). Comparisons of dry-hematology and other methods were also conducted using ex vivo samples obtained from cardiac surgical patients (n = 60). RESULTS: In plasma samples, there were no significant differences between dry-hematology and the Clauss method, while dry-hematology showed lower fibrinogen levels compared with PT-derived and antigen level methods. The dry-hematology method yielded acceptable concordance correlation coefficients (Pc) with the Clauss method, the PT-derived method, and fibrinogen antigen levels (Pc = 0.91-0.99). The type of diluents and heparin affected the results of the PT-derived method and thromboelastometric assay, but not the dry-hematology method. In cardiac surgical patients, the overall correlation in fibrinogen levels between dry-hematology and the other methods was comparable to the results from in vitro dilution experiments. The dry-hematology reported higher fibrinogen values in whole blood compared with those measured in plasma samples, but hematocrit adjustment decreased the bias between whole blood and plasma samples from 73 mg/dL (95% prediction interval: 40, 106) to -13 mg/dL (95% prediction interval: -35, 8.5). CONCLUSIONS: This study demonstrated that fibrinogen levels can be accurately assessed by the dry-hematology method in plasma and the results are not affected by heparin or colloids. For whole blood fibrinogen measurements by dry-hematology, hematocrit adjustment is necessary to compensate for dynamic changes in hematocrit in perioperative bleeding settings.	[Ogawa, Satoru; Nakajima, Yasufumi; Nakayama, Yoshinobu; Takeshita, Jun; Mizobe, Toshiki] Kyoto Prefectural Univ Med, Dept Anesthesiol & Intens Care, Kyoto 6028566, Japan; [Tanaka, Kenichi A.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA USA; [Arai, Masatoshi] A&T Corp, Res Inst, Yokohama, Kanagawa, Japan	Ogawa, S (reprint author), Kyoto Prefectural Univ Med, Dept Anesthesiol, Kamigyo Ku, Kyoto 6028566, Japan.	s-ogawa@koto.kpu-m.ac.jp					Amukele TK, 2010, AM J CLIN PATHOL, V133, P550, DOI 10.1309/AJCPLDT9OVX1TDGT; Solomon C, 2012, ANESTH ANALG, V114, P721, DOI 10.1213/ANE.0b013e31824724c8; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Fenger-Eriksen C, 2010, TRANSFUSION, V50, P2571, DOI 10.1111/j.1537-2995.2010.02752.x; Nielsen VG, 2004, ANESTH ANALG, V99, P120, DOI 10.1213/01.ANE.0000123012.24871.62; Miesbach W, 2010, THROMB RES, V126, pE428, DOI 10.1016/j.thromres.2010.09.004; Solomon C, 2011, TRANSFUSION, V51, P1695, DOI 10.1111/j.1537-2995.2011.03066.x; Ogawa S, 2012, TRANSFUSION, V52, P14, DOI 10.1111/j.1537-2995.2011.03241.x; Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; Levy JH, 2014, TRANSFUSION, V54, P1389, DOI 10.1111/trf.12431; Ogawa S, 2012, ANESTH ANALG, V115, P16, DOI 10.1213/ANE.0b013e31824d523b; Jambor C, 2009, ANESTH ANALG, V109, P1023, DOI 10.1213/ANE.0b013e3181b5a263; Clark RAF, 2001, ANN NY ACAD SCI, V936, P355; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI [10.1213/ane.0b013e318168b367, 10.1213/ane.0013e318168067]; Bolliger D, 2010, ANESTHESIOLOGY, V113, P1205, DOI 10.1097/ALN.0b013e3181f22b5a; Gertler R, 2011, J CARDIOTHOR VASC AN, V25, P981, DOI 10.1053/j.jvca.2010.11.020; Blome M, 2005, THROMB HAEMOSTASIS, V93, P1101, DOI 10.1160/TH04-12-0799; Bolliger D, 2010, BRIT J ANAESTH, V104, P318, DOI 10.1093/bja/aeq001; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Gosselin RC, 1998, LAB HEMATOL, V4, P217; Hiippala ST, 1995, BLOOD COAGUL FIBRIN, V6, P743; Lawrie AS, 1998, J CLIN PATHOL, V51, P462; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mackie J, 2002, Thromb Haemost, V87, P997; McBride GB., 2005, HAM20050622005 NIWA, P1; OBERHARDT BJ, 1991, CLIN CHEM, V37, P520; Roullet S, 2010, BRIT J ANAESTH, V104, P422, DOI 10.1093/bja/aeq022; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Solomon C, 2012, BRIT J ANAESTH, V109, P851, DOI 10.1093/bja/aes361; Tanaka KA, 2013, J CARDIOTHOR VASC AN, V27, pS9, DOI 10.1053/j.jvca.2013.05.012	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999	1526-7598		ANESTH ANALG	Anesth. Analg.	JAN	2015	120	1					18	25		10.1213/ANE.0000000000000448		8	Anesthesiology	Anesthesiology	AW9TW	WOS:000346601300007		
J	Sato, K; Kurita, T; Chitose, S; Umeno, H; Nakashima, T				Sato, Kiminori; Kurita, Takashi; Chitose, Shun-ichi; Umeno, Hirohito; Nakashima, Tadashi			Mechanical Regulation of Human Vocal Fold Stellate Cells	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						unphonated vocal fold; mechanotransduction; vocal fold stellate cell; cytoskeleton; macula flava; human vocal fold; larynx	MACULA FLAVA; HUMAN NEWBORN; FUNCTIONAL HISTOLOGY; SYSTEM; MUCOSA	Objective: It is generally accepted that tensile and compressive strains have direct effects on cell morphology and structure, including changes in cytoskeletal structure and organization. Cytoskeletons play the role of mechanoreceptor of the cells. Vocal fold stellate cells (VFSCs) in the human maculae flavae (MFe) are inferred to be involved in the metabolism of extracellular matrices essential for the viscoelasticity of the vocal fold mucosa. Our previous studies have supported the hypothesis that the tension caused by phonation (vocal fold vibration) regulates the behavior of the VFSCs. The microstructure of the intermediate filaments and the expression of their proteins were investigated in VFSCs in the MFe, which had remained unphonated since birth. Methods: Three adult vocal fold mucosae that had remained unphonated since birth were investigated by immunohistochemistry and electron microscopy. Results: The intermediate filaments of the VFSCs were fewer in number. The expression of their characteristic proteins (vimentin, desmin, and glial fibrillary acidic protein) was also reduced. Conclusion: Vocal fold vibration seems to affect VFSC morphology and structure, such as cytoskeletal structure and organization. This supports the hypothesis that vocal fold vibration regulates VFSC behavior in the human MFe. In addition to chemical factors, mechanical factors also appear to modulate VFSC behavior.	[Sato, Kiminori; Kurita, Takashi; Chitose, Shun-ichi; Umeno, Hirohito; Nakashima, Tadashi] Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kurume, Fukuoka 8300011, Japan	Sato, K (reprint author), Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	kimisato@oct-net.ne.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24592612]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This investigation was supported by a Grant-in-Aid for Scientific Research (No. 24592612) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Zhao LN, 2007, J MOL HISTOL, V38, P53, DOI 10.1007/s10735-007-9078-5; Becker W, 2006, WORLD CELL, P446; Hirano M., 1983, VOCAL FOLD PHYSL CON, P22; Hirano M, 1975, OTOLOGIA FUKUOKA  S1, V21, P239; Hirano MS, 1993, HISTOLOGICAL COLOR A; Kurpinski K, 2010, CELLULAR MECHANOTRAN, P403; Mofrad M.R., 2010, CELLULAR MECHANOTRAN; Sato K, 2003, ACTA OTO-LARYNGOL, V123, P106, DOI 10.1080/0036554021000028077; Sato K, 2008, ACTA OTO-LARYNGOL, V128, P694, DOI 10.1080/00016480701675643; Sato K, 2001, ANN OTO RHINOL LARYN, V110, P319; Sato K, 2012, ANN OTO RHINOL LARYN, V121, P51; Sato K, 2010, FOLIA PHONIATR LOGO, V62, P178, DOI 10.1159/000314261; Sato K, 2012, J VOICE, V26, P37, DOI 10.1016/j.jvoice.2010.10.006; Sato K, 2004, ANN OTO RHINOL LARYN, V113, P108; SATO K, 1995, ANN OTO RHINOL LARYN, V104, P556; Sato K, 2001, ANN OTO RHINOL LARYN, V110, P417; Sato K, 2010, FOLIA PHONIATR LOGO, V62, P263, DOI 10.1159/000316962; Sato K, 2005, ANN OTO RHINOL LARYN, V114, P517; Sato K, 2012, ANN OTO RHINOL LARYN, V121, P798; Sato K, 2009, ANN OTO RHINOL LARYN, V118, P773; Titze IR, 2004, J ACOUST SOC AM, V115, P2264, DOI 10.1121/1.698832	21	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	JAN	2015	124	1					49	54		10.1177/0003489414542091		6	Otorhinolaryngology	Otorhinolaryngology	AX0PF	WOS:000346653400007		
J	Watanabe, K; Okumura, Y; Hashimoto, K; Suzuki, T				Watanabe, Kenichi; Okumura, Yuri; Hashimoto, Ken; Suzuki, Takashi			Clear Cell Carcinoma of the Base of the Tongue: Case Report and Literature Review	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						clear cell carcinoma; CCC; base of the tongue; minor salivary gland tumor	TRANSORAL LASER MICROSURGERY; OF-THE-LITERATURE; SALIVARY-GLANDS; TUMORS; IMMUNOHISTOCHEMISTRY; DIAGNOSIS	Objective: Clear cell carcinoma (CCC) is a rare, low-grade malignant neoplasm of minor salivary glands. Clear cell carcinoma is composed of monomorphic clear cells that contain glycogen within a hyalinized stroma. The microscopic diagnosis can be challenging, and the treatment strategy has not been established. Methods: We report a case of a 56-year-old woman with CCC in the base of the tongue. A literature review, including 22 published cases and our case, was performed to clarify the clinical characteristics of CCC in the base of the tongue. Results: The exophytic tumor showed no infiltration to the neighboring tissues. She underwent a local excision en bloc transorally and is free of the disease 15 months after surgery. In our review of 23 cases of CCC in the base of the tongue, 21 cases received surgical excision for the purpose of the primary treatment modality. The fact that the distinctive features of restricted site-related symptoms and the rare presentation of pain emerged was similar to previously reported cases of CCC. A relatively good prognosis was still indicated. Conclusion: We reveal the features of the unusual occurrence of CCC in the base of the tongue and consider the appropriate surgical approach for primary treatment.	[Watanabe, Kenichi; Okumura, Yuri; Hashimoto, Ken] Sendai Social Insurance Hosp, Dept Otolaryngol, Sendai, Miyagi, Japan; [Watanabe, Kenichi] Tohoku Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Suzuki, Takashi] Tohoku Univ, Sch Med, Dept Pathol & Histotechnol, Sendai, Miyagi 9808574, Japan	Watanabe, K (reprint author), Tohoku Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan.	kenw@orl.med.tohoku.ac.jp					Adil E, 2013, HEAD NECK-J SCI SPEC, V35, pE184, DOI 10.1002/hed.22940; Agrawal A, 2000, LARYNGOSCOPE, V110, P1802, DOI 10.1097/00005537-200011000-00005; Ozcan A, 2012, ARCH PATHOL LAB MED, V136, P1541, DOI 10.5858/arpa.2012-0072-OA; Grant DG, 2006, LARYNGOSCOPE, V116, P2150, DOI 10.1097/01.mlg.0000244159.64179.f0; Steiner W, 2003, ARCH OTOLARYNGOL, V129, P36; Camp AA, 2009, OTOLARYNG HEAD NECK, V141, P66, DOI 10.1016/j.otohns.2009.02.028; Balakrishnan R, 2002, J LARYNGOL OTOL, V116, P851; Barnes L, 2005, WHO CLASSIFICATION T; Casani Augusto Pietro, 2011, Ear Nose Throat J, V90, pE9; Jin Rongyu, 2012, Head Neck Pathol, V6, P389, DOI 10.1007/s12105-012-0338-7; JONES JE, 1992, ARCH OTOLARYNGOL, V118, P1350; Lai G, 2008, EUR J HISTOCHEM, V52, P251; Maiorano E, 1997, SEMIN DIAGN PATHOL, V14, P203; Masilamani S, 2011, INDIAN J PATHOL MICR, V54, P167, DOI 10.4103/0377-4929.77393; MILCHGRUB S, 1994, AM J SURG PATHOL, V18, P74, DOI 10.1097/00000478-199401000-00007; Milchgrub S, 2000, DIAGN CYTOPATHOL, V23, P333, DOI 10.1002/1097-0339(200011)23:5<333::AID-DC10>3.0.CO;2-R; O'Sullivan-Mejia E D, 2009, Head Neck Pathol, V3, P179, DOI 10.1007/s12105-009-0124-3; O'Regan E, 2004, ORAL ONCOL, V40, P348, DOI 10.1016/j.oraloncology.2003.08.023; Pujary K, 2008, INT J ORAL MAX SURG, V37, P93, DOI 10.1016/j.ijom.2007.06.014; Ries LAG, 1991, CANC STAT REV 1973 8; Rinaldo A, 1999, ORL J OTO-RHINO-LARY, V61, P48, DOI 10.1159/000027639; Sangoi AR, 2010, ADV ANAT PATHOL, V17, P377, DOI 10.1097/PAP.0b013e3181f89400; Sicurella F, 2004, Acta Otorhinolaryngol Ital, V24, P157; Solar AA, 2009, CANCER, V115, P75, DOI 10.1002/cncr.23974; Suzuki H, 2006, ACTA OTO-LARYNGOL, V126, P653, DOI 10.1080/00016480500452509; Uzochukwu NO, 2007, AM J NEURORADIOL, V28, P127; Wang B, 2002, ARCH PATHOL LAB MED, V126, P676; Yang SD, 2008, ORAL SURG ORAL MED O, V106, P712, DOI 10.1016/j.tripleo.2008.04.016; Ying YLM, 2006, LARYNGOSCOPE, V116, P1284, DOI 10.1097/01.mlg.0000224358.55022.8a	29	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	JAN	2015	124	1					55	61		10.1177/0003489414542094		7	Otorhinolaryngology	Otorhinolaryngology	AX0PF	WOS:000346653400008		
J	Sato, H; Ebisawa, K; Takanari, K; Yagi, S; Toriyama, K; Yamawaki-Ogata, A; Kamei, Y				Sato, Hideyoshi; Ebisawa, Katsumi; Takanari, Keisuke; Yagi, Shunjiro; Toriyama, Kazuhiro; Yamawaki-Ogata, Aika; Kamei, Yuzuru			Skin-Derived Precursor Cells Promote Wound Healing in Diabetic Mice	ANNALS OF PLASTIC SURGERY			English	Article						skin-derived precursor cells; SKPs; wound healing; diabetes mellitus; diabetic foot ulcer	HUMAN EPIDERMAL-KERATINOCYTES; REFLEX-RELATED VASODILATION; MESENCHYMAL STEM-CELLS; FOOT ULCERS; SECRETORY FACTORS; OBESITY SYNDROMES; DIFFERENTIATION; FIBROBLASTS; NEUROPATHY; STRAINS	Background: Impaired wound healing as one of the complications arising from diabetes mellitus is a serious clinical issue. Recently, various cell therapies have been reported for promotion of wound healing. Skin-derived precursor cells (SKPs) are multipotent adult stem cells with the tendency to differentiate into neurons. We investigated the potency of promoting diabetic wound healing by the application of SKPs. Methods: Skin-derived precursor cells isolated from diabetic murine skin were cultured in sphere formation medium. At passage 2, they were suspended in phosphate-buffered saline (PBS), and applied topically to full-thickness excisional cutaneous wounds in diabetic mice. Application of PBS served as controls (n = 21 for each group; n = 42 total). Time to closure and percentage closure were calculated by morphometry. Wounds were harvested at 10 and 28 days and then processed, sectioned, and stained (CD31, alpha-smooth muscle actin, and neurofilament heavy chain) to quantify vascularity and neurofilaments. Results: Wounds treated with SKPs demonstrated a significantly decreased time to closure (18.63 days) compared with PBS-control wounds (21.72 days, P > 0.01), and a significant improvement in percentage closure at 7, 10, 14, and 18 days compared with PBS-control wounds (P > 0.01). Histological analysis showed that the Capillary Score (the number of vessels/mm(2)) was significantly higher in SKP-treated wounds at day 10 but not at day 28. Nerve Density (the number of neurofilaments/mm(2)) had increased significantly in SKP-treated wounds at day 28 compared with control group. Some applied SKPs were stained by neurofilament heavy chain, which demonstrates that SKPs directly differentiated into neurons. Conclusions: Skin-derived precursor cells promoted diabetic wound healings through vasculogenesis at the early stage of wound healing. Skin-derived precursor cells are a possible therapeutic tool for diabetic impaired wound healing.	[Sato, Hideyoshi; Ebisawa, Katsumi; Takanari, Keisuke; Yagi, Shunjiro; Toriyama, Kazuhiro; Kamei, Yuzuru] Nagoya Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Nagoya, Aichi 4668560, Japan; [Yamawaki-Ogata, Aika] Nagoya Univ, Grad Sch Med, Dept Cardiac Surg, Nagoya, Aichi 4668560, Japan	Ebisawa, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668560, Japan.	hideyosi@med.nagoya-u.ac.jp			Japan Society for the Promotion of Science [23592645]	Supported by Japan Society for the Promotion of Science KAKENHI [Grant-in-Aid for Scientific Research (C)] Grant 23592645.	Cavanagh P, 2012, DIABETES-METAB RES, V28, P107, DOI 10.1002/dmrr.2245; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Chen ZG, 2012, STEM CELLS, V30, P2261, DOI 10.1002/stem.1186; Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Walsh S, 2009, NEUROSCIENCE, V164, P1097, DOI 10.1016/j.neuroscience.2009.08.072; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Hamdy O, 2001, DIABETES CARE, V24, P344, DOI 10.2337/diacare.24.2.344; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Steinbach SK, 2011, ARTERIOSCL THROM VAS, V31, P2938, DOI 10.1161/ATVBAHA.111.232975; Tark KC, 2010, ANN PLAS SURG, V65, P565, DOI 10.1097/SAP.0b013e3181d9aae2; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Mansbridge JN, 1999, DIABETES OBES METAB, V1, P265, DOI 10.1046/j.1463-1326.1999.00032.x; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Caselli A, 2003, NEUROLOGY, V60, P297; COLEMAN DL, 1982, DIABETES, V31, P1; Davidson JM, 1998, ARCH DERMATOL RES, V290, pS1, DOI 10.1007/PL00007448; Hehenberger Karin, 1998, Wound Repair and Regeneration, V6, P135, DOI 10.1046/j.1524-475X.1998.60207.x; Hunt NA, 2011, PLAST RECONSTR SURG, V127, p289S, DOI 10.1097/PRS.0b013e3181fbe2a6; Illigens BMW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054760; Kim SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041105; Lee MJ, 2011, CYTOTHERAPY, V13, P165, DOI 10.3109/14653249.2010.512632; Lin CD, 2008, PLAST RECONSTR SURG, V122, P1341, DOI 10.1097/PRS.0b013e318188217b; OCONNOR NE, 1981, LANCET, V1, P75; Tennvall GR, 2004, CLIN INFECT DIS, V39, pS132; Robson MC, 2003, CLIN PLAST SURG, V30, P57, DOI 10.1016/S0094-1298(02)00073-1	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	JAN	2015	74	1					114	120		10.1097/SAP.0000000000000342		7	Surgery	Surgery	AW9UT	WOS:000346604000025		
J	Yajima, R; Fujii, T; Yanagita, Y; Fujisawa, T; Miyamoto, T; Hirakata, T; Tsutsumi, S; Iijima, M; Kuwano, H				Yajima, Reina; Fujii, Takaaki; Yanagita, Yasuhiro; Fujisawa, Tomomi; Miyamoto, Takeshi; Hirakata, Tomoko; Tsutsumi, Soichi; Iijima, Misa; Kuwano, Hiroyuki			Prognostic Value of Extracapsular Invasion of Axillary Lymph Nodes Combined with Peritumoral Vascular Invasion in Patients with Breast Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							TUMOR SPREAD; LYMPHOVASCULAR INVASION; PREMENOPAUSAL PATIENTS; DISEASE RECURRENCE; METASTASIS; EXTENSION; SURVIVAL; CARCINOMA; RISK	Extracapsular invasion (ECI) of metastatic axillary lymph nodes has been associated with aggressive nodal disease but its prognostic role in breast cancer is unclear. The present study evaluated nodal ECI as a predictor of breast cancer recurrence. We evaluated 154 women with histologically proven node-positive breast cancer who were diagnosed with invasive ductal carcinoma, and investigated the relationships between ECI and recurrences and other clinicopathological factors, particularly vascular invasion and the number of lymph node metastases. The presence of ECI at positive nodes was significantly associated with the number of positive nodes, and with disease recurrence and survival in univariate (but not multivariate) analysis. Interestingly, all ECI+ patients with distant metastases in our series had peritumoral vascular invasion (PVI), which may have reflected systemic disease; ECI with PVI of the primary tumor strongly predicted recurrent disease and shorter survival. ECI of axillary metastases combined with PVI indicates high tumor aggressiveness. Patients with ECI and PVI may be considered for stronger adjuvant therapies because of their high risk for distant recurrences.	[Yajima, Reina; Fujii, Takaaki; Tsutsumi, Soichi; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 371, Japan; [Yanagita, Yasuhiro; Fujisawa, Tomomi; Miyamoto, Takeshi; Hirakata, Tomoko] Gunma Prefectural Canc Ctr, Dept Breast Oncol, Ota, Gunma, Japan; [Iijima, Misa] Gunma Prefectural Canc Ctr, Dept Pathol, Ota, Gunma, Japan	Yajima, R (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 371, Japan.	reinawat5507@yahoo.co.jp					Achen MG, 2009, ANN NY ACAD SCI, V1131, P225; Taghian A, 2004, J CLIN ONCOL, V22, P4247, DOI 10.1200/JCO.2004.01.042; Yano H, 2006, DIS COLON RECTUM, V49, P1867, DOI 10.1007/s10350-006-0733-9; Yamashita H, 1999, CANCER, V86, P842, DOI 10.1002/(SICI)1097-0142(19990901)86:5<842::AID-CNCR21>3.0.CO;2-X; Cornwell LB, 2011, AM SURGEON, V77, P874; Bucci JA, 2001, BREAST, V10, P213, DOI 10.1054/brst.2000.0233; Cserni G, 2008, J CLIN PATHOL, V61, P115, DOI 10.1136/jcp.2007.047357; D'Journo XB, 2009, J THORAC ONCOL, V4, P534; Dobi E, 2013, INT J CLIN ONCOL, V18, P607, DOI 10.1007/s10147-012-0439-z; DONEGAN WL, 1993, CANCER, V72, P778, DOI 10.1002/1097-0142(19930801)72:3<778::AID-CNCR2820720324>3.0.CO;2-J; Fujii T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-216; Fujii T, 2010, WORLD J SURG, V34, P544, DOI 10.1007/s00268-009-0389-4; Fujii T, 2011, WORLD J GASTROENTERO, V17, P2003, DOI 10.3748/wjg.v17.i15.2003; Gruber G, 2005, J CLIN ONCOL, V23, P7089, DOI 10.1200/JCO.2005.08.123; Gruber G, 2008, ANN ONCOL, V19, P1393, DOI 10.1093/annonc/mdn123; Hasebe T, 2003, CANCER SCI, V94, P508, DOI 10.1111/j.1349-7006.2003.tb01474.x; Hetelekidis S, 2000, INT J RADIAT ONCOL, V46, P31, DOI 10.1016/S0360-3016(99)00424-1; LAURIA R, 1995, CANCER, V76, P1772, DOI 10.1002/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O; LEONARD C, 1995, J CLIN ONCOL, V13, P47; Neri A, 2005, ANN SURG ONCOL, V12, P246, DOI 10.1245/ASO.2005.02.029; Okamoto T, 2008, GASTRIC CANCER, V11, P160, DOI 10.1007/s10120-008-0473-8; Royton D, 2009, J PATHOL, V217, P608; Stitzenberg KB, 2003, ANN SURG, V237, P607, DOI 10.1097/00000658-200305000-00002; Stranzl H, 2004, STRAHLENTHER ONKOL, V180, P623, DOI 10.1007/s00066-004-1241-2; Woo CS, 2002, AM J SURG, V184, P337, DOI 10.1016/S0002-9610(02)00950-9; Woodward WA, 2003, J CLIN ONCOL, V21, P3244, DOI 10.1200/JCO.2003.03.052	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					52	58		10.1245/s10434-014-3941-x		7	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400011		
J	Nakagawa, K; Tanaka, K; Homma, Y; Nojiri, K; Kumamoto, T; Takeda, K; Endo, I				Nakagawa, Kazuya; Tanaka, Kuniya; Homma, Yuki; Nojiri, Kazunori; Kumamoto, Takafumi; Takeda, Kazuhisa; Endo, Itaru			Low Infiltration of Peritumoral Regulatory T Cells Predicts Worse Outcome Following Resection of Colorectal Liver Metastases	ANNALS OF SURGICAL ONCOLOGY			English	Article							OVARIAN-CANCER; NEOADJUVANT CHEMOTHERAPY; IMMUNOLOGICAL IMPACT; TUMOR-IMMUNITY; LYMPHOCYTES; CARCINOMA; SURVIVAL; FOXP3; IMMUNOTHERAPY; HEPATECTOMY	The tumor-infiltrating lymphocyte (TIL) count in several types of cancer, including colorectal cancer and colorectal liver metastases (CRLM), reportedly predicts survival following resection; however, the prognostic significance of the TIL counts remains controversial. In total, 162 patients who underwent potentially curative resection for CRLM from 1992 to 2010 were immunohistochemically analyzed retrospectively. CD4, CD8, and FoxP3 were examined as markers for helper T cells, cytotoxic T cells, and regulatory T cells (Tregs), respectively. The correlation between patients' TIL composition and long-term outcome was investigated. The median follow-up time was 46.6 months for all patients and 46.8 months for survivors. Cancer-specific survival (CSS) at 1, 3, and 5 years was 93.2, 65.6, and 51.0 %, respectively. The 5-year disease-free survival and CSS among patients with high infiltration of peritumoral Tregs was 44.2 and 74.8 %, respectively, while those of patients with low infiltration of peritumoral Tregs was 18.9 and 40.3 %, respectively (p < 0.01 for both). Multivariate analyses indicated that synchronous liver metastases, hypoalbuminemia, and low peritumoral Treg infiltration were significant predictors of unfavorable CSS. Low peritumoral Treg infiltration proved to be a significant predictor of unfavorable CSS in patients undergoing resection for CRLM.	[Nakagawa, Kazuya; Homma, Yuki; Nojiri, Kazunori; Kumamoto, Takafumi; Takeda, Kazuhisa; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; [Tanaka, Kuniya] Teikyo Univ, Chiba Med Ctr, Dept Surg, Ichihara, Chiba, Japan	Endo, I (reprint author), Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan.	endoit@med.yokohama-cu.ac.jp					Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Rudy DR, 2000, AM FAM PHYSICIAN, V61, P1759; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Ladoire S, 2008, CLIN CANCER RES, V14, P2413, DOI 10.1158/1078-0432.CCR-07-4491; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Muratore A, 2010, ANN SURG ONCOL, V17, P1324, DOI 10.1245/s10434-009-0770-4; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Miller G, 2007, J AM COLL SURGEONS, V205, P231, DOI 10.1016/j.jamcollsurg.2007.04.039; Howe HL, 2006, CANCER, V107, P1711, DOI 10.1002/cncr.22193; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Tanaka K, 2013, SURGERY, V153, P179, DOI 10.1016/j.surg.2012.06.026; de Haas RJ, 2008, ANN SURG, V248, P626, DOI 10.1097/SLA.0b013e31818a07f1; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Tanaka K, 2008, SURGERY, V143, P259, DOI 10.1016/j.surg.2007.08.015; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Tsuchikawa T, 2012, ANN SURG ONCOL, V19, P1713, DOI 10.1245/s10434-011-1906-x; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Shurin GV, 2009, J IMMUNOL, V183, P137, DOI 10.4049/jimmunol.0900734; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Adam R, 2009, J CLIN ONCOL, V27, P1829, DOI 10.1200/JCO.2008.19.9273; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Gallimore AM, 2008, ONCOGENE, V27, P5886, DOI 10.1038/onc.2008.269; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Homma Y, 2014, ANN SURG ONCOL, V21, P670, DOI 10.1245/s10434-013-3390-y; KAWASAKI S, 1994, SURGERY, V115, P674; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Rudy DR, 2000, AM FAM PHYSICIAN, V61, P1773; Tanaka Kuniya, 2009, World J Hepatol, V1, P79, DOI 10.4254/wjh.v1.i1.79; Zhang YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-4	39	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					180	186		10.1245/s10434-014-3974-1		7	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400030		
J	Kobayashi, H; Kikuchi, A; Okazaki, S; Ishiguro, M; Ishikawa, T; Iida, S; Uetake, H; Sugihara, K				Kobayashi, Hirotoshi; Kikuchi, Akifumi; Okazaki, Satoshi; Ishiguro, Megumi; Ishikawa, Toshiaki; Iida, Satoru; Uetake, Hiroyuki; Sugihara, Kenichi			Diagnostic Performance of Multidetector Row Computed Tomography for Assessment of Lymph Node Metastasis in Patients with Distal Rectal Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							PELVIC SIDEWALL DISSECTION; PREOPERATIVE RADIOTHERAPY; COLORECTAL-CARCINOMA; RANDOMIZED-TRIAL; CT; COLON; SURGERY; MULTICENTER; DYSFUNCTION; RECURRENCE	The accurate preoperative diagnosis of depth of tumor invasion and nodal status in distal rectal cancer is important because neoadjuvant chemotherapy or lateral pelvic lymph node dissection is indicated for patients with T3-T4 tumor or nodal involvement. This study aimed to determine the optimal cutoff value for predicting lymph node metastasis in patients with distal rectal cancer using multidetector row computed tomography (MDCT). The study investigated 77 patients who had undergone surgery for distal rectal cancer at a single institution between 2008 and 2011. Diagnostic performance for depth of tumor invasion and mesorectal and lateral pelvic lymph node metastases was evaluated. The optimal cutoff value was determined by receiver operating characteristic curve analysis. For predicting mesorectal and lateral pelvic lymph node metastasis, MDCT had a sensitivity of 0.36 and 0.89 and a specificity of 0.78 and 0.97, respectively. The optimal cutoff values of major and minor axes lengths for predicting mesorectal lymph node metastasis were 6.5 mm and 5.7 mm, respectively. The areas under the curve (AUCs) were 0.82 and 0.88, respectively. For predicting lateral lymph node metastasis, the optimal cutoff values were 9 mm for the major axis and 6 mm for the minor axis. Both AUCs were 1. Using MDCT, the optimal cutoff value of minor axis length for predicting mesorectal and lateral pelvic lymph node metastases in patients with distal rectal cancer was 6 mm. The accuracy of MDCT was satisfactory for predicting lateral pelvic lymph node metastasis.	[Kobayashi, Hirotoshi] Tokyo Med & Dent Univ, Ctr Minimally Invas Surg, Tokyo, Japan; [Kikuchi, Akifumi; Okazaki, Satoshi; Ishikawa, Toshiaki; Iida, Satoru; Sugihara, Kenichi] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Tokyo, Japan; [Ishiguro, Megumi; Uetake, Hiroyuki] Tokyo Med & Dent Univ, Dept Translat Oncol, Tokyo, Japan	Kobayashi, H (reprint author), Tokyo Med & Dent Univ, Ctr Minimally Invas Surg, Tokyo, Japan.	h-kobayashi.srg2@tmd.ac.jp					ACUNAS B, 1990, EUR J RADIOL, V11, P150, DOI 10.1016/0720-048X(90)90166-9; Akasu T, 2009, ANN SURG ONCOL, V16, P2779, DOI 10.1245/s10434-009-0546-x; Kobayashi H, 2010, ANN SURG ONCOL, V17, P973, DOI 10.1245/s10434-009-0849-y; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Kotake K, 2003, DIS COLON RECTUM, V46, pS32, DOI 10.1097/01.DCR.0000083389.92214.AA; FREENY PC, 1986, RADIOLOGY, V158, P347; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Lange MM, 2008, BRIT J SURG, V95, P1020, DOI 10.1002/bjs.6126; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; Kanamoto T, 2007, J COMPUT ASSIST TOMO, V31, P831; Kobayashi H, 2009, DIS COLON RECTUM, V52, P567, DOI 10.1007/DCR.0b013e3181a1d994; Lange MM, 2009, EUR J CANCER, V45, P1578, DOI 10.1016/j.ejca.2008.12.014; Hundt W, 1999, EUR RADIOL, V9, P78, DOI 10.1007/s003300050632; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Dighe S, 2010, CLIN RADIOL, V65, P708, DOI 10.1016/j.crad.2010.01.024; BALTHAZAR EJ, 1988, AM J ROENTGENOL, V150, P301; Harvey CJ, 1998, AM J ROENTGENOL, V170, P1439; Gerard JP, 2012, J CLIN ONCOL, V30, P4558, DOI 10.1200/JCO.2012.42.8771; Ashraf Kashif, 2006, JPMA Journal of the Pakistan Medical Association, V56, P149; Cademartiri Filippo, 2002, Radiol Med, V104, P295; GAZELLE GS, 1995, J COMPUT ASSIST TOMO, V19, P87, DOI 10.1097/00004728-199501000-00017; Isbister WH, 1996, J ROY COLL SURG EDIN, V41, P232; Kobayashi H, 2011, INT J COLORECTAL DIS, V26, P891, DOI 10.1007/s00384-011-1173-0; McAndrew MR, 1999, AM SURGEON, V65, P205; Muto Tetsuichiro, 2001, International Journal of Clinical Oncology, V6, P171, DOI 10.1007/PL00012102; SOLOMON MJ, 1993, DIS COLON RECTUM, V36, P200, DOI 10.1007/BF02051183; Sugihara K, 1996, CANCER, V78, P1871, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1871::AID-CNCR5>3.0.CO;2-I; TAYLOR AJ, 1991, SEMIN ONCOL, V18, P99	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					203	208		10.1245/s10434-014-3972-3		6	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400033		
J	Yamamoto, K; Tsujinaka, T; Takahashi, T; Sato, S; Nishiguchi, Y; Nakashima, Y; Muguruma, K; Hirota, S; Nishida, T				Yamamoto, Kazuyoshi; Tsujinaka, Toshimasa; Takahashi, Tsuyoshi; Sato, Shinsuke; Nishiguchi, Yukio; Nakashima, Yasuo; Muguruma, Kazuya; Hirota, Seiichi; Nishida, Toshiro			Impact of the Japanese Gastric Cancer Screening System on Treatment Outcomes in Gastric Gastrointestinal Stromal Tumor (GIST): An Analysis Based on the GIST Registry	ANNALS OF SURGICAL ONCOLOGY			English	Article							DIFFERENTIAL-DIAGNOSIS; ADJUVANT IMATINIB; STOMACH-CANCER; C-KIT; MUTATIONS; RESECTION; RISK; PATHOLOGY; PROGNOSIS; MORTALITY	Gastrointestinal stromal tumors (GISTs) of the stomach are found incidentally during gastric cancer screening in Japan. This study investigated whether the Japanese gastric cancer screening system helps to improve treatment outcomes in gastric GIST based on an analysis of the GIST registry conducted by the Kinki GIST Study Group. The registry was designed to collect data on background characteristics, treatment methods, pathologic characteristics, and prognosis of GIST from January 2003 through December 2007 at 40 participating institutions. The study enrolled 672 GIST patients, 482 of whom had gastric GIST. According to the modified National Institutes of Health consensus criteria, 22.6 % of the patients were classified as high risk for recurrence, 18.5 % as intermediate risk, 35.9 % as low risk, and 13.9 % as very low risk. After exclusion of the patients inevaluable for treatment outcome, the study included 137 symptomatic patients (symptomatic group) and 147 asymptomatic patients (asymptomatic group). The diagnosis of the asymptomatic patients was determined through gastric cancer screening. The median tumor size in the asymptomatic group was significantly smaller than in the symptomatic group (3.5 vs. 5.3 cm; P < 0.0001). The 5-year recurrence-free survival rate in the asymptomatic high-risk patients (72.4 %) was lower than in their symptomatic counterparts (46.3 %) (P = 0.017). More patients in the asymptomatic group underwent laparoscopic surgery (42.2 vs. 27.2 %; P = 0.0081). By identifying asymptomatic patients, the Japanese gastric cancer screening system contributes to early detection of gastric GIST and favorable treatment outcomes.	[Yamamoto, Kazuyoshi] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan; [Tsujinaka, Toshimasa] Kaizuka City Hosp, Dept Surg, Osaka, Japan; [Takahashi, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Sato, Shinsuke] Shizuoka Prefectural Gen Hosp, Dept Surg, Shizuoka, Japan; [Nishiguchi, Yukio] Osaka City Gen Hosp, Dept Surg, Osaka, Japan; [Nakashima, Yasuo] Osaka Red Cross Hosp, Dept Surg, Osaka, Japan; [Muguruma, Kazuya] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; [Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo, Japan; [Nishida, Toshiro] Natl Canc Ctr Hosp East, Dept Gastr Surg, Chiba, Japan	Yamamoto, K (reprint author), Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan.	kazuy@onh.go.jp					De Vogelaere K, 2013, SURG ENDOSC, V27, P1546, DOI 10.1007/s00464-012-2622-8; Karakousis GC, 2011, ANN SURG ONCOL, V18, P1599, DOI 10.1245/s10434-010-1517-y; Rutkowski P, 2007, ANN SURG ONCOL, V14, P2018, DOI 10.1245/s10434-007-9377-9; SHIRATORI Y, 1985, AM J GASTROENTEROL, V80, P831; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Koh YX, 2013, ANN SURG ONCOL, V20, P3549, DOI 10.1245/s10434-013-3051-1; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Rossi S, 2010, AM J SURG PATHOL, V34, P1480, DOI 10.1097/PAS.0b013e3181ef7431; Lambert R, 2002, INT J CANCER, V97, P811, DOI 10.1002/ijc.10150; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Agaimy A, 2007, AM J SURG PATHOL, V31, P113, DOI 10.1097/01.pas.0000213307.05811.f0; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Kawanowa K, 2006, HUM PATHOL, V37, P1527, DOI 10.1016/j.humpath.2006.07.002; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Agaimy A, 2006, SEMIN DIAGN PATHOL, V23, P120, DOI 10.1053/j.semdp.2006.09.004; Demetri George D, 2007, J Natl Compr Canc Netw, V5 Suppl 2, pS1; Heinrich MC, 2005, J SURG ONCOL, V90, P195, DOI 10.1002/jso.20230; National Comprehensive Cancer Network, 2007, J NATL COMPR CANC NE, V5, P364; Sun J, 2001, EUR J CANCER PREV, V10, P61, DOI 10.1097/00008469-200102000-00007; Wozniak A, 2010, CANCER INVEST, V28, P839, DOI 10.3109/07357907.2010.494322	29	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					232	239		10.1245/s10434-014-3971-4		8	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400037		
J	Hiyoshi, Y; Morita, M; Kawano, H; Otsu, H; Ando, K; Ito, S; Miyamoto, Y; Sakamoto, Y; Saeki, H; Oki, E; Ikeda, T; Baba, H; Maehara, Y				Hiyoshi, Yukiharu; Morita, Masaru; Kawano, Hiroyuki; Otsu, Hajime; Ando, Koji; Ito, Shuhei; Miyamoto, Yuji; Sakamoto, Yasuo; Saeki, Hiroshi; Oki, Eiji; Ikeda, Tetsuo; Baba, Hideo; Maehara, Yoshihiko			Clinical Significance of Surgical Resection for the Recurrence of Esophageal Cancer After Radical Esophagectomy	ANNALS OF SURGICAL ONCOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE RECURRENCE; LONG-TERM SURVIVAL; PHASE-II; DEFINITIVE CHEMORADIOTHERAPY; SALVAGE ESOPHAGECTOMY; TREATMENT STRATEGY; THORACIC ESOPHAGUS; CURATIVE RESECTION; CISPLATIN	This study aimed to clarify the clinical significance of surgical resection for recurrent lesions after esophagectomy for esophageal cancer. Recurrence was detected in 113 of 365 consecutive patients who underwent surgical resection for esophageal cancer, and some treatment was performed for recurrence in 100 of the 113 patients. The treatments were classified into two groups: chemotherapy and/or radiation with surgery (surgery group, n = 14) and chemotherapy and/or radiation without surgery (no surgery group, n = 86). The outcomes were retrospectively analyzed. Of the 14 patients in the surgery group, 3 underwent repeated resection. Thus, a total of 22 resections were performed for these patients. The resected organs were the lymph nodes in nine patients, the lungs in six patients, local recurrence in two patients, subcutaneous recurrence in two patients, the liver in one patient, the brain in one patient, and the parotid gland in one patient. Among the 22 recurrent cases, 20 involved solitary lesions or multiple lesions located in a small resectable region. When the two groups were compared, the surgery group showed a more favorable prognosis in terms of both survival after esophagectomy (median survival time, 103.3 vs 23.1 months; p = 0.0060) and survival after initial recurrence (92.1 vs 12.2 months; p = 0.0057). Multimodal treatment provides a significant benefit for patients with recurrence after esophagectomy for esophageal cancer. Surgical intervention should be aggressively included in the treatment strategy when the recurrent lesion is solitary or localized.	[Hiyoshi, Yukiharu; Morita, Masaru; Kawano, Hiroyuki; Otsu, Hajime; Ando, Koji; Ito, Shuhei; Saeki, Hiroshi; Oki, Eiji; Ikeda, Tetsuo; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Miyamoto, Yuji; Sakamoto, Yasuo; Baba, Hideo] Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan	Morita, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	masarum@surg2.med.kyushu-u.ac.jp					Swisher SG, 2002, J THORAC CARDIOV SUR, V123, P175, DOI 10.1067/mtc.2002.119070; Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Nakagawa S, 2004, J AM COLL SURGEONS, V198, P205, DOI 10.1016/j.jamcollsurg.2003.10.005; Nakamura T, 2008, ANN SURG ONCOL, V15, P2451, DOI 10.1245/s10434-008-0016-x; Hironaka S, 2003, INT J RADIAT ONCOL, V57, P425, DOI 10.1016/S0360-3016(03)00585-6; Shimada H, 2003, SURGERY, V133, P24, DOI 10.1067/msy.2003.31; Oki E, 2007, DIS ESOPHAGUS, V20, P301, DOI 10.1111/j.1442-2050.2007.00677.x; Law S, 2003, ANN SURG, V238, P339, DOI 10.1097/01.sla.0000086545.45918.ee; Ichikawa H, 2011, SURGERY, V149, P164, DOI 10.1016/j.surg.2010.07.047; Kadota H, 2010, LARYNGOSCOPE, V120, P1103, DOI 10.1002/lary.20887; Chen G, 2007, WORLD J SURG, V31, P1107, DOI 10.1007/s00268-006-0551-1; Kato H, 2012, ANN THORAC CARDIOVAS, V18, P412, DOI 10.5761/atcs.ra.12.01954; Muro K, 2004, ANN ONCOL, V15, P955, DOI 10.1093/annonc/mdh231; Yamasaki M, 2011, ONCOLOGY-BASEL, V80, P307, DOI 10.1159/000329806; AKIYAMA H, 1981, ANN SURG, V194, P438, DOI 10.1097/00000658-198110000-00007; Pfannschmidt J, 2007, ANN THORAC SURG, V84, P324, DOI 10.1016/j.athoracsur.2007.02.093; Bleiberg H, 1997, EUR J CANCER, V33, P1216, DOI 10.1016/S0959-8049(97)00088-9; Morita M, 2011, J GASTROENTEROL, V46, P1284, DOI 10.1007/s00535-011-0448-0; Chen Fengshi, 2008, Interact Cardiovasc Thorac Surg, V7, P809, DOI 10.1510/icvts.2008.180778; Dresner SM, 2000, BRIT J SURG, V87, P1426, DOI 10.1046/j.1365-2168.2000.01541.x; Hayashi K, 2001, JPN J CLIN ONCOL, V31, P419, DOI 10.1093/jjco/hye090; Hulscher JBF, 2000, J AM COLL SURGEONS, V191, P143, DOI 10.1016/S1072-7515(00)00349-5; Ida S, 2014, ANN SURG ONCOL, V21, P1175, DOI 10.1245/s10434-013-3454-z; Ilson DH, 1998, J CLIN ONCOL, V16, P1826; Demeester TR, 2003, ANN SURG, V238, P347; MATTHEWS HR, 1986, BRIT J SURG, V73, P621, DOI 10.1002/bjs.1800730811; MORITA M, 1994, SURGERY, V116, P1; Motoyama S, 2006, WORLD J SURG, V30, P191, DOI 10.1007/s00268-005-0092-z; SKINNER DB, 1986, ANN SURG, V204, P391, DOI 10.1097/00000658-198610000-00007; Sugiyama M, 2012, SURG TODAY, V42, P752, DOI 10.1007/s00595-012-0133-9; Takemura M, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-103; Uchiyama H, 2012, SURG TODAY, V42, P111, DOI 10.1007/s00595-011-0032-5; Yano M, 2006, DIS ESOPHAGUS, V19, P73, DOI 10.1111/j.1442-2050.2006.00543.x	33	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					240	246		10.1245/s10434-014-3970-5		7	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400038		
J	Shen, WD; Sakamoto, N; Yang, LM				Shen, Weidong; Sakamoto, Naoko; Yang, Limin			Cancer-Specific Mortality and Competing Mortality in Patients with Head and Neck Squamous Cell Carcinoma: A Competing Risk Analysis	ANNALS OF SURGICAL ONCOLOGY			English	Article							COMPREHENSIVE NOMOGRAM; RADICAL PROSTATECTOMY; CUMULATIVE INCIDENCE; DEATH; SURVIVAL; CHEMORADIOTHERAPY; PROGNOSIS; HAZARDS; TUMORS	The objective of this study was to estimate probabilities of cancer-specific death and competing death for patients with head and neck squamous cell carcinoma (HNSCC). In addition, we attempted to construct competing risk nomograms to predict prognosis for patients with HNSCC using a large population-based cohort. Patients diagnosed with nonmetastatic HNSCC between 2000 and 2010 were identified from the Surveillance Epidemiology and End Results Program to form the analytic cohort. We estimated cumulative incident function (CIF) of cancer-specific mortality and competing mortality. Nomograms for predicting probability of death were built with proportional subdistribution hazard models. The study cohort included 23,494 patients with HNSCC. The 5-year CIF for cancer-specific death and competing death were 26.7 % (95 % confidence interval [CI] 26-27.3 %) and 12.7 % (95 % CI 12.2-13.3 %), respectively; 10-year CIF were 32.8 % (95 % CI 31.9-33.6 %) and 23 % (95 % CI 22.1-24 %), respectively. On multivariate analysis, increasing cause-specific mortality was associated with increasing age, increasing tumor size, black race, single status, advanced T and N classifications, and high tumor grade. Increasing probability of competing mortality had a relationship with increasing age, male, black race, single status and nonradiotherapy. Models showed good accuracy with c-index of 0.73 for cause-specific mortality model and 0.69 for competing mortality model. We constructed competing risk nomograms for HNSCC using population-based data. The model used for building nomograms represented good performance. These nomograms can serve to guide management of patients with HNSCC.	[Shen, Weidong] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Sakamoto, Naoko] Juntendo Univ, Dept Publ Hlth, Tokyo, Japan; [Yang, Limin] Natl Ctr Child Hlth & Dev, Epidemiol & Clin Res Ctr Childrens Canc, Tokyo, Japan; [Yang, Limin] Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Tokyo, Japan	Yang, LM (reprint author), Natl Ctr Child Hlth & Dev, Epidemiol & Clin Res Ctr Childrens Canc, Tokyo, Japan.	yo-r@ncchd.go.jp					Ali S, 2014, ANN SURG ONCOL, V21, P637, DOI 10.1245/s10434-013-3321-y; Kattan MW, 2003, STAT MED, V22, P3515, DOI 10.1002/sim.1574; Du XL, 2008, AM J CLIN ONCOL-CANC, V31, P105, DOI 10.1097/COC.0b013e318142c865; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Montero PH, 2014, CANCER-AM CANCER SOC, V120, P214, DOI 10.1002/cncr.28407; Argiris A, 2004, CLIN CANCER RES, V10, P1956, DOI 10.1158/1078-0432.CCR-03-1077; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Kutikov A, 2010, J CLIN ONCOL, V28, P311, DOI 10.1200/JCO.2009.22.4816; Yang LM, 2013, J CLIN ONCOL, V31, P468, DOI 10.1200/JCO.2012.42.4457; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Rose BS, 2011, J CLIN ONCOL, V29, P3503, DOI 10.1200/JCO.2011.35.7301; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hanrahan EO, 2007, J CLIN ONCOL, V25, P4952, DOI 10.1200/JCO.2006.08.0499; Stephenson AJ, 2009, J CLIN ONCOL, V27, P4300, DOI 10.1200/JCO.2008.18.2501; Beyersmann J, 2012, COMPETING RISKS MULT; Gray Bob, 2011, CMPRSK SUBDISTRIBUTI; Harrell FE, 2001, REGRESSION MODELING; Harrell Jr Frank E, 2011, RMS REGRESSION MODEL; Hinchliffe SR, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-13; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI; Kuperman DI, 2011, HEAD NECK-J SCI SPEC, V33, P714, DOI 10.1002/hed.21529; Kutikov A, 2012, PROSTATE CANCER P D, V15, P374, DOI 10.1038/pcan.2012.21; Lughezzani G, 2011, CANCER-AM CANCER SOC, V117, P103, DOI 10.1002/cncr.25345; Mell LK, 2010, J CLIN ONCOL, V28, P15, DOI 10.1200/JCO.2008.20.9288; Pathak KA, 2013, J CLIN ENDOCR METAB, V98, P4768, DOI 10.1210/jc.2013-2318; Pintilie M, 2006, COMPETING RISKS PRAC; Porter CR, 2010, UROL INT, V84, P132, DOI 10.1159/000277588; R Core Team, 2013, R LANG ENV STAT COMP; Steyerberg EW, 2009, CLIN PREDICTION MODE; Surveillance Epidemiology and End Results (SEER) Program, SEET DAT INC SEER 9; Wolbers Marcel, 2009, Epidemiology, V20, P555, DOI 10.1097/EDE.0b013e3181a39056	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					264	271		10.1245/s10434-014-3951-8		8	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400042		
J	Matsuda, S; Takeuchi, H; Kawakubo, H; Fukuda, K; Nakamura, R; Takahashi, T; Wada, N; Saikawa, Y; Omori, T; Kitagawa, Y				Matsuda, Satoru; Takeuchi, Hiroya; Kawakubo, Hirofumi; Fukuda, Kazumasa; Nakamura, Rieko; Takahashi, Tsunehiro; Wada, Norihito; Saikawa, Yoshiro; Omori, Tai; Kitagawa, Yuko			Cumulative Prognostic Scores Based on Plasma Fibrinogen and Serum Albumin Levels in Esophageal Cancer Patients Treated with Transthoracic Esophagectomy: Comparison with the Glasgow Prognostic Score	ANNALS OF SURGICAL ONCOLOGY			English	Article							CELL LUNG-CANCER; COLORECTAL-CANCER; GASTRIC-CANCER; ENDOSCOPIC ULTRASONOGRAPHY; HEMATOGENOUS METASTASIS; TUMOR-CELLS; CHEMOTHERAPY; CARCINOMA; HYPERFIBRINOGENEMIA; PREDICTOR	The purpose of this study was to establish a prognostic indicator based on preoperative plasma fibrinogen and serum albumin levels (FA score) in esophageal cancer patients and to compare the correlation with survival to that of the Glasgow prognostic score. Patient characteristics, clinicopathological factors, and preoperative biochemical markers (fibrinogen, albumin, and C-reactive protein) were investigated in esophageal cancer patients who underwent transthoracic esophagectomy. Pretreatment fibrinogen and albumin levels were reviewed in patients who received neoadjuvant treatment. Patients with elevated fibrinogen and decreased albumin levels were allocated a score of 2, those with only one of these abnormalities were allocated a score of 1, and those with neither of these abnormalities were allocated a score of 0. The fibrinogen cut-off value was defined as 350 mg/dL according to our previous report, and the albumin cut-off value was defined as the lower quartile. Among 199 consecutive patients, the interquartile range of preoperative albumin was 3.8-4.3 g/dL and the cut-off value was 3.8 g/dL. Thus, 108 (54 %), 68 (34 %), and 23 (12 %) patients had an FA score of 0, 1, and 2. The patients with a high preoperative FA score showed considerably shorter disease-free survival (DFS) and overall survival (OS). Multivariate analysis showed that pretreatment stage and preoperative FA score were independently associated with postoperative DFS and OS. Preoperative FA score was significantly associated with postoperative survival in esophageal cancer patients, and the prognostic value is currently being validated in a prospective multicenter cohort study.	[Matsuda, Satoru; Takeuchi, Hiroya; Kawakubo, Hirofumi; Fukuda, Kazumasa; Nakamura, Rieko; Takahashi, Tsunehiro; Wada, Norihito; Saikawa, Yoshiro; Omori, Tai; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan	Takeuchi, H (reprint author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	htakeuchi@a6.keio.jp					Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Yamashita H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-147; Palumbo JS, 2002, CANCER RES, V62, P6966; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Son HJ, 2013, ANN SURG ONCOL, V20, P2908, DOI 10.1245/s10434-013-2968-8; Palumbo JS, 2000, BLOOD, V96, P3302; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x; Rajan R, 2004, CANCER, V100, P1365, DOI 10.1002/cncr.20134; Ishizuka M, 2007, ANN SURG, V246, P1047, DOI 10.1097/SLA.0b013e3181454171; Nozoe T, 2011, AM J SURG, V201, P186, DOI 10.1016/j.amjsurg.2010.01.030; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Takeuchi H, 2007, J GASTROEN HEPATOL, V22, P2222, DOI 10.1111/j.1440-1746.2006.04736.x; Al Murri AM, 2006, BRIT J CANCER, V94, P227, DOI 10.1038/sj.bjc.6602922; Miki C, 2004, DIGEST DIS SCI, V49, P970, DOI 10.1023/B:DDAS.0000034556.48527.6e; Roxburgh CSD, 2009, ANN SURG, V249, P788, DOI 10.1097/SLA.0b013e3181a3e738; Matsuda S, 2014, DIS ESOPHAGUS, V27, P654, DOI 10.1111/dote.12115; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Ahn HS, 2009, J SURG ONCOL, V99, P20, DOI 10.1002/jso.21170; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Crumley ABC, 2006, BRIT J CANCER, V94, P637, DOI 10.1038/sj.bjc.6602998; Ando M, 2001, BRIT J CANCER, V85, P1634, DOI 10.1054/bjoc.2001.2162; Bloomston M, 2006, CANCER RES, V66, P2592, DOI 10.1158/0008-5472.CAN-05-3659; Crumley AB, 2008, J GASTROEN HEPATOL, V23, P325; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Ishizuka M, 2009, ANN SURG, V250, P268, DOI 10.1097/SLA.0b013e3181b16e24; Kato H, 2005, ANTICANCER RES, V25, P3461; Lee HH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-190; Mackie IJ, 2003, BRIT J HAEMATOL, V121, P396, DOI 10.1046/j.1365-2141.2003.04256.x; Palumbo JS, 2005, BLOOD, V105, P78; Seth R, 2013, ANN SURG, V258, P158, DOI 10.1097/SLA.0b013e31826fcbdb; Yamaguchi T, 1998, JPN J CLIN ONCOL, V28, P740, DOI 10.1093/jjco/28.12.740; Zhao J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-330	37	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					302	310		10.1245/s10434-014-3857-5		9	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400047		
J	Kasagi, Y; Morita, M; Otsu, H; Kawano, H; Ando, K; Hiyoshi, Y; Ito, S; Miyamoto, Y; Saeki, H; Oki, E; Maehara, Y				Kasagi, Yuta; Morita, Masaru; Otsu, Hajime; Kawano, Hiroyuki; Ando, Koji; Hiyoshi, Yukiharu; Ito, Shuhei; Miyamoto, Yuji; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko			Clinicopathological Characteristics of Esophageal Squamous Cell Carcinoma in Patients Younger Than 50 years	ANNALS OF SURGICAL ONCOLOGY			English	Article							UPPER AERODIGESTIVE TRACT; CANCER; AGE; ADENOCARCINOMA; SMOKING; CARCINOGENESIS; EXPRESSION; DRINKING; FHIT	This study clarifies age differences in clinicopathologic characteristics and risk factor exposure of patients who have undergone esophagectomy for esophageal cancer (EC). Clinical results of esophagectomy were compared between 22 patients younger than 50 years of age (Group I) and 327 patients older than 50 years of age (Group II) with esophageal squamous cell carcinoma. The two groups did not significantly differ in clinicopathological characteristics, including prognosis. Postoperative pulmonary complication incidence rates were 4.2 % (Group I) and 14.4 % (Group II). In Group I, the incidence of multiple ECs was 36.4 %, and association with head and neck cancer was 31.8 %, which were significantly higher than in Group II (13.4 %, p = 0.021; and 9.2 %, p = 0.015, respectively). Furthermore, the patients in Group I with multiple cancers were almost all heavy smokers and/or users of alcohol. These results suggest that multiple upper aerodigestive tract cancers are associated with heavy exposure to risk factors in patients younger than 50 years of age.	[Kasagi, Yuta; Morita, Masaru; Otsu, Hajime; Kawano, Hiroyuki; Ando, Koji; Hiyoshi, Yukiharu; Ito, Shuhei; Miyamoto, Yuji; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Morita, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	masarum@surg2.med.kyushu-u.ac.jp					Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Portale G, 2004, AM SURGEON, V70, P954; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Hashemi N, 2009, DIGEST DIS SCI, V54, P1708, DOI 10.1007/s10620-008-0565-7; Lee CH, 2011, J ORAL PATHOL MED, V40, P684, DOI 10.1111/j.1600-0714.2011.01022.x; Wu IC, 2011, NEOPLASIA, V13, P386, DOI 10.1593/neo.101722; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Morita M, 2008, J GASTROENTEROL, V43, P345, DOI 10.1007/s00535-008-2171-z; Dawsey SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014080; Donohoe CL, 2011, DIS ESOPHAGUS, V24, P560, DOI 10.1111/j.1442-2050.2011.01183.x; Galeone C, 2006, ANN ONCOL, V17, P521, DOI 10.1093/annonc/mdj107; Hamouda A, 2010, WORLD J SURG, V34, P744, DOI 10.1007/s00268-010-0407-6; Ito S, 2005, INT J CANCER, V113, P22, DOI 10.1002/ijc.20500; Kuwano H, 2008, ESOPHAGUS, V5, P117, DOI 10.1007/s10388-008-0158-8; Macfarlane TV, 2012, CANCER CAUSE CONTROL, V21, P2213; Mehta SP, 2010, ANN ROY COLL SURG, V92, P515, DOI 10.1308/003588410X12664192075855; Mori M, 2000, CANCER RES, V60, P1177; Morita M, 2006, ANTICANCER RES, V26, P2243; MORITA M, 1994, INT J CANCER, V58, P207, DOI 10.1002/ijc.2910580211; Morita M, 2003, J SURG ONCOL, V83, P216, DOI 10.1002/jso.10276; Morita M, 2011, ANN SURG ONCOL, V18, P1757, DOI 10.1245/s10434-010-1502-5; Osta EH, 2011, PLOS ONE, V6; PATIL PK, 1992, J SURG ONCOL, V50, P179, DOI 10.1002/jso.2930500310; Saeki H, 2000, BRIT J CANCER, V82, P1892, DOI 10.1054/bjoc.1999.1212; Tachimori Y, 2013, COMPREHENSIVE REGIST, P4; Tsai Chien-Ho, 2003, J Chin Med Assoc, V66, P288; van Nistelrooij AMJ, 2012, WORLD J SURG, V36, P2612, DOI 10.1007/s00268-012-1718-6	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	JAN	2015	22	1					311	315		10.1245/s10434-014-3856-6		5	Oncology; Surgery	Oncology; Surgery	AX2PD	WOS:000346785400048		
J	Ishimoto, T; Hamatake, Y; Kazuno, H; Kishida, T; Koyama, M				Ishimoto, Takayoshi; Hamatake, Yumi; Kazuno, Hiroki; Kishida, Takayuki; Koyama, Michihisa			Theoretical study of support effect of Au catalyst for glucose oxidation of alkaline fuel cell anode	APPLIED SURFACE SCIENCE			English	Article						Glucose oxidation; Gold catalyst; Alkaline solution; Support effect; Fuel cell; Density functional theory	CHEMICAL MOLECULAR-DYNAMICS; METAL-ORGANIC FRAMEWORK; GOLD NANOPARTICLES; HETEROGENEOUS CATALYSIS; ETHANOL OXIDATION; OXYGEN REDUCTION; CARBON-MONOXIDE; CO OXIDATION; MECHANISM; ELECTRODES	We theoretically analyzed the glucose oxidation reaction mechanism and reaction activity of Au catalyst supported by carbon (graphite(0 0 0 1), (1 0 (1) over bar 0), and (1 1 (2) over bar 0)) and oxide (ZrO2(1 1 1) and SnO2(1 1 0)) in alkaline solution environment by using density functional theory method. We observed large stabilization of Au catalyst on support materials due to the electron transfer in the case of graphite(1 1 (2) over bar 0) and SnO2(1 1 0) systems. The catalytic activity for glucose oxidation reaction over Au supported by graphite(1 0 (1) over bar 0) and (1 1 (2) over bar 0) is alculated to be low in comparison with those of unsupported system. We found that SnO2(1 1 0) supported Au catalyst shows high activity toward the glucose oxidation. One of the main factors for the observed high catalytic activity is charge transfer from Au catalyst to support materials. When the atomic charge of Au catalyst becomes positive by the support effect, the activity of glucose oxidation reaction on Au catalyst is improved. (C) 2014 Elsevier B.V. All rights reserved.	[Ishimoto, Takayoshi; Hamatake, Yumi; Koyama, Michihisa] Kyushu Univ, INAMORI Frontier Res Ctr, Frontier Energy Res Div, Nishi Ku, Fukuoka 8190395, Japan; [Kazuno, Hiroki; Kishida, Takayuki] OLYMPUS Corp, Hachioji, Tokyo 1928512, Japan; [Koyama, Michihisa] Kyushu Univ, Int Inst Carbon Neutral Energy Res, Nishi Ku, Fukuoka 8190395, Japan	Koyama, M (reprint author), Kyushu Univ, INAMORI Frontier Res Ctr, Frontier Energy Res Div, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	ishimoto@ifrc.kyushu-u.ac.jp; koyama@ifrc.kyushu-u.ac.jp			KYOCERA Corporation, Japan	The activities of INAMORI Frontier Research Center are supported by KYOCERA Corporation, Japan.	Ahmed F, 2009, J PHYS CHEM C, V113, P15676, DOI 10.1021/jp903606e; Ikeda T, 2008, J PHYS CHEM C, V112, P14706, DOI 10.1021/jp806084d; Thompson DT, 2007, NANO TODAY, V2, P40, DOI 10.1016/S1748-0132(07)70116-0; Cuevas-Muniz FM, 2011, J POWER SOURCES, V196, P5853, DOI 10.1016/j.jpowsour.2011.02.081; Christensen A, 1998, PHYS REV B, V58, P8050, DOI 10.1103/PhysRevB.58.8050; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Galeano C, 2011, CHEM-EUR J, V17, P8434, DOI 10.1002/chem.201100318; Chaudhuri SK, 2003, NAT BIOTECHNOL, V21, P1229, DOI 10.1038/nbt867; Hammer N, 2011, TOP CATAL, V54, P922, DOI 10.1007/s11244-011-9715-9; Zope BN, 2010, SCIENCE, V330, P74, DOI 10.1126/science.1195055; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Yan SH, 2011, J PHYS CHEM C, V115, P6986, DOI 10.1021/jp1086834; Yu EH, 2012, ENERG ENVIRON SCI, V5, P5668, DOI 10.1039/c2ee02552c; Rodriguez P, 2012, NAT CHEM, V4, P177, DOI [10.1038/nchem.1221, 10.1038/NCHEM.1221]; Kwon Y, 2011, J AM CHEM SOC, V133, P6914, DOI 10.1021/ja200976j; Pasta M, 2010, ELECTROCHIM ACTA, V55, P5561, DOI 10.1016/j.electacta.2010.04.069; Okamoto Y, 2006, CHEM PHYS LETT, V420, P382, DOI 10.1016/j.cplett.2006.01.007; Ishimoto T, 2014, SOLID STATE IONICS, V262, P328, DOI 10.1016/j.ssi.2013.10.020; Boronat M, 2011, J CATAL, V278, P50, DOI 10.1016/j.jcat.2010.11.013; Kocak I, 2013, J ELECTROANAL CHEM, V706, P25, DOI 10.1016/j.jelechem.2013.07.035; Genest A, 2009, Z NATURFORSCH B, V64, P1246; Kim HY, 2012, J AM CHEM SOC, V134, P1560, DOI 10.1021/ja207510v; Ye Q, 2010, CATAL LETT, V138, P56, DOI 10.1007/s10562-010-0360-x; Qin YH, 2010, INT J HYDROGEN ENERG, V35, P7667, DOI 10.1016/j.ijhydene.2010.05.034; Pessoa AM, 2010, J MOL STRUC-THEOCHEM, V946, P43, DOI 10.1016/j.theochem.2009.10.024; Da Silva JLF, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205424; Batzill M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.165414; Bligaard T, 2004, J CATAL, V224, P206, DOI 10.1016/j.jcat.2004.02.034; Koper MTM, 2013, NAT CHEM, V5, P255, DOI 10.1038/nchem.1600; Rodrigues EG, 2011, CATAL LETT, V141, P420, DOI 10.1007/s10562-010-0515-9; Tung SP, 2012, RSC ADV, V2, P1068, DOI 10.1039/c1ra00611h; Yang LF, 2010, ANGEW CHEM INT EDIT, V49, P5348, DOI 10.1002/anie.201000863; HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096; Yu EH, 2010, ENERGIES, V3, P1499, DOI 10.3390/en3081499; Aurelien H., 2011, BIOFUELS ENG PROC TE, V1, P467; Efremenko I, 2003, J CATAL, V214, P53, DOI 10.1016/S0021-9517(02)00103-3; Espinal JF, 2004, J PHYS CHEM B, V108, P1003, DOI 10.1021/jp0308211; Fu WJ, 2011, CHEM COMMUN, V47, P5265, DOI 10.1039/c1cc10508f; Ishimoto R, 2006, APPL CATAL A-GEN, V305, P64, DOI 10.1016/j.apcata.2006.02.049; Ishimoto T, 2013, J PHYS CHEM C, V117, P10607, DOI 10.1021/jp4031046; LAREW LA, 1989, J ELECTROANAL CHEM, V262, P167; Jung CH, 2006, APPL CATAL A-GEN, V305, P102, DOI 10.1016/j.apcata.2006.02.050; Koyama M., 2012, ECS T, V50, P1907; MAKOVOS EB, 1986, BIOELECTROCH BIOENER, V15, P157, DOI 10.1016/0302-4598(86)80023-X; Ogura T., 2014, J CHEM ENG IN PRESS; Pessoa AM, 2012, SURF SCI, V606, P69, DOI 10.1016/j.susc.2011.08.023; Stenanovic S.I., 2012, PHYS CHEM CHEM PHYS, V14, P9475; Zhang J., 2014, J POWER SOURCES, V225, P65; Zhao T. S., 2010, Frontiers of Energy and Power Engineering in China, V4, DOI 10.1007/s11708-010-0127-5	49	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	JAN 1	2015	324						76	81		10.1016/j.apsusc.2014.10.125		6	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW1ZT	WOS:000346088500010		
J	Brinzari, V; Cho, BK; Kamei, M; Korotcenkov, G				Brinzari, V.; Cho, B. K.; Kamei, M.; Korotcenkov, G.			Photoemission surface characterization of (001) In2O3 thin film through the interactions with oxygen, water and carbon monoxide: Comparison with (111) orientation	APPLIED SURFACE SCIENCE			English	Article						(001) In2O3 epitaxial films; Synchrotron radiation photoelectron spectroscopy; Valence band; Band bending (BB)	INDIUM OXIDE-FILMS; ELECTRONIC-PROPERTIES; SPRAY-PYROLYSIS; CO ADSORPTION; VALENCE-BAND; GAS SENSORS; SNO2; STABILITY; DEPTH; TIN	Synchrotron radiation ultraviolet photoemission experiments at photon energies of 150 and 49 eV have been performed on (0 0 1) In2O3 epitaxial layer with thickness of 120 nm grown by electron beam evaporation method. Valence band (VB) photoemission spectra have been monitored under separate oxygen, water and carbon monoxide exposures (100 L) at different sample temperatures within the range utilized for chemoresistive gas sensors operation (20-450 degrees C). Large changes in photoemission response within the whole VB were observed for all gases. Surface potential changes were identified as a shift of the valence band edge relative to the Fermi energy. It was found that the initial state of the In2O3 surface after standard preparation procedure corresponded to highly reduced surface, close to "metallic" surface. Treatments in oxygen resulted in oxidation of the surface and regular upward band bending have been changing up to 0.27 eV. These two extreme states of the In2O3 surface corresponded to the surface zone diagrams with accumulation layer and flat bands, respectively. Surface potential changes under water and carbon monoxide treatment have been irregular vs. temperature and small enough (<0.05 eV). However, the magnitudes of photoemission deviations under these treatments were large and comparable with intensity of an initial photoemission itself before the treatment (Delta I-ph similar to 10-40%). The obtained results have been compared with the ones previously received for (1 1 1) surface and it was found that VB spectra under H2O and CO exposure were radically different for these surfaces. As a rule, the spectral response for (0 0 1) surface to the effects of indicated adsorbates was opposite by a sign in comparison with responses obtained for (1 1 1) surface. (C) 2014 Elsevier B.V. All rights reserved.	[Brinzari, V.] State Univ Moldova, MD-2009 Kishinev, Moldova; [Cho, B. K.; Korotcenkov, G.] Gwangju Inst Sci & Technol, Kwangju, South Korea; [Kamei, M.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan	Brinzari, V (reprint author), State Univ Moldova, Lab Phys Nanostruct, Mateevich St 60A, MD-2009 Kishinev, Moldova.	vbrinzari@mail.ru; ghkoro@yahoo.com	Korotcenkov, Ghenadii/G-7666-2014	Korotcenkov, Ghenadii/0000-0002-3973-9051	ICTP-Elettra Users Programme; State Program of Republic of Moldova [11.817.05.10F]; Science and Technology Centre in Ukraine [14.820.18.02.012 STCU. A/5937]; National Research Foundation (NRF) grants - Korean government [2011-0028736, 2013-K000315]; Basic Science Research Program through the NRF - Ministry of Science, ICT and Future Planning of Korea [2012-R1A1A2041564]; Charles University in Prague, Czech Republic	This work was financially and technically supported by the ICTP-Elettra Users Programme, by State Program of Republic of Moldova (project 11.817.05.10F), and partly by the Science and Technology Centre in Ukraine (project 14.820.18.02.012 STCU. A/5937), by the National Research Foundation (NRF) grants funded by the Korean government (Nos. 2011-0028736 and 2013-K000315), and by Basic Science Research Program through the NRF funded by the Ministry of Science, ICT and Future Planning of Korea (2012-R1A1A2041564). The authors wish to thank the personnel of the Material Science Beamline of Sincrotrone Trieste for their assistance, and Prof. V. Matolin from Charles University in Prague, Czech Republic for support and useful discussions.	Agoston P., 2009, PHYS REV LETT, V103, P1; Agoston P., 2011, PHYS REV B, V84, P1; Golovanov V, 2005, SENSOR ACTUAT B-CHEM, V106, P563, DOI 10.1016/j.snb.2004.07.026; Calnan S, 2010, THIN SOLID FILMS, V518, P1839, DOI 10.1016/j.tsf.2009.09.044; Korotcenkov G, 2005, THIN SOLID FILMS, V479, P38, DOI 10.1016/j.tsf.2004.11.107; Walsh A, 2010, J MATER CHEM, V20, P10438, DOI 10.1039/c0jm01816c; Klein A, 2000, APPL PHYS LETT, V77, P2009, DOI 10.1063/1.1312199; King PDC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205211; Brinzari V, 2010, SENSOR ACTUAT B-CHEM, V148, P427, DOI 10.1016/j.snb.2010.05.015; King PDC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.116808; GERCHER VA, 1995, SURF SCI, V322, P177, DOI 10.1016/0039-6028(95)90028-4; Walsh A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.167402; Gottfried JM, 2003, SURF SCI, V536, P206, DOI 10.1016/S0039-6028(03)00595-8; Reuter K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035406; Kamei M, 2001, THIN SOLID FILMS, V392, P265, DOI 10.1016/S0040-6090(01)01041-0; Brinzari V, 2014, THIN SOLID FILMS, V552, P225, DOI 10.1016/j.tsf.2013.12.009; Gassenbauer Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245312; KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2; Korotchenkov G, 1999, SENSOR ACTUAT B-CHEM, V54, P197, DOI 10.1016/S0925-4005(99)00016-7; Tanuma S, 2003, SURF INTERFACE ANAL, V35, P268, DOI 10.1002/sia.1526; Batzill M, 2006, SURF SCI, V600, pL29, DOI 10.1016/j.susc.2005.11.034; CHAZALVIEL JN, 1977, PHYS REV B, V16, P697, DOI 10.1103/PhysRevB.16.697; TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036; Korotcenkov G, 2007, SENSOR ACTUAT B-CHEM, V121, P664, DOI 10.1016/j.snb.2006.04.092; Bartolome J, 2013, ACTA MATER, V61, P1932, DOI 10.1016/j.actamat.2012.12.014; Bierwagen O., 2010, APPL PHYS LETT, V97, P1; Bierwagen O., 2011, APPL PHYS LETT, V98, P1; BOYLE JF, 1977, J ELECTRON MATER, V6, P717, DOI 10.1007/BF02660346; Brinzari V, 2007, SURF SCI, V601, P5585, DOI 10.1016/j.susc.2007.09.049; Emiroglu S, 2001, THIN SOLID FILMS, V391, P176, DOI 10.1016/S0040-6090(01)00979-8; Fuchs F., 2008, PHYS REV B, V77, P1; Gervasini A, 2006, J PHYS CHEM B, V110, P240, DOI 10.1021/jp0532824; Hagleither D.R., 2012, PHYS REV B, V85, P1; Himmerlich M., 2012, J APPL PHYS, V111, P1; Ignatova V, 2002, J ELECTRON SPECTROSC, V122, P115, DOI 10.1016/S0368-2048(01)00348-6; Lany S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.016802; Michel HJ, 1998, APPL SURF SCI, V126, P57, DOI 10.1016/S0169-4332(97)00502-3; Preissler N., 2013, PHYS REV B, V88, P1; Radosavkic D, 2002, SURF SCI, V516, P56, DOI 10.1016/S0039-6028(02)02052-6; Schuster P., 1976, HYDROGEN BOND STRUCT, P670; Seitsonen A.P., 2001, PHYS REV B, V65, P1; Szuber J., 2000, Electron Technology, V33; Tanaka I, 1997, PHYS REV B, V56, P3536, DOI 10.1103/PhysRevB.56.3536; Tougaard S., 2000, QUASES IMFP TPP2M; von Wenckstern H., 2014, APPL MAT, V2, P1; Walsh A., 2008, PHYS REV B, V78, P1; Walsh A., 2011, APPL PHYS LETT, V98, P1; Zhang K.H.L., 2011, J PHYS-CONDENS MAT, V23, P1; Zhang KHL, 2009, CHEM MATER, V21, P4353, DOI 10.1021/cm901127r; Zhang K.H.L., 2013, PHYS REV LETT, V110, P1	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	JAN 1	2015	324						123	133		10.1016/j.apsusc.2014.10.072		11	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW1ZT	WOS:000346088500016		
J	Sun, D; Matsui, H; Wu, CN; Tabata, H				Sun, Dali; Matsui, Hiroaki; Wu, Chun-Nan; Tabata, Hitoshi			Surface treatment on amorphous InGaZnO4 thin film for single-stranded DNA biosensing	APPLIED SURFACE SCIENCE			English	Article						DNA immobilization; Amorphous InGaZnO4; Biosensor; Absorption capacity	DOPED INDIUM OXIDE; ELECTROCHEMICAL BIOSENSOR; ZINC OXIDE; SENSORS; HYBRIDIZATION; SUBSTRATE; CARBON; METAL; TEMPERATURE; DEPOSITION	Amorphous InGaZnO4 (aIGZO) has been widely used as a transparent semiconductor. However, no research has been found yet applying aIGZO to biosensing. This paper examined the single strand DNA (ssDNA) immobilization on aIGZO by absorption with a comparison to ITO, which is the first step for many biosensing schemas. The DNA quantification by florescence intensity shows that the absorption capacity of aIGZO film to ssDNA is 6.7 times greater than that of ITO. XPS and contact angle analysis proved the high DNA absorption affinity on aIGZO film is related to its high effectiveness to OH- attachment. A feasible method to immobilized ssDNA on aIGZO thin film is evaluated in this paper, and consequently, enables a possible approach to apply aIGZO in biosensing. (C) 2014 Elsevier B.V. All rights reserved.	[Sun, Dali; Matsui, Hiroaki; Tabata, Hitoshi] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan; [Matsui, Hiroaki; Tabata, Hitoshi] Univ Tokyo, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Wu, Chun-Nan] Univ Tokyo, Dept Biomath Sci, Bunkyo Ku, Tokyo 1138657, Japan	Sun, D (reprint author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, 1-3-7 Hongo, Tokyo 1138656, Japan.	sundali@bioxide.t.u-tokyo.ac.jp					Liu JF, 2005, ANAL CHEM, V77, P7687, DOI 10.1021/ac0509298; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; Yabuta H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2353811; Kamiya T, 2008, PHYS STATUS SOLIDI C, V5, P3098, DOI 10.1002/pssc.200779300; Zhu XL, 2007, BIOSENS BIOELECTRON, V22, P1600, DOI 10.1016/j.bios.2006.07.007; Lin YC, 2008, APPL SURF SCI, V254, P3262, DOI 10.1016/j.apsusc.2007.11.006; Sassolas A, 2008, CHEM REV, V108, P109, DOI 10.1021/cr0684467; Kelly JA, 1996, J MOL BIOL, V256, P417, DOI 10.1006/jmbi.1996.0097; Hoshi Y, 1999, ELECTROCHIM ACTA, V44, P3927, DOI 10.1016/S0013-4686(99)00100-0; Cai H, 2006, SENSOR ACTUAT B-CHEM, V114, P433, DOI 10.1016/j.snb.2005.06.017; Nomura K, 2006, JPN J APPL PHYS 1, V45, P4303, DOI 10.1143/JJAP.45.4303; Hamdaoui O, 2007, J HAZARD MATER, V147, P381, DOI 10.1016/j.jhazmat.2007.01.021; Kumar N, 2006, NANOTECHNOLOGY, V17, P2875, DOI 10.1088/0957-4484/17/12/009; Erdem B, 2001, LANGMUIR, V17, P2664, DOI 10.1021/la0015213; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Loh KP, 2010, NAT CHEM, V2, P1015, DOI [10.1038/nchem.907, 10.1038/NCHEM.907]; Lei Y, 2011, COLLOID SURFACE B, V82, P168, DOI 10.1016/j.colsurfb.2010.08.034; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Shimizu K, 2010, SURF INTERFACE ANAL, V42, P1432, DOI 10.1002/sia.3586; Ito M, 2008, J NON-CRYST SOLIDS, V354, P2777, DOI 10.1016/j.jnoncrysol.2007.10.083; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Zhang W, 2008, J MEMBRANE SCI, V325, P245, DOI 10.1016/j.memsci.2008.07.038; Sasabayashi T, 2003, THIN SOLID FILMS, V445, P219, DOI 10.1016/j.tsf.2003.08.047; Lee TMH, 2003, LAB CHIP, V3, P100, DOI 10.1039/b300799e; Takeda S, 1999, THIN SOLID FILMS, V339, P220, DOI 10.1016/S0040-6090(98)01152-3; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Das J, 2006, J AM CHEM SOC, V128, P16022, DOI 10.1021/ja0672167; Zhang W, 2008, CHINESE CHEM LETT, V19, P589, DOI 10.1016/j.cclet.2008.03.012; Braun G, 2007, J AM CHEM SOC, V129, P6378, DOI 10.1021/ja070514z; Kim M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742790; Li Z, 2004, NANO LETT, V4, P245, DOI 10.1021/nl034958e; Guo D, 2013, ANAL CHIM ACTA, V773, P83, DOI 10.1016/j.aca.2013.02.019; Bras M, 2004, BIOSENS BIOELECTRON, V20, P797, DOI 10.1016/j.bios.2004.03.018; Erdem A, 1999, ELECTROANAL, V11, P1372, DOI 10.1002/(SICI)1521-4109(199912)11:18<1372::AID-ELAN1372>3.3.CO;2-W; Fallah HR, 2006, PHYSICA B, V373, P274, DOI 10.1016/j.physb.2005.11.159; Meier KR, 2002, CHEMPHYSCHEM, V3, P371, DOI 10.1002/1439-7641(20020415)3:4<371::AID-CPHC371>3.0.CO;2-O; Ito M, 2008, PHYS STATUS SOLIDI A, V205, P1885, DOI 10.1002/pssa.200778910; Jeon K., 2012, APPL PHYS LETT, P1; Kamiya Toshio, 2009, Journal of Display Technology, V5, DOI 10.1109/JDT.2009.2034559; Kaushik A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055105; Kojima I, 1999, SURF INTERFACE ANAL, V28, P267, DOI 10.1002/(SICI)1096-9918(199908)28:1<267::AID-SIA591>3.0.CO;2-O; Liu C, 2012, BIOSENS BIOELECTRON, V38, P19, DOI 10.1016/j.bios.2012.04.026; Moore E, 2006, THIN SOLID FILMS, V515, P2612, DOI 10.1016/j.tsf.2006.03.025; NAMIKI I, 1991, J SOLID STATE CHEM, V315, P298; Napier ME, 1997, BIOCONJUGATE CHEM, V8, P906, DOI 10.1021/bc9701149; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Schuelke M., 2000, NAT BIOTECHNOL, V18, P1; Shin JK, 2004, ELECTROANAL, V16, P1912, DOI 10.1002/elan.200403080; Stambouli V, 2006, ELECTROCHIM ACTA, V51, P5206, DOI 10.1016/j.electacta.2006.03.045; Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113; Xu JZ, 2001, ELECTROCHEM COMMUN, V3, P665, DOI 10.1016/S1388-2481(01)00245-4; Yeung SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl702	52	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	JAN 1	2015	324						310	318		10.1016/j.apsusc.2014.10.115		9	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW1ZT	WOS:000346088500041		
J	Lee, SH; Yamasue, E; Okumura, H; Ishihara, KN				Lee, Seon-Hong; Yamasue, Eiji; Okumura, Hideyuki; Ishihara, Keiichi N.			Effect of substrate roughness and working pressure on photocatalyst of N-doped TiOx films prepared by reactive sputtering with air	APPLIED SURFACE SCIENCE			English	Article						Nitrogen doped titanium dioxide; Photocatalyst; Radio-frequency magnetron sputtering; Substrate roughness; Working pressure	VISIBLE-LIGHT PHOTOCATALYSIS; THIN-FILMS; TITANIUM-DIOXIDE; SURFACE CHARACTERIZATION; ION-IMPLANTATION; PHOTOACTIVITY; TEMPERATURE; DEPOSITION; MORPHOLOGY; DEPENDENCE	N-doped TiOx films on the glass substrate were prepared by radio-frequency (RF) magnetron reactive sputtering of Ti target in a mixed gas of argon and dry air. The effect of substrate roughness and working pressure on the physical properties and the photocatalytic properties of the N-doped TiOx films was investigated. The surface roughness of glass substrate has little influence on the film properties such as produced phases, lattice parameters, introduced nitrogen contents, and atomic bonding configurations, but significant influence on the surface roughness of film resulting in the variation of the photocatalytic ability. The working pressure has little influence on the produced phases and the atomic bonding configurations, but significant influence on the atomic concentration of the N-doped TiOx film, resulting in the large variation of optical, structural, and photocatalytic properties. It is suggested that the high photocatalysis of N-doped TiOx film requires a certain range of the N doping concentration which shows the interstitial complex N doping states in TiO2. 2014 Elsevier B.V. All rights reserved.	[Lee, Seon-Hong] Samsung SDI Co Ltd, Corp R&D Ctr, Yongin 446577, Gyunggido, South Korea; [Yamasue, Eiji; Okumura, Hideyuki; Ishihara, Keiichi N.] Kyoto Univ, Grad Sch Energy Sci, Kyoto 6068501, Japan	Lee, SH (reprint author), Samsung SDI Co Ltd, Corp R&D Ctr, Yongin 446577, Gyunggido, South Korea.	pookter@naver.com	Ishihara, Keiichi/G-4974-2015; Yamasue, Eiji/A-3198-2014; Okumura, Hideyuki/G-2772-2013	Ishihara, Keiichi/0000-0003-4841-7932; Yamasue, Eiji/0000-0002-0230-0985; Okumura, Hideyuki/0000-0002-2576-7510	Global Center of Excellence (GCOE) Program, Kyoto University; Japanese Monbukagakusho Scholarship	This work is supported by the Global Center of Excellence (GCOE) Program, Kyoto University, and the research opportunity (S.-H. Lee) was supported by the Japanese Monbukagakusho Scholarship.	Di Valentin C, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085116; Justicia I, 2002, ADV MATER, V14, P1399, DOI 10.1002/1521-4095(20021002)14:19<1399::AID-ADMA1399>3.0.CO;2-C; Lee SH, 2009, APPL CATAL A-GEN, V371, P179, DOI 10.1016/j.apcata.2009.10.011; Zhou LJ, 2006, MATER LETT, V60, P396, DOI 10.1016/j.matlet.2005.08.065; Toyoda M, 2004, APPL CATAL B-ENVIRON, V49, P227, DOI 10.1016/j.apcatb.2003.12.012; Asahi R, 2007, CHEM PHYS, V339, P57, DOI 10.1016/j.chemphys.2007.07.041; Sergo V, 1998, ACTA MATER, V46, P1701, DOI 10.1016/S1359-6454(97)00348-0; He G, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/4/045304; Yamagishi M, 2003, THIN SOLID FILMS, V442, P227, DOI 10.1016/S0040-6090(03)00987-8; Livraghi S, 2006, J AM CHEM SOC, V128, P15666, DOI 10.1021/ja064164c; Poosanaas P, 1997, J ELECTROCERAM, V1, P105; Wasielewski R, 2008, APPL SURF SCI, V254, P4396, DOI 10.1016/j.apsusc.2008.01.017; Lindgren T, 2003, J PHYS CHEM B, V107, P5709, DOI 10.1021/jp027345j; Vrijenhoek EM, 2001, J MEMBRANE SCI, V188, P115, DOI 10.1016/S0376-7388(01)00376-3; SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465; Barna PB, 1998, THIN SOLID FILMS, V317, P27, DOI 10.1016/S0040-6090(97)00503-8; Sathish M, 2005, CHEM MATER, V17, P6349, DOI 10.1021/cm052047v; Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030; Diwald O, 2004, J PHYS CHEM B, V108, P52, DOI 10.1021/jp030529t; ARMSTRONG NR, 1977, SURF SCI, V67, P451, DOI 10.1016/0039-6028(77)90007-3; Takeda S, 2001, THIN SOLID FILMS, V392, P338, DOI 10.1016/S0040-6090(01)01054-9; KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Anpo M, 1998, RES CHEM INTERMEDIAT, V24, P143, DOI 10.1163/156856798X00735; Xagas AP, 1999, THIN SOLID FILMS, V357, P173, DOI 10.1016/S0040-6090(99)00561-1; Sano T, 2004, J MATER CHEM, V14, P380, DOI 10.1039/b311444a; Gole JL, 2004, J PHYS CHEM B, V108, P1230, DOI 10.1021/jp.030843n; Irie H, 2003, J PHYS CHEM B, V107, P5483, DOI 10.1021/jp030133h; Sakthivel S, 2004, J PHYS CHEM B, V108, P19384, DOI 10.1021/jp046857q; Suda Y, 2004, THIN SOLID FILMS, V453, P162, DOI 10.1016/j.tsf.2003.11.185; Battiston GA, 2000, THIN SOLID FILMS, V371, P126, DOI 10.1016/S0040-6090(00)00998-6; Barnes MC, 2004, THIN SOLID FILMS, V446, P29, DOI 10.1016/S0040-6090(03)01279-3; Cheng Y, 2007, SURF COAT TECH, V201, P6869, DOI 10.1016/j.surfcoat.2006.09.055; Choi YL, 2004, J MATER SCI, V39, P5695, DOI 10.1023/B:JMSC.0000040078.09843.cb; Chopra R, 2002, PART PART SYST CHAR, V19, P277, DOI 10.1002/1521-4117(200208)19:4<277::AID-PPSC277>3.0.CO;2-X; Eufinger K, 2006, THIN SOLID FILMS, V515, P425, DOI 10.1016/j.tsf.2005.12.247; Ho W., 2007, APPL CATAL B-ENVIRON, V73, P135, DOI 10.1016/j.apcatb.2006.06.019; Hossain MF, 2008, THIN SOLID FILMS, V517, P1091, DOI 10.1016/j.tsf.2008.06.020; Ihara T, 2003, APPL CATAL B-ENVIRON, V42, P403, DOI 10.1016/S0926-3373(02)00269-2; Jiang JR, 2000, WEAR, V239, P1, DOI 10.1016/S0043-1648(99)00351-8; Lee J. B., 2003, THIN SOLID FILMS, V423, P262, DOI 10.1016/S0040-6090(02)00977-X; Lee SH, 2009, MATER TRANS, V50, P1805, DOI 10.2320/matertrans.M2009063; Lee SH, 2010, APPL CATAL B-ENVIRON, V93, P217, DOI 10.1016/j.apcatb.2009.09.032; Makeev M.A., 1998, APPL PHYS LETT, V73, P10; Matsui H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1929889; Miyamura A, 2008, THIN SOLID FILMS, V516, P4603, DOI 10.1016/j.tsf.2007.05.079; Negishi N, 1997, APPL SURF SCI, V121, P417, DOI 10.1016/S0169-4332(97)00349-8; Petkovic D.M., 1995, P 20 INT C MICR NIS, pG145; Petrov I., 2003, J VAC SCI TECHNOL A, VA21, P5; Sato S, 2005, APPL CATAL A-GEN, V284, P131, DOI 10.1016/j.apcata.2005.01.028; Shen Y.G., 2004, J MATER RES, V19, P2; SHIN CH, 1991, J SOLID STATE CHEM, V95, P145, DOI 10.1016/0022-4596(91)90384-T; Takahashi T, 2002, THIN SOLID FILMS, V420, P433, DOI 10.1016/S0040-6090(02)00806-4; Takahashi T., 2006, J VAC SCI TECHNOL, V24, P4; Wang HY, 1998, J MATER SCI-MATER EL, V9, P327, DOI 10.1023/A:1008920917493; Zeman P, 2003, THIN SOLID FILMS, V433, P57, DOI 10.1016/S0040-6090(03)00311-0; Zeman P, 2002, SURF COAT TECH, V153, P93, DOI 10.1016/S0257-8972(01)01553-5; Zywitzki O, 2008, SURF COAT TECH, V202, P2488, DOI 10.1016/j.surfcoat.2007.08.036	58	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	JAN 1	2015	324						339	348		10.1016/j.apsusc.2014.10.173		10	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW1ZT	WOS:000346088500045		
J	Uehara, T; Yoshihara, M; Ogino, T				Uehara, Tomoyuki; Yoshihara, Mari; Ogino, Toshio			Morphological evolution from a rough to biphased surface on TiO2(100)	APPLIED SURFACE SCIENCE			English	Article						Titanium oxide; Surface; Phase separation; Atomic force microscopy; Self-assembled monolayer	SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY; SINGLE-CRYSTAL SURFACES; N-TIO2 RUTILE SURFACES; SAPPHIRE SURFACES; TITANIUM-DIOXIDE; TIO2 SURFACES; ADSORPTION; SMOOTH; WATER	We found that a rutile single-crystalline TiO2(1 0 0) surface exhibits "biphased" structure in air that consists of structurally and chemically different domains. We observed their structural evolution caused by thermal annealing at 900 degrees C by the contact mode of atomic force microscopy (AFM) and investigated their chemical properties by frictional mode AFM, which can be used to estimate local hydrophilicity of the surface. The two domains are distinguished by their morphological height and hydrophilicity, the latter of which is determined by the density of hydroxyl groups. The structural evolution and the final domain arrangement upon annealing are influenced by the initial atomic step arrangement before the annealing. We also demonstrated that a self-assembled monolayer of the silane-coupling agent is selectively formed only on the hydrophilic domains and that photochemical reaction using ultraviolet light eliminates the chemically characterized biphase feature. (C) 2014 Elsevier B.V. All rights reserved.	[Uehara, Tomoyuki; Yoshihara, Mari; Ogino, Toshio] Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan	Ogino, T (reprint author), Yokohama Natl Univ, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	togino@ynu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24360013]	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (24360013).	Kamiya Y, 2014, J COLLOID INTERF SCI, V431, P77, DOI 10.1016/j.jcis.2014.06.023; Imanishi A, 2007, J PHYS CHEM C, V111, P2128, DOI 10.1021/jp0668403; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Pang CL, 2013, CHEM REV, V113, P3887, DOI 10.1021/cr300409r; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Henderson MA, 1996, LANGMUIR, V12, P5093, DOI 10.1021/la960360t; Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q; Isono T, 2010, LANGMUIR, V26, P9607, DOI 10.1021/la100179q; Nakamura R, 2005, J AM CHEM SOC, V127, P12975, DOI 10.1021/ja053252e; Yamamoto Y, 2005, JPN J APPL PHYS 2, V44, pL511, DOI 10.1143/JJAP.44.L511; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Lin Y, 2005, ULTRAMICROSCOPY, V105, P129, DOI 10.1016/j.ultramic.2005.06.028; Nakamura R, 2005, J PHYS CHEM B, V109, P1648, DOI 10.1021/jp044710t; Wang R, 1998, ADV MATER, V10, P135, DOI 10.1002/(SICI)1521-4095(199801)10:2<135::AID-ADMA135>3.0.CO;2-M; Tero R, 2008, LANGMUIR, V24, P11567, DOI 10.1021/la801080f; Imanishi A, 2007, J AM CHEM SOC, V129, P11569, DOI 10.1021/ja073206+; Watanabe T, 1999, THIN SOLID FILMS, V351, P260, DOI 10.1016/S0040-6090(99)00205-9; Isono T, 2010, SURF SCI, V604, P2055, DOI 10.1016/j.susc.2010.08.020; Komurasaki H, 2012, APPL SURF SCI, V258, P5666, DOI 10.1016/j.apsusc.2012.02.052; Landree E, 1998, SURF SCI, V408, P300, DOI 10.1016/S0039-6028(98)00255-6; Lindan PJD, 2001, SURF SCI, V479, pL375, DOI 10.1016/S0039-6028(01)01005-6; MURRAY PW, 1992, PHYS REV B, V46, P12877, DOI 10.1103/PhysRevB.46.12877; Noguchi T, 1998, ENVIRON SCI TECHNOL, V32, P3831, DOI 10.1021/es980299+; Yamazaki K, 2011, J COLLOID INTERF SCI, V361, P64, DOI 10.1016/j.jcis.2011.05.016; Raza H, 1999, PHYS REV LETT, V82, P5265, DOI 10.1103/PhysRevLett.82.5265; Raza H, 1999, APPL SURF SCI, V140, P271, DOI 10.1016/S0169-4332(98)00539-X; Saito K., 2014, PHYS CHEM CHEM PHYS, VC118, P5523; Sawai N, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.121801; Sopvan L., 1996, J PHOTOCH PHOTOBIO A, V98, P79; Stone P., 1999, NEW J PHYS, V1, P11; Tsukamoto T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.075502; Zajonz H, 1998, SURF SCI, V398, P369, DOI 10.1016/S0039-6028(98)80042-3	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	JAN 1	2015	324						499	504		10.1016/j.apsusc.2014.10.160		6	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW1ZT	WOS:000346088500064		
J	Rajazadeh, S; Sano, R; Ishigami, T; Kakihana, Y; Ohmukai, Y; Matsuyama, H				Rajazadeh, Saeid; Sano, Rie; Ishigami, Toru; Kakihana, Yuriko; Ohmukai, Yoshikage; Matsuyama, Hideto			Preparation of hydrophilic vinyl chloride copolymer hollow fiber membranes with antifouling properties	APPLIED SURFACE SCIENCE			English	Article						Vinyl chloride copolymer; Hydrophilic hollow fiber membrane; (2-Methacryloyloxyethylphosphorylcholine) (MPC); [2-(Methacryloyloxy) ethyl] dimethyl (3-sulfopropyl) ammonium hydroxide (MEDSAH); Poly(ethylene glycol) methyl ether methacrylate (PEGMA)	ULTRAFILTRATION MEMBRANES; POLY(VINYL CHLORIDE); TRANSPORT-PROPERTIES; PHASE INVERSION; PVC; PERFORMANCE; BLENDS; MICROFILTRATION; FABRICATION; ACID	Hydrophilic vinyl chloride copolymer hollow fiber membranes with antifouling properties were prepared from brominated vinyl chloride-hydroxyethyl methacrylate copolymer (poly(VC-co-HEMA-Br)). The base membrane was grafted with two different zwitterionic monomers, (2-methacryloyloxyethylphosphorylcholine) (MPC) and [2-(methacryloyloxy) ethyl] dimethyl (3-sulfopropyl) ammonium hydroxide) (MEDSAH), and poly( ethylene glycol) methyl ether methacrylate (PEGMA). The effect of the grafting on the base membrane hydrophilicity and antifouling properties was investigated. For comparison of the results, the pure water permeabilities and pore sizes at the outer surfaces of the grafted hollow fiber membranes were controlled to be similar. A poly(VC-co-HEMA-Br) hollow fiber membrane with similar pure water permeability and pore size was also prepared as a control membrane. A BSA solution was used as a model fouling solution for evaluation of the antifouling properties. Grafting with zwitterionic monomers and PEGMA improved the antifouling properties compared with the control membrane. The PEGMA grafted membrane showed the best antifouling properties among the grafted membranes (C) 2014 Elsevier B.V. All rights reserved.	[Rajazadeh, Saeid; Sano, Rie; Ishigami, Toru; Kakihana, Yuriko; Ohmukai, Yoshikage; Matsuyama, Hideto] Kobe Univ, Ctr Membrane & Film Technol, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Matsuyama, H (reprint author), Kobe Univ, Ctr Membrane & Film Technol, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	rajabzadehk@people.kobe-u.ac.jp; pikamandola@yahoo.co.jp; ishigami.toru@nihon-u.ac.jp; kakihana@people.kobe-u.ac.jp; yoshikage.ohmukai@daikin.co.jp; matuyama@kobe-u.ac.jp					Mei S, 2011, J APPL POLYM SCI, V120, P557, DOI 10.1002/app.33219; Xu JA, 2002, J MEMBRANE SCI, V208, P203, DOI 10.1016/S0376-7388(02)00261-2; Fan XC, 2014, J MEMBRANE SCI, V464, P100, DOI 10.1016/j.memsci.2014.04.005; BODZEK M, 1991, J MEMBRANE SCI, V61, P131, DOI 10.1016/0376-7388(91)80011-T; Kim JH, 1998, J MEMBRANE SCI, V138, P153, DOI 10.1016/S0376-7388(97)00224-X; Fu XY, 2008, J MEMBRANE SCI, V320, P483, DOI 10.1016/j.memsci.2008.04.027; Krishnamoorthy L, 2011, J MATER SCI, V46, P2914, DOI 10.1007/s10853-010-5166-0; Babu PR, 1999, J APPL POLYM SCI, V73, P1117, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1117::AID-APP3>3.0.CO;2-H; Alsalhy QF, 2012, DESALINATION, V294, P44, DOI 10.1016/j.desal.2012.03.008; Babu PR, 2000, J APPL POLYM SCI, V77, P2606, DOI 10.1002/1097-4628(20000919)77:12<2606::AID-APP80>3.0.CO;2-Z; Liu BC, 2012, DESALINATION, V307, P26, DOI 10.1016/j.desal.2012.07.036; Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041; Liu F, 2007, J APPL POLYM SCI, V105, P291, DOI 10.1002/app.25641; Fu XY, 2008, J APPL POLYM SCI, V108, P713, DOI 10.1002/app.27711; JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8; Kim DS, 2003, SEPAR SCI TECHNOL, V38, P591, DOI 10.1081/SS-120016653; Li WJ, 2013, DESALIN WATER TREAT, V51, P3960, DOI 10.1080/19443994.2013.797065; Mei SO, 2012, J APPL POLYM SCI, V124, pE9, DOI 10.1002/app.35387; Mulder M., 1997, BASIC PRINCIPLES MEM; OKUNO H, 1993, J MEMBRANE SCI, V83, P199, DOI 10.1016/0376-7388(93)85267-Z; Zhang J, 2012, SEP SCI TECHNOL, V47, P1464, DOI 10.1080/01496395.2011.646379	21	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332	1873-5584		APPL SURF SCI	Appl. Surf. Sci.	JAN 1	2015	324						718	724		10.1016/j.apsusc.2014.11.025		7	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	AW1ZT	WOS:000346088500094		
J	Uemura, H; Katsuura-Kamano, S; Yamaguchi, M; Arisawa, K				Uemura, Hirokazu; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Arisawa, Kokichi			Relationships of elevated levels of serum hepatic enzymes and alcohol intake with arterial stiffness in men	ATHEROSCLEROSIS			English	Article						Alanine aminotransferase; Gamma-glutamyl transferase; Arterial stiffness; Alcohol; Cross-sectional study	GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER-DISEASE; ALANINE AMINOTRANSFERASE LEVELS; FOOD FREQUENCY QUESTIONNAIRE; WAVE VELOCITY-MEASUREMENT; METABOLIC SYNDROME; GENERAL-POPULATION; PHYSICAL-ACTIVITY; RISK; SENSITIVITY	Objective: The present study aimed to evaluate the relationships between elevated serum levels of hepatic enzymes and arterial stiffness and to investigate whether alcohol intake had a modifying effect on these relationships in Japanese men. Methods: A total of 647 eligible men aged 35-69 years who underwent measurement of brachial-ankle pulse wave velocity (baPWV) as an index of arterial stiffness were evaluated. Information on their lifestyle characteristics were obtained from a structured self-administered questionnaire. Serum biochemical factors, including alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT), were determined. The serum ALT and GGT levels were divided into tertiles, and their associations with baPWV values were evaluated using general linear models adjusted for potential confounding factors. The interaction effects between serum hepatic enzymes and alcohol intake on baPWV were further evaluated. Results: Elevated serum ALT and GGT levels were proportionally associated with increased baPWV after adjusting for the multivariable covariates (P values for trend, 0.004 and 0.003, respectively). Further analyses revealed that the proportional associations between serum levels of hepatic enzymes and baPWV were striking in the subjects without alcohol intake but not in those with alcohol intake. The interaction effect between serum GGT level and alcohol intake on baPWV was significant (P for interaction, 0.042). Conclusion: These results demonstrate that elevated serum ALT and GGT levels are associated with increased arterial stiffness, independent of the classical atherosclerotic risk factors in Japanese men, and that the association of elevated serum GGT level with arterial stiffness differs according to alcohol intake. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Uemura, Hirokazu; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Arisawa, Kokichi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Med, Tokushima 7708503, Japan	Uemura, H (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Med, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	uemura@basic.med.tokushima-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [17015018, 221S0001]; Japan Society for the Promotion of Science [24590749]	This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas of Cancer (No. 17015018) and on Innovative Areas (No. 221S0001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by Grants-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number 24590749) from the Japan Society for the Promotion of Science.	Li M, 2009, OBESITY, V17, P809, DOI 10.1038/oby.2008.617; Tahan V, 2008, HEPATO-GASTROENTEROL, V55, P1433; Lehmann ED, 1999, LANCET, V354, P528, DOI 10.1016/S0140-6736(99)00179-8; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; Angelico F, 2003, J GASTROEN HEPATOL, V18, P588, DOI 10.1046/j.1440-1746.2003.02958.x; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI 10.1016/S0002-9270(03)00265-X; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Jo SK, 2009, CLIN CHIM ACTA, V403, P234, DOI 10.1016/j.cca.2009.03.035; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Prati D, 2002, ANN INTERN MED, V137, P1; Angelico F, 2005, J CLIN ENDOCR METAB, V90, P1578, DOI 10.1210/jc.2004-1024; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Jung CH, 2011, CLIN ENDOCRINOL, V75, P328, DOI 10.1111/j.1365-2265.2011.04060.x; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Imaeda N, 2007, J EPIDEMIOL, V17, P100, DOI 10.2188/jea.17.100; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Bradley RD, 2014, ATHEROSCLEROSIS, V233, P387, DOI 10.1016/j.atherosclerosis.2014.01.010; CUSHMAN P, 1984, ALCOHOL CLIN EXP RES, V8, P253, DOI 10.1111/j.1530-0277.1984.tb05506.x; Dong MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014254; Goto C., 2006, Scandinavian Journal of Food & Nutrition, V50, P77, DOI 10.1080/11026480600568720; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Hsu CH, 2011, J AM BOARD FAM MED, V24, P407, DOI 10.3122/jabfm.2011.04.100267; Kweon SS, 2014, J EPIDEMIOL, V24, P7, DOI 10.2188/jea.JE20130032; Lee H.D., 2005, ATHEROSCLEROSIS, V178, P327; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; Sierksma A, 2004, J HYPERTENS, V22, P357, DOI 10.1097/01.hjh.0000098221.37783.09; Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40; Uemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095981; Whitefield J.B., 2002, CRIT REV CLIN LAB SC, V38, P263	33	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	JAN	2015	238	1					83	88		10.1016/j.atherosclerosis.2014.11.021		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX1WR	WOS:000346734600015		
J	Vallabhajosula, S; Haq, IU; Hwynn, N; Oyama, G; Okun, M; Tillman, MD; Hass, CJ				Vallabhajosula, Srikant; Haq, Ihtsham U.; Hwynn, Nelson; Oyama, Genko; Okun, Michael; Tillman, Mark D.; Hass, Chris J.			Low-frequency Versus High-frequency Subthalamic Nucleus Deep Brain Stimulation on Postural Control and Gait in Parkinson's Disease: A Quantitative Study	BRAIN STIMULATION			English	Article						Deep brain stimulation; Parkinson's disease; Gait; Postural control; Gait initiation; Variability	5-YEAR FOLLOW-UP; STN-DBS; BALANCE CONTROL; AXIAL SYMPTOMS; INITIATION; DISORDERS; LEVODOPA; PEDUNCULOPONTINE	Background: High frequency stimulation (HFS) of the subthalamic nucleus (STN-DBS) has been shown to have little impact on postural control and gait improvements in Parkinson's disease (PD). There is a lack of consensus and quantitative evidence to suggest that stimulating STN at a lower frequency (LFS) as compared to HFS will be superior in improving symptoms. Objective/hypothesis: To determine if postural control and gait characteristics of persons with PD improve at an LFS (60 Hz) compared to HFS (> 100 Hz). We hypothesized that persons with PD would perform better on postural control and gait measures at LFS. Methods: Nineteen participants with bilateral STN-DBS underwent UPDRS, static and dynamic postural control using gait initiation, and gait evaluations in three stimulation conditions (baseline voltage stable across conditions: OFF, LFS of 60 Hz, and HFS of > 100 Hz). Additionally 10/19 participants were also stimulated at 30 Hz and 60 Hz and at higher voltages. A one-way ANOVA was performed to compare the conditions. Results: Total UPDRS-III score, step length and velocity during gait initiation, and gait speed significantly improved during 60 Hz and > 100 Hz conditions when compared to the OFF condition (P < 0.05). There were no significant differences between 60 Hz and > 100 Hz conditions. Using LFS at higher voltage showed no improvement over > 100 Hz condition. Conclusions: The positive effects of both LFS and HFS on postural control and gait were similar and clinical changes were relatively small. LFS may not help improve postural control, and gait particularly for persons with PD who do not develop gait-related disorders after HFS. (C) 2015 Elsevier Inc. All rights reserved.	[Vallabhajosula, Srikant] Elon Univ, Dept Phys Therapy Educ, Elon, NC 27244 USA; [Haq, Ihtsham U.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA; [Hwynn, Nelson] Scripps Clin Torrey Pines, Div Neurol, La Jolla, CA USA; [Oyama, Genko] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Okun, Michael] Univ Florida, Dept Neurol, Gainesville, FL USA; [Okun, Michael] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Okun, Michael] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Okun, Michael] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Okun, Michael] Univ Florida, Dept Hist, Gainesville, FL USA; [Tillman, Mark D.] Troy Univ, Dept Kinesiol & Hlth Promot, Troy, AL USA; [Hass, Chris J.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	Vallabhajosula, S (reprint author), Elon Univ, Dept Phys Therapy Educ, Campus Box 2085,762 East Haggard Ave, Elon, NC 27244 USA.	svallabhajosula@elon.edu			National Parkinson Foundation Center of Excellence; UF Foundation; UF Center for Movement Disorders and Neurorestoration	We would like to acknowledge the support of the National Parkinson Foundation Center of Excellence, the UF Foundation, and UF Center for Movement Disorders and Neurorestoration.	Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Khoo HM, 2014, MOVEMENT DISORD, V29, P270, DOI 10.1002/mds.25810; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Takakusaki K, 2004, NEUROSCI RES, V50, P137, DOI 10.1016/j.neures.2004.06.015; Schupbach WMM, 2005, J NEUROL NEUROSUR PS, V76, P1640, DOI 10.1136/jnnp.2005.063206; Lozano AM, 2008, J NEUROL, V255, P30, DOI 10.1007/s00415-008-4005-6; Xie T, 2012, J NEUROL NEUROSUR PS, V83, P1015, DOI 10.1136/jnnp-2011-302091; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Ricchi V, 2012, BRAIN STIMUL, V5, P388, DOI 10.1016/j.brs.2011.07.001; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/aw1346; Hass CJ, 2004, ARCH PHYS MED REHAB, V85, P1593, DOI 10.1016/j.apmr.2004.01.020; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Hamani C, 2008, NEUROSURGERY, V62, P863, DOI [10.1227/01.neu.0000316288.75736.1c, 10.1227/01.NEU.0000159714.28232.C4]; Stegemoller EL, 2013, NEUROREHABILITATION, V33, P305, DOI 10.3233/NRE-130960; Sidiropoulos C, 2013, J NEUROL, V260, P2306, DOI 10.1007/s00415-013-6983-2; KOLLER WC, 1989, CLIN NEUROPHARMACOL, V12, P98; Hass CJ, 2005, ARCH PHYS MED REHAB, V86, P2172, DOI 10.1016/j.apmr.2005.05.013; Alessandro S, 2010, J NEUROL SCI, V289, P44, DOI 10.1016/j.jns.2009.08.017; Kumar R, 1998, NEUROLOGY, V51, P850; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Benatru I, 2008, NEUROPHYSIOL CLIN, V38, P459, DOI 10.1016/j.neucli.2008.07.006; Moreau C, 2008, NEUROLOGY, V71, P80, DOI 10.1212/01.wnl.0000303972.16279.46; Liu W, 2006, GAIT POSTURE, V23, P492, DOI 10.1016/j.gaitpost.2005.06.012; Vallabhajosula S, 2013, GAIT POSTURE, V37, P280, DOI 10.1016/j.gaitpost.2012.07.018; Carpinella I, 2007, P ANN INT IEEE EMBS, P6665; Colnat-Coulbois S, 2005, J NEUROL NEUROSUR PS, V76, P780, DOI 10.1136/jnnp.2004.047829; Crenna P, 2006, EXP BRAIN RES, V172, P519, DOI 10.1007/s00221-006-0360-7; Ebadi M, 2004, PARKINSONS DIS; Guehl D, 2006, EXP BRAIN RES, V170, P206, DOI 10.1007/s00221-005-0202-z; Johnsen EL, 2009, MOVEMENT DISORD, V24, P590, DOI 10.1002/mds.22419; Liu W, 2005, PARKINSONISM RELAT D, V11, P503, DOI 10.1016/j.parkreldis.2005.07.001; Lubik S, 2006, J NEURAL TRANSM, V113, P163, DOI 10.1007/s00702-005-0310-8; Nilsson MH, 2005, ACTA NEUROL SCAND, V111, P301, DOI 10.1111/j.1600-0404.2005.00394.x; Pereira E A, 2008, Br J Neurosurg, V22 Suppl 1, pS41, DOI 10.1080/02688690802448335; Phibbs FT, 2013, NEUROMODULATION; Tabbal SD, 2007, NEUROSURGERY, V61, P119, DOI 10.1227/01.NEU.0000279995.73083.FE; Temperli P, 2003, NEUROLOGY, V60, P78; Vallabhajosula S, 2014, J APPL BIOMECH; van Nuenen BFL, 2008, MOVEMENT DISORD, V23, P2404, DOI 10.1002/mds.21986; Yamada K, 2008, ACTA NEUROCHIR, V150, P15, DOI 10.1007/s00701-007-1451-3	40	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	JAN-FEB	2015	8	1					64	75		10.1016/j.brs.2014.10.011		12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AX1ZA	WOS:000346741700009		
J	Murase, N; Cengiz, B; Rothwell, JC				Murase, Nagako; Cengiz, Buelent; Rothwell, John C.			Inter-individual Variation in the After-effect of Paired Associative Stimulation can be Predicted From Short-interval Intracortical Inhibition With the Threshold Tracking Method	BRAIN STIMULATION			English	Article						Paired associative stimulation; Short-interval intracortical inhibition; Variability; I-wave; Short-latency afferent inhibition	HUMAN MOTOR CORTEX; LONG-TERM POTENTIATION; CORTICAL PLASTICITY; STIMULUS-INTENSITY; 2 PHASES; EXCITABILITY; FACILITATION; INDUCTION; REPRODUCIBILITY; CONTRACTION	Background: Paired associative stimulation (PAS), which is used to test a long term potentiation (LTP)-like effect, involves repeated pairing of peripheral somatosensory input with transcranial magnetic stimulation (TMS) given 25 ms later over M1 (PAS(25)). The effect is usually quantified as an increase in amplitude of motor evoked potentials evoked by single pulse TMS. However, the effect varies greatly between individuals. Objective/Hypothesis: We hypothesized that variability depends on either the individual level of GABAAergic activity in cortex, or on the proportion of late I-wave inputs that are evoked by TMS pulses during PAS(25). Low levels of GABA facilitate LTP, whereas late I-waves are the site of facilitation after PAS(25). Methods: GABAAergic inhibition was quantified using SICI measured with a threshold tracking method (SICI-TT) before and after PAS(25) in 18 healthy volunteers. Results: The PAS(25) effect correlated with the level of SICI-TT (r = 0.6) before PAS(25). Contrary to the GABA hypothesis, people who had good facilitation after PAS(25) had good inhibition measured by SICI-TT. On completion of the PAS(25) protocol, SICI-TT was reduced by an amount correlated with the size of the PAS(25) effect (r = 0.5-0.6 at an interstimulus interval of 2.5-3.0 ms). Conclusions: SICI is known to target late I-waves, thus SICI-TT will depend on the proportion of late I-waves evoked by the TMS test pulse. If the pulse recruits a large fraction of late I-waves, individuals will show good SICI-TT; they will also respond well to PAS(25) since this relies on facilitation of late I-waves. (C) 2015 Elsevier Inc. All rights reserved.	[Murase, Nagako; Cengiz, Buelent; Rothwell, John C.] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1E 6BT, England; [Murase, Nagako] Univ Tokushima, Sch Med, Dept Neurol, Tokushima 770, Japan; [Murase, Nagako] Natl Hosp Org, Kyoto Med Ctr, Dept Neurol, Kyoto, Japan	Murase, N (reprint author), Natl Hosp Org, Kyoto Med Ctr, Dept Neurol, Fushimi Ku, 1-1 Mukoubatacho Fukakusa, Kyoto 6128555, Japan.	nmurase@kyotolan.hosp.go.jp			PLASTICISE: a European Union FP7 Collaborative Project [223524]	This work was supported by PLASTICISE: a European Union FP7 Collaborative Project (223524).	Alle H, 2009, J PHYSIOL-LONDON, V587, P5163, DOI 10.1113/jphysiol.2009.179820; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Ortu E, 2008, J PHYSIOL-LONDON, V586, P5147, DOI 10.1113/jphysiol.2008.158956; Russmann H, 2009, CLIN NEUROPHYSIOL, V120, P1204, DOI 10.1016/j.clinph.2009.04.005; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; Stagg CJ, 2014, NEUROIMAGE, V86, P19, DOI 10.1016/j.neuroimage.2013.01.009; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Fratello F, 2006, CLIN NEUROPHYSIOL, V117, P2667, DOI 10.1016/j.clinph.2006.07.315; Sale MV, 2007, EXP BRAIN RES, V181, P615, DOI 10.1007/s00221-007-0960-x; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Conde V, 2012, NEUROIMAGE, V60, P864, DOI 10.1016/j.neuroimage.2012.01.052; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Hess G, 1996, J NEUROPHYSIOL, V75, P1765; Kujirai K, 2006, J NEUROPHYSIOL, V96, P1337, DOI 10.1152/jn.01140.2005; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Vucic S, 2006, MUSCLE NERVE, V33, P477, DOI 10.1002/mus.20481; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; Di Lazzaro V, 2009, CEREB CORTEX, V19, P2326, DOI 10.1093/cercor/bhn255; Elahi B, 2012, J NEUROPHYSIOL, V107, P1935, DOI 10.1152/jn.00202.2011; Vucic S, 2009, BRAIN RES, V1273, P39, DOI 10.1016/j.brainres.2009.03.043	32	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	JAN-FEB	2015	8	1					105	113		10.1016/j.brs.2014.09.010		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AX1ZA	WOS:000346741700014		
J	Yamamizu, K; Hamada, Y; Narita, M				Yamamizu, Kohei; Hamada, Yusuke; Narita, Minoru			kappa Opioid receptor ligands regulate angiogenesis in development and in tumours	BRITISH JOURNAL OF PHARMACOLOGY			English	Review						opioid; angiogenesis; endothelial cells; embryonic stem cells; tumour; cancer therapy	ENDOTHELIAL GROWTH-FACTOR; VASCULAR PROGENITORS; TYROSINE KINASE; GENE-EXPRESSION; NERVOUS-SYSTEM; CONCISE GUIDE; STEM-CELLS; VEGF; DIFFERENTIATION; NEUROPILIN	Opioid systems mainly regulate physiological functions such as pain, emotional tone and reward circuitry in neural tissues (brain and spinal cord). These systems are also found in extraneural tissues (ganglia, gut, spleen, stomach, lung, pancreas, liver, heart, blood and blood vessels), and recent studies have elucidated their roles in various organs. The current review focuses on the roles of opioid systems in blood vessels, especially angiogenesis, during development and tumour malignancy. The balance between endogenous activators and inhibitors of angiogenesis delicately maintains a normally quiescent vasculature to sustain homeostasis. Disturbance of this balance causes pathogenic angiogenesis and, especially in tumours, several activators such as VEGF are highly expressed in the tumour microenvironment and strongly induce tumour angiogenesis, the so-called angiogenic switch. Recently, we demonstrated that opioid receptor agonists function as anti-angiogenic factors, which impede the angiogenic switch, in vascular development and tumour angiogenesis by inhibiting the expression of receptors for VEGF. In clinical medicine, angiogenesis inhibitors that target VEGF signalling such as bevacizumab are used as anti-cancer drugs. Although therapies that inhibit tumour angiogenesis have been highly successful for tumour therapy, most patients eventually develop resistance to this anti-angiogenic therapy. Thus, we must identify novel targets for anti-angiogenic agents to sustain inhibition of angiogenesis for tumour therapy. The regulation of responses to opioid receptor ligands could be useful for controlling vascular formation under physiological conditions and in cancers, and thus could offer therapeutic benefits beyond the relief of pain. Linked ArticlesThis article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit	[Yamamizu, Kohei] NIA, NIH, Genet Lab, Baltimore, MD 21224 USA; [Hamada, Yusuke; Narita, Minoru] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Tokyo 142, Japan	Yamamizu, K (reprint author), NIA, NIH, Genet Lab, Baltimore, MD 21224 USA.	kohei.yamamizu@nih.gov			Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour and Welfare of Japan; Project for Realization of Regenerative Medicine; Japan Society for the Promotion of Science; Intramural Research Program of the NIH, National Institute on Aging	We thank Dr JK Yamashita for supervising the studies on vascular formation, Dr H Nagase for giving us TRK820 and S Katayama for helping with the figures. This study was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan, the Ministry of Health, Labour and Welfare of Japan, the Project for Realization of Regenerative Medicine, the Japan Society for the Promotion of Science, and the Intramural Research Program of the NIH, National Institute on Aging.	Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Zhu YX, 1998, J NEUROSCI, V18, P2538; Yamamizu K, 2011, BLOOD, V118, P775, DOI 10.1182/blood-2010-09-306001; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Bates D, 2003, DEV BIOL, V255, P77, DOI 10.1016/S0012-1606(02)00045-3; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Gupta K, 2002, CANCER RES, V62, P4491; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/i.tips.2007.06.005; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Miao HQ, 1999, J CELL BIOL, V146, P233; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1676, DOI 10.1111/bph.12449; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Tegeder I, 2003, CANCER RES, V63, P1846; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Carmeliet P, 2008, NEW ENGL J MED, V358, P2511, DOI 10.1056/NEJMcibr0802500; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Blebea J, 2000, J VASC SURG, V32, P364, DOI 10.1067/mva.2000.107763; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; James JM, 2009, DEVELOPMENT, V136, P833, DOI 10.1242/dev.028845; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cao Yihai, 2001, International Journal of Biochemistry and Cell Biology, V33, P357, DOI 10.1016/S1357-2725(01)00023-1; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; Kutcher ME, 2004, FASEB J, V18, P1952, DOI 10.1096/fj.04-2320fje; Luk K, 2012, J ONCOL, V2012; Molina PE, 2002, CLIN EXP PHARMACOL P, V29, P248, DOI 10.1046/j.1440-1681.2002.03638.x; QU ZX, 1993, BRAIN RES, V626, P45, DOI 10.1016/0006-8993(93)90561-Z; Rodriguez Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485; Singleton PA, 2008, MOL CANCER THER, V7, P1669, DOI 10.1158/1535-7163.MCT-07-2217; Suzuki T, 2004, BRAIN RES, V995, P167, DOI 10.1016/j.brainres.2003.09.057; Tripathi A, 2008, NEUROSCI RES, V61, P257, DOI 10.1016/j.neures.2008.03.002; Wu Y, 1998, DEV DYNAM, V211, P327, DOI 10.1002/(SICI)1097-0177(199804)211:4<327::AID-AJA4>3.0.CO;2-J; Yamamizu K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03213; Yamamizu K, 2011, CIRC J, V75, P253, DOI 10.1253/circj.CJ-10-0915; ZABRENETZKY V, 1994, INT J CANCER, V59, P191, DOI 10.1002/ijc.2910590209; Zagon IS, 1996, AM J PHYSIOL-REG I, V270, pR22	58	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JAN	2015	172	2			SI		268	276		10.1111/bph.12573		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX3FU	WOS:000346826500004		
J	Sasaki, K; Sumiyoshi, A; Nonaka, H; Kasahara, Y; Ikeda, K; Hall, FS; Uhl, GR; Watanabe, M; Kawashima, R; Sora, I				Sasaki, Kazumasu; Sumiyoshi, Akira; Nonaka, Hiroi; Kasahara, Yoshiyuki; Ikeda, Kazutaka; Hall, F. Scott; Uhl, George R.; Watanabe, Masahiko; Kawashima, Ryuta; Sora, Ichiro			Specific regions display altered grey matter volume in mu-opioid receptor knockout mice: MRI voxel-based morphometry	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; FORMALIN TEST; PERIAQUEDUCTAL GRAY; SYNAPTIC PLASTICITY; ARRIVE GUIDELINES; INDUCED ANALGESIA; OLFACTORY-BULB; MOUSE-BRAIN; RAT; NEUROGENESIS	Background and Purpose Opioid receptor knockout (MOP-KO) mice display several behavioural differences from wild-type (WT) littermates including differential responses to nociceptive stimuli. Brain structural changes have been tied to behavioural alterations noted in transgenic mice with targeting of different genes. Hence, we assess the brain structure of MOP-KO mice. Experimental ApproachMagnetic resonance imaging (MRI) voxel-based morphometry (VBM) and histological methods were used to identify structural differences between extensively backcrossed MOP-KO mice and WT mice. Key ResultsMOP-KO mice displayed robust increases in regional grey matter volume in olfactory bulb, several hypothalamic nuclei, periaqueductal grey (PAG) and several cerebellar areas, most confirmed by VBM analysis. The largest increases in grey matter volume were detected in the glomerular layer of the olfactory bulb, arcuate nucleus of hypothalamus, ventrolateral PAG (VLPAG) and cerebellar regions including paramedian and cerebellar lobules. Histological analyses confirm several of these results, with increased VLPAG cell numbers and increased thickness of the olfactory bulb granule cell layer and cerebellar molecular and granular cell layers. Conclusions and ImplicationsMOP deletion causes previously undescribed structural changes in specific brain regions, but not in all regions with high MOP receptor densities (e.g. thalamus, nucleus accumbens) or that exhibit adult neurogenesis (e.g. hippocampus). Volume differences in hypothalamus and PAG may reflect behavioural changes including hyperalgesia. Although the precise relationship between volume change and MOP receptor deletion was not determined from this study alone, these findings suggest that levels of MOP receptor expression may influence a broader range of neural structure and function in humans than previously supposed. Linked ArticlesThis article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit	[Sasaki, Kazumasu; Kasahara, Yoshiyuki; Sora, Ichiro] Tohoku Univ, Grad Sch Med, Dept Biol Psychiat, Sendai, Miyagi 980, Japan; [Sasaki, Kazumasu; Sumiyoshi, Akira; Nonaka, Hiroi; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan; [Hall, F. Scott; Uhl, George R.] NIDA, Mol Neurobiol Branch, Intramural Res Program, NIH,DHHS, Baltimore, MD USA; [Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Sora, Ichiro] Kobe Univ, Dept Psychiat, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Sora, I (reprint author), Kobe Univ, Dept Psychiat, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	sora@med.kobe-u.ac.jp	WATANABE, Masahiko/A-4055-2012; Hall, Frank/C-3036-2013	Hall, Frank/0000-0002-0822-4063	MECSST; Health Sciences Research Grants from MHLW, Japan; Global COE Program, MEXT, Japan; Intramural Research Program of the National Institute on Drug Abuse, USA	This work was supported by a grant from Grants-in-Aid from MECSST and Health Sciences Research Grants from MHLW, Japan, and the Global COE Program, MEXT, Japan. This work was also supported in part by funding from the Intramural Research Program of the National Institute on Drug Abuse, USA (FSH, GRU). The authors would like to thank all of our colleagues at Tohoku University for their tremendous support.	LEWIS VA, 1977, BRAIN RES, V124, P283, DOI 10.1016/0006-8993(77)90886-1; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Yang D, 2011, NEUROSCIENCE, V192, P609, DOI 10.1016/j.neuroscience.2011.06.043; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; MANSOUR A, 1987, J NEUROSCI, V7, P2445; Roy S, 1998, MOL BRAIN RES, V61, P190, DOI 10.1016/S0169-328X(98)00212-5; Zagon IS, 2002, BRAIN RES REV, V38, P351, DOI 10.1016/S0165-0173(01)00160-6; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; Anderson BJ, 2011, DEV PSYCHOBIOL, V53, P456, DOI 10.1002/dev.20563; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; ZAGON IS, 1983, SCIENCE, V221, P1179, DOI 10.1126/science.6612331; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; Kitchen I, 1997, BRAIN RES, V778, P73, DOI 10.1016/S0006-8993(97)00988-8; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Harburg GC, 2007, NEUROSCIENCE, V144, P77, DOI 10.1016/j.neuroscience.2006.09.018; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Filliol D, 2000, NAT GENET, V25, P195; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Biedermann S, 2012, NEUROIMAGE, V61, P1206, DOI 10.1016/j.neuroimage.2012.04.010; Ide S, 2004, NEUROPSYCHOPHARMACOL, V29, P1656, DOI 10.1038/sj.npp.1300463; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Sora I, 2001, NEUROPSYCHOPHARMACOL, V25, P41, DOI 10.1016/S0893-133X(00)00252-9; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Han WH, 2006, NEUROREPORT, V17, P941, DOI 10.1097/01.wnr.0000221829.87974.ad; Gaser C, 2012, NEUROIMAGE, V63, P47, DOI 10.1016/j.neuroimage.2012.06.066; Hall FS, 2001, PSYCHOPHARMACOLOGY, V154, P43, DOI 10.1007/s002130000622; Schwartz MW, 2000, NATURE, V404, P661; Nieman BJ, 2007, HUM BRAIN MAPP, V28, P567, DOI 10.1002/hbm.20408; Imayoshi I, 2009, DEV GROWTH DIFFER, V51, P379, DOI 10.1111/j.1440-169X.2009.01094.x; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI [10.1016/j.nbd.2008.09.016, 10.1076/j.nbd.2008.09.016]; Sumiyoshi A, 2011, NEUROIMAGE, V54, P1951, DOI 10.1016/j.neuroimage.2010.09.056; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Cheng MF, 2013, FRONT NEUROENDOCRIN, V34, P161; COHEN SR, 1985, BRAIN RES, V359, P131, DOI 10.1016/0006-8993(85)91420-9; Cominski TP, 2012, NEUROSCIENCE, V206, P49, DOI 10.1016/j.neuroscience.2011.12.046; FREDERICKSON RCA, 1982, PROG NEUROBIOL, V19, P19, DOI 10.1016/0301-0082(82)90020-X; Friston KJ, 1996, STAT PARAMETRIC MAPP; Fuchs PN, 1999, BRAIN RES, V821, P480, DOI 10.1016/S0006-8993(99)01060-4; Hall FS, 2003, GENES BRAIN BEHAV, V2, P114, DOI 10.1034/j.1601-183X.2003.00016.x; Kale SC, 2008, HUM BRAIN MAPP, V29, P1147, DOI 10.1002/hbm.20453; LaBuda CJ, 2000, BRAIN RES, V869, P1, DOI 10.1016/S0006-8993(00)02196-X; LaBuda CJ, 2000, NEUROSCI LETT, V290, P79, DOI 10.1016/S0304-3940(00)01323-9; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; MANNING BH, 1994, NEUROSCIENCE, V63, P289, DOI 10.1016/0306-4522(94)90023-X; Manning BH, 1998, J NEUROSCI, V18, P9453; Mason P, 2005, J NEUROPHYSIOL, V94, P1659, DOI 10.1152/jn.00249.2005; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Sora I, 2003, METH MOLEC MED, V84, P205; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sora I, 1997, EUR J PHARMACOL, V324, pR1, DOI 10.1016/S0014-2999(97)10016-4; Sun YG, 2003, PAIN, V104, P55, DOI 10.1016/S0304-3959(02)00464-5; van de Ven RCG, 2007, MAGN RESON MED, V58, P390, DOI 10.1002/mrm.21313; Wang S.F., 2012, ENZYME RES, V2012, P1; Yang ZJ, 2002, NEUROSCI LETT, V328, P141, DOI 10.1016/S0304-3940(02)00514-1; ZAGON IS, 1992, BRAIN RES, V596, P149, DOI 10.1016/0006-8993(92)91542-M	65	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JAN	2015	172	2			SI		654	667		10.1111/bph.12807		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX3FU	WOS:000346826500036		
J	Kurotobi, T; Kino, N; Tonomura, D; Shimada, Y				Kurotobi, Toshiya; Kino, Naoto; Tonomura, Daisuke; Shimada, Yoshihisa			Macro-Reentrant Atrial Tachycardia Conducting Through a Left Superior Vena Cava After Catheter Ablation in a Patient With Paroxysmal Atrial Fibrillation	CANADIAN JOURNAL OF CARDIOLOGY			English	Article								A left superior vena cava can be a cause of cardiac rhythm or conduction abnormalities, and can also be the arrhythmogenic source of atrial fibrillation (AF) with connections to the coronary sinus and left atrium. In the present study, we report a case with a macro re-entrant atrial tachycardia that coursed through the left superior vena cava after a previous AF ablation, which successfully ablated paroxysmal AF.	[Kurotobi, Toshiya; Kino, Naoto; Tonomura, Daisuke; Shimada, Yoshihisa] Shiroyama Hosp, Div Cardiovasc, Habikino, Osaka 5830872, Japan	Kurotobi, T (reprint author), Shiroyama Hosp, Div Cardiovasc, 2-8-1 Habikino, Habikino, Osaka 5830872, Japan.	drk21cent@gmail.com					Hsu LF, 2004, CIRCULATION, V109, P828, DOI 10.1161/01.CIR.0000116753.56467.BC	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	JAN	2015	31	1							103.e13	10.1016/j.cjca.2014.09.024		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX3QF	WOS:000346853300020		
J	Nomura, Y; Momoi, N; Hirono, K; Hata, Y; Takasaki, A; Nishida, N; Ichida, F				Nomura, Yasuhisa; Momoi, Nobuo; Hirono, Keiichi; Hata, Yukiko; Takasaki, Asami; Nishida, Naoki; Ichida, Fukiko			A Novel MYH7 Gene Mutation in a Fetus With Left Ventricular Noncompaction	CANADIAN JOURNAL OF CARDIOLOGY			English	Article							NON-COMPACTION; CARDIOMYOPATHY; MYOCARDIUM; DIAGNOSIS	Left ventricular noncompaction (LVNC) is a recently defined cardiomyopathy characterized by a pattern of prominent trabecular meshwork and deep intertrabecular recesses. LVNC is rarely described in fetal life, and a small number of cases have been reported. We report the first fetal case, to our knowledge, of LVNC associated with a novel mutation in the MYH7 gene (c. 1625A>C; p. Lys542Thr). This patient showed cardiomegaly on prenatal ultrasonographic examinations, with features indicating noncompaction of the myocardium apparent in the second trimester. This case highlights the importance of prenatal ultrasonography for the diagnosis of LVNC and suggests that abnormal myocardial development underlies the pathogenesis of LVNC.	[Nomura, Yasuhisa] Fukushima Med Univ, Dept Gynecol, Fukushima, Japan; [Momoi, Nobuo] Fukushima Med Univ, Dept Pediat, Fukushima, Japan; [Hirono, Keiichi; Takasaki, Asami; Ichida, Fukiko] Toyama Univ, Grad Sch Med, Dept Pediat, Toyama 9300194, Japan; [Nishida, Naoki] Toyama Univ, Grad Sch Med, Dept Legal Med, Toyama 9300194, Japan	Ichida, F (reprint author), Toyama Univ, Grad Sch Med, Dept Pediat, 2630 Sugitani, Toyama 9300194, Japan.	fukiko@med.u-toyama.ac.jp		Nishida, Naoki/0000-0002-6921-1768			Menon SC, 2007, J AM SOC ECHOCARDIOG, V20, P1344, DOI 10.1016/j.echo.2007.04.028; Hoedemaekers YM, 2010, CIRC-CARDIOVASC GENE, V3, P232, DOI 10.1161/CIRCGENETICS.109.903898; Hoedemaekers YM, 2013, ULTRASOUND OBST GYN, V41, P336, DOI 10.1002/uog.12279; Ichida F, 2009, CIRC J, V73, P19; Ozkutlu S, 2007, PEDIATR INT, V49, P172, DOI 10.1111/j.1442-200X.2007.02339.x	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0828-282X	1916-7075		CAN J CARDIOL	Can. J. Cardiol.	JAN	2015	31	1							103.e1	10.1016/j.cjca.2014.11.012		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX3QF	WOS:000346853300019		
J	Ballester, P; Fujita, M; Rebek, J				Ballester, Pablo; Fujita, Makoto; Rebek, Julius, Jr.			Molecular containers	CHEMICAL SOCIETY REVIEWS			English	Editorial Material									[Ballester, Pablo] Inst Chem Res Catalonia ICIQ, E-43007 Tarragona, Spain; [Ballester, Pablo] ICREA, Barcelona 08010, Spain; [Fujita, Makoto] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Rebek, Julius, Jr.] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Rebek, Julius, Jr.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Rebek, Julius, Jr.] Dept Chem, La Jolla, CA 92037 USA	Ballester, P (reprint author), Inst Chem Res Catalonia ICIQ, Av Paisos Catalans 16, E-43007 Tarragona, Spain.	pballester@ICIQ.ES; mfujita@appchem.t.u-tokyo.ac.jp; jrebek@scripps.edu	Ballester, Pablo/B-6436-2011	Ballester, Pablo/0000-0001-8377-6610				0	8	8	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0306-0012	1460-4744		CHEM SOC REV	Chem. Soc. Rev.		2015	44	2					392	393		10.1039/c4cs90101k		2	Chemistry, Multidisciplinary	Chemistry	AX1JN	WOS:000346703600001		
J	Kobayashi, K; Yamanaka, M				Kobayashi, Kenji; Yamanaka, Masamichi			Self-assembled capsules based on tetrafunctionalized calix[4]resorcinarene cavitands	CHEMICAL SOCIETY REVIEWS			English	Review							HOST-GUEST COMPLEXATION; DYNAMIC COMBINATORIAL CHEMISTRY; WATER-SOLUBLE CAVITANDS; CH-PI INTERACTION; NANOSIZE COORDINATION CAGES; RESORCINOL CYCLIC TETRAMER; HYDROGEN-BONDS; HETERODIMERIC CAPSULE; MOLECULAR CAPSULE; ORIENTATIONAL ISOMERISM	Calix[4]resorcinarene-based cavitands with a bowl-shaped aromatic cavity are widely used as scaffolds for covalently bound and self-assembled capsules. There are two main categories of calix[4]resorcinarene-based cavitands that are tetrafunctionalized at the upper (wider) rim: one category includes derivatives that have functionalized bridges between pairs of hydroxy groups of the calix[4]resorcinarene, and the second category includes derivatives with functional groups at the 2-position on the resorcinol ring and the methylene bridge between pairs of hydroxy groups. This review describes capsular self-assemblies of the latter type of methylene-bridge cavitands, which are formed through hydrogen bonds, metal-coordination bonds, and dynamic covalent bonds.	[Kobayashi, Kenji; Yamanaka, Masamichi] Shizuoka Univ, Grad Sch Sci, Dept Chem, Suruga Ku, Shizuoka 4228529, Japan	Kobayashi, K (reprint author), Shizuoka Univ, Grad Sch Sci, Dept Chem, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	skkobay@ipc.shizuoka.ac.jp			JSPS [25288034, 24310089]	This work was supported in part by Grant-in-Aid from JSPS (no. 25288034 for K.K. and no. 24310089 for M.Y.). We are grateful to the dedication of the co-workers and collaborators who appear in the citations.	Aakeroy CB, 2011, EUR J ORG CHEM, P6789, DOI 10.1002/ejoc.201101036; ETTER MC, 1990, J CHEM SOC CHEM COMM, P589, DOI 10.1039/c39900000589; Bosch E, 2002, CRYST GROWTH DES, V2, P299, DOI 10.1021/cg025517w; Park SJ, 2001, CHEM COMMUN, P1554, DOI 10.1039/b104897j; Jacopozzi P, 1997, ANGEW CHEM INT EDIT, V36, P613, DOI 10.1002/anie.199706131; WHITESIDES GM, 1995, ACCOUNTS CHEM RES, V28, P37, DOI 10.1021/ar00049a006; Rudkevich DA, 2002, B CHEM SOC JPN, V75, P393, DOI 10.1246/bcsj.75.393; Biros SM, 2007, CHEM SOC REV, V36, P93, DOI 10.1039/b508530f; Park YS, 2011, ORG LETT, V13, P5904, DOI 10.1021/ol202550d; Tiedemann BEF, 2006, ANGEW CHEM INT EDIT, V45, P83, DOI 10.1002/anie.200502209; Kobayashi K, 2000, CHEM COMMUN, P41, DOI 10.1039/a908315d; Pun A, 2012, ANGEW CHEM INT EDIT, V51, P13119, DOI 10.1002/anie.201207048; Fochi F, 2001, J AM CHEM SOC, V123, P7539, DOI 10.1021/ja0103492; Liu XJ, 2006, J AM CHEM SOC, V128, P14120, DOI 10.1021/ja0644733; Kobayashi K, 2005, CHEM-EUR J, V11, P4725, DOI 10.1002/chem.200500140; Liu Y, 2007, CHEM-EUR J, V13, P8953, DOI 10.1002/chem.200701067; MORAN JR, 1982, J AM CHEM SOC, V104, P5826, DOI 10.1021/ja00385a064; Frampton MJ, 2007, ANGEW CHEM INT EDIT, V46, P1028, DOI 10.1002/anie.200601780; Shivanyuk A, 2001, P NATL ACAD SCI USA, V98, P7662, DOI 10.1073/pnas.141226898; CRAM DJ, 1985, J AM CHEM SOC, V107, P2575, DOI 10.1021/ja00294a076; Ebbing MHK, 2002, P NATL ACAD SCI USA, V99, P4962, DOI 10.1073/pnas.072652599; Yamanaka M, 2004, P NATL ACAD SCI USA, V101, P2669, DOI 10.1073/pnas.0308584101; Kim E, 1998, J AM CHEM SOC, V120, P11192, DOI 10.1021/ja982620u; Warmuth R, 2001, ACCOUNTS CHEM RES, V34, P95, DOI 10.1021/ar980082k; Fox OD, 2006, J AM CHEM SOC, V128, P6990, DOI 10.1021/ja060982t; Gottschalk T, 2007, ANGEW CHEM INT EDIT, V46, P260, DOI 10.1002/anie.200603366; Haino T, 2009, CHEM-EUR J, V15, P13286, DOI 10.1002/chem.200902526; KOBAYASHI K, 1993, J AM CHEM SOC, V115, P2648, DOI 10.1021/ja00060a013; Timmerman P, 1997, CHEM-EUR J, V3, P1823, DOI 10.1002/chem.19970031115; Hou JL, 2008, J AM CHEM SOC, V130, P7810, DOI 10.1021/ja802288k; Ichihara K, 2013, CHEM-EUR J, V19, P3685, DOI 10.1002/chem.201203937; Sawada T, 2009, NAT CHEM, V1, P53, DOI [10.1038/nchem.100, 10.1038/NCHEM.100]; Kobayashi K, 2007, J ORG CHEM, V72, P3242, DOI 10.1021/jo062563k; Menozzi E, 2004, CHEM-EUR J, V10, P2199, DOI 10.1002/chem.200305570; Rowan SJ, 2002, ANGEW CHEM INT EDIT, V41, P898, DOI 10.1002/1521-3773(20020315)41:6<898::AID-ANIE898>3.0.CO;2-E; Pluth MD, 2009, ACCOUNTS CHEM RES, V42, P1650, DOI 10.1021/ar900118t; CRAM DJ, 1983, SCIENCE, V219, P1177, DOI 10.1126/science.219.4589.1177; Ponnuswamy N, 2012, SCIENCE, V338, P783, DOI 10.1126/science.1227032; Iwasawa T, 2006, J AM CHEM SOC, V128, P9308, DOI 10.1021/ja062768a; Yamanaka M, 2011, J AM CHEM SOC, V133, P16650, DOI 10.1021/ja207092c; Liu SM, 2010, NAT CHEM, V2, P847, DOI [10.1038/nchem.751, 10.1038/NCHEM.751]; Yamanaka M, 2006, J AM CHEM SOC, V128, P1531, DOI 10.1021/ja0555365; Lin ZH, 2012, CHEM-EUR J, V18, P12864, DOI 10.1002/chem.201200602; Northrop BH, 2009, ACCOUNTS CHEM RES, V42, P1554, DOI 10.1021/ar900077c; Li JW, 2013, J AM CHEM SOC, V135, P9222, DOI 10.1021/ja402586c; SHERMAN JC, 1991, J AM CHEM SOC, V113, P2194, DOI 10.1021/ja00006a043; Fox OD, 1998, J AM CHEM SOC, V120, P7111, DOI 10.1021/ja980150y; Giles MD, 2008, J AM CHEM SOC, V130, P14430, DOI 10.1021/ja806457x; Iwasawa N, 2007, J AM CHEM SOC, V129, P7754, DOI 10.1021/ja072319q; Nishiyabu R, 2011, CHEM COMMUN, V47, P1124, DOI 10.1039/c0cc02921a; Kitagawa H, 2009, P NATL ACAD SCI USA, V106, P10444, DOI 10.1073/pnas.0812660106; Gibb CLD, 2004, J AM CHEM SOC, V126, P11408, DOI 10.1021/ja0475611; Park SJ, 2008, CHEM-EUR J, V14, P5353, DOI 10.1002/chem.200701767; Avram L, 2011, CHEM COMMUN, V47, P5368, DOI 10.1039/c1cc10150a; Liu F, 2014, ACCOUNTS CHEM RES, V47, P2168, DOI 10.1021/ar5001296; Kaanumalle LS, 2005, J AM CHEM SOC, V127, P3674, DOI 10.1021/ja0425381; Chapman RG, 1998, J AM CHEM SOC, V120, P6252, DOI 10.1021/ja980081n; Kitagawa H, 2009, TETRAHEDRON, V65, P7234, DOI 10.1016/j.tet.2008.11.093; Chen J, 2002, ORG LETT, V4, P327, DOI 10.1021/ol0168115; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; WYLER R, 1993, ANGEW CHEM INT EDIT, V32, P1699, DOI 10.1002/anie.199316991; Pinalli R, 2004, J AM CHEM SOC, V126, P6516, DOI 10.1021/ja038694; ROBBINS TA, 1994, J AM CHEM SOC, V116, P111, DOI 10.1021/ja00080a014; Yamanaka M, 2006, J ORG CHEM, V71, P8800, DOI 10.1021/jo061516p; LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041; Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b; Yamanaka M, 2013, ASIAN J ORG CHEM, V2, P276, DOI 10.1002/ajoc.201200175; Park SJ, 2005, CHEM-EUR J, V11, P235, DOI 10.1002/chem.200400801; TIMMERMAN P, 1994, ANGEW CHEM INT EDIT, V33, P2345, DOI 10.1002/anie.199423451; Liu XJ, 2006, ANGEW CHEM INT EDIT, V45, P901, DOI 10.1002/ANIE.200504049; Rue NM, 2011, ISR J CHEM, V51, P743, DOI 10.1002/ijch.201100064; Aakeroy CB, 2011, CHEM COMMUN, V47, P11411, DOI 10.1039/c1cc14124d; Wang H, 2013, ANGEW CHEM INT EDIT, V52, P655, DOI 10.1002/anie.201205376; FUJITA M, 1995, NATURE, V378, P469, DOI 10.1038/378469a0; CRAM DJ, 1992, NATURE, V356, P29, DOI 10.1038/356029a0; Park SJ, 2008, B KOREAN CHEM SOC, V29, P205; MacGillivray LR, 1997, NATURE, V389, P469; Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G; Busi M, 2007, CHEM-EUR J, V13, P6891, DOI 10.1002/chem.200700496; Ajami D, 2006, J AM CHEM SOC, V128, P5314, DOI 10.1021/ja060095q; Scarso A, 2004, J AM CHEM SOC, V126, P12728, DOI 10.1021/ja046703o; Choi HJ, 2004, ORG LETT, V6, P4431, DOI 10.1021/ol048446y; KOBAYASHI K, 1992, J AM CHEM SOC, V114, P10307, DOI 10.1021/ja00052a030; Heinz T, 1998, NATURE, V394, P764; Gibb CLD, 2001, J AM CHEM SOC, V123, P5849, DOI 10.1021/ja005931p; Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p; Yamanaka M, 2009, J AM CHEM SOC, V131, P9880, DOI 10.1021/ja903253c; CRAM DJ, 1992, J AM CHEM SOC, V114, P7748, DOI 10.1021/ja00046a022; TANNER ME, 1990, J AM CHEM SOC, V112, P1659, DOI 10.1021/ja00160a072; Oshovsky GV, 2006, J AM CHEM SOC, V128, P5270, DOI 10.1021/ja06022920; Castilla AM, 2014, CHEM LETT, V43, P256, DOI 10.1246/cl.131048; Bringmann S, 2011, ORG BIOMOL CHEM, V9, P7491, DOI 10.1039/c1ob06030a; CHAPMAN RG, 1995, J AM CHEM SOC, V117, P9081, DOI 10.1021/ja00140a031; Mecozzi S, 1998, CHEM-EUR J, V4, P1016, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1016::AID-CHEM1016>3.0.CO;2-B; Chen J, 2002, P NATL ACAD SCI USA, V99, P2593, DOI 10.1073/pnas.052706499; Kataoka K, 2007, J AM CHEM SOC, V129, P15126, DOI 10.1021/ja076792f; Kobayashi K, 1999, ANGEW CHEM INT EDIT, V38, P3483, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3483::AID-ANIE3483>3.0.CO;2-A; Shivanyuk A, 2002, J AM CHEM SOC, V124, P12074, DOI 10.1021/ja020607a; Kerckhoffs JMCA, 2005, J AM CHEM SOC, V127, P12697, DOI 10.1021/ja0536973; Kobayashi K, 2004, J AM CHEM SOC, V126, P13896, DOI 10.1021/ja0465799; SHERMAN JC, 1989, J AM CHEM SOC, V111, P4527, DOI 10.1021/ja00194a074; Lehn JM, 1999, CHEM-EUR J, V5, P2455; Pochorovski I, 2012, J AM CHEM SOC, V134, P14702, DOI 10.1021/ja306473x; Gibb BC, 1996, J ORG CHEM, V61, P1505, DOI 10.1021/jo951633c; Jasat A, 1999, CHEM REV, V99, P931, DOI 10.1021/cr960048o; Yoshizawa M, 2009, ANGEW CHEM INT EDIT, V48, P3418, DOI 10.1002/anie.200805340; Zuccaccia D, 2005, J AM CHEM SOC, V127, P7025, DOI 10.1021/ja042265; Fox OD, 2000, INORG CHEM, V39, P783, DOI 10.1021/ic991235i; Kobayashi K, 2003, J AM CHEM SOC, V125, P10615, DOI 10.1021/ja035337q; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.3.CO;2-E; Pirondini L, 2002, P NATL ACAD SCI USA, V99, P4911, DOI 10.1073/pnas.07261299; Breiner B, 2011, CHEM SCI, V2, P51, DOI 10.1039/c0sc00329h; Haino T, 2006, CHEM-EUR J, V12, P3310, DOI 10.1002/chem.200500976; Cuminetti N, 2001, TETRAHEDRON LETT, V42, P527, DOI 10.1016/S0040-4039(00)01991-2; Fujita N, 2008, CHEM-ASIAN J, V3, P1076, DOI 10.1002/asia.200800069; Kobayashi K, 2005, J ORG CHEM, V70, P749, DOI 10.1021/jo048521i; Asadi A, 2013, CHEM SCI, V4, P1212, DOI 10.1039/c2sc22001f; Asadi A, 2011, J AM CHEM SOC, V133, P10682, DOI 10.1021/ja203602u; Asadi A, 2014, CHEM COMMUN, V50, P533, DOI 10.1039/c3cc47034b; Bare GAL, 2013, J AM CHEM SOC, V135, P11985, DOI 10.1021/ja405100z; Barrett ES, 2004, J AM CHEM SOC, V126, P16747, DOI 10.1021/ja044405l; Barrett ES, 2001, J ORG CHEM, V66, P8227, DOI 10.1021/jo015988+; Boerrigter H, 1997, J ORG CHEM, V62, P7148, DOI 10.1021/jo9703414; BRYANT JA, 1991, J AM CHEM SOC, V113, P2167, DOI 10.1021/ja00006a040; Bussche-Hunnefeld C. v. d., 1996, CROAT CHEM ACTA, V69, P447; Busseron E, 2013, CHEM COMMUN, V49, P4842, DOI 10.1039/c3cc41369a; CHOI HJ, 1992, J CHEM SOC CHEM COMM, P1733, DOI 10.1039/c39920001733; Clark TD, 1999, CHEM-EUR J, V5, P782, DOI 10.1002/(SICI)1521-3765(19990201)5:2<782::AID-CHEM782>3.0.CO;2-A; Cram D.J., 1994, CONTAINER MOL THEIR; CRAM DJ, 1992, J AM CHEM SOC, V114, P7765, DOI 10.1021/ja00046a023; Degardin M, 2012, CHEM COMMUN, V48, P11850, DOI 10.1039/c2cc36517k; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Desiraju GR, 2002, ACCOUNTS CHEM RES, V35, P565, DOI 10.1021/ar010054t; Desiraju G. R., 1999, WEAK HYDROGEN BOND S; Fox OD, 2000, ANGEW CHEM INT EDIT, V39, P136; FUJIMOTO T, 1995, B CHEM SOC JPN, V68, P2113, DOI 10.1246/bcsj.68.2113; Fujita M., 2005, ACCOUNTS CHEM RES, V38, P371, DOI DOI 10.1021/AR040153H; Gruppi F, 2009, TETRAHEDRON, V65, P7289, DOI 10.1016/j.tet.2008.11.111; Haino T, 2005, CHEM COMMUN, P2321, DOI 10.1039/b502598b; Helgeson RC, 2010, J ORG CHEM, V75, P570, DOI 10.1021/jo9012496; Higler I, 2000, EUR J ORG CHEM, P1727; Hirumi Y, 2014, CHEM-ASIAN J, V9, P1282, DOI 10.1002/asia.201400042; Icli B, 2009, J AM CHEM SOC, V131, P3154, DOI 10.1021/ja809279s; Ihm C, 2006, ANGEW CHEM INT EDIT, V45, P2056, DOI 10.1002/anie.200503441; Jude H, 2006, J ORG CHEM, V71, P4155, DOI 10.1021/jo060133o; Kobayashi K, 1999, TETRAHEDRON LETT, V40, P8883, DOI 10.1016/S0040-4039(99)01903-6; Laughrey ZR, 2006, CHEM COMMUN, P970, DOI 10.1039/b515187b; Laughrey ZR, 2003, CHEM-EUR J, V9, P130, DOI 10.1002/chem.200390008; Lin ZH, 2011, CHEM-EUR J, V17, P9395, DOI 10.1002/chem.201100527; LINDSEY JS, 1991, NEW J CHEM, V15, P153; Lutzen A, 1999, J AM CHEM SOC, V121, P7455, DOI 10.1021/ja991747w; Makeiff DA, 2005, J AM CHEM SOC, V127, P12363, DOI 10.1021/ja0520621; Mastalerz M, 2010, ANGEW CHEM INT EDIT, V49, P5042, DOI 10.1002/anie.201000443; Mezo AR, 1998, J ORG CHEM, V63, P6824, DOI 10.1021/jo980305k; Middel O, 2002, EUR J ORG CHEM, P2587; Nakazawa J, 2006, ORG LETT, V8, P4275, DOI 10.1021/ol061561j; Nishimura N, 2010, J AM CHEM SOC, V132, P777, DOI 10.1021/ja9084918; Nishimura N, 2008, ANGEW CHEM INT EDIT, V47, P6255, DOI 10.1002/anie.200802293; Nishimura N, 2010, J ORG CHEM, V75, P6079, DOI 10.1021/jo101255g; Nishio M., 1998, CH PI INTERACTION; Nito Y, 2014, CHEM-ASIAN J, V9, P1076, DOI 10.1002/asia.201301628; Park YS, 2008, ORG LETT, V10, P4867, DOI 10.1021/ol801945p; Park YS, 2010, TETRAHEDRON LETT, V51, P3956, DOI 10.1016/j.tetlet.2010.05.106; Piatnitski EL, 2000, CHEM-EUR J, V6, P999, DOI 10.1002/(SICI)1521-3765(20000317)6:6<999::AID-CHEM999>3.0.CO;2-Y; Pirondini L, 2006, TETRAHEDRON, V62, P2008, DOI 10.1016/j.tet.2005.06.122; QUAN MLC, 1991, J AM CHEM SOC, V113, P2754, DOI 10.1021/ja00007a060; Rebek J, 2005, ANGEW CHEM INT EDIT, V44, P2068, DOI 10.1002/anie.200462839; Rebek J, 2009, ACCOUNTS CHEM RES, V42, P1660, DOI 10.1021/ar9001203; Ro S, 2000, ORG LETT, V2, P2411, DOI 10.1021/ol005962p; Schroder T, 2008, TETRAHEDRON LETT, V49, P5939, DOI 10.1016/j.tetlet.2008.07.143; Sebo L, 2000, HELV CHIM ACTA, V83, P93, DOI 10.1002/(SICI)1522-2675(20000119)83:1<93::AID-HLCA93>3.0.CO;2-5; Sherman J, 2003, CHEM COMMUN, P1617, DOI 10.1039/b208553b; Sun JL, 2011, CHEM COMMUN, V47, P9351, DOI 10.1039/c1cc13381k; Sun JY, 2009, TETRAHEDRON, V65, P7296, DOI 10.1016/j.tet.2008.11.110; Thaimattam R., 1998, NEW J CHEM, P143; Tsuzuki S, 2010, J PHYS CHEM B, V114, P5335, DOI 10.1021/jp101111n; Warmuth R, 2007, J AM CHEM SOC, V129, P1233, DOI 10.1021/ja066130a	178	18	18	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0306-0012	1460-4744		CHEM SOC REV	Chem. Soc. Rev.		2015	44	2					449	466		10.1039/c4cs00153b		18	Chemistry, Multidisciplinary	Chemistry	AX1JN	WOS:000346703600005		
J	Ghosh, AK; Yashchuk, S; Mizuno, A; Chakraborty, N; Agniswamy, J; Wang, YF; Aoki, M; Gomez, PMS; Amano, M; Weber, IT; Mitsuya, H				Ghosh, Arun K.; Yashchuk, Sofiya; Mizuno, Akira; Chakraborty, Nilanjana; Agniswamy, Johnson; Wang, Yuan-Fang; Aoki, Manabu; Gomez, Pedro Miguel Salcedo; Amano, Masayuki; Weber, Irene T.; Mitsuya, Hiroaki			Design of gem-Difluoro-bis-Tetrahydrofuran as P2 Ligand for HIV-1 Protease Inhibitors to Improve Brain Penetration: Synthesis, X-ray Studies, and Biological Evaluation	CHEMMEDCHEM			English	Article						antiviral agents; blood-brain barrier; HIV-1 protease; inhibitors; ligands; multidrug resistance	HUMAN-IMMUNODEFICIENCY-VIRUS; RESOLUTION CRYSTAL-STRUCTURES; DRUG-RESISTANT MUTANTS; IN-VITRO; MEDICINAL CHEMISTRY; POTENT; FLUORINE; BARRIER; PI; CRYSTALLOGRAPHY	The structure-based design, synthesis, biological evaluation, and X-ray structural studies of fluorine-containing HIV-1 protease inhibitors are described. The synthesis of both enantiomers of the gem-difluoro-bis-THF ligands was carried out in a stereoselective manner using a Reformatskii-Claisen reaction as the key step. Optically active ligands were converted into protease inhibitors. Two of these inhibitors, (3R,3aS,6aS)-4,4-difluorohexahydrofuro[2,3-b]furan-3-yl(2S,3R)-3-hydroxy-4-((N-isobutyl-4-methoxyphenyl)sulfonamido)-1-phenylbutan-2-yl) carbamate (3) and (3R,3aS,6aS)-4,4-difluorohexahydrofuro[2,3-b]furan-3-yl(2S,3R)-3-hydroxy-4-((N-isobutyl-4-aminophenyl)sulfonamido)phenylbutan-2-yl) carbamate (4), exhibited HIV-1 protease inhibitory K-i values in the picomolar range. Both 3 and 4 showed very potent antiviral activity, with respective EC50 values of 0.8 and 3.1nM against the laboratory strain HIV-1(LAI). The two inhibitors exhibited better lipophilicity profiles than darunavir, and also showed much improved blood-brain barrier permeability in an in vitro model. A high-resolution X-ray structure of inhibitor 4 in complex with HIV-1 protease was determined, revealing that the fluorinated ligand makes extensive interactions with the S2 subsite of HIV-1 protease, including hydrogen bonding interactions with the protease backbone atoms. Moreover, both fluorine atoms on the bis-THF ligand formed strong interactions with the flap Gly48 carbonyl oxygen atom.	[Ghosh, Arun K.; Yashchuk, Sofiya; Mizuno, Akira; Chakraborty, Nilanjana] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Ghosh, Arun K.; Yashchuk, Sofiya; Mizuno, Akira; Chakraborty, Nilanjana] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA; [Agniswamy, Johnson; Wang, Yuan-Fang; Weber, Irene T.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Aoki, Manabu; Gomez, Pedro Miguel Salcedo; Amano, Masayuki; Mitsuya, Hiroaki] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 8608556, Japan; [Aoki, Manabu; Gomez, Pedro Miguel Salcedo; Amano, Masayuki; Mitsuya, Hiroaki] Kumamoto Univ, Sch Med, Dept Infect Dis, Kumamoto 8608556, Japan; [Mitsuya, Hiroaki] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA; [Mitsuya, Hiroaki] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Shinjuku Ku, Tokyo 1628655, Japan	Ghosh, AK (reprint author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	akghosh@purdue.edu			US National Institutes of Health [GM53386, GM62920]; Intramural Research Program of the Center for Cancer Research, US National Cancer Institute, National Institutes of Health; Ministry of Education, Culture, Sports, Science, and Technology of Japan (Monbu-Kagakusho); Grant for Promotion of AIDS Research from the Ministry of Health, Welfare, and Labor of Japan [Kosei Rohdosho: H15-AIDS-001]; Grant to the Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Reemerging Infectious Diseases (Kumamoto University) of Monbu-Kagakusho	This research was supported by grants from the US National Institutes of Health (GM53386 to A.K.G., and GM62920 to I.T.W.). This work was also supported by the Intramural Research Program of the Center for Cancer Research, US National Cancer Institute, National Institutes of Health, and in part by a Grant-in-aid for Scientific Research (Priority Areas) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Monbu-Kagakusho), a Grant for Promotion of AIDS Research from the Ministry of Health, Welfare, and Labor of Japan (Kosei Rohdosho: H15-AIDS-001), and the Grant to the Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Reemerging Infectious Diseases (Kumamoto University) of Monbu-Kagakusho. The authors also thank Ms. Heather Osswald (Purdue University) for helpful discussions.	Amano M, 2007, ANTIMICROB AGENTS CH, V51, P2143, DOI 10.1128/AAC.01413-06; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ghosh AK, 2007, BIOORGAN MED CHEM, V15, P7576, DOI 10.1016/j.bmc.2007.09.010; Smart BE, 2001, J FLUORINE CHEM, V109, P3, DOI 10.1016/S0022-1139(01)00375-X; Gomez PMS, 2013, ANTIMICROB AGENTS CH, V57, P6110, DOI 10.1128/AAC.01420-13; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Ghosh AK, 2011, J MED CHEM, V54, P5890, DOI 10.1021/jm200649p; Yang YY, 2007, ORG LETT, V9, P5437, DOI 10.1021/ol7023955; Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tie YF, 2004, J MOL BIOL, V338, P341, DOI 10.1016/j.jmb.2004.02.052; Zhou P, 2009, J CHEM INF MODEL, V49, P2344, DOI 10.1021/ci9002393; Yang YY, 2004, ORG LETT, V6, P4257, DOI 10.1021/ol0482947; Ghosh AK, 2006, CHEMMEDCHEM, V1, P939, DOI 10.1002/cmdc.200600103; Ghosh AK, 2008, ACCOUNTS CHEM RES, V41, P78, DOI 10.1021/ar7001232; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Ghosh AK, 2004, J ORG CHEM, V69, P7822, DOI 10.1021/jo049156y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Vulpetti A, 2010, PROTEINS, V78, P3281, DOI 10.1002/prot.22836; Ghosh AK, 2012, ANGEW CHEM INT EDIT, V51, P1778, DOI 10.1002/anie.201102762; Ghosh AK, 1998, BIOORG MED CHEM LETT, V8, P687, DOI 10.1016/S0960-894X(98)00098-5; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Koh Y, 2003, ANTIMICROB AGENTS CH, V47, P3123, DOI 10.1128/AAC.47.10.3123-3129.2003; Mahalingam B, 2001, PROTEINS, V43, P455, DOI 10.1002/prot.1057; FUJITA K, 1982, TETRAHEDRON LETT, V23, P3507, DOI 10.1016/S0040-4039(00)87654-6; Ghosh A. K., 2010, MODERN DRUG SYNTHESI, P29; Ghosh A. K., 2012, ANGEW CHEM, V124, P1812; GREUTER H, 1988, TETRAHEDRON LETT, V29, P3291, DOI 10.1016/0040-4039(88)85143-8; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Langford D, 2006, J NEUROVIROL, V12, P100, DOI 10.1080/13550280600713932; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Tan IL, 2012, CNS DRUGS, V26, P123, DOI 10.2165/11597770-000000000-00000; TOTH MV, 1990, INT J PEPT PROT RES, V36, P544; Wang YF, 2007, J MED CHEM, V50, P4509, DOI 10.1021/jm070482q; Yoshimura K, 2002, J VIROL, V76, P1349, DOI 10.1128/JVI.76.3.1349-1258.2002	42	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-7179	1860-7187		CHEMMEDCHEM	ChemMedChem	JAN	2015	10	1					107	115		10.1002/cmdc.201402358		9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX2IL	WOS:000346766700011		
J	Kaboudin, B; Faghihi, MR; Kazemi, F; Yokomatsu, T				Kaboudin, Babak; Faghihi, Mohammad Reza; Kazemi, Foad; Yokomatsu, Tsutomu			Resolution of Enantiomers of Novel C-2-Symmetric Aminobisphosphinic Acids via Diastereomeric Salt Formation With Quinine	CHIRALITY			English	Article						C-2-symmetric; -aminophosphinic acids; thermal reaction	KABACHNIK-FIELDS REACTION; AMINOPHOSPHONIC ACIDS; PHOSPHINIC ACIDS; ENANTIOSELECTIVE HYDROPHOSPHONYLATION; INHIBITORS; ALPHA; BISPHOSPHONATES; PSEUDODIPEPTIDES; SEPARATIONS; DERIVATIVES	C-2-symmetric N,N-bis(phosphinomethyl)amines were prepared by the thermal reaction of aromatic aldehydes with ammonia and hypophosphorus acid as previously described. Both enantiomers of C-2-symmetric N,N-bis(phosphinomethyl)amine were obtained in a high enantiomeric purity through the diastereomeric salt formation with (-)-quinine, and subsequent fractional crystallization. X-ray crystallographic analysis of one of the diastereomeric salts clearly revealed that (-)-quinine could be an efficient resolving agent for obtaining the single enantiomer (R,R)-N,N-bis(phosphinomethyl)amine. Chirality 27:71-74, 2015. (c) 2014 Wiley Periodicals, Inc.	[Kaboudin, Babak; Faghihi, Mohammad Reza; Kazemi, Foad] IASBS, Dept Chem, Gava Zang 4513766731, Zanjan, Iran; [Yokomatsu, Tsutomu] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo, Japan	Kaboudin, B (reprint author), IASBS, Dept Chem, Gava Zang 4513766731, Zanjan, Iran.	kaboudin@iasbs.ac.ir			Institute for Advanced Studies in Basic Sciences (IASBS)	The Institute for Advanced Studies in Basic Sciences (IASBS) is thanked for supporting this work. The authors also thank Mr. Haruhiko Fukaya, Tokyo University of Pharmacy and Life Sciences, for his hell) carrying out the X-ray crystallographic analysis.	Bhagat S, 2007, J ORG CHEM, V72, P1263, DOI 10.1021/jo062140i; Ohara M, 2011, ADV SYNTH CATAL, V353, P3285, DOI 10.1002/adsc.201100482; PEYMAN A, 1992, TETRAHEDRON LETT, V33, P4549, DOI 10.1016/S0040-4039(00)61309-6; Sanders JM, 2003, J MED CHEM, V46, P5171, DOI 10.1021/jm0302344; Chen HX, 1998, P NATL ACAD SCI USA, V95, P12028, DOI 10.1073/pnas.95.20.12028; Ghosh S, 2004, J MED CHEM, V47, P175, DOI 10.1021/jm030084x; Collinsova M, 2000, CURR MED CHEM, V7, P629; SEYFERTH D, 1971, J ORG CHEM, V36, P1379, DOI 10.1021/jo00809a014; Preinerstorfer B, 2006, ELECTROPHORESIS, V27, P4312, DOI 10.1002/elps.200600253; Zhao DP, 2009, CHEM-EUR J, V15, P10983, DOI 10.1002/chem.200901901; Kaboudin B, 2007, TETRAHEDRON LETT, V48, P9015, DOI 10.1016/j.tetlet.2007.10.082; ALLEN MC, 1989, J MED CHEM, V32, P1652, DOI 10.1021/jm00127a041; Abell JP, 2008, J AM CHEM SOC, V130, P10521, DOI 10.1021/ja803859p; Kaboudin B, 2009, TETRAHEDRON LETT, V50, P1450, DOI 10.1016/j.tetlet.2009.01.055; Gargano AFG, 2013, ANAL BIOANAL CHEM, V405, P8027, DOI 10.1007/s00216-013-6938-6; Joly GD, 2004, J AM CHEM SOC, V126, P4102, DOI 10.1021/ja0494398; Barnhart WW, 2013, CHIRALITY, V25, P369, DOI 10.1002/chir.22146; Berlicki L, 2012, AMINO ACIDS, V42, P1937, DOI 10.1007/s00726-011-0920-4; Gancarzs R, 1978, SYNTHESIS-STUTTGART, V1978, P625; Gittens SA, 2005, ADV DRUG DELIVER REV, V57, P1011, DOI 10.1016/j.addr.2004.12.015; Hassalls CH, 1983, ANTIBIOTICS, VVI, P1; Kaboudin B, 2008, TETRAHEDRON-ASYMMETR, V19, P862, DOI 10.1016/j.tetasy.2008.03.004; Kaboudin B, 2011, TETRAHEDRON-ASYMMETR, V22, P1813, DOI 10.1016/j.tetasy.2011.10.019; Kaboudin B, 2002, PHOSPHORUS SULFUR, V177, P1749, DOI 10.1080/10426500290093577; Kaboudin B, 2006, J ORG CHEM, V71, P6604, DOI 10.1021/jo060547h; Kaboudin B, 2010, SYNLETT, P1837, DOI 10.1055/s-0030-1258115; Kaboudin B, 2012, SYNLETT, P1965, DOI 10.1055/s-0032-1316706; Kaboudin B, 2011, J CHEM ENG DATA, V56, P3651, DOI 10.1021/je2004897; Kaboudin B, 2011, PHOSPHORUS SULFUR, V186, P804, DOI 10.1080/10426507.2010.526677; Kaboudin B, 2011, SYNTHESIS-STUTTGART, P3185, DOI 10.1055/s-0030-1260170; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kukhars VP, 2000, AMINOPHOSPHONIC AMIN; Martins BM, 2001, J MED CHEM, V44, P909; Metlushka KE, 2009, CHEM-EUR J, V15, P6718, DOI 10.1002/chem.200802540; Nakamura S, 2008, ADV SYNTH CATAL, V350, P1209, DOI 10.1002/adsc.200800134; Palecz B, 2012, J CHEM ENG DATA, V57, P1515, DOI 10.1021/je300167m; TAKEUCHI M, 1993, CHEM PHARM BULL, V41, P688; Vayron P, 2000, P NATL ACAD SCI USA, V97, P7058, DOI 10.1073/pnas.97.13.7058; Wormss KH, 1976, ORGANIC PHOSPHORUS C, V7, P1; Yiotakis A, 2004, CURR ORG CHEM, V8, P1135, DOI 10.2174/1385272043370177	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	JAN	2015	27	1					71	74		10.1002/chir.22391		4	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX2RE	WOS:000346790800010		
J	Nakamura, T; Yoshizako, T; Araki, H; Maruyama, M; Uchida, K; Tamaki, Y; Ishikawa, N; Shiina, H; Kitagaki, H				Nakamura, Tomonori; Yoshizako, Takeshi; Araki, Hisayoshi; Maruyama, Mitsunari; Uchida, Koji; Tamaki, Yukihisa; Ishikawa, Noriyuki; Shiina, Hiroaki; Kitagaki, Hajime			The relation between apparent diffusion coefficient and clinical stage of clear-cell renal cell carcinoma	CLINICAL IMAGING			English	Article						Renal cell carcinoma; Apparent diffusion coefficients (ADC); Magnetic resonance (MR) imaging; Clinical stage	WEIGHTED MRI; VALUES; GRADE	Purpose: The utility of the apparent diffusion coefficient (ADC) in patients with clear-cell renal cell carcinoma (RCC) for distinguishing between the four clinical stages was assessed. Methods: Forty-nine patients with pathologically proven RCCs (I, II, III, IV; 27, 5, 10, 7) were included. The ADC was compared between each stage. Results: The difference of ADC between stage land the more advanced stages (HI and IV) was statistically significant. Conclusions: When ADC in primary tumor site of clear-cell RCC would be higher than the cutoff level, the stage might not be an advanced stage (III or IV). (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Tomonori; Yoshizako, Takeshi; Araki, Hisayoshi; Maruyama, Mitsunari; Uchida, Koji; Tamaki, Yukihisa; Kitagaki, Hajime] Shimane Univ, Fac Med, Dept Radiol, Izumo, Shimane, Japan; [Ishikawa, Noriyuki] Shimane Univ, Fac Med, Dept Organ Pathol, Izumo, Shimane, Japan; [Shiina, Hiroaki] Shimane Univ, Fac Med, Dept Urol, Izumo, Shimane, Japan	Yoshizako, T (reprint author), Shimane Univ, Fac Med, Dept Radiol, POB 00693-8501,89-1 Enya, Izumo, Shimane, Japan.	yosizako@med.shimane-u.ac.jp					Beck SDW, 2004, ANN SURG ONCOL, V11, P71, DOI 10.1245/ASO.2004.06.016; Goyal A, 2012, ACTA RADIOL, V53, P349, DOI 10.1258/ar.2011.110415; Yu XD, 2012, EUR J RADIOL, V81, P3061, DOI 10.1016/j.ejrad.2012.04.028; Reuter VE, 2006, SEMIN ONCOL, V33, P534, DOI 10.1053/j.seminoncol.2006.06.009; Tamada T, 2008, J MAGN RESON IMAGING, V28, P720, DOI 10.1002/jmri.21503; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Edge S, 2010, AJCC CANC STAGING MA, P479; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Paudyal B, 2010, BRIT J RADIOL, V83, P336, DOI 10.1259/bjr/74949757; Rosenkrantz AB, 2010, AM J ROENTGENOL, V195, P344	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	JAN-FEB	2015	39	1					72	75		10.1016/j.clinimag.2014.09.006		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX4IJ	WOS:000346896300013		
J	Kato, H; Kanematsu, M; Ohno, T; Oshima, K; Nagano, A; Hatano, Y; Nishibori, H				Kato, Hiroki; Kanematsu, Masayuki; Ohno, Takatoshi; Oshima, Koji; Nagano, Akihito; Hatano, Yuichiro; Nishibori, Hironori			Intraosseous schwannoma of the ilium	CLINICAL IMAGING			English	Article						Intraosseous schwannoma; Ilium; CT; MRI	DIFFUSION-WEIGHTED MRI; SOFT-TISSUE TUMORS; NEURILEMMOMA; BONE	We presented a 27-year-old male diagnosed with intraosseous schwannoma of the ilium. Computed tomographic images revealed a well-demarcated, lobulated, expansile, osteolytic lesion in the right supraacetabular region of the ilium. In addition, an intratumoral punctate calcification and a sclerotic rim were observed. T2-weighted magnetic resonance (MR) images demonstrated a heterogeneously hyperintense lesion with a hypointense rim. Major parts of the lesion, excluding some central areas, were enhanced on gadolinium-enhanced MR images. Pathological examination revealed an intraosseous schwannoma. Our findings indicate that intraosseous schwannoma should be considered when images demonstrate a well-demarcated, lobulated, expansile, osteolytic lesion with a sclerotic rim. (C) 2015 Elsevier Inc. Al rights reserved.	[Kato, Hiroki; Kanematsu, Masayuki] Gifu Univ, Sch Med, Dept Radiol, Gifu 5011194, Japan; [Kanematsu, Masayuki] Gifu Univ Hosp, High Level Imaging Diag Ctr, Gifu 5011194, Japan; [Ohno, Takatoshi; Oshima, Koji; Nagano, Akihito] Gifu Univ, Sch Med, Dept Orthoped Surg, Gifu 500, Japan; [Hatano, Yuichiro] Gifu Univ, Sch Med, Dept Pathol, Gifu 500, Japan; [Nishibori, Hironori] Kizawa Mem Hosp, Dept Radiol, Gifu 5058503, Japan	Kanematsu, M (reprint author), Gifu Univ, Sch Med, Dept Radiol, 1-1 Yanagido, Gifu 5011194, Japan.	masa_gif@yahoo.co.jp	Hatano, Yuichiro/K-7454-2013	Hatano, Yuichiro/0000-0002-5121-6325			AGHA FP, 1972, RADIOLOGY, V102, P325; Aoki J, 1997, SKELETAL RADIOL, V26, P60; Pavlisa G, 2008, CLIN IMAG, V32, P22, DOI 10.1016/j.clinimag.2007.07.007; van Rijswijk CSP, 2002, J MAGN RESON IMAGING, V15, P302, DOI 10.1002/jmri.10061; Einarsdottir H, 2004, EUR RADIOL, V14, P959, DOI 10.1007/s00330-004-2237-0; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; FAWCETT KJ, 1967, AM J CLIN PATHOL, V47, P759; Kashima TG, 2013, SKELETAL RADIOL, V42, P1665, DOI 10.1007/s00256-013-1712-6; Banks KP, 2005, RADIOLOGY, V234, P899, DOI 10.1148/radiol.2343030946; Benazzo F, 2013, ORTHOPEDICS, V36, pE982, DOI 10.3928/01477447-20130624-34; Dunnick NR, 1999, RADIOGRAPHICS, V20, P271; Ida CM, 2011, AM J SURG PATHOL, V35, P989, DOI 10.1097/PAS.0b013e31821fcc0c; Indino C, 2011, B SOC MED CHIR PA, V124, P93; Jee WH, 2004, AM J ROENTGENOL, V183, P629; Nakasato T, 2000, AM J NEURORADIOL, V21, P1945; SAMTER TG, 1960, RADIOLOGY, V75, P215; Sener RN, 2003, J COMPUT ASSIST TOMO, V27, P249, DOI 10.1097/00004728-200303000-00024; Zhang L, 2012, OR SURG OR MED OR PA, V114, pE13, DOI 10.1016/j.oooo.2011.09.026	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	JAN-FEB	2015	39	1					161	164		10.1016/j.clinimag.2014.09.005		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX4IJ	WOS:000346896300030		
J	Shibuya, M; Hatano, M; Kawamura, K				Shibuya, Misa; Hatano, Mitzuki; Kawamura, Kaz			Interactive Histone Acetylation and Methylation in Regulating Transdifferentiation-Related Genes During Tunicate Budding and Regeneration	DEVELOPMENTAL DYNAMICS			English	Article						ascidian; chromatin immunoprecipitation; epigenetics; histone acetyltransferase; retinoic acid	EMBRYONIC STEM-CELLS; POLYANDROCARPA-MISAKIENSIS; MULTIPOTENT EPITHELIUM; ASEXUAL REPRODUCTION; COLONIAL TUNICATES; RETINOIC ACID; POLYCOMB; ACETYLTRANSFERASE; TRANSCRIPTION; COMPLEXES	Background: In the budding tunicate Polyandrocarpa misakiensis, retinoic acid (RA)-triggered transdifferentiation occurs during bud development and zooid regeneration. We aimed to reveal how and to what extent epigenetic histone modifications are involved in transdifferentiation-related gene expression. Results: Acetylated histone H3 lysine 9 (H3K9ac) was observed in transdifferentiating bud tissues and regenerating zooid tissues, where a histone acetyltransferase (HAT) gene, PmGCN5, was strongly expressed. Results of chromatin immunoprecipitation (ChIP) indicated that in transdifferentiating bud tissues, retinoic acid receptor (PmRAR), retinoid X receptor (PmRXR), external signal-regulated kinase (PmERK), and b-catenin (PmbCTN) genes conspicuously underwent H3K9 acetylation in their core promoter regions. RA was found to induce PmGCN5, causing histone acetylation of PmRAR, PmRXR, and PmERK. A GCN5 inhibitor, CPTH2, attenuated acetylation and weakened transcription of transdifferentiation-related genes, except PmERK, indicating that RA-induced GCN5 facilitates gene expression via histone acetylation. In regenerating zooids, H3K9ac occurred exclusively in PmERK, but PmERK expression did not change, and, surprisingly, the PmProhibitin2 expression decreased substantially. In the core promoter regions of these genes, suppressive histone methylation occurred at H3K9 and H3K27. Conclusions: These results, along with other evidence, indicate that cooperative and conflicting histone modifications enable the minute regulation of gene expression in P. misakiensis. Developmental Dynamics 244: 10-20, 2015. VC 2014 Wiley Periodicals, Inc.	[Shibuya, Misa; Hatano, Mitzuki; Kawamura, Kaz] Kochi Univ, Lab Cellular & Mol Biotechnol, Fac Sci, Kochi 7808520, Japan	Kawamura, K (reprint author), Kochi Univ, Lab Cellular & Mol Biotechnol, Fac Sci, Kochi 7808520, Japan.	kazuk@kochi-u.ac.jp			Japan Society for the Promotion of Science [21570227, 25650081]	Grant sponsor: Japan Society for the Promotion of Science; Grant numbers: 21570227 and 25650081.	Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Kawamura K, 2008, DEV GROWTH DIFFER, V50, P1, DOI 10.1111/j.1440-169x.2007.00972.x; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Iizuka M, 2003, CURR OPIN GENET DEV, V13, P154, DOI 10.1016/S0959-437X(03)00020-0; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kawamura K, 2010, DEV GROWTH DIFFER, V52, P69, DOI 10.1111/j.1440-169X.2009.01142.x; Strahl BD, 2000, NATURE, V403, P41; Sunanaga T, 2006, DEV GROWTH DIFFER, V48, P87, DOI 10.1111/j.1440-169x.2006.00849.x; Kawamura K, 2013, DEV BIOL, V384, P343, DOI 10.1016/j.ydbio.2013.10.004; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; GUARENTE L, 1995, TRENDS BIOCHEM SCI, V20, P517, DOI 10.1016/S0968-0004(00)89120-3; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Tatzuke Y, 2012, DEV BIOL, V368, P393, DOI 10.1016/j.ydbio.2012.06.006; Chimenti F, 2009, J MED CHEM, V52, P530, DOI 10.1021/jm800885d; Sunanaga T, 2007, DEV GENES EVOL, V217, P1, DOI 10.1007/s00427-006-0112-5; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; KAWAMURA K, 1994, INT J DEV BIOL, V38, P369; Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Chen HF, 2012, NUCLEIC ACIDS RES, V40, P6534, DOI 10.1093/nar/gks345; FUJIWARA S, 1992, DEV GROWTH DIFFER, V34, P463; Gasser SM, 1998, CELL MOL LIFE SCI, V54, P1, DOI 10.1007/s000180050120; HARA K, 1992, DEV GROWTH DIFFER, V34, P437; Iwama A, 2005, INT J HEMATOL, V81, P294, DOI 10.1532/IJH97.05011; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kaneko N, 2010, DEV GROWTH DIFFER, V52, P457, DOI 10.1111/j.1440-169X.2010.01184.x; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; KAWAMURA K, 1995, SEMIN CELL BIOL, V6, P117, DOI 10.1006/scel.1995.0017; KAWAMURA K, 1993, DEVELOPMENT, V117, P835; Satoh N, 2014, DEV GENOMICS ASCIDIA; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	JAN	2015	244	1					10	20		10.1002/dvdy.24212		11	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	AX2IY	WOS:000346768000002		
J	Mizuta, K; Sakabe, M; Hashimoto, A; Ioka, T; Sakai, C; Okumura, K; Hattammaru, M; Fujita, M; Araki, M; Somekawa, S; Saito, Y; Nakagawa, O				Mizuta, Ken; Sakabe, Masahide; Hashimoto, Aya; Ioka, Tomoko; Sakai, Chihiro; Okumura, Kazuki; Hattammaru, Miwa; Fujita, Masahide; Araki, Mutsumi; Somekawa, Satoshi; Saito, Yoshihiko; Nakagawa, Osamu			Impairment of Endothelial-Mesenchymal Transformation During Atrioventricular Cushion Formation in Tmem100 Null Embryos	DEVELOPMENTAL DYNAMICS			English	Article						mouse embryo; cardiac development; endocardial cushion; EndMT; vascular endothelial growth factor; NFATc1	BONE MORPHOGENETIC PROTEIN-2; CONGENITAL HEART-DEFECTS; BREAST-CANCER CELLS; TRANSCRIPTION FACTOR; VALVE DEVELOPMENT; CARDIAC DEVELOPMENT; NF-ATC; MICE; MOUSE; TRANSITION	Background: Endothelial-mesenchymal transformation (EndMT) is essential for endocardial cushion formation during cardiac morphogenesis. We recently identified Tmem100 as an endothelial gene indispensable for vascular development. In this study, we further investigated its roles for EndMT during atrioventricular canal (AVC) cushion formation. Results: Tmem100 was expressed in AVC endocardial cells, and Tmem100 null embryos showed severe EndMT defect in the AVC cushions. While calcineurin-dependent suppression of vascular endothelial growth factor (VEGF) expression in the AVC myocardium is important for EndMT, significant up-regulation of Vegfa expression was observed in Tmem100 null heart. EndMT impaired in Tmem100 null AVC explants was partially but significantly restored by the expression of constitutively-active calcineurin A, suggesting dysregulation of myocardial calcineurin-VEGF signaling in Tmem100 null heart. Moreover, Tmem100 null endocardial cells in explant culture did not show EndMT in response to the treatment with myocardium-derived growth factors, transforming growth factor b2 and bone morphogenetic protein 2, indicating involvement of an additional endocardial-specific abnormality in the mechanism of EndMT defect. The lack of NFATc1 nuclear translocation in endocardial cells of Tmem100 null embryos suggests impairment of endocardial calcium signaling. Conclusions: The Tmem100 deficiency causes EndMT defect during AVC cushion formation possibly via disturbance of multiple calcium-related signaling events. Developmental Dynamics 244: 31-42, 2015. VC 2014 Wiley Periodicals, Inc.	[Mizuta, Ken; Sakabe, Masahide; Hashimoto, Aya; Ioka, Tomoko; Sakai, Chihiro; Okumura, Kazuki; Hattammaru, Miwa; Fujita, Masahide; Araki, Mutsumi; Nakagawa, Osamu] Nara Med Univ, Adv Med Res Ctr, Lab Cardiovasc Syst Res, Kashihara, Nara 6348521, Japan; [Hattammaru, Miwa] Tokyo Womens Med Univ, Dept Internal Med, Med Ctr East, Tokyo, Japan; [Somekawa, Satoshi; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 6348521, Japan	Nakagawa, O (reprint author), Nara Med Univ, Adv Med Res Ctr, Lab Cardiovasc Syst Res, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	sakabe@naramed-u.ac.jp; nakagawa-nmu@umin.org			Ministry of Education, Culture, Sports, Science and Technology; Astellas Foundation for Research on Metabolic Disorders; Ichiro Kanahara Foundation; Japan Heart Foundation; Japan Vascular Disease Research Foundation; Miyata Cardiac Research Promotion Foundation; Mother and Child Health Foundation; Naito Foundation; Novartis Foundation (Japan) for the Promotion of Science; SENSHIN Medical Research Foundation; Smoking Research Foundation; Suzuken Memorial Foundation; Takeda Science Foundation; Uehara Memorial Foundation	Grant sponsor: Ministry of Education, Culture, Sports, Science and Technology; Grant sponsor: Astellas Foundation for Research on Metabolic Disorders; Grant sponsor: The Ichiro Kanahara Foundation; Grant sponsor: The Japan Heart Foundation; Grant sponsor: Japan Vascular Disease Research Foundation; Grant sponsor: Miyata Cardiac Research Promotion Foundation; Grant sponsor: The Mother and Child Health Foundation; Grant sponsor: The Naito Foundation; Grant sponsor: Novartis Foundation (Japan) for the Promotion of Science; Grant sponsor: SENSHIN Medical Research Foundation; Grant sponsor: The Smoking Research Foundation; Grant sponsor: Suzuken Memorial Foundation; Grant sponsor: Takeda Science Foundation; Grant sponsor: Uehara Memorial Foundation.	Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Yamagishi T, 1999, J CELL PHYSIOL, V180, P35, DOI 10.1002/(SICI)1097-4652(199907)180:1<35::AID-JCP4>3.3.CO;2-I; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Hu JJ, 2011, BIOCHEM BIOPH RES CO, V411, P786, DOI 10.1016/j.bbrc.2011.07.025; de la Pompa JL, 1998, NATURE, V392, P182; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Sridurongrit S, 2008, DEV BIOL, V322, P208, DOI 10.1016/j.ydbio.2008.07.038; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Somekawa S, 2012, P NATL ACAD SCI USA, V109, P12064, DOI 10.1073/pnas.1207210109; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Wu BR, 2011, CIRC RES, V109, P183, DOI 10.1161/CIRCRESAHA.111.245035; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; MARKWALD RR, 1975, DEV BIOL, V42, P160, DOI 10.1016/0012-1606(75)90321-8; Sorensen LK, 2003, DEV BIOL, V261, P235, DOI 10.1016/S0012-1606(03)00158-1; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Urness LD, 2000, NAT GENET, V26, P328; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Ranger AM, 1998, NATURE, V392, P186; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Dor Y, 2001, DEVELOPMENT, V128, P1531; BERNANKE DH, 1982, DEV BIOL, V91, P235, DOI 10.1016/0012-1606(82)90030-6; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Combs MD, 2009, CIRC RES, V105, P565, DOI 10.1161/CIRCRESAHA.109.196469; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Eisenman ST, 2013, NEUROSCIENCE, V240, P117, DOI 10.1016/j.neuroscience.2013.02.034; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Moon EH, 2010, GENESIS, V48, P673, DOI 10.1002/dvg.20674; Nakajima Y, 1997, J CELL BIOL, V136, P193, DOI 10.1083/jcb.136.1.193; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Sakabe Masahide, 2005, Congenital Anomalies, V45, P107, DOI 10.1111/j.1741-4520.2005.00079.x; Sakabe M, 2012, DEVELOPMENT, V139, P385, DOI 10.1242/dev.067058; Uchida K, 2010, PLOS ONE, V5; vansder Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886; vonsGise A, 2012, CIRC RES, V110, P1628; Wang YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060244	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	JAN	2015	244	1					31	42		10.1002/dvdy.24216		12	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	AX2IY	WOS:000346768000004		
J	Hwang, JY; Sim, X; Wu, Y; Liang, J; Tabara, Y; Hu, C; Hara, K; Tam, CHT; Cai, QY; Zhao, Q; Jee, S; Takeuchi, F; Go, MJ; Ong, RTH; Ohkubo, T; Kim, YJ; Zhang, R; Yamauchi, T; So, WY; Long, JR; Gu, DF; Lee, NR; Kim, S; Katsuya, T; Oh, JH; Liu, JJ; Umemura, S; Kim, YJ; Jiang, F; Maeda, S; Chan, JCN; Lu, W; Hixson, JE; Adair, LS; Jung, KJ; Nabika, T; Bae, JB; Lee, MH; Seielstad, M; Young, TL; Teo, YY; Kita, Y; Takashima, N; Osawa, H; Lee, SH; Shin, MH; Shin, DH; Choi, BY; Shi, JJ; Gao, YT; Xiang, YB; Zheng, W; Kato, N; Yoon, M; He, J; Shu, XO; Ma, RCW; Kadowaki, T; Jia, WP; Miki, T; Qi, L; Tai, ES; Mohlke, KL; Han, BG; Cho, YS; Kim, BJ				Hwang, Joo-Yeon; Sim, Xueling; Wu, Ying; Liang, Jun; Tabara, Yasuharu; Hu, Cheng; Hara, Kazuo; Tam, Claudia H. T.; Cai, Qiuyin; Zhao, Qi; Jee, Sunha; Takeuchi, Fumihiko; Go, Min Jin; Ong, Rick Twee Hee; Ohkubo, Takayoshi; Kim, Young Jin; Zhang, Rong; Yamauchi, Toshimasa; So, Wing Yee; Long, Jirong; Gu, Dongfeng; Lee, Nanette R.; Kim, Soriul; Katsuya, Tomohiro; Oh, Ji Hee; Liu, Jianjun; Umemura, Satoshi; Kim, Yeon-Jung; Jiang, Feng; Maeda, Shiro; Chan, Juliana C. N.; Lu, Wei; Hixson, James E.; Adair, Linda S.; Jung, Keum Ji; Nabika, Toru; Bae, Jae-Bum; Lee, Mi Hee; Seielstad, Mark; Young, Terri L.; Teo, Yik Ying; Kita, Yoshikuni; Takashima, Naoyuki; Osawa, Haruhiko; Lee, So-Hyun; Shin, Min-Ho; Shin, Dong Hoon; Choi, Bo Youl; Shi, Jiajun; Gao, Yu-Tang; Xiang, Yong-Bing; Zheng, Wei; Kato, Norihiro; Yoon, Miwuk; He, Jiang; Shu, Xiao Ou; Ma, Ronald C. W.; Kadowaki, Takashi; Jia, Weiping; Miki, Tetsuro; Qi, Lu; Tai, E. Shyong; Mohlke, Karen L.; Han, Bok-Ghee; Cho, Yoon Shin; Kim, Bong-Jo			Genome-Wide Association Meta-analysis Identifies Novel Variants Associated With Fasting Plasma Glucose in East Asians	DIABETES			English	Article							TYPE-2 DIABETES RISK; INSULIN-RESISTANCE; GLYCEMIC TRAITS; BETA-CELLS; LOCI; EXPRESSION; SECRETION; MASS	Fasting plasma glucose (FPG) has been recognized as an important indicator for the overall glycemic state preceding the onset of metabolic diseases. So far, most indentified genome-wide association loci for FPG were derived from populations with European ancestry, with a few exceptions. To extend a thorough catalog for FPG loci, we conducted meta-analyses of 13 genome-wide association studies in up to 24,740 nondiabetic subjects with East Asian ancestry. Follow-up replication analyses in up to an additional 21,345 participants identified three new FPG loci reaching genome-wide significance in or near PDK1-RAPGEF4, KANK1, and IGF1R. Our results could provide additional insight into the genetic variation implicated in fasting glucose regulation.	[Hwang, Joo-Yeon; Go, Min Jin; Kim, Young Jin; Oh, Ji Hee; Kim, Yeon-Jung; Bae, Jae-Bum; Lee, Mi Hee; Lee, So-Hyun; Han, Bok-Ghee; Kim, Bong-Jo] Osong Hlth Technol Adm Complex, Ctr Genome Sci, Natl Inst Hlth, Chungcheongbuk Do, South Korea; [Sim, Xueling] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sim, Xueling; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Liang, Jun; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Tabara, Yasuharu] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Hu, Cheng; Zhang, Rong; Jiang, Feng; Jia, Weiping] Shanghai Jiao Tong Univ, Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus, Dept Endocrinol & Metab,Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Hara, Kazuo; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Hara, Kazuo] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, 22nd Century Med & Res Ctr, Tokyo, Japan; [Tam, Claudia H. T.; So, Wing Yee; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Cai, Qiuyin; Long, Jirong; Shi, Jiajun; Zheng, Wei; Shu, Xiao Ou] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Cai, Qiuyin; Long, Jirong; Shi, Jiajun; Zheng, Wei; Shu, Xiao Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Zhao, Qi; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Jee, Sunha; Kim, Soriul; Jung, Keum Ji; Yoon, Miwuk] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul 120749, South Korea; [Takeuchi, Fumihiko; Kato, Norihiro; Tai, E. Shyong] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Ong, Rick Twee Hee; Teo, Yik Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Ohkubo, Takayoshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Ohkubo, Takayoshi; Kita, Yoshikuni; Takashima, Naoyuki] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga, Japan; [Gu, Dongfeng] Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Dept Epidemiol, Beijing, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lee, Nanette R.] Univ San Carlos, Off Populat Studies Fdn, Cebu, Philippines; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Liu, Jianjun; Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Umemura, Satoshi] Yokohama City Univ, Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan; [Maeda, Shiro] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Lu, Wei] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Hixson, James E.] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Young, Terri L.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Osawa, Haruhiko] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Toon, Japan; [Shin, Min-Ho] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea; [Shin, Dong Hoon] Keimyung Univ, Dongsan Med Ctr, Dept Occupat & Environm Med, Taegu, South Korea; [Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, Renji Hosp, Shanghai 200030, Peoples R China; [Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon, Japan; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Cho, Yoon Shin] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea	Han, BG (reprint author), Osong Hlth Technol Adm Complex, Ctr Genome Sci, Natl Inst Hlth, Chungcheongbuk Do, South Korea.	hanbokghee@gmail.com; yooncho33@hallym.ac.kr; kbj6181@hanmail.net	Jia, Weiping/B-7483-2012; Hu, Cheng/C-3346-2008; Ma, Ronald/C-2788-2009; 	Ma, Ronald/0000-0002-1227-803X; Kita, Yoshikuni/0000-0002-2366-1106	Korea Centers for Disease Control and Prevention [4845-301, 4851-302, 4851-307]; Korea National Institute of Health, the Republic of Korea [2012-N73002-00]; National Research Foundation of Korea - Korean government (Ministry of Education, Science and Technology) [2012R1A2A1A03006155]; U.S. National Institutes of Health (NIH) [DK078150, TW05596, HL085144, TW008288]; Academy of Finland [124243]; Finnish Heart Foundation; Finnish Diabetes Foundation; Tekes [1510/31/06]; Commission of the European Community [HEALTH-F2-2007-201681]; NIH [DK093757, DK072193, DK062370, 1Z01 HG000024, R01CA064277, R01CA082729, R37CA070867, R01CA124558, R01CA148667, R01CA122364, R01CA122756, R01CA137013]; Vanderbilt University School of Medicine; National 973 Program [2011CB504001]; National Natural Science Foundation of China [81170735, 81322010]; Excellent Young Medical Expert of Shanghai [XYQ2011041]; Ministry of Education, Culture, Sports, Science and Technology, Japan; National 863 Program [2012AA02A509]; Shanghai Rising Star Program [12QH1401700]; Shanghai Talent Development Grant [2012041]; National Young Top Talent Support Program; Hong Kong Foundation for Research and Development in Diabetes; Chinese University of Hong Kong; Hong Kong government Research Grant Committee Central Allocation Scheme [CUHK 1/04C]; Theme-Based Research Scheme [T12-402/13-N]; Innovation and Technology Fund [ITS/088/08, ITS/487/09FP]; Chinese University Direct Grant; NIH from the National Institute of Diabetes and Digestive and Kidney Diseases [NIH-RFA DK-085545-01]; NIH National Heart, Lung, and Blood Institute [U01HL072507, R01HL087263, R01HL090682];  [RR20649];  [ES10126];  [DK56350]	This work was supported by grants from Korea Centers for Disease Control and Prevention (4845-301, 4851-302, and 4851-307) and an intramural grant from the Korea National Institute of Health (2012-N73002-00), the Republic of Korea. Y.S.C. acknowledges support from the National Research Foundation of Korea grant funded by the Korean government (Ministry of Education, Science and Technology) (2012R1A2A1A03006155). CLHNS was supported by U.S. National Institutes of Health (NIH) grants DK078150, TW05596, HL085144, and TW008288 and pilot funds from RR20649, ES10126, and DK56350. The authors thank the Office of Population Studies Foundation research and data collection teams and the study participants who generously provided their time for this study. The authors thank Markku Laakso (University of Kuopio, Finland), Michael Boehnke (University of Michigan), Francis Collins (NIH, Bethesda, MD), and the METSIM study investigators for providing access to unpublished data. METSIM data were generated and analyzed with support from the Academy of Finland (contract 124243), the Finnish Heart Foundation, the Finnish Diabetes Foundation, Tekes (contract 1510/31/06), the Commission of the European Community (HEALTH-F2-2007-201681), and NIH grants DK093757, DK072193, DK062370, and 1Z01 HG000024. SBCS was supported by R01CA064277; SMHS by R01CA082729; and GWA studies by R37CA070867, R01CA082729, R01CA124558, R01CA148667, R01CA122364, R01CA122756, and R01CA137013 (all NIH grants), as well as Ingram Professorship and Research Reward funds from the Vanderbilt University School of Medicine. The authors want to thank Regina Courtney (the Vanderbilt University School of Medicine) for DNA preparation and Jing He (the Vanderbilt University School of Medicine) for data processing and analyses. S.O.U. acknowledges a grant from the National 973 Program (2011CB504001), National Natural Science Foundation of China (81170735), and Excellent Young Medical Expert of Shanghai (XYQ2011041). The authors thank all the medical staff of the Shanghai Clinical Center for Diabetes, all the participants and the staff of the BioBank Japan project, and Minoru Iwata, Kazuyuki Tobe (First Department of Internal Medicine, University of Toyama), Kazuki Yasuda, Masato Kasuga (Diabetes Research Center, Research Institute, National Center for Global Health and Medicine), and Hiroshi Hirose (Health Center, Keio University School of Medicine) for the preparation of DNA and clinical information. They also thank the technical staff of the Laboratory for Endocrinology, Metabolism and Kidney diseases at the RIKEN Center for Integrative Medical Sciences for performing SNP genotyping. They thank Hayato Fujita (Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo) for statistical analysis. S.M. acknowledges a grant from the Leading Project of Ministry of Education, Culture, Sports, Science and Technology, Japan. W.J. acknowledges a grant from the National Natural Science Foundation of China (81322010 and 81170735), National 863 Program (2012AA02A509), Shanghai Rising Star Program (12QH1401700), Shanghai Talent Development Grant (2012041), Excellent Young Medical Expert of Shanghai (XYQ2011041), and National Young Top Talent Support Program.; The authors would like to acknowledge support from the Hong Kong Foundation for Research and Development in Diabetes, established under the auspices of the Chinese University of Hong Kong, the Hong Kong government Research Grant Committee Central Allocation Scheme (CUHK 1/04C) and Theme-Based Research Scheme (T12-402/13-N), the Innovation and Technology Fund (ITS/088/08 and ITS/487/09FP), a Chinese University Direct Grant, and NIH grant NIH-RFA DK-085545-01 (from the National Institute of Diabetes and Digestive and Kidney Diseases). GenSalt is supported by research grants (U01HL072507, R01HL087263, and R01HL090682) from the NIH National Heart, Lung, and Blood Institute.	Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Henkin L, 2003, ANN EPIDEMIOL, V13, P211, DOI 10.1016/S1047-2797(02)00412-X; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; [Anonymous], 2012, NAT GENET, DOI DOI 10.1038/NG.1019; Cornu M, 2010, J BIOL CHEM, V285, P10538, DOI 10.1074/jbc.M109.091116; Le Roith D, 2002, CURR OPIN CLIN NUTR, V5, P371, DOI 10.1097/00075197-200207000-00004; Withers DJ, 1999, NAT GENET, V23, P32; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Freeman MS, 2002, DIABETIC MED, V19, P994, DOI 10.1046/j.1464-5491.2002.00843.x; Okamoto Y, 2007, DIABETES, V56, P1000, DOI 10.2337/db06-1322; Panagiotou OA, 2013, ANNU REV GENOM HUM G, V14, P441, DOI 10.1146/annurev-genom-091212-153520; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Nan HR, 2010, DIABETES VASC DIS RE, V7, P40, DOI 10.1177/1479164109347408; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Li WD, 2004, DIABETES, V53, P2487, DOI 10.2337/diabetes.53.9.2487; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Shaye K, 2012, AM HEART J, V164, P111, DOI 10.1016/j.ahj.2012.03.023; Sookoian S, 2010, J HYPERTENS, V28, P1194, DOI 10.1097/HJH.0b013e328337f6d5; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41	27	3	3	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	JAN	2015	64	1					291	298		10.2337/db14-0563		8	Endocrinology & Metabolism	Endocrinology & Metabolism	AX2IB	WOS:000346765600030		
J	Ueda, M; Inaba, R; Matsushima, H; Ohtsuka, T				Ueda, Mikito; Inaba, Ryuichi; Matsushima, Hisayoshi; Ohtsuka, Toshiaki			Electrorefining of Sodium in Sodium Bis(trifluoromethane)sulfonylimide and Tetrabutylammonium Bis(trifluoromethane)sulfonylimide Mixture Ionic Liquids for Metallic Sodium Recycling	ECS ELECTROCHEMISTRY LETTERS			English	Article							PCBS	To develop an electrorefining process for sodium to enable recycling of used sodium-sulfur batteries, a non-aqueous electrolyte with low melting point was investigated. A mixed ionic liquid of NaTFSI (sodium bis(trifluoromethane) sulfonylimide) - TBATFSI (tetrabutylammonium bis(trifluoromethane) sulfonylimide) was selected for the electrolyte. From AC impedance measurements, a maximum ionic conductivity of 16 mS cm(-1) was established of 20 mol% NaTFSI-TBATFSI concentration at 433 K. Electrorefining for 20 hours was carried out with a stable voltage under constant current electrolysis. Liquid pure sodium was electrodeposited by the constant current electrolysis. The calcium content in the sodium cathode was decreased from 250 to 52 ppm by the electrorefining. (C) 2014 The Electrochemical Society. All rights reserved.	[Ueda, Mikito; Inaba, Ryuichi; Matsushima, Hisayoshi; Ohtsuka, Toshiaki] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan	Ueda, M (reprint author), Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan.	mikito@eng.hokudai.ac.jp	Matsushima, Hisayoshi/A-1232-2009	Matsushima, Hisayoshi/0000-0002-3214-2762	New Energy and Industrial Technology Development Organization (NEDO) project [08B44001]; Hokkaido Bureau of Economy, Trade and Industry	This work has been supported by the New Energy and Industrial Technology Development Organization (NEDO) project (08B44001) and Hokkaido Bureau of Economy, Trade and Industry.	[Anonymous], 2004, NGK REV, V60, P38; [Anonymous], 1958, 44671 FIAT, Patent No. [33-9852, 250615]; [Anonymous], 1946, P. B. report. 44, 671: FIAT, P820, Patent No. 339852; [Anonymous], 2004, NGK review, V60, P38, Patent No. 200230049; Atsumi A., 2007, T JAPAN SOC REFRIGER, V82, P638; Hayashi H., 2009, 2009 SPRING M JAP I, P396; Huang H, 2007, CHEM ENG SCI, V62, P5144, DOI 10.1016/j.ces.2007.01.077; Noma Y, 2007, CHEMOSPHERE, V68, P871, DOI 10.1016/j.chemosphere.2007.02.013; Ueda M, 2013, ELECTROCHIM ACTA, V100, P265, DOI 10.1016/j.electacta.2012.10.097; Ueda M, 2009, J JPN I MET, V73, P691, DOI 10.2320/jinstmet.73.691	10	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	2162-8726	2162-8734		ECS ELECTROCHEM LETT	ECS Electrochem. Lett.		2015	4	2					E1	E3		10.1149/2.0031502eel		3	Electrochemistry; Materials Science, Multidisciplinary	Electrochemistry; Materials Science	AX2JN	WOS:000346769600005		
J	Yu, X; Zhang, R; Kang, J; Maeda, T; Itatani, T; Osada, T; Hata, M; Takenaka, M; Takagi, S				Yu, Xiao; Zhang, Rui; Kang, Jian; Maeda, Tatsuro; Itatani, Taro; Osada, Takenori; Hata, Masahiko; Takenaka, Mitsuru; Takagi, Shinichi			Ultrathin Body Germanium-on-Insulator (GeOI) Pseudo-MOSFETs Fabricated by Transfer of Epitaxial Ge Films on III-V Substrates	ECS SOLID STATE LETTERS			English	Article							MOBILITY; SI	We demonstrate thin body GeOI Pseudo-MOSFETs fabricated by a novel GeOI fabrication process based on epitaxial Ge films grown on III-V compound semiconductor wafers and wafer bonding. Ge surfaces before bonding are treated by plasma post oxidation to form GeOx, which can provide better interfacial quality between Ge and buried oxides. Normal operations of n- and p-MOSFETs are confirmed for GeOI with average thickness of 60 to 20 nm. The peak effective hole and electron mobility of 122 and 235 cm(2)/Vs, respectively, have been obtained for 20-nm-thick-GeOI n- and p-MOSFETs. The GeOI thickness dependence of mobility is also examined. (C) The Author(s) 2014. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. All rights reserved.	[Yu, Xiao; Zhang, Rui; Kang, Jian; Takenaka, Mitsuru; Takagi, Shinichi] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Yu, Xiao; Zhang, Rui; Kang, Jian; Takenaka, Mitsuru; Takagi, Shinichi] JST CREST, Bunkyo Ku, Tokyo 1138656, Japan; [Maeda, Tatsuro; Itatani, Taro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Osada, Takenori; Hata, Masahiko] Sumitomo Chem Co Ltd, Tsukuba, Ibaraki 3003294, Japan	Yu, X (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.	yuxiao@mosfet.t.u-tokyo.ac.jp	Maeda, Tatsuro/E-7486-2015		New Energy and Industrial Technology Development Organization (NEDO) in "Photonics Electronics Convergence Technology for Power-Reducing Jisso System"; MEXT	This work was partly supported by New Energy and Industrial Technology Development Organization (NEDO) in "Photonics Electronics Convergence Technology for Power-Reducing Jisso System" and Grant-in-Aid for Specially promoted Research from MEXT.	Ferain I, 2011, NATURE, V479, P310, DOI 10.1038/nature10676; TAKAGI S, 1994, IEEE T ELECTRON DEV, V41, P2363, DOI 10.1109/16.337450; Lee CH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4810002; Dissanayake S, 2011, J APPL PHYS, V109, DOI 10.1063/1.3537919; Zhang R, 2012, IEEE T ELECTRON DEV, V59, P335, DOI 10.1109/TED.2011.2176495; [Anonymous], 2006, IEE ELECT LETT, DOI DOI 10.1049/EL:20060208; Tracy CJ, 2004, J ELECTRON MATER, V33, P886, DOI 10.1007/s11664-004-0216-5; SZE SM, 1968, SOLID STATE ELECTRON, V11, P599, DOI 10.1016/0038-1101(68)90012-9; Shang H, 2006, IBM J RES DEV, V50, P377; Takagi S, 2007, MICROELECTRON ENG, V84, P2314, DOI 10.1016/j.mee.2007.04.129; International technology roadmap for semiconductors (ITRS), 2011, TECH REP; Kabuyanagi S., 2013, SSDM, P626; Kuzum D, 2011, IEEE T ELECTRON DEV, V58, P59, DOI 10.1109/TED.2010.2088124; Lee CH, 2011, IEEE T CIRCUITS SYST, P1; Lee CH, 2010, IEDM, P416; Lin J.-Y., 2013, VLSI S, P32; Maeda T, 2013, MICROELECTRON ENG, V109, P133, DOI 10.1016/j.mee.2013.03.069; Sieg RM, 1998, APPL PHYS LETT, V73, P3111, DOI 10.1063/1.122689; Sze S. M., 2007, PHYS SEMICONDUCTOR D, P789; Takagi S, 2003, IEDM, P57; Zhang R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3564902; Zhang R., 2011, IEDM, P642	22	0	0	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	2162-8742			ECS SOLID STATE LETT	ECS Solid State Lett.		2015	4	2					P15	P18		10.1149/2.0031502ssl		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX2JQ	WOS:000346769900003		
J	Yorifuji, T; Kashima, S; Doi, H				Yorifuji, Takashi; Kashima, Saori; Doi, Hiroyuki			Outdoor air pollution and term low birth weight in Japan	ENVIRONMENT INTERNATIONAL			English	Article						Air pollution; Low birth weight; Nitrogen dioxide; Particulate matter; Pregnancy outcomes; Sulfur dioxide	NATIONWIDE LONGITUDINAL SURVEY; FINE PARTICULATE MATTER; PRETERM BIRTHS; EXPOSURE; HEALTH; OUTCOMES; PM2.5; CALIFORNIA; TOXICS; MODELS	Introduction: Evidence has accumulated on the association between ambient air pollution and adverse birth outcomes. However, most of the previous studies were conducted in geographically distinct areas and suffer from lack of important potential covariates. We examined the effect of ambient air pollution on term low birth weight (LBW) using data from a nationwide population-based longitudinal survey in Japan that began in 2001. Methods: We restricted participants to term singletons (n = 44,109). Air pollution concentrations during the 9 months before birth were obtained at the municipality level and were assigned to the participants who were born in the corresponding municipality. We conducted multilevel logistic regression analyses adjusting for individual and municipality-level variables. Results: We found that air pollution exposure during pregnancy was positively associated with the risk of term LBW. In the fully adjusted models, odds ratios following one interquartile range increase in each pollutant were 1.09 (95% confidence interval: 1.00, 1.19) for suspended particulate matter (SPM), 1.11 (0.99, 1.26) for nitrogen dioxide (NO2), and 1.71 (1.18, 2.46) for sulfur dioxide (SO2). Specifically, effect estimates for SPM and NO2 exposure at the first trimester were higher than those at other trimesters, while SO2 was associated with the risk at all trimesters. Nonsmoking mothers were more susceptible to SPM and NO2 exposure compared with smoking mothers. Conclusions: Ambient air pollution increases the risk of term LBW in amationally representative sample in Japan. (C) 2014 Elsevier Ltd. All rights reserved.	[Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Okayama 7008530, Japan; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Publ Policy, Hiroshima 730, Japan; [Doi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama 7008530, Japan	Yorifuji, T (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yorichan@md.okayama-u.ac.jp					Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; Kannan S, 2006, ENVIRON HEALTH PERSP, V114, P1636, DOI 10.1289/ehp.9081; Ebisu K, 2012, ENVIRON HEALTH PERSP, V120, P1746, DOI 10.1289/ehp.1104763; Shah PS, 2011, ENVIRON INT, V37, P498, DOI 10.1016/j.envint.2010.10.009; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Ghosh JKC, 2012, AM J EPIDEMIOL, V175, P1262, DOI 10.1093/aje/kwr469; Sapkota A, 2012, AIR QUAL ATMOS HLTH, V5, P369, DOI 10.1007/s11869-010-0106-3; Szpiro AA, 2011, EPIDEMIOLOGY, V22, P680, DOI 10.1097/EDE.0b013e3182254cc6; Kan HD, 2010, ENVIRON RES, V110, P258, DOI 10.1016/j.envres.2010.01.006; Wilhelm M, 2012, ENVIRON HEALTH PERSP, V120, P132, DOI 10.1289/ehp.1103408; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Yorifuji T, 2013, SCI TOTAL ENVIRON, V443, P397, DOI 10.1016/j.scitotenv.2012.10.088; Yorifuji T, 2014, J PEDIATR-US, V164, P1019, DOI 10.1016/j.jpeds.2014.01.012; Slama R, 2008, ENVIRON HEALTH PERSP, V116, P791, DOI 10.1289/ehp.11074; Savitz DA, 2014, AM J EPIDEMIOL, V179, P457, DOI 10.1093/aje/kwt268; Yamakawa M, 2013, JAMA PEDIATR, V167, P919, DOI 10.1001/jamapediatrics.2013.2230; Yorifuji T, 2014, STROKE, V45, P1264, DOI 10.1161/STROKEAHA.114.005227; Woodruff TJ, 2009, ENVIRON RES, V109, P311, DOI 10.1016/j.envres.2008.12.012; Hyder A, 2014, EPIDEMIOLOGY, V25, P58, DOI 10.1097/EDE.0000000000000027; Fleischer NL, 2014, ENVIRON HEALTH PERSP, V122, P425, DOI 10.1289/ehp.1306837; Raaschou-Nielsen O, 2011, ENVIRON HEALTH PERSP, V119, P860, DOI 10.1289/ehp.1002353; Basu R, 2014, ENVIRON RES, V128, P42, DOI 10.1016/j.envres.2013.10.008; Committee on Japan's Experience in the Battle against Air Pollution, 1997, JAP EXP BATTL AIR PO; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; HEI International Scientific Oversight Committee, 2010, 18 HEI INT SCI OV CO; Kato T, 2013, J PEDIATR-US, V163, P1578, DOI 10.1016/j.jpeds.2013.07.004; Kioumourtzoglou MA, 2014, ENV HLTH, V13; Kloog I, 2012, ENV HLTH, V11; Pedersen M, 2013, LANCET RESP MED, V1, P695, DOI 10.1016/S2213-2600(13)70192-9; [Statistics Bureau Ministry of Public Management HA. Posts and telecommunication of Japan], 2004, STAT OBS SHI KU MACH; WHO W. H. O., 2005, AIR QUAL GUID GLOB U; Yorifuji T, 2011, EPIDEMIOLOGY, V22, P74, DOI 10.1097/EDE.0b013e3181fe759f	32	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	JAN	2015	74						106	111		10.1016/j.envint.2014.09.003		6	Environmental Sciences	Environmental Sciences & Ecology	AX1AU	WOS:000346681700013		
J	Nagayama, J				Nagayama, Junya			Correspondence to the Editor Re: Maternal exposure to high levels of dioxins in relation to birth weight in women affected by Yusho disease	ENVIRONMENT INTERNATIONAL			English	Letter						Dioxins; Food contamination; Polychlorinated biphenyls; Yusho; Fetal Yusho	YU-CHENG PATIENTS; DIBENZO-P-DIOXINS; POLYCHLORINATED DIBENZOFURANS; FETAL YUSHO; PCDFS; PCBS; TISSUES; BLOOD; PCQS; OIL		[Nagayama, Junya] Kyushu Univ, Grad Sch Med Sci Retd, Lab Environm Mol Epidemiol, Higashi Ku, Fukuoka 8128182, Japan	Nagayama, J (reprint author), 929-22 Mishiro, Fukuoka 8110111, Japan.	xnagayama@ybb.ne.jp					Tsukimori K, 2013, CHEMOSPHERE, V90, P1581, DOI 10.1016/j.chemosphere.2012.08.024; Yao Y, 2002, CHEMOSPHERE, V46, P1461, DOI 10.1016/S0045-6535(01)00254-5; Tsukimori K, 2012, ENVIRON INT, V38, P79, DOI 10.1016/j.envint.2011.08.010; KASHIMOTO T, 1981, ARCH ENVIRON HEALTH, V36, P321; KASHIMOTO T, 1985, ENVIRON HEALTH PERSP, V59, P73, DOI 10.2307/3429877; KUNITA N, 1985, ENVIRON HEALTH PERSP, V59, P79, DOI 10.2307/3429878; KUNITA N, 1984, AM J IND MED, V5, P45; MASUDA Y, 1985, ENVIRON HEALTH PERSP, V59, P53, DOI 10.2307/3429874; MIYATA H, 1985, ENVIRON HEALTH PERSP, V59, P67, DOI 10.2307/3429876; NAGAYAMA J, 1977, FOOD COSMET TOXICOL, V15, P195, DOI 10.1016/S0015-6264(77)80389-1; NAGAYAMA J, 1976, B ENVIRON CONTAM TOX, V15, P9; Nagayama J, 1975, Fukuoka Igaku Zasshi, V66, P593; Nagayama J, 2010, CHEMOSPHERE, V80, P513, DOI 10.1016/j.chemosphere.2010.04.062; Tsukimori K, 2013, J OBSTET GYNAECOL RE, V39, P83, DOI 10.1111/j.1447-0756.2012.01906.x; Yorifuji T, 2014, ENVIRON INT, V64, P69, DOI 10.1016/j.envint.2013.12.005	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	JAN	2015	74						304	304		10.1016/j.envint.2014.10.014		1	Environmental Sciences	Environmental Sciences & Ecology	AX1AU	WOS:000346681700034		
J	Tsuldmori, K; Uchi, H; Furue, M				Tsuldmori, Kiyomi; Uchi, Hiroshi; Furue, Masutaka			Response to: Correspondence to the Editor Re: Maternal exposure to high levels of dioxins in relation to birth weight in women affected by Yusho disease Response	ENVIRONMENT INTERNATIONAL			English	Letter							PCBS; OIL		[Tsuldmori, Kiyomi; Uchi, Hiroshi; Furue, Masutaka] Kyushu Univ Hosp, Res & Clin Ctr Yusho & Dioxin, Fukuoka 812, Japan	Tsuldmori, K (reprint author), Fukuoka Childrens Hosp, Dept Obstet, Chuo Ku, Tojinmachi 2-5-1, Fukuoka 8100063, Japan.	tsuldmori.k@fcho.jp					Soong DK, 1997, CHEMOSPHERE, V34, P1579, DOI 10.1016/S0045-6535(97)00453-0; Tsukimori K, 2012, ENVIRON INT, V38, P79, DOI 10.1016/j.envint.2011.08.010; MIYATA H, 1989, CHEMOSPHERE, V18, P407, DOI 10.1016/0045-6535(89)90149-5; Tokunaga S., 2005, J DERMATOL SCI, V1, pS95, DOI 10.1016/j.descs.2005.03.012	4	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	JAN	2015	74						305	305		10.1016/j.envint.2014.10.011		1	Environmental Sciences	Environmental Sciences & Ecology	AX1AU	WOS:000346681700035		
J	Sakamoto, M; Chan, HM; Domingo, JL; Oliveira, RB; Kawakami, S; Murata, K				Sakamoto, Mineshi; Chan, Hing M.; Domingo, Jose L.; Oliveira, Ricardo B.; Kawakami, Shoichi; Murata, Katsuyuki			Significance of fingernail and toenail mercury concentrations as biomarkers for prenatal methylmercury exposure in relation to segmental hair mercury concentrations	ENVIRONMENTAL RESEARCH			English	Article						Methylmercury; Mercury; Fingernail; Toenail; Hair segment; Fetus; Gestation	FISH CONSUMPTION; GROWTH RATE; BRAIN; BLOOD; RATIO; NAILS; SEYCHELLES; GESTATION; PREGNANCY; CHILDREN	Objective: To investigate the appropriateness of mercury (Hg) concentrations in fingernails and toenails at parturition for detecting prenatal exposure to methylmercury (MeHg). Methods: Total Hg concentrations were measured in 54 paired samples of fingernails, toenails, maternal blood, and maternal hair (1 cm incremental segments from the scalp toward the tip) collected at 4th weeks of (early) pregnancy, and the same specimens and cord blood collected at parturition. Results: Strong correlations were observed between Hg concentrations in fingernails and toenails at early pregnancy (r=0.923, p <0.01) and at parturition (r=0.895, p <0.01). At early pregnancy, Hg concentrations in fingernails and toenails showed the strongest correlations with those in hair 3-4 cm from the scalp (r=0.818 and r=0.747, p <0.01, respectively) among the 1 cm incremental hair segments. Mercury concentrations in fingernails and toenails at parturition represented strong correlations with those in cord blood (r=0.803, p <0.01 for fingernails and r=0.792, p <0.01 for toenails, respectively). At parturition, Hg concentrations in fingernails had the highest correlation with those in hair 0-1 cm from the scalp (r=0.918, p <0.01), and Hg concentrations in toenails showed the highest correlation with those in hair at 2-3 cm from the scalp (r=0.872, p <0.01). In addition, Hg concentrations in both finger and toe nails at parturition had equally high (p < 0.01) correlation coefficients with hair segments at 0-1, 1-2, and 2-3 cm from the scalp. Conclusions: Mercury in fingernails and toenails at early pregnancy reflected the maternal Hg body burden level approximately 5 months retroactively. At parturition, Hg levels in fingernails and toenails also showed strong correlations with those in cord blood. In addition, Hg levels in fingernails and toenails at parturition reflected more recent MeHg exposure, compared with those at early pregnancy. These results suggest that fingernails and toenails at parturition are useful biomarkers for prenatal MeHg exposure for mothers and fetuses, especially during the third-trimester of gestation. (C) 2014 Elsevier Inc. All rights reserved.	[Sakamoto, Mineshi] Natl Inst Minamata Dis, Dept Environm Sci & Epidemiol, Minamata, Japan; [Chan, Hing M.] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Gen, Ottawa, ON, Canada; [Domingo, Jose L.] Univ Rovira & Virgili, IISPV, Sch Med, Lab Toxicol & Environm Hlth, E-43201 Reus, Spain; [Oliveira, Ricardo B.] Univ Fed Oeste Para, Lab Bioprospeccao Biol Expt, Santarem, Brazil; [Kawakami, Shoichi] Fukuda Hosp, Dept Obstet & Gynecol, Kumamoto, Japan; [Murata, Katsuyuki] Akita Univ, Sch Med, Dept Environm Hlth Sci, Akita 010, Japan	Sakamoto, M (reprint author), Natl Inst Minamata Dis, Dept Environm Sci & Epidemiol, Minamata, Japan.	sakamoto@nimd.go.jp	Domingo, Jose/E-8327-2014		JSPS KAKENHI [23510085]	This work was supported by JSPS KAKENHI Grant Number 23510085. We express our deep gratitude to the women who generously participated in the study.	Sakamoto M, 2010, ECOTOX ENVIRON SAFE, V73, P1, DOI 10.1016/j.ecoenv.2009.09.010; Sakamoto M, 2013, ENVIRON INT, V60, P106, DOI 10.1016/j.envint.2013.08.007; Rees JR, 2007, J EXPO SCI ENV EPID, V17, P25, DOI 10.1038/sj.jes.7500516; Yaginuma-Sakurai K, 2012, J TOXICOL SCI, V37, P123; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Stern AH, 2003, ENVIRON HEALTH PERSP, V111, P1465, DOI 10.1289/ehp.6187; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Kajiwara Y, 1996, ARCH TOXICOL, V70, P310, DOI 10.1007/s002040050279; Goulle JP, 2009, J ANAL TOXICOL, V33, P92; Ohno T, 2007, ENVIRON RES, V103, P191, DOI 10.1016/j.envres.2006.06.009; Gupchup GV, 1999, J COSMET SCI, V50, P363; Murata K, 2004, J PEDIATR-US, V144, P177, DOI 10.1016/j.jpeds.2003.10.059; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Yoshizawa K, 2002, NEW ENGL J MED, V347, P1755, DOI 10.1056/NEJMoa021437; Sakamoto M, 2002, BRAIN RES, V949, P51, DOI 10.1016/S0006-8993(02)02964-5; Alfthan GV, 1997, BIOMARKERS, V2, P233, DOI 10.1080/135475097231607; Akagi H, 2000, SCI TOTAL ENVIRON, V259, P31, DOI 10.1016/S0048-9697(00)00547-7; ASCHNER M, 1988, TERATOLOGY, V38, P145, DOI 10.1002/tera.1420380207; BADEN HP, 1973, BIOCHIM BIOPHYS ACTA, V322, P269, DOI 10.1016/0005-2795(73)90303-6; Boischio A A, 2000, Cad Saude Publica, V16, P681, DOI 10.1590/S0102-311X2000000300016; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Hamilton JB, 1955, J GERONTOL, V10, P401; HEWITT D, 1966, AM J CLIN NUTR, V19, P436; Hinners T, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-81; Hislop J.E., 1982, CLIN TOXICOLOGY CHEM, P145; Kalhan SC, 2000, AM J CLIN NUTR, V71, p1249S; Morton J, 2004, BIOMARKERS, V9, P47, DOI 10.1080/13547500410001670312; NRC (National Research Council), 2000, TOX EFF METH; PECORARO V, 1971, J INVEST DERMATOL, V56, P362, DOI 10.1111/1523-1747.ep12261236; PHELPS RW, 1980, ARCH ENVIRON HEALTH, V35, P161; Sass J, 2004, ARCH DERMATOL RES, V296, P188, DOI 10.1007/s00403-004-0483-2; SUZUKI T, 1989, Japanese Journal of Industrial Health, V31, P235; World Health Organization, 1990, METH ENV HLTH CRIT	34	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	JAN	2015	136						289	294		10.1016/j.envres.2014.09.034		6	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	AX2DY	WOS:000346755000036		
J	Tasmin, S; Furusawa, H; Ahmad, SA; Faruquee, MH; Watanabe, C				Tasmin, Saira; Furusawa, Hana; Ahmad, Sk. Akhtar; Faruquee, M. H.; Watanabe, Chiho			Delta-aminolevulinic acid dehydratase (ALAD) polymorphism in lead exposed Bangladeshi children and its effect on urinary aminolevulinic acid (ALA)	ENVIRONMENTAL RESEARCH			English	Article						Blood lead level; ALAD polymorphism; Urinary ALA; Children; Bangladesh	BLOOD LEAD; 5-AMINOLEVULINIC ACID; WORKERS; GENOTYPE; SUSCEPTIBILITY; EXCRETION; CHINA	Background and objective: Lead has long been recognized as a harmful environmental pollutant. People in developing countries like Bangladesh still have a higher risk of lead exposure. Previous research has suggested that the delta-aminolevulinic acid dehydratase (ALAD) genotype can modify lead toxicity and individual susceptibility. As children are more susceptible to lead-induced toxicity, this study investigated whether the ALAD genotype influenced urinary excretion of delta-aminolevulinic acid (U-ALA) among children exposed to environmental lead in Bangladesh. Methods: Subjects were elementary schoolchildren from a semi-urban industrialized area in Bangladesh. A total of 222 children were studied. Blood and urine were collected to determine ALAD genotypes, blood lead levels and urinary aminolevulinic acid (U-ALA). Results: The mean BPb level was 9.7 mu g/d1 for the study children. BPb was significantly positively correlated with hemoglobin (p <0.01). In total, allele frequency for ALAD 1 and 2 was 0.83 and 0.17 respectively. The mean U-ALA concentration was lower in ALAD1-2/2-2 carriers than ALAD1-1 carriers for boys (p = 0.001). But for girls, U-ALA did not differ significantly by genotype (p = 0.26). When U-ALA was compared by genotype at the same exposure level in a multiple linear regression analysis, boys who were ALAD1-2/2-2 carriers still had a lower level of U-ALA compared to ALAD1-1carriers. Conclusion: This study provides information about the influence of ALAD polymorphism and its association with U-ALA in Bangladeshi children. Our results indicate that the ALAD1-2/2-2 genotype may have a protective effect in terms of U-ALA for environmentally lead exposed boys. (C) 2014 Elsevier Inc. All rights reserved.	[Tasmin, Saira; Furusawa, Hana; Watanabe, Chiho] Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Tokyo 1130033, Japan; [Ahmad, Sk. Akhtar] Bangladesh Inst Hlth Sci, Dept Occupat & Environm Hlth, Dhaka 1216, Bangladesh; [Faruquee, M. H.] State Univ Bangladesh, Dept Publ Hlth, Dhaka 1205, Bangladesh	Tasmin, S (reprint author), Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	rimzim1612@yahoo.com			Japan Society for the Promotion of Science (JSPS)	This study was supported by Japan Society for the Promotion of Science (JSPS). The funding agency had no role in the design, data collection and analysis or manuscript preparation for this study. This study was conducted under the "Institutional Program for Young Researcher Overseas Visits".	HENSE HW, 1992, INT J EPIDEMIOL, V21, P753, DOI 10.1093/ije/21.4.753; Pawlas N, 2012, NEUROTOXICOLOGY, V33, P37, DOI 10.1016/j.neuro.2011.10.012; Hruba F, 2012, ENVIRON INT, V41, P29, DOI 10.1016/j.envint.2011.12.001; ZIEMSEN B, 1986, INT ARCH OCC ENV HEA, V58, P245, DOI 10.1007/BF00432107; Suzen HS, 2003, AM J IND MED, V43, P165, DOI 10.1002/ajim.10158; Mitra AK, 2009, INT J ENV RES PUB HE, V6, P84, DOI 10.3390/ijerph6010084; BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; BATTISTUZZI G, 1981, ANN HUM GENET, V45, P223, DOI 10.1111/j.1469-1809.1981.tb00333.x; Gao A, 2010, SCI TOTAL ENVIRON, V408, P4052, DOI 10.1016/j.scitotenv.2010.04.024; Andrade V, 2013, NEUROTOXICOLOGY, V38, P33, DOI 10.1016/j.neuro.2013.06.003; Wasserman GA, 2008, BASIC CLIN PHARMACOL, V102, P212, DOI 10.1111/j.1742-7843.2007.00187.x; Betts KS, 2012, ENVIRON HEALTH PERSP, V120, pA268, DOI 10.1289/ehp.120-a268; Fujihara J, 2009, TOXICOL LETT, V191, P236, DOI 10.1016/j.toxlet.2009.09.005; Sithisarankul P, 1997, AM J IND MED, V32, P15, DOI 10.1002/(SICI)1097-0274(199707)32:1<15::AID-AJIM2>3.0.CO;2-Q; Scinicariello F, 2007, ENVIRON HEALTH PERSP, V115, P35, DOI 10.1289/ehp.9448; WETMUR JG, 1991, ENVIRON RES, V56, P109, DOI 10.1016/S0013-9351(05)80001-5; BELLINGER D, 1994, ARCH ENVIRON HEALTH, V49, P98; Bergkvist C, 2010, ENVIRON RES, V110, P718, DOI 10.1016/j.envres.2010.07.004; Chia SE, 2004, NEUROTOXICOLOGY, V25, P1041, DOI 10.1016/j.neuro.2004.01.010; DESILVA PE, 1984, ANN OCCUP HYG, V28, P417, DOI 10.1093/annhyg/28.4.417; Emanuelli T, 2003, NEUROCHEM INT, V42, P115, DOI 10.1016/S0197-0186(02)00074-8; GRANDJEAN P, 1989, AM J EPIDEMIOL, V129, P732; HUDAK A, 1994, EUR J PEDIATR, V153, P187; Kaiser R, 2001, ENVIRON HEALTH PERSP, V109, P563; Kelada SN, 2001, AM J EPIDEMIOL, V154, P1, DOI 10.1093/aje/154.1.1; Krieg EF, 2009, NEUROTOXICOL TERATOL, V31, P364, DOI 10.1016/j.ntt.2009.08.003; MOORE MR, 1988, SCI TOTAL ENVIRON, V71, P419, DOI 10.1016/0048-9697(88)90214-8; Perez-Bravo F, 2004, ARCH ENVIRON CON TOX, V47, P276, DOI [10.1007/s00244-0044-2215-1, 10.1007/s00244-004-2215-1]; Rajan P, 2008, J OCCUP ENVIRON MED, V50, P1053, DOI 10.1097/JOM.0b013e3181792463; Sakai T, 2000, AM J IND MED, V38, P355, DOI 10.1002/1097-0274(200009)38:3<355::AID-AJIM17>3.0.CO;2-6; Schwartz BS, 1997, OCCUP ENVIRON MED, V54, P241; SCHWARTZ J, 1990, AM J PUBLIC HEALTH, V80, P165, DOI 10.2105/AJPH.80.2.165; Shen XM, 2001, ENVIRON RES, V85, P185, DOI 10.1006/enrs.2000.4230; SILBERGELD EK, 1980, J OCCUP ENVIRON MED, V22, P680, DOI 10.1097/00043764-198010000-00016; Sobin C, 2011, ARCH ENVIRON CON TOX, V61, P521, DOI 10.1007/s00244-011-9645-3; Stromberg U, 2003, OCCUP ENVIRON MED, V60, P370, DOI 10.1136/oem.60.5.370; TOMOKUNI K, 1993, IND HEALTH, V31, P51; Villayandre BM, 2005, BRAIN RES, V1061, P80, DOI 10.1016/j.brainres.2005.08.001; Wang L, 2005, EUR J NEUROSCI, V22, P3122, DOI 10.1111/j.1460-9568.2005.04471.x; WETMUR JG, 1991, AM J HUM GENET, V49, P757	40	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	JAN	2015	136						318	323		10.1016/j.envres.2014.08.045		6	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	AX2DY	WOS:000346755000040		
J	Watanabe, M; Fujimi, T				Watanabe, Masahide; Fujimi, Toshio			Evaluating Change in Objective Ambiguous Mortality Probability: Valuing Reduction in Ambiguity Size and Risk Level	ENVIRONMENTAL & RESOURCE ECONOMICS			English	Article						alpha-Maxmin expected utility; Mortality probability; Objective ambiguity; Valuation	BROWN BEAR POPULATION; EXPECTED UTILITY; DECISION-MAKING; PREFERENCES; UNCERTAINTY; HOKKAIDO; JAPAN; MODEL	This article develops a valuation model to evaluate mortality probability changes under objective ambiguity, where multiple mortality probabilities are exogenously given. We construct the valuation model based on -maxmin expected utility to evaluate the reduction in ambiguity size and risk level as well as estimate the subjects' ambiguity attitude. Our model can bring an interesting policy implication. If the subjects are ambiguity-averse, a reduction in ambiguity size with a constant risk level can increases welfare. Thus, even if risk level cannot be lowered, reduction in ambiguity size can also be used as a measure toward increasing welfare. Our model can empirically estimate this welfare change resulting from the reduction in ambiguity size. To demonstrate how our model works, we apply it to survey data on a public program that reduces mortality probability in accidents caused by wildlife.	[Watanabe, Masahide] Osaka Univ Econ, Dept Econ, Higashiyodogawa Ku, Osaka 5338533, Japan; [Fujimi, Toshio] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Watanabe, M (reprint author), Osaka Univ Econ, Dept Econ, Higashiyodogawa Ku, 2-2-8 Osumi, Osaka 5338533, Japan.	wmasa@osaka-ue.ac.jp; fujimi@kumamoto-u.ac.jp					Ahn DS, 2008, REV ECON STUD, V75, P3, DOI 10.1111/j.1467-937X.2007.00473.x; KRINSKY I, 1986, REV ECON STAT, V68, P715, DOI 10.2307/1924536; Hammitt JK, 2000, ENVIRON SCI TECHNOL, V34, P1396, DOI 10.1021/es990733n; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Klibanoff P, 2005, ECONOMETRICA, V73, P1849, DOI 10.1111/j.1468-0262.2005.00640.x; JONESLEE M, 1974, J POLIT ECON, V82, P835, DOI 10.1086/260238; Riddel M, 2011, J ENVIRON ECON MANAG, V61, P341, DOI 10.1016/j.jeem.2010.11.004; Ohta U, 2012, ECOL MODEL, V242, P20, DOI 10.1016/j.ecolmodel.2012.05.011; Etner J, 2012, J ECON SURV, V26, P234, DOI 10.1111/j.1467-6419.2010.00641.x; Merz B, 2009, NAT HAZARDS, V51, P437, DOI 10.1007/s11069-009-9452-6; Ghirardato P, 2004, J ECON THEORY, V118, P133, DOI 10.1016/j.jet.2003.12.004; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Cameron TA, 2005, J PUBLIC ECON, V89, P283, DOI 10.1016/j.jpubeco.2004.01.005; Cameron TA, 1997, RAND J ECON, V28, P45; Carson R. T., 2005, HDB ENV EC, V2, P821, DOI DOI 10.1016/S1574-0099(05)02017-6; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Hurwicz L, 1951, COWLES COMMISSION DI; Jaffray J.-Y., 1994, ADV DEMPSTER SHAFER, P331; KAHN BE, 1988, J CONSUM RES, V15, P265, DOI 10.1086/209163; Kameda M, 2003, MEMOIRS MURORAN I TE, V53, P6576; Kohira M, 2009, URSUS, V20, P12, DOI 10.2192/1537-6176-20.1.12; LOOMIS JB, 1993, LAND ECON, V69, P287, DOI 10.2307/3146594; Gravel N, 2012, J MATH PSYCHOL, V56, P297, DOI 10.1016/j.jmp.2012.07.006; Olszewski W, 2007, REV ECON STUD, V74, P567, DOI 10.1111/j.1467-937X.2007.00431.x; Riddel M, 2006, J RISK UNCERTAINTY, V32, P131, DOI 10.1007/s11166-006-8290-0; Sato Yoshikazu, 2004, Mammal Study, V29, P47, DOI 10.3106/mammalstudy.29.47; SAVAGE L. J., 1972, FDN STAT; SMITH VK, 1987, J POLIT ECON, V95, P89, DOI 10.1086/261443; VISCUSI WK, 1993, J ECON LIT, V31, P1912	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0924-6460	1573-1502		ENVIRON RESOUR ECON	Environ. Resour. Econ.	JAN	2015	60	1					1	15		10.1007/s10640-013-9754-8		15	Economics; Environmental Studies	Business & Economics; Environmental Sciences & Ecology	AX2LK	WOS:000346775200001		
J	Spicer, J; Baird, R; Suder, A; Cresti, N; Corbacho, JG; Hogarth, L; Frenkel, E; Matsumoto, S; Kawabata, I; Donaldson, K; Posner, J; Sarker, D; Jodrell, D; Plummer, R				Spicer, J.; Baird, R.; Suder, A.; Cresti, N.; Corbacho, J. Garcia; Hogarth, L.; Frenkel, E.; Matsumoto, S.; Kawabata, I.; Donaldson, K.; Posner, J.; Sarker, D.; Jodrell, D.; Plummer, R.			Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours	EUROPEAN JOURNAL OF CANCER			English	Article						Protein kinase inhibitor; Phase 1 clinical trial; EGFR; HER2; HER4	EPIDERMAL-GROWTH-FACTOR; CELL LUNG-CANCER; FACTOR RECEPTOR; PRETREATED PATIENTS; BREAST-CANCER; I TRIAL; NERATINIB; THERAPY; PLACEBO	Background: S-222611 is a reversible inhibitor of EGFR, HER2 and HER4 with preclinical activity in models expressing these proteins. We have performed a Phase 1 study to determine safety, maximum tolerated dose (MTD), pharmacokinetic profile (PK) and efficacy in patients with solid tumours expressing EGFR or HER2. Patients and methods: Subjects had advanced tumours not suitable for standard treatment, expressing EGFR or HER2, and/or with amplified HER2. Daily oral doses of S-222611 were escalated from 100 mg to 1600 mg. Full plasma concentration profiles for drug and metabolites were obtained. Results: 33 patients received S-222611. It was well tolerated, and the most common toxicities, almost all mild (grade 1 or 2), were diarrhoea, fatigue, rash and nausea. Only two dose-limiting toxicities occurred (diarrhoea and rash), which resolved on interruption. MTD was not reached. Plasma exposure increased with dose up to 800 mg, exceeding levels eliciting pre-clinical responses. The plasma terminal half-life was more than 24 h, supporting once daily dosing. Responses were seen over a wide range of doses in oesophageal, breast and renal tumours, including a complete clinical response in a patient with HER2-positive breast carcinoma previously treated with lapatinib and trastuzumab. Four patients have remained on treatment for more than 12 months. Downregulation of pHER3 was seen in paired tumour biopsies from a responding patient. Conclusions: Continuous daily oral S-222611 is well tolerated, modulates oncogenic signalling, and has significant antitumour activity. The recommended Phase 2 dose, based on PK and efficacy, is 800 mg/day. (C) 2014 Elsevier Ltd. All rights reserved.	[Spicer, J.; Suder, A.; Sarker, D.] Kings Coll London, Guys Hosp, London SE1 9RT, England; [Baird, R.; Corbacho, J. Garcia; Jodrell, D.] Univ Cambridge, Dept Oncol, Cambridge, England; [Cresti, N.; Hogarth, L.; Plummer, R.] Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England; [Frenkel, E.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Matsumoto, S.; Kawabata, I.; Donaldson, K.; Posner, J.] Shionogi & Co Ltd, Osaka, Japan	Spicer, J (reprint author), Kings Coll London, Div Canc Studies, Guys Hosp, 3rd Floor Bermondsey Wing,Great Maze Pond, London SE1 9RT, England.	james.spicer@kcl.ac.uk			Shionogi & Co. Ltd, Osaka, Japan	Shionogi & Co. Ltd, Osaka, Japan.	Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Herbst RS, 2002, J CLIN ONCOL, V20, P3815, DOI 10.1200/JCO.2002.03.038; Burstein HJ, 2010, J CLIN ONCOL, V28, P1301, DOI 10.1200/JCO.2009.25.8707; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Ellis PM, 2014, LANCET ONCOL, V15, P1379, DOI 10.1016/S1470-2045(14)70472-3; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267; Kim HH, 1998, BIOCHEM J, V334, P189; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Wong KK, 2009, CLIN CANCER RES, V15, P2552, DOI 10.1158/1078-0432.CCR-08-1978; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Postel-Vinay S, 2011, J CLIN ONCOL, V29, P1728, DOI 10.1200/JCO.2010.31.9236; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Ranson Malcolm, 2002, J Clin Oncol, V20, P2240, DOI 10.1200/JCO.2002.10.112; Tanaka H, 2014, CANCER SCI, V105, P1040, DOI 10.1111/cas.12449	17	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	JAN	2015	51	2					137	145		10.1016/j.ejca.2014.11.003		9	Oncology	Oncology	AX3PL	WOS:000346851200002		
J	Hokuto, D; Sho, M; Yamato, I; Yasuda, S; Obara, S; Nomi, T; Nakajima, Y				Hokuto, Daisuke; Sho, Masayuki; Yamato, Ichiro; Yasuda, Satoshi; Obara, Shinsaku; Nomi, Takeo; Nakajima, Yoshiyuki			Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma	EUROPEAN JOURNAL OF CANCER			English	Article						HVEM; HCC; TIL; Prognosis; Tumour immunity; TNFRSF14	SQUAMOUS-CELL CARCINOMA; HUMAN PANCREATIC-CANCER; CD8(+) T-CELLS; ANTITUMOR IMMUNITY; RECURRENCE RATES; LIGAND HVEM; ACTIVATION; RECEPTOR; LYMPHOCYTE; RESPONSES	Background: Herpes virus entry mediator (HVEM), also known as tumour necrosis factor receptor (TNFR) superfamily 14, regulates a variety of physiological and pathological responses in both innate and acquired immunity. Although HVEM is also suggested to be a critical regulator in tumours, actual roles in human cancer are largely unknown. This study aimed to clarify clinical importance of HVEM in human hepatocellular carcinoma (HCC). Patients and methods: We studied HVEM expression in 150 HCC patients to explore its clinical relevance, and we examined tumour infiltrating T cells and local immune status of them. Results: HVEM was expressed in HCC cells, while no or only limited expression was observed in normal tissues in the liver. Tumour HVEM expression was significantly correlated with age, serum protein induced by vitamin K absence or antagonist-II (PIVKA-II) level, vascular invasion and tumour node metastasis (TNM) stage. Furthermore, tumour HVEM expression significantly correlated with postoperative recurrence and survival. Importantly, multivariate analysis indicated that the HVEM status had an independent prognostic value. Furthermore, HVEM status was inversely correlated with tumour-infiltrating CD4(+), CD8(+) and CD45RO(+) lymphocytes. In addition, it was also associated with reduced expression of perforin, granzyme B and interferon-gamma (IFN-gamma). Taken together, tumour-expressing HVEM plays a functionally important role in HCC. Conclusion: Tumour-expressing HVEM plays a critical role in human HCC, possibly through regulating immune evasion. Therefore, targeting HVEM may be a novel promising therapeutic strategy for HCC. (C) 2014 Elsevier Ltd. All rights reserved.	[Hokuto, Daisuke; Sho, Masayuki; Yamato, Ichiro; Yasuda, Satoshi; Obara, Shinsaku; Nomi, Takeo; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Foundation for Promotion of Cancer Research in Japan; Daiwa Securities Health Foundation; Japanese Society of Gastroenterology; Nakayama Cancer Research Institute	This work was supported by the following grants: Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M. Sho, D. Hokuto), Research Grant from the Foundation for Promotion of Cancer Research in Japan; Research Grant from Daiwa Securities Health Foundation; Research Grant from The Japanese Society of Gastroenterology; and Research Grant from Nakayama Cancer Research Institute (M. Sho).	Steinberg MW, 2011, IMMUNOL REV, V244, P169, DOI 10.1111/j.1600-065X.2011.01064.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Huang Y, 2012, DIGESTION, V86, P329, DOI 10.1159/000342801; Pasero C, 2009, EUR J IMMUNOL, V39, P2502, DOI 10.1002/eji.200939069; Wada Y, 1998, HEPATOLOGY, V27, P407, DOI 10.1002/hep.510270214; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Yasuda S, 2013, CLIN EXP IMMUNOL, V172, P500, DOI 10.1111/cei.12069; Yoong KF, 1998, J IMMUNOL, V160, P3978; Hotta K, 2011, BRIT J CANCER, V105, P1191, DOI 10.1038/bjc.2011.368; Migita K, 2014, CANCER-AM CANCER SOC, V120, P808, DOI 10.1002/cncr.28491; Flecken T, 2014, HEPATOLOGY, V59, P1415, DOI 10.1002/hep.26731; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Enomoto K, 2012, CLIN EXP IMMUNOL, V168, P186, DOI 10.1111/j.1365-2249.2012.04565.x; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Chen LT, 2012, ANN SURG, V255, P8, DOI 10.1097/SLA.0b013e3182363ff9; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Lasaro MO, 2008, NAT MED, V14, P205, DOI 10.1038/nm1704; Hobo W, 2012, J IMMUNOL, V189, P39, DOI 10.4049/jimmunol.1102807; Tada F, 2012, INT J ONCOL, V41, P1601, DOI 10.3892/ijo.2012.1626; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Pedroza-Gonzalez A, 2013, HEPATOLOGY, V57, P183, DOI 10.1002/hep.26013; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Fu JL, 2013, HEPATOLOGY, V58, P139, DOI 10.1002/hep.26054; DiMenna L, 2010, J IMMUNOL, V184, P5475, DOI 10.4049/jimmunol.0903808; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Prendergast GC, 2007, CANCER RES, V67, P3500, DOI 10.1158/0008-5472.CAN-06-4626; Seth' D, 2006, J HEPATOL, V45, P306, DOI 10.1016/j.jhep.2006.04.013; Xu H, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-142	40	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	JAN	2015	51	2					157	165		10.1016/j.ejca.2014.11.004		9	Oncology	Oncology	AX3PL	WOS:000346851200004		
J	Yamauchi, H; Goto, T; Takayoshi, K; Sagara, K; Uoi, M; Kawanabe, C; Matsunaga, M; Miyoshi, T; Uchino, K; Misumi, N; Nishino, T				Yamauchi, H.; Goto, T.; Takayoshi, K.; Sagara, K.; Uoi, M.; Kawanabe, C.; Matsunaga, M.; Miyoshi, T.; Uchino, K.; Misumi, N.; Nishino, T.			A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin	EUROPEAN JOURNAL OF CANCER CARE			English	Article						oxaliplatin; allergic reaction; risk factor; dexamethasone	METASTATIC COLORECTAL-CANCER; HYPERSENSITIVITY REACTIONS; CARBOPLATIN; JAPAN	This study retrospectively investigated the clinical features and risk factors of allergic reactions induced by oxaliplatin administration. This study investigated the incidence of allergic reactions and analysed the background and laboratory data in patients with colorectal cancer treated with oxaliplatin-based chemotherapy at Kyushu Medical Center between April 2012 and September 2012. A total of 62 patients were included in this study. The number of patients in the allergic and non-allergic groups was 7 and 55 respectively. The incidence of allergic reactions was 11.3%. We compared the patients' characteristics and laboratory data between the two groups and found that the average dose of dexamethasone in the allergic group was significantly lower than that observed in the non-allergic group (P=0.0111). Furthermore, the incidence of allergic reactions in the group that received prophylaxis of less than 12mg of dexamethasone was significantly higher than that observed in the group that received more than 12mg of dexamethasone (P=0.0103). In conclusion, a lower dexamethasone dose is a possible risk factor for allergic reactions induced by the administration of oxaliplatin; however, given the retrospective design used in this study, further validation of this finding is warranted.	[Yamauchi, H.; Goto, T.; Uoi, M.; Miyoshi, T.; Misumi, N.; Nishino, T.] Natl Hosp Org, Kyushu Med Ctr, Dept Pharm, Fukuoka 8108563, Japan; [Yamauchi, H.] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Fukuoka 8108563, Japan; [Goto, T.; Takayoshi, K.; Sagara, K.; Uoi, M.; Kawanabe, C.; Matsunaga, M.; Uchino, K.] Natl Hosp Org, Kyushu Med Ctr, Chemotherapy Ctr, Fukuoka 8108563, Japan; [Takayoshi, K.; Sagara, K.; Uchino, K.] Natl Hosp Org, Kyushu Med Ctr, Dept Med Oncol, Fukuoka 8108563, Japan; [Kawanabe, C.; Matsunaga, M.] Natl Hosp Org, Kyushu Med Ctr, Dept Nursing, Fukuoka 8108563, Japan	Goto, T (reprint author), Natl Hosp Org, Kyushu Med Ctr, Dept Pharm, Chuou Ku, 1-8-1 Jigyouhama, Fukuoka 8108563, Japan.	tgotoh@kokura2.hosp.go.jp					Andre T., 2004, NEW ENGL J MED, V350, P2243; Gowda A, 2004, ONCOLOGY-NY, V18, P1671; Ichikawa Y, 2009, JPN J CLIN ONCOL, V39, P616, DOI 10.1093/jjco/hyp070; Arkenau HT, 2008, J CLIN ONCOL, V26, P5910, DOI 10.1200/JCO.2008.16.7759; Polyzos A, 2001, ONCOLOGY-BASEL, V61, P129, DOI 10.1159/000055363; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Brandi G, 2003, BRIT J CANCER, V89, P477, DOI 10.1038/sj.bjc.6601155; Markman M, 1999, J CLIN ONCOL, V17, P1141; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Shibata Y, 2009, INT J CLIN ONCOL, V14, P397, DOI 10.1007/s10147-009-0883-6; CLEARE MJ, 1976, CLIN ALLERGY, V6, P183, DOI 10.1111/j.1365-2222.1976.tb01897.x; Honda S., 2010, JAPANESE J CANC CHEM, V37, P2101; Kitada Noriaki, 2007, J Oncol Pharm Pract, V13, P233, DOI 10.1177/1078155207079877; MORGAN JS, 1994, EUR J CANCER, V30A, P1205, DOI 10.1016/0959-8049(94)90489-8; PLANNER RS, 1991, J NATL CANCER I, V83, P1763, DOI 10.1093/jnci/83.23.1763-a; Roila F, 2010, ANN ONCOL, V21, P232; Suenaga Mitsukuni, 2008, J Support Oncol, V6, P373; Wiesenfeld M., 1979, CANCER TREATMENT REP, V73, P2218	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-5423	1365-2354		EUR J CANCER CARE	Eur. J. Cancer Care	JAN	2015	24	1					111	116		10.1111/ecc.12156		6	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	Oncology; Health Care Sciences & Services; Nursing; Rehabilitation	AX2JD	WOS:000346768500011		
J	Kawajiri, H; Takashima, T; Kashiwagi, S; Noda, S; Onoda, N; Hirakawa, K				Kawajiri, Hidemi; Takashima, Tsutomu; Kashiwagi, Shinichiro; Noda, Satoru; Onoda, Naoyoshi; Hirakawa, Kosei			Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer	EXPERT REVIEW OF ANTICANCER THERAPY			English	Review						CLEOPATRA; docetaxel; double blockade; HER2; metastatic breast cancer; pertuzumab; target therapy; trastuzumab	RANDOMIZED PHASE-III; DIMERIZATION INHIBITOR; MONOCLONAL-ANTIBODY; OVEREXPRESSING HER2; PLUS DOCETAXEL; SOLID TUMORS; RECEPTOR; GROWTH; CLEOPATRA; TRIAL	Overexpression of HER2 - found in approximately 15-20% of all breast cancers - is a negative prognostic factor. Although trastuzumab significantly improves the prognosis of HER2-positive breast cancer, half of the patients with metastatic breast cancer experience disease progression within 1 year. Pertuzumab is a novel HER2-targeted humanized monoclonal antibody that binds to the dimerization domain of HER2 and acts synergically with trastuzumab in inhibiting tumor progression. The CLEOPATRA trial demonstrated that adding pertuzumab to trastuzumab plus docetaxel significantly prolonged progression-free survival and overall survival without increasing severe adverse events. Conclusively, pertuzumab was approved by the US FDA in June 2012 for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer. Furthermore, various clinical trials to evaluate the efficacy and safety of pertuzumab combined with other cytotoxic agents are ongoing at present. Thus, pertuzumab has been becoming important for the treatment of patients with HER2-positive metastatic breast cancer.	[Kawajiri, Hidemi; Takashima, Tsutomu; Kashiwagi, Shinichiro; Noda, Satoru; Onoda, Naoyoshi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan	Kawajiri, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	hkawajiri75@yahoo.co.jp					Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Cortes J, 2012, J CLIN ONCOL, V30, P1594, DOI 10.1200/JCO.2011.37.4207; Swain SM, 2013, ONCOLOGIST, V18, P257, DOI 10.1634/theoncologist.2012-0448; Tural D, 2014, EXPERT REV ANTICANC, V14, P1089, DOI 10.1586/14737140.2014.929946; Agus DB, 2005, J CLIN ONCOL, V23, P2534, DOI 10.1200/JCO.2005.03.184; Cardoso F, 2012, BREAST, V21, P242, DOI 10.1016/j.breast.2012.03.003; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Inoue K, 2010, BREAST CANCER RES TR, V119, P127, DOI 10.1007/s10549-009-0498-7; Gennari R, 2004, CLIN CANCER RES, V10, P5650, DOI 10.1158/1078-0432.CCR-04-0225; Swain SM, 2014, ANN ONCOL, V25, P1116, DOI 10.1093/annonc/mdu133; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Cortes J, 2013, ANN ONCOL, V24, P2630, DOI 10.1093/annonc/mdt274; Yakes FM, 2002, CANCER RES, V62, P4132; Dawood S, 2008, ANN ONCOL, V19, P1242, DOI 10.1093/annonc/mdn036; Park YH, 2009, BRIT J CANCER, V100, P894, DOI 10.1038/sj.bjc.6604941; Varchetta S, 2007, CANCER RES, V67, P11991, DOI 10.1158/0008-5472.CAN-07-2068; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Andersson M, 2011, J CLIN ONCOL, V29, P264, DOI 10.1200/JCO.2010.30.8213; Molina MA, 2001, CANCER RES, V61, P4744; Chan S, 1999, J CLIN ONCOL, V17, P2341; Blackwell KL, 2012, J CLIN ONCOL, V30, P2585, DOI 10.1200/JCO.2011.35.6725; Greenberg PAC, 1996, J CLIN ONCOL, V14, P2197; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Baselga J, 2010, CLIN BREAST CANCER, V10, P489, DOI 10.3816/CBC.2010.n.065; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Harbeck N, 2013, BREAST CARE, V8, P49, DOI 10.1159/000346837; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Cuello M, 2001, CANCER RES, V61, P4892; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; von Minckwitz G, 2011, EUR J CANCER, V47, P2273, DOI 10.1016/j.ejca.2011.06.021; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI [10.1586/era.10.226, 10.1586/ERA.10.226]; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Zagouri F, 2013, CLIN BREAST CANCER, V13, P315, DOI 10.1016/j.clbc.2013.05.002; Ng CM, 2006, PHARM RES, V23, P1275, DOI 10.1007/s11095-006-0205-x; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Swain SM, 2014, ONCOLOGIST, V19, P693, DOI 10.1634/theoncologist.2014-0033; Yamamoto N, 2009, JPN J CLIN ONCOL, V39, P260, DOI 10.1093/jjco/hyp006; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; McKeage K, 2002, DRUGS, V62, P209, DOI 10.2165/00003495-200262010-00008; Miller KD, 2014, J CLIN ONCOL, V32, P1437, DOI 10.1200/JCO.2013.52.6590; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Attard C, 2014, J MED EC, P1; Attard G, 2007, BRIT J CANCER, V97, P1338, DOI 10.1038/sj.bjc.6604043; Bachelot T, 2012, CANC RES, V72, P0; Balduzzi S, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD006242.PUB2; Baselga J, 2014, J CLIN ONCOL, V32, P3753, DOI 10.1200/JCO.2013.54.5384; Elis PA, 2011, J CLIN ONCOL, V29; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kumler I, 2014, CANCER TREAT REV, V40, P259, DOI 10.1016/j.ctrv.2013.09.002; Lamond Nathan Wd, 2014, Int J Womens Health, V6, P509, DOI 10.2147/IJWH.S47357; Le XF, 2006, CELL CYCLE, V5, P1654, DOI 10.4161/cc.5.15.3007; Maly Joseph J, 2014, Breast Cancer (Auckl), V8, P81, DOI 10.4137/BCBCR.S9032; Montserrat MM, 2011, J CLIN ONCOL, V29; Perez EA, 2012, J CLIN ONCOL, V30; Petricevic B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-307; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Swain SM, 2014, ESMO C MADR SPAIN; Tse C, 2012, CANCER TREAT REV, V38, P133, DOI 10.1016/j.ctrv.2011.03.008	67	0	0	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1473-7140	1744-8328		EXPERT REV ANTICANC	Expert Rev. Anticancer Ther	JAN	2015	15	1					17	26		10.1586/14737140.2015.992418		10	Oncology	Oncology	AX0JT	WOS:000346639500004		
J	Yoshida, M; Yoshida-Takashima, Y; Nunoura, T; Takai, K				Yoshida, Mitsuhiro; Yoshida-Takashima, Yukari; Nunoura, Takuro; Takai, Ken			Genomic characterization of a temperate phage of the psychrotolerant deep-sea bacterium Aurantimonas sp.	EXTREMOPHILES			English	Article						Deep-sea virus; Temperate bacteriophage; Genome sequence; Psychrotolerant; Cold-adapted; Marine Rhizobiales	MARINE VIRUSES; MICROCYSTIS-AERUGINOSA; TAILED-BACTERIOPHAGES; SEQUENCE; DIVERSITY; SEDIMENTS; ENVIRONMENTS; COMMUNITIES; POPULATIONS; ECOSYSTEMS	A temperate phage (termed AmM-1) was identified from the psychrotolerant Rhizobiales bacterium Aurantimonas sp. C5-1, which was isolated from bathypelagic water (water depth = 1,500 m) in the northwest Pacific. The AmM-1 genome is 47,800 bp in length and contains 67 coding sequences. Although phage AmM-1 morphologically belongs to the family Myoviridae, its genomic structure, particularly modular genome organization, is similar to that of lambda-type phages of Siphoviridae. Genetic and phylogenetic analyses of the structural core genes also revealed that AmM-1 has a mosaic genomic structure that includes a lambda-like head (Siphoviridae) and P2-like tail (Myoviridae). The sequences of the structural core genes of AmM-1 are distinct from those of previously characterized phage groups but similar to those of recently identified one prophage element and one phage of marine Rhizobiales bacteria: a potential prophage element in the marine psychrotolerant Aureimonas ureilytica DSM 18598 genome and the temperate phage RR-1A infecting Rhizobium radiobacter P007 isolated from deep subseafloor sediment. The mosaic genome structure of AmM-1 suggests the occurrence of genetic exchange between distinct temperate phages in marine Rhizobiales populations.	[Yoshida, Mitsuhiro; Yoshida-Takashima, Yukari; Nunoura, Takuro; Takai, Ken] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan	Yoshida, M (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	mityoshi@jamstec.go.jp			Japan Society for the Promotion of Science (JSPS) [60565555, 24370015]	We would like to thank the captains and crews of the R/V Kairei (JAMSTEC) during the KR12-19 cruise. We also appreciate the operation team of the CTD rosette during the KR12-19 cruise. We are grateful to Katsuyuki Uematsu for technical help with transmission electron microscopy. This work was supported in part by a Grant-in-Aid for Young Scientists (B) (No. 60565555) and a Grant-in-Aid for Scientific Research (B) (No. 24370015) from the Japan Society for the Promotion of Science (JSPS).	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Yoshida M, 2008, APPL ENVIRON MICROB, V74, P3269, DOI 10.1128/AEM.02240-07; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Magiopoulos I, 2012, DEEP-SEA RES PT I, V66, P1, DOI 10.1016/j.dsr.2012.03.009; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Chen F, 2006, APPL ENVIRON MICROB, V72, P4995, DOI 10.1128/AEM.00056-06; Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6; Engelhardt T, 2014, ISME J, V8, P1503, DOI 10.1038/ismej.2013.245; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Rathsack K, 2011, INT J SYST EVOL MICR, V61, P2722, DOI 10.1099/ijs.0.027029-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Batzke A, 2007, GEOMICROBIOL J, V24, P261, DOI 10.1080/01490450701456453; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Fukui Y, 2012, J GEN APPL MICROBIOL, V58, P273; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Dick GJ, 2008, APPL ENVIRON MICROB, V74, P2646, DOI 10.1128/AEM.01656-07; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Yoshida M, 2014, J OCEANOGR, V70, P115, DOI 10.1007/s10872-013-0216-2; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Engelhardt T, 2013, ISME J, V7, P199, DOI 10.1038/ismej.2012.92; Wang YQ, 2010, APPL ENVIRON MICROB, V76, P7861, DOI 10.1128/AEM.01270-10; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Sandaa RA, 2006, APPL ENVIRON MICROB, V72, P4610, DOI 10.1128/AEM.00168-06; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Meiring TL, 2012, EXTREMOPHILES, V16, P715, DOI 10.1007/s00792-012-0467-7; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Yanagawa K, 2014, FEMS MICROBIOL ECOL, V88, P60, DOI 10.1111/1574-6941.12269; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; JIANG SC, 1994, MAR ECOL PROG SER, V104, P163, DOI 10.3354/meps104163; Masui S, 2000, J MOL EVOL, V51, P491; Yoshida M, 2010, MICROBES ENVIRON, V25, P211, DOI 10.1264/jsme2.ME10117; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gorlas A, 2012, ENVIRON MICROBIOL, V14, P503, DOI 10.1111/j.1462-2920.2011.02662.x; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; Engelhardt T, 2011, ENV MICROBIOL REP, V3, P459, DOI 10.1111/j.1758-2229.2010.00232.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; King AMQ, 2012, VIRUS TAXONOMY, P86; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Ronning CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-202; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Yoshida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057271; Yoshida-Takashima Y, 2013, EXTREMOPHILES, V17, P405, DOI 10.1007/s00792-013-0529-5; Yoshida-Takashima Y, 2012, APPL ENVIRON MICROB, V78, P1311, DOI 10.1128/AEM.06491-11	62	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1431-0651	1433-4909		EXTREMOPHILES	Extremophiles	JAN	2015	19	1					49	58		10.1007/s00792-014-0702-5		10	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	AX0QS	WOS:000346657500005		
J	Sasaki, M; Koide, O; Kobayashi, T; Usami, R; Horikoshi, K				Sasaki, Masato; Koide, Osamu; Kobayashi, Tohru; Usami, Ron; Horikoshi, Koki			A pectate lyase from a deep subseafloor Georgenia muralis with unusual molecular characteristics	EXTREMOPHILES			English	Article						Pectate lyase; Subseafloor; Georgenia; Chikyu; Suruga Bay	BACILLUS; STRAIN; PURIFICATION; BACTERIUM; SEQUENCE; ENZYMES; GENES	A novel pectate lyase of a deep subseafloor bacterium, Georgenia muralis strain JAM 3H7-3 (JCM19733), was purified to homogeneity from a culture broth by an anion exchange chromatography, followed by heat treatment of the enzyme solution at 60 A degrees C for 30 min, and a gel filtration in the presence of SDS. The purified enzyme (Pel-S2) had a molecular mass of similar to 51 kDa by SDS-PAGE and similar to 75 kDa by gel filtration. In contrast, without heat treatment, the purified enzyme in SDS sample buffer was found to consist of 23- and 23.5-kDa polypeptides by SDS-PAGE. The enzyme was gradually inactivated by heat treatment with and without SDS in parallel with a shift of polypeptides molecular masses from 23 and 23.5 to 51 kDa on SDS-PAGE. Pel-S2 degraded pectate optimally at pH 10 in a glycine buffer and temperature of 50 A degrees C. The enzyme showed relatively broad substrate specificity toward pectic acid and pectin.	[Sasaki, Masato; Usami, Ron] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama 3508585, Japan; [Koide, Osamu; Kobayashi, Tohru; Horikoshi, Koki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, R&D Ctr Marine Biosci, Yokosuka, Kanagawa 2370061, Japan	Kobayashi, T (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, R&D Ctr Marine Biosci, 2-15 Natsushima, Yokosuka, Kanagawa 2370061, Japan.	kobayashit@jamstec.go.jp					Kobayashi T, 2008, EXTREMOPHILES, V12, P519, DOI 10.1007/s00792-008-0157-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sharma N, 2013, REV ENVIRON SCI BIO, V12, P45, DOI 10.1007/s11157-012-9276-9; Margesin R, 2005, LETT APPL MICROBIOL, V40, P453, DOI 10.1111/j.1472-765X.2005.01704.x; Kobayashi T, 1999, BIOSCI BIOTECH BIOCH, V63, P65, DOI 10.1271/bbb.63.65; Shibasaki H, 2014, APPL MICROBIOL BIOT, V98, P7845, DOI 10.1007/s00253-014-5692-9; NASSER W, 1990, BIOCHIMIE, V72, P689, DOI 10.1016/0300-9084(90)90053-J; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201; Hoondal GS, 2002, APPL MICROBIOL BIOT, V59, P409, DOI 10.1007/s00253-002-1061-1; HASEGAWA S, 1966, J FOOD SCI, V31, P838, DOI 10.1111/j.1365-2621.1966.tb03259.x; KAPITANY RA, 1973, ANAL BIOCHEM, V56, P361, DOI 10.1016/0003-2697(73)90202-9; Boland WE, 2010, APPL ENVIRON MICROB, V76, P6006, DOI 10.1128/AEM.00043-10; Fukada Y., 2011, J APPL GLYCOSCI, V58, P61; Hassan S, 2013, J BACTERIOL, V195, P2197, DOI 10.1128/JB.02118-12; Kobayashi T, 1999, BBA-GEN SUBJECTS, V1427, P145, DOI 10.1016/S0304-4165(99)00017-3; Kobayashi T, 2011, BIOSCI BIOTECH BIOCH, V75, P669, DOI 10.1271/bbb.100782; Mojsov K, 2012, P 2 INT C IND ENG EN, P314; Sato M, 1980, BIOSCI BIOTECH BIOCH, V44, P1345; Shih J, 2000, GENE, V243, P139, DOI 10.1016/S0378-1119(99)00546-6; STARR MP, 1962, SCIENCE, V135, P920, DOI 10.1126/science.135.3507.920; Truong LV, 2001, EXTREMOPHILES, V5, P35; Xiao ZH, 2008, APPL ENVIRON MICROB, V74, P1183, DOI 10.1128/AEM.02220-07	22	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1431-0651	1433-4909		EXTREMOPHILES	Extremophiles	JAN	2015	19	1					119	125		10.1007/s00792-014-0691-4		7	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	AX0QS	WOS:000346657500012		
J	Shahjahan, M; Doi, H; Ando, H				Shahjahan, Md.; Doi, Hiroyuki; Ando, Hironori			Differential expression patterns of PQRFamide peptide and its two receptor genes in the brain and pituitary of grass puffer during the reproductive cycle	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Brain; NPFF; PQRFamide peptide; Puffer; RFamide peptide; Seasonal reproduction	PROTEIN-COUPLED RECEPTOR; GONADOTROPIN-INHIBITORY HORMONE; NEUROPEPTIDE FF; RFAMIDE PEPTIDES; SPAWNING PERIOD; TERMINAL NERVE; SPINAL-CORD; IDENTIFICATION; NEURONS; ACTIVATION	Pain-modulatory neuropeptides, PQRFamide (PQRFa) peptides, have recently been implicated in the regulation of reproduction in fish. As a first step toward investigating the role of PQRFa peptides on reproductive function in the grass puffer Takifugu niphobles, which is a semilunar spawner, we cloned genes encoding PQRFa peptide precursor (pqrfa) and its two types of receptors (pqrfa-rl and pqrfa-r2), and examined changes in their expression levels in the brain and pituitary over several months during the reproductive cycle. The grass puffer PQRFa peptide precursor of 126 amino acid residues contains two putative PQRFa peptides, PQRFa-1 and PQRFa-2, which correspond to NPFF and NPAF in other vertebrates, respectively. The grass puffer PQRFa-R1 and PQRFa-R2 consist of 426 and 453 amino acid residues, respectively, and contain distinct characteristics of G-protein coupled receptors. These three genes were exclusively expressed in the brain and pituitary. The expression levels of pqrfa and pqrfa-rl were significantly increased during the late stage of sexual maturation, but low in the spawning fish just after releasing sperms and eggs. Therefore, the grass puffer PQRFa peptide may have a role in the late stage of sexual maturation before spawning via PQRFa-R1. In contrast, the pqrfa-r2 expression showed maximum levels in the spawning fish and in the post-spawning period. The present results provide fundamental data suggesting that the grass puffer PQRFa peptide may have multiple roles in the control of reproduction that are dependent on the reproductive stages. (C) 2014 Elsevier Inc. All rights reserved.	[Shahjahan, Md.] Bangladesh Agr Univ, Dept Fisheries Management, Mymensingh 2202, Bangladesh; [Doi, Hiroyuki] Shimonoseki Acad Marine Sci, Shimonoseki Marine Sci Museum Kaikyokan, Yamaguchi 7500036, Japan; [Ando, Hironori] Niigata Univ, Fac Sci, Sado Marine Biol Stn, Niigata 9522135, Japan	Ando, H (reprint author), Niigata Univ, Fac Sci, Sado Marine Biol Stn, 87 Tassha, Niigata 9522135, Japan.	hando311@cc.niigata-u.ac.jp			Japan Society for the Promotion of Science [24570069]	We are grateful to Dr. Motohashi, Mr. Furukuma, Mr. Maruo, and Dr. Mori (National Institute for Minamata Disease, Japan) for their help in sampling fish. This work was supported by Grant-in Aid for Basic Research from Japan Society for the Promotion of Science to H. A. (24570069).	Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Yamanoue Y, 2009, MOL BIOL EVOL, V26, P623, DOI 10.1093/molbev/msn283; Ubuka T, 2012, ENDOCRINOLOGY, V153, P373, DOI 10.1210/en.2011-1110; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Shahjahan M, 2011, J NEUROENDOCRINOL, V23, P39, DOI 10.1111/j.1365-2826.2010.02081.x; Ubuka T, 2006, ENDOCRINOLOGY, V147, P1187, DOI 10.1210/en.2005-1178; Yamahira K, 2004, FUNCT ECOL, V18, P4, DOI 10.1046/j.0269-8463.2004.00795.x; Shahjahan M, 2010, GEN COMP ENDOCR, V167, P153, DOI 10.1016/j.ygcen.2010.01.018; Ando H, 2013, GEN COMP ENDOCR, V181, P211, DOI 10.1016/j.ygcen.2012.07.027; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Moussavi M, 2012, MOL CELL ENDOCRINOL, V350, P53, DOI 10.1016/j.mce.2011.11.020; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Arora KK, 1996, MOL ENDOCRINOL, V10, P979, DOI 10.1210/me.10.8.979; Ikemoto T, 2005, J REPROD DEVELOP, V51, P359, DOI 10.1262/jrd.16087; Parhar I, 2012, PROG NEUROBIOL, V98, P176, DOI 10.1016/j.pneurobio.2012.05.011; Shahjahan M, 2010, GEN COMP ENDOCR, V169, P48, DOI 10.1016/j.ygcen.2010.07.008; Zhang Y, 2010, PEPTIDES, V31, P1034, DOI 10.1016/j.peptides.2010.03.003; Arima H, 1996, ENDOCRINOLOGY, V137, P1523, DOI 10.1210/en.137.5.1523; Bonnard E, 2001, PEPTIDES, V22, P1085, DOI 10.1016/S0196-9781(01)00425-9; Daukss D, 2012, GEN COMP ENDOCR, V177, P215, DOI 10.1016/j.ygcen.2012.04.024; Desprat C, 1997, PHARMACOL BIOCHEM BE, V58, P559, DOI 10.1016/S0091-3057(97)00249-9; Jhamandas Jack H, 2013, Front Endocrinol (Lausanne), V4, P8, DOI 10.3389/fendo.2013.00008; Jhamandas JH, 2003, J NEUROENDOCRINOL, V15, P24, DOI 10.1046/j.1365-2826.2003.00869.x; Larsson TA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-184; Motohashi E, 2010, ZOOL SCI, V27, P559, DOI 10.2108/zsj.27.559; Oehlmann VD, 2002, MECH DEVELOP, V117, P357, DOI 10.1016/S0925-4773(02)00210-1; Osugi T, 2006, FEBS J, V273, P1731, DOI 10.1111/j.1742-4658.2006.05187.x; Osugi T, 2011, ENDOCRINOLOGY, V152, P4252, DOI 10.1210/en.2011-1375; Parker RMC, 2000, MOL BRAIN RES, V77, P199, DOI 10.1016/S0169-328X(00)00052-8; Pasquier Jérémy, 2012, Front Endocrinol (Lausanne), V3, P173, DOI 10.3389/fendo.2012.00173; Prokai L, 2006, PEPTIDES, V27, P1015, DOI 10.1016/j.peptides.2005.06.032; ROTH BL, 1987, NEUROPEPTIDES, V10, P37, DOI 10.1016/0143-4179(87)90087-4; Saito TH, 2010, J NEUROPHYSIOL, V104, P3518, DOI 10.1152/jn.01027.2009; Suehiro Y, 2009, GEN COMP ENDOCR, V161, P138, DOI 10.1016/j.ygcen.2008.12.001; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Wirsig-Wiechmann CR, 2002, NEUROSCI RES, V44, P337, DOI 10.1016/S0168-0102(02)00150-5; Yin H, 2005, J ENDOCRINOL, V184, P257, DOI 10.1677/joe.1.05926	43	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	JAN 1	2015	210						152	160		10.1016/j.ygcen.2014.07.005		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4EK	WOS:000346886400017		
J	Kiani, D; Madani, SS; Terai, N				Kiani, Dariush; Madani, Sara Saeedi; Terai, Naoki			GORENSTEIN AND S-r PATH IDEALS OF CYCLES	GLASGOW MATHEMATICAL JOURNAL			English	Article							STANLEY-REISNER IDEALS; ALEXANDER DUALITY; RINGS	Let R = k[x(1),..., x(n)], where k is a field. The path ideal (of length t >= 2) of a directed graph G is the monomial ideal, denoted by It(G), whose generators correspond to the directed paths of length t in G. Let C-n be an n-cycle. We show that R/I-t(C-n) is S-r if and only if it is Cohen-Macaulay or [n/n-t-1] >= r+3. In addition, we prove that R/I-t(C-n) is Gorenstein if and only if n = t or 2t+1. Also, we determine all ordinary and symbolic powers of I-t(C-n) which are Cohen-Macaulay. Finally, we prove that I-t(C-n) has a linear resolution if and only if t >= n-2.	[Kiani, Dariush] Amirkabir Univ Technol, Dept Pure Math, Fac Math & Comp Sci, Tehran Polytech, Tehran 15914, Iran; [Kiani, Dariush] Inst Res Fundamental Sci IPM, Sch Math, Tehran, Iran; [Madani, Sara Saeedi; Terai, Naoki] Saga Univ, Fac Culture & Educ, Dept Math, Saga 8408502, Japan	Kiani, D (reprint author), Amirkabir Univ Technol, Dept Pure Math, Fac Math & Comp Sci, Tehran Polytech, 424 Hafez Ave, Tehran 15914, Iran.	dkiani@aut.ac.ir; sarasaeedi@aut.ac.ir; terai@cc.saga-u.ac.jp			Institute for Research in Fundamental Sciences (IPM); IPM [93050220]	The first and second authors would like to thank the Institute for Research in Fundamental Sciences (IPM) for financial support. The research of the first author was in part supported by a grant from IPM (No. 93050220).	Ha HT, 2008, J ALGEBR COMB, V27, P215, DOI 10.1007/s10801-007-0079-y; Conca A, 1999, J ALGEBRA, V211, P599, DOI 10.1006/jabr.1998.7740; Barile M, 2010, COMMUN ALGEBRA, V38, P3686, DOI 10.1080/00927870903236186; Brumatti P., 2001, MAT CONT, V21, P27; Bruns W., 1993, CAMBRIDGE STUDIES AD, V39; Eagon JA, 1998, J PURE APPL ALGEBRA, V130, P265, DOI 10.1016/S0022-4049(97)00097-2; Haghighi H, 2011, P AM MATH SOC, V139, P1993, DOI 10.1090/S0002-9939-2010-10646-9; Hegedus G., 2011, ARXIVMATHAC11015565V; Herzog J, 2010, MONOMIAL IDEALS; Madani SS, 2011, B MATH SOC SCI MATH, V54, P353; Rinaldo G, 2011, J COMMUT ALGEBR, V3, P405, DOI 10.1216/JCA-2011-3-3405; Saeedi Madani S., ALGEBRA C IN PRESS; Terai N., 2010, ARXIVMATHAC10090833V; Villarreal R., 2001, MONOMIAL ALGEBRAS; Yanagawa K, 2000, J ALGEBRA, V225, P630, DOI 10.1006/jabr.1999.8130	15	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0017-0895	1469-509X		GLASGOW MATH J	Glasg. Math. J.	JAN	2015	57	1					7	15		10.1017/S0017089514000111		9	Mathematics	Mathematics	AX1KB	WOS:000346704900002		
J	Komori, Y; Matsumoto, K; Tsumura, H				Komori, Yasushi; Matsumoto, Kohji; Tsumura, Hirofumi			ON WITTEN MULTIPLE ZETA-FUNCTIONS ASSOCIATED WITH SEMI-SIMPLE LIE ALGEBRAS V	GLASGOW MATHEMATICAL JOURNAL			English	Article							MORDELL-TORNHEIM; BERNOULLI POLYNOMIALS; SPECIAL VALUES; ROOT SYSTEMS; TRIPLE-ZETA	We study the values of the zeta-function of the root system of type G(2) at positive integer points. In our previous work we considered the case when all integers are even, but in the present paper we prove several theorems which include the situation when some of the integers are odd. The underlying reason why we may treat such cases, including odd integers, is also discussed.	[Komori, Yasushi] Rikkyo Univ, Dept Math, Toshima Ku, Tokyo 1718501, Japan; [Matsumoto, Kohji] Nagoya Univ, Grad Sch Math, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tsumura, Hirofumi] Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan	Komori, Y (reprint author), Rikkyo Univ, Dept Math, Toshima Ku, Tokyo 1718501, Japan.	komori@rikkyo.ac.jp; kohjimat@math.nagoya-u.ac.jp; tsumura@tmu.ac.jp					ZAGIER D, 1994, PROG MATH, V120, P497; Nakamura T, 2008, AEQUATIONES MATH, V75, P251, DOI 10.1007/s00010-007-2921-7; TORNHEIM L, 1950, AM J MATH, V72, P303, DOI 10.2307/2372034; APOSTOL T. M., 1976, INTRO ANAL NUMBER TH; Bourbald N., 1968, GROUPES ALGEBRES LIE; Humphreys J.E., 1990, REFLECTION GROUPS CO; Humphreys J.E., 1972, GRADUATE TEXTS MATH, V9; Komori Y, 2008, P JPN ACAD A-MATH, V84, P57; Komori Y, 2010, P LOND MATH SOC, V100, P303, DOI 10.1112/plms/pdp025; Komori Y, 2011, GLASGOW MATH J, V53, P185, DOI 10.1017/S0017089510000613; Komori Y, 2010, J MATH SOC JPN, V62, P355, DOI 10.2969/jmsj/06220355; Komori Y., 2006, P C L FUNCT, P115; Komori Y, 2010, SER NUMB THEORY APPL, V6, P135, DOI 10.1142/9789814289924_0007; Komori Y., PREPRINT; Komori Y., 2012, PROGR MATH, V300, P223; Matsumoto K, 2008, ACTA ARITH, V132, P99, DOI 10.4064/aa132-2-1; Matsumoto K, 2006, ANN I FOURIER, V56, P1457; Matsumoto K, 2008, P AM MATH SOC, V136, P2135, DOI 10.1090/S0002-9939-08-09192-2; Nakamura T, 2006, ACTA ARITH, V125, P257, DOI 10.4064/aa125-3-3; Nakamura T., 2008, TOKYO J MATH, V31, P551; Okamoto T., 2012, COMMENT MATH U ST PA, V61, P9; Onodera K, 2011, T AM MATH SOC, V363, P1463; TSUMURA H, 2004, ARCH MATH, V84, P147; WITTEN E, 1991, COMMUN MATH PHYS, V141, P153, DOI 10.1007/BF02100009; Zagier D., 1999, COMMUNICATION UNPUB; Zhao JQ, 2010, J ALGEBRA APPL, V9, P327, DOI 10.1142/S021949881000394X	26	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0017-0895	1469-509X		GLASGOW MATH J	Glasg. Math. J.	JAN	2015	57	1					107	130		10.1017/S0017089514000160		24	Mathematics	Mathematics	AX1KB	WOS:000346704900006		
J	Cada, R; Chiba, S; Yoshimoto, K				Cada, Roman; Chiba, Shuya; Yoshimoto, Kiyoshi			2-Factors in Claw-Free Graphs with Lower Bounds Cycle Lengths	GRAPHS AND COMBINATORICS			English	Article						2-factor; Claw-free graph; Minimum degree	REGULAR FACTORS; EVEN SUBGRAPHS; COMPONENTS; CLOSURE; NUMBER	For a graph G, we denote by delta(G) the minimum degree of G. A graph G is said to be claw-free if G has no induced subgraph isomorphic to K (1, 3). In this article, we prove that every claw-free graph G with minimum degree at least 4 has a 2-factor in which each cycle contains at least vertices and every 2-connected claw-free graph G with minimum degree at least 3 has a 2-factor in which each cycle contains at least delta(G) vertices. For the case where G is 2-connected, the lower bound on the length of a cycle is best possible.	[Cada, Roman] Univ W Bohemia, New Technol Informat Soc, NTIS, Dept Math, Plzen 30614, Czech Republic; [Cada, Roman] Univ W Bohemia, European Ctr Excellence, CE ITI, Plzen 30614, Czech Republic; [Chiba, Shuya] Kumamoto Univ, Dept Engn Math, Kumamoto 8608555, Japan; [Yoshimoto, Kiyoshi] Nihon Univ, Coll Sci & Technol, Dept Math, Tokyo 1018308, Japan	Chiba, S (reprint author), Kumamoto Univ, Dept Engn Math, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	cadar@kma.zcu.cz; schiba@kumamoto-u.ac.jp; yosimoto@math.cst.nihon-u.ac.jp			Grant Agency of Czech Republic [CE-ITI P202/12/G061]; JSPS KAKENHI [23740087, 22540152]	The authors would like to thank the referees for their helpful suggestions. The research of the first author was partially supported by Grant CE-ITI P202/12/G061 of Grant Agency of Czech Republic, the research of the second author was partially supported by JSPS KAKENHI grant 23740087 and the research of the third author was partially supported by JSPS KAKENHI grant 22540152.	Ando K, 2002, DISCRETE MATH, V243, P195, DOI 10.1016/S0012-365X(01)00214-X; Faudree RJ, 2012, J GRAPH THEOR, V69, P251, DOI 10.1002/jgt.20579; CHOUDUM SA, 1991, J GRAPH THEOR, V15, P259, DOI 10.1002/jgt.3190150304; Broersma HJ, 2001, J GRAPH THEOR, V37, P125, DOI 10.1002/jgt.1008; Yoshimoto K, 2007, DISCRETE MATH, V307, P2808, DOI 10.1016/j.disc.2006.11.022; EGAWA Y, 1991, J GRAPH THEOR, V15, P337, DOI 10.1002/jgt.3190150310; Broersma H, 2009, GRAPH COMBINATOR, V25, P427, DOI 10.1007/s00373-009-0855-7; Cada R., COMMUNICATION; Diestel R., 2010, GRADUATE TEXTS MATH, V173; Faudree R, 1999, DISCRETE MATH, V206, P131, DOI 10.1016/S0012-365X(98)00398-7; Harary F., 1965, CANAD MATH B, V8, P701, DOI 10.4153/CMB-1965-051-3; Jackson B, 2009, J GRAPH THEOR, V62, P37, DOI 10.1002/jgt.20386; Jackson B, 2007, DISCRETE MATH, V307, P2775, DOI 10.1016/j.disc.2006.11.023; Kuzel R, 2012, DISCRETE MATH, V312, P202, DOI 10.1016/j.disc.2011.08.020; MATTHEWS MM, 1984, J GRAPH THEOR, V8, P139, DOI 10.1002/jgt.3190080116; Ozeki K., 2 FACTORS BOUN UNPUB; Ryjacek Z, 1999, J GRAPH THEOR, V32, P109, DOI 10.1002/(SICI)1097-0118(199910)32:2<109::AID-JGT1>3.0.CO;2-O; Ryjacek Z, 1997, J COMB THEORY B, V70, P217, DOI 10.1006/jctb.1996.1732	18	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	JAN	2015	31	1					99	113		10.1007/s00373-013-1375-z		15	Mathematics	Mathematics	AX2LT	WOS:000346776200007		
J	Matsumoto, N				Matsumoto, Naoki			Transitions of Hexangulations on the Sphere	GRAPHS AND COMBINATORICS			English	Article						Planar graph; Hexangulation; Transition diagram	DIAGONAL FLIPS; HAMILTONIAN TRIANGULATIONS; SURFACES; QUADRANGULATIONS; TRANSFORMATIONS	A hexangulation G is a 2-connected simple plane graph such that each face of G is bounded by a 6-cycle. It was recently proved that any two hexangulations with the same number of vertices can be transformed into each other by three specifically defined transformations and . We prove that any two hexangulations G and G' with bipartitions {B, W} and {B', W'}, respectively, such that |B| = |B'| and |W| = |W'|, can be transformed into each other by successive applications of operations in . Moreover, we completely describe the role of the four operations and in the transition diagram of hexangulations.	Yokohama Natl Univ, Hodogaya ku, Yokohama, Kanagawa 2408501, Japan	Matsumoto, N (reprint author), Yokohama Natl Univ, Hodogaya ku, 79-2 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	matsumoto-naoki-gn@ynu.ac.jp					Nakamoto A, 1996, J GRAPH THEOR, V21, P289, DOI 10.1002/(SICI)1097-0118(199603)21:3<289::AID-JGT3>3.0.CO;2-M; Brunet R, 1996, J COMB THEORY B, V68, P295, DOI 10.1006/jctb.1996.0070; Kanno J., PREPRINT; Matsumoto N., 2011, YOKOHAMA MATH J, V57, P89; Mori R, 2005, DISCRETE MATH, V303, P142, DOI 10.1016/j.disc.2004.12.021; Mori R, 2003, GRAPH COMBINATOR, V19, P413, DOI 10.1007/s00373-002-0508-6; Nakamoto A, 1996, J COMB THEORY B, V67, P202, DOI 10.1006/jctb.1996.0041; Nakamoto A., 2001, INTERDISCIP INFORM S, V7, P77, DOI 10.4036/iis.2001.77; Nakamoto A., 2010, YOKOHAMA MATH J, V55, P105; Negami S., 1999, YOKOHAMA MATH J, V47, P1; Negami S., 1999, YOKOHAMA MATH J, V47, P213	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	JAN	2015	31	1					201	219		10.1007/s00373-013-1374-0		19	Mathematics	Mathematics	AX2LT	WOS:000346776200015		
J	Qin, CF; Guo, XF; Ando, K				Qin, Chengfu; Guo, Xiaofeng; Ando, Kiyoshi			The Removable Edges and the Contractible Subgraphs of 5-Connected Graphs	GRAPHS AND COMBINATORICS			English	Article						5-connected graph; Contractible subgraph; Removable edge; Minor minimal	CONNECTIVITY; VERTICES; NUMBER	An edge of a k-connected graph G is said to be k-removable if G - e is still k-connected. A subgraph H of a k-connected graph is said to be k-contractible if its contraction, that is, identification every component of H to a single vertex, results again a k-connected graph. In this paper, we show that there is either a removable edge or a contractible subgraph in a 5-connected graph which contains an edge with both endvertices have degree more than five. Thus every edge of minor minimal 5-connected graph is incident to at least one vertex of degree 5.	[Qin, Chengfu] Guangxi Teachers Educ Univ, Sch Math Sci, Nanning 530001, Peoples R China; [Guo, Xiaofeng] Xiamen Univ, Dept Math, Xiamen 310065, Fujian, Peoples R China; [Ando, Kiyoshi] Univ Electrocommun, Dept Informat & Commun Engn, Chofugao Ku, Chofu, Tokyo 1828585, Japan	Qin, CF (reprint author), Guangxi Teachers Educ Univ, Sch Math Sci, Nanning 530001, Peoples R China.	qtclf@163.com			National Natural Science Foundation of China [11126321, 1161006]; Natural Sciences Foundation of Guangxi Province [2012GXNSFBA053005]; Scientific Research Foundation of Guangxi Education Committee [200103YB069]	The project supported by the National Natural Science Foundation of China (No. 11126321, No. 1161006); Natural Sciences Foundation of Guangxi Province (No. 2012GXNSFBA053005); The Scientific Research Foundation of Guangxi Education Committee (No. 200103YB069).	Ando K, 2009, J GRAPH THEOR, V60, P99, DOI 10.1002/jgt.20350; Ando K, 2011, DISCRETE MATH, V311, P1084, DOI 10.1016/j.disc.2010.10.022; Ando K, 2011, DISCRETE MATH, V311, P1925, DOI 10.1016/j.disc.2011.04.032; Ando K, 2005, GRAPH COMBINATOR, V21, P27, DOI 10.1007/s00373-004-0591-y; Kriesell M, 2002, GRAPH COMBINATOR, V18, P1, DOI 10.1007/s003730200000; PLUMMER MD, 1987, J GRAPH THEOR, V11, P507, DOI 10.1002/jgt.3190110407; Bondy J.A., 1976, GRAPH THEORY APPL; Fijavz G., 2001, THESIS U LJUBLJANA; Kriesell M, 2007, DISCRETE MATH, V307, P494, DOI 10.1016/j.disc.2005.09.040; Kriesell M, 2006, J COMB THEORY B, V96, P881, DOI 10.1016/j.jctb.2006.02.009; Kriesell M, 2006, J GRAPH THEOR, V51, P205, DOI 10.1002/jgt.20131; Li TT, 2009, DISCRETE MATH, V309, P2870, DOI 10.1016/j.disc.2008.07.020; MADER W, 1988, DISCRETE MATH, V72, P267, DOI 10.1016/0012-365X(88)90216-6; Qin C., 2005, AUSTRALAS J COMBIN, V33, P139; Qin CF, 2008, DISCRETE MATH, V308, P5742, DOI 10.1016/j.disc.2007.10.041; Su J., 1997, J GUANGXI NORMAL U, V3, P12; Tutte W. T., 1961, NEDERL AKAD WETENS A, V64, P441; Yuan X., 1994, J GUANGXI NORMAL U, V3, P30	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	JAN	2015	31	1					243	254		10.1007/s00373-013-1368-y		12	Mathematics	Mathematics	AX2LT	WOS:000346776200018		
J	Sugimoto, T				Sugimoto, Teruhisa			Convex Pentagons for Edge-to-Edge Tiling, II	GRAPHS AND COMBINATORICS			English	Article						Convex pentagon; Tiling; Tile; Monohedral tiling; Edge-to-edge tiling	PLANE	Based on Bagina's Proposition, it has previously been demonstrated that there remain 34 cases where it is uncertain whether a convex pentagon can generate an edge-to-edge tiling. In this paper, these cases are further refined by imposing extra edge conditions. To investigate the resulting 42 cases, the properties of convex pentagonal tiles that can generate an edge-to-edge tiling are identified. These properties are the key to generating a perfect list of the types of convex pentagonal tiles that can generate an edge-to-edge tiling.	Technol & Art, Interdisciplinary Inst Sci, Asaka Shi, Saitama 3510036, Japan	Sugimoto, T (reprint author), Technol & Art, Interdisciplinary Inst Sci, Suzukidaini Bldg 211,2-5-28 Kitahara, Asaka Shi, Saitama 3510036, Japan.	ismsugi@gmail.com					Bagina O, 2004, J COMB THEORY A, V105, P221, DOI 10.1016/j.jcta.2003.11.002; Gardner M., 1975, TESSELLATING PLANE C, P112; Grunbaum B., 1987, TILINGS PATTERNS, P15; Hallard T.C., 1994, UNSOLVED PROBLEMS GE, P95; HIRSCHHORN MD, 1985, J COMB THEORY A, V39, P1, DOI 10.1016/0097-3165(85)90078-0; KERSHNER RB, 1968, AM MATH MON, V75, P839, DOI 10.2307/2314332; Sugimoto T., 2009, FORMA, V24, P117; Sugimoto T., FORMA, V27, P93; Sugimoto T., 2006, FORMA, V21, P113; Sugimoto T., FORMA IN PRESS; Wells D., 1991, PENGUIN DICT CURIOUS, P177	11	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0911-0119	1435-5914		GRAPH COMBINATOR	Graphs Comb.	JAN	2015	31	1					281	298		10.1007/s00373-013-1385-x		18	Mathematics	Mathematics	AX2LT	WOS:000346776200021		
J	Siddiki, SMAH; Kon, K; Shimizu, K				Siddiki, S. M. A. Hakim; Kon, Kenichi; Shimizu, Ken-ichi			Selective N-alkylation of indoles with primary alcohols using a Pt/HBEA catalyst	GREEN CHEMISTRY			English	Article							IONIC LIQUIDS; FUNCTIONALIZATION	Pt-loaded HBEA (H+-exchanged BEA zeolite) is found to be an effective and reusable heterogeneous catalyst for regioselective N-alkylation of indoles with primary aliphatic and benzylic alcohols under additive-free conditions driven by the borrowing-hydrogen methodology. Structural and mechanistic studies suggest a cooperative mechanism of the Pt-0 site on Pt metal clusters and the Bronsted acid site of the zeolite, in which the Pt-0 site is responsible for dehydrogenation/hydrogenation steps and the Bronsted acid site is responsible for the regioselective condensation of indoles with aldehydes to the enamine intermediate.	[Siddiki, S. M. A. Hakim; Shimizu, Ken-ichi] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Kyoto 6158520, Japan; [Kon, Kenichi; Shimizu, Ken-ichi] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan	Shimizu, K (reprint author), Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Kyoto 6158520, Japan.	kshimizu@cat.hokudai.ac.jp	Shimizu, Ken-ichi/A-5241-2012		JSPS [25106010]; MEXT program "Elements Strategy Initiative to Form Core Research Center"	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics" (25106010) from JSPS and a MEXT program "Elements Strategy Initiative to Form Core Research Center".	Alonso F, 2009, CHEMCATCHEM, V1, P75, DOI 10.1002/cctc.200900045; Alonso F, 2008, J CATAL, V260, P113, DOI 10.1016/j.jcat.2008.09.009; Guillena G, 2007, ANGEW CHEM INT EDIT, V46, P2358, DOI 10.1002/anie.200603794; Cacchi S, 2005, CHEM REV, V105, P2873, DOI 10.1021/cr040639b; Humphrey GR, 2006, CHEM REV, V106, P2875, DOI 10.1021/cr0505270; Bahn S, 2010, CHEM-EUR J, V16, P3590, DOI 10.1002/chem.200903144; Siddiki SMAH, 2013, CHEM-EUR J, V19, P14416, DOI 10.1002/chem.201302464; Putra AE, 2013, EUR J ORG CHEM, V2013, P6344, DOI 10.1002/ejoc.201300744; Zhang Y, 2011, TETRAHEDRON LETT, V52, P1334, DOI 10.1016/j.tetlet.2011.01.059; Whitney S, 2007, ORG LETT, V9, P3299, DOI 10.1021/ol071274v; Chaudhari C, 2013, TETRAHEDRON LETT, V54, P6490, DOI 10.1016/j.tetlet.2013.09.077; Yamaguchi R, 2010, HETEROCYCLES, V81, P1093, DOI 10.3987/REV-09-665; Kon K, 2013, J CATAL, V304, P63, DOI 10.1016/j.jcat.2013.04.003; Alonso F, 2010, MOL DIVERS, V14, P411, DOI 10.1007/s11030-009-9195-z; DEANGELIS F, 1977, SYNTHESIS-STUTTGART, P335; Jorapur YR, 2006, TETRAHEDRON LETT, V47, P2435, DOI 10.1016/j.tetlet.2006.01.129; Karchava AV, 2012, CHEM HETEROCYCL COM+, V48, P391, DOI 10.1007/s10593-012-1006-2; Krger K., 2008, ADV SYNTH CATAL, V350, P2153; Negwer M., 2007, ORGANIC CHEM DRUGS T, V3, P1915; Negwer M., 2007, ORGANIC CHEM DRUGS T, V4, P2631; Nixon TD, 2009, DALTON T, P753, DOI 10.1039/b813383b; Obora Y, 2011, SYNLETT, P30, DOI 10.1055/s-0030-1259094; Shimizu K, 2012, CATAL SCI TECHNOL, V2, P730, DOI 10.1039/c2cy00476c; Siddiki SMAH, 2014, CATAL SCI TECHNOL, V4, P1716, DOI 10.1039/c4cy00092g; Sundberg R. J., 1996, INDOLES; Vavilina G, 2008, CHEM HETEROCYC COMPD, V44, P530, DOI 10.1007/s10593-008-0072-y	26	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9262	1463-9270		GREEN CHEM	Green Chem.		2015	17	1					173	177		10.1039/c4gc01419g		5	Chemistry, Multidisciplinary	Chemistry	AX1ZJ	WOS:000346742600011		
J	Ouchi, A; Liu, CX; Kunioka, M				Ouchi, Akihiko; Liu, Chuanxiang; Kunioka, Masao			Increasing the dyeability of polyester fabrics by photochemical treatment at room-temperature using H2O2 in air	GREEN CHEMISTRY			English	Article							UV-LASER IRRADIATION; SYNTHETIC-FIBERS; SURFACE MODIFICATION; CELLULOSIC FABRICS; PET; TRIMETHYLSILYLDIAZOMETHANE; MONOMERS; ACIDS	Poly(ethylene terephthalate) (PET) fabrics are currently dyed using disperse dyes at high temperatures and pressures because of their low dyeability, which implies the use of a large amount of energy and pressurized vessels that are unsuitable for safe operation. Simple irradiation with a commercially available germicidal lamp was applied to the PET fabrics using aqueous H2O2 and H2O2 + acrylic acid solutions at room temperature under air. A more than seven-fold increase in dyeability with cationic dyes was obtained at atmospheric pressure at reduced temperatures. For the first time, the increase in dyeability was observed only with H2O2 by a reaction with O-2 in air. The increase in dyeability was attributed to the introduction of carboxylic acid groups on the fabric surface, which was confirmed by IR and UV spectroscopy and chemical reactions.	[Ouchi, Akihiko; Liu, Chuanxiang; Kunioka, Masao] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Ouchi, A (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan.	ouchi.akihiko@aist.go.jp					YAO ZP, 1990, J APPL POLYM SCI, V41, P1459, DOI 10.1002/app.1990.070410709; Knittel D, 1998, POLYM INT, V45, P110, DOI 10.1002/(SICI)1097-0126(199801)45:1<110::AID-PI890>3.0.CO;2-I; HASHIMOTO N, 1981, CHEM PHARM BULL, V29, P1475; Aronoff M. S., 1977, APPL POLYM S, V31, P397; AVNY Y, 1978, J APPL POLYM SCI, V22, P125, DOI 10.1002/app.1978.070220110; Feng Z., 1992, ANGEW MAKROMOL CHEM, V192, P113; Gotoh K, 2008, SEN-I GAKKAISHI, V64, P199; Huang WW, 2009, FIBER POLYM, V10, P27, DOI 10.1007/s12221-009-0027-7; Hyugano T, 2008, J ORG CHEM, V73, P8861, DOI 10.1021/jo801730j; Jaffe H. H., 1962, THEORY APPLICATIONS; Jang JH, 2006, DYES PIGMENTS, V69, P137, DOI 10.1016/j.dyepig.2005.02.010; KALE PD, 1975, J APPL POLYM SCI, V19, P461, DOI 10.1002/app.1975.070190212; Knittel D, 1998, POLYM INT, V45, P103, DOI 10.1002/(SICI)1097-0126(199801)45:1<103::AID-PI917>3.3.CO;2-U; Knittel D, 1997, POLYM INT, V43, P231, DOI 10.1002/(SICI)1097-0126(199707)43:3<231::AID-PI797>3.0.CO;2-E; Knittel D, 1997, POLYM INT, V43, P240, DOI 10.1002/(SICI)1097-0126(199707)43:3<240::AID-PI798>3.0.CO;2-9; Kubelka P., 1931, Zeitschrift fur Technische Physik, V12; Mohamed NH, 2012, APPL SURF SCI, V259, P261, DOI 10.1016/j.apsusc.2012.07.029; Ouchi A, 2003, GREEN CHEM, V5, P516, DOI 10.1039/b304680j; Ouchi A, 2009, ORG LETT, V11, P4870, DOI 10.1021/ol901943f; Ouchi A, 2003, GREEN CHEM, V5, P329, DOI 10.1039/b300183k; Ouchi A, 2013, EUR J ORG CHEM, P3807, DOI 10.1002/ejoc.201300115; Presser A, 2004, MONATSH CHEM, V135, P1015, DOI 10.1007/s00706-004-0188-4; SEIBER RP, 1975, J APPL POLYM SCI, V19, P2187, DOI 10.1002/app.1975.070190812; Watanabe H, 1999, J APPL POLYM SCI, V71, P2027, DOI 10.1002/(SICI)1097-4628(19990321)71:12<2027::AID-APP12>3.0.CO;2-K; Zard S. Z., 2003, RADICAL REACTIONS OR	25	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9262	1463-9270		GREEN CHEM	Green Chem.		2015	17	1					490	498		10.1039/c4gc01464b		9	Chemistry, Multidisciplinary	Chemistry	AX1ZJ	WOS:000346742600052		
J	Yoshihara, H; Yoshinobu, M				Yoshihara, Hiroshi; Yoshinobu, Masahiro			In-plane shear strength of paper measured by asymmetric four-point bending test	HOLZFORSCHUNG			English	Article						asymmetric four-point bending test; clearance; finite element analysis (FEA); in-plane shear strength; off-axis tension test; paper	WOOD; SPECIMEN; MODULUS; STRAIN	The in-plane shear strengths (IPSS) of copy paper, filter paper, and sack paper were obtained from an asymmetric four-point bending (AFPB) test. Rectangular tabs of medium-density fibreboard (MDF) were bonded to the paper specimen. The length of the clearance between the tabs was varied, and the influence of the clearance on the IPSS value was investigated. The IPSS obtained from the AFPB test was compared with that obtained from a 35 degrees off-axis tension (OAT) test, which was proposed in a previous study. The IPSS values obtained from the AFPB tests on the copy paper and sack paper were significantly lower than those obtained from the 35 degrees OAT tests because of the localised buckling caused by the negative principal stress. In contrast, the IPSS values obtained from the AFPB and OAT tests on the filter paper were in agreement when the clearance length was >5 mm because the buckling effect was excluded.	[Yoshihara, Hiroshi; Yoshinobu, Masahiro] Shimane Univ, Fac Sci & Engn, Matsue, Shimane 6908504, Japan	Yoshihara, H (reprint author), Shimane Univ, Fac Sci & Engn, Nishikawazu Cho 1060, Matsue, Shimane 6908504, Japan.	yosihara@riko.shimane-u.ac.jp			Japan Society for the Promotion of Science [24580246]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 24580246) of the Japan Society for the Promotion of Science.	Koerber H, 2010, MECH MATER, V42, P1004, DOI 10.1016/j.mechmat.2010.09.003; Xavier J, 2009, COMPOS PART A-APPL S, V40, P1953, DOI 10.1016/j.compositesa.2009.09.023; Xavier J, 2007, HOLZFORSCHUNG, V61, P573, DOI 10.1515/HF.2007.083; CHOI D, 1991, WOOD SCI TECHNOL, V25, P251; Xavier J, 2013, WOOD SCI TECHNOL, V47, P423, DOI 10.1007/s00226-012-0507-6; Azzi VD, 1965, EXP MECH, V5, P283, DOI 10.1007/BF02326292; Enomae T., 2007, J JPN SOC NONDESTRUC, V56, P561; FELLERS C, 1977, SVEN PAPPERSTIDN, V80, P89; HECKERS W, 1980, PAPIER, V34, P1; Kubojima Y, 2000, J WOOD SCI, V46, P279, DOI 10.1007/BF00766217; Norris C. B., 1962, FOREST PROD LAB REP, V1816, P1; Pan N, 1997, TEXT RES J, V67, P593; Waterhouse J.F., 1984, IPC TECH PAP SER, V146, P1; WU RY, 1984, J COMPOS MATER, V18, P456, DOI 10.1177/002199838401800505; Yoshihara H, 2012, BUILD MAT, V34, P11; Yoshihara H, 2013, BIORESOURCES, V8, P1771; Yoshihara H, 2013, BIORESOURCES, V8, P3858; Yoshihara H, 2009, HOLZFORSCHUNG, V63, P211, DOI 10.1515/HF.2009.035; Yoshihara H, 1998, J WOOD SCI, V44, P15, DOI 10.1007/BF00521869; Yoshihara H, 2014, HOLZFORSCHUNG, V68, P583, DOI 10.1515/hf-2013-0163; Yoshihara H, 1999, J WOOD SCI, V45, P24, DOI 10.1007/BF00579520; Yoshihara H, 2005, J TEST EVAL, V33, P55	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	JAN	2015	69	1					41	46		10.1515/hf-2014-0047		6	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	AX2HR	WOS:000346764600006		
J	Shimizu, K; Iyatomi, H; Celebi, ME; Norton, KA; Tanaka, M				Shimizu, Kouhei; Iyatomi, Hitoshi; Celebi, M. Emre; Norton, Kerri-Ann; Tanaka, Masaru			Four-Class Classification of Skin Lesions With Task Decomposition Strategy	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Basal cell carcinoma (BCC); dermoscopy; image processing; melanoma; skin lesion classification	BASAL-CELL CARCINOMA; COMPUTER-AIDED DIAGNOSIS; DERMOSCOPY IMAGES; BORDER DETECTION; PATTERN-ANALYSIS; ABCD RULE; MELANOMA; CANCER; FEATURES; SYSTEM	This paper proposes a new computer-aided method for the skin lesion classification applicable to both melanocytic skin lesions (MSLs) and nonmelanocytic skin lesions (NoMSLs). The computer-aided skin lesion classification has drawn attention as an aid for detection of skin cancers. Several researchers have developed methods to distinguish between melanoma and nevus, which are both categorized as MSL. However, most of these studies did not focus on NoMSLs such as basal cell carcinoma (BCC), the most common skin cancer and seborrheic keratosis (SK) despite their high incidence rates. It is preferable to deal with these NoMSLs as well as MSLs especially for the potential users who are not enough capable of diagnosing pigmented skin lesions on their own such as dermatologists in training and physicians with different expertise. We developed a new method to distinguish among melanomas, nevi, BCCs, and SKs. Our method calculates 828 candidate features grouped into three categories: color, subregion, and texture. We introduced two types of classification models: a layered model that uses a task decomposition strategy and flat models to serve as performance baselines. We tested our methods on 964 dermoscopy images: 105 melanomas, 692 nevi, 69 BCCs, and 98 SKs. The layered model outperformed the flat models, achieving detection rates of 90.48%, 82.51%, 82.61%, and 80.61% for melanomas, nevi, BCCs, and SKs, respectively. We also identified specific features effective for the classification task including irregularity of color distribution. The results show promise for enhancing the capability of the computer-aided skin lesion classification.	[Shimizu, Kouhei; Iyatomi, Hitoshi] Hosei Univ, Dept Appl Informat, Tokyo 1028160, Japan; [Celebi, M. Emre] Louisiana State Univ, Dept Comp Sci, Shreveport, LA 71115 USA; [Norton, Kerri-Ann] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Tanaka, Masaru] Tokyo Womens Med Univ, Dept Dermatol, Med Ctr East, Tokyo 1628666, Japan	Shimizu, K (reprint author), Hosei Univ, Dept Appl Informat, Tokyo 1028160, Japan.	kohei.shimizu.66@adm.hosei.ac.jp; iyatomi@hosei.ac.jp; emrecelebi1980@gmail.com; kerri.norton@gmail.com; masarutanaka@1984.jukuin.keio.ac.jp			Japan Science and Technology A-STEP Program [AS251Z01435P]; NIH; ACS	This work was supported in part by Japan Science and Technology A-STEP Program (AS251Z01435P, 2013), NIH, and ACS. Asterisk indicates corresponding author.	Garnavi R, 2011, COMPUT MED IMAG GRAP, V35, P105, DOI 10.1016/j.compmedimag.2010.08.001; de Leeuw J, 2009, LASER SURG MED, V41, P96, DOI 10.1002/lsm.20739; STOLZ W, 1994, EUR J DERMATOL, V4, P521; Celebi ME, 2007, SKIN RES TECHNOL, V13, P454, DOI 10.1111/j.1600-0846.2007.00251.x; Sigurdsson S, 2004, IEEE T BIO-MED ENG, V51, P1784, DOI 10.1109/TBME.2004.831538; de Vries E, 2005, BRIT J DERMATOL, V152, P481, DOI 10.1111/J.1365-2133.2005.06386.X; Celebi ME, 2008, SKIN RES TECHNOL, V14, P347, DOI 10.1111/j.1600-0846.2008.00301.x; Iyatomi H, 2006, MELANOMA RES, V16, P183, DOI 10.1097/01.cmr.0000215041.76553.58; Argenziano G, 1998, ARCH DERMATOL, V134, P1563, DOI 10.1001/archderm.134.12.1563; Celebi ME, 2007, COMPUT MED IMAG GRAP, V31, P362, DOI 10.1016/j.compmedimag.2007.01.003; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Yeatman JM, 1997, BRIT J DERMATOL, V137, P411, DOI 10.1111/j.1365-2133.1997.tb03748.x; Crowson AN, 2006, MODERN PATHOL, V19, pS127, DOI 10.1038/modpathol.3800512; Ganster H, 2001, IEEE T MED IMAGING, V20, P233, DOI 10.1109/42.918473; Iyatomi H, 2008, COMPUT MED IMAG GRAP, V32, P566, DOI 10.1016/j.compmedimag.2008.06.005; Balch CM, 2001, J CLIN ONCOL, V19, P3635; Nakayama K, 2010, PIGM CELL MELANOMA R, V23, P338, DOI 10.1111/j.1755-148X.2010.00692.x; Chen XW, 2006, PATTERN RECOGN LETT, V27, P1685, DOI 10.1016/j.patrec.2006.03.013; MARKS R, 1995, CANCER, V75, P607, DOI 10.1002/1097-0142(19950115)75:2+<607::AID-CNCR2820751402>3.0.CO;2-8; Rubegni P, 2002, INT J CANCER, V101, P576, DOI 10.1002/ijc.10620; Stoecker WV, 2009, SKIN RES TECHNOL, V15, P283, DOI 10.1111/j.1600-0846.2009.00354.x; Cheng BB, 2011, SKIN RES TECHNOL, V17, P278, DOI 10.1111/j.1600-0846.2010.00494.x; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Ballerini L., 2012, COLOR MED IMAGE ANAL, P63; Bath-Hextall F, 2007, INT J CANCER, V121, P2105, DOI 10.1002/ijc.22952; Brooke RCC, 2005, CLIN MED, V5, P551; Celebi ME, 2013, SKIN RES TECHNOL, V19, pE252, DOI 10.1111/j.1600-0846.2012.00636.x; Cheng BB, 2013, SKIN RES TECHNOL, V19, pE217, DOI 10.1111/j.1600-0846.2012.00630.x; Deshabhoina SV, 2003, SKIN RES TECHNOL, V9, P348, DOI 10.1034/j.1600-0846.2003.00044.x; Dietterich T., 1994, J ARTIFICIAL INTELLI, V2, P263; Everitt B. S., 1991, APPL MULTIVARIATE DA, P219; Garnavi R, 2012, IEEE T INF TECHNOL B, V16, P1239, DOI 10.1109/TITB.2012.2212282; Iyatomi H, 2010, IEEE ENG MED BIO, P5407, DOI 10.1109/IEMBS.2010.5626500; Jemal A, 2011, J AM ACAD DERMATOL, V65, pS17, DOI 10.1016/j.jaad.2011.04.032; Norton KA, 2012, SKIN RES TECHNOL, V18, P290, DOI 10.1111/j.1600-0846.2011.00569.x; Seidenari S, 2005, SKIN RES TECHNOL, V11, P236, DOI 10.1111/j.0909-725X.2005.00123.x; She ZS, 2011, SKIN RES TECHNOL, V17, P206, DOI 10.1111/j.1600-0846.2010.00485.x; Sheha M., 2012, INT J COMPUT APPL, V42, P22; Shimizu K. K, 2012, P INT C MECH MACH VI, P16; Zhou H, 2008, I S BIOMED IMAGING, P800, DOI 10.1109/ISBI.2008.4541117	40	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JAN	2015	62	1					274	283		10.1109/TBME.2014.2348323		10	Engineering, Biomedical	Engineering	AX2IA	WOS:000346765500029		
J	Chen, WJ; Kong, K; Tomizuka, M				Chen, Wenjie; Kong, Kyoungchul; Tomizuka, Masayoshi			Dual-Stage Adaptive Friction Compensation for Precise Load Side Position Tracking of Indirect Drive Mechanisms	IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY			English	Article						Adaptive observer; friction compensation; hybrid controller; indirect drive; kinematic Kalman filter	SYSTEMS; IDENTIFICATION; ROBOTS; MODEL	This paper investigates the friction compensation of an indirect drive mechanism in the absence of precise end-effector position measurement. Unlike direct drive mechanisms, a typical indirect drive mechanism in the mechanical systems is composed of an actuator (motor side) and an inertia load (load side/end-effector), separated by the gear transmission. Friction in the gear transmission makes the dynamics of the indirect drive mechanism complicated and the precise position control of the end-effector challenging. More specifically, when joint compliance exists in the gear transmission, it is not simple to observe and compensate for the friction. In this paper, a mathematical model and its parameter adaptation method are proposed for the estimation and compensation of the friction in indirect drive mechanisms. For the ultimate objective of tracking the predefined load side reference trajectory, we feed back the estimated friction into the control system by refining the motor side reference trajectory, as well as by adding a feedforward signal to the control input of the motor. Both methods (i.e., the torque compensation and the motor side reference modification) are combined to effectively reject the friction effects in indirect drive mechanisms. The success of the two friction compensation methods depends on their effective integration. For this purpose, a hybrid decision making is adopted to engage or disengage the load side compensation algorithm when the task is repetitive. The proposed method is verified by experimental results on a single-joint indirect drive testbed.	[Chen, Wenjie] FANUC Corp, Robot Lab, Oshino, Yamanashi 4010597, Japan; [Kong, Kyoungchul] Sogang Univ, Dept Mech Engn, Seoul 121742, South Korea; [Tomizuka, Masayoshi] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Chen, WJ (reprint author), FANUC Corp, Robot Lab, Oshino, Yamanashi 4010597, Japan.	wjchen@berkeley.edu; kckong@sogang.ac.kr; tomizuka@me.berkeley.edu			FANUC Corporation, Japan; National Instruments, Inc.	This work was supported in part by FANUC Corporation, Japan, and in part by the National Instruments, Inc., for real-time control hardware and software.	Altpeter F., 1999, THESIS ECOLE POLYTEC; Ruderman M, 2009, IEEE T IND ELECTRON, V56, P3840, DOI 10.1109/TIE.2009.2015752; Lambrechts P, 2005, CONTROL ENG PRACT, V13, P145, DOI 10.1016/j.conengprac.2004.02.010; TUNG ED, 1993, J DYN SYST-T ASME, V115, P279, DOI 10.1115/1.2899032; Tomizuka M, 1989, J DYN SYST-T ASME, V111, P353; DEWIT CC, 1995, IEEE T AUTOMAT CONTR, V40, P419; Jeon S, 2007, CONTROL ENG PRACT, V15, P325, DOI 10.1016/j.conengprac.2005.10.004; ARMSTRONGHELOUVRY B, 1994, AUTOMATICA, V30, P1083, DOI 10.1016/0005-1098(94)90209-7; deWit CC, 1997, INT J ADAPT CONTROL, V11, P65, DOI 10.1002/(SICI)1099-1115(199702)11:1<65::AID-ACS395>3.0.CO;2-3; Chen W., 2012, P ASME DYN SYST CONT, P1480; Chen W., 2012, P IEEE ASME INT C AD, P598; Chen W., 2009, P ASME DYN SYST CONT, P313; Chen WJ, 2010, P AMER CONTR CONF, P6852; Dhaouadi R., 2003, P IEEE ASME INT C AD, V1, P278; Gandhi PS, 2002, IEEE DECIS CONTR P, P160; Han CH, 2008, AMC '08: 10TH INTERNATIONAL WORKSHOP ON ADVANCED MOTION CONTROL, VOLS 1 AND 2, PROCEEDINGS, P182; Hauschild J. P., 2004, P 6 INT C DYN CONTR, P683; Jeon S., 2005, P 2005 IEEE ASME INT, P723; Landau Y. D., 1979, ADAPTIVE CONTROL MOD; Lee D. J., 2001, P ASME IMECE NEW YOR, P11; Mallon N, 2006, IEEE T CONTR SYST T, V14, P374, DOI 10.1109/TCST.2005.863674; Ohnishi K., 1987, T JPN SOC ELECT ENG, V107-D, P83; Roan P, 2012, IEEE INT C INT ROBOT, P4822, DOI 10.1109/IROS.2012.6385893; Ruderman M., 2012, ROBOTIC SYSTEMS APPL, P293; Salmasi H, 2010, ADV ROBOTICS, V24, P2059, DOI 10.1163/016918610X534268; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; SPONG MW, 1987, J DYN SYST-T ASME, V109, P310; Taghirad HD, 1998, J DYN SYST-T ASME, V120, P439, DOI 10.1115/1.2801484; Tan Y., 1999, P AM CONTR C, V4, P2511; Teghirad H. D., 1998, P 1998 IEEE INT C CO, V1, P547, DOI 10.1109/CCA.1998.728527; Tjahjowidodo T, 2007, IEEE ASME INT C ADV, P536, DOI 10.1109/AIM.2007.4412495; Tomizuka M., 1993, P AS PAC WORKSH ADV, P69, DOI 10.1109/APWAM.1993.316194; Wen-Hong Z., 2004, P 43 IEEE C DEC CONT, V3, P2602; Xu L, 2000, P AMER CONTR CONF, P2595, DOI 10.1109/ACC.2000.878676	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-6536	1558-0865		IEEE T CONTR SYST T	IEEE Trans. Control Syst. Technol.	JAN	2015	23	1					164	175		10.1109/TCST.2014.2317776		12	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AX2SN	WOS:000346794600014		
J	Hayati, M; Lotfi, A; Kazimierczuk, MK; Sekiya, H				Hayati, Mohsen; Lotfi, Ali; Kazimierczuk, Marian K.; Sekiya, Hiroo			Generalized Design Considerations and Analysis of Class-E Amplifier for Sinusoidal and Square Input Voltage Waveforms	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Class-E zero-voltage switching and the zero-derivative voltage switching (ZVS/ZDVS) conditions; external linear shunt capacitance; linear gate-drain capacitance; load resistance; nonlinear drain-source capacitance; output power	TUNED POWER-AMPLIFIER; CONVERTER; IMPLEMENTATION; CAPACITANCES; RECTIFIER; OPERATION; SCHEME	In this paper, analytical expressions and design equations are presented for a class-E amplifier with MOSFET nonlinear drain-source capacitance and linear gate-drain parasitic capacitance, along with external linear shunt capacitance. The class-E amplifier characteristics are presented as functions of the ratio of the sum of the external linear shunt capacitance and the MOSFET linear gate-drain capacitance to the MOSFET drain-source junction capacitance when the switch voltage is zero. Although the effect of the MOSFET linear gate-drain capacitance is similar to that of the external linear shunt capacitance on the design of the class-E amplifier with a square input voltage, the difference between their effects should be considered for the sinusoidal input voltage, which is one of the most important suggestions in this paper. Additionally, analytical expressions of the output power capability is given, which is considerably affected by the external linear shunt capacitance. Two design examples are presented, taking into account as design specification the output power of 8.7 W and the operating frequency of 4 MHz, along with the PSpice-simulations and experimental waveforms.	[Hayati, Mohsen; Lotfi, Ali] Razi Univ, Dept Elect Engn, Kermanshah 67149, Iran; [Kazimierczuk, Marian K.] Wright State Univ, Dept Elect Engn, Dayton, OH 45435 USA; [Sekiya, Hiroo] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan	Hayati, M (reprint author), Razi Univ, Dept Elect Engn, Kermanshah 67149, Iran.	mohsen_hayati@yahoo.com; lotfi_electrical@yahoo.com; marian.kazimierczuk@wright.edu; sekiya@faculty.chiba-u.jp					Xi H, 2013, IEEE T IND ELECTRON, V60, P3915, DOI 10.1109/TIE.2012.2206342; Wei XQ, 2011, IEEE T CIRCUITS-I, V58, P2556, DOI 10.1109/TCSI.2011.2123490; Rawat K, 2012, IEEE T IND ELECTRON, V59, P4831, DOI 10.1109/TIE.2011.2176695; Ouyang ZW, 2012, IEEE T IND ELECTRON, V59, P2800, DOI 10.1109/TIE.2010.2046005; Du Y, 2012, IEEE T IND ELECTRON, V59, P4617, DOI 10.1109/TIE.2011.2175669; Sanchez-Ruiz A, 2012, IEEE T IND ELECTRON, V59, P1462, DOI 10.1109/TIE.2011.2162213; Valdez-Fernandez AA, 2013, IEEE T IND ELECTRON, V60, P5019, DOI 10.1109/TIE.2012.2218558; SOKAL NO, 1975, IEEE J SOLID-ST CIRC, VSC10, P168, DOI 10.1109/JSSC.1975.1050582; Zhao BA, 2012, IEEE T IND ELECTRON, V59, P4657, DOI 10.1109/TIE.2011.2181136; Lee IO, 2012, IEEE T IND ELECTRON, V59, P3450, DOI 10.1109/TIE.2011.2170397; Prasanna UR, 2014, IEEE T IND ELECTRON, V61, P1253, DOI 10.1109/TIE.2013.2259784; Nagashima T, 2014, IEEE T IND ELECTRON, V61, P1799, DOI 10.1109/TIE.2013.2267693; Suetsugu T, 2004, IEEE T CIRCUITS-I, V51, P1261, DOI 10.1109/TCSI.2004.830695; KAZIMIERCZUK MK, 1987, IEEE T CIRCUITS SYST, V34, P149, DOI 10.1109/TCS.1987.1086114; RAAB FH, 1977, IEEE T CIRCUITS SYST, V24, P725, DOI 10.1109/TCS.1977.1084296; Fukui K, 2012, IEEE T POWER ELECTR, V27, P3704, DOI 10.1109/TPEL.2012.2184560; Branas C, 2012, IEEE T IND ELECTRON, V59, P1770, DOI 10.1109/TIE.2011.2112322; Chiang JH, 2013, IEEE T IND INFORM, V9, P1322, DOI 10.1109/TII.2012.2227492; Cho SH, 2012, IEEE T IND ELECTRON, V59, P2982, DOI 10.1109/TIE.2011.2170391; Choi DK, 2003, IEEE T CIRCUITS-I, V50, P1556, DOI 10.1109/TCSI.2003.819815; CHUDOBIAK MJ, 1994, IEEE T CIRCUITS-I, V41, P941, DOI 10.1109/81.340867; Hayati M, 2013, IEEE T POWER ELECTR, V28, P5222, DOI 10.1109/TPEL.2013.2247633; Hayati M, 2013, IEEE T POWER ELECTR, V28, P3834, DOI 10.1109/TPEL.2012.2227814; KAZIMIERCZUK MK, 1990, IEEE T IND ELECTRON, V37, P160, DOI 10.1109/41.52966; Kim DY, 2012, IEEE T IND ELECTRON, V59, P3445, DOI 10.1109/TIE.2011.2170395; Liang JR, 2011, IEEE T CIRCUITS-I, V58, P1433, DOI 10.1109/TCSI.2010.2097671; Lin YC, 2012, IEEE T IND ELECTRON, V59, P904, DOI 10.1109/TIE.2011.2158034; Lu WZ, 2014, IEEE T IND ELECTRON, V61, P1516, DOI 10.1109/TIE.2013.2258295; Martinez-Salamero L, 2013, IEEE T IND ELECTRON, V60, P4637, DOI 10.1109/TIE.2012.2210375; Montano JC, 2012, IEEE T IND ELECTRON, V59, P4032, DOI 10.1109/TIE.2011.2174532; Ou SY, 2012, IEEE T IND ELECTRON, V59, P4646, DOI 10.1109/TIE.2011.2181137; Sekiya H, 2008, IEEE T CIRCUITS-I, V55, P3688, DOI 10.1109/TCSI.2008.926288; Zhang GD, 2014, IEEE T IND ELECTRON, V61, P1269, DOI 10.1109/TIE.2013.2257146; Zhou GH, 2012, IEEE T IND ELECTRON, V59, P4851, DOI 10.1109/TIE.2011.2182019	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	JAN	2015	62	1					211	220		10.1109/TIE.2014.2327598		10	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AX2IR	WOS:000346767400023		
J	Sariyildiz, E; Ohnishi, K				Sariyildiz, Emre; Ohnishi, Kouhei			Stability and Robustness of Disturbance-Observer-Based Motion Control Systems	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Disturbance observer (DOB); motion control systems; reaction torque observer (RTOB); robustness and stability	FORCE CONTROL; 2-DEGREE-OF-FREEDOM CONTROL; ROBOT MANIPULATORS; HIGH-PERFORMANCE; DESIGN; VALIDATION; FREEDOM	This paper analyzes the robustness and stability of a disturbance observer (DOB) and a reaction torque observer (RTOB)-based robust motion control systems. Conventionally, a DOB is analyzed by using an ideal velocity measurement that is obtained without using a low-pass filter (LPF); however, it is impractical due to noise constraints. An LPF of velocity measurement changes the robustness of a DOB significantly and puts a new design constraint on the bandwidth of a DOB. An RTOB, which is used to estimate environmental impedance, is an application of a DOB. The stability of an RTOB-based robust force control system has not been reported yet since its oversimplified model is derived by assuming that an RTOB has a feedforward control structure. However, in reality, it has a feedback control structure; therefore, not only the performance but also the stability is affected by the design parameters of an RTOB. A new practical stability analysis method is proposed for an RTOB-based robust force control system. In addition to that, novel and practical design methods, which improve the robustness of a DOB and the stability and performance of an RTOB-based robust force control system, are proposed by using the new analysis methods. The validity of the proposals is verified by simulation and experimental results.	[Sariyildiz, Emre; Ohnishi, Kouhei] Keio Univ, Ohnishi Lab, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan	Sariyildiz, E (reprint author), Keio Univ, Ohnishi Lab, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan.	emre@sum.sd.keio.ac.jp; ohnishi@sd.keio.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25220903, 2013]	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan under Grant-in-Aid for Scientific Research (S), 25220903, 2013.	Shimmyo S, 2013, IEEE T IND ELECTRON, V60, P5137, DOI 10.1109/TIE.2012.2221111; Kobayashi H, 2007, IEEE T IND ELECTRON, V54, P3413, DOI 10.1109/TIE.2007.905948; Yang ZJ, 2012, IEEE T CONTR SYST T, V20, P1357, DOI 10.1109/TCST.2011.2164076; Phuong TT, 2014, IEEE T IND ELECTRON, V61, P994, DOI 10.1109/TIE.2013.2266081; Suzuki A, 2013, IEEE T CONTR SYST T, V21, P882, DOI 10.1109/TCST.2012.2189398; Guvenc BA, 2010, INT J ROBUST NONLIN, V20, P873, DOI 10.1002/rnc.1476; Sariyildiz E, 2015, IEEE-ASME T MECH, V20, P750, DOI 10.1109/TMECH.2014.2321014; Katsura S, 2005, IEEE T IND ELECTRON, V52, P1196, DOI 10.1109/TIE.2005.855699; Ohnishi K, 1996, IEEE-ASME T MECH, V1, P56, DOI 10.1109/3516.491410; Jeon S, 2007, CONTROL ENG PRACT, V15, P325, DOI 10.1016/j.conengprac.2005.10.004; Katsura S, 2007, IEEE T IND ELECTRON, V54, P530, DOI 10.1109/TIE.2006.885459; Shim H, 2009, AUTOMATICA, V45, P296, DOI 10.1016/j.automatica.2008.10.009; Sabanovic A, 2011, IEEE T IND INFORM, V7, P212, DOI 10.1109/TII.2011.2123907; Katsura S, 2008, IEEE T IND ELECTRON, V55, P1699, DOI 10.1109/TIE.2007.907664; Bode H.W., 1945, NETWORK ANAL FEEDBAC; Gradshteyn I. S., 2007, TABLES INTEGRALS SER; Itagaki N, 2008, IEEE-ASME T MECH, V13, P470, DOI 10.1109/TMECH.2008.2000638; Katsura S, 2006, IEEE T IND ELECTRON, V53, P922, DOI 10.1109/TIE.2006.874262; Morari M., 1989, ROBUST PROCESS CONTR; MURAKAMI T, 1993, IEEE T IND ELECTRON, V40, P259, DOI 10.1109/41.222648; Ogata K., 2009, MODERN CONTROL ENG; Ohba Y, 2009, IEEE T IND ELECTRON, V56, P2955, DOI 10.1109/TIE.2009.2024444; Sabanovic A., 2011, ADV MOTION CONTROL; Sariyildiz E, 2013, INT J CONTROL, V86, P1733, DOI 10.1080/00207179.2013.795663; Sariyildiz E, 2013, EUR J CONTROL, V19, P199, DOI 10.1016/j.ejcon.2013.03.009; Sariyildiz E., 2014, T ASME J DYN SYST ME, V136; Tsuji T, 2009, IEEE T IND ELECTRON, V56, P510, DOI 10.1109/TIE.2008.2003208; UMENO T, 1993, IEEE T IND ELECTRON, V40, P473, DOI 10.1109/41.238016; Wai C. H., 2013, IEEE T IND ELECTRON, V60, P139; Yi L, 1999, IEEE-ASME T MECH, V4, P17; Zhou KM, 2001, IEEE T AUTOMAT CONTR, V46, P1613	31	8	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	JAN	2015	62	1					414	422		10.1109/TIE.2014.2327009		9	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AX2IR	WOS:000346767400043		
J	Maeda, Y; Iwasaki, M				Maeda, Yoshihiro; Iwasaki, Makoto			Improvement of Adaptive Property by Adaptive Deadbeat Feedforward Compensation Without Convex Optimization	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Adaptation interval period; adaptive feedforward (FF) compensation; control input amplitude; deadbeat control; fast and precise positioning; resonance frequency fluctuation	PRECISION MOTION CONTROL; ROBUST-CONTROL; DISK-DRIVES; SYSTEMS; MOTORS	This paper presents a novel adaptive feedforward (FF) compensation on the basis of the deadbeat control framework for the fast and precise positioning of high-performance mechatronic systems. Resonance frequency fluctuations in mechanisms generally deteriorate the positioning performance due to temperature variations, age deteriorations, and discrepancies among products. A robust controller design against the fluctuations, therefore, is one of important issues for industrial applications. In this paper, an adaptive deadbeat FF compensation is applied to provide nominal positioning performances under the parameter fluctuations. The proposed approach can adapt the FF compensator with no optimization calculation to shorten the adaptation interval period. In addition, saturation in the control input can be prevented during the adaptive compensation, on the basis of a linear matrix inequality technique. The effectiveness of the proposed approach has been verified by numerical simulations and experiments using a laboratory prototype of a galvano scanner, which is one of typical mechatronic devices for the fast and precise positioning in industrial applications.	[Maeda, Yoshihiro; Iwasaki, Makoto] Nagoya Inst Technol, Dept Comp Sci & Engn, Nagoya, Aichi 4668555, Japan	Maeda, Y (reprint author), Nagoya Inst Technol, Dept Comp Sci & Engn, Nagoya, Aichi 4668555, Japan.	ymaeda@nitech.ac.jp; iwasaki@nitech.ac.jp					Adnan R., 2012, P ICSET BAND IND SEP, P1; Ama S. T., 2013, P IEEE INT C MECH VI, P670; Iwasaki M, 2012, IEEE IND ELECTRON M, V6, P32, DOI 10.1109/MIE.2012.2182859; Wu JH, 2011, IEEE T IND ELECTRON, V58, P4343, DOI 10.1109/TIE.2010.2098363; Yao JY, 2014, IEEE T IND ELECTRON, V61, P3630, DOI 10.1109/TIE.2013.2281165; Na J, 2014, IEEE T IND ELECTRON, V61, P486, DOI 10.1109/TIE.2013.2240635; Kar IN, 2000, IEEE-ASME T MECH, V5, P23; Atsumi T, 2012, IEEE T IND ELECTRON, V59, P521, DOI 10.1109/TIE.2011.2143377; Sun WC, 2013, IEEE T CONTR SYST T, V21, P2417, DOI 10.1109/TCST.2012.2237174; Hu CX, 2011, IEEE T IND ELECTRON, V58, P2454, DOI 10.1109/TIE.2010.2066535; Xia YQ, 2009, IEEE T IND ELECTRON, V56, P3646, DOI 10.1109/TIE.2008.2007987; Yamaguchi T, 1998, IEEE-ASME T MECH, V3, P202, DOI 10.1109/3516.712116; Atsumi T, 2007, IEEE-ASME T MECH, V12, P472, DOI 10.1109/TMECH.2007.901944; Fujimoto H, 2005, IEEE-ASME T MECH, V10, P371, DOI 10.1109/TMECH.2005.852398; Hirata M, 2011, IEEE T MAGN, V47, P1944, DOI 10.1109/TMAG.2011.2127462; Hirose N, 2009, IEEE T IND ELECTRON, V56, P3790, DOI 10.1109/TIE.2009.2025295; Maeda Y., 2011, I ELECT ENG JPN T IN, V131, P403, DOI 10.1541/ieejias.131.403; Yang S., IEEE T IND IN PRESS	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	JAN	2015	62	1					466	474		10.1109/TIE.2014.2331037		9	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AX2IR	WOS:000346767400048		
J	You, DY; Gao, XD; Katayama, S				You, Deyong; Gao, Xiangdong; Katayama, Seiji			WPD-PCA-Based Laser Welding Process Monitoring and Defects Diagnosis by Using FNN and SVM	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						Fault diagnosis; feedforward neural network (FNN); photodiodes; principal component analysis (PCA); process monitoring; support vector machine (SVM); wavelet packet decomposition (WPD)	SEAM TRACKING; NEURAL-NETWORK; ARC PLASMA; RECOGNITION; SYSTEMS	Recent years have seen increasing attention paid to laser welding monitoring. This paper introduces an innovative approach to perform laser welding process monitoring and welded defect diagnosis. The laboratory-scale sensor can be replaced with industrial-scale sensors after the data-driven model has been established by applying multivariate statistics and machine learning methods. In addition, industrial-scale sensor makes effective diagnosis of welded defect by using pattern recognition. Experimental results show that the feature vector affecting estimation and classification accuracy can be obtained by using wavelet packet decomposition principal component analysis. Image processing technology was applied to quantify geometrical parameters of welding process. The feedforward neural network prediction model and the support vector machine classification model built in this research help to guarantee accurate estimation on welding status and effective identification of welded defect. The method proposed by this paper provides an innovative data-driven-based approach for laser welding process monitoring and defects diagnosis.	[You, Deyong; Gao, Xiangdong] Guangdong Univ Technol, Sch Electromech Engn, Guangzhou 510006, Guangdong, Peoples R China; [Katayama, Seiji] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Gao, XD (reprint author), Guangdong Univ Technol, Sch Electromech Engn, Guangzhou 510006, Guangdong, Peoples R China.	gaoxd666@126.com			National Natural Science Foundation of China [51175095]; Natural Science Foundation of Guangdong Province, China [10251009001000001]; Guangdong Provincial Project of Science and Technology Innovation of Discipline Construction, China [2013KJCX0063]	This work was supported in part by the National Natural Science Foundation of China under Grant 51175095, in part by the Natural Science Foundation of Guangdong Province, China, under Grant 10251009001000001, and in part by the Guangdong Provincial Project of Science and Technology Innovation of Discipline Construction, China, under Grant 2013KJCX0063.	Jian L, 2013, IEEE T IND ELECTRON, V60, P3846, DOI 10.1109/TIE.2012.2206336; Ebrahimi BM, 2014, IEEE T IND ELECTRON, V61, P2041, DOI 10.1109/TIE.2013.2263777; Xu QS, 2013, IEEE T IND ELECTRON, V60, P3927, DOI 10.1109/TIE.2012.2206339; Tao DP, 2014, IEEE T IND INFORM, V10, P813, DOI 10.1109/TII.2013.2255061; Yin S, 2014, IEEE T IND ELECTRON, V61, P2402, DOI 10.1109/TIE.2013.2273477; Soualhi A, 2013, IEEE T IND ELECTRON, V60, P4053, DOI 10.1109/TIE.2012.2230598; Gao XD, 2012, IEEE T IND ELECTRON, V59, P4315, DOI 10.1109/TIE.2012.2193854; Han HG, 2014, IEEE T IND ELECTRON, V61, P1970, DOI 10.1109/TIE.2013.2266086; Kong FR, 2012, OPT LASER TECHNOL, V44, P2186, DOI 10.1016/j.optlastec.2012.03.003; Shatnawi Y, 2014, IEEE T IND ELECTRON, V61, P1434, DOI 10.1109/TIE.2013.2261033; Soualhi A, 2014, IEEE T IND ELECTRON, V61, P2864, DOI 10.1109/TIE.2013.2274415; Fang ZJ, 2011, IEEE-ASME T MECH, V16, P540, DOI 10.1109/TMECH.2010.2045766; Huang SC, 2014, IEEE T IND ELECTRON, V61, P2099, DOI 10.1109/TIE.2013.2262764; Yin S, 2014, MECHATRONICS, V24, P298, DOI 10.1016/j.mechatronics.2013.11.009; [Anonymous], 1997, 139191 ISO; Gao XD, 2012, MECHATRONICS, V22, P370, DOI 10.1016/j.mechatronics.2011.09.005; Dadashnialehi A, 2014, IEEE T IND ELECTRON, V61, P1957, DOI 10.1109/TIE.2013.2266085; Yin S, 2012, J PROCESS CONTR, V22, P1567, DOI 10.1016/j.jprocont.2012.06.009; Kim CH, 2012, OPT LASER TECHNOL, V44, P1874, DOI 10.1016/j.optlastec.2012.02.025; Bonaccorso F, 2011, IEEE T IND ELECTRON, V58, P3126, DOI 10.1109/TIE.2011.2114311; Chen MH, 2012, IEEE T PLASMA SCI, V40, P2045, DOI 10.1109/TPS.2012.2199768; Chen MH, 2011, IEEE T PLASMA SCI, V39, P1104, DOI 10.1109/TPS.2011.2109739; Leonardo N, 2012, IEEE INT SYMP CIRC S, P181; Tran D, 2014, IEEE T IND ELECTRON, V61, P2113, DOI 10.1109/TIE.2013.2266084; Tsukamoto S, 2011, SCI TECHNOL WELD JOI, V16, P44, DOI 10.1179/136217110X12785889549949; Wei PS, 2012, IEEE T COMP PACK MAN, V2, P383, DOI 10.1109/TCPMT.2011.2178412; You DY, 2014, SCI TECHNOL WELD JOI, V19, P181, DOI 10.1179/1362171813Y.0000000180; You DY, 2014, OPT LASER ENG, V54, P1, DOI 10.1016/j.optlaseng.2013.09.010; You DY, 2013, NDT&E INT, V60, P32, DOI 10.1016/j.ndteint.2013.07.005	29	5	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0046	1557-9948		IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	JAN	2015	62	1					628	636		10.1109/TIE.2014.2319216		9	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	AX2IR	WOS:000346767400065		
J	Fiori, S; Kaneko, T; Tanaka, T				Fiori, Simone; Kaneko, Tetsuya; Tanaka, Toshihisa			Tangent-Bundle Maps on the Grassmann Manifold: Application to Empirical Arithmetic Averaging	IEEE TRANSACTIONS ON SIGNAL PROCESSING			English	Article						Riemannian geometry; committee machine; subspace analysis; Grassmann manifold; handwritten digit recognition	MEAN SHIFT; SUBSPACE; DISTANCE; DECOMPOSITION; QUANTIZATION; CONSTRAINTS; ALGORITHMS; MATRICES	The present paper elaborates on tangent-bundle maps on the Grassmann manifold, with application to subspace arithmetic averaging. In particular, the present contribution elaborates on the work about retraction/lifting maps devised for the Stiefel manifold in the recently published paper T. Kaneko, S. Fiori and T. Tanaka, "Empirical arithmetic averaging over the compact Stiefel manifold," IEEE Trans. Signal Process., Vol. 61, No. 4, pp. 883-894, February 2013, and discusses the extension of such maps to the Grassmann manifold. Tangent-bundle maps are devised on the basis of the thin QR matrix decomposition, the polar matrix decomposition and the exponential map. Also, tangent-bundle pseudo-maps based on the matrix Cayley transform are devised. Theoretical and numerical comparisons about the devised tangent-bundle maps are performed in order to get an insight into their relative merits and demerits, with special emphasis to their computational burden. The averaging algorithm based on the thin-QR decomposition maps stands out as it exhibits the best trade off between numerical precision and computational burden. Such algorithm is further compared with two Grassmann averaging algorithms drawn from the scientific literature on an handwritten digits recognition data set. The thin-QR tangent-bundle maps-based algorithm exhibits again numerical features that make it preferable over such algorithms.	[Fiori, Simone] Univ Politecn Marche, Dipartimento Ingn Informaz, I-60131 Ancona, Italy; [Kaneko, Tetsuya] Tokyo Univ Agr & Technol TUAT, Lab Signal & Image Proc, Dept Elect & Elect Engn, Koganei, Tokyo 1848588, Japan; [Tanaka, Toshihisa] Tokyo Univ Agr & Technol TUAT, Dept Elect & Elect Engn, Koganei, Tokyo 1848588, Japan	Fiori, S (reprint author), Univ Politecn Marche, Dipartimento Ingn Informaz, I-60131 Ancona, Italy.	s.fiori@univpm.it		Fiori, Simone/0000-0001-5964-7464			Rathinam M, 2003, SIAM J NUMER ANAL, V41, P1893, DOI 10.1137/S0036142901389049; Fan Y, 2011, NEUROIMAGE, V56, P2058, DOI 10.1016/j.neuroimage.2011.03.051; VANLOAN C, 1985, NUMER MATH, V46, P479, DOI 10.1007/BF01389653; Mondal B, 2007, IEEE T SIGNAL PROCES, V55, P4208, DOI 10.1109/TSP.2007.896112; Turaga P, 2011, IEEE T PATTERN ANAL, V33, P2273, DOI 10.1109/TPAMI.2011.52; Dai W, 2008, IEEE T INFORM THEORY, V54, P1108, DOI 10.1109/TIT.2007.915691; Manton JH, 2002, IEEE T SIGNAL PROCES, V50, P635, DOI 10.1109/78.984753; Cetingul HE, 2009, PROC CVPR IEEE, P1896; Srivastava A, 2004, ADV APPL PROBAB, V36, P43, DOI 10.1239/aap/1077134463; Srivastava A, 2002, IEEE T SIGNAL PROCES, V50, P299, DOI 10.1109/78.978385; HENDERSON HV, 1981, SIAM REV, V23, P53, DOI 10.1137/1023004; Besson O, 2011, IEEE T SIGNAL PROCES, V59, P5709, DOI 10.1109/TSP.2011.2166548; Subbarao R, 2009, INT J COMPUT VISION, V84, P1, DOI 10.1007/s11263-008-0195-8; Balzano L., 2010, P ALL C COMM CONTR C, P704; Begelfor E., 2006, P IEEE C COMP VIS PA, V2, P2087, DOI DOI 10.1109/CVPR.2006.50; Chang J.-M., 2011, P 15 INT C IM PROC C, P36; Dong XW, 2014, IEEE T SIGNAL PROCES, V62, P905, DOI 10.1109/TSP.2013.2295553; Edelman A, 1998, SIAM J MATRIX ANAL A, V20, P303, DOI 10.1137/S0895479895290954; Fiori S, 2009, IEEE T SIGNAL PROCES, V57, P4734, DOI 10.1109/TSP.2009.2027754; Fiori S, 2012, IEEE T NEUR NET LEAR, V23, P7, DOI 10.1109/TNNLS.2011.2178561; Fujii K., 2002, J APPL MATH, V2, P371, DOI 10.1155/S1110757X02110163; Gohary RH, 2011, IEEE T SIGNAL PROCES, V59, P1303, DOI 10.1109/TSP.2010.2094615; Gruber P., 2006, 14 EUR SIGN PROC C E; Hastie T., 2001, ELEMENTS STAT LEARNI; HIGHAM NJ, 1990, SIAM J SCI STAT COMP, V11, P648, DOI 10.1137/0911038; Kaneko T, 2013, IEEE T SIGNAL PROCES, V61, P883, DOI 10.1109/TSP.2012.2226167; Kuybeda O, 2010, IEEE T SIGNAL PROCES, V58, P544, DOI 10.1109/TSP.2009.2032580; Lawson JD, 2001, AM MATH MON, V108, P797, DOI 10.2307/2695553; Lui Y. M., 2008, P EUR C COMP VIS PAL; Marks J., 2013, UNPUB; Meyer C., 2000, MATRIX ANAL APPL LIN; Mishra B., 2013, FIXED RANK MATRIX FA; Mittal S, 2012, IMAGE VISION COMPUT, V30, P417, DOI 10.1016/j.imavis.2011.09.005; Ngo T.T., 2012, ADV NEURAL INFORM PR, V25, P1421; Nowicki D., 2005, EUR S ART NEUR NETW; Sun XC, 2006, LECT NOTES COMPUT SC, V4142, P81; Suryanto CH, 2012, LECT NOTES COMPUT SC, V7632, P71, DOI 10.1007/978-3-642-34123-6_7; Trefethen L. N., 1997, NUMERICAL LINEAR ALG; Van Loan C. F., 1996, MATRIX COMPUTATIONS; Washizawa Y, 2014, IEEE T NEUR NET LEAR, V25, P1980, DOI 10.1109/TNNLS.2014.2301178; Xu WY, 2008, 2008 46TH ANNUAL ALLERTON CONFERENCE ON COMMUNICATION, CONTROL, AND COMPUTING, VOLS 1-3, P562, DOI 10.1109/ALLERTON.2008.4797608	41	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1053-587X	1941-0476		IEEE T SIGNAL PROCES	IEEE Trans. Signal Process.	JAN 1	2015	63	1					155	168		10.1109/TSP.2014.2365764		14	Engineering, Electrical & Electronic	Engineering	AX0GK	WOS:000346630900013		
J	Nagai, S; Saitoh, TM; Nasahara, KN; Suzuki, R				Nagai, Shin; Saitoh, Taku M.; Nasahara, Kenlo Nishida; Suzuki, Rikie			Spatio-temporal distribution of the timing of start and end of growing season along vertical and horizontal gradients in Japan	INTERNATIONAL JOURNAL OF BIOMETEOROLOGY			English	Article						Leaf-expansion; Leaf-fall; Deciduous forests; Horizontal gradient; Vertical gradient	DECIDUOUS BROADLEAF FOREST; GROUND-BASED PHENOLOGY; GINKGO-BILOBA L.; CLIMATE-CHANGE; TIME-SERIES; MONITORING VEGETATION; LEAF LONGEVITY; SATELLITE DATA; INDEX; TEMPERATURE	We detected the spatio-temporal variability in the timing of start (SGS) and end of growing season (EGS) in Japan from 2003 to 2012 by analyzing satellite-observed daily green-red vegetation index with a 500-m spatial resolution. We also examined the characteristics of SGS and EGS timing in deciduous broadleaf and needleleaf forests along vertical and horizontal gradients and then evaluated the relationship between their timing and daily mean air temperature. We found that for the timing of SGS and EGS, changes along the vertical gradient in deciduous broadleaf forest tended to be larger than those in deciduous needleleaf forest. For both forest types, changes along the vertical and horizontal gradients in the timing of EGS tended to be smaller than those of SGS. Finally, in both forest types, the sensitivity of the timing of EGS to air temperature was much less than that of SGS. These results suggest that the spatio-temporal variability in the timing of SGS and EGS detected by satellite data, which may be correlated with leaf traits, photosynthetic capacity, and environment conditions, provide useful ground-truthing information along vertical and horizontal gradients.	[Nagai, Shin; Suzuki, Rikie] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Saitoh, Taku M.] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan; [Nasahara, Kenlo Nishida] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Nagai, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	nagais@jamstec.go.jp	Nagai, Shin/G-9902-2011		Environment Research and Technology Development Fund of the Ministry of the Environment of Japan [S-9]; KAKENHI by JSPS [24710021, 23710005]; Centre for Environmental Remote Sensing, Chiba University	We thank the NASA Land Processes Distributed Active Archive Center in the Earth Observing System Data Gateway for providing the MODIS data. We thank the editor and the two anonymous reviewers for their kind and constructive comments. This work was supported by the Environment Research and Technology Development Fund (S-9; to S. Nagai and R. Suzuki) of the Ministry of the Environment of Japan, by KAKENHI (24710021 and 23710005; Grant-in-Aid for Young Scientists B by JSPS to S. Nagai and T. M. Saitoh), and by the Centre for Environmental Remote Sensing, Chiba University (to S. Nagai and R. Suzuki). We are grateful to Yusuke Onoda (Kyoto University) for his valuable discussions.	Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Delbart N, 2005, REMOTE SENS ENVIRON, V97, P26, DOI 10.1016/j.rse.2005.03.011; Doi H, 2012, INT J BIOMETEOROL, V56, P895, DOI 10.1007/s00484-011-0495-5; Chen XQ, 2012, INT J BIOMETEOROL, V56, P695, DOI 10.1007/s00484-011-0471-0; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Nagai S, 2010, AGR FOREST METEOROL, V150, P152, DOI 10.1016/j.agrformet.2009.09.010; Guyon D, 2011, REMOTE SENS ENVIRON, V115, P615, DOI 10.1016/j.rse.2010.10.006; VIOVY N, 1992, INT J REMOTE SENS, V13, P1585; Doi H, 2008, GLOBAL ECOL BIOGEOGR, V17, P556, DOI 10.1111/j.1466-8238.2008.00398.x; Kikuzawa K, 1995, VEGETATIO, V121, P89, DOI 10.1007/BF00044675; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; Shutova E, 2006, INT J BIOMETEOROL, V51, P155, DOI 10.1007/s00484-006-0042-y; Kikuzawa K, 2013, GLOBAL ECOL BIOGEOGR, V22, P982, DOI 10.1111/geb.12042; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Studer S, 2007, INT J BIOMETEOROL, V51, P405, DOI 10.1007/s00484-006-0080-5; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Motohka T, 2010, REMOTE SENS-BASEL, V2, P2369, DOI 10.3390/rs2102369; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; DORMAN JL, 1989, J APPL METEOROL, V28, P833, DOI 10.1175/1520-0450(1989)028<0833:AGCOAR>2.0.CO;2; Barichivich J, 2013, GLOBAL CHANGE BIOL, V19, P3167, DOI 10.1111/gcb.12283; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Nagai S, 2013, SOLA, V9, P106, DOI 10.2151/sola.2013-024; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Stockli R, 2004, INT J REMOTE SENS, V25, P3303, DOI 10.1080/01431160310001618149; Ogawa-Onishi Y, 2013, BIOL CONSERV, V157, P361, DOI 10.1016/j.biocon.2012.06.024; Zhang XY, 2011, REMOTE SENS ENVIRON, V115, P382, DOI 10.1016/j.rse.2010.09.009; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Matsumoto K, 2003, GLOBAL CHANGE BIOL, V9, P1634, DOI 10.1046/j.1529-8817.2003.00688.x; Schwartz MD, 2002, INT J CLIMATOL, V22, P1793, DOI 10.1002/joc.819; Chen XQ, 2012, AGR FOREST METEOROL, V154, P195, DOI 10.1016/j.agrformet.2011.11.006; Rosenthal SI, 1997, TREE PHYSIOL, V17, P767; [Anonymous], 2010, GLOBAL BIODIVERSITY; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Schwartz MD, 2013, AGR FOREST METEOROL, V169, P136, DOI 10.1016/j.agrformet.2012.10.014; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; Chen XQ, 2013, REMOTE SENS LETT, V4, P532, DOI 10.1080/2150704X.2013.764473; Chuine I, 2003, PLANT DEV MODELS PHE; Hadano M, 2013, ECOL EVOL, V3, P1798, DOI 10.1002/ece3.575; Luo XZ, 2013, REMOTE SENS-BASEL, V5, P845, DOI 10.3390/rs5020845; Matsumoto K, 2010, INT J CLIMATOL, V30, P1280, DOI 10.1002/joc.1969; Muraoka H., 2012, BIODIVERSITY OBSERVA, P277; Nagai S., 2011, Forest Science and Technology, V7, P174; Natural Environmental Information GIS, 1999, NAT SURV NAT ENV 5 S; Okuda H, 2003, ENV ENG RES, V40, P257; Osada N., 2013, Japanese Journal of Ecology, V63, P19; Piao SL, 2012, AGR FOREST METEOROL, V151, P1599; Suzuki K, 2013, J GEOGR, V122, P553; Suzuki Keisuke, 2008, Japanese Journal of Ecology (Otsu), V58, P175; Tadaki Yoshiya, 1994, Japanese Journal of Ecology (Sendai), V44, P305; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Ueno K., 2013, J GEOGR, V122, P638; KLOEKE AEE, 2012, GLOBAL ECOLOGY BIOGE, V0021; Yamamoto M, 2006, J JPN SOC REVEGETATI, V32, P112; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	59	3	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0020-7128	1432-1254		INT J BIOMETEOROL	Int. J. Biometeorol.	JAN	2015	59	1					47	54		10.1007/s00484-014-0822-8		8	Biophysics; Environmental Sciences; Meteorology & Atmospheric Sciences; Physiology	Biophysics; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Physiology	AX0JD	WOS:000346637800005		
J	Sueoka, K; Umayahara, K; Abe, A; Usami, T; Yamamoto, A; Nomura, H; Matoda, M; Okamoto, S; Omatsu, K; Kondo, E; Kato, K; Takeshima, N				Sueoka, Kotaro; Umayahara, Kenji; Abe, Akiko; Usami, Tomoka; Yamamoto, Akiko; Nomura, Hidetaka; Matoda, Maki; Okamoto, Sanshiro; Omatsu, Kohei; Kondo, Eiji; Kato, Kazuyoshi; Takeshima, Nobuhiro			Prognosis for Endometrial Cancer Patients Treated With Systematic Pelvic and Para-Aortic Lymphadenectomy Followed by Platinum-Based Chemotherapy	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Endometrial cancer; Prognosis; Systematic pelvic and para-aortic lymphadenectomy; Lymph node metastasis	LYMPH-NODE METASTASIS; CLEAR-CELL CARCINOMAS; UTERINE-CANCER; CORPUS CANCER; SURVIVAL; TRIAL	Objective: The purpose of this study was to analyze the prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy (PLA and PALA) followed by platinum-based chemotherapy. Materials and Methods: From 1994 to 2004, in the Cancer Institute Hospital, 502 patients who were surgically treated with systematic PLA and PALA were enrolled in this study. Their prognosis and clinicopathological features were retrospectively reviewed. Results: One hundred ninety-one (38.0%) patients received adjuvant platinum-based chemotherapy. Lymph node (LN) metastasis was observed in 80 (15.9%) patients, pelvic-only LN metastasis in 27 (5.4%), para-aortic-only LN metastasis in 15 (3.0%), and both pelvic and para-aortic LN metastasis in 38 (7.6%). The median number of metastatic LNs was 2 (range, 1-57), 1 (range, 1-4), and 6 (range, 2-50) in patients with pelvic-only, para-aortic-only, and both pelvic and para-aortic LN metastasis, respectively (P < 0.001). Only 2.6% (2/76) of patients with no myometrial invasion had LN metastasis, and no less than 8.9% (22/247) of patients with myometrial invasion (limited to the inner half) had LN metastasis. Five-year overall survival (OS) for LN metastasis-negative and -positive patients was 96.7% and 76% (P < 0.001), respectively. Five-year OS for patients with metastasis in 1 or 2 LNs was 84.8% and was significantly higher than that for patients with metastasis in 3 or more LNs (57.8%; P = 0.011). In patients with LN metastasis, 5-year OS of endometrioid adenocarcinoma and non-endometrioid adenocarcinoma cell types was 90.2% and 56.7% (P = 0.0016), respectively. Conclusions: Under the settings of thorough PLA and PALA followed by intensive platinum-based chemotherapy for endometrial cancer, metastasis in 1 or 2 LNs seems to have little effect on survival, although para-aortic LNs are involved. This therapeutic strategy could not improve the prognosis of patients with metastasis in 3 or more LNs or patients with non-endometrioid adenocarcinoma cell types along with LN involvement.	[Sueoka, Kotaro; Umayahara, Kenji; Abe, Akiko; Usami, Tomoka; Yamamoto, Akiko; Nomura, Hidetaka; Matoda, Maki; Okamoto, Sanshiro; Omatsu, Kohei; Kondo, Eiji; Kato, Kazuyoshi; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Tokyo, Japan	Sueoka, K (reprint author), Yamaguchi Univ, Dept Obstet & Gynecol, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	suekouta@yamaguchi-u.ac.jp					AlHilli MM, 2013, GYNECOL ONCOL, V131, P103, DOI 10.1016/j.ygyno.2013.06.037; AlHilli MM, 2013, INT J CLIN ONCOL, V18, P193, DOI 10.1007/s10147-013-0528-7; Kang S, 2012, J CLIN ONCOL, V30, P1329, DOI 10.1200/JCO.2011.38.2416; Mariani A, 2000, AM J OBSTET GYNECOL, V182, P1506, DOI 10.1067/mob.2000.107335; Chan JK, 2006, CANCER, V107, P1823, DOI 10.1002/cncr.22185; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Ayeni TA, 2013, GYNECOL ONCOL, V129, P478, DOI 10.1016/j.ygyno.2013.03.011; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Huang CY, 2013, EJSO-EUR J SURG ONC, V39, P350, DOI 10.1016/j.ejso.2013.01.002; Chang SJ, 2008, ACTA OBSTET GYN SCAN, V87, P1361, DOI 10.1080/00016340802503054; Chan JK, 2007, LANCET ONCOL, V8, P831, DOI 10.1016/S1470-2045(07)70275-9; Odagiri T, 2014, ANN SURG ONCOL, V21, P2755, DOI 10.1245/s10434-014-3663-0; Kim HS, 2012, JPN J CLIN ONCOL, V42, P405, DOI 10.1093/jjco/hys019; Lee KB, 2009, ANN SURG ONCOL, V16, P2882, DOI 10.1245/s10434-009-0535-0; Garg G, 2011, INT J GYNECOL CANCER, V21, P1606, DOI 10.1097/IGC.0b013e31822265ad; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Scarfone G, 2013, ARCH GYNECOL OBSTET, V287, P351, DOI 10.1007/s00404-012-2586-x; Chan JK, 2007, CANCER, V109, P2454, DOI 10.1002/cncr.22727; Chi DS, 2008, INT J GYNECOL CANCER, V18, P269, DOI 10.1111/j.1525-1438.2007.00996.x; Aoki D, 2014, J OBSTET GYNAECOL RE, V40, P338, DOI 10.1111/jog.12360; Panici PB, 2008, J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Brown AP, 2013, INT J GYNECOL CANCER, V23, P861, DOI 10.1097/IGC.0b013e3182915c3e; Cooke EW, 2011, CANCER-AM CANCER SOC, V117, P4231, DOI 10.1002/cncr.26030; Garg G, 2011, GYNECOL ONCOL, V123, P208, DOI 10.1016/j.ygyno.2011.07.025; Johnson N, 2011, COCHRANE DB SYST REV, V10; Kato T, 2012, J SURG ONCOL, V106, P938, DOI 10.1002/jso.23203; May T, 2013, INT J SURG ONCOL, V2013, P1; Panici PB, 1998, INT J GYNECOL CANCER, V8, P322; Todo Y, 2011, GYNECOL ONCOL, V121, P126, DOI 10.1016/j.ygyno.2010.12.001; Watari H, 2009, INT J GYNECOL CANCER, V19, P1585, DOI 10.1111/IGC.0b013e3181a833cc	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	JAN	2015	25	1					81	86		10.1097/IGC.0000000000000268		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX2HG	WOS:000346763500014		
J	Otsuki, A; Watanabe, Y; Nomura, H; Futagami, M; Yokoyama, Y; Shibata, K; Kamoi, S; Arakawa, A; Nishiyama, H; Katsuta, T; Kudaka, W; Shimada, M; Sato, N; Kotera, K; Katabuchi, H; Yaegashi, N				Otsuki, Ai; Watanabe, Yoh; Nomura, Hiroyuki; Futagami, Masayuki; Yokoyama, Yoshihito; Shibata, Kiyosumi; Kamoi, Seiryu; Arakawa, Atsushi; Nishiyama, Hiroshi; Katsuta, Takahiro; Kudaka, Wataru; Shimada, Muneaki; Sato, Naoki; Kotera, Kouhei; Katabuchi, Hidetaka; Yaegashi, Nobuo			Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Uterine carcinosarcoma; Adjuvant chemotherapy; Phase II trial	ONCOLOGY-GROUP; IFOSFAMIDE; EXPERIENCE; CISPLATIN; CANCER; TUMORS; STAGE	Objective: This study aimed to evaluate the efficacy of paclitaxel and carboplatin in patients with completely or optimally resected uterine carcinosarcoma. Materials and Methods: We conducted a single-arm multicenter prospective phase II trial at 20 Japanese medical facilities. Eligible patients had histologically confirmed uterine carcinosarcoma without prior chemotherapy or radiotherapy. Patients received 6 courses of 175 mg/m(2) paclitaxel over 3 hours, followed by a 30-minute intravenous administration of carboplatin at an area under the serum concentration-time curve of 6. Results: A total of 51 patients were enrolled in this study, 48 of whom underwent complete resection and 3 of whom underwent optimal resection. At 2 years, the progression-free survival and overall survival rates were 78.2% (95% confidence interval [CI], 64.1%-87.3%) and 87.9% (95% CI, 75.1%-94.4%), respectively. At 4 years, these rates were 67.9% (95% CI, 53.0%-79.0%) and 76.0% (95% CI, 60.5%-86.1%), respectively. Although 15 patients showed disease recurrence during the follow-up period (median, 47.8 months; range, 2.1-72.8 months), a total of 40 (78.4%) patients completed the 6 courses of treatment that had been planned. Conclusions: The combination of paclitaxel and carboplatin was a feasible and effective postoperative adjuvant therapy for patients with completely or optimally resected uterine carcinosarcoma.	[Otsuki, Ai; Watanabe, Yoh; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Watanabe, Yoh] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Dept Clin Res Network, Sendai, Miyagi 9808574, Japan; [Nomura, Hiroyuki] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Futagami, Masayuki; Yokoyama, Yoshihito] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan; [Shibata, Kiyosumi] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kamoi, Seiryu] Nippon Med Sch Chiba Hokusoh Hosp, Dept Obstet & Gynecol, Chiba, Japan; [Arakawa, Atsushi] Nagoya City Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi, Japan; [Nishiyama, Hiroshi] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan; [Katsuta, Takahiro] Fukuoka Univ Hosp, Dept Obstet & Gynecol, Fukuoka, Japan; [Kudaka, Wataru] Univ Ryukyus, Grad Sch Med Sci, Dept Obstet & Gynecol, Okinawa, Japan; [Shimada, Muneaki] Tottori Univ, Sch Med, Dept Obstet & Gynecol, Yonago, Tottori 683, Japan; [Sato, Naoki] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Kotera, Kouhei] Nagasaki Harbour Med Ctr City Hosp, Dept Obstet & Gynecol, Nagasaki, Japan; [Katabuchi, Hidetaka] Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Kumamoto, Japan	Watanabe, Y (reprint author), Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Dept Clin Res Network, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	watanabe@med.tohoku.ac.jp					Ang JE, 2009, ANN ONCOL, V20, P1787, DOI 10.1093/annonc/mdp193; Lacour RA, 2011, INT J GYNECOL CANCER, V21, P517, DOI 10.1097/IGC.0b013e31820da9e2; Sutton G, 2005, GYNECOL ONCOL, V96, P630, DOI 10.1016/j.ygyno.2004.11.022; Hoskins PJ, 2008, GYNECOL ONCOL, V108, P58, DOI 10.1016/j.ygyno.2007.08.084; Powell MA, 2010, J CLIN ONCOL, V28, P2727, DOI 10.1200/JCO.2009.26.8326; Homesley HD, 2007, J CLIN ONCOL, V25, P526, DOI 10.1200/JCO.2006.06.4907; Sutton G, 2000, GYNECOL ONCOL, V79, P147, DOI 10.1006/gyno.2000.6001; Toyoshima M, 2004, GYNECOL ONCOL, V94, P774, DOI 10.1016/j.ygyno.2004.05.048; Galaal K, 2013, COCHRANE DB SYST REV, V2; Matsuo K, 2010, AM J CLIN ONCOL-CANC, V33, P358, DOI 10.1097/COC.0b013e3181af30d3; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Takano T, 2014, INT J CLIN ONCOL, V19, P1052, DOI 10.1007/s10147-013-0658-y	12	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	JAN	2015	25	1					92	97		10.1097/IGC.0000000000000302		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX2HG	WOS:000346763500016		
J	Minami, A; Nakanishi, A; Matsuda, S; Kitagishi, Y; Ogura, Y				Minami, Akari; Nakanishi, Atsuko; Matsuda, Satoru; Kitagishi, Yasuko; Ogura, Yasunori			Function of alpha-synuclein and PINK1 in Lewy body dementia	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						alpha-synuclein; phosphatase and tensin homologue-induced putative kinase 1; Parkin; mitochondria; Lewy body dementia	PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; PROTEIN STABILITY; OXIDATIVE STRESS; QUALITY-CONTROL; IN-VIVO; AUTOPHAGY; AGGREGATION; PATHOLOGY; TOXICITY	alpha-synuclein (-syn) is the major protein component of Lewy bodies, a key pathological characteristic of the degenerating brain. The misfolding and aggregation of -syn is associated with both the idiopathic and familial forms of Parkinson's disease (PD) and Lewy body dementia (LBD). However, the function of -syn is poorly understood, as it shows both neurotoxic and neuroprotective activities. Mutations in phosphatase and tensin homologue-induced putative kinase 1 (PINK1) also cause recessively inherited PD. Studies support the notion of neuroprotective roles for PINK1, as it protects cells from damage-induced mitochondrial dysfunction, oxidative stress and cell apoptosis. PINK1 plays an essential role in mitochondrial quality control and its homeostasis is maintained through mitochondrial stabilization. The -syn aggregation is linked to various aspects of mitochondrial dysfunction and PINK1-related mitophagy. Determination of the molecular pathways that lead to -syn oligomerization and further aggregation may be the basis for the successful design and development of treatments for these neurodegenerative diseases. The present review summarizes the function of PINK1 underlying -syn aggregation and the mechanisms through which mitochondrial dysfunction plays a role in this process.	[Minami, Akari; Nakanishi, Atsuko; Matsuda, Satoru; Kitagishi, Yasuko; Ogura, Yasunori] Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan	Matsuda, S (reprint author), Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan.	smatsuda@cc.nara-wu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	The present review was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Robinson PA, 2008, BIOCHEM J, V413, P1, DOI 10.1042/BJ20080295; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Di Giovanni S, 2010, J BIOL CHEM, V285, P14941, DOI 10.1074/jbc.M109.080390; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Wilhelmus MMM, 2012, FREE RADICAL BIO MED, V53, P983, DOI 10.1016/j.freeradbiomed.2012.05.040; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Wilkaniec A, 2013, NEUROCHEM INT, V62, P776, DOI 10.1016/j.neuint.2013.02.004; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Song JX, 2014, AUTOPHAGY, V10, P144, DOI 10.4161/auto.26751; Todd AM, 2008, GENOME, V51, P1040, DOI 10.1139/G08-085; Sampaio-Marques B, 2012, AUTOPHAGY, V8, P1494, DOI 10.4161/auto.21275; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Goldstein DS, 2011, J CLIN INVEST, V121, P3320, DOI 10.1172/JCI45803; Walker LC, 2012, J BIOL CHEM, V287, P33109, DOI 10.1074/jbc.R112.399378; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Onofrj M, 2010, NEUROLOGY, V74, P1598, DOI 10.1212/WNL.0b013e3181df09dd; Hong L, 1998, NEUROREPORT, V9, P1239, DOI 10.1097/00001756-199804200-00051; Eid N, 2013, J MOL HISTOL, V44, P311, DOI 10.1007/s10735-013-9483-x; Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Cheng FR, 2011, J NEUROCHEM, V119, P815, DOI 10.1111/j.1471-4159.2011.07460.x; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Muller SK, 2013, NEUROBIOL AGING, V34, P2231, DOI 10.1016/j.neurobiolaging.2013.03.016; Dryanovski DI, 2013, J NEUROSCI, V33, P10154, DOI 10.1523/JNEUROSCI.5311-12.2013; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Eckert GP, 2010, PHARMACOL RES, V61, P234, DOI 10.1016/j.phrs.2010.01.005; Bornhorst J, 2014, METALLOMICS, V6, P476, DOI 10.1039/c3mt00325f; Braak H, 2006, J NEURAL TRANSM-SUPP, P89; Matsuda S, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/601587; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Das S, 2014, OXID MED CELL LONGEV, DOI 10.1155/2014/345105; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Chai YJ, 2013, FEBS LETT, V587, P452, DOI 10.1016/j.febslet.2013.01.008; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Villegas I, 2008, MOL NUTR FOOD RES, V52, P1040, DOI 10.1002/mnfr.200700280; Isella V, 2013, J NEUROL, V260, P1099, DOI 10.1007/s00415-012-6767-0; Tamura T, 2012, NEUROPATHOLOGY, V32, P13, DOI 10.1111/j.1440-1789.2011.01211.x; Schwarz S, 2012, CURR OPIN PSYCHIATR, V25, P542, DOI 10.1097/YCO.0b013e328358e4f2; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Blackinton JG, 2007, BRAIN RES, V1184, P10, DOI 10.1016/j.brainres.2007.09.056; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Funabe S, 2013, NEUROPATHOLOGY, V33, P47, DOI 10.1111/j.1440-1789.2012.01329.x; Giordano S., 2013, REDOX BIOL, V2, P82, DOI DOI 10.1016/J.REDOX.2013.12.013; Girish C, 2012, NEUROTOXICOLOGY, V33, P444, DOI 10.1016/j.neuro.2012.04.002; Hajjar T, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-109; Israeli E, 2009, J NEUROCHEM, V108, P465, DOI 10.1111/j.1471-4159.2008.05776.x; Jensen PH, 1997, BIOCHEM J, V323, P539; Kones R, 2010, NUTR CLIN PRACT, V25, P371, DOI 10.1177/0884533610373932; Lee J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-72; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; Luk KC, 2007, BIOCHEMISTRY-US, V46, P12522, DOI 10.1021/bi701128c; Matus S, 2014, AUTOPHAGY, V10, P710, DOI 10.4161/auto.28434; Murakami T, 2007, J NEUROL NEUROSUR PS, V78, P653, DOI 10.1136/jnnp.2006.100123; Pabon MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045256; Paleologou Katerina E, 2012, Subcell Biochem, V65, P109, DOI 10.1007/978-94-007-5416-4_6; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Schapira A. H., 2011, PARKINSONS DIS, V2011; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6; Wakabayashi K, 1999, NEUROPATH APPL NEURO, V25, P363	77	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JAN	2015	35	1					3	9		10.3892/ijmm.2014.1980		7	Medicine, Research & Experimental	Research & Experimental Medicine	AX0MW	WOS:000346647300001		
J	Tokuhira, N; Kitagishi, Y; Suzuki, M; Minami, A; Nakanishi, A; Ono, Y; Kobayashi, K; Matsuda, S; Ogura, Y				Tokuhira, Nana; Kitagishi, Yasuko; Suzuki, Miho; Minami, Akari; Nakanishi, Atsuko; Ono, Yuna; Kobayashi, Keiko; Matsuda, Satoru; Ogura, Yasunori			PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						Crohn's disease; nucleotide-binding oligomerization domain-containing protein 2; phosphatidylinositol 3-kinase; AKT; mammalian target of rapamycin; phosphatase and tensin homolog; inflammation	POLYUNSATURATED FATTY-ACIDS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; WORMWOOD ARTEMISIA-ABSINTHIUM; INFLAMMATORY-BOWEL-DISEASE; KAPPA-B ACTIVATION; MULTIDRUG-RESISTANCE; CELL PROLIFERATION; SIGNALING PATHWAYS; INSULIN-RESISTANCE; IMMUNE-RESPONSES	The pathogenesis of inflammatory bowel disease (IBD), including Crohn's disease, is a subject of increasing interest. Loss-of-function mutations in nucleotide-binding oligomerization domain-containing protein 2 (NOD2) are strong genetic factors linked to Crohn's disease, which eventually leads to an excessive mucosal inflammatory response directed against components of normal gut microbiota. Reactive oxygen species (ROS) play an important role in inflammation processes, as well as in transduction of signals from receptors for several cytokines, such as tumor necrosis factor (TNF). ROS activate nuclear factor-B (NF-B) via IB kinase (IKK) through the PI3K/AKT/PTEN pathway. Therefore, this pathway is recognized to play a key role in Crohn's disease. Loss of function has been demonstrated to occur as an early event in a wide variety of diseases. Given this prevalent involvement in a number of diseases, the molecular development that modulates this pathway has been the subject of several studies. In addition, it has been the focus of extensive research and drug discovery activities. A better understanding of the molecular assemblies may reveal novel targets for the therapeutic development against Crohn's disease.	[Tokuhira, Nana; Kitagishi, Yasuko; Suzuki, Miho; Minami, Akari; Nakanishi, Atsuko; Ono, Yuna; Kobayashi, Keiko; Matsuda, Satoru; Ogura, Yasunori] Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan	Matsuda, S (reprint author), Nara Womens Univ, Dept Food Sci & Nutr, Nara 6308506, Japan.	smatsuda@cc.nara-wu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	This study was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Alvarado Y, 2011, TARGET ONCOL, V6, P69, DOI 10.1007/s11523-011-0178-5; Terra X, 2011, FREE RADICAL RES, V45, P611, DOI 10.3109/10715762.2011.564165; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Husain N, 2013, J CLIN GASTROENTEROL, V47, P246, DOI 10.1097/MCG.0b013e3182582cdb; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Omer B, 2007, PHYTOMEDICINE, V14, P87, DOI 10.1016/j.phymed.2007.01.001; Nauroth JM, 2010, LIPIDS, V45, P375, DOI 10.1007/s11745-010-3406-3; Chanoit G, 2008, AM J PHYSIOL-HEART C, V295, pH1227, DOI 10.1152/ajpheart.00610.2008; Park S, 2014, EUR J PHARMACOL, V735, P184, DOI 10.1016/j.ejphar.2014.04.024; Yo YT, 2009, J AGR FOOD CHEM, V57, P8266, DOI 10.1021/jf901054c; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Zhao L, 2008, BIOCHEM PHARMACOL, V75, P1515, DOI 10.1016/j.bcp.2007.12.014; Son JE, 2013, PLANTA MED, V79, P1009, DOI 10.1055/s-0033-1350621; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Johnson SE, 2008, J IMMUNOL, V180, P8109; Taschuk Ryan, 2012, Animal Health Research Reviews, V13, P129, DOI 10.1017/S1466252312000096; Liao XH, 2010, J CELL SCI, V123, P983, DOI 10.1242/jcs.064022; Krebs S, 2010, PHYTOMEDICINE, V17, P305, DOI 10.1016/j.phymed.2009.10.013; Albiges L, 2012, ANN ONCOL, V23, P1943, DOI 10.1093/annonc/mds115; van Lent AU, 2013, DIGEST DIS, V31, P222, DOI 10.1159/000353374; Hales EC, 2014, CELL SIGNAL, V26, P149, DOI 10.1016/j.cellsig.2013.09.021; Zhang Z, 2011, INT J CARDIOL, V153, P14, DOI 10.1016/j.ijcard.2010.08.024; Bartolome A, 2010, ENDOCRINOLOGY, V151, P3084, DOI 10.1210/en.2010-0048; Kirkegaard T, 2010, HISTOPATHOLOGY, V56, P203, DOI 10.1111/j.1365-2559.2009.03467.x; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Kong D, 2009, CURR MED CHEM, V16, P2839; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Liu HQ, 2013, NUTR RES, V33, P849, DOI 10.1016/j.nutres.2013.07.004; Bassaganya-Riera J, 2012, CLIN NUTR, V31, P721, DOI 10.1016/j.clnu.2012.03.002; Massey DCO, 2008, GUT, V57, P1294, DOI 10.1136/gut.2008.157297; Nepal S, 2013, INFLAMM BOWEL DIS, V19, P1518, DOI 10.1097/MIB.0b013e3182813365; Cromer WE, 2011, WORLD J GASTROENTERO, V17, P578, DOI 10.3748/wjg.v17.i5.578; Aggarwal BB, 2013, BRIT J PHARMACOL, V169, P1672, DOI 10.1111/bph.12131; Guo YA, 2013, MOL CANCER RES, V11, P467, DOI 10.1158/1541-7786.MCR-12-0605; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Kuehn HS, 2008, J IMMUNOL, V181, P7706; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Tamrakar AK, 2010, ENDOCRINOLOGY, V151, P5624, DOI 10.1210/en.2010-0437; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Korbecki J, 2013, J PHYSIOL PHARMACOL, V64, P409; Liu H, 2008, EUR J PHARMACOL, V591, P43, DOI 10.1016/j.ejphar.2008.06.026; Blandizzi C, 2014, INT J IMMUNOPATHO S1, V27, pS1; Brand C, 2006, BIOCHEM BIOPH RES CO, V349, P954, DOI 10.1016/j.bbrc.2006.08.100; Burke JP, 2011, INFLAMM BOWEL DIS, V17, P1665, DOI 10.1002/ibd.21543; Cenit MC, 2014, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbadis.2014.05.02324882755, DOI 10.1016/J.BBADIS.2014.05.02324882755]; Chen Y, 2006, J CELL BIOCHEM, V98, P1021, DOI 10.1002/jcb.20839; de Boer Nanne Kh, 2014, Clin Exp Gastroenterol, V7, P83, DOI 10.2147/CEG.S47627; Downes CP, 2007, BIOCHEM SOC SYMP, V74, P69; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Fontani F, 2014, EXP CELL RES, V323, P77, DOI 10.1016/j.yexcr.2014.02.019; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055468; Gross ER, 2005, AM J PHYSIOL-HEART C, V288, pH2744, DOI 10.1152/ajpheart.00918.2004; Hodgkinson CP, 2002, BIOCHEMISTRY-US, V41, P10351, DOI 10.1021/bi026065r; Huang SL, 2012, CELL CYCLE, V11, P844, DOI [10.4161/cc.11.5.19598, 10.4161/cc.11.3.19096]; Imai Y., 2012, CLIN TRANSL MED, V1, P1, DOI DOI 10.1186/2001-1326-1-24; Irie T, 2004, PATHOL INT, V54, P850, DOI 10.1111/j.1440-1827.2004.01768.x; Jacot JL, 2011, J OPHTHALMOLOGY, V2011, DOI 10.1155/2011/589813221323113205601; Kim YM, 2010, ANN NY ACAD SCI, V1201, P65, DOI 10.1111/j.1749-6632.2010.05617.x; Lee SB, 2005, CELL SIGNAL, V17, P197, DOI 10.1016/j.cellsig.2004.07.001; Molz S, 2011, J NEUROSCI RES, V89, P1400, DOI 10.1002/jnr.22681; Nakanishi A, 2014, AGING DIS, V5, P203, DOI 10.14336/AD.2014.0500203; Nomura F, 2000, GENES CELLS, V5, P191; Okumura N, 2012, ADV HEMATOL, V2012; Roy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068543; Song YX, 2013, J CARDIOVASC PHARM T, V18, P560, DOI 10.1177/1074248413503044; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; Tyagi A, 2012, BRIT J NUTR, V108, P1612, DOI 10.1017/S0007114511007197; Waters SM, 2014, MOL BIOL REP, V41, P2745, DOI 10.1007/s11033-014-3129-2; Wu XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083013; Yang JY, 2008, OBESITY, V16, P1232, DOI 10.1038/oby.2008.66; Yin H, 2013, IMMUNOLOGY, V139, P494, DOI 10.1111/imm.12096; Yoshida H, 2011, INT J APPL BOIL PHAR, V2, P316	77	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JAN	2015	35	1					10	16		10.3892/ijmm.2014.1981		7	Medicine, Research & Experimental	Research & Experimental Medicine	AX0MW	WOS:000346647300002		
J	Nakajima, F; Aratani, S; Fujita, H; Yagishita, N; Ichinose, S; Makita, K; Setoguchi, Y; Nakajima, T				Nakajima, Fukami; Aratani, Satoko; Fujita, Hidetoshi; Yagishita, Naoko; Ichinose, Shizuko; Makita, Koshi; Setoguchi, Yasuhiro; Nakajima, Toshihiro			Synoviolin inhibitor LS-102 reduces endoplasmic reticulum stress-induced collagen secretion in an in vitro model of stress-related interstitial pneumonia	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						endoplasmic reticulum stress; fibrosis; E3 ubiquitin ligase synoviolin	SURFACTANT PROTEIN-C; ALVEOLAR EPITHELIAL-CELLS; E3 UBIQUITIN LIGASE; LUNG-DISEASE; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; GROWTH-FACTOR; FIBROSIS; MUTATION; BIOSYNTHESIS	The deletion mutation of exon 4 in surfactant protein C (SP-C), a lung surfactant protein, has been identified in parent-child cases of familial interstitial pneumonia. It has been shown that this mutation induces endoplasmic reticulum (ER) stress. Synoviolin is an E3 ubiquitin ligase that is localized to the ER and is an important factor in the degradation of ER-related proteins. It has been demonstrated that synoviolin is involved in liver fibrosis. In the present study, we investigated the involvement of synoviolin in the pathogenesis of interstitial pneumonia caused by the exon 4 deletion in the SP-C gene. We transfected wild-type and exon 4-deleted SP-C genes into A549 human lung adenocarcinoma cells and measured the secretion of collagen, which is a representative extracellular matrix protein involved in fibrosis. Secreted collagen levels were increased in the culture medium in SP-C mutants compared to the wild-type cells. Furthermore, the transcription of mRNAs coding for factors associated with fibrosis was increased. Subsequently, to assess the involvement of synoviolin, we constructed plasmids with a luciferase gene under the control of the synoviolin promoter. The A549 cells were transfected with the construct along with the exon 4-deleted SP-C plasmid for use in the luciferase assay. We found a 1.6-fold increase in luciferase activaty in the cells carrying exon 4 deleted SP-C, as well as an increase in intrinsic synoviolin expression at the mRNA and protein levels. Collagen secretion was decreased by the addition of LS-102, a synoviolin inhibitor, to the A549 culture medium following transfection with wild-type and exon 4-deleted SP-C. These results demonstrate that synoviolin is involved in the onset of interstitial pneumonia induced by exon 4-deleted SP-C, which suggests that synoviolin inhibitors may be used in the treatment of the disease.	[Nakajima, Fukami; Makita, Koshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Bunkyo Ku, Tokyo 1138519, Japan; [Nakajima, Fukami; Aratani, Satoko; Fujita, Hidetoshi; Nakajima, Toshihiro] Tokyo Med Univ, Inst Med Sci, Dept Locomotor Sci, Shinjuku Ku, Tokyo 1608402, Japan; [Aratani, Satoko; Fujita, Hidetoshi; Nakajima, Toshihiro] Tokyo Med Univ, Inst Med Sci, Shinjuku Ku, Tokyo 1608402, Japan; [Yagishita, Naoko] St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa 2168512, Japan; [Ichinose, Shizuko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Setoguchi, Yasuhiro] Tokyo Med Univ, Dept Resp Med, Shinjuku Ku, Tokyo 1608402, Japan; [Nakajima, Toshihiro] Tokyo Med Univ, Integrated Genome Editing Sect, Shinjuku Ku, Tokyo 1608402, Japan	Nakajima, T (reprint author), Tokyo Med Univ, Dept Locomotor Sci, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	marlin@tokyo-med.ac.jp			Naito Foundation; Natural Science Scholarship Daiichi-Sankyo Foundation of Life Science; Mitsubishi Tanabe Pharma Corporation; Bureau of Social Welfare and Public Health; Ministry of Health Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Health Labour Sciences Research Grant; Takeda Science Foundation; AstraZeneca RD Grant	We thank the staff at the Future Medical Science at the Institute of Medical Science and the Integrated Gene Editing Section of Tokyo Medical University for their assistance. This study was funded in part by grants from the Naito Foundation, Natural Science Scholarship Daiichi-Sankyo Foundation of Life Science, Mitsubishi Tanabe Pharma Corporation, Bureau of Social Welfare and Public Health, The Ministry of Health Labour and Welfare, The Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, Health Labour Sciences Research Grant, Takeda Science Foundation, AstraZeneca R&D Grant 2013, Grant-in-Aid for Exploratory Research, Grant-in-Aid for Young Scientists (B).	Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Mulugeta S, 2006, MICROBES INFECT, V8, P2317, DOI 10.1016/j.micinf.2006.04.009; Arai M, 2013, J DERMATOL SCI, V69, P250, DOI 10.1016/j.jdermsci.2012.10.010; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC; Tanjore H, 2013, BBA-MOL BASIS DIS, V1832, P940, DOI 10.1016/j.bbadis.2012.11.011; Nogee LM, 1998, BBA-MOL BASIS DIS, V1408, P323, DOI 10.1016/S0925-4439(98)00078-7; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Li L, 2014, MOL CELL BIOCHEM, V386, P35, DOI 10.1007/s11010-013-1843-z; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Bonniaud P, 2003, AM J RESP CRIT CARE, V168, P770, DOI 10.1164/rccm.200210-1254OC; Hasegawa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013590; Hogaboam CM, 1998, KIDNEY INT, V54, P2152, DOI 10.1046/j.1523-1755.1998.00176.x; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Tsuchimochi K, 2005, MOL CELL BIOL, V25, P7344, DOI 10.1128/MCB.25.16.7344-7356.2005; Yagishita N, 2012, INT J MOL MED, V30, P1281, DOI 10.3892/ijmm.2012.1129	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JAN	2015	35	1					110	116		10.3892/ijmm.2014.1984		7	Medicine, Research & Experimental	Research & Experimental Medicine	AX0MW	WOS:000346647300013		
J	Choi, YH; Yamaguchi, K; Oda, T; Nam, TJ				Choi, Youn Hee; Yamaguchi, Kenichi; Oda, Tatsuya; Nam, Taek Jeong			Chemical and mass spectrometry characterization of the red alga Pyropia yezoensis chemoprotective protein (PYP): Protective activity of the N-terminal fragment of PYP1 against acetaminophen-induced cell death in Chang liver cells	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						Pyropia yezoensis; acetaminophen-induced cell death; chemoprotective protein; mass spectrometry	EXPRESSED SEQUENCE TAGS; PORPHYRA-YEZOENSIS; OXIDATIVE STRESS; PHOTOSYSTEM-II; HIZIKIA-FUSIFORMIS; GLYCOPROTEIN; PSBU; APOPTOSIS; SEAWEEDS; SUBUNIT	In the present study, the chemical structure and chemoprotective activity of Pyropia yezoensis protein (PYP) were investigated using sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, automated protein sequencing, matrix-assisted laser desorption/ionization-quadrupole ion trap-time-of-flight mass spectrometry and a chemoprotective assay using a synthetic peptide. The PYP fraction was demonstrated to contain two proteins: PYP1 (10 kDa, SDS-resistant dimer) and PYP2 (10 kDa). PYP1 is a novel protein showing sequence homology with the hypothetical function-unknown proteins of Chondrus crispus (Rhodophyta) and Emiliania huxleyi (Haptophyceae). PYP2 is a paralog of an extrinsic protein of photosystem II found in other Rhodophyta. The synthetic peptide PYP1 (1-20), corresponding to the N-terminal 20 residues of PYP1 (ALEGGKSSGGGEATRDPEPT), exhibits chemoprotective activity against acetaminophen-induced cell death in Chang liver cells, indicating that PYP1 is a chemoprotectant of the PYP fraction. A possible association between the structure of PYP and its chemoprotective activity is discussed.	[Choi, Youn Hee; Nam, Taek Jeong] Pukyong Natl Univ, Inst Fisheries Sci, Pusan 619911, South Korea; [Yamaguchi, Kenichi; Oda, Tatsuya] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 8528521, Japan; [Yamaguchi, Kenichi; Oda, Tatsuya] Nagasaki Univ, Fac Fisheries, Div Biochem, Nagasaki 8528521, Japan	Nam, TJ (reprint author), Pukyong Natl Univ, Inst Fisheries Sci, 474 Ilgwang Ro, Pusan 619911, South Korea.	namtj@pknu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A6A1028677]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24580303]	The authors thank Ms. Natsumi Kawano and Ms. Yuri Shima for their technical assistance. The present study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (no. 2012R1A6A1028677), and in part by a Grant-in-Aid for Scientific Research (no. 24580303) to K.Y. from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abasova L, 2011, J PHOTOCH PHOTOBIO B, V105, P149, DOI 10.1016/j.jphotobiol.2011.08.004; ADAMSON GM, 1993, BIOCHEM PHARMACOL, V45, P2289, DOI 10.1016/0006-2952(93)90201-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Yuan YV, 2006, FOOD CHEM TOXICOL, V44, P1144, DOI 10.1016/j.fct.2006.02.002; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Velasquez-Orta SB, 2009, BIOTECHNOL BIOENG, V103, P1068, DOI 10.1002/bit.22346; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; Balint I, 2006, FEBS LETT, V580, P2117, DOI 10.1016/j.febslet.2006.03.020; Go H, 2010, TOXICOL IN VITRO, V24, P1546, DOI 10.1016/j.tiv.2010.06.018; Hwang HJ, 2008, PHYTOTHER RES, V22, P1149, DOI 10.1002/ptr.2368; Nikaido I, 2000, DNA RES, V7, P223, DOI 10.1093/dnares/7.3.223; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; WEBER K, 1969, J BIOL CHEM, V244, P4406; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Shin ES, 2011, INT J MOL MED, V28, P809, DOI 10.3892/ijmm.2011.729; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; Cabra V, 2006, BIOCHIM BIOPHYS ACTA, V1764, P110; Choi YH, 2014, COMP BIOCHEM PHYS A, V167, P1, DOI 10.1016/j.cbpa.2013.09.011; Hirayasu H, 2005, J NUTR SCI VITAMINOL, V51, P475; Hwang HJ, 2008, FOOD CHEM TOXICOL, V46, P3475, DOI 10.1016/j.fct.2008.08.032; Kim YM, 2012, NUTR CANCER, V64, P761, DOI 10.1080/01635581.2012.683228; Lee EK, 2000, MOL CELLS, V10, P338; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057122; Nishiyama Y, 1999, PLANT PHYSIOL, V120, P301, DOI 10.1104/pp.120.1.301; Saga N, 2002, FISH SCI S, V68, P1075; Tatsuno R, 2013, BIOSCI BIOTECH BIOCH, V77, P208, DOI 10.1271/bbb.120701; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065902; Yamaguchi K, 2011, METHODS MOL BIOL, V775, P241, DOI 10.1007/978-1-61779-237-3_13	30	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JAN	2015	35	1					271	276		10.3892/ijmm.2014.1992		6	Medicine, Research & Experimental	Research & Experimental Medicine	AX0MW	WOS:000346647300032		
J	Puppulin, L; Zhu, WL; Sugano, N; Pezzotti, G				Puppulin, Leonardo; Zhu, Wenliang; Sugano, Nobuhiko; Pezzotti, Giuseppe			Microstructural modifications induced by accelerated aging and lipid absorption in remelted and annealed UHMWPEs for total hip arthroplasty	JOURNAL OF BIOMATERIALS APPLICATIONS			English	Article						Polyethylene; lipid absorption; hip replacement; oxidation; Raman spectroscopy	MOLECULAR-WEIGHT POLYETHYLENE; CROSS-LINKED UHMWPE; MECHANICAL-PROPERTIES; CLINICAL-PERFORMANCE; GAMMA-STERILIZATION; TIBIAL BEARINGS; IN-VIVO; OXIDATION; WEAR; CRYSTALLINITY	Three types of commercially available ultra-high molecular weight polyethylene (UHMWPE) acetabular cups currently used in total hip arthroplasty have been studied by means of Raman micro-spectroscopy to unfold the microstructural modification induced by the oxidative degradation after accelerated aging with and without lipid absorption. The three investigated materials were produced by three different manufacturing procedures, as follows: irradiation followed by remelting, one-step irradiation followed by annealing, 3-step irradiation and annealing. Clear microstructural differences were observed in terms of phase contents (i.e. amorphous, crystalline and intermediate phase fraction). The three-step annealed material showed the highest crystallinity fraction in the bulk, while the remelted polyethylene is clearly characterized by the lowest content of crystalline phase and the highest content of amorphous phase. After accelerated aging either with or without lipids, the amount of amorphous phase decreased in all the samples as a consequence of the oxidation-induced recrystallization. The most remarkable variations of phase contents were detected in the remelted and in the single-step annealed materials. The presence of lipids triggered oxidative degradation especially in the remelted polyethylene. Such experimental evidence might be explained by the highest amount of amorphous phase in which lipids can be absorbed prior to accelerated aging. The results of these spectroscopic characterizations help to rationalize the complex effect of different irradiation and post-irradiation treatments on the UHMWPE microstructure and gives useful information on how significantly any single step of the manufacturing procedures might affect the oxidative degradation of the polymer.	[Puppulin, Leonardo] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Kamigyo Ku Hirokoji Agaru, Kyoto, Japan; [Zhu, Wenliang; Sugano, Nobuhiko] Osaka Univ, Dept Orthoped Surg, Sch Med, Suita, Osaka 5650871, Japan; [Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 606, Japan; [Pezzotti, Giuseppe] Kyoto Inst Technol, Res Inst Nanosci, Sakyo Ku, Kyoto 606, Japan; [Pezzotti, Giuseppe] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 606, Japan.	pezzotti@kit.ac.jp					Bargmann LS, 1999, CLIN ORTHOP RELAT R, P49; Kurtz SM, 2006, BIOMATERIALS, V27, P24, DOI 10.1016/j.biomaterials.2005.05.102; Costa L, 2008, POLYM DEGRAD STABIL, V93, P1695, DOI 10.1016/j.polymdegradstab.2008.06.003; Wang A, 2006, J PHYS D APPL PHYS, V39, P3213, DOI 10.1088/0022-3727/39/15/S12; Dumbleton JH, 2006, CLIN ORTHOP RELAT R, P265, DOI 10.1097/01.blo.0000238856.61862.7d; Oral E, 2012, J BIOMED MATER RES B, V100B, P742, DOI 10.1002/jbm.b.32507; Besong AA, 1997, BIO-MED MATER ENG, V7, P59; Wannomae KK, 2006, J ARTHROPLASTY, V21, P1005, DOI 10.1016/j.arth.2005.07.019; Greenbaum ES, 2004, BIOMATERIALS, V25, P4479, DOI 10.1016/j.biomaterials.2003.11.049; Kurtz SM, 2003, J ARTHROPLASTY, V18, P68, DOI 10.1054/S0883-5403(03)00292-4; Currier BH, 2000, J BIOMED MATER RES, V53, P143, DOI 10.1002/(SICI)1097-4636(2000)53:2<143::AID-JBM3>3.0.CO;2-5; GLOTIN M, 1982, COLLOID POLYM SCI, V260, P182, DOI 10.1007/BF01465438; MUTTER R, 1993, J POLYM SCI POL PHYS, V31, P99, DOI 10.1002/polb.1993.090310113; RULL F, 1993, J RAMAN SPECTROSC, V24, P545, DOI 10.1002/jrs.1250240813; Costa L, 2001, BIOMATERIALS, V22, P307, DOI 10.1016/S0142-9612(00)00182-4; [Anonymous], 2008, F218302 ASTM; Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8; Edidin AA, 2000, BIOMATERIALS, V21, P1451, DOI 10.1016/S0142-9612(00)00021-1; McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203; STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704; Kurtz SM, 1998, CLIN ORTHOP RELAT R, P209; Collier JP, 1996, J ARTHROPLASTY, V11, P377, DOI 10.1016/S0883-5403(96)80026-X; Costa L, 2009, UHMWPE BIOMATERILAS, P329; Currier BH, 1997, CLIN ORTHOP RELAT R, P111; Lancaster JK, 1985, ENCY POLYM SCI ENG, V1, P12; Morrison ML, 2009, J BIOMED MATER RES B, V90B, P87, DOI 10.1002/jbm.b.31257; Nylor C.C., 1995, MACROMOLECULES, V28, P2969; Oonishi H, 1997, J MATER SCI-MATER M, V8, P11, DOI 10.1023/A:1018582027349; SUTULA LC, 1995, CLIN ORTHOP RELAT R, P28; Taddei P, 2002, J MOL STRUCT, V613, P121, DOI 10.1016/S0022-2860(02)00141-2	30	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0885-3282	1530-8022		J BIOMATER APPL	J. Biomater. Appl.	JAN	2015	29	6					791	800		10.1177/0885328214548693		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AX2II	WOS:000346766400001		
J	Kodama, Y; Ohkubo, C; Kurosaki, T; Egashira, K; Sato, K; Fumoto, S; Nishida, K; Higuchi, N; Kitahara, T; Nakamura, T; Sasaki, H				Kodama, Yukinobu; Ohkubo, Chikako; Kurosaki, Tomoaki; Egashira, Kanoko; Sato, Kayoko; Fumoto, Shintaro; Nishida, Koyo; Higuchi, Norihide; Kitahara, Takashi; Nakamura, Tadahiro; Sasaki, Hitoshi			Secure and effective gene delivery system of plasmid DNA coated by polynucleotide	JOURNAL OF DRUG TARGETING			English	Article						Gene delivery; polyethylenimine; pDNA; polynucleotide; ternary complex	ENDOTHELIAL-CELLS; SCAVENGER RECEPTORS; CATIONIC LIPOSOMES; IN-VIVO; THERAPY; LIVER; POLYETHYLENIMINE; NANOPARTICLES; DEGRADATION; MACROPHAGES	Polynucleotides are anionic macromolecules which are expected to transfer into the targeted cells through specific uptake mechanisms. So, we developed polynucleotides coating complexes of plasmid DNA (pDNA) and polyethylenimine (PEI) for a secure and efficient gene delivery system and evaluated their usefulness. Polyadenylic acid (polyA), polyuridylic acid (polyU), polycytidylic acid (polyC), and polyguanylic acid (polyG) were examined as the coating materials. pDNA/PEI/polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes formed nanoparticles with a negative surface charge although pDNA/PEI/polyG was aggregated. The pDNA/PEI/polyC complex showed high transgene efficiency in B16-F10 cells although there was little efficiency in pDNA/PEI/polyA and pDNA/PEI/polyU complexes. An inhibition study strongly indicated the specific uptake mechanism of pDNA/PEI/polyC complex. Polynucleotide coating complexes had lower cytotoxicity than pDNA/PEI complex. The pDNA/PEI/polyC complex showed high gene expression selectively in the spleen after intravenous injection into mice. The pDNA/PEI/polyC complex showed no agglutination with erythrocytes and no acute toxicity although these were observed in pDNA/PEI complex. Thus, we developed polynucleotide coating complexes as novel vectors for clinical gene therapy, and the pDNA/PEI/polyC complex as a useful candidate for a gene delivery system.	[Kodama, Yukinobu; Ohkubo, Chikako; Kurosaki, Tomoaki; Egashira, Kanoko; Sato, Kayoko; Higuchi, Norihide; Kitahara, Takashi; Nakamura, Tadahiro; Sasaki, Hitoshi] Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki 8528501, Japan; [Fumoto, Shintaro; Nishida, Koyo] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmaceut, Nagasaki 852, Japan	Sasaki, H (reprint author), Nagasaki Univ Hosp, Dept Hosp Pharm, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sasaki@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors report no declarations of interest.	Cherif MS, 2011, VACCINE, V29, P9038, DOI 10.1016/j.vaccine.2011.09.031; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Su CH, 2012, AM J PHYSIOL-HEART C, V303, pH629, DOI 10.1152/ajpheart.00126.2012; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Sato A, 2007, BIOMATERIALS, V28, P1434, DOI 10.1016/j.biomaterials.2006.11.010; Hisazumi J, 2004, PHARM RES, V21, P1223, DOI 10.1023/B:PHAM.0000033009.17594.e5; Martens JH, 2006, J PATHOL, V208, P574, DOI 10.1002/path.1921; Nishikawa M, 2005, ADV DRUG DELIVER REV, V57, P675, DOI 10.1016/j.addr.2004.12.003; Qian H, 2009, BIOCHEM BIOPH RES CO, V390, P883, DOI 10.1016/j.bbrc.2009.10.068; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Kawakami S, 2000, GENE THER, V7, P292, DOI 10.1038/sj.gt.3301089; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; Kurosaki T, 2011, MOL PHARMACEUT, V8, P913, DOI 10.1021/mp2001268; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Pezzoli D, 2012, J APPL BIOMATER FUNC, V10, P82, DOI 10.5301/JABFM.2012.9707; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Zarogouldis P, 2012, INT J MOL SCI, V13, P10828, DOI 10.3390/ijms130910828; Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Kircheis R, 1999, J GENE MED, V1, P111; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Tagalakis AD, 2011, BIOMATERIALS, V32, P6302, DOI 10.1016/j.biomaterials.2011.05.022; Cavazzana-Calvo M, 2012, CURR OPIN IMMUNOL, V24, P580, DOI 10.1016/j.coi.2012.08.008; Chen LA, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105708; Li RM, 2009, MICROCIRCULATION, V16, P640, DOI 10.1080/10739680903133185; Liu F, 2004, FASEB J, V18, P1779, DOI 10.1096/fj.04-2187fje; Yoshinaga T, 2002, BIOCHEM BIOPH RES CO, V299, P389, DOI 10.1016/S0006-291X(02)02648-7	33	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1061-186X	1029-2330		J DRUG TARGET	J. Drug Target.	JAN	2015	23	1					43	51		10.3109/1061186X.2014.950665		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX4QC	WOS:000346915600003		
J	Kazemifar, F; Kyritsis, DC				Kazemifar, Farzan; Kyritsis, Dimitrios C.			Near-Critical CO2 Flow Measurement and Visualization	JOURNAL OF ENERGY RESOURCES TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article							SUPERCRITICAL CARBON-DIOXIDE; NUMERICAL-SIMULATION; PORE NETWORK; SEQUESTRATION; CAPTURE; STORAGE; WATER; DISPLACEMENT; MICROMODEL; EXSOLUTION	Near-critical CO2 flow has been studied because of its potential application in carbon dioxide capture and sequestration, which is one of the proposed solutions for reducing greenhouse gas emission. Near the critical point the thermophysical properties of the fluid undergo abrupt changes that affect the flow structure and characteristics. Pressure drop across a stainless steel tube, 2 ft long with 0.084 in. ID, at different inlet conditions and mass flow rates have been measured. The effects of variations of inlet conditions have been studied. The results show extreme sensitivity of pressure drop to inlet conditions especially inlet temperature in the vicinity of the critical point. Also, shadowgraphs have been acquired to study the flow structure qualitatively.	[Kazemifar, Farzan; Kyritsis, Dimitrios C.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Kazemifar, Farzan; Kyritsis, Dimitrios C.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan; [Kyritsis, Dimitrios C.] Khalifa Univ Sci Technol & Res, Dept Mech Engn, Abu Dhabi, U Arab Emirates	Kazemifar, F (reprint author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	kazemif1@illinois.edu; kyritsis@illinois.edu		Kazemifar, Farzan/0000-0001-6260-9119	International Institute for Carbon Neutral Energy Research (WPI-I2CNER) - World Premier International Research Center Initiative (WPI), MEXT, Japan	The author(s) gratefully acknowledge the support of the International Institute for Carbon Neutral Energy Research (WPI-I<SUP>2</SUP>CNER), sponsored by the World Premier International Research Center Initiative (WPI), MEXT, Japan.	Haszeldine RS, 2009, SCIENCE, V325, P1647, DOI 10.1126/science.1172246; [Anonymous], 2013, DOEIEA0383ER US EN I; Bae YY, 2010, EXP THERM FLUID SCI, V34, P1295, DOI 10.1016/j.expthermflusci.2010.06.001; Bae YY, 2009, EXP THERM FLUID SCI, V33, P329, DOI 10.1016/j.expthermflusci.2008.10.002; Ciferno JP, 2009, CHEM ENG PROG, V105, P33; Bandara UC, 2011, INT J GREENH GAS CON, V5, P1566, DOI 10.1016/j.ijggc.2011.08.014; Zuo L, 2013, ADV WATER RESOUR, V53, P188, DOI 10.1016/j.advwatres.2012.11.004; Zhang CY, 2011, ENVIRON SCI TECHNOL, V45, P7581, DOI 10.1021/es201858r; [Anonymous], 2011, DOEIEA05732009 US EN; Zuo L, 2012, TRANSPORT POROUS MED, V91, P459, DOI 10.1007/s11242-011-9854-2; Wildenschild D, 2013, ADV WATER RESOUR, V51, P217, DOI 10.1016/j.advwatres.2012.07.018; Herring AL, 2013, ADV WATER RESOUR, V62, P47, DOI 10.1016/j.advwatres.2013.09.015; Liao SM, 2002, J HEAT TRANS-T ASME, V124, P413, DOI 10.1115/1.1423906; Pruess K, 2011, TRANSPORT POROUS MED, V90, P135, DOI 10.1007/s11242-011-9729-6; Pruess K, 2002, ENVIRON GEOL, V42, P282, DOI 10.1007/s00254-001-0498-3; Robinson DM, 1998, INT J REFRIG, V21, P577, DOI 10.1016/S0140-7007(98)00024-3; Wang Y, 2013, ENVIRON SCI TECHNOL, V47, P212, DOI 10.1021/es3014503; Clifford T, 1999, FUNDAMENTALS SUPERCR; Colebrook C.F., 1939, Journal of the Institution of Civil Engineers, DOI 10.1680/ijoti.1939.13150; Daneshfar J, 2009, J ENERG RESOUR-ASME, V131, DOI 10.1115/1.3124115; Kazemifar F, 2014, EXP THERM FLUID SCI, V53, P161, DOI 10.1016/j.expthermflusci.2013.11.026; KURGANOV VA, 1992, EXP THERM FLUID SCI, V5, P465, DOI 10.1016/0894-1777(92)90033-2; Law DHS, 1996, ENERG CONVERS MANAGE, V37, P1167, DOI 10.1016/0196-8904(95)00315-0; Lengler U, 2010, INT J GREENH GAS CON, V4, P1016, DOI 10.1016/j.ijggc.2010.07.004; Liepmann H. W., 2001, ELEMENTS GAS DYNAMIC; Lorentzen G., INT J REFRIG, V17, P292; LORENTZEN G, 1993, INT J REFRIG, V16, P4, DOI 10.1016/0140-7007(93)90014-Y; Mohamed I. M., 2012, ASME J ENERGY RESOUR, V135; Orr FM, 2009, ENERG ENVIRON SCI, V2, P449, DOI 10.1039/b822107n; Perrin J.C., 2009, TRANSPORT POROUS MED, V82, P93; Reid R.C., 1987, PROPERTIES GASES LIQ; Sasaki K, 2008, ENERG CONVERS MANAGE, V49, P54, DOI 10.1016/j.enconman.2007.05.015; Seo JG, 2005, J ENERG RESOUR-ASME, V127, P1, DOI 10.1115/1.1790538; Uddin M, 2008, J ENERG RESOUR-ASME, V130, DOI 10.1115/1.2956978; Uddin M, 2008, J ENERG RESOUR-ASME, V130, DOI 10.1115/1.2956979	35	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0195-0738			J ENERG RESOUR-ASME	J. Energy Resour. Technol.-Trans. ASME	JAN	2015	137	1							012002	10.1115/1.4027961		5	Energy & Fuels	Energy & Fuels	AX4FQ	WOS:000346889500004		
J	Taki, H; Asai, H; Kitagawa, K; Oyama, H; Gupta, AK				Taki, Hirotoshi; Asai, Hiroshi; Kitagawa, Kuniyuki; Oyama, Hiroyuki; Gupta, Ashwani K.			Laser-Induced Plasma Spectrometry With Chemical Seeding and Application to Flow Mixing Analysis in Methane-Air Flames	JOURNAL OF ENERGY RESOURCES TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article						chemical seeding; methane-air diffusion flame; laser-induced plasma spectroscopy; flow mixing	INDUCED BREAKDOWN SPECTROSCOPY; ENVIRONMENTAL PERFORMANCE; EXCESS AIR; OPTIMIZATION; IMPROVEMENT	Spectroscopic measurements of flames are amongst the most important analytical diagnostic techniques that allow one to improve thermal and energy efficiency of industrial furnaces. A chemical seeding laser-induced plasma spectroscopy (CS-LIPS) was successfully developed and applied for mixing analysis of a methane-air diffusion flame. The results obtained showed that sensitivity of this system was much improved using silica rod as the target material in place of the tungsten material used in our previous studies. Profiling of Mg spectral emission and mixing in the flame was made more clearly with the introduction of magnesium aerosols as a tracer into the combustion air flow.	[Taki, Hirotoshi; Asai, Hiroshi] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kitagawa, Kuniyuki] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Oyama, Hiroyuki] AIST, Toyohira Ku, Sapporo, Hokkaido 0620051, Japan; [Gupta, Ashwani K.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA	Gupta, AK (reprint author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	waterfall.wide.city@hotmail.com; hisroshi@asai.tec.toyota.co.jp; a41596a@yahoo.co.jp; h.oyama@aist.go.jp; akgupta@umd.edu					Romero C, 2005, APPL THERM ENG, V25, P659, DOI 10.1016/j.applthermaleng.2004.07.020; Zhang SH, 2012, OPT LASER ENG, V50, P877, DOI 10.1016/j.optlaseng.2012.01.004; Hasegawa T, 2002, J PROPUL POWER, V18, P233, DOI 10.2514/2.5943; Askari O, 2013, J ENERG RESOUR-ASME, V135, DOI 10.1115/1.4007911; BAKER MR, 1959, ANAL CHEM, V31, P2036, DOI 10.1021/ac60156a048; Desmira N., 2014, ASME J ENERGY RESOUR, V136; Itoh S, 2001, MICROCHEM J, V70, P143, DOI 10.1016/S0026-265X(01)00107-2; Janbozorgi M., 2013, ASME J ENERGY RESOUR, V135; Kitagawa K., 2002, ENERGY CONVERS ENG C, V37, P382; Kodama Kenji, 2008, Journal of the Spectroscopical Society of Japan, V57; Kouprianov VI, 2003, APPL ENERG, V74, P445, DOI 10.1016/S0306-2619(02)00199-X; Kuprianov VI, 2005, RENEW SUST ENERG REV, V9, P474, DOI 10.1016/j.rser.2004.05.006; Majd AE, 2011, APPL SPECTROSC, V65, P36, DOI 10.1366/10-05863; Oyama H., 2014, ASME J RESOUR TECHNO, V136; Shen QC, 2013, J ENERG RESOUR-ASME, V135, DOI 10.1115/1.4023744	15	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0195-0738			J ENERG RESOUR-ASME	J. Energy Resour. Technol.-Trans. ASME	JAN	2015	137	1							012202	10.1115/1.4027980		5	Energy & Fuels	Energy & Fuels	AX4FQ	WOS:000346889500006		
J	Okada, S; Fukuda, Y; Takahashi, MK				Okada, Sumio; Fukuda, Yukihiro; Takahashi, Mizuki K.			Paternal care behaviors of Japanese giant salamander Andrias japonicus in natural populations	JOURNAL OF ETHOLOGY			English	Article						Agitating eggs; Andrias japonicus; Egg attendance; Filial cannibalism; Paternal care; Salamander; Tail fanning; Water mold infection	PARENTAL CARE; FILIAL CANNIBALISM; EVOLUTION	Parental care among salamanders is typically provided by females. A rare case of parental care by male salamanders appears to occur in Cryptobranchidae. Yet, paternal behaviors have rarely been reported from natural populations of any Cryptobranchid salamanders, and their adaptive significance is poorly understood. The present study aimed to examine paternal care behaviors in a fully aquatic Japanese giant salamander (Andrias japonicus) in situ. At the beginning of the summer breeding season, large males, called den-masters, occupy burrows along stream banks for breeding and nesting. We videotaped post-breeding behaviors of two den-masters that stayed with the eggs, one in a natural and the other in an artificial nest in natural streams. We identified three behaviors, tail fanning, agitating and egg eating, to be parental care. Tail fanning provides oxygenated water for the eggs. We found that the den-master in the artificial nest, where dissolved oxygen level was lower, displayed tail fanning more frequently. Agitating the eggs with its head and body likely prevents yolk adhesions. The den-masters selectively ate whiter eggs that appeared to be dead or infected with water mold. This behavior, which we termed hygienic filial cannibalism, likely prevents water mold from spreading over healthy eggs. Digital video images relating to this article are available at http://www.momo-p.com/showdetail-e.php?movieid=momo140906aj01a, http://www.momop.com/showdetail-e.php?movieid=momo140906aj02a, http://www.momo-p.com/showdetail-e.php?movieid=momo140906aj03a and http://www.momo-p.com/showdetail-e.php?movieid=momo140906aj04a.	[Okada, Sumio] Tottori Univ, Dept Social Syst Engn, Tottori 6808552, Japan; [Fukuda, Yukihiro] Nichinan Hanzaki Dojo, Tottori 6895225, Japan; [Takahashi, Mizuki K.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA	Okada, S (reprint author), Tottori Univ, Dept Social Syst Engn, Tottori 6808552, Japan.	okadasumio@gmail.com			grant for the Tottori University Research Project for Rural Sustainability	We thank Hiroko Yamasaki for the dissolved oxygen measurements, Etsuko Yuki for her assistance in videotaping the natural nest den-master, and Takeyoshi Tochimoto for his assistance in videotaping the artificial nest den-master. Yuki Taguchi kindly provided us with requested literature. We also thank Atsushi Koike for his mentorship and Toshifumi Wada, Rebecca Hale, and two anonymous reviewers for their valuable comments on the earlier draft. We are grateful to the Tottori and Hyogo Prefectural Boards of Education for the research permits. This research was in part funded by the grant for the Tottori University Research Project for Rural Sustainability.	Andersson M., 1994, SEXUAL SELECTION; Hale RE, 2003, ENVIRON BIOL FISH, V67, P107, DOI 10.1023/A:1025676315344; Gomez-Mestre I, 2006, ECOLOGY, V87, P2570, DOI 10.1890/0012-9658(2006)87[2570:AEAPDA]2.0.CO;2; BLAUSTEIN AR, 1994, BIOL CONSERV, V67, P251, DOI 10.1016/0006-3207(94)90616-5; DAWKINS R, 1976, NATURE, V262, P131, DOI 10.1038/262131a0; ROHWER S, 1978, AM NAT, V112, P429, DOI 10.1086/283284; GROSS MR, 1981, EVOLUTION, V35, P775, DOI 10.2307/2408247; Klug H, 2006, EVOLUTION, V60, P2087, DOI 10.1111/j.0014-3820.2006.tb01846.x; Smith BG, 1907, BIOL BULL-US, V13, P5, DOI 10.2307/1535594; Jones JC, 1999, BEHAVIOUR, V136, P819, DOI 10.1163/156853999501586; NUSSBAUM RA, 1987, RES POPUL ECOL, V29, P27, DOI 10.1007/BF02515423; Klug H, 2007, AM NAT, V170, P886, DOI 10.1086/522936; Clutton-Brock T., 1991, EVOLUTION PARENTAL C; Crump Martha L., 1996, Advances in the Study of Behavior, V25, P109; Duellman WE, 1986, BIOL AMPHIBIANS; GROSS MR, 1985, AM ZOOL, V25, P807; Kawamichi T, 1998, J HERPETOL, V32, P133, DOI 10.2307/1565495; Kobara J, 1985, GIANT SALAMANDER; Kuwabara K, 2009, NAT HIST NISHI CHUGO, V14, P11; Kuwabara K, 2005, NAT HIST NISHI CHUGO, V10, P101; McDonald J. H., 2009, HDB BIOL STAT; Nussbaum RA, 1985, ANN ARBOR; REEBS SG, 1984, CAN J ZOOL, V62, P329, DOI 10.1139/z84-051; Reinhard S, 2013, ZOOL ANZ, V253, P1, DOI 10.1016/j.jcz.2013.06.002; Salthe SN, 1974, PHYSL AMPHIBIANS, P310; Suzuki N, 1984, B HIROSHIMA CITY ASA, V13, P7; Suzuki N, 1981, B HIROSHIMA CITY ASA, V10, P8; Tago K, 1927, 10 C INT ZOOL EN BUD, P828; Tochimoto Takeyoshi, 1995, Journal of Japanese Association of Zoological Gardens and Aquariums, V37, P13; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1111/J.1420-9101.2008.01540.X; Williams GC, 1975, SEX EVOLUTION	31	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0289-0771	1439-5444		J ETHOL	J. Ethol.	JAN	2015	33	1					1	7		10.1007/s10164-014-0413-5		7	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	AX3TX	WOS:000346862600001		
J	Kawaminami, T; Goshima, S				Kawaminami, Takuma; Goshima, Seiji			Guarding males of the hermit crab climb up algae to avoid male-male competition	JOURNAL OF ETHOLOGY			English	Article						Counter tactic; Guarding behavior; Hermit crab; Indirect female choice; Male-male competition; Pagurus filholi; Sex pheromone; Sexual conflict	PAGURUS-FILHOLI; FEMALE CHOICE; MATE CHOICE; PREDATION RISK; UCA-LACTEA; CONFLICT; ISOPOD; SIZE	Males of the hermit crab Pagurus filholi show precopulatory guarding behavior in which a male grasps the shell of a mature female with his left cheliped before copulation. Hermit crabs were most common in rocky intertidal areas with cobbles and boulders, while many guarding pairs were observed on fronds of brown algae such as Sargassum confusum in Hakodate Bay, Japan. We examined three hypotheses explaining why the guarding pairs were most common on algae; (1) aggregation place for mature males and females to find mates, (2) avoidance of male-male combat, and (3) avoidance of predators. If solitary males and females climbed up algae, then many guarding pairs were observed after pairing, but only guarding pairs climbed up the algae after removing all crabs. Experiments in aquariums showed that the disturbance rate for guarding pairs due to male-male competition was lower on the algae than in boulder and rocky flat areas, and few disturbances were observed by predatory crabs in all habitat types. These results suggest that the guarding males climb up the fronds of algae to sequester guarded females from rival males and avoid male-male combat. This behavior could be considered as a male counter tactic against indirect female choice mediated by sex pheromones in which females release sex pheromones while guarded, attracting many rival males and inducing male-male competition.	[Kawaminami, Takuma] Hokkaido Univ, Grad Sch Fisheries Sci, Marine Biol Lab, Hakodate, Hokkaido 0418611, Japan; [Goshima, Seiji] Hokkaido Univ, Marine Biol Lab, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Goshima, S (reprint author), Hokkaido Univ, Marine Biol Lab, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan.	goshima@fish.hokudai.ac.jp					Andersson M., 1994, SEXUAL SELECTION; MURAI M, 1987, ANIM BEHAV, V35, P1334, DOI 10.1016/S0003-3472(87)80005-2; Wiley RH, 1996, EVOLUTION, V50, P1371, DOI 10.2307/2410875; Jormalainen V, 1998, Q REV BIOL, V73, P275, DOI 10.1086/420306; Kokko H, 2005, EVOL ECOL, V19, P123, DOI 10.1007/s10682-004-7919-1; Sparkes TC, 2002, BEHAVIOUR, V139, P875, DOI 10.1163/156853902320387873; Sih A, 2002, ANIM BEHAV, V63, P1079, DOI 10.1006/anbe.2002.2002; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Cordero C, 2003, J EVOLUTION BIOL, V16, P1, DOI 10.1046/j.1420-9101.2003.00506.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Arnqvist G, 2005, SEXUAL CONFLICT; Cothran RD, 2004, ANIM BEHAV, V68, P1133, DOI 10.1016/j.anbehav.2003.09.021; Goshima S, 2006, BIOL ANOMURA, V6, P87; GOSHIMA S, 1988, ANIM BEHAV, V36, P1249, DOI 10.1016/S0003-3472(88)80091-5; Goshima S, 1998, ECOL RES, V13, P151, DOI 10.1046/j.1440-1703.1998.00254.x; Goshima Seiji, 1996, Crustacean Research, V25, P86; IMAFUKU M, 1986, J ETHOL, V4, P39, DOI 10.1007/BF02348251; Jormalainen Veijo, 2007, P167; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Mima A, 2003, OIKOS, V102, P104, DOI 10.1034/j.1600-0706.2003.12361.x; Minouchi S, 1998, J CRUSTACEAN BIOL, V18, P710, DOI 10.2307/1549147; Murata Y, 2002, J NAT HIST, V36, P25, DOI 10.1080/00222930110087401; Okamura S, 2010, J ETHOL, V28, P323, DOI 10.1007/s10164-009-0188-2; Wade M, 2003, MATING SYSTEMS STRAT; Wellborn Gary A., 2007, P147; Yamanoi T, 2006, J ETHOL, V24, P213, DOI 10.1007/s10164-005-0182-2; Yoshino K, 2002, MAR BIOL, V141, P1069, DOI 10.1007/s00227-002-0876-8	28	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0289-0771	1439-5444		J ETHOL	J. Ethol.	JAN	2015	33	1					25	33		10.1007/s10164-014-0411-7		9	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	AX3TX	WOS:000346862600004		
J	Tokuda, K; Masuda, R; Yamashita, Y				Tokuda, Koji; Masuda, Reiji; Yamashita, Yoh			Conditional discrimination in Octopus vulgaris	JOURNAL OF ETHOLOGY			English	Article						Invertebrate; Cephalopod; Mollusk; Learning; Successive discrimination	ACQUISITION; EVOLUTION; GOLDFISH	Conditional discrimination in the octopus (Octopus vulgaris) was studied using successive discrimination training. The experimental animals were divided into two groups, and a barrel-shaped white object (stimulus) was presented to each group. One of the groups was rewarded with food for responding to the stimulus, but only when the tank was aerated, whereas the other group was rewarded with food for responding to the stimulus when the aeration was switched off. The number of trials in which octopuses responded to the stimulus, and the latency of the responses, were significantly different between trials with the aeration on and trials with the aeration off, in both groups. Therefore, the octopuses learned to conditionally discriminate.	[Tokuda, Koji; Masuda, Reiji; Yamashita, Yoh] Kyoto Univ, Maizuru Fisheries Res Stn, Field Sci Educ & Res Ctr, Kyoto 6250086, Japan	Tokuda, K (reprint author), Kyoto Univ, Maizuru Fisheries Res Stn, Field Sci Educ & Res Ctr, Kyoto 6250086, Japan.	pallas-athena@asahinet.jp					Katsanevakis S, 2004, SCI MAR, V68, P553; Hvorecny LM, 2007, ANIM COGN, V10, P449, DOI 10.1007/s10071-007-0085-4; Grasso FW, 2009, BRAIN BEHAV EVOLUT, V74, P231, DOI 10.1159/000258669; Castro L, 2010, BEHAV PROCESS, V83, P162, DOI 10.1016/j.beproc.2009.10.007; Huffard CL, 2010, J COMP PSYCHOL, V124, P38, DOI 10.1037/a0017230; Brown KL, 2005, DEV PSYCHOBIOL, V46, P97, DOI 10.1002/dev.20044; COLWILL RM, 1988, J NEUROSCI, V8, P4440; COUVILLON PA, 1988, ANIM LEARN BEHAV, V16, P67, DOI 10.3758/BF03209045; FUJITA K, 1983, JPN PSYCHOL RES, V25, P1; Hanlon RT, 1996, CEPHALOPOD BEHAV; Kuba MJ, 2006, INT J COMP PSYCHOL, V19, P426; LIPSITT LP, 1961, CHILD DEV, V32, P337, DOI 10.1111/j.1467-8624.1961.tb05032.x; Martinez L, 2009, BEHAV PROCESS, V82, P90, DOI 10.1016/j.beproc.2009.03.010; MESSENGE.JB, 1972, ANIM BEHAV, V20, P580, DOI 10.1016/S0003-3472(72)80023-X; Myers CE, 2000, PSYCHOBIOLOGY, V28, P275; R Core Team, 2013, R LANG ENV STAT COMP; Rogers RF, 1998, NEUROBIOL LEARN MEM, V69, P307, DOI 10.1006/nlme.1998.3826; Sanders GD, 1975, INVERTEBRATE LEARNIN, V3, P1; Thomas RK, 1996, COGNITIVE BRAIN RES, V3, P157, DOI 10.1016/0926-6410(96)00003-1; THOMAS RK, 1980, BRAIN BEHAV EVOLUT, V17, P454, DOI 10.1159/000121814; WELLS MJ, 1965, J EXP BIOL, V43, P553; ZERBOLIO DJ, 1984, ANIM LEARN BEHAV, V12, P163, DOI 10.3758/BF03213136; ZUCKERMA.DC, 1974, ANIM LEARN BEHAV, V2, P215, DOI 10.3758/BF03199181	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0289-0771	1439-5444		J ETHOL	J. Ethol.	JAN	2015	33	1					35	40		10.1007/s10164-014-0414-4		6	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	AX3TX	WOS:000346862600005		
J	Lee, M; Marusawa, H; Yamashita, Y				Lee, M.; Marusawa, H.; Yamashita, Y.			Gastrointestinal: Recurrent pancreatitis due to pancreatic arteriovenous malformation	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Lee, M.; Marusawa, H.] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Yamashita, Y.] Wakayama Red Cross Hosp, Dept Gastroenterol & Hepatol, Wakayama, Japan	Lee, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JAN	2015	30	1					2	2		10.1111/jgh.12815		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX2OO	WOS:000346783900002		
J	Yamashina, T; Takeuchi, Y; Uedo, N; Aoi, K; Matsuura, N; Nagai, K; Matsui, F; Ito, T; Fujii, M; Yamamoto, S; Hanaoka, N; Higashino, K; Ishihara, R; Tomita, Y; Iishi, H				Yamashina, Takeshi; Takeuchi, Yoji; Uedo, Noriya; Aoi, Kenji; Matsuura, Noriko; Nagai, Kengo; Matsui, Fumi; Ito, Takashi; Fujii, Mototsugu; Yamamoto, Sachiko; Hanaoka, Noboru; Higashino, Koji; Ishihara, Ryu; Tomita, Yasuhiko; Iishi, Hiroyasu			Diagnostic features of sessile serrated adenoma/polyps on magnifying narrow band imaging: A prospective study of diagnostic accuracy	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						hyperplastic polyp; magnifying narrow band imaging; NICE classification; sessile serrated adenoma/polyp	COLORECTAL-CANCER; ENDOSCOPIC FEATURES; POLYPS; CLASSIFICATION; VALIDATION; ADENOMAS	Background and AimsThe narrow band imaging classification system (NBI International Colorectal Endoscopic [NICE] classification) classifies colorectal polyps very accurately. However, sessile serrated adenoma/polyps (SSA/Ps) pathologically resembles hyperplastic polyp and has a possibility to be left in situ on NICE classification. The aim of this study was to establish and evaluate new simple diagnostic features for SSA/Ps using magnifying narrow band imaging (M-NBI). MethodsWe performed a single-arm observational study of diagnostic accuracy in two stages, as follows: seeking stage, development of simple diagnostic features for SSA/P and definition of diagnostic criteria based on retrospective assessments of M-NBI; and validation stage, prospective validation and evaluation of the new diagnostic criteria. ResultsIn the seeking stage, we identified brownish, oval, expanded crypt openings and thick-branched vessels on the surfaces of SSA/Ps. We named these expanded crypt openings (ECOs) and thick and branched vessels (TBVs), respectively. In the validation stage, we enrolled 796 polyps in 261 patients, and classified 126 polyps as NICE type 1; all these lesions were endoscopically removed and assessed histopathologically. The sensitivity, specificity, and accuracy of ECOs for SSA/Ps were 84.3%, 81.1%, and 82.4%, whereas those of TBVs were 45.1%, 68.9%, and 59.2%, respectively. M-NBI provided a sensitivity of 98% and specificity of 59.5% for discrimination of SSA/Ps from other lesions classified as NICE type 1. ConclusionsIdentification of ECOs, supplemented with TBVs, has high sensitivity for the diagnosis of SSA/P. These findings may facilitate the use of endoscopic optical diagnosis in clinical practice.	[Yamashina, Takeshi; Takeuchi, Yoji; Uedo, Noriya; Aoi, Kenji; Matsuura, Noriko; Nagai, Kengo; Matsui, Fumi; Ito, Takashi; Fujii, Mototsugu; Yamamoto, Sachiko; Hanaoka, Noboru; Higashino, Koji; Ishihara, Ryu; Iishi, Hiroyasu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka 5378511, Japan; [Tomita, Yasuhiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan	Takeuchi, Y (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Higashinari Ku, 3-3 Nakamichi 1 Chome, Osaka 5378511, Japan.	takeuti-yo@mc.pref.osaka.jp					Hewett DG, 2012, GASTROENTEROLOGY, V143, P599, DOI 10.1053/j.gastro.2012.05.006; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Tadepalli US, 2011, GASTROINTEST ENDOSC, V74, P1360, DOI 10.1016/j.gie.2011.08.008; Kumar S, 2013, GASTROINTEST ENDOSC, V78, P902, DOI 10.1016/j.gie.2013.06.004; Hazewinkel Y, 2013, GASTROINTEST ENDOSC, V77, P916, DOI 10.1016/j.gie.2012.12.018; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Boparai KS, 2009, GASTROINTEST ENDOSC, V70, P947, DOI 10.1016/j.gie.2009.03.1172; Kimura T, 2012, AM J GASTROENTEROL, V107, P460, DOI 10.1038/ajg.2011.457; Nakao Y, 2013, EUR J GASTROEN HEPAT, V25, P981, DOI 10.1097/MEG.0b013e3283614b2b; Hetzel JT, 2010, AM J GASTROENTEROL, V105, P2656, DOI 10.1038/ajg.2010.315; Tanaka S, 2011, DIGEST ENDOSC, V23, P131, DOI 10.1111/j.1443-1661.2011.01106.x; Uraoka T, 2011, STOMACH INTESTINE, V46, P406; Wallace MB, 2013, GASTROINTEST ENDOSC, V78, P910, DOI 10.1016/j.gie.2013.07.053; Yamada T, 2009, DIGEST DIS SCI, V54, P2002, DOI 10.1007/s10620-008-0573-7; Yao T., 2011, STOMACH INTEST, V46, P442	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JAN	2015	30	1					117	123		10.1111/jgh.12688		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX2OO	WOS:000346783900021		
J	Aoyama, T; Oka, S; Aikata, H; Igawa, A; Nakano, M; Naeshiro, N; Yoshida, S; Tanaka, S; Chayama, K				Aoyama, Taiki; Oka, Shiro; Aikata, Hiroshi; Igawa, Atsushi; Nakano, Makoto; Naeshiro, Noriaki; Yoshida, Shigeto; Tanaka, Shinji; Chayama, Kazuaki			Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						capsule endoscopy; liver cirrhosis; portal hypertensive enteropathy; portosystemic shunts	DOUBLE-BALLOON ENDOSCOPY; CAPSULE ENDOSCOPY; SMALL-BOWEL; ESOPHAGEAL-VARICES; HEPATOCELLULAR-CARCINOMA; PORTOSYSTEMIC SHUNT; ABNORMALITIES; SURVEILLANCE; MULTICENTER; ENTEROSCOPY	Background and AimPortal hypertensive enteropathy (PHE) is acknowledged as a source of bleeding, and predicting its presence has become more important. We assessed PHE using capsule endoscopy (CE) and investigated factors that may predict its presence, including portosystemic shunts (PSs). MethodsWe analyzed data from 134 consecutive patients with liver cirrhosis, from February 2009 to September 2013. All patients had undergone dynamic computed tomography and esophagogastroduodenoscopy before CE examination. The frequencies and types of PHE lesions, and the relationships between the presence of PHE and patients' clinical characteristics were evaluated. The distribution of the lesions was also determined. ResultsPHE was found in 91 (68%), erythema in 70 (52%), erosions in 25 (19%), angioectasia in 24 (18%), villous edema in 18 (13%), and varices in 10 (7%) patients. Most lesions were located in the jejunum. The clinical characteristics associated with the presence of PHE were a Child-Pugh grade of B or C (P=0.0058), and the presence of PSs (P<0.0001), ascites (P=0.0017), portal thrombosis (P=0.016), esophageal varices (P=0.0017), and portal hypertensive gastropathy (P=0.0029). The presence of PSs was an independent predictor of PHE (odds ratio [OR]: 3.15; 95% confidence interval [CI]: 1.27-7.95). Among the shunt types, left gastric vein (OR: 5.31; 95% CI: 1.97-17.0) and splenorenal shunts (OR: 4.26; 95% CI: 1.29-19.4) were independent predictors of PHE. ConclusionPSs, especially left gastric vein and splenorenal shunts, appear to reliably predict the presence of PHE.	[Aoyama, Taiki; Aikata, Hiroshi; Igawa, Atsushi; Nakano, Makoto; Naeshiro, Noriaki; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Oka, Shiro; Yoshida, Shigeto; Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima 7348551, Japan	Oka, S (reprint author), Hiroshima Univ Hosp, Dept Endoscopy, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	oka4683@hiroshima-u.ac.jp					Akyuz F, 2010, SCAND J GASTROENTERO, V45, P1497, DOI 10.3109/00365521.2010.510568; Matsushita Y, 2013, J GASTROENTEROL, V48, P633, DOI 10.1007/s00535-012-0660-6; Teshima CW, 2011, J GASTROEN HEPATOL, V26, P796, DOI 10.1111/j.1440-1746.2010.06530.x; Li X, 2009, ENDOSCOPY, V41, P762, DOI 10.1055/s-0029-1215009; Fukumoto A, 2009, GASTROINTEST ENDOSC, V69, P857, DOI 10.1016/j.gie.2008.06.007; Imagawa H, 2011, GASTROINTEST ENDOSC, V73, P299, DOI 10.1016/j.gie.2010.10.016; Trevisani F, 2002, AM J GASTROENTEROL, V97, P734; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Kumamoto M, 2010, J GASTROEN HEPATOL, V25, P1129, DOI 10.1111/j.1440-1746.2010.06262.x; DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1016/0270-9139(95)90388-7; Jeon SR, 2014, DIGEST DIS SCI, V59, P1036, DOI 10.1007/s10620-014-3036-3; Bosch J, 2008, SEMIN LIVER DIS, V28, P3, DOI 10.1055/s-2008-1040318; Aoyama T, 2013, DIGEST DIS SCI, V58, P1390, DOI 10.1007/s10620-012-2502-z; Barakat M, 2007, AM J GASTROENTEROL, V102, P2793, DOI 10.1111/j.1572-0241.2007.01536.x; De Palma GD, 2005, GASTROINTEST ENDOSC, V62, P529, DOI 10.1016/S0016-5107(05)01588-9; Goulas S, 2008, CAN J GASTROENTEROL, V22, P469; Higaki N, 2008, J GASTROENTEROL, V43, P327, DOI 10.1007/s00535-008-2166-9; Hino S, 2002, GASTROINTEST ENDOSC, V55, P512, DOI 10.1067/mge.2002.122333; Kodama M, 2008, J GASTROENTEROL, V43, P589, DOI 10.1007/s00535-008-2198-1; Martinez-Noguera A, 2002, SEMIN ULTRASOUND CT, V23, P19, DOI 10.1053/sult.2002.29796; Misra V, 1997, AM J CLIN PATHOL, V108, P652; Nagaoki Y, 2013, J GASTROENTEROL, V48, P847, DOI 10.1007/s00535-012-0679-8; North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices, 1988, N ENGL J MED, V319, P983; Raju Gottumukkala S, 2007, Gastroenterology, V133, P1697, DOI 10.1053/j.gastro.2007.06.007; Roberts-Thomson IC, 2010, J GASTROEN HEPATOL, V25, P1051, DOI 10.1111/j.1440-1746.2010.06333.x; Saad Wael E A, 2013, Tech Vasc Interv Radiol, V16, P60, DOI 10.1053/j.tvir.2013.02.002; Shishido T, 2012, HEPATO-GASTROENTEROL, V59, P955, DOI 10.5754/hge12242; Takahashi Y, 2012, DIGESTION, V86, P48, DOI 10.1159/000338180; Tang SJ, 2004, GASTROINTEST ENDOSC, V60, P129, DOI 10.1016/S0016-5107(04)01458-0; Toyoda H, 2001, DIGEST DIS SCI, V46, P2353, DOI 10.1023/A:1012390812488; VIGGIANO TR, 1992, AM J GASTROENTEROL, V87, P944; Weishaupt D, 2002, AM J ROENTGENOL, V178, P399; Yamada A, 2011, DIGEST ENDOSC, V23, P124, DOI 10.1111/j.1443-1661.2010.01050.x; Zardi EM, 2009, J GASTROENTEROL, V44, P76, DOI 10.1007/s00535-008-2279-1	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JAN	2015	30	1					124	130		10.1111/jgh.12658		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX2OO	WOS:000346783900022		
J	Hayashi, K; Katano, Y; Ishizu, Y; Kuzuya, T; Honda, T; Ishigami, M; Itoh, A; Hirooka, Y; Ishikawa, T; Nakano, I; Yoshioka, K; Toyoda, H; Kumada, T; Goto, H				Hayashi, Kazuhiko; Katano, Yoshiaki; Ishizu, Yoji; Kuzuya, Teiji; Honda, Takashi; Ishigami, Masatoshi; Itoh, Akihiro; Hirooka, Yoshiki; Ishikawa, Tetsuya; Nakano, Isao; Yoshioka, Kentaro; Toyoda, Hidenori; Kumada, Takashi; Goto, Hidemi			Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						genotype 2; hepatitis C virus; interleukin 28B; NS5A	RIBAVIRIN COMBINATION THERAPY; AMINO-ACID SUBSTITUTION; PROTEIN 5A GENE; VIROLOGICAL RESPONSE; VIRAL LOAD; IL28B; INFECTION; ALPHA; CORE; 1B	Background and AimThe single nucleotide polymorphism (SNP) of interleukin 28B (IL28B) and the mutations in the NS5A region of hepatitis C virus (HCV) genotype 1 have been associated with response to interferon (IFN) therapy. However, these relationships in patients with HCV genotype 2 are not well understood. The aim of this study was to investigate whether the SNP of IL28B (rs8099917) and amino acid substitutions in the NS5A region in patients with HCV genotype 2 affect the response to IFN and ribavirin combination therapy. MethodsThe study enrolled 286 patients with chronic hepatitis C genotype 2. Patients received pegylated-IFN-alpha 2b once each week plus oral ribavirin daily for 24 weeks. ResultsOf the 286 patients, 215 (75.2%) achieved sustained virologic response (SVR). Rate of SVR was similar in patients with IL28B TT allele (76%) and those with TG or GG alleles (72%). Patients with SVR were younger than those without SVR (P<0.001). SVR was achieved in 65.9% of patients with wild-type IFN sensitivity-determining region (ISDR) and 83.5% of patients with mutant type (P<0.001). There were no significant differences in other factors, including sex, alanine aminotransferase, platelet count, HCV viral load, HCV genotype, and IL28B genotype. The factors related to SVR on multivariate analysis were age (P=0.019) and ISDR (P=0.003). ConclusionsISDR sequence variations are significantly associated with IFN responsiveness in patients with HCV genotype 2. The SNP of IL28B was not associated with SVR in patients with HCV genotype 2.	[Hayashi, Kazuhiko; Ishizu, Yoji; Kuzuya, Teiji; Honda, Takashi; Ishigami, Masatoshi; Itoh, Akihiro; Hirooka, Yoshiki; Ishikawa, Tetsuya; Nakano, Isao; Goto, Hidemi] Fujita Hlth Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4548509, Japan; [Katano, Yoshiaki] Fujita Hlth Univ, Sch Med, Banbuntane Hotokukai Hosp, Dept Internal Med, Nagoya, Aichi 4548509, Japan; [Yoshioka, Kentaro] Fujita Hlth Univ, Dept Internal Med, Div Liver & Biliary Dis, Toyoake, Aichi, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan	Katano, Y (reprint author), Fujita Hlth Univ, Sch Med, Banbuntane Hotokukai Hosp, Dept Internal Med,Nakagawa Ku, 3-6-10 Otobashi, Nagoya, Aichi 4548509, Japan.	ykatano@med.nagoya-u.ac.jp					Akuta N, 2012, INTERVIROLOGY, V55, P231, DOI 10.1159/000328327; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Akuta N, 2012, J MED VIROL, V84, P1593, DOI 10.1002/jmv.23368; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Tanaka Y, 2010, HEPATOL RES, V40, P449, DOI 10.1111/j.1872-034X.2010.00671.x; Conjeevaram HS, 2007, HEPATOLOGY, V45, P80, DOI 10.1002/hep.21455; Kawaoka T, 2011, J HEPATOL, V54, P408, DOI 10.1016/j.jhep.2010.07.032; Hayashi K, 2011, J VIRAL HEPATITIS, V18, P280, DOI 10.1111/j.1365-2893.2010.01305.x; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Murakami T, 1999, HEPATOLOGY, V30, P1045, DOI 10.1002/hep.510300405; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Asselah T, 2010, J HEPATOL, V52, P452, DOI 10.1016/j.jhep.2009.11.016; Hayashi K, 2011, LIVER INT, V31, P1359, DOI 10.1111/j.1478-3231.2011.02571.x; Hayashi K, 2013, HEPATOL RES, V43, P580, DOI 10.1111/hepr.12005; Hayashi K, 2009, J MED VIROL, V81, P459, DOI 10.1002/jmv.21407; Hayashi K, 2003, HEPATOL RES, V25, P409, DOI 10.1016/S1386-6346(03)00016-0; Kumada H, 2010, HEPATOL RES, V40, P8, DOI 10.1111/j.1872-034X.2009.00634.x; Lindh M, 2011, J INFECT DIS, V203, P1748, DOI 10.1093/infdis/jir193; Nagase Y, 2008, HEPATOL RES, V38, P252, DOI 10.1111/j.1872-034X.2007.00257.x; Otagiri H, 2002, J VIROL METHODS, V103, P137, DOI 10.1016/S0166-0934(02)00018-6; Sakamoto N, 2011, J MED VIROL, V83, P871, DOI 10.1002/jmv.22038	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JAN	2015	30	1					178	183		10.1111/jgh.12673		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX2OO	WOS:000346783900029		
J	Ikemoto, T; Sugimoto, K; Shimada, M; Utsunomiya, T; Morine, Y; Imura, S; Arakawa, Y; Kanamoto, M; Iwahashi, S; Saito, Y; Yamada, S				Ikemoto, Tetsuya; Sugimoto, Koji; Shimada, Mitsuo; Utsunomiya, Tohru; Morine, Yuji; Imura, Satoru; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shu-ichi; Saito, Yu; Yamada, Shinichiro			Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						intraductal papillary mucinous neoplasms; Jagged1; Notch signaling; regulatory T cell	TUMOR-INDUCED TOLERANCE; NF-KAPPA-B; T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; CANCER PROGRESSION; PERIPHERAL-BLOOD; CARCINOMA; RESECTION; IMMUNITY; GROWTH	Background and AimThis study was performed to elucidate the expression of the Notch signaling pathway and its correlations to clinicopathological factors of intraductal papillary mucinous neoplasms (IPMNs). It is incontrovertible that regulatory T cells (Tregs) play an important role in tumor immunity. However, the whole mechanism of control of peripheral Tregs remains unclear. It is also known that the Notch signaling pathway is involved in Treg suppressor function. Moreover, IPMNs have a high malignant potential. MethodsPeripheral blood samples and resected specimens from 18 patients with IPMN were evaluated. All patients were pathologically diagnosed with IPMN. Resected specimens were immunohistochemically evaluated (anti-Notch1, anti-Notch2, and anti-Notch2-intracellular domain antibody staining) and compared in terms of clinicopathological factors. Peripheral Treg populations were analyzed with an automated flow cytometer. ResultsDisease-free survival was significantly worse in the Notch1 high-expression group (P=0.023). Notch2 family expressions were higher in intraductal papillary mucinous carcinoma (IPMC) than in intraductal papillary mucinous adenoma (IPMA) (Notch2, P=0.012; Notch2-intracellular domain, P=0.036). Jagged1 expression was significantly higher in IPMC than in IPMA (P<0.05) and was significantly related to recurrence. The Treg population in peripheral blood was higher in patients with IPMC than in those with IPMA (P<0.01). ConclusionsNotch signaling, especially Jagged1 expression, reflects IPMN aggressiveness. Our data may suggest that the Notch signaling pathway is a key pathway that determines IPMN pathological aggressiveness and reflects the peripheral Treg population.	[Ikemoto, Tetsuya; Sugimoto, Koji; Shimada, Mitsuo; Utsunomiya, Tohru; Morine, Yuji; Imura, Satoru; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shu-ichi; Saito, Yu; Yamada, Shinichiro] Univ Tokushima, Inst Hlth Biosci, Dept Surg, Tokushima 7708503, Japan	Ikemoto, T (reprint author), Univ Tokushima, Inst Hlth Biosci, Grad Sch Med, Dept Digest & Pediat Surg, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	ikemoto.tetsuya@tokushima-u.ac.jp					Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1127/JCI26490; Shimizu J, 1999, J IMMUNOL, V163, P5211; Yopp AC, 2011, ANN SURG, V253, P968, DOI 10.1097/SLA.0b013e318214bcb4; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Imamura M, 2004, SURGERY, V136, P1003, DOI 10.1016/j.surg.2004.04.030; Mitsuhashi Y, 2012, HISTOPATHOLOGY, V60, P826, DOI 10.1111/j.1365-2559.2011.04158.x; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Sethi N, 2011, BRIT J CANCER, V105, P1805, DOI 10.1038/bjc.2011.497; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; Sugimoto K, 2010, J IMMUNOL, V184, P4673, DOI 10.4049/jimmunol.0903661; Asano N, 2008, J IMMUNOL, V180, P2796; Ikemoto T, 2006, PANCREAS, V33, P386, DOI 10.1097/01.mpa.0000240275.68279.13; Keerthivasan S, 2011, J IMMUNOL, V187, P692, DOI 10.4049/jimmunol.1003658; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; Viguier M, 2004, J IMMUNOL, V173, P1444; Munn DH, 2006, CURR OPIN IMMUNOL, V18, P220, DOI 10.1016/j.coi.2006.01.002; D'Angelica M, 2004, ANN SURG, V239, P400, DOI 10.1097/01.sla.0000114132.47816.dd; Huang MT, 2009, J IMMUNOL, V183, P4745, DOI 10.4049/jimmunol.0804371; Chen HT, 2011, ANN SURG ONCOL S3, pS464; Ikemoto T, 2013, PANCREAS, V42, P130, DOI 10.1097/MPA.0b013e3182575e4a; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Ma YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033414; Sandy AR, 2012, ADV EXP MED BIOL, V727, P71, DOI 10.1007/978-1-4614-0899-4_6; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020537	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JAN	2015	30	1					217	222		10.1111/jgh.12660		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX2OO	WOS:000346783900034		
J	Itokawa, F; Itoi, T; Sofuni, A; Kurihara, T; Tsuchiya, T; Ishii, K; Tsuji, S; Ikeuchi, N; Umeda, J; Tanaka, R; Tonozuka, R; Honjyo, M; Moriyasu, F; Kasuya, K; Tsuchida, A				Itokawa, Fumihide; Itoi, Takao; Sofuni, Atsushi; Kurihara, Toshio; Tsuchiya, Takayoshi; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Umeda, Junko; Tanaka, Reina; Tonozuka, Ryosuke; Honjyo, Mitsuyoshi; Moriyasu, Fuminori; Kasuya, Kazuhiko; Tsuchida, Akihiko			Mid-term outcome of endoscopic sphincterotomy combined with large balloon dilation	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						endoscopic papillary large balloon dilation; endoscopic sphincterotomy; large balloon dilation; large bile duct stone	BILE-DUCT STONES; BILLROTH-II GASTRECTOMY; TERM-FOLLOW-UP; BILIARY SPHINCTEROTOMY; PAPILLARY DILATION; RISK-FACTORS; LIMITED SPHINCTEROTOMY; MULTICENTER SERIES; RANDOMIZED-TRIAL; REMOVAL	Background and AimEndoscopic sphincterotomy (ES) combined with large balloon dilation (ESLBD) can be useful for extracting large and multiple bile duct stones. Although there are many studies on the feasibility and short-term outcome, there are few reports about mid- to long-term outcome after ESLBD. The aim of our study is to prospectively evaluate the mid-term outcome of ESLBD. MethodsOne hundred eighty-three patients who underwent ESLBD between November 2006 and May 2012 were included. The patients were followed up periodically after the procedure until April 2013. Papillary dilation was performed at the time of initial ES or prior ES. Early and late adverse events and stone recurrence were evaluated in this study. ResultsThe patients' mean age was 76.610.7 years. Surgically altered anatomy was present: Billroth I gastrectomy (2), Billroth II gastrectomy (13), and gastrectomy with Roux-en Y reconstruction (18). Seventy-eight (42.6%) patients had periampullary diverticulum. Prior ES had been performed in 40 (21.9%) patients. The mean follow-up period was 43.5 +/- 19.7 months (range 11-78). Eight (4.4%) patients had stone recurrence. There was rare stone recurrence after initial ESLBD treatment and native gastrointestinal anatomy. Univariate and multivariate analyses showed that prior ES and previous history of stone recurrence were predictive of stone recurrence (P<0.001). ConclusionAt mid-term outcome, ESLBD is associated with a low rate of recurrent bile duct stones, although long-term follow up is needed.	[Itokawa, Fumihide; Itoi, Takao; Sofuni, Atsushi; Kurihara, Toshio; Tsuchiya, Takayoshi; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Umeda, Junko; Tanaka, Reina; Tonozuka, Ryosuke; Honjyo, Mitsuyoshi; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan; [Kasuya, Kazuhiko; Tsuchida, Akihiko] Tokyo Med Univ, Dept Surg 3, Tokyo 1600023, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Shimatani M, 2009, ENDOSCOPY, V41, P849, DOI 10.1055/s-0029-1215108; Attasaranya S, 2008, GASTROINTEST ENDOSC, V67, P1046, DOI 10.1016/j.gie.2007.08.047; Cheon YK, 2006, EUR J GASTROEN HEPAT, V18, P461, DOI 10.1097/00042737-200605000-00001; Tanaka M, 1998, GASTROINTEST ENDOSC, V48, P465, DOI 10.1016/S0016-5107(98)70086-0; Keizman D, 2006, SURG ENDOSC, V20, P1594, DOI 10.1007/s00464-005-0656-x; Park SJ, 2013, DIGEST DIS SCI, V58, P1100, DOI 10.1007/s10620-012-2494-8; HAWES RH, 1990, GASTROENTEROLOGY, V98, P1008; Mallery JS, 2003, GASTROINTEST ENDOSC, V57, P633, DOI 10.1053/ge.2003.v57.amge030576633; KAWAI K, 1974, GASTROINTEST ENDOSC, V20, P148, DOI 10.1016/S0016-5107(74)73914-1; Faylona JMV, 1999, ENDOSCOPY, V31, P546; Kim HG, 2009, WORLD J GASTROENTERO, V15, P4298, DOI 10.3748/wjg.15.4298; Teoh AYB, 2013, GASTROENTEROLOGY, V144, P341, DOI 10.1053/j.gastro.2012.10.027; Meine GC, 2011, GASTROINTEST ENDOSC, V74, P1119, DOI 10.1016/j.gie.2011.06.042; Yasuda I, 2010, GASTROINTEST ENDOSC, V72, P1185, DOI 10.1016/j.gie.2010.07.006; Feng YD, 2012, J GASTROENTEROL, V47, P655, DOI 10.1007/s00535-012-0528-9; Kim KO, 2010, J GASTROENTEROL, V45, P1283, DOI 10.1007/s00535-010-0284-7; Kurita A, 2010, SCAND J GASTROENTERO, V45, P1242, DOI 10.3109/00365521.2010.495420; Ersoz G, 2003, GASTROINTEST ENDOSC, V57, P156, DOI 10.1067/mge.2003.52; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Heo JH, 2007, GASTROINTEST ENDOSC, V66, P720, DOI 10.1016/j.gie.2007.02.033; CLASSEN M, 1974, DEUT MED WOCHENSCHR, V99, P496; Kim DI, 2001, GASTROINTEST ENDOSC, V54, P42, DOI 10.1067/mge.2001.115335; Itoi T, 2009, AM J GASTROENTEROL, V104, P560, DOI 10.1038/ajg.2008.67; Draganov PV, 2009, J CLIN GASTROENTEROL, V43, P782, DOI 10.1097/MCG.0b013e31818f50a2; Lee TH, 2009, ENDOSCOPY, V41, pE241, DOI 10.1055/s-0029-1214984; Bergman JJGHM, 2001, GASTROINTEST ENDOSC, V53, P19, DOI 10.1067/mge.2001.110454; Bang S, 2006, YONSEI MED J, V47, P805; Bergman JJGHM, 1996, GASTROINTEST ENDOSC, V44, P643, DOI 10.1016/S0016-5107(96)70045-7; Espinel J, 2007, REV ESP ENFERM DIG, V66, P720; IKEDA S, 1988, ENDOSCOPY, V20, P13, DOI 10.1055/s-2007-1018117; Itoi T, 2011, DIGEST LIVER DIS, V43, P237, DOI 10.1016/j.dld.2010.09.002; Itoi T, 2010, DIGEST ENDOSC, V22, pS98, DOI 10.1111/j.1443-1661.2010.00955.x; Itoi T, 2010, GASTROINTEST ENDOSC, V72, P825, DOI 10.1016/j.gie.2010.06.018; Jakobs R, 2006, EUR J GASTROEN HEPAT, V18, P469, DOI 10.1097/00042737-200605000-00003; Jang SE, 2013, DIGEST DIS SCI, V58, P2353, DOI 10.1007/s10620-013-2647-4; Kim Jung Ho, 2011, Clin Endosc, V44, P123, DOI 10.5946/ce.2011.44.2.123; Kim KH, 2012, GUT LIVER, V6, P107, DOI 10.5009/gnl.2012.6.1.107; Lee Dong Ki, 2012, Clin Endosc, V45, P299, DOI 10.5946/ce.2012.45.3.299; Maple JT, 2011, GASTROINTEST ENDOSC, V74, P731, DOI 10.1016/j.gie.2011.04.012; Maydeo A, 2007, Endoscopy, V39, P958, DOI 10.1055/s-2007-966784; Minami A, 2007, WORLD J GASTROENTERO, V13, P2179; Prat F, 1996, GASTROENTEROLOGY, V110, P894, DOI 10.1053/gast.1996.v110.pm8608900; Tanaka S, 2004, GASTROINTEST ENDOSC, V59, P614, DOI 10.1016/S0016-5107(04)00157-9; Youn YH, 2011, DIGEST DIS SCI, V56, P1572, DOI 10.1007/s10620-010-1438-4	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	JAN	2015	30	1					223	229		10.1111/jgh.12675		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX2OO	WOS:000346783900035		
J	Iizuka, M; Tsuboi, H; Matsuo, N; Asashima, H; Hirota, T; Kondo, Y; Iwakura, Y; Takahashi, S; Matsumoto, I; Sumida, T				Iizuka, Mana; Tsuboi, Hiroto; Matsuo, Naomi; Asashima, Hiromitsu; Hirota, Tomoya; Kondo, Yuya; Iwakura, Yoichiro; Takahashi, Satoru; Matsumoto, Isao; Sumida, Takayuki			A Crucial Role of ROR gamma t in the Development of Spontaneous Sialadenitis-like Sjogren's Syndrome	JOURNAL OF IMMUNOLOGY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; SALIVARY-GLAND DYSFUNCTION; TH17 CELLS; REGULATORY CELLS; FOXP3 GENE; RECEPTOR; EXPRESSION; BETA; MICE; DIFFERENTIATION	The nuclear receptor retinoic acid-related orphan receptor (ROR)gamma t is required for the generation of Th17 cells, which are involved in various autoimmune diseases, including Sjogren's syndrome (SS). However, the pathological role of ROR gamma t in SS remains to be elucidated. The present study was designed to clarify the role of ROR gamma t in the pathogenesis of sialadenitis-like SS. Histological analysis of ROR gamma t transgenic (Tg) mice was determined, and then Tg mice developed severe spontaneous sialadenitis-like SS. The analysis of infiltrating cells showed that most infiltrating cells were CD4(+) T cells. ROR gamma t-overexpressing CD4(+) T cells induced sialadenitis as a result of transferred CD4(+) T cells from Tg mice into Rag2(-/-) mice. The examination of IL-17-deficient Tg mice indicated that IL-17 was not essential for the development of sialadenitis. The number of CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells was significantly decreased in Tg mice, and CD25 expression and IL-2 stimulated STAT5 activation were inhibited in Treg cells. The inhibitory function of Treg cells of Tg mice was equal to that of wild-type mice in vitro. The abundant Treg cells of Tg mice could suppress the development of sialadenitis, but the reduced Treg cells of Tg mice could not inhibit the induction of sialadenitis in Rag2(-/-) mice transferred with effector cells from Tg mice. These results suggest that both ROR gamma t-overexpressed CD4(+) T cells and reduced Treg cells might contribute to the development of SS-like sialadenitis.	[Iizuka, Mana; Tsuboi, Hiroto; Matsuo, Naomi; Asashima, Hiromitsu; Hirota, Tomoya; Kondo, Yuya; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Dept Internal Med, Fac Med, Tsukuba, Ibaraki 3050006, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 2780022, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Sumida, T (reprint author), Univ Tsukuba, Dept Internal Med, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	tsumida@md.tsukuba.ac.jp			Ministry of Health, Labor and Welfare, Japan	This work was supported by Research Program for Intractable Diseases Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan.	Sakai A, 2008, J IMMUNOL, V181, P2898; Li XM, 2007, J RHEUMATOL, V34, P2438; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; ADAMSON TC, 1983, J IMMUNOL, V130, P203; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Naito Y, 2005, ANN RHEUM DIS, V64, P510, DOI 10.1136/ard.2004.025478; Mitsias DI, 2002, CLIN EXP IMMUNOL, V128, P562, DOI 10.1046/j.1365-2249.2002.01869.x; Dawson LJ, 2006, ARTHRITIS RHEUM, V54, P1165, DOI 10.1002/art.21764; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Manoussakis MN, 2010, J AUTOIMMUN, V35, P219, DOI 10.1016/j.jaut.2010.06.011; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Burchill MA, 2007, J IMMUNOL, V178, P280; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; He YW, 2000, J IMMUNOL, V164, P5668; Vosters JL, 2009, ARTHRITIS RHEUM, V60, P3633, DOI 10.1002/art.24980; Leach MW, 1996, AM J PATHOL, V148, P1503; Cheng GY, 2013, J IMMUNOL, V190, P1567, DOI 10.4049/jimmunol.1201218; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P178, DOI 10.1016/j.coi.2012.02.003; Nguyen CQ, 2008, ARTHRITIS RHEUM, V58, P734, DOI 10.1002/art.23214; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Christodoulou MI, 2008, AM J PATHOL, V173, P1389, DOI 10.2353/ajpath.2008.080246; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Christodoulou MI, 2010, J AUTOIMMUN, V34, P400, DOI 10.1016/j.jaut.2009.10.004; Font J, 1998, ANN RHEUM DIS, V57, P42, DOI 10.1136/ard.57.1.42; Fox R I, 1992, J Rheumatol Suppl, V32, P18; Fox RI, 2002, SCAND J RHEUMATOL, V31, P3; GREENSPA.JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4; Iizuka M, 2010, J AUTOIMMUN, V35, P383, DOI 10.1016/j.jaut.2010.08.004; Kamimura T, 2005, INTERNAL MED, V44, P657, DOI 10.2169/internalmedicine.44.657; Matsumoto I, 1999, INT J MOL MED, V3, P485; Nguyen CQ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3207; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sharma R, 2006, J AUTOIMMUN, V27, P289, DOI 10.1016/j.jaut.2006.11.003; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Sumida T, 2000, Mod Rheumatol, V10, P193, DOI 10.3109/s101650070001; Sumida T, 1996, LANCET, V348, P1667, DOI 10.1016/S0140-6736(05)65741-8; Wakamatsu E, 2006, ARTHRITIS RHEUM, V54, P3476, DOI 10.1002/art.22176; Wright SA, 2003, RHEUMATOLOGY, V42, P697, DOI 10.1093/rheumatology/keg149	51	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JAN 1	2015	194	1					56	67		10.4049/jimmunol.1401118		12	Immunology	Immunology	AX1IH	WOS:000346700500008		
J	Liu, S; Kiyoi, T; Takemasa, E; Maeyama, K				Liu, Shuang; Kiyoi, Takeshi; Takemasa, Erika; Maeyama, Kazutaka			Systemic Lentivirus-Mediated Delivery of Short Hairpin RNA Targeting Calcium Release-Activated Calcium Channel 3 as Gene Therapy for Collagen-Induced Arthritis	JOURNAL OF IMMUNOLOGY			English	Article							OPERATED CA2+ ENTRY; OSTEOCLAST DIFFERENTIATION; RHEUMATOID-ARTHRITIS; CRAC CHANNELS; ORAI1; DISEASE; INHIBITION; AUTOIMMUNE; MIGRATION; PROTEINS	Immune cells, including T cells, B cells, and osteoclasts, in conjunction with their associated cytokines, have been studied as primary molecular therapeutic targets for the management of rheumatoid arthritis (RA) patients. The increase in cytosolic Ca2+ levels through the activation of store-operated Ca2+ release-activated channels (CRACs) is involved in mediating a disparate array of cellular responses by these immune cells. This study was undertaken to investigate the feasibility and efficiency of the regulation of Ca2+ entry in the treatment of RA. To moderately suppress Ca2+ entry via CRACs, we gene silenced CRACM3,which was induced by systemic application of specific short hairpin RNAs (shRNAs) using a lentiviral-delivery system, in a murine model of collagen-induced arthritis (CIA). The inflammatory responses were determined by measuring the levels of a panel of cytokines and chemokines in the joints and serum. Ag-specific responses were evaluated by determining the cytokine profile of T cells stimulated with autoantigen. We also analyzed the ability of specific CRACM3-shRNA to regulate mature osteoclast function in CIA mice. The therapeutic effect of lentiviral-delivered CRACM3-shRNA was associated with gene silencing of CRACM3, along with the successful biodistribution of the virus. Extracellular Ca2+ influx in the splenocytes, thymocytes, and knee joint synovial cells was moderately suppressed. Inflammatory responses and autoimmune responses were reduced by CRACM3 gene silencing. A decrease in mature osteoclast activity also was observed in CRACM3-shRNA-treated CIA mice. These results indicate that regulation of Ca2+ entry through lentivirus-mediated CRACM3 gene silencing is beneficial in the treatment of RA.	[Liu, Shuang; Kiyoi, Takeshi; Takemasa, Erika; Maeyama, Kazutaka] Ehime Univ, Dept Pharmacol, Grad Sch Med, Toon, Ehime 7910295, Japan; [Kiyoi, Takeshi] Ehime Univ, Dept Biosci, Integrated Ctr Sci, Toon, Ehime 7910295, Japan	Liu, S (reprint author), Ehime Univ, Dept Pharmacol, Grad Sch Med, Toon, Ehime 7910295, Japan.	liussmzk@m.ehime-u.ac.jp			Ehime University [054102020]	This work was supported by Grant-in-Aid for Research Promotion 054102020 from Ehime University.	McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Lin FF, 2013, J PHARMACOL EXP THER, V345, P225, DOI 10.1124/jpet.112.202788; Baryshnikov SG, 2009, AM J PHYSIOL-CELL PH, V297, pC1103, DOI 10.1152/ajpcell.00283.2009; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Zhou YD, 2011, J CELL PHYSIOL, V226, P1082, DOI 10.1002/jcp.22423; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Robinson LJ, 2012, LAB INVEST, V92, P1071, DOI 10.1038/labinvest.2012.72; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Hoth M, 2013, CURR TOP MEMBR, V71, P237, DOI 10.1016/B978-0-12-407870-3.00010-X; Baba Y, 2011, TRENDS IMMUNOL, V32, P589, DOI 10.1016/j.it.2011.09.004; El Azreq MA, 2013, J IMMUNOL, V191, P5941, DOI 10.4049/jimmunol.1301940; Hwang SY, 2012, FASEB J, V26, P1484, DOI 10.1096/fj.11-194399; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Bogado CE, 2011, DRUG TODAY, V47, P605, DOI 10.1358/dot.2011.47.8.1603507; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Liu S, 2014, IMMUNOL CELL BIOL, V92, P752, DOI 10.1038/icb.2014.45; Qu Bin, 2011, Cell Calcium, V50, P261, DOI 10.1016/j.ceca.2011.05.015	24	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JAN 1	2015	194	1					76	83		10.4049/jimmunol.1401976		8	Immunology	Immunology	AX1IH	WOS:000346700500010		
J	Nakamura, M; Shibata, K; Hatano, S; Sato, T; Ohkawa, Y; Yamada, H; Ikuta, K; Yoshikai, Y				Nakamura, Masataka; Shibata, Kensuke; Hatano, Shinya; Sato, Tetsuya; Ohkawa, Yasuyuki; Yamada, Hisakata; Ikuta, Koichi; Yoshikai, Yasunobu			A Genome-Wide Analysis Identifies a Notch-RBP-J kappa-IL-7R alpha Axis That Controls IL-17-Producing gamma delta T Cell Homeostasis in Mice	JOURNAL OF IMMUNOLOGY			English	Article							RECEPTOR-DEFICIENT MICE; IN-VIVO; LINEAGE DETERMINATION; IMMUNE-SYSTEM; FETAL THYMUS; NOTCH; EXPRESSION; DIFFERENTIATION; MEMORY; IL-7	Notch signaling is an important regulator for the development and function of both alpha beta and gamma delta T cells, whereas roles of Notch signaling in T cell maintenance remain unclear. We reported previously that the Notch-Hes1 pathway was involved in the intrathymic development of naturally occurring IL-17-producing (IL-17(+)) gamma delta T cells. To gain insight into additional roles for the Notch axis in the homeostasis of gamma delta T cells, we performed a genome-wide analysis of Notch target genes and identified the novel promoter site of IL-7R alpha driven by the Notch-RBP-J kappa pathway. Constitutive Notch signaling had the potential to induce IL-7R alpha expression on gamma delta T cells in vivo, as well as in vitro, whereas conditional deletion of RBP-J kappa abrogated IL-7R alpha expression, but not Hes1 expression, by gamma delta T cells and selectively reduced the pool size of IL-7R alpha high IL-17(+) gamma delta T cells in the periphery. In the absence of IL-7R alpha-mediated signaling, IL-17(+) gamma delta T cells were barely maintained in adult mice. Addition of exogenous IL-7 in vitro selectively expanded IL-17(+) gamma delta T cells. Thus, our results revealed a novel role for the Notch-RBP-J kappa-IL-7R alpha axis that is independent of Hes1 for homeostasis of IL-17(+) gamma delta T cells.	[Nakamura, Masataka; Shibata, Kensuke; Hatano, Shinya; Yamada, Hisakata; Yoshikai, Yasunobu] Kyushu Univ, Med Inst Bioregulat, Div Host Def, Fukuoka 8128582, Japan; [Sato, Tetsuya] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Fukuoka 8128582, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Epigenet, Fukuoka 8128582, Japan; [Ikuta, Koichi] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Biol Protect, Kyoto 6068507, Japan	Shibata, K (reprint author), Kyushu Univ, Med Inst Bioregulat, Div Host Def, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	k_shibata@bioreg.kyushu-u.ac.jp			Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases; Japan Society for Promotion of Science; Japanese Ministry of Education, Science and Culture; Kaibara Morikazu Medical Science Promotion Foundation; Takeda Science Foundation	This work was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, which is a project launched and commissioned by the Japanese Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid from the Japan Society for Promotion of Science; and by grants from the Japanese Ministry of Education, Science and Culture (to Y.Y. and K.S.). K.S. received support from the Kaibara Morikazu Medical Science Promotion Foundation and the Takeda Science Foundation.	Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Kang J, 1999, J EXP MED, V190, P973, DOI 10.1084/jem.190.7.973; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Schmolka N, 2013, NAT IMMUNOL, V14, P1093, DOI 10.1038/ni.2702; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Shibata K, 2014, J IMMUNOL, V192, P2210, DOI 10.4049/jimmunol.1302145; Anastasi E, 2003, J IMMUNOL, V171, P4504; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; HEILIG JS, 1986, NATURE, V322, P836, DOI 10.1038/322836a0; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kared H, 2006, IMMUNITY, V25, P823, DOI 10.1016/j.immuni.2006.09.008; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Ferrero I, 2001, J EXP MED, V194, P1473, DOI 10.1084/jem.194.10.1473; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Shibata K, 2008, J IMMUNOL, V181, P5940; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Ferrero I, 2013, EUR J IMMUNOL, V43, P2845, DOI 10.1002/eji.201343527; Fiorini E, 2009, J IMMUNOL, V183, P7212, DOI 10.4049/jimmunol.0902432; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kagami S, 2001, BLOOD, V97, P2358, DOI 10.1182/blood.V97.8.2358; Laky K, 2003, J IMMUNOL, V170, P4087; Lee J. S., 2011, NAT IMMUNOL, V13, P144, DOI DOI 10.1038/NI.2187; Maki K, 1996, J EXP MED, V184, P2423, DOI 10.1084/jem.184.6.2423; Masuda K, 2007, J IMMUNOL, V179, P3699; Nakazato K, 2007, J IMMUNOL, V178, P757; Rothenberg EV, 2010, IMMUNOL REV, V238, P5, DOI 10.1111/j.1600-065X.2010.00965.x; Sheridan BS, 2013, IMMUNITY, V39, P184, DOI 10.1016/j.immuni.2013.06.015; Sun X, 2013, MUCOSAL IMMUNOL, V6, P1191, DOI 10.1038/mi.2013.18; Takatori H, 2005, J IMMUNOL, V174, P4105; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	58	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JAN 1	2015	194	1					243	251		10.4049/jimmunol.1401619		9	Immunology	Immunology	AX1IH	WOS:000346700500027		
J	Suenaga, F; Ueha, S; Abe, J; Kosugi-Kanaya, M; Wang, Y; Yokoyama, A; Shono, Y; Shand, FHW; Morishita, Y; Kunisawa, J; Sato, S; Kiyono, H; Matsushima, K				Suenaga, Fumiko; Ueha, Satoshi; Abe, Jun; Kosugi-Kanaya, Mizuha; Wang, Yong; Yokoyama, Akihiro; Shono, Yusuke; Shand, Francis H. W.; Morishita, Yasuyuki; Kunisawa, Jun; Sato, Shintaro; Kiyono, Hiroshi; Matsushima, Kouji			Loss of Lymph Node Fibroblastic Reticular Cells and High Endothelial Cells Is Associated with Humoral Immunodeficiency in Mouse Graft-versus-Host Disease	JOURNAL OF IMMUNOLOGY			English	Article							BONE-MARROW-TRANSPLANTATION; ANTIVIRAL IMMUNE-RESPONSES; STEM-CELL; T-CELLS; B-CELLS; LEUKEMIA; ANTIGEN; MICE; TRAFFICKING; GUIDELINES	Graft-versus-host disease (GVHD) is a major risk factor for prolonged humoral immunodeficiency and vaccine unresponsiveness after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the underlying mechanisms for this immunodeficiency are poorly understood. In this article, we describe previously overlooked impacts of GVHD on lymph node (LN) stromal cells involved in humoral immune responses. In major-and minor-mismatched mouse allo-HSCT models, recipients with CD8(+) T cell-mediated GVHD suffered severe and irreversible damage to LN structure. These mice were susceptible to pathogenic infection and failed to mount humoral immune responses despite the presence of peripheral T and B cells. These humoral immune defects were associated with the early loss of fibroblastic reticular cells, most notably the CD157(+) cell subset, as well as structural defects in high endothelial venules. The disruption to these LN stromal cells was dependent on alloantigens expressed by nonhematopoietic cells. Blockade of the Fas-FasL pathway prevented damage to CD157(+) fibroblastic reticular cells and ameliorated LN GVHD. However, blockade of CD62L- or CCR7-dependent migration of CD8(+) T cells to the LN was insufficient to prevent stromal cell injury. Overall, our results highlight GVHD-associated loss of functional stromal cells and LN GVHD as a possible explanation for the prolonged susceptibility to infectious disease that is experienced by allo-HSCT patients.	[Suenaga, Fumiko; Ueha, Satoshi; Abe, Jun; Kosugi-Kanaya, Mizuha; Wang, Yong; Yokoyama, Akihiro; Shono, Yusuke; Shand, Francis H. W.; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan; [Suenaga, Fumiko; Ueha, Satoshi; Abe, Jun; Kosugi-Kanaya, Mizuha; Wang, Yong; Yokoyama, Akihiro; Shand, Francis H. W.; Matsushima, Kouji] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020076, Japan; [Kosugi-Kanaya, Mizuha; Shono, Yusuke] Hokkaido Univ, Grad Sch Med, Dept Hematol & Oncol, Sapporo, Hokkaido 0608638, Japan; [Morishita, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Kunisawa, Jun; Sato, Shintaro; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo 1080071, Japan	Matsushima, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	koujim@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology KAKENHI [23790432]; Challenging Exploratory Research [24659216]	This work was supported by Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grants-in-Aid for Japan Society for the Promotion of Science Fellows (to E.S.), Young Scientists (B) Grant 23790432 (to S.U.), and Challenging Exploratory Research Grant 24659216 (to K.M.).	Abe J, 2012, INT IMMUNOL, V24, P17, DOI 10.1093/intimm/dxr089; Jimenez M, 2007, LEUKEMIA, V21, P1628, DOI 10.1038/sj.leu.2404681; LJUNGMAN P, 1990, J INFECT DIS, V162, P496; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Engelhard D, 2011, VACCINE, V29, P1777, DOI 10.1016/j.vaccine.2010.12.113; D'Orsogna L, 2009, BIOL BLOOD MARROW TR, V15, P795, DOI 10.1016/j.bbmt.2008.11.024; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Hossain MS, 2007, BLOOD, V109, P4548, DOI 10.1182/blood-2006-04-017442; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Cooke KR, 1996, BLOOD, V88, P3230; Baldomero H, 2011, BONE MARROW TRANSPL, V46, P485, DOI 10.1038/bmt.2011.11; Shand FHW, 2014, P NATL ACAD SCI USA, V111, P7771, DOI 10.1073/pnas.1402914111; Biedermann BC, 2002, LANCET, V359, P2078, DOI 10.1016/S0140-6736(02)08907-9; Shono Y, 2010, BLOOD, V115, P5401, DOI 10.1182/blood-2009-11-253559; Schmaltz C, 2001, BLOOD, V97, P2886, DOI 10.1182/blood.V97.9.2886; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; DILLY SA, 1986, J PATHOL, V150, P213, DOI 10.1002/path.1711500310; Forster R, 2008, SEMIN IMMUNOL, V20, P171, DOI 10.1016/j.smim.2008.03.001; Frangoul H, 2012, SEMIN HEMATOL, V49, P94, DOI 10.1053/j.seminhematol.2011.10.012; Friedrich T, 1991, Verh Dtsch Ges Pathol, V75, P136; Hilgendorf Inken, 2011, Vaccine, V29, P2825, DOI 10.1016/j.vaccine.2011.02.018; HORNY HP, 1988, BLUT, V57, P31, DOI 10.1007/BF00320632; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Kunisawa J, 2007, BLOOD, V109, P3749, DOI 10.1182/blood-2006-08-041582; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Roll D, 2012, INFECTION, V40, P153, DOI 10.1007/s15010-011-0206-5; Tomblyn M, 2009, BONE MARROW TRANSPL, V44, P453, DOI 10.1038/bmt.2009.254; Tsukada N, 1999, BLOOD, V93, P2738; Voedisch S, 2009, INFECT IMMUN, V77, P3170, DOI 10.1128/IAI.00272-09	39	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JAN 1	2015	194	1					398	406		10.4049/jimmunol.1401022		9	Immunology	Immunology	AX1IH	WOS:000346700500042		
J	Iemura, A; Kondoh, E; Kawasaki, K; Fujita, K; Ueda, A; Mogami, H; Baba, T; Konishi, I				Iemura, Asako; Kondoh, Eiji; Kawasaki, Kaoru; Fujita, Kohei; Ueda, Akihiko; Mogami, Haruta; Baba, Tsukasa; Konishi, Ikuo			Expectant management of a herniated amniotic sac presenting as silent uterine rupture: a case report and literature review	JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE			English	Article						Conservative management; diffuse uterine leiomyomatosis; pregnancy; uterine dehiscence; uterine rupture	SONOGRAPHIC DIAGNOSIS; CONSERVATIVE MANAGEMENT; WEEKS GESTATION; 2ND TRIMESTER; DEHISCENCE; PREGNANCY; ULTRASOUND; CURETTAGE; AMNIOCELE; HISTORY	Foetal membranes bulging into the abdominal cavity is a unique initial manifestation of silent or complete uterine rupture during pregnancy. Since silent uterine rupture has potential risk for complete uterine rupture, which leads to acute life-threatening complications for both the mother and baby, it is difficult to determine whether to manage expectantly or surgically, including repair of the uterine wall or termination of the pregnancy, especially in the early second trimester. We present here a case of a herniated amniotic sac with overstretched uterine wall of the fundus presenting as silent uterine rupture, which was incidentally detected on routine ultrasonography at 18 weeks' gestation in a 38-year-old primigravida with a history of myomectomy for diffuse uterine leiomyomatosis. Magnetic resonance imaging examination revealed that the myometrium thickness was fully maintained at the site of the foetal membranes ballooning. The pregnancy was therefore managed expectantly and continued to successful delivery at 30 weeks' gestation. The precise assessment of the uterine wall may be essential to manage a herniated amniotic sac presenting as silent uterine rupture and to optimise the outcome of the pregnancy. We review all cases of a herniated amniotic sac out of focally overstretched uterine wall before 34 weeks' gestation.	[Iemura, Asako; Kondoh, Eiji; Kawasaki, Kaoru; Fujita, Kohei; Ueda, Akihiko; Mogami, Haruta; Baba, Tsukasa; Konishi, Ikuo] Kyoto Univ, Dept Obstet & Gynaecol, Kyoto 6068507, Japan	Kondoh, E (reprint author), Kyoto Univ, Dept Obstet & Gynaecol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kondo@kuhp.kyoto-u.ac.jp					Hamar BD, 2003, OBSTET GYNECOL, V102, P1139, DOI 10.1016/S0029-7844(03)00162-5; Cheng PJ, 2003, ULTRASOUND OBST GYN, V21, P501, DOI 10.1002/uog.109; AVRECH OM, 1994, ULTRASOUND OBST GYN, V4, P151, DOI 10.1046/j.1469-0705.1994.04020151.x; Bujold E, 2009, AM J OBSTET GYNECOL, V201; Catanzarite VA, 1996, AM J PERINAT, V13, P177, DOI 10.1055/s-2007-994320; Chen FP, 2007, J REPROD MED, V52, P981; Chou MM, 2007, ULTRASOUND OBST GYN, V30, P364, DOI 10.1002/uog.4089; COTTON DB, 1982, AM J OBSTET GYNECOL, V142, P1059; Deka Deepika, 2011, Arch Gynecol Obstet, V283 Suppl 1, P45, DOI 10.1007/s00404-010-1798-1; Fujii T, 2000, INT J GYNECOL OBSTET, V68, P261, DOI 10.1016/S0020-7292(99)00217-9; Gorthi S, 2009, EUR J OBSTET GYN R B, V147, P241, DOI 10.1016/j.ejogrb.2009.08.018; HAMRICKTURNER JE, 1995, ABDOM IMAGING, V20, P486, DOI 10.1007/BF01213280; Hasbargen U, 2002, HUM REPROD, V17, P2180, DOI 10.1093/humrep/17.8.2180; Hunter TJ, 2009, FETAL DIAGN THER, V25, P123, DOI 10.1159/000207451; Jo YS, 2012, INT J MED SCI, V9, P387, DOI 10.7150/ijms.3383; KUSHNIR O, 1990, J ULTRAS MED, V9, P367; Liao CY, 2009, J MINIM INVAS GYN, V16, P493, DOI 10.1016/j.jmig.2009.03.025; MARKOS F, 1995, AM J OBSTET GYNECOL, V172, P224, DOI 10.1016/0002-9378(95)90124-8; Nomizo M, 2013, ADV OBSTET GYNECOL, V65, P40; Oyelese Y, 2003, J ULTRAS MED, V22, P977; Rabinowitz R, 2006, ULTRASOUND OBST GYN, V28, P235, DOI 10.1002/uog.2847; Taipale P, 2005, ULTRASOUND OBST GYN, V25, P418, DOI 10.1002/uog.1869; VANALPHEN M, 1995, ULTRASOUND OBST GYN, V5, P419, DOI 10.1046/j.1469-0705.1995.05060419.x; Youngs DJ, 2004, J DIAGN MED SONOG, V20, P418, DOI 10.1177/8756479304268938; Zuckerwise LC, 2011, OBSTET GYNECOL, V118, P497, DOI 10.1097/AOG.0b013e3182257b51	25	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1476-7058	1476-4954		J MATERN-FETAL NEO M	J. Matern.-Fetal Neonatal Med.	JAN	2015	28	1					106	112		10.3109/14767058.2014.900533		7	Obstetrics & Gynecology	Obstetrics & Gynecology	AX0SA	WOS:000346660800024		
J	Casellas, R; Munoz, R; Martinez, R; Vilalta, R; Liu, L; Tsuritani, T; Morita, I; Lopez, V; de Dios, OG; Fernandez-Palacios, JP				Casellas, Ramon; Munoz, Rauel; Martinez, Ricardo; Vilalta, Ricard; Liu, Lei; Tsuritani, Takehiro; Morita, Itsuro; Lopez, Victor; Gonzalez de Dios, Oscar; Pedro Fernandez-Palacios, Juan			SDN Orchestration of OpenFlow and GMPLS Flexi-Grid Networks With a Stateful Hierarchical PCE	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Hierarchical PCE (H-PCE); Optical network control and management; Optical OpenFlow; Orchestration; Path computation element (PCE); Software-defined networking (SDN); Stateful	OPTICAL NETWORKS; CONTROL PLANE	New and emerging use cases, such as the interconnection of geographically remote data centers, are drawing attention to the need for provisioning end-to-end connectivity services spanning multiple and heterogeneous network domains. This heterogeneity is due not only to the data transmission and switching technology (the so-called data plane) but also to the deployed control plane, which may be used within each domain to automate the setup and recovery of such services, dynamically. The choice of a control plane is affected by factors such as availability, maturity, operator's preference, and the ability to satisfy a list of functional requirements. Given the current developments around OpenFlow and software-defined networking (SDN) along with the need to account for existing deployments based on GMPLS, the problem of heterogeneous control plane interworking needs to be solved. The retained solution must equally address the specific issues of multidomain networks, such as limited domain topology visibility, given the scalability and confidentiality constraints that characterize them. In this setting, we propose a functional and protocol architecture for such interworking, based on the key concepts of network abstraction and overarching control, implemented in terms of a hierarchical stateful path computation element (PCE), which provides the orchestration and coordination layer. In the proposed architecture, the PCEP and BGP-LS protocols are extended to support OpenFlow addresses and datapath identifiers, unifying both GMPLS and OpenFlow domains. The solution is deployed in an experimental testbed and validated. Although the main scope of the approach is the interworking of OpenFlow and GMPLS, the same approach can be directly applied to a wide range of multidomain scenarios, with either homogeneous or heterogeneous control technologies.	[Casellas, Ramon; Martinez, Ricardo] CTTC, Opt Networking Area, Barcelona, Spain; [Munoz, Rauel] CTTC, Barcelona, Spain; [Vilalta, Ricard] CTTC, Opt Networks & Syst Dept, Barcelona, Spain; [Liu, Lei] Univ Calif Davis, Davis, CA 95616 USA; [Tsuritani, Takehiro; Morita, Itsuro] KDDI R&D Labs Inc, Photon Networks, Saitama, Japan; [Lopez, Victor; Gonzalez de Dios, Oscar; Pedro Fernandez-Palacios, Juan] Telefonica, I D, Madrid, Spain	Casellas, R (reprint author), CTTC, Barcelona, Spain.	ramon.casellas@cttc.es			Spanish MINECO project FARO [TEC2012-38119]; EU FP7 project IDEALIST [317999]; EU-Japan FP7 project STRAUSS [FP7-ICT-2013-EU-Japan 608528]; PACE CSA project [619712]	This work was funded partially by the Spanish MINECO project FARO (TEC2012-38119), the EU FP7 project IDEALIST (317999), and the EU-Japan FP7 project STRAUSS (FP7-ICT-2013-EU-Japan 608528). The authors thank the members of the PACE CSA project (619712) regarding PCE applicability and best current practices.	Casellas R, 2013, J OPT COMMUN NETW, V5, pA57, DOI 10.1364/JOCN.5.000A57; Liu L, 2013, OPT EXPRESS, V21, P4194, DOI 10.1364/OE.21.004194; Azodolmolky S, 2011, OPT EXPRESS, V19, P421, DOI 10.1364/OE.19.00B421; Casellas R, 2012, OPT EXPRESS, V20, P29137, DOI 10.1364/OE.20.029137; Casellas R., 2013, EUR C EXH OPT COMM E; Casellas Ramon, 2011, Opt Express, V19, pB611, DOI 10.1364/OE.19.00B611; Casellas R., 2014, OPT FIB COMM C EXP O; Chen M., 2009, 5392 IETF RFC; Crabbe E., 2013, IETF INTERN IN PRESS; Cuaresma M., 2013, EUR C EXH OPT COMM E; Das S., 2010, EXTENSIONS OPENFLOW; Farrel A., 2006, 4655 IETF RFC; Gredler H., 2014, IETF INTERN IN PRESS; King D., 2012, 6805 IETF RFC; Paolucci F., 2012, OPT FIB COMM C LOS A	15	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	JAN 1	2015	7	1			SI				A106	10.1364/JOCN.7.00A106		12	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AX3UN	WOS:000346864200002		
J	Fujiwara, M; Suzuki, KI; Oguma, M; Soma, S; Yoshimoto, N				Fujiwara, Masamichi; Suzuki, Ken-Ichi; Oguma, Manabu; Soma, Shunichi; Yoshimoto, Naoto			High-Splitting-Ratio PON Systems Using a PLC-Based Funnel-Shaped Waveguide With Dual-Mode Fiber	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Dual-mode fiber (DMF); Fiber to the home (FTTH); High-splitting-ratio PON; Low-loss splitter; Mode combiner; Mode coupler; Optical access system; Passive optical network (PON); Planar lightwave circuit (PLC)	SOAS	This paper increases the splitting ratio of 10 Gb/s-class passive optical network (PON) systems by using a novel low-loss optical splitter based on single-mode (SM) to multimode (MM) coupling. It consists of a planar lightwave circuit (PLC)-based funnel-shaped waveguide (FW) and a dual-mode fiber (DMF) that supports both SM and MM propagation through its dual core configuration. While conventional low-loss splitters based on a similar principle, called mode couplers or mode combiners (MCs), pass through only upstream signals, the proposed FW-DMF acts as a low-loss splitter for upstream and a conventional splitter for downstream despite its simple configuration. Compared to conventional MCs, it greatly reduces the number of optical components required for an optical line terminal. Considering the more efficient use of existing infrastructures, we develop two types of FW-DMFs with branching ratios of 4 and 16. Bit error rate measurements assuming 10 G-EPON systems show the ability of our prototypes to realize 128-split 10 Gb/s-class PON systems.	[Fujiwara, Masamichi; Suzuki, Ken-Ichi; Yoshimoto, Naoto] NTT Corp, NTT Access Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan; [Oguma, Manabu; Soma, Shunichi] NTT Corp, NTT Photon Labs, Atsugi, Kanagawa 2430198, Japan	Fujiwara, M (reprint author), NTT Corp, NTT Access Serv Syst Labs, 1-1 Hikari No Oka, Yokosuka, Kanagawa 2390847, Japan.	fujiwara.masamichi@lab.ntt.co.jp					Kani J, 2009, IEEE COMMUN MAG, V47, P43, DOI 10.1109/MCOM.2009.5307465; Cheng N., 2010, P ECOC; Fujiwara M., 2014, P OFC; Fujiwara M, 2012, IEICE ELECTRON EXPR, V9, P371, DOI 10.1587/elex.9.371; Fujiwara M, 2013, J LIGHTWAVE TECHNOL, V31, P634, DOI 10.1109/JLT.2012.2222632; Hanada T., 1996, P IEICE SOC C, P160; Nakanishi K., 1997, P IEICE GEN C, P621, DOI 10.1109/APMC.1997.654618; Nesset D., 2012, P ECOC; OKAMOTO K, 1992, IEEE PHOTONIC TECH L, V4, P61, DOI 10.1109/68.124877; Piehler D., 2011, OFC NFOEC; Piehler D., 2012, P OFC NFOEC LOS ANG; Raharimanitra F., 2010, P ANIC KARLSR; Sasaoka E., 1998, P IEICE GEN C, P329; Sugawa J., 2012, P OFC NFOEC LOS ANG; Tanobe H., 2007, P ECOC; Vos B., 2002, P OFC	16	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	JAN 1	2015	7	1			SI				A1	10.1364/JOCN.7.0000A1		6	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AX3UN	WOS:000346864200010		
J	Taguchi, K; Asaka, K; Kimura, S; Yoshimoto, N				Taguchi, Katsuhisa; Asaka, Kota; Kimura, Shunji; Yoshimoto, Naoto			High Output Power and Burst Extinction Ratio lambda-Tunable ONU Transmitter Using Burst-Mode Booster SOA for WDM/TDM-PON	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						Next generation optical access network (NGOAN); Pattern effect; Semiconductor optical amplifier (SOA); Wavelength division multiplexing and time division multiplexing passive optical network (WDM/ TDM-PON)	NETWORKS; SYSTEMS; ACCESS	This paper proposes a high output power and high burst extinction ratio wavelength (lambda)-tunable optical network unit (ONU) transmitter for long-reach and high-splitting ratio wavelength-division multiplexing and time-division multiplexing passive optical network (WDM/TDM-PON) systems. Our lambda-tunable ONU burst-mode transmitter (B-Tx) utilizes a simply configured burst-mode controlled booster semiconductor optical amplifier (SOA) that employs the pattern effect mitigation technique of gain peak detuning. A high output power and burst extinction ratio are successfully achieved at all upstream wavelength channels, over +10.0 dBm and 66.0 dB, respectively. This burst extinction ratio performance satisfies the ONU requirement for a 64-split WDM/TDM-PON with crosstalk penalty of better than under 0.1 dB. Moreover, the pattern effect is greatly mitigated and 40 km transmission penalty of under 0.8 dB is achieved. We successfully demonstrate over a 41 dB loss budget and 40 km reach lambda-tunable WDM/TDM-PON without an optical-amplifier-based PON repeater.	[Taguchi, Katsuhisa; Asaka, Kota; Yoshimoto, Naoto] NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan; [Kimura, Shunji] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan	Taguchi, K (reprint author), NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan.	taguchi.katsuhisa@lab.ntt.co.jp			Ministry of Internal Affairs and Communication (MIC) of Japan	A part of this work was supported by the Ministry of Internal Affairs and Communication (MIC) of Japan.	Davey RP, 2009, J LIGHTWAVE TECHNOL, V27, P273, DOI 10.1109/JLT.2008.2006991; Chanclou P, 2012, IEEE NETWORK, V26, P8, DOI 10.1109/MNET.2012.6172269; Liu FH, 1999, IEEE PHOTONIC TECH L, V11, P137; Shinohara H, 2005, IEEE COMMUN MAG, V43, P72, DOI 10.1109/MCOM.2005.1509970; Cauvin A., 2006, IEEE Communications Magazine, V44, DOI 10.1109/MCOM.2006.1710410; Fujiwara M, 2013, J LIGHTWAVE TECHNOL, V31, P634, DOI 10.1109/JLT.2012.2222632; Hara K, 2010, J LIGHTWAVE TECHNOL, V28, P2775, DOI 10.1109/JLT.2010.2062486; INOUE K, 1987, IEE ELECT LETT, V23, P328; Jain S, 2011, J LIGHTWAVE TECHNOL, V29, P524, DOI 10.1109/JLT.2010.2104313; Kaneko S., 2014, P OFC; Nakagawa J.-I., 2010, P OFC NFOEC LOS ANG; SALEH AAM, 1990, IEEE T COMMUN, V38, P839, DOI 10.1109/26.57476; Sugawa J., 2012, P OFC NFOEC LOS ANG; Suzuki K.-I., 2012, P ECOC; Taguchi K., 2013, P ECOC; Taguchi K., 2014, P OFC; Taguchi K, 2013, J OPT COMMUN NETW, V5, pA144, DOI 10.1364/JOCN.5.00A144	17	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	JAN 1	2015	7	1			SI				1	10.1364/JOCN.7.000001		7	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AX3UN	WOS:000346864200022		
J	Vilalta, R; Munoz, R; Casellas, R; Martinez, R; Peng, SP; Channegowda, M; Vlachogiannis, T; Nejabati, R; Simeonidou, D; Cao, XY; Tsuritani, T; Morita, I				Vilalta, Ricard; Munoz, Raul; Casellas, Ramon; Martinez, Ricardo; Peng, Shuping; Channegowda, Mayur; Vlachogiannis, Tasos; Nejabati, Reza; Simeonidou, Dimitra; Cao, Xiaoyuan; Tsuritani, Takehiro; Morita, Itsuro			Dynamic Multi-Domain Virtual Optical Network Deployment With Heterogeneous Control Domains	JOURNAL OF OPTICAL COMMUNICATIONS AND NETWORKING			English	Article						EON; GMPLS/PCE; OpenFlow; OPS; Optical network virtualization; Resource allocation algorithms		We propose a multi-domain resource broker to dynamically provision multi-domain virtual optical networks across heterogeneous control domains (i.e., GMPLS and OpenFlow) and transport (i.e., optical packet switching and elastic optical networks) technologies. We have designed, implemented, and experimentally evaluated the multi-domain resource broker in an international test-bed across Spain, the UK, and Japan.	[Vilalta, Ricard; Munoz, Raul; Casellas, Ramon; Martinez, Ricardo] CTTC, Castelldefels 08860, Spain; [Peng, Shuping; Channegowda, Mayur; Vlachogiannis, Tasos; Nejabati, Reza; Simeonidou, Dimitra] Univ Bristol, High Performance Networks Grp, Bristol BS8 1TH, Avon, England; [Cao, Xiaoyuan; Tsuritani, Takehiro; Morita, Itsuro] KDDI R&D Labs Inc, Fujimino, Saitama 3568502, Japan	Vilalta, R (reprint author), CTTC, Ave Carl Friedrich Gauss 7, Castelldefels 08860, Spain.	ricard.vilalta@cttc.es			EU FP7 STRAUSS [FP7-ICT-2013-EU-Japan 608528]; Spanish MINECO project FARO [TEC2012-38119]	This work was partially funded by EU FP7 STRAUSS (FP7-ICT-2013-EU-Japan 608528) and Spanish MINECO project FARO (TEC2012-38119).	Wang Y, 2011, IEEE COMMUN MAG, V49, P92, DOI 10.1109/MCOM.2011.5762804; Casellas R, 2009, J OPT COMMUN NETW, V1, pA180, DOI 10.1364/JOCN.1.00A180; Channegowda M, 2013, OPT EXPRESS, V21, P5487, DOI 10.1364/OE.21.005487; [Anonymous], 2013, CISCO GLOBAL CLOUD I; Casellas R., 2014, OPT FIB COMM C SAN F; Cuaresma M., 2013, P 39 EUR C EXH OPT C, P1; Munoz R., 2011, EUR C EXP OPT COMM G; Nejabati R., 2011, 15 INT C OPT NETW DE; Pang P., 2012, 8 INT C IP OPT NETW; Peng S., 2013, 39 EUR C EXH OPT COM; Sherwood R., 2009, FLOWVISOR NETWORK VI; Vahdat A., 2011, OPT FIB COMM C LOS A; Vilalta R., 2013, 15 INT C TRANSP OPT, P1; Vilalta R., 2014, OPT FIB COMM C SAN F; Vilalta R., 2012, EUR C EXH OPT COMM E	15	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1943-0620	1943-0639		J OPT COMMUN NETW	J. Opt. Commun. Netw.	JAN 1	2015	7	1			SI				A135	10.1364/JOCN.7.00A135		7	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Optics; Telecommunications	Computer Science; Optics; Telecommunications	AX3UN	WOS:000346864200005		
J	Shinjo, T; Morita, T; Hirai, K; Miyashita, M; Shimizu, M; Tsuneto, S; Shima, Y				Shinjo, Takuya; Morita, Tatsuya; Hirai, Kei; Miyashita, Mitsunori; Shimizu, Megumi; Tsuneto, Satoru; Shima, Yasuo			Why People Accept Opioids: Role of General Attitudes Toward Drugs, Experience as a Bereaved Family, Information From Medical Professionals, and Personal Beliefs Regarding a Good Death	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Opioid; pain; cancer; attitudes; bereaved family	LIFE CANCER CARE; PAIN MANAGEMENT; PALLIATIVE CARE; DECISION-MAKING; BARRIERS; PREDICTORS; HOSPICE; JAPAN; PERSPECTIVE; ANALGESICS	Context. Many surveys have evaluated patient-related barriers to pain management. Objectives. To explore associations between a preference for opioids and general attitudes toward drugs, the experience and information received as a bereaved family, and beliefs regarding a good death. Methods. A cross-sectional survey, performed in 2010, of bereaved families of patients with cancer in palliative care units across Japan. Questionnaires were sent to 997 families. Results. A total of 66% of families responded. Of these, 224 responses were excluded because the family declined to participate in the study (n = 38), the patient was not receiving any opioid analgesics, and there were missing data (n = 164), or data were missing for the primary end points (n = 22). Thus, 432 responses were finally analyzed (43%). In total, 26%, 41%, and 31% of family members stated that they strongly want to receive, want to receive, or slightly want to receive opioids if needed in the future, respectively. Determinants associated with a preference for receiving opioid treatment were the following: a general appreciation of the drugs (P = 0.005), witnessing an improvement in the patient's quality of life as a result of pain relief (P = 0.003), information provided by medical professionals that the opioid could be discontinued if side effects developed (P = 0.042), and the belief that a good death was one that was free from pain and physical distress (P < 0.001). Conclusion. More than 90% of bereaved families whose relatives were treated with opioid analgesics reported a preference to receive opioid analgesics for the treatment of cancer pain, if necessary, in the future. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Shinjo, Takuya] Shinjo Clin, Kobe, Hyogo 6511131, Japan; [Morita, Tatsuya] Seirei Mikatahara Hosp, Palliat Care Team, Dept Palliat & Support Care, Hamamatsu, Shizuoka, Japan; [Morita, Tatsuya] Seirei Mikatahara Hosp, Seirei Hosp, Hamamatsu, Shizuoka, Japan; [Hirai, Kei] Osaka Univ, Grad Sch Med, Dept Complementary Med, Osaka, Japan; [Hirai, Kei] Osaka Univ, Grad Sch Med, Dept Alternat Med, Osaka, Japan; [Tsuneto, Satoru] Kyoto Univ, Dept Multidisciplinary Canc Treatment, Grad Sch Med, Kyoto, Japan; [Miyashita, Mitsunori; Shimizu, Megumi] Tohoku Univ, Grad Sch Med, Dept Palliat Nursing, Sendai, Miyagi 980, Japan; [Shima, Yasuo] Tsukuba Med Ctr Hosp, Dept Palliat Med, Tsukuba, Ibaraki, Japan	Shinjo, T (reprint author), Shinjo Clin, Kita Ku, 1-5-1-307 Kitagoyou, Kobe, Hyogo 6511131, Japan.	shinjo@doctor.email.ne.jp			Japan Hospice Palliative Care Foundation	This work was supported by a Grant-in-Aid from the Japan Hospice Palliative Care Foundation. The opinions and findings in this article are those of the authors and do not necessarily represent the views of the Japan Hospice Palliative Care Foundation. The Japan Hospice Palliative Care Foundation did not participate in any of the following: design and conduct of study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the article. The authors declare no conflicts of interest.	Gunnarsdottir S, 2002, PAIN, V99, P385, DOI 10.1016/S0304-3959(02)00243-9; Goldberg GR, 2007, J CLIN ONCOL, V25, P1792, DOI 10.1200/JCO.2006.07.9038; Morita T, 2005, J CLIN ONCOL, V23, P2637; Nguyen LMT, 2013, J PAIN SYMPTOM MANAG, V45, P506, DOI 10.1016/j.jpainsymman.2012.02.023; Reid CM, 2008, ANN ONCOL, V19, P44, DOI 10.1093/annonc/mdm462; Sanjo M, 2007, ANN ONCOL, V18, P1539, DOI 10.1093/annonc/mdm199; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Keirns CC, 2009, JAMA-J AM MED ASSOC, V302, P1805, DOI 10.1001/jama.2009.1550; Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006777.pub2; Weiss SC, 2001, LANCET, V357, P1311, DOI 10.1016/S0140-6736(00)04515-3; Morita T, 2007, J PAIN SYMPTOM MANAG, V34, P579, DOI 10.1016/j.jpainsymman.2007.01.012; Miyashita M, 2008, J CLIN ONCOL, V26, P3845, DOI 10.1200/JCO.2007.15.8287; Sun VCY, 2007, J PAIN SYMPTOM MANAG, V34, P359, DOI 10.1016/jpainsymman.2006.12.011; Miyashita M, 2007, ANN ONCOL, V18, P1090, DOI 10.1093/annonc/mom068; Valeberg BT, 2008, CLIN J PAIN, V24, P627, DOI 10.1097/AJP.0b013e31816fe020; Mamede S, 2010, JAMA-J AM MED ASSOC, V304, P1198, DOI 10.1001/jama.2010.1276; Chapman GB, 2004, BLACKWELL HDB JUDGME, P585, DOI 10.1002/9780470752937.ch29; Groopman J, 2012, YOUR MED MIND DECIDE; Kondo Y, 2002, J JPN SOC CANC NURS, V16, P5; Kwon JH, 2013, SUPPORT CARE CANCER, V21, P1175, DOI 10.1007/s00520-012-1646-x; Kwon JH, 2013, J PALLIAT MED, V16, P908, DOI 10.1089/jpm.2012.0610; Maltoni M, 2005, SUPPORT CARE CANCER, V13, P888, DOI 10.1007/s00520-005-0807-6; McDermott R, 2008, UROL ONCOL-SEMIN ORI, V26, P665, DOI 10.1016/j.urolonc.2007.12.006; Miyashita M, 2008, J PAIN SYMPTOM MANAG, V35, P486, DOI [10.1016/j.jpainsymman.2007.07.009, 10.1016/j.jpainsmman.2007.07.009]; Miyashita M, JAPAN HOSPICE PALLIA; Miyashita M, 2008, AM J HOSP PALLIAT ME, V25, P223, DOI 10.1177/1049909108315517; Morita T, 2000, J PALLIATIVE CARE, V16, P54; Shinjo T, 2010, J CLIN ONCOL, V28, P142, DOI 10.1200/JCO.2009.23.2793; Steinhauser Karen E., 2000, JAMA (Journal of the American Medical Association), V284, P2476, DOI 10.1001/jama.284.19.2476; Ward SE, 1996, RES NURS HEALTH, V19, P205, DOI 10.1002/(SICI)1098-240X(199606)19:3<205::AID-NUR4>3.0.CO;2-O; World Health Organization, 2007, WHOS PAIN REL LADD	31	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	JAN	2015	49	1					46	55		10.1016/j.jpainsymman.2014.04.015		10	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	AX1ZI	WOS:000346742500005		
J	Xin, XJ; Zhang, J; Chang, YN; Wu, YX				Xin, Xiujuan; Zhang, Jing; Chang, Yaning; Wu, Yixin			Association study of TAC3 and TACR3 gene polymorphisms with idiopathic precocious puberty in Chinese girls	JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM			English	Article						association study; genotyping; idiopathic puberty; TAC3; TACR3	NEUROKININ-B; RECEPTOR; NEURONS	Background and aims: The allele variant of neurokinin B and its receptor genes were thought important in regulating the human reproductive axis in many populations. The aim of this study was to investigate whether the variances in TAC3 and TACR3 genes that encoded neurokinin B (NKB) and its receptor (NK3R), individually, were associated with idiopathic precocious puberty in Chinese girls. Methods: The genotyping method of polymerase chain reaction-restriction fragment length polymorphism was applied in this study; the distribution of five active single nucleon acid polymorphisms (SNPs) in TAC3 (p.G34R, p.A63P, p.Q66*, p.S99P, and a mutation on 5'UTR) and four sites in TACR3 (A29V or G, G59E, S455G, and A449S or T) genes was analyzed in 267 healthy and 186 idiopathic precocious puberty Chinese girls. Results: Among the nine active SNPs, only A63P in TAC3 gene showed statistical differences; the p value was 0.024. Conclusion: A63P in TAC3 gene was statistically associated with the puberty onset time in Chinese girls.	[Xin, Xiujuan; Zhang, Jing; Chang, Yaning] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Wu, Yixin] Hamamatsu Univ Sch Med, Dept Biochem, Higasi Ku, Hamamatsu, Shizuoka 4313192, Japan	Xin, XJ (reprint author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, 130 Meilong Rd, Shanghai 200237, Peoples R China.	xinxj@ecust.edu.cn			Fundamental Research Funds for the Central Universities of China [WF1114045]; State Key Laboratory of Bioreactor Engineering [2060204]	This research was supported by Fundamental Research Funds for the Central Universities of China (WF1114045) and Open Project for the State Key Laboratory of Bioreactor Engineering (2060204).	Partsch CJ, 2002, CLIN ENDOCRINOL, V56, P129, DOI 10.1046/j.0300-0664.2001.01490.x; Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Rance NE, 2009, PEPTIDES, V30, P111, DOI 10.1016/j.peptides.2008.05.016; Tusset C, 2012, ARQ BRAS ENDOCRINOL, V56, P646, DOI 10.1590/S0004-27302012000900008; Caronia LM, 2011, NEW ENGL J MED, V364, P215, DOI 10.1056/NEJMoa0911064; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600; Rohrig UF, 2010, J MED CHEM, V53, P1172, DOI 10.1021/jm9014718; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P2364, DOI 10.1210/jc.86.6.2364; Keen KL, 2008, ENDOCRINOLOGY, V149, P4151, DOI 10.1210/en.2008-0231; Zhao J, 2007, HUM REPROD, V22, P1789, DOI 10.1093/humrep/dem052; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Cai DP, 2003, PRECOCIOUS DELAYED P, P35; Clarisa R, 2003, OBSTET GYN CLIN N AM, V31, P12; Hamilton AS, 2003, NEW ENGL J MED, V348, P2313, DOI 10.1056/NEJMoa021293; Heman GM, 1997, PEDIATRICS, V99, P505; John IB, 2002, ARTHRITID RES, V4, P273; Kadlubar Fred F., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P408; Krajewski SJ, 2010, NEUROSCIENCE, V166, P680, DOI 10.1016/j.neuroscience.2009.12.053; Pinto FM, 1999, ENDOCRINOLOGY, V140, P2526, DOI 10.1210/en.140.6.2526; Roldan MB, 2007, FERTIL STERIL, V88, P410, DOI 10.1016/j.fertnstert.2006.11.126; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Van Delemarre WH, 2005, ENDOCR DEV, V8, P1; Barker-Gibb M, 2004, FERTIL STERIL, V82, P491, DOI 10.1016/j.fertnstert.2003.12.040; Xin XJ, 2006, NEUROENDOCRINOL LETT, V27, P101	27	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-018X	2191-0251		J PEDIATR ENDOCR MET	J. Pediatr. Endocrinol. Metab.	JAN	2015	28	1-2					65	71		10.1515/jpem-2013-0460		7	Endocrinology & Metabolism; Pediatrics	Endocrinology & Metabolism; Pediatrics	AX2HQ	WOS:000346764500010		
J	Uchiyama, A; Kushima, R; Watanabe, T; Kusuda, S				Uchiyama, Atsushi; Kushima, Reiko; Watanabe, Toyoko; Kusuda, Satoshi			Effect of L-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial	JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM			English	Article						free thyroxine; levothyroxine sodium; thyroxine-stimulating hormone; transient hypothyroxinemia of prematurity; very-low-birth-weight infants	BIRTH-WEIGHT INFANTS; PRETERM INFANTS; GESTATIONAL-AGE; THYROID-HORMONE; NEUROLOGIC DEVELOPMENT; LESS-THAN-28 WEEKS; FOLLOW-UP; BORN	Objective: Our objective was to evaluate effects of levo-thyroxine (L-T4) supplementation against neurodevelopmental outcomes at 18 months of corrected age in very-low-birth-weight (VLBW) infants with hypothyroxinemia but without elevated thyroid-stimulating hormone (TSH) concentration. Methods: VLBW infants who had plasma TSH concentrations <10 mu U/mL and free thyroxine (FT4) concentrations <0.8 ng/dL between 2 and 4 weeks of age were enrolled. They were randomly assigned to either the Treated (n=25) or Untreated group (n=45). The Treated group received L-T4 at a dose of 5 mu g/kg/day. We compared growth and neurodevelopmental outcomes at 18 months of corrected age in the two groups. Results: There were no significant differences in growth, the incidences of developmental delay, cerebral palsy, visual impairment, and hearing impairment in the two groups. Conclusions: In such infants, L-T4 supplementation at a dose of 5 mu g/kg/day did not affect FT4 levels and showed no beneficial effect at 18 months of corrected age.	[Uchiyama, Atsushi] Tokyo Womens Med Univ, Dept Neonatal Med, Maternal & Perinatal Ctr, Shinjuku Ku, Tokyo 1628666, Japan; [Uchiyama, Atsushi; Kushima, Reiko; Watanabe, Toyoko; Kusuda, Satoshi] Tokyo Metropolitan Neonatal Res Grp, Tokyo, Japan; [Kushima, Reiko; Watanabe, Toyoko] Tokyo Metropolitan Bokutoh Hosp, Dept Neonatol, Tokyo, Japan; [Kusuda, Satoshi] Tokyo Womens Med Univ, Dept Neonatal Med, Maternal & Perinatal Ctr, Tokyo 1628666, Japan	Uchiyama, A (reprint author), Tokyo Womens Med Univ, Dept Neonatal Med, Maternal & Perinatal Ctr, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	uchiyama.atsushi@twmu.ac.jp					Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; van Wassenaer AG, 2008, SEMIN PERINATOL, V32, P423, DOI 10.1053/j.semperi.2008.09.008; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; van Wassenaer AG, 2005, PEDIATRICS, V116, pE613, DOI 10.1542/peds.2005-0876; Kono Y, 2008, PEDIATR INT, V50, P23, DOI 10.1111/j.1442-200X.2007.02516.x; Masumoto K, 2008, PEDIATR RES, V63, P686, DOI 10.1203/PDR.0b013e31816c8fcc; Valerio PG, 2004, PEDIATR RES, V55, P248, DOI 10.1203/01.PDR.0000104153.72572.F5; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Yen PM, 2001, PHYSIOL REV, V81, P1097; Golombek SG, 2008, SEMIN PERINATOL, V32, P413, DOI 10.1053/j.semperi.2008.09.010; La Gamma EF, 2012, CURR OPIN PEDIATR, V24, P172, DOI 10.1097/MOP.0b013e32835067cc; vanWassenaer AG, 1997, NEW ENGL J MED, V336, P21, DOI 10.1056/NEJM199701023360104; Bax MC, 1964, DEV MED CHILD NEUROL, V6, P295; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Dilli D, 2012, INDIAN PEDIATR, V49, P711, DOI 10.1007/s13312-012-0162-x; Fisher Delbert A, 2007, Pediatr Endocrinol Rev, V4, P317; La Gamma Edmund F, 2006, Treat Endocrinol, V5, P335, DOI 10.2165/00024677-200605060-00002; La Gamma EF, 2009, PEDIATRICS, V124, pE258, DOI 10.1542/peds.2008-2837; La Gamma EF, 2008, SEMIN PERINATOL, V32, P377, DOI 10.1053/j.semperi.2008.09.001; Leviton A, 1999, J PEDIATR-US, V134, P706, DOI 10.1016/S0022-3476(99)70285-4; Lucas A, 1996, BRIT MED J, V312, P1132; MERCADO M, 1988, EARLY HUM DEV, V16, P131, DOI 10.1016/0378-3782(88)90093-X; Osborn DA, 2007, COCHRANE DB SYST REV, V24; Reuss ML, 1996, NEW ENGL J MED, V334, P821, DOI 10.1056/NEJM199603283341303; Uchiyama A, 2011, PEDIATR INT, V53, P322, DOI 10.1111/j.1442-200X.2010.03251.x; van Wassenaer Aleid G, 2004, Semin Neonatol, V9, P3, DOI 10.1016/S1084-2756(03)00114-3; van Wassenaer AG, 2002, PEDIATRICS, V110, P534, DOI 10.1542/peds.110.3.534; van Wassenaer AG, 1998, EUR J ENDOCRINOL, V139, P508, DOI 10.1530/eje.0.1390508	28	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-018X	2191-0251		J PEDIATR ENDOCR MET	J. Pediatr. Endocrinol. Metab.	JAN	2015	28	1-2					177	182		10.1515/jpem-2014-0024		6	Endocrinology & Metabolism; Pediatrics	Endocrinology & Metabolism; Pediatrics	AX2HQ	WOS:000346764500028		
J	Asada, N; Kato, I; Daifu, T; Umeda, K; Hiramatsu, H; Okamoto, T; Toguchida, J; Yamawaki, S; Yoshikawa, K; Adachi, S; Heike, T; Watanabe, K				Asada, Nariaki; Kato, Itaru; Daifu, Tomoo; Umeda, Katsutsugu; Hiramatsu, Hidefumi; Okamoto, Takeshi; Toguchida, Junya; Yamawaki, Satoko; Yoshikawa, Katsuhiro; Adachi, Souichi; Heike, Toshio; Watanabe, Kenichiro			Good Response to Chemotherapy Spares Irradiation for Extrarenal Rhabdoid Tumor Conferring Better Activities of Daily Living	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						rhabdoid tumor; chemotherapy; radiation therapy; long-term survival; stem cell transplantation	STEM-CELL TRANSPLANTATION; WILMS-TUMOR; SURVIVAL; CHILDREN; THERAPY; KIDNEY; CANCER; TRIAL; AGE	A 7-year-old girl with stage IIA extrarenal rhabdoid tumor near the left cubital fossa received preoperative chemotherapy and surgical resection with median nerve reconstruction followed by postoperative high-dose chemotherapy. As preoperative chemotherapy resulted in decreased tumor size, disappearance of fluorodeoxyglucose-uptake, and pathologic complete response with total tumor resection, irradiation was successfully spared to avoid injury to the reconstructed nerve and inhibition of normal bone development. Two years after diagnosis, recurrence has not been observed and median nerve palsy is improving. This case suggests that radiation therapy could be spared for clinically and pathologically chemotherapy-good-responders in case total surgical resection is achieved.	[Asada, Nariaki; Kato, Itaru; Daifu, Tomoo; Umeda, Katsutsugu; Hiramatsu, Hidefumi; Heike, Toshio; Watanabe, Kenichiro] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Okamoto, Takeshi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto 6068507, Japan; [Yamawaki, Satoko; Yoshikawa, Katsuhiro] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto 6068507, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto 6068507, Japan	Watanabe, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	wataken@kuhp.kyoto-u.ac.jp					Morgenstern DA, 2010, PEDIATR BLOOD CANCER, V54, P29, DOI 10.1002/pbc.22231; Tekautz TM, 2005, J CLIN ONCOL, V23, P1491, DOI 10.1200/JCO.2005.05.187; Sultan I, 2010, PEDIATR BLOOD CANCER, V54, P35, DOI 10.1002/pbc.22285; Koga Y, 2009, PEDIATR BLOOD CANCER, V52, P888, DOI 10.1002/pbc.21958; Oda Y, 2006, PATHOL INT, V56, P287, DOI 10.1111/j.1440-1827.2006.01962.x; Hashii Y, 2012, LEUKEMIA, V26, P530, DOI 10.1038/leu.2011.226; Tomlinson GE, 2005, J CLIN ONCOL, V23, P7641, DOI 10.1200/JCO.2004.00.8110; Madigan CE, 2007, CANCER, V110, P2061, DOI 10.1002/cncr23020; Brennan BMD, 2004, EUR J CANCER, V40, P624, DOI 10.1016/j.ejca.2003.11.014; Fanburg-Smith J C, 1998, Ann Diagn Pathol, V2, P351, DOI 10.1016/S1092-9134(98)80038-5; Kaida M, 2011, J IMMUNOTHER, V34, P92, DOI 10.1097/CJI.0b013e3181fb65b9; Mitchell C, 2000, BRIT J CANCER, V83, P602, DOI 10.1054/bjoc.2000.1338; Miyatake T, 2013, J CANCER RES CLIN, V139, P457, DOI 10.1007/s00432-012-1348-2; Puri DR, 2008, PEDIATR BLOOD CANCER, V50, P167, DOI 10.1002/pbc.20947; Van den Heuvel-Eibrink MM, 2008, PEDIATR BLOOD CANCER, V50, P1130, DOI 10.1002/pbc.21389	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	JAN	2015	37	1					E57	E59				3	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	AX0HO	WOS:000346633800012		
J	Shimizu, Y; Nagasao, T; Shido, H; Fujii, T; Kato, T; Aoki, M; Takada, K; Kishi, K				Shimizu, Yusuke; Nagasao, Tomohisa; Shido, Hirokazu; Fujii, Takako; Kato, Tatsuya; Aoki, Marie; Takada, Keiko; Kishi, Kazuo			Intra-eyebrow frontalis suspension using inverted Y-shaped short autogenous fascia lata for blepharoptosis with poor levator function	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article							RANDOMIZED CLINICAL-TRIAL; CONGENITAL PTOSIS	Frontalis suspension using autogenous fascia lata is a common procedure for blepharoptosis with poor levator function. However, donor-site morbidity associated with fascia lata harvest cannot be ignored. In conventional procedures, the required length of the fascia lata is usually >5-12 cm with a lateral thigh skin incision of approximately 5 cm or more. The present study introduces a new frontalis suspension procedure in which the required size (length and width) of the fascia lata and length of lateral thigh incision is much smaller. The harvested fascia lata is tailored to an inverted Y shape and the separated caudal legs are fixed to the tarsus while the cephalic end is grafted inside the eyebrow through a suborbital septum tunnel. In the present study, 11 patients who underwent the new procedure with a minimum of 6 months of follow-up were evaluated. The average length and width of the harvested fascia lata in unilateral ptosis cases were 2.85 and 0.89 cm, respectively. The average length of the lateral thigh incision was 1.25 cm. The margin reflex distance improved in all cases at 6 months postoperatively. The cosmetic result was graded as good to excellent in most of the patients. Trichiasis, widened donor scar, and eyebrow notch were noted as complications. The present method is a good alternative for the treatment of blepharoptosis with poor levator function. It potentially reduces donor-site morbidity as compared with conventional frontalis muscle suspension procedures using autogenous fascia lata. (C) 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Shimizu, Yusuke; Nagasao, Tomohisa; Shido, Hirokazu; Fujii, Takako; Kato, Tatsuya; Aoki, Marie; Takada, Keiko; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ku, Tokyo 1608582, Japan	Shimizu, Y (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yyssprs@gmail.com					Wasserman BN, 2001, ARCH OPHTHALMOL-CHIC, V119, P687; Bagheri A, 2007, OPHTHAL PLAST RECONS, V23, P217, DOI 10.1097/IOP.0b013e3180557479; WAGNER RS, 1984, OPHTHALMOLOGY, V91, P245; Knize DM, 1996, PLAST RECONSTR SURG, V97, P1321, DOI 10.1097/00006534-199606000-00001; Arajy ZY, 2012, J CRANIO MAXILL SURG, V40, P129, DOI 10.1016/j.jcms.2011.03.002; Carraway JH, 1994, OPER TECH PLAST RECO, V1, P113; Carter SR, 1996, OPHTHALMOLOGY, V103, P623; CRAWFORD JS, 1977, OPHTHALMIC SURG LAS, V8, P31; CRAWFORD JS, 1982, J PEDIAT OPHTH STRAB, V19, P21; Dresner S, 2001, OCULOPLASTIC SURG ES, P75; Gundeslioglu AO, 2013, J PLAST RECONSTR AES, V66, P224, DOI 10.1016/j.bjps.2012.09.022; Leibovitch I, 2003, AM J OPHTHALMOL, V136, P866, DOI 10.1016/S0002-9394(03)00466-5; Salour H, 2008, EUR J OPHTHALMOL, V18, P853; Shimizu Y, 2014, EUR NEUROL, V71, P161; Wright WW, 1922, ARCH OPHTHALMOL-CHIC, V51, P99	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JAN	2015	68	1					49	55		10.1016/j.bjps.2014.08.068		7	Surgery	Surgery	AX0JM	WOS:000346638800016		
J	Hayashi, A; Labbe, D; Natori, Y; Yoshizawa, H; Kudo, H; Sakai, T; Mizuno, H				Hayashi, Ayato; Labbe, Daniel; Natori, Yuhei; Yoshizawa, Hidekazu; Kudo, Hiroyuki; Sakai, Tatsuo; Mizuno, Hiroshi			Experience and anatomical study of modified lengthening temporalis myoplasty for established facial paralysis	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article; Proceedings Paper	12th Annual International Facial Nerve Symposium	JUN 28-JUL 01, 2013	Boston, MA			Facial paralysis; Facial reanimation; Muscle transfer; Fascia graft; Temporalis myoplasty	MUSCLE TRANSFER; REANIMATION; PALSY; RECONSTRUCTION; SMILE	Lengthening temporalis myoplasty, reported by Daniel Labbe in 1997, is a unique and definite facial reanimation procedure that involves moving the whole temporal muscle anteroinferiorly and inserting its tendon directly into the nasolabial fold. In the present article, we report our experience in the use of his modified method of the procedure, which preserves the zygomatic arch by transecting the coronoid process through the nasolabial fold incision. We also describe our cadaveric study that aimed to elucidate a secure approach for coronoid process transection. We performed this procedure in five patients with permanent facial paralysis. To improve facial symmetry, we also performed several additional static reconstructions such as T-shaped double-sleeve fascia grafts for lower lip deformities. We were successful in achieving considerable static improvement at rest, immediately after the surgery, and the recovery of facial movement was apparent approximately 3 months after the surgery. With regard to the cadaveric study, we noted that the entry to the buccal fat region, which is also the pathway of the temporal fascia, was a narrow space, and a short transection of the medial upper edge of the masseter fascia would make it easy to locate the coronoid process. Therefore, for a safe and secure access to the coronoid process from the nasolabial fold, we believe that we should first expose the cranial side and continue to dissect along the side and lower edge of the maxilla to locate the medial upper edge of the masseter fascia. By transecting along its edge, we could easily access the coronoid process, located immediately behind it, and widen the pathway of the temporal fascia. This modified method is less invasive and simpler compared to the original procedure, and understanding the detailed anatomy for dissection would help surgeons perform this procedure more confidently. (C) 2014 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Hayashi, Ayato; Natori, Yuhei; Yoshizawa, Hidekazu; Mizuno, Hiroshi] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138421, Japan; [Kudo, Hiroyuki; Sakai, Tatsuo] Juntendo Univ, Sch Med, Dept Anat & Life Struct, Bunkyo Ku, Tokyo 1138421, Japan; [Labbe, Daniel] Caen Univ Hosp, Serv Chirurg Maxillo Faciale & Plast, F-14033 Caen, France	Hayashi, A (reprint author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	ayhayasi@juntendo.ac.jp					Guillou-Jamard MR, 2011, ANN PLAS SURG, V67, pS31, DOI 10.1097/SAP.0b013e318218360b; HARII K, 1976, PLAST RECONSTR SURG, V57, P133, DOI 10.1097/00006534-197602000-00001; Nduka C, 2012, J PLAST RECONSTR AES, V65, P851, DOI 10.1016/j.bjps.2012.02.006; Labbe D, 2000, PLAST RECONSTR SURG, V105, P1289, DOI 10.1097/00006534-200004040-00005; TERZIS JK, 1989, PLAST RECONSTR SURG, V83, P767, DOI 10.1097/00006534-198905000-00001; Labbe D, 2009, ANN CHIR PLAST ESTH, V54, P571, DOI 10.1016/j.anplas.2009.04.002; Harii K, 1998, PLAST RECONSTR SURG, V102, P941, DOI 10.1097/00006534-199809040-00001; KOSHIMA I, 1994, PLAST RECONSTR SURG, V94, P421, DOI 10.1097/00006534-199409000-00001; Terzis JK, 2008, PLAST RECONSTR SURG, V122, P1723, DOI 10.1097/PRS.0b013e31818a9adc; Hayashi A, 2011, FACIAL NERVE RES JPN, V31, P129; Hayashi A, 2010, FACIAL NERVE RES JPN, V29, P108; Ioi H, 2007, EUR J ORTHODONT, V29, P493, DOI 10.1093/ejo/cjm059; Labbé D, 1997, Ann Chir Plast Esthet, V42, P44; OBRIEN BM, 1980, BRIT J PLAST SURG, V33, P202, DOI 10.1016/0007-1226(80)90013-2; TOH H, 1993, ANAT REC, V236, P586, DOI 10.1002/ar.1092360319; Udagawa A, 2007, PLAST RECONSTR SURG, V120, P238, DOI 10.1097/01.prs.0000264062.64251.10; Yamamoto Y, 2008, FACIAL NERVE RES JPN, V27, P199	17	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JAN	2015	68	1					63	70		10.1016/j.bjps.2014.09.037		8	Surgery	Surgery	AX0JM	WOS:000346638800018		
J	Yamamoto, T; Yamashita, M; Furuya, M; Hayashi, A				Yamamoto, Takumi; Yamashita, Marie; Furuya, Megumi; Hayashi, Akitatsu			Lymph preserving lipectomy under indocyanine green lymphography navigation	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Letter							LOWER-EXTREMITY LYMPHEDEMA		[Yamamoto, Takumi; Yamashita, Marie; Furuya, Megumi; Hayashi, Akitatsu] Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Fischer JP, 2013, PLAST RECONSTR SURG, V132, P1411, DOI 10.1097/PRS.0b013e3182a806b3; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2013, ANN PLAST SURG, V71, P59; Yamamoto T, 2013, J VASC SURG VENOUS L, V1, P400	5	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	JAN	2015	68	1					136	137		10.1016/j.bjps.2014.08.014		4	Surgery	Surgery	AX0JM	WOS:000346638800037		
J	Kato, M; Okamuro, H; Honjo, Y				Kato, Masatoshi; Okamuro, Hiroyuki; Honjo, Yuji			Does Founders' Human Capital Matter for Innovation? Evidence from Japanese Start-ups	JOURNAL OF SMALL BUSINESS MANAGEMENT			English	Article							TECHNOLOGY-BASED FIRMS; GROWTH; CONSTRAINTS; KNOWLEDGE	Using an original questionnaire survey, this paper explores whether and how founders' human capital affects the innovation outcomes of start-ups. We found that founders with greater human capital are more likely to yield innovation outcomes. Because certain types of human capital may boost research and development (R&D) investment, which possibly results in innovation outcomes, we estimate the determinants of innovation outcomes by an instrumental variable probit model. Our findings suggest that specific human capital for innovation, such as prior innovation experience, is directly associated with innovation outcomes, whereas generic human capital, such as educational background, indirectly affects innovation outcomes through R&D investment.	[Kato, Masatoshi] Kwansei Gakuin Univ, Sch Econ, Nishinomiya, Hyogo 6628501, Japan; [Okamuro, Hiroyuki] Hitotsubashi Univ, Grad Sch Econ, Tokyo, Japan; [Honjo, Yuji] Chuo Univ, Fac Commerce, Tokyo, Japan	Kato, M (reprint author), Kwansei Gakuin Univ, 1-155 Uegahara Ichiban Cho, Nishinomiya, Hyogo 6628501, Japan.	mkato@kwansei.ac.jp					Acs Z.J., 1990, INNOVATION SMALL FIR; Cressy R, 1996, ECON J, V106, P1253, DOI 10.2307/2235519; HAUSMAN J, 1984, ECONOMETRICA, V52, P909, DOI 10.2307/1911191; BATES T, 1990, REV ECON STAT, V72, P551, DOI 10.2307/2109594; Marvel MR, 2007, ENTREP THEORY PRACT, V31, P807, DOI 10.1111/j.1540-6520.2007.00209.x; Gimmon E, 2010, RES POLICY, V39, P1214, DOI 10.1016/j.respol.2010.05.017; Coleman S, 2007, J SMALL BUS MANAGE, V45, P303, DOI 10.1111/j.1540-627X.2007.00214.x; Tang JT, 2012, J SMALL BUS MANAGE, V50, P41, DOI 10.1111/j.1540-627X.2011.00343.x; Rauch A, 2013, ENTREP THEORY PRACT, V37, P923, DOI 10.1111/j.1540-6520.2011.00487.x; De Winne S, 2010, INT J HUM RESOUR MAN, V21, P1863, DOI 10.1080/09585192.2010.505088; Okamuro H, 2011, RES POLICY, V40, P728, DOI 10.1016/j.respol.2011.01.012; Huang HC, 2012, TECHNOVATION, V32, P316, DOI 10.1016/j.technovation.2011.12.004; Parker SC, 2006, J BUS ECON STAT, V24, P416, DOI 10.1198/073500106000000215; Sullivan D, 2011, J SMALL BUS MANAGE, V49, P185, DOI 10.1111/j.1540-627X.2011.00321.x; Audretsch D.B., 2006, ENTREPRENEURSHIP EC; Colombo MG, 2004, INT J IND ORGAN, V22, P1183, DOI 10.1016/j.ijindorg.2004.06.006; EVANS DS, 1989, J POLIT ECON, V97, P808, DOI 10.1086/261629; Ganotakis P, 2012, SMALL BUS ECON, V39, P495, DOI 10.1007/s11187-010-9309-0; Honjo Y, 2004, APPL ECON, V36, P343, DOI 10.1080/00036840410001674277; Colombo MG, 2005, RES POLICY, V34, P795, DOI 10.1016/j.respol.2005.03.010; Okamuro H, 2009, SMALL BUSINESS: INNOVATION, PROBLEMS AND STRATEGY, P27; Robson PJA, 2012, SMALL BUS ECON, V39, P603, DOI 10.1007/s11187-011-9333-8; stebro T., 2003, J ECON BUS, V55, P303; stebro T., 2005, SMALL BUSINESS EC, V24, P63; Sterlacchini A., 1990, SMALL BUSINESS EC, V2, P223, DOI DOI 10.1007/BF00389530	25	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2778	1540-627X		J SMALL BUS MANAGE	J. Small Bus. Manag.	JAN	2015	53	1					114	128		10.1111/jsbm.12094		15	Management	Business & Economics	AW9NM	WOS:000346584400006		
J	Mikami, T; Ochi, S; Houkin, K; Akiyama, Y; Wanibuchi, M; Mikuni, N				Mikami, Takeshi; Ochi, Satoko; Houkin, Kiyohiro; Akiyama, Yukinori; Wanibuchi, Masahiko; Mikuni, Nobuhiro			Predictive Factors for Epilepsy in Moyamoya Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Seizure; hemorrhage; epileptic type; stroke	CEREBRAL HYPERPERFUSION; NEUROLOGIC DETERIORATION; EPIDEMIOLOGIC FEATURES; ISCHEMIC-STROKE; SEIZURES; DIAGNOSIS; ADULTS; TRIAL; ONSET; CARBAMAZEPINE	Background: Epilepsy cannot always be recognized in patients with moyamoya disease. In this report, the clinical features of patients with epilepsy were evaluated for assessing the predictive factors of epilepsy in moyamoya disease. Methods: A total of 64 consecutive patients with moyamoya disease were included in this study. During their follow-up periods, 7 patients were diagnosed with epilepsy. Then, the patients with epilepsy were compared with the patients without epilepsy regarding their clinical features. Results: Analysis of patient background characteristics revealed a significantly higher incidence of epilepsy in patients with high modified Rankin Scale (mRS) scores, high cerebrovascular attack scores, onset age of 3 years or less, early seizures, cortical involvement, stroke subtype, and diffuse brain atrophy. A logistic analysis of epilepsy data revealed significant differences between the 2 groups in mRS score, cerebrovascular attack score, onset age 3 years or less, early seizure, cortical involvement, stroke subtype, and diffuse brain atrophy. Of these, significant differences were noted in 3 items (mRS score, early seizure, and diffuse brain atrophy) on multivariate analysis. These 3 items were selected as the basis of our new moyamoya disease epilepsy risk scale (MDERS), which we then evaluated. The cutoff value estimated by the receiver operating characteristic curve was set at 1 (sensitivity,.857; specificity,.825) or 2 (sensitivity,.571; specificity, 1.000). Conclusions: Epilepsy in moyamoya disease is associated with clinical factors and is not an independent category. For prediction of epilepsy in moyamoya disease, MDERS is a simple and convenient assessment scale.	[Mikami, Takeshi; Ochi, Satoko; Akiyama, Yukinori; Wanibuchi, Masahiko; Mikuni, Nobuhiro] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido 0608543, Japan; [Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan	Mikami, T (reprint author), Sapporo Med Univ, Dept Neurosurg, Chuo Ku, South1 West16, Sapporo, Hokkaido 0608543, Japan.	mikunin@sapmed.ac.jp					Amlie-Lefond C, 2011, PEDIATR NEUROL, V44, P299, DOI 10.1016/j.pediatrneurol.2010.10.016; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; SALINSKY M, 1987, EPILEPSIA, V28, P331, DOI 10.1111/j.1528-1157.1987.tb03652.x; [Anonymous], 1983, STROKE, V14, P668; van Mook WNKA, 2005, LANCET NEUROL, V4, P877, DOI 10.1016/S1474-4422(05)70251-9; SUZUKI J, 1983, STROKE, V14, P104; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Burn J, 1997, BRIT MED J, V315, P1582; Rowan AJ, 2005, NEUROLOGY, V64, P1868, DOI 10.1212/01.WNL.0000167384.68207.3E; Strzelczyk A, 2010, J NEUROL, V257, P1322, DOI 10.1007/s00415-010-5520-9; Fujimura M, 2007, SURG NEUROL, V67, P273, DOI 10.1016/j.surneu.2006.07.017; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Tsivgoulis G, 2011, STROKE, V42, P1771, DOI 10.1161/STROKEAHA.110.609339; Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; So EL, 1996, NEUROLOGY, V46, P350; Lamy C, 2003, NEUROLOGY, V60, P400; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Jin QN, 2011, NEUROL MED-CHIR, V51, P195; Fujimura M, 2011, NEUROSURGERY, V68, P957, DOI 10.1227/NEU.0b013e318208f1da; Fujimura M, 2011, NEUROSURGERY, V68, P64; Hoshino H, 2012, NEUROL MED-CHIR, V52, P295; Jin SC, 2011, NEUROSURGERY, V68, P1227, DOI 10.1227/NEU.0b013e31820c045a; Karceski S, 2005, EPILEPSY BEHAV, V7, pS1, DOI 10.1016/j.yebeh.2005.06.001; Karceski S, 2005, EPILEPSY BEHAV S1, V7, pS5; Kikuta KI, 2006, J NEUROSURG, V104, P265, DOI 10.3171/ped.2006.104.4.265; Kraemer M, 2012, BRIT J NEUROSURG, V26, P896, DOI 10.3109/02688697.2012.697213; Kurokawa T, 1985, Pediatr Neurol, V1, P274, DOI 10.1016/0887-8994(85)90027-X; Kwan J, 2007, ACTA NEUROL SCAND, V115, P331, DOI 10.1111/j.1600-0404.2006.00783.x; Manaka S, 2003, NEUROL MED-CHIR, V43, P589, DOI 10.2176/nmc.43.589; Manceau E, 1997, CHILD NERV SYST, V13, P595, DOI 10.1007/s003810050148; Nakase Hiroyuki, 1993, Neurologia Medico-Chirurgica, V33, P621, DOI 10.2176/nmc.33.621; Nakase H, 1993, No To Shinkei, V45, P973; Nunes VD, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e281; Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, NEUROL MED CHIR TOKY, V52, P245; Robertson NP, 1999, J NEUROL NEUROSUR PS, V66, P111, DOI 10.1136/jnnp.66.1.111; SCHOENBERG BS, 1977, ARCH NEUROL-CHICAGO, V34, P511; Schulz UGR, 2002, POSTGRAD MED J, V78, P246, DOI 10.1136/pmj.78.918.246; SHINTON RA, 1988, J NEUROL NEUROSUR PS, V51, P273, DOI 10.1136/jnnp.51.2.273; Teng R J, 1990, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V31, P373; Yonekawa Yasuhiro, 2003, Adv Neurol, V92, P113	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					17	23		10.1016/j.jstrokecerebrovasdis.2014.07.050		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700015		
J	Maruwaka, M; Yoshikawa, K; Okamoto, S; Araki, Y; Sumitomo, M; Kawamura, A; Yokoyama, K; Wakabayashi, T				Maruwaka, Mikio; Yoshikawa, Kazuhiro; Okamoto, Sho; Araki, Yoshio; Sumitomo, Masaki; Kawamura, Akino; Yokoyama, Kinya; Wakabayashi, Toshihiko			Biomarker Research for Moyamoya Disease in Cerebrospinal Fluid Using Surface-enhanced Laser Desorption/Ionization Time-of-flight Mass Spectrometry	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Moyamoya disease (MMD); surface-enhanced laser desorption/ionization mass spectrometry; (SELDI-TOF-MS); biomarker; cerebrospinal fluid (CSF); angiogenesis	NEURODEGENERATIVE DISEASES; EPIDEMIOLOGIC FEATURES; PROTEOMIC PATTERNS; GROWTH-FACTOR; SERUM; DIAGNOSIS; CANCER; REVASCULARIZATION; DIFFERENTIATION; SYNANGIOSIS	Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by steno-occlusive change in bilateral internal carotid arteries with unknown etiology. To discover biomarker candidates in cerebrospinal fluid fromMMD patients, proteome analysis was performed by the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Three peptides, 4473Da, 4475Da, and 6253Da, were significantly elevated in MMD group. A positive correlation between 4473Da peptide and postoperative angiogenesis was determined. Twenty MMD patients were enrolled in this pilot study, including 11 pediatric cases less than 18 years of age (mean age, 8.67 years) and 9 adult MMD patients (mean age, 38.1 years). This study also includes 17 control cases with the mean age of 27.9 years old. In conclusion, 4473Da peptide is supposed to be a reliable biomarker of MMD. 4473Da peptide showed higher intensity peaks especially in younger MMD patients, and it was proved to be highly related to postoperative angiogenesis. Further study is needed to show how 4473Da peptide is involved with the etiology and the onset of MMD.	[Maruwaka, Mikio] Nagoya Univ, Dept Neurosurg, Grad Sch Med, Nagoya, Aichi, Japan; [Yoshikawa, Kazuhiro] Inst Comprehens Med Res, Div Adv Res Promot, Nagakute, Aichi, Japan; [Yoshikawa, Kazuhiro] Nagoya Univ, Grad Sch Med, Div Adv Med, Adv Med Res Ctr, Nagoya, Aichi 4648601, Japan; [Yoshikawa, Kazuhiro] Nagoya Univ, Grad Sch Med, Lab Cell Therapy, Div Adv Med Res Ctr, Nagoya, Aichi 4648601, Japan; [Okamoto, Sho; Araki, Yoshio; Kawamura, Akino; Yokoyama, Kinya; Wakabayashi, Toshihiko] Nagoya Univ, Grad Sch Med, Dept Neurosurg, Nagoya, Aichi, Japan; [Sumitomo, Masaki] Komaki Municipal Hosp, Dept Neurosurg, Komaki, Japan	Maruwaka, M (reprint author), Ichinomiya Municipal Hosp, Dept Neurosurg, Ichinomiya, Aichi 4918558, Japan.	maruwakamikio@gmail.com			Ministry of Health, Labour and Welfare, Japan	This work was supported by a Grant-in-Aid for Scientific Research C by the Ministry of Health, Labour and Welfare, Japan.	Adachi S, 2004, PEDIATR RES, V55, P485, DOI 10.1203/01.PDR.0000106805.54926.2C; Skold K, 2006, J PROTEOME RES, V5, P262, DOI 10.1021/pr050281f; Sawada T, 2012, NEURORADIOLOGY, V54, P1089, DOI 10.1007/s00234-012-1020-1; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Houkin K, 1997, CHILD NERV SYST, V13, P24, DOI 10.1007/s003810050034; Scott RM, 2004, J NEUROSURG, V100, P142; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Fujimura M, 2009, SURG NEUROL, V72, P476, DOI 10.1016/j.surneu.2008.10.009; Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Houkin K, 2012, NEUROL MED-CHIR, V52, P267; Becker S, 2004, ANN SURG ONCOL, V11, P907, DOI 10.1245/ASO.2004.03.557; Wei X, 2009, INT J CLIN EXP PATHO, V2, P132; Lopez MF, 2005, CLIN CHEM, V51, P1946, DOI 10.1373/clinchem.2005.053090; AOYAGI M, 1991, J CELL PHYSIOL, V147, P191, DOI 10.1002/jcp.1041470202; Araki Y, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-112; Caputo E, 2003, ANAL BIOCHEM, V321, P116, DOI 10.1016/S0003-2697(03)00361-0; Davidsson P, 2005, DIS MARKERS, V21, P81; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Hojo M, 1998, J NEUROSURG, V89, P623, DOI 10.3171/jns.1998.89.4.0623; Houkin K, 2004, CHILD NERV SYST, V20, P734, DOI 10.1007/s00381-004-0971-x; Houkin K, 1998, Neurosurg Focus, V5, pe2; HUTCHENS TW, 1993, RAPID COMMUN MASS SP, V7, P576, DOI 10.1002/rcm.1290070703; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Ishikawa K, 1997, STROKE, V28, P1170; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Nanba R, 2004, STROKE, V35, P2837, DOI 10.1161/01.STR.0000148237.13659.e6; Petricoin EF, 2002, J NATL CANCER I, V94, P1576; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Soriano SG, 2002, NEUROSURGERY, V50, P544, DOI 10.1097/00006123-200203000-00022; Takagi Y, 2007, NEUROSURGERY, V60, P338, DOI 10.1227/01.NEU.0000249275.87310.FF; Wakai K, 1997, CLIN NEUROL NEUROSUR, V99, pS1, DOI 10.1016/S0303-8467(97)00031-0	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					104	111		10.1016/j.jstrokecerebrovasdis.2014.07.028		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700028		
J	Mitsumura, H; Miyagawa, S; Komatsu, T; Sakamoto, Y; Kono, Y; Furuhata, H; Iguchi, Y				Mitsumura, Hidetaka; Miyagawa, Shinji; Komatsu, Teppei; Sakamoto, Yuki; Kono, Yu; Furuhata, Hiroshi; Iguchi, Yasuyuki			Transcranial Color Flow Imaging Can Evaluate the Severity of Periventricular Hyperintensity	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						White matter lesion; periventricular hyperintensity; transcranial color flow imaging; middle cerebral artery; pulsatility index; end-diastolic velocity	WHITE-MATTER HYPERINTENSITIES; PULSE-WAVE VELOCITY; SMALL-VESSEL DISEASE; HYPERTENSIVE PATIENTS; ISCHEMIC-STROKE; ROTTERDAM-SCAN; BLOOD-PRESSURE; LESIONS; DOPPLER; RISK	Background: The goal of this study was to investigate the relationship between white matter lesions on magnetic resonance imaging and flow parameters in the middle cerebral artery (MCA) measured by transcranial color flow imaging. Methods: Patients with acute ischemic stroke or transient ischemic attack were included. The relationship between severities of periventricular hyperintensity (PVH) and ultrasonographic parameters in the MCA was investigated. The frequency of PVH was calculated for different categories according to the presence or absence of 2 considerable parameters according to the value of area under the receiver operating characteristic curve. Results: MCA flow was successfully measured in 203 temporal windows among 124 patients. After determining the cutoff value of end-diastolic velocity (EDV) and pulsatility index (PI) for the presence of PVH, 4 different categories were established: Category A, EDV more than 40 cm/second and PI less than.7; Category B, EDV more than 40 cm/second and PI more than.7; Category C, EDV less than 40 cm/second and PI less than.7; and Category D, EDV less than 40 cm/second and PI more than.7. The prevalence of PVH gradually increased along with category (P < . 01). Conclusions: The evaluation of MCA parameters using the combination of PI and EDV may be useful for the prediction of PVH.	[Mitsumura, Hidetaka; Miyagawa, Shinji; Komatsu, Teppei; Sakamoto, Yuki; Kono, Yu; Furuhata, Hiroshi; Iguchi, Yasuyuki] Jikei Univ, Sch Med, Dept Neurol, Tokyo 1058461, Japan	Mitsumura, H (reprint author), Jikei Univ, Sch Med, Dept Neurol, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	hmitsumura@jikei.ac.jp					Shinohara Y, 2007, CEREBROVASC DIS, V24, P202, DOI 10.1159/000104478; Smith EE, 2008, ARCH NEUROL-CHICAGO, V65, P94, DOI 10.1001/archneurol.2007.23; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; REVESZ T, 1989, J NEUROL NEUROSUR PS, V52, P1337, DOI 10.1136/jnnp.52.12.1337; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; de Groot JC, 2001, NEUROLOGY, V56, P1539; Novak V, 2006, DIABETES CARE, V29, P1529, DOI 10.2337/dc06-0261; Saji N, 2011, NEUROEPIDEMIOLOGY, V36, P252, DOI 10.1159/000328260; Pico F, 2002, CEREBROVASC DIS, V14, P109, DOI 10.1159/000064741; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837; HALSEY JH, 1990, STROKE, V21, P1573; Kim DH, 2008, CLIN NEUROL NEUROSUR, V110, P599, DOI 10.1016/j.clineuro.2008.03.009; Pantoni L, 1997, STROKE, V28, P652; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; Bokura Hirokazu, 2006, J Stroke Cerebrovasc Dis, V15, P57, DOI 10.1016/j.jstrokecerebrovasdis.2005.11.001; CHIMOWITZ MI, 1992, ARCH NEUROL-CHICAGO, V49, P747; Choi JC, 2009, CEREBROVASC DIS, V27, P417, DOI 10.1159/000209236; Fu JH, 2006, J NEUROIMAGING, V16, P120, DOI 10.1111/j.1552-6569.2006.00030.x; Fujishima S, 2001, HYPERTENS RES, V24, P345, DOI 10.1291/hypres.24.345; Heliopoulos I, 2012, CARDIOVASC PSYCHIAT, V2012, P1; INZITARI D, 1989, EUR NEUROL, V29, P23, DOI 10.1159/000116461; Kang HJ, 2013, CEREBROVASC DIS, V35, P138, DOI 10.1159/000346604; Kim DH, 2010, EUR NEUROL, V64, P247, DOI 10.1159/000319923; LEIFER D, 1990, NEUROLOGY, V40, P911; Nakano T, 2012, HYPERTENS RES, V35, P729, DOI 10.1038/hr.2012.24; Xiong YY, 2013, J NEUROIMAGING, V23, P53, DOI 10.1111/j.1552-6569.2011.00649.x	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					112	116		10.1016/j.jstrokecerebrovasdis.2014.07.027		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700029		
J	Igase, K; Kumon, Y; Matsubara, I; Arai, M; Goishi, J; Watanabe, H; Ohnishi, T; Sadamoto, K				Igase, Keiji; Kumon, Yoshiaki; Matsubara, Ichiro; Arai, Masamori; Goishi, Junji; Watanabe, Hideaki; Ohnishi, Takanori; Sadamoto, Kazuhiko			Utility of 3-Dimensional Ultrasound Imaging to Evaluate Carotid Artery Stenosis: Comparison with Magnetic Resonance Angiography	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Carotid artery stenosis; 3-dimensional ultrasonography; magnetic resonance angiography; ulceration; mobile plaque	DIGITAL-SUBTRACTION-ANGIOGRAPHY; PLAQUE VOLUME; SYMPTOMATIC PATIENTS; SURFACE-MORPHOLOGY; DOPPLER SONOGRAPHY; ULCERATION; PROGRESSION	Background: We evaluated the utility of 3-dimensional (3-D) ultrasound imaging for assessment of carotid artery stenosis, as compared with similar assessment via magnetic resonance angiography (MRA). Methods: Subjects comprised 58 patients with carotid stenosis who underwent both 3-D ultrasound imaging and MRA. We studied whether abnormal findings detected by ultrasound imaging could be diagnosed using MRA. Ultrasound images were generated using Voluson 730 Expert and Voluson E8. Results: The degree of stenosis was mild in 17, moderate in 16, and severe in 25 patients, according to ultrasound imaging. Stenosis could not be recognized using MRA in 4 of 17 patients diagnosed with mild stenosis using ultrasound imaging. Ultrasound imaging showed ulceration in 13 patients and mobile plaque in 6 patients. When assessing these patients, MRA showed ulceration in only 2 of 13 patients and did not detect mobile plaque in any of these 6 patients. Static 3-D B mode images demonstrated distributions of plaque, ulceration, and mobile plaque, and static 3-D flow images showed flow configuration as a total structure. Real-time 3-D B mode images demonstrated plaque and vessel movement. Carotid artery stenting was not selected for patients diagnosed with ulceration or mobile plaque. Conclusions: Ultrasound imaging was necessary to detect mild stenosis, ulcerated plaque, or mobile plaque in comparison with MRA, and 3-D ultrasound imaging was useful to recognize carotid stenosis and flow pattern as a total structure by static and real-time 3-D demonstration. This information may contribute to surgical planning.	[Igase, Keiji; Matsubara, Ichiro; Arai, Masamori; Goishi, Junji; Sadamoto, Kazuhiko] Washoukai Sadamoto Hosp, Dept Neurosurg, Matsuyama, Ehime, Japan; [Kumon, Yoshiaki; Watanabe, Hideaki; Ohnishi, Takanori] Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon City, Ehime 7910295, Japan	Kumon, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon City, Ehime 7910295, Japan.	ykumon@m.ehime-u.ac.jp					Yoshida K, 2012, NEUROSURGERY, V70, P1143, DOI 10.1227/NEU.0b013e31823fe50b; Barnett PA, 1997, J HYPERTENS, V15, P49, DOI 10.1097/00004872-199715010-00004; WARLOW C, 1991, LANCET, V337, P1235; Lovett JK, 2004, CIRCULATION, V110, P2190, DOI 10.1161/01.CIR.0000144307.82502.32; Nederkoorn PJ, 2003, STROKE, V34, P1324, DOI 10.1161/01.STR.0000068367.08991.A2; Landry A, 2004, STROKE, V35, P864, DOI 10.1161/01.STR.0000121161.61324.ab; Fisher M, 2005, STROKE, V36, P253, DOI 10.1161/01.STR.0000152336.71224.21; Yoshimura S, 2011, STROKE, V42, P3132, DOI 10.1161/STROKEAHA.111.615708; Heliopoulos J, 2011, J NEUROIMAGING, V21, P126, DOI 10.1111/j.1552-6569.2009.00450.x; MERZ E, 1995, ULTRASOUND OBST GYN, V5, P222, DOI 10.1046/j.1469-0705.1995.05040222.x; Wessels T, 2004, STROKE, V35, P1847, DOI 10.1161/01.STR.0000133248.71808.38; Watanabe Y, 2010, NEURORADIOLOGY, V52, P253, DOI 10.1007/s00234-010-0663-z; Ainsworth CD, 2005, STROKE, V36, P1904, DOI 10.1161/01.STR.0000178543.19433.20; Schminke U, 2000, STROKE, V31, P1651; Kume S, 2010, NEUROSURG REV, V33, P419, DOI 10.1007/s10143-010-0270-9; Bucek RA, 2003, AM J NEURORADIOL, V24, P1294; Fenster A, 2006, ULTRASONICS, V44, pE153, DOI 10.1016/j.ultras.2006.06.027; Funaki T, 2011, J VASC SURG, V53, P977, DOI 10.1016/j.jvs.2010.10.105; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Netuka D, 2010, ACTA NEUROCHIR, V152, P1215, DOI 10.1007/s00701-010-0645-2; Prabhakaran S, 2006, STROKE, V37, P1; Schminke U, 2002, J NEUROIMAGING, V12, P245, DOI 10.1177/10528402012003006	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					148	153		10.1016/j.jstrokecerebrovasdis.2014.08.007		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700035		
J	Miyagi, T; Koga, M; Yamagami, H; Okuda, S; Okada, Y; Kimura, K; Shiokawa, Y; Nakagawara, J; Furui, E; Hasegawa, Y; Kario, K; Arihiro, S; Sato, S; Minematsu, K; Toyoda, K				Miyagi, Tetsuya; Koga, Masatoshi; Yamagami, Hiroshi; Okuda, Satoshi; Okada, Yasushi; Kimura, Kazumi; Shiokawa, Yoshiaki; Nakagawara, Jyoji; Furui, Eisuke; Hasegawa, Yasuhiro; Kario, Kazuomi; Arihiro, Shoji; Sato, Shoichiro; Minematsu, Kazuo; Toyoda, Kazunori			Reduced Estimated Glomerular Filtration Rate Affects Outcomes 3 Months after Intracerebral Hemorrhage: The Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage Study	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Glomerular filtration rate; intracerebral hemorrhage; renal dysfunction; outcome	CHRONIC KIDNEY-DISEASE; SMALL VESSEL DISEASE; ACUTE CEREBRAL-HEMORRHAGE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RENAL DYSFUNCTION; JAPANESE POPULATION; ISCHEMIC-STROKE; LONG-TERM; ASSOCIATION	Background: The effect of renal dysfunction on intracerebral hemorrhage (ICH) remains unclear. We investigated associations of renal dysfunction assessed by estimated glomerular filtration rate (eGFR) with clinical courses and outcomes in ICH patients. Methods: From a prospective, multicenter, observational study, 203 patients who had supratentorial ICH within 3 hours of onset were included. Patients were classified into 3 groups based on eGFR: Group 1 (eGFR <60 mL/minute/m(2)), Group 2 (60-89), and Group 3 (>= 90). Outcomes included neurologic deterioration within 72 hours, hematoma expansion (>33% in volume) at 24 hours, and favorable (modified Rankin Scale [mRS]<= 2) or unfavorable (mRS >= 5) outcome at 3 months. Results: Thirty-seven patients (16 women, 74.6 +/- 13.2 years) were assigned to Group 1, 99 (34 women, 65.2 +/- 11.4 years) to Group 2, and 67 (30 women, 61.3 +/- 9.4 years) to Group 3. Significant differences were found in age (P < .001) and initial systolic blood pressure among the groups (208.4 +/- 18.0, 201.9 +/- 15.1, and 198.1 +/- 14.2 mm Hg for Group 1, 2, and 3, respectively; P = .006). Similar rates of neurologic deterioration (14%, 6%, and 6%) and hematoma expansion (16%, 14%, and 18%) were observed among the groups. However, in Group 1, favorable outcome was less frequent (17%, 48%, and 42%; P = .002) and unfavorable outcome was more frequent (24%, 7%, and 6%; P = .013) than in the other groups. After adjustment for confounders, eGFR <60 mL/minute/m(2) was independently associated with both favorable outcome (odds ratio [OR], .21; 95% CI, .07-.54) and unfavorable outcome (OR, 5.64; 95% CI, 1.80-18.58). Conclusions: Renal dysfunction (eGFR <60 mL/minute/m(2)) was associated with poor clinical outcome after ICH.	[Miyagi, Tetsuya; Sato, Shoichiro; Minematsu, Kazuo; Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Koga, Masatoshi; Arihiro, Shoji] Natl Cerebral & Cardiovasc Ctr, Dept Stroke Care Unit, Suita, Osaka 5658565, Japan; [Yamagami, Hiroshi] Kobe City Gen Hosp, Stroke Ctr, Dept Neurol, Kobe, Hyogo, Japan; [Okuda, Satoshi] Natl Hosp Org, Nagoya Med Ctr, Dept Neurol, Nagoya, Aichi, Japan; [Okada, Yasushi] Natl Hosp Org, Kyushu Med Ctr, Dept Cerebrovasc Med & Neurol, Fukuoka, Japan; [Kimura, Kazumi] Kawasaki Med Univ, Dept Stroke Med, Kurashiki, Okayama, Japan; [Shiokawa, Yoshiaki] Kyorin Univ, Sch Med, Dept Neurosurg, Mitaka, Tokyo 181, Japan; [Shiokawa, Yoshiaki] Kyorin Univ, Sch Med, Stroke Ctr, Mitaka, Tokyo 181, Japan; [Nakagawara, Jyoji] Nakamura Mem Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Nakagawara, Jyoji] Nakamura Mem Hosp, Stroke Ctr, Sapporo, Hokkaido, Japan; [Furui, Eisuke] Kohnan Hosp, Dept Stroke Neurol, Sendai, Miyagi, Japan; [Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa 213, Japan; [Kario, Kazuomi] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Japan	Koga, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	koga@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	Ministry of Health, Labour and Welfare, Japan [H20-Junkanki-Ippan-019, H23-Junkanki-Ippan-010]	This study was supported in part by Grants-in-Aid (H20-Junkanki-Ippan-019 and H23-Junkanki-Ippan-010) from the Ministry of Health, Labour and Welfare, Japan.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Hirano T, 2013, CONTRIB NEPHROL, V179, P110, DOI 10.1159/000346729; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882; Lyrer PA, 2008, NEUROLOGY, V71, P1548, DOI 10.1212/01.wnl.0000338459.82173.78; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; MacWalter RS, 2002, STROKE, V33, P1630, DOI 10.1161/01.STR.0000016344.49819.F7; Wada M, 2008, J NEUROL SCI, V272, P36, DOI 10.1016/j.jns.2008.04.029; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Tsagalis G, 2009, NEPHROL DIAL TRANSPL, V24, P194, DOI 10.1093/ndt/gfn471; Naganuma M, 2011, CEREBROVASC DIS, V31, P123, DOI 10.1159/000321516; Kendrick J, 2008, NAT CLIN PRACT NEPHR, V4, P672, DOI 10.1038/ncpneph0954; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Hao ZL, 2010, EUR NEUROL, V63, P237, DOI 10.1159/000285165; Oksala NKJ, 2010, STROKE, V41, P1914, DOI 10.1161/STROKEAHA.110.587352; Kokubo Y, 2009, STROKE, V40, P2674, DOI 10.1161/STROKEAHA.109.550707; Koga M, 2012, J HYPERTENS, V30, P2357, DOI 10.1097/HJH.0b013e328359311b; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Toyoda K, 2013, CONTRIB NEPHROL, V179, P1, DOI 10.1159/000346944; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Qureshi AI, 2008, CIRCULATION, V118, P176, DOI 10.1161/CIRCULATIONAHA.107.723874; Qureshi AI, 2010, CRIT CARE MED, V38, P637, DOI 10.1097/CCM.0b013e3181b9e1a5; Arima H, 2010, HYPERTENSION, V56, P852, DOI 10.1161/HYPERTENSIONAHA.110.154328; Cutting S, 2014, J STROKE CEREBROVASC, V23, P86, DOI 10.1016/j.jstrokecerebrovasdis.2012.09.010; Hu MC, 2000, KIDNEY INT, V58, P1202, DOI 10.1046/j.1523-1755.2000.00275.x; Kuwabara A, 2010, DIABETOLOGIA, V50, P2056; Lee M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4249; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Molshatzki N, 2011, CEREBROVASC DIS, V31, P271, DOI 10.1159/000322155; Ovbiagele B, 2011, J STROKE CEREBROVASC, V20, P145, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.012; Qureshi AI, 2012, AM J MED, V125; Rodriguez-Yanez M, 2006, NEUROLOGY, V67, P1172, DOI 10.1212/01.wnl.0000238353.89194.08; Toyoda K, 2012, NEUROLOGY, V78, P1898, DOI 10.1212/WNL.0b013e318259e29f	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					176	182		10.1016/j.jstrokecerebrovasdis.2014.08.015		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700039		
J	Atsumi, C; Hasegawa, Y; Tsumura, K; Ueda, T; Suzuki, K; Sugiyama, M; Nozaki, H; Suzuki, S; Nakane, M; Nagashima, G; Kitamura, T; Nikaido, H; Sasanuma, J				Atsumi, Chihiro; Hasegawa, Yasuhiro; Tsumura, Kohtaro; Ueda, Toshihiro; Suzuki, Kazunari; Sugiyama, Makoto; Nozaki, Hiroyuki; Suzuki, Shinichi; Nakane, Makoto; Nagashima, Goro; Kitamura, Takayuki; Nikaido, Hirofumi; Sasanuma, Jinichi			Quality Assurance Monitoring of a Citywide Transportation Protocol Improves Clinical Indicators of Intravenous Tissue Plasminogen Activator Therapy: A Community-based, Longitudinal Study	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Stroke-bypass transportation; plan-do-study-act cycle; stroke scale; alteplase	ACUTE ISCHEMIC-STROKE; HEALTH-CARE; WEEKEND; TIME; ADMISSION; ASSOCIATION; THROMBOLYSIS; NOTIFICATION; MORTALITY; FATALITY	Background: Stroke-bypass transportation to the stroke center by paramedics is important to maximize the efficiency of intravenous tissue plasminogen activator (iv-tPA) therapy. To improve access to stroke thrombolysis, a citywide protocol was launched on January 2007 in Kawasaki City (population 1.4 million) using the Maria Prehospital Stroke Scale (MPSS), and quality assurance monitoring has been performed every 6 months. The aim was to identify whether the citywide quality assurance monitoring improves the process and outcome of iv-tPA therapy. Methods: All of the MPSS-based transportation data prospectively recorded by the Kawasaki City Fire Department and the associated clinical data in the 11 hospitals that accept stroke-bypass transfers were merged every 6 months for the quality assurance monitoring. Clinical indicators such as ambulance call-to-door time, onset-to-needle time, door-to-needle time, frequency of thrombolytic use, and outcome of thrombolytic therapy were analyzed. These clinical indicators were also compared between patients transferred on weekdays and on weekends. Results: A total of 2049 patients was registered from April 2009 to March 2013. Their mean age was 70.4 +/- 13.2 (range, 24-98) years, and 64.3% were male. Ambulance call-todoor time decreased gradually from 37.5 +/- 12.5 minutes to 33.9 +/- 11.7 minutes over 4 years (P = .000, analysis of variance with the post hoc Dunnett test). Onset-to-needle time and door-to-needle time were similar over the 4 years. Good outcome (modified Rankin Scale score <2) after iv-tPA therapy increased from 24.1% to 35.3% (P = .045, 2010 vs. 2012). No deleterious effect of weekend admission was observed based on these clinical indicators. Conclusions: A citywide MPSS-based transportation protocol significantly decreased the delay in the ambulance call-to-door time. The implementation of standardized cross-institutional quality assurance programs for acute stroke therapy may improve the process and outcome of iv-tPA therapy in the community.	[Atsumi, Chihiro; Hasegawa, Yasuhiro] St Marianna Univ, Sch Med, Dept Neurol, Kawasaki, Kanagawa 2168511, Japan; [Tsumura, Kohtaro] Kawasaki Saiwai Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Tsumura, Kohtaro] Kawasaki Saiwai Hosp, Neurovasc Ctr, Kawasaki, Kanagawa, Japan; [Ueda, Toshihiro] St Marianna Univ, Toyoko Hosp, Dept Strokol, Stroke Ctr, Kawasaki, Kanagawa 2168511, Japan; [Suzuki, Kazunari] Ohta Gen Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Sugiyama, Makoto] Kanto Rosai Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Nozaki, Hiroyuki] Kawasaki City Hosp, Dept Neurol, Kawasaki, Kanagawa, Japan; [Suzuki, Shinichi] Asao Gen Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Nakane, Makoto] Teikyo Univ, Sch Med, Univ Hosp Mizonokuchi, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Nagashima, Goro] Municipal Tama Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Kitamura, Takayuki] Nippon Med Sch, Musashikosugi Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Nikaido, Hirofumi] Daiichi Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan; [Sasanuma, Jinichi] Shinyurigaoka Gen Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan	Hasegawa, Y (reprint author), St Marianna Univ, Sch Med, Dept Neurol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan.	shinnai@marianna-u.ac.jp					Abdullah AR, 2008, PREHOSP EMERG CARE, V12, P426, DOI 10.1080/10903120802290828; Park TH, 2014, J STROKE CEREBROVASC, V23, P1805, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.027; Hasegawa Y, 2005, CEREBROVASC DIS, V20, P325, DOI 10.1159/000087932; Xian Y, 2014, STROKE, V45, P1387, DOI 10.1161/STROKEAHA.113.003898; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Janszky I, 2007, STROKE, V38, pE94, DOI 10.1161/STROKEAHA.107.491449; Jauss M, 2009, EUR J NEUROL, V16, P1165, DOI 10.1111/j.1468-1331.2009.02656.x; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Kim SK, 2009, EUR J NEUROL, V16, P1331, DOI 10.1111/j.1468-1331.2009.02762.x; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862; Miyamatsu N, 2012, STROKE, V43, P545, DOI 10.1161/STROKEAHA.111.634196; Bejot Y, 2013, EUR J NEUROL, V20, P1177, DOI 10.1111/ene.12154; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; Hasegawa Y, 2013, J STROKE CEREBROVASC, V22, P514, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.007; McKinney JS, 2013, J STROKE CEREBROVASC, V22, P113, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.018; Patel MD, 2011, STROKE, V42, P2263, DOI 10.1161/STROKEAHA.110.605857; Rudd AG, 2007, AGE AGEING, V36, P247, DOI 10.1093/ageing/afm007; Tekle WG, 2012, CEREBROVASC DIS, V34, P400, DOI 10.1159/000343504; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; Xu ZP, 2014, J CLIN NEUROSCI, V21, P822, DOI 10.1016/j.jocn.2013.08.014	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					183	188		10.1016/j.jstrokecerebrovasdis.2014.08.013		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700040		
J	Nii, K; Nakai, K; Tsutsumi, M; Aikawa, H; Iko, M; Sakamoto, K; Mitsutake, T; Eto, A; Hanada, H; Kazekawa, K				Nii, Kouhei; Nakai, Kanji; Tsutsumi, Masanori; Aikawa, Hiroshi; Iko, Minoru; Sakamoto, Kimiya; Mitsutake, Takafumi; Eto, Ayumu; Hanada, Hayatsura; Kazekawa, Kiyoshi			A Manual Carotid Compression Technique to Overcome Difficult Filter Protection Device Retrieval during Carotid Artery Stenting	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Carotid artery stenting; difficult retrieval; filter protection device; manual carotid compression; proximal stent terminus	ENDARTERECTOMY; COMPLICATIONS; ANGIOPLASTY	Background: We investigated the incidence of embolic protection device retrieval difficulties at carotid artery stenting (CAS) with a closed-cell stent and demonstrated the usefulness of a manual carotid compression assist technique. Methods: Between July 2010 and October 2013, we performed 156 CAS procedures using selfexpandable closed-cell stents. All procedures were performed with the aid of a filter design embolic protection device. We used FilterWire EZ in 118 procedures and SpiderFX in 38 procedures. The embolic protection device was usually retrieved by the accessory retrieval sheath after CAS. We applied a manual carotid compression technique when it was difficult to navigate the retrieval sheath through the deployed stent. We compared clinical outcomes in patients where simple retrieval was possible with patients where the manual carotid compression assisted technique was used for retrieval. Results: Among the 156 CAS procedures, we encountered 12 (7.7%) where embolic protection device retrieval was hampered at the proximal stent terminus. Our manual carotid compression technique overcame this difficulty without eliciting neurologic events, artery dissection, or stent deformity. Conclusions: In patients undergoing closed-cell stent placement, embolic protection device retrieval difficulties may be encountered at the proximal stent terminus. Manual carotid compression assisted retrieval is an easy, readily available solution to overcome these difficulties.	[Nii, Kouhei; Nakai, Kanji; Tsutsumi, Masanori; Aikawa, Hiroshi; Iko, Minoru; Sakamoto, Kimiya; Mitsutake, Takafumi; Eto, Ayumu; Hanada, Hayatsura; Kazekawa, Kiyoshi] Fukuoka Univ, Chikushi Hosp, Dept Neurosurg, Chikushino, Japan	Nii, K (reprint author), Fukuoka Univ, Chikushi Hosp, Dept Neurosurg, 1-1-1 Zokumyoin, Fukuoka 8188502, Japan.	k.nii@cis.fukuoka-u.ac.jp					Garg N, 2009, J ENDOVASC THER, V16, P412, DOI 10.1583/09-2713.1; Daugherty WP, 2008, AM J NEURORADIOL, V29, P1594, DOI 10.3174/ajnr.A1118; Lian XG, 2012, CARDIOVASC INTER RAD, V35, P43, DOI 10.1007/s00270-011-0117-y; Muller-Hulsbeck S, 2009, J ENDOVASC THER, V16, P168, DOI 10.1583/08-2539.1; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Cremonesi A, 2003, STROKE, V34, P1936, DOI 10.1161/01.STR.0000081000.23561.61; Malik RK, 2009, J VASC SURG, V50, P216, DOI 10.1016/j.jvs.2009.01.040; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Shilling Kimberly, 2006, Vasc Endovascular Surg, V40, P229, DOI 10.1177/153857440604000308; Touze E, 2009, STROKE, V40, pe683; Tsutsumi M, 2008, AM J NEURORADIOL, V29, P1590, DOI [10.3174/ajnr.A1126, 10.3174/ajar.A1126]; Watanabe Masaki, 2013, J Vasc Interv Neurol, V6, P52	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					210	214		10.1016/j.jstrokecerebrovasdis.2014.08.022		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700044		
J	Suzuki, M; Yoneda, H; Ishihara, H; Shirao, S; Nomura, S; Koizumi, H; Suehiro, E; Goto, H; Sadahiro, H; Maruta, Y; Inoue, T; Oka, F				Suzuki, Michiyasu; Yoneda, Hiroshi; Ishihara, Hideyuki; Shirao, Satoshi; Nomura, Sadahiro; Koizumi, Hiroyasu; Suehiro, Eiichi; Goto, Hisaharu; Sadahiro, Hirokazu; Maruta, Yuichi; Inoue, Takao; Oka, Fumiaki			Adverse Events after Unruptured Cerebral Aneurysm Treatment: A Single-center Experience with Clipping/Coil Embolization Combined Units	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Adverse event; Clip; Coil; outcome; quality of life; unruptured cerebral aneurysm	QUALITY-OF-LIFE; INTRACRANIAL ANEURYSMS; VASOCONSTRICTION SYNDROME; ENDOVASCULAR TREATMENT; VASOSPASM; PREVALENCE; MANAGEMENT; COILING; RUPTURE; JAPAN	Background: Indications of clipping (Clip) or coil embolization (Coil) for unruptured cerebral aneurysms (uAN) was not elaborated because prediction of rupture and risk of treatment are difficult. This study aims to determine the risk-benefit analysis of treating uAN by a comprehensive and retrospective investigation of the adverse events and sequelae in patients treated by our Clip/Coil combined units. Methods: Clip and Coil were performed in 141 and 80 patients, respectively; Clip for middle cerebral artery AN and Coil for paraclinoid or basilar apex AN. Worsening of modified Rankin scale or mini-mental state examination was defined as major morbidity. Minor morbidity or transient morbidity was defined as other neurologic deficits. Mortality and these morbidities were considered as serious adverse events. Convulsion or events outside the brain were defined as mild adverse events. Results: Total mortality and major morbidity were low. Incidence of serious adverse events was not significantly different between the Clip and Coil (17 patients [12.1%] and 6 patients [7.5%]), but the number of total adverse events was significantly different (32 patients [22.7%] in Clip vs. 8 patients [10.0%] in Coil). Because mild morbidities were significantly more frequent in the Clip (20 patients [14.2%]) compared with the Coil (2 patients [2.5%]). Convulsion occurred in 11 (7.8%) patients in the Clip but none in the Coil. Conclusions: Our combined unit decreased the occurrence of mortality/major morbidity; however, minor adverse effects were common, especially in the Clip group because of many intrinsic problems of Clip itself. This result suggests further consideration for the treatment modality for uAN.	[Suzuki, Michiyasu; Yoneda, Hiroshi; Ishihara, Hideyuki; Shirao, Satoshi; Nomura, Sadahiro; Koizumi, Hiroyasu; Suehiro, Eiichi; Goto, Hisaharu; Sadahiro, Hirokazu; Maruta, Yuichi; Inoue, Takao; Oka, Fumiaki] Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan	Suzuki, M (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan.	michi@yamaguchi-u.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology	This work was partially supported by a Grant-in-Aid for Specially Promoted Research (Project No. 20001008) sanctioned in 2008 to Kyushu Institute of Technology, Yamaguchi University, and Shizuoka University by the Japan Ministry of Education, Culture, Sports, Science, and Technology.	Akiyama Y, 2010, CEREBROVASC DIS, V30, P491, DOI 10.1159/000317087; Lad SP, 2013, NEUROSURGERY, V72, P1000, DOI 10.1227/01.neu.0000429284.91142.56; Greving JP, 2009, NEUROLOGY, V73, P258, DOI 10.1212/01.wnl.0b013e3181a2a4ea; Brilstra EH, 2004, CEREBROVASC DIS, V17, P44, DOI 10.1159/000073897; Yamashiro S, 2007, J NEUROL NEUROSUR PS, V78, P497, DOI 10.1136/jnnp.2006.098871; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Igase K, 2012, CEREBROVASC DIS, V33, P348, DOI 10.1159/000336015; Shigematsu T, 2013, STROKE, V44, P2735, DOI 10.1161/STROKEAHA.111.000609; Regli L, 1999, J NEUROSURG, V90, P1025, DOI 10.3171/jns.1999.90.6.1025; Alshekhlee A, 2010, STROKE, V41, P1471, DOI 10.1161/STROKEAHA.110.580647; Eskridge JM, 1998, J NEUROSURG, V89, P81, DOI 10.3171/jns.1998.89.1.0081; Brinjikji W, 2012, STROKE, V43, P3200, DOI 10.1161/STROKEAHA.112.671214; Park HK, 2003, NEUROSURGERY, V53, P14, DOI 10.1227/01.NEU.000068789.08955.1C; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Halkes PHA, 2006, CEREBROVASC DIS, V22, P40, DOI 10.1159/000092336; Kitazawa K, 2005, J CLIN NEUROSCI, V12, P150, DOI 10.1016/j.jocn.2004.02.023; Morita A, 2005, J NEUROSURG, V102, P601, DOI 10.3171/jns.2005.102.4.0601; Fargen KM, 2013, J NEUROSURG, V119, P966, DOI 10.3171/2013.5.JNS122378; Brinjikji W, 2011, STROKE, V42, P1320, DOI 10.1161/STROKEAHA.110.607986; Raymond J, 2008, INTERV NEURORADIOL, V14, P85; BLOOMFIELD SM, 1985, NEUROSURGERY, V17, P792; Chen PR, 2004, NEUROSURG FOCUS, V17, P1; DeLong W B, 1980, Neurosurgery, V6, P729, DOI 10.1097/00006123-198006000-00021; FRIEDMAN P, 1983, SURG NEUROL, V19, P21, DOI 10.1016/0090-3019(83)90204-5; Gerretsen P, 2009, CURR NEUROL NEUROSCI, V9, P108, DOI 10.1007/s11910-009-0018-5; Gruber DP, 1999, J NEUROSURG, V90, P868, DOI 10.3171/jns.1999.90.5.0868; Houkin K, 2009, NEUROSURGERY, V65, P587, DOI 10.1227/01.NEU.0000350860.59902.68; Komotar RJ, 2008, NEUROSURGERY, V62, P183, DOI [10.1227/01.NEU.0000311076.64109.2E, 10.1227/01.NEU.0000296982.54288.12]; Morita A, 2011, JPN J NEUROSURG TOKY, V20, P484; Morita A, 2012, NEW ENGL J MED, V366, P2474; Nickele C, 2007, NEUROCRIT CARE, V7, P81, DOI 10.1007/s12028-007-0001-4; Ogata A, 2010, SHINKEI GEKA, V38, P47; Sugino T, 2009, NEUROL MED CHIR TOKY, V50, P306; Suzuki M, 2013, JPN J NEUROSURG TOKY, V22, P759; Woitzik J, 2011, J CEREB BLOOD FLOW M, V32, P203; Yoshimoto Y, 2013, ACTA NEUROCHIR, V155, P2029, DOI 10.1007/s00701-013-1829-3	36	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					223	231		10.1016/j.jstrokecerebrovasdis.2014.08.018		9	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700046		
J	Otsubo, T; Goto, E; Morishima, T; Ikai, H; Yokota, C; Minematsu, K; Imanaka, Y				Otsubo, Tetsuya; Goto, Etsu; Morishima, Toshitaka; Ikai, Hiroshi; Yokota, Chiaki; Minematsu, Kazuo; Imanaka, Yuichi			Regional Variations in In-hospital Mortality, Care Processes, and Spending in Acute Ischemic Stroke Patients in Japan	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Ischemic stroke; acute care; regional variation; indicator; claims data	MULTILEVEL LOGISTIC-REGRESSION; QUALITY-OF-CARE; GEOGRAPHIC-VARIATION; UNITED-STATES; RESOURCE USE; ASSOCIATION; NATIONWIDE; OUTCOMES; RATES; TUTORIAL	Background: Little is known about the regional variations in ischemic stroke care in Japan. This study investigates the regional variations and associations among outcomes, care processes, spending, and physician workforce availability in acute ischemic stroke care. Methods: Using administrative claims data from National Claims Database, we identified National Health Insurance beneficiaries aged 65 years and older and Long Life Medical Care System beneficiaries from 9 prefectures who had been hospitalized for acute ischemic stroke between April 2010 and March 2012. Patients were grouped according to their subprefectural regions of residence known as secondary medical areas (SMAs). Performances in 8 outcome and process of care measures were analyzed in each SMA. Multilevel regression models with 2 levels (patient and regional) were used to analyze age-and sex-adjusted inhospital mortality, hospitalization spending, and tissue plasminogen activator (tPA) utilization rate. The associations between regional supply of physicians for stroke care and the various quality measures were investigated. Results: We analyzed 49,440 acute ischemic stroke patients. The regional variations among SMAs in in-hospital mortality, spending, and tPA utilization were 3.2-, 1.7-, and 5.9-fold, respectively. Higher physician supply was significantly associated with lower in-hospital mortality and higher spending. Additionally, spending had a significantly negative correlation with regional continuity of care planning rate but a significantly positive correlation with rehabilitation rate. Conclusions: The study revealed substantial regional variations in Japanese ischemic stroke care. Improving the allocative efficiency of physicians and establishing continuity of care networks may be useful in mitigating regional disparities and reconstructing the stroke care system.	[Otsubo, Tetsuya; Goto, Etsu; Morishima, Toshitaka; Ikai, Hiroshi; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Kyoto 6068501, Japan; [Yokota, Chiaki] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan	Imanaka, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	imanaka-y@umin.net			Japan Society for the Promotion of Science [25253033, 25860380]	Grant support: This study was supported by a Grant-in-Aid for Scientific Research (A) (25253033) and a Grant-in-Aid for Young Scientists (B) (25860380) from the Japan Society for the Promotion of Science.	Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Corallo AN, 2014, HEALTH POLICY, V114, P5, DOI 10.1016/j.healthpol.2013.08.002; Fonarow GC, 2014, STROKE, V45, P1589, DOI 10.1161/STR.0000000000000014; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Allen NB, 2010, NEUROEPIDEMIOLOGY, V34, P123, DOI 10.1159/000274804; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Kleindorfer D, 2009, STROKE, V40, P3580, DOI 10.1161/STROKEAHA.109.554626; Goldstein LB, 1998, STROKE, V29, P1602; Park S, 2013, HEALTH POLICY, V111, P264, DOI 10.1016/j.healthpol.2013.05.015; Stolz E, 2011, DTSCH ARZTEBL INT, V108, P607, DOI 10.3238/arztebl.2011.0607; Kapral MK, 2013, CAN MED ASSOC J, V185, pE483, DOI 10.1503/cmaj.121418; Hussey PS, 2013, ANN INTERN MED, V158, P27, DOI 10.7326/0003-4819-158-1-201301010-00006; Bambauer KZ, 2006, ARCH NEUROL-CHICAGO, V63, P661, DOI 10.1001/archneur.63.5.661; Bergen DC, 2002, J NEUROL SCI, V198, P3, DOI 10.1016/S0022-510X(02)00071-0; Casper M.L., 2008, ATLAS STROKE HOSP ME; El-Saed A, 2006, STROKE, V37, P1975, DOI 10.1161/01.STR.0000231453.98473.67; Fujino Y, 2014, MED CARE, V52, P634, DOI 10.1097/MLR.0000000000000146; Hall R, 2012, ONTARIO STROKE EVALU; Iguchi Y, 2009, CEREBROVASC DIS, V28, P460, DOI 10.1159/000235991; Iihara K, 2014, J STROKE CEREBROVASC, V23, P1001, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.016; Inoue Y, 2012, JPN J STROKE, V34, P289; Institute of Medicine, 2013, VAR HLTH CAR SPEND T; Ishizaki T, 2004, HEALTH POLICY, V69, P179, DOI 10.1016/j.healthpol.2003.12.018; Kunisawa S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000336; LANSKA DJ, 1994, NEUROLOGY, V44, P1541; Lee J, 2013, J HEALTH SERV RES PO, V18, P77, DOI 10.1177/1355819612473454; Matsui H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-213; Ministry of Health Labour and Welfare, 2010, EST NAT MED CAR EXP; Ministry of Health Labour and Welfare, 2010, SURV NAT HLTH INS; Motohashi T, 2013, HEALTH POLICY, V111, P60, DOI 10.1016/j.healthpol.2013.03.014; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Pickle LW, 1997, STROKE, V28, P1639; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Sanagou M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-28; The Joint Committee on Guidelines for the Management of Stroke, JAP GUID MAN STROK 2; Toyoda Kazunori, 2013, J Stroke, V15, P21, DOI 10.5853/jos.2013.15.1.21	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					239	251		10.1016/j.jstrokecerebrovasdis.2014.09.016		13	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700048		
J	Naganuma, M; Inatomi, Y; Kobayashi, O; Nishi, T; Yonehara, T; Ando, Y				Naganuma, Masaki; Inatomi, Yuichiro; Kobayashi, Osamu; Nishi, Toru; Yonehara, Toshiro; Ando, Yukio			Reappearance of Free-floating Carotid Thrombus after Discontinuation of Anticoagulant Therapy	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Carotid endarterectomy; carotid ultrasonography; free-floating thrombus; mobile plaque	ARTERY; MOBILE; MANAGEMENT; PLAQUE	A 73-year-old woman who suddenly developed left hemiparesis was admitted to our hospital. Ultrasonography on admission showed a free-floating thrombus (FFT) attached to an ulcerative plaque in the right common carotid artery. The FFT almost disappeared during treatment with intravenous anticoagulation therapy for acute stroke, but it reappeared when the therapy was discontinued. She underwent endarterectomy on day 13, after which she was free from stroke recurrence.	[Naganuma, Masaki; Inatomi, Yuichiro; Yonehara, Toshiro] Saiseikai Kumamoto Hosp, Stroke Ctr, Dept Neurol, Kumamoto 8614193, Japan; [Kobayashi, Osamu; Nishi, Toru] Saiseikai Kumamoto Hosp, Stroke Ctr, Dept Neurosurg, Kumamoto 8614193, Japan; [Ando, Yukio] Kumamoto Univ, Fac Life Sci, Dept Neurol, Kumamoto, Japan	Naganuma, M (reprint author), Saiseikai Kumamoto Hosp, Stroke Ctr, Dept Neurol, Minami Ku, 5-3-1 Chikami, Kumamoto 8614193, Japan.	naganuma@f6.dion.ne.jp					Golledge J, 2000, STROKE, V31, P774; Bhatti AF, 2007, J VASC SURG, V45, P199, DOI 10.1016/j.jvs.2006.09.057; BILLER J, 1986, SURG NEUROL, V25, P467, DOI 10.1016/0090-3019(86)90086-8; Chakhtoura EY, 2003, J ENDOVASC THER, V10, P653, DOI 10.1583/1545-1550(2003)010<0653:MOMFCP>2.0.CO;2; Funaki T, 2011, J VASC SURG, V53, P977, DOI 10.1016/j.jvs.2010.10.105; Hill SL, 2005, AM SURGEON, V71, P853; Lane TRA, 2010, VASC ENDOVASC SURG, V44, P586, DOI 10.1177/1538574410375312; Ogata T, 2010, CEREBROVASC DIS, V30, P606, DOI 10.1159/000319889; Pisimisis GT, 2010, VASC ENDOVASC SURG, V44, P302, DOI 10.1177/1538574410364420; Urbano LA, 2003, CIRCULATION, V107, pE19, DOI 10.1161/01.CIR.0000046345.41702.33	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	JAN	2015	24	1					E45	E47		10.1016/j.jstrokecerebrovasdis.2014.08.031		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1WJ	WOS:000346733700011		
J	Hiraoka, A; Chikazawa, G; Tamura, K; Totsugawa, T; Sakaguchi, T; Yoshitaka, H				Hiraoka, Arudo; Chikazawa, Genta; Tamura, Kentaro; Totsugawa, Toshinori; Sakaguchi, Taichi; Yoshitaka, Hidenori			Clinical outcomes of different approaches to aortic arch disease	JOURNAL OF VASCULAR SURGERY			English	Article							HIGH-RISK PATIENTS; HYPOTHERMIC CIRCULATORY ARREST; SELECTIVE CEREBRAL PERFUSION; HYBRID PROCEDURES; ZONE 0; ENDOVASCULAR REPAIR; REPLACEMENT; ANEURYSMS; RECONSTRUCTION; METAANALYSIS	Objective: The aim of this study was to evaluate the midterm clinical outcomes of various approaches, including hybrid procedures, to aortic arch pathologies. Methods: Of 305 consecutive patients who underwent aortic arch repair between 2005 and 2013, 244 underwent conventional open total aortic arch repair (CTAR) with antegrade cerebral perfusion under circulatory arrest, 35 underwent debranching of the arch with thoracic endovascular aortic repair (DTEVAR), and 26 underwent staged TEVAR after TAR with elephant trunk (TARET). We retrospectively evaluated the outcomes of the three groups. Results: The DTEVAR group had a greater percentage of patients with preoperative comorbidities. Significant differences were observed in 30-day mortality (DTEVAR, 14.3% [5 of 35] vs TARET TEVAR, 0% [0 of 26] vs CTAR, 5.3% [13 of 244]; P = .045) and stroke (DTEVAR, 28.6% [10 of 35] vs TARET TEVAR, 7.7% [2 of 26] vs CTAR, 8.2% [20 of 244]; P = .001). In overall midterm survival, the DTEVAR group had a lower survival rate (63.9% 3-year survival) compared with the CTAR (90.1% 7-year survival) and the TARET TEVAR (95.5% 2.5-year survival) groups. In elective cases, better midterm results were observed in CTAR and TARET TEVAR groups. An increased number of debranching graft and emergency operations resulted in a much lower follow-up survival rate in the DTEVAR group. Atherosclerotic disease had a great effect on midterm outcomes in the DTEVAR (P = .045) and CTAR groups (P = .002). Conclusions: The clinical feasibility of DTEVAR for high-risk patients requiring zone 0 landing or emergency surgery is still controversial. Atherosclerotic disease of the aorta has a significant negative effect on midterm outcomes in any surgical approach.	[Hiraoka, Arudo; Chikazawa, Genta; Tamura, Kentaro; Totsugawa, Toshinori; Sakaguchi, Taichi; Yoshitaka, Hidenori] Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Kita Ku, Okayama 7000804, Japan	Hiraoka, A (reprint author), Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Kita Ku, 2-5-1 Nakaicho, Okayama 7000804, Japan.	bassbord1028@yahoo.co.jp					Milewski RK, 2010, J THORAC CARDIOV SUR, V140, P590, DOI 10.1016/j.jtcvs.2010.02.055; Khaladj N, 2008, J THORAC CARDIOV SUR, V135, P908, DOI 10.1016/j.jtcvs.2007.07.067; Murashita T, 2012, J THORAC CARDIOV SUR, V143, P1007, DOI 10.1016/j.jtcvs.2011.06.024; Czerny M, 2012, ANN THORAC SURG, V94, P84, DOI 10.1016/j.athoracsur.2012.03.024; Weigang E, 2009, ANN THORAC SURG, V87, P603, DOI 10.1016/j.athoracsur.2008.08.036; Buth J, 2007, J VASC SURG, V46, P1103, DOI 10.1016/j.jvs.2007.08.020; Koullias GJ, 2010, ANN THORAC SURG, V90, P689, DOI 10.1016/j.athoracsur.2009.12.016; Vallejo N, 2012, J VASC SURG, V55, P318, DOI 10.1016/j.jvs.2011.08.042; Numata S, 2013, J CARDIAC SURG, V28, P537, DOI 10.1111/jocs.12166; Cao P, 2012, J THORAC CARDIOV SUR, V144, P1286, DOI 10.1016/j.jtcvs.2012.06.013; Benedetto U, 2013, J THORAC CARDIOV SUR, V145, P305, DOI 10.1016/j.jtcvs.2012.09.011; Okada K, 2012, J THORAC CARDIOV SUR, V144, P139, DOI 10.1016/j.jtcvs.2011.08.039; Preventza O, 2013, EUR J CARDIO-THORAC, V44, P446, DOI 10.1093/ejcts/ezt068; Ishimaru S, 2004, J ENDOVASC THER, V11, P62, DOI 10.1583/04-1407.1; Saleh HM, 2006, J VASC SURG, V44, P460, DOI 10.1016/j.jvs.2006.04.057; Zierer A, 2012, J THORAC CARDIOV SUR, V144, P1042, DOI 10.1016/j.jtcvs.2012.07.063; Bavaria J, 2013, J THORAC CARDIOV SUR, V145, pS85, DOI 10.1016/j.jtcvs.2012.11.044; Hiraoka A, 2014, J THORAC CARDIOV SUR, V148, P77, DOI 10.1016/j.jtcvs.2013.07.042; Hiraoka A, 2012, J CARDIAC SURG, V27, P518, DOI 10.1111/j.1540-8191.2012.01482.x; Kawaharada N, 2009, EUR J CARDIO-THORAC, V36, P956, DOI 10.1016/j.ejcts.2009.05.033; Numata S, 2012, ANN THORAC SURG, V94, P90, DOI 10.1016/j.athoracsur.2012.03.055; Ogino H, 2006, EUR J CARDIO-THORAC, V29, P255, DOI 10.1016/j.ejcts.2005.10.040; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Amarenco P, 1996, NEW ENGL J MED, V334, P1216	24	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JAN	2015	61	1					88	95		10.1016/j.jvs.2014.06.121		8	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AX0JB	WOS:000346637600015		
J	Suematsu, Y; Morizumi, S; Okamura, K; Kawata, M				Suematsu, Yoshihiro; Morizumi, Sei; Okamura, Kenichi; Kawata, Mitsuhiro			A rare case of axillobifemoral bypass graft infection caused by Helicobacter cinaedi	JOURNAL OF VASCULAR SURGERY			English	Article							BACTEREMIA	Helicobacter cinaedi infection is rarely encountered in nonimmunocompromised patients. We report the case of an 85-year-old man who presented with axillobifemoral bypass graft infection caused by Helicobacter cinaedi. The patient was not immunocompromised. We successfully treated him by iliac stenting of the native iliac artery, with near-total removal of the infected graft. At present, 48 months later, the patient is doing well at home, with no evidence of infection. To the best of our knowledge, this is the first report of infection of a prosthetic graft caused by Helicobacter cinaedi.	[Suematsu, Yoshihiro; Morizumi, Sei; Okamura, Kenichi; Kawata, Mitsuhiro] Tsukuba Mem Hosp, Dept Cardiovasc Surg, Tsukuba, Ibaraki 1187299, Japan	Suematsu, Y (reprint author), Tsukuba Mem Hosp, Dept Cardiovasc Surg, Tsukuba, Ibaraki 1187299, Japan.	suematsu@tf7.so-net.ne.jp					Aboshady I, 2012, J VASC SURG, V56, P794, DOI 10.1016/j.jvs.2012.02.008; Chen BL, 2011, J VASC SURG, V53, P367, DOI 10.1016/j.jvs.2010.08.073; Lasry S, 2000, CLIN INFECT DIS, V31, P201, DOI 10.1086/313930; Kitamura T, 2007, J CLIN MICROBIOL, V45, P31, DOI 10.1128/JCM.01507-06; Sachwani GR, 2013, J VASC SURG, V57, P1030, DOI 10.1016/j.jvs.2012.09.038; Calligaro KD, 1995, J VASC SURG, V22, P680, DOI 10.1016/S0741-5214(95)70058-7; GEARY K J, 1990, Journal of Vascular Surgery, V11, P339, DOI 10.1067/mva.1990.17626; Murakami Hinako, 2003, Journal of Infection and Chemotherapy, V9, P344, DOI 10.1007/s10156-003-0265-3; SAMSON R H, 1988, Journal of Vascular Surgery, V8, P147, DOI 10.1067/mva.1988.avs0080147; Schmalstieg J, 2012, J CARDIOVASC SURG, V53, P291; Verma H, 2013, J CARDIOVASC SURG, V54, P55	11	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JAN	2015	61	1					231	233		10.1016/j.jvs.2013.08.048		3	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AX0JB	WOS:000346637600036		
J	Ito, H; Matsumoto, A				Ito, Hiroya; Matsumoto, Atsuko			Isolation and genetic characterization of an Actinobacillus pleuropneumoniae serovar K12:O3 strain	JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION			English	Article						Actinobacillus pleuropneumoniae; atypical serovar 12; serovar K12:O3	LONG-CHAIN LIPOPOLYSACCHARIDES; LINKED-IMMUNOSORBENT-ASSAY; SEROLOGICAL CHARACTERIZATION; SWINE PLEUROPNEUMONIA; CAPSULAR POLYSACCHARIDES; SEROTYPES 1; SERODIAGNOSIS; PIGS; ANTIGENS	An atypical Actinobacillus pleuropneumoniae serovar 12 strain, termed QAS106, was isolated from a clinical case of porcine pleuropneumonia in Japan. An immunodiffusion (ID) test identified the strain as serovar 12. However, the ID test also demonstrated that strain QAS106 shared antigenic determinants with both the serovar 3 and 15 reference strains. Strain QAS106 was positive in the capsular serovar 12-specific polymerase chain reaction (PCR) assay, while the PCR toxin gene profiling and omlA PCR typing assays indicated that strain QAS106 was similar to serovar 3. The nucleotide sequence of the 16S ribosomal DNA (rDNA) of strain QAS106 was identical with that of serovars 3 and 12, but it showed 99.7% identity with that of serovar 15. Nucleotide sequence analysis revealed that genes involved in biosynthesis of the capsular polysaccharide (CPS) of strain QAS106 were identical to those of serovar 12 at the amino acid level. On the other hand, strain QAS106 would express putative proteins involved in the biosynthesis of lipopolysaccharide (LPS) O-polysaccharide (O-PS), the amino acid sequences of which were identical or nearly identical to those of serovars 3 and 15. In conclusion, strain QAS106 should be recognized as K12:O3, even though typical serovar 12 strains are K12:O12. The emergence of an atypical A. pleuropneumoniae serovar 12 strain expressing a rare combination of CPS and O-PS antigens would hamper precise serodiagnosis by the use of either CPS- or LPS-based serodiagnostic methodology alone.	[Ito, Hiroya] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Ibaraki, Japan; [Matsumoto, Atsuko] Chiba Chuo Livestock Hyg Serv Ctr, Chiba, Japan	Ito, H (reprint author), Natl Inst Anim Hlth, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.	itohiroy@affrc.go.jp			National Agriculture and Food Research Organization, Japan	This study was supported by grants from the National Agriculture and Food Research Organization, Japan.	Nielsen R, 1997, VET MICROBIOL, V54, P35, DOI 10.1016/S0378-1135(96)01267-9; GOTTSCHALK M, 1994, VET MICROBIOL, V38, P315, DOI 10.1016/0378-1135(94)90150-3; Jessing SG, 2008, VET MICROBIOL, V129, P350, DOI 10.1016/j.vetmic.2007.12.003; Angen O, 2008, VET MICROBIOL, V132, P312, DOI 10.1016/j.vetmic.2008.05.010; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Inzana TJ, 2001, J CLIN MICROBIOL, V39, P1279, DOI 10.1128/JCM.39.4.1279-1282.2001; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; GOTTSCHALK M, 1994, VET MICROBIOL, V42, P91, DOI 10.1016/0378-1135(94)90009-4; BOSSE JT, 1990, CAN J VET RES, V54, P427; MITTAL KR, 1992, VET MICROBIOL, V32, P135, DOI 10.1016/0378-1135(92)90101-X; FREY J, 1995, MOL CELL PROBE, V9, P277, DOI 10.1016/S0890-8508(95)90158-2; Perry MB, 2012, VET MICROBIOL, V156, P403, DOI 10.1016/j.vetmic.2011.11.024; Gram T, 2000, VET MICROBIOL, V75, P43, DOI 10.1016/S0378-1135(00)00206-6; BEYNON LM, 1993, EUR J BIOCHEM, V214, P209, DOI 10.1111/j.1432-1033.1993.tb17914.x; Gottschalk M, 1997, CAN J VET RES, V61, P62; Gottschalk M., 2012, DIS SWINE, P653; Gottschalk M, 2000, J VET DIAGN INVEST, V12, P444; Ito H, 2004, PLASMID, V51, P41, DOI 10.1016/j.plasmid.2003.10.001; ITO H, 1995, MICROB PATHOGENESIS, V18, P29; Nielsen R, 1996, ACTA VET SCAND, V37, P327; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Sambrook J, 2001, MOL CLONING, V2; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450	24	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1040-6387	1943-4936		J VET DIAGN INVEST	J. Vet. Diagn. Invest.	JAN	2015	27	1					102	106		10.1177/1040638714555898		5	Veterinary Sciences	Veterinary Sciences	AX0PD	WOS:000346653200015		
J	Santostefano, KE; Hamazaki, T; Biel, NM; Jin, SG; Umezawa, A; Terada, N				Santostefano, Katherine E.; Hamazaki, Takashi; Biel, Nikolett M.; Jin, Shouguang; Umezawa, Akihiro; Terada, Naohiro			A practical guide to induced pluripotent stem cell research using patient samples	LABORATORY INVESTIGATION			English	Article							TAL EFFECTOR NUCLEASES; DOUBLE-STRAND BREAKS; HUMAN SOMATIC-CELLS; REGENERATIVE MEDICINE; REPROGRAMMING FACTORS; PARKINSONS-DISEASE; HUMAN FIBROBLASTS; GENE-EXPRESSION; DEFINED FACTORS; SELF-FORMATION	Approximately 3 years ago, we assessed how patient induced pluripotent stem cell (iPSC) research could potentially impact human pathobiology studies in the future. Since then, the field has grown considerably with numerous technical developments, and the idea of modeling diseases 'in a dish' is becoming increasingly popular in biomedical research. Likely, it is even acceptable to include patient iPSCs as one of the standard research tools for disease mechanism studies, just like knockout mice. However, as the field matures, we acknowledge there remain many practical limitations and obstacles for their genuine application to understand diseases, and accept that it has not been as straightforward to model disorders as initially proposed. A major practical challenge has been efficient direction of iPSC differentiation into desired lineages and preparation of the large numbers of specific cell types required for study. Another even larger obstacle is the limited value of in vitro outcomes, which often do not closely represent disease conditions. To overcome the latter issue, many new approaches are underway, including three-dimensional organoid cultures from iPSCs, xeno-transplantation of human cells to animal models and in vitro interaction of multiple cell types derived from isogenic iPSCs. Here we summarize the areas where patient iPSC studies have provided truly valuable information beyond existing skepticism, discuss the desired technologies to overcome current limitations and include practical guidance for how to utilize the resources. Undoubtedly, these human patient cells are an asset for experimental pathology studies. The future rests on how wisely we use them.	[Santostefano, Katherine E.; Biel, Nikolett M.; Terada, Naohiro] Univ Florida, Coll Med, Ctr Cellular Reprogramming, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Hamazaki, Takashi] Univ Florida, Coll Med, Ctr Cellular Reprogramming, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Jin, Shouguang] Osaka City Univ, Dept Pediat, Osaka 558, Japan; [Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol & Pathol, Tokyo, Japan	Terada, N (reprint author), Univ Florida, Coll Med, Ctr Cellular Reprogramming, Dept Pathol Immunol & Lab Med, POB 100275, Gainesville, FL 32610 USA.	terada@pathology.ufl.edu					Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ochiai H, 2014, P NATL ACAD SCI USA, V111, P1461, DOI 10.1073/pnas.1317008111; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/nature06534; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/nmeth.1323, 10.1038/NMETH.1323]; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Martins-Taylor K, 2014, HUM MOL GENET, V23, P2364, DOI 10.1093/hmg/ddt628; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/nmeth.1426, 10.1038/NMETH.1426]; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Hankowski KE, 2011, LAB INVEST, V91, P972, DOI 10.1038/labinvest.2011.85; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Cai J, 2012, STEMBOOK INTERN 0610; Cruvinel E, 2014, HUM MOL GENET; Hiura H, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-32; Jia JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091547; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085755; Marchand M, 2014, STEM CELL TRANSL MED, V3, P91, DOI 10.5966/sctm.2013-0124; McKernan R, 2013, NAT BIOTECHNOL, V31, P875, DOI 10.1038/nbt.2710; Melton DA, 2011, PHILOS T R SOC B, V366, P2307, DOI 10.1098/rstb.2011.0019; Nguyen Ha Nam, 2011, Cell Stem Cell, V8, P267, DOI 10.1016/j.stem.2011.01.013; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Pennisi E, 2012, SCIENCE, V338, P1408, DOI 10.1126/science.338.6113.1408; Pick M, 2012, STEM CELLS, V30, P2700, DOI 10.1002/stem.1242; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang JY, 2010, J BIOL CHEM, V285, P40303, DOI 10.1074/jbc.M110.183392	79	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JAN	2015	95	1					4	13		10.1038/labinvest.2014.104		10	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AX5QA	WOS:000346980700001		
J	Higuchi, A; Ling, QD; Kumar, SS; Munusamy, MA; Alarfaj, AA; Chang, Y; Kao, SH; Lin, KC; Wang, HC; Umezawa, A				Higuchi, Akon; Ling, Qing-Dong; Kumar, S. Suresh; Munusamy, Murugan A.; Alarfaj, Abdullah A.; Chang, Yung; Kao, Shih-Hsuan; Lin, Ke-Chen; Wang, Han-Chow; Umezawa, Akihiro			Generation of pluripotent stem cells without the use of genetic material	LABORATORY INVESTIGATION			English	Review							SMALL-MOLECULE COMPOUNDS; HUMAN CORD BLOOD; P53 PROTEIN TRANSDUCTION; HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; REGENERATIVE MEDICINE; DEFINED FACTORS; REPROGRAMMING FACTORS; DIRECT CONVERSION; CANCER-CELLS	Induced pluripotent stem cells (iPSCs) provide a platform to obtain patient-specific cells for use as a cell source in regenerative medicine. Although iPSCs do not have the ethical concerns of embryonic stem cells, iPSCs have not been widely used in clinical applications, as they are generated by gene transduction. Recently, iPSCs have been generated without the use of genetic material. For example, protein-induced PSCs and chemically induced PSCs have been generated by the use of small and large (protein) molecules. Several epigenetic characteristics are important for cell differentiation; therefore, several small-molecule inhibitors of epigenetic-modifying enzymes, such as DNA methyltransferases, histone deacetylases, histone methyltransferases, and histone demethylases, are potential candidates for the reprogramming of somatic cells into iPSCs. In this review, we discuss what types of small chemical or large (protein) molecules could be used to replace the viral transduction of genes and/or genetic reprogramming to obtain human iPSCs.	[Higuchi, Akon; Kao, Shih-Hsuan; Lin, Ke-Chen] Natl Cent Univ, Dept Chem & Mat Engn, Jhongli 32001, Taiwan; [Higuchi, Akon; Munusamy, Murugan A.; Alarfaj, Abdullah A.] King Saud Univ, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Ling, Qing-Dong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Ling, Qing-Dong] Cathay Gen Hosp, Cathay Med Res Inst, Taipei, Taiwan; [Kumar, S. Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Slangor, Malaysia; [Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Dept Chem Engn, Jhongli, Taiwan; [Wang, Han-Chow] Hungchi Women & Childrens Hosp, Dept Obstet & Gynecol, Jhongli, Taiwan; [Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod, Tokyo, Japan	Higuchi, A (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongda Rd, Jhongli 32001, Taiwan.	higuchi@ncu.edu.tw			Ministry of Science and Technology of Taiwan [102-2120-M-008-002, 102-2221-E-008-112-MY2]; LandSeed Hospital project [NCU-LSH-101-A-001, NCU-LSH-102-A-003]; National Defense Medical Center Project [102NCU-NDMC-01]; Cathay General Hospital Project [101CGH-NCU-A2, 102NCU-CGH-02, CGH-MR-10115, CGH-MR-A10204]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24560968]	This research was partially supported by the Ministry of Science and Technology of Taiwan under Grant numbers 102-2120-M-008-002, and 102-2221-E-008-112-MY2. This work was also supported by the LandSeed Hospital project (NCU-LSH-101-A-001 and NCU-LSH-102-A-003), the National Defense Medical Center Project (102NCU-NDMC-01), and the Cathay General Hospital Project (101CGH-NCU-A2, 102NCU-CGH-02, CGH-MR-10115 and CGH-MR-A10204). A Grant-in-Aid for Scientific Research (number 24560968) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan is also acknowledged. We acknowledge the International High Cited Research Group (IHCRG #14-104), Deanship of Scientific Research, King Saud University, Riyadh, Kingdom of Saudi Arabia. Akon Higuchi thanks King Saud University, Riyadh, Kingdom of Saudi Arabia, for the Visiting Professorship.	Allsopp TE, 2010, MEDCHEMCOMM, V1, P16, DOI 10.1039/c0md00055h; Anastasia L, 2010, CELL DEATH DIFFER, V17, P1230, DOI 10.1038/cdd.2010.14; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Masip M, 2010, MOL HUM REPROD, V16, P856, DOI 10.1093/molehr/gaq059; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Xie M, 2014, ACS CHEM BIOL, V9, P34, DOI 10.1021/cb400865w; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604; Chun YS, 2010, INT J BIOL SCI, V6, P796; Lu JY, 2013, MED RES REV, V33, P790, DOI 10.1002/med.21265; Firestone AJ, 2010, ACS CHEM BIOL, V5, P15, DOI 10.1021/cb900249y; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Li WL, 2013, CELL RES, V23, P81, DOI 10.1038/cr.2012.182; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028; Jung DW, 2014, ACS CHEM BIOL, V9, P80, DOI 10.1021/cb400754f; de Wert G, 2003, HUM REPROD, V18, P672, DOI 10.1093/humrep/DEG143; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Zhu SY, 2011, ANNU REV BIOMED ENG, V13, P73, DOI 10.1146/annurev-bioeng-071910-124715; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Wu YL, 2013, CHEM BIOL, V20, P1311, DOI 10.1016/j.chembiol.2013.09.016; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zheng Z, 2012, BIOMATERIALS, V33, P5821, DOI 10.1016/j.biomaterials.2012.04.049; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Hankowski KE, 2011, LAB INVEST, V91, P972, DOI 10.1038/labinvest.2011.85; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Moon JH, 2011, CELL RES, V21, P1305, DOI 10.1038/cr.2011.107; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Li WL, 2012, STEM CELLS, V30, P61, DOI 10.1002/stem.768; Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Roessler R, 2013, STEM CELL REV REP, V9, P505, DOI 10.1007/s12015-012-9369-4; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Higuchi A, 2014, PROG POLYM SCI, V39, P1348, DOI 10.1016/j.progpolymsci.2014.01.002; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Efe JA, 2011, PHILOS T R SOC B, V366, P2208, DOI 10.1098/rstb.2011.0006; Fujimoto M, 2012, LAB INVEST, V92, P522, DOI 10.1038/labinvest.2012.1; Giorgetti A, 2010, NAT PROTOC, V5, P811, DOI 10.1038/nprot.2010.16; Gokhale PJ, 2009, LAB INVEST, V89, P259, DOI 10.1038/labinvest.2008.162; Gross B, 2013, CURR MOL MED, V13, P765; Inoue M, 2006, EUR UROL, V49, P161, DOI 10.1016/j.eururo.2005.08.019; Jin J, 2011, J PROTEOME RES, V10, P977, DOI 10.1021/pr100624f; LaFevre-Bernt M, 2008, MOL CANCER THER, V7, P1420, DOI 10.1158/1535-7163.MCT-08-0078; Lee J, 2012, ANGEW CHEM INT EDIT, V51, P12509, DOI 10.1002/anie.201206691; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Li ZH, 2012, NAT COMMUN, V3, P2059; Lukaszewicz AI, 2010, J MED CHEM, V53, P3439, DOI 10.1021/jm901361d; MacArthur C.C., 2012, STEM CELLS INT, V2012; Masuda S, 2013, J MOL CELL BIOL, V5, P354, DOI 10.1093/jmcb/mjt034; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Page RL, 2009, CLONING STEM CELLS, V11, P417, DOI 10.1089/clo.2009.0015; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Si-Tayeb K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-81; Staerk J, 2011, ANGEW CHEM INT EDIT, V50, P5733, DOI 10.1002/anie.201101042; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Szablowska-Gadomska I, 2012, ACTA NEUROBIOL EXP, V72, P337; Tapia N, 2012, CELL STEM CELL, V10, P653, DOI 10.1016/j.stem.2012.04.010; Vezoli J, 2011, MOVEMENT DISORD, V26, P1409, DOI 10.1002/mds.23858; Zhang XZ, 2010, REPROD BIOMED ONLINE, V21, P26, DOI 10.1016/j.rbmo.2010.03.021; Zhu XQ, 2010, BIOMATERIALS, V31, P2779, DOI 10.1016/j.biomaterials.2009.12.027	99	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JAN	2015	95	1					26	42		10.1038/labinvest.2014.132		17	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AX5QA	WOS:000346980700003		
J	Yano, T; Nozaki, Y; Kinoshita, K; Hino, S; Hirooka, Y; Niki, K; Shimazu, H; Kishimoto, K; Funauch, M; Matsumura, I				Yano, Tomohiro; Nozaki, Yuji; Kinoshita, Koji; Hino, Shoichi; Hirooka, Yasuaki; Niki, Kaoru; Shimazu, Hideki; Kishimoto, Kazuya; Funauch, Masanori; Matsumura, Itaru			The pathological role of IL-18R alpha in renal ischemia/reperfusion injury	LABORATORY INVESTIGATION			English	Article							FAS LIGAND EXPRESSION; IFN-GAMMA PRODUCTION; ACUTE KIDNEY INJURY; T-CELLS; CISPLATIN NEPHROTOXICITY; INTERLEUKIN-18 RECEPTOR; MRL-FAS(LPR) MICE; INTERFERON-GAMMA; GENE-EXPRESSION; UP-REGULATION	Interleukin (IL)-18 is a proinflammatory cytokine produced by leukocytes and parenchymal cells (eg, tubular epithelial cells (TECs), mesangial cells, and podocytes). IL-18 receptor (IL-18R) is expressed on these cells in the kidney during ischemia/reperfusion injury (IRI), but its role in this injury is unknown. Fas/Fas ligand (FasL) is also involved in the pathogenesis of renal IRI via tubular apoptosis. In addition, IL-18 enhances the expression of FasL on TECs, but the mechanism underlying this enhancement is not known. Here we used IL-18R alpha-deficient mice to explore the pathological role of IL-18R alpha in renal IRI. We found that compared to wild-type (WT) mice with renal IRI as an acute kidney injury (AKI), the IL-18R alpha-deficient mice demonstrated decreased renal function (as represented by blood urea nitrogen), tubular damage, an increased accumulation of leukocytes (CD4+ T cells, neutrophils, and macrophages), upregulated early AKI biomarkers (ie, urinary kidney injury molecule-1 levels), and increased mRNA expressions of proinflammatory cytokines (IL-1 beta, IL-12p40, and IL-18) and chemokines (intercellular adhesion molecule-1 and CCL2/monocyte chemoattractant protein-1). The mRNA expression of FasL in the kidney was increased in the IL-18R alpha-deficient mice compared to the WT mice. The adoptive transfer of splenocytes by WT mice led to decreased renal IRI compared to the IL-18R alpha-deficient mice. In vitro, the mRNA expression of FasL on TECs was promoted in the presence of recombinant IL-18. These data reveal that IL-18R alpha has an anti-inflammatory effect in IRI-induced AKI. Above all, IL-18 enhanced the inflammatory mechanisms and the apoptosis of TECs through the Fas/FasL pathway by blocking IL-18R alpha.	[Yano, Tomohiro; Nozaki, Yuji; Kinoshita, Koji; Hino, Shoichi; Hirooka, Yasuaki; Niki, Kaoru; Shimazu, Hideki; Kishimoto, Kazuya; Funauch, Masanori; Matsumura, Itaru] Kinki Univ, Sch Med, Dept Hematol & Rheumatol, Sayama, Osaka 5898511, Japan	Yano, T (reprint author), Kinki Univ, Sch Med, Dept Hematol & Rheumatol, 377-2 Ohno Higashi, Sayama, Osaka 5898511, Japan.	yano0317tomohiro@yahoo.co.jp					BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Ortiz A, 1999, NEPHROL DIAL TRANSPL, V14, P1831, DOI 10.1093/ndt/14.8.1831; Lewis EC, 2006, P NATL ACAD SCI USA, V103, P16852, DOI 10.1073/pnas.0607917103; Takagi H, 2003, SCAND J GASTROENTERO, V38, P837, DOI 10.1080/00365520310004047; Park DR, 2003, J IMMUNOL, V170, P6209; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236; Fiorina P, 2006, J AM SOC NEPHROL, V17, P716, DOI 10.1681/ASN.2005090954; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Phoon RKS, 2008, J AM SOC NEPHROL, V19, P477, DOI 10.1681/ASN.2007030392; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Kitaura H, 2002, J IMMUNOL, V169, P4732; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Finotto S, 2004, GUT, V53, P392, DOI 10.1136/gut.2003.018572; Nozaki Y, 2012, KIDNEY INT, V82, P892, DOI 10.1038/ki.2012.226; Kinoshita K, 2004, J IMMUNOL, V173, P5312; Kanakaraj P, 1999, J EXP MED, V189, P1129, DOI 10.1084/jem.189.7.1129; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Cruise MW, 2005, J LEUKOCYTE BIOL, V78, P412, DOI 10.1189/jlb.0105005; Devalaraja-Narashimha K, 2005, PHARMACOL RES, V52, P44, DOI 10.1016/j.phrs.2005.02.022; Dupont PJ, 2007, IMMUNOLOGY, V120, P133, DOI 10.1111/j.1365-2567.2006.02504.x; Fan XH, 1997, KIDNEY INT, V51, P79, DOI 10.1038/ki.1997.10; Fantuzzi L, 2000, J LEUKOCYTE BIOL, V68, P707; Furuichi Kengo, 2012, Nephron Extra, V2, P27, DOI 10.1159/000335533; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; Hamad A R, 2001, Int Rev Immunol, V20, P535, DOI 10.3109/08830180109045577; Laura F, 2000, J LEUKOCYTE BIOL, V68, P707; Liu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102; Marino E, 2003, CYTOKINE, V22, P142, DOI 10.1016/S1043-4666(03)00150-9; Murphy KM, 1999, ONCOGENE, V18, P5991, DOI 10.1038/sj.onc.1203001; Nogae S, 1998, J AM SOC NEPHROL, V9, P620; Nold-Petry CA, 2009, J BIOL CHEM, V284, P25900, DOI 10.1074/jbc.M109.004184; Nozaki Y, 2006, RHEUMATOL INT, V26, P810, DOI 10.1007/s00296-005-0076-1; Nozaki Y, 2011, KIDNEY INT, V81, P844; Ohtsuki T, 1997, ANTICANCER RES, V17, P3253; Sareneva T, 2000, J IMMUNOL, V165, P1933; Striz I, 2005, IMMUNOL LETT, V99, P30, DOI 10.1016/j.imlet.2005.01.010; Timo S, 2000, J IMMUNOL, V165, P1933; Wyburn K, 2005, NEPHROL DIAL TRANSPL, V20, P699, DOI 10.1093/ndt/gfh712; Zhang H, 2011, AM J PHYSIOL-RENAL, V301, P171	45	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JAN	2015	95	1					78	91		10.1038/labinvest.2014.120		14	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AX5QA	WOS:000346980700007		
J	Okazaki, S; Nagoya, S; Matsumoto, H; Mizuo, K; Sasaki, M; Watanabe, S; Yamashita, T; Inoue, H				Okazaki, Shunichiro; Nagoya, Satoshi; Matsumoto, Hiroshi; Mizuo, Keisuke; Sasaki, Mikito; Watanabe, Satoshi; Yamashita, Toshihiko; Inoue, Hiromasa			Development of non-traumatic osteonecrosis of the femoral head requires toll-like receptor 7 and 9 stimulations and is boosted by repression on nuclear factor kappa B in rats	LABORATORY INVESTIGATION			English	Article							STEROID-INDUCED OSTEONECROSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLASMACYTOID DENDRITIC CELLS; SIGNALING PATHWAY; OXIDATIVE STRESS; INDUCTION; RABBITS; MODEL; METHYLPREDNISOLONE; GLUCOCORTICOIDS	Non-traumatic osteonecrosis of the femoral head (ONFH) often occurs after corticosteroid therapy in patients with inflammatory diseases. Recent studies suggest that toll-like receptor (TLR) signaling may contribute to the pathogenesis of inflammatory diseases, and that the reason for corticosteroid therapy for inflammatory diseases is related to the anti-inflammatory activities of corticosteroids through the reduction of NF-kappa B. We hypothesized that the administration of TLR ligands in combination with corticosteroid causes ONFH and that transcription factors may contribute to the pathogenesis of ONFH. The aim of the study was to evaluate (1) the incidence of ONFH in rats after the administration of TLR7 or TLR9 ligands together with methylprednisolone (MPSL) and (2) whether transcription factors contribute to the development of ONFH. Male Wistar rats (n = 148) were divided into five groups as follows: Group 1: Saline+MPSL, Group 2: Imiquimod+Saline, Group 3: Imiquimod+MPSL, Group 4: CpG-C+MPSL, Group 5: Imiquimod+BAY11-7082_MPSL. As a result, ONFH was observed in 0 of 12 rats in Group 1, in 1 of 10 in Group 2, in 6 of 12 in Group 3, in 4 of 12 in Group 4, in 0 of 9 in Group 5. MPSL treatment did not significantly affect IRF7 activity, whereas NF-kappa B activity was significantly repressed in Group 2 and Group 3. Furthermore, the repression in interferon regulatory factor 7 (IRF7) activity by BAY-117082 interfered with the development of ONFH simultaneously with the MPSL treatment-induced repression in NF-kappa B activity. In conclusion, in the present study, corticosteroid treatment after the administration of TLR7 or TLR9 ligands caused ONFH. Repression in NF-kappa B activity by corticosteroid treatment boosted the development of ONFH.	[Okazaki, Shunichiro; Nagoya, Satoshi; Sasaki, Mikito] Sapporo Med Univ, Sch Med, Dept Musculoskeletal Biomech & Surg Dev, Sapporo, Hokkaido 0608556, Japan; [Okazaki, Shunichiro; Matsumoto, Hiroshi; Mizuo, Keisuke; Watanabe, Satoshi; Inoue, Hiromasa] Sapporo Med Univ, Sch Med, Dept Legal Med, Sapporo, Hokkaido 0608556, Japan; [Sasaki, Mikito; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido 0608556, Japan	Okazaki, S (reprint author), Sapporo Med Univ, Sch Med, Dept Musculoskeletal Biomech & Surg Dev, S-1W-17, Sapporo, Hokkaido 0608556, Japan.	oka@sapmed.ac.jp			Japanese Society for the Promotion of Science [22791390, 20390196]; Japan Science and Technology Agency [AS232Z02563G]	This work was supported in part by the Grants-in-Aid for Young Scientists (B) (SO, 22791390) and for Scientific Research (B) (HM, 20390196) from the Japanese Society for the Promotion of Science, and A-STEP (SO, AS232Z02563G) from Japan Science and Technology Agency.	ABELES M, 1978, ARCH INTERN MED, V138, P750, DOI 10.1001/archinte.138.5.750; Fukushima W, 2010, CLIN ORTHOP RELAT R, V468, P2715, DOI 10.1007/s11999-010-1292-x; Tateda K, 2012, LAB INVEST, V92, P1318, DOI 10.1038/labinvest.2012.89; Lv H, 2009, TROP MED INT HEALTH, V14, P79, DOI 10.1111/j.1365-3156.2008.02187.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Okazaki S, 2012, INT J EXP PATHOL, V93, P458, DOI 10.1111/j.1365-2613.2012.00836.x; Toubi E, 2004, AUTOIMMUNITY, V37, P183, DOI 10.1080/089169304110001704944; Ichiseki T, 2011, ARTHRITIS RHEUM-US, V63, P2138, DOI 10.1002/art.30365; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Guma M, 2011, ARTHRITIS RHEUM-US, V63, P1603, DOI 10.1002/art.30271; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Fischer M, 2008, ANN NY ACAD SCI, V1143, P21, DOI 10.1196/annals.1443.012; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119; Hemmi H, 2000, NATURE, V408, P740; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Lovgren T, 2004, ARTHRITIS RHEUM, V50, P1861, DOI 10.1002/art.20254; Lichtnekert J, 2009, AM J PHYSIOL-RENAL, V296, pF867, DOI 10.1152/ajprenal.90213.2008; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Okazaki S, 2009, RHEUMATOLOGY, V48, P227, DOI 10.1093/rheumatology/ken462; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Erken HY, 2012, INT ORTHOP, V36, P1523, DOI 10.1007/s00264-012-1497-6; Higaki J, 2001, INTERNAL MED, V40, P144, DOI 10.2169/internalmedicine.40.144; Holmes KV, 2003, SCIENCE, V300, P1377, DOI 10.1126/science.1086418; Ichiseki T, 2006, RHEUMATOLOGY, V45, P287, DOI 10.1093/rheumatology/kei149; MATSUI M, 1992, CLIN ORTHOP RELAT R, P61; Matsumoto H, 2002, ALCOHOL CLIN EXP RES, V26, p6S, DOI 10.1097/01.ALC.0000026827.79925.C9; Miyamoto R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3014; Murata M, 2007, J ORTHOP SCI, V12, P289, DOI 10.1007/s00776-007-1129-y; Nam SH, 2012, BONE, V50, P149, DOI 10.1016/j.bone.2011.10.017; Okazaki S, 2013, RHEUMATOL INT, V33, P51, DOI 10.1007/s00296-011-2295-y; Ries MD, 2002, J ARTHROPLASTY, V17, P135, DOI 10.1054/arth.2002.28727; Tokuhara Y, 2009, J ORTHOP SCI, V14, P794, DOI 10.1007/s00776-009-1400-5; Varis T, 2000, CLIN PHARMACOL THER, V68, P487, DOI 10.1067/mcp.2000.110772; Wing PC, 1998, SPINAL CORD, V36, P633, DOI 10.1038/sj.sc.3100647; Yu HM, 2011, EUR J HAEMATOL, V86, P67, DOI 10.1111/j.1600-0609.2010.01534.x	39	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JAN	2015	95	1					92	99		10.1038/labinvest.2014.134		8	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AX5QA	WOS:000346980700008		
J	Kaminskii, AA; Lux, O; Hanuza, J; Rhee, H; Eichler, HJ; Zhang, J; Tang, D; Shen, D; Yu, H; Wang, J; Yoneda, H; Shirakawa, A				Kaminskii, A. A.; Lux, O.; Hanuza, J.; Rhee, H.; Eichler, H. J.; Zhang, J.; Tang, D.; Shen, D.; Yu, H.; Wang, J.; Yoneda, H.; Shirakawa, A.			Monoclinic beta-BaY2F8-a novel crystal simultaneously active for SRS and Ln(3+)-ion lasing	LASER PHYSICS			English	Article						stimulated Raman scattering (SRS); monoclinic beta-BaY2F8 crystal; Raman four-wave mixing; chi((3))-nonlinear optical effects; many-phonon SRS; cascaded and cross-cascaded SRS	STIMULATED RAMAN-SCATTERING; ANTI-STOKES COMB; SINGLE-CRYSTALS; BAF2-(Y,LN)F3 SYSTEMS; LASER CRYSTALS; EMISSION; BAY2F8; EFFICIENT; FLUORIDE; SPECTROSCOPY	This paper presents the first investigation of stimulated Raman scattering (SRS) in the monoclinic fluoride crystal beta-BaY2F8, which is known as a promising host-material for trivalent lanthanide (Ln(3+)) lasant ions. Picosecond laser excitation in the visible and near-IR spectral range at room temperature revealed the manifestation of nine SRS-promoting phonon modes, which are related to Ag and Bg vibrations of the crystal. Besides multi-phonon Stokes and anti-Stokes generation, we observed cross-cascaded chi((3))<->chi((3)) processes involving different pairs of SRS-active phonons. A comparative estimation of the first Stokes steady-state Raman gain coefficients, both in the visible and near-IR region related to the most active SRS-phonon mode omega(SRS1) approximate to 208 cm(-1) of beta-BaY2F8, was also performed. Furthermore, a brief review of the pioneering papers on laser action of Ln(3+)-ions doped in beta-BaY2F8 single crystals and other known SRS-active fluoride crystals is given in tabular form.	[Kaminskii, A. A.] Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia; [Lux, O.; Rhee, H.; Eichler, H. J.] Tech Univ Berlin, Inst Opt & Atom Phys, D-10623 Berlin, Germany; [Hanuza, J.] Polish Acad Sci, Inst Low Temp & Struct Res, PL-50950 Wroclaw, Poland; [Zhang, J.; Tang, D.; Shen, D.] Jiangsu Normal Univ, Sch Phys & Elect Engn, Xuzhou 221116, Peoples R China; [Yu, H.; Wang, J.] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Yu, H.; Wang, J.] Shandong Univ, Inst Crystal Mat, Jinan 250100, Peoples R China; [Yoneda, H.; Shirakawa, A.] Univ Electrocommun, Inst Laser Sci, Tokyo 1828585, Japan	Kaminskii, AA (reprint author), Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia.	oliver.lux@physik.tu-berlin.de	Zhang, Jian/G-8296-2011	Zhang, Jian/0000-0001-9061-3940	Russian Foundation for Basic Research; Program 'Extreme Light Fields and Their Applications'	The authors wish to note that this work was considerably enhanced through mutual scientific help within the 'Joint Open Laboratory for Laser Crystals and Precise Laser Systems' and was stimulated by research programs of the Institute of Crystallography of the Russian Academy of Sciences, of the Institute of Optics and Atomic Physics of the Technische Universitat Berlin, of the Institute of Low Temperature and Structure Research of the Polish Academy of Sciences, of the School of Physics and Electronic Engineering, Jiangsu Normal University, of the State Key Laboratory of Crystal Materials and Institute of Crystal Materials of the Shandong University and of the Institute for Laser Science of the Tokyo University of Electro-Communications. One of us (AAK) is grateful to the Russian Foundation for Basic Research and the Program 'Extreme Light Fields and Their Applications' for partial support, as well as to the Alexander von Humboldt Foundation for encouragement during many years of cooperation with the Technische Universitat Berlin in the field of laser physics, nonlinear optics and solid-state physics. The authors also thank E Smirnova for crystallographic help and Dr N P Barnes for providing Sellmeier coefficients.	JOHNSON LF, 1973, APPL PHYS LETT, V23, P96, DOI 10.1063/1.1654822; Galzerano G, 2010, OPT EXPRESS, V18, P6255, DOI 10.1364/OE.18.006255; JOHNSON LF, 1971, APPL PHYS LETT, V19, P44, DOI 10.1063/1.1653816; Cornacchia F, 2004, OPT EXPRESS, V12, P1982, DOI 10.1364/OPEX.12.001982; Bigotta S, 2006, J APPL PHYS, V100, DOI 10.1063/1.2211633; IZOTOVA OE, 1970, DOKL AKAD NAUK SSSR+, V192, P1037; KAMINSKII AA, 1990, OPT QUANT ELECTRON, V22, pS95, DOI 10.1007/BF02089003; KAMINSKII AA, 1991, PHYS STATUS SOLIDI A, V125, pK109, DOI 10.1002/pssa.2211250246; KAMINSKII AA, 1987, INORG MATER+, V23, P940; Kaminskii AA, 2013, PHYS STATUS SOLIDI B, V250, P169, DOI 10.1002/pssb.201248273; KAMINSKII AA, 1984, INORG MATER+, V20, P622; KAMINSKII AA, 1988, INORG MATER+, V24, P439; MCFARLANE RA, 1994, J OPT SOC AM B, V11, P871, DOI 10.1364/JOSAB.11.000871; Kaminskii AA, 2007, LASER PHOTONICS REV, V1, P93, DOI 10.1002/lpor.200710008; Kaminskii AA, 2000, QUANTUM ELECTRON+, V30, P1035, DOI 10.1070/QE2000v030n12ABEH001880; Bohaty L, 2012, LASER PHOTONICS REV, V6, P690, DOI 10.1002/lpor.201200028; GUILBERT LH, 1993, MATER RES BULL, V28, P923, DOI 10.1016/0025-5408(93)90039-G; KAMINSKII AA, 1983, INORG MATER+, V19, P1718; Kaminskii AA, 2006, LASER PHYS LETT, V3, P385, DOI 10.1002/lapl.200610029; Kaminskii AA, 2008, LASER PHYS LETT, V5, P304, DOI 10.1002/lapl.200710130; LAI KK, 1990, PHYS REV B, V42, P5834, DOI 10.1103/PhysRevB.42.5834; Kaminskii AA, 2001, OPT COMMUN, V194, P201, DOI 10.1016/S0030-4018(01)01274-3; Kaminskii AA, 2002, OPT COMMUN, V206, P179, DOI 10.1016/S0030-4018(02)01386-X; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1579, DOI 10.1002/pssb.201451279; KAMINSKII AA, 1988, INORG MATER+, V24, P1788; Kaminskii AA, 2007, LASER PHYS LETT, V4, P291, DOI 10.1002/lapl.200610108; SOBOLEV BP, 1982, J LESS-COMMON MET, V85, P155, DOI 10.1016/0022-5088(82)90067-4; Kaminskii AA, 1998, J ALLOY COMPD, V275, P442, DOI 10.1016/S0925-8388(98)00364-8; ROUSSEAU DL, 1981, J RAMAN SPECTROSC, V10, P253, DOI 10.1002/jrs.1250100152; Greis O, 1982, HDB PHYS CHEM RARE E, P408; JOHNSON LF, 1974, IEEE J QUANTUM ELECT, VQE10, P442, DOI 10.1109/JQE.1974.1068158; JOHNSON LF, 1972, APPL PHYS LETT, V20, P474, DOI 10.1063/1.1654022; Kaiser W., 1972, LASER HDB, V2, P1077; Kaminskii A A, 1989, J QUANTUM ELECT, V19, P340; Kaminskii A. A, 1996, CRYSTALLINE LASERS P; Kaininskii AA, 2007, LASER PHYS LETT, V4, P668, DOI 10.1002/lapl.200710038; Kaminskii AA, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075803; Kaminskii AA, 2008, PHYS-USP+, V51, P899, DOI 10.1070/PU2008v051n09ABEH006650; Kaminskii AA, 2013, PHYS STATUS SOLIDI B, V250, P1837, DOI 10.1002/pssb.201349201; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1045, DOI 10.1002/pssb.201451009; Kaminskii AA, 2012, LASER PHYS LETT, V9, P259, DOI 10.1002/lapl.201110102; Kaminskii AA, 2014, LASER PHOTONICS REV, V8, P324, DOI 10.1002/lpor.201300223; Kaminskii A.A., 1981, LASER CRYSTALS THEIR; Kaminskii AA, 2012, LASER PHYS LETT, V9, P306, DOI 10.1002/lapl.201110135; TKACHENK.NL, 1973, J SOLID STATE CHEM, V8, P213, DOI 10.1016/0022-4596(73)90087-X; Weber M J, 2000, HDB LASER WAVELENGTH	46	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1054-660X	1555-6611		LASER PHYS	Laser Phys.	JAN	2015	25	1							015801	10.1088/1054-660X/25/1/015801		16	Optics; Physics, Applied	Optics; Physics	AX2UL	WOS:000346800100015		
J	Wan, CF; Chen, R; Xue, ST; Wu, ZS				Wan, Chunfeng; Chen, Rong; Xue, Songtao; Wu, Zhishen			Development of a Novel Beam Model and Its Dynamic Characteristics	MECHANICS OF ADVANCED MATERIALS AND STRUCTURES			English	Article						beam model; rotatory inertia; shear deformation; natural frequency; phase velocity; group velocity	2ND FREQUENCY-SPECTRUM; TRANSVERSE VIBRATIONS; TIMOSHENKO BEAMS; UNIFORM; BARS	Rotatory inertia due to the shear deformation is usually neglected for all engineering beam models. This article, however, introduces a novel beam model that further considers the rotatory inertia caused by the shear deformation, based on the Timoshenko beam model. The equation of motion for the proposed beam model is derived. Its dynamic characteristics, including wave and vibration characteristics, are studied in detail. Numerical simulations are conducted and related issues are discussed. It is found that the improvement is negligible when the wave number or vibration order is small for thin beams. However, the improvement is evident when the wave number or vibration intensity is fairly large for thick beams. This research finding reveals that only one frequency spectrum, one set of the wave phase velocities, and one set of group velocities should be considered in Timoshenko-type beams. This finding can help settle the debate in the literature on how many frequency spectra should be considered for these analyses. This research study shows that the proposed new beam model is more reasonable, accurate, and it is a more realistic model.	[Wan, Chunfeng; Wu, Zhishen] Southeast Univ, Sch Civil Engn, Key Lab C&PC Struct, Minist Educ, Nanjing 210096, Jiangsu, Peoples R China; [Wan, Chunfeng; Chen, Rong; Xue, Songtao] Tongji Univ, Res Inst Struct Engn & Disaster Reduct, Shanghai 200092, Peoples R China; [Xue, Songtao] Tohoku Inst Technol, Dept Architecture, Sendai, Miyagi 982, Japan	Wan, CF (reprint author), Southeast Univ, Sch Civil Engn, Key Lab C&PC Struct, Minist Educ, Nanjing 210096, Jiangsu, Peoples R China.	chunfengwan@gmail.com			National Science Fund for Distinguished Young Scholars [59925820]; Key Laboratory of Concrete and Pre-stressed Concrete Structure of Ministry of Education of Southeast University, China (CPCSME); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work is supported by the National Science Fund for Distinguished Young Scholars (59925820), Open Fund of Key Laboratory of Concrete and Pre-stressed Concrete Structure of Ministry of Education of Southeast University, China (CPCSME), Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	ANDERSON RA, 1953, J APPL MECH-T ASME, V20, P504; Timoshenko SP, 1921, PHILOS MAG, V41, P744; Timoshenko SP, 1922, PHILOS MAG, V43, P125; TRAILLNASH RW, 1953, Q J MECH APPL MATH, V6, P186, DOI 10.1093/qjmam/6.2.186; BHASHYAM GR, 1981, J SOUND VIB, V76, P407, DOI 10.1016/0022-460X(81)90520-4; Chen Rong, 2005, Journal of Tongji University (Natural Science), V33; Craig R. R., 1996, STRUCTURAL DYNAMICS; DOWNS B, 1976, J APPL MECH-T ASME, V43, P671; Huang T.C., 1961, J APPLIED MECHANICS, V28, P579, DOI DOI 10.1115/1.3641787; HUTCHINSON JR, 1981, J APPL MECH-T ASME, V48, P923; LEVINSON M, 1982, J SOUND VIB, V84, P319, DOI 10.1016/0022-460X(82)90480-1; Nesterenko V.V., 1993, PMM-J APPL MATH MEC, V57, P669, DOI 10.1016/0021-8928(93)90036-L; PRATHAP G, 1983, J SOUND VIB, V90, P443, DOI 10.1016/0022-460X(83)90724-1; Stephen NG, 2006, J SOUND VIB, V292, P372, DOI 10.1016/j.jsv.2005.08.003; STEPHEN NG, 1982, J SOUND VIB, V80, P578, DOI 10.1016/0022-460X(82)90501-6; Stephen NG, 2006, J SOUND VIB, V297, P1082, DOI 10.1016/j.jsv.2006.04.020; Wan C. F., 2003, THESIS TONGJI U SHAN; Yang G. T., ELASTIC DYNAMICS	18	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1537-6494	1537-6532		MECH ADV MATER STRUC	Mech. Adv. Mater. Struct.		2015	22	5					402	412		10.1080/15376494.2012.736065		11	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing; Materials Science, Composites	Materials Science; Mechanics	AX3NX	WOS:000346847100009		
J	Koi, C; Hachisuga, T; Murakami, M; Kurita, T; Nguyen, TT; Shimajiri, S; Fujino, Y				Koi, Chiho; Hachisuga, Toru; Murakami, Midori; Kurita, Tomoko; Thuy Thi Nguyen; Shimajiri, Shohei; Fujino, Yoshihisa			Overexpression of p53 in the endometrial gland in postmenopausal women	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Article						Postmenopausal endometrium; p53 signature; p53; Ki-67; Estrogen receptor; Apoptosis	SEROUS CARCINOGENESIS; PRECURSOR; SIGNATURE; ALPHA; BRCA	Objective: The p53 signature, which (although morphologically unremarkable) displays diffuse and strong p53 nuclear staining, has been proposed to be a precursor of serous endometrial intraepithelial carcinoma. We examined the overexpression of p53 in postmenopausal endometrial glands. Methods: Postmenopausal endometrial tissues of 82 women with benign disease, including 10 hormone users, were evaluated in this study. Tissues with endometrial hyperplasia and/or polyps were excluded based on a histopathologic review. Expressions of estrogen receptor-alpha, Ki-67, and p53 were immunohistochemically examined. Apoptotic cells were identified using a terminal deoxynucleotidyl transferase dUTP nick end labeling assay. Overexpression of p53 was categorized as moderate to strong in more than 50% of glandular cell nuclei. Results: Focal glandular overexpression of p53 was observed in 1 (9%) of 10 and in 8 (11%) of 72 postmenopausal endometrial tissue specimens in women with and women without a history of hormone use, respectively. Among nonhormone users, the median Ki-67 and apoptotic indices in the postmenopausal endometrial glands of women with and women without overexpression of p53 were 16% and 6% (P = 0.007) and 1% and 1% (P = 0.345), respectively. All postmenopausal endometrial glands were positive for estrogen receptor->, regardless of the overexpression of p53. The postmenopausal endometrial glands of estrogen users exhibited significantly higher Ki-67 and apoptotic indices than those of nonestrogen users (P = 0.001 and P < 0.001, respectively). Conclusions: Overexpression of p53 may be responsible for the high proliferative activity of postmenopausal endometrial glandular cells associated with conditions of low apoptotic cell death.	[Koi, Chiho; Hachisuga, Toru; Murakami, Midori; Kurita, Tomoko; Thuy Thi Nguyen] Univ Occupat & Environm Hlth, Sch Med, Dept Obstet & Gynecol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Shimajiri, Shohei] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Fujino, Yoshihisa] Univ Occupat & Environm Hlth, Sch Med, Dept Prevent Med & Community Hlth, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Hachisuga, T (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Obstet & Gynecol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	thachisu@med.uoeh-u.ac.jp					Folkins AK, 2008, GYNECOL ONCOL, V109, P168, DOI 10.1016/j.ygyno.2008.01.012; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; SHIN TH, 1995, MOL CELL BIOL, V15, P4694; Berger CE, 2012, J BIOL CHEM, V287, P30117, DOI 10.1074/jbc.M112.367326; Crum CP, 2009, MOL ONCOL, V3, P165, DOI 10.1016/j.molonc.2009.01.004; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; Crum CP, 2012, INT J GYNECOL CANCER, V22, pS29, DOI 10.1097/IGC.0b013e31824d7269; Dahmoun M, 2004, MATURITAS, V49, P114, DOI 10.1016/j.maturitas.2003.12.008; Ellenson LH, 2011, BLAUSTEINS PATHOLOGY, P394, DOI 10.1007/978-1-4419-0489-8_9; Hanifi-Moghaddam P, 2008, HUM REPROD, V23, P298, DOI 10.1093/humrep/dem366; Hatanaka Y, 2003, PATHOL INT, V53, P693, DOI 10.1046/j.1440-1827.2003.01547.x; Jarboe EA, 2009, MODERN PATHOL, V22, P345, DOI 10.1038/modpathol.2008.197; Maia H, 2004, BJOG-INT J OBSTET GY, V111, P1242, DOI 10.1111/j.1471-0528.2004.00406.x; Shirley AH, 2009, CANCER RES, V69, P3405; Zheng WX, 2011, AM J SURG PATHOL, V35, pE1, DOI 10.1097/PAS.0b013e318202772e	15	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	JAN	2015	22	1					104	107		10.1097/gme.0000000000000265		4	Obstetrics & Gynecology	Obstetrics & Gynecology	AX2GC	WOS:000346760500018		
J	Insomphun, C; Xie, H; Mifune, J; Kawashima, Y; Orita, I; Nakamura, S; Fukui, T				Insomphun, Chayatip; Xie, Huan; Mifune, Jun; Kawashima, Yui; Orita, Izumi; Nakamura, Satoshi; Fukui, Toshiaki			Improved artificial pathway for biosynthesis of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) with high C-6-monomer composition from fructose in Ralstonia eutropha	METABOLIC ENGINEERING			English	Article						Polyhydroxyalkanoates; Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate); Ralstonia eutropha; Artificial pathway; Crotonyl-CoA carboxylase/reductase	RECOMBINANT ESCHERICHIA-COLI; CROTONYL-COA CARBOXYLASE/REDUCTASE; CUPRIAVIDUS-NECATOR CHROMOSOME; UNRELATED CARBON-SOURCES; PSEUDOMONAS SP 61-3; POLYHYDROXYALKANOATE BIOSYNTHESIS; AEROMONAS-CAVIAE; MICROBIAL SYNTHESIS; VEGETABLE-OIL; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE)	Poly((R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate) [P(3HB-co-3HHx)1, a flexible and practical kind of polyhydroxyalkanoates, is generally produced from plant oils and fatty acids by several wild and recombinant bacteria. This study established an improved artificial pathway for the biosynthesis of P (3HB-co-3HHx) with high 3HHx composition from structurally unrelated fructose in Ralstonia eutropha. Depression of (R)-specific reduction of acetoacetyl-CoA by the deletion of phaB1 was an effective modification for formation of the C-6-monomer unit from fructose driven by crotonyl-CoA carboxylase/reductase (Ccr). Co-overexpression of phaJ4a, which encodes medium-chain-length (R)-enoyl-CoA hydratase, with ccT promoted the incorporation of both 3HB and 3HHx units. Further introduction of emd(Mm), a synthetic gene encoding ethylmalonyl-CoA decarboxylase derived from mouse, was remarkably effective for P(3HB-co-3HHx) biosynthesis, probably by converting ethylmalonyl-CoA generated by the reductive carboxylase activity of Ccr back into butyryl-CoA. A high cellular content of P(3HB-co-3HHx) composed of 22 mol% 3HHx could be produced from fructose by the engineered strain of R. eutropha with Delta phaB1 genotype expressing ccr, phaJ4a, and emd. (C) 2014 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.	[Insomphun, Chayatip; Xie, Huan; Mifune, Jun; Kawashima, Yui; Orita, Izumi; Nakamura, Satoshi; Fukui, Toshiaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Fukui, T (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	tfukui@bio.titech.ac.jp	福居, 俊昭/K-5056-2012; Nakamura, Satoshi/D-2450-2015	Nakamura, Satoshi/0000-0001-5130-2488	JSPS KAKENHI [25292058]	The authors greatly thank to Dr. M. S. Carter (Department of Microbiology, The Ohio State University, USA) for valuable discussion, The authors also thank to Assoc. Prof. T. Hata (Department of Biomolecular Engineering, Tokyo Institute of technology, Japan) for NMR analysis, and Assoc. Prof. T. Tsuge and Dr. A. Hiroe (Department of Innovative and Engineered Materials, Tokyo Institute of Technology, Japan) for GPC analyses. This work was supported by JSPS KAKENHI Grant number 25292058.	Alber BE, 2011, APPL MICROBIOL BIOT, V89, P17, DOI 10.1007/s00253-010-2873-z; Aldor Ilana S., 2002, Applied and Environmental Microbiology, V68, P3848, DOI 10.1128/AEM.68.8.3848-3854.2002; Valentin HE, 1997, J BIOTECHNOL, V58, P33, DOI 10.1016/S0168-1656(97)00127-2; Liu HB, 1999, J BACTERIOL, V181, P6806; Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Fukui T, 2002, BIOMACROMOLECULES, V3, P618, DOI 10.1021/bm0255084; Fukui T, 1998, J BACTERIOL, V180, P667; Matsumoto K, 2013, CURR OPIN BIOTECH, V24, P1054, DOI 10.1016/j.copbio.2013.02.021; Slater S, 1998, J BACTERIOL, V180, P1979; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6; Kato M, 1996, APPL MICROBIOL BIOT, V45, P363; Wang Q, 2013, APPL MICROBIOL BIOT, V97, P3301, DOI 10.1007/s00253-013-4809-x; Budde CF, 2010, J BACTERIOL, V192, P5319, DOI 10.1128/JB.00207-10; Qiu YZ, 2005, BIOTECHNOL LETT, V27, P1381, DOI 10.1007/s10529-005-3685-6; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Mifune J, 2010, POLYM DEGRAD STABIL, V95, P1305, DOI 10.1016/j.polymdegradstab.2010.02.026; Tsuge T, 2007, FEMS MICROBIOL LETT, V277, P217, DOI 10.1111/j.1574-6968.2007.00958.x; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Fukui T, 1997, J BACTERIOL, V179, P4821; Chen Q, 2011, APPL ENVIRON MICROB, V77, P4886, DOI 10.1128/AEM.00091-11; Agnew DE, 2012, METAB ENG, V14, P705, DOI 10.1016/j.ymben.2012.08.003; Budde CF, 2011, APPL ENVIRON MICROB, V77, P2847, DOI 10.1128/AEM.02429-10; Mifune J, 2008, CAN J CHEM, V86, P621, DOI 10.1139/V08-047; Fukui T, 2014, APPL MICROBIOL BIOT, V98, P7559, DOI 10.1007/s00253-014-5831-3; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Yang JE, 2014, APPL MICROBIOL BIOT, V98, P95, DOI 10.1007/s00253-013-5285-z; Kawashima Y, 2012, APPL ENVIRON MICROB, V78, P493, DOI 10.1128/AEM.06937-11; Wang Q, 2014, APPL MICROBIOL BIOT, V98, P3923, DOI 10.1007/s00253-013-5494-5; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; Fukui T, 2011, APPL MICROBIOL BIOT, V89, P1527, DOI 10.1007/s00253-011-3100-2; Fukui T, 2009, BIOMACROMOLECULES, V10, P700, DOI 10.1021/bm801391j; Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8; Insomphun C, 2014, J BIOSCI BIOENG, V117, P184, DOI [10.1016/j.jbiosc.2013.07.016, 10.1016/j.biosc.2013.07.016]; Jeon JM, 2014, APPL MICROBIOL BIOT, V98, P5461, DOI 10.1007/s00253-014-5617-7; Klinke S, 1999, APPL ENVIRON MICROB, V65, P540; Le Meur S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-123; Li Z.J., 2010, METAB ENG, V12; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Matsumoto K, 2001, BIOMACROMOLECULES, V2, P934, DOI 10.1021/bm0155367; Matsumoto K, 2013, APPL ENVIRON MICROB, V79, P6134, DOI 10.1128/AEM.01768-13; Matsusaki H, 2000, APPL MICROBIOL BIOT, V53, P401; Meng DC, 2014, CURR OPIN BIOTECH, V29, P24, DOI 10.1016/j.copbio.2014.02.013; Nomura CT, 2005, APPL ENVIRON MICROB, V71, P4297, DOI 10.1128/AEM.71.8.4297-4306.2005; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; Rehm BHA, 2001, APPL MICROBIOL BIOT, V55, P205; Shimizu R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-169; Taguchi S, 2012, POLYM SCI COMPREHENS, P157; Valentin HE, 1999, INT J BIOL MACROMOL, V25, P303, DOI 10.1016/S0141-8130(99)00045-8; Wang Q, 2012, J MICROBIOL, V50, P693, DOI 10.1007/s12275-012-2234-y; Wang Q, 2012, APPL ENVIRON MICROB, V78, P519, DOI 10.1128/AEM.07020-11; Zhou XY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-54; Zou XH, 2007, MACROMOL BIOSCI, V7, P174, DOI 10.1002/mabi.200600186	55	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7176	1096-7184		METAB ENG	Metab. Eng.	JAN	2015	27						38	45		10.1016/j.ymben.2014.10.006		8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AX0NN	WOS:000346649000005		
J	Zhang, XG; Matsuura, K; Ohno, M				Zhang, Xianguang; Matsuura, Kiyotaka; Ohno, Munekazu			Increase of Austenite Grain Coarsening Temperature in Banded Ferrite/Pearlite Steel by Cold Deformation	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							MICROALLOYED STEELS; GROWTH; PRECIPITATION; MANGANESE; NIOBIUM	The grain coarsening temperature (T (c)) is quite low in a ferrite/pearlite (F/P) banded steel as compared with a non-banded steel. Here it is shown that the low T (c) in the F/P banded steel can be increased significantly by applying cold deformation prior to austenitizing. The kinetics of abnormal grain coarsening above T (c) is also largely retarded by cold deformation. These observations should be attributed to the uniform distribution of fine AlN precipitates caused by cold deformation.	[Zhang, Xianguang] Hokkaido Univ, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Matsuura, Kiyotaka; Ohno, Munekazu] Hokkaido Univ, Fac Engn, Div Mat Sci & Engn, Sapporo, Hokkaido 0608628, Japan	Zhang, XG (reprint author), Hokkaido Univ, Grad Sch Engn, Kita Ku, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	zhangxg@ec.hokudai.ac.jp	Ohno, Munekazu/A-5222-2012	Ohno, Munekazu/0000-0001-5383-412X			Zhang XG, 2014, METALL MATER TRANS A, V45A, P4623, DOI 10.1007/s11661-014-2364-4; GLADMAN T, 1966, PROC R SOC LON SER-A, V294, P298, DOI 10.1098/rspa.1966.0208; IRVINE KJ, 1967, J IRON STEEL I, V205, P161; GRANGE RA, 1971, METALL TRANS, V2, P417, DOI 10.1007/BF02663328; CUDDY LJ, 1983, METALL TRANS A, V14, P1989, DOI 10.1007/BF02662366; Rainforth WM, 2002, ACTA MATER, V50, P735, DOI 10.1016/S1359-6454(01)00389-5; Bastien P.G., 1957, J IRON STEEL I, V187, P281; DOGAN ON, 1992, METALL TRANS A, V23, P2121, DOI 10.1007/BF02646005; FURUBAYA.E, 1974, MATER SCI ENG, V14, P123, DOI 10.1016/0025-5416(74)90005-6; GLADMAN T, 1992, JOM-J MIN MET MAT S, V44, P21; Gulyaev A.P., 1977, METALLOVED TERM OBRA, V4, P2; IRVINE KJ, 1963, J IRON STEEL I, V201, P944; Jatczak C.F., 1956, T ASM, V48, P279; Kirkaldy J.S., 1963, CAN METALL Q, V3, P233; Kirkaldy J.S., 1962, CAN METALL Q, V1, P59; McCall J.L., 1969, P 1 ANN TECHN M INT, P153; MORRISON WB, 1963, J IRON STEEL I, V201, P317; Pandit A, 2005, SCRIPTA MATER, V53, P1309, DOI 10.1016/j.scriptamat.2005.07.003; SMITH CS, 1948, T AM I MIN MET ENG, V175, P15; TURKDOGA.ET, 1970, J IRON STEEL I, V208, P482; WARD RG, 1965, J IRON STEEL I, V203, P930; WEBSTER D, 1964, J IRON STEEL I, V202, P987; Wiester H.J., 1959, STAHL EISEN, V79, P1120; Zhang X., 2014, RES UNPUB	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	JAN	2015	46A	1					32	36		10.1007/s11661-014-2618-1		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX2QI	WOS:000346788600007		
J	Yan, M; Dargusch, MS; Kong, C; Kimpton, JA; Kohara, S; Brandt, M; Qian, M				Yan, Ming; Dargusch, M. S.; Kong, C.; Kimpton, J. A.; Kohara, S.; Brandt, M.; Qian, M.			In Situ Synchrotron Radiation Study of TiH2-6Al-4V and Ti-6Al-4V: Accelerated Alloying and Phase Transformation, and Formation of an Oxygen-Enriched Ti4Fe2O Phase in TiH2-6Al-4V	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							TITANIUM HYDRIDE; MICROWAVE-RADIATION; TIH2 POWDERS; DECOMPOSITION; FABRICATION; HYDROGEN; IMPACTS	In situ heating, synchrotron radiation X-ray diffraction has been used to study the alloying and phase transformation behavior of TiH2-6Al-4V and Ti-6Al-4V alloys. Accelerated alloying and phase transformation were observed in the powder compact of the TiH2-6Al-4V alloy subjected to a high heating rate. In addition, an oxygen-stabilized Ti4Fe2O phase, which is present as sub-micron or nanoscaled particles, has been identified in the TiH2-6Al-4V alloy. The implications of these experimental findings have been discussed in terms of alloying, improved densification and oxygen scavenging in titanium and titanium alloys.	[Yan, Ming; Brandt, M.; Qian, M.] RMIT Univ, Ctr Addit Mfg, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3001, Australia; [Yan, Ming; Dargusch, M. S.] Univ Queensland, Queensland Ctr Adv Mat Proc & Mfg, Brisbane, Qld 4072, Australia; [Kong, C.] Univ New S Wales, Electron Microscopy Unit, Sydney, NSW 2052, Australia; [Kimpton, J. A.] Australian Synchrotron, Clayton, Vic 3168, Australia; [Kohara, S.] SPring 8 JASRI, Sayo, Hyogo 6795198, Japan	Yan, M (reprint author), RMIT Univ, Ctr Addit Mfg, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3001, Australia.	ming.yan@rmit.edu.au			Australian Synchrotron; JSPS [S13717]; Australian Research Council (ARC) through the Linkage Projects programme	We thank the Australian Synchrotron for access to the beamline (Powder Diffraction) and a Travel Grant. M.Y. further acknowledges the support of a JSPS Fellowship (Invitation; Short Term; No. S13717). The project was partially funded by the Australian Research Council (ARC) through the Linkage Projects programme. Constructive suggestions and comments received from the reviewers are acknowledged.	Matijasevic-Lux B, 2006, ACTA MATER, V54, P1887, DOI 10.1016/j.actamat.2005.12.012; Froes FH, 2004, INT MATER REV, V49, P227, DOI [10.1179/095066004225010550, 10.1179/095066044225010550]; Yan M, 2014, ACTA MATER, V68, P196, DOI 10.1016/j.actamat.2014.01.015; Liu Y, 2006, MAT SCI ENG A-STRUCT, V418, P25, DOI [10.1016/j.msea.2005.10.057, 10.1016/j.msca.2005.10.057]; Liu H, 2009, INT J HYDROGEN ENERG, V34, P3018, DOI 10.1016/j.ijhydene.2009.01.095; Luo SD, 2013, SCRIPTA MATER, V69, P69, DOI 10.1016/j.scriptamat.2013.03.005; Dumitrescu LFS, 1998, J PHASE EQUILIB, V19, P441, DOI 10.1361/105497198770341923; Jimenez C, 2011, ACTA MATER, V59, P6318, DOI 10.1016/j.actamat.2011.06.042; Cui YH, 2014, RSC ADV, V4, P30471, DOI 10.1039/c4ra04244a; Alavi S, 2006, J PHYS CHEM A, V110, P1518, DOI 10.1021/jp053318s; Asavavisithchai S, 2007, MATER TRANS, V48, P2712, DOI 10.2320/matertrans.MRA2007036; Burton BP, 2012, CALPHAD, V39, P97, DOI 10.1016/j.calphad.2012.09.004; Chuprina V.G., 1996, POWDER METALL MET C, V34, P663, DOI 10.1007/BF00559499; Duz V.A., 2011, US Patent, Patent No. 7993577; Fang ZZ, 2012, ADV ENG MATER, V14, P383, DOI 10.1002/adem.201100269; Gregory E., 1967, US Patent, Patent No. 3472705; Ivasishin OM, 2010, KEY ENG MAT, V436, P113, DOI 10.4028/www.scientific.net/KEM.436.113; Ivasishin O.M., 2012, US Patent, Patent No. [2012/0058002 A1, 20120058002]; Kadoi K, 2009, MATER TRANS, V50, P727, DOI 10.2320/matertrans.MBW200829; Luo SD, 2011, METALL MATER TRANS A, V42A, P2466, DOI 10.1007/s11661-011-0645-8; Lutjering G., 2007, TITANIUM; Mimoto T, 2012, TMS 2012 141ST ANNUAL MEETING & EXHIBITION - SUPPLEMENTAL PROCEEDINGS, VOL 1: MATERIALS PROCESSING AND INTERFACES, P879; MINTZ MH, 1980, J LESS-COMMON MET, V74, P287, DOI 10.1016/0022-5088(80)90164-2; NORBY P, 1986, ACTA CHEM SCAND A, V40, P157, DOI 10.3891/acta.chem.scand.40a-0157; Robertson IM, 2010, POWDER METALL, V53, P12, DOI 10.1179/003258909X12450768327063; ROZENBAND VI, 1992, COMBUST FLAME, V88, P113, DOI 10.1016/0010-2180(92)90011-D; Sandim Hugo Ricardo Zschommler, 2005, Mat. Res., V8, P293, DOI 10.1590/S1516-14392005000300012; San-Martin A., 1987, B ALLOY PHASE DIAGRA, V8, P30, DOI 10.1007/BF02868888; SCHLAPBACH L, 1983, APPL PHYS A-MATER, V32, P169, DOI 10.1007/BF00820257; Sima C, 2009, J OPTOELECTRON ADV M, V11, P826; Yan M, 2014, ACTA BIOMATER, V10, P1014, DOI 10.1016/j.actbio.2013.10.034; Yan M, 2013, METALL MATER TRANS A, V44A, P3961, DOI 10.1007/s11661-013-1720-0; Yan M, 2012, SCRIPTA MATER, V67, P491, DOI 10.1016/j.scriptamat.2012.06.009; Yan M, 2013, SCRIPTA MATER, V68, P63, DOI 10.1016/j.scriptamat.2012.09.024	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	JAN	2015	46A	1					41	45		10.1007/s11661-014-2631-4		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX2QI	WOS:000346788600009		
J	Terada, T				Terada, Tadashi			Stem Cells in the Development and Differentiation of the Human Adrenal Glands	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						adrenal glands; development; fetus; humans; stem cells; immunohistochemistry	INTRAHEPATIC PERIBILIARY GLANDS; BILE-DUCT DEVELOPMENT; CONSECUTIVE AUTOPSY LIVERS; ALPHA-AMYLASE ISOZYMES; PATHOLOGICAL OBSERVATIONS; GROWTH-FACTOR; EXPRESSION; CHOLANGIOCARCINOMA; RECEPTOR; INNERVATION	There are no studies on stem cells (SCs) and development and differentiation (DD) of the human adrenal glands. The SCs in DD of the adrenal glands were herein investigated histochemically and immunohistochemically in 18 human embryonic adrenal glands at gestational week (GW) 7-40. At 7 GW, the adrenal glands were present, and at 7 GW, numerous embryonic SCs (ESCs) are seen to create the adrenal cortex. The ESCs were composed exclusively of small cells with hyperchromatic nuclei without nucleoli. The ESCs were positive for neural cell adhesion molecule, KIT, neuron-specific enolase, platelet-derived growth factor receptor-, synaptophysin, and MET. They were negative for other SC antigens, including chromogranin, ErbB2, and bcl-2. They were also negative for lineage antigens, including cytokeratin (CK)7, CK8, CK18, and CK19, carcinoembryonic antigen, carbohydrate antigen 19-9, epithelial membrane antigen, HepPar1, mucin core apoprotein (MUC)1, MUC2, MUC5AC, and MUC6, and cluster differentiation (CD)3, CD45, CD20, CD34, and CD31. The Ki-67 labeling index (LI) was high (Ki-67 LI=around 20%). -Fetoprotein was positive in the ESCs and adrenal cells. The ESC was first seen in the periphery of the adrenal cortex at 7-10 GW. The ESC migrates into the inner part of the adrenal cortex. Huge islands of ESC were present near the adrenal, and they appeared to provide the ESC of the adrenal. At 16 GW, adrenal medulla appeared, and the adrenal ESCs were present in the periphery or the cortex, in the cortical parenchyma, corticomedullary junctions, and in the medulla. The adrenal essential architecture was established around 20 GW; however, there were still ESCs. At term, there are a few ESCs. These data suggest that the adrenal glands were created by ESCs. Microsc. Res. Tech., 78:59-64, 2015. (c) 2014 Wiley Periodicals, Inc.	Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Shizuoka 4248636, Japan	Terada, T (reprint author), Shizuoka City Shimizu Hosp, Dept Pathol, Shimizu Ku, Miyakami 1231, Shizuoka 4248636, Japan.	piyo0111jp@yahoo.co.jp					Allison MR, 2005, STEM CELL REV, V1, P253; NALDINI L, 1991, EMBO J, V10, P2867; Oben JA, 2004, GUT, V53, P438, DOI 10.1136/gut.2003.026658; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Fabris L, 2000, AM J PATHOL, V156, P1599, DOI 10.1016/S0002-9440(10)65032-8; TERADA T, 1990, GASTROENTEROLOGY, V98, P1333; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Terada T, 1997, TOHOKU J EXP MED, V181, P19, DOI 10.1620/tjem.181.19; TERADA T, 1989, J HEPATOL, V8, P139, DOI 10.1016/0168-8278(89)90001-9; Ishimoto H, 2011, ENDOCR REV, V32, P317, DOI 10.1210/er.2010-0001; TERADA T, 1992, HUM PATHOL, V23, P483, DOI 10.1016/0046-8177(92)90124-L; BIOULACSAGE P, 1990, J HEPATOL, V10, P105, DOI 10.1016/0168-8278(90)90080-B; Cardinale Vincenzo, 2012, Hepatology, V55, P2041, DOI 10.1002/hep.25587; Cassiman D, 2002, AM J PATHOL, V161, P521, DOI 10.1016/S0002-9440(10)64208-3; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Cassiman D, 2007, LIVER INT, V27, P323, DOI 10.1111/j.1478-3231.2006.01427.x; Oben JA, 2003, HEPATOLOGY, V38, P664, DOI 10.1053/jhep.2003.50371; Sirica AE, 2008, WORLD J GASTROENTERO, V14, P7033, DOI 10.3748/wjg.14.7033; Strain AJ, 2000, GUT, V46, P743, DOI 10.1136/gut.46.6.743; TERADA T, 1995, GASTROENTEROLOGY, V108, P1236, DOI 10.1016/0016-5085(95)90225-2; TERADA T, 1994, HISTOPATHOLOGY, V25, P143, DOI 10.1111/j.1365-2559.1994.tb01570.x; TERADA T, 1993, HEPATOLOGY, V18, P529, DOI 10.1016/0270-9139(93)90351-M; TERADA T, 1994, HEPATOLOGY, V20, P388, DOI 10.1016/0270-9139(94)90191-0; TERADA T, 1995, AM J PATHOL, V147, P1207; TERADA T, 1994, VIRCHOWS ARCH, V424, P669, DOI 10.1007/BF01069749; TERADA T, 1995, HEPATOLOGY, V22, P75, DOI 10.1016/0270-9139(95)90355-0; Terada Tadashi, 2000, Liver, V20, P450, DOI 10.1034/j.1600-0676.2000.020006450.x; TERADA T, 1995, AM J PATHOL, V146, P67; Terada T, 1998, LIVER, V18, P313; TERADA T, 1989, J HEPATOL, V9, P141, DOI 10.1016/0168-8278(89)90044-5; TERADA T, 1993, HEPATOLOGY, V18, P803, DOI 10.1002/hep.1840180409; TERADA T, 1990, HEPATOLOGY, V12, P92, DOI 10.1002/hep.1840120115; Terada T, 2012, HEPATOLOGY, V56, P2004, DOI 10.1002/hep.25750; TERADA T, 1992, J HISTOCHEM CYTOCHEM, V40, P1627; TERADA T, 1990, HEPATOLOGY, V12, P1229, DOI 10.1002/hep.1840120525; TERADA T, 1993, LAB INVEST, V68, P261; Terada T, 1998, J HEPATOL, V28, P263, DOI 10.1016/0168-8278(88)80013-8; Ueno T, 1997, NUTRITION, V13, P141, DOI 10.1016/S0899-9007(96)00389-9; Ueno T, 2004, ANAT REC PART A, V280A, P868, DOI 10.1002/ar.a.20092	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	JAN	2015	78	1					59	64		10.1002/jemt.22445		6	Anatomy & Morphology; Biology; Microscopy	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	AX2IW	WOS:000346767800009		
J	Grammatikopoulos, P; Toulkeridou, E; Nordlund, K; Sowwan, M				Grammatikopoulos, P.; Toulkeridou, E.; Nordlund, K.; Sowwan, M.			Simple analytical model of nanocluster coalescence for porous thin film design	MODELLING AND SIMULATION IN MATERIALS SCIENCE AND ENGINEERING			English	Article						nanoparticles; coalescence; molecular dynamics; analytical modelling; thin films	EMBEDDED-ATOM METHOD; MOLECULAR-DYNAMICS; PALLADIUM NANOPARTICLES; TANTALUM NANOPARTICLES; GOLD; SIMULATION; PARTICLES; SOLIDS; PHASE	We propose an approach to coalescence studies that encompasses the random nature of nanoparticle deposition, which results in a statistical cancellation of individual sintering mechanisms. We present a rigorous, yet simple and intuitive, analytical method that describes the average coalescence behaviour of nanoparticles, regardless of constituent element or crystallinity, emphasizing only the predominant coalescence dependencies on temperature and size-dependent nanoparticle melting points. We assessed our model using molecular dynamics (MD) computer simulations of dissimilar systems, and found remarkable agreement between its predictions and the MD results. Its simplicity makes our model a suitable starting point for the development of a meso-scale simulation technique that can describe the growth of porous films and allow for their bespoke design.	[Grammatikopoulos, P.; Sowwan, M.] Grad Univ, Okinawa Inst Sci & Technol, Nanoparticles Design Unit, Onna, Okinawa 9040495, Japan; [Nordlund, K.] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Nordlund, K.] Univ Helsinki, Helsinki Inst Phys, FIN-00014 Helsinki, Finland; [Sowwan, M.] Al Quds Univ, Nanotechnol Res Lab, IL-51000 East Jerusalem, Israel	Grammatikopoulos, P (reprint author), Grad Univ, Okinawa Inst Sci & Technol, Nanoparticles Design Unit, 1919-1 Onna Son, Onna, Okinawa 9040495, Japan.	pgrammatikopoulos@oist.jp	Grammatikopoulos, Panagiotis/G-2511-2015				Lewis LJ, 1997, PHYS REV B, V56, P2248, DOI 10.1103/PhysRevB.56.2248; Buesser B, 2012, ANNU REV CHEM BIOMOL, V3, P103, DOI 10.1146/annurev-chembioeng-062011-080930; Fan YZ, 2011, BIOSENS BIOELECTRON, V26, P1908, DOI 10.1016/j.bios.2010.05.006; Zhu HL, 1996, PHIL MAG LETT, V73, P27, DOI 10.1080/095008396181073; Cookson J, 2012, PLATIN MET REV, V56, P83, DOI 10.1595/147106712X632415; Mohanty A, 2010, ANGEW CHEM INT EDIT, V49, P4962, DOI 10.1002/anie.201000902; Palmer RE, 2003, NAT MATER, V2, P443, DOI 10.1038/nmat897; Arcidiacono S, 2004, INT J MULTIPHAS FLOW, V30, P979, DOI [10.1016/j.ijmultiphaseflow.2004.03.006, 10.1016/j.multiphaseflow.2004.03.006]; Kruis FE, 1998, J AEROSOL SCI, V29, P511, DOI 10.1016/S0021-8502(97)10032-5; Jose-Yacaman M, 2005, J PHYS CHEM B, V109, P9703, DOI 10.1021/jp0509459; Jarvi TT, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115422; Gale JD, 1997, J CHEM SOC FARADAY T, V93, P629, DOI 10.1039/a606455h; Smyder JA, 2011, MATER TODAY, V14, P382, DOI 10.1016/S1369-7021(11)70182-1; Mei QS, 2007, PROG MATER SCI, V52, P1175, DOI 10.1016/j.pmatsci.2007.01.001; HABERLAND H, 1992, J VAC SCI TECHNOL A, V10, P3266, DOI 10.1116/1.577853; Wang EC, 2014, INTEGR BIOL-UK, V6, P9, DOI 10.1039/c3ib40165k; Ayesh AI, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574012; JOHNSON RA, 1989, PHYS REV B, V39, P12554, DOI 10.1103/PhysRevB.39.12554; Ingham B, 2011, CHEM MATER, V23, P3312, DOI 10.1021/cm200354d; Sheng HW, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134118; Eggersdorfer ML, 2012, J AEROSOL SCI, V46, P7, DOI 10.1016/j.jaerosci.2011.11.005; BUFFAT P, 1976, PHYS REV A, V13, P2287, DOI 10.1103/PhysRevA.13.2287; FINNIS MW, 1984, PHILOS MAG A, V50, P45; Ding F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.075416; Backman M, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30429-y; DAW MS, 1993, MATER SCI REP, V9, P251, DOI 10.1016/0920-2307(93)90001-U; Grammatikopoulos P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05779; Grammatikopoulos P, 2014, J MATER SCI, V49, P3890, DOI 10.1007/s10853-013-7893-5; Kart H H, 2009, INT J MOD PHYS C, V2, P179; Leach A R, 2001, MOL MODELLING PRINCI, P267; Ling M., 2005, PHYS REV B, V72; Meinander K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235435; Meinander K, 2003, THIN SOLID FILMS, V425, P297, DOI 10.1016/S0040-6090(02)01092-1; Meinander K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2410220; Park KY, 2007, POWDER TECHNOL, V172, P144, DOI 10.1016/j.powtec.2006.11.011; Pawlow P Z, 1909, PHYS CHEM, V65, P545; Singh V, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2373-7; Sounderya N, 2008, RECENT PAT BIOMED EN, V1, P34; Teleki A, 2008, POWDER TECHNOL, V181, P292, DOI 10.1016/j.powtec.2007.05.016; Tsantilis S, 1999, J AEROSOL SCI, V30, P785, DOI 10.1016/S0021-8502(98)00764-2; Wang Y, 2004, MATER LETT, V58, P3017, DOI 10.1016/j.matlet.2004.05.031; Zhao SJ, 2001, J PHYS-CONDENS MAT, V13, P8061, DOI 10.1088/0953-8984/13/35/313	42	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0965-0393	1361-651X		MODEL SIMUL MATER SC	Model. Simul. Mater. Sci. Eng.	JAN	2015	23	1							015008	10.1088/0965-0393/23/1/015008		15	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX0QF	WOS:000346656000008		
J	Takamoto, S; Izumi, S; Nakata, T; Sakai, S; Oinuma, S; Nakatani, Y				Takamoto, S.; Izumi, S.; Nakata, T.; Sakai, S.; Oinuma, S.; Nakatani, Y.			Analytical method for estimating the thermal expansion coefficient of metals at high temperature	MODELLING AND SIMULATION IN MATERIALS SCIENCE AND ENGINEERING			English	Article						thermal expansion; molecular dynamics; metal; high-temperature materials; interatomic potential; potential fitting	EMBEDDED-ATOM METHOD; THERMODYNAMIC PROPERTIES; MOLECULAR-DYNAMICS; SYSTEMS	In this paper, we propose an analytical method for estimating the thermal expansion coefficient (TEC) of metals at high-temperature ranges. Although the conventional method based on quasiharmonic approximation (QHA) shows good results at low temperatures, anharmonic effects caused by large-amplitude thermal vibrations reduces its accuracy at high temperatures. Molecular dynamics (MD) naturally includes the anharmonic effect. However, since the computational cost of MD is relatively high, in order to make an interatomic potential capable of reproducing TEC, an analytical method is essential. In our method, analytical formulation of the radial distribution function (RDF) at finite temperature realizes the estimation of the TEC. Each peak of the RDF is approximated by the Gaussian distribution. The average and variance of the Gaussian distribution are formulated by decomposing the fluctuation of interatomic distance into independent elastic waves. We incorporated two significant anharmonic effects into the method. One is the increase in the averaged interatomic distance caused by large amplitude vibration. The second is the variation in the frequency of elastic waves. As a result, the TECs of fcc and bcc crystals estimated by our method show good agreement with those of MD. Our method enables us to make an interatomic potential that reproduces the TEC at high temperature. We developed the GEAM potential for nickel. The TEC of the fitted potential showed good agreement with experimental data from room temperature to 1000 K. As compared with the original potential, it was found that the third derivative of the wide-range curve was modified, while the zeroth, first and second derivatives were unchanged. This result supports the conventional theory of solid state physics. We believe our analytical method and developed interatomic potential will contribute to future high-temperature material development.	[Takamoto, S.; Izumi, S.; Nakata, T.; Sakai, S.] Univ Tokyo, Dept Mech Engn, Sch Engn, Bunkyo Ku, Tokyo 113, Japan; [Oinuma, S.; Nakatani, Y.] Toshiba Co Ltd, Power & Ind Syst R&D Ctr, Met Technol R&D Dept, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Takamoto, S (reprint author), Univ Tokyo, Dept Mech Engn, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	takamoto.so@fml.t.u-tokyo.ac.jp; izumi@fml.t.u-tokyo.ac.jp			Graduate School of Engineering, The University of Tokyo Doctoral Student Special Incentives Program (SEUT RA)	S Takamoto acknowledges financial support from the Graduate School of Engineering, The University of Tokyo Doctoral Student Special Incentives Program (SEUT RA).	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Mishin Y, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224106; Berger O, 1997, BIOPHYS J, V72, P2002; Zhou XW, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144113; Zhou XW, 2001, ACTA MATER, V49, P4005, DOI 10.1016/S1359-6454(01)00287-7; Zakharchenko KV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046808; FOILES SM, 1989, PHYS REV B, V40, P5909, DOI 10.1103/PhysRevB.40.5909; Cui ZW, 2012, MODEL SIMUL MATER SC, V20, DOI 10.1088/0965-0393/20/1/015014; Sheng HW, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134118; Bian Q, 2008, J PHYS CHEM SOLIDS, V69, P168, DOI 10.1016/j.jpcs.2007.08.046; Dove M T, 1993, INTRO LATTICE DYNAMI; FOILES SM, 1988, PHYS REV B, V38, P12643, DOI 10.1103/PhysRevB.38.12643; Kittel C, 2004, INTRO SOLID STATE PH, V8; Kumagai T, 2006, MODEL SIMUL MATER SC, V14, pS29, DOI 10.1088/0965-0393/14/5/S04; Kumagai T, 2004, INT C COMP METH SING, P75; Kumagai T., 2011, T JAPAN SOC MECH ENG, V77, P2026; Kumagai T, 2007, MATER TRANS, V48, P1313, DOI 10.2320/matertrans.MF200602; Lee BJ, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.144112; Simmons G., 1971, SINGLE CRYSTAL ELAST; Touloukian Y S, 1975, THERMOPHYSICAL PROPE, V12	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0965-0393	1361-651X		MODEL SIMUL MATER SC	Model. Simul. Mater. Sci. Eng.	JAN	2015	23	1							015010	10.1088/0965-0393/23/1/015010		15	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX0QF	WOS:000346656000010		
J	Cheung, M; Shen, DK; Makino, F; Kato, T; Roehrich, AD; Martinez-Argudo, I; Walker, ML; Murillo, I; Liu, X; Pain, M; Brown, J; Frazer, G; Mantell, J; Mina, P; Todd, T; Sessions, RB; Namba, K; Blocker, AJ				Cheung, Martin; Shen, Da-Kang; Makino, Fumiaki; Kato, Takayuki; Roehrich, A. Dorothea; Martinez-Argudo, Isabel; Walker, Matthew L.; Murillo, Isabel; Liu, Xia; Pain, Maria; Brown, James; Frazer, Gordon; Mantell, Judith; Mina, Petros; Todd, Thomas; Sessions, Richard B.; Namba, Keiichi; Blocker, Ariel J.			Three-dimensional electron microscopy reconstruction and cysteine-mediated crosslinking provide a model of the type III secretion system needle tip complex	MOLECULAR MICROBIOLOGY			English	Article							SHIGELLA-FLEXNERI; EPITHELIAL-CELLS; PROTEIN SECRETION; APPARATUS NEEDLE; HOST MEMBRANES; YOP SECRETION; IPAB; IDENTIFICATION; DOMAINS; ANTIGEN	Type III secretion systems are found in many Gram-negative bacteria. They are activated by contact with eukaryotic cells and inject virulence proteins inside them. Host cell detection requires a protein complex located at the tip of the device's external injection needle. The Shigella tip complex (TC) is composed of IpaD, a hydrophilic protein, and IpaB, a hydrophobic protein, which later forms part of the injection pore in the host membrane. Here we used labelling and crosslinking methods to show that TCs from a ipaB strain contain five IpaD subunits while the TCs from wild-type can also contain one IpaB and four IpaD subunits. Electron microscopy followed by single particle and helical image analysis was used to reconstruct three-dimensional images of TCs at approximate to 20 angstrom resolution. Docking of an IpaD crystal structure, constrained by the crosslinks observed, reveals that TC organisation is different from that of all previously proposed models. Our findings suggest new mechanisms for TC assembly and function. The TC is the only site within these secretion systems targeted by disease-protecting antibodies. By suggesting how these act, our work will allow improvement of prophylactic and therapeutic strategies.	[Cheung, Martin; Shen, Da-Kang; Roehrich, A. Dorothea; Martinez-Argudo, Isabel; Murillo, Isabel; Liu, Xia; Pain, Maria; Brown, James; Frazer, Gordon; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Cheung, Martin; Shen, Da-Kang; Roehrich, A. Dorothea; Martinez-Argudo, Isabel; Murillo, Isabel; Liu, Xia; Pain, Maria; Brown, James; Frazer, Gordon; Blocker, Ariel J.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Makino, Fumiaki; Kato, Takayuki; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Walker, Matthew L.] MLW Electron Microscopy Consulting Launceston, Launceston PL15 9BB, Cornwall, England; [Mantell, Judith] Univ Bristol, Sch Biochem, Wolfson Bioimaging Facil, Bristol BS8 1TD, Avon, England; [Mina, Petros; Todd, Thomas] Univ Bristol, Bristol Ctr Complex Sci, Bristol BS8 1TR, Avon, England; [Sessions, Richard B.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Namba, Keiichi] Riken Quantitat Biol Ctr, Suita, Osaka 5650871, Japan	Blocker, AJ (reprint author), Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.	ariel.blocker@bristol.ac.uk			Wellcome Trust [082398, 088231]; UK Medical Research Council [G0701243, MRJ002097]; School of Cellular & Molecular Medicine, University of Bristol; Centenary Postgraduate Fund, University of Bristol; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology in Japan [21227006, 25000013]	This work was supported by projects grants from the Wellcome Trust (082398 to AJB and 088231 to AJB and KN) and the UK Medical Research Council (G0701243 to AJB and MRJ002097 to AJB and KN) and studentships from the School of Cellular & Molecular Medicine (MC) and Centenary Postgraduate Fund (ADR), University of Bristol, a Research Fellowship from the Japan Society for the Promotion of Science (FM), and Grants-in-Aid for Scientific Research (21227006 and 25000013 to K.N.) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. We thank: Julie Hodgkinson (Oxford, now Hannover) for early 2D analysis of TCs and she, Koji Yonekura (SPring-8) and Richard Henderson (MRC-LMB) for contributions to project design; John Rubinstein (Ontario) for advice on biotinylation and avidin labelling; Frank Booy and Sarah Daniell (Bristol) for the grid preparation technique; Zaelle Devaux (Bristol) for some data acquisition and particle selection and a team of Bristol undergraduates for particle selection; Vince Fernando (Bristol) for the 2D alignment procedure, which he used to process most data sets; Andreas Veenendaal (Oxford, then Utrecht) for suggesting cysteine-mediated crosslinking and Steven Johnson and Susan Lea (Oxford) for structure-based design of the cysteine mutants; Dorieke van den Brom and Anthony Hollander (Bristol) for project management assistance; CCPEM for software distribution support. AJB dedicates this this work to her last daughter, Johanna Longchamp, born on the 20 February 2009.	ALLAOUI A, 1995, MOL MICROBIOL, V17, P461, DOI 10.1111/j.1365-2958.1995.mmi_17030461.x; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; Chatterjee S, 2011, PROTEIN SCI, V20, P75, DOI 10.1002/pro.537; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Roehrich AD, 2013, MOL MICROBIOL, V87, P690, DOI 10.1111/mmi.12124; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Dickenson NE, 2013, BIOCHEMISTRY-US, V52, P8790, DOI 10.1021/bi400755f; Harmon DE, 2013, J BACTERIOL, V195, P2244, DOI 10.1128/JB.02011-12; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; MENARD R, 1993, J BACTERIOL, V175, P5899; Cordes FS, 2005, J MOL BIOL, V354, P206, DOI 10.1016/j.jmb.2005.09.062; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BARZU S, 1993, INFECT IMMUN, V61, P3825; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Abrusci P, 2014, CURR OPIN STRUC BIOL, V25, P111, DOI 10.1016/j.sbi.2013.11.001; Bahrani FK, 1997, INFECT IMMUN, V65, P4005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Kosarewicz A, 2012, PHILOS T R SOC B, V367, P1140, DOI 10.1098/rstb.2011.0205; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Shen DK, 2010, INFECT IMMUN, V78, P4999, DOI 10.1128/IAI.00470-10; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Kendall A, 2007, VIROLOGY, V369, P226, DOI 10.1016/j.virol.2007.08.013; Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Wang Y, 2010, BIOCHEMISTRY-US, V49, P4220, DOI 10.1021/bi100335u; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; MENARD R, 1994, EMBO J, V13, P5293; Stensrud KF, 2008, J BIOL CHEM, V283, P18646, DOI 10.1074/jbc.M802799200; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Epler CR, 2009, INFECT IMMUN, V77, P2754, DOI 10.1128/IAI.00190-09; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Campbell-Valois FX, 2014, CELL HOST MICROBE, V15, P177, DOI 10.1016/j.chom.2014.01.005; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Barta ML, 2012, J MOL BIOL, V417, P395, DOI 10.1016/j.jmb.2012.01.026; Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109; Barta M. L., 2011, PROTEINS, V80, P935; Demers JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5976; Demers JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003245; Dickenson N. E., 2010, BIOCHEMISTRY-US, V50, P172; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Epler CR, 2012, J MOL BIOL, V420, P29, DOI 10.1016/j.jmb.2012.03.025; Harlow E.D., 1988, ANTIBODIES LAB MANUA; Lokareddy RK, 2010, J BIOL CHEM, V285, P39965, DOI 10.1074/jbc.M110.135616; Lunelli M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002163; Meitert T, 1991, Roum Arch Microbiol Immunol, V50, P45; Milla C. E., 2013, PEDIAT PULMONOL, V49, P650; Moody MF, 1999, J MOL BIOL, V293, P401, DOI 10.1006/jmbi.1999.3011; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Rathinavelan T, 2014, J MOL BIOL, V426, P2958, DOI 10.1016/j.jmb.2014.06.009; Sani M, 2007, BBA-GEN SUBJECTS, V1770, P307, DOI 10.1016/j.bbagen.2006.10.007; Sato H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00142; VALENTIN.AF, 1966, J BACTERIOL, V91, P819; Wahid R, 2013, CLIN IMMUNOL, V148, P35, DOI 10.1016/j.clim.2013.03.009; Zenk SF, 2007, MICROBIOL-SGM, V153, P2405, DOI 10.1099/mic.0.2007/007781-0	66	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	JAN	2015	95	1					31	50		10.1111/mmi.12843		20	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	AX0QH	WOS:000346656200003		
J	Koide, H; Asai, T; Kato, H; Yonenaga, N; Yokota, M; Ando, H; Dewa, T; Nango, M; Maeda, N; Oku, N				Koide, Hiroyuki; Asai, Tomohiro; Kato, Hiroki; Yonenaga, Norihito; Yokota, Masafumi; Ando, Hidenori; Dewa, Takehisa; Nango, Mamoru; Maeda, Noriyuki; Oku, Naoto			Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						Small interfering RNA; Mammalian target of rapamycin; PTEN; Angiogenesis; Polycation liposomes	CANCER-CELLS; MTOR; GROWTH; INHIBITION; PATHWAY; ANGIOGENESIS; THERAPY; AKT; INFLAMMATION; TRANSLATION	PTEN-positive tumors are not susceptible to the treatment with rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR). Here, we determined the susceptibility of PTEN-positive cells to small interfering RNA for mTOR (si-mTOR) by using a novel liposomal delivery system. We prepared dicetyl phosphate-tetraethylenepentamine-based polycation liposomes (TEPA-PCL) decorated with polyethylene glycol (PEG) grafting Ala-Pro-Arg-Pro-Gly (APRPG), a VRGFR-1-targeting peptide. APRPG-PEG-decorated TEPA-PCL carrying si-mTOR (APRPG-TEPA- PCL/si-mTOR) had an antiproliferative effect against B16F10 murine melanoma cells (PTEN-positive) and significantly inhibited both the proliferation and tube formation of mouse 2H-11 endothelial-like cells (PTEN-positive). APRPG-TEPA-PCL/si-mTOR treatment did not induce Akt phosphorylation (Ser473) in either B16F10 or 2H-11 cells although there was strong phosphorylation of Akt in response to rapamycin treatment. Intravenous injection of APRPG-TEPA-PCL/si-mTOR significantly suppressed the tumor growth compared with rapamycin treatment in mice bearing B16F10 melanoma. These findings suggest that APRPG-TEPA-PCL/si-mTOR is useful for the treatment of PTEN-positive tumors. From the Clinical Editor: The authors determined the susceptibility of PTEN-positive cancer cells to small interfering RNA for mTOR by using a novel liposomal delivery system, and concluded that the method is useful in a rodent model, which may suggest potential future human applicability as well. (C) 2015 Elsevier Inc. All rights reserved.	[Koide, Hiroyuki; Asai, Tomohiro; Kato, Hiroki; Yonenaga, Norihito; Yokota, Masafumi; Ando, Hidenori; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4240857, Japan; [Dewa, Takehisa; Nango, Mamoru] Nagoya Inst Technol, Nagoya, Aichi, Japan; [Maeda, Noriyuki] Nippon Fine Chem Co Ltd, Takasago, Hyogo, Japan	Oku, N (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4240857, Japan.	oku@u-shizuoka-ken.ac.jp			Japan Society for the Promotion of Science (JSPS)	~This research was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS).	Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sarbassov DD, 2004, CURR BIOL, V14, P1296; Asai T, 2011, BIOCONJUGATE CHEM, V22, P429, DOI 10.1021/bc1004697; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Arboleda MJ, 2003, CANCER RES, V63, P196; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Dimmeler S, 2000, CIRC RES, V86, P4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Chiang CT, 2007, MOL CANCER THER, V6, P2127, DOI 10.1158/1535-7163.MCT-07-0107; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Walter-Yohrling J, 2004, CLIN CANCER RES, V10, P2179, DOI 10.1158/1078-0432.CCR-03-1013; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Lee DF, 2007, CELL CYCLE, V6, P3011; Grunwald V, 2002, CANCER RES, V62, P6141; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Harris TE, 2003, SCI STKE, V2003, P1; Koide H, 2011, BIOL PHARM BULL, V34, P602; Maeda N, 2006, BIOL PHARM BULL, V29, P1936, DOI 10.1248/bpb.29.1936; Oku N, 2002, ONCOGENE, V21, P2662, DOI 10.1038/sj/onc/1205347; Tomohiro Asai, 2010, BIOCONJUG CHEM, V22, P429	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	JAN	2015	11	1					185	194		10.1016/j.nano.2014.09.003		10	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science & Technology - Other Topics; Research & Experimental Medicine	AX3NQ	WOS:000346846500019		
J	Kokuryo, D; Nakashima, S; Ozaki, F; Yuba, E; Chuang, KH; Aoshima, S; Ishizaka, Y; Saga, T; Kono, K; Aoki, I				Kokuryo, Daisuke; Nakashima, Seiji; Ozaki, Fuminori; Yuba, Eiji; Chuang, Kai-Hsiang; Aoshima, Sadahito; Ishizaka, Yukihito; Saga, Tsuneo; Kono, Kenji; Aoki, Ichio			Evaluation of thermo-triggered drug release in intramuscular-transplanted tumors using thermosensitive polymer-modified liposomes and MRI	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						Drug targeting tumor therapeutics; Liposome; Thermo-sensitive polymer; MRI; Thermo-triggering	TEMPERATURE-SENSITIVE LIPOSOMES; STERICALLY STABILIZED LIPOSOMES; PROLONGED CIRCULATION TIME; MILD HYPERTHERMIA; THERAPEUTIC-EFFICACY; COLON-CARCINOMA; ANTITUMOR AGENT; SOLID TUMORS; DELIVERY; CANCER	Multi-modal thermo-sensitive polymer-modified liposomes (MTPLs) containing an anticancer drug, MR contrast agent, and fluorescent dye have been investigated as "theranostic" nanodevices that can be used to monitor drug delivery in cancer therapy. Here, we measured the physical characteristics of MTPLs, observed the dynamics of MTPLs in vivo, visualized heat-triggered drug release using MRI, and evaluated the treatment effects of the MTPLs with and without heating. In vitro experiments demonstrated that the MTPLs released drugs at temperatures above 41 degrees C. In vivo MTPLs accumulated in tumor tissue, with the accumulation maximized for 4-12 hours. MR signal in the tumor was significantly elevated after mild heating for 15 minutes, indicating release of the contrast agent from the MTPLs was facilitated by heat-triggering. Tumor size after treatment with MTPLs and heating was significantly smaller than those of the control groups. In conclusion, MTPLs with MRI are useful for low-invasive cancer theranostics. From the Clinical Editor: This team of investigators measured the physical characteristics of multi-modal thermo-sensitive polymer-modified liposomes, observed their dynamics in vivo, visualized drug release after heat-triggering using MRI, and evaluated the treatment effects of the MTPLs with and without heating, concluding that their approach may be useful in low-invasive cancer therapy. Crown Copyright (C) 2015 Published by Elsevier Inc. All rights reserved.	[Kokuryo, Daisuke; Saga, Tsuneo; Aoki, Ichio] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Nakashima, Seiji; Ozaki, Fuminori; Yuba, Eiji; Kono, Kenji] Osaka Prefecture Univ, Grad Sch Engn, Sakai, Osaka 591, Japan; [Chuang, Kai-Hsiang] Singapore Bioimaging Consortium, Lab Mol Imaging, Singapore, Singapore; [Aoshima, Sadahito] Osaka Univ, Grad Sch Sci, Osaka, Japan; [Ishizaka, Yukihito] Natl Ctr Global Hlth & Med, Res Inst, Dept Intractable Dis, Tokyo, Japan	Aoki, I (reprint author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	aoki@nirs.go.jp		Chuang, Kai-Hsiang/0000-0002-8356-0657	Research on Nano-Medicine from the Ministry of Health, Labor and Welfare of Japan; Center of Innovation (COI) Program, Japan Science and Technology Agency (JST), Japan; JSPS; Ministry of Education, Culture, Sports, Science and Technology, Japan	This research was supported by Grants for Research on Nano-Medicine from the Ministry of Health, Labor and Welfare of Japan, and partly by the Center of Innovation (COI) Program, Japan Science and Technology Agency (JST), Japan. In addition, some of the key technology in this research was partly supported by a Kakenhi grant from the JSPS and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	de Smet M, 2010, J CONTROL RELEASE, V143, P120, DOI 10.1016/j.jconrel.2009.12.002; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; Lindner LH, 2005, INT J HYPERTHER, V21, P575, DOI 10.1080/02656730500158410; ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5; Viglianti BL, 2006, MAGN RESON MED, V56, P1011, DOI 10.1002/mrm.21032; Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; Anyarambhatla GR, 1999, J LIPOSOME RES, V9, P491, DOI 10.3109/08982109909035549; Kono K, 2010, BIOMATERIALS, V31, P7096, DOI 10.1016/j.biomaterials.2010.05.045; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Kong G, 2000, CANCER RES, V60, P4440; HUANG SK, 1992, CANCER RES, V52, P6774; DEWEY WC, 1977, RADIOLOGY, V123, P463; Needham D, 2000, CANCER RES, V60, P1197; Choi CHJ, 2011, P NATL ACAD SCI USA, V108, P6656, DOI 10.1073/pnas.1103573108; Kono K, 2011, BIOMATERIALS, V32, P1387, DOI 10.1016/j.biomaterials.2010.10.050; de Smet M, 2011, J CONTROL RELEASE, V150, P102, DOI 10.1016/j.jconrel.2010.10.036; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Tagami T, 2011, BIOMATERIALS, V32, P6570, DOI 10.1016/j.biomaterials.2011.05.029; HAHN GM, 1975, P NATL ACAD SCI USA, V72, P937, DOI 10.1073/pnas.72.3.937; Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Chuang KH, 2006, MAGN RESON MED, V55, P604, DOI 10.1002/mrm.20797; GABER MH, 1995, PHARMACEUT RES, V12, P1407, DOI 10.1023/A:1016206631006; AOSHIMA S, 1992, J POLYM SCI POL CHEM, V30, P2407, DOI 10.1002/pola.1992.080301115; KONO K, 1994, J CONTROL RELEASE, V30, P69, DOI 10.1016/0168-3659(94)90045-0; SAPARETO SA, 1978, CANCER RES, V38, P393; Viglianti BL, 2004, MAGNET RESON MED, V51, P1153, DOI 10.1002/mrm.20074; Peller M, 2008, INVEST RADIOL, V43, P877, DOI 10.1097/RLI.0b013e31818768cd; Li L, 2010, J CONTROL RELEASE, V143, P274, DOI 10.1016/j.jconrel.2010.01.006; YATVIN MB, 1981, CANCER RES, V41, P1602; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Manzoor AA, 2012, CANCER RES, V72, P5566, DOI 10.1158/0008-5472.CAN-12-1683; Lindner LH, 2004, CLIN CANCER RES, V10, P2168, DOI 10.1158/1078-0432.CCR-03-0035; Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003; DEPOORTER J, 1995, MAGNET RESON MED, V33, P74; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Nishiyama N, 2003, CANCER RES, V63, P8977; RINGSDORF H, 1993, BIOCHIM BIOPHYS ACTA, V1153, P335, DOI 10.1016/0005-2736(93)90424-X; Kojima C, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/24/245104; Aoki I, 2008, ISMRM 16 SCI M EXH T, P796; Chow TH, 2009, J NUCL MED, V50, P2073, DOI 10.2967/jnumed.109.063503; GABIZON A, 1988, P NATL ACAD SCI USA, V85, P6949, DOI 10.1073/pnas.85.18.6949; Kim JC, 1997, J BIOCHEM-TOKYO, V121, P15; Kokuryo D, 2009, ISMRM 17 SCI M EXH H, P894; Saeed M, 2000, EUR RADIOL, V10, P310, DOI 10.1007/s003300050050; TOMITA T, 1989, BIOCHIM BIOPHYS ACTA, V978, P185, DOI 10.1016/0005-2736(89)90113-2	49	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	JAN	2015	11	1					229	238		10.1016/j.nano.2014.09.001		10	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science & Technology - Other Topics; Research & Experimental Medicine	AX3NQ	WOS:000346846500023		
J	Imajo, M; Ebisuya, M; Nishida, E				Imajo, Masamichi; Ebisuya, Miki; Nishida, Eisuke			Dual role of YAP and TAZ in renewal of the intestinal epithelium	NATURE CELL BIOLOGY			English	Article							HIPPO SIGNALING PATHWAY; ORGAN SIZE CONTROL; CELL SELF-RENEWAL; LARGE GENE LISTS; STEM-CELLS; PROMOTES APOPTOSIS; WNT/BETA-CATENIN; TUMOR-SUPPRESSOR; GROWTH-CONTROL; CANCER CELLS	The rapidly self-renewing intestinal epithelium represents an exquisite model for stem cell biology. So far, genetic studies in mice have uncovered crucial roles for several signalling pathways in the tissue. Here we show, by using intestine-specific gene transfer (iGT), that Hippo signalling effectors, YAP and TAZ, promote both the proliferation of intestinal stem/progenitor cells and their differentiation into goblet cells. These functions of YAP/TAZ are regulated by the upstream Hippo pathway kinases MST1/2 and LATS1/2. Moreover, we identify TEADs and Klf4 as partner transcription factors of YAP/TAZ in the proliferation and differentiation processes, respectively. These results indicate that Hippo signalling plays a dual role in renewal of the intestinal epithelium through the regulation of two different processes, stem/progenitor cell proliferation and differentiation into goblet cells, using two different types of transcription factor. Moreover, iGT should provide a robust platform to elucidate molecular mechanisms of intestinal epithelium self-renewal.	[Imajo, Masamichi; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Imajo, Masamichi; Nishida, Eisuke] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Imajo, Masamichi] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Ebisuya, Miki] Kyoto Univ, Career Path Promot Unit Young Life Scientist, Sakyo Ku, Kyoto 6068501, Japan; [Ebisuya, Miki] RIKEN, Ctr Dev Biol, Lab Reconstitut Dev Biol, Kobe, Hyogo 6500047, Japan	Imajo, M (reprint author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	mimajo@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp	Ebisuya, Miki/N-5388-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology	We thank members of our laboratory for thoughtful discussion and helpful comments on the manuscript. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology (to E.N. and M.I.).	Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Katz JP, 2002, DEVELOPMENT, V129, P2619; Zhou Dawang, 2011, Proc Natl Acad Sci U S A, V108, pE1312, DOI 10.1073/pnas.1110428108; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Goldie SJ, 2012, CANCER RES, V72, P3424, DOI 10.1158/0008-5472.CAN-12-0423; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Jensen J, 2000, NAT GENET, V24, P36; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Fre S, 2008, ADV CANCER RES, V100, P85, DOI 10.1016/S0065-230X(08)00003-1; Gaffney C. J., 2012, GENE, V509, P215; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imajo M., 2014, PROTOC EXCH; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060	70	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					7	+		10.1038/ncb3084		23	Cell Biology	Cell Biology	AX3ET	WOS:000346823900004		
J	Okada, T; Sinha, S; Esposito, I; Schiavon, G; Lopez-Lago, MA; Su, WJ; Pratilas, CA; Abele, C; Hernandez, JM; Ohara, M; Okada, M; Viale, A; Heguy, A; Socci, ND; Sapino, A; Seshan, VE; Long, S; Inghirami, G; Rosen, N; Giancotti, FG				Okada, Tomoyo; Sinha, Surajit; Esposito, Ilaria; Schiavon, Gaia; Lopez-Lago, Miguel A.; Su, Wenjing; Pratilas, Christine A.; Abele, Cristina; Hernandez, Jonathan M.; Ohara, Masahiro; Okada, Morihito; Viale, Agnes; Heguy, Adriana; Socci, Nicholas D.; Sapino, Anna; Seshan, Venkatraman E.; Long, Stephen; Inghirami, Giorgio; Rosen, Neal; Giancotti, Filippo G.			The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling	NATURE CELL BIOLOGY			English	Article							HUMAN BREAST-CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; RECEPTOR TYROSINE KINASE; GENE-EXPRESSION ANALYSIS; ACTIVATING PROTEIN; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; B-RAF; INDUCED SENESCENCE; EFFECTOR DOMAIN	We identified the Rho GTPase Rnd1 as a candidate metastasis suppressor in basal-like and triple-negative breast cancer through bioinformatics analysis. Depletion of Rnd1 disrupted epithelial adhesion and polarity, induced epithelial-to-mesenchymal transition, and cooperated with deregulated expression of c-Myc or loss of p53 to cause neoplastic conversion. Mechanistic studies revealed that Rnd1 suppresses Ras signalling by activating the GAP domain of Plexin B1, which inhibits Rap1. Rap1 inhibition in turn led to derepression of p120 Ras-GAP, which was able to inhibit Ras. Inactivation of Rnd1 in mammary epithelial cells induced highly undifferentiated and invasive tumours in mice. Conversely, Rnd1 expression inhibited spontaneous and experimental lung colonization in mouse models of metastasis. Genomic studies indicated that gene deletion in combination with epigenetic silencing or, more rarely, point mutation inactivates RND1 in human breast cancer. These results reveal a previously unappreciated mechanism through which Rnd1 restrains activation of Ras-MAPK signalling and breast tumour initiation and progression.	[Okada, Tomoyo; Sinha, Surajit; Esposito, Ilaria; Schiavon, Gaia; Lopez-Lago, Miguel A.; Su, Wenjing; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Cell Biol Program, New York, NY 10065 USA; [Pratilas, Christine A.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Pratilas, Christine A.] Mem Sloan Kettering Canc Ctr, Mem Hosp, Dept Pediat, New York, NY 10065 USA; [Abele, Cristina; Inghirami, Giorgio] Univ Turin, Dept Biomed Sci & Human Oncol, Ctr Expt Med & Res, I-10126 Turin, Italy; [Hernandez, Jonathan M.] Mem Sloan Kettering Canc Ctr, Mem Hosp, Dept Surg, New York, NY 10065 USA; [Ohara, Masahiro; Okada, Morihito] Hiroshima Univ, Res Inst Radiat Biol & Med, Grad Sch Biomed Sci, Dept Surg Oncol, Hiroshima 7348551, Japan; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Facil, New York, NY 10065 USA; [Heguy, Adriana] Mem Sloan Kettering Canc Ctr, Geoffrey Beene Translat Oncol Core Facil, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Facil, New York, NY 10065 USA; [Sapino, Anna] Univ Turin, Ctr Expt Med & Res, Dept Med Sci, I-10126 Turin, Italy; [Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Mem Hosp, New York, NY 10065 USA; [Long, Stephen] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Struct Biol Program, New York, NY 10065 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mem Hosp, Dept Med, New York, NY 10065 USA	Giancotti, FG (reprint author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Cell Biol Program, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org			National Institutes of Health [P01 CA094060, P30 CA08748]; Geoffrey Beene Cancer Center at MSKCC	We thank X. Zhang for advice, reagents, and for sharing the structure of the Plexin-GAP-Rap1 complex before its publication, R. A. Weinberg, J. S. Brugge, M. Overholtzer, A. Ridley, B. Park, L. Tamagnome, M. Resh, H. Djaballah, T. Kataoka, M. Negishi and D. Medina for reagents, K.Manova for assistance with confocal microscopy, R. Khanin and G. P. Gupta for help with multivariate analysis, M. Buck for comments on the manuscript, and members of the Giancotti laboratory for discussions. We thank the Geoffrey Beene Translational Oncology Core, the Genomic Core, and the HTG Core of MSKCC for technical assistance. This work was supported by grants from the National Institutes of Health (P01 CA094060 Project 4 to F.G.G. and P30 CA08748 to MSKCC) and the Geoffrey Beene Cancer Center at MSKCC.	Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; York RD, 1998, NATURE, V392, P622; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Rutherford S, 2005, LAB INVEST, V85, P1076, DOI 10.1038/labinvest.3700314; Ginestier C, 2006, CLIN CANCER RES, V12, P4533, DOI 10.1158/1078-0432.CCR-05-2339; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; FRECH M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; HATA Y, 1990, J BIOL CHEM, V265, P7104; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Rhodes DR, 2004, NEOPLASIA, V6, P1; Argast GM, 2009, ONCOGENE, V28, P2697, DOI 10.1038/onc.2009.133; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hess K. R., 2006, J CLIN ONCOL, V24, P4263; Itoh M, 2007, CANCER RES, V67, P4759, DOI 10.1158/0008-5472.CAN-06-4246; Ohtsuka T, 1996, J BIOL CHEM, V271, P1258; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Wang YX, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002636	74	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2015	17	1					81	+		10.1038/ncb3082		44	Cell Biology	Cell Biology	AX3ET	WOS:000346823900010		
J	Horiuchi, N				Horiuchi, Noriaki			VIEW FROM ... QCMC 2014 Expanding ambitions	NATURE PHOTONICS			English	News Item									Noriaki Horiuchi Nat Photon, Shinjuku Ku, Tokyo 1620843, Japan	Horiuchi, N (reprint author), Noriaki Horiuchi Nat Photon, Shinjuku Ku, 2-37 Ichigayatamachi, Tokyo 1620843, Japan.	n.horiuchi@nature.com						0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	JAN	2015	9	1					13	14		10.1038/nphoton.2014.310		3	Optics; Physics, Applied	Optics; Physics	AX3GK	WOS:000346828000008		
J	Satoh, T; Iida, R; Higuchi, T; Fiebig, M; Shimura, T				Satoh, Takuya; Iida, Ryugo; Higuchi, Takuya; Fiebig, Manfred; Shimura, Tsutomu			Writing and reading of an arbitrary optical polarization state in an antiferromagnet	NATURE PHOTONICS			English	Article							HEXAGONAL YMNO3; MAGNETIZATION; NICKEL; LIGHT	The interaction between light and magnetism is considered a promising route to the development of energy-efficient data storage technologies. To date, however, ultrafast optical magnetization control has been limited to a binary process, whereby light in either of two polarization states generates (writes) or adopts (reads) a magnetic bit carrying either a positive or negative magnetization. Here, we report how the fundamental limitation of just two states can be overcome, allowing an arbitrary optical polarization state to be written magnetically. The effect is demonstrated using a three-sublattice antiferromagnet-hexagonal YMnO3. Its three magnetic oscillation eigenmodes are selectively excited by the three polarization eigenstates of the light. The magnetic oscillation state is then transferred back into the polarization state of an optical probe pulse, thus completing an arbitrary optomagnonic write-read cycle.	[Satoh, Takuya; Iida, Ryugo; Shimura, Tsutomu] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Satoh, Takuya] Kyushu Univ, Dept Phys, Fukuoka 8128581, Japan; [Satoh, Takuya] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020076, Japan; [Higuchi, Takuya] Univ Erlangen Nurnberg, Lehrstuhl Laserphys, D-91058 Erlangen, Germany; [Fiebig, Manfred] ETH, Dept Mat, CH-8093 Zurich, Switzerland	Satoh, T (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan.	satoh@phys.kyushu-u.ac.jp	Satoh, Takuya/B-2564-2010; Higuchi, Takuya/A-5312-2011		Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO)	The authors thank A.M. Kalashnikova, T.J. Sato and D. Meier for discussions. This work was supported by the Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) (T.Sa.).	Satoh T, 2012, NAT PHOTONICS, V6, P662, DOI [10.1038/nphoton.2012.218, 10.1038/NPHOTON.2012.218]; Ju GP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.197403; Popova D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094419; Satoh T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077402; FREY J, 1992, J OPT SOC AM B, V9, P132, DOI 10.1364/JOSAB.9.000132; Kalashnikova AM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.167205; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Sato TJ, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014432; Hansteen F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.047402; Higuchi T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.047401; Takubo N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017404; Kadlec C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174120; Koopmans B, 2000, PHYS REV LETT, V85, P844, DOI 10.1103/PhysRevLett.85.844; Muller GM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/123004; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; Iliev MN, 1997, PHYS REV B, V56, P2488, DOI 10.1103/PhysRevB.56.2488; van Kampen M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.227201; Nishitani J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3436635; Demokritov SO, 2013, TOP APPL PHYS, V125, P1, DOI 10.1007/978-3-642-30247-3; Goian V, 2010, PHASE TRANSIT, V83, P931, DOI 10.1080/01411594.2010.509603; Gridnev VN, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094426; Iida R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064402; Kanda N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1366; Kimel AV, 2005, NATURE, V435, P655, DOI 10.1038/nature03S64; Lorenz B., 2013, ISRN CONDENS MATTER, V2013; Ostler TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1666; PENNEY T, 1969, J APPL PHYS, V40, P1234, DOI 10.1063/1.1657606; Toulouse C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.094415; Yariv A., 2007, PHOTONICS OPTICAL EL; Zvezdin A. K., 1997, MODERN MAGNETOOPTICS	30	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	JAN	2015	9	1					25	29		10.1038/NPHOTON.2014.273		5	Optics; Physics, Applied	Optics; Physics	AX3GK	WOS:000346828000010		
J	Yamashita, T; Shimoyama, Y; Haga, Y; Matsuda, TD; Yamamoto, E; Onuki, Y; Sumiyoshi, H; Fujimoto, S; Levchenko, A; Shibauchi, T; Matsuda, Y				Yamashita, T.; Shimoyama, Y.; Haga, Y.; Matsuda, T. D.; Yamamoto, E.; Onuki, Y.; Sumiyoshi, H.; Fujimoto, S.; Levchenko, A.; Shibauchi, T.; Matsuda, Y.			Colossal thermomagnetic response in the exotic superconductor URu2Si2	NATURE PHYSICS			English	Article							FLUCTUATIONS; ORDER	The superconducting fluctuation effect, due to preformed Cooper pairs above the critical temperature T-c, has been generally understood by the standard Gaussian fluctuation theories in most superconductors(1). The transverse thermoelectric (Nernst) effect is particularly sensitive to the fluctuations, and the large Nernst signal found in the pseudogap regime of the underdoped cuprates(2,3) has raised much debate. Here we report on the observation of a colossal Nernst signal due to the superconducting fluctuations in the heavy-fermion superconductor URu2Si2. The Nernst coeffcient is anomalously enhanced (by a factor of similar to 10(6)) as compared with the theoretically expected value of the Gaussian fluctuations. Moreover, contrary to the conventional wisdom, the enhancement is more significant with a reduction of the impurity scattering rate. This unconventional Nernst effect intimately reflects the highly unusual superconducting state of URu2Si2. The results invoke possible chiral or Berry-phase fluctuations associated with the broken time-reversal symmetry(4-7) of the superconducting order parameter.	[Yamashita, T.; Shimoyama, Y.; Sumiyoshi, H.; Shibauchi, T.; Matsuda, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Haga, Y.; Yamamoto, E.; Onuki, Y.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Matsuda, T. D.] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan; [Onuki, Y.] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 9030213, Japan; [Fujimoto, S.] Osaka Univ, Dept Mat Engn Sci, Toyonaka, Osaka 5608531, Japan; [Levchenko, A.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Shibauchi, T.] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan	Matsuda, Y (reprint author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	matsuda@scphys.kyoto-u.ac.jp	Shibauchi, Takasada/B-9349-2008	Shibauchi, Takasada/0000-0001-5831-4924	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25103713]; NSF [DMR-1401908]	We thank K. Behnia, R. Ikeda and A. Kapitulnik for fruitful discussions, and S. Tonegawa for technical assistance. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (JSPS), and by the 'Topological Quantum Phenomena' (No. 25103713) Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. This work at MSU (A.L.) was supported by NSF Grant No. DMR-1401908.	Pourret A, 2006, NAT PHYS, V2, P683, DOI 10.1038/nphys413; EMERY VJ, 1995, NATURE, V374, P434, DOI 10.1038/374434a0; Kasahara Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116402; Xu ZA, 2000, NATURE, V406, P486; Ussishkin I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.287001; Yano K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.017004; Behnia K, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/11/113101; Izawa K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.147005; Behnia K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.076603; Wang Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024510; Podolsky D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.117004; Rullier-Albenque F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067002; Bel R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217002; Bel R, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.220501; Chang J, 2012, NAT PHYS, V8, P751, DOI [10.1038/nphys2380, 10.1038/NPHYS2380]; Goswami P., 2013, TOPOLOGICAL PROPERTI; Higemoto W, 2002, J PHYS SOC JPN, V71, P1023, DOI 10.1143/JPSJ.71.1023; Kotetes P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.106404; Levchenko A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.020506; Li G, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.134517; Li PC, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174512; Matsuda TD, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.114710; Michaeli K, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/27007; Mydosh JA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1301; Oganesyan V, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054503; Okazaki R, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.084705; Pourret A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055071; Serbyn MN, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.067001; Sumiyoshi H., 2014, GIANT NERNST HALL EF	29	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	JAN	2015	11	1					17	20		10.1038/NPHYS3170		4	Physics, Multidisciplinary	Physics	AX3HQ	WOS:000346831100017		
J	Piazza, BD; Mourigal, M; Christensen, NB; Nilsen, GJ; Tregenna-Piggott, P; Perring, TG; Enderle, M; McMorrow, DF; Ivanov, DA; Ronnow, HM				Piazza, B. Dalla; Mourigal, M.; Christensen, N. B.; Nilsen, G. J.; Tregenna-Piggott, P.; Perring, T. G.; Enderle, M.; McMorrow, D. F.; Ivanov, D. A.; Ronnow, H. M.			Fractional excitations in the square-lattice quantum antiferromagnet	NATURE PHYSICS			English	Article							SPIN-1/2 HEISENBERG-ANTIFERROMAGNET; FUNCTION MONTE-CARLO; VALENCE-BOND STATE; NEUTRON-SCATTERING; WAVE; SUPERCONDUCTIVITY; DYNAMICS; LIQUID; CONTINUUM; LA2CUO4	Quantum magnets have occupied the fertile ground between many-body theory and low-temperature experiments on real materials since the early days of quantum mechanics. However, our understanding of even deceptively simple systems of interacting spin-1/2 particles is far from complete. The quantum square-lattice Heisenberg antiferromagnet, for example, exhibits a striking anomaly of hitherto unknown origin in its magnetic excitation spectrum. This quantum effect manifests itself for excitations propagating with the specific wavevector (pi,0). We use polarized neutron spectroscopy to fully characterize the magnetic fluctuations in the metal-organic compound Cu(DCOO)(2)center dot 4D(2)O, a known realization of the quantum square-lattice Heisenberg antiferromagnet model. Our experiments reveal an isotropic excitation continuum at the anomaly, which we analyse theoretically using Gutzwiller-projected trial wavefunctions. The excitation continuum is accounted for by the existence of spatially extended pairs of fractional S=1/2 quasiparticles, 2D analogues of 1D spinons. Away from the anomalous wavevector, these fractional excitations are bound and form conventional magnons. Our results establish the existence of fractional quasiparticles in the high-energy spectrum of a quasi-two-dimensional antiferromagnet, even in the absence of frustration.	[Piazza, B. Dalla; Mourigal, M.; Nilsen, G. J.; Ronnow, H. M.] Ecole Polytech Fed Lausanne, Lab Quantum Magnetism, CH-1015 Lausanne, Switzerland; [Mourigal, M.; Enderle, M.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France; [Mourigal, M.] Johns Hopkins Univ, Inst Quantum Matter, Baltimore, MD 21218 USA; [Mourigal, M.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Christensen, N. B.] Tech Univ Denmark DTU, Dept Phys, DK-2800 Lyngby, Denmark; [Christensen, N. B.; Tregenna-Piggott, P.] Paul Scherrer Inst, Neutron Scattering Lab, CH-5232 Villigen, Switzerland; [Nilsen, G. J.] Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Perring, T. G.] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; [McMorrow, D. F.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [McMorrow, D. F.] UCL, Dept Phys & Astron, London WC1H 0AH, England; [Ivanov, D. A.] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Ivanov, D. A.] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; [Ronnow, H. M.] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Piazza, BD (reprint author), Ecole Polytech Fed Lausanne, Lab Quantum Magnetism, CH-1015 Lausanne, Switzerland.	bastien.dallapiazza@epfl.ch; mourigal@gatech.edu	Mourigal, Martin/F-4495-2010; Christensen, Niels/A-3947-2012; Ivanov, Dmitri/B-1410-2012	Mourigal, Martin/0000-0003-2772-8440; Ivanov, Dmitri/0000-0001-6903-0679	Swiss National Science Foundation; MPBH network; European Research Council; National Foundation through the NCCR QSIT; Swiss National Supercomputing Center (CSCS) [s347]; US Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering [DE-FG02-08ER46544]; Danish Agency for Science, Technology and Innovation	We gratefully acknowledge fruitful discussions with C. Broholm, L. P. Regnault, S. Sachdev and M. Zhitomirsky. Work in EPFL was supported by the Swiss National Science Foundation, the MPBH network, and European Research Council grant CONQUEST. The work of D. A. I. was supported by the Swiss National Foundation through the NCCR QSIT. Computational work was supported by the Swiss National Supercomputing Center (CSCS) under project ID s347. Work at Johns Hopkins University was supported by the US Department of Energy, Office of Basic Energy Sciences, Division of Material Sciences and Engineering under grant DE-FG02-08ER46544. N.B.C. was supported by the Danish Agency for Science, Technology and Innovation under DANSCATT.	ANDERSON PW, 1987, PHYS REV LETT, V58, P2790, DOI 10.1103/PhysRevLett.58.2790; Buonaura MC, 1998, PHYS REV B, V57, P11446, DOI 10.1103/PhysRevB.57.11446; Kohno M, 2007, NAT PHYS, V3, P790, DOI 10.1038/nphys749; FADDEEV LD, 1981, PHYS LETT A, V85, P375, DOI 10.1016/0375-9601(81)90335-2; HSU TC, 1990, PHYS REV B, V41, P11379, DOI 10.1103/PhysRevB.41.11379; Guarise M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.157006; Laughlin RB, 1999, REV MOD PHYS, V71, P863, DOI 10.1103/RevModPhys.71.863; Mourigal M, 2013, NAT PHYS, V9, P435, DOI [10.1038/nphys2652, 10.1038/NPHYS2652]; GREVEN M, 1995, Z PHYS B CON MAT, V96, P465, DOI 10.1007/BF01313844; Nayak C, 2000, PHYS REV B, V62, P4880, DOI 10.1103/PhysRevB.62.4880; Tsyrulin N, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134409; Headings NS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.247001; TENNANT DA, 1995, PHYS REV B, V52, P13368, DOI 10.1103/PhysRevB.52.13368; Zheng WH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.184440; Han TH, 2012, NATURE, V492, P406, DOI 10.1038/nature11659; TRIVEDI N, 1990, PHYS REV B, V41, P4552, DOI 10.1103/PhysRevB.41.4552; Franjic F, 1997, PROG THEOR PHYS, V97, P399, DOI 10.1143/PTP.97.399; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Coldea R, 2001, PHYS REV LETT, V86, P5377, DOI 10.1103/PhysRevLett.86.5377; HAMER CJ, 1992, PHYS REV B, V46, P6276, DOI 10.1103/PhysRevB.46.6276; LEE TK, 1988, PHYS REV B, V38, P11809, DOI 10.1103/PhysRevB.38.11809; MULLER G, 1981, PHYS REV B, V24, P1429, DOI 10.1103/PhysRevB.24.1429; Coldea R, 2001, PHYS REV LETT, V86, P1335, DOI 10.1103/PhysRevLett.86.1335; GROS C, 1988, PHYS REV B, V38, P931, DOI 10.1103/PhysRevB.38.931; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; Christensen NB, 2007, P NATL ACAD SCI USA, V104, P15264, DOI 10.1073/pnas.0703293104; Ho CM, 2001, PHYS REV LETT, V86, P1626, DOI 10.1103/PhysRevLett.86.1626; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Zhitomirsky ME, 2013, REV MOD PHYS, V85, P219, DOI 10.1103/RevModPhys.85.219; REGER JD, 1988, PHYS REV B, V37, P5978, DOI 10.1103/PhysRevB.37.5978; MANOUSAKIS E, 1991, REV MOD PHYS, V63, P1, DOI 10.1103/RevModPhys.63.1; Sandvik AW, 2001, PHYS REV LETT, V86, P528, DOI 10.1103/PhysRevLett.86.528; AUERBACH A, 1988, PHYS REV LETT, V61, P617, DOI 10.1103/PhysRevLett.61.617; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Balents L, 1999, PHYS REV B, V60, P1654, DOI 10.1103/PhysRevB.60.1654; BASKARAN G, 1987, SOLID STATE COMMUN, V63, P973, DOI 10.1016/0038-1098(87)90642-9; Braicovich L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.077002; CANALI CM, 1993, PHYS REV B, V48, P3264, DOI 10.1103/PhysRevB.48.3264; Dmitriev DV, 1996, FIZ TVERD TELA+, V38, P397; Enderle M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.237207; Ghaemi P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054415; GROS C, 1989, ANN PHYS-NEW YORK, V189, P53, DOI 10.1016/0003-4916(89)90077-8; Ishii K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4714; Ivanov DA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024525; Jeong M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.237201; Kim YJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024435; Kozlenko DP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.187207; Li T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214509; LIU ZP, 1989, PHYS REV B, V40, P11437, DOI 10.1103/PhysRevB.40.11437; Luscher A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195102; Dalla Piazza B, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.100508; Mudry C., 1979, PHYS REV LETT, V98, P1698; Paramekanti A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.054504; Plumb KW, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.180410; Ronnow HM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037202; Singh RRP, 1995, PHYS REV B, V52, P15695; Syljuasen O. F., 2000, J PHYS CONDENS MATT, V12, pL405; Syromyatnikov AV, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/21/216003; Tang Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217213; Tsyrulin N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.197201; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503	62	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	JAN	2015	11	1					62	68		10.1038/NPHYS3172		7	Physics, Multidisciplinary	Physics	AX3HQ	WOS:000346831100025		
J	Kobayashi, T; Owczarek, TB; McKiernan, JM; Abate-Shen, C				Kobayashi, Takashi; Owczarek, Tomasz B.; McKiernan, James M.; Abate-Shen, Cory			Modelling bladder cancer in mice: opportunities and challenges	NATURE REVIEWS CANCER			English	Review							TRANSITIONAL-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR-3; BETA-CATENIN ACTIVATION; URINARY-BLADDER; UROTHELIAL CARCINOMA; TRANSGENIC MICE; GENE-EXPRESSION; WHOLE-GENOME; STEM-CELLS; IN-SITU	The prognosis and treatment of bladder cancer have improved little in the past 20 years. Bladder cancer remains a debilitating and often fatal disease, and is among the most costly cancers to treat. The generation of informative mouse models has the potential to improve our understanding of bladder cancer progression, as well as to affect its diagnosis and treatment. However, relatively few mouse models of bladder cancer have been described, and in particular, few that develop invasive cancer phenotypes. This Review focuses on opportunities for improving the landscape of mouse models of bladder cancer.	[Kobayashi, Takashi] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto 6068507, Japan; [Owczarek, Tomasz B.; McKiernan, James M.; Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Urol, New York, NY 10032 USA; [Owczarek, Tomasz B.; Abate-Shen, Cory] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Inst Canc Genet, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Abate-Shen, C (reprint author), Columbia Univ, Med Ctr, Dept Urol, New York, NY 10032 USA.	cabateshen@columbia.edu			Japan Society for the Promotion of Science; Urology Care Foundation Research Scholars Program; Dornier MedTech; National Cancer Institute; T.J. Martell Foundation for Leukemia, Cancer and AIDS research	The authors would like to thank H. Al-Ahmadie, M. Castillo-Martin, G. Iyer, C. Mendelsohn and M. Shen for helpful comments on the manuscript. Work in the authors' laboratories is funded by a Grant-in-Aid for Young Scientists (A) from the Japan Society for the Promotion of Science (to T.K.), a grant from the Urology Care Foundation Research Scholars Program and Dornier MedTech (to T.B.O.), and funding from the National Cancer Institute and the T.J. Martell Foundation for Leukemia, Cancer and AIDS research (to C.A.S.). C.A.S. is is an American Cancer Society Research Professor supported in part by a generous gift from the F.M. Kirby Foundation.	Abate-Shen C., 2013, COLD SPRING HARB PRO, V2013; Ahmad I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.7; Ahmad I, 2011, DIS MODEL MECH, V4, P548, DOI 10.1242/dmm.006874; Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Morrison CD, 2014, P NATL ACAD SCI USA, V111, pE672, DOI 10.1073/pnas.1313580111; Baskin LS, 1996, J UROLOGY, V156, P1820, DOI 10.1016/S0022-5347(01)65545-9; Gust KM, 2013, MOL CANCER THER, V12, P1245, DOI 10.1158/1535-7163.MCT-12-1150; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Ahmad I, 2012, DIS MODEL MECH, V5, P323, DOI 10.1242/dmm.008888; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Gaisa NT, 2011, J PATHOL, V225, P163, DOI 10.1002/path.2945; Gandhi D, 2013, DEV CELL, V26, P469, DOI 10.1016/j.devcel.2013.07.017; Yoo LI, 2006, CANCER RES, V66, P1929, DOI 10.1158/0008-5472.CAN-05-1986; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Herr HW, 2008, J UROLOGY, V179, P53, DOI 10.1016/j.juro.2007.08.122; Dahm P, 2003, EUR UROL, V44, P672, DOI 10.1016/S0302-2838(03)00416-0; Ross JS, 2014, MODERN PATHOL, V27, P271, DOI 10.1038/modpathol.2013.135; Tsuruta H, 2006, CANCER RES, V66, P8389, DOI 10.1158/0008-5472.CAN-05-4627; Black PC, 2010, BJU INT, V106, P1799, DOI 10.1111/j.1464-410X.2010.09424.x; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Oottamasathien S, 2006, DEV DYNAM, V235, P2795, DOI 10.1002/dvdy.20886; Mitra AP, 2009, J CLIN ONCOL, V27, P3929, DOI 10.1200/JCO.2008.18.5744; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; He XB, 2009, STEM CELLS, V27, P1487, DOI 10.1002/stem.92; He F, 2009, CANCER RES, V69, P9413, DOI 10.1158/0008-5472.CAN-09-2158; Said N, 2013, J CLIN INVEST, V123, P751, DOI 10.1172/JCI64782; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Hsu JW, 2013, AM J PATHOL, V182, P1811, DOI 10.1016/j.ajpath.2013.01.018; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Politi K, 2011, J CLIN ONCOL, V29, P2273, DOI 10.1200/JCO.2010.30.8304; Williamson SR, 2010, CRIT REV ONCOL HEMAT, V76, P112, DOI 10.1016/j.critrevonc.2010.01.005; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; de la Pena FA, 2011, J BIOL CHEM, V286, P20778, DOI 10.1074/jbc.M110.198069; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Gao J, 2004, ONCOGENE, V23, P687, DOI 10.1038/sj.onc.1207169; Santos M, 2014, CANCER RES, V74, P6565, DOI 10.1158/0008-5472.CAN-14-1218; Foth M, 2014, J PATHOL, V233, P148, DOI 10.1002/path.4334; Cohen SM, 1998, TOXICOL PATHOL, V26, P121; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Hanahan D, 2007, GENE DEV, V21, P2258, DOI 10.1101/gad.1583307; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Park B, 2013, CANCER SCI, V104, P631, DOI 10.1111/cas.12123; Mo L, 2005, AM J PHYSIOL-RENAL, V289, pF562, DOI 10.1152/ajprenal.00368.2004; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Nordentoft I, 2014, CELL REP, V7, P1649, DOI 10.1016/j.celrep.2014.04.038; Resnick MJ, 2013, CURR OPIN ONCOL, V25, P281, DOI 10.1097/CCO.0b013e32835eb583; Gontero P, 2010, EUR UROL, V57, P410, DOI 10.1016/j.eururo.2009.11.023; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Lin CX, 2013, CANCER RES, V73, P5914, DOI 10.1158/0008-5472.CAN-12-4198; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Grippo PJ, 2000, AM J PATHOL, V157, P805, DOI 10.1016/S0002-9440(10)64594-4; Kiriluk KJ, 2012, UROL ONCOL-SEMIN ORI, V30, P199, DOI 10.1016/j.urolonc.2011.10.010; Nese N, 2009, J NATL COMPR CANC NE, V7, P48; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; Chan ESY, 2009, J UROLOGY, V182, P2926, DOI 10.1016/j.juro.2009.08.020; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Crivelli JJ, 2014, EUR UROL, V65, P742, DOI 10.1016/j.eururo.2013.06.010; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001; Gunther JH, 1999, CANCER RES, V59, P2834; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Marcinkiewicz K, 2012, INT J ONCOL, V40, P5, DOI 10.3892/ijo.2011.1212; Baskin LS, 1996, ACTA ANAT, V155, P163; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Zhang ZT, 1999, CANCER RES, V59, P3512; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; van der Horst G, 2011, EUR UROL, V60, P337, DOI 10.1016/j.eururo.2011.05.005; Chen SC, 2009, J UROLOGY, V181, P336, DOI 10.1016/j.juro.2008.08.123; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Nishizawa K, 2011, CARCINOGENESIS, V32, P1459, DOI 10.1093/carcin/bgr137; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; Dash A, 2008, CANCER, V113, P2471, DOI 10.1002/cncr.23848; DeGraff DJ, 2013, MOL CANCER THER, V12, P121, DOI 10.1158/1535-7163.MCT-12-0508; Wu XF, 2009, CANCER METAST REV, V28, P269, DOI 10.1007/s10555-009-9190-y; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446; Choi W, 2014, NAT REV UROL, V11, P400, DOI 10.1038/nrurol.2014.129; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Barlow LJ, 2010, UROL ONCOL-SEMIN ORI, V28, P108, DOI 10.1016/j.urolonc.2009.03.029; Bex A, 2002, J UROLOGY, V168, P2641, DOI 10.1097/01.ju.0000030146.03639.90; BRADLEY WE, 1969, INVEST UROL, V7, P66; Cazier JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4756; Chan E. S., 2012, UROLOGY, V80, P736; Cheng J, 2002, CANCER RES, V62, P4157; Cirone P, 2014, CANCER CHEMOTH PHARM, V73, P525, DOI 10.1007/s00280-014-2376-1; Colopy SA, 2014, DEV DYNAM, V243, P988, DOI [10.1002/dvdy.24143, 10.1002/DVDY.24143]; COOPER EH, 1972, J PATHOL, V108, P151, DOI 10.1002/path.1711080209; Dancik GM, 2014, STEM CELLS, V32, P974, DOI 10.1002/stem.1625; de la Rosette J, 2002, J UROLOGY, V168, P709, DOI 10.1016/S0022-5347(05)64731-3; Delto JC, 2013, ONCOTARGET, V4, P269; Ding J, 2014, EXP THER MED, V8, P691, DOI 10.3892/etm.2014.1837; DOBEK GL, 2011, J VIS EXP, V6, P2535, DOI DOI 10.3791/2535; DRUCKREY H., 1964, Z KREBSFORSCH, V66, P280, DOI 10.1007/BF00524156; FUKUSHIMA S, 1976, GANN, V67, P81; Garcia-Espana A, 2005, CANCER RES, V65, P1150, DOI 10.1158/0008-5472.CAN-04-2074; Hamed S, 2004, CANCER RES, V64, P1938, DOI 10.1158/0008-5472.CAN-03-2031; He ZM, 2012, MUTAT RES-GEN TOX EN, V742, P92, DOI 10.1016/j.mrgentox.2011.11.015; HICKS RM, 1972, CHEM-BIOL INTERACT, V5, P139, DOI 10.1016/0009-2797(72)90040-3; Hikosaka A, 2008, INT J CANCER, V122, P1222, DOI 10.1002/ijc.23249; Hoogervorst EM, 2004, CANCER RES, V64, P5118, DOI 10.1158/0008-5472.CAN-04-0350; Hursting SD, 2009, MOL CARCINOGEN, V48, P671, DOI 10.1002/mc.20548; JOST SP, 1986, CELL TISSUE KINET, V19, P155, DOI 10.1111/j.1365-2184.1986.tb00725.x; KERBEL RS, 1991, CANCER METAST REV, V10, P201, DOI 10.1007/BF00050792; Kim JH, 2005, LAB INVEST, V85, P532, DOI 10.1038/labinvest.3700250; Kim SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026131; Lauss M, 2010, CLIN CANCER RES, V16, P4421, DOI 10.1158/1078-0432.CCR-10-0606; LIN JH, 1995, P NATL ACAD SCI USA, V92, P679, DOI 10.1073/pnas.92.3.679; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; OSHINSKY GS, 1995, J UROLOGY, V154, P1925, DOI 10.1016/S0022-5347(01)66827-7; Ozaki K, 1998, CANCER RES, V58, P3806; Rampias T, 2014, NAT MED, V20, P1199, DOI 10.1038/nm.3678; Rebouissou S., 2014, SCI TRANSL MED, V6; Seager C., 2010, CURR PROTOC PHARM; Seager CM, 2009, CANCER PREV RES, V2, P1008, DOI 10.1158/1940-6207.CAPR-09-0169; Shen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035243; Shorning BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016209; Singer S, 2013, SUPPORT CARE CANCER, V21, P1383, DOI 10.1007/s00520-012-1680-8; SOLOWAY MS, 1975, CANCER, V36, P333, DOI 10.1002/1097-0142(197508)36:2<333::AID-CNCR2820360207>3.0.CO;2-1; Somani BK, 2009, UROLOGY, V74, P1138, DOI 10.1016/j.urology.2009.05.087; Stein JP, 2001, J CLIN ONCOL, V19, P666; Stone R, 2010, CANCER PREV RES, V3, P776, DOI 10.1158/1940-6207.CAPR-09-0189; Sun WL, 2014, DEV BIOL, V393, P84, DOI 10.1016/j.ydbio.2014.06.018; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; Vasconcelos-Nobrega C, 2012, IN VIVO, V26, P727; Weldon T E, 1975, Urology, V5, P824, DOI 10.1016/0090-4295(75)90367-2; Xiao Z, 1999, BRIT J CANCER, V81, P638, DOI 10.1038/sj.bjc.6690741; YAMAMOTO S, 1995, CARCINOGENESIS, V16, P2363, DOI 10.1093/carcin/16.10.2363; Yang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074809; Zargar H, 2015, EUR UROL, V67, P241, DOI 10.1016/j.eururo.2014.09.007; ZIEGER K, 2009, J INT CANC, V125, P2095	160	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-175X	1474-1768		NAT REV CANCER	Nat. Rev. Cancer	JAN	2015	15	1					42	54		10.1038/nrc3858		13	Oncology	Oncology	AX3IL	WOS:000346833100008		
J	Bazzi, C; Stivali, G; Rachele, G; Rizza, V; Casellato, D; Nangaku, M				Bazzi, Claudio; Stivali, Gilda; Rachele, Gregorio; Rizza, Virginia; Casellato, Daniela; Nangaku, Masaomi			Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis	NEPHROLOGY			English	Article						arterial hypertension; arteriolar hyalinosis; interstitial hypoxia; tubulo-interstitial damage markers	STAGE RENAL-FAILURE; TUBULOINTERSTITIAL INJURY; URINARY-EXCRETION; INDUCIBLE FACTOR; IGA NEPHROPATHY; KIDNEY; MECHANISMS; DISEASE; PROTEINURIA; PROGRESSION	BackgroundIn glomerulonephritis the final common pathway to end-stage renal disease (ESRD) is tubulo-interstitial damage (TID) whose main determinants are proteinuria and hypoxia consequent to haemodynamic and vascular alterations that reduce interstitial blood flow. Since oxygen tension is difficult to measure in human disease, arteriolar hyalinosis and arterial hypertension have been considered as possible surrogate markers of interstitial hypoxia. MethodsThe relationship between TID and arteriolar hyalinosis and arterial hypertension was evaluated in 132 IgA nephropathy (IgAN) and 79 idiopathic membranous nephropathy (IMN) patients. At biopsy tubulo-interstitial damage and arteriolar hyalinosis score were semi-quantitatively evaluated; urinary protein/creatinine ratio (P/C), fractional excretion (FE) of 1-microglobulin, urinary -NAG/creatinine ratio (NAG/C/eGFR) and urinary SDS-PAGE pattern were measured. ResultsIn IgAN arteriolar hyalinosis (AH) score correlates with TID score (P<0.0001), FE 1m (P=0.004) and NAG/C/eGFR (P=0.001), but not with P/C (P=0.10). Patients with or without AH were different in terms of global glomerulosclerosis (GGS: P<0.001), TID score (P<0.001), FE 1m (P=0.015), NAG/C/eGFR (P=0.002), but not of P/C (P=0.19). In IMN AH score correlates with TID score (P<0.0001), FE1m (P=0.04), NAG/C/eGFR (P=0.001), SDS-PAGE pattern (P=0.018), but not with P/C (P=0.10). Patients with or without AH were different in term of GGS% (P=0.05), TID score (P=0.001), FE 1m (P=0.039), NAG/C/eGFR (P=0.001), SDS-PAGE pattern (P=0.02), but not of P/C (P=0.065). Similar results for normal versus high blood pressure. ConclusionsArteriolar hyalinosis and arterial hypertension, associated with TID and GGS, factors that reduce interstitial capillary bed and blood flow, may be considered as reliable surrogate markers of hypoxia and co-determinants of TID. Summary at a Glance Arteriolar hyalinosis in IgA nephropathy and membranous nephropathy was significantly associated with tubulointerstitial damage severity, and this can be a surrogate marker of hypoxia.	[Bazzi, Claudio] DAmico Fdn Renal Dis Res, I-20145 Milan, Italy; [Rizza, Virginia] San Carlo Borromeo Hosp, Biochem Lab, Milan, Italy; [Casellato, Daniela] San Carlo Borromeo Hosp, Nephrol & Dialysis Unit, Milan, Italy; [Stivali, Gilda; Rachele, Gregorio] Baxter SpA, Rome, Italy; [Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Tokyo 113, Japan	Bazzi, C (reprint author), DAmico Fdn Renal Dis Res, Via Cherubini 6, I-20145 Milan, Italy.	claudio.bazzi@alice.it					Bazzi C, 2001, AM J KIDNEY DIS, V38, P240, DOI 10.1053/ajkd.2001.26080; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1917, DOI 10.1681/ASN.2012040390; Levey AS, 2009, ANN INTERN MED, V150, P604; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; RISDON RA, 1968, LANCET, V2, P363; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Nangaku M, 2008, HYPERTENS RES, V31, P175, DOI 10.1291/hypres.31.175; Bazzi C, 2002, NEPHROL DIAL TRANSPL, V17, P1890, DOI 10.1093/ndt/17.11.1890; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Bazzi C, 2012, J NEPHROL, V25, P810, DOI 10.5301/jn.5000069; Bazzi C, 1997, AM J KIDNEY DIS, V29, P27, DOI 10.1016/S0272-6386(97)90005-6; Bazzi C, 2009, J NEPHROL, V22, P387; Cravedi P, 2013, BR J CLIN PHARM, V13, P1159; DAMICO G, 1981, CLIN NEPHROL, V16, P251; Eto N, 2005, J AM SOC NEPHROL, V16, P2997, DOI 10.1681/ASN.2005020137; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85; Mimura I, 2013, SEMIN NEPHROL, V33, P375, DOI 10.1016/j.semnephrol.2013.05.009; Nangaku M, 2013, CLIN EXP PHARMACOL P, V40, P148, DOI 10.1111/1440-1681.12005; Nangaku M, 2008, NEPHRON EXP NEPHROL, V110, pE1, DOI 10.1159/000148256; Nangaku M, 2007, ADV EXP MED BIOL, V618, P85; Norman JT, 2003, NEPHRON PHYSIOL, V94, P39; Tanaka T, 2010, CURR OPIN NEPHROL HY, V19, P43, DOI 10.1097/MNH.0b013e3283328eed; Tanaka T, 2013, NAT REV NEPHROL, V9, P211, DOI 10.1038/nrneph.2013.35; Tsutomu I, 2011, J AM SOC NEPHROL, V22, P1429	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	JAN	2015	20	1					11	17		10.1111/nep.12339		7	Urology & Nephrology	Urology & Nephrology	AX2OG	WOS:000346783000003		
J	Tangkaratt, V; Xie, N; Sugiyama, M				Tangkaratt, Voot; Xie, Ning; Sugiyama, Masashi			Conditional Density Estimation with Dimensionality Reduction via Squared-Loss Conditional Entropy Minimization	NEURAL COMPUTATION			English	Article							INVERSE REGRESSION; DIVERGENCE	Regression aims at estimating the conditional mean of output given input. However, regression is not informative enough if the conditional density is multimodal, heteroskedastic, and asymmetric. In such a case, estimating the conditional density itself is preferable, but conditional density estimation (CDE) is challenging in high-dimensional space. A naive approach to coping with high dimensionality is to first perform dimensionality reduction (DR) and then execute CDE. However, a two-step process does not perform well in practice because the error incurred in the first DR step can be magnified in the second CDE step. In this letter, we propose a novel single-shot procedure that performs CDE and DR simultaneously in an integrated way. Our key idea is to formulate DR as the problem of minimizing a squared-loss variant of conditional entropy, and this is solved using CDE. Thus, an additional CDE step is not needed after DR. We demonstrate the usefulness of the proposed method through extensive experiments on various data sets, including humanoid robot transition and computer art.	[Tangkaratt, Voot; Xie, Ning; Sugiyama, Masashi] Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 1528552, Japan	Tangkaratt, V (reprint author), Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 1528552, Japan.	voot@sg.cs.titech.ac.jp; xie@sg.cs.titech.ac.jp; sugi@cs.titech.ac.jp					Reich BJ, 2011, BIOMETRICS, V67, P886, DOI 10.1111/j.1541-0420.2010.01501.x; Wang H, 2008, J AM STAT ASSOC, V103, P811, DOI 10.1198/016214508000000418; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Amari S, 1998, NEURAL COMPUT, V10, P251, DOI 10.1162/089976698300017746; Cook RD, 2005, J AM STAT ASSOC, V100, P410, DOI 10.1198/016214504000001501; Suzuki T, 2013, NEURAL COMPUT, V25, P725, DOI 10.1162/NECO_a_00407; Basu A, 1998, BIOMETRIKA, V85, P549, DOI 10.1093/biomet/85.3.549; ALI SM, 1966, J ROY STAT SOC B, V28, P131; Fukumizu K, 2009, ANN STAT, V37, P1871, DOI 10.1214/08-AOS637; Nguyen XL, 2010, IEEE T INFORM THEORY, V56, P5847, DOI 10.1109/TIT.2010.2068870; Bache K., 2013, UCI MACHINE LEARNING; Cheng G, 2007, ADV ROBOTICS, V21, P1097, DOI 10.1163/156855307781389356; Csiszar I., 1967, STUD SCI MATH HUNG, V2, P229; Edelman A, 1998, SIAM J MATRIX ANAL A, V20, P303, DOI 10.1137/S0895479895290954; Huber PJ, 1981, ROBUST STAT; Keziou A, 2003, CR MATH, V336, P857, DOI 10.1016/S1631-073X(03)00215-2; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LI KC, 1991, J AM STAT ASSOC, V86, P316, DOI 10.2307/2290563; Sugiyama M., 2010, P 13 INT C ART INT S, P781; Sugiyama M, 2012, ANN I STAT MATH, V64, P1009, DOI 10.1007/s10463-011-0343-8; Sutton R., 1998, REINFORCEMENT LEARNI; Xia YC, 2007, ANN STAT, V35, P2654, DOI 10.1214/009053607000000352; Xie N., 2012, P INT C MACH LEARN, P153	23	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0899-7667	1530-888X		NEURAL COMPUT	Neural Comput.	JAN	2015	27	1					228	254		10.1162/NECO_a_00683		27	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	AX2GY	WOS:000346762700010		
J	Kitamura, A; Kurikami, H; Yamaguchi, M; Oda, Y; Saito, T; Kato, T; Niizato, T; Iijima, K; Sato, H; Yui, M; Machida, M; Yamada, S; Itakura, M; Okumura, M; Onishi, Y				Kitamura, Akihiro; Kurikami, Hiroshi; Yamaguchi, Masaaki; Oda, Yoshihiro; Saito, Tatsuo; Kato, Tomoko; Niizato, Tadafumi; Iijima, KaZuki; Sato, Haruo; Yui, Mikazu; Machida, Masahiko; Yamada, Susumu; Itakura, Mitsuhiro; Okumura, Masahiko; Onishi, Yasuo			Mathematical Modeling of Radioactive Contaminants in the Fukushima Environment	NUCLEAR SCIENCE AND ENGINEERING			English	Article							SUBSURFACE SEDIMENTS; HANFORD SITE; RADIOCESIUM; SORPTION; ILLITE; USA	Significant amounts of radioactive materials were released to the atmosphere from the Fukushima Daiichi nuclear power plant after the accident caused by the major earthquake and devastating tsunami on March 11, 2011. Accurate and efficient prediction of the distribution and fate of radioactive materials eventually deposited at the surface in the Fukushima area is of primary importance. In order to make such a prediction, it is important to gather information regarding the main migration pathways for radioactive materials in the environment and the time dependences of radioactive material transport over the long term. The radionuclide of most concern in the Fukushima case is radioactive cesium. Previous surveys indicate that the primary transportation mechanisms of cesium are either soil erosion and water transport of sediment-sorbed contaminants or transport of dissolved cesium in the water drainage system such as by rivers. A number of mathematical models of radioactive contaminants, with particular attention paid to radiocesium, on the land and in rivers, reservoirs, and estuaries in the Fukushima area are developed. Simulation results are examined while simultaneously implementing field investigations. For example, the orders of magnitude of the radiocesium concentration on the flood plain of the Ukedo River by model prediction and field investigation results were both 10(5) Bq/kg. Microscopic studies of the adsorption/desorption mechanism of cesium and soils have been performed to shed light on the mechanisms of macroscopic diffusive transport of radiocesium through soil. The maximum exchange energy between cesium and prelocated potassium in the frayed edge site was simulated to be 27 kJ/mol, which reproduces the corresponding value previously achieved by experiments. These predictions will be utilized for assessment of dose from the environmental contamination and proposed countermeasures to limit dispersion of the contaminants.	[Kitamura, Akihiro; Kurikami, Hiroshi; Yamaguchi, Masaaki; Oda, Yoshihiro; Saito, Tatsuo; Kato, Tomoko; Niizato, Tadafumi; Iijima, KaZuki; Sato, Haruo; Yui, Mikazu] Japan Atom Energy Agcy, Fukushima Environm Safety Ctr, Fukushima, Japan; [Kitamura, Akihiro; Kurikami, Hiroshi; Yamaguchi, Masaaki; Oda, Yoshihiro; Saito, Tatsuo; Kato, Tomoko; Niizato, Tadafumi; Iijima, KaZuki; Sato, Haruo; Yui, Mikazu] Geol Isolat Res & Dev Directorate, Ibaraki, Japan; [Machida, Masahiko; Yamada, Susumu; Itakura, Mitsuhiro; Okumura, Masahiko] Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Chiba, Japan; [Onishi, Yasuo] Pacific NW Natl Lab, Energy & Environm Directorate, Richland, WA 99352 USA	Kitamura, A (reprint author), Japan Atom Energy Agcy, Fukushima Environm Safety Ctr, Fukushima, Japan.	kitamura.akihiro@jaea.go.jp					Liu CX, 2003, GEOCHIM COSMOCHIM AC, V67, P2893, DOI 10.1016/S0016-7037(00)00267-9; Okumura M, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.033802; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Churakov SV, 2011, J PHYS CHEM C, V115, P6703, DOI 10.1021/jp112325n; Jang CL, 2005, J HYDRAUL ENG-ASCE, V131, P565, DOI 10.1061/(ASCE)0733-9429(2005)131:7(565); Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Zachara JM, 2002, GEOCHIM COSMOCHIM AC, V66, P193, DOI 10.1016/S0016-7037(01)00759-1; BROUWER E, 1983, J PHYS CHEM-US, V87, P1213, DOI 10.1021/j100230a024; Wentworth CK, 1922, J GEOL, V30, P377; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; de Koning A, 2004, GEOCHIM COSMOCHIM AC, V68, P2815, DOI 10.1016/j.gca.2003.12.025; Delvaux B, 2001, TRACE ELEMENTS IN THE RHIZOSPHERE, P61; DuBoys M. P., 1879, ANN PONTS CHAUSSEES, V18, P141; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Krone RB, 1962, FLUME STUDIES TRANSP, P110; ONISHI Y., 1982, PNL3370; ONISHI Y., 2007, CHERNOBYL WHAT HAVE; ONISHI Y, 1985, J HAZARD MATER, V10, P389, DOI 10.1016/0304-3894(85)87012-6; Partheniades E, 1962, THESIS U CALIFORNIA; SATO Y., 1996, COAST ENG J, V43, P621; Shimizu Y, 2012, IRIC SOFTWARE NAYS2D; Shimizu Y., 2003, ANN J HYDRAUL ENG, V47, P643; van Rijn L., 1993, PRINCIPLES SEDIMENT; Wischmeier W.H., 1978, AGR HDB USDA, V537, P58; Yamaguchi M., 2013, J NUCL FUEL CYCLE EN, V20, P53; Yamashiki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03714	26	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	JAN	2015	179	1					104	118				15	Nuclear Science & Technology	Nuclear Science & Technology	AX4BZ	WOS:000346880300006		
J	Yamagata, K; Tagami, M; Yamori, Y				Yamagata, Kazuo; Tagami, Motoki; Yamori, Yukio			Dietary polyphenols regulate endothelial function and prevent cardiovascular disease	NUTRITION			English	Review						Epidemiologic study; Endothelial cells; Epigallocatechin-3-gallate; Nitric oxide; Polyphenol	CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; GREEN TEA POLYPHENOLS; SMOOTH-MUSCLE-CELLS; LOW-DENSITY-LIPOPROTEIN; RED WINE; TNF-ALPHA; EPIGALLOCATECHIN GALLATE; FRENCH PARADOX; DEPENDENT VASODILATION	Vascular endothelial cell (EC) dysfunction strongly induces development of cardiovascular and cerebrovascular diseases. Epidemiologic studies demonstrated a preventative effect of dietary polyphenols toward cardiovascular disease. In studies using cultured vascular ECs, polyphenols were recognized to regulate nitric oxide and endothelin-1 (ET-1) production. Furthermore, epigallocatechin-3-gallate inhibited the expression of adhesion molecules by a signaling pathway that is similar to that of high-density lipoprotein and involves induction of Ca2+/calmodulin-dependent kinase II, liver kinase B, and phosphatidylinositol 3-kinase expression. The effects of polyphenols on ECs include antioxidant activity and enhancement of the expression of several protective proteins, including endothelial nitric oxide synthase and paraoxonase 1. However, the observed effects of dietary polyphenols in vitro do not always translate to an in vivo setting. As such, there are many questions concerning their physiological mode of action. In this review, we discuss research on the effect of dietary polyphenols on cardiovascular disease and their protective effect on EC dysfunction. (C) 2015 Elsevier Inc. All rights reserved.	[Yamagata, Kazuo] Nihon Univ, Dept Food Biosci & Biotechnol, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Yamagata, Kazuo] Nihon Univ, Coll Bioresource Sci, Adv Res Ctr Food Funct, Fujisawa, Kanagawa, Japan; [Tagami, Motoki] Sanraku Hosp, Dept Internal Med, Lifestyle Dis Clin, Chiyoda Ku, Tokyo, Japan; [Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan	Yamagata, K (reprint author), Nihon Univ, Dept Food Biosci & Biotechnol, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.	kyamagat@brs.nihon-u.ac.jp			Nihon University Multidisciplinary Research Grant	The work was supported by grants from the Nihon University Multidisciplinary Research Grant for 2013.	Alhosin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057883; Ameer B, 1996, CLIN PHARMACOL THER, V60, P34, DOI 10.1016/S0009-9236(96)90164-2; Yamagata K, 2010, J NUTR BIOCHEM, V21, P116, DOI 10.1016/j.jnutbio.2008.11.003; Miyagi Y, 1997, AM J CARDIOL, V80, P1627, DOI 10.1016/S0002-9149(97)00755-8; Thangapazham RL, 2007, CANCER LETT, V245, P232, DOI 10.1016/j.canlet.2006.01.027; Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C; Petyaev IM, 2012, MED HYPOTHESES, V79, P746, DOI 10.1016/j.mehy.2012.08.018; Dudley JI, 2008, J AGR FOOD CHEM, V56, P9362, DOI 10.1021/jf801791d; Mann GE, 2007, CARDIOVASC RES, V75, P261, DOI 10.1016/j.cardiores.2007.04.004; Aziz AA, 1998, FREE RADICAL RES, V29, P257, DOI 10.1080/10715769800300291; Poli A, 2013, NUTR METAB CARDIOVAS, V23, P487, DOI 10.1016/j.numecd.2013.02.007; Arranz S, 2013, MOL NUTR FOOD RES, V57, P936, DOI 10.1002/mnfr.201200595; Song WO, 2007, J MED FOOD, V10, P571, DOI 10.1089/jmf.2006.0620; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Pu YF, 2013, CELL PHYSIOL BIOCHEM, V32, P1167, DOI 10.1159/000354516; Heiss C, 2006, J CARDIOVASC PHARM, V47, pS128, DOI 10.1097/00005344-200606001-00007; Meyer H, 2006, ANN NUTR METAB, V50, P167, DOI 10.1159/000090736; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693; Zhu BH, 2007, WORLD J GASTROENTERO, V13, P1162; Martin S, 2002, BRIT J PHARMACOL, V135, P1579, DOI 10.1038/sj.bjp.0704603; Pullikotil P, 2012, J NUTR BIOCHEM, V23, P1134, DOI 10.1016/j.jnutbio.2011.06.007; Chen CY, 2011, CELL BIOCHEM BIOPHYS, V61, P337, DOI 10.1007/s12013-011-9216-2; Lapidot T, 1999, J AGR FOOD CHEM, V47, P67, DOI 10.1021/jf980704g; Yi L, 2012, BIOCHIMIE, V94, P2035, DOI 10.1016/j.biochi.2012.05.027; Speciale A, 2010, J AGR FOOD CHEM, V58, P12048, DOI 10.1021/jf1029515; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; Klatsky AL, 2003, AM J EPIDEMIOL, V158, P585, DOI 10.1093/aje/kwg184; Zhao XY, 1999, J ETHNOPHARMACOL, V67, P279, DOI 10.1016/S0378-8741(99)00055-0; Babu PVA, 2012, J NUTR, V142, P724, DOI 10.3945/jn.111.152322; Ruxton CHS, 2006, INT J FOOD SCI NUTR, V57, P249, DOI 10.1080/0963748060085134; VANE JR, 1990, NEW ENGL J MED, V323, P27; IMAI K, 1995, BRIT MED J, V310, P693; Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/01.hjh.0000084783.15238.eb; Li PG, 2012, PHARMACOLOGY, V89, P220, DOI 10.1159/000337182; Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034; Luo XQ, 2012, MOL CELL BIOCHEM, V362, P211, DOI 10.1007/s11010-011-1144-3; Kokubo Y, 2007, CIRCULATION, V116, P2553, DOI 10.1161/CIRCULATIONAHA.106.683755; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Reiter CEN, 2010, ENDOCRINOLOGY, V151, P103, DOI 10.1210/en.2009-0997; Arnal JF, 1999, CELL MOL LIFE SCI, V55, P1078, DOI 10.1007/s000180050358; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; VITA JA, 1990, CIRCULATION, V81, P491; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Qian LB, 2010, PHARMACOL RES, V61, P281, DOI 10.1016/j.phrs.2009.10.004; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Manach C, 2004, AM J CLIN NUTR, V79, P727; Jin BH, 2009, EUR J PHARMACOL, V616, P200, DOI 10.1016/j.ejphar.2009.06.020; Paixao J, 2012, CHEM-BIOL INTERACT, V199, P192, DOI 10.1016/j.cbi.2012.08.013; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Saponara S, 2006, BRIT J PHARMACOL, V149, P1013, DOI 10.1038/sj.bjp.0706951; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Liu L, 2008, J AGR FOOD CHEM, V56, P824, DOI 10.1021/jf0723007; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Day AJ, 2000, FREE RADICAL BIO MED, V29, P1234, DOI 10.1016/S0891-5849(00)00416-0; Dauchet L, 2006, J NUTR, V136, P2588; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Stapleton PD, 2004, INT J ANTIMICROB AG, V23, P462, DOI 10.1016/j.ijantimicag.2003.09.027; Crespo I, 2008, BRIT J NUTR, V100, P968, DOI 10.1017/S0007114508966083; Osada M, 2004, FEBS LETT, V575, P59, DOI 10.1016/j.febslet.2004.08.036; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; XU X, 1994, J NUTR, V124, P825; Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7; Dona M, 2003, J IMMUNOL, V170, P4335; Sano M, 2001, ANALYST, V126, P816, DOI 10.1039/b102541b; Wang Y, 2012, J NUTR, V142, P1033, DOI 10.3945/jn.112.157701; Yamagata K, 2012, MICROVASC RES, V84, P297, DOI 10.1016/j.mvr.2012.06.007; ARTAUDWILD SM, 1993, CIRCULATION, V88, P2771; Auger C, 2010, BIOCHEM BIOPH RES CO, V393, P162, DOI 10.1016/j.bbrc.2010.01.112; BERETZ A, 1978, EXPERIENTIA, V34, P1054, DOI 10.1007/BF01915343; Best PJM, 2000, J CARDIOVASC PHARM, V35, pS61, DOI 10.1097/00005344-200000002-00014; Cayci C, 2010, ANN PLAS SURG, V64, P105, DOI 10.1097/SAP.0b013e31819b03cd; Chanet A, 2013, BRIT J NUTR, V110, P587, DOI 10.1017/S0007114512005454; Cho HY, 2011, NUTR RES PRACT, V5, P381, DOI 10.4162/nrp.2011.5.5.381; Chung J.H., 2012, ADIPOCYTE, V1, P256; Eichholzer M, 2001, INT J VITAM NUTR RES, V71, P5, DOI 10.1024/0300-9831.71.1.5; FUHR U, 1995, CLIN PHARMACOL THER, V58, P365, DOI 10.1016/0009-9236(95)90048-9; Gooderham MJ, 1996, J NUTR, V126, P2000; Guo XD, 2013, MOL NUTR FOOD RES, V57, P1037, DOI 10.1002/mnfr.201200569; Hirata K, 2004, AM J CARDIOL, V93, P1384, DOI 10.1016/j.amjcard.2004.02.035; Joy S, 2006, J BIOL CHEM, V281, P27335, DOI 10.1074/jbc.M602803200; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970; Kasprzak Jarosław D, 2006, Pharmacol Rep, V58 Suppl, P33; Khaza'ai Huzwah, 1996, Biochemical Society Transactions, V24, p173S; Landmesser U, 2005, CURR OPIN CARDIOL, V20, P547, DOI 10.1097/01.hco.0000179821.11071.79; Liu ZQ, 2000, CHEM PHYS LIPIDS, V106, P53, DOI 10.1016/S0009-3084(00)00133-X; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; Manach Claudine, 2005, Am J Clin Nutr, V81, p230S; Mizugaki M, 2000, PROSTAG OTH LIPID M, V62, P157, DOI 10.1016/S0090-6980(00)00060-5; Mochizuki M, 2004, BIOFACTORS, V22, P201; Ndiaye Mamadou, 2005, FASEB J, V19, P455; Oak MH, 2006, BRIT J PHARMACOL, V149, P283, DOI 10.1038/sj.bjp.0706843; Razandi M, 1996, AM J PHYSIOL-HEART C, V270, pH1342; RICHARD JL, 1981, NOUV PRESSE MED, V10, P1111; Rosenkranz S, 2002, FASEB J, V16, P1958, DOI 10.1096/fj.02-0207fje; Scalbert A, 2000, J NUTR, V130, p2073S; Sesso HD, 1999, AM J EPIDEMIOL, V149, P162; Severi S, 1997, EUR J CANCER PREV, V6, pS21, DOI 10.1097/00008469-199703001-00005; Shankar S, 2007, FRONT BIOSCI, V12, P4881, DOI 10.2741/2435; Si HW, 2012, ENDOCRINOLOGY, V153, P3190, DOI 10.1210/en.2012-1076; Squadrito F, 2002, ATHEROSCLEROSIS, V163, P339, DOI 10.1016/S0021-9150(02)00013-8; Taubert D, 2002, J CARDIOVASC PHARM, V40, P701, DOI 10.1097/00005344-200211000-00008; Unno T, 1996, BIOSCI BIOTECH BIOCH, V60, P2066; Vane J R, 1992, J Physiol Pharmacol, V43, P195; Wallerath T, 2005, NITRIC OXIDE-BIOL CH, V12, P97, DOI 10.1016/j.niox.2004.12.004; Wu L, 2012, BBA-MOL BASIS DIS, V1822, P1815, DOI 10.1016/j.bbadis.2012.08.009; Xia N, 2013, NITRIC OXIDE-BIOL CH, V32, P29, DOI 10.1016/j.niox.2013.04.001; Xiang QL, 2010, PHARMACOLOGY, V86, P117, DOI 10.1159/000315065; Xu SQ, 2011, J CARDIOVASC PHARM, V58, P263, DOI 10.1097/FJC.0b013e3182239eb7; Yamagata K, 2013, MICROVASC RES, V88, P25, DOI 10.1016/j.mvr.2013.03.006; Yamagata K, 2011, MICROVASC RES, V81, P60, DOI 10.1016/j.mvr.2010.10.005; Yamagata K, 2012, J NUTR BIOCHEM, V23, P929, DOI 10.1016/j.jnutbio.2011.04.019	117	8	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JAN	2015	31	1					28	37		10.1016/j.nut.2014.04.011		10	Nutrition & Dietetics	Nutrition & Dietetics	AX1CJ	WOS:000346685600004		
J	Sugihara, K; Yamanaka-Okumura, H; Teramoto, A; Urano, E; Katayama, T; Morine, Y; Imura, S; Utsunomiya, T; Shimada, M; Takeda, E				Sugihara, Kohei; Yamanaka-Okumura, Hisami; Teramoto, Arisa; Urano, Eri; Katayama, Takafumi; Morine, Yuji; Imura, Satoru; Utsunomiya, Tohru; Shimada, Mitsuo; Takeda, Eiji			Recovery of nutritional metabolism after liver transplantation	NUTRITION			English	Article						Liver transplantation; Non-protein respiratory quotient; Non-esterified fatty acid; Nitrogen balance; Small and frequent meals	GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; ENTERAL NUTRITION; ENERGY-METABOLISM; CIRRHOSIS; GUIDELINES; SUPPORT; PATTERN; COHORT	Objective: Perioperative nutritional assessment is critically important to reflect nutritional management because liver transplantation (LTx) often is undertaken in patients with poor nutritional status. The aim of this study was to evaluate nutritional status, including the non-protein respiratory quotient (npRQ), resting energy expenditure (REE), nitrogen balance, and blood biochemical parameters in patients before and after LTx. Methods: Fourteen patients undergoing LTx and 10 healthy controls were enrolled in this study. The npRQ and REE were measured using indirect calorimetry before LTx and at 2, 3, and 4 wk after the procedure. Blood biochemistry and nitrogen balance calculated by 24-h urine collection were performed concurrently with indirect calorimetric measurement; the results were compared between the two groups. Results: Before LTx, npRQ was significantly lower and serum non-esterified fatty acid levels were significantly higher in the patients than in the controls. Furthermore, a negative nitrogen balance was observed in the patients. These, however, improved significantly at 4 wk after LTx. REE did not significantly increase compared with the preoperative values in recipients. Blood biochemistry showed gradually increasing levels of serum cholinesterase and albumin. These failed to reach to normal levels by 4 wk post-transplant. Conclusions: The findings revealed that improvement of nutritional metabolism after LTx may require 4 wk. Additional nutritional strategies, therefore, may be needed to minimize catabolic state during the early post-transplant period. Adequate, individualized nutritional guidance before and after LTx should be performed in these patients. (C) 2015 Elsevier Inc. All rights reserved.	[Sugihara, Kohei; Yamanaka-Okumura, Hisami; Teramoto, Arisa; Urano, Eri; Takeda, Eiji] Univ Tokushima, Dept Clin Nutr, Inst Hlth Biosci, Grad Sch, Tokushima, Japan; [Katayama, Takafumi] Univ Hyogo, Coll Nursing Art & Sci, Dept Stat & Comp Sci, Kobe, Hyogo 6500044, Japan; [Morine, Yuji; Imura, Satoru; Utsunomiya, Tohru; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Digest Surg, Tokushima, Japan; [Morine, Yuji; Imura, Satoru; Utsunomiya, Tohru; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pediat Surg, Tokushima, Japan	Yamanaka-Okumura, H (reprint author), Univ Tokushima, Dept Clin Nutr, Inst Hlth Biosci, Grad Sch, Tokushima, Japan.	yamanaka@nutr.med.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [HY-O26560056, ET24300256]	This study was supported by grants from Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number HY-O26560056 and ET24300256). HY-O designed and conducted the study. AT, HY-O, EU, and KS performed the data collection. KS and TK performed the statistical analysis. YM, SI, TU, MS, and ET provided significant advice and the critical revision of the manuscript. The authors have no conflicts of interest to declare.	Ferreira LG, 2013, TRANSPLANTATION, V96, P579, DOI 10.1097/TP.0b013e31829d924e; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; PLEVAK DJ, 1994, MAYO CLIN PROC, V69, P225; Merli M, 2010, LIVER INT, V30, P208, DOI 10.1111/j.1478-3231.2009.02135.x; Merli M, 1999, HEPATOLOGY, V30, P649, DOI 10.1002/hep.510300306; Selberg O, 1997, HEPATOLOGY, V25, P652, DOI 10.1002/hep.510250327; OWEN OE, 1981, J CLIN INVEST, V68, P240, DOI 10.1172/JCI110240; Krahenbuhl L, 2003, LIVER INT, V23, P101, DOI 10.1034/j.1600-0676.2003.00805.x; Sanchez AJ, 2006, LIVER TRANSPLANT, V12, P1310, DOI 10.1002/lt.20894; SELBERG O, 1993, J CLIN INVEST, V91, P1897, DOI 10.1172/JCI116407; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Plank LD, 2001, ANN SURG, V234, P245, DOI 10.1097/00000658-200108000-00015; PETRIDES AS, 1994, HEPATOLOGY, V19, P616, DOI 10.1002/hep.1840190312; Yoshida R, 2012, J HEPATO-BIL-PAN SCI, V19, P438, DOI 10.1007/s00534-011-0459-5; Yamanaka H, 1999, NUTRITION, V15, P749, DOI 10.1016/S0899-9007(99)00149-5; HASSE JM, 1995, JPEN-PARENTER ENTER, V19, P437, DOI 10.1177/0148607195019006437; Kaido T, 2012, WORLD J SURG, V36, P1666, DOI 10.1007/s00268-012-1529-9; McCullough AJ, 1997, AM J GASTROENTEROL, V92, P734; Merli M, 2011, ESPEN J, V6, P142; MERLI M, 1990, HEPATOLOGY, V12, P106, DOI 10.1002/hep.1840120117; RIGGIO O, 1984, METABOLISM, V33, P646, DOI 10.1016/0026-0495(84)90064-7; Schneiter P, 2000, TRANSPLANTATION, V69, P978; Sugihara K, 2014, NUTRITION, V30, P443, DOI 10.1016/j.nut.2013.09.012; Suzuki K, 2012, HEPATOL RES, V42, P621, DOI 10.1111/j.1872-034X.2012.00990.x; Tajika M, 2002, NUTRITION, V18, P229, DOI 10.1016/S0899-9007(01)00754-7; Urano E, 2014, HEPATOL RES, V44, P1102, DOI 10.1111/hepr.12263; Yamanaka-Okumura H, 2013, E SPEN J, V8, P90	28	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JAN	2015	31	1					105	110		10.1016/j.nut.2014.05.016		6	Nutrition & Dietetics	Nutrition & Dietetics	AX1CJ	WOS:000346685600015		
J	Miyake, Y; Tanaka, K; Okubo, H; Sasaki, S; Arakawa, M				Miyake, Yoshihiro; Tanaka, Keiko; Okubo, Hitomi; Sasaki, Satoshi; Arakawa, Masashi			Dietary vitamin D intake and prevalence of depressive symptoms during pregnancy in Japan	NUTRITION			English	Article						Depressive symptoms; Intake; Japanese; Pregnancy; Vitamin D	25-HYDROXYVITAMIN D; PARATHYROID-HORMONE; BRAIN-DEVELOPMENT; D SUPPLEMENTATION; HEALTH; POPULATION; TRIAL; ASSOCIATIONS; ADULTS	Objective: Although the relationship between vitamin D levels and depressive symptoms has been explored, the results are inconsistent. Epidemiologic evidence concerning the relationship between dietary vitamin D intake and depressive symptoms in pregnancy is nonexistent. The aim of this current cross-sectional study was to examine this issue in Japan. Methods: The study included 1745 pregnant women. Depressive symptoms were defined as present when women had a Center for Epidemiologic Studies Depression Scale score of 16 or higher. Dietary intake during the preceding month was assessed using a self-administered diet history questionnaire. Adjustment was made for age, gestation, region of residence, number of children, family structure, history of depression, family history of depression, smoking, secondhand smoke exposure at home and at work, job type, household income, education, body mass index, intake of saturated fatty acids, and intake of eicosapentaenoic acid plus docosahexaenoic acid. Results: The prevalence of depressive symptoms during pregnancy was 19.3%. Higher dietary vitamin D intake was significantly associated with a lower prevalence of depressive symptoms during pregnancy, independent of potential dietary and nondietary confounding factors. Multivariate odds ratios (95% confidence intervals) for depressive symptoms during pregnancy in the first, second, third, and fourth quartiles of assessed intake of vitamin D were 1 (reference), 0.79 (0.55-1.11), 0.73 (0.49-1.07), and 0.52 (0.30-0.89), respectively (P for trend = 0.02). Conclusion: The current cross-sectional study in Japan suggests that higher vitamin D intake may be associated with a lower prevalence of depressive symptoms during pregnancy. (C) 2015 Elsevier Inc. All rights reserved.	[Miyake, Yoshihiro] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 790, Japan; [Tanaka, Keiko] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka 81401, Japan; [Okubo, Hitomi] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan; [Sasaki, Satoshi] Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Arakawa, Masashi] Univ Ryukyus, Grad Sch Tourism Sci, Hlth Tourism Res Ctr, Okinawa, Japan	Miyake, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 790, Japan.	miyake.yoshihiro.ls@ehime-u.ac.jp			JSPS KAKENHI [19590606, 20791654, 21590673, 22592355, 22119507, 24390158, 25463275, 25670305]; Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour and Welfare, Japan; Meiji Co. Ltd.; Food Science Institute Foundation	This research was supported by JSPS KAKENHI Grant Numbers 19590606, 20791654, 21590673, 22592355,22119507, 24390158, 25463275, and 25670305, by Health and Labour Sciences Research Grants for Research on Allergic Disease and Immunology and Health Research on Children, Youth and Families from the Ministry of Health, Labour and Welfare, Japan, by Meiji Co. Ltd., and by the Food Science Institute Foundation. YM, KT, and MA contributed to the study concept and design and the acquisition of data. HO and SS were responsible for the estimation of dietary factors. YM was responsible for the analysis and interpretation of data and the drafting of the manuscript.	Nagase Y, 2009, PSYCHIAT RES, V168, P57, DOI 10.1016/j.psychres.2008.03.024; Raedler TJ, 2011, CURR OPIN PSYCHIATR, V24, P519, DOI 10.1097/YCO.0b013e32834b9db6; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Sanders KM, 2011, BRIT J PSYCHIAT, V198, P357, DOI 10.1192/bjp.bp.110.087544; Nanri A, 2009, EUR J CLIN NUTR, V63, P1444, DOI 10.1038/ejcn.2009.96; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; May HT, 2010, AM HEART J, V159, P1037, DOI 10.1016/j.ahj.2010.03.017; Fulkerson JA, 2004, PREV MED, V38, P865, DOI 10.1016/j.ypmed.2003.12.028; Zhao GX, 2010, BRIT J NUTR, V104, P1696, DOI 10.1017/S0007114510002588; Kesby JP, 2011, MOL CELL ENDOCRINOL, V347, P121, DOI 10.1016/j.mce.2011.05.014; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17; Humble MB, 2010, J PHOTOCH PHOTOBIO B, V101, P142, DOI 10.1016/j.jphotobiol.2010.08.003; Bertone-Johnson ER, 2012, AM J EPIDEMIOL, V176, P1, DOI 10.1093/aje/kwr482; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Brouwer-Brolsma EM, 2013, EUR J NUTR, V52, P917, DOI 10.1007/s00394-012-0399-0; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Chan R, 2011, J AFFECT DISORDERS, V130, P251, DOI 10.1016/j.jad.2010.10.029; Brandenbarg J, 2012, PSYCHOSOM MED, V74, P751, DOI 10.1097/PSY.0b013e3182639fdb; Pan A, 2009, J AFFECT DISORDERS, V118, P240, DOI 10.1016/j.jad.2009.02.002; Bertone-Johnson ER, 2011, AM J CLIN NUTR, V94, P1104, DOI 10.3945/ajcn.111.017384; Cassidy-Bushrow AE, 2012, J WOMENS HEALTH, V21, P1189, DOI 10.1089/jwh.2012.3528; Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966; Holick Michael F, 2012, Dermatoendocrinol, V4, P183, DOI 10.4161/derm.20015; Miyake Y, 2013, J PSYCHIATR RES, V47, P572, DOI 10.1016/j.jpsychires.2013.01.012; Murphy Pamela K, 2010, J Am Psychiatr Nurses Assoc, V16, P170, DOI 10.1177/1078390310370476; Nakamura K, 2006, J BONE MINER METAB, V24, P1, DOI 10.1007/s00774-005-0637-0; Pompili M, 2012, J AFFECT DISORDERS, V136, P405, DOI 10.1016/j.jad.2011.11.011; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sasaki S, 1998, J Epidemiol, V8, P203; Shima S, 1985, JPN J CLIN PSYCHIAT, V27, P717; Statistics Bureau Ministry of Public Management Home Affairs Posts and Telecommunications, 2002, 2000 POP CENS JAP, V3-2-40; Tavera LE, 2007, SCI AM, V297, P62; Tavera-Mendoza LE, 2007, SCI AM, P68; Tavera-Mendoza LE, 2007, SCI AM, V297, P72	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JAN	2015	31	1					160	165		10.1016/j.nut.2014.06.013		6	Nutrition & Dietetics	Nutrition & Dietetics	AX1CJ	WOS:000346685600023		
J	Hanai, T; Shiraki, M; Nishimura, K; Ohnishi, S; Imai, K; Suetsugu, A; Takai, K; Shimizu, M; Moriwaki, H				Hanai, Tatsunori; Shiraki, Makoto; Nishimura, Kayoko; Ohnishi, Sachiyo; Imai, Kenji; Suetsugu, Atsushi; Takai, Koji; Shimizu, Masahito; Moriwaki, Hisataka			Sarcopenia impairs prognosis of patients with liver cirrhosis	NUTRITION			English	Article						Liver cirrhosis; Sarcopenia; Branched-chain amino acids; Protein-energy malnutrition; Skeletal muscle index; Survival	CHAIN AMINO-ACIDS; SKELETAL-MUSCLE; NUTRITIONAL MANAGEMENT; BODY-COMPOSITION; MALNUTRITION; DISEASE; METABOLISM; SURVIVAL; PREVALENCE; STRENGTH	Objective: Sarcopenia is characterized by the loss of skeletal muscle mass, and is reported to appear in patients with liver cirrhosis (LC). The aim of this study was to investigate the prevalence of sarcopenia in patients with LC, and to test the association between sarcopenia and patient outcomes. We also analyzed the effect of branched-chain amino acid (BCAA) supplementation on sarcopenic LC. Methods: Clinical and blood biochemical data of 130 patients with LC who underwent abdominal computed tomography scan were analyzed in this retrospective study. The cross-sectional area of skeletal muscles was measured at the level of the third lumbar vertebra on the scan. The skeletal muscle index was calculated to identify sarcopenia. Cirrhotic patients who were treated with BCAA supplementation of 12 g/d for >= 1 y were defined as the BCAA group, and the effect of BCAA on sarcopenic LC was evaluated. Results: Sixty-eight percent of all patients (82% of men and 50% of women) were diagnosed with sarcopenia. Male sex (P = 0.01) and body mass index (P < 0.0001) were predictors of sarcopenia. The multivariate Cox proportional hazards model found BCAA supplementation (hazard ratio [HR], 0.38; P = 0.01), sarcopenia (HR, 3.03; P < 0.01), and Child-Pugh classes B (HR, 2.39; P = 0.03) and C (HR, 5.49; P < 0.001) to be independently associated with mortality. The mortality of sarcopenic LC was significantly higher than that of non-sarcopenic LC (P = 0.01). Moreover, BCAA supplementation improved the survival of sarcopenic patients in subgroup analysis (P < 0.01). Conclusions: Sarcopenia is significantly associated with mortality in patients with LC. BCAA supplementation might be associated with improved survival of such patients. (C) 2015 Elsevier Inc. All rights reserved.	[Hanai, Tatsunori; Shiraki, Makoto; Ohnishi, Sachiyo; Imai, Kenji; Suetsugu, Atsushi; Takai, Koji; Shimizu, Masahito; Moriwaki, Hisataka] Gifu Univ, Sch Med, Dept Internal Med 1, Yanagi, Gifu, Japan; [Nishimura, Kayoko] Gifu Univ Hosp, Ctr Nutr Support & Infect Control, Yanagi, Gifu, Japan	Shiraki, M (reprint author), Gifu Univ, Sch Med, Dept Internal Med 1, Yanagi, Gifu, Japan.	Mshiraki-gif@umin.ac.jp			Ministry of Health, Labor, and Welfare of Japan	This work was supported in part by the Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan. TH, M Shiraki, M Shimizu, and HM were involved in the conception and design of the study. Generation, collection, assembly, analysis, and/or interpretation of data was handled by TH, M Shiraki, KN, SO, KI, AS, and KT. Drafting or revision of the manuscript was the responsibility of TH, M Shiraki, M Shimizu, and HM. All the authors read and approved the final version of the manuscript. The authors have no conflicts of interest to declare.	Periyalwar P, 2012, CLIN LIVER DIS, V16, P95, DOI 10.1016/j.cld.2011.12.009; Merli M, 1996, HEPATOLOGY, V23, P1041; Manders RJ, 2012, NUTRIENTS, V4, P1664, DOI 10.3390/nu4111664; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Tessari P, 2003, CURR OPIN CLIN NUTR, V6, P79, DOI 10.1097/01.mco.0000049044.06038.30; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168; Nicastro H, 2011, AMINO ACIDS, V40, P287, DOI 10.1007/s00726-010-0636-x; Alberino F, 2001, NUTRITION, V17, P445, DOI 10.1016/S0899-9007(01)00521-4; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Riggio O, 2003, CLIN NUTR, V22, P553, DOI 10.1016/S0261-5614(03)00058-X; OWEN OE, 1983, J CLIN INVEST, V72, P1821, DOI 10.1172/JCI111142; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115; Cheung K, 2012, CLIN GASTROENTEROL H, V10, P117, DOI 10.1016/j.cgh.2011.08.016; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Dasarathy S, 2012, J CACHEXIA SARCOPENI, V3, P225, DOI 10.1007/s13539-012-0069-3; Amodio P, 2013, HEPATOLOGY, V58, P325, DOI 10.1002/hep.26370; Peng S, 2007, AM J CLIN NUTR, V85, P1257; Marchesini G, 2003, GASTROENTEROLOGY, V124, P1792, DOI 10.1016/S0016-5085(03)00323-8; Tsien CD, 2012, J GASTROEN HEPATOL, V27, P430, DOI 10.1111/j.1440-1746.2011.06951.x; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Moriwaki H, 2008, HEPATOL RES, V38, pS102, DOI 10.1111/j.1872-034X.2008.00434.x; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Alvares-da-Silva MR, 2005, NUTRITION, V21, P113, DOI 10.1016/j.nut.2004.02.002; O'Brien A, 2008, GASTROENTEROLOGY, V134, P1729, DOI 10.1053/j.gastro.2008.02.001; Moriwaki H, 2004, BIOCHEM BIOPH RES CO, V313, P405, DOI 10.1016/j.bbrc.2003.07.016; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1053/S1542-3565(05)00017-0; Charlton M, 2003, GASTROENTEROLOGY, V124, P1980, DOI 10.1016/S0016-5085(03)00550-X; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI [10.1016/S1470-2045(08)70153-0, 10.1016/51470-2045(08)70153-0]; Kato M, 1998, INTERNAL MED, V37, P429, DOI 10.2169/internalmedicine.37.429; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Nakaya Y, 2007, NUTRITION, V23, P113, DOI 10.1016/j.nut.2006.10.008; Suzuki K, 2012, HEPATOL RES, V42, P621, DOI 10.1111/j.1872-034X.2012.00990.x; Tajika M, 2002, NUTRITION, V18, P229, DOI 10.1016/S0899-9007(01)00754-7	39	8	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JAN	2015	31	1					193	199		10.1016/j.nut.2014.07.005		7	Nutrition & Dietetics	Nutrition & Dietetics	AX1CJ	WOS:000346685600029		
J	Yamada, T; Hara, K; Svensson, AK; Shojima, N; Hosoe, J; Iwasaki, M; Yamauchi, T; Kadowaki, T				Yamada, Tomohide; Hara, Kazuo; Svensson, Akiko Kishi; Shojima, Nobuhiro; Hosoe, Jun; Iwasaki, Minaka; Yamauchi, Toshimasa; Kadowaki, Takashi			Successfully Achieving Target Weight Loss Influences Subsequent Maintenance of Lower Weight and Dropout From Treatment	OBESITY			English	Article							OBESITY; ADULTS; PREVENTION; STRATEGIES; PROGRAM; TRIALS; GAIN	ObjectivesThe influence of the amount and rate of weight loss on subsequently regaining weight and dropout from treatment in severely obese patients targeting 5% weight loss was investigated. MethodsA total of 120 consecutive hospital patients with severe obesity (BMI: 429 kg/m(2)) participated in an inpatient program targeting 5% weight loss that involved goal setting, charting weight four times daily, and diet and exercise. They were followed after discharge to assess subsequent regaining of weight and dropout. ResultsMean weight loss was 4.9 +/- 2.4% after a mean of 19 days in the hospital, and 43% of the patients achieved the target weight loss (>5%). Over the median 2-year follow-up period, greater than 5% in-hospital weight loss was associated with a significantly lower risk of regaining weight after adjustment for various factors (>5% to 7% loss: hazard ratio 0.30 [0.11-0.85] for regaining all of the lost weight and 0.32 [0.13-0.78] for regaining half of the lost weight). No significant relation between the amount or rate of weight loss and dropout from subsequent outpatient treatment was seen. ConclusionsSuccessfully achieving the target weight loss in a comprehensive program predicts subsequent maintenance of lower weight without increasing the risk of dropout. Successful in-hospital weight loss might increase the motivation of obese patients.	[Yamada, Tomohide; Hara, Kazuo; Svensson, Akiko Kishi; Shojima, Nobuhiro; Hosoe, Jun; Iwasaki, Minaka; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138654, Japan	Hara, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138654, Japan.	haratky@gmail.com					American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; American Diabetes Association, 2013, DIABETES CARE S1, V36, pS67, DOI DOI 10.2337/DC13-S067; Nackers LM, 2010, INT J BEHAV MED, V17, P161, DOI 10.1007/s12529-010-9092-y; Russell-Jones D, 2007, DIABETES OBES METAB, V9, P799, DOI 10.1111/j.1463-1326.2006.00686.x; [Anonymous], 2000, WHO TECH REP SER, V894, p[i, 1]; Hemmingsson E, 2012, AM J CLIN NUTR, V96, P953, DOI 10.3945/ajcn.112.038265; Linde JA, 2005, ANN BEHAV MED, V30, P210, DOI 10.1207/s15324796abm3003_5; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dombrowski SU, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2646; FUJIMOTO K, 1992, AM J MED SCI, V303, P145, DOI 10.1097/00000441-199203000-00002; Iizuka Y, 2011, J DIABETES, V3, P104, DOI 10.1111/j.1753-0407.2011.00117.x; Jensen M.D., 2014, OBESITY, V22, pS1, DOI DOI 10.1002/OBY.20821; KANFER FH, 1972, BEHAV THER, V3, P398, DOI 10.1016/S0005-7894(72)80140-0; OECD, 2014, OECD HLTH S IN PRESS; Price DW, 2013, DIABETES CARE, V36, P216, DOI 10.2337/dc12-0293; Raynor HA, 2008, DIABETES CARE, V31, P1299, DOI 10.2337/dc07-2295; Sasaki A, 2014, J GASTROENTEROL, V49, P57, DOI 10.1007/s00535-013-0802-5; The Japan Diabetes Society, 2002, FOOD EXCH LISTS DIET; Turner RC, 1998, LANCET, V352, P837; Yamada T, 2014, DIABETES VASC DIS RE, V11, P118, DOI 10.1177/1479164113508141	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	JAN	2015	23	1					183	191		10.1002/oby.20874		9	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	AX2JS	WOS:000346770100030		
J	Ohzawa, H; Miki, A; Hozumi, Y; Miyazaki, C; Sagara, Y; Tanaka, Y; Shiba, S; Joutoku, H; Sakuragi, M; Takehara, M; Sakuma, Y; Nishimura, W; Fujii, H; Yasuda, Y				Ohzawa, Hideyuki; Miki, Atsushi; Hozumi, Yasuo; Miyazaki, Chieko; Sagara, Yuka; Tanaka, Yumiko; Shiba, Satomi; Joutoku, Hiromi; Sakuragi, Masako; Takehara, Megumi; Sakuma, Yasunaru; Nishimura, Wataru; Fujii, Hirofumi; Yasuda, Yoshikazu			Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline-based regimens	ONCOLOGY LETTERS			English	Article						palonosetron; granisetron; antiemetic therapy	CHEMOTHERAPY-INDUCED NAUSEA; ONCOLOGY-GROUP; VOMITING CINV	Chemotherapy-induced nausea and vomiting is a serious adverse side-effect of anthracycline-based chemotherapy regimens, in patients with breast cancer. A combination of three drugs, 5-hydroxytryptamine (5-HT3) receptor antagonist, aprepitant and dexamethasone, is recommended for antiemetic therapy. Palonosetron (PALO), a novel 5-HT3 receptor antagonist has been identified to be effective against delayed nausea and vomiting. In this study, the results of PALO for patients who received anthracycline-based chemotherapy were compared with that of granisetron (GRA) using a crossover study design. This study evaluated the efficacy of antiemetics in the first cycle of chemotherapy, as well as the second and third cycles. A total of 21 patients and 19 patients were assigned to PALO and GRA treatment groups during the first cycle of chemotherapy, respectively. The patients switched to the other antiemetic drug for the second chemotherapy cycle (PALO followed by GRA or GRA followed by PALO). The patients could select PALO or GRA antiemetics for the third cycle, according to their preference. A total of 21 patients selected PALO and 18 patients selected GRA in the third cycle, and one patient was withdrawn from the study as their third cycle questionnaire was not obtained. No significant differences between PALO and GRA were identified in first and second cycles. However, during the third cycle, a significant difference was observed in acute-phase complete control of emetic events between the PALO and GRA groups, which was defined as no emetic episode, no additional antiemetic treatment and no more than mild nausea, between PALO and GRA. These results demonstrated that changing antiemetics may affect the efficacy of antiemetics. This study indicates that alteration of antiemetic regimens, including drug combination and order, may improve the efficacy of antiemetic treatment.	[Ohzawa, Hideyuki; Hozumi, Yasuo; Miyazaki, Chieko; Sagara, Yuka; Tanaka, Yumiko; Shiba, Satomi; Joutoku, Hiromi; Sakuragi, Masako; Takehara, Megumi] Jichi Med Univ, Dept Breast Surg, Shimotsuke, Tochigi 3290498, Japan; [Miki, Atsushi; Sakuma, Yasunaru; Yasuda, Yoshikazu] Jichi Med Univ, Dept Gastrointestinal Surg, Shimotsuke, Tochigi 3290498, Japan; [Nishimura, Wataru] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Fujii, Hirofumi] Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Tochigi 3290498, Japan	Hozumi, Y (reprint author), Jichi Med Univ, Dept Breast Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	y-hozumi@jichi.ac.jp		Nishimura, Wataru/0000-0002-8068-1277			Rojas C, 2010, EUR J PHARMACOL, V626, P193, DOI 10.1016/j.ejphar.2009.10.002; Schwartzberg L, 2014, SUPPORT CARE CANCER, V22, P469, DOI 10.1007/s00520-013-1999-9; SULLIVAN JR, 1983, NEW ENGL J MED, V309, P796; Cohen L, 2007, SUPPORT CARE CANCER, V15, P497, DOI 10.1007/s00520-006-0173-z; TONATO M, 1991, ANN ONCOL, V2, P107; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P456; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Botrel TEA, 2011, SUPPORT CARE CANCER, V19, P823, DOI 10.1007/s00520-010-0908-8; Rojas C, 2010, J PHARMACOL EXP THER, V335, P362, DOI 10.1124/jpet.110.166181; Basch Ethan, 2011, J Oncol Pract, V7, P395, DOI 10.1200/JOP.2011.000397; Hesketh PJ, 2008, NEW ENGL J MED, V358, P2482, DOI 10.1056/NEJMra0706547; Hothersall JD, 2013, BRIT J PHARMACOL, V169, P1252, DOI 10.1111/bph.12204; Langford Patrick, 2010, Core Evid, V5, P77; ROILA F, 1987, J CLIN ONCOL, V5, P141	15	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					119	124		10.3892/ol.2014.2640		6	Oncology	Oncology	AX0JH	WOS:000346638300020		
J	Ito, K; Seguchi, K; Shimazaki, H; Takahashi, E; Tasaki, S; Kuroda, K; Sato, A; Asakuma, J; Horiguchi, A; Asano, T				Ito, Keiichi; Seguchi, Kenji; Shimazaki, Hideyuki; Takahashi, Eiji; Tasaki, Shinsuke; Kuroda, Kenji; Sato, Akinori; Asakuma, Junichi; Horiguchi, Akio; Asano, Tomohiko			Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma	ONCOLOGY LETTERS			English	Article						renal cell carcinoma; pathological T1a; recurrence; predictor; tumor necrosis	PROGNOSIS; IMPACT; METASTASIS; SIZE	Patients with pT1aN0M0 renal cell carcinoma (RCC) generally have good prognosis, and recurrence is rare. However, metastasis develops postoperatively in a small number of patients with pT1aN0M0 RCC. The present study was undertaken to identify predictors for recurrence in patients with pT1aN0M0 RCC. We reviewed the clinicopathological factors of 133 patients with pT1aN0M0 RCC who underwent radical or partial nephrectomy at the Department of Urology, National Defense Medical College (Saitama, Japan). Clinicopathological factors, including age, gender, tumor size, histological subtype, tumor grade, microvascular invasion, histological tumor necrosis, C-reactive protein levels and performance status were reviewed. These factors were compared between patients with and without postoperative recurrence. Recurrence-free survival (RFS) and cause-specific survival (CSS) rates were calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed to determine independent factors predicting recurrence in patients with pT1aN0M0 RCC. The 5-year RFS and CSS rates were 97.2 and 99.1%, respectively. When clinicopathological factors were compared between patients with and without recurrence, tumor size (P=0.0390) and percentage of tumor necrosis (P<0.0001) were significantly different between groups. All patients with recurrence had primary lesions 3 cm. By univariate analysis, tumor size (P=0.0379) and the presence of tumor necrosis (P=0.0319) were significant predictors for recurrence; tumor necrosis was also an independent predictor for recurrence (P=0.0143). In patients with pT1b tumors 5 cm (recurrence rate, 16.8%; n=48), the percentage of tumor necrosis was significantly higher in patients with recurrence compared with those without (P=0.0261). This suggests that tumor necrosis may be an important predictor for recurrence in small RCCs. Although recurrence is rare in pT1a RCC, the presence of tumor necrosis may be an important predictor for recurrence. Particularly, patients presenting with pT1a RCC with histological tumor necrosis should undergo careful follow-up.	[Ito, Keiichi; Seguchi, Kenji; Takahashi, Eiji; Tasaki, Shinsuke; Kuroda, Kenji; Sato, Akinori; Asakuma, Junichi; Horiguchi, Akio; Asano, Tomohiko] Natl Def Med Coll, Dept Urol, Tokorozawa, Saitama 3598513, Japan; [Shimazaki, Hideyuki] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 3598513, Japan	Ito, K (reprint author), Natl Def Med Coll, Dept Urol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	itok@ndmc.ac.jp					Ito K, 2006, INT J UROL, V13, P1365, DOI 10.1111/j.1442-2042.2006.01563.x; Sengupta S, 2005, CANCER, V104, P511, DOI 10.1002/cncr.21206; Hafez KS, 1997, J UROLOGY, V157, P2067, DOI 10.1016/S0022-5347(01)64675-5; Zisman A, 2001, J CLIN ONCOL, V19, P1649; Kume H, 2010, J UROLOGY, V184, P64, DOI 10.1016/j.juro.2010.03.019; Siddiqui SA, 2009, BJU INT, V104, P778, DOI 10.1111/j.1464-410X.2009.08499.x; Goncalves PD, 2004, J UROLOGY, V172, P470, DOI 10.1097/01.ju.0000130582.31467.30; Ito K, 2011, J UROLOGY, V186, P430, DOI 10.1016/j.juro.2011.03.113; Takayama T, 2011, J CANCER RES CLIN, V137, P1653, DOI 10.1007/s00432-011-1040-y; Antonelli A, 2006, BJU INT, V97, P505, DOI 10.1111/j.1464-410X.2006.05934.x; Greene FL, 2002, AJCC CANC STAGING MA, P323; Ito K, 2009, JPN J CLIN ONCOL, V39, P588, DOI 10.1093/jjco/hyp068; Kim Jong Min, 2010, Korean J Urol, V51, P233, DOI 10.4111/kju.2010.51.4.233; Kitagawa Y, 2011, JPN J CLIN ONCOL, V41, P637, DOI 10.1093/jjco/hyr007; Klatte T, 2008, J UROLOGY, V179, P1719, DOI 10.1016/j.juro.2008.01.018; National Cancer Institute, COMM TOX CRIT VERS 2; Nishikimi T, 2011, PATHOL INT, V61, P116, DOI 10.1111/j.1440-1827.2010.02633.x	17	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					125	130		10.3892/ol.2014.2670		6	Oncology	Oncology	AX0JH	WOS:000346638300021		
J	Maeda, E; Oryu, M; Tani, J; Miyoshi, H; Morishita, A; Yoneyama, H; Kobara, H; Mori, H; Masaki, T				Maeda, Emiko; Oryu, Makoto; Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Kobara, Hideki; Mori, Hirohito; Masaki, Tsutomu			Characteristic waffle-like appearance of gastric linitis plastica: A case report	ONCOLOGY LETTERS			English	Article						linitis plastica; scirrhous gastric cancer; diffuse type cancers; signet ring cell adenocarcinoma; waffle-like appearance	ENDOSCOPIC DIAGNOSIS; SCIRRHOUS CARCINOMA; BLOC BIOPSY; CANCER; CYTOLOGY; STOMACH; DIFFUSE; TUMOR	Linitis plastica is a gastric cancer of diffuse histotype that presents in the fundic gland area, and is characterized by thickening of the stomach wall and deformation of the stomach, resulting in a leather bottle-like appearance. A 66-year-old female was admitted to Kagawa University Hospital (Kagawa, Japan) with epigastric pain. X-ray examination revealed reduced gastric distension and deformation of the stomach, which exhibited a leather bottle-like appearance. Endoscopy indicated a depressed lesion in the gastric antrum, and abnormal folds, which crossed to form a waffle-like appearance in the upper gastric body. Analysis of biopsy specimens from the depressed lesion revealed a poorly differentiated adenocarcinoma. Morphological changes in the gastric folds indicated that the tumor had invaded the upper gastric body, therefore, a total gastrectomy was performed. Subsequent pathological findings demonstrated that the tumor had spread from the primary lesion to the upper gastric body. Therefore, the present report recommends that the diagnosis of the spread of linitis plastica-type gastric cancer should include assessments of the primary lesion, as well as evaluation of morphological changes in the gastric folds.	[Maeda, Emiko; Oryu, Makoto; Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Kobara, Hideki; Mori, Hirohito; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Miki, Kagawa 7610793, Japan	Masaki, T (reprint author), Kagawa Univ, Fac Med, Grad Sch Med, Dept Gastroenterol & Neurol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	tmasaki@med.kagawa-u.ac.jp					LEVINE MS, 1990, RADIOLOGY, V175, P151; Pedrazzani C, 2012, GASTRIC CANCER, V15, P56, DOI 10.1007/s10120-011-0063-z; Park MS, 2004, RADIOLOGY, V231, P421, DOI 10.1148/radiol.2312030248; ANFORAKER SH, 1981, ACTA CYTOL, V25, P361; Otsuji E, 2004, AM J SURG, V188, P327, DOI 10.1016/j.amjsurg.2004.06.010; Kodera Y, 2004, JPN J CLIN ONCOL, V34, P525, DOI 10.1093/jjco/hyh097; Kodera Y, 2001, J SURG ONCOL, V78, P175, DOI 10.1002/jso.1144; Kobara H, 2012, ENDOSCOPY, V44, pE197, DOI 10.1055/s-0031-1291821; WINAWER SJ, 1975, GASTROENTEROLOGY, V69, P1183; Kobara H, 2013, GASTROINTEST ENDOSC, V77, P141, DOI 10.1016/j.gie.2012.08.008; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; EVANS E, 1985, AUST NZ J SURG, V55, P541, DOI 10.1111/j.1445-2197.1985.tb00941.x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kobara H, 2014, ONCOL LETT, V8, P161, DOI 10.3892/ol.2014.2126; LLANOS O, 1982, ANN SURG, V195, P224, DOI 10.1097/00000658-198202000-00018; Maruyama Y, 2010, STOMACH INTESTINE, V45, P445; Murata Y, 2010, STOMACH INTESTINE, V45, P457; QIZILBASH AH, 1980, ACTA CYTOL, V24, P313; Whitehead R., 1995, P823; Yamamoto T, 2010, STOMACH INTESTINE TO, V45, P428	20	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					262	264		10.3892/ol.2014.2688		3	Oncology	Oncology	AX0JH	WOS:000346638300047		
J	Satoh, N; Yokoyama, C; Itamura, N; Miyajima-Nakano, Y; Hisatomi, H				Satoh, Nana; Yokoyama, Chikako; Itamura, Noriaki; Miyajima-Nakano, Yoshiharu; Hisatomi, Hisashi			Alternative splicing isoform in succinate dehydrogenase complex, subunit C causes downregulation of succinate-coenzyme Q oxidoreductase activity in mitochondria	ONCOLOGY LETTERS			English	Article						succinate dehydrogenase complex; subunit C; alternative splicing; dominant-negative inhibitor	FUMARATE REDUCTASE; SDHC MUTATION; BINDING-SITES; CELL-DEATH; PARAGANGLIOMA; GENE; GROWTH; PHEOCHROMOCYTOMA; MECHANISM; APOPTOSIS	Mitochondrial succinate dehydrogenase (SDH) is localized to the inner mitochondrial membrane and is responsible for the redox of succinic acid. SDH is a tetrameric iron-sulfur flavoprotein of the tricarboxylic acid cycle and respiratory chain. The SDH complex, subunit C (SDHC) transcript has deletion-type alternative splicing sites. Generally, alternative splicing produces variant proteins and expression patterns, as products of different genes. In certain cases, specific alternative splicing variants (ASVs) have been associated with human disease. Due to a frameshift mutation causing loss of the heme binding region, the SDHC 5 isoform (lacking exon 5) exhibits no SDHC activity. To investigate whether the SDHC splicing variants can function as dominant-negative inhibitors, SDHC ASVs were overexpressed in HCT-15 human colorectal cancer cells. Using real-time reverse transcription-polymerase chain reaction, a dominant-negative effect of the 5 isoform on SDHC mRNA was shown. In addition, 5 overexpression increased the levels of reactive oxygen species. Furthermore, in the 5 isoform-overexpressing cells, SDH activity was reduced. SDHC activation is a significant event during the electron transport chain, and the function of the SDHC 5 variant may be significant for the differentiation of tumor cells.	[Satoh, Nana; Yokoyama, Chikako; Itamura, Noriaki; Miyajima-Nakano, Yoshiharu; Hisatomi, Hisashi] Seikei Univ, Dept Mat & Life Sci, Lab Cellular & Mol Biochem, Musashino, Tokyo 1808633, Japan	Hisatomi, H (reprint author), Seikei Univ, Dept Mat & Life Sci, Lab Cellular & Mol Biochem, 3-3-1 Kichijoji Kita Machi, Musashino, Tokyo 1808633, Japan.	hisatomi@st.seikei.ac.jp					Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; van Nederveen FH, 2009, LANCET ONCOL, V10, P764, DOI 10.1016/S1470-2045(09)70164-0; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Lopez-Jimenez E, 2008, CLIN ENDOCRINOL, V69, P906, DOI 10.1111/j.1365-2265.2008.03368.x; Ishii T, 2011, MITOCHONDRION, V11, P155, DOI 10.1016/j.mito.2010.09.006; Schiavi F, 2005, JAMA-J AM MED ASSOC, V294, P2057, DOI 10.1001/jama.294.16.2057; Niemann S, 2000, NAT GENET, V26, P268; Pasini B, 2009, J INTERN MED, V266, P19, DOI 10.1111/j.1365-2796.2009.02111.x; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P747, DOI 10.1016/j.bbabio.2010.01.019; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Zaunmuller T, 2006, MICROBIOL-SGM, V152, P2443, DOI 10.1099/mic.0.28849-0; Peczkowska M, 2008, NAT CLIN PRACT ENDOC, V4, P111, DOI 10.1038/ncpendmet0726; Pantaleo MA, 2014, EUR J HUM GENET, V22, P32, DOI 10.1038/ejhg.2013.80; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Aratake K, 2005, J LAB CLIN MED, V146, P184, DOI 10.1016/j.lab.2005.05.004; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Hirawake H, 1997, CYTOGENET CELL GENET, V79, P132, DOI 10.1159/000134700; Ishii N, 2007, CORNEA, V26, pS3, DOI 10.1097/ICO.0b013e31812f6745; Miyazawa M, 2008, BIOSCI TRENDS, V2, P22; StallingsMann ML, 1996, P NATL ACAD SCI USA, V93, P12394, DOI 10.1073/pnas.93.22.12394; Yankovskaya V, 1996, J BIOL CHEM, V271, P21020	25	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					330	334		10.3892/ol.2014.2699		5	Oncology	Oncology	AX0JH	WOS:000346638300063		
J	Sakai, K; Takeda, M; Okamoto, I; Nakagawa, K; Nishio, K				Sakai, Kazuko; Takeda, Masayuki; Okamoto, Isamu; Nakagawa, Kazuhiko; Nishio, Kazuto			Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoter	ONCOLOGY LETTERS			English	Article						hepatocyte growth factor; poly(dA); deletion; methylation; cancer	LUNG-CANCER; FUNCTIONAL POLYMORPHISM; TYROSINE KINASE; FACTOR RECEPTOR; BREAST-CANCER; LINES; ESTABLISHMENT; CARCINOMA; SUSCEPTIBILITY; AMPLIFICATION	Hepatocyte growth factor (HGF) expression is a poor prognostic factor in various types of cancer. Expression levels of HGF have been reported to be regulated by shorter poly(dA) sequences in the promoter region. In the present study, the poly(dA) mononucleotide tract in various types of human cancer cell lines was examined and compared with the HGF expression levels in those cells. Short deoxyadenosine repeat sequences were detected in five of the 55 cell lines used in the present study. The H69, IM95, CCK-81, Sui73 and H28 cells exhibited a truncated poly(dA) sequence in which the number of poly(dA) repeats was reduced by 5 bp. Two of the cell lines exhibited high HGF expression, determined by reverse transcription quantitative polymerase chain reaction and enzyme-linked immunosorbent assay. The CCK-81, Sui73 and H28 cells with shorter poly(dA) sequences exhibited low HGF expression. The cause of the suppression of HGF expression in the CCK-81, Sui73 and H28 cells was clarified by two approaches, suppression by methylation and single nucleotide polymorphisms in the HGF gene. Exposure to 5-Aza-dC, an inhibitor of DNA methyltransferase 1, induced an increased expression of HGF in the CCK-81 cells, but not in the other cells. Single-nucleotide polymorphism (SNP) rs72525097 in intron 1 was detected in the Sui73 and H28 cells. Taken together, it was found that the defect of poly(dA) in the HGF promoter was present in various types of cancer, including lung, stomach, colorectal, pancreas and mesothelioma. The present study proposes the negative regulation mechanisms by methylation and SNP in intron 1 of HGF for HGF expression in cancer cells with short poly(dA).	[Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka 5898511, Japan; [Takeda, Masayuki; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka 5898511, Japan; [Okamoto, Isamu] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka, Kyushu 8128581, Japan	Nishio, K (reprint author), Kinki Univ, Fac Med, Dept Genome Biol, 377-2 Ohnohigashi, Osaka 5898511, Japan.	knishio@med.kindai.ac.jp			Third-Term Comprehensive 10-Year Strategy for Cancer Control;  [20-9];  [23701106]	The present study was supported by the Third-Term Comprehensive 10-Year Strategy for Cancer Control and funds for Health and Labor Scientific Research Grants (20-9), and a Grant-in-Aid for Scientific Research (B) (23701106).	Ogunwobi OO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063765; Ma JH, 2009, J CLIN INVEST, V119, P478, DOI 10.1172/JCI36640; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Toi M, 1998, CLIN CANCER RES, V4, P659; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Schoenleber SJ, 2009, BRIT J CANCER, V100, P1385, DOI 10.1038/sj.bjc.6605017; Seidel C, 1998, BLOOD, V91, P806; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Takezawa K, 2009, CANCER RES, V69, P6515, DOI 10.1158/0008-5472.CAN-09-1076; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; NALDINI L, 1991, ONCOGENE, V6, P501; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Kasahara K, CLIN CANC RES, V16, P4616; Kawamura-Akiyama Y, 2002, LUNG CANCER-J IASLC, V38, P43, DOI 10.1016/S0169-5002(02)00175-7; MIYAZAWA K, 1991, BIOCHEMISTRY-US, V30, P9170, DOI 10.1021/bi00102a007; NISHIO K, 1995, INT J CANCER, V63, P688, DOI 10.1002/ijc.2910630514; OKAJIMA A, 1993, EUR J BIOCHEM, V213, P113, DOI 10.1111/j.1432-1033.1993.tb17740.x; PLASCHKESCHLUTTER A, 1995, J BIOL CHEM, V270, P830; YANAGIHARA K, 1991, CANCER RES, V51, P381; Yanagihara K, 2008, CANCER SCI, V99, P1859, DOI 10.1111/j.1349-7006.2008.00896.x	25	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					405	410		10.3892/ol.2014.2702		6	Oncology	Oncology	AX0JH	WOS:000346638300076		
J	Shimazaki, J; Tabuchi, T; Nakachi, T; Motohashi, G; Nishida, K; Ubukata, H; Tabuchi, T				Shimazaki, Jiro; Tabuchi, Takanobu; Nakachi, Takeshi; Motohashi, Gyo; Nishida, Kiyotaka; Ubukata, Hideyuki; Tabuchi, Takafumi			Pre-operative granulocyte/lymphocyte ratio as a predictive marker of post-operative complications in patients with colorectal cancer	ONCOLOGY LETTERS			English	Article						granulocyte; lymphocyte ratio; colorectal cancer; post-operative complication; predictive marker	CELL LUNG-CANCER; LYMPHOCYTE RATIO; RISK-FACTORS; NEUTROPHIL/LYMPHOCYTE RATIO; CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN-6 LEVEL; COLON-CANCER; SURGERY; RESECTION; SURVIVAL	The aim of the present study was to assess the clinical relevance of the pre-operative granulocyte/lymphocyte (G/L) ratio as a predictive marker of post-operative complications in patients with colorectal cancer. In total, 85 patients (59 males and 26 females; mean age, 68.9 years) underwent surgery for colorectal cancer at the Department of Surgery, Ibraki Medical Center, Tokyo Medical University (Ami, Japan), and were divided into post-operative complication and non-complication groups. Clinical data, including age, gender, body mass index, tumor localization, tumor pathological type, cancer staging, surgery time, volume of surgical bleeding, pre-operative G/L ratio and further pre-operative laboratory data, including levels of albumin and C-reactive protein, Glasgow Prognostic Score, white blood cell count and levels of hemoglobin, creatine kinase, lactate dehydrogenase, carcinoembryonic antigen and carbohydrate antigen 19-9 were analyzed between these groups. The total post-operative complication rate was 18.8%. On univariate analysis, the amount of surgical bleeding and the pre-operative G/L ratio were significantly higher in the complication group than in the non-complication group (299.8 +/- 361.7 vs. 155.6 +/- 268.6 ml, P<0.05; and 6.73 +/- 10.38 vs. 3.49 +/- 2.78, P<0.05, respectively). Multivariate logistic regression analysis for the risk factors of post-operative complications, determined using univariate analysis, demonstrated that the amount of surgical bleeding and the pre-operative G/L ratio were independent risk factors of post-operative complications in patients with colorectal cancer. In conclusion, the G/L ratio may be a clinically relevant pre-operative predictive marker for post-operative complications.	[Shimazaki, Jiro; Tabuchi, Takanobu; Nakachi, Takeshi; Motohashi, Gyo; Nishida, Kiyotaka; Ubukata, Hideyuki; Tabuchi, Takafumi] Tokyo Med Univ, Ibaraki Med Ctr, Dept Gastrointestinal Surg, Ibaraki 3000395, Japan	Shimazaki, J (reprint author), Tokyo Med Univ, Ibaraki Med Ctr, Dept Gastrointestinal Surg, 3-20-1 Chuo, Ibaraki 3000395, Japan.	shima-j@tokyo-med.ac.jp					Yasunaga H, 2013, BRIT J SURG, V100, P1335, DOI 10.1002/bjs.9221; Jean-Claude M, 2012, CLIN NUTR, V31, P896, DOI 10.1016/j.clnu.2012.03.011; Shimazaki J, 2013, ONCOLOGY-BASEL, V84, P356, DOI 10.1159/000350836; Chapuis PH, 2013, ANN SURG, V257, P909, DOI 10.1097/SLA.0b013e318268a693; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Mohri Y, 2010, WORLD J SURG, V34, P285, DOI 10.1007/s00268-009-0302-1; Itatsu K, 2014, SURG TODAY, V44, P1242, DOI 10.1007/s00595-013-0677-3; Telem DA, 2010, ARCH SURG-CHICAGO, V145, P371, DOI 10.1001/archsurg.2010.40; Ishizuka M, 2013, AM J SURG, V205, P22, DOI 10.1016/j.amjsurg.2012.04.012; Ishizuka M, 2007, ANN SURG, V246, P1047, DOI 10.1097/SLA.0b013e3181454171; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Malicki S, 2009, J PHYSIOL PHARMACOL, V60, P141; Whistance RN, 2013, COLORECTAL DIS, V15, pe548, DOI 10.1111/codi.12378; Cho H, 2009, CANCER IMMUNOL IMMUN, V58, P15, DOI 10.1007/s00262-008-0516-3; Lai CC, 2011, INT J COLORECTAL DIS, V26, P473, DOI 10.1007/s00384-010-1113-4; Tabuchi T, 2011, CYTOKINE, V53, P243, DOI 10.1016/j.cyto.2010.10.004; Kwag SJ, 2014, ANN SURG TREAT RES, V86, P206, DOI 10.4174/astr.2014.86.4.206; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; Esfandi F, 2006, CANCER LETT, V244, P76, DOI 10.1016/j.canlet.2005.12.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Bot J, 2013, DIS COLON RECTUM, V56, P568, DOI 10.1097/DCR.0b013e318282e790; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Hung HY, 2011, INT J COLORECTAL DIS, V26, P1059, DOI 10.1007/s00384-011-1192-x; Pommergaard HC, 2014, COLORECTAL DIS, V16, P662, DOI 10.1111/codi.12618; Lee L, 2014, ANN SURG, V259, P670, DOI 10.1097/SLA.0b013e318295fef8; Ishizuka M, 2012, ANN SURG ONCOL, V19, P3422, DOI 10.1245/s10434-012-2384-5; Ardestani SK, 1999, CANCER DETECT PREV, V23, P215, DOI 10.1046/j.1525-1500.1999.99021.x; Aytac E, 2013, DIS COLON RECTUM, V56, P689, DOI 10.1097/DCR.0b013e3182880ffa; Damle RN, 2014, J GASTROINTEST S AUG, DOI [10.1007/s11605-014-2600-725091840, DOI 10.1007/S11605-014-2600-725091840]; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Kvarnstrom A, 2013, ARCH IMMUNOL THER EX, V61, P407, DOI 10.1007/s00005-013-0239-9; Sobin LH, 2009, TNM CLASSIFICATION M; Takakura Y, 2013, LANGENBECK ARCH SURG, V398, P833, DOI 10.1007/s00423-013-1095-0; Tang Y, 2012, EXP ANIM TOKYO, V61, P417	38	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					425	429		10.3892/ol.2014.2669		5	Oncology	Oncology	AX0JH	WOS:000346638300079		
J	Zhang, YB; Suehiro, Y; Shindo, Y; Sakai, K; Hazama, S; Higaki, S; Sakaida, I; Oka, M; Yamasaki, T				Zhang, Yibo; Suehiro, Yutaka; Shindo, Yoshitaro; Sakai, Kouhei; Hazama, Shoichi; Higaki, Shingo; Sakaida, Isao; Oka, Masaaki; Yamasaki, Takahiro			Long-fragment DNA as a potential marker for stool-based detection of colorectal cancer	ONCOLOGY LETTERS			English	Article						colorectal cancer; stool DNA test	FECAL OCCULT BLOOD; CELL-DEATH; APOPTOSIS; POPULATION; RELEVANCE; TESTS	Neoplastic cells that are exfoliated from the colorectal epithelium exhibit dysfunctional apoptotic mechanisms, and thus it is possible to identify high-molecular-weight DNA fragments (long DNA) in feces. In the present study, the sensitivity and specificity of fecal-based long DNA assays were evaluated for the detection of colorectal cancer (CRC). Feces were collected from 54 healthy volunteers and 130 patients with CRC prior to surgical treatment. The presence of long DNA of the adenomatosis polyposis coli, Kirsten rat sarcoma viral oncogene homolog (KRAS), B-raf proto-oncogene, serine/threonine kinase and p53 genes was assessed by polymerase chain reaction followed by electrophoresis. The identification of long DNA in feces was found to exhibit a sensitivity of 56.2% and specificity of 96.3% for CRC detection. In addition, long DNA was identified in the feces of 58/90 (64.4%) patients with distal CRC and 15/40 (37.5%) patients with proximal CRC. This study indicates the potential of the fecal long DNA assay as a non-invasive and easily performed method for the detection of individuals with CRC.	[Zhang, Yibo; Suehiro, Yutaka; Sakai, Kouhei; Yamasaki, Takahiro] Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Ube, Yamaguchi 7558505, Japan; [Shindo, Yoshitaro; Hazama, Shoichi; Oka, Masaaki] Yamaguchi Univ, Grad Sch Med, Dept Digest Surg & Surg Oncol Surg 2, Ube, Yamaguchi 7558505, Japan; [Higaki, Shingo; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 7558505, Japan	Suehiro, Y (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	ysuehiro@yamaguchi-u.ac.jp					Ahlquist DA, 2002, CLIN CHIM ACTA, V315, P157, DOI 10.1016/S0009-8981(01)00712-4; Ahlquist DA, 2000, HUM PATHOL, V31, P51, DOI 10.1016/S0046-8177(00)80198-7; Boynton KA, 2003, CLIN CHEM, V49, P1058, DOI 10.1373/49.7.1058; Velez JP, 2002, SURG ENDOSC, V16, P117, DOI 10.1007/s004640080183; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Ahlquist DA, 2010, GASTROENTEROLOGY, V138, P2127, DOI 10.1053/j.gastro.2010.01.055; Di Lena M, 2013, WORLD J GASTROENTERO, V19, P1855, DOI 10.3748/wjg.v19.i12.1855; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Pawa N, 2011, NAT REV GASTRO HEPAT, V8, P711, DOI 10.1038/nrgastro.2011.205; Caldarella A, 2013, INT J COLORECTAL DIS, V28, P637, DOI 10.1007/s00384-013-1672-2; Carmona FJ, 2013, CANCER PREV RES, V6, P656, DOI 10.1158/1940-6207.CAPR-12-0501; Leung WK, 2007, AM J GASTROENTEROL, V102, P1070, DOI 10.1111/j.1572-0241.2007.01108.x; BEDI A, 1995, CANCER RES, V55, P1811; Calistri D, 2003, CLIN GASTROENTEROL H, V1, P377, DOI 10.1053/S1542-3565(03)00186-1; Calistri D, 2009, CELL ONCOL, V31, P11, DOI 10.3233/CLO-2009-0443; Japanese Society for Cancer of the Colon and Rectum, 2013, JAP CLASS COL CARC, P17; Kalimutho M, 2011, INT J COLORECTAL DIS, V26, P583, DOI 10.1007/s00384-010-1128-x; Kalimutho M, 2010, CLIN CHEM LAB MED, V48, P1303, DOI 10.1515/CCLM.2010.245; Leung WK, 2004, CLIN CHEM, V50, P2179, DOI 10.1373/clinchem.2004.039305; Loganayagam A, 2008, INT J CLIN PRACT, V62, P454, DOI 10.1111/j.1742-1241.2007.01532.x; Peitsch Manuel C., 1994, Trends in Cell Biology, V4, P37, DOI 10.1016/0962-8924(94)90002-7; Strater J, 1996, GASTROENTEROLOGY, V110, P1776, DOI 10.1053/gast.1996.v110.pm8964403; Tsujitani S, 1996, CANCER, V77, P1711, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1711::AID-CNCR20>3.0.CO;2-#; van Turenhout ST, 2012, GASTROINTEST ENDOSC, V76, P136, DOI 10.1016/j.gie.2012.03.169; Zou HZ, 2006, CANCER EPIDEM BIOMAR, V15, P1115, DOI 10.1158/1055-9965.EPI-05-0992	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					454	458		10.3892/ol.2014.2632		5	Oncology	Oncology	AX0JH	WOS:000346638300084		
J	Uzawa, N; Suzuki, M; Miura, C; Tomomatsu, N; Izumo, T; Harada, K				Uzawa, Narikazu; Suzuki, Miho; Miura, Chika; Tomomatsu, Nobuyoshi; Izumo, Toshiyuki; Harada, Kiyoshi			Primary ameloblastic carcinoma of the maxilla: A case report and literature review	ONCOLOGY LETTERS			English	Article						ameloblastic carcinoma; maxilla; odontogenic; primary	OF-THE-LITERATURE; MALIGNANT AMELOBLASTOMA; RARE NEOPLASM; METASTASES; HYPERCALCEMIA; CHILD	Ameloblastic carcinoma (AC) is a rare malignant odontogenic neoplasm that tends to occur in the mandible rather than in the maxilla. This malignancy is classified as a tumor that combines the morphological features of ameloblastoma and carcinoma, regardless of the presence or absence of metastasis. In addition, AC has been classified into two types, primary and secondary. The former develops de novo and the latter develops by malignant transformation of a pre-existing benign ameloblastoma. The present study describes the case of a 22-year-old patient with primary AC of the maxilla. A review of the literature focusing on the clinical details, treatment results and histopathological and phenotypic information available for ameloblastic carcinoma of the maxilla from a 60-year period was also performed. As a result, it was found that primary AC is dominant in the maxilla and does not exhibit an aggressive phenotype compared with secondary AC. In addition, the presence of recurrence was found to correlate with mortality, indicating that early, aggressive and complete removal of the tumor is the best treatment for survival.	[Uzawa, Narikazu; Suzuki, Miho; Miura, Chika; Tomomatsu, Nobuyoshi; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Reconstruct & Funct, Div Maxillofacial & Neck Reconstruct, Tokyo 1138549, Japan; [Izumo, Toshiyuki] Tokyo Med & Dent Univ, Grad Sch, Div Oral Hlth Sci, Tokyo 1138549, Japan	Uzawa, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Reconstruct & Funct, Div Maxillofacial & Neck Reconstruct, 1-5-45 Yushima, Tokyo 1138549, Japan.	n-uzawa.mfs@tmd.ac.jp					ANDERSEN E, 1986, J MAXILLOFAC SURG, V14, P338, DOI 10.1016/S0301-0503(86)80320-4; Angiero F, 2008, ANTICANCER RES, V28, P3847; Zwahlen RA, 2002, J CRANIO MAXILL SURG, V30, P273, DOI 10.1054/jcms.2002.0317; Hall JM, 2007, ORAL SURG ORAL MED O, V103, P799, DOI 10.1016/j.tripleo.2006.11.048; INOUE N, 1988, AM J CLIN PATHOL, V90, P474; GRIMES OF, 1948, ANN SURG, V128, P999, DOI 10.1097/00000658-194811000-00018; SLOOTWEG PJ, 1984, ORAL SURG ORAL MED O, V57, P168, DOI 10.1016/0030-4220(84)90207-X; Yoon HJ, 2009, ORAL SURG ORAL MED O, V108, P904, DOI 10.1016/j.tripleo.2009.06.045; ELZAY RP, 1982, ORAL SURG ORAL MED O, V54, P299, DOI 10.1016/0030-4220(82)90099-8; DUFFEY DC, 1995, AM J OTOLARYNG, V16, P66, DOI 10.1016/0196-0709(95)90012-8; Goldenberg D, 2004, LARYNGOSCOPE, V114, P1770, DOI 10.1097/00005537-200410000-00018; Avon Sylvie Louise, 2003, J Can Dent Assoc, V69, P573; Barnes L, 2005, WHO CLASSIFICATION T, P287; Benlyazid A, 2007, ORAL SURG ORAL MED O, V104, pE17, DOI 10.1016/j.tripleo.2007.05.026; Casaroto AR, 2012, ANTICANCER RES, V32, P1515; CORIO RL, 1987, ORAL SURG ORAL MED O, V64, P570, DOI 10.1016/0030-4220(87)90063-6; DARAMOLA JO, 1980, J ORAL SURG, V38, P203; Dhir K, 2003, ORAL ONCOL, V39, P736, DOI 10.1016/S1368-8375(03)00036-8; Eda S, 1972, Bull Tokyo Dent Coll, V13, P91; Franca DCC, 2012, ONCOL LETT, V4, P1297, DOI 10.3892/ol.2012.937; Infante-Cossio P, 1998, J CRANIO MAXILL SURG, V26, P159, DOI 10.1016/S1010-5182(98)80006-1; Ingram EA, 1996, DIAGN CYTOPATHOL, V14, P249, DOI 10.1002/(SICI)1097-0339(199604)14:3<249::AID-DC10>3.0.CO;2-L; Kramer IRH, 1971, INT HISTOLOGICAL CLA; KREMPIEN B, 1979, VIRCHOWS ARCH A, V381, P211, DOI 10.1007/BF01257886; LANHAM RJ, 1987, ONCOLOGY, V44, P133; LEE L, 1990, J CRANIO MAXILL SURG, V18, P247, DOI 10.1016/S1010-5182(05)80424-X; LOLACHI CM, 1995, J LARYNGOL OTOL, V109, P1019; Lucca M, 2010, J ORAL MAXIL SURG, V68, P2564, DOI 10.1016/j.joms.2009.09.088; MADIEDO G, 1981, AM J CLIN PATHOL, V75, P585; Matsuzaki H, 2011, ORAL SURG ORAL MED O, V112, pE40, DOI 10.1016/j.tripleo.2011.01.023; MCCLATCHEY KD, 1989, J OTOLARYNGOL, V18, P109; NADIMI H, 1986, Journal of Oral Medicine, V41, P79; Naik V, 2007, QUINTESSENCE INT, V38, P873; Nicolotti M, 2011, J CRANIOFAC SURG, V22, P2353, DOI 10.1097/SCS.0b013e318231e49b; Oginni F O, 2003, Odontostomatol Trop, V26, P19; Philip M, 2005, J HK COLL RADIOL, V8, P157; RAMADAS K, 1990, CANCER, V66, P1475, DOI 10.1002/1097-0142(19901001)66:7<1475::AID-CNCR2820660707>3.0.CO;2-D; Sastre J, 2002, J ORAL MAXIL SURG, V60, P102, DOI 10.1053/joms.2002.29086; Ward BB, 2007, J ORAL MAXIL SURG, V65, P1800, DOI 10.1016/j.joms.2006.06.265; Yazici N, 2008, PEDIATR BLOOD CANCER, V50, P175, DOI 10.1002/pbc.20889; Zwablen RA, 2003, J ORAL MAXILLOFAC SU, V61, p[731, 734], DOI [10.1053/joms.2003.50146, DOI 10.1053/JOMS.2003.50146]	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					459	467		10.3892/ol.2014.2654		9	Oncology	Oncology	AX0JH	WOS:000346638300085		
J	Sato, R; Yamasaki, M; Hirai, K; Matsubara, T; Nomura, T; Sato, F; Mimata, H				Sato, Ryuta; Yamasaki, Mutsushi; Hirai, Kenichi; Matsubara, Takanori; Nomura, Takeo; Sato, Fuminori; Mimata, Hiromitsu			Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells	ONCOLOGY REPORTS			English	Article						ANGPTL2; prostate cancer; EMT; apoptosis; integrin 51	CHRONIC INFLAMMATION; TUMOR-SUPPRESSOR; METASTASIS; ANGIOGENESIS; CARCINOGENESIS; CONTRIBUTES; INTEGRINS; ADHESION; ANGPTL2	Angiopoietin-like proteins (ANGPTLs), which comprise 7 members (ANGPTL1-ANGPTL7), structurally resemble angiopoietins. We investigated the roles of ANGPTLs in the acquisition of androgen independence and the malignant behavior of human prostate cancer cells. Expression of ANGPTL messenger RNA (mRNA) and proteins were ascertained using RT-qPCR and western blot analysis in human prostate cancer cell lines. Androgen-dependent LNCaP and androgen-independent LNCaP/AI cells, respectively, were cultured in fetal bovine and charcoal-stripped medium. Cell proliferation, androgen dependence, migration and invasion, respectively, were examined under the overexpression and knockdown of ANGPTL2 by transfection of ANGPTL2 cDNA and its small-interfering RNA (siRNA). The effects of exogenous ANGPTL2 and blocking of its receptor, integrin 51, were also investigated. Human prostate cancer cell lines predominantly expressed ANGPTL2 among the members. Interrupting ANGPTL2 expression with siRNA suppressed the proliferation, migration and invasion of LNCaP cells. LNCaP/AI cells showed a higher ANGPTL2 expression than that of LNCaP cells. Furthermore, siRNA led to apoptosis of LNCaP/AI cells. The ANGPTL2-overexpressing LNCaP cells markedly increased proliferation, epithelial-to-mesenchymal transition (EMT) and malignant behavior in androgen-deprived medium. The migration rates were increased depending on the concentration of ANGPTL2 recombinant protein and were inhibited by anti-integrin 51 antibodies. To the best of our knowledge, this is the first study to elucidate the expression of ANGPTL2 in human prostate cancer cells. ANGPTL2 may be important in the acquisition of androgen independency and tumor progression of prostate cancer in an autocrine and/or paracrine manner via the integrin 51 receptor. Targeting ANGPTL2 may therefore be an efficacious therapeutic modality for prostate cancer.	[Sato, Ryuta; Yamasaki, Mutsushi; Hirai, Kenichi; Matsubara, Takanori; Nomura, Takeo; Sato, Fuminori; Mimata, Hiromitsu] Oita Univ, Dept Urol, Fac Med, Yufu City, Oita 8795593, Japan	Sato, R (reprint author), Oita Univ, Dept Urol, Fac Med, 1-1 Idaigaoka, Yufu City, Oita 8795593, Japan.	r.sato@med.oita-u.ac.jp					Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Ito Y, 2003, CANCER RES, V63, P6651; Dhanabal M, 2002, CANCER RES, V62, P3834; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Kubota Y, 2005, P NATL ACAD SCI USA, V102, P13502, DOI 10.1073/pnas.0501902102; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Kuo TC, 2013, J CLIN INVEST, V123, P1082, DOI 10.1172/JCI64044; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Kikuchi R, 2008, CANCER RES, V68, P5067, DOI 10.1158/0008-5472.CAN-08-0062; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Aoi J, 2014, MOL CANCER RES, V12, P239, DOI 10.1158/1541-7786.MCR-13-0336; Endo M, 2014, INT J BIOL MARKER, V29, P239; Gronberg H, 2003, LANCET, V361, P1048, DOI [10.1016/S0140-6736(03)12713-4, DOI 10.1016/S0140-6736(03)12713-4]; Katoh Y, 2006, INT J MOL MED, V17, P1145; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Oike Y, 2009, CIRC J, V73, P2192; Okochi-Takada E, 2014, ONCOGENE, V33, P2273, DOI 10.1038/onc.2013.174; Schroder FH, 2008, EUR UROL, V53, P1129, DOI 10.1016/j.eururo.2008.01.049; Zeng L, 2003, J HUM GENET, V48, P393, DOI 10.1007/s10038-003-0033-3	27	3	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					58	66		10.3892/or.2014.3586		9	Oncology	Oncology	AX0IN	WOS:000346636200007		
J	Kubota, S; Chiba, M; Watanabe, M; Sakamoto, M; Watanabe, N				Kubota, Shiori; Chiba, Mitsuru; Watanabe, Miki; Sakamoto, Maki; Watanabe, Narumi			Secretion of small/microRNAs including miR-638 into extracellular spaces by sphingomyelin phosphodiesterase 3	ONCOLOGY REPORTS			English	Article						microRNA; miR-638; extracellular RNA; sphingomyelin phosphodiesterase 3; neutral sphingomyelinase 2; GW4869; exosome; extracellular vesicle	MULTIVESICULAR ENDOSOMES; MICRORNAS; CELLS; EXOSOMES; VESICLES; PLASMA; BIOMARKERS; MECHANISMS; PROTEINS; CANCER	A recent study demonstrated that intracellular small/microRNAs are released from cells, and some of these extracellular RNAs are embedded in vesicles, such as ceramide-rich exosomes, on lipid-bilayer membranes. In the present study, we examined the effects of sphingomyelin phosphodiesterase 3 (SMPD3), which generates ceramide from sphingomyelin, on the release of small/microRNAs from intracellular to extracellular spaces. In these experiments, SW480 human colorectal and HuH-7 human hepatocellular cancer cells were cultured for 48 h in serum-free media. Culture supernatants were then collected, and floating cells and debris were removed by centrifugation and filtration through a 0.22-m filter. Extracellular small RNAs in purified culture supernatants were stable for 4 weeks at room temperature, after 20 freeze-thaw cycles and exposure to pH 2.0, and were resistant to ribonuclease A degradation. Amino acid sequence analyses of SMPD3 showed high homology between mammals, indicating evolutionary conservation. Therefore, to investigate the mechanisms of cellular small/microRNA export, SW480 and HuH-7 cells were treated with the SMPD3 inhibitor GW4869 in serum-free media. Culture supernatants were collected for microarray and/or reverse transcription quantitative polymerase chain reaction (RT-qPCR) experiments. The number of microRNAs in culture supernatants was decreased following treatment with GW4869. Among these, extracellular and intracellular miR-638 were dose-dependently decreased and increased, respectively. These data suggest that SMPD3 plays an important role in the release of microRNAs into extracellular spaces.	[Kubota, Shiori; Watanabe, Miki; Sakamoto, Maki; Watanabe, Narumi] Hirosaki Univ, Dept Med Technol, Sch Hlth Sci, Hirosaki, Aomori 0368564, Japan; [Chiba, Mitsuru] Hirosaki Univ, Grad Sch Hlth Sci, Div Med Life Sci, Dept Biomed Sci, Hirosaki, Aomori 0368564, Japan; [Chiba, Mitsuru] Hirosaki Univ, Grad Sch Hlth Sci, Res Ctr Biomed Sci, Hirosaki, Aomori 0368564, Japan	Chiba, M (reprint author), Hirosaki Univ, Grad Sch Hlth Sci, Div Med Life Sci, Dept Biomed Sci, 66-1 Hon Cho, Hirosaki, Aomori 0368564, Japan.	mchiba32@cc.hirosaki-u.ac.jp			Hirosaki University Institutional Research Grant for Young Scientists, KAKENHI [23790613]; KAKENHI [25670264]; Suzuken Memorial Foundation [11-076]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	This study was supported in part by the Hirosaki University Institutional Research Grant for Young Scientists, KAKENHI (no. 23790613), a Grant-in-Aid for Young Scientists (B), a grant from KAKENHI (no. 25670264) for Challenging Exploratory Research, a grant from the Suzuken Memorial Foundation (no. 11-076), a grant from the Takeda Science Foundation, and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Savina A, 2002, J CELL SCI, V115, P2505; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lee DH, 2011, ARCH PHARM RES, V34, P229, DOI 10.1007/s12272-011-0208-y; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Muturi HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074654	32	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					67	73		10.3892/or.2014.3605		7	Oncology	Oncology	AX0IN	WOS:000346636200008		
J	Yukawa, T; Shimizu, K; Maeda, A; Yasuda, K; Saisho, S; Okita, R; Nakata, M				Yukawa, Takuro; Shimizu, Katsuhiko; Maeda, Ai; Yasuda, Koichiro; Saisho, Shinsuke; Okita, Riki; Nakata, Masao			Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer	ONCOLOGY REPORTS			English	Article						non-small cell lung cancer; regulatory T cells; single nucleotide polymorphism; cyclooxygenase-2	TRANSCRIPTION FACTOR FOXP3; EXPRESSION; PROGNOSIS; POLYMORPHISMS; ASSOCIATION; RECURRENCE; SURVIVAL; RISK	The immune microenvironment of primary tumors has been reported to be a prognostic factor. We previously reported that the tumor-infiltrating regulatory T cell (Treg) count was positively correlated with the intratumoral cyclooxygenase-2 (COX-2) expression level and was associated with a poor survival among patients with non-small cell lung cancer (NSCLC). Recently, numerous single nucleotide polymorphisms (SNPs) in the COX-2 gene have been identified, and these SNPs may contribute to differential gene expression and enzyme activity levels. However, whether COX-2 genetic variants influence the functions of COX-2 in NSCLC remains unclear. Eighty NSCLC patients who underwent a complete resection at our institute were enrolled. We extracted DNA from the peripheral blood and identified five different COX-2 SNPs. The correlations between the COX-2 SNPs and the expression levels of COX-2, Tregs and Ki-67 were studied. The prognostic significance of the COX-2 SNPs was also evaluated. COX-2 SNPs were not correlated with the expression of COX-2. However, for the COX-2 -1195G/A polymorphism, the AA genotype group had a significantly higher Treg score. Furthermore, the AA group had a significantly higher Treg score regardless of the COX-2 expression level. The COX-2 -1195AA genotype group tended to have a shorter disease-free survival period than the GA/GG group. In conclusion, the COX-2 -1195G/A polymorphism influences the infiltration of Tregs into NSCLC, and the COX-2 SNP factor may be a prognostic factor reflecting Treg infiltration in NSCLC.	[Yukawa, Takuro; Shimizu, Katsuhiko; Maeda, Ai; Yasuda, Koichiro; Saisho, Shinsuke; Okita, Riki; Nakata, Masao] Kawasaki Med Univ, Dept Gen Thorac Surg, Kurashiki, Okayama 7010192, Japan	Shimizu, K (reprint author), Kawasaki Med Univ, Dept Gen Thorac Surg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	kshimizu@med.kawasaki-m.ac.jp					Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; Shi J, 2008, CLIN EXP ALLERGY, V38, P913, DOI 10.1111/j.1365-2222.2008.02986.x; Dubois RN, 1998, FASEB J, V12, P1063; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Petersen RP, 2006, CANCER, V107, P2866, DOI 10.1002/cncr.22282; Shimizu K, 2010, J THORAC ONCOL, V5, P585, DOI 10.1097/JTO.0b013e3181d60fd7; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Hida T, 1998, CANCER RES, V58, P3761; Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Bi N, 2010, CLIN CANCER RES, V16, P2383, DOI 10.1158/1078-0432.CCR-09-2793; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Griswold DE, 1996, MED RES REV, V16, P181, DOI 10.1002/(SICI)1098-1128(199603)16:2<181::AID-MED3>3.0.CO;2-X; Li SY, 2013, FAM CANCER, V12, P755, DOI 10.1007/s10689-013-9659-2; Martin B, 2004, BRIT J CANCER, V91, P2018, DOI 10.1038/sj.bjc.6602233	19	3	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					74	80		10.3892/or.2014.3561		7	Oncology	Oncology	AX0IN	WOS:000346636200009		
J	Nishikawa, H; Osaki, Y; Komekado, H; Sakamoto, A; Saito, S; Nishijima, N; Nasu, A; Arimoto, A; Kita, R; Kimura, T				Nishikawa, Hiroki; Osaki, Yukio; Komekado, Hideyuki; Sakamoto, Azusa; Saito, Sumio; Nishijima, Norihiro; Nasu, Akihiro; Arimoto, Akira; Kita, Ryuichi; Kimura, Toru			Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection	ONCOLOGY REPORTS			English	Article						non-B non-C hepatocellular carcinoma; liver fibrosis; FIB-4 index; overall survival; recurrence-free survival	SIMPLE NONINVASIVE INDEX; CHRONIC HEPATITIS-C; FATTY LIVER-DISEASE; SIGNIFICANT FIBROSIS; DIABETES-MELLITUS; RECURRENCE; OBESITY; PREDICT; BIOPSY; JAPAN	The aims of the present study were to examine the relationship between the preoperative FIB-4 index and background liver fibrosis in non-tumor parts obtained from surgical specimens and to investigate whether the FIB-4 index can be a useful predictor for non-B non-C hepatocellular carcinoma (NBNC-HCC) patients treated with surgical resection (SR). A total of 118 patients with NBNC-HCC treated with SR with curative intent were analyzed. Receiver operating characteristic (ROC) curve analysis was performed for calculating the area under the ROC (AUROC) for the FIB-4 index, aspartate aminotransferase (AST) to platelet ratio index, AST to alanine aminotransferase ratio, serum albumin, total bilirubin and platelet count for cirrhosis. We also examined predictors linked to overall survival (OS) and recurrence-free survival (RFS) after SR. The mean patient age was 68.9 +/- 9.0 years (93 males and 25 females) with a median observation period of 3.2 years. In extracted surgical specimens, background liver cirrhosis (F4) was observed in 39 patients (33.1%). The mean maximum tumor size was 5.7 +/- 3.2 cm. The mean body mass index was 24.3 +/- 3.9 kg/m(2). The FIB-4 index yielded the highest AUROC for cirrhosis with a level of 0.887 at an optimal cut-off value of 2.97 (sensitivity, 92.3; specificity, 69.6%). In the multivariate analysis, serum -fetoprotein >40 ng/ml (P=0.026) was the only significant independent predictor linked to OS, while tumor number (P=0.002) and FIB-4 index >2.97 (P=0.044) were significant factors linked to RFS. In conclusion, preoperative FIB-4 index can be a useful predictor for NBNC-HCC patients who undergo SR.	[Nishikawa, Hiroki; Osaki, Yukio; Komekado, Hideyuki; Sakamoto, Azusa; Saito, Sumio; Nishijima, Norihiro; Nasu, Akihiro; Kita, Ryuichi; Kimura, Toru] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, Osaka 5430027, Japan; [Arimoto, Akira] Osaka Red Cross Hosp, Dept Surg, Tennoji Ku, Osaka 5430027, Japan	Nishikawa, H (reprint author), Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka 5430027, Japan.	h-nishikawa@osaka-med.jrc.or.jp					El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Nishikawa H, 2014, HEPATOL RES, V44, P149, DOI 10.1111/hepr.12194; Umemura T, 2007, HEPATOL RES, V37, pS95, DOI 10.1111/j.1872-034X.2007.00169.x; Chon YE, 2012, J CLIN GASTROENTEROL, V46, P518, DOI 10.1097/MCG.0b013e31825079f1; Kaibori M, 2012, AM J SURG, V204, P300, DOI 10.1016/j.amjsurg.2011.11.014; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Nishikawa H, 2013, INT J ONCOL, V43, P1333, DOI 10.3892/ijo.2013.2061; Yu ML, 2006, HEPATOLOGY, V44, P1086, DOI 10.1002/hep.21363; Nalbantoglu I, 2014, WORLD J GASTROENTERO, V20, P9026, DOI 10.3748/wjg.v20.i27.9026; Jung KS, 2012, ANN SURG ONCOL, V19, P4278, DOI 10.1245/s10434-012-2422-3; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Smith JO, 2009, ALIMENT PHARM THER, V30, P557, DOI 10.1111/j.1365-2036.2009.04062.x; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; D'Onofrio M, 2013, WORLD J GASTROENTERO, V19, P4841, DOI 10.3748/wjg.v19.i30.4841; [Anonymous], 1989, JPN J SURG, V19, P98, DOI [10.1007/BF024715762659865, DOI 10.1007/BF024715762659865]; Castera L, 2011, BEST PRACT RES CL GA, V25, P291, DOI 10.1016/j.bpg.2011.02.003; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chrostek L, 2014, WORLD J GASTROENTERO, V20, P8018, DOI 10.3748/wjg.v20.i25.8018; Zhou WP, 2009, ANN SURG, V249, P195, DOI 10.1097/SLA.0b013e3181961c16; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; McCurry J, 2007, LANCET, V369, P451, DOI 10.1016/S0140-6736(07)60214-1; Examination Committee of Criteria for Obesity Disease' in Japan, 2002, CIRC J, V66, P987, DOI [10.1253/circj.66.987, DOI 10.1253/CIRCJ.66.987]; Hung HH, 2010, HEPATOL INT, V4, P691, DOI 10.1007/s12072-010-9213-3; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Nishikawa H, 2014, ONCOL REP, V31, P65, DOI 10.3892/or.2013.2845; Nishikawa H, 2012, INT J ONCOL, V41, P903, DOI 10.3892/ijo.2012.1512; Osaki Y, 2015, HEPATOL RES, V45, P59, DOI 10.1111/hepr.12378; Shen SL, 2014, ANN SURG ONCOL, V21, P3802, DOI 10.1245/s10434-014-3771-x; Tamaki N, 2013, J GASTROENTEROL 1215; Utsunomiya T, 2014, ANN SURG, DOI [10.1097/SLA.000000000000082125072437, DOI 10.1097/SLA.000000000000082125072437]; Utsunomiya T, 2011, HEPATOL RES, V41, P711, DOI 10.1111/j.1872-034X.2011.00818.x	38	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					88	94		10.3892/or.2014.3573		7	Oncology	Oncology	AX0IN	WOS:000346636200011		
J	Murakami, I; Gogusev, J; Jaubert, F; Matsushita, M; Hayashi, K; Miura, I; Tanaka, T; Oka, T; Yoshino, T				Murakami, Ichiro; Gogusev, Jean; Jaubert, Francis; Matsushita, Michiko; Hayashi, Kazuhiko; Miura, Ikuo; Tanaka, Takehiro; Oka, Takashi; Yoshino, Tadashi			Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics	ONCOLOGY REPORTS			English	Article						Langerhans cell histiocytosis; cell line; dermal dendritic cell	CYTOGENETIC ABNORMALITIES; INFECTION; BONE; POLYOMAVIRUS; CONCORDANT; DIFFERENTIATION; LYMPHOCYTES; DISCORDANT; RESOLUTION; MUTATIONS	A cell line named PRU-1, derived from a Langerhans cell (LC) histiocytosis (LCH) skull lesion of a 7-year-old boy, was established and characterized. PRU-1 is an adherent spindle-shaped cell line that shows no Birbeck granules on electron microscopy. Flow cytometric analysis of cells collected from the early seventh passage showed no LC phenotypes of CD1a and S100 protein. Immunostaining of PRU-1 cells also revealed no expression of LC markers but showed expression of CD11c, CD54 (ICAM-1) and CD68, which was also observed in some peripherally located cells of the original LCH lesion. The PRU-1 cells stained positive for factor XIIIa and negative for CD34, suggesting a dermal dendritic cell phenotype. Cytogenetic analyses revealed abnormalities such as 39, XY, -2, -4, -8, -12, -12, -14, add (18)(q21), 20, +mar and 44, XY, -11, -14, add(18)(q21). TCR rearrangement in the PRU-1 cells was not amplified by PCR. Tumorigenicity was not proven by xenografting into SCID mice. A conditioned medium from PRU-1 culture induced the proliferation of peripheral blood lymphocytes as well as the activation of monocytes from a healthy donor into CD1a-positive LC-like cells. Because the phenotypic characteristics of PRU-1 differed from those of CD1a-positive abnormal LC-like cells (LCH cells), it was likely that the PRU-1 cells were derived from peripherally located cells of the LCH lesion rather than LCH cells. LCH has been regarded as a type of granulomatous neoplasm with several intermingled inflammatory cells and influenced by stimuli such as Merkel cell polyomavirus (MCPyV) infection or cigarette smoking. However, in the PRU-1 cells, MCPyV-DNA was not detected by PCR. Stromal cell-like PRU-1 cells are likely to produce some growth or differentiation factors, which may play important roles in LCH lesion formation, cell maintenance and LC-like cell induction.	[Murakami, Ichiro; Hayashi, Kazuhiko] Tottori Univ, Div Mol Pathol, Fac Med, Yonago, Tottori 6838503, Japan; [Gogusev, Jean] Inst Cochin Genet Mol, INSERM, U507, F-75014 Paris, France; [Gogusev, Jean] Inst Cochin Genet Mol, U1016, F-75014 Paris, France; [Jaubert, Francis] Univ Paris 05, F-75006 Paris, France; [Matsushita, Michiko] Tottori Univ, Dept Pathobiol Sci & Technol, Sch Hlth Sci, Fac Med, Yonago, Tottori 6838503, Japan; [Miura, Ikuo] St Marianna Univ, Sch Med Hosp, Div Hematol & Oncol, Kawasaki, Kanagawa 2168511, Japan; [Tanaka, Takehiro] Okayama Univ Hosp, Dept Pathol, Okayama 7008530, Japan; [Oka, Takashi; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008530, Japan	Murakami, I (reprint author), Tottori Univ, Div Mol Pathol, Fac Med, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	ichiro.murakami.09@gmail.com					Aiba S, 1998, J CUTAN PATHOL, V25, P65, DOI 10.1111/j.1600-0560.1998.tb01692.x; Yousem SA, 2013, CHEST, V143, P1679, DOI 10.1378/chest.12-1917; Chen CJ, 2004, EUR J PEDIATR, V163, P536, DOI 10.1007/s00431-004-1493-y; Feldman AL, 2005, LANCET ONCOL, V6, P435, DOI 10.1016/S1470-2045(05)70211-4; Mogulkoc N, 1999, CHEST, V115, P1452, DOI 10.1378/chest.115.5.1452; Geissmann F, 2001, BLOOD, V97, P1241, DOI 10.1182/blood.V97.5.1241; Lu H, 2007, J INVEST DERMATOL, V127, P2781, DOI 10.1038/sj.jid.5700918; Betts DR, 1998, BRIT J CANCER, V77, P552, DOI 10.1038/bjc.1998.89; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Jenson HB, 2000, AM J HEMATOL, V64, P237, DOI 10.1002/1096-8652(200008)64:4<237::AID-AJH1>3.0.CO;2-D; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Yousem SA, 2001, AM J SURG PATHOL, V25, P630, DOI 10.1097/00000478-200105000-00010; VONESSEN S, 1990, CHEST, V98, P765, DOI 10.1378/chest.98.3.765; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Kuwamoto S, 2011, HUM PATHOL, V42, P632, DOI 10.1016/j.humpath.2010.09.011; Sakata N, 2008, PEDIATR BLOOD CANCER, V50, P924, DOI 10.1002/pbc.21249; Nezelof C, 2004, PEDIATR BLOOD CANCER, V42, P398, DOI 10.1002/pbc.10463; Murakami I, 2014, HUM PATHOL, V45, P119, DOI 10.1016/j.humpath.2013.05.028; [Anonymous], 1987, LANCET, V1, p[208, 209]; Egeler RM, 1999, BLOOD, V94, P4195; Murakami I, 2002, HUM PATHOL, V33, P555, DOI 10.1053/hupa.2002.124035; ARENZANASEISDEDOS F, 1986, J CLIN INVEST, V77, P326, DOI 10.1172/JCI112296; Arico M, 1999, BRIT J HAEMATOL, V107, P883, DOI 10.1046/j.1365-2141.1999.01777.x; CORBEEL L, 1988, EUR J PEDIATR, V148, P32, DOI 10.1007/BF00441809; Dufour C, 2001, MED PEDIATR ONCOL, V37, P70, DOI 10.1002/mpo.1169; ENJOLRAS O, 1992, ANN DERMATOL VENER, V119, P111; Erlandson RA, 1994, DIAGNOSTIC TRANSMISS, p[243, 832]; Glotzbecker MP, 2004, J PEDIATR ORTHOPED, V24, P123; Gogusev J, 2005, PEDIATR BLOOD CANCER, V44, P128, DOI 10.1002/pbe.20090; Kawakubo Y, 1999, VIRCHOWS ARCH, V434, P109, DOI 10.1007/s004280050313; Larrengina AT, 2001, DENDRITIC CELLS BIOL, p[301, 314], DOI 10.1016/B978-012455851-9/50062-6; LEAHY MA, 1993, J INVEST DERMATOL, V101, P642, DOI 10.1111/1523-1747.ep12371669; MIYATANI K, 1994, ACTA MED OKAYAMA, V48, P67; Nezelof C, 1998, HEMATOL ONCOL CLIN N, V12, P385, DOI 10.1016/S0889-8588(05)70518-9; Raushenbakh MO, 1981, VESTN AKAD MED NAUK, V19, P24; Scappaticci S, 2000, BRIT J HAEMATOL, V111, P258, DOI 10.1046/j.1365-2141.2000.02313.x; Tazi A, 2005, HISTIOCYTIC DISORDERS OF CHILDREN AND ADULTS, P187; Weitzman S, 2005, HISTIOCYTIC DISORDERS OF CHILDREN AND ADULTS, P154, DOI 10.1017/CBO9780511545252.009	38	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					171	178		10.3892/or.2014.3567		8	Oncology	Oncology	AX0IN	WOS:000346636200022		
J	Kobara, H; Mori, H; Rafiq, K; Fujihara, S; Nishiyama, N; Chiyo, T; Matsunaga, T; Ayaki, M; Yachida, T; Kato, K; Kamada, H; Fujita, K; Morishita, A; Oryu, M; Tsutsui, K; Iwama, H; Kushida, Y; Haba, R; Masaki, T				Kobara, Hideki; Mori, Hirohito; Rafiq, Kazi; Fujihara, Shintaro; Nishiyama, Noriko; Chiyo, Taiga; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Kato, Kiyohito; Kamada, Hideki; Fujita, Koji; Morishita, Asahiro; Oryu, Makoto; Tsutsui, Kunihiko; Iwama, Hisakazu; Kushida, Yoshio; Haba, Reiji; Masaki, Tsutomu			Analysis of the amount of tissue sample necessary for mitotic count and Ki-67 index in gastrointestinal stromal tumor sampling	ONCOLOGY REPORTS			English	Article						subepithelial tumor; histological analysis; tissue sampling method	FINE-NEEDLE-ASPIRATION; SUBMUCOSAL ENDOSCOPY; DIAGNOSTIC YIELD; TRUCUT BIOPSY; SAFETY; GIST; ESMO	There are no established opinions concerning whether the amount of tissue affects the accuracy of histological analyses in gastrointestinal stromal tumors (GISTs). The aim of the present study was to investigate the appropriate amount of tissue sample needed for mitotic count based on the risk classification of GISTs and the Ki-67 index using the following three methods: endoscopic ultrasound-guided fine-needle aspiration (FNA), a novel sampling method called tunneling bloc biopsy (TBB), and biopsy forceps followed by TBB (Bf). Forty-three samples (12 FNA, 17 TBB and 14 Bf) diagnosed as GISTs by immunohistological analysis were utilized. The major and minor axes and overlay area of one piece of specimen (OPS) from the three sampling methods were measured using digital imaging software and were analyzed comparatively regarding the acquisition of histological data. The mean major and minor axes (mm) and overlay areas (mm(2)) were in the order of TBB > Bf > FNA. The evaluable rates by mitotic count and Ki-67 were, respectively, 75% (9/12) and 83.3% (10/12) for FNA samples, 100% (17/17) and 100% (17/17) for TBB samples, and 100% (14/14) and 100% (14/14) for Bf samples (P>0.05). Three FNA samples were judged unevaluable due to too small specimens in overall diagnosis including mitotic count and Ki-67, calculating the cut-off value for the overlay area of OPS as 0.17 mm(2). Comparing the concordance rates between the pre- and post-operative samples, TBB samples was significantly better than FNA (P<0.05). Conclusively, while the amounts of tissues obtained by TBB and Bf are unnecessary for the histological assessment of mitotic count and Ki-67 index, developments of the FNA method are needed to minimize sample error. Considering the technical aspects, as well as the size of the specimens, could help to guide therapeutic planning and improve diagnostic yield for GI subepithelial tumors.	[Kobara, Hideki; Mori, Hirohito; Fujihara, Shintaro; Nishiyama, Noriko; Chiyo, Taiga; Matsunaga, Tae; Ayaki, Maki; Yachida, Tatsuo; Kato, Kiyohito; Kamada, Hideki; Fujita, Koji; Morishita, Asahiro; Oryu, Makoto; Tsutsui, Kunihiko; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Kita Ku, Miki, Kagawa 7610793, Japan; [Rafiq, Kazi] Kagawa Univ, Dept Pharmacol, Fac Med, Kita Ku, Miki, Kagawa 7610793, Japan; [Kushida, Yoshio; Haba, Reiji] Kagawa Univ, Dept Diagnost Pathol, Fac Med, Kita Ku, Miki, Kagawa 7610793, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Fac Med, Kita Ku, Miki, Kagawa 7610793, Japan	Kobara, H (reprint author), Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	kobara@med.kagawa-u.ac.jp					Sepe PS, 2009, GASTROINTEST ENDOSC, V70, P254, DOI 10.1016/j.gie.2008.11.038; Polkowski M, 2009, ENDOSCOPY, V41, P329, DOI 10.1055/s-0029-1214447; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Hoda KM, 2009, GASTROINTEST ENDOSC, V69, P1218, DOI 10.1016/j.gie.2008.09.045; Blay JY, 2005, ANN ONCOL, V16, P566, DOI 10.1093/annonc/mdi127; Hwang JH, 2004, GASTROENTEROLOGY, V126, P301, DOI 10.1053/j.gastro.2003.11.040; Sumiyama K, 2007, GASTROINTEST ENDOSC, V65, P688, DOI 10.1016/j.gie.2006.07.030; Sakamoto H, 2009, J GASTROEN HEPATOL, V24, P384, DOI 10.1111/j.1440-1746.2008.05636.x; Casali PG, 2009, ANN ONCOL, V20, P64, DOI 10.1093/annonc/mdp131; Kobara H, 2013, GASTROINTEST ENDOSC, V77, P141, DOI 10.1016/j.gie.2012.08.008; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Mekky MA, 2010, GASTROINTEST ENDOSC, V71, P913, DOI 10.1016/j.gie.2009.11.044; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Ando N, 2002, GASTROINTEST ENDOSC, V55, P37, DOI 10.1067/mge.2002.120323; Blackstein ME, 2006, CAN J GASTROENTEROL, V20, P157; Demetri George D, 2007, J Natl Compr Canc Netw, V5 Suppl 2, pS1; Fernandez-Esparrach G, 2010, ENDOSCOPY, V42, P292, DOI 10.1055/s-0029-1244074; Fu Kai, 2002, Ann Diagn Pathol, V6, P294, DOI 10.1053/adpa.2002.35741; Kobara Hideki, 2014, Clin Exp Gastroenterol, V7, P67, DOI 10.2147/CEG.S43139; Lai R, 2002, ENDOSCOPY, V34, P715, DOI 10.1055/s-2002-33443; Mori H, 2011, ENDOSCOPY, V43, P631, DOI 10.1055/s-0030-1256227; National Comprehensive Cancer Network, 2009, CLIN PRACT GUID ONC; Stelow EB, 2003, AM J CLIN PATHOL, V119, P703, DOI 10.1309/UWUVQ001D9W0HPN	23	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					215	222		10.3892/or.2014.3608		8	Oncology	Oncology	AX0IN	WOS:000346636200028		
J	Lo, PHY; Tanikawa, C; Katagiri, T; Nakamura, Y; Matsuda, K				Lo, Paulisally Hau Yi; Tanikawa, Chizu; Katagiri, Toyomasa; Nakamura, Yusuke; Matsuda, Koichi			Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma	ONCOLOGY REPORTS			English	Article						breast carcinoma; epigenetically inactivated gene; PAMR1; microarray	TUMOR-SUPPRESSOR; DNA METHYLATION; CANCER CELLS; EXPRESSION; OVEREXPRESSION; INVOLVEMENT; PATHWAY; CARCINOGENESIS; PROFILES	Development of cancer is a complex process involving multiple genetic and epigenetic alterations. In our microarray analysis of 81 breast carcinoma specimens, we identified peptidase domain containing associated with muscle regeneration 1 (PAMR1) as being frequently suppressed in breast cancer tissues. PAMR1 expression was also reduced in all tested breast cancer cell lines, while PAMR1 was expressed moderately in normal breast tissues and primary mammary epithelial cells. DNA sequencing of the PAMR1 promoter after sodium bisulfite treatment revealed that CpG sites were hypermethylated in the breast cancer tissues and cell lines. PAMR1 expression was restored by 5-aza-2 deoxycytidine treatment, demonstrating that promoter hypermethylation contributed to PAMR1 inactivation in the breast cancer cells. In addition, ectopic expression of PAMR1 markedly suppressed cancer cell growth. In summary, our study identified PAMR1 as a putative tumor suppressor which was frequently inactivated by promoter hypermethylation in breast cancer tissues.	[Lo, Paulisally Hau Yi; Tanikawa, Chizu; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 770, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	Matsuda, K (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	koichima@ims.u-tokyo.ac.jp					Agrawal A, 2007, MODERN PATHOL, V20, P711, DOI 10.1038/modpathol.3800822; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Issa JPJ, 2005, NAT REV DRUG DISCOV, V4, P275, DOI 10.1038/nrd1698; Van de Voorde L, 2012, MUTAT RES-REV MUTAT, V751, P304, DOI 10.1016/j.mrrev.2012.06.001; Gao YX, 2011, HUM PATHOL, V42, P1693, DOI 10.1016/j.humpath.2010.12.027; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Tanikawa C, 2009, ONCOGENE, V28, P3081, DOI 10.1038/onc.2009.154; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Campo E, 2013, MODERN PATHOL, V26, pS97, DOI 10.1038/modpathol.2012.179; Lin JY, 2014, INT J ONCOL, V44, P1490, DOI 10.3892/ijo.2014.2314; Huang Y, 1999, MOL CARCINOGEN, V24, P118, DOI 10.1002/(SICI)1098-2744(199902)24:2<118::AID-MC6>3.0.CO;2-L; Niwa Y, 2000, JPN J CANCER RES, V91, P519; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; Radpour R, 2009, ONCOGENE, V28, P2969, DOI 10.1038/onc.2009.149; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ajiro M, 2009, INT J ONCOL, V35, P673, DOI 10.3892/ijo_00000379; Barekati Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-244; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Hawthorn L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-460; Kim JW, 2010, INT J ONCOL, V37, P861, DOI 10.3892/ijo_00000737; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Lin YC, 2014, J CELL SCI, V127, P85, DOI 10.1242/jcs.132779; LIN YC, 2011, SCUBE2 J BIOL CHEM, V286, P27039, DOI DOI 10.1074/JBC.M111.244418216527203143662; Medina-Franco JL, 2011, DRUG DISCOV TODAY, V16, P418, DOI 10.1016/j.drudis.2011.02.003; Nishidate T, 2004, INT J ONCOL, V25, P797; Shimo A, 2007, CANCER SCI, V98, P174, DOI 10.1111/j.1349-7006.2006.00381.x; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443; Yu ZJ, 2015, MOL CARCINOGEN, V54, P707, DOI 10.1002/mc.22133	29	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					267	273		10.3892/or.2014.3581		7	Oncology	Oncology	AX0IN	WOS:000346636200033		
J	Toyota, H; Yanase, N; Yoshimoto, T; Harada, M; Kato, Y; Mizuguchi, J				Toyota, Hiroko; Yanase, Noriko; Yoshimoto, Takayuki; Harada, Mitsunori; Kato, Yasuki; Mizuguchi, Junichiro			Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo	ONCOLOGY REPORTS			English	Article						vaccination; nanoparticles; tumor antigen; E; G7-OVA tumor cells	T-CELLS; POLYMERIC MICELLES; IMMUNE-RESPONSES; IMMUNOTHERAPY; CYTOKINES; DELIVERY; EFFICACY; DRUG	Immunotherapy has gained special attention due to its specific effects on tumor cells and systemic action to block metastasis. We recently demonstrated that ovalbumin (OVA) conjugated to the surface of nanoparticles (NPs) (OVA-NPs) can manipulate humoral immune responses. In the present study, we aimed to ascertain whether vaccination with OVA-NPs entrapping IL-7 (OVA-NPs-IL-7) are able to induce antitumor immune responses in vivo. Pretreatment with a subcutaneous inoculation of OVA-NPs delayed the growth of thymic lymphoma cells expressing a model tumor antigen OVA (E.G7-OVA), and OVA-NPs-IL-7 substantially blocked the growth of E.G7-OVA tumor cells, although NPs-IL-7 alone had a meager effect, as assessed by the mean tumor size and the percentage of tumor-free mice. However, pretreatment with OVA-NPs-IL-7 failed to reduce the growth of parental thymic tumor cells, suggesting that the antitumor effect was antigen-specific. A tetramer assay revealed that vaccination with OVA-NPs-IL-7 tended to enhance the proportion of cytotoxic T cells (CTLs) specific for OVA. When the tumor-free mice inoculated with OVA-NPs-IL-7 plus EG.7 cells were rechallenged with E.G7-OVA cells, they demonstrated reduced growth compared with that in the control mice. Thus, a single subcutaneous injection of OVA-NPs-IL-7 into mice induced tumor-specific and also memory-like immune responses, resulting in regression of tumor cells. Antigens on NPs entrapping IL-7 would be a promising carrier to develop and enhance immune responses, including humoral and cellular immunity as well as a method of drug delivery to a specific target of interest.	[Toyota, Hiroko; Yanase, Noriko; Mizuguchi, Junichiro] Tokyo Med Univ, Dept Immunol, Shinjuku Ku, Tokyo 1608402, Japan; [Yoshimoto, Takayuki] Tokyo Med Univ, Inst Med Sci, Dept Immunoregulat, Shinjuku Ku, Tokyo 1608402, Japan; [Harada, Mitsunori; Kato, Yasuki] NanoCarrier Co Ltd, Kashiwa, Chiba 2770871, Japan	Mizuguchi, J (reprint author), Tokyo Med Univ, Dept Immunol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	mizu@tokyo-med.ac.jp					Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Krishnamachari Y, 2011, PHARM RES-DORDR, V28, P215, DOI 10.1007/s11095-010-0241-4; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Disis ML, 2009, LANCET, V373, P673, DOI 10.1016/S0140-6736(09)60404-9; Radford KJ, 2014, CURR OPIN IMMUNOL, V27, P26, DOI 10.1016/j.coi.2014.01.005; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Oppenheim JJ, 2001, INT J HEMATOL, V74, P3, DOI 10.1007/BF02982543; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI [10.1586/erv.10.89, 10.1586/ERV.10.89]; Andersen BM, 2012, CANCER LETT, V325, P155, DOI 10.1016/j.canlet.2012.07.012; Christian DA, 2012, IMMUNOTHERAPY-UK, V4, P425, DOI [10.2217/imt.12.26, 10.2217/IMT.12.26]; Gou HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085789; Harada M, 2011, J CONTROL RELEASE, V156, P101, DOI 10.1016/j.jconrel.2011.06.024; Hussein MR, 2005, BRIT J DERMATOL, V153, P18, DOI 10.1111/j.1365-2133.2005.06629.x; Katzman SD, 2011, CYTOKINE, V56, P116, DOI 10.1016/j.cyto.2011.07.005; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55; Moller P, 1998, BRIT J CANCER, V77, P1907, DOI 10.1038/bjc.1998.317; Osada K, 2009, J R SOC INTERFACE, V6, pS325, DOI 10.1098/rsif.2008.0547.focus; Sanlorenzo M, 2014, CANCER BIOL THER, V15, P665, DOI 10.4161/cbt.28555; Yanase N, 2014, VACCINE, V32, P5918, DOI 10.1016/j.vaccine.2014.08.059	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					292	296		10.3892/or.2014.3603		5	Oncology	Oncology	AX0IN	WOS:000346636200036		
J	Umeguchi, H; Sueoka-Aragane, N; Kobayashi, N; Nakamura, T; Sato, A; Takeda, Y; Hayashi, S; Sueoka, E; Kimura, S				Umeguchi, Hitomi; Sueoka-Aragane, Naoko; Kobayashi, Naomi; Nakamura, Tomomi; Sato, Akemi; Takeda, Yuji; Hayashi, Shinichiro; Sueoka, Eisaburo; Kimura, Shinya			Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer	ONCOLOGY REPORTS			English	Article						lung cancer; HGF; T790M; plasma; monitoring system	HEPATOCYTE GROWTH-FACTOR; FACTOR RECEPTOR; PULMONARY ADENOCARCINOMA; GEFITINIB RESISTANCE; MET AMPLIFICATION; PHASE-II; ERLOTINIB; CHEMOTHERAPY; NEUTROPHILS; MUTATIONS	Monitoring of molecular markers is indispensable for deciding subsequent treatment after acquired resistance to molecular-targeted therapy. According to results using re-biopsy, EGFR T790M mutation and overexpression of hepatocyte growth factor (HGF) are major mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The aim of the present study was to assess whether quantification of HGF using peripheral blood in addition to detection of T790M with plasma DNA is useful for monitoring as an alternative to invasive re-biopsy. HGF levels in plasma were determined using ELISA and T790M mutation was detected using mutation-biased PCR and quenched probe system (MBP-QP). The median level of HGF in plasma at baseline was 140 pg/ml and was significantly higher in the advanced stage of cancer and in smokers and predicted poor survival as determined using 315 plasma samples from 225 lung cancer patients. T790M was detected with plasma DNA in 9 of 16 patients who acquired resistance to EGFR-TKIs and a greater than 1.5-fold elevation compared with pretreatment HGF levels was observed in 6 patients after acquired resistance. Eleven of 16 patients (69%) showed either HGF elevation or T790M in plasma samples, with both outcomes observed in 25% of patients; this is consistent with results based on re-biopsy reported from other laboratories. Considering these results, assessing HGF and T790M using peripheral blood could be useful for monitoring mechanisms of acquired resistance to EGFR-TKIs.	[Umeguchi, Hitomi; Sueoka-Aragane, Naoko; Kobayashi, Naomi; Nakamura, Tomomi; Sato, Akemi; Hayashi, Shinichiro; Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, Saga 8498501, Japan; [Takeda, Yuji] Saga Univ, Fac Med, Dept Thorac Surg, Saga 8498501, Japan; [Sueoka, Eisaburo] Saga Univ Hosp, Dept Lab Med, Saga 8498501, Japan	Sueoka-Aragane, N (reprint author), Saga Univ, Fac Med, Dept Internal Med, Div Hematol Resp Med & Oncol, 5-1-1 Nabeshima, Saga 8498501, Japan.	sueokan@cc.saga-u.ac.jp			 [25870518]	This study was supported in part by a Grant-in-Aid for Young Scientists (B) 25870518. The authors are grateful to Dr John B. Cologne for suggestions regarding the statistical analysis.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Wislez M, 2003, CANCER RES, V63, P1405; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Mizuno S, 2013, INT J MOL SCI, V14, P888, DOI 10.3390/ijms14010888; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Wang W, 2012, CLIN CANCER RES, V18, P1663, DOI 10.1158/1078-0432.CCR-11-1171; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Martin TA, 2003, CARCINOGENESIS, V24, P1317, DOI 10.1093/carcin/bgg072; Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Nakagawa T, 2012, MOL CANCER THER, V11, P2149, DOI 10.1158/1535-7163.MCT-12-0195; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Tanaka K, 2004, SCAND J GASTROENTERO, V39, P754, DOI 10.1080/00365520410005973; Toiyama Y, 2009, INT J CANCER, V125, P1657, DOI 10.1002/ijc.24554; Nakamura T, 2011, J THORAC ONCOL, V6, P1639, DOI 10.1097/JTO.0b013e31822956e8; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Katakami N, 2013, J CLIN ONCOL, V31, P3335, DOI 10.1200/JCO.2012.45.0981; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Gupta A, 2008, CLIN CANCER RES, V14, P7385, DOI 10.1158/1078-0432.CCR-07-5110; Seidel C, 1998, BLOOD, V91, P1806; Siegfried JM, 1998, ANN THORAC SURG, V66, P1915, DOI 10.1016/S0003-4975(98)01165-5; Takanami I, 1996, ONCOLOGY, V53, P392	31	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					391	396		10.3892/or.2014.3560		6	Oncology	Oncology	AX0IN	WOS:000346636200048		
J	Iesato, A; Oba, T; Ono, M; Hanamura, T; Watanabe, T; Ito, T; Kanai, T; Maeno, K; Ishizaka, K; Kitabatake, H; Takeuchi, D; Suzuki, A; Nakayama, J; Ito, K				Iesato, Asumi; Oba, Takaaki; Ono, Mayu; Hanamura, Toru; Watanabe, Takayuki; Ito, Tokiko; Kanai, Toshiharu; Maeno, Kazuma; Ishizaka, Katsuhiko; Kitabatake, Hiroyuki; Takeuchi, Daisuke; Suzuki, Akira; Nakayama, Jun; Ito, Ken-ichi			Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature	ONCOTARGETS AND THERAPY			English	Review						gastric carcinoma; breast metastasis; signet-ring cell carcinoma; gastric cancer; breast cancer	INFLAMMATORY CARCINOMA; CANCER; STOMACH; NEOPLASMS; TUMOR	It is occasionally difficult to diagnose breast metastasis of gastric carcinoma because of its rarity. However, to appropriately treat patients with breast tumors without delay, it is important to distinguish metastatic cancer from primary breast cancer. We report two cases of breast metastasis of gastric carcinoma and review the literature. The first case was a 41-year-old female diagnosed with bilateral pelvic tumors who visited the outpatient clinic because of pain and enlargement of both breasts. Ultrasonography showed diffuse hypoechoic lesions, which were enhanced on gadolinium-enhanced magnetic resonance imaging in the bilateral mammary gland. Core needle biopsy of the right breast revealed signet-ring cells, which were also identified in the resected bilateral pelvic tumors. Subsequent upper gastrointestinal endoscopy revealed signet-ring cell carcinoma in the stomach, and the bilateral breast lesions were diagnosed as metastases of gastric carcinoma. The second case was a 34-year-old female diagnosed with cervical metastasis of signet-ring cell carcinoma who was referred to the breast cancer clinic because of a nodule in the left breast detected by computed tomography. Ultrasonography showed a hypoechoic nodule that was enhanced on gadolinium-enhanced magnetic resonance imaging. Because the pathologic findings for the left breast nodule were quite similar to those of gastric cancer and its cervical metastasis, the breast nodule was diagnosed as a metastasis of gastric carcinoma. When a breast tumor is suspected to have metastasized from a primary tumor in another organ, particularly if signet-ring cells are found, the possibility that gastric cancer is present should be considered.	[Iesato, Asumi; Oba, Takaaki; Ono, Mayu; Hanamura, Toru; Watanabe, Takayuki; Ito, Tokiko; Kanai, Toshiharu; Maeno, Kazuma; Ito, Ken-ichi] Shinshu Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, Matsumoto, Nagano 3908621, Japan; [Ishizaka, Katsuhiko] Iiyama Red Cross Hosp, Dept Surg, Iiyama, Japan; [Kitabatake, Hiroyuki] Iiyama Red Cross Hosp, Dept Gastroenterol, Iiyama, Japan; [Takeuchi, Daisuke; Suzuki, Akira] Shinshu Univ, Sch Med, Dept Gastrointestinal Surg, Matsumoto, Nagano 3908621, Japan; [Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan	Ito, K (reprint author), Shinshu Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kenito@shinshu-u.ac.jp					ALEXANDER HR, 1989, J SURG ONCOL, V42, P264, DOI 10.1002/jso.2930420412; TOOMBS BD, 1977, AM J ROENTGENOL, V129, P673; ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7; Otsuji E, 1998, J SURG ONCOL, V67, P216, DOI 10.1002/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.3.CO;2-N; Boutis AL, 2006, WORLD J GASTROENTERO, V12, P2958; Briest S, 1999, GYNECOL ONCOL, V74, P491, DOI 10.1006/gyno.1999.5478; CAVAZZINI G, 1993, TUMORI, V79, P450; CHAMPAULT G, 1982, ANN CHIR, V36, P246; Chang S, 1998, CANCER, V82, P2366; Dawson EK, 1936, J PATHOL BACTERIOL, V43, P53, DOI 10.1002/path.1700430107; Di Cosimo S, 2003, ANN ONCOL, V14, P803, DOI 10.1093/annonc/mdg218; Domanski HA, 1996, ACTA CYTOL, V40, P1293; Gugic D, 2007, LIBRI ONCOL, V35, P59; Hadju SI, 1972, CANCER, V29, P1691; HAMBY LS, 1991, J SURG ONCOL, V48, P117, DOI 10.1002/jso.2930480209; Hasegawa S, 2007, JPN J CANC CHEMOTHER, V34, P1115; Howlader N, SEER CANC STAT REV 1; Iijima M, 2007, AM J DERMATOPATH, V29, P452; Isobe T, 2006, J JPN SURG ASS, V67, P2800; Japanese Breast Cancer Society, 2010, NAT BREAST CANC REG; Kasuga Y, 1986, Gan No Rinsho, V32, P407; Kreibich C, 1909, MED KLIN, V5, P1436; Kudo H, 1999, J JPN SURG ASS, V60, P1486; Kwak JY, 2000, YONSEI MED J, V41, P669; Lee SK, 2010, J SURG ONCOL, V101, P137, DOI 10.1002/jso.21453; Madan AK, 2002, SURGERY, V132, P889, DOI 10.1067/msy.2002.126013; Makni SK, 2007, CANCER RADIOTHER, V11, P276, DOI 10.1016/j.canrad.2007.04.003; MCGUIRE WL, 1977, CANCER, V39, P2934, DOI 10.1002/1097-0142(197706)39:6<2934::AID-CNCR2820390680>3.0.CO;2-P; Mera AD, 1998, ACTA CYTOL, V42, P1304; Mishina Y, 1993, J JPN SURG ASS, V54, P112; Mourier F, 1910, ARCH MED EXP ANAT PA, V22, P433; NANCE FC, 1966, AM J SURG, V112, P932, DOI 10.1016/0002-9610(66)90154-1; NIELSEN M, 1981, ACTA PATH MICRO IM A, V89, P251; Qureshi S S, 2005, J Postgrad Med, V51, P125; Reitmann K, 1908, ARCH DERMATOL SYPH-G, V90, P351, DOI 10.1007/BF01830233; SANDISON AT, 1959, BRIT J SURG, V47, P54, DOI 10.1002/bjs.18004720111; Satake T, 1980, GAN TO KAGAKU RYOHO, V26, P577; Sato T, 2008, BREAST CANCER-TOKYO, V15, P315, DOI 10.1007/s12282-008-0040-5; Schmutzer K J, 1973, J Natl Med Assoc, V65, P426; SILVERMA.EM, 1974, SURG GYNECOL OBSTET, V138, P26; Stahr H, 1922, Z KREBSFORSCH, V19, P231, DOI 10.1007/BF02122630; Tachibana S, 1986, J CLIN SURG, V41, P1719; Timucin C., 2009, TURK J CANC, V39, P62; Togo S, 1980, GAN NO RINSHO, V26, P386	44	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-6930			ONCOTARGETS THER	OncoTargets Ther.		2015	8						91	97		10.2147/OTT.S67921		7	Biotechnology & Applied Microbiology; Oncology	Biotechnology & Applied Microbiology; Oncology	AX4JT	WOS:000346899800001		
J	Hiraoka, T; Kakita, T; Okamoto, F; Oshika, T				Hiraoka, Takahiro; Kakita, Tetsuhiko; Okamoto, Fumiki; Oshika, Tetsuro			Influence of Ocular Wavefront Aberrations on Axial Length Elongation in Myopic Children Treated with Overnight Orthokeratology	OPHTHALMOLOGY			English	Article							HIGHER-ORDER ABERRATIONS; REFRACTIVE ERROR; ACCOMMODATIVE RESPONSE; PERIPHERAL REFRACTION; CONTRAST SENSITIVITY; SPECTACLE LENSES; CRYSTALLINE LENS; UNITED-STATES; RISK-FACTORS; PROGRESSION	Purpose: To determine ocular optical parameters that affect axial length elongation in myopic children undergoing overnight orthokeratology. Design: Prospective, noncomparative study. Participants: Fifty-nine subjects who met the inclusion criteria were enrolled in this study. Methods: Axial length and ocular wavefront aberration were assessed before and 1 year after the start of orthokeratology. Corneal topography was performed, and then corneal multifocality was calculated for a 4-mm pupil. After evaluating simple correlations between axial elongation and optical parameters, multiple linear regression analysis was performed to identify explanatory variables with a statistically significant contribution to axial elongation. Main Outcome Measures: Axial length and ocular wavefront aberration before and 1 year after the start of orthokeratology. Results: Fifty-five subjects completed the 1-year follow-up examinations. At baseline, their age ranged from 7.2 to 12.0 years. The manifest spherical equivalent refractive error ranged from -3.50 to -0.75 diopters. The mean axial length significantly increased from 24.20 mm at baseline to 24.43 mm 1 year after treatment. The axial elongation showed significant simple correlations with the change in C-2(0), change in second-order aberration, change in coma-like aberration, change in spherical-like aberration, change in total higher-order aberrations, change in corneal multifocality, baseline age, and baseline spherical equivalent refractive error, but not C-4(0). Multiple linear regression analysis showed that the change in coma-like aberration was the most relevant variable. Conclusions: Asymmetric corneal shapes, rather than concentric and radially symmetric shapes, have a considerable effect on retardation of axial elongation, suggesting that the inhibitory effect of orthokeratology on myopia progression is caused by mechanisms other than the reduction in peripheral hyperopic defocus. (C) 2015 by the American Academy of Ophthalmology.	[Hiraoka, Takahiro; Okamoto, Fumiki; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan; [Kakita, Tetsuhiko] Kakita Eye Clin, Chiba, Japan	Hiraoka, T (reprint author), Univ Tsukuba, Fac Med, Dept Ophthalmol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	thiraoka@md.tsukuba.ac.jp			Charitable Trust Fund for Ophthalmic Research in commemoration of the founder of Santen Pharmaceutical's Founder; Japan National Society for the Prevention of Blindness	Supported by the Charitable Trust Fund for Ophthalmic Research in commemoration of the founder of Santen Pharmaceutical's Founder and by the grant from Japan National Society for the Prevention of Blindness.	Tong L, 2009, OPHTHALMOLOGY, V116, P572, DOI 10.1016/j.ophtha.2008.10.020; Atchison DA, 2004, INVEST OPHTH VIS SCI, V45, P3380, DOI 10.1167/iovs.04-0292; Hiraoka T, 2012, INVEST OPHTH VIS SCI, V53, P3913, DOI 10.1167/iovs.11-8453; Saw SM, 1996, EPIDEMIOL REV, V18, P175; Jones LA, 2005, INVEST OPHTH VIS SCI, V46, P2317, DOI 10.1167/iovs.04-0945; Drexler W, 1998, INVEST OPHTH VIS SCI, V39, P2140; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Smith EL, 2009, VISION RES, V49, P2386, DOI 10.1016/j.visres.2009.07.011; Cho P, 2005, CURR EYE RES, V30, P71, DOI 10.1080/02713680590907256; ZADNIK K, 1995, INVEST OPHTH VIS SCI, V36, P1581; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; JENSEN H, 1995, ACTA OPHTHALMOL SCAN, V73, P389; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Kakita T, 2011, INVEST OPHTH VIS SCI, V52, P2170, DOI 10.1167/iovs.10-5485; Kang PL, 2011, OPTOMETRY VISION SCI, V88, P476, DOI 10.1097/OPX.0b013e31820f16fb; Phillips JR, 2005, BRIT J OPHTHALMOL, V89, P1196, DOI 10.1136/bjo.2004.064212; Chen Z, 2012, OPTOMETRY VISION SCI, V89, P1636, DOI 10.1097/OPX.0b013e31826c1831; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Sankaridurg P, 2010, OPTOMETRY VISION SCI, V87, P631, DOI 10.1097/OPX.0b013e3181ea19c7; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Saw SM, 2005, INVEST OPHTH VIS SCI, V46, P51, DOI 10.1167/iovs.04-0565; Wang TJ, 2009, EYE, V23, P1168, DOI 10.1038/eye.2008.184; Walline JJ, 2009, BRIT J OPHTHALMOL, V93, P1181, DOI 10.1136/bjo.2008.151365; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Vitale S, 2006, OPHTHALMOLOGY, V113, P2163, DOI 10.1016/j.ophtha.2006.06.033; McCarty CA, 2006, BRIT J OPHTHALMOL, V90, P521, DOI 10.1136/bjo.2006.090233; Mutti DO, 2011, INVEST OPHTH VIS SCI, V52, P199, DOI 10.1167/iovs.09-4826; GWIAZDA J, 1993, INVEST OPHTH VIS SCI, V34, P690; Charman WN, 1999, OPHTHAL PHYSL OPT, V19, P126, DOI 10.1046/j.1475-1313.1999.00414.x; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Mutti DO, 1998, INVEST OPHTH VIS SCI, V39, P120; Berntsen DA, 2005, OPTOMETRY VISION SCI, V82, P490, DOI 10.1097/01.opx.0000168586.36165.bb; Berntsen DA, 2010, OPTOMETRY VISION SCI, V87, P823, DOI 10.1097/OPX.0b013e3181f6f776; Charman WN, 2006, OPTOMETRY VISION SCI, V83, P641, DOI 10.1097/01.opx.0000232840.66716.af; Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P237; Goss DA, 1999, OPTOMETRY VISION SCI, V76, P292, DOI 10.1097/00006324-199905000-00016; Goss D A, 1985, J Am Optom Assoc, V56, P608; Hiraoka T, 2007, INVEST OPHTH VIS SCI, V48, P550, DOI 10.1167/iovs.06-0914; Hiraoka T, 2009, BRIT J OPHTHALMOL, V93, P203, DOI 10.1136/bjo.2007.136655; Joslin CE, 2003, OPTOMETRY VISION SCI, V80, P805, DOI 10.1097/00006324-200312000-00010; Kuroda T, 2002, J CATARACT REFR SURG, V28, P438, DOI 10.1016/S0886-3350(01)01176-2; Lim MCC, 2009, EYE, V23, P1086, DOI 10.1038/eye.2008.225; Lin Z, 2010, OPTOMETRY VISION SCI, V87, P4, DOI 10.1097/OPX.0b013e3181c078f1; Mathur A, 2009, OPTOMETRY VISION SCI, V86, P476, DOI 10.1097/OPX.0b013e31819fa5aa; Mutti DO, 2000, INVEST OPHTH VIS SCI, V41, P1022; Oshika T, 2002, INVEST OPHTH VIS SCI, V43, P2882; PHILLIPS CI, 1990, BRIT J OPHTHALMOL, V74, P47, DOI 10.1136/bjo.74.1.47; RICHLER A, 1980, ACTA OPHTHALMOL, V58, P468; Seidemann A, 2002, J OPT SOC AM A, V19, P2363, DOI 10.1364/JOSAA.19.002363; SHUM PJT, 1993, AM J OPHTHALMOL, V115, P76; Smith EL, 2005, INVEST OPHTH VIS SCI, V46, P3965, DOI 10.1167/iovs.05-0445; SVEINSSON K, 1982, ACTA OPHTHALMOL, V60, P779; Tan NWH, 2000, OPTOMETRY VISION SCI, V77, P465, DOI 10.1097/00006324-200009000-00007	54	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JAN	2015	122	1					93	100		10.1016/j.ophtha.2014.07.042		8	Ophthalmology	Ophthalmology	AX1XK	WOS:000346737000024		
J	Kadonosono, K; Arakawa, A; Yamane, S; Inoue, M; Yamakawa, T; Uchio, E; Yanagi, Y				Kadonosono, Kazuaki; Arakawa, Akira; Yamane, Shin; Inoue, Maiko; Yamakawa, Tadashi; Uchio, Eiichi; Yanagi, Yasuo			Displacement of Submacular Hemorrhages in Age-Related Macular Degeneration with Subretinal Tissue Plasminogen Activator and Air	OPHTHALMOLOGY			English	Article							PNEUMATIC DISPLACEMENT; INJECTION; MANAGEMENT; SURGERY; SECONDARY; REMOVAL	Objective: To study the anatomic and visual outcomes of a surgical procedure in which tissue plasminogen activator and air are injected subretinally to displace massive submacular hemorrhages secondary to age-related macular degeneration. Design: Prospective, consecutive, interventional case series. Participants: Thirteen consecutive patients (13 eyes) with massive submacular hemorrhages secondary to age-related macular degeneration. Intervention: The surgical procedure consisted of a 25-gauge vitrectomy and submacular injection of tissue plasminogen activator (25 mu g) and 0.4 ml air with a microneedle having an outer diameter of 50 mu m. The procedure was followed by having the patient remain in the prone position overnight. Main Outcome Measures: Mean visual acuity change from baseline, mean central lesion thickness change from baseline, fluorescein angiography findings, and surgical complications. Results: Total subfoveal blood displacement was achieved in all 13 eyes (100%). Central lesion thickness decreased from a mean baseline value of 867 mm to a mean value of 379 mu m at 1 month after surgery. There was visual improvement in 11 eyes, no visual improvement in 1 eye, and poorer vision in 1 eye. The mean change in Early Treatment Diabetic Retinopathy Study letter score from baseline was 19.4 letters at 1 month (P = 0.006) and 23.3 letters at 3 months (P = 0.001). There was intraoperative macular hole formation. Conclusions: Submacular air injection with a microneedle facilitates displacement of clots dissolved with tissue plasminogen activator with fewcomplications and results in earlier visual improvement. (C) 2015 by the American Academy of Ophthalmology.	[Kadonosono, Kazuaki; Arakawa, Akira; Yamane, Shin; Inoue, Maiko; Yamakawa, Tadashi] Yokohama City Univ, Med Ctr, Dept Ophthalmol, Yokohama, Kanagawa 2320024, Japan; [Uchio, Eiichi] Fukuoka Univ, Dept Ophthalmol, Fukuoka 81401, Japan; [Yanagi, Yasuo] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 113, Japan	Kadonosono, K (reprint author), Yokohama City Univ, Med Ctr, Dept Ophthalmol, 4-57 Urafune Cho Minami Ku, Yokohama, Kanagawa 2320024, Japan.	kado@med.yokohama-cu.ac.jp					Kamei M, 1996, AM J OPHTHALMOL, V121, P267; Ohji M, 1998, ARCH OPHTHALMOL-CHIC, V116, P1326; Hassan AS, 1999, OPHTHALMOLOGY, V106, P1900, DOI 10.1016/S0161-6420(99)90399-8; Shienbaum G, 2013, AM J OPHTHALMOL, V155, P1009, DOI 10.1016/j.ajo.2013.01.012; Fine HF, 2010, RETINA-J RET VIT DIS, V30, P1588, DOI 10.1097/IAE.0b013e3181e2263c; Chen CY, 2007, RETINA-J RET VIT DIS, V27, P321, DOI 10.1097/01.iae.0000237586.48231.75; Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; Olivier S, 2004, OPHTHALMOLOGY, V111, P1201, DOI 10.1016/j.ophtha.2003.10.020; Berrocal MH, 1996, AM J OPHTHALMOL, V122, P486; Bressler NM, 2004, OPHTHALMOLOGY, V111, P1993, DOI 10.1016/j.ophtha.2004.07.023; Stopa M, 2007, RETINA-J RET VIT DIS, V27, P370, DOI 10.1097/IAE.0b013e3180439bc9; TOTH CA, 1991, ARCH OPHTHALMOL-CHIC, V109, P723; GLATT H, 1982, AM J OPHTHALMOL, V94, P762, DOI 10.1016/0002-9394(82)90301-4; TOTH CA, 1992, AM J OPHTHALMOL, V113, P175; Oshima Y, 2007, BRIT J OPHTHALMOL, V91, P193, DOI 10.1136/bjo.2006.101444; Berger JW, 1998, RETINA, V18, P86; Berger JW, 1998, RETINA-J RET VIT DIS, V18, P84; Hillenkamp J, 2012, OPHTHALMOLOGE, V109, P648, DOI 10.1007/s00347-012-2564-5; Kadonosono K, 2013, JAMA OPHTHALMOL, V131, P783, DOI 10.1001/jamaophthalmol.2013.2585; Kadonosono K, 2011, INVEST OPHTH VIS SCI, V52, P5790, DOI 10.1167/iovs.11-7327; Martel JN, 2013, JAMA OPHTHALMOL, V131, P1632, DOI 10.1001/jamaophthalmol.2013.5464	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JAN	2015	122	1					123	128		10.1016/j.ophtha.2014.07.027		6	Ophthalmology	Ophthalmology	AX1XK	WOS:000346737000028		
J	Ishida, T; Moriyama, M; Tanaka, Y; Shinohara, K; Shimada, N; Yoshida, T; Ohno-Matsui, K				Ishida, Tomoka; Moriyama, Muka; Tanaka, Yuichiro; Shinohara, Kosei; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko			Radial Tracts Emanating from Staphyloma Edge in Eyes with Pathologic Myopia	OPHTHALMOLOGY			English	Editorial Material									[Ishida, Tomoka; Moriyama, Muka; Tanaka, Yuichiro; Shinohara, Kosei; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo 101138510, Japan	Ohno-Matsui, K (reprint author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual, Bunkyo Ku, 9 Sci,1-5-45 Yushima, Tokyo 101138510, Japan.	k.ohno.oph@tmd.ac.jp					Imamura Y, 2011, OPHTHALMOLOGY, V118, P700, DOI 10.1016/j.ophtha.2010.08.017; Ohno-Matsui K, 2014, OPHTHALMOLOGY, V121, P1798, DOI 10.1016/j.ophtha.2014.03.035; Spaide RF, 2005, OPHTHALMOLOGY, V112, P825, DOI 10.1016/j.ophtha.2005.01.003; Curtin B J, 1977, Trans Am Ophthalmol Soc, V75, P67; Spaide RF, 2014, STAPHYLOMA 1, P167	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JAN	2015	122	1					215	216				3	Ophthalmology	Ophthalmology	AX1XK	WOS:000346737000040		
J	Nakakura, S; Okamoto, A; Nagasato, D; Tabuchi, H; Kiuchi, Y				Nakakura, Shunsuke; Okamoto, Akiko; Nagasato, Daisuke; Tabuchi, Hitoshi; Kiuchi, Yoshiaki			Hypotony Maculopathy Obtained by Retro-mode Retinal Imaging	OPHTHALMOLOGY			English	Editorial Material									[Nakakura, Shunsuke; Okamoto, Akiko; Nagasato, Daisuke; Tabuchi, Hitoshi] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo 6711227, Japan; [Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	Nakakura, S (reprint author), Saneikai Tsukazaki Hosp, Dept Ophthalmol, Aboshi Waku 68-1, Himeji, Hyogo 6711227, Japan.	shunsukenakakura@yahoo.co.jp					Bitrian E, 2014, AM J OPHTHALMOL, V158, P597, DOI 10.1016/j.ajo.2014.05.021; Diniz B, 2013, BRIT J OPHTHALMOL, V97, P285, DOI 10.1136/bjophthalmol-2012-302575; Shin YU, 2012, AM J OPHTHALMOL, V154, P155, DOI 10.1016/j.ajo.2012.01.023; Tanaka Y, 2010, AM J OPHTHALMOL, V149, P635, DOI 10.1016/j.ajo.2009.10.024; Vujosevic S, 2012, ACTA OPHTHALMOL, V90, P374, DOI DOI 10.1111/J.1755-3768.2012.02410.X.PUBMED:22489939	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JAN	2015	122	1					216	217				3	Ophthalmology	Ophthalmology	AX1XK	WOS:000346737000041		
J	Oishi, A; Oh, H; Mandai, M; Honda, S; Miyamoto, N				Oishi, Akio; Oh, Hideyasu; Mandai, Michiko; Honda, Shigeru; Miyamoto, Noriko			Re: Oishi et al.: LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy (Ophthalmology 2014;121:1151-2) reply	OPHTHALMOLOGY			English	Letter							MONOTHERAPY		[Oishi, Akio; Mandai, Michiko; Miyamoto, Noriko] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan; [Oh, Hideyasu] Hyogo Kenritsu Amagasaki Hosp, Amagasaki, Hyogo, Japan; [Honda, Shigeru] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan	Oishi, A (reprint author), Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan.	aquio@kuhp.kyoto-u.ac.jp					Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Oishi A, 2014, OPHTHALMOLOGY, V121, P1151, DOI 10.1016/j.ophtha.2013.12.037; Hikichi T, 2014, BRIT J OPHTHALMOL, V98, DOI 10.1136/bjophthalmol-2013-304688; Kang HM, 2013, AM J OPHTHALMOL, V156, P652, DOI 10.1016/j.ajo.2013.05.038	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JAN	2015	122	1					E6	E7				3	Ophthalmology	Ophthalmology	AX1XK	WOS:000346737000004		
J	Varallyay, Z; Szabo, A; Rosales, A; Gonzales, E; Tobioka, H; Headley, C				Varallyay, Z.; Szabo, A.; Rosales, A.; Gonzales, E.; Tobioka, H.; Headley, C.			Accurate modeling of cladding pumped, star-shaped, Yb-doped fiber amplifiers	OPTICAL FIBER TECHNOLOGY			English	Article						Optical fiber amplifiers; Ytterbium doped fibers; Cladding pumped amplifier; Star-shaped cladding; Amplification measurements; Numerical simulations	LASERS; POWER; AMPLIFICATION; FUTURE	Based on an iterative numerical approach, we model continuous wave (CW), high power, cladding-pumped Yb-doped fiber amplifiers with bi-directional pumping of the star-shaped cladding. Accurate prediction of over 1 kWoutput power is demonstrated, and the calculation results are in good agreement with experiments. Absorption and emission cross sections for the used doped fiber are determined experimentally in advance. Using the model at such high powers, it is shown that the Giles model parameter of the effective overlap integral in the star-shaped cladding may vary coupling the light from diodes with different numerical apertures, which is believed caused by the increasing amount of pump light launched into higher order modes. (C) 2014 Elsevier Inc. All rights reserved.	[Varallyay, Z.] Furukawa Elect Inst Technol Ltd, H-1158 Budapest, Hungary; [Szabo, A.] Budapest Univ Technol & Econ, Dept TMI, H-1117 Budapest, Hungary; [Rosales, A.; Gonzales, E.; Headley, C.] OFS Labs, Somerset, NJ 08873 USA; [Tobioka, H.] Furukawa Elect Corp Ltd, Chiba, Japan	Varallyay, Z (reprint author), Furukawa Elect Inst Technol Ltd, H-1158 Budapest, Hungary.	z.varallyay@feti.hu			European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]	This research was supported in part by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 ''National Excellence Program''.	Varallyay Z, 2009, OPT EXPRESS, V17, P17242, DOI 10.1364/OE.17.017242; Florea C, 1999, J LIGHTWAVE TECHNOL, V17, P1593, DOI 10.1109/50.788565; [Anonymous], 1992, The Art of Scientific Computing, Patent No. 6157763; Smith AV, 2011, OPT EXPRESS, V19, P11318, DOI 10.1364/OE.19.011318; Richardson DJ, 2010, J OPT SOC AM B, V27, pB63, DOI 10.1364/JOSAB.27.000B63; Paschotta R, 1997, IEEE J QUANTUM ELECT, V33, P1049, DOI 10.1109/3.594865; Jetschke S, 2007, OPT EXPRESS, V15, P14838, DOI 10.1364/OE.15.014838; [Anonymous], 1992, ART SCI COMPUTING; Fermann ME, 2013, NAT PHOTONICS, V7, P868, DOI 10.1038/nphoton.2013.280; Koshiba M, 2000, J LIGHTWAVE TECHNOL, V18, P737, DOI 10.1109/50.842091; Mourou G, 2013, NAT PHOTONICS, V7, P258; Xu C, 2013, NAT PHOTONICS, V7, P875, DOI 10.1038/nphoton.2013.284; Hansen KR, 2013, OPT EXPRESS, V21, P1944, DOI 10.1364/OE.21.001944; GILES CR, 1991, J LIGHTWAVE TECHNOL, V9, P271, DOI 10.1109/50.65886; Jauregui C, 2013, NAT PHOTONICS, V7, P861, DOI 10.1038/nphoton.2013.273; Grubb S.G., 2000, NUMERICAL RECIPIES C, Patent No. 6,157,763; Liu AP, 1996, OPT COMMUN, V132, P511; Marciante JR, 1996, APPL PHYS LETT, V69, P593, DOI 10.1063/1.117917; Martinez-Rios A, 2005, OPT COMMUN, V246, P385, DOI 10.1016/j.optcom.2004.11.013; Nguyen DT, 2007, IEEE J QUANTUM ELECT, V43, P1018, DOI 10.1109/JQE.2007.905010; Sands D., 2005, DIODE LASERS; Snitzer E., 1988, P OPTICAL FIBER SENS, V88, pPD5; Valley GC, 2001, OPT FIBER TECHNOL, V7, P21, DOI 10.1006/ofte.2000.0351; Wang Y, 2005, J LIGHTWAVE TECHNOL, V23, P2139, DOI 10.1109/JLT.2005.849946; Young D, 2003, OPT EXPRESS, V11, P830, DOI 10.1364/OE.11.000830	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	JAN	2015	21						180	186		10.1016/j.yofte.2014.11.003		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	AX0MD	WOS:000346645500029		
J	Ruan, YL; Ji, H; Johnson, BC; Ohshima, T; Greentree, AD; Gibson, BC; Monro, TM; Ebendorff-Heidepriem, H				Ruan, Yinlan; Ji, Hong; Johnson, Brett C.; Ohshima, Takeshi; Greentree, Andrew D.; Gibson, Brant C.; Monro, Tanya M.; Ebendorff-Heidepriem, Heike			Nanodiamond in tellurite glass Part II: practical nanodiamond-doped fibers	OPTICAL MATERIALS EXPRESS			English	Article							SINGLE-PHOTON SOURCE; DIAMOND SPINS; CENTERS; LIGHT	Tellurite glass fibers with embedded nanodiamond are attractive materials for quantum photonics applications. Reducing the loss of these fibers in the 600-800 nm wavelength range of nanodiamond fluorescence is essential to exploit the unique properties of nanodiamond in the new hybrid material. The first part of this study reported the origin of loss in nanodiamond-doped glass and impact of glass fabrication conditions. Here, we report the fabrication of nanodiamond-doped tellurite fibers with significantly reduced loss in the visible through further understanding of the impact of glass fabrication conditions on the interaction of the glass melt with the embedded nanodiamond. We fabricated tellurite fibers containing nanodiamond in concentrations up to 0.7 ppm-weight, while reducing the loss by more than an order of magnitude down to 10 dB/m at 600-800 nm. (C)2014 Optical Society of America	[Ruan, Yinlan; Ji, Hong; Monro, Tanya M.; Ebendorff-Heidepriem, Heike] Univ Adelaide, Inst Photon & Adv Sensing, ARC Ctr Excellence Nanoscale BioPhoton, Adelaide, SA 5005, Australia; [Johnson, Brett C.] Univ Melbourne, Sch Phys, Ctr Quantum Comp & Commun Technol, Parkville, Vic 3010, Australia; [Ohshima, Takeshi] Japan Atom Energy Agcy, Takasaki, Gunma 3701292, Japan; [Greentree, Andrew D.; Gibson, Brant C.] RMIT Univ, Sch Appl Sci, ARC Ctr Excellence Nanoscale BioPhoton, Melbourne, Vic 3001, Australia	Ruan, YL (reprint author), Univ Adelaide, Inst Photon & Adv Sensing, ARC Ctr Excellence Nanoscale BioPhoton, Adelaide, SA 5005, Australia.	heike.ebendorff@adelaide.edu.au	Ebendorff-Heidepriem, Heike/D-7773-2015; Greentree, Andrew/A-8503-2008	Ebendorff-Heidepriem, Heike/0000-0002-4877-7770; Greentree, Andrew/0000-0002-3505-9163	ARC [DP120100901, DP130102494, FF0883189, FT110100225, LE100100104, CE110001027, CE140100003]; ARC Georgina Sweet Laureate Fellowship; Australian National Fabrication Facility utilizing Commonwealth and SA State Government funding	This work has been supported by ARC grants (DP120100901, DP130102494, FF0883189, FT110100225, LE100100104, CE110001027, CE140100003). T.M. acknowledges the support of an ARC Georgina Sweet Laureate Fellowship. This work was performed in part at the OptoFab node of the Australian National Fabrication Facility utilizing Commonwealth and SA State Government funding. We wish to thank Alastair Dowler and Tim Zhao at the University of Adelaide for fiber fabrication and help with measuring gold content in glass samples, respectively.	Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Schmunk W, 2011, J MOD OPTIC, V58, P1252, DOI 10.1080/09500340.2011.601327; Schroder T, 2012, OPT EXPRESS, V20, P10490, DOI 10.1364/OE.20.010490; Brown R.H., 1956, Nature, V177, DOI 10.1038/177027a0; Beveratos A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.187901; Henderson MR, 2011, ADV MATER, V23, P2806, DOI 10.1002/adma.201100151; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Ampem-Lassen E, 2009, OPT EXPRESS, V17, P11287, DOI 10.1364/OE.17.011287; van der Sar T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120558; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Da N, 2011, J NON-CRYST SOLIDS, V357, P1558, DOI 10.1016/j.jnoncrysol.2010.12.032; Wang J. S., 1994, Optical Materials, V3, DOI 10.1016/0925-3467(94)90004-3; Cole JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495401; Ebendorff-Heidepriem H, 2012, OPT MATER EXPRESS, V2, P432; Ebendorff-Heidepriem H, 2012, OPT MATER EXPRESS, V2, P304; Ebendorff-Heidepriem H, 2014, OPT MATER EXPRESS, V4, P2608, DOI 10.1364/OME.4.002608; Kuhn S, 2001, J MICROSC-OXFORD, V202, P2, DOI 10.1046/j.1365-2818.2001.00829.x; Manning S, 2012, OPT MATER EXPRESS, V2, P140; McGuinness LP, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/7/073042; Mori A, 2008, J CERAM SOC JPN, V116, P1040, DOI 10.2109/jcersj2.116.1040; Oermann MR, 2009, OPT EXPRESS, V17, P15578, DOI 10.1364/OE.17.015578; Schroder T, 2011, NANO LETT, V11, P198, DOI 10.1021/nl103434r	22	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2159-3930			OPT MATER EXPRESS	Opt. Mater. Express	JAN 1	2015	5	1					73	87		10.1364/OME.5.000073		15	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AX4BF	WOS:000346878400008		
J	Matsui, T; Yamashita, S; Wado, H; Fujikawa, H; Iizuka, H				Matsui, Takayuki; Yamashita, Shuichi; Wado, Hiroyuki; Fujikawa, Hisayoshi; Iizuka, Hideo			Flat grating lens utilizing widely variable transmission-phase via guided-modes	OPTICS LETTERS			English	Article							HIGH-CONTRAST GRATINGS; REFLECTORS; RESONANCES; DESIGN; MIRROR	We experimentally demonstrate a polarization-independent flat grating lens in the near-infrared region. The grating lens consists of ridges in the square lattice arrangement, and the ridge dimensions are gradually changed to distribute a phase map with focusing ability. It is well known that guided modes in gratings offer unity-reflection at a resonance, and therefore the transmission phase is widely varied around the resonance. We employ such transmission phase behavior and show that high transmittance is obtained in each unit cell for wide variation range of the transmission phase at the operation wavelength by sharpening the resonance. This enables us to accomplish a highly efficient transmissive grating lens. (C) 2014 Optical Society of America	[Matsui, Takayuki; Fujikawa, Hisayoshi; Iizuka, Hideo] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Yamashita, Shuichi; Wado, Hiroyuki] DENSO Corp, Res Labs, Nisshin, Aichi 4700111, Japan	Matsui, T (reprint author), Toyota Cent Res & Dev Labs Inc, 41-1 Yokomichi, Nagakute, Aichi 4801192, Japan.	t-matsui@mosk.tytlabs.co.jp			Kyoto University Nano Technology Hub in "Nanotechnology Platform Project" - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The authors would like to thank S. Harada for helpful discussions, and T. M. and H. I. would like to thank A. Miura for his technical support. A part of this work was supported by Kyoto University Nano Technology Hub in "Nanotechnology Platform Project" sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Karagodsky V, 2012, OPT EXPRESS, V20, P10888, DOI 10.1364/OE.20.010888; Fattal D, 2010, NAT PHOTONICS, V4, P466, DOI [10.1038/NPHOTON.2010.116, 10.1038/nphoton.2010.116]; Aieta F, 2012, NANO LETT, V12, P4932, DOI 10.1021/nl302516v; Lu FL, 2010, OPT EXPRESS, V18, P12606, DOI 10.1364/OE.18.012606; Chase C, 2010, OPT EXPRESS, V18, P15461, DOI 10.1364/OE.18.015461; Mateus CFR, 2004, IEEE PHOTONIC TECH L, V16, P518, DOI 10.1109/LPT.2003.821258; WANG SS, 1990, J OPT SOC AM A, V7, P1470, DOI 10.1364/JOSAA.7.001470; Lalanne P, 1999, J OPT SOC AM A, V16, P1143, DOI 10.1364/JOSAA.16.001143; Klemm AB, 2013, OPT LETT, V38, P3410, DOI 10.1364/OL.38.003410; Chang-Hasnain CJ, 2012, ADV OPT PHOTONICS, V4, P379, DOI 10.1364/AOP.4.000379; Staude I, 2013, ACS NANO, V7, P7824, DOI 10.1021/nn402736f; Born M., 1999, PRINCIPLES OPTICS; Brundrett DL, 1998, OPT LETT, V23, P700, DOI 10.1364/OL.23.000700; Fan SH, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235112; Fattal D., 2011, INTEGRATED PHOTONICS; Goodman J. W., 2004, INTRO FOURIER OPTICS; Iizuka H, 2010, OPT LETT, V35, P3973, DOI 10.1364/OL.35.003973; Joannopoulos J D, 2011, PHOTONIC CRYSTALS MO; Kim H., 2012, FOURIER MODAL METHOD; Lousse V, 2004, OPT EXPRESS, V12, P1575, DOI 10.1364/OPEX.12.001575; Matsui T, 2014, OPT EXPRESS, V22, P25362, DOI 10.1364/OE.22.025362; MOHARAM MG, 1995, J OPT SOC AM A, V12, P1068, DOI 10.1364/JOSAA.12.001068	22	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	JAN 1	2015	40	1					25	28		10.1364/OL.40.000025		4	Optics	Optics	AX4BE	WOS:000346878300007		
J	Zaitsu, SI; Imasaka, T				Zaitsu, Shin-ichi; Imasaka, Totaro			Continuous-wave anti-Stokes Raman laser based on phase-matched nondegenerate four-wave mixing	OPTICS LETTERS			English	Article							ALL-SOLID-STATE; SIDE-BAND; H-2; GENERATION; SCATTERING	We demonstrate phase-matched nondegenerate four-wave mixing (FWM) in a high-finesse optical cavity using a gaseous Raman-active medium pumped by two independent continuous-wave lasers. Efficient upconversion is achieved for pump beams at different wavelengths under phase-matched conditions by optimizing the total dispersion of the hydrogen-filled optical cavity. The independent control of the pump-beam polarizations leads to further enhancement of the upconversion efficiency arising from a larger Raman gain than that in degenerate FWM. This approach offers a promising alternative for a narrow-linewidth tunable light source for highly precise laser spectroscopy. (C) 2014 Optical Society of America	[Zaitsu, Shin-ichi; Imasaka, Totaro] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Zaitsu, Shin-ichi] Japan Sci & Technol Agcy JST, PRESTO, Saitama 3320012, Japan; [Zaitsu, Shin-ichi; Imasaka, Totaro] Kyushu Univ, Ctr Future Chem, Div Optoelect & Photon, Nishi Ku, Fukuoka 8190395, Japan	Zaitsu, SI (reprint author), Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	s-zaitsu@cstf.kyushu-u.ac.jp			Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS KAKENHI) [26620120]; Simadzu Science Foundation	This research was supported by the PRESTO program from the Japan Science and Technology Agency (JST) and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI, Grant No. 26620120). This study was also partly supported by the Simadzu Science Foundation.	Agrawal G. P., 2012, NONLINEAR FIBER OPTI; Pask HM, 2005, OPT LETT, V30, P2454, DOI 10.1364/OL.30.002454; Rong HS, 2005, NATURE, V433, P725, DOI 10.1038/nature03346; HILL KO, 1976, APPL PHYS LETT, V29, P181, DOI 10.1063/1.89016; MINCK RW, 1966, PHYS REV LETT, V17, P229, DOI 10.1103/PhysRevLett.17.229; Min B, 2003, OPT LETT, V28, P1507, DOI 10.1364/OL.28.001507; Grabtchikov AS, 2004, OPT LETT, V29, P2524, DOI 10.1364/OL.29.002524; Brasseur JK, 1999, J OPT SOC AM B, V16, P1305, DOI 10.1364/JOSAB.16.001305; Brasseur JK, 1998, OPT LETT, V23, P367, DOI 10.1364/OL.23.000367; Brasseur JK, 2000, J OPT SOC AM B, V17, P1223, DOI 10.1364/JOSAB.17.001223; Grasyuk A. Z., 1990, Soviet Journal of Quantum Electronics, V20, DOI 10.1070/QE1990v020n10ABEH007430; Green JT, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.011805; Mildren RP, 2009, OPT EXPRESS, V17, P810, DOI 10.1364/OE.17.000810; PECK ER, 1977, J OPT SOC AM, V67, P1550, DOI 10.1364/JOSA.67.001550; Shen Y. R., 2002, PRINCIPLES NONLINEAR; SHEN YR, 1965, PHYS REV, V137, P1787, DOI 10.1103/PhysRev.137.A1787; Siegman A. E., 1986, LASERS; Sokolov AV, 2001, OPT LETT, V26, P728, DOI 10.1364/OL.26.000728; Zaitsu S, 2011, OPT EXPRESS, V19, P24298, DOI 10.1364/OE.19.024298; Zaitsu S, 2012, OPT COMMUN, V285, P347, DOI 10.1016/j.optcom.2011.09.054; Zaitsu SI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073901; Zaitsu SI, 2014, ANAL SCI, V30, P75	22	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	JAN 1	2015	40	1					73	76		10.1364/OL.40.000073		4	Optics	Optics	AX4BE	WOS:000346878300020		
J	Sebio, A; Gerger, A; Matsusaka, S; Yang, DY; Zhang, W; Stremitzer, S; Stintzing, S; Sunakawa, Y; Yamauchi, S; Ning, Y; Fujimoto, Y; Ueno, M; Lenz, HJ				Sebio, Ana; Gerger, Armin; Matsusaka, Satoshi; Yang, Dongyun; Zhang, Wu; Stremitzer, Stefan; Stintzing, Sebastian; Sunakawa, Yu; Yamauchi, Shinichi; Ning, Yan; Fujimoto, Yoshiya; Ueno, Masashi; Lenz, Heinz-Josef			Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer	PHARMACOGENETICS AND GENOMICS			English	Article						adjuvant; colon cancer; obesity; polymorphisms; recurrence	ACTIVATED RECEPTOR-GAMMA; BODY-MASS INDEX; NF-KAPPA-B; COLORECTAL-CANCER; ADJUVANT TREATMENT; EPITHELIAL-CELLS; DOWNS-SYNDROME; EXPRESSION; PATHWAYS; LEPTIN	ObjectiveObesity is an established risk factor for colorectal cancer (CRC) incidence and it is also linked to CRC recurrence and survival. Polymorphisms located in obesity-related genes are associated with an increased risk of developing several cancer types including CRC. We evaluated whether single-nucleotide polymorphisms in obesity-related genes may predict tumor recurrence in colon cancer patients.Materials and methodsGenotypes were obtained from germline DNA from 207 patients with stage II or III colon cancer at the Norris Comprehensive Cancer Center. Nine polymorphisms in eight obesity-related genes (PPAR, LEP, NFKB, CD36, DRG1, NGAL, REGIA, and DSCR1) were evaluated. The primary endpoint of the study was the 3-year recurrence rate. Positive associations were also tested in an independent Japanese cohort of 350 stage III CRC patients.ResultsIn univariate analysis, for PPARrs1801282, patients with a CC genotype had significantly lower recurrence probability (294% SE) compared with patients with a CG genotype (48 +/- 8% SE) [hazard ratio (HR): 1.77; 95% confidence interval (CI), 1.01-3.10; P=0.040]. For DSCR1rs6517239, patients with an AA genotype had higher recurrence probability than patients carrying at least one allele G (37 +/- 4% SE vs. 15 +/- 6% SE) (HR: 0.51; 95% CI, 0.27-0.94; P=0.027). This association was stronger in the patients bearing a left-sided tumor (HR: 0.34; 95% CI, 0.13-0.88; P=0.018). In the Japanese cohort, no associations were found.ConclusionThis hypothesis-generating study suggests a potential influence of polymorphisms within obesity-related genes in the recurrence probability of colon cancer. These interesting results should be evaluated further. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Sebio, Ana; Gerger, Armin; Matsusaka, Satoshi; Yang, Dongyun; Zhang, Wu; Stremitzer, Stefan; Stintzing, Sebastian; Sunakawa, Yu; Yamauchi, Shinichi; Ning, Yan; Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90033 USA; [Lenz, Heinz-Josef] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gerger, Armin] Med Univ Graz, Div Clin Oncol, Dept Med, Graz, Austria; [Fujimoto, Yoshiya; Ueno, Masashi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan	Lenz, HJ (reprint author), Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Sharon A Carpenter Lab, 1441 Eastlake Ave, Los Angeles, CA 90033 USA.	lenz@usc.edu			National Cancer Institute [P30CA014089]	The project described was supported in part by award number P30CA014089 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Adams KF, 2007, AM J EPIDEMIOL, V166, P36, DOI 10.1093/aje/kwm049; Barzi A, 2013, CLIN CANCER RES, V19, P5842, DOI 10.1158/1078-0432.CCR-13-0325; Xu W, 2010, ONCOL REP, V24, P579, DOI 10.3892/or_00000895; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; Jaffe T, 2008, INT J CANCER, V123, P2543, DOI 10.1002/ijc.23821; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Poplin EA, 2005, J CLIN ONCOL, V23, P1819, DOI 10.1200/JCO.2005.04.169; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Meyerhardt JA, 2008, J CLIN ONCOL, V26, P4109, DOI 10.1200/JCO.2007.15.6687; Meyerhardt JA, 2003, CANCER, V98, P484, DOI 10.1002/cncr.11544; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-05-5085-4; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Bendardaf R, 2008, ANTICANCER RES, V28, P3865; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Dong Z, 2014, BRIT J CANCER, V110, P1801, DOI 10.1038/bjc.2014.70; Riemann K, 2007, INT J CLIN PHARM TH, V45, P423; Dignam JJ, 2006, J NATL CANCER I, V98, P1647, DOI 10.1093/jnci/djj442; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Vaiopoulos AG, 2013, J MOL MED, V91, P1029, DOI 10.1007/s00109-013-1045-x; Rechreche H, 1999, INT J CANCER, V81, P688, DOI 10.1002/(SICI)1097-0215(19990531)81:5<688::AID-IJC3>3.0.CO;2-R; Campbell PT, 2012, J CLIN ONCOL, V30, P42, DOI 10.1200/JCO.2011.38.0287; Gao JC, 2009, CANCER SCI, V100, P389, DOI 10.1111/j.1349-7006.2008.01053.x; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Hoffstedt J, 2002, HORM METAB RES, V34, P355, DOI 10.1055/s-2002-33466; Bauer KM, 2012, MOL CARCINOGEN, V51, P411, DOI 10.1002/mc.20804; Bush CR, 2007, J BIOL CHEM, V282, P23387, DOI 10.1074/jbc.M702708200; Chen JZ, 2012, CANCER CAUSE CONTROL, V23, P1767, DOI 10.1007/s10552-012-0066-z; Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z; Edge SB, 2010, AJCC CANC STAGING MA; Furstenau U, 1999, J BIOL CHEM, V274, P5851, DOI 10.1074/jbc.274.9.5851; Guang RJ, 2000, CANCER RES, V60, P749; Kato M, 2004, J CANCER RES CLIN, V130, P73, DOI 10.1007/s00432-003-0510-2; Meirhaeghe A, 1998, HUM MOL GENET, V7, P435, DOI 10.1093/hmg/7.3.435; Shao JY, 2002, CANCER RES, V62, P3282; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Zhu H, 2013, ONCOL LETT, V6, P353, DOI 10.3892/ol.2013.1414	43	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	JAN	2015	25	1					30	37		10.1097/FPC.0000000000000101		8	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	AX0HF	WOS:000346632900004		
J	Lin, CY; Huang, LY; Chi, WC; Huang, TL; Kakimoto, T; Tsai, CR; Huang, HJ				Lin, Chung-Yi; Huang, Li-Yao; Chi, Wen-Chang; Huang, Tsai-Lien; Kakimoto, Tatsuo; Tsai, Chang-Rong; Huang, Hao-Jen			Pathways involved in vanadate-induced root hair formation in Arabidopsis	PHYSIOLOGIA PLANTARUM			English	Article							CELL-FATE SPECIFICATION; PHOSPHORUS AVAILABILITY; CAPRICE TRANSCRIPTION; CHEMICAL COMPOSITION; THALIANA SEEDLINGS; HYDROGEN-PEROXIDE; GROWTH; EPIDERMIS; ETHYLENE; PROTEIN	Root hair formation is controlled by environmental signals. We found significantly increased Arabidopsis root hair density and length in response to low-dose vanadate (V). Reactive oxygen species (ROS) production was induced with V treatment. We investigated the possible role of NADPH oxidase in altering root system architecture induced by V by using diphenylene iodonium (DPI), an inhibitor of NADPH oxidase, and an NADPH oxidase mutant (rhd2/AtrbohC). NADPH oxidase was involved in root hair elongation induced by V. As well, ethylene receptor (ETR1) and ROOT HAIR DEFECTIVE (RHD6) participated in inducing root hair formation induced by V. Furthermore, the kinase inhibitors, genistein (tyrosine kinase inhibitor) and K252a (ser/thr kinase inhibitor), and a phosphatase inhibitor, cantharidin (ser/thr phosphatase inhibitor), suppressed root hair formation induced by V. To elucidate the regulation of gene expression in response to V, we investigated transcriptional changes in roots by microarray assay. Exposure to V triggered changes in transcript levels of genes related to cell wall formation, ROS activity and signaling. Several genes involved in root hair formation were also regulated.	[Lin, Chung-Yi; Huang, Li-Yao; Chi, Wen-Chang; Huang, Tsai-Lien; Tsai, Chang-Rong; Huang, Hao-Jen] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Kakimoto, Tatsuo] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Huang, HJ (reprint author), Natl Cheng Kung Univ, Dept Life Sci, 1 Univ Rd 701, Tainan 70101, Taiwan.	haojen@mail.ncku.edu.tw					Lin CW, 2009, PLANT PHYSIOL BIOCH, V47, P369, DOI 10.1016/j.plaphy.2009.01.005; Ryu KH, 2005, DEVELOPMENT, V132, P4765, DOI 10.1242/dev.02055; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335; Borch K, 1999, PLANT CELL ENVIRON, V22, P425, DOI 10.1046/j.1365-3040.1999.00405.x; Bibikova TN, 1998, DEVELOPMENT, V125, P2925; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Schmidt W, 2001, PLANT PHYSIOL, V125, P2078, DOI 10.1104/pp.125.4.2078; Kapulnik Y, 2011, J EXP BOT, V62, P2915, DOI 10.1093/jxb/erq464; SMITH RD, 1994, PLANTA, V194, P516, DOI 10.1007/BF00714465; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235; Masucci JD, 1996, PLANT CELL, V8, P1505, DOI 10.1105/tpc.8.9.1505; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Libault M, 2010, TRENDS PLANT SCI, V15, P641, DOI 10.1016/j.tplants.2010.08.010; DUNLOP J, 1993, J EXP BOT, V44, P1801, DOI 10.1093/jxb/44.12.1801; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Pasternak T, 2005, J EXP BOT, V56, P1991, DOI 10.1093/jxb/eri196; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Wubben MJE, 2001, MOL PLANT MICROBE IN, V14, P1206, DOI 10.1094/MPMI.2001.14.10.1206; Kang YH, 2009, PLANT CELL, V21, P1080, DOI 10.1105/tpc.108.063180; Koltai H, 2011, NEW PHYTOL, V190, P545, DOI 10.1111/j.1469-8137.2011.03678.x; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Strader LC, 2010, PLANT J, V64, P874, DOI 10.1111/j.1365-313X.2010.04373.x; Pasternak T, 2005, ENVIRON EXP BOT, V53, P299, DOI 10.1016/j.envexpbot.2004.04.009; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Yang TJW, 2008, J EXP BOT, V59, P3453, DOI 10.1093/jxb/ern195; Ohashi Y, 2003, SCIENCE, V300, P1427, DOI 10.1126/science.1083695; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Tanimoto M, 1995, PLANT J, V8, P943; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Bruex A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002446; Brueggemann J, 2010, PLANT CELL REP, V29, P285, DOI 10.1007/s00299-010-0821-0; Castro RO, 2007, PLANT SCI, V172, P684, DOI 10.1016/j.plantsci.2006.11.004; Dolan L, 2006, J EXP BOT, V57, P51, DOI 10.1093/jxb/erj037; Grierson C, 2002, ARABIDOPSIS BOOK, V41, P1, DOI DOI 10.1199/TAB.0060; Kabata-Pendias A, 1993, BIOGEOCHEMISTRY TRAC, P126; Lombardo María Cristina, 2006, Plant Signal Behav, V1, P28, DOI 10.4161/psb.1.1.2398; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NECHAY BR, 1984, ANNU REV PHARMACOL, V24, P501; ONEILL SD, 1984, PLANT PHYSIOL, V75, P586, DOI 10.1104/pp.75.3.586; Orman B, 2011, ROOT GENOMICS, P11; Samaj J, 2002, EMBO J, V21, P3296, DOI 10.1093/emboj/cdf349; SCHIEFELBEIN JW, 1992, PLANTA, V187, P455, DOI 10.1007/BF00199963; SERRA M A, 1989, Biological Trace Element Research, V23, P151, DOI 10.1007/BF02917186; SINGH B, 1969, PLANT PHYSIOL, V44, P1321, DOI 10.1104/pp.44.9.1321; SINGH BB, 1971, PLANT SOIL, V34, P209, DOI 10.1007/BF01372773; Wymer CL, 1997, PLANT J, V12, P427, DOI 10.1046/j.1365-313X.1997.12020427.x; Ziemacki G, 1989, Ann Ist Super Sanita, V25, P531	63	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-9317	1399-3054		PHYSIOL PLANTARUM	Physiol. Plant.	JAN	2015	153	1					137	148		10.1111/ppl.12229		12	Plant Sciences	Plant Sciences	AX0MQ	WOS:000346646800011		
J	Mishra, S; Alavilli, H; Lee, BH; Panda, SK; Sahoo, L				Mishra, Sagarika; Alavilli, Hemasundar; Lee, Byeong-ha; Panda, Sanjib Kumar; Sahoo, Lingaraj			Cloning and characterization of a novel vacuolar Na+/H+ antiporter gene (VuNHX1) from drought hardy legume, cowpea for salt tolerance	PLANT CELL TISSUE AND ORGAN CULTURE			English	Article						Na+/H+ antiporter gene; Cowpea; RACE; Transgenic Arabidopsis; Salt tolerance	ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; VIGNA-UNGUICULATA; ION HOMEOSTASIS; CATION/PROTON ANTIPORTER; SACCHAROMYCES-CEREVISIAE; MEDIATED TRANSFORMATION; FUNCTIONAL-ANALYSIS; ATRIPLEX GMELINI; EXPRESSION	Soil salinity is a major abiotic stress that seriously affects crop productivity worldwide. One of the mechanisms that allow plants to withstand salt stress is vacuolar sequestration of Na+, through a Na+/H+ antiporter. We isolated a new vacuolar Na+/H+ antiporter gene (VuNHX1) from a drought hardy grain legume, cowpea (Vigna unguiculata L.). The cDNA is 1,981 bp, with an open reading frame of 1,629 bp encoding a predicted protein of 542 amino acids with a deduced molecular mass of 59.6 kDa. VuNHX1 displays a conserved amiloride binding domain ((LFFIYLLPPI93)-L-84) in third transmembrane (TM3) region. Phylogenetic and bioinformatic analysis indicated VuNHX1 belonging to Class-I clade of plant NHX exchangers with high similarity with legume Na+/H+ antiporters. To assess its role in Na+ exchange, we performed complementation studies using the salt sensitive yeast mutant strain AXT3. The results showed that VuNHX1 complemented for the loss of yeast NHX1 under NaCl, KCl and LiCl stress in the salt sensitive phenotype of the yeast strain AXT3. The expression profiles revealed significant induction of VuNHX1 in cowpea seedlings under salt, cold and dehydration stress. Both expression analysis and ion estimation under salt stress indicated the VuNHX1 expression preferentially in roots than in leaves. Overexpression of VuNHX1 in transgenic Arabidopsis conferred enhanced salt tolerance in transgenic Arabidopsis lines while the wild type plants exhibited growth retardation. This study shows that VuNHX1 is a potential gene for salt tolerance, and can be used in future for developing cisgenic salt tolerant cowpea and transgenic salt tolerant crops.	[Mishra, Sagarika; Sahoo, Lingaraj] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati 781039, India; [Alavilli, Hemasundar; Lee, Byeong-ha] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Panda, Sanjib Kumar] Assam Univ, Dept Life Sci & Bioinformat, Silchar 788011, India; [Panda, Sanjib Kumar] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Sahoo, Lingaraj] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Sahoo, L (reprint author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati 781039, India.	drskpanda@gmail.com; ls@iitg.ernet.in	Lee, Byeong-ha/B-8478-2009; 	Lee, Byeong-ha/0000-0001-7633-3264; Panda, Sanjib/0000-0001-5131-9693	DBT (Department of Biotechnology, Government of India) [BT/PR10818/AGR/02/ 591/2008, BT/01/NE/PS/08]	We express our sincere thanks to Prof. Edward Blumwald and Dr. Olivier Cagnac for the yeast strains, W303 and AXT3 respectively. We also thank Dr. Luciana LoureiroPenha for providing pYES2.0 vector for yeast expression analysis, Department of Civil Engineering, IIT Guwahati for use of Flame Photometry. LS is grateful to DBT (Department of Biotechnology, Government of India) for its support through various Grants (BT/PR10818/AGR/02/ 591/2008 and BT/01/NE/PS/08) for legume improvement program. BhL is grateful to Rural Development Administration, Republic of Korea for its support by Next- Generation BioGreen 21 Program (PJ009104). SM is grateful to MHRD for Research Fellowship. SKP is grateful to DBT (Department of Biotechnology, Government of India) for its support.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; An BaoYan, 2008, Acta Agronomica Sinica, V34, P557, DOI 10.3724/SP.J.1006.2008.00557; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Wu C, 2009, PLANT MOL BIOL REP, V27, P1, DOI 10.1007/s11105-008-0048-1; Ma XL, 2004, BIOL PLANTARUM, V48, P219, DOI 10.1023/B:BIOP.0000033448.96998.44; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Xue ZY, 2004, PLANT SCI, V167, P849, DOI 10.1016/j.plantsci.2004.05.034; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Chen LH, 2008, TRANSGENIC RES, V17, P121, DOI 10.1007/s11248-007-9085-z; Wang S, 2011, AFR J BIOTECHNOL, V10, P1752; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Gouiaa S, 2012, PLANT MOL BIOL, V79, P137, DOI 10.1007/s11103-012-9901-6; Qiao WH, 2007, PLANT CELL REP, V26, P1663, DOI 10.1007/s00299-007-0354-3; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; LICHTENTHALER HK, 1987, J PLANT PHYSIOL, V131, P101; Wu YY, 2005, PLANT SCI, V169, P65, DOI 10.1016/j.plantsci.2005.02.030; Yamaguchi T, 2001, PLANT CELL PHYSIOL, V42, P451, DOI 10.1093/pcp/pce080; Zhang GH, 2008, PLANT PHYSIOL BIOCH, V46, P117, DOI 10.1016/j.plaphy.2007.10.022; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Wang J, 2003, DNA SEQUENCE, V14, P351, DOI 10.1080/10855660310001596211; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Sottosanto JB, 2004, PLANT J, V40, P752, DOI 10.1111/j.1365-313X.2004.02253.x; Fukuda A, 1999, BBA-GENE STRUCT EXPR, V1446, P149, DOI 10.1016/S0167-4781(99)00065-2; Zhao JS, 2007, J PLANT PHYSIOL, V164, P1377, DOI 10.1016/j.jplph.2007.04.001; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Jha A, 2011, MOL BIOL REP, V38, P1965, DOI 10.1007/s11033-010-0318-5; Hamada A, 2001, PLANT MOL BIOL, V46, P35, DOI 10.1023/A:1010603222673; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; He CX, 2005, PLANT CELL PHYSIOL, V46, P1848, DOI 10.1093/pcp/pci201; Hasegawa PM, 2013, ENVIRON EXP BOT, V92, P19, DOI 10.1016/j.envexpbot.2013.03.001; Wu CA, 2004, PLANT CELL PHYSIOL, V45, P600, DOI 10.1093/pcp/pch071; Baltierra Q, 2012, BIOCHEM BIOPH RES CO, V430, P535; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, P223; Brini F, 2005, PLANT PHYSIOL BIOCH, V43, P347, DOI 10.1016/j.plaphy.2005.02.010; Chauhan S, 2000, PLANT J, V24, P511, DOI 10.1046/j.1365-313x.2000.00903.x; Duzdemir O, 2009, NEW ZEAL J CROP HORT, V37, P271; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Hall AE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00155; Hanana M, 2007, PLANT CELL PHYSIOL, V48, P804, DOI 10.1093/pcp/pcm048; Hofmann K., 1993, BIOL CHEM HOPPESEYLE, V347, P166, DOI DOI 10.1016/J.JTBI.2009.11.002; Kagami T, 2005, GENES GENET SYST, V80, P121, DOI 10.1266/ggs.80.121; Kinclova-Zimmermannova O, 2004, FOLIA MICROBIOL, V49, P519, DOI 10.1007/BF02931527; Lee BH, 2010, COLD SPRING HARB PRO, V2010; Li WYF, 2006, PLANT CELL ENVIRON, V29, P1122, DOI 10.1111/j.1365-3040.2005.01487.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murillo-Amador B, 2006, SCI HORTIC-AMSTERDAM, V108, P423, DOI 10.1016/j.scienta.2006.02.010; Ohta M, 2002, FEBS LETT, V532, P279, DOI 10.1016/S0014-5793(02)03679-7; Qingxia Z, 2009, AFR J BIOTECHNOL, V8, P4774; Rajagopal D, 2007, MOL BREEDING, V19, P137, DOI 10.1007/s11032-006-9052-z; Reguera M, 2014, MOL PLANT, V7, P261, DOI 10.1093/mp/sst091; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Singh BB, 2005, GEN RESOUR CHROM ENG, V1, P117; Tang R, 2010, PLANT MOL BIOL REP, V28, P102, DOI 10.1007/s11105-009-0135-y; Timko MP, 2007, GENOME MAPPING MOL B, V3, P49; Xia T, 2002, PHYSIOL PLANTARUM, V116, P206, DOI 10.1034/j.1399-3054.2002.1160210.x; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zorb C, 2005, J PLANT PHYSIOL, V162, P55, DOI 10.1016/j.jplph.2004.03.010	72	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	JAN	2015	120	1					19	33		10.1007/s11240-014-0572-7		15	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	AW9WJ	WOS:000346605700003		
J	Mejima, M; Kashima, K; Kuroda, M; Takeyama, N; Kurokawa, S; Fukuyama, Y; Kiyono, H; Itoh, K; Mitsui, T; Yuki, Y				Mejima, Mio; Kashima, Koji; Kuroda, Masaharu; Takeyama, Natsumi; Kurokawa, Shiho; Fukuyama, Yoshiko; Kiyono, Hiroshi; Itoh, Kimiko; Mitsui, Toshiaki; Yuki, Yoshikazu			Determination of genomic location and structure of the transgenes in marker-free rice-based cholera vaccine by using whole genome resequencing approach	PLANT CELL TISSUE AND ORGAN CULTURE			English	Article						Selection marker-free; Gene location; MucoRice-CTB; Oral vaccine; Oryza sativa; Cholera	T-DNA INTEGRATION; TOXIN B-SUBUNIT; AGROBACTERIUM-TUMEFACIENS; ILLEGITIMATE RECOMBINATION; SEQUENCE-ANALYSIS; GENE INTEGRATION; INDICA RICE; PLANTS; TRANSFORMATION; EXPRESSION	We previously developed a molecularly uniform rice-based oral cholera vaccine (MucoRice-CTB) by using an overexpression system for modified cholera toxin B-subunit, CTB (N4Q) with RNAi to suppress production of the major rice endogenous storage proteins. To establish MucoRice-CTB for human use, here we developed hygromycin phosphotransferase selection marker-free MucoRice-CTB by using two different Agrobacterium tumefaciens, each carrying a distinct T-DNA for co-transformation. In the marker-free candidates from co-transformants by segregation in the seed progeny, we selected a line with high CTB expression, line 51A, which we advanced to the T6 generation by self-pollination to obtain a homozygous line without down-regulation of CTB expression. Southern blot analyses showed that three copies of the CTB gene, but not the backbone of the T-DNA binary vector, were inserted into the rice genome of MucoRice-CTB line 51A. By whole genome resequencing, we showed that the transgenes in this line were inserted into intergenic regions in chromosome 3 and chromosome 12. We determined that two full-length copies, each containing the CTB and RNAi expression cassettes, were inserted in a tandem reverted orientation into chromosome 3. An additional copy of the CTB over-expression cassette with a truncated RNAi cassette was inserted into chromosome 12. These findings provide useful information for the establishment of a seed bank of marker-free MucoRice-CTB for human use.	[Mejima, Mio; Kashima, Koji; Takeyama, Natsumi; Kurokawa, Shiho; Fukuyama, Yoshiko; Kiyono, Hiroshi; Yuki, Yoshikazu] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Mejima, Mio; Itoh, Kimiko; Mitsui, Toshiaki] Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan; [Kuroda, Masaharu] NARO Agr Res Ctr, Crop Dev Div, Joetsu, Japan; [Kiyono, Hiroshi; Yuki, Yoshikazu] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccine, Tokyo, Japan	Yuki, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	yukiy@ims.u-tokyo.ac.jp			Programs of Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	We are grateful to Drs. Masaaki Oyama, Hiroko Kozuka-Hata, Satoshi Kaneto, Shintaro Sato, and Mr. Yuji Suzuki for useful discussions and technical support. This work was supported by Grants from the Programs of Special Coordination Funds for Promoting Science and Technology and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.Y., H.K.); the Ministry of Health, Labor and Welfare of Japan (Y.Y., H.K.); the New Energy and Industrial Technology Development Organization (NEDO) ( H.K.); and the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-step); and the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution (Y.Y.).	Chen SY, 2003, PLANT J, V36, P105, DOI 10.1046/j.1365-313X.2003.01860.x; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Li GH, 2007, CURR GENET, V51, P233, DOI 10.1007/s00294-007-0122-5; Endo S, 2002, PLANT J, V30, P115, DOI 10.1046/j.1365-313X.2002.01272.x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Nandy S, 2012, PLANT BIOTECHNOL J, V10, P904, DOI 10.1111/j.1467-7652.2012.00715.x; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Nochi T, 2009, J IMMUNOL, V183, P6538, DOI 10.4049/jimmunol.0901480; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; HOOD EE, 1986, J BACTERIOL, V168, P1291; Srivastava V, 2004, PLANT BIOTECHNOL J, V2, P169, DOI 10.1111/j.258-7652.2003.00061.x; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; GHEYSEN G, 1991, GENE DEV, V5, P287, DOI 10.1101/gad.5.2.287; De Buck S, 1999, PLANT J, V20, P295, DOI 10.1046/j.1365-313X.1999.00602.x; MAYERHOFER R, 1991, EMBO J, V10, P697; Nanto K, 2009, PLANT CELL REP, V28, P777, DOI 10.1007/s00299-009-0683-5; Krizkova L, 1998, PLANT J, V16, P673, DOI 10.1046/j.1365-313x.1998.00330.x; Parkhi V, 2005, MOL GENET GENOMICS, V274, P325, DOI 10.1007/s00438-005-0030-7; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Kurokawa S, 2013, J PROTEOME RES, V12, P3372, DOI 10.1021/pr4002146; Yuki Y, 2013, PLANT BIOTECHNOL J, V11, P799, DOI 10.1111/pbi.12071; DEBLOCK M, 1991, THEOR APPL GENET, V82, P257, DOI 10.1007/BF02190610; Ebinuma H, 1997, P NATL ACAD SCI USA, V94, P2117, DOI 10.1073/pnas.94.6.2117; EMA, 2008, GUID QUAL BIOL ACT S; FDA, 2002, GUID IND DRUGS BIOL; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; GHEYSEN G, 1990, GENE, V94, P155, DOI 10.1016/0378-1119(90)90382-2; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Rao MVR, 2011, PLANT CELL REP, V30, P1241, DOI 10.1007/s00299-011-1033-y; Sambrook J., 1989, MOL CLONING LAB MANU; Sha Y, 2004, THEOR APPL GENET, V108, P306, DOI 10.1007/s00122-003-1423-9	39	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	JAN	2015	120	1					35	48		10.1007/s11240-014-0575-4		14	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	AW9WJ	WOS:000346605700004		
J	Sone, Y; Suzumura, J; Koga, H; Tamoto, Y; Ishida, M; Yamazaki, H; Sasaki, T				Sone, Yasutomo; Suzumura, Junichi; Koga, Hidetoshi; Tamoto, Yoshitaka; Ishida, Makoto; Yamazaki, Hiro-o; Sasaki, Toshihiko			Effects on braking distance from the use of traction fluid as a wheel/rail lubricant	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART F-JOURNAL OF RAIL AND RAPID TRANSIT			English	Article						Wheel; rail lubricant; traction fluid; synthetic oil; traction coefficient; braking distance	FRICTION; ADHESION	Mineral oil and other lubricants are commonly applied to the gauge corner of high rails to avoid wheel/rail interface wear on railways. Although not directly applied to the top of the rail, these lubricants sometimes end up on this surface, and the relatively low coefficient of friction they produce can cause slipping or sliding at the wheel/rail interface during vehicle acceleration or braking. It has been reported in the literature that the application of traction fluid (a modern technique involving the use of a synthetic lubricant) produced a higher coefficient of friction than that of a conventional wheel/rail interface lubricant. In this study, tests were performed using traction fluid to evaluate its influence on a vehicle's braking distance and other important performance elements from a practical point of view. The results of the braking performance evaluation carried out on a braking test stand showed that the braking distance increase with synthetic traction fluids was roughly one-half of that observed with conventional wheel/rail lubrication oil. This suggests the potential of using traction fluid as a wheel/rail lubricant.	[Sone, Yasutomo; Suzumura, Junichi] Railway Tech Res Inst, Kokubunji, Tokyo 1858540, Japan; [Koga, Hidetoshi; Tamoto, Yoshitaka] Idemitsu Kosan Co Ltd, Chiba, Japan; [Ishida, Makoto] Nippon Koei Co Ltd, Tokyo, Japan; [Sasaki, Toshihiko] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan	Sone, Y (reprint author), Railway Tech Res Inst, 2-8-38 Hikari Cho, Kokubunji, Tokyo 1858540, Japan.	ysone@rtri.or.jp					Eadie DT, 2002, WEAR, V253, P185, DOI 10.1016/S0043-1648(02)00098-4; Chen H, 2008, WEAR, V265, P1504, DOI 10.1016/j.wear.2008.02.034; Eadie D, 2001, RAILWAY AGE, V202, P48; Ishida M, 2003, 6 INT C CONT MECH WE, P23; Ishida M, 2008, WEAR, V265, P1497, DOI 10.1016/j.wear.2008.02.041; Jensen WB, 2007, J CHEM EDUC, V84, P1913; Kumagai N, 1993, Q REP RTRI, V34, P154; Machida H, 2000, NSK TECH J, V669, P15; Sone Yasutomo, 2010, Quarterly Report of RTRI, V51, DOI 10.2219/rtriqr.51.12; Tanaka H., 1996, J ENG TRIBOL J, V210, P205; TSUBOUCHI T, 1995, TRIBOL INT, V28, P335, DOI 10.1016/0301-679X(95)00085-I; Yamazaki H, 2004, JSME INT J C-MECH SY, V47, P496, DOI 10.1299/jsmec.47.496	12	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4097	2041-3017		P I MECH ENG F-J RAI	Proc. Inst. Mech. Eng. Part F-J. Rail Rapid Transit	JAN	2015	229	1					89	96		10.1177/0954409713502954		8	Engineering, Civil; Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	AX0LP	WOS:000346644200008		
J	Green, MA; Emery, K; Hishikawa, Y; Warta, W; Dunlop, ED				Green, Martin A.; Emery, Keith; Hishikawa, Yoshihiro; Warta, Wilhelm; Dunlop, Ewan D.			Solar cell efficiency tables (Version 45)	PROGRESS IN PHOTOVOLTAICS			English	Article						solar cell efficiency; photovoltaic efficiency; energy conversion efficiency	CONCENTRATOR; STABILITY	Consolidated tables showing an extensive listing of the highest independently confirmed efficiencies for solar cells and modules are presented. Guidelines for inclusion of results into these tables are outlined and new entries since July 2014 are reviewed. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Green, Martin A.] Univ New S Wales, Australian Ctr Adv Photovolta, Sydney, NSW 2052, Australia; [Emery, Keith] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Hishikawa, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol RCPVT, Tsukuba, Ibaraki 3058568, Japan; [Warta, Wilhelm] Fraunhofer Inst Solar Energy Syst, Dept Solar Cells Mat & Technol, D-79110 Freiburg, Germany; [Dunlop, Ewan D.] Commiss European Communities, Joint Res Ctr, Renewable Energy Unit, Inst Energy, IT-21027 Ispra, Italy	Green, MA (reprint author), Univ New S Wales, Sch Photovolta & Renewable Energy Engn, Sydney, NSW 2052, Australia.	m.green@unsw.edu.au			U.S. Department of Energy [DE-AC36-08-GO28308]; National Renewable Energy Laboratory	The Australian Centre for Advanced Photovoltaics commenced operation in February 2013 with support from the Australian Government through the Australian Renewable Energy Agency (ARENA). The Australian Government does not accept responsibility for the views, information or advice expressed herein. The work by K. Emery was supported by the U.S. Department of Energy under Contract No. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory.	Ahn SW, 2012, 27 EUR PHOT SOL EN C; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Tanenbaum DM, 2012, RSC ADV, V2, P882, DOI 10.1039/c1ra00686j; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P85, DOI 10.1002/pip.880; Ozawa H, 2014, CHEMPHYSCHEM, V15, P1201, DOI 10.1002/cphc.201301025; Krasovec UO, 2013, SOL ENERG MAT SOL C, V117, P67, DOI 10.1016/j.solmat.2013.05.029; Jorgensen M, 2012, ADV MATER, V24, P580, DOI 10.1002/adma.201104187; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Geisz JF, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816837; ZHANG FZ, 1995, IEEE T ELECTRON DEV, V42, P144; Asghar MI, 2010, ENERG ENVIRON SCI, V3, P418, DOI 10.1039/b922801b; Service RF, 2011, SCIENCE, V332, P293, DOI 10.1126/science.332.6027.293; Gueymard CA, 2002, SOL ENERGY, V73, P443, DOI 10.1016/S0038-092X(03)00005-7; Matsui T, 2013, PROG PHOTOVOLTAICS, V21, P1363, DOI 10.1002/pip.2300; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Zhao J, 1997, PROG PHOTOVOLTAICS, V5, P269, DOI 10.1002/(SICI)1099-159X(199707/08)5:4<269::AID-PIP174>3.0.CO;2-1; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; Ward JS, 2002, PROG PHOTOVOLTAICS, V10, P41, DOI 10.1002/pip.424; Chiang C. J., 1990, 21 IEEE PHOT SPEC C, P861; Cousins PJ, 2010, 35 IEEE PVSC HON HI; Eguchi T, 2011, 21 INT PHOT SCI ENG; Engelhart P, 2010, EN PROC 1 INT C SIL; Hosoya M., 2014, GRAND REN EN C TOK J, P21; Jager-Waldau A, 2004, 21087 EUR EN; Kawai M, 2013, NIKKEI ELECT    0201; Kayes B. M., 2011, P 37 IEEE PHOT SPEC; Keavney CJ, 1990, 21 IEEE PHOT SPEC C, P141; Keevers MJ, 2007, 22 EUR PHOT SOL EN C; Keevers MJ, 2014, 6 WORLD C PV EN CONV; Komiya R, 2011, 21 INT PHOT SCI ENG; Krebs F.C., 2012, STABILITY DEGRADATIO; Matsui T., 2013, P 28 EUR PHOT SOL EN, P2213; Mattos L. S., 2012, P 38 IEEE PHOT SPEC; Moslehi MM, 2012, PV AS PAC C APVIA PV; Nakamura M, 2013, 39 IEEE PVSC TAMP US; Osborne M., 2014, HANERGYS SOLIBRO HAS; Osterwald CR, 2014, NRELTP520060748; Osterwald CR, 2014, 10 INT C CONC PHOT S; Powalla M., 2014, 29 EUR PHOT SOL EN C; Program milestones and decision points for single junction thin films, 1985, DOECE0128 PHOT SOL E; Roselund C, 2014, PV MAGAZINE      SEP, P60; Sai H, 2014, IEEE J PHOT IN PRESS; Sakata I, 2006, 2006 IEEE 4 WORLD C, V1, P1; Sasaki K., 2013, P 9 INT C CONC PHOT; Slade A, 2005, 15 INT PHOT SCI ENG, P701; Slooff LH, 2008, PHYS STATUS SOLIDI-R, V2, P257, DOI 10.1002/pssr.200802186; Steiner M., 2014, PROGR PHOTOVOLTAICS; Sugimoto H, 2014, 40 IEEE PHOT SPEC C; Swanson R, 2012, CHALL PV SCI TECHN M; Tanabe Nobuo, 2013, Fujikura Technical Review; Venkatasubramanian R, 1997, 25 IEEE PHOT SPEC C, P31; Verlinden P., 2014, 6 WORLD C PV EN CONV; Wallin E, 2012, PROG PHOTOVOLTAICS, V20, P851, DOI 10.1002/pip.2246	54	206	208	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	JAN	2015	23	1					1	9		10.1002/pip.2573		9	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AX0NX	WOS:000346650000001		
J	Sogabe, T; Ogura, A; Ohba, M; Okada, Y				Sogabe, Tomah; Ogura, Akio; Ohba, Mitsuyoshi; Okada, Yoshitaka			Self-consistent electrical parameter extraction from bias dependent spectral response measurements of III-V multi-junction solar cells	PROGRESS IN PHOTOVOLTAICS			English	Article						Multijunction solar cell; spectra response; self-consistent; electrical parameters extraction		Spectral response of multi-junction solar cell is complicated because of the interplay between external measurement conditions such as bias light intensity, monochromatic light intensity, bias voltage, and intrinsic electrical properties of series interconnected subcells. In this paper, we report an experimental study on the bias voltage-dependent spectral response (SR) for multi-junction solar cell. A self-consistent iteration loop was developed from a nonlinear least square Powell hybrid algorithm that was used for curve fitting the experimental SR versus bias voltage data of each subcell. We demonstrated for the first time that this approach enabled us to derive the electrical parameters such as dark saturation currents (J(0)), shunt resistance (R-sh), series resistance (R-s), and spectra response (J(photo)) for each subcell of a Ga0.99In0.01As/Ge dual junction solar cell with stable convergence. The accuracies of the fitting results were confirmed by the agreement between the J-V curves calculated on the basis of these parameters and the experimental J-V curve of multi-junction solar cell measured under AM1.5 and 1sun condition. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Sogabe, Tomah; Ogura, Akio; Ohba, Mitsuyoshi; Okada, Yoshitaka] Univ Tokyo, RCAST, Tokyo 1538904, Japan	Sogabe, T (reprint author), Univ Tokyo, RCAST, Tokyo 1538904, Japan.	sogabe@mbe.rcast.u-tokyo.ac.jp; ogura@mbe.rcast.u-tokyo.ac.jp			Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI), Japan	The authors appreciate D.J. Farrell for manuscript proofreading and suggestions. This work is supported by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade and Industry (METI), Japan.	Adelhelm R, 1998, SOL ENERG MAT SOL C, V50, P185, DOI 10.1016/S0927-0248(97)00143-8; METZDORF J, 1987, APPL OPTICS, V26, P1701, DOI 10.1364/AO.26.001701; Meusel M, 2003, PROG PHOTOVOLTAICS, V11, P499, DOI 10.1002/pip.514; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P606, DOI 10.1002/pip.2267; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; Bendel C, 2003, WCPEC 3 WORLD C PHOT, P1; Chhabra B, 2006, IEEE 4 WORLD C PHOT, V1, P791; Dimroth F, 2005, 31 IEEE PHOT SPEC C, P525; King R.R., 2007, ADV OPTOELECTRONICS, P1; Kirchartz T, 2008, 23 EU PVSEC, P86; Lim SH, 2010, IEEE PHOT SPEC CONF, P712; Meusel M, 2006, SOL ENERG MAT SOL C, V90, P3268, DOI 10.1016/j.solmat.2006.06.025; or A Ben, 2012, PROGR PHOTOVOLTAICS, DOI [10.1002/pip.215, DOI 10.1002/PIP.215]; Rabinowitz P., 1970, NUMERICAL METHODS NO; Tsuno Y, 2005, IEEE PHOT SPEC CONF, P1476, DOI 10.1109/PVSC.2005.1488421; Warner JH, 2004, P SOC PHOTO-OPT INS, V5520, P45, DOI 10.1117/12.559734; Yamaguchi M, 2004, P 19 EUR PHOT SOL EN, P3610	17	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1062-7995	1099-159X		PROG PHOTOVOLTAICS	Prog. Photovoltaics	JAN	2015	23	1					37	48		10.1002/pip.2392		12	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AX0NX	WOS:000346650000005		
J	Xue, B; Ma, ZX; Geng, Y; Heck, P; Ren, WX; Tobias, M; Maas, A; Jiang, P; de Oliveira, JAP; Fujita, T				Xue, Bing; Ma, Zhixiao; Geng, Yong; Heck, Peter; Ren, Wanxia; Tobias, Mario; Maas, Achim; Jiang, Ping; de Oliveira, Jose A. Puppim; Fujita, Tsuyoshi			A life cycle co-benefits assessment of wind power in China	RENEWABLE & SUSTAINABLE ENERGY REVIEWS			English	Review						Co-benefit; Life cycle assessment; Wind power; Renewable energy policy; China	GREENHOUSE-GAS EMISSIONS; AIR-POLLUTION; RENEWABLE ENERGY; CLIMATE-CHANGE; MITIGATION; REDUCTION; SECTOR; SHENYANG; INDUSTRY; POLICY	Wind power can help ensure regional energy security and also mitigate both global greenhouse gas and local air pollutant emissions, leading to co-benefits. With rapid installation of wind power equipment, it is critical to uncover the embodied emissions of greenhouse gas and air pollutants from wind power sector so that emission mitigation costs can be compared with a typical coal-fired power plant. In order to reach such a target, we conduct a life cycle analysis for wind power sector by using the Chinese inventory standards. Wind farms only release 1/40 of the total CO2 emissions that would be produced by the coal power system for the same amount of power generation, which is equal to 97.48% of CO2 emissions reduction. Comparing with coal power system, wind farms can also significantly reduce air pollutants (SO2, NOx and PM10),leading to 80.38%, 57.31% and 30.91% of SO2, NOx and PM10 emissions reduction, respectively. By considering both recycling and disposal, wind power system could reduce 2.74 x 10(4) t of CO2 emissions, 5.65 x 10(4) kg of NOx emissions, 2.95 x 10(5) kg of SO2 emissions and 7.97 x 10(4) kg of PM10 emissions throughout its life cycle. In terms of mitigation cost, a wind farm could benefit 37.14 US$ from mitigating 1ton of CO2 emissions. The mitigation cost rates of air pollutants were 7.94 US$/kg of SO2, 10.79 US$/kg of NOx, and 80.79 US$/kg of PM10. Our research results strongly support the development of wind power so that more environmental benefits can be gained. However, decentralized wind power developers should consider not only project locations close to the demand of electricity and wind resources, but also the convenient transportation for construction and recycling, while centralized wind power developers should focus on incorporating wind power into the grids in order to avoid wind power loss. (C) 2014 Elsevier Ltd. All rights reserved.	[Xue, Bing; Ma, Zhixiao; Geng, Yong; Ren, Wanxia] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Xue, Bing; Heck, Peter] Univ Appl Sci Trier, Inst Appl Mat Flow Management IaS, D-55768 Birkenfeld, Germany; [Xue, Bing; Tobias, Mario; Maas, Achim] IASS, D-14467 Potsdam, Germany; [Jiang, Ping] Fudan Univ, Dept Environm Sci & Engn, Shanghai 200433, Peoples R China; [Ma, Zhixiao; de Oliveira, Jose A. Puppim] United Nations Univ, Inst Adv Studies, Shibuya Ku, Tokyo 1508925, Japan; [Fujita, Tsuyoshi] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Ma, Zhixiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Xue, B (reprint author), Chinese Acad Sci, Inst Appl Ecol, 72 Wenhua Rd, Shenyang 110016, Peoples R China.	xuebing@iae.ac.cn			National Natural Science Foundation of China [41101126, 41471116, 71325006, 71303230]; Ministry of Science & Technology of China [2011DFA91810]; International Postdoctoral Exchange Fellowship Program under China Postdoctoral Council [2014-33]	This study was supported by National Natural Science Foundation of China (41101126, 41471116, 71325006, and 71303230), Ministry of Science & Technology of China (2011DFA91810), International Postdoctoral Exchange Fellowship Program under China Postdoctoral Council (2014-33). Special thanks go to the Alexander von Humboldt Foundation of Germany and the Green Talents Program under Federal Ministry of Education and Research of Germany.	Peters GP, 2012, NAT CLIM CHANGE, V2, P2; Martinez E, 2009, RENEW ENERG, V34, P667, DOI 10.1016/j.renene.2008.05.020; Chae Y, 2010, ENVIRON SCI POLICY, V13, P205, DOI 10.1016/j.envsci.2010.01.003; York R, 2012, NAT CLIM CHANGE, V2, P441, DOI 10.1038/NCLIMATE1451; Berbel J, 2011, WATER RESOUR MANAG, V25, P623, DOI 10.1007/s11269-010-9717-6; Liu Z, 2013, NATURE, V500, P143, DOI 10.1038/500143a; Frank ED, 2013, MITIG ADAPT STRAT GL, V18, P137, DOI 10.1007/s11027-012-9395-1; Tian YH, 2013, ENERG POLICY, V56, P352, DOI 10.1016/j.enpol.2012.12.068; Kabir MR, 2012, RENEW ENERG, V37, P133, DOI 10.1016/j.renene.2011.06.003; Jiang P, 2013, J CLEAN PROD, V58, P130, DOI 10.1016/j.jclepro.2013.07.042; Geng Y, 2013, J CLEAN PROD, V58, P82, DOI 10.1016/j.jclepro.2013.06.034; Bao C, 2013, RENEW SUST ENERG REV, V27, P464, DOI 10.1016/j.rser.2013.07.008; Zhang WJ, 2006, BIOMED ENVIRON SCI, V19, P461; Pehnt M, 2008, ENERGY, V33, P747, DOI 10.1016/j.energy.2008.01.007; Oebels KB, 2013, RENEW ENERG, V53, P60, DOI 10.1016/j.renene.2012.10.026; Burtraw D, 2003, J ENVIRON ECON MANAG, V45, P650, DOI 10.1016/S0095-0696(02)00022-0; de Lucena AFP, 2010, GLOBAL ENVIRON CHANG, V20, P342, DOI 10.1016/j.gloenvcha.2010.01.004; Xi FM, 2011, ENERG POLICY, V39, P5999, DOI 10.1016/j.enpol.2011.06.063; Sahin AD, 2004, PROG ENERG COMBUST, V30, P501, DOI 10.1016/j.pecs.2004.04.001; Ardente F, 2008, RENEW SUST ENERG REV, V12, P200, DOI 10.1016/j.rser.2006.05.013; Bieda B., 2012, INT J LIFE CYCLE ASS, P1; BP, 2013, BP STAT REV WORLD EN; British Petroleum (BP), BP STAT REV WORLD EN; Cai Hao, 2010, Acta Scientiarum Naturalium Universitatis Pekinensis, V46; Chouinard-Dussault P, 2011, CLEAN TECHNOL ENVIR, V13, P673, DOI 10.1007/s10098-010-0339-8; Corbiere-Nicollier T, 2001, RESOUR CONSERV RECY, V33, P267, DOI 10.1016/S0921-3449(01)00089-1; Davison S., 2012, International Conference on BioScience: Biotechnology and Biodiversity -  Step in the Future. The Fourth Joint UNS - PSU Conference, Novi Sad, Serbia, 18-20 June 2012.  Conference Proceedings., P1; Dong S, 2008, ENV PROT, P39; ESB National Grid, 2004, IMP WIND POW GEN IR; Fenglin Wind Power Company China, 2008, PROJ APPL REP WIND F; Global Wind Energy Council, GLOB WIN EN OUTL 201; Government of Canada, 2010, NAT INV REP 1990 200; [贾顺平 JIA Shun-ping], 2010, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V10, P22; [姜金龙 Jiang Jinlong], 2006, [兰州理工大学学报, Journal of Lanzhou University of Technology], V32, P19; Kang J, 2012, RENEW SUST ENERG REV, V16, P1926; Kaygusuz K, 2010, RENEW SUST ENERG REV, V14, P2104, DOI 10.1016/j.rser.2010.03.022; Liu TY, 2012, WIND ENERGY, V16, P786; Ma ZhiXiao, 2012, Climate Change Research Letters, V1, P80, DOI 10.4236/CCRL.2012.12010; Ma ZX, 2013, RENEW ENERG, V57, P35, DOI 10.1016/j.renene.2013.01.018; Mian Yang, 2012, Renewable Energy, V41, DOI 10.1016/j.renene.2011.10.013; Ministry of Environment Japan, COB APPR GHG EM RED; Nguyen TKO, 2012, ATMOS ENVIRON, V59, P438, DOI 10.1016/j.atmosenv.2012.04.057; UN-Energy, UN FRAM CONV CLIM CH; Wang CB, 2012, ENERGIES, V5, P2708, DOI 10.3390/en5082708; Wang YL, 2013, J CLEAN PROD, V53, P252, DOI 10.1016/j.jclepro,2013.04.001; White S., 2006, NATURAL RESOURCES RE, V15, P271; Xia Changliang, 2009, Renewable and Sustainable Energy Reviews, V13, DOI 10.1016/j.rser.2009.01.004; Xin H, 2010, SCIENCE, V328, P1216, DOI 10.1126/science.328.5983.1216-b; Xue B, 2012, NAT CLIM CHANGE, V2, P762; [杨建新 Yang Jianxin], 2002, [环境科学学报, Acta Scientic Circumstantance], V22, P519; Yousuf I, 2014, RENEW SUST ENERG REV, V34, P71, DOI 10.1016/j.rser.2014.03.003; Zeng Ming, 2013, Renewable and Sustainable Energy Reviews, V24, DOI 10.1016/j.rser.2013.03.029; Zhang D, 2012, ENERGY, V41, P436, DOI 10.1016/j.energy.2012.02.056; Zhang KS, 2010, ENVIRON PROG SUSTAIN, V29, P265, DOI 10.1002/ep.10377; [赵斌 ZHAO Bin], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P368; Zhao YH, 2008, FEASIBILITY REPORT Y; Zhao ZY, 2011, RENEW ENERG, V36, P1105, DOI 10.1016/j.renene.2010.09.002; Zou GL, 2012, ENERG POLICY, V47, P456, DOI 10.1016/j.enpol.2012.05.022	58	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-0321			RENEW SUST ENERG REV	Renew. Sust. Energ. Rev.	JAN	2015	41						338	346		10.1016/j.rser.2014.08.056		9	Energy & Fuels	Energy & Fuels	AX0DA	WOS:000346622400027		
J	Wang, BB; Jin, P; Yue, YZ; Ji, SD; Li, YM; Luo, HJ				Wang, Bingbing; Jin, Ping; Yue, Yuanzheng; Ji, Shidong; Li, Yamei; Luo, Hongjie			Synthesis of NaCl single crystals with defined morphologies as templates for fabricating hollow nano/micro-structures	RSC ADVANCES			English	Article							SHAPE-CONTROLLED SYNTHESIS; RHOMBIC DODECAHEDRA; 110 FACETS; NANOCRYSTALS; PARTICLES; SPHERES; GROWTH; GOLD; NANOPARTICLES	Hollow nanostructures have a wide range of applications in nanotechnology. To accurately fabricate such nanostructures, the first and common key step is to synthesize high quality templates with controlled symmetry and geometry, ideally through a green, efficient, and economical approach. However, this has always been a challenge up to now. In the present work, we report a conceptually new simple approach, i.e., directly synthesizing templates from NaCl solutions. The properties of the templates can be tailored by selecting appropriate organic solvents and varying the crystal growth conditions. These naturally abundant NaCl single crystal templates are water-soluble, environmentally-friendly and uniform in both geometry and size, and hence are ideal for preparing high quality hollow nano/micro structures. The new approach may have the potential to replace the conventional hard or soft template approaches. Furthermore, this work has revealed the formation mechanism of nano/micron NaCl crystals with different sizes and geometries.	[Wang, Bingbing; Jin, Ping; Ji, Shidong; Li, Yamei] Chinese Acad Sci, Shanghai Inst Ceram, Res Ctr Ind Ceram, Shanghai 200050, Peoples R China; [Jin, Ping] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Yue, Yuanzheng] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China; [Yue, Yuanzheng] Aalborg Univ, Sect Chem, DK-9000 Aalborg, Denmark; [Li, Yamei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Luo, Hongjie] Shanghai Univ, Sch Mat Sci & Engn, Shanghai 200444, Peoples R China	Jin, P (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Res Ctr Ind Ceram, Dingxi 1295, Shanghai 200050, Peoples R China.	p-jin@mail.sic.ac.cn			MOST [2012BAA10B03, 2014AA032802]; National Natural Science Foundation of China (NSFC) [51272273, 51172265, 51372264]; Science and Technology Commission of Shanghai Municipality (STCSM) [13PJ1409000, 13NM1402200]	This study was financially supported by the high-tech project of MOST (2012BAA10B03, 2014AA032802), the national sci-tech support plan the National Natural Science Foundation of China (NSFC, no.: 51272273, 51172265, 51372264), and the Science and Technology Commission of Shanghai Municipality (STCSM, no.: 13PJ1409000, 13NM1402200).	STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Schmidt S, 2013, ADV FUNCT MATER, V23, P116, DOI 10.1002/adfm.201201321; Jeong GH, 2009, J AM CHEM SOC, V131, P1672, DOI 10.1021/ja809112n; Liu R, 2012, ACS APPL MATER INTER, V4, P1537, DOI 10.1021/am201756m; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Zhang J, 2011, ANGEW CHEM INT EDIT, V50, P6044, DOI 10.1002/anie.201101704; Cao HL, 2005, J AM CHEM SOC, V127, P16024, DOI 10.1021/ja055265y; Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295; Wang F, 2012, ANGEW CHEM INT EDIT, V51, P8796, DOI 10.1002/anie.201203069; Niu WX, 2009, J AM CHEM SOC, V131, P697, DOI 10.1021/ja804115r; Pu YC, 2006, J AM CHEM SOC, V128, P11606, DOI 10.1021/ja063221z; Hu J, 2011, CHEM SOC REV, V40, P5472, DOI 10.1039/c1cs15103g; Setny P, 2010, J CHEM THEORY COMPUT, V6, P2866, DOI 10.1021/ct1003077; Lin HX, 2013, J AM CHEM SOC, V135, P9311, DOI 10.1021/ja404371k; Niu WX, 2010, ACS NANO, V4, P1987, DOI 10.1021/nn100093y; Lee YW, 2011, ANGEW CHEM INT EDIT, V50, P3466, DOI 10.1002/anie.201007220; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756; Liu J, 2009, J MATER CHEM, V19, P6073, DOI 10.1039/b900116f; Personick ML, 2011, J AM CHEM SOC, V133, P6170, DOI 10.1021/ja201826r; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Jiang XM, 2006, J AM CHEM SOC, V128, P4512, DOI 10.1021/ja058260+; Callister W. D., 2001, FUNDAMENTALS MAT SCI; Guo XF, 2009, J PHYS CHEM C, V113, P8313, DOI 10.1021/jp8108122; Murphy TJ, 2009, J CHEM EDUC, V86, P519; Radenovic N, 2005, SURF SCI, V599, P196, DOI 10.1016/j.susc.2005.10.004; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229	26	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	7					5072	5076		10.1039/c4ra15385e		5	Chemistry, Multidisciplinary	Chemistry	AX1WH	WOS:000346733500050		
J	Gen, M; Lenggoro, W				Gen, Masao; Lenggoro, Wuled			Probing a dip-coated layer of organic molecules by an aerosol nanoparticle sensor with sub-100 nm resolution based on surface-enhanced Raman scattering	RSC ADVANCES			English	Article							SILVER ELECTRODE; SPECTROSCOPY; MONOLAYERS; THICKNESS; WITHDRAWAL; LIQUIDS; GROWTH; FILMS; SERS	A surface coated with organic molecules has been probed by a sub 100 nm resolution particulate sensor by surface-enhanced Raman scattering (SERS) technique. The spatial distribution of those molecules formed on the solid surface was altered by a dip-coating method as a function of a substrate-lifting rate. Isolated silver nanoparticles (similar to 50 nm) as "antenna" particles were deposited from the gas phase onto the surface by means of an electrostatic-assisted spray. The surface with the particles was analyzed with Raman spectroscopy technique. These analyses provide spatial information on the molecules over the surface, when SERS spectra of the molecules obtained from each measurement point are converted into the position of molecules. The occurrence frequency of SERS is found to be correlated with the two-third power law of the lifting rate which is proportional to a mass concentration of molecules per unit area, whereas the average Raman intensity is independent. A gas-phase route assisted SERS technique offers direct measurement of the molecular patterns on target surfaces.	[Gen, Masao; Lenggoro, Wuled] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn BASE, Koganei, Tokyo 1848588, Japan; [Lenggoro, Wuled] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan	Lenggoro, W (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn BASE, Koganei, Tokyo 1848588, Japan.	wuled.@cc.tuat.ac.jp	Lenggoro, Wuled/B-8629-2009; Gen, Masao/P-9490-2015	Lenggoro, Wuled/0000-0002-0048-8486; 	Ministry of Education, Culture, Sports, Science and Technology MEXT Kakenhi [20120010]; JSPS Kakenhi [23560904, 26420761, 23246132]	The authors gratefully thank M. Iijima, M. Tsukada, H. Kamiya, and H. Kakuta for the valuable comments, M. Horio for the instrument of Raman spectroscopy and C. Hayashi (passed away in 2010) for guiding us to this research. eld. This work was supported by Ministry of Education, Culture, Sports, Science and Technology MEXT Kakenhi Grant (no. 20120010), and JSPS Kakenhi Grant (no. 23560904, 26420761, 23246132).	PARADKAR RP, 1994, ANAL CHEM, V66, P2752, DOI 10.1021/ac00089a024; Constantino CJL, 2001, ANAL CHEM, V73, P3674, DOI 10.1021/ac0101961; Futamata M, 2005, J MOL STRUCT, V735, P75, DOI 10.1016/j.molstruc.2004.11.017; Yimsiri P, 2006, CHEM ENG SCI, V61, P3496, DOI 10.1016/j.ces.2005.12.018; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Frey BL, 1996, ANAL CHEM, V68, P3187, DOI 10.1021/ac9605861; Wustholz KL, 2010, J AM CHEM SOC, V132, P10903, DOI 10.1021/ja104174m; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Jing CB, 2006, SURF COAT TECH, V201, P2655, DOI 10.1016/j.surfcoat.2006.05.007; Liu BH, 2012, ANAL CHEM, V84, P255, DOI 10.1021/ac202452t; GUGLIELMI M, 1992, J MATER SCI, V27, P5052, DOI 10.1007/BF01105273; Vongsvivut J, 2010, J RAMAN SPECTROSC, V41, P1137, DOI 10.1002/jrs.2579; ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071; Liu B, 2013, FOOD BIOPROCESS TECH, V6, P710, DOI 10.1007/s11947-011-0774-5; Landau L, 1942, ACTA PHYSICOCHIM URS, V17, P42; Vericat C, 2005, PHYS CHEM CHEM PHYS, V7, P3258, DOI 10.1039/b505903h; Jang J, 2012, ADV FUNCT MATER, V22, P1005, DOI 10.1002/adfm.201102284; Han Y, 2011, ANAL CHEM, V83, P5873, DOI 10.1021/ac2005839; JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6; Jiang J, 2003, J PHYS CHEM B, V107, P9964, DOI 10.1021/jp034632u; Li LQ, 2010, J AM CHEM SOC, V132, P8807, DOI 10.1021/ja1017267; Li JF, 2010, NATURE, V464, P392, DOI 10.1038/nature08907; Qu D, 2002, PHYS FLUIDS, V14, P1154, DOI 10.1063/1.1449467; Chu PK, 2006, MATER CHEM PHYS, V96, P253, DOI 10.1016/j.matchemphys.2005.07.048; Gen M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GG10; Gen M., 2014, E J SURF SCI NANOTEC, V12, P238; GROENVEL.P, 1970, CHEM ENG SCI, V25, P33, DOI 10.1016/0009-2509(70)85019-9; Xie YF, 2012, EUR FOOD RES TECHNOL, V234, P1091, DOI 10.1007/s00217-012-1724-9	28	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	7					5158	5163		10.1039/c4ra03850a		6	Chemistry, Multidisciplinary	Chemistry	AX1WH	WOS:000346733500060		
J	Moriguchi, H; Kawai, T; Tanaka, Y				Moriguchi, Hiroyuki; Kawai, Takayuki; Tanaka, Yo			Simple bilayer on-chip valves using reversible sealability of PDMS	RSC ADVANCES			English	Article							TOTAL ANALYSIS SYSTEMS; LARGE-SCALE INTEGRATION; MICROFLUIDIC DEVICES; CELL-CULTURE; FUNDAMENTAL ADVANCES; FABRICATION; PUMPS; MICROVALVES; MICROSCOPY; SEPARATION	Valves are the most important components of lab-on-a-chip systems for the manipulation of small-volume samples. Various types of valves have been developed, but most of them require external actuators or complicated control lines (displacement chambers) to deform microchannels for valve functionalization. The development of a simple microfluidic valve has thus far been quite a technical challenge. Herein is presented the development of a simple, normally-closed passive valve on a microchip using a new patterning technique involving oxygen plasma with aluminum sacrificial lines, where surface activation is not induced. Only the valve sections are inactivated which produces a non-covalent, reversible seal between the polydimethylsiloxane (PDMS) lid and the glass substrate. When a fluid pressure in excess of the burst pressure is applied to this non-covalent seal area, the PDMS detaches slightly from the glass so that the fluid can pass through. Valve function was demonstrated by observation of the microchannels with a fluorescence microscope. A fluorescent dye was injected through the valve, and the burst pressure was measured to be 20 kPa. The opened valve was calculated to have a 2.1 mm gap (maximum) via the Hagen-Poiseuille law. Injection from multiple channels was also demonstrated, and the burst pressure did not change significantly over 6 injection cycles. This extremely simple structure can be utilized practically as an easy-to-implement and back-flow-free check valve, so long as the pressure in the outlet channel does not exceed the burst pressure threshold.	[Moriguchi, Hiroyuki; Kawai, Takayuki; Tanaka, Yo] RIKEN, Quantitat Biol Ctr QBiC, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kawai, Takayuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Tanaka, Yo] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Tanaka, Y (reprint author), RIKEN, Quantitat Biol Ctr QBiC, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	yo.tanaka@riken.jp			JSPS bilateral program; Challenging Exploratory Research [23651133]; JST PRESTO [14528962]; Leading-edge Research Infrastructure Program, Japan;  [13J04430];  [25709081]	This study was supported by the JSPS bilateral program, Grants-in-Aid for Young Scientist (A) (25709081), Challenging Exploratory Research (23651133), JSPS Fellows (13J04430), JST PRESTO (14528962), and Leading-edge Research Infrastructure Program, Japan. The authors thank Dr R. Yamada, Mr G. Kanda, and Dr H. R. Ueda (RIKEN, Japan) for useful discussion, and also Dr K. Matsumoto (RIKEN, Japan) for providing the fluorescent dye.	Xu YC, 2012, BIOSENS BIOELECTRON, V32, P300, DOI 10.1016/j.bios.2011.12.009; Fordyce PM, 2012, LAB CHIP, V12, P4287, DOI 10.1039/c2lc40414a; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Nanni G, 2012, MICROELECTRON ENG, V98, P607, DOI 10.1016/j.mee.2012.05.052; Kim J, 2012, ANAL CHEM, V84, P2067, DOI 10.1021/ac202934x; Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Jahanshahi A, 2013, J MICROELECTROMECH S, V22, P1354, DOI 10.1109/JMEMS.2013.2262595; SUTERA SP, 1993, ANNU REV FLUID MECH, V25, P1; Takei G, 2007, LAB CHIP, V7, P596, DOI 10.1039/b618851f; Gu P, 2014, ELECTROPHORESIS, V35, P289, DOI 10.1002/elps.201300160; Wang TQ, 2014, NANOSCALE, V6, P3846, DOI 10.1039/c3nr05865d; Araci IE, 2012, LAB CHIP, V12, P2803, DOI 10.1039/c2lc40258k; Hitzbleck M, 2012, LAB CHIP, V12, P1972, DOI 10.1039/c2lc00015f; Yildirim E, 2012, SENSOR ACTUAT A-PHYS, V181, P81, DOI 10.1016/j.sna.2012.05.008; Lee PJ, 2009, LAB CHIP, V9, P164, DOI 10.1039/b807682k; Arora A, 2010, ANAL CHEM, V82, P4830, DOI 10.1021/ac100969k; Tourovskaia A, 2003, LANGMUIR, V19, P4754, DOI 10.1021/la0267948; Kvach MV, 2009, BIOCONJUGATE CHEM, V20, P1673, DOI 10.1021/bc900037b; Kim H, 2014, MICROFLUID NANOFLUID, V16, P623, DOI 10.1007/s10404-013-1267-9; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Gu W, 2004, P NATL ACAD SCI USA, V101, P15861, DOI 10.1073/pnas.0404353101; Chen CY, 2011, LAB CHIP, V11, P733, DOI 10.1039/c0lc00415d; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Kovarik ML, 2012, ANAL CHEM, V84, P516, DOI 10.1021/ac202611x; Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9; Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y; Kovarik ML, 2013, ANAL CHEM, V85, P451, DOI 10.1021/ac3031543; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Culbertson CT, 2014, ANAL CHEM, V86, P95, DOI 10.1021/ac403688g; Chen Y.-J., 2011, MICROTOTAL ANAL SYST, P1692; Domenichini M, 2013, MICROFLUID NANOFLUID, V15, P753, DOI 10.1007/s10404-013-1187-8; Dziuban JA, 2004, SENSOR ACTUAT A-PHYS, V115, P318, DOI 10.1016/j.sna.2004.04.028; Godino N, 2010, LAB CHIP, V10, P1841, DOI 10.1039/c003000g; Jamshaid A., 2012, MICROMACHINES, V12, P4287; Kanda G., 2013, MICROTOTAL ANAL SYST, P1063; Kitamori T, 2004, ANAL CHEM, V76, p52A, DOI 10.1021/ac041508d; Kuo CH, 2009, ELECTROPHORESIS, V30, P3228, DOI 10.1002/elps.200900112; Liu CT, 2011, BULK METALLIC GLASSES, P11; Mawatari K, 2013, ANAL CHEM, V84, P10812; Mosadegh B, 2011, LAB CHIP, V11, P738, DOI 10.1039/c0lc00112k; Ren KN, 2011, P NATL ACAD SCI USA, V108, P8162, DOI 10.1073/pnas.1100356108; Takahashi K., 2002, SCIENCE, V298, P580; Tanaka Y, 2013, RSC ADV, V3, P10213, DOI 10.1039/c3ra41218k; Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Zheng YZ, 2009, LAB CHIP, V9, P469, DOI 10.1039/b811526e	46	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	7					5237	5243		10.1039/c4ra10300a		7	Chemistry, Multidisciplinary	Chemistry	AX1WH	WOS:000346733500071		
J	Fujiwara, T; Yasuda, H; Nishimura, Y; Nambu, H; Yakura, T				Fujiwara, Tomoya; Yasuda, Hiroko; Nishimura, Yushi; Nambu, Hisanori; Yakura, Takayuki			Synthesis of 10b-fluorinated analogues of protubonine A and its 11a-epimer via fluorocyclisation of tryptophan-containing dipeptides	RSC ADVANCES			English	Article							D-AMINO ACIDS; INDOLE ALKALOIDS; STEREOCONTROLLED SYNTHESIS; MEDICINAL CHEMISTRY; DERIVATIVES; PEPTIDE; DIKETOPIPERAZINES; HOMOCHIRALITY; MICROBIOLOGY; CYCLIZATION	The synthesis of 10b-fluorinated analogues of protubonine A and its 11a-epimer was accomplished using fluorocyclisation of tryptophan-containing dipeptides with N-fluoro-2,4,6-trimethylpyridinium triflate to 3a-fluoropyrrolo[2,3-b]indoles as a key step. Acetylation of the indole nitrogen and the following diketopiperazine formation gave the 10b-fluorinated analogues of protubonine A and its 11a-epimer.	[Fujiwara, Tomoya; Yasuda, Hiroko; Nishimura, Yushi; Nambu, Hisanori; Yakura, Takayuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan	Fujiwara, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan.	tfuji@pha.u-toyama.ac.jp					Fischer PM, 2003, J PEPT SCI, V9, P9, DOI 10.1002/psc.446; Capasso S, 1998, J AM CHEM SOC, V120, P1990, DOI 10.1021/ja972051a; Che Q, 2012, ORG LETT, V14, P3438, DOI 10.1021/ol301396h; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Deng X, 2014, ORG LETT, V16, P3276, DOI 10.1021/ol501287x; Masi M, 2013, TETRAHEDRON, V69, P7466, DOI 10.1016/j.tet.2013.06.031; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Friedman M, 2012, AMINO ACIDS, V42, P1553, DOI 10.1007/s00726-011-0915-1; Fujii N, 2004, CHEM REC, V4, P267, DOI 10.1002/tcr.20020; O'Hagan D, 2010, J FLUORINE CHEM, V131, P1071, DOI 10.1016/j.jfluchem.2010.03.003; Wang J, 2014, CHEM REV, V114, P2432, DOI 10.1021/cr4002879; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Mali SM, 2012, CHEM COMMUN, V48, P7085, DOI 10.1039/c2cc32581k; Depew KM, 1999, J AM CHEM SOC, V121, P11953, DOI 10.1021/ja991558d; Ohide H, 2011, J CHROMATOGR B, V879, P3162, DOI 10.1016/j.jchromb.2011.06.028; Lorenzo P, 2014, EUR J ORG CHEM, V2014, P2557, DOI 10.1002/ejoc.201400029; Nge CE, 2013, ORG LETT, V15, P4774, DOI 10.1021/ol4021404; Koyama K, 2012, TETRAHEDRON, V68, P1502, DOI 10.1016/j.tet.2011.12.014; Crich D, 1999, J ORG CHEM, V64, P7218, DOI 10.1021/jo991093+; Lopez CS, 2008, ORG LETT, V10, P77, DOI 10.1021/ol702732j; Tullberg M, 2006, TETRAHEDRON, V62, P7484, DOI 10.1016/j.tet.2006.05.010; FRIED J, 1954, J AM CHEM SOC, V76, P1455, DOI 10.1021/ja01634a101; Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Reategui R, 2013, J NAT PROD, V76, P1523, DOI 10.1021/np300894y; Lee SU, 2011, J NAT PROD, V74, P1284, DOI 10.1021/np100880b; Rukachaisirikul V, 2013, TETRAHEDRON, V69, P11116, DOI 10.1016/j.tet.2013.11.009; Raju R, 2011, ORG LETT, V13, P2770, DOI 10.1021/ol200904v; Fujii N, 2005, BIOL PHARM BULL, V28, P1585, DOI 10.1248/bpb.28.1585; Beniddir MA, 2012, ORG LETT, V14, P4162, DOI 10.1021/ol301832t; Fujiwara T, 2014, J FLUORINE CHEM, V165, P7, DOI 10.1016/j.jfluchem.2014.05.011; Chen MH, 2012, J NAT PROD, V75, P1167, DOI 10.1021/np3002833; Ruiz-Sanchis P, 2011, CHEM-EUR J, V17, P1388, DOI 10.1002/chem.201001451; Wang FZ, 2012, BIOORG MED CHEM LETT, V22, P7265, DOI 10.1016/j.bmcl.2012.08.115; Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u; Li LY, 2012, J NAT PROD, V75, P920, DOI 10.1021/np3000443; Fujii N, 2010, CHEM BIODIVERS, V7, P1389, DOI 10.1002/cbdv.200900337; Gan CY, 2013, J NAT PROD, V76, P957, DOI 10.1021/np400214y; Begue J.-P., 2008, BIOORGANIC MED CHEM; BEREZNAK JF, 1989, SYNTHETIC COMMUN, V19, P3573, DOI 10.1080/00397918908052767; Du FY, 2012, BIOORG MED CHEM LETT, V22, P4650, DOI 10.1016/j.bmcl.2012.05.088; Fujiwara T, 2010, CURR ORG CHEM, V14, P950; Ji ZQ, 2012, CHEM BIODIVERS, V9, P1567, DOI 10.1002/cbdv.201100364; KREIL G, 1994, J BIOL CHEM, V269, P10967; Ley SV, 2003, ORG BIOMOL CHEM, V1, P3492, DOI 10.1039/b308288a; Li XN, 2011, ORG LETT, V13, P5896, DOI 10.1021/ol202536b; Martinez-Rodriguez S, 2010, CHEM BIODIVERS, V7, P1531, DOI 10.1002/cbdv.200900245; Ruiz-Sanchis P, 2012, EUR J ORG CHEM, P67, DOI 10.1002/ejoc.201101057; Sela M, 1997, FASEB J, V11, P449; Shibata N, 2001, ANGEW CHEM INT EDIT, V40, P4461, DOI 10.1002/1521-3773(20011203)40:23<4461::AID-ANIE4461>3.0.CO;2-E; Takeuchi Y., 2009, U.S. Patent, Patent No. [0,171,093, 0171093]; TANIGUCHI M, 1981, TETRAHEDRON, V37, P1487, DOI 10.1016/S0040-4020(01)92088-5	52	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	7					5464	5473		10.1039/c4ra08741k		10	Chemistry, Multidisciplinary	Chemistry	AX1WH	WOS:000346733500099		
J	Tanaka, Y; Kato, G; Nishio, T; Arisawa, S				Tanaka, Y.; Kato, G.; Nishio, T.; Arisawa, S.			Observation of quantum oscillations in a narrow channel with a hole fabricated on a film of multiband superconductors	SOLID STATE COMMUNICATIONS			English	Article							AC	We observe oscillations in the resistivity as a function of the magnetic field at 80 K in a 5-mu m-wide channel with a 100-nm-diameter hole fabricated in a multi-band superconducting (Tl-x, Cu1-x)(Ba-y, Sr1-y)(2)Ca2Cu3Oz film. A phase shift is observed in the oscillations at magnetic fields around 200 mT, which is similar to previous observations in mesoscopic superconducting rings with two order parameters. (C) 2014 Elsevier Ltd. All rights reserved.	[Tanaka, Y.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Kato, G.; Nishio, T.] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan; [Arisawa, S.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Tanaka, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	y.tanaka@aist.go.jp			National Institute for Materials Science (NIMS) Nanofabrication Platform in Nanotechnology Platform Project - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [F-13-NM-0036]	This study was supported by the National Institute for Materials Science (NIMS) Nanofabrication Platform in Nanotechnology Platform Project sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (subject ID: F-13-NM-0036).	Ooi S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247002; Hamada N, 2001, PHYSICA C, V357, P108, DOI 10.1016/S0921-4534(01)00177-0; LITTLE WA, 1962, PHYS REV LETT, V9, P9, DOI 10.1103/PhysRevLett.9.9; Bluhm H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237002; Jang J, 2011, SCIENCE, V331, P186, DOI 10.1126/science.1193839; Koshnick NC, 2007, SCIENCE, V318, P1440, DOI 10.1126/science.1148758; Bonn D. A., 1996, PHYSICAL PROPERTIES, P7, DOI 10.1142/9789814261289_0002; Carillo F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054505; COON DD, 1965, PHYS REV, V138, pA744, DOI 10.1103/PhysRev.138.A744; Crisan A, 2007, JPN J APPL PHYS 2, V46, pL451, DOI 10.1143/JJAP.46.L451; Kuplevakhsky SV, 2011, LOW TEMP PHYS+, V37, P667, DOI 10.1063/1.3660216; Sundaresan A, 2003, SUPERCOND SCI TECH, V16, pL23, DOI 10.1088/0953-2048/16/5/102; Tanaka Y, 2007, JPN J APPL PHYS 1, V46, P134, DOI 10.1143/JJAP.46.134; Tanaka Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017002; Tanaka Y, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.074705; Tinkham M., 1996, INTRO SUPERCONDUCTIV, P215	16	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	JAN	2015	201						95	97		10.1016/j.ssc.2014.10.014		3	Physics, Condensed Matter	Physics	AX2FY	WOS:000346760100020		
J	Wiek, A; Harlow, J; Melnick, R; van der Leeuw, S; Fukushi, K; Takeuchi, K; Farioli, F; Yamba, F; Blake, A; Geiger, C; Kutter, R				Wiek, Arnim; Harlow, John; Melnick, Rob; van der Leeuw, Sander; Fukushi, Kensuke; Takeuchi, Kazuhiko; Farioli, Francesca; Yamba, Francis; Blake, Ann; Geiger, Chris; Kutter, Robert			Sustainability science in action: a review of the state of the field through case studies on disaster recovery, bioenergy, and precautionary purchasing	SUSTAINABILITY SCIENCE			English	Article						Sustainability science; Disasters; Urban sustainability; Bioenergy; Precautionary purchasing; Developing countries	CHALLENGES; PROGRAM; ENERGY; TRANSITION; MANAGEMENT; UNIVERSITY; FUKUSHIMA; FRAMEWORK; EDUCATION; LESSONS	Sustainability science still struggles with transitioning from problem-focused to solution-oriented endeavors that yield positive impacts on mitigating sustainability challenges. This article presents and compares three sustainability science studies on the reconstruction after the 2011 triple-disaster in Japan; limited energy and livelihood options in rural Africa; and toxic chemical dispersion in San Francisco. Research varied in design and conduct, with opportunities for improvement in transdisciplinary collaboration, institutional incentives and rewards, competency development in future researchers, articulation of relevant political economies, and orientation towards feasible solution options. Of particular interest are insights synthesized across the cases, mainly success factors and their transferability, sustainability science pedagogical opportunities, and potential future research areas. These insights emerged from presentations and breakout discussions of the three studies at the 2012 International Conference on Sustainability Science held at Arizona State University.	[Wiek, Arnim; Harlow, John; Melnick, Rob; van der Leeuw, Sander; Kutter, Robert] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85004 USA; [van der Leeuw, Sander] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Fukushi, Kensuke; Takeuchi, Kazuhiko] Univ Tokyo, Tokyo, Japan; [Takeuchi, Kazuhiko] United Nations Univ, Inst Sustainabil & Peace, Tokyo, Japan; [Farioli, Francesca] Univ Roma La Sapienza, Interuniv Res Ctr Sustainable Dev, I-00185 Rome, Italy; [Farioli, Francesca] Univ Roma La Sapienza, Dept Mech Engn, I-00185 Rome, Italy; [Yamba, Francis] Ctr Energy Environm & Engn Zambia CEEZ, Lusaka, Zambia; [Blake, Ann] Environm & Publ Hlth Consulting, Alameda, CA USA; [Geiger, Chris] San Francisco Dept Environm, Tox Reduct Program, San Francisco, CA USA	Wiek, A (reprint author), Arizona State Univ, Sch Sustainabil, Tempe, AZ 85004 USA.	arnim.wiek@asu.edu			University of Tokyo; Arizona State University; U.S. Environmental Protection Agency	The authors would like to thank all co-organizers, case study presenters, panelists, participants, and volunteers from the 2012 International Conference on Sustainability Science at Arizona State University (Tempe, AZ, February 20-23, 2012) for important contributions to and feedback on this article. We also recognize the support and valuable keynote inputs from ASU's President Michael Crow and Dean Pamela Matson from Stanford University. We acknowledge financial support from the University of Tokyo, Arizona State University, and the U.S. Environmental Protection Agency. We thank Michael Bernstein for editorial support.	Aldrich DP, 2011, STUD EMERG ORDER, V4, P58; Norio O, 2011, INT J DISAST RISK SC, V2, P34, DOI 10.1007/s13753-011-0004-9; Whitmer A, 2010, FRONT ECOL ENVIRON, V8, P314, DOI 10.1890/090241; Perrow C, 2011, B ATOM SCI, V67, P44, DOI 10.1177/0096340211426395; Yarime M, 2012, SUSTAIN SCI, V7, P101, DOI 10.1007/s11625-012-0157-5; Landrigan PJ, 2002, ENVIRON HEALTH PERSP, V110, P721; Ferrer-Balas D, 2010, J CLEAN PROD, V18, P607, DOI 10.1016/j.jclepro.2009.12.009; Smith RJ, 2009, NATURE, V462, P280, DOI 10.1038/462280a; Hoogwijk M, 2005, BIOMASS BIOENERG, V29, P225, DOI 10.1016/j.biombioe.2005.05.002; Brundiers K, 2013, SUSTAINABILITY-BASEL, V5, P1725, DOI 10.3390/su5041725; Chamlee-Wright E, 2010, PUBLIC CHOICE, V144, P253, DOI 10.1007/s11127-009-9516-x; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Jerneck A, 2011, SUSTAIN SCI, V6, P69, DOI 10.1007/s11625-010-0117-x; Amigun B, 2011, RENEW SUST ENERG REV, V15, P1360, DOI 10.1016/j.rser.2010.10.015; Birkmann J, 2010, SUSTAIN SCI, V5, P185, DOI 10.1007/s11625-010-0111-3; Dauer LT, 2011, J NUCL MED, V52, P1423, DOI 10.2967/jnumed.111.091413; Blackstock KL, 2007, GEOGR J, V173, P343, DOI 10.1111/j.1475-4959.2007.00258.x; Rowe D, 2007, SCIENCE, V317, P323, DOI 10.1126/science.1143552; Wiek A, 2011, ENVIRONMENT, V53, P3, DOI 10.1080/00139157.2011.554496; Suppasri A, 2013, PURE APPL GEOPHYS, V170, P993, DOI 10.1007/s00024-012-0511-7; Crow MM, 2010, BIOSCIENCE, V60, P488, DOI 10.1525/bio.2010.60.7.2; Spangenberg JH, 2011, ENVIRON CONSERV, V38, P275, DOI 10.1017/S0376892911000270; Kauffman J, 2009, SUSTAIN SCI, V4, P233, DOI 10.1007/s11625-009-0088-y; Smeets EMW, 2007, PROG ENERG COMBUST, V33, P56, DOI 10.1016/j.pecs.2006.08.001; Faulkner H, 2007, AMBIO, V36, P692, DOI 10.1579/0044-7447(2007)36[692:DATDTC]2.0.CO;2; Matson P, 2009, ISSUES SCI TECHNOL, V25, P39; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Blackstock KL, 2007, ECOL ECON, V60, P726, DOI 10.1016/j.ecolecon.2006.05.014; Talwar S, 2011, SCI PUBL POLICY, V38, P379, DOI 10.3152/030234211X12960315267615; BERKE PR, 1993, DISASTERS, V17, P93, DOI 10.1111/j.1467-7717.1993.tb01137.x; Mimura N, 2011, MITIG ADAPT STRAT GL, V16, P803, DOI 10.1007/s11027-011-9297-7; Wiek A, 2012, SUSTAIN SCI, V7, P1, DOI 10.1007/s11625-011-0154-0; Wiek A, 2012, SUSTAIN SCI, V7, P5, DOI 10.1007/s11625-011-0148-y; Komiyama H, 2006, SUSTAIN SCI, V1, P1, DOI 10.1007/s11625-006-0007-4; Romijn HA, 2011, RES POLICY, V40, P618, DOI 10.1016/j.respol.2011.01.005; Robinson J, 2008, FUTURES, V40, P70, DOI 10.1016/j.futures.2007.06.007; Wicke B, 2011, BIOMASS BIOENERG, V35, P2773, DOI 10.1016/j.biombioe.2011.03.010; van der Leeuw S, 2012, SUSTAIN SCI, V7, P115, DOI 10.1007/s11625-011-0153-1; Wiek A, 2011, SUSTAIN SCI, V6, P203, DOI 10.1007/s11625-011-0132-6; Park Jeryang, 2011, Integrated Environmental Assessment and Management, V7, P396, DOI 10.1002/ieam.228; Barrett B, 2012, FUTURE, V3, P99; Battisti B., 2008, INT J SUSTAINABILITY, V9, P68, DOI DOI 10.1108/14676370810842193; CHAPIN III F. STUART, 2011, J ENV STUDIES SCI, V1, P44; Clark W. C., 2011, P NATL ACAD SCI US; Cotula L., 2009, LAND GRAB DEV OPPORT; Crow MM, 2012, 3 INT C SUST SCI ICS, P9; Dalal-Clayton B, 2003, LESSONS LUANGWA STOR; Davis C, 2012, INT J DISAST RISK RE, V1, P17, DOI 10.1016/j.ijdrr.2012.03.001; Dong X., 2011, THESIS U ILLINOIS UR; Dovers S, 2012, HDB DISASTER EMERGEN; Farioli F, 2012, ICSS 2012 DOCUMENTS; Farioli F, 2009, COMPETE DOCUMENTS; Farioli F, 2013, HDB SUSTAINABLE ENG; Fisker-Nielsen AM, 2012, ANTHR TODAY, V28, P16; German L, 2011, ECOL SOC, V16, DOI 10.5751/ES-04280-160412; Gilligan A, 2011, JAPAN EARTHQUAKE CAL; Guston DH, 2008, NATURE, V454, P940, DOI 10.1038/454940a; Jerneck A, 2011, ENV INNOVATION SOC T, V1, P255; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Kurihara S, 2012, J FOOD SYST RES, V18, P415; Lang DJ, 2012, I SOCIAL INNOVATION, P393; Loorbach D. A., 2007, TRANSITION MANAGEMEN; Lynd LR, 2011, NATURE, V474, pS20, DOI 10.1038/474S020a; Matanle P., 2011, LOCAL ENV, V16, P823; Matson P, 2012, 3 INT C SUST SCI ICS, P12; McCullough EB, P NATL ACAD IN PRESS; Ministry of the Environment Japan United Nations University Institute for sustainability and peace, 2012, BUILD BETT PARTN LEA; Muir T, 2001, ENVIRON HEALTH PERSP, V109, P885, DOI 10.2307/3454651; Ogimoto K, 2012, CLIM CHANG MITIG LEC, V4, P223; Onuki M, 2009, SUSTAIN SCI, V4, P55, DOI 10.1007/s11625-009-0073-5; Pearce F, 2007, NEW SCI, V196, P6; Perrow C., 1984, NORMAL ACCIDENTS LIV; Quay R, 2010, INT J MICROW WIREL T, V2, P1, DOI 10.1017/S1759078710000188; Raphael Debbie O, 2011, New Solut, V21, P345, DOI 10.2190/NS.21.3.d; Reconstruction Design Council, 2011, REC HOP DIS PROV TRA; Sarewitz Daniel, 2012, New Solut, V22, P139, DOI 10.2190/NS.22.2.c; Janssen R, 2012, BIOENERGY FOR SUSTAINABLE DEVELOPMENT IN AFRICA, P1, DOI 10.1007/978-94-007-2181-4; Shaw WT, 2011, 2011 TOHOKU JAPAN QU; Siebenhuner B., 2004, INT J SUST DEV WORLD, V7, P146, DOI 10.1504/IJSD.2004.005368; Taele BM, 2012, RENEW SUST ENERG REV, V16, P973, DOI 10.1016/j.rser.2011.09.019; Tainter J, 2003, WORLD FUTURES J GEN, V59, P213, DOI 10.1080/02604020310132; Takahashi S, 2011, ANTHR NEWS, V52, P5; Takeuchi K, APPL SUSTAINAB UNPUB; Takeuchi K, 2011, SUSTAIN SCI, V6, P117, DOI 10.1007/s11625-011-0136-2; Thomas D. K., 2013, SOCIAL VULNERABILITY, V2nd; Tweed F, 2011, LOCAL ENV INT J JUST, V16, P937; United Nations, 2013, MILL DEV GOALS REP 2; Voss JP, 2011, ECOL SOC, V16; Watson HK, 2011, INTERFACE FOCUS, V1, P263, DOI 10.1098/rsfs.2010.0022; Wiek A, 2012, 3 INT C SUST SCI ICS; Wiek A, 2010, DISASTER PREV MANAG, V19, P423, DOI 10.1108/09653561011070358; Wiek A, SUSTAIN SCI IN PRESS; Wiek A, 2009, WORKING PAPER; Yamba F, 2008, DECLARATION SUSTAINA; Yin Robert K, 1994, CASE STUDY RES METHO	95	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1862-4065	1862-4057		SUSTAIN SCI	Sustain. Sci.	JAN	2015	10	1					17	31		10.1007/s11625-014-0261-9		15	Environmental Sciences	Environmental Sciences & Ecology	AX3UQ	WOS:000346864500002		
J	Miyoshi-Akiyama, T; Satou, K; Kato, M; Shiroma, A; Matsumura, K; Tamotsu, H; Iwai, H; Teruya, K; Funatogawa, K; Hirano, T; Kirikae, T				Miyoshi-Akiyama, Tohru; Satou, Kazuhito; Kato, Masako; Shiroma, Akino; Matsumura, Kazunori; Tamotsu, Hinako; Iwai, Hiroki; Teruya, Kuniko; Funatogawa, Keiji; Hirano, Takashi; Kirikae, Teruo			Complete annotated genome sequence of Mycobacterium tuberculosis (Zopf) Lehmann and Neumann (ATCC35812) (Kurono)	TUBERCULOSIS			English	Article						PacBio sequencer; Kurono; PE-PPE; Phyrogenetic tree; Complete genome		We report the completely annotated genome sequence of Mycobacterium tuberculosis (Zopf) Lehmannand Neumann (ATCC35812) (Kurono), which is a used for virulence and/or immunization studies. The complete genome sequence of M. tuberculosis Kurono was determined with a length of 4,415,078 bp and a G+C content of 65.60%. The chromosome was shown to contain a total of 4,340 protein-coding genes, 53 tRNA genes, one transfer messenger RNA for all amino acids, and 1 rrn operon. Lineage analysis based on large sequence polymorphisms indicated that M. tuberculosis Kurono belongs to the Euro-American lineage (lineage 4). Phylogenetic analysis using whole genome sequences of M. tuberculosis Kurono in addition to 22 M. tuberculosis complex strains indicated that H37Rv is the closest relative of Kurono based on the results of phylogenetic analysis. These findings provide a basis for research using M. tuberculosis Kurono, especially in animal models. (C) 2014 Elsevier Ltd. All rights reserved.	[Miyoshi-Akiyama, Tohru; Kato, Masako; Matsumura, Kazunori; Iwai, Hiroki; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, Tokyo 1628655, Japan; [Satou, Kazuhito; Shiroma, Akino; Tamotsu, Hinako; Teruya, Kuniko; Hirano, Takashi] Okinawa Life Sci Res Ctr, Uruma, Okinawa 9042234, Japan; [Funatogawa, Keiji] Tochigi Prefectural Inst Publ Hlth & Environm Sci, Kawachi, Tochigi 3291196, Japan; [Miyoshi-Akiyama, Tohru] Natl Ctr Global Hlth & Med, Res Inst, Pathogen Microbe Lab, Shinjuku Ku, Tokyo 1628655, Japan	Miyoshi-Akiyama, T (reprint author), Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	takiyam@ri.ncgm.go.jp			International Health Research from the Ministry of Health, Labor, and Welfare of Japan [24A-103, 26A-103]	T. K. and T. M. A. were supported by Grants for International Health Research (24A-103) and (26A-103) from the Ministry of Health, Labor, and Welfare of Japan, respectively. The funding resources did not have any roles in this study. The authors thank Mrs. Komiya and Mrs. Sakurai for their excellent work in the genome analysis.	Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Trudeau Institute, 1972, TRUD MYC CULT COLL, V124, P24	5	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1472-9792			TUBERCULOSIS	Tuberculosis	JAN	2015	95	1					37	39		10.1016/j.tube.2014.10.007		3	Immunology; Microbiology; Respiratory System	Immunology; Microbiology; Respiratory System	AX3RT	WOS:000346857300006		
J	Tsujimura, A; Fukuhara, S; Soda, T; Takezawa, K; Kiuchi, H; Takao, T; Miyagawa, Y; Nonomura, N; Adachi, S; Tokita, Y; Nomura, T				Tsujimura, Akira; Fukuhara, Shinichiro; Soda, Tetsuji; Takezawa, Kentaro; Kiuchi, Hiroshi; Takao, Tetsuya; Miyagawa, Yasushi; Nonomura, Norio; Adachi, Shigeki; Tokita, Yoriko; Nomura, Taisei			Histologic Evaluation of Human Benign Prostatic Hyperplasia Treated by Dutasteride: A Study by Xenograft Model With Improved Severe Combined Immunodeficient Mice	UROLOGY			English	Article							5-ALPHA-REDUCTASE INHIBITOR DUTASTERIDE; URINARY-TRACT SYMPTOMS; CELL-PROLIFERATION; EPITHELIAL-CELLS; THYROID TISSUES; APOPTOSIS; CANCER; MEN; CYCLOOXYGENASE-2; EXPRESSION	OBJECTIVE To evaluate histologic change in human prostate samples treated with dutasteride and to elucidate direct effects of dutasteride on human prostate tissue, the present study was conducted by using a xenograft model with improved severe combined immunodeficient (super-SCID) mice, although it is well known that dutasteride reduces prostate volume. METHODS After establishment of a xenograft model of human benign prostatic hyperplasia in morphology and function, samples implanted into super-SCID mice with and without dutasteride were evaluated pathohistologically at 2 and 6 months after initiation of dutasteride administration. RESULTS The proliferative index evaluated by Ki-67 staining was significantly lower in the dutasteride group than the control at 2 and 6 months after administration. Apoptotic index evaluated by the terminal transferase TdT-mediated dUTP-biotin nick end labeling staining was higher in the dutasteride group than the control at 2 and 6 months after administration. Quick scores in the dutasteride group for staining of both cyclooxygenase-2 (Cox-2) and Ras homolog gene family, member A (RhoA) were significantly lower than those in the control group at 2 and 6 months after administration. CONCLUSION Dutasteride inhibits cell proliferation and induces apoptosis of prostatic cells, causing a reduced prostate volume. Furthermore, decreased expression of Cox-2 and RhoA within benign prostatic hyperplasia tissue by dutasteride may induce an early effect on improvement of lower urinary tract symptoms, probably by attenuating inflammation reaction of the prostate and decreasing intraurethral pressure, other than the mechanism of reduced prostate volume. (C) 2015 Elsevier Inc.	[Tsujimura, Akira] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka 5650871, Japan; Natl Inst Biomed Innovat, Ibaraki, Osaka, Japan	Tsujimura, A (reprint author), Osaka Univ, Grad Sch Med, Dept Urol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	akitsuji@uro.med.osaka-u.ac.jp			GlaxoSmithKline	This study was partially supported by research funding from GlaxoSmithKline.	Roehrborn CG, 2008, J UROLOGY, V179, P616, DOI 10.1016/j.juro.2007.09.084; Feneley MR, 1999, PROSTATE CANCER P D, V2, P277, DOI 10.1038/sj.pcan.4500377; Tsukamoto T, 2009, INT J UROL, V16, P745, DOI 10.1111/j.1442-2042.2009.02357.x; ONEILL GP, 1993, FEBS LETT, V330, P156; Kiuchi H, 2009, BJU INT, V104, P826, DOI 10.1111/j.1464-410X.2009.08467.x; Lepor H, 2012, CURR OPIN UROL, V22, P7, DOI 10.1097/MOU.0b013e32834d9bfd; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Takahashi R, 2007, NEUROUROL URODYNAM, V26, P547, DOI 10.1002/nau.20365; Andriole GL, 2004, J UROLOGY, V172, P915, DOI 10.1097/01.ju.0000136430.37245.b9; Nickel JC, 2011, J UROLOGY, V186, P1313, DOI 10.1016/j.juro.2011.05.071; Kyprianou N, 1996, HUM PATHOL, V27, P668, DOI 10.1016/S0046-8177(96)90396-2; Iadecola C, 2005, STROKE, V36, P182, DOI 10.1161/01.STR.0000153797.33611.d8; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nomura T, 1997, CANCER RES, V57, P2081; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Debruyne F, 2004, EUR UROL, V46, P488, DOI 10.1016/j.eururo.2004.05.008; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Fooanant Supranee, 2008, Journal of the Medical Association of Thailand, V91, P1558; Fukuda K, 1998, CANCER LETT, V132, P153, DOI 10.1016/S0304-3835(98)00169-4; Glassman DT, 2001, PROSTATE, V46, P45, DOI 10.1002/1097-0045(200101)46:1<45::AID-PROS1007>3.0.CO;2-U; Gleave M, 2006, PROSTATE, V66, P1674, DOI 10.1002/pros.20499; Gonzalez-Montelongo MC, 2010, MOL ENDOCRINOL, V24, P1007, DOI 10.1210/me.2009-0472; Kehrl W, 2000, LARYNGO RHINO OTOL, V79, P151; McCrohan AM, 2006, CANCER, V106, P2743, DOI 10.1002/cncr.21938; Nomura T, 2008, MUTAT RES-GEN TOX EN, V657, P68, DOI 10.1016/j.mrgentox.2008.08.006; NOMURA T, 1990, J RADIAT RES, V31, P288, DOI 10.1269/jrr.31.288; Nomura T, 2004, RADIOBIOLOGY BIOMEDI, P200; Ohlson N, 2005, PROSTATE, V62, P307, DOI 10.1002/pros.20139; Osterlund KL, 2010, AM J PHYSIOL-ENDOC M, V298, pE838, DOI 10.1152/ajpendo.00693.2009; Raczyńska Krystyna, 2003, Klin Oczna, V105, P179; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	JAN	2015	85	1							274.e1	10.1016/j.urology.2014.09.024		9	Urology & Nephrology	Urology & Nephrology	AX0NI	WOS:000346648500069		
J	van der Meer, PF; Dumont, LJ; Lozano, M; Bondar, N; Wong, J; Ismay, S; Pink, J; Nussbaumer, W; Coene, J; Feys, HB; Compernolle, V; Devine, DV; Howe, D; Lin, CK; Sun, J; Ringwald, J; Strasser, EF; Eckstein, R; Seltsam, A; Perseghin, P; Proserpio, P; Wakamoto, S; Akino, M; Takamoto, S; Tadokoro, K; Teo, D; Shu, PH; Chua, SS; Jimenez-Marco, T; Cid, J; Castro, E; Munoz, I; Gulliksson, H; Sandgren, P; Thomas, S; Petrik, J; McColl, K; Kamel, H; Dugger, J; Sweeney, JD; Gorlin, JB; Sutor, LJ; Heath, D; Sayers, MH				van der Meer, P. F.; Dumont, L. J.; Lozano, M.; Bondar, N.; Wong, J.; Ismay, S.; Pink, J.; Nussbaumer, W.; Coene, J.; Feys, H. B.; Compernolle, V.; Devine, D. V.; Howe, D.; Lin, C. K.; Sun, J.; Ringwald, J.; Strasser, E. F.; Eckstein, R.; Seltsam, A.; Perseghin, P.; Proserpio, P.; Wakamoto, S.; Akino, M.; Takamoto, S.; Tadokoro, K.; Teo, D.; Shu, P. H.; Chua, S. S.; Jimenez-Marco, T.; Cid, J.; Castro, E.; Munoz, I.; Gulliksson, H.; Sandgren, P.; Thomas, S.; Petrik, J.; McColl, K.; Kamel, H.; Dugger, J.; Sweeney, J. D.; Gorlin, J. B.; Sutor, L. J.; Heath, D.; Sayers, M. H.			Aggregates in platelet concentrates	VOX SANGUINIS			English	Article							IN-VITRO QUALITY; ADDITIVE SOLUTION; ACTIVATION STATE; BLOOD-PLATELETS; CELL SEPARATORS; RICH PLASMA; WHOLE-BLOOD; BUFFY COAT; P-SELECTIN; STORAGE		[van der Meer, P. F.] Sanquin Blood Bank, Dept Prod & Proc Dev, NL-1006 AC Amsterdam, Netherlands; [Dumont, L. J.] Geisel Sch Med Dartmouth, Ctr Transfus Med Res, Dept Pathol, Lebanon, NH USA; [Lozano, M.] Hosp Clin Barcelona, Dept Hemotherapy & Hemostasis, Barcelona, Spain; [Coene, J.; Feys, H. B.; Compernolle, V.] Belgian Red Cross Flanders Blood Serv, B-9000 Ghent, Belgium; [Sun, J.] WHO Collaborating Ctr, Shanghai Red Cross Blood Ctr, Blood Transfus Clin Serv, Shanghai 200051, Peoples R China; [Ringwald, J.; Strasser, E. F.; Eckstein, R.] Univ Hosp Erlangen, Dept Transfus Med & Hemostaseol, D-91054 Erlangen, Germany; [Seltsam, A.] Inst Springe, German Red Cross Blood Serv NSTOB, D-31832 Springe, Germany; [Perseghin, P.; Proserpio, P.] AO San Gerardo, Lab Prod Emocomponenti, SIMT UOS Aferesi & Nuove Tecnol Trasfus, I-20900 Monza, Italy; [Wakamoto, S.; Akino, M.; Takamoto, S.] Japanese Red Cross Hokkaido Block Blood Ctr, Nishi Ku, Sapporo, Hokkaido 0630802, Japan; [Tadokoro, K.] Japanese Red Cross Soc, Blood Serv Headquarters, Cent Blood Inst, Koto Ku, Tokyo 1358521, Japan; [Jimenez-Marco, T.] Fdn Banc Sang & Teixits Illes Balears, Balearic Isl 07004, Spain; [Lozano, M.; Cid, J.] Univ Clin Hosp, Dept Hemotherapy & Hemostasis, Barcelona 08036, Spain; [Gulliksson, H.; Sandgren, P.] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, SE-14186 Stockholm, Sweden; [Sweeney, J. D.] Miriam Hosp, Providence, RI 02906 USA; [Sutor, L. J.] Carter BloodCare, Med & Tech Serv, Bedford, TX 76021 USA; [Heath, D.] Carter BloodCare, Lab Operat, Bedford, TX 76021 USA; [Sayers, M. H.] Carter BloodCare, Bedford, TX 76021 USA	van der Meer, PF (reprint author), Sanquin Blood Bank, Dept Prod & Proc Dev, Plesmanlaan 125,POB 9713, NL-1006 AC Amsterdam, Netherlands.	p.vandermeer@sanquin.nl; Larry.J.Dumont@hitchcock.org; mlozano@clinic.ub.es; jose.coene@rodekruis.be; hendrik.feys@rodekruis.be; veerle.compernolle@rodekruis.be; cklin@ha.org.hk; sunjie@sbc.org.cn; juergen.ringwald@uk-erlangen.de; erwin.strasser@uk-erlangen.de; reinhold.eckstein@uk-erlangen.de; axel.seltsam@bsd-nstob.de; p.perseghin@hsgerardo.org; p.proserpio@hsgerardo.org; wakamoto@hokkaido.bc.jrc.or.jp; mitsuaki@hokkaido.bc.jrc.or.jp; shigetan@hokkaido.bc.jrc.or.jp; k-tadokoro@jrc.or.jp; matejimenez@hotmail.com; jcid@clinic.ub.es; hans.gulliksson@karolinska.se; jsweeney@lifespan.org; jed@mbc.org; lsutor@carterbloodcare.org; dheath@carterbloodcare.org; msayers@carterbloodcare.org		Lozano, Miguel/0000-0003-2593-833X; Cid, Joan/0000-0001-5445-4508			Ringwald J, 2005, VOX SANG, V89, P11, DOI 10.1111/j.1423-0410.2005.00645.x; Sandgren P, 2014, TRANSFUSION, V54, P602, DOI 10.1111/trf.12345; Skripchenko A, 2008, TRANSFUSION, V48, P1469, DOI 10.1111/j.1537-2995.2008.01733.x; Holme S, 1997, TRANSFUSION, V37, P12, DOI 10.1046/j.1537-2995.1997.37197176945.x; Ringwald J, 2012, TRANSFUSION, V52, P1237, DOI 10.1111/j.1537-2995.2011.03435.x; Ringwald J, 2006, TRANSFUS MED REV, V20, P158, DOI 10.1016/j.tmrv.2005.11.003; ASTER RH, 1969, VOX SANG, V17, P23; Berger G, 1998, BLOOD, V92, P4446; Canadian Blood Services, VIS ASS GUID 2009; Devine DV, 1999, TRANSFUSION, V39, P724, DOI 10.1046/j.1537-2995.1999.39070724.x; Feys B, 2013, VOX SANG, V105, P11; Flesch BK, 2010, TRANSFUSION, V50, P894, DOI 10.1111/j.1537-2995.2009.02502.x; HOLMSEN H, 1977, BIOCHIM BIOPHYS ACTA, V497, P46, DOI 10.1016/0304-4165(77)90138-6; Jimenez TM, 2003, TRANSFUSION, V43, P328, DOI 10.1046/j.1537-2995.2003.00326.x; KATTLOVE HE, 1971, BLOOD-J HEMATOL, V38, P39; Lozano M, 2013, TRANSFUS APHER SCI, V49, P560, DOI 10.1016/j.transci.2013.09.008; Lozano M, 1998, MED CLIN-BARCELONA, V110, P774; Macher S, 2010, VOX SANG, V99, P332, DOI 10.1111/j.1423-0410.2010.01353.x; MASSINI P, 1971, THROMB DIATH HAEMOST, V25, P13; Maurad N, 1968, TRANSFUSION, V8, P48; Nakajo S, 1999, TRANSFUSION, V39, P913, DOI 10.1046/j.1537-2995.1999.3908913.x; Perseghin P, 2004, TRANSFUSION, V44, P125, DOI 10.1046/j.0041-1132.2004.00613.x; Pretorius E, 2010, TRANSFUS APHER SCI, V43, P347, DOI 10.1016/j.transci.2010.10.002; Rentas FJ, 2004, TRANSFUSION, V44, P959, DOI 10.1111/j.1537-2995.2004.03398.x; RINGWALD J, 2013, VOX SANG S1, V105, P142; Ringwald J, 2014, VOX SANG, V106, P209, DOI 10.1111/vox.12089; Skripchenko A, 2012, TRANSFUSION, V52, P1433, DOI 10.1111/j.1537-2995.2011.03493.x; Stohlawetz P, 1999, TRANSFUSION, V39, P420, DOI 10.1046/j.1537-2995.1999.39499235677.x; Sweeney J, 2007, TRANSFUSION, V47, P1154, DOI 10.1111/j.1537-2995.2007.01250.x; SWEENEY JD, 1995, TRANSFUSION, V35, P131, DOI 10.1046/j.1537-2995.1995.35295125735.x; Sweeney JD, 2000, TRANSFUSION, V40, P615, DOI 10.1046/j.1537-2995.2000.40050615.x; Sweeney JD, 2004, TRANSFUSION, V44, P1212, DOI 10.1111/j.1537-2995.2004.03438.x; Valeri CR, 2005, TRANSFUS APHER SCI, V32, P139, DOI 10.1016/j.transci.2004.03.004; van der Meer PF, 2013, PLATELET TRANSFUSION, P75; Van der Planken MG, 1999, ANN HEMATOL, V78, P1, DOI 10.1007/s002770050463	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	JAN	2015	108	1					96	125		10.1111/vox.12184		30	Hematology	Hematology	AW9SI	WOS:000346597100013		
J	Ito, S				Ito, Seigo			Printable solar cells	WILEY INTERDISCIPLINARY REVIEWS-ENERGY AND ENVIRONMENT			English	Review							STATE PHOTOVOLTAIC CELL; EXTREMELY-THIN ABSORBER; ORGANOMETAL HALIDE PEROVSKITES; DYE-SENSITIZED PHOTOVOLTAICS; POWER CONVERSION EFFICIENCY; HOLE CONDUCTOR; ELECTRON-TRANSPORT; TITANIUM-DIOXIDE; ZINC-OXIDE; LOW-COST	Printable solar cells attract academic and industrial interests because solar cells should be cost-effective systems and have to be fabricated by non-vacuum methods such as screen printing, doctor blading, spin coating, spray deposition, and electrochemical deposition. In order to be a cost-effective solar system, the solar cells neither include expensive (indium) and toxic materials (cadmium and mercury) nor expensive processes such as chemical vapor deposition and sputtering. Similar to printed solar cells, many types of solar cells have been investigated in the past two decades: organic, dye-sensitized solar cells, Cu(In,Ga)(S,Se)(2), Cu2ZnSn(S,Se)(4), organic thin-film photovoltaic cells, and so on. Now, the photoenergy conversion efficiencies of printed solar cells have been improved by more than 10% with the efforts of scientists. In this review, prominent progress has been presented for the future of our society. WIREs Energy Environ 2015, 4:51-73. doi: 10.1002/wene.112 For further resources related to this article, please visit the . Conflict of interest: The author has declared no conflicts of interest for this article.	Univ Hyogo, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712201, Japan	Ito, S (reprint author), Univ Hyogo, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712201, Japan.	itou@eng.u-hyogo.ac.jp					Tang J, 2011, NAT MATER, V10, P765, DOI [10.1038/nmat3118, 10.1038/NMAT3118]; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Levy-Clement C, 2005, ADV MATER, V17, P1512, DOI 10.1002/adma.200401848; Nezu S, 2010, J PHYS CHEM C, V114, P6854, DOI 10.1021/jp100401e; O'Regan B, 2002, CHEM MATER, V14, P5023, DOI 10.1021/cm020572d; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Tennakone K, 1998, J PHYS D APPL PHYS, V31, P2326, DOI 10.1088/0022-3727/31/18/019; Todorov TK, 2013, PROG PHOTOVOLTAICS, V21, P82, DOI 10.1002/pip.1253; Guo L, 2014, PROG PHOTOVOLTAICS, V22, P58, DOI 10.1002/pip.2332; Kopidakis N, 2000, J PHYS CHEM B, V104, P3930, DOI 10.1021/jp9936603; Repins I, 2012, SOL ENERG MAT SOL C, V101, P154, DOI 10.1016/j.solmat.2012.01.008; Nair MTS, 1998, J ELECTROCHEM SOC, V145, P2113, DOI 10.1149/1.1838605; Ennaoui A, 2009, THIN SOLID FILMS, V517, P2511, DOI 10.1016/j.tsf.2008.11.061; Kobayashi T, 2014, PROG PHOTOVOLTAICS, V22, P115, DOI 10.1002/pip.2339; Im SH, 2011, NANO LETT, V11, P4789, DOI 10.1021/nl2026184; Wurfel U, 2008, J PHYS CHEM C, V112, P1711, DOI 10.1021/jp077016x; O'Regan B, 2000, ADV MATER, V12, P1263, DOI 10.1002/1521-4095(200009)12:17<1263::AID-ADMA1263>3.0.CO;2-T; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Etgar L, 2012, J AM CHEM SOC, V134, P17396, DOI 10.1021/ja307789s; Ito S, 2013, INT J HYDROGEN ENERG, V38, P16749, DOI 10.1016/j.ijhydene.2013.02.069; Tennakone K, 1999, J PHYS D APPL PHYS, V32, P374, DOI 10.1088/0022-3727/32/4/004; Spiekermann S, 2001, SYNTHETIC MET, V121, P1603, DOI 10.1016/S0379-6779(00)00650-0; Kruger J, 2002, APPL PHYS LETT, V81, P367, DOI 10.1063/1.1490394; Belaidi A, 2008, PHYS STATUS SOLIDI-R, V2, P172, DOI 10.1002/pssr.200802092; Bach U, 1998, NATURE, V395, P583; Kambe S, 2002, J PHYS CHEM B, V106, P2967, DOI 10.1021/jp013397h; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Burschka J, 2011, J AM CHEM SOC, V133, P18042, DOI 10.1021/ja207367t; Larramona G, 2006, CHEM MATER, V18, P1688, DOI 10.1021/cm052819n; Lee SM, 2012, ELECTROCHIM ACTA, V79, P189, DOI 10.1016/j.electacta.2012.06.103; Chang JA, 2010, NANO LETT, V10, P2609, DOI 10.1021/nl101322h; Lincot D, 2004, SOL ENERGY, V77, P725, DOI 10.1016/j.solener.2004.05.024; Kitamura T, 2001, CHEM LETT, P1054; Scragg JJ, 2010, J ELECTROANAL CHEM, V646, P52, DOI 10.1016/j.jelechem.2010.01.008; Nazeeruddin MK, 2005, J AM CHEM SOC, V127, P16835, DOI 10.1021/ja052467l; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Kuwabara T, 2010, ORG ELECTRON, V11, P1136, DOI 10.1016/j.orgel.2010.04.008; Guo QJ, 2012, SOL ENERG MAT SOL C, V105, P132, DOI 10.1016/j.solmat.2012.05.039; Ball JM, 2013, ENERG ENVIRON SCI, V6, P1739, DOI 10.1039/c3ee40810h; TSUBOMURA H, 1976, NATURE, V261, P402, DOI 10.1038/261402a0; Tennakone K, 2000, APPL PHYS LETT, V77, P2367, DOI 10.1063/1.1312858; Mozer AJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240296; Kumara GRRA, 2001, SOL ENERG MAT SOL C, V69, P195, DOI 10.1016/S0927-0248(01)00027-7; Kumara GRA, 2004, J PHOTOCH PHOTOBIO A, V164, P183, DOI 10.1016/j.jphotochem.2003.11.020; Valdes MH, 2010, SURF COAT TECH, V204, P3995, DOI 10.1016/j.surfcoat.2010.05.028; Wada T, 2006, PHYS STATUS SOLIDI A, V203, P2593, DOI 10.1002/pssa.200669652; Park SJ, 2014, PROG PHOTOVOLTAICS, V22, P122, DOI 10.1002/pip.2354; Perera VPS, 2005, SOL ENERG MAT SOL C, V86, P443, DOI 10.1016/j.solmat.2004.11.003; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Moon SJ, 2010, J PHYS CHEM LETT, V1, P1524, DOI 10.1021/jz100308q; Todorov TK, 2013, ADV ENERGY MATER, V3, P34, DOI 10.1002/aenm.201200348; Murakoshi K, 1997, CHEM LETT, P471, DOI 10.1246/cl.1997.471; Kopidakis N, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2130723; Krunks M, 2010, SOL ENERG MAT SOL C, V94, P1191, DOI 10.1016/j.solmat.2010.02.036; Tsujimoto K, 2012, J PHYS CHEM C, V116, P13465, DOI 10.1021/jp208937j; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; John TT, 2005, SOL ENERG MAT SOL C, V89, P27, DOI 10.1016/j.solmat.2004.12.005; Han LY, 2012, ENERG ENVIRON SCI, V5, P6057, DOI 10.1039/c2ee03418b; SAVADOGO O, 1992, SOL ENERG MAT SOL C, V26, P117, DOI 10.1016/0927-0248(92)90131-8; Itzhaik Y, 2009, J PHYS CHEM C, V113, P4254, DOI 10.1021/jp900302b; Guo QJ, 2013, PROG PHOTOVOLTAICS, V21, P64, DOI 10.1002/pip.2200; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Rajeshmon VG, 2013, J ALLOY COMPD, V553, P239, DOI 10.1016/j.jallcom.2012.11.106; Zhu K, 2006, J PHYS CHEM B, V110, P25174, DOI 10.1021/jp065284+; Saito Y, 2004, ELECTROCHEM COMMUN, V6, P71, DOI 10.1016/j.elecom.2003.10.016; Schmidt-Mende L, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1844032; Kim S, 2013, THIN SOLID FILMS, V547, P178, DOI 10.1016/j.tsf.2013.03.094; Xia JB, 2008, J AM CHEM SOC, V130, P1258, DOI 10.1021/ja075704o; Katagiri H, 1997, SOL ENERG MAT SOL C, V49, P407, DOI 10.1016/S0927-0248(97)00119-0; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; O'Regan B, 1998, CHEM MATER, V10, P1501, DOI 10.1021/cm9705855; Premalal EVA, 2012, J POWER SOURCES, V203, P288, DOI 10.1016/j.jpowsour.2011.12.034; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Wada T, 2003, THIN SOLID FILMS, V431, P11, DOI 10.1016/S0040-6090(03)00231-1; TENNAKONE K, 1995, SEMICOND SCI TECH, V10, P1689, DOI 10.1088/0268-1242/10/12/020; Etgar L, 2012, ADV MATER, V24, P2202, DOI 10.1002/adma.201104497; Ryo T, 2011, THIN SOLID FILMS, V519, P7184, DOI 10.1016/j.tsf.2010.12.176; Snaith HJ, 2007, NANO LETT, V7, P3372, DOI 10.1021/nl071656u; ORegan B, 1996, J APPL PHYS, V80, P4749, DOI 10.1063/1.363412; Katagiri H, 2009, THIN SOLID FILMS, V517, P2455, DOI 10.1016/j.tsf.2008.11.002; Yang L, 2012, PHYS CHEM CHEM PHYS, V14, P779, DOI 10.1039/c1cp23031j; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; HIRAMOTO M, 1991, APPL PHYS LETT, V58, P1062, DOI 10.1063/1.104423; Cherian AS, 2012, ENRGY PROCED, V15, P283, DOI 10.1016/j.egypro.2012.02.033; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Duchatelet A, 2013, J RENEW SUSTAIN ENER, V5, DOI 10.1063/1.4791782; Fukuri N, 2006, J PHYS CHEM B, V110, P25251, DOI 10.1021/jp064439a; Gebeyehu D, 2002, THIN SOLID FILMS, V403, P271, DOI 10.1016/S0040-6090(01)01580-2; Goossens A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/42/424018; Gratzel M, 2013, EMRS SPRING M STRASB; Haeldermans I, 2008, THIN SOLID FILMS, V516, P7245, DOI 10.1016/j.tsf.2007.12.023; Hagen J, 1997, SYNTHETIC MET, V89, P215, DOI 10.1016/S0379-6779(97)81221-0; Hanaro N, 2013, J ADV OXID TECHNOL, V16, P102; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI 10.1038/NPHOTON.2013.80; Ito S, 2013, EMRS SPRING M STRASB, pXIV; Ito S, 2012, ADV MATER SCI ENG, DOI 10.1155/2012/136092; Jianbo G, 2011, NANO LETT, V11, P3263; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kitagawa N, 2013, NAT RESOUR, V4, P142; Knoll B, 2013, PHOTON INT, V6, P48; Konno A, 2007, CHEM LETT, V36, P716, DOI 10.1246/cl.2007.716; Krause MB, 2013, PHOTON INT, V2, P60; Kumara GRA, 2005, CHEM LETT, V34, P572, DOI 10.1246/cl.2005.572; Liu Q, PARTICUOLOG IN PRESS; Liu XZ, 2010, ADV MATER, V22, pE150, DOI 10.1002/adma.200904168; Mendonca M., 2007, FEED IN TARIFFS ACCE, P91; Moribe S, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.112302; Nazzeruddin MK, 1993, J AM CHEM SOC, V115, P6382; New Energy and Industrial Technology Development Organization (NEDO), OV PV ROADM 2030 VER; Nguyen DC, 2012, ENERGY SCI TECHNOL, V3, P1; Nguyen DC, 2012, ENERGY SCI TECHNOL, V4, P1; Nguyen DC, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC23; Nguyen DC, 2013, INT J NANOTECHNOL, V10, P269, DOI 10.1504/IJNT.2013.053140; Nguyen DC, 2013, INT J NANOTECHNOL, V10, P279, DOI 10.1504/IJNT.2013.053141; Nguyen DC, 2013, INT J PHOTOENERGY, V2013; Nguyen DC, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-8; Nguyen DC, 2011, ENRGY PROCED, V10, DOI 10.1016/j.egypro.2011.10.151; Pattantyus-Abraham AG, 2010, ACS NANO, V4, P3374, DOI 10.1021/nn100335g; Pawar SM, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC27; Sato M, 2013, 60 SPRING M JAP SOC; Schmidt-Mende L, 2005, ADV MATER, V17, P813, DOI 10.1002/adma.200401410; Tennakone K, 1998, J PHYS D APPL PHYS, V31, P1492, DOI 10.1088/0022-3727/31/12/014; Tennakone K, 1997, J PHOTOCH PHOTOBIO A, V108, P175, DOI 10.1016/S1010-6030(97)00092-0; Tennakone K, 1998, J PHOTOCH PHOTOBIO A, V117, P137, DOI 10.1016/S1010-6030(98)00344-X; Thelakkat M, 1999, SYNTHETIC MET, V102, P1125, DOI 10.1016/S0379-6779(98)01412-X; WANG P, 2005, APPL PHYS LETT, V86, DOI DOI 10.1063/1.1887825; Wang YP, 2006, CHEM MATER, V18, P4215, DOI 10.1021/cm0609045; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411	131	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2041-8396	2041-840X		WIRES ENERGY ENVIRON	Wiley Interdiscip. Rev. Energy Environ.	JAN-FEB	2015	4	1					51	73		10.1002/wene.112		23	Energy & Fuels	Energy & Fuels	AX2KK	WOS:000346772300003		
J	Nishimura, M				Nishimura, Mutsuyoshi			A new market-based climate change solution achieving 2 degrees C and equity	WILEY INTERDISCIPLINARY REVIEWS-ENERGY AND ENVIRONMENT			English	Article							CARBON MARKETS	Current climate change strategies seem increasingly incapable of averting planetary catastrophe. The United Nations (UN) strategy places responsibility for CO2 reduction on governments, but governments by nature seek lower burdens. Moreover, arbitrary, ambition-based pledges seriously fail to produce what science tells us is necessary to achieve any identified climate target. In addition, climate financing holds little hope as increasingly dire fiscal circumstances are to persist for decades. The time has come to seek a new effective system before it is too late. Such a system would cap global emissions with a global carbon budget that achieves the adopted target. The most cost-effective plan is to put a global price on carbon, which can be accomplished by creating a global upstream carbon market. In such a market system, a limited amount of allowances would be sold to polluters. It would achieve the target most cost-effectively, raise new revenue from the sales of allowances which would help vulnerable countries in their energy transition and low-carbon sustainable growth. WIREs Energy Environ 2015, 4:133-138. doi: 10.1002/wene.131 For further resources related to this article, please visit the . Conflict of interest: The author has declared no conflicts of interest for this article.	Japan Inst Int Affairs, Tokyo, Japan	Nishimura, M (reprint author), Japan Inst Int Affairs, Tokyo, Japan.	Nshmr6@gmail.com					Allen MR, 2009, NATURE; [Anonymous], 2013, CARBON FINANCE AT TH; [Anonymous], 1990, CONTRACTION AND CONV; Fankhauser S, 2010, ENERG POLICY, V38, P4363, DOI 10.1016/j.enpol.2010.03.064; Center for Clean Air Policy, 1998, US CARBON EMISSIONS; Fankhauser S, 2011, CENTRE FOR CLIMATE C; Fankhauser S, 2010, ENERG POLICY, V38, P4381, DOI 10.1016/j.enpol.2010.03.066; IPCC, 2013, CLIMATE CHANGE 2013; Klingenfeld D, 2012, ON STRATEGIES FOR AV, P241; Klingenfeld D, 2012, ON STRATEGIES FOR AV; Klingenfeld D., 2012, ON STRATEGIES FOR AV, P100; Messner D, 2010, THE BUDGET APPROACH; Ngwadla X., 2013, EQUITABLE ACCESS TO; Nishimura M, 2011, CCEP WORKING PAPER 1; OECD, 2013, CLIMATE AND CARBON A; OECD, 2013, EFFECTIVE CARBON PRI; The Carbon Price Communique, 2012, THE PRINCE OF WALESS; United Nations Environment Programme (UNEP), 2013, THE EMISSIONS GAP RE; WBGU (German Advisory Council on Global Change), SOLVING THE CLIMATE; Wicke L, 2005, BEYOND KYOTO A NEW G; Wilcoxen P, 2002, CLIMATE CHANGE AFTER; Yasumoto A, 2004, CLIMATE CHANGE FIVE	22	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2041-8396	2041-840X		WIRES ENERGY ENVIRON	Wiley Interdiscip. Rev. Energy Environ.	JAN-FEB	2015	4	1					133	138		10.1002/wene.131		6	Energy & Fuels	Energy & Fuels	AX2KK	WOS:000346772300007		
J	Ishihara, T; Yamaguchi, A				Ishihara, Takeshi; Yamaguchi, Atsushi			Prediction of the extreme wind speed in the mixed climate region by using Monte Carlo simulation and measure-correlate-predict method	WIND ENERGY			English	Article						Monte Carlo simulation; measure-correlate-predict method; mixed climate; extreme wind speed; prediction uncertainty; observation period		The extreme wind speed at an offshore location was predicted using Monte Carlo simulation (MCS) and measure-correlate-predict (MCP) method. The Gumbel distribution could successfully express the annual maximum wind speed of extratropical cyclone. On the other hand, the estimated extreme wind speed of tropical cyclones by analytical probability distribution shows larger uncertainty. In the mixed climate like Japan, the extreme wind speed estimated from the combined probability distribution obtained by MCP and MCS methods agrees well with the observed data as compared with the combined probability distribution obtained by the MCP method only. The uncertainty of extreme wind speed due to limited observation period of wind speed and pressure was also evaluated by the Gumbel theory and Monte Carlo simulation. As a result, it was found that the uncertainty of 50year recurrence wind speed obtained by MCS method is considerably smaller than that obtained by MCP method in the mixed climate. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ishihara, Takeshi; Yamaguchi, Atsushi] Univ Tokyo, Dept Civil Engn, Sch Engn, Tokyo 113, Japan	Yamaguchi, A (reprint author), Univ Tokyo, Dept Civil Engn, Sch Engn, 7-3-1 Hongo, Tokyo 113, Japan.	atsushi@bridge.t.u-tokyo.ac.jp			New Energy and Industrial Development Organization (NEDO)	This research was carried out as a part of 'Development of offshore wind power generation system' funded by New Energy and Industrial Development Organization (NEDO).	[Anonymous], 2000, 798 ASCE ANSI; Yasui H, 2002, J WIND ENG IND AEROD, V90, P1529, DOI 10.1016/S0167-6105(02)00268-4; Architectural Institute of Japan, 2004, AIJ REC LOADS BUILD; Cook NJ, 2003, J WIND ENG IND AEROD, V91, P403, DOI 10.1016/S0167-6105(02)00397-5; GEORGIOU PN, 1983, J WIND ENG IND AEROD, V13, P139, DOI 10.1016/0167-6105(83)90136-8; GOMES L, 1978, J IND AERODYNAM, V2, P331, DOI 10.1016/0167-6105(78)90018-1; Gumbels EJ, 1958, STAT EXTREMES; International Electrotechnical Commission (IEC), 2005, 614001 IEC; Ishiharas T, 2005, 6 AS PAC C WIND ENG, P412; Ishihara T, 2002, WIND STRUCT, V5, P317; Ishiharas T, 2002, P WORLD WIND EN C EX, V4, P1; Schloemers RW, 1954, 31 HYDR; Tarp-Johansens NJ, 2002, R1319EN RIS; Vickerys PJ, 1955, J STRUCTURAL ENG ASC, V121, P1691; Yamaguchis A, 2012, EWEA2012	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1095-4244	1099-1824		WIND ENERGY	Wind Energy	JAN	2015	18	1					171	186		10.1002/we.1693		16	Energy & Fuels; Engineering, Mechanical	Energy & Fuels; Engineering	AX1HM	WOS:000346698400010		
J	Honjo, H; Mike, M; Kusanagi, H; Kano, N				Honjo, Hirotaka; Mike, Makio; Kusanagi, Hiroshi; Kano, Nobuyasu			Adult Intussusception: A Retrospective Review	WORLD JOURNAL OF SURGERY			English	Article								Intussusception is common in children but rare in adults. The goal of this study was to review retrospectively the symptoms, diagnosis, and treatment of intussusception in adults. From 1997 to 2013, we experienced 44 patients of intussusception in patients older than 18 years. The patients were divided into enteric, ileocolic, ileocecal, and colocolonic (rectal) types. The diagnosis and treatment of these patients were reviewed. Of the 44 patients of adult intussusception, 42 were diagnosed with abdominal ultrasonography and abdominal computed tomography. There were 12 patients of enteric intussusception, six patients of ileocolic intussusception, 16 patients of ileocecal type intussusception, and 10 patients of colonic (rectal) intussusception. Among them, 77.3 % were associated with a tumor. Among 12 patients of enteric intussusception, three were associated with a metastatic intestinal tumor, and one was associated with a benign tumor. Among six patients of ileocolic intussusception, two patients were associated with malignant disease. Also, 93.8 % of ileocecal intussusceptions were associated with tumors, 80.0 % of which were malignant. Similarly, 90.0 % of colonic intussusceptions were associated with malignant tumors. Intussusception was reduced before or during surgery in 28 patients. Surgery was performed in 41 patients, and laparoscopy-assisted surgery was performed for ab underlying disease in 12 patients. Preoperative diagnoses were possible in almost all patients. Reduction greatly benefited any surgery required and the extent of the resection regardless of the underlying disease and surgical site.	[Honjo, Hirotaka; Mike, Makio; Kusanagi, Hiroshi; Kano, Nobuyasu] Kameda Med Ctr, Dept Surg, Chiba 2968602, Japan	Honjo, H (reprint author), Kameda Med Ctr, Dept Surg, 929 Higashi Cho, Chiba 2968602, Japan.	h-honjo@wood.odn.ne.jp					AGHA FP, 1986, AM J ROENTGENOL, V146, P527; NAGORNEY DM, 1981, ANN SURG, V193, P230, DOI 10.1097/00000658-198102000-00019; Azar T, 1997, ANN SURG, V226, P134, DOI 10.1097/00000658-199708000-00003; FELIX EL, 1976, AM J SURG, V131, P758, DOI 10.1016/0002-9610(76)90196-3; Barbete P, 1674, OEUVRES CHIRURG ANAT, P5221; BRAYTON D, 1954, AM J SURG, V88, P32, DOI 10.1016/0002-9610(54)90328-1; GORDON R S, 1991, Journal of Emergency Medicine, V9, P337, DOI 10.1016/0736-4679(91)90377-R; Hunter J, 1837, WORKS J HUNTER FRS, P587; Hutchinson J, 1873, P R MED CHIR SOC, V7, P195; IKO BO, 1984, AM J ROENTGENOL, V143, P769; Omori H, 2003, DIGEST SURG, V20, P433, DOI 10.1159/000072712; SARR MG, 1981, ARCH SURG-CHICAGO, V116, P144; WEILBAEC.D, 1971, AM J SURG, V121, P531, DOI 10.1016/0002-9610(71)90133-4	13	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JAN	2015	39	1					134	138		10.1007/s00268-014-2759-9		5	Surgery	Surgery	AX2QQ	WOS:000346789500022		
J	Fujikawa, T; Tanaka, A; Abe, T; Yoshimoto, Y; Tada, S; Maekawa, H				Fujikawa, Takahisa; Tanaka, Akira; Abe, Toshihiro; Yoshimoto, Yasunori; Tada, Seiichiro; Maekawa, Hisatsugu			Effect of Antiplatelet Therapy on Patients Undergoing Gastroenterological Surgery: Thromboembolic Risks Versus Bleeding Risks During Its Perioperative Withdrawal	WORLD JOURNAL OF SURGERY			English	Article							ELUTING STENT IMPLANTATION; NONCARDIAC SURGERY; PREMATURE DISCONTINUATION; ENDOSCOPIC PROCEDURES; HEART-ASSOCIATION; AMERICAN-COLLEGE; LATE THROMBOSIS; CARDIAC RISK; MANAGEMENT; ASPIRIN	Antiplatelet agents given to prevent thromboembolic disease are frequently withdrawn prior to surgical procedures to reduce bleeding complications. This action may expose patients to increased thromboembolic morbidity and mortality. A series of 2012 patients who had undergone gastroenterologic surgery between January 2005 and June 2010 at our institution were reviewed. Among this cohort, antiplatelet therapy (APT) was used in 519 patients (25.8 %). The perioperative management included interruption of APT 1 week before surgery and early postoperative reinstitution in patients at low thromboembolic risk, although APT was maintained until surgery in those at high thromboembolic risk. Bleeding and thromboembolic complications, as well as other outcome variables, were assessed in patients with and without APT. Among 519 patients with APT, 99 (19.1 %) underwent multidrug APT. Among them, 124 (23.9 %) required preoperative continuation of APT. None suffered from excessive bleeding intraoperatively. There were 19 thromboembolic events (0.9 %) in the whole cohort. Postoperative bleeding complications occurred in 37 patients (1.8 %). Multivariate analysis showed that increased postoperative bleeding complications were independently associated with multidrug APT [hazard ratio (HR) 4.3, p = 0.014], high-risk surgical procedures (HR 3.5, p = 0.003), and perioperative heparin bridging (HR 2.8, p = 0.029). High-risk surgery (HR 8.3, p < 0.001) and poor performance status (HR 4.9, p = 0.005)-but neither APT nor anticoagulation use-were significant prognostic factors for thromboembolic complications. Satisfactory outcomes were obtained during gastroenterologic surgery under rigorous perioperative management, including single-agent APT continuation in patients at high thromboembolic risk. Patients treated with multidrug APT still represent a challenging group, however, and need to be carefully managed to prevent perioperative complications.	[Fujikawa, Takahisa; Tanaka, Akira; Abe, Toshihiro; Yoshimoto, Yasunori; Tada, Seiichiro; Maekawa, Hisatsugu] Kokura Mem Hosp, Dept Surg, Kokurakita Ku, Kitakyushu, Fukuoka 8028555, Japan	Fujikawa, T (reprint author), Kokura Mem Hosp, Dept Surg, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka 8028555, Japan.	fujikawa-t@kokurakinen.or.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Cattaneo M, 2004, ARTERIOSCL THROM VAS, V24, P1980, DOI 10.1161/01.ATV.0000145980.39477.a9; Eagle KA, 1997, CIRCULATION, V96, P1882; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Nasser M, 2005, CATHETER CARDIO INTE, V65, P516, DOI 10.1002/ccd.20391; Cahill RA, 2005, J AM COLL SURGEONS, V200, P564, DOI 10.1016/j.jamcollsurg.2004.11.002; SORENSEN JB, 1993, BRIT J CANCER, V67, P773, DOI 10.1038/bjc.1993.140; Korte W, 2011, THROMB HAEMOSTASIS, V105, P743, DOI 10.1160/TH10-04-0217; PALMER JD, 1994, NEUROSURGERY, V35, P1061; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956; Wilson SH, 2003, J AM COLL CARDIOL, V42, P234, DOI 10.1016/S0735-1097(03)00622-3; Artang R, 2007, AM J CARDIOL, V99, P1039, DOI 10.1016/j.amjcard.2006.12.025; Bowry ADK, 2008, AM J CARDIOL, V101, P960, DOI 10.1016/j.amjcard.2007.11.057; Broad L, 2007, BRIT J ANAESTH, V98, P19, DOI 10.1093/bja/ael318; Cahill RA, 2005, J AM COLL SURGEONS, V200, pA559; Chassot Pierre-Guy, 2007, Best Pract Res Clin Anaesthesiol, V21, P241, DOI 10.1016/j.bpa.2007.02.002; Chechik O, 2011, ISR MED ASSOC J, V13, P342; Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0; de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Fleisher LA, 2009, J AM COLL CARDIOL, V54, pe13, DOI DOI 10.1016/J.JACC.2009.07.010; Fujikawa T, 2013, BMJ CASE REP    0326, DOI [10.1136/bcr-2013-008948, DOI 10.1136/BCR-2013-008948]; Fujikawa T, 2013, J AM COLL SURGEONS, V217, P1044, DOI 10.1016/j.jamcollsurg.2013.08.005; Fujikawa T, 2012, BMJ CASE REP, DOI [10.1136/bcr-2012-006779, DOI 10.1136/BCR-2012-006779]; Hermiz S, 2009, ANZ J SURG, V79, P521, DOI 10.1111/j.1445-2197.2009.04981.x; Jerjes-Sanchez C, 2005, EUR HEART J, V26, P3, DOI 10.1093/eurheratj/ehi018; Kimchi NA, 2007, DIGESTION, V75, P36, DOI 10.1159/000101565; King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002; Komatsu T, 2005, J GASTROENTEROL, V40, P698, DOI 10.1007/s00535-005-1613-0; Mita K, 2012, ANN SURG ONCOL, V19, P3745, DOI 10.1245/s10434-012-2500-6; Nuttall G. A., 1996, Transfusion (Bethesda), V36, P144, DOI 10.1046/j.1537-2995.1996.36296181927.x; Palmer JD, 1994, NEUROSURGERY, V35, P1064; Thachil J, 2008, BRIT J SURG, V95, P1437, DOI 10.1002/bjs.6381; Vasudeva Pawan, 2009, Indian J Urol, V25, P296, DOI 10.4103/0970-1591.56174; Weber AA, 2001, BRIT J CLIN PHARMACO, V52, P333, DOI 10.1046/j.0306-5251.2001.01453.x; Yusuf S, 2001, NEW ENGL J MED, V345, P494	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JAN	2015	39	1					139	149		10.1007/s00268-014-2760-3		11	Surgery	Surgery	AX2QQ	WOS:000346789500023		
J	Tamura, N; Ishihara, S; Kuriyama, A; Watanabe, S; Suzuki, K				Tamura, Nobuichiro; Ishihara, Satoshi; Kuriyama, Akira; Watanabe, Shigeru; Suzuki, Koichiro			Long-Term Follow-Up After Non-operative Management of Biloma Due to Blunt Liver Injury	WORLD JOURNAL OF SURGERY			English	Article							HEPATIC-TRAUMA; COMPLICATIONS	Some case series have reported that hepatectomy was used to treat major bile leakage and biloma. However, it is unknown whether non-operative management (NOM) can be used to treat these complications. Our hospital uses NOM primarily for blunt liver injuries. This study describes the incidence and treatment of newly developed biloma in hemodynamically stable patients with blunt liver trauma and investigates NOM as a treatment option. A retrospective chart review was conducted from January 2006 to May 2012 at a tertiary care hospital in Japan. The primary outcome measures were the incidence of biloma and the number of patients who required operative management. Biloma was defined as a cystic lesion with low density near the site of liver injury on contrast-enhanced abdominal computed tomography. Chart review identified 98 patients (63 males and 35 females). Thirty-five of 98 patients (35.7 % [95 % CI, 26.2-45.2]) developed biloma. Infected biloma in three, of whom one required percutaneous drainage. Hepatectomy was not performed. Our data suggest that biloma after NOM of blunt liver injury is common (36 %), but infected biloma is rare. All patients with bilomas were treated using NOM. Most bilomas are self-limited, and NOM is feasible.	[Tamura, Nobuichiro] Kurashiki Cent Hosp, Dept Emergency Med, Okayama 7108602, Japan; [Ishihara, Satoshi] Hyogo Emergency Med Ctr, Kobe, Hyogo 6510073, Japan; [Kuriyama, Akira] Kurashiki Cent Hosp, Dept Gen Med, Okayama 7108602, Japan; [Watanabe, Shigeru] Kawasaki Med Univ, Dept Radiol, Okayama 7010192, Japan; [Suzuki, Koichiro] Kawasaki Med Univ, Dept Acute Med, Okayama 7010192, Japan	Kuriyama, A (reprint author), Kurashiki Cent Hosp, Dept Gen Med, 1-1-1 Miwa Kurashiki, Okayama 7108602, Japan.	nobuichiro.tamura@gmail.com; nrk40448@nifty.com					Kozar RA, 2006, ARCH SURG-CHICAGO, V141, P451, DOI 10.1001/archsurg.141.5.451; Malhotra AK, 2000, ANN SURG, V231, P804, DOI 10.1097/00000658-200006000-00004; CROCE MA, 1995, ANN SURG, V221, P744, DOI 10.1097/00000658-199506000-00013; Bridges A, 2007, GASTROINTEST ENDOSC, V65, P1081, DOI 10.1016/j.gie.2006.11.038; FABIAN TC, 1991, ANN SURG, V213, P540; Anand RJ, 2011, J TRAUMA, V71, P480, DOI 10.1097/TA.0b013e3181efc270; Richardson JD, 2000, ANN SURG, V232, P324; Goffette PP, 2002, EUR RADIOL, V12, P994, DOI 10.1007/s00330-002-1396-0; Giss SR, 2006, J TRAUMA, V61, P334, DOI 10.1097/01.ta.0000197605.27190.2c; Baker SP, 1974, J TRAUMA, V14, P6; Boone DC, 1995, J TRAUMA, V39, P35; Cachecho R, 1998, J TRAUMA, V45, P2; Croce MA, 1995, ANN SURG, V221, P753; Fabian TC, 1991, ANN SURG, V213, P548; Hsieh CH, 2003, LANGENBECK ARCH SURG, V387, P7; Kozar RA, 2006, ARCH SURG-CHICAGO, V141, P458; Lubezky N, 2006, BRIT J SURG, V93, P1; MOORE EE, 1995, J TRAUMA, V38, P323, DOI 10.1097/00005373-199503000-00001; Pachter HL, 1992, ANN SURG, V215, P500; PACHTER HL, 1992, ANN SURG, V215, P492, DOI 10.1097/00000658-199205000-00012	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JAN	2015	39	1					179	183		10.1007/s00268-014-2780-z		5	Surgery	Surgery	AX2QQ	WOS:000346789500028		
J	Kato, Y; Takahashi, S; Gotohda, N; Konishi, M				Kato, Yuichiro; Takahashi, Shinichiro; Gotohda, Naoto; Konishi, Masaru			Risk Factors for Malignancy in Branched-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas During the Follow-Up Period	WORLD JOURNAL OF SURGERY			English	Article							INTERNATIONAL CONSENSUS GUIDELINES; CYSTIC NEOPLASMS; 208 RESECTIONS; EXPERIENCE; MANAGEMENT; IPMN	The international consensus guidelines for the management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas were revised in 2012 Tanaka (Pancreatology 12(3):183-197, 2012), making the indications for operation less aggressive. Therefore, the number of branch duct-type IPMN (BD-IPMN) patients requiring follow-up care is expected to increase in the future. The aim of this study was to identify risk factors for malignancy in BD-IPMN patients during the follow-up period. This study included 47 BD-IPMN patients without a mural nodule (MN) at the time of initial diagnosis and who subsequently underwent resection after a follow-up period of more than 3 months. Data for the patients were reviewed retrospectively, and the clinicopathological factors were investigated. In a univariate analysis, age (a parts per thousand 65 years), an increase in the main pancreatic duct (MPD) diameter, the MPD diameter at resection (a parts per thousand 5 mm), and the occurrence of MN were significantly associated with malignancy. The occurrence of MN was the only significant factor in a multivariate analysis. In addition, 7 of the 17 patients (41.2 %) who only exhibited an increase in the cyst diameter during the follow-up period were diagnosed as having malignancies. All 6 patients who exhibited an increase in the cyst diameter of 100 % or more were diagnosed as having carcinoma. During the follow-up period, the incidence of malignancy was higher among patients with BD-IPMNs and the occurrence of MN, an increase in the MPD diameter, or an increase ratio of 100 % or more in cyst diameter than the others; resection was recommended for these patients.	[Kato, Yuichiro; Takahashi, Shinichiro; Gotohda, Naoto; Konishi, Masaru] Natl Canc Ctr Hosp East, Div Hepatobiliary Pancreat Surg, Kashiwa, Chiba 2778577, Japan	Kato, Y (reprint author), Natl Canc Ctr Hosp East, Div Hepatobiliary Pancreat Surg, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	yuikato@east.ncc.go.jp					Sugiyama M, 2003, BRIT J SURG, V90, P1244, DOI 10.1002/bjs.4265; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c; Schnelldorfer T, 2008, ARCH SURG-CHICAGO, V143, P639, DOI 10.1001/archsurg.143.7.639; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Rodriguez JR, 2007, GASTROENTEROLOGY, V133, P72, DOI 10.1053/j.gastro.2007.05.010; Maguchi H, 2011, PANCREAS, V40, P364, DOI 10.1097/MPA.0b013e31820a5975; Kang MJ, 2011, CLIN GASTROENTEROL H, V9, P87, DOI 10.1016/j.cgh.2010.09.008; Irie H, 2004, J COMPUT ASSIST TOMO, V28, P117, DOI 10.1097/00004728-200401000-00020; Woo SM, 2009, BRIT J SURG, V96, P405, DOI 10.1002/bjs.6557; Rautou PE, 2008, CLIN GASTROENTEROL H, V6, P807, DOI 10.1016/j.cgh.2007.12.021; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Tanno S, 2010, PANCREAS, V39, P36, DOI 10.1097/MPA.0b013e3181b91cd0; Bosman FT, 2010, WHO CLASSIFICATION T; Brugge WR, 2004, NEW ENGL J MED, V351, P1218, DOI 10.1056/NEJMra031623; Burns E A, 2000, Cancer Control, V7, P513; Fessler J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00231; ITAI Y, 1986, RADIOLOGY, V161, P697; Provinciali M, 2005, CANCER IMMUNOL IMMUN, V54, P93, DOI 10.1007/s00262-004-0539-3; Salvia R, 2007, GASTROENTEROLOGY, V133, P309, DOI [10.1053/ j. gastro. 2007.05.010, DOI 10.1053/J.GASTR0.2007.05.010]; Lillemoe KD, 2008, ARCH SURG-CHICAGO, V143, P646; Sobin LH, 2002, TNM CLASSIFICATION M; Vadasz Z, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-94; Yamaguchi T, 2005, CLIN GASTROENTEROL H, V3, P1136, DOI 10.1053/S1542-3565(05)00756-1	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JAN	2015	39	1					244	250		10.1007/s00268-014-2789-3		7	Surgery	Surgery	AX2QQ	WOS:000346789500038		
J	Tsujikura, M; Nagasawa, T; Ichiki, S; Nakamura, R; Somamoto, T; Nakao, M				Tsujikura, Masakazu; Nagasawa, Takahiro; Ichiki, Satoko; Nakamura, Ryota; Somamoto, Tomonori; Nakao, Miki			A CD46-like Molecule Functional in Teleost Fish Represents an Ancestral Form of Membrane-Bound Regulators of Complement Activation	JOURNAL OF IMMUNOLOGY			English	Article							DECAY-ACCELERATING FACTOR; CARP CYPRINUS-CARPIO; HEMOLYTIC-UREMIC SYNDROME; CARASSIUS-AURATUS-LANGSDORFII; COFACTOR PROTEIN CD46; GINBUNA CRUCIAN CARP; FACTOR-H; ADAPTIVE IMMUNITY; JAPANESE FLOUNDER; COMPONENT C3	In the complement system, the regulators of complement activation (RCA) play crucial roles in controlling excessive complement activation and in protecting host cell from misdirected attack of complement. Several members of RCA family have been cloned from cyclostome and bony fish species and classified into soluble and membrane-bound type as in mammalian RCA factors. Complement-regulatory functions have been described only for soluble RCA of lamprey and barred sand bass; however, little is known on the biological function of the membrane-bound RCA proteins in the lower vertebrates. In this study, a membrane- bound RCA protein, designated teleost complement-regulatory membrane protein (Tecrem), was cloned and characterized for its complement-regulatory roles. Carp Tecrem, an ortholog of a zebrafish type 2 RCA, ZCR1, consists of four short consensus repeat modules, a serine/threonine/proline-rich domain, a transmembrane region, and a cytoplasmic domain, from the N terminus, as does mammalian CD46. Tecrem showed a ubiquitous mRNA expression in carp tissues, agreeing well with the putative regulatory role in complement activation. A recombinant Chinese hamster ovary cell line bearing carp Tecrem showed a significantly higher tolerance against lytic activity of carp complement and less deposition of C3-S, the major C3 isotypes acting on the target cell, than control Chinese hamster ovary (mock transfectant). Anti-Tecrem mAb enhanced the depositions of carp C3 and two C4 isotypes on autologous erythrocytes. Thus, the present findings provide the evidence of complement regulation by a membrane-bound group 2 RCA in bony fish, implying the host-cell protection is an evolutionarily conserved mechanism in regulation of the complement system.	[Tsujikura, Masakazu; Nagasawa, Takahiro; Ichiki, Satoko; Nakamura, Ryota; Somamoto, Tomonori; Nakao, Miki] Kyushu Univ, Dept Biosci & Biotechnol, Marine Biochem Lab, Fukuoka 8128581, Japan	Nakao, M (reprint author), Kyushu Univ, Dept Biosci & Biotechnol, Marine Biochem Lab, Fukuoka 8128581, Japan.	mikimnakao@kyudai.jp			Japan Society for the Promotion of Science KAKENHI Grant [22380111]	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 22380111 (to M.N.).	Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Oshiumi H, 2005, J IMMUNOL, V175, P1724; Ichiki S, 2012, DEV COMP IMMUNOL, V38, P10, DOI 10.1016/j.dci.2012.03.004; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; RUSSELL SM, 1992, EUR J IMMUNOL, V22, P1513, DOI 10.1002/eji.1830220625; Kemper C, 2005, IMMUNOL RES, V32, P31, DOI 10.1385/IR:32:1-3:031; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; Auchincloss H, 1998, ANNU REV IMMUNOL, V16, P433, DOI 10.1146/annurev.immunol.16.1.433; Fuchs A, 2009, EUR J IMMUNOL, V39, P3097, DOI 10.1002/eji.200939392; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; HOLERS VM, 1992, IMMUNOL TODAY, V13, P231; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Noris M, 2003, LANCET, V362, P1542, DOI 10.1016/S0140-6736(03)14742-3; Brodbeck WG, 1996, J IMMUNOL, V156, P2528; DALMASSO AP, 1991, TRANSPLANTATION, V52, P530, DOI 10.1097/00007890-199109000-00029; GORDON DL, 1995, J IMMUNOL, V155, P348; OHNO S, 1967, CHROMOSOMA, V23, P1, DOI 10.1007/BF00293307; FEARON DT, 1980, J EXP MED, V152, P20, DOI 10.1084/jem.152.1.20; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; ADAMS EM, 1991, J IMMUNOL, V147, P3005; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Cardone J, 2011, CLIN EXP IMMUNOL, V164, P301, DOI 10.1111/j.1365-2249.2011.04400.x; CARROLL MC, 1988, J EXP MED, V167, P1271, DOI 10.1084/jem.167.4.1271; COLE JL, 1985, P NATL ACAD SCI USA, V82, P859, DOI 10.1073/pnas.82.3.859; DAHMEN A, 1994, BIOCHEM J, V301, P391; FINGEROTH JD, 1990, J IMMUNOL, V144, P3458; FINGEROTH JD, 1989, P NATL ACAD SCI USA, V86, P242, DOI 10.1073/pnas.86.1.242; Inoue N, 2001, J IMMUNOL, V166, P424; IWATA K, 1995, J BIOL CHEM, V270, P15148; Katagiri T, 1998, FISHERIES SCI, V64, P140; Katagiri T, 1998, FISH PATHOL, V33, P351; Kemper C, 1998, J BIOL CHEM, V273, P19398, DOI 10.1074/jbc.273.31.19398; Kimura Y, 2004, J IMMUNOL, V173, P1118; KINGSMORE SF, 1989, J EXP MED, V169, P1479, DOI 10.1084/jem.169.4.1479; Krushkal J, 1998, J MOL EVOL, V47, P625, DOI 10.1007/PL00013152; Krushkal J, 2000, MOL BIOL EVOL, V17, P1718; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Li J, 2010, INFECT IMMUN, V78, P3129, DOI 10.1128/IAI.01263-09; Liszewski MK, 1998, J IMMUNOL, V161, P3711; Morgan BP, 1999, COMPLEMENT REGULATOR; Mossakowska D, 1999, EUR J IMMUNOL, V29, P1955, DOI 10.1002/(SICI)1521-4141(199906)29:06<1955::AID-IMMU1955>3.3.CO;2-F; Mutsuro J, 2005, J IMMUNOL, V175, P4508; Nakao M, 2003, IMMUNOGENETICS, V54, P801, DOI 10.1007/s00251-002-0518-9; Nakao M, 1998, J IMMUNOL, V161, P4811; Nakao M, 2000, EUR J IMMUNOL, V30, P858, DOI 10.1002/1521-4141(200003)30:3<858::AID-IMMU858>3.3.CO;2-D; NICHOLSONWELLER A, 1983, P NATL ACAD SCI-BIOL, V80, P5066, DOI 10.1073/pnas.80.16.5066; Nur I, 2013, FISH SHELLFISH IMMUN, V35, P1333, DOI 10.1016/j.fsi.2013.08.002; Oladiran A, 2010, DEV COMP IMMUNOL, V34, P396, DOI 10.1016/j.dci.2009.11.005; Oshiumi H, 2009, IMMUNOGENETICS, V61, P371, DOI 10.1007/s00251-009-0368-9; PURCELL DFJ, 1991, IMMUNOGENETICS, V33, P335, DOI 10.1007/BF00216692; Schmidt C, 2008, REV ECON POLIT, V118, P3; Somamoto T, 2013, DEV COMP IMMUNOL, V39, P370, DOI 10.1016/j.dci.2012.11.001; Sun GN, 2010, FUNCT INTEGR GENOMIC, V10, P577, DOI 10.1007/s10142-010-0182-3; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Walport MJ, 2001, NEW ENGL J MED, V344, P1058; Wu J, 2012, FUNCT INTEGR GENOMIC, V12, P367, DOI 10.1007/s10142-012-0262-7; YANO T, 1994, MOL IMMUNOL, V31, P337; Zipfel PF, 1996, DEV COMP IMMUNOL, V20, P407, DOI 10.1016/S0145-305X(96)00025-0	64	2	2	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JAN 1	2015	194	1					262	272		10.4049/jimmunol.1303179		11	Immunology	Immunology	AX1IH	WOS:000346700500029		
J	Chaiyasat, P; Noppalit, S; Okubo, M; Chaiyasat, A				Chaiyasat, Preeyaporn; Noppalit, Sayrung; Okubo, Masayoshi; Chaiyasat, Amorn			Do encapsulated heat storage materials really retain their original thermal properties?	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							PHASE-CHANGE MATERIALS; MICROENCAPSULATED N-OCTADECANE; THERMOREGULATING TEXTILE MATERIALS; SUSPENSION-LIKE POLYMERIZATION; CHANGE MATERIALS PCM; ENERGY-STORAGE; BUILDING-MATERIALS; MINIEMULSION POLYMERIZATION; POLYSTYRENE SHELL; PARAFFIN WAX	The encapsulation of Rubitherm(R)27 (RT27), which is one of the most common commercially supplied heat storage materials, by polystyrene (PS), polydivinyl benzene (PDVB) and polymethyl methacrylate (PMMA) was carried out using conventional radical microsuspension polymerization. The products were purified to remove free RT27 and free polymer particles without RT27. In the cases of PS and PDVB microcapsules, the latent heats of melting and crystallization for RT27 (delta H*(m) and delta H*(c), J/g-RT27) were clearly decreased by the encapsulation. On the other hand, those of the PMMA microcapsules were the same as pure RT27. A supercooling phenomenon was observed not only for PS and PDVB but also forthe PMMA microcapsules. These results indicate that the thermal properties of the heat storage materials encapsulated depend on the type of polymer shells, i.e., encapsulation by polymer shell changes the thermal properties of RT27. This is quite different from the idea of other groups in the world, in which they discussed the thermal properties based on the delta H-m and delta H-c values expressed in J/g-capsule, assuming that the thermal properties of the heat storage materials are not changed by the encapsulation. Hereafter, this report should raise an alarm concerning the "wrong" common knowledge behind developing the encapsulation technology of heat storage materials.	[Chaiyasat, Preeyaporn; Noppalit, Sayrung; Okubo, Masayoshi; Chaiyasat, Amorn] Rajamangala Univ Technol Thanyaburi, Fac Sci & Technol, Dept Chem, Thanyaburi 12110, Pathumthani, Thailand; [Okubo, Masayoshi] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan	Okubo, M (reprint author), Rajamangala Univ Technol Thanyaburi, Fac Sci & Technol, Dept Chem, Klong 6, Thanyaburi 12110, Pathumthani, Thailand.	okubo@kobe-u.ac.jp; a_chaiyasat@mail.rmutt.ac.th			Japan Society for the Promotion of Science (JSPS) [25288054]; National Research Council, Thailand [145450]	This work was supported by a Grant-in Aid for Scientific Research (B) (Grant 25288054; given to M.O.) from the Japan Society for the Promotion of Science (JSPS) and The National Research Council, Thailand (No. 145450; given to A.C. and P.C.).	Tyagi VV, 2007, RENEW SUST ENERG REV, V11, P1146, DOI 10.1016/j.rser.2005.10.002; Chaiyasat P, 2013, RSC ADV, V3, P10202, DOI 10.1039/c3ra40802g; Mochane MJ, 2012, THERMOCHIM ACTA, V544, P63, DOI 10.1016/j.tca.2012.06.017; Zhang XX, 2005, J COLLOID INTERF SCI, V281, P299, DOI 10.1016/j.jcis.2004.08.046; Qiu XL, 2013, SOL ENERGY, V91, P212, DOI 10.1016/j.solener.2013.01.022; Zhang HZ, 2009, COLLOID SURFACE A, V332, P129, DOI 10.1016/j.colsurfa.2008.09.013; Sanchez-Silva L, 2011, COLLOID SURFACE A, V390, P62, DOI 10.1016/j.colsurfa.2011.09.004; Chaiyasat P, 2009, J APPL POLYM SCI, V112, P3257, DOI 10.1002/app.29648; Sarier N, 2007, THERMOCHIM ACTA, V454, P90, DOI 10.1016/j.tca.2006.12.024; Zhang HZ, 2009, SOL ENERG MAT SOL C, V93, P1366, DOI 10.1016/j.solmat.2009.02.021; Qiu XL, 2013, THERMOCHIM ACTA, V551, P136, DOI 10.1016/j.tca.2012.10.027; Fang GY, 2009, CHEM ENG J, V153, P217, DOI 10.1016/j.cej.2009.06.019; Wang WL, 2009, APPL ENERG, V86, P1479, DOI 10.1016/j.apenergy.2008.12.004; Hawlader MNA, 2003, APPL ENERG, V74, P195, DOI 10.1016/S0306-2619(02)00146-0; Lee SH, 2007, KOREAN J CHEM ENG, V24, P332, DOI 10.1007/s11814-007-5054-8; Agyenim F, 2010, RENEW SUST ENERG REV, V14, P615, DOI 10.1016/j.rser.2009.10.015; Sarier N, 2007, THERMOCHIM ACTA, V452, P149, DOI 10.1016/j.tca.2006.08.002; Qiu XL, 2012, ENERGY, V46, P188, DOI 10.1016/j.energy.2012.08.037; Shin Y, 2005, J APPL POLYM SCI, V96, P2005, DOI 10.1002/app.21438; Sari A, 2010, APPL ENERG, V87, P1529, DOI 10.1016/j.apenergy.2009.10.011; Sanchez P, 2010, THERMOCHIM ACTA, V498, P16, DOI 10.1016/j.tca.2009.09.005; Sharma A, 2009, RENEW SUST ENERG REV, V13, P318, DOI 10.1016/j.rser.2007.10.005; Sanchez L, 2008, COLLOID POLYM SCI, V286, P1019, DOI 10.1007/s00396-008-1864-4; Shirin-Abadi AR, 2011, MACROMOLECULES, V44, P7405, DOI 10.1021/ma201509d; Shin Y, 2005, J APPL POLYM SCI, V97, P910, DOI 10.1002/app.21846; Mondal S, 2008, APPL THERM ENG, V28, P1536, DOI 10.1016/j.applthermaleng.2007.08.009; Fang YT, 2013, ENERG CONVERS MANAGE, V76, P430, DOI 10.1016/j.enconman.2013.07.060; Fang YT, 2008, ENERG CONVERS MANAGE, V49, P3704, DOI 10.1016/j.enconman.2008.06.027; Sari A, 2009, SOL ENERGY, V83, P1757, DOI 10.1016/j.solener.2009.05.008; Zhang GH, 2012, SOL ENERGY, V86, P1149, DOI 10.1016/j.solener.2012.01.003; Fuensanta M, 2013, THERMOCHIM ACTA, V565, P95, DOI 10.1016/j.tca.2013.04.028; Sanchez L, 2007, COLLOID POLYM SCI, V285, P1377, DOI 10.1007/s00396-007-1696-7; Nelson G, 2002, INT J PHARM, V242, P55, DOI 10.1016/S0378-5173(02)00141-2; Chen ZH, 2012, APPL ENERG, V91, P7, DOI 10.1016/j.apenergy.2011.08.041; Salaun F, 2010, THERMOCHIM ACTA, V506, P82, DOI 10.1016/j.tca.2010.04.020; Zhang P, 2010, RENEW SUST ENERG REV, V14, P598, DOI 10.1016/j.rser.2009.08.015; Tumirah K, 2014, ENERGY, V66, P881, DOI 10.1016/j.energy.2014.01.033; Okubo M, 1998, COLLOID POLYM SCI, V276, P638, DOI 10.1007/s003960050291; Kenisarin M, 2007, RENEW SUST ENERG REV, V11, P1913, DOI 10.1016/j.rser.2006.05.005; Sari A, 2014, SOL ENERG MAT SOL C, V126, P42, DOI 10.1016/j.solmat.2014.03.023; Peng S, 2004, J APPL POLYM SCI, V93, P1240, DOI 10.1002/app.20578; HAWES DW, 1993, ENERG BUILDINGS, V20, P77, DOI 10.1016/0378-7788(93)90040-2; Kwon HJ, 2010, MACROMOL RES, V18, P923, DOI 10.1007/s13233-010-0915-0; Onder E, 2008, THERMOCHIM ACTA, V467, P63, DOI 10.1016/j.tca.2007.11.007; Sanchez-Silva L, 2010, CHEM ENG J, V157, P216, DOI 10.1016/j.cej.2009.12.013; CHAIYASAT CWA, 2012, EXPRESS POLYM LETT, V6, P70; CHAIYASAT P, 2011, MAT SCI APPL, V2, P1007, DOI DOI 10.4236/MSA.2011.28136; Chaiyasat P, 2008, COLLOID POLYM SCI, V286, P753, DOI 10.1007/s00396-007-1831-5; Chaiyasat P, 2008, COLLOID POLYM SCI, V286, P217, DOI 10.1007/s00396-007-1764-z; Coupland JN, 2002, CURR OPIN COLLOID IN, V7, P445, DOI 10.1016/S1359-0294(02)00080-8; NAMWONG S, POLYM-PLAST TECHNOL, DOI DOI 10.1080/03602559.2014.974282; Ogino Y, 2007, KOBUNSHI RONBUNSHU, V64, P171, DOI 10.1295/koron.64.171; Sanchez-Silva L, 2010, IND ENG CHEM RES, V49, P12204, DOI 10.1021/ie101727b; Su JF, 2005, J APPL POLYM SCI, V97, P1755, DOI 10.1002/app.21205; Supatimusro D, 2012, POLYM-PLAST TECHNOL, V51, P1167, DOI 10.1080/03602559.2012.694949	55	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2015	17	2					1053	1059		10.1039/c4cp03458a		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AW4FH	WOS:000346236000089		
J	Inage, S				Inage, Shin-ichi			The role of large-scale energy storage under high shares of renewable energy	WILEY INTERDISCIPLINARY REVIEWS-ENERGY AND ENVIRONMENT			English	Review								This paper discusses how a high share of renewable energy (referred to as renewables) will influence the power quality of the grid. The mix of power generation varies from country to country. Each power generator has an important role in minimizing total operating costs and maintaining power quality. Conventionally, middle-scale thermal power plants play a role in mitigating demand and supply variations. Under a high share of renewables, the supply adjustability of thermal power to mitigate the output variations due to renewables will run short. Therefore, energy storage systems will be required as a countermeasure. The energy storage capacity required will depend on the net variation due to a smoothing effect. The magnitude of this net variation is the key for estimating the correct storage capacities. Under net variations of 15 and 30%, the respective global energy storage capacities needed have been predicted to be 189 and 305GW in 2050 when aiming at 50% carbon dioxide emission reductions globally. In this working paper, several energy storage systems are reviewed. Specifications for each energy storage system will be identified. It is concluded that an optimum mix of different energy storage systems will be essential to realize decarbonized power grids. WIREs Energy Environ 2015, 4:115-132. doi: 10.1002/wene.114 For further resources related to this article, please visit the . Conflict of interest: The author has declared no conflicts of interest for this article.	Hitachi Ltd, Renewable Energy & Smart Grids, Tokyo, Japan	Inage, S (reprint author), Hitachi Ltd, Renewable Energy & Smart Grids, Tokyo, Japan.	shinichi.inage.wk@hitachi.com					Asanuma K, 2008, FUJI JIHO, V81, P203; Crotogino F, 2001, CROT HUNT CAES COMPR; EPRI, 2009, 067247 EPRI; EPRI, 2010, EL EN STOR TECHN OPT; Hiitter U., 1954, ENTWICKLUNG WINDKRAF, V6; IEA, 2006, IEA EL INF 2006; IEA, 2009, PROSP LARG SCAL EN S; IEA, 2008, EMP VAR REN OPT FLEX; IEA, 2008, EN TECHN PERSP 2008; IEEJ, 2005, ENERGY, V2005-8, P85; Okamura M., 2001, ELECT DOUBLE LAYER C; OOZEKI T, 2010, IEEJ T POWER ENERGY, V130, P491	12	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2041-8396	2041-840X		WIRES ENERGY ENVIRON	Wiley Interdiscip. Rev. Energy Environ.	JAN-FEB	2015	4	1					115	132		10.1002/wene.114		18	Energy & Fuels	Energy & Fuels	AX2KK	WOS:000346772300006		
J	Sukegawa, S; Matsuzaki, H; Katase, N; Kanno, T; Mandai, T; Takahashi, Y; Asaumi, JI; Furuki, Y				Sukegawa, Shintaro; Matsuzaki, Hidenobu; Katase, Naoki; Kanno, Takahiro; Mandai, Toshiko; Takahashi, Yuka; Asaumi, Jun-Ichi; Furuki, Yoshihiko			Primary intraosseous squamous cell carcinoma of the maxilla possibly arising from an infected residual cyst: A case report	ONCOLOGY LETTERS			English	Article						primary intraosseous squamous cell carcinoma; residual cyst; computed tomography	ODONTOGENIC CYST; CANCER; INFLAMMATION; JAWS	Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare type of odontogenic carcinoma arising from the jawbone. Odontogenic cysts are true cysts that arise from the dental epithelium, which is associated with tooth formation. The epithelial lining of odontogenic cysts has the potential to transform into various types of odontogenic tumor; however, this transformation from an odontogenic cyst to a malignant tumor is rare. The definitive diagnosis for PIOSCC generally requires the observation of either features of squamous cell carcinoma (SCC) within the jawbone that are distinct from direct invasion from the surface oral epithelium, or evidence of SCC arising from odontogenic epithelium and from tumors that have metastasized to the jawbone from distant sites. In the present study, a case of PIOSCC of the maxilla is presented, which, based on the results of computed tomography and the clinical course, was hypothesized to have originated from an infected residual cyst.	[Sukegawa, Shintaro; Kanno, Takahiro; Mandai, Toshiko; Takahashi, Yuka; Furuki, Yoshihiko] Kagawa Prefectural Cent Hosp, Div Oral & Maxillofacial Surg, Takamatsu, Kagawa 7608557, Japan; [Matsuzaki, Hidenobu; Asaumi, Jun-Ichi] Okayama Univ Hosp, Dept Oral Diag & Dentomaxillofacial Radiol, Okayama 7008558, Japan; [Katase, Naoki] Kawasaki Med Univ, Dept Mol & Dev Biol, Kurashiki, Okayama 7010192, Japan; [Kanno, Takahiro] Shimane Univ, Dept Oral & Maxillofacial Surg, Fac Med, Izumo, Shimane 6938501, Japan	Sukegawa, S (reprint author), Kagawa Prefectural Cent Hosp, Div Oral & Maxillofacial Surg, 1-2-1 Asahi Cho, Takamatsu, Kagawa 7608557, Japan.	gouwan19@gmail.com	KATASE, Naoki/B-2344-2011				Alevizos I, 2002, ORAL ONCOL, V38, P504, DOI 10.1016/S1368-8375(01)00093-8; EVERSOLE LR, 1975, CANCER, V35, P270, DOI 10.1002/1097-0142(197501)35:1<270::AID-CNCR2820350134>3.0.CO;2-Y; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Choi S, 2008, J DENT RES, V87, P14; SUEI Y, 1994, J ORAL MAXIL SURG, V52, P580, DOI 10.1016/0278-2391(94)90094-9; Hold GL, 2008, BIOCHEM J, V410, P225, DOI 10.1042/BJ20071341; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; GARDNER AF, 1969, J AM DENT ASSOC, V78, P746; HAMPL PF, 1973, J ORAL SURG, V31, P359; Karakida K, 2010, ORAL SURG ORAL MED O, V110, pE33, DOI 10.1016/j.tripleo.2010.08.018; PINDBORG JJ, 1972, INT HISTOLOGICAL CLA, P35; Sciubba JJ, 2005, PATHOLOGY GENETICS H, P287; Sobin LH, 2009, TNM CLASSIFICATION M; STOELINGA PJW, 1988, J CRANIO MAXILL SURG, V16, P184, DOI 10.1016/S1010-5182(88)80044-1; TO EHW, 1991, BRIT J ORAL MAX SURG, V29, P19, DOI 10.1016/0266-4356(91)90168-5	15	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	JAN	2015	9	1					131	135		10.3892/ol.2014.2644		5	Oncology	Oncology	AX0JH	WOS:000346638300022		
J	Tsujimoto, T; Yamamoto, Y; Wasa, M; Takenaka, Y; Nakahara, S; Takagi, T; Tsugane, M; Hayashi, N; Maeda, K; Inohara, H; Uejima, E; Ito, T				Tsujimoto, Takae; Yamamoto, Yoshifumi; Wasa, Masafumi; Takenaka, Yukinori; Nakahara, Susumu; Takagi, Tastuya; Tsugane, Mamiko; Hayashi, Noriyuki; Maeda, Kazuhisa; Inohara, Hidenori; Uejima, Etsuko; Ito, Toshinori			L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial	ONCOLOGY REPORTS			English	Article						glutamine; mucositis; chemoradiotherapy; head and neck cancer; clinical trial; supportive care; adverse effect; nutrition; quality of life; pharynx; larynx	STEM-CELL TRANSPLANT; BONE-MARROW TRANSPLANTATION; ORAL GLUTAMINE; PARENTERAL GLUTAMINE; AMINO-ACID; CHEMOTHERAPY; SUPPLEMENTATION; PREVENTION; RADIOTHERAPY; TOXICITY	The incidence of severe mucositis in the oral cavity, pharynx and larynx is high among patients with head and neck cancer (HNC) receiving chemoradiotherapy (CRT), resulting in significant pain and impairment of quality of life. The present study investigated whether L-glutamine (glutamine) decreases the severity of mucositis in the oral cavity, pharynx and larynx induced by CRT. This double-blind, randomized, placebo-controlled trial included 40 untreated patients with squamous cell carcinoma of the nasopharynx, oropharynx, hypopharynx or larynx. Patients received 66 or 70 Gy of total radiation at the rate of 2 Gy/fraction daily and 5 fractions/week. Cisplatin (20 mg/m(2)) and docetaxel (10 mg/m(2)) were intravenously co-administered once a week for 6 weeks. Patients were randomized to orally receive either glutamine (group G) or placebo (group P) at a dose of 10 g 3 times a day throughout the CRT course. Mucositis was assessed using the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0. The primary end point was mucositis severity. Mucositis developed in all patients. A maximal mucositis grade of G4 was observed in 0 and 25% group G and P patients, respectively, while that of G2 was observed in 10 and 0% group G and P patients, respectively (p=0.023). Glutamine significantly decreased the maximal mucositis grade (group G, 2.9 +/- 0.3; group P, 3.3 +/- 0.4; p=0.005) and pain score at weeks 4, 5 and 6. Glutamine significantly decreased mucositis severity in the oral cavity, pharynx and larynx induced by CRT in patients with HNC.	[Tsujimoto, Takae; Hayashi, Noriyuki; Maeda, Kazuhisa; Ito, Toshinori] Osaka Univ, Dept Complementary & Alternat Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Tsujimoto, Takae; Tsugane, Mamiko; Uejima, Etsuko] Osaka Univ, Dept Clin Pharm Res & Educ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Tsujimoto, Takae] Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kobe, Hyogo, Japan; [Yamamoto, Yoshifumi; Takenaka, Yukinori; Nakahara, Susumu; Inohara, Hidenori] Osaka Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Wasa, Masafumi] Osaka Univ, Dept Pediat Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Takagi, Tastuya] Osaka Univ, Dept Pharmainformat & Pharmacometr, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Ito, T (reprint author), Osaka Univ, Dept Complementary & Alternat Med, Grad Sch Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	juki@cam.med.osaka-u.ac.jp					Cerchietti LCA, 2006, INT J RADIAT ONCOL, V65, P1330, DOI 10.1016/j.ijrobp.2006.03.042; Keefe DM, 2007, CANCER, V109, P820, DOI 10.1002/cncr.22484; Sonis ST, 2004, CANCER, V100, P1995, DOI 10.1002/cncr.20162; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Rosenthal DI, 2009, SEMIN RADIAT ONCOL, V19, P29, DOI 10.1016/j.semradonc.2008.09.006; ZIEGLER TR, 1992, ANN INTERN MED, V116, P821; Daniele B, 2001, GUT, V48, P28, DOI 10.1136/gut.48.1.28; Huang EY, 2000, INT J RADIAT ONCOL, V46, P535, DOI 10.1016/S0360-3016(99)00402-2; Alpers DH, 2006, GASTROENTEROLOGY, V130, pS106, DOI 10.1053/j.gastro.2005.11.049; Forastiere AA, 1999, J NATL CANCER I, V91, P2065, DOI 10.1093/jnci/91.24.2065; ALVERDY JA, 1992, J SURG RES, V52, P34; Le QT, 2011, J CLIN ONCOL, V29, P2808, DOI 10.1200/JCO.2010.32.4095; Blijlevens NM, 2005, SUPPORT CARE CANCER, V13, P790, DOI 10.1007/s00520-005-0790-y; Duggan C, 2002, AM J CLIN NUTR, V75, P789; Nose S, 2010, JPEN-PARENTER ENTER, V34, P530, DOI 10.1177/0148607110362694; Anderson PM, 1998, CANCER, V83, P1433, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1433::AID-CNCR22>3.0.CO;2-4; Savarese DMF, 2003, CANCER TREAT REV, V29, P501, DOI 10.1016/S0305-7372(03)00133-6; Aquino VM, 2005, BONE MARROW TRANSPL, V36, P611, DOI 10.1038/sj.bmt.1705084; BELLON G, 1995, BBA-MOL CELL RES, V1268, P311, DOI 10.1016/0167-4889(95)00093-8; BELLON G, 1987, BIOCHIM BIOPHYS ACTA, V930, P39, DOI 10.1016/0167-4889(87)90153-4; Cetinbas Ferda, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.03.011; DICKSON TMC, 2002, JPEN J PARENTER ENTE, V24, P61, DOI DOI 10.1177/014860710002400261; Groome PA, 2006, INT J RADIAT ONCOL, V64, P1002, DOI 10.1016/j.ijrobp.2005.10.010; JEBB SA, 1995, CLIN NUTR, V14, P162, DOI 10.1016/S0261-5614(95)80014-X; JEBB SA, 1994, BRIT J CANCER, V70, P732, DOI 10.1038/bjc.1994.385; LACEY JM, 1990, NUTR REV, V48, P297; Leitao RFC, 2008, CANCER CHEMOTH PHARM, V61, P215, DOI 10.1007/s00280-007-0463-2; OKABE S, 1974, J PHARM PHARMACOL, V26, P605; Piccirillo N, 2004, BONE MARROW TRANSPL, V33, P455, DOI 10.1038/sj.bmt.1704363; Quinn B, 2008, EUR J CANCER, V44, P61, DOI 10.1016/j.ejca.2007.09.014; Reeds PJ, 2001, J NUTR, V131, p2505S; SCHLOERB PR, 1993, JPEN-PARENTER ENTER, V17, P407, DOI 10.1177/0148607193017005407; Skubitz KM, 1996, J LAB CLIN MED, V127, P223, DOI 10.1016/S0022-2143(96)90082-7; SMITH RJ, 1990, JPEN-PARENTER ENTER, V14, pS40; Sykorova A, 2005, NEOPLASMA, V52, P476; Topkan E, 2009, LUNG CANCER, V63, P393, DOI 10.1016/j.lungcan.2008.06.015; VANZAANEN HCT, 1994, CANCER, V74, P2879, DOI 10.1002/1097-0142(19941115)74:10<2879::AID-CNCR2820741022>3.0.CO;2-H; YOUNG LS, 1993, JPEN-PARENTER ENTER, V17, P422, DOI 10.1177/0148607193017005422	38	2	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JAN	2015	33	1					33	39		10.3892/or.2014.3564		7	Oncology	Oncology	AX0IN	WOS:000346636200004		
J	Kidoh, M; Utsunomiya, D; Oda, S; Yuki, H; Funama, Y; Namimoto, T; Yamamuro, M; Yamashita, Y				Kidoh, Masafumi; Utsunomiya, Daisuke; Oda, Seitaro; Yuki, Hideaki; Funama, Yoshinori; Namimoto, Tomohiro; Yamamuro, Megumi; Yamashita, Yasuyuki			Optimized Subtraction Coronary CT Angiography Protocol for Clinical Use with Short Breath-Holding Time-Initial Experience	ACADEMIC RADIOLOGY			English	Article						Computed tomography; coronary CT angiography; contrast media; diagnosis		Rationale and Objectives: Subtraction coronary computed tomography (CT) angiography (CCTA), which enables the removal of calcium and coronary stents from CCTA images, has been clinically introduced on a second-generation 320-row CT scanner. However, this technique for clinical use is not optimized. The long breath-holding time for two data acquisitions, which causes image misregistration and patient's discomfort, may limit the clinical availability of this subtraction technique. Materials and Methods: This study received approval from the institutional review board; prior informed consent to participate was obtained from all patients. We performed subtraction CCTA of five patients using the test injection method and optimized the interval time between the first (pulmonary-arterial phase) and the second (coronary-arterial phase) scans to achieve robust subtraction. The patients' breath-holding times were recorded. We compared breath-holding times between our new protocol and previous study's protocol (estimated). Results: Mean breath-holding time in our new protocol was 18.3 +/- 3.4 seconds and that in previous protocol was 29.8 +/- 3.6 seconds (difference in mean breath-holding time was 11.5 seconds). Misregistration artifacts were not shown in final subtraction CCTA images. These images improved luminal visualization in the calcified lesion. Conclusions: Our test injection protocol can shorten the breath-holding time, which is helpful for successful subtraction CCTA imaging, potentially resulting in an increase of subtraction CCTA examinations in many institutions.	[Kidoh, Masafumi; Utsunomiya, Daisuke; Oda, Seitaro; Yuki, Hideaki; Namimoto, Tomohiro; Yamashita, Yasuyuki] Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, Kumamoto 8608556, Japan; [Funama, Yoshinori] Kumamoto Univ, Fac Life Sci, Dept Med Phys, Kumamoto 8608556, Japan; [Yamamuro, Megumi] Kumamoto Univ, Fac Life Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Kidoh, M (reprint author), Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	masafkidoh@yahoo.co.jo					Yoshioka K, 2012, CARDIOL CLIN, V30, P93, DOI 10.1016/j.ccl.2011.10.004; Taylor AJ, 2010, CIRCULATION, V122, pE525, DOI 10.1161/CIR.0b013e3181fcae66; Tanaka R, 2013, INT J CARDIOVAS IMAG, V29, P75, DOI 10.1007/s10554-013-0316-5; Vavere AL, 2011, RADIOLOGY, V261, P100, DOI 10.1148/radiol.11110537; Kawaguchi N, 2014, CIRC J, V78, P662, DOI 10.1253/circj.CJ-13-1101; Kidoh M, 2014, HEART VESSELS, V29, P149, DOI 10.1007/s00380-013-0338-x	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	JAN	2015	22	1					117	120		10.1016/j.acra.2014.09.020		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX1FF	WOS:000346692700014		
J	Wada, J; Fueki, K; Yatabe, M; Takahashi, H; Wakabayashi, N				Wada, Junichiro; Fueki, Kenji; Yatabe, Masaru; Takahashi, Hidekazu; Wakabayashi, Noriyuki			A comparison of the fitting accuracy of thermoplastic denture base resins used in non-metal clasp dentures to a conventional heat-cured acrylic resin	ACTA ODONTOLOGICA SCANDINAVICA			English	Article						denture base; fitting accuracy; removable partial denture; thermoplastic resin	REMOVABLE PARTIAL DENTURES; CLINICAL-APPLICATION; COPOLYMER BLENDS	Objective. To incorporate a metal framework into removable partial dentures, the dimensional accuracy of thermoplastic resins requires precision equivalent to conventional acrylic resins. This study aimed to evaluate the fitting accuracy of thermoplastic resins compared to heat-cured acrylic resin. Materials and methods. Four thermoplastic resins (polyethylene terephthalate [EstheShot, ES; EstheShot Bright, ES-B], polyamide [Lucitone FRS, LF], polycarbonate [Reigning Resin N, RN] and a heat-curing acrylic resin [Acron, AC]) were used. The specimens were created on master casts constructed of high-strength stone that simulated a maxillary edentulous ridge. Additionally, high-expansion stone was used as the master cast for RN specimens. The ES-B, LF and RN specimens were prepared with and without annealing after injection molding. The gaps between the molded resin and the cast were measured. Results. ES had the smallest gap and was significantly smaller than AC (p < 0.05). The gap sizes of ES-B, LF and RN (high-expansion stone) without annealing were similar to AC (p > 0.05), while the gap size of RN (high-strength stone) with and without annealing was significantly greater than AC (p < 0.001). The gap sizes of ES-B and LF with annealing were significantly less than AC (p < 0.05). Further, the gap sizes of ES-B, LF and RN with annealing were significantly smaller than the gaps without annealing (p < 0.05). Conclusions. The results suggested that ES, ES-B and LF have adequate fitting accuracy for incorporating metal framework into dentures and that annealing effectively improved the fitting accuracy of ES-B, LF and RN.	[Wada, Junichiro; Fueki, Kenji; Yatabe, Masaru; Wakabayashi, Noriyuki] Tokyo Med & Dent Univ, Fac Dent, Grad Sch Med & Dent Sci, Dept Masticatory Funct Rehabil,Sect Removable Par, Tokyo 1138549, Japan; [Takahashi, Hidekazu] Tokyo Med & Dent Univ, Fac Dent, Dept Oral Mat Sci & Technol, Tokyo 1138549, Japan	Fueki, K (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Masticatory Funct Rehabil, Sect Removable Partial Prosthodont,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	kunfu.rpro@tmd.ac.jp	Fueki, Kenji/A-9909-2008		Ministry of Education, Culture, Sports, Science and Technology of Japan [23592836]	The authors would like to thank Dr S. Inukai, Dr J. Hamaguchi and Dr H. Kumagai for their kind assistance with data collection. This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 23592836) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ahn CH, 2000, POLYM J, V32, P471, DOI 10.1295/polymj.32.471; You JC, 2012, ACS APPL MATER INTER, V4, P4825, DOI 10.1021/am301161s; Fueki K, 2014, J PROSTHODONT RES, V58, P3, DOI 10.1016/j.jpor.2013.12.002; Fueki K, 2014, J PROSTHODONT RES, V58, P71, DOI 10.1016/j.jpor.2014.03.002; STAFFORD GD, 1986, J DENT, V14, P18, DOI 10.1016/0300-5712(86)90097-7; Goiato Marcelo Coelho, 2008, Dent Today, V27, P116; Jagger RG, 2003, J ORAL REHABIL, V30, P364, DOI 10.1046/j.1365-2842.2003.01048.x; Parvizi Ali, 2004, J Prosthodont, V13, P83, DOI 10.1111/j.1532-849X.2004.04014.x; Samal M, 2011, J NANOSCI NANOTECHNO, V11, P10069, DOI 10.1166/jnn.2011.4977; Wadachi J, 2013, DENT MATER J, V32, P508, DOI 10.4012/dmj.2013-061	10	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6357	1502-3850		ACTA ODONTOL SCAND	Acta Odontol. Scand.	JAN	2015	73	1					33	37		10.3109/00016357.2014.946966		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW5SH	WOS:000346333700006		
J	Ichijo, H				Ichijo, Hiroaki			The second and third phases of caloric nystagmus	ACTA OTO-LARYNGOLOGICA			English	Article						Video-oculography; prone position; hydrostatic pressure theory; perilymph; specific heat; ossicles	EYE-MOVEMENT ANALYSIS; SEMICIRCULAR CANALS; STIMULATION; DIMENSIONS	Conclusion: The second and third phases of caloric nystagmus occur at a high rate. We can explain this phenomenon based on the hydrostatic pressure theory involved in perilymph. Objectives: To clarify the incidence of the second and third phases of caloric nystagmus, and to measure their intensity. Methods: The subjects were 12 healthy humans. The right ear was stimulated using iced water. The first phase of caloric nystagmus was recorded in a supine position. Immediately after the cessation of the first phase, each subject was repositioned to a prone position, and the second phase was recorded. Immediately after the halt of the second phase, each subject was repositioned to a supine position, and the third phase was recorded. Nystagmus was analyzed using three-dimensional video-oculography. Results: The mean value of maximum slow-phase velocity (MSV) of the first phase was 27.2 degrees/s. All subjects revealed the second phase, and the direction was toward the right. The mean value of MSV was 7.2 degrees/s. Nine subjects (75%) showed the third phase, and the direction was toward the left. The mean value of MSV was 2.7 degrees/s.	Ichijo Ear Nose & Throat Clin, Hirosaki, Aomori 0368002, Japan	Ichijo, H (reprint author), Ichijo Ear Nose & Throat Clin, 3-2-1 Ekimae, Hirosaki, Aomori 0368002, Japan.	hiro3387@mvj.biglobe.ne.jp					Imai T, 2005, AURIS NASUS LARYNX, V32, P3, DOI 10.1016/j.anl.2004.11.009; Della Santina CC, 2005, JARO-J ASSOC RES OTO, V6, P191, DOI 10.1007/s10162-005-0003-x; Fetter M, 1998, AM J OTOL, V19, P180; Arai M, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P770; ARAI Y, 1990, ORL J OTO-RHINO-LARY, V52, P218; BLANKS RHI, 1975, ACTA OTO-LARYNGOL, V80, P185, DOI 10.3109/00016487509121318; Coats A C, 1967, Acta Otolaryngol, V63, P515, DOI 10.3109/00016486709128785; CURTHOYS IS, 1987, ACTA OTO-LARYNGOL, V103, P254, DOI 10.3109/00016488709107791; FREEMAN DM, 1990, HEARING RES, V48, P37, DOI 10.1016/0378-5955(90)90198-X; Ichijo H, 2011, ACTA OTO-LARYNGOL, V131, P716, DOI 10.3109/00016489.2011.554436; Ichijo H, 2012, AM J OTOLARYNG, V33, P718, DOI 10.1016/j.amjoto.2012.06.006; Ikeda T, 2002, EQUILIBRIUM RES, V61, P90; Otsuka K, 2005, EQUILIBRIUM RES, V64, P100; YAGI T, 1992, ARCH OTOLARYNGOL, V118, P1077	14	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JAN	2015	135	1					1	6		10.3109/00016489.2014.949850		6	Otorhinolaryngology	Otorhinolaryngology	AW4UK	WOS:000346275600001		
J	Iizuka, Y; Yoshimura, M; Inokuchi, H; Matsuo, Y; Nakamura, A; Mizowaki, T; Hirano, S; Kitamura, M; Tateya, I; Hiraoka, M				Iizuka, Yusuke; Yoshimura, Michio; Inokuchi, Haruo; Matsuo, Yukinori; Nakamura, Akira; Mizowaki, Takashi; Hirano, Shigeru; Kitamura, Morimasa; Tateya, Ichiro; Hiraoka, Masahiro			Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx	ACTA OTO-LARYNGOLOGICA			English	Article						Metastasis; postoperative radiotherapy; prognostic factors	INTENSITY-MODULATED RADIOTHERAPY; LOCALLY ADVANCED HEAD; NECK-CANCER; CHEMOTHERAPY; THERAPY	Conclusions: Distant metastasis was a major pattern of recurrence after postoperative radiotherapy (PORT) for squamous cell carcinoma (SCC) of the oropharynx, hypopharynx, and larynx. PORT provided good loco-regional control, with tolerable toxicities. Advanced pT and pN were unfavorable prognostic factors. Objective: To determine the clinical outcomes, and the patterns and risk factors for recurrence of SCCs of the oropharynx, hypopharynx, and larynx treated with surgery and PORT. Methods: We retrospectively reviewed 84 patients who received PORT after definitive surgery for SCC of the oropharynx, hypopharynx, or larynx between 2000 and 2010. The primary sites were the oropharynx in 25 patients, hypopharynx in 47 patients, and larynx in 12 patients. Results: The 3-year overall survival (OS), progression-free survival (PFS), and loco-regional control (LRC) rates were 64.9%, 56.7%, and 92.1%, respectively. Recurrences were observed in 27 patients: 6 patients had loco-regional recurrence and 23 patients developed distant metastasis. On multivariate analysis, pT4 and pN2c-N3 displayed significantly worse effects on OS (p = 0.02 and p < 0.01, respectively) and PFS (p = 0.02 and p < 0.001, respectively). In the acute phase, 12 patients experienced grade 3 or 4 toxicities. There were no grade 5 toxicities. Late grade 3 toxicity developed in six patients and no grade 4 or 5 toxicities were observed.	[Iizuka, Yusuke; Yoshimura, Michio; Inokuchi, Haruo; Matsuo, Yukinori; Nakamura, Akira; Mizowaki, Takashi; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Hirano, Shigeru; Kitamura, Morimasa; Tateya, Ichiro] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan	Yoshimura, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan.	myossy@kuhp.kyoto-u.ac.jp	Matsuo, Yukinori/O-6200-2014	Matsuo, Yukinori/0000-0002-4372-8259			Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Lee JH, 2013, CANCER RES TREAT, V45, P31, DOI 10.4143/crt.2013.45.1.31; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Cannon DM, 2008, INT J RADIAT ONCOL, V70, P660, DOI 10.1016/j.ijrobp.2007.09.018; Chen AM, 2011, INT J RADIAT ONCOL, V80, P1423, DOI 10.1016/j.ijrobp.2010.04.011; Denaro N, 2011, ONCOLOGY-BASEL, V81, P21, DOI 10.1159/000330818; Hinerman RW, 2006, AM J CLIN ONCOL-CANC, V29, P613, DOI 10.1097/01.coc.0000242319.09994.78; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bussels B, 2004, RADIOTHER ONCOL, V72, P119, DOI 10.1016/j.radone.2004.03.014; Chu PY, 2004, J LARYNGOL OTOL, V118, P443; Duprez F, 2011, INT J RADIAT ONCOL, V79, P450, DOI 10.1016/j.ijrobp.2009.10.028; Garden AS, 2008, INT J RADIAT ONCOL, V71, P1351, DOI 10.1016/j.ijrobp.2008.04.006; Goto Y, 2013, JPN J CLIN ONCOL, V43, P719, DOI 10.1093/jjco/hyt066; Langendijk JA, 2010, ORAL ONCOL, V46, P577, DOI 10.1016/j.oraloncology.2010.03.023; R Development Core Team, 2012, R LANG ENV STAT COMP	16	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JAN	2015	135	1					96	102		10.3109/00016489.2014.949848		7	Otorhinolaryngology	Otorhinolaryngology	AW4UK	WOS:000346275600014		
J	Hoshikawa, H; Kishino, T; Mori, T; Indo, K; Inamoto, R; Akiyama, K; Miyashita, T; Mori, N				Hoshikawa, Hiroshi; Kishino, Takehito; Mori, Terushige; Indo, Kanako; Inamoto, Ryuhei; Akiyama, Kosuke; Miyashita, Takenori; Mori, Nozomu			Clinical outcomes of nedaplatin and S-1 treatment with concurrent radiotherapy in advanced head and neck cancer	ACTA OTO-LARYNGOLOGICA			English	Article						CDGP; S-1; chemoradiation; survival	2 BIOCHEMICAL MODULATORS; SQUAMOUS-CELL HEAD; PHASE-II; PLATINUM COMPOUND; CHEMOTHERAPY; 254-S; 5-FLUOROURACIL; CARCINOMA; TOXICITY; EFFICACY	Conclusion: Nedaplatin and S-1 treatment with concurrent radiotherapy was effective, with acceptable toxicities. This regimen does not require extensive intravenous hydration and continuous infusion. Nedaplatin and S-1 may contribute to better clinical outcomes and improve quality of life for patients. Objectives: We retrospectively analyzed the clinical efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell cancer. Methods: Forty-six patients with oropharyngeal, hypopharyngeal, and laryngeal cancer were treated with S-1 on days 1 through 14 and nedaplatin on day 1 every 4 weeks for two cycles of radiotherapy. Therapeutic responses and adverse events were assessed. Results: Primary site tumors and neck lymph nodes exhibited complete response rates of 91% and 64.3%, respectively. The 4-year relapse-free survival and overall survival rates were 76.2% and 85.3%, respectively. The main grade 3 and 4 toxicities were mucositis (30%), leukopenia (30%), anorexia (22%), dermatitis (15%), and thrombocytopenia (9%).	[Hoshikawa, Hiroshi; Kishino, Takehito; Mori, Terushige; Indo, Kanako; Inamoto, Ryuhei; Akiyama, Kosuke; Miyashita, Takenori; Mori, Nozomu] Kagawa Univ, Fac Med, Dept Otolaryngol, Kagawa 7610793, Japan	Hoshikawa, H (reprint author), Kagawa Univ, Fac Med, Dept Otolaryngol, 1750-1 Ikenobe, Kagawa 7610793, Japan.	hiro@med.kagawa-u.ac.jp					Adelstein DJ, 1997, HEAD NECK-J SCI SPEC, V19, P567, DOI 10.1002/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5; AKAZA H, 1992, CANCER CHEMOTH PHARM, V31, P187, DOI 10.1007/BF00685546; Ang KK, 2005, J CLIN ONCOL, V23, P3008, DOI 10.1200/JCO.2005.12.060; Ohashi T, 2011, JPN J CLIN ONCOL, V41, P348, DOI 10.1093/jjco/hyq196; Browman GP, 2001, HEAD NECK-J SCI SPEC, V23, P579, DOI 10.1002/hed.1081; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Kodaira T, 2006, ANTICANCER RES, V26, P2265; FUKUDA M, 1990, CANCER CHEMOTH PHARM, V26, P393, DOI 10.1007/BF02994087; Wendt TG, 1998, J CLIN ONCOL, V16, P1318; Bourhis J, 2007, CURR OPIN ONCOL, V19, P188, DOI 10.1097/CCO.0b013e3280f01010; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fukushima M, 1998, ANTI-CANCER DRUG, V9, P817, DOI 10.1097/00001813-199810000-00012; Inuyama Y, 1992, Gan To Kagaku Ryoho, V19, P871; KAMEYAMA Y, 1990, TOXICOL LETT, V52, P15, DOI 10.1016/0378-4274(90)90161-E; KANZAWA F, 1988, ANTICANCER RES, V8, P323; Kato H, 2003, ANTICANCER RES, V23, P3493; KOENUMA M, 1995, ANTICANCER RES, V15, P417; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Takemura Hideki, 2005, Gan To Kagaku Ryoho, V32, P2065; Uchida N, 1998, EUR J CANCER, V34, P1796, DOI 10.1016/S0959-8049(98)00194-4	20	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	JAN	2015	135	1					103	108		10.3109/00016489.2014.952046		6	Otorhinolaryngology	Otorhinolaryngology	AW4UK	WOS:000346275600015		
J	Shimohira, M; Hashizume, T; Ohta, K; Suzuki, K; Kurosaka, K; Muto, M; Shibamoto, Y				Shimohira, Masashi; Hashizume, Takuya; Ohta, Kengo; Suzuki, Kazushi; Kurosaka, Kenichiro; Muto, Masahiro; Shibamoto, Yuta			Triaxial coil embolization using Guglielmi detachable coils with the voltage-dependent coil-detaching technique	ACTA RADIOLOGICA			English	Article						Triple co-axial; coil; embolization	TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; LOWER GASTROINTESTINAL HEMORRHAGE; HEPATOCELLULAR-CARCINOMA; MICROCOIL EMBOLIZATION; MICROCATHETER; SYSTEM; TIP	Background: A triple co-axial (triaxial) system, consisting of a 1.9-Fr non-tapered microcatheter with one marker, a 2.7-Fr microcatheter, and a 4-Fr catheter, has been recently developed, and can be used in coil embolizations using 0.010-inch Guglielmi detachable coils (GDCs) with a voltage-dependent coil-detaching technique. Purpose: To describe this new technique and evaluate its technical feasibility and clinical efficacy. Material and Methods: Twenty patients underwent this procedure. Diseases were gastrointestinal bleeding in five patients, traumatic bleeding in three patients, and other diseases in 12 patients. The technical success rate, clinical success rate, and complications of this procedure were evaluated. Technical success was defined as the successful delivery and detachment of a GDC, and clinical success was defined as the immediate postembolic complete cessation of blood flow confirmed by digital subtraction angiography. Results: A total of 140 GDCs were used and 20 arteries were embolized. The technical success rate was 94% (131/140) and clinical success rate was 95% (19/20). No major complications were reported. Conclusion: The triaxial system in coil embolization using a GDC by monitoring the voltage for coil-detaching appeared to be safe and effective.	[Shimohira, Masashi; Hashizume, Takuya; Ohta, Kengo; Suzuki, Kazushi; Kurosaka, Kenichiro; Muto, Masahiro; Shibamoto, Yuta] Nagoya City Univ, Dept Radiol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan	Shimohira, M (reprint author), Nagoya City Univ, Dept Radiol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan.	mshimohira@gmail.com					Yamamoto S, 2008, CARDIOVASC INTER RAD, V31, P527, DOI 10.1007/s00270-007-9237-9; Yamakado K, 2010, CARDIOVASC INTER RAD, V33, P410, DOI 10.1007/s00270-009-9564-0; Kuo WT, 2003, J VASC INTERV RADIOL, V14, P1503, DOI 10.1097/01.RV1.0000099780.23569.E6; Miyayama S, 2007, J VASC INTERV RADIOL, V18, P365, DOI 10.1016/j.jvir.2006.12.004; Shimohira M, 2011, BRIT J RADIOL, V84, P184, DOI 10.1259/bjr/26974088; Bandi R, 2001, J VASC INTERV RADIOL, V12, P1399, DOI 10.1016/S1051-0443(07)61697-2; Padia SA, 2009, J VASC INTERV RADIOL, V20, P461, DOI 10.1016/j.jvir.2009.01.006; Hayashi S, 2012, J VASC INTERV RADIOL, V23, P1566, DOI 10.1016/j.jvir.2012.09.008; Koganemaru M, 2012, AM J ROENTGENOL, V198, P370; Miyayama S, 2011, JPN J RADIOL, V29, P286, DOI 10.1007/s11604-010-0540-z; OKAZAKI M, 1992, ACTA RADIOL, V33, P57; Shimohira M, 2012, ACTA RADIOL, V53, P857, DOI 10.1258/ar.2012.120044; Sommer CM, 2010, CARDIOVASC INTER RAD, V33, P498, DOI 10.1007/s00270-009-9787-0	13	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	JAN	2015	56	1					51	55		10.1177/0284185113518771		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW8PJ	WOS:000346524000012		
J	Sakamoto, R; Okada, T; Kanagaki, M; Yamamoto, A; Fushimi, Y; Kakigi, T; Arakawa, Y; Takahashi, JC; Mikami, Y; Togashi, K				Sakamoto, Ryo; Okada, Tomohisa; Kanagaki, Mitsunori; Yamamoto, Akira; Fushimi, Yasutaka; Kakigi, Takahide; Arakawa, Yoshiki; Takahashi, Jun C.; Mikami, Yoshiki; Togashi, Kaori			Estimation of proliferative potentiality of central neurocytoma: correlational analysis of minimum ADC and maximum SUV with MIB-I labeling index	ACTA RADIOLOGICA			English	Article						Central neurocytoma; central nervous system (CNS); brain; MR diffusion; positron emission tomography (PET)	APPARENT DIFFUSION-COEFFICIENT; GRADE; TUMOR; DISSEMINATION; ASTROCYTOMAS; PREDICTION; PROGNOSIS; FEATURES	Background: Central neurocytoma was initially believed to be benign tumor type, although atypical cases with more aggressive behavior have been reported. Preoperative estimation for proliferating activity of central neurocytoma is one of the most important considerations for determining tumor management. Purpose: To investigate predictive values of image characteristics and quantitative measurements of minimum apparent diffusion coefficient (ADCmin) and maximum standardized uptake value (SUVmax) for proliferative activity of central neurocytoma measured by MIB-I labeling index (LI). Material and Methods: Twelve cases of central neurocytoma including one recurrence from January 2001 to December 2011 were included. Preoperative scans were conducted in 11, nine, and five patients for computed tomography (CT), diffusion-weighted imaging (DWI), and fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET), respectively, and ADCmin and SUVmax of the tumors were measured. Image characteristics were investigated using CT, T2-weighted (T2W) imaging and contrast-enhanced TI-weighted (TIW) imaging, and their differences were examined using the Fisher's exact test between cases with MIB-I LI below and above 2%, which is recognized as typical and atypical central neurocytoma, respectively. Correlational analysis was conducted for ADCmin and SUVmax with MIB-I LI. A P value <0.05 was considered significant. Results: Morphological appearances had large variety, and there was no significant correlation with MIB-I LI except a tendency that strong enhancement was observed in central neurocytomas with higher MIB-I LI (P = 0.061). High linearity with MIB-I LI was observed in ADCmin and SUVmax (r = -0.91 and 0.74, respectively), but only ADCmin was statistically significant (P = 0.0006). Conclusion: Central neurocytoma had a wide variety of image appearance, and assessment of proliferative potential was considered difficult only by morphological aspects. ADCmin was recognized as a potential marker for differentiation of atypical central neurocytomas from the typical ones.	[Sakamoto, Ryo; Okada, Tomohisa; Kanagaki, Mitsunori; Yamamoto, Akira; Fushimi, Yasutaka; Kakigi, Takahide; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto 6068507, Japan; [Arakawa, Yoshiki; Takahashi, Jun C.] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Mikami, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Clin Pathol, Kyoto 6068507, Japan	Okada, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	tomokada@kuhp.kyoto-u.ac.jp					Rades D, 2004, CANCER, V100, P814, DOI 10.1002/cncr.20032; Soylemezoglu F, 1997, J NEUROPATH EXP NEUR, V56, P551; Brat DJ, 2001, AM J SURG PATHOL, V25, P1252, DOI 10.1097/00000478-200110000-00005; Padma MV, 2003, J NEURO-ONCOL, V64, P227, DOI 10.1023/A:1025665820001; Chen HH, 2012, J CLIN NEUROSCI, V19, P849, DOI 10.1016/j.jocn.2011.06.038; Bulakbasi N, 2004, J COMPUT ASSIST TOMO, V28, P735, DOI 10.1097/00004728-200411000-00003; Vasiljevic A, 2012, AM J SURG PATHOL, V36, P220, DOI 10.1097/PAS.0b013e31823b8232; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Yamasaki F, 2010, EUR J RADIOL, V73, P532, DOI 10.1016/j.ejrad.2009.01.013; Mackenzie IRA, 1999, CANCER, V85, P1606, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1606::AID-CNCR24>3.0.CO;2-B; Lee EJ, 2008, AM J NEURORADIOL, V29, P1872, DOI 10.3174/ajnr.A1254; HASSOUN J, 1993, BRAIN PATHOL, V3, P297, DOI 10.1111/j.1750-3639.1993.tb00756.x; Higano S, 2006, RADIOLOGY, V241, P839, DOI 10.1148/radiol.2413051276; Kono K, 2001, AM J NEURORADIOL, V22, P1081; HASSOUN J, 1982, ACTA NEUROPATHOL, V56, P151; Bertalanffy A, 2005, CANCER-AM CANCER SOC, V104, P135, DOI 10.1002/cncr.21109; Ashkan K, 2000, CANCER-AM CANCER SOC, V89, P1111; Kocaoglu M, 2009, MAGN RESON IMAGING, V27, P434, DOI 10.1016/j.mri.2008.07.012; Kruer MC, 2009, J NEURO-ONCOL, V95, P239, DOI 10.1007/s11060-009-9922-4; Kuchiki Hideo, 2002, Brain Tumor Pathol, V19, P105, DOI 10.1007/BF02478936; MINEURA K, 1995, CANCER, V76, P1224, DOI 10.1002/1097-0142(19951001)76:7<1224::AID-CNCR2820760720>3.0.CO;2-R; Ogawa Y, 2006, J NEURO-ONCOL, V79, P211, DOI 10.1007/s11060-006-9129-x; Ohtani T, 2001, ANN NUCL MED, V15, P161, DOI 10.1007/BF02988610; Takao H, 2003, J NEURO-ONCOL, V61, P255, DOI 10.1023/A:1022553110232; Warmuth-Metz M, 1999, J NEUROSURG, V91, P506, DOI 10.3171/jns.1999.91.3.0506; Wharton SB, 1998, CLIN NEUROPATHOL, V17, P136; Zhang B, 2004, NEURORADIOLOGY, V46, P888, DOI 10.1007/s00234-004-1289-9; Zulfiqar M, 2013, AM J ROENTGENOL, V200, P624, DOI 10.2214/AJR.12.8679	28	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	JAN	2015	56	1					114	120		10.1177/0284185114521187		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AW8PJ	WOS:000346524000020		
J	Kagoya, R; Kondo, K; Baba, S; Toma-Hirano, M; Nishijima, H; Suzukawa, K; Kikuta, S; Yamasoba, T				Kagoya, Ryoji; Kondo, Kenji; Baba, Shintaro; Toma-Hirano, Makiko; Nishijima, Hironobu; Suzukawa, Keigo; Kikuta, Shu; Yamasoba, Tatsuya			Correlation of basophil infiltration in nasal polyps with the severity of chronic rhinosinusitis	ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY			English	Article							EOSINOPHILIC CHRONIC RHINOSINUSITIS; POSITION PAPER; AIRWAY; INFLAMMATION; EXPRESSION; ASTHMA; RESPONSES; CELLS		[Kagoya, Ryoji; Kondo, Kenji; Toma-Hirano, Makiko; Nishijima, Hironobu; Kikuta, Shu; Yamasoba, Tatsuya] Univ Tokyo, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Tokyo 1130033, Japan; [Baba, Shintaro] Japanese Red Cross Med Ctr, Dept Otolaryngol, Tokyo, Japan; [Suzukawa, Keigo] Tokyo Metropolitan Bokuto Gen Hosp, Dept Otolaryngol, Tokyo, Japan	Kagoya, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kagoya-tky@umin.ac.jp					Suzukawa M, 2008, J IMMUNOL, V181, P5981; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Fokkens W, 2007, RHINOLOGY, V45, P97; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Reh DD, 2010, AM J RHINOL ALLERGY, V24, P105, DOI 10.2500/ajra.2010.24.3446; Peric A, 2010, ACTA CLIN CROAT, V49, P395; Wilson DR, 2001, CLIN EXP ALLERGY, V31, P1705, DOI 10.1046/j.1365-2222.2001.01231.x; Fiset PO, 2005, J ALLERGY CLIN IMMUN, V116, P233, DOI 10.1016/j.jaci.2005.03.019; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Hao J, 2006, OTOLARYNG HEAD NECK, V134, P267, DOI 10.1016/j.otolins.2005.09.026; Ishitoya Junichi, 2010, Allergol Int, V59, P239, DOI 10.2332/allergolint.10-RAI-0231; Kang JY, 2013, CLIN INTERV AGING, V8, P1393, DOI 10.2147/CIA.S50496; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Meltzer EO, 2006, J ALLERGY CLIN IMMUN, V118, pS17, DOI 10.1016/j.jaci.2006.09.005; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS155; Nouri-Aria KT, 2001, J ALLERGY CLIN IMMUN, V108, P205, DOI 10.1067/mai.2001.117175; Ono E, 2010, J ALLERGY CLIN IMMUN, V125, P483, DOI 10.1016/j.jaci.2009.10.074; Pawankar Ruby, 2007, Clin Allergy Immunol, V20, P93; Poposki JA, 2011, J ALLERGY CLIN IMMUN, V128, P73, DOI 10.1016/j.jaci.2011.03.017; STOOP AE, 1991, J ALLERGY CLIN IMMUN, V87, P470, DOI 10.1016/0091-6749(91)90004-8; van Beek AA, 2013, INT ARCH ALLERGY IMM, V160, P7, DOI 10.1159/000341633; Yagi T, 1997, J ALLERGY CLIN IMMUN, V99, P38, DOI 10.1016/S0091-6749(97)81042-1	24	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1081-1206	1534-4436		ANN ALLERG ASTHMA IM	Ann. Allergy Asthma Immunol.	JAN	2015	114	1					30	35		10.1016/j.anai.2014.09.017		6	Allergy; Immunology	Allergy; Immunology	AW9PD	WOS:000346588600007		
J	Sumitani, S; Morita, S; Deguchi, R; Hirai, K; Mukai, K; Utsu, Y; Miki, S; Sato, B; Nakamura, H; Kasayama, S; Koga, M				Sumitani, Satoru; Morita, Shinya; Deguchi, Reiko; Hirai, Koichi; Mukai, Kosuke; Utsu, Yoshihiko; Miki, Shunji; Sato, Bunzo; Nakamura, Hideji; Kasayama, Soji; Koga, Masafumi			Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						Glycated haemoglobin; glycated albumin; metformin; type 2 diabetes; postprandial hyperglycaemia	GLUCOSE EXCURSION; GLYCEMIC CONTROL; INSULIN; MELLITUS; IMPACT; HBA1C	Background To know whether metformin improves postprandial hyperglycaemia, we examined the effect of metformin on the glycated albumin (GA) to glycated haemoglobin (HbA(1c)) ratio (GA/HbA(1c) ratio) in patients with newly diagnosed type 2 diabetes. Methods Metformin and lifestyle interventions were initiated in 18 patients with newly diagnosed type 2 diabetes. Metformin was titrated to 1500mg/day or maximum-tolerated dose. HbA(1c) and GA were measured every four weeks up to 24 weeks. Results HbA(1c) decreased significantly from 9.02.1% at baseline to 6.5 +/- 0.9% at week 24, and GA decreased significantly from 24.3 +/- 8.2% to 16.2 +/- 3.1%. The GA/HbA(1c) ratio decreased significantly from 2.66 +/- 0.37 at baseline to 2.47 +/- 0.29 at week 24 (P<0.01), despite that the GA/HbA(1c) ratio reached a plateau value at week 16. The change in the GA/HbA(1c) ratio during 24 weeks (GA/HbA(1c) ratio) was significantly correlated with both baseline HbA(1c) and GA. Moreover, the GA/HbA(1c) ratio was significantly correlated with the change in GA during 24 weeks but not with the change in HbA(1c). Conclusions Metformin decreased the GA/HbA(1c) ratio in patients with newly diagnosed type 2 diabetes. This suggests that metformin improves postprandial hyperglycaemia in patients with newly diagnosed type 2 diabetes.	[Sumitani, Satoru; Nakamura, Hideji] Nissay Hosp, Ctr Prevent Med, Osaka 5500012, Japan; [Sumitani, Satoru; Morita, Shinya; Deguchi, Reiko; Hirai, Koichi; Mukai, Kosuke; Utsu, Yoshihiko; Miki, Shunji; Sato, Bunzo; Kasayama, Soji] Nissay Hosp, Dept Med, Osaka 5500012, Japan; [Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Japan	Sumitani, S (reprint author), Nissay Hosp, Ctr Prevent Med, Nishi Ku, 6-3-8 Itachibori, Osaka 5500012, Japan.	sa_sumitani@yahoo.co.jp					Koga M, 2010, ENDOCR J, V57, P751; Koga M, 2010, ANN CLIN BIOCHEM, V47, P313, DOI 10.1258/acb.2010.009234; Takahashi S, 2007, ENDOCR J, V54, P139, DOI 10.1507/endocrj.K06-103; Koga M, 2011, DIABETES RES CLIN PR, V94, pE12, DOI 10.1016/j.diabres.2011.06.022; Kouzuma T, 2004, CLIN CHIM ACTA, V346, P135, DOI 10.1016/j.cccn.2004.02.019; Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020; Suwa T, 2010, ENDOCR J, V57, P135; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; WU MS, 1990, DIABETES CARE, V13, P1, DOI 10.2337/diacare.13.1.1; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089; Lund SS, 2008, EUR J ENDOCRINOL, V158, P35, DOI 10.1530/EJE-07-0500; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Koga M, 2010, DIABETES CARE, V33, P270, DOI 10.2337/dc09-1002; Beisswenger P., 2003, DIABETES METAB, V29; Cervera A, 2008, AM J PHYSIOL-ENDOC M, V294, pE846, DOI 10.1152/ajpendo.00030.2008; Chon S, 2013, DIABETES TECHNOL THE, V15, P455, DOI 10.1089/dia.2012.0315; Kim D, 2011, CLIN ENDOCRINOL OXF, V77, P679; Koga M, 2010, ANN CLIN BIOCHEM, V47, P39, DOI 10.1258/acb.2009.009127; Matsuhisa M, 2010, J NEW REM CLIN, V60, P1960; RAPIN JR, 1991, DIABETES METAB, V17, P164; Saisho Y., 2011, DIABETOL INT, V2, P146; Sakuma N, 2011, DIABETOL INT, V2, P162; Sumitani Satoru, 2012, J Med Invest, V59, P166; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P854; World Health Organization. Definition, 1999, DEF DIAGN CLASS DI 1; Wulffele MG, 2002, DIABETES CARE, V25, P2133, DOI 10.2337/diacare.25.12.2133; Zafon C, 2013, PLOS ONE, V8	28	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	JAN	2015	52	1					76	81		10.1177/0004563214522984		6	Medical Laboratory Technology	Medical Laboratory Technology	AW7BB	WOS:000346418300009		
J	Ueyama, J; Ishikawa, Y; Kondo, T; Motoyama, M; Matsumoto, H; Matsushita, T				Ueyama, Jun; Ishikawa, Yusuke; Kondo, Takaaki; Motoyama, Megumi; Matsumoto, Hiroyuki; Matsushita, Tadashi			A revised method for determination of serum mercaptalbumin and non-mercaptalbumin by high-performance liquid chromatography coupled with postcolumn bromocresol green reaction	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article						Mercaptalbumin; non-mercaptalbumin; high-performance liquid chromatography	ALBUMIN DETERMINATION; BROMCRESOL PURPLE	Background Previously, high-performance liquid chromatography (HPLC) equipped with ultraviolet or fluorescence detectors has been used for separation of human mercaptalbumin (HMA) and human non-mercaptalbumin (HNA). However, it is difficult to perform reliable chromatographic analysis due to peak interference of such serum compounds as uric acid and bilirubin. The aim of this study is to explore a selective and simple analytical method for the determination of HMA and HNA. Method HMA and HNA in serum sample were separated by HPLC and reacted with bromocresol green using a postcolumn reaction scheme. Results A complete separation of HMA and HNA is achieved in less than 30min by using weak anion exchange columns and isocratic elution. Within-run and between-day precisions at albumin concentration of 45g/L were 4.2 and 1.7% for HMA and 4.5 and 4.6% for HNA, respectively. There was no interference in HMA and HNA peaks when bilirubin-, haemoglobin- or chyle-spiked pooled serum samples were analysed. Conclusion Our method is reliable and not labour-intensive and, therefore, might be applicable for clinical and epidemiological studies.	[Ueyama, Jun; Kondo, Takaaki; Motoyama, Megumi] Nagoya Univ, Dept Pathophysiol Lab Sci, Field Radiol & Med Lab Sci, Grad Sch Med, Nagoya, Aichi 4618673, Japan; [Ishikawa, Yusuke; Matsumoto, Hiroyuki] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan	Ueyama, J (reprint author), Nagoya Univ, Dept Pathophysiol Lab Sci, Field Radiol & Med Lab Sci,Grad Sch Med, Higashi Ku, 1-1-20 Daikominami, Nagoya, Aichi 4618673, Japan.	ueyama@met.nagoya-u.ac.jp			Japan Society for the Promotion of Science [23689034]; JSPS KAKENHI [23689034]	This work was supported in part by Grants-in-Aid for Scientific Research (23689034) from the Japan Society for the Promotion of Science and by JSPS KAKENHI (Grant Number 23689034).	WEBSTER D, 1974, CLIN CHIM ACTA, V53, P109, DOI 10.1016/0009-8981(74)90358-1; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Muramoto Y, 1999, CLIN CHIM ACTA, V289, P69, DOI 10.1016/S0009-8981(99)00158-8; PINNELL AE, 1978, CLIN CHEM, V24, P80; Ono M, 2009, CLIN CHIM ACTA, V407, P75, DOI 10.1016/j.cca.2009.06.038; Committee on Enzymes Biochemical Constituents and Their Analytical Reagents, 2013, JPN J CLIN CHEM, V42, P68; GUSTAFSSON JEC, 1976, CLIN CHEM, V22, P616; Hayashi T, 2000, PATHOPHYSIOLOGY, V66, P237, DOI DOI 10.1016/S0928-4680(99)00022-X; Ishikawa T, 2009, HEPATO-GASTROENTEROL, V56, P1491; Kawai K, 2001, Tokai J Exp Clin Med, V26, P93; SOGAMI M, 1985, J CHROMATOGR, V332, P19, DOI 10.1016/S0021-9673(01)83283-0; SPEICHER CE, 1978, AM J CLIN PATHOL, V69, P347; Terawaki H, 2007, BLOOD PURIFICAT, V25, P274, DOI 10.1159/000101986	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	JAN	2015	52	1					144	150		10.1177/0004563214531930		7	Medical Laboratory Technology	Medical Laboratory Technology	AW7BB	WOS:000346418300018		
